Citrus Sinensis ID: 021526
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 311 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.826 | 0.563 | 0.712 | 1e-110 | |
| Q9SFT7 | 414 | Serine/threonine-protein | no | no | 0.829 | 0.623 | 0.689 | 1e-104 | |
| Q9LQQ8 | 423 | Probable serine/threonine | no | no | 0.884 | 0.650 | 0.644 | 1e-104 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.810 | 0.591 | 0.568 | 3e-81 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.816 | 0.596 | 0.548 | 1e-79 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.816 | 0.515 | 0.556 | 3e-79 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.819 | 0.621 | 0.562 | 8e-79 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.842 | 0.673 | 0.528 | 3e-78 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.816 | 0.518 | 0.544 | 7e-78 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.887 | 0.669 | 0.480 | 3e-74 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 399 bits (1026), Expect = e-110, Method: Compositional matrix adjust.
Identities = 183/257 (71%), Positives = 215/257 (83%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
Q+VA+KQL+ GLQG++EF+VEVLMLSLLHH NLV LIGYC GDQRLLVYE+MP+GSLE
Sbjct: 110 QVVAVKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLE 169
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 140
DHL+DL PD+E L WN RMKIA GAA+GLE+LH KANPPVIYRD KS+NILLD F+PKL
Sbjct: 170 DHLHDLPPDKEALDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKL 229
Query: 141 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 200
SDFGLAKLGP GD +HVSTRVMGTYGYCAPEYAM+G+LT+KSD+YSFGVV LELITGRKA
Sbjct: 230 SDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKA 289
Query: 201 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANF 260
+D GEQNLV+W+RP D++KF+ L DP L GR+P R L A+AV +MC+ E+A
Sbjct: 290 IDSEMPHGEQNLVAWARPLFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAAT 349
Query: 261 RPLINDIVVALDYLVSQ 277
RPLI D+V AL YL +Q
Sbjct: 350 RPLIADVVTALSYLANQ 366
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 379 bits (974), Expect = e-104, Method: Compositional matrix adjust.
Identities = 178/258 (68%), Positives = 211/258 (81%)
Query: 22 LVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
+VA+KQL+ GLQG++EFIVEVLMLSLLHH +LV LIGYC GDQRLLVYEYM GSLED
Sbjct: 104 IVAVKQLDRNGLQGNKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLED 163
Query: 82 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 141
HL DL PDQ PL W+TR++IA+GAA GLEYLH KANPPVIYRDLK+ANILLD +FN KLS
Sbjct: 164 HLLDLTPDQIPLDWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLS 223
Query: 142 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 201
DFGLAKLGPVGD HVS+RVMGTYGYCAPEY +G+LT KSD+YSFGVVLLELITGR+ +
Sbjct: 224 DFGLAKLGPVGDKQHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVI 283
Query: 202 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFR 261
D ++ + EQNLV+W++P K+ +F L DP L G +P + LN AVAV AMCL EEA R
Sbjct: 284 DTTRPKDEQNLVTWAQPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVR 343
Query: 262 PLINDIVVALDYLVSQRD 279
PL++D+V AL +L + D
Sbjct: 344 PLMSDVVTALGFLGTAPD 361
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LQQ8|RLCK7_ARATH Probable serine/threonine-protein kinase RLCKVII OS=Arabidopsis thaliana GN=At1g07870 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 378 bits (971), Expect = e-104, Method: Compositional matrix adjust.
Identities = 178/276 (64%), Positives = 220/276 (79%), Gaps = 1/276 (0%)
Query: 14 GLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 73
G + DQ+VAIKQL+ G+QG +EF+VEVL LSL H NLV LIG+C GDQRLLVYEY
Sbjct: 120 GTIEKLDQVVAIKQLDRNGVQGIREFVVEVLTLSLADHPNLVKLIGFCAEGDQRLLVYEY 179
Query: 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD 133
MP GSLEDHL+ L ++PL WNTRMKIA GAARGLEYLH + PPVIYRDLK +NILL
Sbjct: 180 MPQGSLEDHLHVLPSGKKPLDWNTRMKIAAGAARGLEYLHDRMTPPVIYRDLKCSNILLG 239
Query: 134 NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLE 193
D+ PKLSDFGLAK+GP GD THVSTRVMGTYGYCAP+YAM+G+LT KSDIYSFGVVLLE
Sbjct: 240 EDYQPKLSDFGLAKVGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLE 299
Query: 194 LITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMC 253
LITGRKA+D +K + +QNLV W+RP KD++ F +VDPLL G+YP R L A+A++AMC
Sbjct: 300 LITGRKAIDNTKTRKDQNLVGWARPLFKDRRNFPKMVDPLLQGQYPVRGLYQALAISAMC 359
Query: 254 LNEEANFRPLINDIVVALDYLVSQR-DSHPVSRNAG 288
+ E+ RP+++D+V+AL++L S + D + S ++G
Sbjct: 360 VQEQPTMRPVVSDVVLALNFLASSKYDPNSPSSSSG 395
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 302 bits (773), Expect = 3e-81, Method: Compositional matrix adjust.
Identities = 145/255 (56%), Positives = 188/255 (73%), Gaps = 3/255 (1%)
Query: 22 LVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
+VA+KQL EG QGH+E++ EV L L H NLV L+GYC G+ RLLVYE+MP GSLE+
Sbjct: 120 VVAVKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLEN 179
Query: 82 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 141
HL+ +PL+W RMK+AVGAA+GL +LH +A VIYRD K+ANILLD DFN KLS
Sbjct: 180 HLF--RRGAQPLTWAIRMKVAVGAAKGLTFLH-EAKSQVIYRDFKAANILLDADFNAKLS 236
Query: 142 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 201
DFGLAK GP GDNTHVST+V+GT+GY APEY +G+LT KSD+YSFGVVLLELI+GR+AM
Sbjct: 237 DFGLAKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAM 296
Query: 202 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFR 261
D S G E +LV W+ P+L D++K ++D L G+YP++ A + CLN +A R
Sbjct: 297 DNSNGGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLR 356
Query: 262 PLINDIVVALDYLVS 276
P +++++V L+ L S
Sbjct: 357 PKMSEVLVTLEQLES 371
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 296 bits (758), Expect = 1e-79, Method: Compositional matrix adjust.
Identities = 141/257 (54%), Positives = 188/257 (73%), Gaps = 3/257 (1%)
Query: 22 LVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
+VA+K+L EG QGH+E++ EV L L H NLV L+GYC G+ RLLVYE+MP GSLE+
Sbjct: 117 VVAVKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLEN 176
Query: 82 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 141
HL+ +PL+W RMK+A+GAA+GL +LH A VIYRD K+ANILLD +FN KLS
Sbjct: 177 HLF--RRGAQPLTWAIRMKVAIGAAKGLTFLH-DAKSQVIYRDFKAANILLDAEFNSKLS 233
Query: 142 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 201
DFGLAK GP GD THVST+VMGT+GY APEY +G+LT KSD+YSFGVVLLEL++GR+A+
Sbjct: 234 DFGLAKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAV 293
Query: 202 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFR 261
D SK EQ+LV W+ P+L D++K ++D L G+YP++ A ++ CLN +A R
Sbjct: 294 DKSKVGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLR 353
Query: 262 PLINDIVVALDYLVSQR 278
P +++++ LD L S +
Sbjct: 354 PKMSEVLAKLDQLESTK 370
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 295 bits (755), Expect = 3e-79, Method: Compositional matrix adjust.
Identities = 143/257 (55%), Positives = 183/257 (71%), Gaps = 3/257 (1%)
Query: 23 VAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDH 82
VA+K LN +GLQGH+E++ E+ L L H NLV L+GYC DQRLLVYE+MP GSLE+H
Sbjct: 177 VAVKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENH 236
Query: 83 LYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 142
L+ PL W+ RMKIA+GAA+GL +LH +A PVIYRD K++NILLD D+N KLSD
Sbjct: 237 LFR---RSLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSD 293
Query: 143 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 202
FGLAK P THVSTRVMGTYGY APEY M+G LT KSD+YSFGVVLLE++TGR++MD
Sbjct: 294 FGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD 353
Query: 203 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 262
++ GE NLV W+RP L D+++F L+DP L G + + + A CL+ + RP
Sbjct: 354 KNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRP 413
Query: 263 LINDIVVALDYLVSQRD 279
++D+V AL L +D
Sbjct: 414 KMSDVVEALKPLPHLKD 430
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 293 bits (751), Expect = 8e-79, Method: Compositional matrix adjust.
Identities = 145/258 (56%), Positives = 185/258 (71%), Gaps = 3/258 (1%)
Query: 23 VAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDH 82
VA+K LN EGLQGH+E++ EV L L H NLV LIGYC D RLLVYE+M GSLE+H
Sbjct: 101 VAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENH 160
Query: 83 LYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 142
L+ PLSW+ RM IA+GAA+GL +LH A PVIYRD K++NILLD+D+ KLSD
Sbjct: 161 LF--RKTTAPLSWSRRMMIALGAAKGLAFLH-NAERPVIYRDFKTSNILLDSDYTAKLSD 217
Query: 143 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 202
FGLAK GP GD THVSTRVMGTYGY APEY M+G LT +SD+YSFGVVLLE++TGRK++D
Sbjct: 218 FGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVD 277
Query: 203 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 262
++ EQNLV W+RP L D++K + ++DP L +Y R A ++ CL++ RP
Sbjct: 278 KTRPSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP 337
Query: 263 LINDIVVALDYLVSQRDS 280
L++D+V L+ L D+
Sbjct: 338 LMSDVVETLEPLQCTGDA 355
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 291 bits (746), Expect = 3e-78, Method: Compositional matrix adjust.
Identities = 141/267 (52%), Positives = 200/267 (74%), Gaps = 5/267 (1%)
Query: 22 LVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
++A+K+LN EG QGH+E++ E+ L L H NLV LIGYC + RLLVYE+M GSLE+
Sbjct: 102 VIAVKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLEN 161
Query: 82 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 141
HL+ +PLSWNTR+++A+GAARGL +LH A P VIYRD K++NILLD+++N KLS
Sbjct: 162 HLFRRGTFYQPLSWNTRVRMALGAARGLAFLH-NAQPQVIYRDFKASNILLDSNYNAKLS 220
Query: 142 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 201
DFGLA+ GP+GDN+HVSTRVMGT GY APEY +G L++KSD+YSFGVVLLEL++GR+A+
Sbjct: 221 DFGLARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAI 280
Query: 202 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP-RRCLNYAVAVTAM-CLNEEAN 259
D ++ GE NLV W+RP+L ++++ + ++DP L G+Y R L +AV A+ C++ +A
Sbjct: 281 DKNQPVGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALK--IAVLALDCISIDAK 338
Query: 260 FRPLINDIVVALDYLVSQRDSHPVSRN 286
RP +N+IV ++ L Q+++ +N
Sbjct: 339 SRPTMNEIVKTMEELHIQKEASKEQQN 365
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 290 bits (743), Expect = 7e-78, Method: Compositional matrix adjust.
Identities = 140/257 (54%), Positives = 183/257 (71%), Gaps = 3/257 (1%)
Query: 23 VAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDH 82
VA+K LN +GLQGH+E++ E+ L L H NLV L+GYC DQRLLVYE+MP GSLE+H
Sbjct: 171 VAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENH 230
Query: 83 LYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 142
L+ PL W+ RMKIA+GAA+GL +LH +A PVIYRD K++NILLD ++N KLSD
Sbjct: 231 LFR---RSLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSD 287
Query: 143 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 202
FGLAK P THVSTRVMGTYGY APEY M+G LT KSD+YSFGVVLLE++TGR++MD
Sbjct: 288 FGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD 347
Query: 203 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 262
++ GE NLV W+RP L D+++F L+DP L G + + + A CL+ ++ RP
Sbjct: 348 KNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRP 407
Query: 263 LINDIVVALDYLVSQRD 279
++++V L L +D
Sbjct: 408 KMSEVVEVLKPLPHLKD 424
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 278 bits (712), Expect = 3e-74, Method: Compositional matrix adjust.
Identities = 139/289 (48%), Positives = 191/289 (66%), Gaps = 13/289 (4%)
Query: 22 LVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
++A+K+LN +G QGHQE++ EV L H NLV LIGYC + RLLVYE+MP GSLE+
Sbjct: 103 VIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLEN 162
Query: 82 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 141
HL+ +PLSW R+K+A+GAA+GL +LH A VIYRD K++NILLD+++N KLS
Sbjct: 163 HLFRRGSYFQPLSWTLRLKVALGAAKGLAFLH-NAETSVIYRDFKTSNILLDSEYNAKLS 221
Query: 142 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 201
DFGLAK GP GD +HVSTR+MGTYGY APEY +G LT KSD+YS+GVVLLE+++GR+A+
Sbjct: 222 DFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAV 281
Query: 202 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFR 261
D ++ GEQ LV W+RP L +++K ++D L +Y + CL E R
Sbjct: 282 DKNRPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLR 341
Query: 262 PLINDIVVALDYLVSQRDSHPVSRNAGARGVPTSASDVSQGSNSRRSSS 310
P +N++V L+++ + + AG R + D+ Q RRS S
Sbjct: 342 PNMNEVVSHLEHIQTLNE-------AGGRNI-----DMVQRRMRRRSDS 378
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 311 | ||||||
| 255539234 | 381 | receptor serine-threonine protein kinase | 0.932 | 0.761 | 0.789 | 1e-134 | |
| 224061871 | 313 | predicted protein [Populus trichocarpa] | 0.826 | 0.821 | 0.879 | 1e-133 | |
| 51971074 | 381 | unknown protein [Arabidopsis thaliana] | 0.884 | 0.721 | 0.804 | 1e-131 | |
| 145335950 | 381 | protein kinase-like protein [Arabidopsis | 0.884 | 0.721 | 0.804 | 1e-131 | |
| 297850486 | 381 | protein kinase [Arabidopsis lyrata subsp | 0.884 | 0.721 | 0.804 | 1e-130 | |
| 359491840 | 401 | PREDICTED: serine/threonine-protein kina | 0.913 | 0.708 | 0.803 | 1e-130 | |
| 297745557 | 433 | unnamed protein product [Vitis vinifera] | 0.913 | 0.655 | 0.803 | 1e-130 | |
| 224086050 | 338 | predicted protein [Populus trichocarpa] | 0.926 | 0.852 | 0.780 | 1e-129 | |
| 449485117 | 385 | PREDICTED: serine/threonine-protein kina | 0.884 | 0.714 | 0.787 | 1e-126 | |
| 449455605 | 389 | PREDICTED: serine/threonine-protein kina | 0.884 | 0.706 | 0.783 | 1e-125 |
| >gi|255539234|ref|XP_002510682.1| receptor serine-threonine protein kinase, putative [Ricinus communis] gi|223551383|gb|EEF52869.1| receptor serine-threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 483 bits (1242), Expect = e-134, Method: Compositional matrix adjust.
Identities = 229/290 (78%), Positives = 258/290 (88%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
Q+VA+KQLNH+G+QG QEFIVEVLMLSLLHH NLVTLIGYCT+GDQRLLVYEYM MGS+E
Sbjct: 87 QIVAVKQLNHDGVQGFQEFIVEVLMLSLLHHSNLVTLIGYCTAGDQRLLVYEYMQMGSVE 146
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 140
DH++DL+PD+EPL+W+TRMKIA+GAARGLEYLHCKANPPVIYRDLKSANILLD DFNPKL
Sbjct: 147 DHIFDLDPDKEPLNWSTRMKIAIGAARGLEYLHCKANPPVIYRDLKSANILLDTDFNPKL 206
Query: 141 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 200
SDFGLAKLGPVG+NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA
Sbjct: 207 SDFGLAKLGPVGENTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 266
Query: 201 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANF 260
+D SK GEQNLV+W+RPFLKDQKKF LVDPLL G YPRRCLNYA+A+TAMCL+EEANF
Sbjct: 267 IDRSKRPGEQNLVAWARPFLKDQKKFYQLVDPLLQGCYPRRCLNYAIAITAMCLHEEANF 326
Query: 261 RPLINDIVVALDYLVSQRDSHPVSRNAGARGVPTSASDVSQGSNSRRSSS 310
RPLI DIVVAL+YL SQ + + G+P S+ ++G+ S+ S
Sbjct: 327 RPLIGDIVVALEYLASQCHGSESNSSQVRSGIPQSSMATNRGAVSQEPMS 376
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224061871|ref|XP_002300640.1| predicted protein [Populus trichocarpa] gi|222842366|gb|EEE79913.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 481 bits (1239), Expect = e-133, Method: Compositional matrix adjust.
Identities = 226/257 (87%), Positives = 245/257 (95%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
++VA+KQLN +GLQGHQEFIVEVLMLSLLHH NLVTLIGYCTSGDQRLLVYEYMPMGSLE
Sbjct: 47 EIVAVKQLNQDGLQGHQEFIVEVLMLSLLHHSNLVTLIGYCTSGDQRLLVYEYMPMGSLE 106
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 140
DHL+DLEPD+EPLSW+TRMKIAVGAARGLEYLHCKA+PPVIYRDLKSANILLDNDFNPKL
Sbjct: 107 DHLFDLEPDKEPLSWSTRMKIAVGAARGLEYLHCKADPPVIYRDLKSANILLDNDFNPKL 166
Query: 141 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 200
SDFGLAKLGPVG+NTHVSTRVMGTYGYCAPEYAMSGKLT+KSDIYSFGVVLLELITGRKA
Sbjct: 167 SDFGLAKLGPVGENTHVSTRVMGTYGYCAPEYAMSGKLTVKSDIYSFGVVLLELITGRKA 226
Query: 201 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANF 260
+D SK GEQNLV+WSR FLK+QKK+ L DPLL G YPRRCLNYA+A+TAMCLNEEANF
Sbjct: 227 IDRSKKPGEQNLVAWSRAFLKEQKKYCQLADPLLEGCYPRRCLNYAIAITAMCLNEEANF 286
Query: 261 RPLINDIVVALDYLVSQ 277
RPLI+DI+VAL+YL SQ
Sbjct: 287 RPLISDILVALEYLASQ 303
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|51971074|dbj|BAD44229.1| unknown protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 473 bits (1217), Expect = e-131, Method: Compositional matrix adjust.
Identities = 226/281 (80%), Positives = 252/281 (89%), Gaps = 6/281 (2%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
Q+VAIKQLN +GLQG++EFIVEVLMLSLLHH NLVTLIGYCTSGDQRLLVYEYMPMGSLE
Sbjct: 101 QVVAIKQLNPDGLQGNREFIVEVLMLSLLHHPNLVTLIGYCTSGDQRLLVYEYMPMGSLE 160
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 140
DHL+DLE +QEPLSWNTRMKIAVGAARG+EYLHC ANPPVIYRDLKSANILLD +F+PKL
Sbjct: 161 DHLFDLESNQEPLSWNTRMKIAVGAARGIEYLHCTANPPVIYRDLKSANILLDKEFSPKL 220
Query: 141 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 200
SDFGLAKLGPVGD THVSTRVMGTYGYCAPEYAMSGKLT+KSDIY FGVVLLELITGRKA
Sbjct: 221 SDFGLAKLGPVGDRTHVSTRVMGTYGYCAPEYAMSGKLTVKSDIYCFGVVLLELITGRKA 280
Query: 201 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANF 260
+DL + QGEQNLV+WSRP+LKDQKKF HLVDP L G+YPRRCLNYA+A+ AMCLNEEA++
Sbjct: 281 IDLGQKQGEQNLVTWSRPYLKDQKKFGHLVDPSLRGKYPRRCLNYAIAIIAMCLNEEAHY 340
Query: 261 RPLINDIVVALDYLVSQRDSHPVSRNAGARGVPTSASDVSQ 301
RP I DIVVAL+YL +Q SH AR V + + ++S+
Sbjct: 341 RPFIGDIVVALEYLAAQSRSHE------ARNVSSPSPEISR 375
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|145335950|ref|NP_173489.2| protein kinase-like protein [Arabidopsis thaliana] gi|8778594|gb|AAF79602.1|AC027665_3 F5M15.3 [Arabidopsis thaliana] gi|8886951|gb|AAF80637.1|AC069251_30 F2D10.13 [Arabidopsis thaliana] gi|51971194|dbj|BAD44289.1| unknown protein [Arabidopsis thaliana] gi|332191880|gb|AEE30001.1| protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 473 bits (1216), Expect = e-131, Method: Compositional matrix adjust.
Identities = 226/281 (80%), Positives = 252/281 (89%), Gaps = 6/281 (2%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
Q+VAIKQLN +GLQG++EFIVEVLMLSLLHH NLVTLIGYCTSGDQRLLVYEYMPMGSLE
Sbjct: 101 QVVAIKQLNPDGLQGNREFIVEVLMLSLLHHPNLVTLIGYCTSGDQRLLVYEYMPMGSLE 160
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 140
DHL+DLE +QEPLSWNTRMKIAVGAARG+EYLHC ANPPVIYRDLKSANILLD +F+PKL
Sbjct: 161 DHLFDLESNQEPLSWNTRMKIAVGAARGIEYLHCTANPPVIYRDLKSANILLDKEFSPKL 220
Query: 141 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 200
SDFGLAKLGPVGD THVSTRVMGTYGYCAPEYAMSGKLT+KSDIY FGVVLLELITGRKA
Sbjct: 221 SDFGLAKLGPVGDRTHVSTRVMGTYGYCAPEYAMSGKLTVKSDIYCFGVVLLELITGRKA 280
Query: 201 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANF 260
+DL + QGEQNLV+WSRP+LKDQKKF HLVDP L G+YPRRCLNYA+A+ AMCLNEEA++
Sbjct: 281 IDLGQKQGEQNLVTWSRPYLKDQKKFGHLVDPSLRGKYPRRCLNYAIAIIAMCLNEEAHY 340
Query: 261 RPLINDIVVALDYLVSQRDSHPVSRNAGARGVPTSASDVSQ 301
RP I DIVVAL+YL +Q SH AR V + + ++S+
Sbjct: 341 RPFIGDIVVALEYLAAQSRSHE------ARNVSSPSPEISR 375
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297850486|ref|XP_002893124.1| protein kinase [Arabidopsis lyrata subsp. lyrata] gi|297338966|gb|EFH69383.1| protein kinase [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 471 bits (1211), Expect = e-130, Method: Compositional matrix adjust.
Identities = 226/281 (80%), Positives = 252/281 (89%), Gaps = 6/281 (2%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
Q+VAIKQLN +GLQG++EFIVEVLMLSLLHH NLVTLIGYCTSGDQRLLVYEYMPMGSLE
Sbjct: 101 QVVAIKQLNPDGLQGNREFIVEVLMLSLLHHPNLVTLIGYCTSGDQRLLVYEYMPMGSLE 160
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 140
DHL+DLE +QEPLSWNTRMKIAVGAARG+EYLHC ANPPVIYRDLKSANILLD +F+PKL
Sbjct: 161 DHLFDLESNQEPLSWNTRMKIAVGAARGIEYLHCTANPPVIYRDLKSANILLDKEFSPKL 220
Query: 141 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 200
SDFGLAKLGPVGD THVSTRVMGTYGYCAPEYAMSGKLT+KSDIY FGVVLLELITGRKA
Sbjct: 221 SDFGLAKLGPVGDRTHVSTRVMGTYGYCAPEYAMSGKLTVKSDIYCFGVVLLELITGRKA 280
Query: 201 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANF 260
+DLS+ QGEQNLV+WSR +LKDQKKF HLVDP L G+YPRRCLNYA+A+ AMCLNEEA++
Sbjct: 281 IDLSQKQGEQNLVTWSRSYLKDQKKFGHLVDPSLRGKYPRRCLNYAIAIIAMCLNEEAHY 340
Query: 261 RPLINDIVVALDYLVSQRDSHPVSRNAGARGVPTSASDVSQ 301
RP I DIVVAL+YL +Q SH AR V + + +V++
Sbjct: 341 RPFIGDIVVALEYLAAQSRSHE------ARNVSSPSPEVTR 375
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491840|ref|XP_002271454.2| PREDICTED: serine/threonine-protein kinase PBS1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 470 bits (1210), Expect = e-130, Method: Compositional matrix adjust.
Identities = 229/285 (80%), Positives = 250/285 (87%), Gaps = 1/285 (0%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
++VAIKQLNH+GLQG QEFIVEVLMLSLLHH NLVTLIGYCT GDQRLLVYEYM MGSLE
Sbjct: 107 EIVAIKQLNHDGLQGFQEFIVEVLMLSLLHHSNLVTLIGYCTDGDQRLLVYEYMAMGSLE 166
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 140
HL+DL PDQEPL WNTR++IAVGAARGLEYLHCKANPPVIYRDLKSANILLDN+FNPKL
Sbjct: 167 HHLFDLGPDQEPLGWNTRIQIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNEFNPKL 226
Query: 141 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 200
SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA
Sbjct: 227 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 286
Query: 201 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANF 260
+D SK QGEQNLV+WSRPFLKD+KKF+ LVDP L G +P R L++A+A+TAMCL E+ NF
Sbjct: 287 IDTSKRQGEQNLVAWSRPFLKDRKKFIQLVDPQLQGNFPVRALHHAIAITAMCLQEQPNF 346
Query: 261 RPLINDIVVALDYLVSQRDSHPVSRNAGARGVPTSASDVSQGSNS 305
RPLI DIVVAL+YL S+ S RN R +S S S+ SNS
Sbjct: 347 RPLIGDIVVALEYLASESHSSEPHRNQ-VRLPSSSPSQGSRNSNS 390
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297745557|emb|CBI40722.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 469 bits (1207), Expect = e-130, Method: Compositional matrix adjust.
Identities = 229/285 (80%), Positives = 250/285 (87%), Gaps = 1/285 (0%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
++VAIKQLNH+GLQG QEFIVEVLMLSLLHH NLVTLIGYCT GDQRLLVYEYM MGSLE
Sbjct: 139 EIVAIKQLNHDGLQGFQEFIVEVLMLSLLHHSNLVTLIGYCTDGDQRLLVYEYMAMGSLE 198
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 140
HL+DL PDQEPL WNTR++IAVGAARGLEYLHCKANPPVIYRDLKSANILLDN+FNPKL
Sbjct: 199 HHLFDLGPDQEPLGWNTRIQIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNEFNPKL 258
Query: 141 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 200
SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA
Sbjct: 259 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 318
Query: 201 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANF 260
+D SK QGEQNLV+WSRPFLKD+KKF+ LVDP L G +P R L++A+A+TAMCL E+ NF
Sbjct: 319 IDTSKRQGEQNLVAWSRPFLKDRKKFIQLVDPQLQGNFPVRALHHAIAITAMCLQEQPNF 378
Query: 261 RPLINDIVVALDYLVSQRDSHPVSRNAGARGVPTSASDVSQGSNS 305
RPLI DIVVAL+YL S+ S RN R +S S S+ SNS
Sbjct: 379 RPLIGDIVVALEYLASESHSSEPHRNQ-VRLPSSSPSQGSRNSNS 422
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224086050|ref|XP_002307795.1| predicted protein [Populus trichocarpa] gi|222857244|gb|EEE94791.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 466 bits (1198), Expect = e-129, Method: Compositional matrix adjust.
Identities = 231/296 (78%), Positives = 255/296 (86%), Gaps = 8/296 (2%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
+LVA+KQLN +GLQG QEFIVEVLMLSLLHH NLVTL GYCTSGDQRLLVYEYMPMGSLE
Sbjct: 44 ELVAVKQLNQDGLQGDQEFIVEVLMLSLLHHSNLVTLTGYCTSGDQRLLVYEYMPMGSLE 103
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 140
DHL+DLEP +EPLSW+TR+KIAVGAARGLEYLHCKA+PPVIYRDLKSANILLDNDF PKL
Sbjct: 104 DHLFDLEPGKEPLSWSTRIKIAVGAARGLEYLHCKADPPVIYRDLKSANILLDNDFQPKL 163
Query: 141 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 200
SDFG+AKLGPVG+NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA
Sbjct: 164 SDFGIAKLGPVGENTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 223
Query: 201 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANF 260
+D SK GEQNL +WS+PFLKDQKK+ L DPLL G YPRRC NYA+A+TAMCLNE+A+F
Sbjct: 224 IDRSKKPGEQNLAAWSQPFLKDQKKYCQLADPLLEGCYPRRCFNYAIAITAMCLNEQASF 283
Query: 261 RPLINDIVVALDYLVSQRDSHPVSRNAG-ARGVPTSA--SD---VSQGSNSRRSSS 310
RPLI DI+ AL+YL +Q H N G RG S+ SD VSQ +SR +S
Sbjct: 284 RPLIGDILGALEYLAAQ--CHVSEPNTGRVRGTNPSSPYSDRKVVSQERDSRSRAS 337
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449485117|ref|XP_004157074.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 456 bits (1172), Expect = e-126, Method: Compositional matrix adjust.
Identities = 218/277 (78%), Positives = 244/277 (88%), Gaps = 2/277 (0%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
Q+VAIKQLNH+GLQG+QEFIVEVLMLSLLHH NLVTLIGYCT GDQRLLVYEYM MGSLE
Sbjct: 90 QIVAIKQLNHDGLQGYQEFIVEVLMLSLLHHSNLVTLIGYCTDGDQRLLVYEYMSMGSLE 149
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 140
+HL+ L P + PLSWNTR+KIA+GAA+GLEYLHC ANPPVIYRDLKSANILLD+DFNPKL
Sbjct: 150 NHLFGLFPKRSPLSWNTRIKIALGAAQGLEYLHCTANPPVIYRDLKSANILLDDDFNPKL 209
Query: 141 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 200
SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIY FGVVLLE+ITGRKA
Sbjct: 210 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYCFGVVLLEIITGRKA 269
Query: 201 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANF 260
+D +K GEQNLV+WSRPFLKD++KFV LVDPLL GRYP RCL++A+A+ AMCL E+ F
Sbjct: 270 IDTTKKPGEQNLVAWSRPFLKDRRKFVQLVDPLLEGRYPLRCLHHAIAIAAMCLQEQPMF 329
Query: 261 RPLINDIVVALDYLVSQRDSHPVSRNAGARGVPTSAS 297
RP+I+DIVVAL+YL SQ SH + G P+ S
Sbjct: 330 RPIISDIVVALEYLASQ--SHASEQPREGVGSPSKLS 364
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449455605|ref|XP_004145543.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 454 bits (1167), Expect = e-125, Method: Compositional matrix adjust.
Identities = 217/277 (78%), Positives = 244/277 (88%), Gaps = 2/277 (0%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
++VAIKQLNH+GLQG+QEFIVEVLMLSLLHH NLVTLIGYCT GDQRLLVYEYM MGSLE
Sbjct: 94 EIVAIKQLNHDGLQGYQEFIVEVLMLSLLHHSNLVTLIGYCTDGDQRLLVYEYMSMGSLE 153
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 140
+HL+ L P + PLSWNTR+KIA+GAA+GLEYLHC ANPPVIYRDLKSANILLD+DFNPKL
Sbjct: 154 NHLFGLFPKRSPLSWNTRIKIALGAAQGLEYLHCTANPPVIYRDLKSANILLDDDFNPKL 213
Query: 141 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 200
SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIY FGVVLLE+ITGRKA
Sbjct: 214 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYCFGVVLLEIITGRKA 273
Query: 201 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANF 260
+D +K GEQNLV+WSRPFLKD++KFV LVDPLL GRYP RCL++A+A+ AMCL E+ F
Sbjct: 274 IDTTKKPGEQNLVAWSRPFLKDRRKFVQLVDPLLEGRYPLRCLHHAIAIAAMCLQEQPMF 333
Query: 261 RPLINDIVVALDYLVSQRDSHPVSRNAGARGVPTSAS 297
RP+I+DIVVAL+YL SQ SH + G P+ S
Sbjct: 334 RPIISDIVVALEYLASQ--SHASEQPREGVGSPSKLS 368
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 311 | ||||||
| TAIR|locus:2034344 | 381 | ASG5 "ALTERED SEED GERMINATION | 0.861 | 0.703 | 0.832 | 1.2e-120 | |
| TAIR|locus:2014604 | 381 | AT1G76370 [Arabidopsis thalian | 0.858 | 0.700 | 0.767 | 7.8e-110 | |
| TAIR|locus:2151191 | 378 | CDL1 "CDG1-like 1" [Arabidopsi | 0.877 | 0.722 | 0.702 | 1.1e-103 | |
| TAIR|locus:2183018 | 513 | AT5G18610 [Arabidopsis thalian | 0.877 | 0.532 | 0.705 | 2e-102 | |
| TAIR|locus:2179857 | 456 | PBS1 "avrPphB susceptible 1" [ | 0.826 | 0.563 | 0.712 | 1.5e-99 | |
| TAIR|locus:2098580 | 414 | AT3G07070 [Arabidopsis thalian | 0.829 | 0.623 | 0.689 | 6.8e-95 | |
| TAIR|locus:2087263 | 363 | AT3G24790 [Arabidopsis thalian | 0.855 | 0.732 | 0.657 | 3e-94 | |
| TAIR|locus:2085720 | 386 | AT3G20530 [Arabidopsis thalian | 0.819 | 0.660 | 0.660 | 1.5e-92 | |
| TAIR|locus:2056613 | 424 | AT2G28590 [Arabidopsis thalian | 0.864 | 0.634 | 0.625 | 5.9e-89 | |
| TAIR|locus:2119350 | 389 | AT4G13190 [Arabidopsis thalian | 0.836 | 0.668 | 0.626 | 7.5e-89 |
| TAIR|locus:2034344 ASG5 "ALTERED SEED GERMINATION 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1187 (422.9 bits), Expect = 1.2e-120, P = 1.2e-120
Identities = 224/269 (83%), Positives = 247/269 (91%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
Q+VAIKQLN +GLQG++EFIVEVLMLSLLHH NLVTLIGYCTSGDQRLLVYEYMPMGSLE
Sbjct: 101 QVVAIKQLNPDGLQGNREFIVEVLMLSLLHHPNLVTLIGYCTSGDQRLLVYEYMPMGSLE 160
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 140
DHL+DLE +QEPLSWNTRMKIAVGAARG+EYLHC ANPPVIYRDLKSANILLD +F+PKL
Sbjct: 161 DHLFDLESNQEPLSWNTRMKIAVGAARGIEYLHCTANPPVIYRDLKSANILLDKEFSPKL 220
Query: 141 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 200
SDFGLAKLGPVGD THVSTRVMGTYGYCAPEYAMSGKLT+KSDIY FGVVLLELITGRKA
Sbjct: 221 SDFGLAKLGPVGDRTHVSTRVMGTYGYCAPEYAMSGKLTVKSDIYCFGVVLLELITGRKA 280
Query: 201 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANF 260
+DL + QGEQNLV+WSRP+LKDQKKF HLVDP L G+YPRRCLNYA+A+ AMCLNEEA++
Sbjct: 281 IDLGQKQGEQNLVTWSRPYLKDQKKFGHLVDPSLRGKYPRRCLNYAIAIIAMCLNEEAHY 340
Query: 261 RPLINDIVVALDYLVSQRDSHPVSRNAGA 289
RP I DIVVAL+YL +Q SH +RN +
Sbjct: 341 RPFIGDIVVALEYLAAQSRSHE-ARNVSS 368
|
|
| TAIR|locus:2014604 AT1G76370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1085 (387.0 bits), Expect = 7.8e-110, P = 7.8e-110
Identities = 205/267 (76%), Positives = 234/267 (87%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
Q+VAIKQLN +G QG+QEFIVEV MLS+ HH NLVTLIGYCTSG QRLLVYEYMPMGSLE
Sbjct: 98 QVVAIKQLNPDGHQGNQEFIVEVCMLSVFHHPNLVTLIGYCTSGAQRLLVYEYMPMGSLE 157
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 140
DHL+DLEPDQ PLSW TRMKIAVGAARG+EYLHCK +P VIYRDLKSANILLD +F+ KL
Sbjct: 158 DHLFDLEPDQTPLSWYTRMKIAVGAARGIEYLHCKISPSVIYRDLKSANILLDKEFSVKL 217
Query: 141 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 200
SDFGLAK+GPVG+ THVSTRVMGTYGYCAPEYAMSG+LT+KSDIYSFGVVLLELI+GRKA
Sbjct: 218 SDFGLAKVGPVGNRTHVSTRVMGTYGYCAPEYAMSGRLTIKSDIYSFGVVLLELISGRKA 277
Query: 201 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANF 260
+DLSK GEQ LV+W+RP+LKD KKF LVDPLL G++ +RCLNYA+++T MCLN+EAN
Sbjct: 278 IDLSKPNGEQYLVAWARPYLKDPKKFGLLVDPLLRGKFSKRCLNYAISITEMCLNDEANH 337
Query: 261 RPLINDIVVALDYLVSQRDSHPVSRNA 287
RP I D+VVA +Y+ SQ S+ R A
Sbjct: 338 RPKIGDVVVAFEYIASQSKSYEDRRTA 364
|
|
| TAIR|locus:2151191 CDL1 "CDG1-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1027 (366.6 bits), Expect = 1.1e-103, P = 1.1e-103
Identities = 194/276 (70%), Positives = 228/276 (82%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
Q AIKQL+H GLQG++EF+VEVLMLSLLHH NLV LIGYC GDQRLLVYEYMP+GSLE
Sbjct: 97 QTAAIKQLDHNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLE 156
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 140
DHL+D+ P ++PL WNTRMKIA GAA+GLEYLH K PPVIYRDLK +NILLD+D+ PKL
Sbjct: 157 DHLHDISPGKQPLDWNTRMKIAAGAAKGLEYLHDKTMPPVIYRDLKCSNILLDDDYFPKL 216
Query: 141 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 200
SDFGLAKLGPVGD +HVSTRVMGTYGYCAPEYAM+G+LTLKSD+YSFGVVLLE+ITGRKA
Sbjct: 217 SDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKA 276
Query: 201 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANF 260
+D S+ GEQNLV+W+RP KD++KF + DP+L G+YP R L A+AV AMC+ E+ N
Sbjct: 277 IDSSRSTGEQNLVAWARPLFKDRRKFSQMADPMLQGQYPPRGLYQALAVAAMCVQEQPNL 336
Query: 261 RPLINDIVVALDYLVSQR-D--SHPVSRNAGARGVP 293
RPLI D+V AL YL SQ+ D + PV + A G P
Sbjct: 337 RPLIADVVTALSYLASQKFDPLAQPVQGSLFAPGTP 372
|
|
| TAIR|locus:2183018 AT5G18610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1015 (362.4 bits), Expect = 2.0e-102, P = 2.0e-102
Identities = 194/275 (70%), Positives = 227/275 (82%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
Q+VA+KQL+ GLQG++EF+VEVLMLSLLHH NLV LIGYC GDQRLLVYEYMP+GSLE
Sbjct: 107 QIVAVKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLE 166
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 140
DHL+DL PD+EPL W+TRM IA GAA+GLEYLH KANPPVIYRDLKS+NILL + ++PKL
Sbjct: 167 DHLHDLPPDKEPLDWSTRMTIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLGDGYHPKL 226
Query: 141 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 200
SDFGLAKLGPVGD THVSTRVMGTYGYCAPEYAM+G+LTLKSD+YSFGVV LELITGRKA
Sbjct: 227 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKA 286
Query: 201 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANF 260
+D ++ GE NLV+W+RP KD++KF + DP L GRYP R L A+AV AMCL E+A
Sbjct: 287 IDNARAPGEHNLVAWARPLFKDRRKFPKMADPSLQGRYPMRGLYQALAVAAMCLQEQAAT 346
Query: 261 RPLINDIVVALDYLVSQR-DSH-PVSRNAGARGVP 293
RPLI D+V AL YL SQ D + P +N+ + P
Sbjct: 347 RPLIGDVVTALTYLASQTFDPNAPSGQNSRSGSGP 381
|
|
| TAIR|locus:2179857 PBS1 "avrPphB susceptible 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 988 (352.9 bits), Expect = 1.5e-99, P = 1.5e-99
Identities = 183/257 (71%), Positives = 215/257 (83%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
Q+VA+KQL+ GLQG++EF+VEVLMLSLLHH NLV LIGYC GDQRLLVYE+MP+GSLE
Sbjct: 110 QVVAVKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLE 169
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 140
DHL+DL PD+E L WN RMKIA GAA+GLE+LH KANPPVIYRD KS+NILLD F+PKL
Sbjct: 170 DHLHDLPPDKEALDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKL 229
Query: 141 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 200
SDFGLAKLGP GD +HVSTRVMGTYGYCAPEYAM+G+LT+KSD+YSFGVV LELITGRKA
Sbjct: 230 SDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKA 289
Query: 201 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANF 260
+D GEQNLV+W+RP D++KF+ L DP L GR+P R L A+AV +MC+ E+A
Sbjct: 290 IDSEMPHGEQNLVAWARPLFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAAT 349
Query: 261 RPLINDIVVALDYLVSQ 277
RPLI D+V AL YL +Q
Sbjct: 350 RPLIADVVTALSYLANQ 366
|
|
| TAIR|locus:2098580 AT3G07070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 944 (337.4 bits), Expect = 6.8e-95, P = 6.8e-95
Identities = 178/258 (68%), Positives = 211/258 (81%)
Query: 22 LVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
+VA+KQL+ GLQG++EFIVEVLMLSLLHH +LV LIGYC GDQRLLVYEYM GSLED
Sbjct: 104 IVAVKQLDRNGLQGNKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLED 163
Query: 82 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 141
HL DL PDQ PL W+TR++IA+GAA GLEYLH KANPPVIYRDLK+ANILLD +FN KLS
Sbjct: 164 HLLDLTPDQIPLDWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLS 223
Query: 142 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 201
DFGLAKLGPVGD HVS+RVMGTYGYCAPEY +G+LT KSD+YSFGVVLLELITGR+ +
Sbjct: 224 DFGLAKLGPVGDKQHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVI 283
Query: 202 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFR 261
D ++ + EQNLV+W++P K+ +F L DP L G +P + LN AVAV AMCL EEA R
Sbjct: 284 DTTRPKDEQNLVTWAQPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVR 343
Query: 262 PLINDIVVALDYLVSQRD 279
PL++D+V AL +L + D
Sbjct: 344 PLMSDVVTALGFLGTAPD 361
|
|
| TAIR|locus:2087263 AT3G24790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 938 (335.3 bits), Expect = 3.0e-94, P = 3.0e-94
Identities = 175/266 (65%), Positives = 213/266 (80%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
Q+VA+KQL+ GLQG +EF+VEVLMLSLLHH NLV LIGYC GDQRLLVYEYMP+GSLE
Sbjct: 71 QVVAVKQLDRNGLQGQREFLVEVLMLSLLHHRNLVNLIGYCADGDQRLLVYEYMPLGSLE 130
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 140
DHL DLEP Q+PL WNTR+KIA+GAA+G+EYLH +A+PPVIYRDLKS+NILLD ++ KL
Sbjct: 131 DHLLDLEPGQKPLDWNTRIKIALGAAKGIEYLHDEADPPVIYRDLKSSNILLDPEYVAKL 190
Query: 141 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 200
SDFGLAKLGPVGD HVS+RVMGTYGYCAPEY +G LT KSD+YSFGVVLLELI+GR+
Sbjct: 191 SDFGLAKLGPVGDTLHVSSRVMGTYGYCAPEYQRTGYLTNKSDVYSFGVVLLELISGRRV 250
Query: 201 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANF 260
+D + EQNLV+W+ P +D ++ L DPLL G YP + LN A+AV AMCL+EE
Sbjct: 251 IDTMRPSHEQNLVTWALPIFRDPTRYWQLADPLLRGDYPEKSLNQAIAVAAMCLHEEPTV 310
Query: 261 RPLINDIVVALDYLVSQRDSHPVSRN 286
RPL++D++ AL +L + +S N
Sbjct: 311 RPLMSDVITALSFLGASSNSSNTGSN 336
|
|
| TAIR|locus:2085720 AT3G20530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 922 (329.6 bits), Expect = 1.5e-92, P = 1.5e-92
Identities = 169/256 (66%), Positives = 212/256 (82%)
Query: 20 DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79
+Q+VA+KQL+ G QG++EF+VEV+MLSLLHH NLV L+GYC GDQR+LVYEYM GSL
Sbjct: 105 EQVVAVKQLDRNGYQGNREFLVEVMMLSLLHHQNLVNLVGYCADGDQRILVYEYMQNGSL 164
Query: 80 EDHLYDLEPDQE-PLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 138
EDHL +L +++ PL W+TRMK+A GAARGLEYLH A+PPVIYRD K++NILLD +FNP
Sbjct: 165 EDHLLELARNKKKPLDWDTRMKVAAGAARGLEYLHETADPPVIYRDFKASNILLDEEFNP 224
Query: 139 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 198
KLSDFGLAK+GP G THVSTRVMGTYGYCAPEYA++G+LT+KSD+YSFGVV LE+ITGR
Sbjct: 225 KLSDFGLAKVGPTGGETHVSTRVMGTYGYCAPEYALTGQLTVKSDVYSFGVVFLEMITGR 284
Query: 199 KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEA 258
+ +D +K EQNLV+W+ P KD++KF + DPLL G+YP + L A+AV AMCL EEA
Sbjct: 285 RVIDTTKPTEEQNLVTWASPLFKDRRKFTLMADPLLEGKYPIKGLYQALAVAAMCLQEEA 344
Query: 259 NFRPLINDIVVALDYL 274
RP+++D+V AL+YL
Sbjct: 345 ATRPMMSDVVTALEYL 360
|
|
| TAIR|locus:2056613 AT2G28590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 888 (317.7 bits), Expect = 5.9e-89, P = 5.9e-89
Identities = 169/270 (62%), Positives = 209/270 (77%)
Query: 9 KFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 68
K Y G + +Q+VAIKQL+ G QG +EF+VEVL LSL H NLV LIG+C G QRL
Sbjct: 111 KVYK-GFIEKINQVVAIKQLDRNGAQGIREFVVEVLTLSLADHPNLVKLIGFCAEGVQRL 169
Query: 69 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 128
LVYEYMP+GSL++HL+DL + PL+WNTRMKIA GAARGLEYLH PPVIYRDLK +
Sbjct: 170 LVYEYMPLGSLDNHLHDLPSGKNPLAWNTRMKIAAGAARGLEYLHDTMKPPVIYRDLKCS 229
Query: 129 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFG 188
NIL+D ++ KLSDFGLAK+GP G THVSTRVMGTYGYCAP+YA++G+LT KSD+YSFG
Sbjct: 230 NILIDEGYHAKLSDFGLAKVGPRGSETHVSTRVMGTYGYCAPDYALTGQLTFKSDVYSFG 289
Query: 189 VVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVA 248
VVLLELITGRKA D ++ + Q+LV W+ P KD+K F +VDPLL G YP R L A+A
Sbjct: 290 VVLLELITGRKAYDNTRTRNHQSLVEWANPLFKDRKNFKKMVDPLLEGDYPVRGLYQALA 349
Query: 249 VTAMCLNEEANFRPLINDIVVALDYLVSQR 278
+ AMC+ E+ + RP+I D+V+ALD+L S +
Sbjct: 350 IAAMCVQEQPSMRPVIADVVMALDHLASSK 379
|
|
| TAIR|locus:2119350 AT4G13190 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 887 (317.3 bits), Expect = 7.5e-89, P = 7.5e-89
Identities = 163/260 (62%), Positives = 210/260 (80%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
Q+VA+KQL+ GLQG++EF+VE+ LSLLHH NL LIGYC GDQRLLV+E+MP+GSLE
Sbjct: 95 QVVAVKQLDRNGLQGNREFLVEIFRLSLLHHPNLANLIGYCLDGDQRLLVHEFMPLGSLE 154
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 140
DHL D+ Q+PL WN+R++IA+GAA+GLEYLH KANPPVIYRD KS+NILL+ DF+ KL
Sbjct: 155 DHLLDVVVGQQPLDWNSRIRIALGAAKGLEYLHEKANPPVIYRDFKSSNILLNVDFDAKL 214
Query: 141 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 200
SDFGLAKLG VGD +VS+RV+GTYGYCAPEY +G+LT+KSD+YSFGVVLLELITG++
Sbjct: 215 SDFGLAKLGSVGDTQNVSSRVVGTYGYCAPEYHKTGQLTVKSDVYSFGVVLLELITGKRV 274
Query: 201 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANF 260
+D ++ EQNLV+W++P ++ +F L DPLL G +P + LN AVA+ AMCL EE
Sbjct: 275 IDTTRPCHEQNLVTWAQPIFREPNRFPELADPLLQGEFPEKSLNQAVAIAAMCLQEEPIV 334
Query: 261 RPLINDIVVALDYLVSQRDS 280
RPLI+D+V AL ++ ++ S
Sbjct: 335 RPLISDVVTALSFMSTETGS 354
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 311 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-46 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-46 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-46 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-45 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-44 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-33 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-32 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-28 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-27 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-27 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-26 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-26 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-25 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-24 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-22 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-22 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-22 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-21 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-21 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-20 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-20 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-18 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-18 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-16 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-16 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-15 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-14 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-13 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-13 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-12 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-11 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-08 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-08 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-06 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 9e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.002 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.003 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.003 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 2e-49
Identities = 72/189 (38%), Positives = 102/189 (53%), Gaps = 16/189 (8%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQG-HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 67
G V+L + VAIK + E +E + E+ +L L+H N+V L G +
Sbjct: 7 GTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHL 66
Query: 68 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 127
LV EY GSL+D L + E LS + ++I + GLEYLH +I+RDLK
Sbjct: 67 YLVMEYCEGGSLKDLLKENEG---KLSEDEILRILLQILEGLEYLHSN---GIIHRDLKP 120
Query: 128 ANILLDND-FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIY 185
NILLD+D KL+DFGL+KL + + + ++GT Y APE + G + KSDI+
Sbjct: 121 ENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIW 178
Query: 186 SFGVVLLEL 194
S GV+L EL
Sbjct: 179 SLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 2e-46
Identities = 68/191 (35%), Positives = 95/191 (49%), Gaps = 16/191 (8%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIGYCTSGDQR 67
G V+L +LVAIK + + ++ +E I+ E+ +L L H N+V L D+
Sbjct: 13 GKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKL 72
Query: 68 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 127
LV EY G L D L E + LEYLH K +++RDLK
Sbjct: 73 YLVMEYCEGGDLFDLLKKRGRLSEDEAR----FYLRQILSALEYLHSK---GIVHRDLKP 125
Query: 128 ANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSF 187
NILLD D + KL+DFGLA+ + ++T V GT Y APE + DI+S
Sbjct: 126 ENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-GTPEYMAPEVLLGKGYGKAVDIWSL 182
Query: 188 GVVLLELITGR 198
GV+L EL+TG+
Sbjct: 183 GVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 3e-46
Identities = 66/178 (37%), Positives = 96/178 (53%), Gaps = 7/178 (3%)
Query: 20 DQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78
+ VA+K L + Q +EF+ E ++ L H N+V L+G CT + ++V EYMP G
Sbjct: 28 EVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGD 87
Query: 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 138
L D+L P + LS + + A+ ARG+EYL K I+RDL + N L+ +
Sbjct: 88 LLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVV 142
Query: 139 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
K+SDFGL++ D V + APE GK T KSD++SFGV+L E+ T
Sbjct: 143 KISDFGLSRDLYDDDYYKVKGG-KLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 8e-46
Identities = 63/178 (35%), Positives = 90/178 (50%), Gaps = 8/178 (4%)
Query: 20 DQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78
VA+K L + Q +EF+ E ++ L H N+V L+G CT + +V EYM G
Sbjct: 28 KVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGD 87
Query: 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 138
L +L P LS + + A+ ARG+EYL K I+RDL + N L+ +
Sbjct: 88 LLSYLRKNRP---KLSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVV 141
Query: 139 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
K+SDFGL++ D + APE GK T KSD++SFGV+L E+ T
Sbjct: 142 KISDFGLSRDLYDDDYYRKRGG-KLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 4e-45
Identities = 73/193 (37%), Positives = 99/193 (51%), Gaps = 17/193 (8%)
Query: 14 GLVWLC-----DQLVAIKQLN--HEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 66
G V+ ++VA+K L E + Q E+ +L L H N+V LI D
Sbjct: 13 GTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDH 72
Query: 67 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 126
LV EY G L D+L PLS + KIA+ RGLEYLH +I+RDLK
Sbjct: 73 LYLVMEYCEGGDLFDYLSR----GGPLSEDEAKKIALQILRGLEYLHSNG---IIHRDLK 125
Query: 127 SANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-YAMSGKLTLKSDIY 185
NILLD + K++DFGLAK + ++ ++T V GT Y APE K D++
Sbjct: 126 PENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPKVDVW 183
Query: 186 SFGVVLLELITGR 198
S GV+L EL+TG+
Sbjct: 184 SLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 1e-44
Identities = 62/179 (34%), Positives = 93/179 (51%), Gaps = 7/179 (3%)
Query: 20 DQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78
+ VA+K L + +EF+ E ++ L H N+V L+G CT G+ +V EYMP G
Sbjct: 28 ETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGD 87
Query: 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 138
L D L E L+ +++A+ A+G+EYL K ++RDL + N L+ +
Sbjct: 88 LLDFLRKH---GEKLTLKDLLQMALQIAKGMEYLESK---NFVHRDLAARNCLVTENLVV 141
Query: 139 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 197
K+SDFGL++ D + APE GK T KSD++SFGV+L E+ T
Sbjct: 142 KISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 9e-43
Identities = 62/181 (34%), Positives = 92/181 (50%), Gaps = 9/181 (4%)
Query: 22 LVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
VA+K L + + ++F+ E ++ L H N+V L+G CT + LV EYM G L
Sbjct: 25 EVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLL 84
Query: 81 DHL-----YDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 135
D+L P++ LS + A+ A+G+EYL K ++RDL + N L+ D
Sbjct: 85 DYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGED 141
Query: 136 FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 195
K+SDFGL++ D T + APE G T KSD++SFGV+L E+
Sbjct: 142 LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIF 201
Query: 196 T 196
T
Sbjct: 202 T 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-33
Identities = 56/184 (30%), Positives = 88/184 (47%), Gaps = 15/184 (8%)
Query: 21 QLVAIKQLN-HEGLQGHQEFIV-EVLMLSLLHHDNLVTLIGYCTS--GDQRLLVYEYMPM 76
+L+A+K + + E + E+ +LS L H N+V G + + EY+
Sbjct: 26 ELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSG 85
Query: 77 GSLEDHLYDLEPDQEPL--SWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN 134
GSL L EP+ + TR + GL YLH +++RD+K ANIL+D+
Sbjct: 86 GSLSSLLKKFGKLPEPVIRKY-TRQIL-----EGLAYLHSNG---IVHRDIKGANILVDS 136
Query: 135 DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLEL 194
D KL+DFG AK + + V GT + APE + +DI+S G ++E+
Sbjct: 137 DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEM 196
Query: 195 ITGR 198
TG+
Sbjct: 197 ATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 6e-32
Identities = 77/268 (28%), Positives = 127/268 (47%), Gaps = 30/268 (11%)
Query: 21 QLVAIKQLNHEGLQGHQ-EFIVEVLMLSLLHHDNLVTLIGYCTSGDQR--LLVYEYMPMG 77
+ VA+K LNH G + H+ +F E+ +L L H+N+V G C R L+ EY+P G
Sbjct: 34 EQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSG 93
Query: 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 137
SL D+L ++ ++ + + +G++YL + I+RDL + NIL++++
Sbjct: 94 SLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDL 147
Query: 138 PKLSDFGLAKLGPVGDNTHVST--RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 195
K+SDFGLAK+ P + + + Y APE + K + SD++SFGV L EL
Sbjct: 148 VKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLRTSKFSSASDVWSFGVTLYELF 206
Query: 196 TGRKAMDLSKGQGEQNLVSWSRPFL-----KDQKKFVHLVDPLLHG-RYPR--RCLNYAV 247
T G+ + + + Q L++ L G R PR C +
Sbjct: 207 T----------YGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVY 256
Query: 248 AVTAMCLNEEANFRPLINDIVVALDYLV 275
+ +C E RP D+++ +D L
Sbjct: 257 DLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 7e-32
Identities = 68/223 (30%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
+ VAIK + E + ++ I E+ +L H N+V G D+ +V E+ GSL+
Sbjct: 26 KEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLK 85
Query: 81 DHLYDL-EPDQEPLSWNTRMKIAV---GAARGLEYLHCKANPPVIYRDLKSANILLDNDF 136
D L + E +IA +GLEYLH +I+RD+K+ANILL +D
Sbjct: 86 DLLKSTNQTLTES-------QIAYVCKELLKGLEYLH-SNG--IIHRDIKAANILLTSDG 135
Query: 137 NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
KL DFGL+ +T ++GT + APE K+DI+S G+ +EL
Sbjct: 136 EVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAE 192
Query: 197 GR---------KAMDLSKGQGE---QNLVSWSRPFLKDQKKFV 227
G+ KA+ G +N WS F K F+
Sbjct: 193 GKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEF----KDFL 231
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-28
Identities = 65/188 (34%), Positives = 95/188 (50%), Gaps = 13/188 (6%)
Query: 14 GLVWLCDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 71
GL VAIKQ++ E + + + + E+ +L L H N+V IG + D ++
Sbjct: 19 GLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIIL 78
Query: 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANIL 131
EY GSL + P E L ++ +GL YLH VI+RD+K+ANIL
Sbjct: 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVL----QGLAYLH---EQGVIHRDIKAANIL 131
Query: 132 LDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-YAMSGKLTLKSDIYSFGVV 190
D KL+DFG+A + D + V+GT + APE MSG + SDI+S G
Sbjct: 132 TTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCT 188
Query: 191 LLELITGR 198
++EL+TG
Sbjct: 189 VIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 7e-28
Identities = 72/199 (36%), Positives = 105/199 (52%), Gaps = 22/199 (11%)
Query: 12 NVGLVWLC---------DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 62
N G V LC ++VA+K+L H + ++F E+ +L L HDN+V G C
Sbjct: 16 NFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCY 75
Query: 63 SGDQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 120
S +R LV EY+P GSL D+ L+ +E L + A +G+EYL K
Sbjct: 76 SAGRRNLRLVMEYLPYGSLRDY---LQKHRERLDHRKLLLYASQICKGMEYLGSKR---Y 129
Query: 121 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG---TYGYCAPEYAMSGK 177
++RDL + NIL++++ K+ DFGL K+ P D + R G + Y APE K
Sbjct: 130 VHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREPGESPIFWY-APESLTESK 187
Query: 178 LTLKSDIYSFGVVLLELIT 196
++ SD++SFGVVL EL T
Sbjct: 188 FSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-27
Identities = 62/186 (33%), Positives = 91/186 (48%), Gaps = 14/186 (7%)
Query: 22 LVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
LVA+K L ++F E +L+ H+N+V G CT GD ++V+EYM G L
Sbjct: 37 LVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLN 96
Query: 81 DHLYDLEPD----------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANI 130
L PD L+ + ++IAV A G+ YL A+ ++RDL + N
Sbjct: 97 KFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNC 153
Query: 131 LLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVV 190
L+ D K+ DFG+++ D V M + PE M K T +SD++SFGVV
Sbjct: 154 LVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVV 213
Query: 191 LLELIT 196
L E+ T
Sbjct: 214 LWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 7e-27
Identities = 63/187 (33%), Positives = 97/187 (51%), Gaps = 14/187 (7%)
Query: 16 VWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75
W VA+K L G + F+ E ++ L HD LV L C+ + +V EYM
Sbjct: 26 TWNGTTKVAVKTLK-PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84
Query: 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 135
GSL D L + + L + +A A G+ YL + I+RDL + NIL+ +
Sbjct: 85 KGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGEN 139
Query: 136 FNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLTLKSDIYSFGVVLL 192
K++DFGLA+L + D+ + + G + APE A G+ T+KSD++SFG++L
Sbjct: 140 LVCKIADFGLARL--IEDDEYTAR--EGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLT 195
Query: 193 ELIT-GR 198
E++T GR
Sbjct: 196 EIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 108 bits (269), Expect = 8e-27
Identities = 75/207 (36%), Positives = 103/207 (49%), Gaps = 18/207 (8%)
Query: 14 GLVWLC--DQLVAIKQLNHEG---LQGHQEFIVEVLML-SLLHHDNLVTLIGYCTSGDQR 67
G V+L +LVA+K L + + + F+ E+ +L SL H N+V L +
Sbjct: 14 GEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSL 73
Query: 68 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 127
LV EY+ GSLED L + PLS + + I LEYLH K +I+RD+K
Sbjct: 74 YLVMEYVDGGSLED-LLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKP 129
Query: 128 ANILLD-NDFNPKLSDFGLAKL----GPVGDNTHVSTRVMGTYGYCAPEYAMSGKL---T 179
NILLD + KL DFGLAKL G + + +GT GY APE + L +
Sbjct: 130 ENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYAS 189
Query: 180 LKSDIYSFGVVLLELITGRKAMDLSKG 206
SDI+S G+ L EL+TG + K
Sbjct: 190 SSSDIWSLGITLYELLTGLPPFEGEKN 216
|
Length = 384 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-26
Identities = 62/180 (34%), Positives = 97/180 (53%), Gaps = 7/180 (3%)
Query: 17 WLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76
W VAIK L + L Q+F EV L L H +L++L C+ G+ ++ E M
Sbjct: 27 WKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEK 86
Query: 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF 136
GSL L P+ + L + + +A A G+ YL + I+RDL + NIL+ D
Sbjct: 87 GSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDL 141
Query: 137 NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
K++DFGLA+L + ++ ++S+ Y + APE A G + KSD++SFG++L E+ T
Sbjct: 142 VCKVADFGLARL--IKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-26
Identities = 62/188 (32%), Positives = 94/188 (50%), Gaps = 18/188 (9%)
Query: 21 QLVAIKQL--NHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78
VAIK L N E + QEF E ++S L H N+V L+G CT +++EY+ G
Sbjct: 36 TSVAIKTLKENAEP-KVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGD 94
Query: 79 LEDHL------------YDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 126
L + L E + L + + IA+ A G+EYL ++ ++RDL
Sbjct: 95 LHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLA 151
Query: 127 SANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYS 186
+ N L+ K+SDFGL++ D V ++ + + PE + GK T +SDI+S
Sbjct: 152 ARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWS 211
Query: 187 FGVVLLEL 194
FGVVL E+
Sbjct: 212 FGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 6e-26
Identities = 65/191 (34%), Positives = 98/191 (51%), Gaps = 15/191 (7%)
Query: 12 NVGLVWLCD---QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 68
G V L D Q VA+K L + Q F+ E +++ L H NLV L+G G+
Sbjct: 18 EFGDVMLGDYRGQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76
Query: 69 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 128
+V EYM GSL D+L + ++ ++ A+ G+EYL K ++RDL +
Sbjct: 77 IVTEYMAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAAR 131
Query: 129 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFG 188
N+L+ D K+SDFGLAK G S ++ + APE K + KSD++SFG
Sbjct: 132 NVLVSEDLVAKVSDFGLAKEASQG---QDSGKL--PVKWTAPEALREKKFSTKSDVWSFG 186
Query: 189 VVLLELIT-GR 198
++L E+ + GR
Sbjct: 187 ILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 102 bits (258), Expect = 7e-26
Identities = 64/261 (24%), Positives = 112/261 (42%), Gaps = 29/261 (11%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGL-QGHQEFIV-EVLMLSLLHHDNLVTLIGYCTSGDQ 66
G V+L +L +K+++ + + +E + EV +L L+H N++ +
Sbjct: 14 GKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGK 73
Query: 67 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 126
+V EY G L + + + +P + V L+YLH + +++RD+K
Sbjct: 74 LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIK 130
Query: 127 SANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYS 186
NI L ++ KL DFG++K+ + ++ V+GT Y +PE + KSDI+S
Sbjct: 131 PQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWS 188
Query: 187 FGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYA 246
G VL EL T + + G+ L K + P + +Y L
Sbjct: 189 LGCVLYELCTLKHPFE---GENLLELA----------LKILKGQYPPIPSQYSSE-LRNL 234
Query: 247 VAVTAMCLNEEANFRPLINDI 267
V + L ++ RP I I
Sbjct: 235 V---SSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 78/260 (30%), Positives = 111/260 (42%), Gaps = 36/260 (13%)
Query: 22 LVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
LVA+K L Q+F E +L++L H ++V G CT G L+V+EYM G L
Sbjct: 37 LVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNR 96
Query: 82 HLYDLEPDQE-----------PLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANI 130
L PD + L+ + IA A G+ YL A+ ++RDL + N
Sbjct: 97 FLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNC 153
Query: 131 LLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVV 190
L+ K+ DFG+++ D V R M + PE + K T +SDI+SFGVV
Sbjct: 154 LVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVV 213
Query: 191 LLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR---YPRRCLNYAV 247
L E+ T G+Q W Q ++ + GR PR C
Sbjct: 214 LWEIFT----------YGKQ---PWY------QLSNTEAIECITQGRELERPRTCPPEVY 254
Query: 248 AVTAMCLNEEANFRPLINDI 267
A+ C E R +I DI
Sbjct: 255 AIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 4e-25
Identities = 66/196 (33%), Positives = 91/196 (46%), Gaps = 23/196 (11%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLIGYCTSGD 65
G V L +L A+K L + + +E + E +LS ++H +V L +
Sbjct: 7 GKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL--HYAFQT 64
Query: 66 QR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMK-IAVGAARGLEYLHCKANPPVIY 122
+ LV EY P G L HL E R + A LEYLH +IY
Sbjct: 65 EEKLYLVLEYAPGGELFSHLSKEGRFSEE-----RARFYAAEIVLALEYLHSLG---IIY 116
Query: 123 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKS 182
RDLK NILLD D + KL+DFGLAK + + +T GT Y APE +
Sbjct: 117 RDLKPENILLDADGHIKLTDFGLAKELSS-EGSRTNTFC-GTPEYLAPEVLLGKGYGKAV 174
Query: 183 DIYSFGVVLLELITGR 198
D +S GV+L E++TG+
Sbjct: 175 DWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 6e-25
Identities = 55/182 (30%), Positives = 91/182 (50%), Gaps = 15/182 (8%)
Query: 21 QLVAIK--QLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIG-YCTSGDQRLLVYEYMPMG 77
++ A+K ++ + Q + E+ L +V G + G+ + V EYM G
Sbjct: 27 KIYALKKIHVDGDEEFRKQ-LLRELKTLRSCESPYVVKCYGAFYKEGEISI-VLEYMDGG 84
Query: 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 137
SL D L + EP+ IA +GL+YLH K + +I+RD+K +N+L+++
Sbjct: 85 SLADLLKKVGKIPEPVL----AYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGE 138
Query: 138 PKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
K++DFG++K L D + T V GT Y +PE + +DI+S G+ LLE
Sbjct: 139 VKIADFGISKVLENTLDQCN--TFV-GTVTYMSPERIQGESYSYAADIWSLGLTLLECAL 195
Query: 197 GR 198
G+
Sbjct: 196 GK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 76/255 (29%), Positives = 118/255 (46%), Gaps = 20/255 (7%)
Query: 21 QLVAIKQLNHEGLQGHQE-FIVEVLMLSLLHHDNLVTLIGYCTSGDQR--LLVYEYMPMG 77
++VA+K L E Q + + E+ +L L+H+N+V G C+ + L+ EY+P+G
Sbjct: 34 EMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLG 93
Query: 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 137
SL D+L + L+ + A G+ YLH + I+RDL + N+LLDND
Sbjct: 94 SLRDYL-----PKHKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRL 145
Query: 138 PKLSDFGLAKLGPVGDNTH-VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
K+ DFGLAK P G + V + A E K + SD++SFGV L EL+T
Sbjct: 146 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
Query: 197 GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRY---PRRCLNYAVAVTAMC 253
+ + E+ + + Q V L++ L G P+ C + C
Sbjct: 206 HCDSKQSPPKKFEEMI-----GPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNC 260
Query: 254 LNEEANFRPLINDIV 268
EA FRP ++
Sbjct: 261 WETEAKFRPTFRSLI 275
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 74/241 (30%), Positives = 112/241 (46%), Gaps = 32/241 (13%)
Query: 49 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 108
L H N+V LIG C S L++EY+ +L + L +L SW R KIA+G A+
Sbjct: 740 LQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNL-------SWERRRKIAIGIAKA 792
Query: 109 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 168
L +LHC+ +P V+ +L I++D P L +L G T+ + Y
Sbjct: 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPG-LLCTDTKCFISSAYV 845
Query: 169 APEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 228
APE + +T KSDIY FG++L+EL+TG+ D G ++V W+R D H
Sbjct: 846 APETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSD----CH 900
Query: 229 L---VDPLL------HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 279
L +DP + + +N A+ TA + RP ND++ L+
Sbjct: 901 LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTAT----DPTARPCANDVLKTLESASRSSS 956
Query: 280 S 280
S
Sbjct: 957 S 957
|
Length = 968 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 2e-23
Identities = 62/203 (30%), Positives = 93/203 (45%), Gaps = 30/203 (14%)
Query: 10 FYNVGLVWLCD--QLVAIKQLN--HEGLQGHQ---EFIVEVLMLSLLHHDNLVTLIGYCT 62
F +V D A+K+++ +G G + + E+ +LS L H N+V +G
Sbjct: 13 FGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER 72
Query: 63 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWN-TRMKIAVGAARGLEYLHCKANPPVI 121
D + E +P GSL L EP+ TR + GLEYLH + +
Sbjct: 73 EEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GLEYLH---DRNTV 124
Query: 122 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-----GTYGYCAPEYAMS- 175
+RD+K ANIL+D + KL+DFG+AK V G+ + APE
Sbjct: 125 HRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSPYWMAPEVIAQQ 176
Query: 176 GKLTLKSDIYSFGVVLLELITGR 198
G L +DI+S G +LE+ TG+
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 3e-23
Identities = 58/183 (31%), Positives = 98/183 (53%), Gaps = 17/183 (9%)
Query: 23 VAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
VAIK L E + ++E + E +++ + H ++V L+G C S Q L+ + MP+G L D
Sbjct: 39 VAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLD 97
Query: 82 HLYD----LEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 137
++ + + Q L+W V A+G+ YL K +++RDL + N+L+ +
Sbjct: 98 YVRNHKDNIGS-QYLLNW------CVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQH 147
Query: 138 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT- 196
K++DFGLAKL V + + + + A E + T KSD++S+GV + EL+T
Sbjct: 148 VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTF 207
Query: 197 GRK 199
G K
Sbjct: 208 GAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 3e-23
Identities = 64/183 (34%), Positives = 89/183 (48%), Gaps = 14/183 (7%)
Query: 23 VAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
VAIK+++ E Q + + EV +S +H N+V GD+ LV Y+ GSL
Sbjct: 29 VAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSL-- 86
Query: 82 HLYDLEPDQEPLSWNTRMKIAV---GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 138
D+ P IA +GLEYLH I+RD+K+ NILL D +
Sbjct: 87 --LDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSV 141
Query: 139 KLSDFGL-AKLGPVGDNTH-VSTRVMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELI 195
K++DFG+ A L GD T V +GT + APE K+DI+SFG+ +EL
Sbjct: 142 KIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELA 201
Query: 196 TGR 198
TG
Sbjct: 202 TGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 4e-23
Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 28/202 (13%)
Query: 21 QLVAIKQLNHEGLQGHQEF----IVEVLMLSLLHHDNLVTLIGYCTSGDQR--LLVYEYM 74
+LVA+K++ E + F I E+ +L L H N+V L TS + +V+EYM
Sbjct: 25 ELVALKKIRME--NEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM 82
Query: 75 P---MGSLEDHLYDLEPDQEPLSWNTRMK-IAVGAARGLEYLHCKANPPVIYRDLKSANI 130
G L+ Q +K GL+YLH +++RD+K +NI
Sbjct: 83 DHDLTGLLDSPEVKFTESQ--------IKCYMKQLLEGLQYLHSNG---ILHRDIKGSNI 131
Query: 131 LLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGV 189
L++ND KL+DFGLA+ N+ T + T Y PE + + + + D++S G
Sbjct: 132 LINNDGVLKLADFGLARP-YTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGC 190
Query: 190 VLLELITGRKAMDLSKGQGEQN 211
+L EL G+ +G E
Sbjct: 191 ILAELFLGKPIF---QGSTELE 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 7e-23
Identities = 74/231 (32%), Positives = 105/231 (45%), Gaps = 36/231 (15%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
+ VAIK++ Q + I E+L++ H N+V GD+ +V EYM GSL
Sbjct: 45 KEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLT 103
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAA--RGLEYLHCKANPPVIYRDLKSANILLDNDFNP 138
D + Q + N V +GLEYLH + VI+RD+KS NILL D +
Sbjct: 104 DIIT-----QNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSV 155
Query: 139 KLSDFGLAKLGPVGDNTHVSTR--VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
KL+DFG A S R V+GT + APE K DI+S G++ +E+
Sbjct: 156 KLADFGFAAQL----TKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAE 211
Query: 197 GR---------KAMDL--SKGQGE-QNLVSWSRPFLKDQKKFVHL---VDP 232
G +A+ L +KG +N WS F K F++ DP
Sbjct: 212 GEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEF----KDFLNKCLVKDP 258
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 1e-22
Identities = 64/249 (25%), Positives = 107/249 (42%), Gaps = 36/249 (14%)
Query: 21 QLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78
++ A+KQ++ + +E I E +L+ L ++ + +V EY G
Sbjct: 26 RVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGD 85
Query: 79 LED--HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF 136
L + P E W + + GL +LH K +++RD+KS N+ LD
Sbjct: 86 LHKLLKMQRGRPLPEDQVW----RFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYD 138
Query: 137 NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
N K+ D G+AKL + DNT+ + ++GT Y +PE KSD+++ GVVL E T
Sbjct: 139 NVKIGDLGVAKL--LSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCT 196
Query: 197 GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAM---C 253
G+ PF D L+ ++ G +P Y+ + + C
Sbjct: 197 GK------------------HPF--DANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236
Query: 254 LNEEANFRP 262
L ++ RP
Sbjct: 237 LTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 1e-22
Identities = 67/185 (36%), Positives = 101/185 (54%), Gaps = 11/185 (5%)
Query: 16 VWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75
W + VA+K L G + F+ E ++ L HD LV L S + +V EYM
Sbjct: 26 TWNGNTKVAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQLYA-VVSEEPIYIVTEYMS 83
Query: 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 135
GSL D L D + L + +A A G+ Y+ + N I+RDL+SANIL+ +
Sbjct: 84 KGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIE-RMN--YIHRDLRSANILVGDG 138
Query: 136 FNPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLEL 194
K++DFGLA+L + DN + + + + APE A+ G+ T+KSD++SFG++L EL
Sbjct: 139 LVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196
Query: 195 IT-GR 198
+T GR
Sbjct: 197 VTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 1e-22
Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 24/201 (11%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIV--EVLMLSLLHHDNLVTLIGYCTSGDQ 66
G+V LC +LV IKQ+ E + + E +L LL H N++
Sbjct: 14 GIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKA 73
Query: 67 RLLVYEYMPMGSLEDHLYD----LEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 122
++V EY P G+L +++ L + L + ++ +A L ++H K +++
Sbjct: 74 LMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------LHHVHTKL---ILH 124
Query: 123 RDLKSANILLDNDFNP-KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK 181
RDLK+ NILLD K+ DFG++K+ + + T V+GT Y +PE K
Sbjct: 125 RDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT-VVGTPCYISPELCEGKPYNQK 181
Query: 182 SDIYSFGVVLLELITGRKAMD 202
SDI++ G VL EL + ++A +
Sbjct: 182 SDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 2e-22
Identities = 57/180 (31%), Positives = 90/180 (50%), Gaps = 16/180 (8%)
Query: 23 VAIKQLNHEGLQG-HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
VA+K L + L +F+ E ++ L H+NL+ L G + ++V E P+GSL D
Sbjct: 26 VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLD 84
Query: 82 HLYDLEPDQEPLS--WNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 139
L +S + ++IA G+ YL K I+RDL + NILL +D K
Sbjct: 85 RLRKDALGHFLISTLCDYAVQIA----NGMRYLESKR---FIHRDLAARNILLASDDKVK 137
Query: 140 LSDFGLAKLGPVGDNTHVST---RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
+ DFGL + P ++ +V +V + +CAPE + + SD++ FGV L E+ T
Sbjct: 138 IGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 5e-22
Identities = 62/186 (33%), Positives = 89/186 (47%), Gaps = 14/186 (7%)
Query: 17 WLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76
W VAIK + EG +FI E ++ L H NLV L G CT +V EYM
Sbjct: 25 WRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83
Query: 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF 136
G L ++L + + W M V +EYL I+RDL + N L+ D
Sbjct: 84 GCLLNYLRE-RKGKLGTEWLLDMCSDV--CEAMEYLESNG---FIHRDLAARNCLVGEDN 137
Query: 137 NPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLTLKSDIYSFGVVLLE 193
K+SDFGLA+ V D+ + S+ GT + PE + + KSD++SFGV++ E
Sbjct: 138 VVKVSDFGLARY--VLDDQYTSS--QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWE 193
Query: 194 LITGRK 199
+ + K
Sbjct: 194 VFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 6e-22
Identities = 54/180 (30%), Positives = 94/180 (52%), Gaps = 14/180 (7%)
Query: 23 VAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDH 82
VA+K L G ++F+ E ++ L H L+ L CT + +V E M GSL ++
Sbjct: 33 VAVKTLK-PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEY 91
Query: 83 LYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 142
L L + +A A G+ YL + I+RDL + N+L+ + K++D
Sbjct: 92 LQGGAGRA--LKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVAD 146
Query: 143 FGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GR 198
FGLA++ + ++ + + G + APE A+ + ++KSD++SFG++L E++T GR
Sbjct: 147 FGLARV--IKEDIYEARE--GAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 8e-22
Identities = 59/187 (31%), Positives = 89/187 (47%), Gaps = 15/187 (8%)
Query: 22 LVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
LVA+K L L ++F E +L+ L H+++V G C GD ++V+EYM G L
Sbjct: 37 LVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNK 96
Query: 82 HLYDLEPDQ------EPLSWNTR------MKIAVGAARGLEYLHCKANPPVIYRDLKSAN 129
L PD +P + IA A G+ YL A+ ++RDL + N
Sbjct: 97 FLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRN 153
Query: 130 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGV 189
L+ + K+ DFG+++ D V M + PE M K T +SD++SFGV
Sbjct: 154 CLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGV 213
Query: 190 VLLELIT 196
+L E+ T
Sbjct: 214 ILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-21
Identities = 70/255 (27%), Positives = 121/255 (47%), Gaps = 20/255 (7%)
Query: 22 LVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
LVA+K L + + +F+ E+ ++S L + N++ L+G C S D ++ EYM G L
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 81 DHLYDLEPDQE--------PLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL 132
L E + +S + +AV A G++YL A+ ++RDL + N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLV 162
Query: 133 DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLL 192
N + K++DFG+++ GD + R + + A E + GK T SD+++FGV L
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLW 222
Query: 193 ELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAM 252
E+ T K S EQ ++ + F ++Q + ++L L C + +
Sbjct: 223 EMFTLCKEQPYSLLSDEQ-VIENTGEFFRNQGRQIYLSQTPL-------CPSPVFKLMMR 274
Query: 253 CLNEEANFRPLINDI 267
C + + RP N I
Sbjct: 275 CWSRDIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 3e-21
Identities = 65/191 (34%), Positives = 99/191 (51%), Gaps = 15/191 (7%)
Query: 14 GLVWLC----DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 69
G VW+ VAIK L +G + F+ E ++ L H LV L T + +
Sbjct: 20 GEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ-EPIYI 77
Query: 70 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 129
+ EYM GSL D L P+ L+ N + +A A G+ ++ K I+RDL++AN
Sbjct: 78 ITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAAN 132
Query: 130 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAMSGKLTLKSDIYSFG 188
IL+ K++DFGLA+L + DN + + + APE G T+KSD++SFG
Sbjct: 133 ILVSETLCCKIADFGLARL--IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG 190
Query: 189 VVLLELIT-GR 198
++L E++T GR
Sbjct: 191 ILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-21
Identities = 57/182 (31%), Positives = 83/182 (45%), Gaps = 13/182 (7%)
Query: 21 QLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77
++ A K+L+ + L +G Q + E +L + +V+L + D LV M G
Sbjct: 19 KMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGG 78
Query: 78 SLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF 136
L+ H+Y++ EP R A GLE+LH ++YRDLK N+LLD+
Sbjct: 79 DLKYHIYNVG---EPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHG 132
Query: 137 NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
N ++SD GLA G GT GY APE D ++ G L E+I
Sbjct: 133 NVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIA 189
Query: 197 GR 198
GR
Sbjct: 190 GR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 5e-21
Identities = 68/257 (26%), Positives = 123/257 (47%), Gaps = 19/257 (7%)
Query: 19 CDQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77
LVA+K L + + +F+ E+ ++S L N++ L+ C + D ++ EYM G
Sbjct: 45 QPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENG 104
Query: 78 SLEDHLYDLEPDQEP-------LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANI 130
L L EP + +S++T + +A A G++YL ++ ++RDL + N
Sbjct: 105 DLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNC 161
Query: 131 LLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVV 190
L+ ++ K++DFG+++ GD + R + + + E + GK T SD+++FGV
Sbjct: 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVT 221
Query: 191 LLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVT 250
L E++T K S+ EQ ++ + F +DQ + V+L P C + +
Sbjct: 222 LWEILTLCKEQPYSQLSDEQ-VIENTGEFFRDQGRQVYLPK-------PALCPDSLYKLM 273
Query: 251 AMCLNEEANFRPLINDI 267
C A RP +I
Sbjct: 274 LSCWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 8e-21
Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 35/203 (17%)
Query: 12 NVGLVWLC-----DQLVAIKQLNHEGLQGHQEFIV---EVLMLSLLHHDNLVTLIGYCTS 63
N G+V +++A+K + E + Q+ I+ ++L + +V G +
Sbjct: 13 NSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC--NSPYIVGFYGAFYN 70
Query: 64 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 123
+ EYM GSL D + + P KIAV +GL YLH K +I+R
Sbjct: 71 NGDISICMEYMDGGSL-DKILKEVQGRIPER--ILGKIAVAVLKGLTYLHEKHK--IIHR 125
Query: 124 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM--------GTYGYCAPEYAMS 175
D+K +NIL+++ KL DFG VS +++ GT Y APE
Sbjct: 126 DVKPSNILVNSRGQIKLCDFG------------VSGQLVNSLAKTFVGTSSYMAPERIQG 173
Query: 176 GKLTLKSDIYSFGVVLLELITGR 198
++KSDI+S G+ L+EL TGR
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-20
Identities = 54/177 (30%), Positives = 93/177 (52%), Gaps = 7/177 (3%)
Query: 20 DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79
VA+K L + ++ EF+ E ++ + H NLV L+G CT ++ E+M G+L
Sbjct: 31 SLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 89
Query: 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 139
D+L E +++ ++ + +A + +EYL K I+RDL + N L+ + K
Sbjct: 90 LDYLR--ECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVK 144
Query: 140 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
++DFGL++L GD + APE K ++KSD+++FGV+L E+ T
Sbjct: 145 VADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-20
Identities = 67/184 (36%), Positives = 102/184 (55%), Gaps = 11/184 (5%)
Query: 17 WLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76
W VAIK L G + F+ E ++ L HD LV L S + +V E+M
Sbjct: 27 WNGTTKVAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVPLYA-VVSEEPIYIVTEFMGK 84
Query: 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF 136
GSL D L E D + L + +A A G+ Y+ + N I+RDL++ANIL+ ++
Sbjct: 85 GSLLDFLK--EGDGKYLKLPQLVDMAAQIADGMAYIE-RMN--YIHRDLRAANILVGDNL 139
Query: 137 NPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 195
K++DFGLA+L + DN + + + + APE A+ G+ T+KSD++SFG++L EL+
Sbjct: 140 VCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELV 197
Query: 196 T-GR 198
T GR
Sbjct: 198 TKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 4e-20
Identities = 58/180 (32%), Positives = 91/180 (50%), Gaps = 18/180 (10%)
Query: 23 VAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
VA+K L E + G +EF+ E +++ L H +V LIG C G+ +LV E P+G L
Sbjct: 26 VAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLK 84
Query: 82 HLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 139
+L P + ++ A G+ YL K ++RDL + N+LL N K
Sbjct: 85 YLKKRREIPVSDLKELAHQV------AMGMAYLESKH---FVHRDLAARNVLLVNRHQAK 135
Query: 140 LSDFGLAK-LGPVGDNTHVSTRVMGTY--GYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
+SDFG+++ LG + + G + + APE GK + KSD++S+GV L E +
Sbjct: 136 ISDFGMSRALGA--GSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 6e-20
Identities = 70/262 (26%), Positives = 125/262 (47%), Gaps = 27/262 (10%)
Query: 22 LVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
LVA+K L + + +F+ EV +LS L N++ L+G C D ++ EYM G L
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 81 DHL--YDLEPDQEP-------------LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 125
L + L+ +E +S+++ + +A+ A G++YL ++ ++RDL
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDL 164
Query: 126 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIY 185
+ N L+ + K++DFG+++ GD + R + + A E + GK T SD++
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVW 224
Query: 186 SFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNY 245
+FGV L E++ K + EQ ++ + F +DQ + V+L R P C
Sbjct: 225 AFGVTLWEILMLCKEQPYGELTDEQ-VIENAGEFFRDQGRQVYL------FR-PPPCPQG 276
Query: 246 AVAVTAMCLNEEANFRPLINDI 267
+ C + + RP +DI
Sbjct: 277 LYELMLQCWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 6e-20
Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 33/204 (16%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHHDNLVTLIGYCTSGD 65
G V+L + AIK + + + + E +LS +V L Y G
Sbjct: 7 GRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSFQGK 65
Query: 66 QRL-LVYEYMPMG---SLEDHLYDLEPDQEPLSWNTRMKIA--VGAARGLEYLHCKANPP 119
+ L LV EY+P G SL +++ L+ D R+ IA V A LEYLH +
Sbjct: 66 KNLYLVMEYLPGGDLASLLENVGSLDED------VARIYIAEIVLA---LEYLH---SNG 113
Query: 120 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS------TRVMGTYGYCAPEYA 173
+I+RDLK NIL+D++ + KL+DFGL+K+G V +++ R++GT Y APE
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 174 MSGKLTLKSDIYSFGVVLLELITG 197
+ + D +S G +L E + G
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 2e-19
Identities = 54/182 (29%), Positives = 91/182 (50%), Gaps = 19/182 (10%)
Query: 22 LVAIKQLNHEGLQGHQ--EFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79
VAIK L G Q +F+ E ++ H N++ L G T +++ EYM GSL
Sbjct: 34 DVAIKTL-KAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSL 92
Query: 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 139
+ L E D + + + + G A G++YL + ++RDL + NIL++++ K
Sbjct: 93 DKFLR--ENDGK-FTVGQLVGMLRGIASGMKYL---SEMNYVHRDLAARNILVNSNLVCK 146
Query: 140 LSDFGLAKLGPVGDNTHVSTRVMGTYG-----YCAPEYAMSGKLTLKSDIYSFGVVLLEL 194
+SDFG L +++ + G G + APE K T SD++SFG+V+ E+
Sbjct: 147 VSDFG---LSRRLEDSEATYTTKG--GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEV 201
Query: 195 IT 196
++
Sbjct: 202 MS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-19
Identities = 54/162 (33%), Positives = 85/162 (52%), Gaps = 13/162 (8%)
Query: 42 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI 101
E+ +L L H+N+V +G D + EY+P GS+ L + +E L N +I
Sbjct: 56 EIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQI 115
Query: 102 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-----LGPVGDNTH 156
+GL YLH N +I+RD+K ANIL+DN K+SDFG++K N
Sbjct: 116 L----KGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGA 168
Query: 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 198
+ + G+ + APE T K+DI+S G +++E++TG+
Sbjct: 169 RPS-LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (212), Expect = 3e-19
Identities = 62/195 (31%), Positives = 97/195 (49%), Gaps = 21/195 (10%)
Query: 14 GLVWLC-----DQLVAIKQL----NHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG 64
G+V+ ++VA+K++ EG+ + E+ +L L H N+V L+ +
Sbjct: 13 GVVYKARDKKTGEIVALKKIRLDNEEEGIP--STALREISLLKELKHPNIVKLLDVIHTE 70
Query: 65 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 124
+ LV+EY M L+ +L PLS N I RGL Y H +++RD
Sbjct: 71 RKLYLVFEYCDM-DLKKYLDKRPG---PLSPNLIKSIMYQLLRGLAYCHSHR---ILHRD 123
Query: 125 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSD 183
LK NIL++ D KL+DFGLA+ + T+ + V+ T Y APE + K + D
Sbjct: 124 LKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-TLWYRAPEILLGSKHYSTAVD 181
Query: 184 IYSFGVVLLELITGR 198
I+S G + E+ITG+
Sbjct: 182 IWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 3e-19
Identities = 63/190 (33%), Positives = 96/190 (50%), Gaps = 18/190 (9%)
Query: 14 GLV----WLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 69
GLV WL + VAIK + EG ++FI E ++ L H LV L G CT L
Sbjct: 18 GLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICL 76
Query: 70 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 129
V+E+M G L D+ L + S T + + + G+ YL VI+RDL + N
Sbjct: 77 VFEFMEHGCLSDY---LRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARN 130
Query: 130 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLTLKSDIYS 186
L+ + K+SDFG+ + V D+ + S+ GT + +PE K + KSD++S
Sbjct: 131 CLVGENQVVKVSDFGMTRF--VLDDQYTSST--GTKFPVKWSSPEVFSFSKYSSKSDVWS 186
Query: 187 FGVVLLELIT 196
FGV++ E+ +
Sbjct: 187 FGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-19
Identities = 58/184 (31%), Positives = 88/184 (47%), Gaps = 12/184 (6%)
Query: 22 LVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
LVA+K L ++F E +L+ L H+++V G C GD ++V+EYM G L
Sbjct: 37 LVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNK 96
Query: 82 HLYDLEPDQ---------EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL 132
L PD L+ + + IA A G+ YL A+ ++RDL + N L+
Sbjct: 97 FLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLV 153
Query: 133 DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLL 192
+ K+ DFG+++ D V M + PE M K T +SD++S GVVL
Sbjct: 154 GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLW 213
Query: 193 ELIT 196
E+ T
Sbjct: 214 EIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-19
Identities = 57/177 (32%), Positives = 92/177 (51%), Gaps = 14/177 (7%)
Query: 23 VAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDH 82
VAIK + EG EFI E ++ L H+ LV L G CT +V EYM G L ++
Sbjct: 31 VAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNY 89
Query: 83 LYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 142
L + +P +++ G+ YL K I+RDL + N L+D+ K+SD
Sbjct: 90 LREHGKRFQPSQL---LEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSD 143
Query: 143 FGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
FGL++ V D+ + S+ +G+ + PE + K + KSD+++FGV++ E+ +
Sbjct: 144 FGLSRY--VLDDEYTSS--VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 5e-19
Identities = 54/197 (27%), Positives = 85/197 (43%), Gaps = 34/197 (17%)
Query: 21 QLVAIKQLNHEGLQGH--QEFIVEVLMLSLLHHDNLVTLIG---------------YCTS 63
+++ K++++ + Q+ + EV +L L H N+V YC
Sbjct: 26 KILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEG 85
Query: 64 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH--CKANPPVI 121
GD L+ + ++ Y +E E W +I L H V+
Sbjct: 86 GDLAQLIQKCK-----KERKY-IE---EEFIW----RILTQLLLALYECHNRSDPGNTVL 132
Query: 122 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK 181
+RDLK ANI LD + N KL DFGLAK+ +G ++ + +GT Y +PE K
Sbjct: 133 HRDLKPANIFLDANNNVKLGDFGLAKI--LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEK 190
Query: 182 SDIYSFGVVLLELITGR 198
SDI+S G ++ EL
Sbjct: 191 SDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 5e-19
Identities = 68/257 (26%), Positives = 114/257 (44%), Gaps = 26/257 (10%)
Query: 23 VAIKQLN-HEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
VAIK +N + ++ EF+ E ++ + ++V L+G ++G L+V E M G L+
Sbjct: 39 VAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKS 98
Query: 82 HLYDLEPDQE------PLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 135
+L P+ E P + +++A A G+ YL K ++RDL + N ++ D
Sbjct: 99 YLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAED 155
Query: 136 FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 195
K+ DFG+ + D + + + APE G T KSD++SFGVVL E+
Sbjct: 156 LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMA 215
Query: 196 TGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLN 255
T A +G + ++ F+ D H P C + + + MC
Sbjct: 216 T--LAEQPYQGLSNEEVLK----FVIDGG----------HLDLPENCPDKLLELMRMCWQ 259
Query: 256 EEANFRPLINDIVVALD 272
RP +IV +L
Sbjct: 260 YNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 6e-19
Identities = 58/181 (32%), Positives = 94/181 (51%), Gaps = 20/181 (11%)
Query: 23 VAIKQL-NHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
VAIK + + G Q QE +L + L H +V L+G C G LV + P+GSL D
Sbjct: 39 VAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLD 97
Query: 82 HLY----DLEPDQEPLSWNTRMKIAVGAARGLEYL--HCKANPPVIYRDLKSANILLDND 135
H+ L+P Q L+W V A+G+ YL H +++R+L + NILL +D
Sbjct: 98 HVRQHRDSLDP-QRLLNW------CVQIAKGMYYLEEHR-----MVHRNLAARNILLKSD 145
Query: 136 FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 195
+++DFG+A L D + + + A E + G+ T +SD++S+GV + E++
Sbjct: 146 SIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMM 205
Query: 196 T 196
+
Sbjct: 206 S 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 7e-19
Identities = 49/161 (30%), Positives = 81/161 (50%), Gaps = 6/161 (3%)
Query: 37 QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWN 96
++F+ E +L H N+V LIG C +V E +P GSL L + L+
Sbjct: 37 RKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTF---LRKKKNRLTVK 93
Query: 97 TRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156
+++++ AA G+EYL K I+RDL + N L+ + K+SDFG+++ G T
Sbjct: 94 KLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV 150
Query: 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 197
+ APE G+ T +SD++S+G++L E +
Sbjct: 151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 7e-19
Identities = 59/176 (33%), Positives = 92/176 (52%), Gaps = 11/176 (6%)
Query: 23 VAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDH 82
VA+K L G Q F+ E ++ L HD LV L T + ++ EYM GSL D
Sbjct: 33 VAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDF 91
Query: 83 LYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 142
L E + L + + A G+ Y+ K I+RDL++AN+L+ K++D
Sbjct: 92 LKSDEGGKVLLP--KLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIAD 146
Query: 143 FGLAKLGPVGDNTHVSTRVMGTY--GYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
FGLA++ + DN + + R + + APE G T+KSD++SFG++L E++T
Sbjct: 147 FGLARV--IEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 9e-19
Identities = 55/164 (33%), Positives = 90/164 (54%), Gaps = 14/164 (8%)
Query: 37 QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWN 96
Q F+ E +++ LHH NLV L+G + +V E M G+L + L +
Sbjct: 44 QAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVI-- 100
Query: 97 TRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG-DNT 155
++ ++ A G+EYL K +++RDL + NIL+ D K+SDFGLA++G +G DN+
Sbjct: 101 QLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNS 157
Query: 156 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GR 198
+ + + APE K + KSD++S+GV+L E+ + GR
Sbjct: 158 KLPVK------WTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-18
Identities = 60/190 (31%), Positives = 93/190 (48%), Gaps = 17/190 (8%)
Query: 21 QLVAIKQL-NHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79
QLVAIK L + Q EF E +++ LHH N+V L+G T +++EY+ G L
Sbjct: 35 QLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDL 94
Query: 80 EDHLYDLEPDQE-------------PLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 126
+ L P + L + IA+ A G+EYL ++ +++DL
Sbjct: 95 HEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLA 151
Query: 127 SANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYS 186
+ NIL+ + K+SD GL++ D V + + + PE M GK + SDI+S
Sbjct: 152 ARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWS 211
Query: 187 FGVVLLELIT 196
FGVVL E+ +
Sbjct: 212 FGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-18
Identities = 75/269 (27%), Positives = 122/269 (45%), Gaps = 48/269 (17%)
Query: 23 VAIKQLNH-EGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD-QRLLVYEYMPMGSLE 80
A+K LN L+ ++F+ E +++ H N+++L+G C + L+V YM G L
Sbjct: 26 CAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLR 85
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVG----AARGLEYLHCKANPPVIYRDLKSANILLDNDF 136
+ + + N +K +G A+G+EYL A+ ++RDL + N +LD F
Sbjct: 86 NFIRSE-------THNPTVKDLIGFGLQVAKGMEYL---ASKKFVHRDLAARNCMLDESF 135
Query: 137 NPKLSDFGLAK------LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVV 190
K++DFGLA+ V ++T V + A E + K T KSD++SFGV+
Sbjct: 136 TVKVADFGLARDIYDKEYYSVHNHTGAKLPVK----WMALESLQTQKFTTKSDVWSFGVL 191
Query: 191 LLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR---YPRRCLNYAV 247
L EL+T R A P D F + LL GR P C +
Sbjct: 192 LWELMT-RGA-----------------PPYPDVDSF-DITVYLLQGRRLLQPEYCPDPLY 232
Query: 248 AVTAMCLNEEANFRPLINDIVVALDYLVS 276
V C + + RP +++V ++ + S
Sbjct: 233 EVMLSCWHPKPEMRPTFSELVSRIEQIFS 261
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-18
Identities = 55/183 (30%), Positives = 96/183 (52%), Gaps = 16/183 (8%)
Query: 21 QLVAIKQLNHEGLQGH-QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR--LLVYEYMPMG 77
+ VA+K L E H + E+ +L L+H+N+V G CT L+ E++P G
Sbjct: 34 EQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSG 93
Query: 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 137
SL+++L ++ ++ ++K AV +G++YL + ++RDL + N+L++++
Sbjct: 94 SLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQ 147
Query: 138 PKLSDFGLAKLGPVGDNTHVST----RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLE 193
K+ DFGL K + + T + Y APE + K + SD++SFGV L E
Sbjct: 148 VKIGDFGLTK--AIETDKEYYTVKDDLDSPVFWY-APECLIQSKFYIASDVWSFGVTLYE 204
Query: 194 LIT 196
L+T
Sbjct: 205 LLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-18
Identities = 57/190 (30%), Positives = 95/190 (50%), Gaps = 15/190 (7%)
Query: 20 DQLVAIKQLNHEGLQGHQEFIV--EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77
D LV K++N L + E+++LSLL H N++ + + L+ EY G
Sbjct: 25 DSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGG 84
Query: 78 SLED---HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN 134
+L D ++E + W + +A + Y+H KA +++RD+K+ NI L
Sbjct: 85 TLYDKIVRQKGQLFEEEMVLW---YLFQIVSA--VSYIH-KAG--ILHRDIKTLNIFLTK 136
Query: 135 DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLEL 194
KL DFG++K+ +G ++ V+GT Y +PE K KSDI++ G VL EL
Sbjct: 137 AGLIKLGDFGISKI--LGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYEL 194
Query: 195 ITGRKAMDLS 204
+T ++ D +
Sbjct: 195 LTLKRTFDAT 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 3e-18
Identities = 58/187 (31%), Positives = 88/187 (47%), Gaps = 18/187 (9%)
Query: 22 LVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79
L+A+K++ + +E E+ +L LL H NLV G ++ + EY G+L
Sbjct: 27 LMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTL 86
Query: 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 139
E+ L E + + GL YLH +++RD+K ANI LD++ K
Sbjct: 87 EELLEHGRILDE----HVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIK 139
Query: 140 LSDFGLAKLGPVGDNTHVSTRVM----GTYGYCAPEYAMSGKLTLK---SDIYSFGVVLL 192
L DFG A + +NT + GT Y APE GK +DI+S G V+L
Sbjct: 140 LGDFGCAVK--LKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVL 197
Query: 193 ELITGRK 199
E+ TG++
Sbjct: 198 EMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-18
Identities = 48/172 (27%), Positives = 74/172 (43%), Gaps = 23/172 (13%)
Query: 36 HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL--VYEYMPMGSLEDHLYDLEPDQEPL 93
++ + E+ + +V G + EY GSL D +Y ++
Sbjct: 43 QKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIY-----KKVK 96
Query: 94 SWNTRM------KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA- 146
R+ KIA +GL YLH + +I+RD+K +NILL KL DFG++
Sbjct: 97 KRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSG 153
Query: 147 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 198
+L T GT Y APE ++ SD++S G+ LLE+ R
Sbjct: 154 ELVNSLAGTFT-----GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 3e-18
Identities = 56/183 (30%), Positives = 92/183 (50%), Gaps = 11/183 (6%)
Query: 22 LVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
LVA+K L + ++F+ EV +LS L N+ L+G CT ++ EYM G L
Sbjct: 48 LVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107
Query: 81 DHLYDLEP-------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD 133
L + + LS++T + +A A G+ YL + ++RDL + N L+
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVG 164
Query: 134 NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLE 193
++ K++DFG+++ D V R + A E + GK T KSD+++FGV L E
Sbjct: 165 KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWE 224
Query: 194 LIT 196
++T
Sbjct: 225 ILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 3e-18
Identities = 58/220 (26%), Positives = 89/220 (40%), Gaps = 54/220 (24%)
Query: 16 VWLC-----DQLVAIKQLNHEGL--QGHQEFI-VEVLMLSLL-HHDNLVTLIGYCTSGDQ 66
V L ++ AIK L+ L + +++ +E +L+ L H ++ L Y T D+
Sbjct: 17 VVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL--YYTFQDE 74
Query: 67 RLL--VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR--------GLEYLHCKA 116
L V EY P G L ++ + R LEYLH K
Sbjct: 75 ENLYFVLEYAPNGELLQYI------------RKYGSLDEKCTRFYAAEILLALEYLHSKG 122
Query: 117 NPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVM------------- 162
+I+RDLK NILLD D + K++DFG AK L P
Sbjct: 123 ---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179
Query: 163 ----GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 198
GT Y +PE SD+++ G ++ +++TG+
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 4e-18
Identities = 63/179 (35%), Positives = 98/179 (54%), Gaps = 14/179 (7%)
Query: 21 QLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79
Q VAIKQ+N + Q +E I+ E+L++ H N+V + GD+ +V EY+ GSL
Sbjct: 45 QEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSL 103
Query: 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 139
D + + D+ ++ R + + LE+LH VI+RD+KS NILL D + K
Sbjct: 104 TDVVTETCMDEGQIAAVCRECL-----QALEFLHSNQ---VIHRDIKSDNILLGMDGSVK 155
Query: 140 LSDFGL-AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 197
L+DFG A++ P + + ST V GT + APE K DI+S G++ +E++ G
Sbjct: 156 LTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 4e-18
Identities = 57/181 (31%), Positives = 86/181 (47%), Gaps = 16/181 (8%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
Q+VAIK + E QE I E+ +L +V G +V EY GS+
Sbjct: 29 QVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVS 86
Query: 81 DHLYDLEPDQEPLSWNTRMKIAV---GAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 137
D + + + L T +IA +GLEYLH I+RD+K+ NILL+ +
Sbjct: 87 DIM---KITNKTL---TEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQ 137
Query: 138 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 197
KL+DFG++ G + D V+GT + APE K+DI+S G+ +E+ G
Sbjct: 138 AKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEG 195
Query: 198 R 198
+
Sbjct: 196 K 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 5e-18
Identities = 58/195 (29%), Positives = 86/195 (44%), Gaps = 22/195 (11%)
Query: 12 NVGLVWL-----CDQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIGYCTSGD 65
+ G V+ +Q+VAIK ++ E + E I E+ LS + G G
Sbjct: 13 SFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS 72
Query: 66 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV---GAARGLEYLHCKANPPVIY 122
+ ++ EY GS D L E IA GLEYLH + I+
Sbjct: 73 KLWIIMEYCGGGSCLD-LLKPGKLDE-------TYIAFILREVLLGLEYLHEEG---KIH 121
Query: 123 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKS 182
RD+K+ANILL + + KL+DFG++ G + +GT + APE K+
Sbjct: 122 RDIKAANILLSEEGDVKLADFGVS--GQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKA 179
Query: 183 DIYSFGVVLLELITG 197
DI+S G+ +EL G
Sbjct: 180 DIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 6e-18
Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 16/225 (7%)
Query: 20 DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79
+ VA+K+++ Q + EV+++ H N+V + GD+ +V E++ G+L
Sbjct: 44 GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103
Query: 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 139
D + ++E ++ + + + L +LH + VI+RD+KS +ILL +D K
Sbjct: 104 TDIVTHTRMNEEQIA-----TVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVK 155
Query: 140 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 199
LSDFG V ++GT + APE + DI+S G++++E++ G
Sbjct: 156 LSDFGFC--AQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEP 213
Query: 200 A-MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCL 243
+ Q + + P LK+ K V P L + R L
Sbjct: 214 PYFNEPPLQAMKRIRDNLPPKLKNLHK----VSPRLRS-FLDRML 253
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-18
Identities = 61/191 (31%), Positives = 100/191 (52%), Gaps = 15/191 (7%)
Query: 14 GLVWLCD----QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 69
G VW+ VA+K + G + F+ E ++ L HD LV L T + +
Sbjct: 20 GEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI 77
Query: 70 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 129
+ E+M GSL D L E ++PL + + A G+ ++ + N I+RDL++AN
Sbjct: 78 ITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIE-QRN--YIHRDLRAAN 132
Query: 130 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAMSGKLTLKSDIYSFG 188
IL+ K++DFGLA++ + DN + + + APE G T+KSD++SFG
Sbjct: 133 ILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFG 190
Query: 189 VVLLELIT-GR 198
++L+E++T GR
Sbjct: 191 ILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 9e-18
Identities = 58/195 (29%), Positives = 92/195 (47%), Gaps = 20/195 (10%)
Query: 14 GLVWLCDQL-----VAIKQLNHEGLQGH-----QEFIVEVLMLSLLHHDNLVTLIGYCTS 63
G V+LC + +A+KQ+ + E+ +L L H+ +V G C
Sbjct: 16 GRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYG-CLR 74
Query: 64 GDQRLLVY-EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 122
D+ L ++ EYMP GS++D L L+ K G+EYLH +++
Sbjct: 75 DDETLSIFMEYMPGGSVKDQL----KAYGALTETVTRKYTRQILEGVEYLHSNM---IVH 127
Query: 123 RDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK 181
RD+K ANIL D+ N KL DFG +K L + + V GT + +PE K
Sbjct: 128 RDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRK 187
Query: 182 SDIYSFGVVLLELIT 196
+D++S G ++E++T
Sbjct: 188 ADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-17
Identities = 64/184 (34%), Positives = 98/184 (53%), Gaps = 11/184 (5%)
Query: 17 WLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76
W VAIK L G + F+ E ++ L H+ LV L S + +V EYM
Sbjct: 27 WNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSEEPIYIVTEYMSK 84
Query: 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF 136
GSL D L + L + +A A G+ Y+ + N ++RDL++ANIL+ +
Sbjct: 85 GSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE-RMN--YVHRDLRAANILVGENL 139
Query: 137 NPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 195
K++DFGLA+L + DN + + + + APE A+ G+ T+KSD++SFG++L EL
Sbjct: 140 VCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 197
Query: 196 T-GR 198
T GR
Sbjct: 198 TKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-17
Identities = 62/193 (32%), Positives = 96/193 (49%), Gaps = 27/193 (13%)
Query: 23 VAIKQLNHEGLQGH-QEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
VA+K L + + + I E+ M+ ++ H N++ L+G CT ++ EY G+L
Sbjct: 53 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 112
Query: 81 DHL---------YDLEPDQEP---LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 128
++L Y P Q P LS+ + A ARG+EYL A+ I+RDL +
Sbjct: 113 EYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAAR 169
Query: 129 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----YCAPEYAMSGKLTLKSD 183
N+L+ D K++DFGLA+ D H+ T G + APE T +SD
Sbjct: 170 NVLVTEDNVMKIADFGLAR-----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 224
Query: 184 IYSFGVVLLELIT 196
++SFGV+L E+ T
Sbjct: 225 VWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-17
Identities = 57/181 (31%), Positives = 88/181 (48%), Gaps = 8/181 (4%)
Query: 21 QLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77
+L A K+LN + L +G++ +VE +L+ +H +V+L + LV M G
Sbjct: 19 KLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGG 78
Query: 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 137
L H+Y+++ + GLE+LH + +IYRDLK N+LLDND N
Sbjct: 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGN 135
Query: 138 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 197
++SD GLA + D + GT G+ APE + D ++ GV L E+I
Sbjct: 136 VRISDLGLAV--ELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAA 193
Query: 198 R 198
R
Sbjct: 194 R 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-17
Identities = 58/179 (32%), Positives = 92/179 (51%), Gaps = 16/179 (8%)
Query: 23 VAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLED 81
VA+K + ++ Q F+ E +++ L H NLV L+G L +V EYM GSL D
Sbjct: 32 VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD 89
Query: 82 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 141
+L + L + +K ++ +EYL +AN ++RDL + N+L+ D K+S
Sbjct: 90 YLR--SRGRSVLGGDCLLKFSLDVCEAMEYL--EANN-FVHRDLAARNVLVSEDNVAKVS 144
Query: 142 DFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GR 198
DFGL K D + + + APE K + KSD++SFG++L E+ + GR
Sbjct: 145 DFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-17
Identities = 72/260 (27%), Positives = 113/260 (43%), Gaps = 32/260 (12%)
Query: 17 WLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76
W VAIK +N EG ++FI E ++ L H LV L G CT +V E+M
Sbjct: 25 WRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83
Query: 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF 136
G L L L Q LS + + + G+EYL + I+RDL + N L+ +
Sbjct: 84 GCL---LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTG 137
Query: 137 NPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 195
K+SDFG+ + V D+ + S+ + PE K + KSD++SFGV++ E+
Sbjct: 138 VVKVSDFGMTRY--VLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVF 195
Query: 196 TGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR---YPRRCLNYAVAVTAM 252
T K PF ++K +V+ + G P+ V
Sbjct: 196 TEGKM-----------------PF--EKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYS 236
Query: 253 CLNEEANFRPLINDIVVALD 272
C +E+ RP +++ A+
Sbjct: 237 CWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-17
Identities = 50/183 (27%), Positives = 85/183 (46%), Gaps = 10/183 (5%)
Query: 20 DQLVAIKQLNHEGLQGHQ-EFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78
+ LV +K L + Q EF E+ M L H N+V L+G C + ++ EY +G
Sbjct: 35 ETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGD 94
Query: 79 LEDHL-----YDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD 133
L+ L D + PLS ++ + A G+++L +N ++RDL + N L+
Sbjct: 95 LKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVS 151
Query: 134 NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLE 193
+ K+S L+K + + + APE + KSD++SFGV++ E
Sbjct: 152 SQREVKVSLLSLSK-DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWE 210
Query: 194 LIT 196
+ T
Sbjct: 211 VFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 80.2 bits (197), Expect = 3e-17
Identities = 60/178 (33%), Positives = 96/178 (53%), Gaps = 12/178 (6%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
Q VAIKQ+N + + I E+L++ L + N+V + GD+ +V EY+ GSL
Sbjct: 45 QEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT 104
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 140
D + + D+ ++ R + + LE+LH VI+RD+KS N+LL D + KL
Sbjct: 105 DVVTETCMDEAQIAAVCRECL-----QALEFLHANQ---VIHRDIKSDNVLLGMDGSVKL 156
Query: 141 SDFGL-AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 197
+DFG A++ P + + ST V GT + APE K DI+S G++ +E++ G
Sbjct: 157 TDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 56/193 (29%), Positives = 93/193 (48%), Gaps = 19/193 (9%)
Query: 21 QLVAIKQLNHEGLQGHQE---FIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL-VYEYMPM 76
VAIK L + + + F E + + L+H N+V L+ + L V+EY+P
Sbjct: 4 HEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPG 63
Query: 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---D 133
+L + L L ++ + L+ L C N +++RDLK NI++
Sbjct: 64 RTLREVL----AADGALPAGETGRLM---LQVLDALACAHNQGIVHRDLKPQNIMVSQTG 116
Query: 134 NDFNPKLSDFGLAKLGP-VGDNTHV----STRVMGTYGYCAPEYAMSGKLTLKSDIYSFG 188
+ K+ DFG+ L P V D +T V+GT YCAPE +T SD+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 189 VVLLELITGRKAM 201
++ LE +TG++ +
Sbjct: 177 LIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 5e-17
Identities = 62/181 (34%), Positives = 89/181 (49%), Gaps = 17/181 (9%)
Query: 20 DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79
+LVAIK + E + E+ ML H N+V G D+ +V EY GSL
Sbjct: 28 GELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSL 87
Query: 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 139
+D +Y + + PLS + +GL YLH I+RD+K ANILL D + K
Sbjct: 88 QD-IYQV--TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVK 141
Query: 140 LSDFGL-AKLGPVGDNTHVSTR--VMGTYGYCAPEYA---MSGKLTLKSDIYSFGVVLLE 193
L+DFG+ A+L T ++ R +GT + APE A G K DI++ G+ +E
Sbjct: 142 LADFGVSAQL----TAT-IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIE 196
Query: 194 L 194
L
Sbjct: 197 L 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-17
Identities = 66/256 (25%), Positives = 119/256 (46%), Gaps = 26/256 (10%)
Query: 23 VAIKQLNHEGLQGH-QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
VAIK L + Q+F+ E ++ H N++ L G T +++ EYM G+L+
Sbjct: 36 VAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDK 95
Query: 82 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 141
+L D + + ++ G A G++YL ++ ++RDL + NIL++++ K+S
Sbjct: 96 YLRDHDGEFSSYQLVGMLR---GIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVS 149
Query: 142 DFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 200
DFGL++ L + T+ ++ + APE K T SD++SFG+V+ E+++
Sbjct: 150 DFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS---- 205
Query: 201 MDLSKGQGEQNLVSWSRPFLK-DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEAN 259
GE RP+ + + ++ P C + + C ++
Sbjct: 206 ------FGE-------RPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRA 252
Query: 260 FRPLINDIVVALDYLV 275
RP DIV LD L+
Sbjct: 253 RRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 5e-17
Identities = 61/201 (30%), Positives = 88/201 (43%), Gaps = 38/201 (18%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGL--QGHQEFIV-EVLMLSLLHHDNLVTLIGYCTSGD 65
G V L + A+K L+ + E ++ E +L + H LV L G D
Sbjct: 15 GRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG-SFQDD 73
Query: 66 QRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR--------GLEYLHCKA 116
L LV EY+P G L HL + AR LEYLH
Sbjct: 74 SNLYLVMEYVPGGELFSHL------------RKSGRFPEPVARFYAAQVVLALEYLH--- 118
Query: 117 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG 176
+ ++YRDLK N+LLD+D K++DFG AK V T+ + GT Y APE +S
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFAKR--VKGRTYT---LCGTPEYLAPEIILSK 173
Query: 177 KLTLKSDIYSFGVVLLELITG 197
D ++ G+++ E++ G
Sbjct: 174 GYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 7e-17
Identities = 55/202 (27%), Positives = 89/202 (44%), Gaps = 34/202 (16%)
Query: 20 DQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78
+VA+K L E +F E +++ H N+V L+G C G L++EYM G
Sbjct: 35 FTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGD 94
Query: 79 LEDHLYDLEP------------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 120
L + L P + PLS ++ IA A G+ YL +
Sbjct: 95 LNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYL---SERKF 151
Query: 121 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD------NTHVSTRVMGTYGYCAPEYAM 174
++RDL + N L+ + K++DFGL++ D N + R M PE
Sbjct: 152 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWM------PPESIF 205
Query: 175 SGKLTLKSDIYSFGVVLLELIT 196
+ T +SD++++GVVL E+ +
Sbjct: 206 YNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 9e-17
Identities = 52/196 (26%), Positives = 83/196 (42%), Gaps = 22/196 (11%)
Query: 14 GLVWLC-----DQLVAIKQL--NHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 66
G+V C ++VAIK+ + + + + EV +L L H+N+V L +
Sbjct: 15 GVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGR 74
Query: 67 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 126
LV+EY+ LE LE L + + + Y H +I+RD+K
Sbjct: 75 LYLVFEYVERTLLEL----LEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIK 127
Query: 127 SANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE----YAMSGKLTLKS 182
NIL+ KL DFG A+ + ++ V T Y APE GK
Sbjct: 128 PENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLVGDTNYGK---PV 183
Query: 183 DIYSFGVVLLELITGR 198
D+++ G ++ EL+ G
Sbjct: 184 DVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 9e-17
Identities = 55/181 (30%), Positives = 91/181 (50%), Gaps = 10/181 (5%)
Query: 23 VAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
VAIK +N ++ EF+ E ++ + ++V L+G + G L++ E M G L+
Sbjct: 39 VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 98
Query: 82 HLYDLEPDQE------PLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 135
+L L P+ E P S +++A A G+ YL+ AN ++RDL + N ++ D
Sbjct: 99 YLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN--AN-KFVHRDLAARNCMVAED 155
Query: 136 FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 195
F K+ DFG+ + D + + + +PE G T SD++SFGVVL E+
Sbjct: 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 215
Query: 196 T 196
T
Sbjct: 216 T 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 32/202 (15%)
Query: 8 CKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIV------EVLMLSLLHHDNLVTLIGYC 61
K + L ++VAIK++ + + E+ +L L+H N++ L+
Sbjct: 16 YKARDK----LTGEIVAIKKI----KLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF 67
Query: 62 TSGDQRLLVYEYMPMGSLEDHLYDLEPD-QEPLSWNTRMKIAVGAARGLEYLHCKANPPV 120
LV+E+M + LY L D Q L + +GL + H +
Sbjct: 68 RHKGDLYLVFEFM-----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH-SHG--I 119
Query: 121 IYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNTH-VSTRVMGTYGYCAPEYAM-SG 176
++RDLK N+L++ + KL+DFGLA+ PV TH V TR Y APE +
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGDK 174
Query: 177 KLTLKSDIYSFGVVLLELITGR 198
+ DI+S G + EL++ R
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-16
Identities = 53/175 (30%), Positives = 90/175 (51%), Gaps = 10/175 (5%)
Query: 23 VAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDH 82
VA+K+++ Q + EV+++ HH+N+V + GD+ +V E++ G+L D
Sbjct: 50 VAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDI 109
Query: 83 LYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 142
+ ++E ++ + + R L YLH N VI+RD+KS +ILL +D KLSD
Sbjct: 110 VTHTRMNEEQIA-----TVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSD 161
Query: 143 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 197
FG V ++GT + APE + DI+S G++++E+I G
Sbjct: 162 FGFC--AQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 2e-16
Identities = 62/169 (36%), Positives = 79/169 (46%), Gaps = 17/169 (10%)
Query: 34 QGHQEFIV-EVLMLSLLHHDNLVTLIGYCTSGDQRLLVY---EYMPMGSLEDHLYDLEPD 89
G QE I E +L +H +V L Y T D++ +Y EY G L L D
Sbjct: 34 TGQQEHIFSEKEILEECNHPFIVKL--YRTFKDKKY-IYMLMEYCLGGELWTILRDRGLF 90
Query: 90 QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 149
E + R IA EYLH N +IYRDLK N+LLD++ KL DFG AK
Sbjct: 91 DE---YTARFYIA-CVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL 143
Query: 150 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 198
G T GT Y APE ++ D +S G++L EL+TGR
Sbjct: 144 KSGQKTWT---FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 69/263 (26%), Positives = 110/263 (41%), Gaps = 38/263 (14%)
Query: 21 QLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79
Q VAIK L + +EF E +M S L H N+V L+G T +++ Y L
Sbjct: 36 QAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDL 95
Query: 80 EDHLYDLEPDQ---------------EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 124
+ L P EP + + I A G+E+L ++ V+++D
Sbjct: 96 HEFLVMRSPHSDVGSTDDDKTVKSTLEPADF---VHIVTQIAAGMEFL---SSHHVVHKD 149
Query: 125 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDI 184
L + N+L+ + N K+SD GL + D + + + +PE M GK ++ SDI
Sbjct: 150 LATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDI 209
Query: 185 YSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLN 244
+S+GVVL E+ + + G Q+++ R V P P C
Sbjct: 210 WSYGVVLWEVFS--YGLQPYCGYSNQDVIEMIRN---------RQVLPC-----PDDCPA 253
Query: 245 YAVAVTAMCLNEEANFRPLINDI 267
+ + C NE + RP DI
Sbjct: 254 WVYTLMLECWNEFPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-16
Identities = 76/273 (27%), Positives = 115/273 (42%), Gaps = 37/273 (13%)
Query: 20 DQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78
+ VA+K +N L+ EF+ E ++ ++V L+G + G L+V E M G
Sbjct: 36 ETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGD 95
Query: 79 LEDHLYDLEPDQE------PLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL 132
L+ +L L P+ E P + +++A A G+ YL+ K ++RDL + N ++
Sbjct: 96 LKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMV 152
Query: 133 DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLL 192
+DF K+ DFG+ + D + + + APE G T SD++SFGVVL
Sbjct: 153 AHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLW 212
Query: 193 ELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRY---PRRCLNYAVAV 249
E IT EQ L KFV + G Y P C +
Sbjct: 213 E-ITSLAEQPYQGLSNEQVL------------KFV------MDGGYLDQPDNCPERVTDL 253
Query: 250 TAMCLNEEANFRPLINDIVVALDYLVSQRDSHP 282
MC RP +IV L + D HP
Sbjct: 254 MRMCWQFNPKMRPTFLEIVNLL-----KDDLHP 281
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-16
Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 30/206 (14%)
Query: 14 GLVWLC-----DQLVAIKQ--LNHEGLQGHQEFIV--------EVLMLSLLHHDNLVTLI 58
G V+L +++A+KQ L H E+ L L H N+V +
Sbjct: 15 GRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYL 74
Query: 59 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 118
G+ T+ + + EY+P GS+ L +E L ++ GL YLH K
Sbjct: 75 GFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL----EGLAYLHSKG-- 128
Query: 119 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM---GTYGYCAPEYAMS 175
+++RDLK+ N+L+D D K+SDFG++K D+ + + + M G+ + APE S
Sbjct: 129 -ILHRDLKADNLLVDADGICKISDFGISKK---SDDIYDNDQNMSMQGSVFWMAPEVIHS 184
Query: 176 GK--LTLKSDIYSFGVVLLELITGRK 199
+ K DI+S G V+LE+ GR+
Sbjct: 185 YSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 4e-16
Identities = 63/229 (27%), Positives = 108/229 (47%), Gaps = 31/229 (13%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
+LVA+K+++ Q + EV+++ H+N+V + GD+ +V E++ G+L
Sbjct: 46 KLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 140
D + ++E ++ + + + L LH + VI+RD+KS +ILL +D KL
Sbjct: 106 DIVTHTRMNEEQIA-----AVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKL 157
Query: 141 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR-- 198
SDFG V ++GT + APE + DI+S G++++E++ G
Sbjct: 158 SDFGFC--AQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
Query: 199 -------KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPR 240
KAM + + NL P LK+ +H V P L G R
Sbjct: 216 YFNEPPLKAMKMIR----DNL----PPKLKN----LHKVSPSLKGFLDR 252
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-16
Identities = 54/189 (28%), Positives = 84/189 (44%), Gaps = 23/189 (12%)
Query: 20 DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLI-GYCTSGDQRLLVYEYMPMGS 78
A K + E + ++F+VE+ +LS H N+V L Y +L+ E+ G+
Sbjct: 30 GLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI-EFCDGGA 88
Query: 79 LEDHLYDLE-PDQEPLSWNTRMKIAV---GAARGLEYLHCKANPPVIYRDLKSANILLDN 134
L+ + +LE EP +I L +LH VI+RDLK+ NILL
Sbjct: 89 LDSIMLELERGLTEP-------QIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTL 138
Query: 135 DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGV 189
D + KL+DFG++ + +GT + APE K+DI+S G+
Sbjct: 139 DGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGI 196
Query: 190 VLLELITGR 198
L+EL
Sbjct: 197 TLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 5e-16
Identities = 56/188 (29%), Positives = 93/188 (49%), Gaps = 17/188 (9%)
Query: 23 VAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
VA+K L + + + + E+ M+ ++ H N++ L+G CT ++ EY G+L
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLR 106
Query: 81 DHLYDLEPD------------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 128
++L P +E L++ + A ARG+EYL A+ I+RDL +
Sbjct: 107 EYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAAR 163
Query: 129 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFG 188
N+L+ D K++DFGLA+ D +T + APE T +SD++SFG
Sbjct: 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 223
Query: 189 VVLLELIT 196
V+L E+ T
Sbjct: 224 VLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 6e-16
Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 14/155 (9%)
Query: 60 YCT--SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 117
+CT + + V EY+ G L H+ E + +I G L++LH K
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICG----LQFLHKKG- 116
Query: 118 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK 177
+IYRDLK N+LLD D + K++DFG+ K G+ ++ GT Y APE K
Sbjct: 117 --IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIAPEILKGQK 172
Query: 178 LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 212
D +SFGV+L E++ G+ G+ E L
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSPF---HGEDEDEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-16
Identities = 52/195 (26%), Positives = 89/195 (45%), Gaps = 24/195 (12%)
Query: 23 VAIKQLNHEGLQGH-QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
VA+K L ++ + E +L ++H +++ L G C+ LL+ EY GSL
Sbjct: 33 VAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRS 92
Query: 82 HL--------------------YDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 121
L Y PD+ L+ + A +RG++YL A ++
Sbjct: 93 FLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL---AEMKLV 149
Query: 122 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK 181
+RDL + N+L+ K+SDFGL++ D+ ++ + A E T +
Sbjct: 150 HRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQ 209
Query: 182 SDIYSFGVVLLELIT 196
SD++SFGV+L E++T
Sbjct: 210 SDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 8e-16
Identities = 66/181 (36%), Positives = 91/181 (50%), Gaps = 21/181 (11%)
Query: 21 QLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77
++VAIK++++ G Q + Q+ I EV L L H N + G LV EY +G
Sbjct: 41 EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYC-LG 99
Query: 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 137
S D L E ++PL I GA +GL YLH + I+RD+K+ NILL
Sbjct: 100 SASDIL---EVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGT 153
Query: 138 PKLSDFGLAKL-GPVGDNTHVSTRVMGTYGYCAPE--YAM-SGKLTLKSDIYSFGVVLLE 193
KL+DFG A L P N+ V GT + APE AM G+ K D++S G+ +E
Sbjct: 154 VKLADFGSASLVSPA--NSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 206
Query: 194 L 194
L
Sbjct: 207 L 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 9e-16
Identities = 65/269 (24%), Positives = 104/269 (38%), Gaps = 48/269 (17%)
Query: 23 VAIKQLNHEGLQGHQE-FIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
VA+K L + + F++E L++S +H N+V LIG R ++ E M G L+
Sbjct: 39 VAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKS 98
Query: 82 HLYDLEPDQE---PLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 138
L + P E L+ + A A+G +YL I+RD+ + N LL P
Sbjct: 99 FLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCK-GP 154
Query: 139 ----KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLEL 194
K++DFG+A+ R M + PE + G T K+D++SFGV+L E+
Sbjct: 155 GRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
Query: 195 I----------TGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLN 244
T ++ M+ G G + P+ C
Sbjct: 215 FSLGYMPYPGRTNQEVMEFVTGGGRLD--------------------------PPKGCPG 248
Query: 245 YAVAVTAMCLNEEANFRPLINDIVVALDY 273
+ C RP I+ + Y
Sbjct: 249 PVYRIMTDCWQHTPEDRPNFATILERIQY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-15
Identities = 58/192 (30%), Positives = 92/192 (47%), Gaps = 25/192 (13%)
Query: 23 VAIKQLN---HEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78
VA+K L E + + + E+ M+ ++ H N++ L+G CT +V EY G+
Sbjct: 45 VAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGN 102
Query: 79 LEDHL------------YDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 126
L D L D P +E L+ + A ARG+E+L A+ I+RDL
Sbjct: 103 LRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLA 159
Query: 127 SANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG--TYGYCAPEYAMSGKLTLKSDI 184
+ N+L+ D K++DFGLA+ + + G + APE T +SD+
Sbjct: 160 ARNVLVTEDHVMKIADFGLAR--DIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDV 217
Query: 185 YSFGVVLLELIT 196
+SFGV+L E+ T
Sbjct: 218 WSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-15
Identities = 57/178 (32%), Positives = 93/178 (52%), Gaps = 12/178 (6%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
Q VAI+Q+N + + I E+L++ + N+V + GD+ +V EY+ GSL
Sbjct: 46 QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 140
D + + D+ ++ R + + LE+LH VI+RD+KS NILL D + KL
Sbjct: 106 DVVTETCMDEGQIAAVCRECL-----QALEFLHSNQ---VIHRDIKSDNILLGMDGSVKL 157
Query: 141 SDFGL-AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 197
+DFG A++ P + ++GT + APE K DI+S G++ +E+I G
Sbjct: 158 TDFGFCAQITP---EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-15
Identities = 51/158 (32%), Positives = 82/158 (51%), Gaps = 17/158 (10%)
Query: 46 LSLLHH---DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 102
L ++H +V+ G + + + E+M GSL D +Y P+ KIA
Sbjct: 54 LQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYK---KGGPIPVEILGKIA 109
Query: 103 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD--NTHVSTR 160
V GL YL+ +++RD+K +NIL+++ KL DFG++ G+ N+ T
Sbjct: 110 VAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVS-----GELINSIADTF 162
Query: 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 198
V GT Y +PE GK T+KSD++S G+ ++EL G+
Sbjct: 163 V-GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-15
Identities = 55/188 (29%), Positives = 91/188 (48%), Gaps = 17/188 (9%)
Query: 23 VAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
VA+K L + + I E+ ++ L+ H N++ L+G CT ++ EY G+L
Sbjct: 47 VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLR 106
Query: 81 DHLY-------DLEPD-----QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 128
+ L D D +E LS+ + A ARG+EYL + I+RDL +
Sbjct: 107 EFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAAR 163
Query: 129 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFG 188
N+L+ D K++DFGLA+ D ++ + APE T +SD++SFG
Sbjct: 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFG 223
Query: 189 VVLLELIT 196
+++ E+ T
Sbjct: 224 ILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 59/189 (31%), Positives = 94/189 (49%), Gaps = 24/189 (12%)
Query: 24 AIKQLNHEGLQG-HQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
AIK L + H++F E+ +L L HH N++ L+G C + + EY P G+L D
Sbjct: 33 AIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLD 92
Query: 82 HLYD---LEPD---------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 129
L LE D L+ ++ A A G++YL K I+RDL + N
Sbjct: 93 FLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARN 149
Query: 130 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG--YCAPEYAMSGKLTLKSDIYSF 187
+L+ + K++DFGL++ G+ +V + MG + A E T KSD++SF
Sbjct: 150 VLVGENLASKIADFGLSR----GEEVYVK-KTMGRLPVRWMAIESLNYSVYTTKSDVWSF 204
Query: 188 GVVLLELIT 196
GV+L E+++
Sbjct: 205 GVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-15
Identities = 59/178 (33%), Positives = 95/178 (53%), Gaps = 12/178 (6%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
Q VAIKQ+N + + I E+L++ + N+V + GD+ +V EY+ GSL
Sbjct: 45 QEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 104
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 140
D + + D+ ++ R + + L++LH VI+RD+KS NILL D + KL
Sbjct: 105 DVVTETCMDEGQIAAVCRECL-----QALDFLHSNQ---VIHRDIKSDNILLGMDGSVKL 156
Query: 141 SDFGL-AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 197
+DFG A++ P + + ST V GT + APE K DI+S G++ +E++ G
Sbjct: 157 TDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 59/181 (32%), Positives = 90/181 (49%), Gaps = 19/181 (10%)
Query: 20 DQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76
+++VA+K++++ G Q + Q+ I EV L L H N + G LV EY +
Sbjct: 46 NEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYC-L 104
Query: 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF 136
GS D L E ++PL I GA +GL YLH +I+RD+K+ NILL
Sbjct: 105 GSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPG 158
Query: 137 NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS---GKLTLKSDIYSFGVVLLE 193
KL+DFG A ++ +GT + APE ++ G+ K D++S G+ +E
Sbjct: 159 QVKLADFGSASKSSPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 212
Query: 194 L 194
L
Sbjct: 213 L 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-15
Identities = 48/159 (30%), Positives = 68/159 (42%), Gaps = 12/159 (7%)
Query: 42 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI 101
E +L L+H LV L + LV + + G L HL E ++K
Sbjct: 50 ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSE-----EQVKF 104
Query: 102 -AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160
LEYLH K +I+RD+K NILLD + ++DF +A T T
Sbjct: 105 WICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TS 158
Query: 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 199
GT GY APE ++ D +S GV E + G++
Sbjct: 159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 58/175 (33%), Positives = 85/175 (48%), Gaps = 15/175 (8%)
Query: 40 IVEVLMLSLLHHDNLVTLIGYCT--SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNT 97
+VE +LSL +T + YCT + + V EY+ G L H+ P +
Sbjct: 43 MVEKRVLSLAWEHPFLTHL-YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY 101
Query: 98 RMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157
+I G L++LH K ++YRDLK NILLD D + K++DFG+ K +GD
Sbjct: 102 AAEIICG----LQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-- 152
Query: 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 212
+ GT Y APE + K D +SFGV+L E++ G+ G E+ L
Sbjct: 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPF---HGHDEEEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-15
Identities = 55/189 (29%), Positives = 95/189 (50%), Gaps = 19/189 (10%)
Query: 23 VAIKQLNHEGLQGH-QEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
VA+K L + + + + E+ M+ ++ H N++ L+G CT ++ EY G+L
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109
Query: 81 DHL-----------YDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 127
++L YD+ PD E +++ + ARG+EYL A+ I+RDL +
Sbjct: 110 EYLRARRPPGMEYSYDIARVPD-EQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAA 165
Query: 128 ANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSF 187
N+L+ + K++DFGLA+ D +T + APE T +SD++SF
Sbjct: 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 225
Query: 188 GVVLLELIT 196
GV++ E+ T
Sbjct: 226 GVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-15
Identities = 54/163 (33%), Positives = 84/163 (51%), Gaps = 16/163 (9%)
Query: 40 IVEVLMLSLLHHDNLVTLIGYCT--SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNT 97
+VE +L+L + +T + YCT + + V E++ G L H+ Q+ ++
Sbjct: 43 MVEKRVLALAWENPFLTHL-YCTFQTKEHLFFVMEFLNGGDLMFHI------QDKGRFDL 95
Query: 98 RMKIAVGAAR--GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155
A GL++LH K +IYRDLK N++LD D + K++DFG+ K GDN
Sbjct: 96 YRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR 152
Query: 156 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 198
++ GT Y APE K T D +SFGV+L E++ G+
Sbjct: 153 --ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-15
Identities = 49/186 (26%), Positives = 90/186 (48%), Gaps = 16/186 (8%)
Query: 22 LVAIKQL----NHEGLQGH--QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75
L+A+KQ+ N Q + E+ +++ L+H +++ ++G L E+M
Sbjct: 27 LMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMA 86
Query: 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 135
GS+ L +E + N ++ RGL YLH +I+RD+K AN+L+D+
Sbjct: 87 GGSVSHLLSKYGAFKEAVIINYTEQLL----RGLSYLH---ENQIIHRDVKGANLLIDST 139
Query: 136 FNP-KLSDFGLA-KLGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLL 192
+++DFG A +L G +++GT + APE + D++S G V++
Sbjct: 140 GQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVII 199
Query: 193 ELITGR 198
E+ T +
Sbjct: 200 EMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-15
Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 13/154 (8%)
Query: 44 LMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 103
+M+ + L S D LV EY+ G + L P W +
Sbjct: 49 IMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG--LPEDWAK--QYIA 104
Query: 104 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 163
G+E LH + +I+RD+K N+L+D + KL+DFGL++ G + + +G
Sbjct: 105 EVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVG 155
Query: 164 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 197
T Y APE + SD +S G V+ E + G
Sbjct: 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 3e-15
Identities = 60/189 (31%), Positives = 93/189 (49%), Gaps = 24/189 (12%)
Query: 24 AIKQLNHEGLQG-HQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
AIK++ + H++F E+ +L L HH N++ L+G C L EY P G+L D
Sbjct: 26 AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 85
Query: 82 HLYD---LEPD---------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 129
L LE D LS + A ARG++YL K I+RDL + N
Sbjct: 86 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARN 142
Query: 130 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG--YCAPEYAMSGKLTLKSDIYSF 187
IL+ ++ K++DFGL++ G +V + MG + A E T SD++S+
Sbjct: 143 ILVGENYVAKIADFGLSR----GQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSY 197
Query: 188 GVVLLELIT 196
GV+L E+++
Sbjct: 198 GVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-15
Identities = 57/184 (30%), Positives = 86/184 (46%), Gaps = 16/184 (8%)
Query: 54 LVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA-ARGLEY 111
LVTL Y D +L L+ +Y+ G L HLY E E + +++ + L++
Sbjct: 67 LVTL-HYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE-----SEVRVYIAEIVLALDH 120
Query: 112 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 171
LH +IYRD+K NILLD++ + L+DFGL+K + + + GT Y APE
Sbjct: 121 LHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEF-LAEEEERAYSFCGTIEYMAPE 176
Query: 172 YAMSGKLTLKS--DIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 229
G D +S GV+ EL+TG + Q Q+ + SR LK + F
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI--SRRILKSKPPFPKT 234
Query: 230 VDPL 233
+
Sbjct: 235 MSAE 238
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-15
Identities = 77/285 (27%), Positives = 121/285 (42%), Gaps = 55/285 (19%)
Query: 6 LSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIV------EVLMLSLLHHDNLVTLIG 59
+ CK G Q+VAIK+ L+ + +V E+ ML L H+NLV LI
Sbjct: 18 MKCKHKETG------QIVAIKKF----LESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 60 YCTSGDQRLLVYEYMPMGSLEDH--LYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 117
+ LV+E++ DH L DLE L + K RG+E+ H +
Sbjct: 68 VFRRKKRLYLVFEFV------DHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH---S 118
Query: 118 PPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYAMSG 176
+I+RD+K NIL+ KL DFG A+ L G+ V T + T Y APE +
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYTDYVATRWYRAPELLVGD 175
Query: 177 -KLTLKSDIYSFGVVLLELITG-----------------RKAMDLSKGQGEQNLVSWSRP 218
K DI++ G ++ E++TG + +L Q + +
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRH--QEIFQKNPL 233
Query: 219 FLKDQKKFVHLVDPLLHGRYPRRCLN-YAVAVTAMCLNEEANFRP 262
F + V ++P L R+P+ L+ + + CL + + RP
Sbjct: 234 FAGMRLPEVKEIEP-LEKRFPK--LSGLVLDLAKQCLRIDPDDRP 275
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 5e-15
Identities = 69/203 (33%), Positives = 99/203 (48%), Gaps = 28/203 (13%)
Query: 20 DQLVAIKQLNHEGLQGHQEFIVEVLM-----LSLLHHDNLVTLIGYCTSGDQRL-LVYEY 73
D+L AIK L + + Q+ VE M L+L +T + C RL V EY
Sbjct: 25 DELYAIKILKKDVII--QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 82
Query: 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD 133
+ G L H+ + +EP + +IA+G L +LH K +IYRDLK N++LD
Sbjct: 83 VNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG----LFFLHSKG---IIYRDLKLDNVMLD 135
Query: 134 NDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPE---YAMSGKLTLKSDIYSFGV 189
+ + K++DFG+ K G T TR GT Y APE Y GK D ++FGV
Sbjct: 136 AEGHIKIADFGMCKENIFGGKT---TRTFCGTPDYIAPEIIAYQPYGK---SVDWWAFGV 189
Query: 190 VLLELITGRKAMDLSKGQGEQNL 212
+L E++ G+ D G+ E L
Sbjct: 190 LLYEMLAGQPPFD---GEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-15
Identities = 53/183 (28%), Positives = 93/183 (50%), Gaps = 15/183 (8%)
Query: 21 QLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS---GDQRLLVYEYMP 75
Q A+K+++ + + ++ + E+ +L+ ++H N+ I Y + G++ +V EY P
Sbjct: 26 QFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI---ISYKEAFLDGNKLCIVMEYAP 82
Query: 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 135
G L + + ++ + +I + RGL+ LH + +++RDLKSANILL +
Sbjct: 83 FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVAN 139
Query: 136 FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 195
K+ D G++K V T +GT Y APE + KSDI+S G +L E+
Sbjct: 140 DLVKIGDLGISK---VLKKNMAKT-QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMA 195
Query: 196 TGR 198
T
Sbjct: 196 TFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 5e-15
Identities = 62/200 (31%), Positives = 94/200 (47%), Gaps = 22/200 (11%)
Query: 20 DQLVAIKQLNHEGLQGHQEFIVEVLM-----LSLL-HHDNLVTLIGYCTSGDQRLLVYEY 73
D+L A+K L + + Q+ VE M L+L H L L + D+ V EY
Sbjct: 20 DELYAVKVLKKDVIL--QDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEY 77
Query: 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEYLHCKANPPVIYRDLKSANILL 132
+ G L H+ EP R + A GL++LH + +IYRDLK N+LL
Sbjct: 78 VNGGDLMFHIQRSGRFDEP-----RARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLL 129
Query: 133 DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLL 192
D++ + K++DFG+ K G +G T ++ GT Y APE D ++ GV+L
Sbjct: 130 DSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLY 187
Query: 193 ELITGRKAMDLSKGQGEQNL 212
E++ G+ + G E L
Sbjct: 188 EMLAGQSPFE---GDDEDEL 204
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 6e-15
Identities = 56/185 (30%), Positives = 90/185 (48%), Gaps = 12/185 (6%)
Query: 21 QLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79
VA+K L Q +EF+ E ++S +H N+V L+G C + + ++ E M G L
Sbjct: 27 IRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDL 86
Query: 80 EDHLYDLEPDQEP---LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---- 132
+L D ++ L+ + I + A+G YL I+RDL + N L+
Sbjct: 87 LSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKG 143
Query: 133 -DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 191
D D K+ DFGLA+ D + + APE + GK T +SD++SFGV++
Sbjct: 144 YDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLM 203
Query: 192 LELIT 196
E++T
Sbjct: 204 WEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 9e-15
Identities = 57/188 (30%), Positives = 93/188 (49%), Gaps = 17/188 (9%)
Query: 21 QLVAIKQLNHE------GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74
QL+A+KQ+ + + +++ EV +L L H N+V +G C + + E++
Sbjct: 25 QLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFV 84
Query: 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN 134
P GS+ L P EP+ +I G A YLH N V++RD+K N++L
Sbjct: 85 PGGSISSILNRFGPLPEPVFCKYTKQILDGVA----YLH---NNCVVHRDIKGNNVMLMP 137
Query: 135 DFNPKLSDFGLAK----LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVV 190
+ KL DFG A+ +G G ++++ + GT + APE KSDI+S G
Sbjct: 138 NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCT 197
Query: 191 LLELITGR 198
+ E+ TG+
Sbjct: 198 VFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-14
Identities = 60/185 (32%), Positives = 102/185 (55%), Gaps = 15/185 (8%)
Query: 23 VAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
VAIK LN G + + EF+ E L+++ + H +LV L+G C S +L V + MP G L D
Sbjct: 39 VAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLD 97
Query: 82 HLYDLEPD---QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 138
++++ + + Q L+W V A+G+ YL + +++RDL + N+L+ + +
Sbjct: 98 YVHEHKDNIGSQLLLNW------CVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHV 148
Query: 139 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-G 197
K++DFGLA+L + + + + A E K T +SD++S+GV + EL+T G
Sbjct: 149 KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFG 208
Query: 198 RKAMD 202
K D
Sbjct: 209 GKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 59/181 (32%), Positives = 89/181 (49%), Gaps = 19/181 (10%)
Query: 20 DQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76
++VAIK++++ G Q + Q+ I EV L L H N + G LV EY +
Sbjct: 40 SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-L 98
Query: 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF 136
GS D L E ++PL + GA +GL YLH + +I+RD+K+ NILL
Sbjct: 99 GSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPG 152
Query: 137 NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS---GKLTLKSDIYSFGVVLLE 193
KL DFG A + + +GT + APE ++ G+ K D++S G+ +E
Sbjct: 153 LVKLGDFGSASI------MAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 206
Query: 194 L 194
L
Sbjct: 207 L 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 70/249 (28%), Positives = 107/249 (42%), Gaps = 28/249 (11%)
Query: 21 QLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79
++VAIK ++ E + E I E+ +LS + G + ++ EY+ GS
Sbjct: 30 KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA 89
Query: 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 139
D L EP PL I +GL+YLH + I+RD+K+AN+LL K
Sbjct: 90 LDLL---EPG--PLDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVK 141
Query: 140 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 199
L+DFG+A G + D +GT + APE K+DI+S G+ +EL G
Sbjct: 142 LADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEP 199
Query: 200 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEAN 259
L+ + P P L G Y + + A CLN+E +
Sbjct: 200 PHSELHPMKVLFLIPKNNP-------------PTLEGNYSKPLKEFVEA----CLNKEPS 242
Query: 260 FRPLINDIV 268
FRP +++
Sbjct: 243 FRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 56/199 (28%), Positives = 100/199 (50%), Gaps = 25/199 (12%)
Query: 20 DQLVAIKQL-NHEGLQGHQEFIV----EVLMLSLLHHDNLVTL--IGYCTSGDQRLLVYE 72
++VA+K+L + +G F + E+ +L L H N+VT+ + ++ D+ +V E
Sbjct: 30 GEIVALKKLKMEKEKEG---FPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVME 86
Query: 73 YMPMGSLEDHLYDL-EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANIL 131
Y+ E L L E ++P + + + G+ +LH +++RDLK++N+L
Sbjct: 87 YV-----EHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLL 138
Query: 132 LDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVV 190
L+N K+ DFGLA+ G T+++ T Y APE + K + D++S G +
Sbjct: 139 LNNRGILKICDFGLAR--EYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCI 196
Query: 191 LLELITGRKAMDLSKGQGE 209
EL+T + L G+ E
Sbjct: 197 FAELLTKKP---LFPGKSE 212
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-14
Identities = 54/168 (32%), Positives = 82/168 (48%), Gaps = 26/168 (15%)
Query: 100 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159
KIAV + LEYLH K + VI+RD+K +N+L++ + KL DFG++ G + D+ T
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS--GYLVDSV-AKT 161
Query: 160 RVMGTYGYCAPEY---AMSGK-LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSW 215
G Y APE ++ K +KSD++S G+ ++EL TGR D SW
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD-----------SW 210
Query: 216 SRPFLKDQKKFVHLVDPLL-HGRYPRRCLNYAVAVTAMCLNEEANFRP 262
PF + K+ V P L ++ ++ CL + RP
Sbjct: 211 KTPF-QQLKQVVEEPSPQLPAEKFSPEFQDF----VNKCLKKNYKERP 253
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 56/198 (28%), Positives = 88/198 (44%), Gaps = 41/198 (20%)
Query: 20 DQLVAIKQ--LNH--EGLQG-HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74
++VAIK+ L E G + + E+ +L L H N++ L+ LV+E+M
Sbjct: 25 GRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM 84
Query: 75 PMGSLEDHLYDLE------------PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 122
DLE D + T RGLEYLH + +++
Sbjct: 85 E--------TDLEKVIKDKSIVLTPADIKSYMLMT--------LRGLEYLH---SNWILH 125
Query: 123 RDLKSANILLDNDFNPKLSDFGLAKLGPVGD-NTHVSTRVMGTYGYCAPEYAMSGKL-TL 180
RDLK N+L+ +D KL+DFGLA+ G N ++ +V+ T Y APE + +
Sbjct: 126 RDLKPNNLLIASDGVLKLADFGLARS--FGSPNRKMTHQVV-TRWYRAPELLFGARHYGV 182
Query: 181 KSDIYSFGVVLLELITGR 198
D++S G + EL+
Sbjct: 183 GVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 3e-14
Identities = 59/181 (32%), Positives = 91/181 (50%), Gaps = 19/181 (10%)
Query: 20 DQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76
+++VAIK++++ G Q + Q+ I EV L + H N + G LV EY +
Sbjct: 50 NEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-L 108
Query: 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF 136
GS D L E ++PL I GA +GL YLH +I+RD+K+ NILL
Sbjct: 109 GSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPG 162
Query: 137 NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS---GKLTLKSDIYSFGVVLLE 193
KL+DFG A + ++ +GT + APE ++ G+ K D++S G+ +E
Sbjct: 163 QVKLADFGSASIASPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 216
Query: 194 L 194
L
Sbjct: 217 L 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-14
Identities = 53/179 (29%), Positives = 92/179 (51%), Gaps = 13/179 (7%)
Query: 23 VAIKQLNHEGLQGHQEFIVEVL--MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
VA+K L +E ++ L M L +H+N+V L+G CT G L++ EY G L
Sbjct: 68 VAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLL 127
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 140
+ L + L+ + + A+G+ +L K I+RDL + N+LL + K+
Sbjct: 128 NFLR--RKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKI 182
Query: 141 SDFGLAKLGPVGDNTHV---STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
DFGLA+ + D+ +V + R+ + APE + T +SD++S+G++L E+ +
Sbjct: 183 CDFGLAR-DIMNDSNYVVKGNARL--PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-14
Identities = 49/156 (31%), Positives = 80/156 (51%), Gaps = 7/156 (4%)
Query: 38 EFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNT 97
+F+ E +L H N+V LIG CT QR +Y M + D L L ++ L
Sbjct: 38 KFLSEARILKQYDHPNIVKLIGVCT---QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQ 94
Query: 98 RMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157
+K A+ AA G+ YL K I+RDL + N L+ + K+SDFG+++ G +
Sbjct: 95 LVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSS 151
Query: 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLE 193
+ + + APE G+ + +SD++S+G++L E
Sbjct: 152 GLKQI-PIKWTAPEALNYGRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-14
Identities = 70/249 (28%), Positives = 113/249 (45%), Gaps = 28/249 (11%)
Query: 21 QLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79
++VAIK ++ E + E I E+ +LS + G G + ++ EY+ GS
Sbjct: 30 EVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSA 89
Query: 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 139
D L +P PL I +GL+YLH + I+RD+K+AN+LL + K
Sbjct: 90 LDLL---KPG--PLEETYIATILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVK 141
Query: 140 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 199
L+DFG+A G + D +GT + APE K+DI+S G+
Sbjct: 142 LADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGIT--------- 190
Query: 200 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEAN 259
A++L+KG+ + + R K P L G+Y + + A CLN++
Sbjct: 191 AIELAKGEPPNSDLHPMRVLFLIPKN----SPPTLEGQYSKPFKEFVEA----CLNKDPR 242
Query: 260 FRPLINDIV 268
FRP +++
Sbjct: 243 FRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-14
Identities = 61/199 (30%), Positives = 97/199 (48%), Gaps = 25/199 (12%)
Query: 7 SCKFYNVGLVWLCDQLVA--IKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC-TS 63
+C+ G ++ C +L IK+ E + +++ I+E + + V + Y +
Sbjct: 18 ACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV------NSQFVVNLAYAYET 71
Query: 64 GDQRLLVYEYMPMGSLEDHLYDL-EPDQEPLSWNTRMKIAVGAAR---GLEYLHCKANPP 119
D LV M G L+ H+Y++ P E + AA GLE LH +
Sbjct: 72 KDALCLVLTIMNGGDLKFHIYNMGNPGFE------EERALFYAAEILCGLEDLHREN--- 122
Query: 120 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT 179
+YRDLK NILLD+ + ++SD GLA P G++ + RV GT GY APE + + T
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMAPEVLNNQRYT 179
Query: 180 LKSDIYSFGVVLLELITGR 198
L D + G ++ E+I G+
Sbjct: 180 LSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 7e-14
Identities = 54/180 (30%), Positives = 95/180 (52%), Gaps = 9/180 (5%)
Query: 21 QLVAIKQLNHEGLQGH-QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79
++VA+K+++ + +G I E+ ++ L H+N+V L + ++ +LV+EYM L
Sbjct: 26 EIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD-KDL 84
Query: 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 139
+ ++ D + L NT +G+ + H V++RDLK N+L++ K
Sbjct: 85 KKYM-DTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELK 140
Query: 140 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKS-DIYSFGVVLLELITGR 198
L+DFGLA+ + NT + V T Y AP+ + + S DI+S G ++ E+ITGR
Sbjct: 141 LADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-14
Identities = 51/158 (32%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 38 EFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNT 97
+F+ E +L H N+V LIG CT Q+ +Y M + D L L + L
Sbjct: 39 KFLQEARILKQYSHPNIVRLIGVCT---QKQPIYIVMELVQGGDFLTFLRTEGPRLKVKE 95
Query: 98 RMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157
+++ AA G+EYL K I+RDL + N L+ K+SDFG+++ D +
Sbjct: 96 LIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYA 150
Query: 158 STRVMGT--YGYCAPEYAMSGKLTLKSDIYSFGVVLLE 193
ST M + APE G+ + +SD++SFG++L E
Sbjct: 151 STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 8e-14
Identities = 60/189 (31%), Positives = 93/189 (49%), Gaps = 24/189 (12%)
Query: 24 AIKQLNHEGLQG-HQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
AIK++ + H++F E+ +L L HH N++ L+G C L EY P G+L D
Sbjct: 38 AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 97
Query: 82 HLYD---LEPD---------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 129
L LE D LS + A ARG++YL K I+RDL + N
Sbjct: 98 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARN 154
Query: 130 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG--YCAPEYAMSGKLTLKSDIYSF 187
IL+ ++ K++DFGL++ G +V + MG + A E T SD++S+
Sbjct: 155 ILVGENYVAKIADFGLSR----GQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSY 209
Query: 188 GVVLLELIT 196
GV+L E+++
Sbjct: 210 GVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 9e-14
Identities = 68/249 (27%), Positives = 115/249 (46%), Gaps = 28/249 (11%)
Query: 21 QLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79
Q+VAIK ++ E + E I E+ +LS + G G + ++ EY+ GS
Sbjct: 30 QVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSA 89
Query: 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 139
D L D+ ++ T +K + +GL+YLH + I+RD+K+AN+LL + K
Sbjct: 90 LDLLRAGPFDEFQIA--TMLKEIL---KGLDYLHSEKK---IHRDIKAANVLLSEQGDVK 141
Query: 140 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 199
L+DFG+A G + D +GT + APE K+DI+S G+
Sbjct: 142 LADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGIT--------- 190
Query: 200 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEAN 259
A++L+KG+ + + R K P L G + + + CLN++ +
Sbjct: 191 AIELAKGEPPNSDMHPMRVLFLIPK----NNPPTLTGEFSKPFKEF----IDACLNKDPS 242
Query: 260 FRPLINDIV 268
FRP +++
Sbjct: 243 FRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-13
Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 13/211 (6%)
Query: 21 QLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77
++ A K+L+ + L+ G + ++E +L ++ +V L S LV M G
Sbjct: 19 KMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGG 78
Query: 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 137
L+ H+Y++ + L + + G+ +LH + ++YRD+K N+LLD+ N
Sbjct: 79 DLKYHIYNV--GERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGN 133
Query: 138 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 197
+LSD GLA G T+ GT GY APE + D ++ G + E++ G
Sbjct: 134 CRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAG 190
Query: 198 RKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 228
R K + + + R L+D+ KF H
Sbjct: 191 RTPFKDHKEKVAKEEL--KRRTLEDEVKFEH 219
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-13
Identities = 50/171 (29%), Positives = 77/171 (45%), Gaps = 17/171 (9%)
Query: 37 QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR------LLVYEYMPMGSLEDHLYD--LEP 88
+EF+ E + H N++ LIG C +++ +M G L L L
Sbjct: 46 EEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGG 105
Query: 89 DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 148
E L T +K V A G+EYL +N I+RDL + N +L D ++DFGL+K
Sbjct: 106 LPEKLPLQTLLKFMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKK 162
Query: 149 GPVGD---NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
GD ++ + + A E T KSD+++FGV + E+ T
Sbjct: 163 IYSGDYYRQGRIAKMPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 2e-13
Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 30/203 (14%)
Query: 14 GLVWLC-----DQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 66
G+V + VAIK++++ + L + + E+ +L L H+N++ L+
Sbjct: 14 GVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSP 73
Query: 67 R-----LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMK-IAVGAARGLEYLHCKANPPV 120
+V E M D L+ + +PL+ + ++ RGL+YLH AN V
Sbjct: 74 EDFNDVYIVTELMET----D-LHKVIKSPQPLT-DDHIQYFLYQILRGLKYLH-SAN--V 124
Query: 121 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY----GYCAPEYAMSG 176
I+RDLK +NIL++++ + K+ DFGLA+ D + Y Y APE +S
Sbjct: 125 IHRDLKPSNILVNSNCDLKICDFGLAR---GVDPDEDEKGFLTEYVVTRWYRAPELLLSS 181
Query: 177 K-LTLKSDIYSFGVVLLELITGR 198
T DI+S G + EL+T +
Sbjct: 182 SRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-13
Identities = 63/280 (22%), Positives = 113/280 (40%), Gaps = 45/280 (16%)
Query: 11 YNVGLVWLCDQ-----------LVAIKQLNHEGLQGHQ----EFIVEVLMLSLLHHDNLV 55
Y L+ DQ V I+ +GH+ E+ L + +N++
Sbjct: 23 YTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFH-KGHKVLIDITENEIKNLRRIDSNNIL 81
Query: 56 TLIGY----CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 111
+ G+ + L+ EY G L + L D E D LS+ T++ +A+ +GL
Sbjct: 82 KIYGFIIDIVDDLPRLSLILEYCTRGYLREVL-DKEKD---LSFKTKLDMAIDCCKGLYN 137
Query: 112 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 171
L+ N P Y++L S + L+ ++ K+ GL K+ +V+ V +Y
Sbjct: 138 LYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDI 195
Query: 172 YAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231
++ + T+K DIYS GVVL E+ TG+ + + +L+ +
Sbjct: 196 FS---EYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI------INKNNSL----- 241
Query: 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 271
+ P C + C + ++ RP I +I+ L
Sbjct: 242 -----KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNL 276
|
Length = 283 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-13
Identities = 65/264 (24%), Positives = 117/264 (44%), Gaps = 34/264 (12%)
Query: 20 DQLVAIKQLNHEGLQGHQ--EFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77
+ VAIK L G Q +F+ E ++ H N++ L G T +++ E+M G
Sbjct: 32 EIFVAIKTLK-SGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENG 90
Query: 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 137
+L+ L + + ++ G A G++YL + ++RDL + NIL++++
Sbjct: 91 ALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYL---SEMNYVHRDLAARNILVNSNLV 144
Query: 138 PKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----YCAPEYAMSGKLTLKSDIYSFGVVLL 192
K+SDFGL++ + D+T T G + APE K T SD++S+G+V+
Sbjct: 145 CKVSDFGLSRF--LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMW 202
Query: 193 ELITGRKAMDLSKGQGEQNLVSWSRPFLK-DQKKFVHLVDPLLHGRYPRRCLNYAVAVTA 251
E+ +S G+ RP+ + ++ ++ P C +
Sbjct: 203 EV--------MSYGE---------RPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQLML 245
Query: 252 MCLNEEANFRPLINDIVVALDYLV 275
C ++ N RP IV LD ++
Sbjct: 246 DCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 62/198 (31%), Positives = 98/198 (49%), Gaps = 18/198 (9%)
Query: 20 DQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLIGYCTSGDQRL-LVYEYMP 75
D+L AIK L + + + +VE +L+L +T + C RL V EY+
Sbjct: 25 DELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVN 84
Query: 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 135
G L H+ + +EP + +I+VG L +LH + +IYRDLK N++LD++
Sbjct: 85 GGDLMYHIQQVGKFKEPQAVFYAAEISVG----LFFLHRRG---IIYRDLKLDNVMLDSE 137
Query: 136 FNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLEL 194
+ K++DFG+ K V V+TR GT Y APE D +++GV+L E+
Sbjct: 138 GHIKIADFGMCKEHMVDG---VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEM 194
Query: 195 ITGRKAMDLSKGQGEQNL 212
+ G+ D G+ E L
Sbjct: 195 LAGQPPFD---GEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 3e-13
Identities = 55/187 (29%), Positives = 90/187 (48%), Gaps = 21/187 (11%)
Query: 20 DQLVAIKQLN----HEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75
+ VA+K++ G+ + + E+ L H +V L+ G +LV EYMP
Sbjct: 25 GETVALKKVALRRLEGGIP--NQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMP 82
Query: 76 MGSLEDHLYDLE---PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL 132
L + L D E P+ + S+ RM + +G+ Y+H +++RDLK AN+L+
Sbjct: 83 -SDLSEVLRDEERPLPEAQVKSY-MRMLL-----KGVAYMHANG---IMHRDLKPANLLI 132
Query: 133 DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVL 191
D K++DFGLA+L + S +V T Y APE + K D+++ G +
Sbjct: 133 SADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYGARKYDPGVDLWAVGCIF 191
Query: 192 LELITGR 198
EL+ G
Sbjct: 192 AELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-13
Identities = 58/195 (29%), Positives = 92/195 (47%), Gaps = 17/195 (8%)
Query: 7 SCKFYNVGLVWLCDQLVA--IKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC-TS 63
+C+ G ++ C +L IK+ E + +++ I+E + + V + Y +
Sbjct: 18 ACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV------NSRFVVSLAYAYET 71
Query: 64 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 123
D LV M G L+ H+Y + + + A GLE LH ++YR
Sbjct: 72 KDALCLVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLH---QERIVYR 126
Query: 124 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSD 183
DLK NILLD+ + ++SD GLA P G + RV GT GY APE + + T D
Sbjct: 127 DLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYMAPEVVKNERYTFSPD 183
Query: 184 IYSFGVVLLELITGR 198
++ G +L E+I G+
Sbjct: 184 WWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (167), Expect = 4e-13
Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 45/207 (21%)
Query: 14 GLVWLCD-----QLVAIKQLNHEGLQGHQEFI----VEVLMLSLLHHDNLVTLIGYCTSG 64
G V+L +LVAIK++ + +E + V+ L L H N+V L
Sbjct: 13 GSVYLARNKETGELVAIKKMKKK-FYSWEECMNLREVKSLR-KLNEHPNIVKLKEVFREN 70
Query: 65 DQRLLVYEYMPMGSLEDHLYDLEPDQE--PLSWNTRMKIAVGAARGLEYLHCKANPPVIY 122
D+ V+EYM E +LY L D++ P S + I +GL ++H K +
Sbjct: 71 DELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH-KHG--FFH 122
Query: 123 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDN----THVSTRVMGTYGYCAPEYAMSGKL 178
RDLK N+L+ K++DFGLA+ + +VSTR Y APE +
Sbjct: 123 RDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTR-----WYRAPE------I 169
Query: 179 TLKS-------DIYSFGVVLLELITGR 198
L+S DI++ G ++ EL T R
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-13
Identities = 54/186 (29%), Positives = 85/186 (45%), Gaps = 23/186 (12%)
Query: 23 VAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDH 82
+AIK++ + Q E+ + S L H N+V +G + + E +P GSL
Sbjct: 36 IAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSAL 95
Query: 83 LYDLEPDQEPLSWNTRMKIAVGAA--RGLEYLHCKANPPVIYRDLKSANILLDNDFNP-- 138
L PL N + I GL+YLH + +++RD+K N+L+ N ++
Sbjct: 96 ---LRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLV-NTYSGVV 148
Query: 139 KLSDFG----LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK--LTLKSDIYSFGVVLL 192
K+SDFG LA + P + GT Y APE G +DI+S G ++
Sbjct: 149 KISDFGTSKRLAGINPCTET------FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIV 202
Query: 193 ELITGR 198
E+ TG+
Sbjct: 203 EMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 4e-13
Identities = 61/200 (30%), Positives = 87/200 (43%), Gaps = 33/200 (16%)
Query: 22 LVAIKQ-LNHEGLQG-HQEFIVEVLMLSLLHHDNLVTLIGYC-----TSGDQRLLVYEYM 74
+VA+K+ L H G + E+ +L L H N+V LI S +R VY
Sbjct: 35 VVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVT 94
Query: 75 P-M-----GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 128
P M G LE+ L Q M + G+ YLH +++RD+K+A
Sbjct: 95 PYMDHDLSGLLENPSVKLTESQIKCY----MLQLL---EGINYLHENH---ILHRDIKAA 144
Query: 129 NILLDNDFNPKLSDFGLAKL---------GPVGDNTHVSTRVMGTYGYCAPEYAMSGK-L 178
NIL+DN K++DFGLA+ G G T T ++ T Y PE + +
Sbjct: 145 NILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRY 204
Query: 179 TLKSDIYSFGVVLLELITGR 198
T DI+ G V E+ T R
Sbjct: 205 TTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 5e-13
Identities = 39/94 (41%), Positives = 61/94 (64%), Gaps = 5/94 (5%)
Query: 107 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG-PVGDNTHVSTRVMGTY 165
RGL+Y+H AN V++RDLK +N+LL+ + + K+ DFGLA++ P D+T T + T
Sbjct: 117 RGLKYIH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 166 GYCAPEYAMSGKLTLKS-DIYSFGVVLLELITGR 198
Y APE ++ K K+ DI+S G +L E+++ R
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 7e-13
Identities = 52/156 (33%), Positives = 76/156 (48%), Gaps = 18/156 (11%)
Query: 61 CTSGDQRL-LVYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCKAN 117
C RL LV EY+ G L H+ P++ + + IA L +LH +
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA------LNFLHERG- 116
Query: 118 PPVIYRDLKSANILLDNDFNPKLSDFGLAK--LGPVGDNTHVSTRVMGTYGYCAPEYAMS 175
+IYRDLK N+LLD D + KL+D+G+ K LGP GD T + GT Y APE
Sbjct: 117 --IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTT---STFCGTPNYIAPEILRG 170
Query: 176 GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN 211
+ D ++ GV++ E++ GR D+ + N
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN 206
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 8e-13
Identities = 61/199 (30%), Positives = 97/199 (48%), Gaps = 26/199 (13%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFI---VEVLMLSLLHHD--NLVTLIGYCTS 63
G V+ ++A+KQ+ G + + I ++V++ S HD +V GY +
Sbjct: 29 GQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS---HDCPYIVKCYGYFIT 85
Query: 64 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 123
+ E M + D L L+ Q P+ + K+ V + L YL K VI+R
Sbjct: 86 DSDVFICMELM--STCLDKL--LKRIQGPIPEDILGKMTVAIVKALHYL--KEKHGVIHR 139
Query: 124 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY----AMSGKLT 179
D+K +NILLD N KL DFG++ G + D + TR G Y APE + K
Sbjct: 140 DVKPSNILLDASGNVKLCDFGIS--GRLVD-SKAKTRSAGCAAYMAPERIDPPDPNPKYD 196
Query: 180 LKSDIYSFGVVLLELITGR 198
+++D++S G+ L+EL TG+
Sbjct: 197 IRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 8e-13
Identities = 62/195 (31%), Positives = 92/195 (47%), Gaps = 27/195 (13%)
Query: 20 DQLVAIKQ--LNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL--------- 68
+LVA+K+ L++E I E+ +L L+H N+V L T L
Sbjct: 32 GELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAF 91
Query: 69 -LVYEYMP---MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 124
LV+EYM MG LE L D + MK + GL Y H K ++RD
Sbjct: 92 YLVFEYMDHDLMGLLESGLVHFSEDHI----KSFMKQLL---EGLNYCHKKN---FLHRD 141
Query: 125 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSD 183
+K +NILL+N KL+DFGLA+L ++ + +V+ T Y PE + + D
Sbjct: 142 IKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TLWYRPPELLLGEERYGPAID 200
Query: 184 IYSFGVVLLELITGR 198
++S G +L EL T +
Sbjct: 201 VWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 9e-13
Identities = 48/168 (28%), Positives = 76/168 (45%), Gaps = 11/168 (6%)
Query: 37 QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR------LLVYEYMPMGSLEDHLYDLEPDQ 90
++F+ E + + H N++ LIG C + +++ +M G L L
Sbjct: 45 EDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGD 104
Query: 91 EPLSWNTRM--KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 148
P T+M K A G+EYL K+ I+RDL + N +L+ + N ++DFGL+K
Sbjct: 105 CPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKK 161
Query: 149 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
GD + A E T KSD++SFGV + E+ T
Sbjct: 162 IYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 64/198 (32%), Positives = 94/198 (47%), Gaps = 29/198 (14%)
Query: 14 GLVWLC-----DQLVAIKQL--NHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 66
G+V+ C Q+VAIK+ + + + + E+ ML L H NLV LI +
Sbjct: 15 GVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRK 74
Query: 67 RLLVYEYMPMGSLEDH--LYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 124
LV+EY DH L +LE + + + KI + + + H K N I+RD
Sbjct: 75 LHLVFEYC------DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH-KHN--CIHRD 125
Query: 125 LKSANILLDNDFNPKLSDFGLAKL--GPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLK 181
+K NIL+ KL DFG A++ GP D T +V+TR Y APE + G
Sbjct: 126 VKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPEL-LVGDTQYG 179
Query: 182 S--DIYSFGVVLLELITG 197
D+++ G V EL+TG
Sbjct: 180 PPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-12
Identities = 50/161 (31%), Positives = 79/161 (49%), Gaps = 18/161 (11%)
Query: 42 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL-----EDHLYDLEPDQEPLSWN 96
EV++L+ + H N+VT + +V EY G L DQ LSW
Sbjct: 49 EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ-ILSWF 107
Query: 97 TRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAKLGPVGDNT 155
++ + GL+++H + +++RD+KS NI L N KL DFG+A+ + D+
Sbjct: 108 VQISL------GLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSM 156
Query: 156 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
++ +GT Y +PE + K+DI+S G VL EL T
Sbjct: 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-12
Identities = 67/262 (25%), Positives = 117/262 (44%), Gaps = 38/262 (14%)
Query: 23 VAIKQLNHEGLQGHQE-----FIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77
VAIK L G+ E F+ E ++ H N++ L G T ++V EYM G
Sbjct: 35 VAIKTLK----AGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENG 90
Query: 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 137
SL+ L + + ++ G A G++YL ++ ++RDL + NIL++++
Sbjct: 91 SLDAFLRKHDGQFTVIQLVGMLR---GIASGMKYL---SDMGYVHRDLAARNILVNSNLV 144
Query: 138 PKLSDFGLAKLGPVGDNTHVSTRVMG---TYGYCAPEYAMSGKLTLKSDIYSFGVVLLEL 194
K+SDFGL+++ + D+ + G + APE K T SD++S+G+V+ E+
Sbjct: 145 CKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 202
Query: 195 ITGRKAMDLSKGQGEQNLVSWSRPFLK-DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMC 253
++ GE RP+ + + + ++ P C + C
Sbjct: 203 MS----------YGE-------RPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDC 245
Query: 254 LNEEANFRPLINDIVVALDYLV 275
++ N RP IV LD L+
Sbjct: 246 WQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 50/157 (31%), Positives = 77/157 (49%), Gaps = 20/157 (12%)
Query: 45 MLSLLHHDNLVTLIGYCTSGDQRLL--VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 102
+L + H ++ L + T DQR L + EY+P G L +L + ++ +
Sbjct: 54 VLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYL------RNSGRFSNSTGLF 105
Query: 103 VGA--ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160
+ LEYLH K ++YRDLK NILLD + + KL+DFG AK + D T
Sbjct: 106 YASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK--KLRDRTWT--- 157
Query: 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 197
+ GT Y APE S D ++ G+++ E++ G
Sbjct: 158 LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 37/102 (36%), Positives = 59/102 (57%), Gaps = 12/102 (11%)
Query: 100 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD---NTH 156
KI++ RGL YL + +++RD+K +NIL+++ KL DFG++ G + D N+
Sbjct: 103 KISIAVLRGLTYL--REKHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSF 158
Query: 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 198
V TR Y +PE T++SDI+S G+ L+E+ GR
Sbjct: 159 VGTR-----SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 46/175 (26%), Positives = 86/175 (49%), Gaps = 10/175 (5%)
Query: 23 VAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDH 82
VA+K ++ Q + EV+++ H N+V + G++ ++ E++ G+L D
Sbjct: 49 VAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDI 108
Query: 83 LYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 142
+ ++E ++ + + L YLH + VI+RD+KS +ILL D KLSD
Sbjct: 109 VSQTRLNEEQIA-----TVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSD 160
Query: 143 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 197
FG + + ++GT + APE + DI+S G++++E++ G
Sbjct: 161 FGFC--AQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 38/92 (41%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 106 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 165
A L++LH + +IYRDLK NILLD + + KL+DFGL+K + S GT
Sbjct: 108 ALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTV 162
Query: 166 GYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 197
Y APE T +D +SFGV++ E++TG
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 37/90 (41%), Positives = 54/90 (60%), Gaps = 6/90 (6%)
Query: 109 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 168
L+Y+H VI+RD+K+ANIL+ N N KL DFG+A L + N+ + +GT +
Sbjct: 114 LKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAAL--LNQNSSKRSTFVGTPYWM 168
Query: 169 APEYAMSGKL-TLKSDIYSFGVVLLELITG 197
APE GK K+DI+S G+ + E+ TG
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 48/169 (28%), Positives = 89/169 (52%), Gaps = 20/169 (11%)
Query: 39 FIVEVLMLSLLHHDNLVTLIGYCTS-GDQRLLVYEYMPMGSLEDHLYD--LEPDQEPLSW 95
+ E +L L H N++ ++ C G+ ++Y YM G+L+ L L P +
Sbjct: 55 LLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL 114
Query: 96 NTR--MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGP-- 150
+T+ + +A+ A G+ YLH + VI++D+ + N ++D + K++D L++ L P
Sbjct: 115 STQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMD 171
Query: 151 ---VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
+GDN + + M A E ++ + + SD++SFGV+L EL+T
Sbjct: 172 YHCLGDNENRPVKWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 49/158 (31%), Positives = 77/158 (48%), Gaps = 20/158 (12%)
Query: 61 CTSGDQRL-LVYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCKAN 117
C + RL V E++ G L H+ P++ ++ + +A L +LH +
Sbjct: 64 CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA------LNFLHERG- 116
Query: 118 PPVIYRDLKSANILLDNDFNPKLSDFGLAK--LGPVGDNTHVSTRVMGTYGYCAPEYAMS 175
+IYRDLK N+LLD + + KL+D+G+ K + P GD T ST GT Y APE
Sbjct: 117 --IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTT--ST-FCGTPNYIAPEILRG 170
Query: 176 GKLTLKSDIYSFGVVLLELITGRKAMDL--SKGQGEQN 211
D ++ GV++ E++ GR D+ +QN
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-12
Identities = 48/137 (35%), Positives = 70/137 (51%), Gaps = 14/137 (10%)
Query: 65 DQRLLVYEYMPMGSLEDHLYDLEP---DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 121
D LV M G L+ H+Y++ D+E + A GLE LH + ++
Sbjct: 73 DALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF-----YAAEITCGLEDLHRER---IV 124
Query: 122 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK 181
YRDLK NILLD+ + ++SD GLA P G+ + RV GT GY APE + + T
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMAPEVVKNERYTFS 181
Query: 182 SDIYSFGVVLLELITGR 198
D + G ++ E+I G+
Sbjct: 182 PDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 20/198 (10%)
Query: 14 GLVWLC-----DQLVAIKQL--NHEGLQGHQE---FIVEVLMLSLLHHDNLVTLIGYCTS 63
G V+LC + +A+KQ+ + E + +E E+ +L L H+ +V G
Sbjct: 16 GRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD 75
Query: 64 GDQRLL--VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 121
+R L E+MP GS++D L L+ N K G+ YLH ++
Sbjct: 76 PMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILEGVSYLHSNM---IV 128
Query: 122 YRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTL 180
+RD+K ANIL D+ N KL DFG +K L + + V GT + +PE
Sbjct: 129 HRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGR 188
Query: 181 KSDIYSFGVVLLELITGR 198
K+DI+S G ++E++T +
Sbjct: 189 KADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 61/223 (27%), Positives = 91/223 (40%), Gaps = 50/223 (22%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGL--QGH-QEFIVEVLMLSLLHHDNLVTLIGYCTSGD 65
G VWL Q+ A+K L + + E +L+ +V L Y + D
Sbjct: 15 GEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL--YYSFQD 72
Query: 66 QRLL--VYEYMPMGSLEDHL--YDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 121
+ L V EYMP G L + L D+ P++ + + +A+ + L ++H
Sbjct: 73 EEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIH-------- 124
Query: 122 YRDLKSANILLDNDFNPKLSDFGLAK----------------LGPVGDNTHVSTR----- 160
RD+K NIL+D D + KL+DFGL K DN V R
Sbjct: 125 -RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQR 183
Query: 161 ------VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 197
+GT Y APE L+ D +S GV+L E++ G
Sbjct: 184 RVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 4e-12
Identities = 58/185 (31%), Positives = 85/185 (45%), Gaps = 19/185 (10%)
Query: 20 DQLVAIKQLNHEGLQGHQEFIVEVLM-----LSLLHHDNLVTLIGYCTSGDQRLL-VYEY 73
+L A+K L + + Q+ VE M LSL + +T + C RL V E+
Sbjct: 20 GRLYAVKVLKKDVIL--QDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEF 77
Query: 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEYLHCKANPPVIYRDLKSANILL 132
+ G L H+ E R + A L +LH K +IYRDLK N+LL
Sbjct: 78 VNGGDLMFHIQKSRRFDEA-----RARFYAAEITSALMFLHDKG---IIYRDLKLDNVLL 129
Query: 133 DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLL 192
D++ + KL+DFG+ K G + + ST GT Y APE D ++ GV+L
Sbjct: 130 DHEGHCKLADFGMCKEG-IFNGKTTST-FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLY 187
Query: 193 ELITG 197
E++ G
Sbjct: 188 EMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-12
Identities = 51/186 (27%), Positives = 84/186 (45%), Gaps = 13/186 (6%)
Query: 21 QLVAIKQLNHEGLQGH--QEFIVEVLMLSLLHHDNLVTLIGYC--TSGDQRL----LVYE 72
Q VA+K L + +EF+ E + H N++ LIG + RL ++
Sbjct: 28 QKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILP 87
Query: 73 YMPMGSLEDHLYDLEPDQEP--LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANI 130
+M G L L +EP L T ++ + A G+EYL ++ I+RDL + N
Sbjct: 88 FMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYL---SSKNFIHRDLAARNC 144
Query: 131 LLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVV 190
+L+ + ++DFGL+K GD + A E T SD+++FGV
Sbjct: 145 MLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVT 204
Query: 191 LLELIT 196
+ E++T
Sbjct: 205 MWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 4e-12
Identities = 50/157 (31%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 61 CTSGDQRLL-VYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCKAN 117
C + RL V EY+ G L H+ P++ ++ + +A L YLH +
Sbjct: 64 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA------LNYLHERG- 116
Query: 118 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLG-PVGDNTHVSTRVMGTYGYCAPEYAMSG 176
+IYRDLK N+LLD++ + KL+D+G+ K G GD T + GT Y APE
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRGE 171
Query: 177 KLTLKSDIYSFGVVLLELITGRKAMDL--SKGQGEQN 211
D ++ GV++ E++ GR D+ S +QN
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-12
Identities = 58/195 (29%), Positives = 91/195 (46%), Gaps = 17/195 (8%)
Query: 7 SCKFYNVGLVWLCDQLVA--IKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC-TS 63
+C+ G ++ C +L IK+ E + +++ I+E + + V + Y +
Sbjct: 18 ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV------NSRFVVSLAYAYET 71
Query: 64 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 123
D LV M G L+ H+Y++ + A GLE L ++YR
Sbjct: 72 KDALCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYR 126
Query: 124 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSD 183
DLK NILLD+ + ++SD GLA P G+ V RV GT GY APE + K T D
Sbjct: 127 DLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYMAPEVINNEKYTFSPD 183
Query: 184 IYSFGVVLLELITGR 198
+ G ++ E+I G+
Sbjct: 184 WWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-12
Identities = 48/160 (30%), Positives = 78/160 (48%), Gaps = 10/160 (6%)
Query: 42 EVLMLSLLHHDNLVTLIGYCTSGDQRLLV--YEYMPMGSLEDHLYDLEPDQEPLSWNTRM 99
E+ +L L H+ +V G ++ L EYMP GS++D L E ++
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR 113
Query: 100 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVS 158
+I G+ YLH +++RD+K ANIL D+ N KL DFG +K L + +
Sbjct: 114 QIL----EGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGI 166
Query: 159 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 198
V GT + +PE K+D++S G ++E++T +
Sbjct: 167 RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-12
Identities = 51/161 (31%), Positives = 74/161 (45%), Gaps = 19/161 (11%)
Query: 42 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYD----LEPDQEPLSWNT 97
E ++L+ + H N+V + +V EY G L + L P+ L W
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107
Query: 98 RMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNT 155
+M + V +++H K V++RD+KS NI L + KL DFG A+L P
Sbjct: 108 QMCLGV------QHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG---A 155
Query: 156 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
+ T V GT Y PE + KSDI+S G +L EL T
Sbjct: 156 YACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 6e-12
Identities = 50/182 (27%), Positives = 92/182 (50%), Gaps = 21/182 (11%)
Query: 22 LVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
L A K + + + ++++VE+ +L+ +H +V L+G + ++ E+ P G+++
Sbjct: 39 LAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDA 98
Query: 82 HLYDLEPD-QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 140
+ +L+ EP +I V + LE L + +I+RDLK+ N+LL D + KL
Sbjct: 99 IMLELDRGLTEP-------QIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKL 151
Query: 141 SDFGLAKLGPVGDNTHVSTR---VMGTYGYCAPEYAMSGKLT-----LKSDIYSFGVVLL 192
+DFG++ N R +GT + APE M + K+DI+S G+ L+
Sbjct: 152 ADFGVS-----AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLI 206
Query: 193 EL 194
E+
Sbjct: 207 EM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-12
Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 10/158 (6%)
Query: 42 EVLMLSLLHHDNLVTLIGYCTSGDQRLL--VYEYMPMGSLEDHLYDLEPDQEPLSWNTRM 99
E+ +L L HD +V G +++ L EYMP GS++D L L+ N
Sbjct: 54 EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVTR 109
Query: 100 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVS 158
+ +G+ YLH +++RD+K ANIL D+ N KL DFG +K + + +
Sbjct: 110 RYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGI 166
Query: 159 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
V GT + +PE K+D++S ++E++T
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 8e-12
Identities = 54/186 (29%), Positives = 98/186 (52%), Gaps = 17/186 (9%)
Query: 23 VAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYC-TSGDQRLLVYEYMPMGSLE 80
VAIK+L + ++E + E +++ + + ++ L+G C TS Q L+ + MP G L
Sbjct: 39 VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ--LITQLMPFGCLL 96
Query: 81 DHLYDLEPD---QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 137
D++ + + + Q L+W V A+G+ YL + +++RDL + N+L+ +
Sbjct: 97 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQH 147
Query: 138 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT- 196
K++DFGLAKL + + + + A E + T +SD++S+GV + EL+T
Sbjct: 148 VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 207
Query: 197 GRKAMD 202
G K D
Sbjct: 208 GSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 8e-12
Identities = 58/180 (32%), Positives = 81/180 (45%), Gaps = 16/180 (8%)
Query: 24 AIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
A+K L E + E + E +L H L L + D+ V EY G L
Sbjct: 24 AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF 83
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGA--ARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 138
HL +E + R + GA LEYLH + V+YRD+K N++LD D +
Sbjct: 84 FHL-----SRERVFTEERARF-YGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHI 134
Query: 139 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 198
K++DFGL K G + D + T GT Y APE D + GVV+ E++ GR
Sbjct: 135 KITDFGLCKEG-ISDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 8e-12
Identities = 52/165 (31%), Positives = 84/165 (50%), Gaps = 19/165 (11%)
Query: 40 IVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRM 99
I E+ +L L+H N+V L+ S ++ LV+E++ + L+ ++ D PL+
Sbjct: 46 IREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYM-----DSSPLTGLDPP 99
Query: 100 KIA---VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LG-PVGDN 154
I +G+ Y H V++RDLK N+L+D + KL+DFGLA+ G PV
Sbjct: 100 LIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY 156
Query: 155 THVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 198
TH V+ T Y APE + + + DI+S G + E++ R
Sbjct: 157 TH---EVV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 8e-12
Identities = 60/188 (31%), Positives = 83/188 (44%), Gaps = 26/188 (13%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLM--------LSLLHHDNLVTLIGYCTSGDQRL-LVY 71
+L AIK L + E VE LM + H LV L C + + V
Sbjct: 25 ELYAIKALKKGDIIARDE--VESLMCEKRIFETANSERHPFLVNLFA-CFQTEDHVCFVM 81
Query: 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANIL 131
EY G L H++ + S + A GL+YLH ++YRDLK N+L
Sbjct: 82 EYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLL 133
Query: 132 LDNDFNPKLSDFGLAK--LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGV 189
LD + K++DFGL K +G GD T ST GT + APE T D + GV
Sbjct: 134 LDTEGFVKIADFGLCKEGMGF-GDRT--ST-FCGTPEFLAPEVLTETSYTRAVDWWGLGV 189
Query: 190 VLLELITG 197
++ E++ G
Sbjct: 190 LIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 22/200 (11%)
Query: 20 DQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLIGYCTSGDQRL-LVYEYMP 75
D+L AIK L + + + +VE +L+L +T + C RL V EY+
Sbjct: 25 DELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVN 84
Query: 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 135
G L + + +EP + +IA+G L +LH K +IYRDLK N++LD++
Sbjct: 85 GGDLMYQIQQVGRFKEPHAVFYAAEIAIG----LFFLHSKG---IIYRDLKLDNVMLDSE 137
Query: 136 FNPKLSDFGLAKLGPVGDNT--HVSTRVM-GTYGYCAPEYAMSGKLTLKSDIYSFGVVLL 192
+ K++DFG+ K +N V+T+ GT Y APE D ++FGV+L
Sbjct: 138 GHIKIADFGMCK-----ENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLY 192
Query: 193 ELITGRKAMDLSKGQGEQNL 212
E++ G+ + G+ E L
Sbjct: 193 EMLAGQAPFE---GEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 55/186 (29%), Positives = 97/186 (52%), Gaps = 17/186 (9%)
Query: 23 VAIKQL-NHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC-TSGDQRLLVYEYMPMGSLE 80
VAIK L + + ++E + E +++ + + L+G C TS Q LV + MP G L
Sbjct: 39 VAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQ--LVTQLMPYGCLL 96
Query: 81 DHLY---DLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 137
D++ D Q+ L+W V A+G+ YL +++RDL + N+L+ + +
Sbjct: 97 DYVRENKDRIGSQDLLNW------CVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNH 147
Query: 138 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT- 196
K++DFGLA+L + + + + + A E + + T +SD++S+GV + EL+T
Sbjct: 148 VKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTF 207
Query: 197 GRKAMD 202
G K D
Sbjct: 208 GAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-11
Identities = 39/88 (44%), Positives = 48/88 (54%), Gaps = 8/88 (9%)
Query: 110 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 169
EYLH K +IYRDLK N+LLDN + K++DFG AK V D T + GT Y A
Sbjct: 132 EYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRTFT---LCGTPEYLA 183
Query: 170 PEYAMSGKLTLKSDIYSFGVVLLELITG 197
PE S D ++ GV+L E I G
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 39/103 (37%), Positives = 57/103 (55%), Gaps = 10/103 (9%)
Query: 100 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA-KLGPVGDNTHVS 158
KIAV + L YL K +I+RD+K +NILLD + N KL DFG++ +L ++
Sbjct: 111 KIAVATVKALNYL--KEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL----VDSIAK 164
Query: 159 TRVMGTYGYCAPEYAMSG---KLTLKSDIYSFGVVLLELITGR 198
TR G Y APE ++SD++S G+ L E+ TG+
Sbjct: 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-11
Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 5/148 (3%)
Query: 49 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 108
L H N+V D+ +V + + L +H L+ ++ + I V
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 109 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 168
L YLH + +++RDL NI+L D ++DFGLAK + + T V+GT Y
Sbjct: 126 LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKL-TSVVGTILYS 180
Query: 169 APEYAMSGKLTLKSDIYSFGVVLLELIT 196
PE + K+D+++FG +L ++ T
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-11
Identities = 61/189 (32%), Positives = 89/189 (47%), Gaps = 27/189 (14%)
Query: 54 LVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAA-RGLEY 111
LVTL Y + +L L+ +Y+ G + HLY + E ++ G LE+
Sbjct: 67 LVTL-HYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE-----DEVRFYSGEIILALEH 120
Query: 112 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK--LGPVGDNTHVSTRVMGTYGYCA 169
LH ++YRD+K NILLD++ + L+DFGL+K L + T+ GT Y A
Sbjct: 121 LH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY---SFCGTIEYMA 174
Query: 170 PEYAMS----GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS-WSRPFLKDQK 224
PE GK D +S G+++ EL+TG L +GE+N S SR LK
Sbjct: 175 PEIIRGKGGHGKAV---DWWSLGILIFELLTGASPFTL---EGERNTQSEVSRRILKCDP 228
Query: 225 KFVHLVDPL 233
F + P
Sbjct: 229 PFPSFIGPE 237
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-11
Identities = 58/189 (30%), Positives = 96/189 (50%), Gaps = 14/189 (7%)
Query: 23 VAIKQLNHEGLQG-HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
VAIK L +E + E + E ++ L + +V +IG C + + +LV E G L
Sbjct: 25 VAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNK 83
Query: 82 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 141
L + D+ +S + V + G++YL K ++RDL + N+LL N K+S
Sbjct: 84 FLSG-KKDEITVSNVVELMHQV--SMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKIS 137
Query: 142 DFGLAK-LGPVGDNTHVSTRVMGTY--GYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-G 197
DFGL+K LG D+++ R G + + APE K + +SD++S+G+ + E + G
Sbjct: 138 DFGLSKALG--ADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYG 195
Query: 198 RKAMDLSKG 206
+K KG
Sbjct: 196 QKPYKKMKG 204
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 54/184 (29%), Positives = 89/184 (48%), Gaps = 16/184 (8%)
Query: 21 QLVAIKQLNHEGLQGHQE-----FIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75
Q+VA+K++ L+ +E I E+ +L L H N+V L + L++E++
Sbjct: 26 QIVAMKKIR---LESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS 82
Query: 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 135
M L+ +L L Q + +G+ + H + V++RDLK N+L+DN
Sbjct: 83 M-DLKKYLDSLPKGQY-MDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNK 137
Query: 136 FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLEL 194
KL+DFGLA+ G V T + T Y APE + S + + DI+S G + E+
Sbjct: 138 GVIKLADFGLAR--AFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEM 195
Query: 195 ITGR 198
T +
Sbjct: 196 ATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 62/194 (31%), Positives = 87/194 (44%), Gaps = 26/194 (13%)
Query: 20 DQLVAIKQLNHEGLQGHQEFI-VEVLML-SLLHHDNLVTLIG------YCTSGDQRLLVY 71
QLVAIK ++ +E I E +L +H N+ T G + DQ LV
Sbjct: 31 GQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVM 88
Query: 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANIL 131
E GS+ D + L + L I RGL YLH VI+RD+K NIL
Sbjct: 89 ELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNIL 145
Query: 132 LDNDFNPKLSDFGL-AKLGPVGDNTHVSTR--VMGTYGYCAPEYAMSGK-----LTLKSD 183
L + KL DFG+ A+L D+T + R +GT + APE + +SD
Sbjct: 146 LTKNAEVKLVDFGVSAQL----DST-LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSD 200
Query: 184 IYSFGVVLLELITG 197
++S G+ +EL G
Sbjct: 201 VWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 54/165 (32%), Positives = 81/165 (49%), Gaps = 18/165 (10%)
Query: 40 IVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRM 99
I E+ +L + H N+V L S + LV+EY+ + L+ H+ D PD + N R+
Sbjct: 49 IREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHM-DSSPD---FAKNPRL 103
Query: 100 --KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP-KLSDFGLAK-LG-PVGDN 154
RG+ Y H V++RDLK N+L+D N KL+DFGLA+ G PV
Sbjct: 104 IKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160
Query: 155 THVSTRVMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGR 198
TH T Y APE + + + DI+S G + E++ +
Sbjct: 161 THEVV----TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 49/156 (31%), Positives = 83/156 (53%), Gaps = 13/156 (8%)
Query: 46 LSLLHHDN---LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 102
L +LH N +V G S + + E+M GSL+ L + + E + K++
Sbjct: 54 LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEI----LGKVS 109
Query: 103 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 162
+ RGL YL K +++RD+K +NIL+++ KL DFG++ G + D+ ++ +
Sbjct: 110 IAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFV 163
Query: 163 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 198
GT Y +PE +++SDI+S G+ L+EL GR
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-11
Identities = 51/181 (28%), Positives = 91/181 (50%), Gaps = 19/181 (10%)
Query: 22 LVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
L A K ++ + + ++++VE+ +L+ H N+V L+ + ++ E+ G+++
Sbjct: 32 LAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDA 91
Query: 82 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 141
+ +LE PL T +I V + LE L+ +I+RDLK+ NIL D + KL+
Sbjct: 92 VMLELE---RPL---TEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLA 145
Query: 142 DFGLAKLGPVGDNTHVSTR---VMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLE 193
DFG++ NT R +GT + APE M K+D++S G+ L+E
Sbjct: 146 DFGVS-----AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIE 200
Query: 194 L 194
+
Sbjct: 201 M 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 58/198 (29%), Positives = 96/198 (48%), Gaps = 11/198 (5%)
Query: 18 LCDQLVAIKQLNHEGLQGHQ-EFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76
L + LVA+K++ E +G I EV +L L H N+VTL + LV+EY+
Sbjct: 29 LTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK 88
Query: 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF 136
L+ ++ D +S + RGL Y H + V++RDLK N+L++
Sbjct: 89 -DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERG 141
Query: 137 NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELI 195
KL+DFGLA+ V T+ + V T Y P+ + S + + + D++ G + E+
Sbjct: 142 ELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMA 199
Query: 196 TGRKAMDLSKGQGEQNLV 213
+GR S + E +L+
Sbjct: 200 SGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 60/185 (32%), Positives = 87/185 (47%), Gaps = 18/185 (9%)
Query: 54 LVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA-ARGLEY 111
LVTL Y D +L L+ +Y+ G L HL E +E ++I G LE+
Sbjct: 67 LVTL-HYAFQTDTKLHLILDYINGGELFTHLSQRERFKE-----QEVQIYSGEIVLALEH 120
Query: 112 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 171
LH +IYRD+K NILLD++ + L+DFGL+K D + GT Y AP+
Sbjct: 121 LH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFHEDEVERAYSFCGTIEYMAPD 176
Query: 172 YAMSGKLTLKS--DIYSFGVVLLELITGRKAMDLSKGQGEQNLVS-WSRPFLKDQKKFVH 228
G D +S GV++ EL+TG + GE+N + SR LK + +
Sbjct: 177 IVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD---GEKNSQAEISRRILKSEPPYPQ 233
Query: 229 LVDPL 233
+ L
Sbjct: 234 EMSAL 238
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-11
Identities = 34/93 (36%), Positives = 56/93 (60%), Gaps = 9/93 (9%)
Query: 107 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 166
RGL+Y+H V++RDLK +NIL++ + + K+ DFGLA++ +VSTR
Sbjct: 119 RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY----- 170
Query: 167 YCAPEYAMS-GKLTLKSDIYSFGVVLLELITGR 198
Y APE ++ K ++ DI+S G + E++ G+
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-11
Identities = 54/180 (30%), Positives = 89/180 (49%), Gaps = 18/180 (10%)
Query: 21 QLVAIKQLNHEGLQGHQEFIV---EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77
+L AIK + L+ ++F V E++M+ H N+V G D+ + E+ G
Sbjct: 35 ELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGG 91
Query: 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 137
SL+D +Y + PLS + ++ +GL YLH K ++RD+K ANILL ++ +
Sbjct: 92 SLQD-IYHV---TGPLSESQIAYVSRETLQGLYYLHSKGK---MHRDIKGANILLTDNGH 144
Query: 138 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLEL 194
KL+DFG++ + +GT + APE A G DI++ G+ +EL
Sbjct: 145 VKLADFGVS--AQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 6e-11
Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 109 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 168
L +LH VIYRDLK NILLD + + KL+DFG+ K G + T +T GT Y
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYI 163
Query: 169 APEYAMSGKLTLKSDIYSFGVVLLELITGR 198
APE + D ++ GV++ E++ G+
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 6e-11
Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 5/158 (3%)
Query: 42 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI 101
E+ ML HDN+++ + Y+ ++ L+ + +PLS +
Sbjct: 49 ELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVF 108
Query: 102 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 161
RGL+YLH A +++RD+K N+L++++ K+ DFGLA++ ++ H++ V
Sbjct: 109 LYQILRGLKYLH-SAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEV 165
Query: 162 MGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGR 198
+ Y Y APE M S T DI+S G + EL+ R
Sbjct: 166 VTQY-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 7e-11
Identities = 50/179 (27%), Positives = 82/179 (45%), Gaps = 14/179 (7%)
Query: 22 LVAIKQLNHEGLQGHQE--FIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79
VAI L G Q F+ E L L H N+V L G T G+ ++V EYM G+L
Sbjct: 35 PVAIHTL-RAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGAL 93
Query: 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 139
+ L E L M + G A G++YL + +++ L + +L+++D K
Sbjct: 94 DSFLRKHEGQ---LVAGQLMGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCK 147
Query: 140 LSDFGLAKLGPVGDNTHVSTRVMGTYG--YCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
+S F + + T + G + APE + SD++SFG+V+ E+++
Sbjct: 148 ISGFR---RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 8e-11
Identities = 37/91 (40%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 108 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 167
L+YLH + N V+YRDLK N++LD D + K++DFGL K G + D + T GT Y
Sbjct: 107 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FCGTPEY 162
Query: 168 CAPEYAMSGKLTLKSDIYSFGVVLLELITGR 198
APE D + GVV+ E++ GR
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 8e-11
Identities = 58/173 (33%), Positives = 82/173 (47%), Gaps = 25/173 (14%)
Query: 34 QGHQEFIVEVLMLSLLHHDN---LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQ 90
QG + E +MLSL+ + +V + + D+ + + M G L HL Q
Sbjct: 36 QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-----SQ 90
Query: 91 EPLSWNTRMKI-AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA--- 146
+ M+ A GLE++H N V+YRDLK ANILLD + ++SD GLA
Sbjct: 91 HGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF 147
Query: 147 -KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKS-DIYSFGVVLLELITG 197
K P H S +GT+GY APE G S D +S G +L +L+ G
Sbjct: 148 SKKKP-----HAS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 8e-11
Identities = 52/186 (27%), Positives = 83/186 (44%), Gaps = 18/186 (9%)
Query: 23 VAIKQLNHEGLQGHQ-EFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
V +K+L Q F+ EV L+H N++ +G C LLV E+ P+G L++
Sbjct: 25 VVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKN 84
Query: 82 HLYDLEPDQEPLSW----NTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 137
+ L ++ ++ + ++A A GL +LH +A+ I+ DL N L D +
Sbjct: 85 Y---LRSNRGMVAQMAQKDVLQRMACEVASGLLWLH-QAD--FIHSDLALRNCQLTADLS 138
Query: 138 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA-------MSGKLTLKSDIYSFGVV 190
K+ D+GLA D + APE + T KS+I+S GV
Sbjct: 139 VKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVT 198
Query: 191 LLELIT 196
+ EL T
Sbjct: 199 MWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 52/235 (22%), Positives = 93/235 (39%), Gaps = 27/235 (11%)
Query: 37 QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWN 96
Q+ + E+ +L L H N++ + ++ +V E G L + + + +
Sbjct: 47 QDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPER 106
Query: 97 TRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156
T K V LE++H K +++RD+K AN+ + KL D GL + T
Sbjct: 107 TIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTT 161
Query: 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS 216
+ ++GT Y +PE KSDI+S G +L E + +
Sbjct: 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE------------------MAALQ 203
Query: 217 RPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVA----VTAMCLNEEANFRPLINDI 267
PF D+ L + YP ++ + + C+N + RP I+ +
Sbjct: 204 SPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 1e-10
Identities = 58/182 (31%), Positives = 87/182 (47%), Gaps = 52/182 (28%)
Query: 42 EVLMLS-LLHHDNLVTLIG-YCTSGDQRL-LVYEYMPM--------GSLED-H----LYD 85
E++ L L H N+V L+ D+ + LV+EYM LED H +Y
Sbjct: 56 EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQ 115
Query: 86 LEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 145
L + L+Y+H N VI+RDLK +NILL++D KL+DFGL
Sbjct: 116 L-------------------LKALKYIH-SGN--VIHRDLKPSNILLNSDCRVKLADFGL 153
Query: 146 AK-LGPVGDNT-------HVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELIT 196
A+ L + +N +V+TR Y APE + S + T D++S G +L E++
Sbjct: 154 ARSLSELEENPENPVLTDYVATR-----WYRAPEILLGSTRYTKGVDMWSVGCILGEMLL 208
Query: 197 GR 198
G+
Sbjct: 209 GK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 56/183 (30%), Positives = 89/183 (48%), Gaps = 11/183 (6%)
Query: 18 LCDQLVAIKQLNHEGLQGHQ-EFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76
L D LVA+K++ E +G I EV +L L H N+VTL + LV+EY+
Sbjct: 29 LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK 88
Query: 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF 136
L+ +L D ++ + RGL Y H + V++RDLK N+L++
Sbjct: 89 -DLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERG 141
Query: 137 NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELI 195
KL+DFGLA+ + T+ + V T Y P+ + S + + D++ G + E+
Sbjct: 142 ELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMS 199
Query: 196 TGR 198
TGR
Sbjct: 200 TGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-10
Identities = 53/187 (28%), Positives = 92/187 (49%), Gaps = 23/187 (12%)
Query: 25 IKQLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR---LLVYEYMPMGSL 79
IK++N + +E EV +LS + H N+V Y S ++ +V +Y G L
Sbjct: 30 IKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ---YQESFEENGNLYIVMDYCEGGDL 86
Query: 80 EDHLYD----LEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 135
+ L P+ + L W ++ +A L+++H + +++RD+KS NI L D
Sbjct: 87 YKKINAQRGVLFPEDQILDWFVQICLA------LKHVH---DRKILHRDIKSQNIFLTKD 137
Query: 136 FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 195
KL DFG+A++ + ++ +GT Y +PE + KSDI++ G VL E+
Sbjct: 138 GTIKLGDFGIARV--LNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMC 195
Query: 196 TGRKAMD 202
T + A +
Sbjct: 196 TLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-10
Identities = 49/156 (31%), Positives = 76/156 (48%), Gaps = 12/156 (7%)
Query: 42 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI 101
E+ M+ H N+V G S ++ + EY GSL+D +Y + PLS +
Sbjct: 56 EIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHV---TGPLSELQIAYV 111
Query: 102 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 161
+GL YLH K ++RD+K ANILL ++ + KL+DFG+A +
Sbjct: 112 CRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVA--AKITATIAKRKSF 166
Query: 162 MGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLEL 194
+GT + APE A +G DI++ G+ +EL
Sbjct: 167 IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 56/188 (29%), Positives = 95/188 (50%), Gaps = 20/188 (10%)
Query: 21 QLVAIKQL----NHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76
++VA+K++ EG+ I E+ +L L+H N+V L+ + ++ LV+E++
Sbjct: 26 EVVALKKIRLDTETEGVPSTA--IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 83
Query: 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF 136
L+ + PL + +GL + H V++RDLK N+L++ +
Sbjct: 84 -DLKKFMDASPLSGIPLPLIKSYLFQL--LQGLAFCHSHR---VLHRDLKPQNLLINTEG 137
Query: 137 NPKLSDFGLAK-LG-PVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLE 193
KL+DFGLA+ G PV TH V+ T Y APE + K + DI+S G + E
Sbjct: 138 AIKLADFGLARAFGVPVRTYTH---EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 193
Query: 194 LITGRKAM 201
++T R+A+
Sbjct: 194 MVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 40/89 (44%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 109 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 168
LE LH K N VIYRDLK NILLD + L DFGL KL D+ + GT Y
Sbjct: 106 LENLH-KFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYL 160
Query: 169 APEYAMSGKLTLKSDIYSFGVVLLELITG 197
APE + T D ++ GV+L E++TG
Sbjct: 161 APELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 66/246 (26%), Positives = 111/246 (45%), Gaps = 30/246 (12%)
Query: 19 CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL---------- 68
CD+ VA+K++ Q + + E+ ++ L HDN+V + L
Sbjct: 29 CDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTEL 88
Query: 69 ----LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 124
+V EYM E L ++ +Q PLS RGL+Y+H AN V++RD
Sbjct: 89 NSVYIVQEYM-----ETDLANVL-EQGPLSEEHARLFMYQLLRGLKYIH-SAN--VLHRD 139
Query: 125 LKSANILLD-NDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLK 181
LK AN+ ++ D K+ DFGLA+ + P + + + T Y +P +S T
Sbjct: 140 LKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKA 199
Query: 182 SDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL-VDPLL---HGR 237
D+++ G + E++TG+ + + L+ S P ++++ + L V P G
Sbjct: 200 IDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGG 259
Query: 238 YPRRCL 243
PRR L
Sbjct: 260 EPRRPL 265
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 18 LCDQLVAIKQLNHEGLQGHQ-EFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP- 75
L + LVA+K++ E +G I EV +L L H N+VTL + LV+EY+
Sbjct: 28 LTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS 87
Query: 76 -MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN 134
+ D+ +L +S + RGL Y H + +++RDLK N+L++
Sbjct: 88 DLKQYLDNCGNL------MSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINE 138
Query: 135 DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLE 193
KL+DFGLA+ V T+ + V T Y P+ + S + + D++ G +L E
Sbjct: 139 KGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTEYSTPIDMWGVGCILYE 196
Query: 194 LITGRKAMDLSKGQGEQNLV 213
+ TGR S + E +L+
Sbjct: 197 MATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 50/162 (30%), Positives = 76/162 (46%), Gaps = 16/162 (9%)
Query: 42 EVLMLSLLHHDNLVTLIGYCT--SGDQRLLVYEY--MPMGSLEDHLYDLEPDQEPLSWNT 97
E+ +L L H N+V L D LV EY + SL D++ P S +
Sbjct: 56 EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNM------PTPFSESQ 109
Query: 98 RMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157
+ + RGL+YLH +I+RDLK +N+LL + K++DFGLA+ G
Sbjct: 110 VKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKP 164
Query: 158 STRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGR 198
T + T Y APE + T D+++ G +L EL+ +
Sbjct: 165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-10
Identities = 58/173 (33%), Positives = 82/173 (47%), Gaps = 25/173 (14%)
Query: 34 QGHQEFIVEVLMLSLLHHDN---LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQ 90
QG + E +MLSL+ + +V + + D+ + + M G L HL Q
Sbjct: 36 QGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL-----SQ 90
Query: 91 EPLSWNTRMKI-AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA--- 146
+ M+ A GLE++H N V+YRDLK ANILLD + ++SD GLA
Sbjct: 91 HGVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF 147
Query: 147 -KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKS-DIYSFGVVLLELITG 197
K P H S +GT+GY APE G S D +S G +L +L+ G
Sbjct: 148 SKKKP-----HAS---VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 56/227 (24%), Positives = 97/227 (42%), Gaps = 45/227 (19%)
Query: 21 QLVAIKQLNHEGLQG---HQEFIVEVLMLSLLHHDNLVTLIGYC-TSGDQRL-LVYEYMP 75
+ AIK+ + Q Q E+ +L L H+N+V+L+ D+ + L+++Y
Sbjct: 28 KEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAE 87
Query: 76 MGSLEDHLYDL--------EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 127
+DL + + + + + G+ YLH +N V++RDLK
Sbjct: 88 --------HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH--SNW-VLHRDLKP 136
Query: 128 ANILLDNDFNP----KLSDFGLAKL------GPVGDNTHVSTRVMGTYGYCAPEYAMSGK 177
ANIL+ + K+ D GLA+L + V+ T Y APE + +
Sbjct: 137 ANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD-----PVVVTIWYRAPELLLGAR 191
Query: 178 LTLKS-DIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 223
K+ DI++ G + EL+T +G + + S PF +DQ
Sbjct: 192 HYTKAIDIWAIGCIFAELLTLEPIF-----KGREAKIKKSNPFQRDQ 233
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 36/90 (40%), Positives = 48/90 (53%), Gaps = 5/90 (5%)
Query: 109 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 168
L YLH V+YRDLK N++LD D + K++DFGL K G + D + T GT Y
Sbjct: 108 LGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTPEYL 162
Query: 169 APEYAMSGKLTLKSDIYSFGVVLLELITGR 198
APE D + GVV+ E++ GR
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 3e-10
Identities = 55/179 (30%), Positives = 81/179 (45%), Gaps = 14/179 (7%)
Query: 24 AIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
A+K L E + E + E +L H L +L + D+ V EY+ G L
Sbjct: 24 AMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELF 83
Query: 81 DHLYDLEPDQEPLSWNTRMKI-AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 139
HL +E + R + L+YLH + ++YRDLK N++LD D + K
Sbjct: 84 FHL-----SRERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIK 135
Query: 140 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 198
++DFGL K G + D + T GT Y APE D + GVV+ E++ GR
Sbjct: 136 ITDFGLCKEG-ITDAATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 61/200 (30%), Positives = 90/200 (45%), Gaps = 21/200 (10%)
Query: 18 LCDQLVAIKQ--LNHEGLQGHQ-EFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74
L QLVA+K+ L HE +G I E +L L H N+VTL + LV+EY+
Sbjct: 28 LTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL 85
Query: 75 PMG---SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANIL 131
++D L N R+ RGL Y H + V++RDLK N+L
Sbjct: 86 DTDLKQYMDDCGGGLSMH------NVRL-FLFQLLRGLAYCHQRR---VLHRDLKPQNLL 135
Query: 132 LDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVV 190
+ KL+DFGLA+ V T+ + V T Y P+ + S + + D++ G +
Sbjct: 136 ISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDVLLGSTEYSTSLDMWGVGCI 193
Query: 191 LLELITGRKAMDLSKGQGEQ 210
E+ TGR S +Q
Sbjct: 194 FYEMATGRPLFPGSTDVEDQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 57/188 (30%), Positives = 88/188 (46%), Gaps = 18/188 (9%)
Query: 21 QLVAIKQLNH--EGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR-----LLVYEY 73
+ VAIK++N E + + E+ +L LL H ++V + +R +V+E
Sbjct: 26 EKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL 85
Query: 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD 133
M E L+ + + L+ R L+Y+H AN V +RDLK NIL +
Sbjct: 86 M-----ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH-TAN--VFHRDLKPKNILAN 137
Query: 134 NDFNPKLSDFGLAKLGPVGDNTHVS-TRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVV 190
D K+ DFGLA++ T + T + T Y APE S K T DI+S G +
Sbjct: 138 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 197
Query: 191 LLELITGR 198
E++TG+
Sbjct: 198 FAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 4e-10
Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 27/200 (13%)
Query: 8 CKFYNVGLVWLCDQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT--- 62
C ++ + VAIK+L+ + + E+ +L + H+N++ L+ T
Sbjct: 32 CSAFDTKT----GRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPAS 87
Query: 63 SGDQRLLVYEYMP-MGSLEDHLYDLEP--DQEPLSWNTRMKIAVGAARGLEYLHCKANPP 119
S + VY MG+ DL + LS + + RGL+Y+H A
Sbjct: 88 SLEDFQDVYLVTHLMGA------DLNNIVKCQKLSDDHIQFLVYQILRGLKYIH-SAG-- 138
Query: 120 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKL 178
+I+RDLK +NI ++ D K+ DFGLA+ +V+TR Y APE ++
Sbjct: 139 IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHY 193
Query: 179 TLKSDIYSFGVVLLELITGR 198
DI+S G ++ EL+TG+
Sbjct: 194 NQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 5e-10
Identities = 49/170 (28%), Positives = 79/170 (46%), Gaps = 26/170 (15%)
Query: 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANIL 131
E+M GSL+ +Y P+ +IAV +GL YL + +++RD+K +N+L
Sbjct: 79 EFMDGGSLD--VYRKIPEH------VLGRIAVAVVKGLTYLW---SLKILHRDVKPSNML 127
Query: 132 LDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 191
++ KL DFG++ ++ +GT Y APE + + SD++S G+
Sbjct: 128 VNTRGQVKLCDFGVSTQLV----NSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISF 183
Query: 192 LELITGR-KAMDLSKGQGE-------QNLVSWSRPFLKD---QKKFVHLV 230
+EL GR + K QG Q +V P L +KFVH +
Sbjct: 184 MELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFI 233
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 5e-10
Identities = 43/156 (27%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 40 IVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRM 99
++E ++L ++H +++ + SG +V +P S + + Y L PL + +
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTY-LTKRSRPLPIDQAL 160
Query: 100 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159
I GL YLH + +I+RD+K+ NI +++ + D G A+ PV +
Sbjct: 161 IIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLG- 215
Query: 160 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 195
+ GT APE K K+DI+S G+VL E++
Sbjct: 216 -LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 5e-10
Identities = 60/228 (26%), Positives = 100/228 (43%), Gaps = 23/228 (10%)
Query: 41 VEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMK 100
E +LS L H +V D ++ EY L+ L +L+ + LS N +
Sbjct: 51 QEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCE 110
Query: 101 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160
+ G+ Y+H + +++RDLK+ NI L N+ K+ DFG+++L + + ++T
Sbjct: 111 WFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLATT 164
Query: 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFL 220
GT Y +PE KSDI+S G +L E+ A + FL
Sbjct: 165 FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-------------FL 211
Query: 221 KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 268
+ V P L Y R+ LN ++ LN++ + RP +I+
Sbjct: 212 SVVLRIVEGPTPSLPETYSRQ-LN---SIMQSMLNKDPSLRPSAAEIL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 5e-10
Identities = 33/83 (39%), Positives = 49/83 (59%)
Query: 120 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT 179
+I+RD+KSANILL ++ KL DFG +K+ + V GT Y APE +
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223
Query: 180 LKSDIYSFGVVLLELITGRKAMD 202
K+D++S GV+L EL+T ++ D
Sbjct: 224 KKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-10
Identities = 51/235 (21%), Positives = 93/235 (39%), Gaps = 27/235 (11%)
Query: 34 QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPL 93
+ Q+ + E+ +L L+H N++ + ++ +V E G L + + + +
Sbjct: 44 KARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLI 103
Query: 94 SWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 153
T K V +E++H + V++RD+K AN+ + KL D GL +
Sbjct: 104 PERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSS 158
Query: 154 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV 213
T + ++GT Y +PE KSDI+S G +L E +
Sbjct: 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE------------------MA 200
Query: 214 SWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVA----VTAMCLNEEANFRPLI 264
+ PF D+ L + YP + + +MC+ + + RP I
Sbjct: 201 ALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 8e-10
Identities = 52/155 (33%), Positives = 69/155 (44%), Gaps = 11/155 (7%)
Query: 44 LMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-A 102
++L + H LV L + D+ V +Y+ G L HL EP R + A
Sbjct: 48 VLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP-----RARFYA 102
Query: 103 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 162
A L YLH +IYRDLK NILLD+ + L+DFGL K G T ++
Sbjct: 103 AEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFC 157
Query: 163 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 197
GT Y APE D + G VL E++ G
Sbjct: 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 8e-10
Identities = 52/185 (28%), Positives = 91/185 (49%), Gaps = 19/185 (10%)
Query: 23 VAIKQLNH--EGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR-----LLVYEYMP 75
VAIK++ + + + + E+ +L L H+N++ + + +VYE M
Sbjct: 33 VAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM- 91
Query: 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 135
+ L+ + + LS + RGL+Y+H AN V++RDLK +N+LL+ +
Sbjct: 92 ----DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH-SAN--VLHRDLKPSNLLLNAN 144
Query: 136 FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLEL 194
+ K+ DFGLA+ + T + T Y APE ++ + T D++S G + EL
Sbjct: 145 CDLKICDFGLAR--TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAEL 202
Query: 195 ITGRK 199
+ GRK
Sbjct: 203 L-GRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 9e-10
Identities = 61/231 (26%), Positives = 87/231 (37%), Gaps = 58/231 (25%)
Query: 12 NVGLVWLC-----DQLVAIKQLNHEGLQGHQEFIVEVL----MLSLLHHDNLVTLIGYCT 62
+VG V+L +L A+K L+ + + + + VL +L+ L H L TL
Sbjct: 13 DVGRVFLVRLKGTGKLFALKVLDKKEMIKRNK-VKRVLTEQEILATLDHPFLPTLYASFQ 71
Query: 63 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR--------GLEYLHC 114
+ LV +Y P G L L +P + + V AR LEYLH
Sbjct: 72 TETYLCLVMDYCPGGEL-FRLLQRQPGK-------CLSEEV--ARFYAAEVLLALEYLHL 121
Query: 115 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV----------------- 157
++YRDLK NILL + LSDF L+K V
Sbjct: 122 LG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 158 -------STRVM---GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 198
S R GT Y APE D ++ G++L E++ G
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 50/155 (32%), Positives = 73/155 (47%), Gaps = 13/155 (8%)
Query: 45 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 104
+L + H +V LI +G + L+ EY+ G L HL ++E + +
Sbjct: 53 ILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHL-----EREGIFMEDTACFYLS 107
Query: 105 A-ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN-THVSTRVM 162
+ LE+LH + +IYRDLK NILLD + KL+DFGL K TH
Sbjct: 108 EISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FC 161
Query: 163 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 197
GT Y APE M D +S G ++ +++TG
Sbjct: 162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 44/135 (32%), Positives = 67/135 (49%), Gaps = 17/135 (12%)
Query: 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANIL 131
EYM GSL D LY E + + +I +GL++L K +I+RD+K N+L
Sbjct: 79 EYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFL--KEEHNIIHRDVKPTNVL 135
Query: 132 LDNDFNPKLSDFGLAKLGPVGDN--THVSTRVMGTYGYCAPEYAMSGKL------TLKSD 183
++ + KL DFG V N ++ +G Y APE SG T++SD
Sbjct: 136 VNGNGQVKLCDFG------VSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSD 189
Query: 184 IYSFGVVLLELITGR 198
++S G+ +LE+ GR
Sbjct: 190 VWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 47/156 (30%), Positives = 81/156 (51%), Gaps = 13/156 (8%)
Query: 46 LSLLHHDN---LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 102
L +LH N +V G S + + E+M GSL+ L E + K++
Sbjct: 54 LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVS 109
Query: 103 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 162
+ +GL YL K +++RD+K +NIL+++ KL DFG++ G + D+ ++ +
Sbjct: 110 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFV 163
Query: 163 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 198
GT Y +PE +++SDI+S G+ L+E+ GR
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 59/223 (26%), Positives = 91/223 (40%), Gaps = 46/223 (20%)
Query: 19 CDQLVAIKQLNHEGLQG----HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74
C + VA+K++ E L + F+ E + + L H +V + C+ GD VY M
Sbjct: 26 CSRRVALKKI-REDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD---PVYYTM 81
Query: 75 PM--GSLEDHLYDLEPDQEPLSWNTRMKIAVGA--------ARGLEYLHCKANPPVIYRD 124
P G L +E LS K +VGA +EY+H K V++RD
Sbjct: 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRD 138
Query: 125 LKSANILLDNDFNPKLSDFGLAKL----------------GPVGDNTHVSTRVMGTYGYC 168
LK NILL + D+G A + + +++GT Y
Sbjct: 139 LKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYM 198
Query: 169 APEYAMSGKLTLKSDIYSFGVVLLELIT---------GRKAMD 202
APE + + +DIY+ GV+L +++T GRK
Sbjct: 199 APERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY 241
|
Length = 932 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 36/90 (40%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 109 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 168
LE+LH K + ++YRDLK NILLD + L DFGL+K + T + GT Y
Sbjct: 109 LEHLH-KYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYL 163
Query: 169 APEYAMSGK-LTLKSDIYSFGVVLLELITG 197
APE + K T D +S GV++ E+ G
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 73/242 (30%), Positives = 105/242 (43%), Gaps = 34/242 (14%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTS------GDQRLLVYEY 73
QL AIK ++ + +E +E+ ML HH N+ T G DQ LV E+
Sbjct: 42 QLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEF 100
Query: 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD 133
GS+ D + + + + W I RGL +LH VI+RD+K N+LL
Sbjct: 101 CGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHAHK---VIHRDIKGQNVLLT 155
Query: 134 NDFNPKLSDFGL-AKLGPVGDNTHVSTR--VMGTYGYCAPEYAM-----SGKLTLKSDIY 185
+ KL DFG+ A+L D T V R +GT + APE +SDI+
Sbjct: 156 ENAEVKLVDFGVSAQL----DRT-VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIW 210
Query: 186 SFGVVLLELITGRKAMDLSKGQGEQNLVSWSR---PFLKDQ---KKFVHLVDPLLHGRYP 239
S G+ +E+ G A L + L R P LK + KKF+ ++ L Y
Sbjct: 211 SLGITAIEMAEG--APPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYL 268
Query: 240 RR 241
R
Sbjct: 269 SR 270
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 55/188 (29%), Positives = 88/188 (46%), Gaps = 29/188 (15%)
Query: 23 VAIKQLNHEGLQGH---QEFIVEVLMLSLLHHDNLVTLIGYCT---SGDQRLLVYEYMP- 75
VAIK+L + Q + E+ +L + H+N++ L+ T S D+ Y MP
Sbjct: 43 VAIKKL-YRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPF 101
Query: 76 ----MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANIL 131
+G L H E LS + + +GL+Y+H +I+RDLK N+
Sbjct: 102 MGTDLGKLMKH--------EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLA 150
Query: 132 LDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVV 190
++ D K+ DFGLA+ +V TR Y APE ++ T DI+S G +
Sbjct: 151 VNEDCELKILDFGLARQTDSEMTGYVVTR-----WYRAPEVILNWMHYTQTVDIWSVGCI 205
Query: 191 LLELITGR 198
+ E++TG+
Sbjct: 206 MAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-09
Identities = 44/149 (29%), Positives = 68/149 (45%), Gaps = 18/149 (12%)
Query: 53 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL--YDLEPDQEPLSWNTRMKIAVGAARGLE 110
N+V L Y S D LV ++ G L H+ + P++ W M +A L+
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVA------LD 99
Query: 111 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG-LAKLGPVGDNTHVSTRVMGTYGYCA 169
LH + ++ RDL NILLD+ + +L+ F +++ D V YCA
Sbjct: 100 ALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCA 150
Query: 170 PEYAMSGKLTLKSDIYSFGVVLLELITGR 198
PE + T D +S G +L EL+TG+
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 35/99 (35%), Positives = 59/99 (59%), Gaps = 9/99 (9%)
Query: 107 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL---GPVGDNTHVSTRVMG 163
RGL+Y+H AN VI+RDLK +N+L++ D ++ DFG+A+ P ++ + T +
Sbjct: 118 RGLKYIH-SAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT-EHKYFMTEYVA 173
Query: 164 TYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAM 201
T Y APE +S + T D++S G + E++ GR+ +
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-09
Identities = 52/233 (22%), Positives = 90/233 (38%), Gaps = 27/233 (11%)
Query: 34 QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPL 93
+ + I E+ +L L+H N++ ++ +V E G L + + + +
Sbjct: 44 KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI 103
Query: 94 SWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 153
T K V LE++H + V++RD+K AN+ + KL D GL +
Sbjct: 104 PEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSS 158
Query: 154 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV 213
T + ++GT Y +PE KSDI+S G +L E +
Sbjct: 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE------------------MA 200
Query: 214 SWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAV----AVTAMCLNEEANFRP 262
+ PF D+ L + YP ++ + MC+N + RP
Sbjct: 201 ALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 40/99 (40%), Positives = 59/99 (59%), Gaps = 9/99 (9%)
Query: 107 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK---LGPVGDNTHVSTRVMG 163
GL+Y+H AN V++RDLK N+L++ D K+ DFGLA+ P G+N T +
Sbjct: 116 CGLKYIH-SAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENP-GENAGFMTEYVA 171
Query: 164 TYGYCAPEYAMSGKLTLKS-DIYSFGVVLLELITGRKAM 201
T Y APE +S + K+ D++S G +L EL+ GRK +
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 3e-09
Identities = 55/189 (29%), Positives = 82/189 (43%), Gaps = 20/189 (10%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTS------GDQRLLVYEY 73
QL AIK ++ G + +E E+ ML HH N+ T G DQ LV E+
Sbjct: 32 QLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF 90
Query: 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD 133
GS+ D + + + + W I RGL +LH VI+RD+K N+LL
Sbjct: 91 CGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLH---QHKVIHRDIKGQNVLLT 145
Query: 134 NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFG 188
+ KL DFG++ + +GT + APE KSD++S G
Sbjct: 146 ENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 203
Query: 189 VVLLELITG 197
+ +E+ G
Sbjct: 204 ITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 58/196 (29%), Positives = 85/196 (43%), Gaps = 28/196 (14%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIVEVL----MLSLLHHDNLVTLIGYCTSG 64
G V+L ++VA+K++ L E + VL +L+ + LV L+ Y
Sbjct: 15 GQVFLAKKKDTGEIVALKRMKKSLLFKLNE-VRHVLTERDILTTTKSEWLVKLL-YAFQD 72
Query: 65 DQRL-LVYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 121
D+ L L EY+P G L +L + + M AV A L Y+H
Sbjct: 73 DEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIH-------- 124
Query: 122 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK 181
RDLK N L+D + KL+DFGL+K N+ V+G+ Y APE
Sbjct: 125 -RDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDYMAPEVLRGKGYDFT 178
Query: 182 SDIYSFGVVLLELITG 197
D +S G +L E + G
Sbjct: 179 VDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 5e-09
Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 26/203 (12%)
Query: 21 QLVAIK----QLNHEGLQGHQEFIVEVLMLSLLH---HDNLVTLIGYCTSG--DQRL--- 68
VA+K Q N +GL + EV +L L H N+V L+ C + D+
Sbjct: 26 HFVALKSVRVQTNEDGLP--LSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVT 83
Query: 69 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 128
LV+E++ L +L + P P T + RGL++LH +++RDLK
Sbjct: 84 LVFEHVDQ-DLRTYLDKVPPPGLPA--ETIKDLMRQFLRGLDFLHANC---IVHRDLKPE 137
Query: 129 NILLDNDFNPKLSDFGLAKLGPVGDNTHVS-TRVMGTYGYCAPEYAMSGKLTLKSDIYSF 187
NIL+ + KL+DFGLA++ + ++ T V+ T Y APE + D++S
Sbjct: 138 NILVTSGGQVKLADFGLARIY----SCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSV 193
Query: 188 GVVLLELITGRKAMDLSKGQGEQ 210
G + E+ RK + + +Q
Sbjct: 194 GCIFAEMFR-RKPLFCGNSEADQ 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-09
Identities = 44/175 (25%), Positives = 84/175 (48%), Gaps = 34/175 (19%)
Query: 42 EVLMLSLLHHDNLVT--------------LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLE 87
E +LS L H N+V ++G+C GD +Y L++ L
Sbjct: 49 EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGD----LYH-----KLKEQKGKLL 99
Query: 88 PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 147
P+ + + W ++ +A L+YLH K +++RDLK+ N+ L K+ D G+A+
Sbjct: 100 PENQVVEWFVQIAMA------LQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIAR 150
Query: 148 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 202
+ + + +++ ++GT Y +PE + KSD+++ G + E+ T + A +
Sbjct: 151 V--LENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 6e-09
Identities = 58/196 (29%), Positives = 95/196 (48%), Gaps = 29/196 (14%)
Query: 21 QLVAIKQLNHEGL----QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL--VYEYM 74
Q A+K++N + L Q Q F VE +L+ + +V++ +C+ +R L V EY+
Sbjct: 27 QRFAMKKINKQNLILRNQIQQVF-VERDILTFAENPFVVSM--FCSFETKRHLCMVMEYV 83
Query: 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN 134
G L ++ ++ RM A LEYLH N +++RDLK N+L+ +
Sbjct: 84 EGGDCATLLKNIGALPVDMA---RMYFA-ETVLALEYLH---NYGIVHRDLKPDNLLITS 136
Query: 135 DFNPKLSDFGLAKLGPVGDNTHV-------STR------VMGTYGYCAPEYAMSGKLTLK 181
+ KL+DFGL+K+G + T++ TR V GT Y APE +
Sbjct: 137 MGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKP 196
Query: 182 SDIYSFGVVLLELITG 197
D ++ G++L E + G
Sbjct: 197 VDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 7e-09
Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 18/94 (19%)
Query: 107 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 166
RG+++LH +++RDLK NIL+ +D K++DFGLA+ + T V+ T
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMALTSVVVTLW 171
Query: 167 YCAPE------YAMSGKLTLKSDIYSFGVVLLEL 194
Y APE YA D++S G + EL
Sbjct: 172 YRAPEVLLQSSYATP------VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 7e-09
Identities = 56/186 (30%), Positives = 84/186 (45%), Gaps = 22/186 (11%)
Query: 23 VAIKQLN-HEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
V +K+L +Q +F+ E L H NL+ +G CT LLV E+ P+G L+
Sbjct: 25 VVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKG 84
Query: 82 HLY------DLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 135
+L + PD L ++A A GL +LH K N I+ DL N LL D
Sbjct: 85 YLRSCRKAELMTPDPTTLQ-----RMACEIALGLLHLH-KNN--FIHSDLALRNCLLTAD 136
Query: 136 FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA--MSGKL-----TLKSDIYSFG 188
K+ D+GL+ D ++ + APE + G L T +S+++S G
Sbjct: 137 LTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLG 196
Query: 189 VVLLEL 194
V + EL
Sbjct: 197 VTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 9e-09
Identities = 44/125 (35%), Positives = 65/125 (52%), Gaps = 12/125 (9%)
Query: 78 SLEDHLYDLEPD---QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN 134
SL D D E D +EPL+ + + ARG+E+L A+ I+RDL + NILL
Sbjct: 152 SLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSE 208
Query: 135 DFNPKLSDFGLAKLGPVGDNTHV---STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 191
+ K+ DFGLA+ D +V R+ + APE T +SD++SFGV+L
Sbjct: 209 NNVVKICDFGLAR-DIYKDPDYVRKGDARL--PLKWMAPESIFDKVYTTQSDVWSFGVLL 265
Query: 192 LELIT 196
E+ +
Sbjct: 266 WEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 9e-09
Identities = 46/155 (29%), Positives = 71/155 (45%), Gaps = 3/155 (1%)
Query: 42 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI 101
E+ L+ H +V S D+ LL+ EY G L + + P +
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174
Query: 102 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 161
L+ +H + +++RDLKSANI L KL DFG +K + V++
Sbjct: 175 FYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSF 231
Query: 162 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
GT Y APE + + K+D++S GV+L EL+T
Sbjct: 232 CGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 53/196 (27%), Positives = 84/196 (42%), Gaps = 42/196 (21%)
Query: 42 EVLMLSLLHHDNLVTLIGYCTSGDQR--------LLVYEYMPMGSLEDHLYDLEPDQEPL 93
E+ +L LL H+N+V LI C + LV+E+ +H D L
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFC------EH------DLAGL 108
Query: 94 SWNTRMKIAVGAAR--------GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 145
N +K + + GL Y+H +++RD+K+ANIL+ D KL+DFGL
Sbjct: 109 LSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165
Query: 146 AK---LGPVGDNTHVSTRVMGTYGYCAPEYAMS----GKLTLKSDIYSFGVVLLELITGR 198
A+ L + RV+ T Y PE + G D++ G ++ E+ T
Sbjct: 166 ARAFSLSKNSKPNRYTNRVV-TLWYRPPELLLGERDYGP---PIDMWGAGCIMAEMWTRS 221
Query: 199 KAMDLSKGQGEQNLVS 214
M + Q + L+S
Sbjct: 222 PIMQGNTEQHQLTLIS 237
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 51/155 (32%), Positives = 70/155 (45%), Gaps = 11/155 (7%)
Query: 44 LMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-A 102
++L L H LV L + ++ V +Y+ G L HL EP R + A
Sbjct: 48 VLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP-----RARFYA 102
Query: 103 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 162
A + YLH +IYRDLK NILLD+ + L+DFGL K G + T ++
Sbjct: 103 AEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFC 157
Query: 163 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 197
GT Y APE D + G VL E++ G
Sbjct: 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 50/154 (32%), Positives = 70/154 (45%), Gaps = 9/154 (5%)
Query: 44 LMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 103
++L + H LV L + ++ V +++ G L HL EP R A
Sbjct: 48 VLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP---RARFYAA- 103
Query: 104 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 163
A L YLH + ++YRDLK NILLD+ + L+DFGL K G +T +T G
Sbjct: 104 EIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCG 158
Query: 164 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 197
T Y APE D + G VL E++ G
Sbjct: 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 48/181 (26%), Positives = 91/181 (50%), Gaps = 22/181 (12%)
Query: 42 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE--YMPMGSLEDHL---YDLEPDQEPLSWN 96
E+++L ++H N+++L+ T + L ++ Y+ M ++ +L +E D E +S+
Sbjct: 70 ELVLLKCVNHKNIISLLNVFTP-QKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYL 128
Query: 97 TRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156
+ G+++LH +I+RDLK +NI++ +D K+ DFGLA+ N
Sbjct: 129 LYQMLC-----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACT--NFM 178
Query: 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS 216
++ V+ Y Y APE + DI+S G ++ EL+ G QG ++ W+
Sbjct: 179 MTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIF-----QGTDHIDQWN 232
Query: 217 R 217
+
Sbjct: 233 K 233
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-08
Identities = 52/186 (27%), Positives = 88/186 (47%), Gaps = 17/186 (9%)
Query: 21 QLVAIKQLNHEGLQGHQ-EFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG-- 77
+LVA+K + + +G I E +L L H N+V L + + LV+EY+
Sbjct: 31 KLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLC 90
Query: 78 -SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF 136
++ H L P+ L RGL Y+H + +++RDLK N+L+ +
Sbjct: 91 QYMDKHPGGLHPENVKL-------FLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTG 140
Query: 137 NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELI 195
KL+DFGLA+ V +T+ + V T Y P+ + S + + D++ G + +E+I
Sbjct: 141 ELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI 198
Query: 196 TGRKAM 201
G A
Sbjct: 199 QGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 36/105 (34%), Positives = 48/105 (45%), Gaps = 5/105 (4%)
Query: 91 EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA-KLG 149
PL + I L YLH + +I+RD+K+ NI LD N L DFG A KL
Sbjct: 180 GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLD 236
Query: 150 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLEL 194
+T GT +PE K+DI+S G+VL E+
Sbjct: 237 -AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 17/201 (8%)
Query: 21 QLVAIKQLNHEGLQGHQ-EFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG-- 77
QLVA+K ++ + +G I E +L L H N+V L + + V+EYM
Sbjct: 31 QLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLA 90
Query: 78 -SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF 136
+ H L P +N R+ RGL Y+H + +++RDLK N+L+
Sbjct: 91 QYMIQHPGGLHP------YNVRL-FMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLG 140
Query: 137 NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELI 195
KL+DFGLA+ + T+ S V T Y P+ + + + DI+ G + +E++
Sbjct: 141 ELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198
Query: 196 TGRKAMDLSKGQGEQNLVSWS 216
G+ A EQ W+
Sbjct: 199 QGQPAFPGVSDVFEQLEKIWT 219
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 49/182 (26%), Positives = 84/182 (46%), Gaps = 37/182 (20%)
Query: 42 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI 101
E+ +L ++H N+V + ++ E+M GSLE E L+ +
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQF---LA-----DV 173
Query: 102 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTR 160
A G+ YLH + +++RD+K +N+L+++ N K++DFG+++ L D + S
Sbjct: 174 ARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS-- 228
Query: 161 VMGTYGYCAPE-------------YAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQ 207
+GT Y +PE YA DI+S GV +LE GR + + Q
Sbjct: 229 -VGTIAYMSPERINTDLNHGAYDGYA--------GDIWSLGVSILEFYLGRFPFGVGR-Q 278
Query: 208 GE 209
G+
Sbjct: 279 GD 280
|
Length = 353 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 49/176 (27%), Positives = 76/176 (43%), Gaps = 46/176 (26%)
Query: 42 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE---YMPMGSLEDHLY------DLEPDQEP 92
E+L L L+H+N++ + + +L E YM + LY + P
Sbjct: 213 EILALGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRP 264
Query: 93 LSWNTR--MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA---- 146
L TR MK + A +EY+H K +I+RD+K NI L+ D L DFG A
Sbjct: 265 LLKQTRAIMKQLLCA---VEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFE 318
Query: 147 ------KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
G VG S ++ GYC +DI+S G++LL++++
Sbjct: 319 KEREAFDYGWVGTVATNSPEILAGDGYCE-----------ITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 62/227 (27%), Positives = 106/227 (46%), Gaps = 21/227 (9%)
Query: 21 QLVAIKQL--NHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78
++VAIK+ + E + + + E+ ML L +N+V L + LV+EY+
Sbjct: 27 EIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNM 86
Query: 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH-CKANPPVIYRDLKSANILLDNDFN 137
LE L + P+ P K+ + ++ +H C N +++RD+K N+L+ ++
Sbjct: 87 LE--LLEEMPNGVPPE-----KVRSYIYQLIKAIHWCHKND-IVHRDIKPENLLISHNDV 138
Query: 138 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 197
KL DFG A+ G N + T + T Y +PE + D++S G +L EL G
Sbjct: 139 LKLCDFGFARNLSEGSNANY-TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDG 197
Query: 198 RKAMDLSKGQGE-QNLVSWSR---PFLKDQKKFVHLVDPLLHG-RYP 239
+ L G+ E L + + P +Q K + +P HG R+P
Sbjct: 198 QP---LFPGESEIDQLFTIQKVLGPLPAEQMKLFY-SNPRFHGLRFP 240
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 9/93 (9%)
Query: 107 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 166
RGL+Y+H + +I+RDLK +N+ ++ D K+ DFGLA+ +V+TR
Sbjct: 131 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 182
Query: 167 YCAPEYAMSG-KLTLKSDIYSFGVVLLELITGR 198
Y APE ++ DI+S G ++ EL+TGR
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 57/189 (30%), Positives = 84/189 (44%), Gaps = 21/189 (11%)
Query: 21 QLVAIK----QLNHEGLQGHQEFIVEVL-MLSLLHHDNLVTLIGYCT-SGDQR----LLV 70
+ VA+K Q EG+ V VL L H N+V L CT S R LV
Sbjct: 28 RFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLV 87
Query: 71 YEYMPMGSLEDHLYDLEPDQEP-LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 129
+E++ +D L+ EP + T + RGL++LH V++RDLK N
Sbjct: 88 FEHVD----QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQN 140
Query: 130 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGV 189
IL+ + KL+DFGLA++ T V+ T Y APE + D++S G
Sbjct: 141 ILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGC 197
Query: 190 VLLELITGR 198
+ E+ +
Sbjct: 198 IFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 5e-08
Identities = 44/175 (25%), Positives = 85/175 (48%), Gaps = 11/175 (6%)
Query: 23 VAIKQLNHEGLQGHQE-FIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
VA+K + +E F+ E ++ H ++V LIG T + +V E P+G L
Sbjct: 37 VAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRS 95
Query: 82 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 141
+L + ++ L + + + + L YL K ++RD+ + N+L+ + KL
Sbjct: 96 YL---QVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLG 149
Query: 142 DFGLAKLGPVGDNTHV-STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 195
DFGL++ + D ++ +++ + APE + T SD++ FGV + E++
Sbjct: 150 DFGLSRY--LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 6e-08
Identities = 51/154 (33%), Positives = 71/154 (46%), Gaps = 9/154 (5%)
Query: 44 LMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 103
++L + H LV L + D+ V +Y+ G L Y L+ ++ L R A
Sbjct: 48 VLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARF-YAA 103
Query: 104 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 163
A L YLH + ++YRDLK NILLD+ + L+DFGL K + N ST G
Sbjct: 104 EIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN-IEHNGTTST-FCG 158
Query: 164 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 197
T Y APE D + G VL E++ G
Sbjct: 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 6e-08
Identities = 56/194 (28%), Positives = 94/194 (48%), Gaps = 35/194 (18%)
Query: 20 DQLVAIKQLNH------EGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL---- 69
Q VAIK+L+ + ++E VLM L++H N++ L+ T Q+ L
Sbjct: 41 GQNVAIKKLSRPFQNVTHAKRAYREL---VLM-KLVNHKNIIGLLNVFTP--QKSLEEFQ 94
Query: 70 -VYEYMPMGSLEDH----LYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 124
VY M L D + ++ D E +S+ + G+++LH + +I+RD
Sbjct: 95 DVYLVM---ELMDANLCQVIQMDLDHERMSYLLYQMLC-----GIKHLH---SAGIIHRD 143
Query: 125 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDI 184
LK +NI++ +D K+ DFGLA+ G + ++ V+ Y Y APE + DI
Sbjct: 144 LKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDI 200
Query: 185 YSFGVVLLELITGR 198
+S G ++ E+I G
Sbjct: 201 WSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 7e-08
Identities = 51/211 (24%), Positives = 88/211 (41%), Gaps = 41/211 (19%)
Query: 18 LCDQLVAIKQL-NHEGLQGHQE-----------FIV--EVLMLSLLHHDNLVTLIGYCTS 63
L ++VAIK++ E + F E+ +++ + H+N++ L+
Sbjct: 32 LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE 91
Query: 64 GDQRLLVYEYMPMGSLEDHLYDLEP---DQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 120
GD LV + M DL+ + L+ + I + GL LH
Sbjct: 92 GDFINLVMDIMA--------SDLKKVVDRKIRLTESQVKCILLQILNGLNVLH---KWYF 140
Query: 121 IYRDLKSANILLDNDFNPKLSDFGLAK-------LGPVGDNTHVSTRVMGTYG-----YC 168
++RDL ANI +++ K++DFGLA+ + + + R T Y
Sbjct: 141 MHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYR 200
Query: 169 APEYAM-SGKLTLKSDIYSFGVVLLELITGR 198
APE M + K D++S G + EL+TG+
Sbjct: 201 APELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 7e-08
Identities = 56/192 (29%), Positives = 93/192 (48%), Gaps = 20/192 (10%)
Query: 23 VAIKQL----NHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78
VA+K L N L+ E + E ++ L + +V +IG C + +LV E +G
Sbjct: 25 VAVKILKNDNNDPALK--DELLREANVMQQLDNPYIVRMIGIC-EAESWMLVMELAELGP 81
Query: 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 138
L L + ++ ++ + G++YL + N ++RDL + N+LL
Sbjct: 82 LNKFL----QKNKHVTEKNITELVHQVSMGMKYLE-ETN--FVHRDLAARNVLLVTQHYA 134
Query: 139 KLSDFGLAK-LGPVGDNTHVSTRVMGTY--GYCAPEYAMSGKLTLKSDIYSFGVVLLELI 195
K+SDFGL+K LG D + + G + + APE K + KSD++SFGV++ E
Sbjct: 135 KISDFGLSKALG--ADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAF 192
Query: 196 T-GRKAMDLSKG 206
+ G+K KG
Sbjct: 193 SYGQKPYKGMKG 204
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 54/184 (29%), Positives = 85/184 (46%), Gaps = 22/184 (11%)
Query: 23 VAIKQLNHEGLQGH---QEFIVEVLMLSLLHHDNLVTLIGYCTS---GDQRLLVYEYMPM 76
VAIK+L Q + E+ +L + H+N++ L+ TS GD+ Y MP
Sbjct: 43 VAIKKL-SRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPY 101
Query: 77 GSLEDHLYDLEPDQ-EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 135
DL+ PLS + + GL+Y+H +I+RDLK N+ ++ D
Sbjct: 102 MQT-----DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNED 153
Query: 136 FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLEL 194
K+ DFGLA+ +V TR Y APE ++ DI+S G ++ E+
Sbjct: 154 CELKILDFGLARHADAEMTGYVVTR-----WYRAPEVILNWMHYNQTVDIWSVGCIMAEM 208
Query: 195 ITGR 198
+TG+
Sbjct: 209 LTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 52/195 (26%), Positives = 84/195 (43%), Gaps = 44/195 (22%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVL-------MLSLLHHDNLVTLIGYC---TSGDQRL-L 69
+ AIK + H + + +V + L H N++ LI +G RL L
Sbjct: 25 KYYAIKCMKK-----HFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTG--RLAL 77
Query: 70 VYEYMPMGSLEDHLYDLEPDQ-EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 128
V+E M M +LY+L + PL + L+++H + +RD+K
Sbjct: 78 VFELMDM-----NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPE 129
Query: 129 NILLDNDFNPKLSDFGLAKLGPVGDNTH------VSTRVMGTYGYCAPEYAM-SGKLTLK 181
NIL+ +D KL+DFG + G + +STR Y APE + G K
Sbjct: 130 NILIKDD-ILKLADFGSCR----GIYSKPPYTEYISTR-----WYRAPECLLTDGYYGPK 179
Query: 182 SDIYSFGVVLLELIT 196
DI++ G V E+++
Sbjct: 180 MDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 41/120 (34%), Positives = 61/120 (50%), Gaps = 16/120 (13%)
Query: 87 EPDQE-------PLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 139
P QE PL+ + + ARG+E+L A+ I+RDL + NILL + K
Sbjct: 158 NPPQETDDLWKSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVK 214
Query: 140 LSDFGLAKLGPVGDNTHV---STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
+ DFGLA+ D +V S R+ + APE T +SD++SFGV+L E+ +
Sbjct: 215 ICDFGLAR-DIYKDPDYVRKGSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 51/195 (26%), Positives = 99/195 (50%), Gaps = 23/195 (11%)
Query: 8 CKFYNVGLVWLCDQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD 65
C Y+ L D+ VAIK+L+ + + E++++ ++H N+++L+ T
Sbjct: 34 CAAYDAVL----DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP-Q 88
Query: 66 QRLLVYE--YMPMGSLEDHL---YDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 120
+ L ++ Y+ M ++ +L +E D E +S+ + G+++LH +
Sbjct: 89 KSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSAG---I 140
Query: 121 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTL 180
I+RDLK +NI++ +D K+ DFGLA+ G + ++ V+ Y Y APE +
Sbjct: 141 IHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YRAPEVILGMGYKE 197
Query: 181 KSDIYSFGVVLLELI 195
DI+S G ++ E++
Sbjct: 198 NVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 48/160 (30%), Positives = 76/160 (47%), Gaps = 20/160 (12%)
Query: 48 LLHHDN-LVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLE---PDQEPLSWNTRMKIA 102
L++ DN +T + Y + L LV +Y G L L E P+ + M IA
Sbjct: 55 LVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIA 114
Query: 103 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 162
+ + L Y+H RD+K NIL+D + + +L+DFG + L + D T S+ +
Sbjct: 115 IDSVHQLHYVH---------RDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAV 164
Query: 163 GTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLELITG 197
GT Y +PE + GK + D +S GV + E++ G
Sbjct: 165 GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 41/162 (25%), Positives = 70/162 (43%), Gaps = 9/162 (5%)
Query: 40 IVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRM 99
E +L ++H +++ L G T L+ + + LY + ++ +
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLI-----LPRYKTDLYCYLAAKRNIAICDIL 185
Query: 100 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159
I R ++YLH +I+RD+K+ NI +++ + L DFG A PV N +
Sbjct: 186 AIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACF-PVDINANKYY 241
Query: 160 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 201
GT APE DI+S G+VL E+ T ++
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 51/184 (27%), Positives = 81/184 (44%), Gaps = 23/184 (12%)
Query: 20 DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79
+ V +K L + F ++S L H +LV L G C D+ ++V EY+ G L
Sbjct: 30 EVSVVLKVL-GSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPL 87
Query: 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL----DND 135
+ L+ E + L W ++ +A A L YL K +++ ++ NIL+ N+
Sbjct: 88 DVFLH-REKNNVSLHW--KLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNE 141
Query: 136 FNP---KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY--AMSGKLTLKSDIYSFGVV 190
KLSD G+ V R+ + APE LT+ +D +SFG
Sbjct: 142 GYVPFIKLSDPGIPI--TVLSREERVERI----PWIAPECIRNGQASLTIAADKWSFGTT 195
Query: 191 LLEL 194
LLE+
Sbjct: 196 LLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 44/162 (27%), Positives = 84/162 (51%), Gaps = 17/162 (10%)
Query: 42 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE--YMPMGSLEDHL---YDLEPDQEPLSWN 96
E++++ ++H N++ L+ T + L ++ Y+ M ++ +L +E D E +S+
Sbjct: 73 ELVLMKCVNHKNIIGLLNVFTP-QKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 97 TRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156
+ G+++LH +I+RDLK +NI++ +D K+ DFGLA+ G +
Sbjct: 132 LYQMLC-----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFM 181
Query: 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 198
++ V+ Y Y APE + DI+S G ++ E+I G
Sbjct: 182 MTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 43/136 (31%), Positives = 66/136 (48%), Gaps = 19/136 (13%)
Query: 69 LVYEYMPMGSLEDHL--YDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 126
+V EYMP G L + + YD+ P++ + + +A+ A + ++H RD+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDI-PEKWARFYTAEVVLALDAIHSMGFIH---------RDVK 169
Query: 127 SANILLDNDFNPKLSDFGLA-KLGPVGDNTHVSTRVMGTYGYCAPEYAMS----GKLTLK 181
N+LLD + KL+DFG K+ G T V GT Y +PE S G +
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKMDANG-MVRCDTAV-GTPDYISPEVLKSQGGDGYYGRE 227
Query: 182 SDIYSFGVVLLELITG 197
D +S GV L E++ G
Sbjct: 228 CDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 29/81 (35%), Positives = 45/81 (55%), Gaps = 11/81 (13%)
Query: 120 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR---VMGTYGYCAPEYAMSG 176
++YRDLK N+LLD D K++DFG AK+ V TR + GT Y APE ++
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFAKV--------VDTRTYTLCGTPEYIAPEILLNV 203
Query: 177 KLTLKSDIYSFGVVLLELITG 197
+D ++ G+ + E++ G
Sbjct: 204 GHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 36/127 (28%), Positives = 62/127 (48%), Gaps = 7/127 (5%)
Query: 71 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANI 130
Y+ +++ L D E L+ + ARG+E+L A+ ++RDL + N+
Sbjct: 214 YKGSNDSEVKNLLSD--DGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNV 268
Query: 131 LLDNDFNPKLSDFGLAKLGPVGDNTHVST-RVMGTYGYCAPEYAMSGKLTLKSDIYSFGV 189
LL K+ DFGLA+ + D+ +VS + APE T SD++S+G+
Sbjct: 269 LLAQGKIVKICDFGLAR-DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGI 327
Query: 190 VLLELIT 196
+L E+ +
Sbjct: 328 LLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 5e-07
Identities = 58/199 (29%), Positives = 89/199 (44%), Gaps = 24/199 (12%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
++ ++ E L+ Q EV++ H N++T T+G ++ +M GS
Sbjct: 31 RITDLENCTEEHLKALQN---EVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSAN 87
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 140
L P E +S I GA RGL YLH I+R++K+++IL+ D L
Sbjct: 88 SLLKTYFP--EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSL 142
Query: 141 SD----FGLAKLGP----VGDNTHVSTRVMGTYGYCAPEYA---MSGKLTLKSDIYSFGV 189
S + L + G V D ST V+ + +PE + G +KSDIYS G+
Sbjct: 143 SGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP---WLSPELLRQDLYG-YNVKSDIYSVGI 198
Query: 190 VLLELITGRKA-MDLSKGQ 207
EL TGR D+ + Q
Sbjct: 199 TACELATGRVPFQDMLRTQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 46/147 (31%), Positives = 69/147 (46%), Gaps = 21/147 (14%)
Query: 60 YCTSGDQRLL--VYEYMPMGSLEDHL--YDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 115
+C D + L V EYMP G L + + YD+ P++ + + +A+ A + +H
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV-PEKWAKFYTAEVVLALDAIHSMGLIH-- 165
Query: 116 ANPPVIYRDLKSANILLDNDFNPKLSDFGLA-KLGPVGDNTHVSTRVMGTYGYCAPEYAM 174
RD+K N+LLD + KL+DFG K+ G T V GT Y +PE
Sbjct: 166 -------RDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MVRCDTAV-GTPDYISPEVLK 216
Query: 175 S----GKLTLKSDIYSFGVVLLELITG 197
S G + D +S GV L E++ G
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 7e-07
Identities = 43/156 (27%), Positives = 78/156 (50%), Gaps = 9/156 (5%)
Query: 45 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 104
M+S L H +LV G C GD+ ++V EY+ GSL+ +L + +SW ++++A
Sbjct: 52 MMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKK-NKNLINISW--KLEVAKQ 108
Query: 105 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 164
A L +L K + + ++ + N+LL + + K + KL G + V + +
Sbjct: 109 LAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILL 165
Query: 165 --YGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITG 197
+ PE + + L+L +D +SFG L E+ +G
Sbjct: 166 ERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 9e-07
Identities = 48/156 (30%), Positives = 71/156 (45%), Gaps = 14/156 (8%)
Query: 42 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI 101
E+ +L L H N+V L S + LV+EY L+ + D +P
Sbjct: 49 EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDP---EIVKSF 104
Query: 102 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LG-PVGDNTHVST 159
+GL + H V++RDLK N+L++ + KL+DFGLA+ G PV S
Sbjct: 105 MFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV---RCYSA 158
Query: 160 RVMGTYGYCAPEYAMSGKLTLKS-DIYSFGVVLLEL 194
V+ T Y P+ KL S D++S G + EL
Sbjct: 159 EVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 43/141 (30%), Positives = 68/141 (48%), Gaps = 23/141 (16%)
Query: 69 LVYEYMPMGSLEDHL--YDLEPDQEPLS--WNTRMKIAVGAARGLEYLHCKANPPVIYRD 124
LV EY P G L L Y+ + E ++ + + +A+ + + Y+H RD
Sbjct: 78 LVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVH---------RD 127
Query: 125 LKSANILLDNDFNPKLSDFG-LAKLGPVGDNTHVSTRVMGTYGYCAPEY--AMSGKLT-- 179
+K N+L+D + KL+DFG A+L + S +GT Y APE M+G
Sbjct: 128 IKPENVLIDRTGHIKLADFGSAARLT--ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGT 185
Query: 180 --LKSDIYSFGVVLLELITGR 198
++ D +S GV+ E+I GR
Sbjct: 186 YGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 41/157 (26%), Positives = 67/157 (42%), Gaps = 16/157 (10%)
Query: 48 LLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLY---DLEPDQEPLSWNTRMKIAVG 104
+L H N++ +G C LLV+EY +G L+ +L + + L ++A
Sbjct: 51 ILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACE 107
Query: 105 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 164
A G+ ++H K N ++ DL N L +D K+ D+G+ D
Sbjct: 108 IAAGVTHMH-KHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVP 164
Query: 165 YGYCAPEYAMS--GKL-----TLKSDIYSFGVVLLEL 194
+ APE G L T S++++ GV L EL
Sbjct: 165 LRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 107 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 166
RGL+Y+H +I+RDLK +N+ ++ D ++ DFGLA+ +V+TR
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180
Query: 167 YCAPEYAMSG-KLTLKSDIYSFGVVLLELITGR 198
Y APE ++ DI+S G ++ EL+ G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 34/94 (36%), Positives = 53/94 (56%), Gaps = 9/94 (9%)
Query: 106 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV---STRVM 162
A+G+E+L A+ I+RDL + NILL + K+ DFGLA+ D +V R+
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGDARL- 243
Query: 163 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
+ APE T++SD++SFGV+L E+ +
Sbjct: 244 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 44/139 (31%), Positives = 68/139 (48%), Gaps = 25/139 (17%)
Query: 69 LVYEYMPMGSLEDHL--YDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 126
+V EYMP G L + + YD+ P++ + + +A+ A + ++H RD+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDV-PEKWARFYTAEVVLALDAIHSMGFIH---------RDVK 169
Query: 127 SANILLDNDFNPKLSDFG----LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS----GKL 178
N+LLD + KL+DFG + K G V +T V GT Y +PE S G
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-----GTPDYISPEVLKSQGGDGYY 224
Query: 179 TLKSDIYSFGVVLLELITG 197
+ D +S GV L E++ G
Sbjct: 225 GRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 46/152 (30%), Positives = 71/152 (46%), Gaps = 19/152 (12%)
Query: 55 VTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLE---PDQEPLSWNTRMKIAVGAARGLE 110
+T + Y + L LV +Y G L L E P+ + M +A+ + L
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 111 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 170
Y+H RD+K N+LLD + + +L+DFG + L D T S+ +GT Y +P
Sbjct: 123 YVH---------RDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISP 172
Query: 171 EY--AMS---GKLTLKSDIYSFGVVLLELITG 197
E AM GK + D +S GV + E++ G
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 52/197 (26%), Positives = 82/197 (41%), Gaps = 34/197 (17%)
Query: 20 DQLVAIKQLN-----HEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74
+ LVA+K++N E L+ Q+ E++ L H N++ + + +V M
Sbjct: 25 NTLVAVKKINLDSCSKEDLKLLQQ---EIITSRQLQHPNILPYVTSFIVDSELYVVSPLM 81
Query: 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAV---GAARGLEYLHCKANPPVIYRDLKSANIL 131
GS ED L P+ P + IA L+Y+H K I+R +K+++IL
Sbjct: 82 AYGSCEDLLKTHFPEGLP-----ELAIAFILKDVLNALDYIHSKG---FIHRSVKASHIL 133
Query: 132 LDNDFNPKLSDFGLA--------KLGPVGDNTHVSTRVMGTYGYCAPEY---AMSGKLTL 180
L D LS + + V D S + + + +PE + G
Sbjct: 134 LSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP---WLSPEVLQQNLQG-YNE 189
Query: 181 KSDIYSFGVVLLELITG 197
KSDIYS G+ EL G
Sbjct: 190 KSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 52/187 (27%), Positives = 88/187 (47%), Gaps = 25/187 (13%)
Query: 23 VAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGY----CTSGDQRLL----VYEYM 74
VAIK++ LQ Q E+L++ L+H N++ L Y C +++ + V E++
Sbjct: 94 VAIKKV----LQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFI 149
Query: 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD- 133
P ++ ++ + L + R L Y+H K + +RDLK N+L+D
Sbjct: 150 PQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDP 205
Query: 134 NDFNPKLSDFGLAK--LGPVGDNTHVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVV 190
N KL DFG AK L +++ +R Y APE + + T D++S G +
Sbjct: 206 NTHTLKLCDFGSAKNLLAGQRSVSYICSRF-----YRAPELMLGATNYTTHIDLWSLGCI 260
Query: 191 LLELITG 197
+ E+I G
Sbjct: 261 IAEMILG 267
|
Length = 440 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 45/164 (27%), Positives = 69/164 (42%), Gaps = 15/164 (9%)
Query: 44 LMLSLLHHDNLVTLIGY-----CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTR 98
++ +L H N+V G +GDQ LV E GS+ D + E +
Sbjct: 67 ILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPII 126
Query: 99 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158
I A GL++LH I+RD+K NILL + KL DFG++ +
Sbjct: 127 AYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRR 181
Query: 159 TRVMGTYGYCAPEY-----AMSGKLTLKSDIYSFGVVLLELITG 197
+GT + APE + + D++S G+ +EL G
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 50/162 (30%), Positives = 72/162 (44%), Gaps = 11/162 (6%)
Query: 44 LMLSLLHHDNLVTLIGYC-----TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTR 98
++ SL +H N+V G G Q LV E GS+ + + L + L
Sbjct: 71 ILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMI 130
Query: 99 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGP--VGDNT 155
I GA GL++LH N +I+RD+K NILL + KL DFG+ A+L + NT
Sbjct: 131 SYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 187
Query: 156 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 197
V T A E + D++S G+ +EL G
Sbjct: 188 SVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 4e-06
Identities = 32/111 (28%), Positives = 58/111 (52%), Gaps = 5/111 (4%)
Query: 88 PDQEPLSWNTR--MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 145
+++ L+ +T + + A+G+ +L A+ I+RDL + NILL + K+ DFGL
Sbjct: 204 LEEDELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGL 260
Query: 146 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
A+ N V + APE + T +SD++S+G++L E+ +
Sbjct: 261 ARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 9e-06
Identities = 31/109 (28%), Positives = 56/109 (51%), Gaps = 3/109 (2%)
Query: 88 PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 147
D PL + ++ + A+G+++L K I+RD+ + N+LL + K+ DFGLA+
Sbjct: 204 EDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLAR 260
Query: 148 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
N V + APE T++SD++S+G++L E+ +
Sbjct: 261 DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 46/188 (24%), Positives = 74/188 (39%), Gaps = 49/188 (26%)
Query: 70 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 129
V +Y+P G + L L +E L+ R IA +E +H I+RD+K N
Sbjct: 79 VMDYIPGGDMMSLLIRLGIFEEDLA---RFYIA-ELTCAIESVH---KMGFIHRDIKPDN 131
Query: 130 ILLDNDFNPKLSDFGL-----------------------------------AKLGPVGD- 153
IL+D D + KL+DFGL +L P+
Sbjct: 132 ILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERR 191
Query: 154 NTHVSTRVM-----GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA-MDLSKGQ 207
R + GT Y APE + T D +S GV+L E++ G+ + + +
Sbjct: 192 RKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAE 251
Query: 208 GEQNLVSW 215
+ +++W
Sbjct: 252 TQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 44/151 (29%), Positives = 72/151 (47%), Gaps = 25/151 (16%)
Query: 52 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 111
+NL ++ Y GD L+ ++ ED L P+ + M +A+ + L Y
Sbjct: 74 NNLYLVMDYYVGGDLLTLLSKF------EDRL----PEDMARFYLAEMVLAIDSVHQLGY 123
Query: 112 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 171
+H RD+K N+LLD + + +L+DFG + L + D T S +GT Y +PE
Sbjct: 124 VH---------RDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPE 173
Query: 172 Y--AM---SGKLTLKSDIYSFGVVLLELITG 197
AM G+ + D +S GV + E++ G
Sbjct: 174 ILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 3/85 (3%)
Query: 109 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 168
++Y+H + +I+RD+K+ N+L++ + L DFG A +T + GT
Sbjct: 273 IDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTN 329
Query: 169 APEYAMSGKLTLKSDIYSFGVVLLE 193
APE T DI+S G+V+ E
Sbjct: 330 APEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 2e-05
Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 42/222 (18%)
Query: 24 AIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIG-YCTSGDQRL-LVYEYMPMGSLED 81
A+KQ+ G+ E+ +L L H N++ L + + D+++ L+++Y E
Sbjct: 32 ALKQIEGTGIS--MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA-----EH 84
Query: 82 HLYDL-------EPDQEPLSWNTRM--KIAVGAARGLEYLHCKANPPVIYRDLKSANILL 132
L+ + + +++P+ M + G+ YLH V++RDLK ANIL+
Sbjct: 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILV 141
Query: 133 DNDFNP-----KLSDFGLAK-----LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKS 182
+ P K++D G A+ L P+ D V+ T+ Y APE + + K+
Sbjct: 142 MGE-GPERGRVKIADMGFARLFNSPLKPLAD----LDPVVVTFWYRAPELLLGARHYTKA 196
Query: 183 -DIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 223
DI++ G + EL+T Q + S PF DQ
Sbjct: 197 IDIWAIGCIFAELLTSEPIF-----HCRQEDIKTSNPFHHDQ 233
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 3e-05
Identities = 49/200 (24%), Positives = 89/200 (44%), Gaps = 30/200 (15%)
Query: 26 KQLNHEGLQGHQ--EFIVEVLMLSLLHHDNLVTLIG-YCTSGDQRL-LVYEYMPMGSLED 81
K +++ GL+ + + ++EV ++ L H N+V I + +Q+L ++ E+ G L
Sbjct: 44 KAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSR 103
Query: 82 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP----VIYRDLKSANILLD---- 133
++ + + + I L Y H + P V++RDLK NI L
Sbjct: 104 NIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163
Query: 134 ---------NDFN----PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTL 180
N+ N K+ DFGL+K + H +GT Y +PE + +
Sbjct: 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSY 220
Query: 181 --KSDIYSFGVVLLELITGR 198
KSD+++ G ++ EL +G+
Sbjct: 221 DDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 28/80 (35%), Positives = 45/80 (56%), Gaps = 7/80 (8%)
Query: 69 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 128
LV EY+ G ++ L+ E ++ +K A L+YLH +I+RDLK
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEMA----VKYISEVALALDYLHRHG---IIHRDLKPD 133
Query: 129 NILLDNDFNPKLSDFGLAKL 148
N+L+ N+ + KL+DFGL+K+
Sbjct: 134 NMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 4e-05
Identities = 57/226 (25%), Positives = 102/226 (45%), Gaps = 42/226 (18%)
Query: 20 DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIG-YCTSGDQRL-LVYEYMPMG 77
D+ A+KQ+ G+ E+ +L L H N+++L + + D+++ L+++Y
Sbjct: 28 DRDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA--- 82
Query: 78 SLEDHLYDL-------EPDQEPLSWNTRM--KIAVGAARGLEYLHCKANPPVIYRDLKSA 128
E L+ + + +++P+ M + G+ YLH V++RDLK A
Sbjct: 83 --EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPA 137
Query: 129 NILLDNDFNP-----KLSDFGLAK-----LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL 178
NIL+ + P K++D G A+ L P+ D V+ T+ Y APE + +
Sbjct: 138 NILVMGE-GPERGRVKIADMGFARLFNSPLKPLAD----LDPVVVTFWYRAPELLLGARH 192
Query: 179 TLKS-DIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 223
K+ DI++ G + EL+T Q + S P+ DQ
Sbjct: 193 YTKAIDIWAIGCIFAELLTSEPIF-----HCRQEDIKTSNPYHHDQ 233
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 6e-05
Identities = 46/188 (24%), Positives = 71/188 (37%), Gaps = 51/188 (27%)
Query: 50 HHDNLVTLIGYCTSGDQR--LLVYEYMPMGSLEDHL--YDLEPDQEPLSWNTRMKIAVGA 105
+ +V L Y + D+ L+ EY+P G + L D ++E TR IA
Sbjct: 59 DNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE-----TRFYIA-ET 110
Query: 106 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-----------------L 148
++ +H K I+RD+K N+LLD + KLSDFGL L
Sbjct: 111 ILAIDSIH-KLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHAL 167
Query: 149 GPVGDNTHVSTR-------------------VMGTYGYCAPEYAMSGKLTLKSDIYSFGV 189
+ +GT Y APE + + D +S GV
Sbjct: 168 PSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227
Query: 190 VLLELITG 197
++ E++ G
Sbjct: 228 IMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 7e-05
Identities = 32/109 (29%), Positives = 57/109 (52%), Gaps = 5/109 (4%)
Query: 89 DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 148
+ LS+ + + A G+E+L A+ ++RDL + N+L+ K+ DFGLA+
Sbjct: 232 ESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLAR- 287
Query: 149 GPVGDNTHVST-RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
+ D+ ++S + APE + T SD++SFG++L E+ T
Sbjct: 288 DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 9e-05
Identities = 36/135 (26%), Positives = 55/135 (40%), Gaps = 15/135 (11%)
Query: 69 LVYEYMP--MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 126
LV+EY+ + D PL T +G+ + H V++RDLK
Sbjct: 83 LVFEYLDSDLKKFMDSNGRGPG--RPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLK 137
Query: 127 SANILLDNDFNP-KLSDFGLAKLG--PVGDNTHVSTRVMGTYGYCAPEYAMSGK-LTLKS 182
N+L+D K++D GL + PV TH + T Y APE + +
Sbjct: 138 PQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH----EIVTLWYRAPEVLLGSTHYSTPV 193
Query: 183 DIYSFGVVLLELITG 197
DI+S G + E+
Sbjct: 194 DIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 1e-04
Identities = 44/160 (27%), Positives = 77/160 (48%), Gaps = 24/160 (15%)
Query: 45 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 104
M+ + H ++V L G C + ++V E++ G L+ L+ + + L+ + K+A
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LF-MHRKSDVLTTPWKFKVAKQ 113
Query: 105 AARGLEYLHCKANPPVIYRDLKSANILL-----DNDFNP--KLSDFGLAKLGPVGDNTHV 157
A L YL K +++ ++ + NILL D + P KLSD G+ P+ V
Sbjct: 114 LASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI----PIT----V 162
Query: 158 STR--VMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLEL 194
+R + + APE K L++ +D +SFG L E+
Sbjct: 163 LSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 42/181 (23%), Positives = 69/181 (38%), Gaps = 56/181 (30%)
Query: 65 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLS--WNTRMKIAVGAARGLEYLHCKANPPVIY 122
D V +Y+P G + L + E L+ + + AV + + ++H
Sbjct: 74 DNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIH--------- 124
Query: 123 RDLKSANILLDNDFNPKLSDFGL---------AKLGPVGDNTH----------------- 156
RD+K NIL+D D + KL+DFGL +K GD+
Sbjct: 125 RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCR 184
Query: 157 -------------------VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 197
++ ++GT Y APE + T D +S GV+L E++ G
Sbjct: 185 CGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 244
Query: 198 R 198
+
Sbjct: 245 Q 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 7e-04
Identities = 39/164 (23%), Positives = 61/164 (37%), Gaps = 44/164 (26%)
Query: 69 LVYEYMPMGSLEDHLY--DLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 126
L+ E++P G + L D ++ + +A+ A L ++H RD+K
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIH---------RDIK 128
Query: 127 SANILLDNDFNPKLSDFGLA---------------KLGPVGD------------------ 153
N+LLD + KLSDFGL P D
Sbjct: 129 PDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKN 188
Query: 154 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 197
++ +GT Y APE M D +S GV++ E++ G
Sbjct: 189 RRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 9e-04
Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 20/158 (12%)
Query: 45 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 104
++S + H +L + G C G + ++V E++ G L D E + P++W ++ +A
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DVCLRKEKGRVPVAW--KITVAQQ 125
Query: 105 AARGLEYLHCKANPPVIYRDLKSANIL-----LDNDFNP--KLSDFGLAKLGPVGDNTHV 157
A L YL K +++ ++ + NIL L +P KLSD G++ + V
Sbjct: 126 LASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS-FTALSREERV 181
Query: 158 STRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLEL 194
R+ + APE G L+ +D +SFG LLE+
Sbjct: 182 E-RI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 43/181 (23%), Positives = 68/181 (37%), Gaps = 56/181 (30%)
Query: 65 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLS--WNTRMKIAVGAARGLEYLHCKANPPVIY 122
D V +Y+P G + L +E E L+ + + +A+ + + ++H
Sbjct: 74 DNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIH--------- 124
Query: 123 RDLKSANILLDNDFNPKLSDFGL---------AKLGPVGD-----------------NTH 156
RD+K NIL+D D + KL+DFGL +K G N
Sbjct: 125 RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCR 184
Query: 157 VSTRVM-------------------GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 197
R+ GT Y APE + T D +S GV+L E++ G
Sbjct: 185 CGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVG 244
Query: 198 R 198
+
Sbjct: 245 Q 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.003
Identities = 27/83 (32%), Positives = 40/83 (48%), Gaps = 17/83 (20%)
Query: 69 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA-----VGAARGLEYLHCKANPPVIYR 123
L+ E++P G L L + E + TR +A + A L ++H R
Sbjct: 78 LIMEFLPGGDLMTMLIKYDTFSEDV---TRFYMAECVLAIEAVHKLGFIH---------R 125
Query: 124 DLKSANILLDNDFNPKLSDFGLA 146
D+K NIL+D + KLSDFGL+
Sbjct: 126 DIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 30/122 (24%), Positives = 50/122 (40%), Gaps = 13/122 (10%)
Query: 92 PLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-----------FNPKL 140
P S +I L+Y H + + +++ DLK NIL++ P
Sbjct: 227 PFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRALPPDP 284
Query: 141 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 200
+ LG D H T ++ T Y +PE + +D++S G ++ EL TG+
Sbjct: 285 CRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL 344
Query: 201 MD 202
D
Sbjct: 345 YD 346
|
Length = 467 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.004
Identities = 38/164 (23%), Positives = 62/164 (37%), Gaps = 44/164 (26%)
Query: 69 LVYEYMPMGSLEDHLY--DLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 126
L+ E++P G + L D ++E + +A+ + L ++H RD+K
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIH---------RDIK 128
Query: 127 SANILLDNDFNPKLSDFGLAKLGPVGDNT------------------------------- 155
N+LLD+ + KLSDFGL T
Sbjct: 129 PDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRN 188
Query: 156 --HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 197
++ +GT Y APE M D +S GV++ E++ G
Sbjct: 189 RRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 311 | |||
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.76 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.7 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.65 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.6 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.59 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.5 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.45 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.44 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.36 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.35 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.3 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.29 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.29 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.27 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.16 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.16 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.16 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.08 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.03 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.99 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.96 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.88 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.82 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.73 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.66 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.62 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.59 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.41 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.4 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.36 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.24 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.18 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.15 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.14 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.12 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.11 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.09 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.09 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.97 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.94 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.84 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.72 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.69 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.63 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.62 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.5 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.42 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.4 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.23 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.17 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.16 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 97.16 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.92 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.91 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.9 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.9 | |
| PLN02236 | 344 | choline kinase | 96.85 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.83 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.81 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.76 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.62 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.38 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.18 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.12 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.0 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.33 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.25 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.06 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 95.04 |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-51 Score=325.76 Aligned_cols=248 Identities=25% Similarity=0.337 Sum_probs=208.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccC--CccchhHHHHHHHHHhcCCCCcccceeE-EEEeCCe-eEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLHHDNLVTLIG-YCTSGDQ-RLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~-~~lv~e~~~ 75 (311)
+.++|.|+||.||++.. +|..||.|.++-. +....+....|+.+|++|+||||+++++ .|.+++. ++++||+|+
T Consensus 24 l~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~ 103 (375)
T KOG0591|consen 24 LKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCD 103 (375)
T ss_pred HHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhc
Confidence 46789999999999999 8999999988644 3345578899999999999999999998 5555555 899999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-CCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA-NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~-~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
+|+|.+.+...+.....+++..+|+++.|++.||..+|++- ...+.||||||.|||++.+|.|||+|||+++.... .
T Consensus 104 ~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s--~ 181 (375)
T KOG0591|consen 104 AGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSS--K 181 (375)
T ss_pred ccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcc--h
Confidence 99999999998889999999999999999999999999831 12399999999999999999999999999986432 2
Q ss_pred cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccC
Q 021526 155 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
...-....||+.||+||.++..+|+.++||||+||++|||+.-++||. ..++.++..+..
T Consensus 182 ~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~--------------------g~n~~~L~~KI~ 241 (375)
T KOG0591|consen 182 TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFY--------------------GDNLLSLCKKIE 241 (375)
T ss_pred hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcc--------------------cccHHHHHHHHH
Confidence 223344679999999999999999999999999999999999999997 233444444444
Q ss_pred CCCCc----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 021526 235 HGRYP----RRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 271 (311)
Q Consensus 235 ~~~~~----~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L 271 (311)
++++| ..++..+..+|..|+.+||..||+...+++.+
T Consensus 242 qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 242 QGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred cCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 55554 46789999999999999999999954444433
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=324.65 Aligned_cols=246 Identities=26% Similarity=0.321 Sum_probs=204.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccC-CccchhHHHHHHHHHhcCCCCcccceeEEEEeCCe-eEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ-RLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~ 77 (311)
+..+|+|.-|.|+++.+ +++-+|+|.+... ++...+++.+|+++++..+||||+.+|+.|.++.. ..++||||++|
T Consensus 84 ~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgG 163 (364)
T KOG0581|consen 84 LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGG 163 (364)
T ss_pred hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCC
Confidence 34689999999999999 7999999999544 34556799999999999999999999999999984 99999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
+|.+.+.. .+.+++..+-.++.++++||.|||. .+ |+||||||.|||++..|.|||+|||.+......
T Consensus 164 SLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---- 232 (364)
T KOG0581|consen 164 SLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---- 232 (364)
T ss_pred CHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh----
Confidence 99999954 4789999999999999999999996 77 999999999999999999999999999764333
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
.-....||..|||||.+++..|+.++||||||++++|+++|+.||..... ...........+ ++.. .-
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-~~~~~~~Ll~~I----------v~~p-pP 300 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-PYLDIFELLCAI----------VDEP-PP 300 (364)
T ss_pred hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-CCCCHHHHHHHH----------hcCC-CC
Confidence 23456799999999999999999999999999999999999999964311 011111111111 1100 01
Q ss_pred CCcH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 237 RYPR-RCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 237 ~~~~-~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
..|. .++.++++|+..||+.||.+||++.++++.
T Consensus 301 ~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 301 RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 2233 378899999999999999999999999873
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-49 Score=330.32 Aligned_cols=244 Identities=26% Similarity=0.302 Sum_probs=202.1
Q ss_pred CeeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc-------chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEE
Q 021526 1 MLCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ-------GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 71 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 71 (311)
+...+|+|+||.|-.+.. .++.||||++++.... ......+|+++|++++||||++++++|+.....|+||
T Consensus 176 i~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVl 255 (475)
T KOG0615|consen 176 ISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVL 255 (475)
T ss_pred eeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEE
Confidence 357899999999999999 8999999999875322 2234679999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCC---CceEEeecCCCcc
Q 021526 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND---FNPKLSDFGLAKL 148 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~---~~vkl~Df~~~~~ 148 (311)
||++||+|.+++ ..++.+.+..-..++.|++.|+.|||++| |+||||||+|||+..+ -.+||.|||++.
T Consensus 256 E~v~GGeLfd~v----v~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK- 327 (475)
T KOG0615|consen 256 EYVEGGELFDKV----VANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAK- 327 (475)
T ss_pred EEecCccHHHHH----HhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhh-
Confidence 999999999999 46777888888999999999999999999 9999999999999766 568999999998
Q ss_pred CCCCCCcceeeeccccccccCCccccCCCC---CccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccc
Q 021526 149 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKL---TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 225 (311)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~---~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
.......+.+.+||+.|.|||++.+... ..+.|+|||||++|-+++|.+||...-+...
T Consensus 328 --~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s---------------- 389 (475)
T KOG0615|consen 328 --VSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS---------------- 389 (475)
T ss_pred --ccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc----------------
Confidence 4456677888999999999999987543 3478999999999999999999963332211
Q ss_pred hhhhcCccCCCCC---cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 226 FVHLVDPLLHGRY---PRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 226 ~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
+.+.+...-.... -.+.+++..++|.+||..||++|||+.|+++.
T Consensus 390 l~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 390 LKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred HHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 1111111111111 13568889999999999999999999999874
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=342.13 Aligned_cols=238 Identities=23% Similarity=0.332 Sum_probs=209.3
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccC---CccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHE---GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
.+||.|+|..+|++.. +|+.||+|++.+. .....+.+.+|+++.++|+||||++++++|++.++.|+|.|.|..+
T Consensus 24 ~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~ 103 (592)
T KOG0575|consen 24 RFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRG 103 (592)
T ss_pred eeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCc
Confidence 5799999999999999 8999999999875 3456678999999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|..++. +.+.+++..+..++.||+.||.|||+.+ |+|||||..|+|++++.+|||+|||++..... ....
T Consensus 104 sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~--~~Er 174 (592)
T KOG0575|consen 104 SLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEY--DGER 174 (592)
T ss_pred cHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecC--cccc
Confidence 9999994 5789999999999999999999999999 99999999999999999999999999986433 3344
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC-
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG- 236 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 236 (311)
..+.+||+-|.|||++.....+..+||||+||++|-|+.|++||+... +.+........
T Consensus 175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~--------------------vkety~~Ik~~~ 234 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT--------------------VKETYNKIKLNE 234 (592)
T ss_pred cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch--------------------HHHHHHHHHhcC
Confidence 567899999999999999999999999999999999999999997332 22222222222
Q ss_pred -CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 237 -RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 237 -~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.+|...+.+..+||.++|+.||.+|||+++|+.
T Consensus 235 Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 235 YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 235577888999999999999999999999986
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=330.50 Aligned_cols=256 Identities=34% Similarity=0.443 Sum_probs=213.4
Q ss_pred eeeeeceeccEEEEEECCeE-EEEEEeccCCccc--hhHHHHHHHHHhcCCCCcccceeEEEEeCC-eeEEEEecCCCCC
Q 021526 3 CCYLSCKFYNVGLVWLCDQL-VAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLIGYCTSGD-QRLLVYEYMPMGS 78 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~~~~~-vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~ 78 (311)
+.+|+|+||.||++.+.|+. ||+|.+....... ...+.+|+.+|..++||||+++++++.+.. .+++||||+.+|+
T Consensus 47 ~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~Gs 126 (362)
T KOG0192|consen 47 EVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGS 126 (362)
T ss_pred hhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCc
Confidence 45899999999999998888 9999997654332 458999999999999999999999998887 7999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCC-ceEEeecCCCccCCCCCCcce
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-NPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~-~vkl~Df~~~~~~~~~~~~~~ 157 (311)
|.+++... ....+++..++.++.+|+.|+.|||+++. |+|+||||+|+|++.++ .+||+|||+++...... ..
T Consensus 127 L~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~ 200 (362)
T KOG0192|consen 127 LSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TS 200 (362)
T ss_pred HHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--cc
Confidence 99999763 57889999999999999999999999863 89999999999999998 99999999997533221 22
Q ss_pred eeeccccccccCCcccc--CCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 158 STRVMGTYGYCAPEYAM--SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~--~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
.....||..|+|||++. ...++.++||||||+++|||+||..||..... ............+
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~----------------~~~~~~v~~~~~R 264 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP----------------VQVASAVVVGGLR 264 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH----------------HHHHHHHHhcCCC
Confidence 23367999999999999 56999999999999999999999999973332 0111111222233
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCC
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 280 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~ 280 (311)
-..+..++..+..++.+||..||..||++.+++..|+.+......
T Consensus 265 p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 265 PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 334555888999999999999999999999999999998875544
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-48 Score=335.48 Aligned_cols=254 Identities=31% Similarity=0.427 Sum_probs=220.0
Q ss_pred CeeeeeeceeccEEEEEECCe-EEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 1 MLCCYLSCKFYNVGLVWLCDQ-LVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~~~~-~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
|+..||+|.||.|+.|.+++. +||+|.+... .-..+.|.+|++++++|+|++|++++++++.+..++|||||+..|+|
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 356799999999999999665 9999998643 44557888999999999999999999999998899999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
.+||.. ..+..+.....+.++.|||+|++||++++ +|||||...||||++++.+||+|||+++.. ..+......
T Consensus 289 l~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~-~d~~Y~~~~ 362 (468)
T KOG0197|consen 289 LDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLI-GDDEYTASE 362 (468)
T ss_pred HHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEccccccccc-CCCceeecC
Confidence 999976 46788999999999999999999999999 999999999999999999999999999932 233333444
Q ss_pred eccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCC
Q 021526 160 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRY 238 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
....+..|.|||.+..+.++.++||||||++||||+| |+.||.... ...+.+.+....+-..
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-----------------n~ev~~~le~GyRlp~ 425 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-----------------NEEVLELLERGYRLPR 425 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-----------------HHHHHHHHhccCcCCC
Confidence 4556789999999999999999999999999999998 666765222 3445566666777778
Q ss_pred cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 021526 239 PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 278 (311)
Q Consensus 239 ~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~ 278 (311)
|..|+.++.+++..||..+|++|||++.+...|+.+....
T Consensus 426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 426 PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 8899999999999999999999999999999998876543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=325.90 Aligned_cols=270 Identities=53% Similarity=0.857 Sum_probs=230.2
Q ss_pred eeeeeceeccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCC-eeEEEEecCCCCCHH
Q 021526 3 CCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD-QRLLVYEYMPMGSLE 80 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~ 80 (311)
.++|.|+||.||+|.+ ++..||||.+.........+|.+|++++..++|||+++++++|.+++ ..+||+||+..|+|.
T Consensus 81 ~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~ 160 (361)
T KOG1187|consen 81 NLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLE 160 (361)
T ss_pred cceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHH
Confidence 4799999999999999 55999999876544331456999999999999999999999999888 599999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++...... .++|..+++++.++|.||+|||....++|+|||||+.|||+|++...||+|||++...... ......
T Consensus 161 d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~--~~~~~~ 236 (361)
T KOG1187|consen 161 DHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG--DTSVST 236 (361)
T ss_pred HHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc--ccceee
Confidence 999763222 8899999999999999999999988778999999999999999999999999999643221 112222
Q ss_pred c-cccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC-CCC
Q 021526 161 V-MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH-GRY 238 (311)
Q Consensus 161 ~-~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 238 (311)
. .||..|++||....+..+.++||||||++++|+++|+.+.+.........+..|....+.+. .+.+++|+.+. ..+
T Consensus 237 ~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~-~~~eiiD~~l~~~~~ 315 (361)
T KOG1187|consen 237 TVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG-KLREIVDPRLKEGEY 315 (361)
T ss_pred ecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc-chhheeCCCccCCCC
Confidence 2 79999999999988999999999999999999999999888766555556788876666644 88999999987 666
Q ss_pred cH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 021526 239 PR-RCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 277 (311)
Q Consensus 239 ~~-~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~ 277 (311)
+. .....+..+..+|++.+|++||++.+|++.|..+...
T Consensus 316 ~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 316 PDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred ChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 65 6778899999999999999999999999999666554
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=319.79 Aligned_cols=193 Identities=30% Similarity=0.360 Sum_probs=174.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccC--CccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
...+|+|+|+.||+|++ .+..||||.+.+. ..+..+.+..|+.+|+.++||||+.+++++..++.+|+|||||+||
T Consensus 15 ~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gG 94 (429)
T KOG0595|consen 15 SREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGG 94 (429)
T ss_pred hhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCC
Confidence 45689999999999999 7899999999877 4556677899999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCC------CceEEeecCCCccCCC
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND------FNPKLSDFGLAKLGPV 151 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~------~~vkl~Df~~~~~~~~ 151 (311)
+|.+|+. ..+.+++..+..++.||+.|+++||+++ |+||||||.|||++.. ..+||+|||+++...
T Consensus 95 DLs~yi~----~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~- 166 (429)
T KOG0595|consen 95 DLSDYIR----RRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ- 166 (429)
T ss_pred CHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhCC-
Confidence 9999994 4568999999999999999999999999 9999999999999765 458999999999543
Q ss_pred CCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCcccc
Q 021526 152 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 204 (311)
Q Consensus 152 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 204 (311)
....-.+.+|++.|||||+++...|+.|+|+||+|+++|+|++|.+||+..
T Consensus 167 --~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 167 --PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred --chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 444456688999999999999999999999999999999999999999733
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=315.53 Aligned_cols=256 Identities=27% Similarity=0.324 Sum_probs=211.6
Q ss_pred CeeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc---chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCC
Q 021526 1 MLCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
++.++|+|+||+|+.++. .++.+|+|+++++... .......|..+|..++||+|++++-.|.+.+.+|+|+||+.
T Consensus 29 ~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~ 108 (357)
T KOG0598|consen 29 ILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLN 108 (357)
T ss_pred eeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccC
Confidence 468999999999999999 7899999999887543 34678899999999999999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
||.|..+| ++.+.+++..+..++..|+.||.|||++| |+|||+||+|||+|.+|.++|+|||++... ....
T Consensus 109 GGeLf~hL----~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~--~~~~ 179 (357)
T KOG0598|consen 109 GGELFYHL----QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKED--LKDG 179 (357)
T ss_pred CccHHHHH----HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhc--ccCC
Confidence 99999999 46788999999999999999999999999 999999999999999999999999999852 2333
Q ss_pred ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 156 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
..+.+.+||+.|+|||++.+..++.++|.||||+++|+|++|.+||...+. .+..+..++
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~--------------------~~~~~~I~~ 239 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV--------------------KKMYDKILK 239 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH--------------------HHHHHHHhc
Confidence 445568999999999999999999999999999999999999999963321 111111111
Q ss_pred C---CCcHHHHHHHHHHHHHhhccCCCCCC----CHHHHHHH-------HHHhhhccCCCCCCC
Q 021526 236 G---RYPRRCLNYAVAVTAMCLNEEANFRP----LINDIVVA-------LDYLVSQRDSHPVSR 285 (311)
Q Consensus 236 ~---~~~~~~~~~l~~li~~~l~~~p~~RP----s~~~l~~~-------L~~l~~~~~~~~~~~ 285 (311)
+ ..+.-.+.+..+++.++|..||++|- ++.+|.+. ++.+.+..-.++-.+
T Consensus 240 ~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P 303 (357)
T KOG0598|consen 240 GKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKP 303 (357)
T ss_pred CcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeec
Confidence 1 22334678899999999999999994 56665542 345544444444333
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=306.09 Aligned_cols=256 Identities=26% Similarity=0.293 Sum_probs=206.0
Q ss_pred CeeeeeeceeccEEEEEE--CCeEEEEEEeccCCccch-hHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 1 MLCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGH-QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
|.|++|.|..+.||.+++ .+..||||++..+.+.+. +.+.+|++.++.++||||++++..|..+..+|+||+++.+|
T Consensus 30 L~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~G 109 (516)
T KOG0582|consen 30 LQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGG 109 (516)
T ss_pred EEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCC
Confidence 579999999999999999 789999999998877655 88999999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
++.+.+.... ...+.+..+..++.++++||.|||.+| .+|||||+.||||+.+|.|||+|||.+...........
T Consensus 110 S~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~ 184 (516)
T KOG0582|consen 110 SLLDIIKTYY--PDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQV 184 (516)
T ss_pred cHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCceee
Confidence 9999997744 345999999999999999999999999 99999999999999999999999998654333222211
Q ss_pred -e-eeccccccccCCccccC--CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 158 -S-TRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 158 -~-~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
. .+..|+++|+|||+++. ..|+.|+||||||++..|+++|+.||......+- ....++ ..........
T Consensus 185 ~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv------Ll~tLq--n~pp~~~t~~ 256 (516)
T KOG0582|consen 185 TRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV------LLLTLQ--NDPPTLLTSG 256 (516)
T ss_pred EeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH------HHHHhc--CCCCCccccc
Confidence 1 45689999999999553 4799999999999999999999999974432110 000000 0000001111
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
+..+........+.++|..||+.||++|||++++++
T Consensus 257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 211222334557999999999999999999999987
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=303.92 Aligned_cols=249 Identities=27% Similarity=0.332 Sum_probs=198.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCC--eeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD--QRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~ 77 (311)
..++|+|+||.||.+.. +|...|||.+........+.+.+|+.+|+.++||||+++++...... .++++|||+.+|
T Consensus 22 ~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~G 101 (313)
T KOG0198|consen 22 GKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGG 101 (313)
T ss_pred hccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCC
Confidence 35789999999999999 47999999987664333677999999999999999999999744333 689999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcC-CCceEEeecCCCccCCC-CCCc
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-DFNPKLSDFGLAKLGPV-GDNT 155 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~-~~~vkl~Df~~~~~~~~-~~~~ 155 (311)
+|.+++.+ .+..+++..+..+..|+++||+|||++| ++|+||||+|||++. ++.+||+|||++..... ....
T Consensus 102 sL~~~~~~---~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~ 175 (313)
T KOG0198|consen 102 SLSDLIKR---YGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS 175 (313)
T ss_pred cHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence 99999965 2237999999999999999999999999 999999999999999 79999999998875432 1112
Q ss_pred ceeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccC
Q 021526 156 HVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
.......||+.|+|||+.... ....++|||||||++.||+||.+||..... .. .....+.....
T Consensus 176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~-----~~----------~~~~~ig~~~~ 240 (313)
T KOG0198|consen 176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE-----EA----------EALLLIGREDS 240 (313)
T ss_pred cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc-----hH----------HHHHHHhccCC
Confidence 223346799999999999853 344699999999999999999999863200 00 00011110001
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 271 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L 271 (311)
.-..|...+.+..+|+.+|+..+|+.|||++++++..
T Consensus 241 ~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 241 LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 1134566788899999999999999999999999853
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=311.96 Aligned_cols=242 Identities=25% Similarity=0.311 Sum_probs=204.9
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
.++|+|+.|.||.+.. .++.||||.+....-...+-+.+|+.+++..+|+||+.+++.|..++.+|+||||++||+|.
T Consensus 279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT 358 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT 358 (550)
T ss_pred hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence 3689999999999999 78999999988766556678999999999999999999999998889999999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+.+.. ..+++..+..++.+++.||+|||.+| |+|+|||.+|||++.+|.+||+|||++...... ......
T Consensus 359 DvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~--~~KR~T 428 (550)
T KOG0578|consen 359 DVVTK-----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE--QSKRST 428 (550)
T ss_pred hhhhc-----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccc--cCcccc
Confidence 99954 45999999999999999999999999 999999999999999999999999998754332 223456
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCcH
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPR 240 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (311)
..||+.|||||+.....|+++.||||||++++||+-|.+||-..... .....+..-..+ ....+.
T Consensus 429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl-------------rAlyLIa~ng~P--~lk~~~ 493 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-------------RALYLIATNGTP--KLKNPE 493 (550)
T ss_pred ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH-------------HHHHHHhhcCCC--CcCCcc
Confidence 78999999999999999999999999999999999999998521110 001111111111 123356
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 241 RCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 241 ~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..+..+.+|+.+||+.|+++||++.|||+
T Consensus 494 klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 494 KLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred ccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 77889999999999999999999999998
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=309.76 Aligned_cols=247 Identities=25% Similarity=0.315 Sum_probs=204.5
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccC----Cc-cchhHHHHHHHHHhcCC-CCcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHE----GL-QGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
-..+|.|.||+|+.++. .+..||+|++..+ .. ...+.+.+|+.+++.++ ||||+++++++......++||||
T Consensus 22 ~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy 101 (370)
T KOG0583|consen 22 GRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEY 101 (370)
T ss_pred eeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEe
Confidence 35789999999999988 7899999987664 12 23456778999999999 99999999999999999999999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCC-CceEEeecCCCccCCCC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-FNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~-~~vkl~Df~~~~~~~~~ 152 (311)
+.||+|.+++. ..+.+.+..+..++.|++.|++|+|++| |+||||||+||+++.+ +++||+|||++....
T Consensus 102 ~~gGdL~~~i~----~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~-- 172 (370)
T KOG0583|consen 102 CSGGDLFDYIV----NKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAISP-- 172 (370)
T ss_pred cCCccHHHHHH----HcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccccC--
Confidence 99999999994 4678888999999999999999999999 9999999999999999 999999999998542
Q ss_pred CCcceeeeccccccccCCccccCCC-CC-ccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhc
Q 021526 153 DNTHVSTRVMGTYGYCAPEYAMSGK-LT-LKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 230 (311)
Q Consensus 153 ~~~~~~~~~~~~~~~~aPE~~~~~~-~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (311)
.......+.+|++.|+|||++.+.. |+ .++||||+|+++|.|++|..||+.... . .....+.
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~------~----------~l~~ki~ 236 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV------P----------NLYRKIR 236 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH------H----------HHHHHHh
Confidence 2334456688999999999999876 76 899999999999999999999974211 0 0111111
Q ss_pred CccCCCCCcHHH-HHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 021526 231 DPLLHGRYPRRC-LNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 276 (311)
Q Consensus 231 ~~~~~~~~~~~~-~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~ 276 (311)
... -.+|... +.++..++++||..||.+|+++.+++ .-.-++.
T Consensus 237 ~~~--~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 237 KGE--FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred cCC--ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 111 1234455 88899999999999999999999999 4444443
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=299.72 Aligned_cols=246 Identities=20% Similarity=0.270 Sum_probs=200.3
Q ss_pred eeeeeceeccEEEEEECCeEEEEEEeccCCccc---hhHHHHHHHHHhcCCCCcccceeEEEEe----CCeeEEEEecCC
Q 021526 3 CCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQG---HQEFIVEVLMLSLLHHDNLVTLIGYCTS----GDQRLLVYEYMP 75 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~ 75 (311)
+.++.|+++.||+|..+|+.||+|.+....... .+.+.+|+.++++++||||+++++++.+ ....+++|||++
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~ 105 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence 578999999999999999999999987654333 3667899999999999999999999876 346799999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~-~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
+++|.+++.. ...+++.....++.+++.|+++||+. + ++|+||+|+||++++++.+||+|||++.......
T Consensus 106 ~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 106 RGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 9999999954 45688899999999999999999984 7 8899999999999999999999999986432211
Q ss_pred cceeeeccccccccCCccccC--CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCc
Q 021526 155 THVSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 232 (311)
Q Consensus 155 ~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
....++..|+|||++.+ ..++.++||||||+++|+|++|..||...... .... .....
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~------~~~~----------~i~~~ 237 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK------EIYD----------LIINK 237 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH------HHHH----------HHHhc
Confidence 12346788999999876 67899999999999999999999999633211 0000 01111
Q ss_pred cCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 021526 233 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 276 (311)
Q Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~ 276 (311)
......+..++..+.+++.+||+.||++|||+.++++.|++++.
T Consensus 238 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 238 NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 11112334567889999999999999999999999999998864
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=287.51 Aligned_cols=253 Identities=26% Similarity=0.301 Sum_probs=212.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+..+|.|+||.|..++. +|..+|+|++.+... +..++..+|..+|+.+.||+++++++.|.+.+.+++||||+.|
T Consensus 49 ~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~G 128 (355)
T KOG0616|consen 49 LKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPG 128 (355)
T ss_pred eeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCC
Confidence 56799999999999999 899999999987643 3456788999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
|.|..+++ ..+.+++..+..++.+|+.||+|||+.+ |++||+||+|||+|++|.+||+|||.+.... .
T Consensus 129 GElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~-----~ 196 (355)
T KOG0616|consen 129 GELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS-----G 196 (355)
T ss_pred ccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec-----C
Confidence 99999994 4678999999999999999999999999 9999999999999999999999999997532 2
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
..-+.+||+.|+|||++...++..++|.||||+++|||+.|.+||..... .....+++...+
T Consensus 197 rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~----------------~~iY~KI~~~~v-- 258 (355)
T KOG0616|consen 197 RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP----------------IQIYEKILEGKV-- 258 (355)
T ss_pred cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh----------------HHHHHHHHhCcc--
Confidence 25678999999999999999999999999999999999999999963332 122233333333
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCCCCCCCCCC
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSRNAGAR 290 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~~~~~~~~~~~ 290 (311)
.+|...+..+.+|+...|+.|-.+|- -.+..=...-+.++|.++.+|.
T Consensus 259 ~fP~~fs~~~kdLl~~LL~vD~t~R~------gnlknG~~dIk~H~wF~~v~W~ 306 (355)
T KOG0616|consen 259 KFPSYFSSDAKDLLKKLLQVDLTKRF------GNLKNGVEDIKNHPWFKGVDWE 306 (355)
T ss_pred cCCcccCHHHHHHHHHHHhhhhHhhh------cCcCCCccccccCcccccccHH
Confidence 46778888999999999999999991 1111112344566777766663
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=306.22 Aligned_cols=257 Identities=25% Similarity=0.323 Sum_probs=199.0
Q ss_pred eeeeeeceeccEEEEEE-------CCeEEEEEEeccCCc-cchhHHHHHHHHHhcC-CCCcccceeEEEEeC-CeeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL-------CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSG-DQRLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~~~~lv~ 71 (311)
..++|+|+||.||++.. .++.||+|.+..... .....+.+|+.++..+ +||||+++++++... ...+++|
T Consensus 12 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ 91 (338)
T cd05102 12 GKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIV 91 (338)
T ss_pred eeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEE
Confidence 46799999999999974 346899999864432 3345788999999999 899999999987654 4578999
Q ss_pred ecCCCCCHHHHhcccCCC----------------------------------------------------------CCCC
Q 021526 72 EYMPMGSLEDHLYDLEPD----------------------------------------------------------QEPL 93 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~----------------------------------------------------------~~~l 93 (311)
||+++|+|.+++...... ...+
T Consensus 92 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 171 (338)
T cd05102 92 EFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPL 171 (338)
T ss_pred ecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCC
Confidence 999999999998642210 2347
Q ss_pred CHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeeeccccccccCCccc
Q 021526 94 SWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 173 (311)
Q Consensus 94 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 173 (311)
.+..+..++.|++.||+|||+++ ++|+||||.||+++.++.++|+|||+++...............++..|+|||++
T Consensus 172 ~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 248 (338)
T cd05102 172 TMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESI 248 (338)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHh
Confidence 78889999999999999999999 999999999999999999999999998753222211122223456789999999
Q ss_pred cCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHH
Q 021526 174 MSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAM 252 (311)
Q Consensus 174 ~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 252 (311)
.+..++.++||||||+++|+|++ |..||........ . . .... .......+..++..+.+++.+
T Consensus 249 ~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~---~-~~~~----------~~~~~~~~~~~~~~l~~li~~ 312 (338)
T cd05102 249 FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--F---C-QRLK----------DGTRMRAPENATPEIYRIMLA 312 (338)
T ss_pred hcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--H---H-HHHh----------cCCCCCCCCCCCHHHHHHHHH
Confidence 88889999999999999999997 9999864322110 0 0 0000 001111233456779999999
Q ss_pred hhccCCCCCCCHHHHHHHHHHhhhc
Q 021526 253 CLNEEANFRPLINDIVVALDYLVSQ 277 (311)
Q Consensus 253 ~l~~~p~~RPs~~~l~~~L~~l~~~ 277 (311)
||..||++|||+.++++.|+.+...
T Consensus 313 cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 313 CWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=305.92 Aligned_cols=243 Identities=25% Similarity=0.291 Sum_probs=202.3
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
..+|.|+|+.|++++. .++.+|||++.+.-. ...+-+..|-+.|..| .||+|++++..|.++..+|+|+||+.+
T Consensus 79 ~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~n 158 (604)
T KOG0592|consen 79 KILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPN 158 (604)
T ss_pred heeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCC
Confidence 4789999999999999 899999999876521 1223466788888888 799999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc-
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT- 155 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~- 155 (311)
|+|.+++.+ -+.|++.-...++.+|+.||+|||++| |+||||||+|||+|++++++|.|||.+.........
T Consensus 159 Gdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~ 231 (604)
T KOG0592|consen 159 GDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQ 231 (604)
T ss_pred CcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChhhccc
Confidence 999999954 578999999999999999999999999 999999999999999999999999999865432221
Q ss_pred --------cee--eeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccc
Q 021526 156 --------HVS--TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 225 (311)
Q Consensus 156 --------~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
... ....||..|.+||++.....++.+|+|+|||++|+|+.|.+||...++-. .
T Consensus 232 ~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl----------------i 295 (604)
T KOG0592|consen 232 ENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL----------------I 295 (604)
T ss_pred cCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH----------------H
Confidence 111 33679999999999999999999999999999999999999996433210 0
Q ss_pred hhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 226 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
+.++. .+.-.+|...++...+||.+.|..||.+|++.++|.+.
T Consensus 296 FqkI~--~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 296 FQKIQ--ALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHHH--HhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 11111 11224566677889999999999999999999998874
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=312.47 Aligned_cols=238 Identities=26% Similarity=0.333 Sum_probs=208.9
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
.-||.|+.|.|-.+.+ .|+.+|||++.+... .....+.+|+-+++.++||||+++|++|++...+|+|.||+++|
T Consensus 18 kTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gG 97 (786)
T KOG0588|consen 18 KTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGG 97 (786)
T ss_pred ccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCc
Confidence 3589999999999999 899999999987632 23457889999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
.|.+++ ...+.+++..+..+++||+.|+.|+|..+ |||+|+||+|+|+|..+++||+|||.+.. ......
T Consensus 98 ELFdyl----v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsL---e~~gkl 167 (786)
T KOG0588|consen 98 ELFDYL----VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASL---EVPGKL 167 (786)
T ss_pred hhHHHH----HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeec---ccCCcc
Confidence 999999 56789999999999999999999999999 99999999999999999999999999873 344445
Q ss_pred eeeccccccccCCccccCCCCC-ccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 158 STRVMGTYGYCAPEYAMSGKLT-LKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
-.+-+|.+.|.+||+.++.+|+ .++||||.|+++|.|++|+.||+ ..++..++.+..++
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd--------------------DdNir~LLlKV~~G 227 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD--------------------DDNIRVLLLKVQRG 227 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC--------------------CccHHHHHHHHHcC
Confidence 5677899999999999999886 79999999999999999999998 33344444444433
Q ss_pred C--CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 237 R--YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 237 ~--~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
. +|...+.+.++||++||.+||++|.|++||++.
T Consensus 228 ~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 228 VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 3 466788999999999999999999999999984
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=303.81 Aligned_cols=242 Identities=26% Similarity=0.284 Sum_probs=203.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
+.++|+|+||.||+|.. .++.||+|++..+.. ...+++.+|+.+|.+++++||.++|+.+..+..++++||||.||+
T Consensus 18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 46799999999999999 799999999987643 455789999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
+.+.+. .+..+.+..+..++.+++.|+.|||..+ .+|+|||+.||++..+|.|||+|||.+........ ..
T Consensus 98 v~~lL~----~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--rr 168 (467)
T KOG0201|consen 98 VLDLLK----SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--RR 168 (467)
T ss_pred hhhhhc----cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh--cc
Confidence 999993 4555688888889999999999999999 99999999999999999999999999876443322 23
Q ss_pred eeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCC
Q 021526 159 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRY 238 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
.+..||+.|||||+.+...|+.++||||||++.+||++|.+|+....+..- ...+.+..-|.+
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv-------------lflIpk~~PP~L---- 231 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV-------------LFLIPKSAPPRL---- 231 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE-------------EEeccCCCCCcc----
Confidence 667899999999999988999999999999999999999999863332111 011111112222
Q ss_pred cHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 239 PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 239 ~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
...++..+++|+..||+.||+.||++.++++
T Consensus 232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 232 DGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 2356777999999999999999999999987
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=307.95 Aligned_cols=264 Identities=28% Similarity=0.394 Sum_probs=212.6
Q ss_pred CeeeeeeceeccEEEEEECCeEEEEEEeccCCcc--chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 1 MLCCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
|...+|+|+||+||+|.+-| .||||+++...+. ..+.|++|+..|++-+|.||+-+.+++..... .||+.||+|.+
T Consensus 396 l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsS 473 (678)
T KOG0193|consen 396 LGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSS 473 (678)
T ss_pred ccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCch
Confidence 35679999999999999976 5799999877544 44789999999999999999999999987766 99999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
|..+++. ....|+....+.++.|++.|+.|||.++ |+|+|+|..|||+.++++|||+|||++............
T Consensus 474 LY~hlHv---~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~ 547 (678)
T KOG0193|consen 474 LYTHLHV---QETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQL 547 (678)
T ss_pred hhhhccc---hhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeecccccc
Confidence 9999976 4578999999999999999999999999 999999999999999999999999999765554443334
Q ss_pred eeccccccccCCccccC---CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 159 TRVMGTYGYCAPEYAMS---GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
....|...|+|||++.. .+|++++||||||+++|||++|..||. ....+..+....+.+.. .+..
T Consensus 548 ~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys--i~~~dqIifmVGrG~l~-----pd~s----- 615 (678)
T KOG0193|consen 548 EQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS--IQNRDQIIFMVGRGYLM-----PDLS----- 615 (678)
T ss_pred CCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC--CCChhheEEEecccccC-----ccch-----
Confidence 44567889999998863 579999999999999999999999997 22112111111111111 0111
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCCCCCCC
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSRNA 287 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~~~~~~~~ 287 (311)
...-.++.+|.+|+..||..++++||.+.+|+..|+.+... .++..+++
T Consensus 616 -~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~--~pki~RS~ 664 (678)
T KOG0193|consen 616 -KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS--LPKINRSA 664 (678)
T ss_pred -hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc--ccccccCc
Confidence 11235778999999999999999999999999999888775 44444433
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=322.17 Aligned_cols=258 Identities=31% Similarity=0.435 Sum_probs=218.4
Q ss_pred eeeeeeceeccEEEEEEC-------CeEEEEEEeccCCcc-chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWLC-------DQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~-------~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
...+|.|+||+||++... ...||||.++..... ..++|.+|++++..++||||++++++|..++..++|+||
T Consensus 491 ~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEY 570 (774)
T KOG1026|consen 491 KEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEY 570 (774)
T ss_pred hhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEe
Confidence 357999999999999992 478999999866554 668999999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcccCCC----------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeec
Q 021526 74 MPMGSLEDHLYDLEPD----------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 143 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~----------~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df 143 (311)
++.|+|.++|...... ...+...+.+.++.|||.|+.||-++. +|||||..+|+||.++..|||+||
T Consensus 571 m~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VKIsDf 647 (774)
T KOG1026|consen 571 MDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVKISDF 647 (774)
T ss_pred cccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEEeccc
Confidence 9999999999764321 233888999999999999999999998 999999999999999999999999
Q ss_pred CCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhc
Q 021526 144 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKD 222 (311)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 222 (311)
|+++.....++........-+.+||+||-+..++|+.++||||+|+++||+++ |..||.....
T Consensus 648 GLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn---------------- 711 (774)
T KOG1026|consen 648 GLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN---------------- 711 (774)
T ss_pred ccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch----------------
Confidence 99997666666666555566889999999999999999999999999999988 6667753322
Q ss_pred ccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 021526 223 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 279 (311)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~ 279 (311)
.+.+..+-...+ -..|..|+.++.+|+..||+.+|++||++.||-..|+......+
T Consensus 712 ~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 712 QEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred HHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 122222222222 45678899999999999999999999999999999998665443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=286.68 Aligned_cols=258 Identities=23% Similarity=0.250 Sum_probs=200.0
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccC--CccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
|-++|.|+||.|++-+. .|+-||||.|-.. ++...+-..+|+.+|++++|+|++.++++|.....+++|+|||+.
T Consensus 7 LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh- 85 (396)
T KOG0593|consen 7 LGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH- 85 (396)
T ss_pred hhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-
Confidence 45789999999999988 7999999998533 233445688999999999999999999999999999999999987
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
++.+.+.. ....++.+.+..+++|++.|+.|+|+++ ++||||||+|||++.+|.+||||||.++..... ...
T Consensus 86 TvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p--gd~ 157 (396)
T KOG0593|consen 86 TVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP--GDN 157 (396)
T ss_pred HHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC--cch
Confidence 55555543 5678999999999999999999999999 999999999999999999999999999876532 222
Q ss_pred eeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCccccccchh--------cchhhhhcccchhh
Q 021526 158 STRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS--------WSRPFLKDQKKFVH 228 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~ 228 (311)
...-.-|.+|.|||++.+ ..|....||||+||++.||++|.+.|...+.......+. .-...+....-+.-
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 333456889999999988 689999999999999999999999886554322211111 00111111111111
Q ss_pred hcCccC------CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 229 LVDPLL------HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 229 ~~~~~~------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
+.-|.. ..+| +..+..+.+++..||..||++|++-++++.
T Consensus 238 v~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111111 1122 234567899999999999999999999986
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=307.23 Aligned_cols=241 Identities=28% Similarity=0.305 Sum_probs=205.7
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
+..+|.|+||.||+|+- ..+.||+|.+.+... ++...+.+|+++++.++||||+.++++|++..++|+|+||+.|
T Consensus 7 ~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g- 85 (808)
T KOG0597|consen 7 YEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG- 85 (808)
T ss_pred HHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-
Confidence 45689999999999999 789999999876543 3446799999999999999999999999999999999999977
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|..++ .+.+.++++.+..++.+++.||.|||+.+ |.|+|+||.||++.+.+.+|++|||+++-.. ....+
T Consensus 86 ~L~~il----~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~--~~t~v 156 (808)
T KOG0597|consen 86 DLFTIL----EQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMS--TNTSV 156 (808)
T ss_pred hHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcc--cCcee
Confidence 999999 56889999999999999999999999999 9999999999999999999999999998643 23445
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCC
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 237 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
...+.||+.|+|||+..+.+|+..+|+|||||++||+++|++||.... +.+..+.+..++ -.
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~d~------------v~ 218 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILKDP------------VK 218 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhcCC------------CC
Confidence 566789999999999999999999999999999999999999995111 111111111111 12
Q ss_pred CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 238 YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.|...+..+..++.-.|+.||..|.+..+++..
T Consensus 219 ~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 219 PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 455778889999999999999999999999873
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=304.07 Aligned_cols=258 Identities=22% Similarity=0.238 Sum_probs=200.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchh-HHHHHHHHHhcCC-CCcccceeEEEEeCC-eeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQ-EFIVEVLMLSLLH-HDNLVTLIGYCTSGD-QRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~-~~~~e~~~l~~l~-h~~i~~~~~~~~~~~-~~~lv~e~~~~ 76 (311)
+..+|.|.||.||.+.. .++.||||.++++-..+.+ .=.+|+..|++++ ||||+++.+++.+.. .+++|||||++
T Consensus 15 i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~ 94 (538)
T KOG0661|consen 15 IRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC 94 (538)
T ss_pred HHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh
Confidence 56899999999999999 8999999998765433332 3457999999999 999999999987777 99999999966
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
+|.+.+.. ++..|++..+..|+.||++||+++|.+| +.|||+||+|||+.....+||+|||+++..... .
T Consensus 95 -NLYqLmK~---R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk---p 164 (538)
T KOG0661|consen 95 -NLYQLMKD---RNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRSK---P 164 (538)
T ss_pred -hHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccccC---C
Confidence 99999976 4789999999999999999999999999 999999999999999999999999999854332 2
Q ss_pred eeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcc-----hhhhhcccchhhhc
Q 021526 157 VSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS-----RPFLKDQKKFVHLV 230 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ 230 (311)
....-..|.+|.|||++.. ..|+.+.|+||+||+++|+++-++.|.+.++.+....+.-+ ...+....++...+
T Consensus 165 PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~m 244 (538)
T KOG0661|consen 165 PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAM 244 (538)
T ss_pred CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHh
Confidence 2233456889999998764 57899999999999999999999998765542221111100 00011011111111
Q ss_pred C--------ccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 231 D--------PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 231 ~--------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
+ ..+..-.+ .++.+..++|.+|+.+||.+|||+.++++.
T Consensus 245 nf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 245 NFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred ccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1 11111122 378889999999999999999999999985
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=300.99 Aligned_cols=240 Identities=27% Similarity=0.275 Sum_probs=196.5
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
.++|+|+||.||++.. +++.||+|++.... ......+.+|+++++.++||||+++++++..+...++||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999998 78999999987542 223356778999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|.+++. ....+++..+..++.||+.||+|||+.| ++|+||||+||+++.++.+||+|||++..... ....
T Consensus 81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~ 151 (323)
T cd05571 81 ELFFHLS----RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGAT 151 (323)
T ss_pred cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCc
Confidence 9999984 3467899999999999999999999999 99999999999999999999999999864211 1112
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCC
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 237 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
.....|+..|+|||++.+..++.++|+|||||++|+|++|..||...+.... ..... .. ...
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~------~~~~~----------~~--~~~ 213 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FELIL----------ME--EIR 213 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH------HHHHH----------cC--CCC
Confidence 2335689999999999998999999999999999999999999963221100 00000 00 112
Q ss_pred CcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 021526 238 YPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 269 (311)
Q Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~l~~ 269 (311)
++...+..+.++|.+||+.||++|| ++.++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 3445677899999999999999999 7999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=291.62 Aligned_cols=247 Identities=25% Similarity=0.310 Sum_probs=198.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+..+|.|+||.||++.. +++.||+|.+..... .....+.+|+.+++.++|++|+++++++.++...+++|||+.+
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05631 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCC
Confidence 56899999999999998 789999999865432 2234678899999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. .....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++...... .
T Consensus 85 g~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~---~ 156 (285)
T cd05631 85 GDLKFHIYN--MGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG---E 156 (285)
T ss_pred CcHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC---C
Confidence 999988854 23346899999999999999999999999 999999999999999999999999998753211 1
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......|+..|+|||++.+..++.++||||||+++|+|++|..||.......... .....+ .....
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~-------------~~~~~~-~~~~~ 222 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE-------------EVDRRV-KEDQE 222 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH-------------HHHHHh-hcccc
Confidence 1223458899999999999999999999999999999999999997443211100 000000 00111
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVVA 270 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs-----~~~l~~~ 270 (311)
.++...+..+.+|+.+||+.||++||+ ++++++.
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 234456778999999999999999997 7888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=272.67 Aligned_cols=259 Identities=23% Similarity=0.270 Sum_probs=203.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc--chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
+..+|.|.||.||++.. +|+.||||.+...... -.....+|+..|+.++|+||+.++++|.+.+.+.+|+||++.
T Consensus 7 ~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t- 85 (318)
T KOG0659|consen 7 LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT- 85 (318)
T ss_pred hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-
Confidence 46799999999999999 8999999998765433 235788999999999999999999999999999999999965
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|...+.+ ....+....+..++.++++|++|+|++. |+||||||.|+|++.+|.+||+|||+++.........
T Consensus 86 dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~- 158 (318)
T KOG0659|consen 86 DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ- 158 (318)
T ss_pred cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCccc-
Confidence 89999965 6678899999999999999999999999 9999999999999999999999999998754433332
Q ss_pred eeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCcccc----------ccchhcchhh-hhcccc
Q 021526 158 STRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE----------QNLVSWSRPF-LKDQKK 225 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~----------~~~~~~~~~~-~~~~~~ 225 (311)
.....|.+|.|||++.+. .|+...|+||.||++.||+-|.+.|.+.+.-+. ....+|..-. +.+=..
T Consensus 159 -~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 159 -THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred -ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 223678999999988875 789999999999999999998887755442111 1111121100 011111
Q ss_pred hhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 226 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
+.....+.+..-+ ..++....+++.+||..||.+|+++.++++.
T Consensus 238 ~~~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 238 IQQFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HhcCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1122222222222 3456677999999999999999999999875
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=274.02 Aligned_cols=258 Identities=26% Similarity=0.297 Sum_probs=208.7
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEe-----CCeeEEEEecCC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS-----GDQRLLVYEYMP 75 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~ 75 (311)
.++|.|+|.-|+.+.. +++.+|+|++.....++.+..++|++..++++|||+++++++... ....|++++|+.
T Consensus 27 ~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~ 106 (302)
T KOG2345|consen 27 RLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYK 106 (302)
T ss_pred eeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhc
Confidence 5799999999999997 899999999988887888899999999999999999999887533 335899999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
.|+|.+.++.....+..+++..++.++.++++||++||+.. ++++|+||||.||++.+.+..+|.|||.++........
T Consensus 107 ~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~ 185 (302)
T KOG2345|consen 107 RGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEG 185 (302)
T ss_pred cccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccccceEeec
Confidence 99999999988878889999999999999999999999984 56999999999999999999999999998753322111
Q ss_pred cee-------eeccccccccCCccccC---CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccc
Q 021526 156 HVS-------TRVMGTYGYCAPEYAMS---GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 225 (311)
Q Consensus 156 ~~~-------~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
... .....+..|.|||++.- ...+.++|||||||++|.|+.|..||+.--+.+..--..
T Consensus 186 ~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA----------- 254 (302)
T KOG2345|consen 186 SRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA----------- 254 (302)
T ss_pred hHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe-----------
Confidence 110 11346788999999874 467899999999999999999999997433322211000
Q ss_pred hhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 021526 226 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 275 (311)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~ 275 (311)
..++.....-...+++.+.++|.+||+.||.+||++.+++..++.+.
T Consensus 255 ---v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 255 ---VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ---eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 01111111112236888999999999999999999999999998875
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=296.58 Aligned_cols=239 Identities=25% Similarity=0.267 Sum_probs=196.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
...+|+|+||.||++.. +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.++...+++|||+.+
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 102 (329)
T PTZ00263 23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVG 102 (329)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCC
Confidence 46799999999999999 68999999986542 23446788999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 103 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---- 171 (329)
T PTZ00263 103 GELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR---- 171 (329)
T ss_pred ChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC----
Confidence 999999953 457889999999999999999999999 999999999999999999999999998753221
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
.....|++.|+|||++.+..++.++|+|||||++|+|++|..||...... ... ..+.... .
T Consensus 172 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~----------~~i~~~~--~ 232 (329)
T PTZ00263 172 -TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------RIY----------EKILAGR--L 232 (329)
T ss_pred -cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------HHH----------HHHhcCC--c
Confidence 12346899999999999888999999999999999999999999532210 000 0111111 1
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVVA 270 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs-----~~~l~~~ 270 (311)
.++...+..+.++|.+||+.||.+||+ +++++..
T Consensus 233 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 223345667899999999999999986 6887754
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=292.48 Aligned_cols=248 Identities=31% Similarity=0.467 Sum_probs=194.9
Q ss_pred eeeeeeceeccEEEEEEC------CeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWLC------DQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~------~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
...+|.|.||.|+.|... +..|+||.+..... ...+.+.+|++.++.++||||+++++++......++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999999999999997 78999999965432 34678999999999999999999999999888899999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
.+++|.+++... ....+++..++.++.|++.||+|||+++ ++|++|+++||++++++.+||+|||+.........
T Consensus 84 ~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 84 PGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccc--cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 999999999762 3577999999999999999999999999 99999999999999999999999999876422222
Q ss_pred cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 155 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
............|+|||.+....++.++||||||+++|||++ |..||...... .+.+.+...
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~-----------------~~~~~~~~~ 221 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE-----------------EIIEKLKQG 221 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH-----------------HHHHHHHTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc-----------------ccccccccc
Confidence 223333456778999999988889999999999999999999 67887522111 011111111
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 271 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L 271 (311)
.+...+..++..+.+++.+||..+|++||++.++++.|
T Consensus 222 ~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 222 QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11223445677899999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=310.17 Aligned_cols=248 Identities=21% Similarity=0.192 Sum_probs=201.2
Q ss_pred eeeeeeceeccEEEEEE--C-CeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--C-DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
..++|+|++|.||.+.. . ++.|++|.+..........+.+|+++++.++||||+++++++..++..++||||+++++
T Consensus 72 ~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~ 151 (478)
T PTZ00267 72 TTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGD 151 (478)
T ss_pred EEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCC
Confidence 46789999999999988 3 67899998765555555678889999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
|.+++.........+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++............
T Consensus 152 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~ 228 (478)
T PTZ00267 152 LNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA 228 (478)
T ss_pred HHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccc
Confidence 99988654445567899999999999999999999999 999999999999999999999999998754332222223
Q ss_pred eeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCC
Q 021526 159 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRY 238 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
....|++.|+|||++.+..++.++|||||||++|+|++|..||...... ..... ..... ....
T Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~~~----------~~~~~-~~~~ 291 (478)
T PTZ00267 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIMQQ----------VLYGK-YDPF 291 (478)
T ss_pred cccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH----------HHhCC-CCCC
Confidence 3456899999999999889999999999999999999999998632210 00000 00000 0112
Q ss_pred cHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 239 PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 239 ~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
+..++..+.++|.+||..+|++||++.+++.
T Consensus 292 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 3345678999999999999999999999875
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=298.86 Aligned_cols=245 Identities=29% Similarity=0.315 Sum_probs=208.7
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc--chhHHHHHHHHHhcCCCCcccceeEEEEeCCe-eEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ-RLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~ 76 (311)
++.+|+|+||.++.+.. +++.+++|.+...... ..+...+|..++++++||||+.+++.|..++. ++|+|+||+|
T Consensus 9 ~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eG 88 (426)
T KOG0589|consen 9 LRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEG 88 (426)
T ss_pred hhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCC
Confidence 46789999999998888 7899999998766533 33578899999999999999999999988888 9999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
|++.+.+.. +.+..++++.++.|+.|++.|+.|||++. |+|||||+.|||++.++.|+|+|||+++...... .
T Consensus 89 g~l~~~i~~--~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~--~ 161 (426)
T KOG0589|consen 89 GDLAQLIKE--QKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED--S 161 (426)
T ss_pred CCHHHHHHH--HhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch--h
Confidence 999999977 44788999999999999999999999988 9999999999999999999999999998765443 2
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......||+.|++||++.+.+|..++|+|||||++|||++-+++|...+- . .+..-+......
T Consensus 162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m------~-----------~Li~ki~~~~~~ 224 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM------S-----------ELILKINRGLYS 224 (426)
T ss_pred hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch------H-----------HHHHHHhhccCC
Confidence 33456799999999999999999999999999999999999999963221 1 111111111223
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
..|..++.++..+|..||..+|..||++.+++..
T Consensus 225 Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 4566788999999999999999999999999986
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=294.61 Aligned_cols=241 Identities=25% Similarity=0.272 Sum_probs=195.3
Q ss_pred eeeeeeceeccEEEEEE-----CCeEEEEEEeccCC----ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL-----CDQLVAIKQLNHEG----LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-----~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 72 (311)
++.+|+|+||.||.++. .++.||+|.+.... ......+.+|+++++.++||||+++++++..+...+++||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 46899999999999986 57899999986532 2233567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCC
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~ 152 (311)
|+.+++|.+++. ..+.+.+..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 81 YLSGGELFMHLE----REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 999999999984 3456788889999999999999999999 999999999999999999999999998632111
Q ss_pred CCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCc
Q 021526 153 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 232 (311)
Q Consensus 153 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
........|+..|+|||++.+..++.++||||||+++|+|++|..||....... ....+...
T Consensus 154 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~----------------~~~~~~~~ 215 (323)
T cd05584 154 --GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK----------------TIDKILKG 215 (323)
T ss_pred --CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH----------------HHHHHHcC
Confidence 112233468999999999988888999999999999999999999996332110 00011111
Q ss_pred cCCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 021526 233 LLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 269 (311)
Q Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~l~~ 269 (311)
. ...+...+..+.++|.+||+.+|++|| +++++++
T Consensus 216 ~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 216 K--LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred C--CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 1 123445567799999999999999999 8888877
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=305.23 Aligned_cols=236 Identities=28% Similarity=0.387 Sum_probs=201.5
Q ss_pred CeeeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHHHHHhcCC-CCcccceeEEEEeCCeeEEEEecC
Q 021526 1 MLCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
++.+||+|+||+|+.+.. +++.+|||.+++... ++.+..+.|..++...+ ||+++.++..|.+.+++|+||||+
T Consensus 372 ~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~ 451 (694)
T KOG0694|consen 372 LLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYV 451 (694)
T ss_pred EEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEec
Confidence 478999999999999999 789999999988743 34567888988887775 999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
.||++.... +...|++.++..+++.|+.||.|||++| |+|||||.+|||+|.+|.+||+|||++.... ..
T Consensus 452 ~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m--~~ 521 (694)
T KOG0694|consen 452 AGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGM--GQ 521 (694)
T ss_pred CCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccC--CC
Confidence 999943333 5688999999999999999999999999 9999999999999999999999999998532 23
Q ss_pred cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccC
Q 021526 155 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
.....+.+||+.|+|||++.+..|+.+.|.||||++||+|+.|..||...+..+. +..++..-
T Consensus 522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~----------------FdsI~~d~- 584 (694)
T KOG0694|consen 522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV----------------FDSIVNDE- 584 (694)
T ss_pred CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH----------------HHHHhcCC-
Confidence 4466789999999999999999999999999999999999999999975543221 11111111
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCCH
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRPLI 264 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~ 264 (311)
-.||..++.+..++++++|..+|++|--.
T Consensus 585 -~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 -VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 14788899999999999999999999744
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=291.86 Aligned_cols=239 Identities=25% Similarity=0.332 Sum_probs=204.0
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCccchh---HHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQ---EFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~---~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
..||.|.||+|.+++. .|+.||||.+.+...++.+ .+.+|++++..|+||||+.++.+|++.+...+||||..+|
T Consensus 59 etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~G 138 (668)
T KOG0611|consen 59 ETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGG 138 (668)
T ss_pred HHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCc
Confidence 5689999999999998 8999999999877655554 6789999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
.|.+|+ ...+.+++..+..++.||++|+.|+|.++ ++|+|+|.+|||+|.++++||+|||++..+. ....
T Consensus 139 eLYDYi----Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~---~~kf 208 (668)
T KOG0611|consen 139 ELYDYI----SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA---DKKF 208 (668)
T ss_pred cHHHHH----HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc---cccH
Confidence 999999 46788999999999999999999999999 9999999999999999999999999997542 2334
Q ss_pred eeeccccccccCCccccCCCCC-ccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 158 STRVMGTYGYCAPEYAMSGKLT-LKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
-.+.+|.+.|.+||+..+.+|. +..|-||||+++|-|+.|..||+..+. ..++...-++
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh--------------------k~lvrQIs~G 268 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH--------------------KRLVRQISRG 268 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH--------------------HHHHHHhhcc
Confidence 4568899999999999998885 899999999999999999999984431 1111111111
Q ss_pred C-CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 021526 237 R-YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 271 (311)
Q Consensus 237 ~-~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L 271 (311)
. ..+.-+....-||++||-+||++|.|+++|....
T Consensus 269 aYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 269 AYREPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred cccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1 1234456678899999999999999999998864
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=296.87 Aligned_cols=238 Identities=25% Similarity=0.258 Sum_probs=193.0
Q ss_pred eeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 5 YLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 5 ~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
+|.|+||.||++.. +++.||+|.+.... ......+.+|+++++.++||||+++++++.++...+++|||+.+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 58999999999999 68899999986532 23345678899999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
.+++.. ...+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++...... .....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~ 151 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTN 151 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccC--CCccc
Confidence 999953 456899999999999999999999999 999999999999999999999999998642111 11223
Q ss_pred eccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 160 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
...|+..|+|||++.+..++.++|+||||+++|+|++|..||...... ...... ... ...++
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~~----------~~~--~~~~~ 213 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRKI----------LQE--PLRFP 213 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHHH----------HcC--CCCCC
Confidence 356899999999999989999999999999999999999999632211 001011 111 11234
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPL---INDIVV 269 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs---~~~l~~ 269 (311)
...+..+.+++.+||..||++||+ +.++++
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 456778999999999999999985 555554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=320.55 Aligned_cols=260 Identities=28% Similarity=0.340 Sum_probs=215.0
Q ss_pred CeeeeeeceeccEEEEEE---CC----eEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEe
Q 021526 1 MLCCYLSCKFYNVGLVWL---CD----QLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 72 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~---~~----~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 72 (311)
|...+|+|+||.||.|.. .+ ..||+|.+.... .+...+|.+|+.+++.++||||+++++++.+....++++|
T Consensus 696 l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~le 775 (1025)
T KOG1095|consen 696 LLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLE 775 (1025)
T ss_pred eeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEeh
Confidence 457899999999999999 23 359999987553 4455789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcccCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccC
Q 021526 73 YMPMGSLEDHLYDLEP---DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 149 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~---~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~ 149 (311)
||.+|+|..||++.+. +...+....++.++.+||+|+.||+++. ++||||..+|+|++....||++|||+++..
T Consensus 776 yM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlArDi 852 (1025)
T KOG1095|consen 776 YMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLARDI 852 (1025)
T ss_pred hcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchhHhh
Confidence 9999999999987432 2567999999999999999999999999 999999999999999999999999999854
Q ss_pred CCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhh
Q 021526 150 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 228 (311)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
.............-...|||||.+....++.|+||||||+++||+++ |..||.... +..+..
T Consensus 853 y~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~-----------------n~~v~~ 915 (1025)
T KOG1095|consen 853 YDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS-----------------NFEVLL 915 (1025)
T ss_pred hhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc-----------------hHHHHH
Confidence 34333333333344678999999999999999999999999999999 667885222 111122
Q ss_pred hcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCC
Q 021526 229 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 280 (311)
Q Consensus 229 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~ 280 (311)
.....-+-..|..|+..+.+++.+||+.+|++||++..|++.+.++.....+
T Consensus 916 ~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 916 DVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred HHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 1112224566788999999999999999999999999999999888774443
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=288.51 Aligned_cols=253 Identities=30% Similarity=0.419 Sum_probs=201.8
Q ss_pred eeeeeeceeccEEEEEEC--C-----eEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWLC--D-----QLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~--~-----~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
++.+|.|++|.||.+... + ..|++|.+..... .....+.+|++.+..++||||+++++++..+...+++|||
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~ 89 (283)
T cd05048 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEY 89 (283)
T ss_pred hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEec
Confidence 578999999999999872 2 5799998864432 3345788999999999999999999999998899999999
Q ss_pred CCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEe
Q 021526 74 MPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 141 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~ 141 (311)
+++++|.+++..... ....+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~L~ 166 (283)
T cd05048 90 LAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKIS 166 (283)
T ss_pred CCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCcEEEC
Confidence 999999999965321 1156888999999999999999999999 9999999999999999999999
Q ss_pred ecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhh
Q 021526 142 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFL 220 (311)
Q Consensus 142 Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 220 (311)
|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||.......
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~------------ 234 (283)
T cd05048 167 DFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE------------ 234 (283)
T ss_pred CCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH------------
Confidence 9999875332222222233445778999999888889999999999999999998 988986322110
Q ss_pred hcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 021526 221 KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274 (311)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l 274 (311)
....+........+..++..+.+++.+||+.+|.+||++.+|++.|+.+
T Consensus 235 -----~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 235 -----VIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred -----HHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 0011111111123456778899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=283.40 Aligned_cols=246 Identities=24% Similarity=0.311 Sum_probs=196.1
Q ss_pred eeeeceeccEEEEEE--CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 4 CYLSCKFYNVGLVWL--CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
.+|+|+||.||.+.. +++.||+|.+.... ......+.+|+++++.++||||+++++++..+...+++|||+.+++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 589999999999998 78999999876443 233467899999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++.. ....+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||.+..............
T Consensus 82 ~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 82 TFLRT---EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 99954 3456889999999999999999999999 99999999999999999999999999864322111111111
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
...+..|+|||.+.+..++.++|+||||+++|+|++ |..||....... ....+........+
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-----------------~~~~~~~~~~~~~~ 218 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-----------------TREAIEQGVRLPCP 218 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-----------------HHHHHHcCCCCCCc
Confidence 123456999999988889999999999999999997 888885322110 01111111112233
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 272 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~ 272 (311)
..++..+.+++.+||+.+|++||++.++++.|+
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 455678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=292.84 Aligned_cols=240 Identities=26% Similarity=0.282 Sum_probs=196.0
Q ss_pred eeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 4 CYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
.+|+|+||.||.+.. +++.||+|++.... ......+.+|+.+++.++||||+++++++..+...++||||+.+++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 689999999999998 78999999987542 2334577889999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
|.+++. ....+++..+..++.||+.||+|||+++ ++|+||||+|||++.++.+||+|||++..... .....
T Consensus 82 L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~ 152 (328)
T cd05593 82 LFFHLS----RERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATM 152 (328)
T ss_pred HHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCC--ccccc
Confidence 998884 3457899999999999999999999999 99999999999999999999999999864211 11122
Q ss_pred eeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCC
Q 021526 159 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRY 238 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
....|+..|+|||++.+..++.++|+|||||++|+|++|..||........ .... .. ....+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~------~~~~----------~~--~~~~~ 214 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FELI----------LM--EDIKF 214 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH------HHHh----------cc--CCccC
Confidence 334689999999999888899999999999999999999999963221100 0000 00 01123
Q ss_pred cHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 021526 239 PRRCLNYAVAVTAMCLNEEANFRP-----LINDIVVA 270 (311)
Q Consensus 239 ~~~~~~~l~~li~~~l~~~p~~RP-----s~~~l~~~ 270 (311)
+...+.++.++|.+||+.||++|| ++.++++.
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 445677899999999999999997 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=293.38 Aligned_cols=241 Identities=27% Similarity=0.328 Sum_probs=192.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHH---hcCCCCcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLML---SLLHHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
+..+|+|++|.||.+.. +++.||||.+.+.. ....+.+.+|..++ +.++||||+++++++.++...++||||
T Consensus 4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~ 83 (324)
T cd05589 4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEY 83 (324)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcC
Confidence 57899999999999998 68999999987542 22334566666554 567899999999999999999999999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 153 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~ 153 (311)
+.+++|..++. ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 84 ~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~- 154 (324)
T cd05589 84 AAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF- 154 (324)
T ss_pred CCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC-
Confidence 99999998883 357899999999999999999999999 999999999999999999999999987642211
Q ss_pred CcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 154 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 154 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
........|+..|+|||.+.+..++.++|+||||+++|+|++|..||....... .... +...
T Consensus 155 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~------~~~~----------i~~~- 216 (324)
T cd05589 155 -GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE------VFDS----------IVND- 216 (324)
T ss_pred -CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH------HHHH----------HHhC-
Confidence 112233568899999999998899999999999999999999999996432110 0000 1100
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVVA 270 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~l~~~ 270 (311)
...++...+..+.++|.+||+.||.+|| ++.++++.
T Consensus 217 -~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 217 -EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred -CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 0123445577789999999999999999 57777663
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=295.35 Aligned_cols=257 Identities=21% Similarity=0.238 Sum_probs=205.3
Q ss_pred CeeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCC
Q 021526 1 MLCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
+|-.+|+|+||.|+.+.- .|+.+|+|++.+.. ......+..|-.+|...++|+|++++..|.+...+||||||++
T Consensus 145 ~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylP 224 (550)
T KOG0605|consen 145 LLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLP 224 (550)
T ss_pred hheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecC
Confidence 467899999999999999 89999999998764 3344678889999999999999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCC----
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV---- 151 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~---- 151 (311)
||++..+| .....+++..+..++.+++.|+..+|+.| ++|+||||+|+|||..|.+||.|||++.....
T Consensus 225 GGD~mTLL----~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 225 GGDMMTLL----MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred CccHHHHH----HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 99999999 46789999999999999999999999999 99999999999999999999999999852111
Q ss_pred ------------------CCCcc---ee--------------------eeccccccccCCccccCCCCCccccchhHHHH
Q 021526 152 ------------------GDNTH---VS--------------------TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVV 190 (311)
Q Consensus 152 ------------------~~~~~---~~--------------------~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~ 190 (311)
..... .. ....||+.|+|||++.+..|+..+|.|||||+
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI 377 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence 00000 00 02368999999999999999999999999999
Q ss_pred HHHHHhCCCCccccCcccc-ccchhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCC---HHH
Q 021526 191 LLELITGRKAMDLSKGQGE-QNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL---IND 266 (311)
Q Consensus 191 l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs---~~~ 266 (311)
+|||+.|.+||........ ..+..|...+. ..-...++.+..+||.+|+. ||.+|-- ++|
T Consensus 378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~l~---------------fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~E 441 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQETYRKIVNWRETLK---------------FPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEE 441 (550)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc---------------CCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHH
Confidence 9999999999975543221 12222221111 11112345789999999999 9999964 444
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCC
Q 021526 267 IVVALDYLVSQRDSHPVSRNAGARG 291 (311)
Q Consensus 267 l~~~L~~l~~~~~~~~~~~~~~~~~ 291 (311)
| +.++..+..+|.+
T Consensus 442 I-----------K~HPfF~~v~W~~ 455 (550)
T KOG0605|consen 442 I-----------KKHPFFKGVDWDH 455 (550)
T ss_pred H-----------hcCCccccCCcch
Confidence 4 3456666665544
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=300.42 Aligned_cols=255 Identities=26% Similarity=0.352 Sum_probs=199.0
Q ss_pred eeeeeeceeccEEEEEE-------CCeEEEEEEeccCC-ccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL-------CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 72 (311)
...+|+|+||.||+++. ++..||+|.+.... ......+.+|+++++.+ +|+||+++++++..+...+++||
T Consensus 43 ~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~e 122 (374)
T cd05106 43 GKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITE 122 (374)
T ss_pred hheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHh
Confidence 46799999999999885 23589999986543 23345688999999999 89999999999999999999999
Q ss_pred cCCCCCHHHHhcccCC----------------------------------------------------------------
Q 021526 73 YMPMGSLEDHLYDLEP---------------------------------------------------------------- 88 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~---------------------------------------------------------------- 88 (311)
|+.+++|.+++.....
T Consensus 123 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (374)
T cd05106 123 YCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEED 202 (374)
T ss_pred hccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhc
Confidence 9999999998854210
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeeecccccc
Q 021526 89 --DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 166 (311)
Q Consensus 89 --~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~ 166 (311)
....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++................++..
T Consensus 203 ~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~ 279 (374)
T cd05106 203 TEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK 279 (374)
T ss_pred cCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccc
Confidence 1134788889999999999999999999 99999999999999999999999999865332222112222334567
Q ss_pred ccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCcHHHHHH
Q 021526 167 YCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNY 245 (311)
Q Consensus 167 ~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
|+|||++.+..++.++||||||+++|+|++ |..||....... ..............+...+.+
T Consensus 280 y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~ 343 (374)
T cd05106 280 WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS----------------KFYKMVKRGYQMSRPDFAPPE 343 (374)
T ss_pred eeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH----------------HHHHHHHcccCccCCCCCCHH
Confidence 999999988889999999999999999997 999986322110 001111111111122334678
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 021526 246 AVAVTAMCLNEEANFRPLINDIVVALDYLV 275 (311)
Q Consensus 246 l~~li~~~l~~~p~~RPs~~~l~~~L~~l~ 275 (311)
+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 344 l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 344 IYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=291.20 Aligned_cols=258 Identities=25% Similarity=0.371 Sum_probs=196.4
Q ss_pred eeeeeeceeccEEEEEE------------------CCeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL------------------CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCT 62 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~------------------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 62 (311)
...+|+|+||.||.+.. .+..||+|.+..... ....++.+|++++..++||||+++++++.
T Consensus 10 ~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 89 (304)
T cd05096 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCV 89 (304)
T ss_pred eeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe
Confidence 35799999999999975 234799999875432 23457889999999999999999999999
Q ss_pred eCCeeEEEEecCCCCCHHHHhcccCC---------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCC
Q 021526 63 SGDQRLLVYEYMPMGSLEDHLYDLEP---------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 127 (311)
Q Consensus 63 ~~~~~~lv~e~~~~~~L~~~l~~~~~---------------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p 127 (311)
++...+++|||+.+++|.+++..... ....+++..++.++.|++.||+|||+.+ ++|+||||
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH~dlkp 166 (304)
T cd05096 90 DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLAT 166 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccccCcch
Confidence 99999999999999999999864321 1235777889999999999999999999 99999999
Q ss_pred CcEEEcCCCceEEeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhC--CCCccccC
Q 021526 128 ANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG--RKAMDLSK 205 (311)
Q Consensus 128 ~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g--~~p~~~~~ 205 (311)
+||+++.++.+||+|||++................++..|+|||.+.+..++.++|+||||+++|+|+++ ..||....
T Consensus 167 ~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 246 (304)
T cd05096 167 RNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELT 246 (304)
T ss_pred hheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCC
Confidence 9999999999999999998754332222222334457789999998888899999999999999999874 45665322
Q ss_pred ccccccchhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 021526 206 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 272 (311)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~ 272 (311)
.. ........... ..........++.++..+.+++.+||..+|++|||+.+|.+.|+
T Consensus 247 ~~---~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 247 DE---QVIENAGEFFR-------DQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HH---HHHHHHHHHhh-------hccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 11 01111000000 00001111123456778999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=291.53 Aligned_cols=266 Identities=22% Similarity=0.317 Sum_probs=205.6
Q ss_pred eeeeeeceeccEEEEEE--CCe----EEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQ----LVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
+..+|+|+||.||+|.. +++ .||+|.+.... ....+++.+|+.+++.++||||+++++++..+ ..+++++++
T Consensus 12 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~ 90 (316)
T cd05108 12 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM 90 (316)
T ss_pred eeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecC
Confidence 56899999999999986 333 48999986443 23446788999999999999999999998764 578999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
.+++|.+++.. ....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++........
T Consensus 91 ~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 164 (316)
T cd05108 91 PFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164 (316)
T ss_pred CCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccCCCc
Confidence 99999999964 3456888999999999999999999999 99999999999999999999999999975433222
Q ss_pred cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 155 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
.........+..|++||.+.+..++.++|+||||+++|+|++ |..||....... +.......
T Consensus 165 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-----------------~~~~~~~~ 227 (316)
T cd05108 165 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----------------ISSILEKG 227 (316)
T ss_pred ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-----------------HHHHHhCC
Confidence 111122234567999999988899999999999999999997 899986322110 01111111
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCCCCCCCCCCC
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSRNAGARG 291 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~~~~~~~~~~~~ 291 (311)
.....+..++..+.+++.+||..+|.+||++.+++..|..+..........+......
T Consensus 228 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~~~~~~~ 285 (316)
T cd05108 228 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMH 285 (316)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCchheEecCCcccC
Confidence 1112233456679999999999999999999999999999887765544444443333
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=293.55 Aligned_cols=240 Identities=26% Similarity=0.276 Sum_probs=195.3
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
+++|+|+||.||++.. +|+.||+|.+.... ......+.+|+++++.++||||+++++++..+...++||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4689999999999998 78999999987542 223356778999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|..++. ....+++..++.++.|++.||+|||+++ ++|+||||+|||++.++.+||+|||++...... ...
T Consensus 81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~ 151 (323)
T cd05595 81 ELFFHLS----RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GAT 151 (323)
T ss_pred cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCc
Confidence 9998884 3457899999999999999999999999 999999999999999999999999987632111 111
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCC
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 237 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
.....|+..|+|||++.+..++.++|+|||||++|+|++|..||........ . ...... ...
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~----------~~~~~~--~~~ 213 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL------F----------ELILME--EIR 213 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH------H----------HHHhcC--CCC
Confidence 2234588999999999888999999999999999999999999963321100 0 000000 012
Q ss_pred CcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 021526 238 YPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 269 (311)
Q Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~l~~ 269 (311)
++...+..+.++|.+||+.||++|| ++.++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 3445577899999999999999998 8888876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=283.70 Aligned_cols=248 Identities=28% Similarity=0.292 Sum_probs=206.7
Q ss_pred CeeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc---chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCC
Q 021526 1 MLCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
++..||.|++|.||.+.+ .+..+|+|++.++... ...+...|-+||..++||++..+|..|+.+...|++||||.
T Consensus 81 llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCp 160 (459)
T KOG0610|consen 81 LLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCP 160 (459)
T ss_pred HHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCC
Confidence 467899999999999999 4589999999876433 33467779999999999999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCC--
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD-- 153 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~-- 153 (311)
||+|....++ +.++.+++..+..++..++.||+|||-.| |++|||||+||||.++|.|.|.||+++.......
T Consensus 161 GGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 161 GGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred CccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence 9999999977 77889999999999999999999999999 9999999999999999999999999976432100
Q ss_pred -----------------------------C-c----------------------ceeeeccccccccCCccccCCCCCcc
Q 021526 154 -----------------------------N-T----------------------HVSTRVMGTYGYCAPEYAMSGKLTLK 181 (311)
Q Consensus 154 -----------------------------~-~----------------------~~~~~~~~~~~~~aPE~~~~~~~~~~ 181 (311)
. . .......||-.|+|||++.+..-+.+
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsA 315 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSA 315 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCch
Confidence 0 0 00112458899999999999999999
Q ss_pred ccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCC
Q 021526 182 SDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFR 261 (311)
Q Consensus 182 ~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 261 (311)
.|+|+||+++|||+.|..||.+.+. ...+..++...+...-.+..+...++||++.|..||++|
T Consensus 316 VDWWtfGIflYEmLyG~TPFKG~~~----------------~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kR 379 (459)
T KOG0610|consen 316 VDWWTFGIFLYEMLYGTTPFKGSNN----------------KETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKR 379 (459)
T ss_pred hhHHHHHHHHHHHHhCCCCcCCCCc----------------hhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhh
Confidence 9999999999999999999975553 233333443333333334667889999999999999999
Q ss_pred CC----HHHHHH
Q 021526 262 PL----INDIVV 269 (311)
Q Consensus 262 Ps----~~~l~~ 269 (311)
-- +.||.+
T Consensus 380 lg~~rGA~eIK~ 391 (459)
T KOG0610|consen 380 LGSKRGAAEIKR 391 (459)
T ss_pred hccccchHHhhc
Confidence 87 888876
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=285.11 Aligned_cols=249 Identities=29% Similarity=0.393 Sum_probs=204.8
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
...+|.|++|.||.+.. +++.+++|.+..........+.+|+++++.++||||+++++++.+....+++|||+++++|.
T Consensus 11 ~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 90 (261)
T cd05148 11 ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLL 90 (261)
T ss_pred hhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHH
Confidence 45789999999999998 78999999987766656778999999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++.+ ..+..+++..++.++.|++.|+.|||+++ ++|+||+|+||++++++.++|+|||.+....... .....
T Consensus 91 ~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~--~~~~~ 163 (261)
T cd05148 91 AFLRS--PEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV--YLSSD 163 (261)
T ss_pred HHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc--ccccC
Confidence 99965 33567899999999999999999999999 9999999999999999999999999986542221 11122
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
..++..|++||...+..++.++|+||||+++|+|++ |..||........ ........+...+
T Consensus 164 ~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~-----------------~~~~~~~~~~~~~ 226 (261)
T cd05148 164 KKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV-----------------YDQITAGYRMPCP 226 (261)
T ss_pred CCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH-----------------HHHHHhCCcCCCC
Confidence 335678999999888889999999999999999998 8889863321100 0000111112234
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l 274 (311)
..++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 227 AKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 55677899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=291.84 Aligned_cols=259 Identities=23% Similarity=0.237 Sum_probs=199.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeC--CeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~ 75 (311)
+..+|+|.||.||+++. .|+.||+|.+.... .....-..+|+.+|++|+||||+++.+...+. ..+|+|+|||+
T Consensus 122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd 201 (560)
T KOG0600|consen 122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD 201 (560)
T ss_pred HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc
Confidence 56799999999999999 89999999987654 33445677899999999999999999987765 68999999997
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
. +|.-++.. ..-.|++..+.-++.||+.||+|+|++| ++|||||..|||||.+|.+||+|||+++.+......
T Consensus 202 h-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~ 274 (560)
T KOG0600|consen 202 H-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA 274 (560)
T ss_pred c-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCCCCc
Confidence 6 78887743 4568999999999999999999999999 999999999999999999999999999865444333
Q ss_pred ceeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCcccccc----------chhcchhhhhc--
Q 021526 156 HVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN----------LVSWSRPFLKD-- 222 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~----------~~~~~~~~~~~-- 222 (311)
. ......|.+|.|||++.+. .|+.+.|+||.||++.||+.|++.|.......... ...|....+..
T Consensus 275 ~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~ 353 (560)
T KOG0600|consen 275 P-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHAT 353 (560)
T ss_pred c-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccc
Confidence 2 3335579999999999875 79999999999999999999999997655321110 01121111000
Q ss_pred ccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 223 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
......-....+... -...+....+|+..+|..||.+|.|+.++++
T Consensus 354 ~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 354 IFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 000000000001111 1234666889999999999999999999886
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=298.80 Aligned_cols=254 Identities=25% Similarity=0.336 Sum_probs=197.6
Q ss_pred eeeeeeceeccEEEEEE-------CCeEEEEEEeccCC-ccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL-------CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 72 (311)
...+|+|+||.||++.. .+..||+|++.... ....+.+.+|+.++..+ +||||+++++++..+...++|||
T Consensus 40 ~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E 119 (375)
T cd05104 40 GKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITE 119 (375)
T ss_pred hheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeeh
Confidence 35789999999999864 35689999986443 23446788999999999 89999999999999999999999
Q ss_pred cCCCCCHHHHhcccCC----------------------------------------------------------------
Q 021526 73 YMPMGSLEDHLYDLEP---------------------------------------------------------------- 88 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~---------------------------------------------------------------- 88 (311)
|+.+|+|.+++.....
T Consensus 120 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (375)
T cd05104 120 YCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDV 199 (375)
T ss_pred hccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceeccccc
Confidence 9999999999864221
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeeec
Q 021526 89 -------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 161 (311)
Q Consensus 89 -------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~~ 161 (311)
....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++...............
T Consensus 200 ~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 276 (375)
T cd05104 200 TSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNA 276 (375)
T ss_pred HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCC
Confidence 1125788889999999999999999999 999999999999999999999999998754332221222223
Q ss_pred cccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCcH
Q 021526 162 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPR 240 (311)
Q Consensus 162 ~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (311)
.++..|+|||.+.+..++.++|+||||+++|+|++ |..||........ .. ..+....+...+.
T Consensus 277 ~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~--~~--------------~~~~~~~~~~~~~ 340 (375)
T cd05104 277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK--FY--------------KMIKEGYRMLSPE 340 (375)
T ss_pred CCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH--HH--------------HHHHhCccCCCCC
Confidence 34567999999998899999999999999999998 8888853321110 00 0111111111123
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 021526 241 RCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274 (311)
Q Consensus 241 ~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l 274 (311)
..+.++.+++.+||+.||++||++.+|++.|++.
T Consensus 341 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 341 CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 3456799999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=293.70 Aligned_cols=239 Identities=27% Similarity=0.294 Sum_probs=196.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
...+|+|+||.||++.. +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.++...+++|||+.+
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 85 (291)
T cd05612 6 IKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPG 85 (291)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCC
Confidence 56899999999999999 58999999986542 23345688999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ...+++..+..++.|++.||+|||++| ++|+||+|+||+++.++.++|+|||++......
T Consensus 86 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---- 154 (291)
T cd05612 86 GELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---- 154 (291)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC----
Confidence 999999953 457889999999999999999999999 999999999999999999999999998743211
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
.....|++.|+|||++.+..++.++||||||+++|+|++|..||....... ....... . ..
T Consensus 155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~------~~~~i~~----------~--~~ 215 (291)
T cd05612 155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG------IYEKILA----------G--KL 215 (291)
T ss_pred -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh----------C--Cc
Confidence 123458899999999988889999999999999999999999996432110 0001100 0 01
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVVA 270 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs-----~~~l~~~ 270 (311)
.++...+..+.++|.+||+.||.+||+ ++++++.
T Consensus 216 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 233445667999999999999999995 8888754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=299.19 Aligned_cols=254 Identities=27% Similarity=0.357 Sum_probs=210.2
Q ss_pred eeeeeceeccEEEEEE---CC--eE-EEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEec
Q 021526 3 CCYLSCKFYNVGLVWL---CD--QL-VAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~---~~--~~-vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
..||.|+||.|+.|.+ ++ .. ||+|....+. .....++++|++++++++||||++++|+...+..+++|||+
T Consensus 163 kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl 242 (474)
T KOG0194|consen 163 KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMEL 242 (474)
T ss_pred ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEe
Confidence 5799999999999999 22 23 8999987532 34557899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 153 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~ 153 (311)
|.||+|.+++.+ .++.++...+..++.+.+.||+|||+++ ++||||..+|+|++.++.+||+|||+++...
T Consensus 243 ~~gGsL~~~L~k---~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~--- 313 (474)
T KOG0194|consen 243 CNGGSLDDYLKK---NKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGS--- 313 (474)
T ss_pred cCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCCc---
Confidence 999999999965 3347999999999999999999999999 9999999999999999999999999987422
Q ss_pred Ccceee-eccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcC
Q 021526 154 NTHVST-RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231 (311)
Q Consensus 154 ~~~~~~-~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
...... ...-+..|+|||.+....++.++||||||+++||+++ |..||...... .....+..
T Consensus 314 ~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~----------------~v~~kI~~ 377 (474)
T KOG0194|consen 314 QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY----------------EVKAKIVK 377 (474)
T ss_pred ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH----------------HHHHHHHh
Confidence 111111 2235779999999999999999999999999999999 67788633321 11112223
Q ss_pred ccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCC
Q 021526 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSH 281 (311)
Q Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~~ 281 (311)
...+...+...+.++..++.+||..+|++||++.++.+.|+.+.......
T Consensus 378 ~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 378 NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 33344456677889999999999999999999999999999998877653
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=307.80 Aligned_cols=260 Identities=23% Similarity=0.225 Sum_probs=207.7
Q ss_pred eeeeeceeccEEEEEE-CC-eEEEEEEeccCCccchhHHHHHHHHHhcCC-CCcccceeEE-EEe------CCeeEEEEe
Q 021526 3 CCYLSCKFYNVGLVWL-CD-QLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGY-CTS------GDQRLLVYE 72 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~-~~-~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~-~~~------~~~~~lv~e 72 (311)
+.|-.|+|+.||.+.. ++ ..+|+|++-..+....+.+.+|+++++.|+ |+||+.+++. ... ...++|.||
T Consensus 43 ~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmE 122 (738)
T KOG1989|consen 43 KVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLME 122 (738)
T ss_pred EEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehh
Confidence 5677899999999999 44 899999877777777789999999999997 9999999983 211 134689999
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCC
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~ 152 (311)
||.|+.|-+++..+.+ ..|.+..+++|+.++++|+++||.. .++|+|||||.+|||++.+|.+||||||.+......
T Consensus 123 yC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~ 199 (738)
T KOG1989|consen 123 YCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILS 199 (738)
T ss_pred hccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccCC
Confidence 9999999999976443 3499999999999999999999999 677999999999999999999999999998642221
Q ss_pred CCc-c------eeeeccccccccCCcccc---CCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhc
Q 021526 153 DNT-H------VSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 222 (311)
Q Consensus 153 ~~~-~------~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 222 (311)
... . ..-...-|+.|++||++. +.++++|+|||||||+||-|+....||+..+
T Consensus 200 ~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg----------------- 262 (738)
T KOG1989|consen 200 PTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG----------------- 262 (738)
T ss_pred CccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-----------------
Confidence 110 0 011234688999999765 6689999999999999999999999997332
Q ss_pred ccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCCCCC
Q 021526 223 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSR 285 (311)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~~~~~~ 285 (311)
-..+++......-.+.++..|.+||+.||+.||.+||++.+++..+-.+...........
T Consensus 263 ---~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~ 322 (738)
T KOG1989|consen 263 ---KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY 322 (738)
T ss_pred ---ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence 112222222222235788999999999999999999999999999988877655444333
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=283.61 Aligned_cols=249 Identities=24% Similarity=0.342 Sum_probs=197.9
Q ss_pred eeeeeeceeccEEEEEE-----CCeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL-----CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
...+|.|+||.||+++. .+..||+|.+..... .....+.+|+..++.++||||+++++++..+...++||||+.
T Consensus 10 ~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 89 (266)
T cd05064 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMS 89 (266)
T ss_pred eeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCC
Confidence 35789999999999986 357999999875532 233578899999999999999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++++|||......... .
T Consensus 90 ~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~-~ 162 (266)
T cd05064 90 NGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA-I 162 (266)
T ss_pred CCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccccc-h
Confidence 9999999964 3457899999999999999999999999 9999999999999999999999999875321111 1
Q ss_pred ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccC
Q 021526 156 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
.......++..|+|||.+.+..++.++|+||||+++|++++ |..||....... ... . . ....
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~---~-~----------~~~~ 225 (266)
T cd05064 163 YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIK---A-V----------EDGF 225 (266)
T ss_pred hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHH---H-H----------HCCC
Confidence 11112234568999999988899999999999999999775 999986432210 000 0 0 0011
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l 274 (311)
....+..++..+.+++.+||+.+|++||++++|.+.|..+
T Consensus 226 ~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1122445677899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=294.61 Aligned_cols=247 Identities=22% Similarity=0.222 Sum_probs=198.5
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+..+|+|+||.||++.. +++.||+|++.... ......+.+|++++..++||||+++++++.++...++||||+.+
T Consensus 6 ~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g 85 (333)
T cd05600 6 LTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPG 85 (333)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCC
Confidence 57899999999999999 68999999987542 23345688899999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++. ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 86 ~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----- 153 (333)
T cd05600 86 GDFRTLLN----NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----- 153 (333)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-----
Confidence 99999994 3457889999999999999999999999 99999999999999999999999999874322
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......|++.|+|||++.+..++.++|||||||++|+|++|..||.......... .. .............
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~------~i----~~~~~~~~~~~~~ 223 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE------NL----KYWKETLQRPVYD 223 (333)
T ss_pred ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHH------HH----HhccccccCCCCC
Confidence 2233568899999999998899999999999999999999999996433211100 00 0000000000000
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
......+.++.+++.+||..+|++||+++++++.
T Consensus 224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0012346779999999999999999999999974
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=285.76 Aligned_cols=251 Identities=29% Similarity=0.399 Sum_probs=200.2
Q ss_pred eeeeeeceeccEEEEEE-C------CeEEEEEEeccCCcc-chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL-C------DQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~------~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
+..+|+|++|.||.+.. . ++.||+|.+...... ..+.+.+|+++++.++||||+++++++..+...+++|||
T Consensus 10 ~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 89 (280)
T cd05049 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEY 89 (280)
T ss_pred HhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEec
Confidence 45789999999999986 2 478999998755443 456899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcccC----------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeec
Q 021526 74 MPMGSLEDHLYDLE----------PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 143 (311)
Q Consensus 74 ~~~~~L~~~l~~~~----------~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df 143 (311)
+.+++|.+++.... .....+++..+..++.|++.++.+||+++ ++|+||+|+||+++.++.++|+||
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~kl~d~ 166 (280)
T cd05049 90 MEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDF 166 (280)
T ss_pred CCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeEEECCc
Confidence 99999999996532 22356888899999999999999999999 999999999999999999999999
Q ss_pred CCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhc
Q 021526 144 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKD 222 (311)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 222 (311)
|++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||........ ..
T Consensus 167 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~---~~-------- 235 (280)
T cd05049 167 GMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV---IE-------- 235 (280)
T ss_pred ccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HH--------
Confidence 99864322222222223345678999999998899999999999999999998 9999853322110 00
Q ss_pred ccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 021526 223 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 272 (311)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~ 272 (311)
..........+...+..+.+++.+||+.||++||++.|+++.|+
T Consensus 236 ------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 236 ------CITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ------HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 00001111122345678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=285.29 Aligned_cols=256 Identities=28% Similarity=0.385 Sum_probs=203.2
Q ss_pred eeeeeeceeccEEEEEE-------CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWL-------CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
...+|.|++|.||.+.. .+..+++|.+........+.+.+|+++++.++||||+++++++..+...+++|||+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (291)
T cd05094 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYM 89 (291)
T ss_pred eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecC
Confidence 35789999999999975 34679999986555555577899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEee
Q 021526 75 PMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 142 (311)
Q Consensus 75 ~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~D 142 (311)
.+++|.+++..... ....+++..++.++.|++.|++|||+++ ++|+||+|+||+++.++.++|+|
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~d 166 (291)
T cd05094 90 KHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGD 166 (291)
T ss_pred CCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEECC
Confidence 99999999965321 2345889999999999999999999999 99999999999999999999999
Q ss_pred cCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhh
Q 021526 143 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLK 221 (311)
Q Consensus 143 f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 221 (311)
||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||....... ... ...
T Consensus 167 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~----~~~ 239 (291)
T cd05094 167 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIE----CIT 239 (291)
T ss_pred CCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHh
Confidence 999864322221122223345678999999988889999999999999999998 999985332110 000 000
Q ss_pred cccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 021526 222 DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 277 (311)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~ 277 (311)
.......+..++..+.+++.+||+.+|++||++.++++.|+++...
T Consensus 240 ----------~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 240 ----------QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred ----------CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 0000011233566799999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=291.81 Aligned_cols=258 Identities=22% Similarity=0.240 Sum_probs=197.5
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
+..+|+|++|.||++.. ++..||+|.+..... .....+.+|+++++.++||||+++++++..+...+++|||+++++
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 89 (331)
T cd06649 10 ISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 89 (331)
T ss_pred EEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCc
Confidence 56899999999999999 688999999875432 334678999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~-~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
|.+++.. ...+++..+..++.|++.||+|||++ + ++|+||+|+||+++.++.++|+|||++...... .
T Consensus 90 L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~ 158 (331)
T cd06649 90 LDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----M 158 (331)
T ss_pred HHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEcCCCChhhEEEcCCCcEEEccCccccccccc----c
Confidence 9999953 45688999999999999999999985 5 999999999999999999999999998643221 1
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhc------------chh-------
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSW------------SRP------- 218 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------------~~~------- 218 (311)
.....++..|+|||++.+..++.++|+|||||++|+|++|..||.......-...... ...
T Consensus 159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (331)
T cd06649 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGR 238 (331)
T ss_pred cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccc
Confidence 2234588899999999988999999999999999999999999964321100000000 000
Q ss_pred -------hhhcccchhhhcCccC----CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 219 -------FLKDQKKFVHLVDPLL----HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 219 -------~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.........+..+... ........+.++.+||.+||+.||++|||++++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000000000 000112356789999999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=280.63 Aligned_cols=248 Identities=25% Similarity=0.333 Sum_probs=199.6
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
..+|.|++|.||++.. .++.|++|.+... ......+.+|++.++.++||||+++++++..+...+++|||+.+++|.
T Consensus 12 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 90 (263)
T cd05052 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 90 (263)
T ss_pred eecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHH
Confidence 5689999999999998 5899999998643 334567889999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++.. .....+++..++.++.|++.+|++||+++ ++|+||+|+||++++++.++|+|||.+........ .....
T Consensus 91 ~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~~~~~ 164 (263)
T cd05052 91 DYLRE--CNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAG 164 (263)
T ss_pred HHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee-eccCC
Confidence 99965 23456899999999999999999999999 99999999999999999999999999875322111 11111
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
..++..|+|||.+.+..++.++|+||||+++|+|++ |..||....... .. ..+........+
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~------~~-----------~~~~~~~~~~~~ 227 (263)
T cd05052 165 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VY-----------ELLEKGYRMERP 227 (263)
T ss_pred CCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HH-----------HHHHCCCCCCCC
Confidence 223567999999888889999999999999999998 888885332110 00 001111112233
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l 274 (311)
..++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 228 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 228 EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 45667899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=289.13 Aligned_cols=247 Identities=26% Similarity=0.322 Sum_probs=195.7
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
.++|+|+||.||.+.. +++.||+|++..... .....+.+|..++..+ +||||+++++++.++...++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3689999999999998 688999999875422 2335677899999888 699999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++. ....+++..+..++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++..... ...
T Consensus 81 g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~ 151 (329)
T cd05588 81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGD 151 (329)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccccc--CCC
Confidence 99998884 3467999999999999999999999999 99999999999999999999999998863211 111
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCcccc--ccchhcchhhhhcccchhhhcCccC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE--QNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
......|+..|+|||++.+..++.++|+||||+++|+|++|..||+....... .....+... .+....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~---------~~~~~~- 221 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ---------VILEKQ- 221 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHH---------HHHcCC-
Confidence 22345689999999999998999999999999999999999999974332211 111111100 011111
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCC------HHHHHH
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRPL------INDIVV 269 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs------~~~l~~ 269 (311)
...|...+..+.+++.+||+.||.+||+ ++++++
T Consensus 222 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 222 -IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1234455677999999999999999997 677765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=279.04 Aligned_cols=249 Identities=26% Similarity=0.350 Sum_probs=199.4
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
...+|.|++|.||++.. +++.||+|.+.... ...+++.+|+++++.++||||+++++++..+...+++||++.+++|.
T Consensus 11 ~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 89 (261)
T cd05068 11 LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLL 89 (261)
T ss_pred EEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHH
Confidence 46799999999999998 67889999986443 34567889999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++... ....+++..+..++.|++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||++......... ....
T Consensus 90 ~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~ 163 (261)
T cd05068 90 EYLQGG--AGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE-AREG 163 (261)
T ss_pred HHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-ccCC
Confidence 999652 2457899999999999999999999999 999999999999999999999999998754321111 1111
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
...+..|+|||...+..++.++|+||||+++++|++ |..||........ . ...........+
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~--------------~~~~~~~~~~~~ 226 (261)
T cd05068 164 AKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV---L--------------QQVDQGYRMPCP 226 (261)
T ss_pred CcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---H--------------HHHHcCCCCCCC
Confidence 122457999999988889999999999999999999 8889853221100 0 000011111223
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l 274 (311)
..++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 227 ~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 227 PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 34567899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=280.81 Aligned_cols=249 Identities=27% Similarity=0.379 Sum_probs=199.5
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
+..+|.|++|.||.+.. +++.|++|.+... ....+.+.+|+.+++.++|+||+++++.+..+...++++|++.+++|.
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 89 (261)
T cd05072 11 VKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLL 89 (261)
T ss_pred eeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHH
Confidence 57899999999999998 6788999987643 334578899999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++.. .....+++..++.++.+++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 90 ~~l~~--~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 163 (261)
T cd05072 90 DFLKS--DEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TAREG 163 (261)
T ss_pred HHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce-eccCC
Confidence 99965 23556888899999999999999999999 99999999999999999999999999875432211 11122
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
..++..|+|||...+..++.++|+||||+++|+|++ |..||....... ... . .. ........
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~---~-~~----------~~~~~~~~ 226 (261)
T cd05072 164 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMS---A-LQ----------RGYRMPRM 226 (261)
T ss_pred CccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHH---H-HH----------cCCCCCCC
Confidence 335668999999888889999999999999999998 888985322110 000 0 00 00011112
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l 274 (311)
..++..+.+++.+||..+|++||+++++.+.|+++
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 227 ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 23566799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=289.47 Aligned_cols=236 Identities=25% Similarity=0.280 Sum_probs=188.1
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHHH-HHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEVL-MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+++|+|+||.||++.. +++.||+|.+..... .....+.+|.. +++.++||||+++++.+.++...++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4689999999999999 789999999875422 22234555554 45788999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|..++. ....+++..+..++.||+.||.|||++| ++|+||+|+|||++.++.+||+|||++..... ...
T Consensus 81 g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~ 151 (323)
T cd05575 81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSK 151 (323)
T ss_pred CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCC
Confidence 99999984 3567899999999999999999999999 99999999999999999999999998864211 112
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......|+..|+|||++.+..++.++|+||||+++|+|++|..||...... ..... +.....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~----------i~~~~~-- 213 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYDN----------ILNKPL-- 213 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHHH----------HHcCCC--
Confidence 223346899999999999889999999999999999999999999633211 00001 111111
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLIN 265 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~ 265 (311)
..++..+..+.++|.+||+.||.+||++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 214 RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 12234567799999999999999999884
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=284.06 Aligned_cols=256 Identities=27% Similarity=0.369 Sum_probs=201.8
Q ss_pred eeeeeeceeccEEEEEE-------CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWL-------CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
...+|.|+||.||.+.. .+..+++|.+..........+.+|+++++.++||||+++++++..+...++++||+
T Consensus 10 ~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (288)
T cd05093 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYM 89 (288)
T ss_pred ccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcC
Confidence 35789999999999985 34678999887555455668999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccC---------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCC
Q 021526 75 PMGSLEDHLYDLE---------PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 145 (311)
Q Consensus 75 ~~~~L~~~l~~~~---------~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~ 145 (311)
.+++|.+++.... .....+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||.
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~ 166 (288)
T cd05093 90 KHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGM 166 (288)
T ss_pred CCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEeccCCc
Confidence 9999999996432 12235899999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhccc
Q 021526 146 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQK 224 (311)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 224 (311)
+................++..|+|||.+.+..++.++|+||||+++++|++ |..||........ ......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~------~~~i~~--- 237 (288)
T cd05093 167 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV------IECITQ--- 237 (288)
T ss_pred cccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHc---
Confidence 864322221111222334668999999988889999999999999999998 8888853321100 000000
Q ss_pred chhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 021526 225 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 277 (311)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~ 277 (311)
... ...+...+..+.+++.+||+.+|.+|||+.++.+.|+.+...
T Consensus 238 -------~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 238 -------GRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -------CCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 000 011223456799999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=291.98 Aligned_cols=238 Identities=25% Similarity=0.264 Sum_probs=192.5
Q ss_pred eeeeeeceeccEEEEEE-----CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWL-----CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
+..+|+|+||.||.+.. .++.||+|++..... .....+.+|+++++.++||||+++++++.++...++||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 46799999999998875 578999999875432 23356778999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
.+++|.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~-- 151 (318)
T cd05582 81 RGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-- 151 (318)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC--
Confidence 99999999843 456899999999999999999999999 999999999999999999999999998643221
Q ss_pred cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccC
Q 021526 155 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
........|+..|+|||.+.+..++.++|+||||+++|+|++|..||........ . ..+....
T Consensus 152 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~------~----------~~i~~~~- 214 (318)
T cd05582 152 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET------M----------TMILKAK- 214 (318)
T ss_pred CCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH------H----------HHHHcCC-
Confidence 1122335688999999999888889999999999999999999999963321100 0 0010000
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRPLIND 266 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~ 266 (311)
...+...+..+.++|.+||+.||++||++.+
T Consensus 215 -~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 215 -LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1233445677999999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=279.62 Aligned_cols=255 Identities=20% Similarity=0.221 Sum_probs=202.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
...+|.|++|.||++.. +++.||+|.+.... ......+.+|+++++.++||||+++++++......++++|++.+
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 86 (267)
T cd08228 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADA 86 (267)
T ss_pred eeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCC
Confidence 46789999999999998 78999999876432 23335688999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.........+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~--~ 161 (267)
T cd08228 87 GDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--T 161 (267)
T ss_pred CcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccchh--H
Confidence 9999988654444566899999999999999999999999 9999999999999999999999999886532211 1
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......++..|+|||.+.+..++.++|+||+|+++|+|++|..||....... ..+.... .. .....
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~~~~~-------~~---~~~~~ 227 (267)
T cd08228 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FSLCQKI-------EQ---CDYPP 227 (267)
T ss_pred HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HHHHHHH-------hc---CCCCC
Confidence 1123457788999999988888999999999999999999999985322110 0100000 00 00000
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 275 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~ 275 (311)
..+...+..+.+++.+||..+|++||++.++++.|+++.
T Consensus 228 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 228 LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 112345677999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=278.11 Aligned_cols=245 Identities=27% Similarity=0.343 Sum_probs=194.7
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
+..+|.|+||.||.+.. .+..+|+|.+... .....++.+|+++++.++||||+++++++..+...+++|||+.+++|.
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 87 (256)
T cd05114 9 MKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLL 87 (256)
T ss_pred eeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHH
Confidence 46799999999999988 5678999987643 334567889999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++.. ....+++..++.++.+++.||+|||+++ ++|+||+|+||+++.++.++|+|||.++........ ....
T Consensus 88 ~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~~~ 160 (256)
T cd05114 88 NYLRQ---RQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSG 160 (256)
T ss_pred HHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-ccCC
Confidence 99864 2346889999999999999999999999 999999999999999999999999988753221111 1112
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
..++..|+|||.+.+..++.++|+||||+++|+|++ |..||........ ...... . .....+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~------~~~i~~-~----------~~~~~~ 223 (256)
T cd05114 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV------VEMISR-G----------FRLYRP 223 (256)
T ss_pred CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHHC-C----------CCCCCC
Confidence 234567999999988889999999999999999999 8889853321100 000000 0 000112
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 271 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L 271 (311)
...+..+.+++.+||+.+|++||++.++++.|
T Consensus 224 ~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 23456789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=295.48 Aligned_cols=256 Identities=24% Similarity=0.284 Sum_probs=200.1
Q ss_pred eeeeeeceeccEEEEEEC-------CeEEEEEEeccCCc-cchhHHHHHHHHHhcCC-CCcccceeEEEEeCCeeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWLC-------DQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~-------~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e 72 (311)
..++|.|+||.||++... +..||||++..... ...+.+.+|+++++.+. ||||+++++++.+....++|||
T Consensus 42 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 121 (400)
T cd05105 42 GRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITE 121 (400)
T ss_pred hheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEE
Confidence 467999999999999862 34799999865432 33467899999999996 9999999999999999999999
Q ss_pred cCCCCCHHHHhcccCC----------------------------------------------------------------
Q 021526 73 YMPMGSLEDHLYDLEP---------------------------------------------------------------- 88 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~---------------------------------------------------------------- 88 (311)
|+.+++|.+++.....
T Consensus 122 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (400)
T cd05105 122 YCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYS 201 (400)
T ss_pred ecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhh
Confidence 9999999998864211
Q ss_pred ----------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEE
Q 021526 89 ----------------------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 140 (311)
Q Consensus 89 ----------------------------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl 140 (311)
....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~~~~~kL 278 (400)
T cd05105 202 DIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKI 278 (400)
T ss_pred hcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeCCCEEEE
Confidence 1134788888999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhh
Q 021526 141 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPF 219 (311)
Q Consensus 141 ~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 219 (311)
+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||........ .
T Consensus 279 ~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~---------~ 349 (400)
T cd05105 279 CDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST---------F 349 (400)
T ss_pred EeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH---------H
Confidence 99999875432222222223345678999999988889999999999999999997 8888853221100 0
Q ss_pred hhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 021526 220 LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 276 (311)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~ 276 (311)
...+........+..++..+.+++.+||+.+|++||++.+|.+.|+++.+
T Consensus 350 -------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 350 -------YNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred -------HHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 00000011112234567789999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=278.72 Aligned_cols=250 Identities=26% Similarity=0.362 Sum_probs=199.0
Q ss_pred eeeeeeceeccEEEEEEC-----CeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWLC-----DQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~-----~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
...+|+|+||.||+|... ...|++|.+..... .....+.+|+.+++.++||||+++++++..+...+++||++.
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 88 (266)
T cd05033 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYME 88 (266)
T ss_pred eeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCC
Confidence 457899999999999882 35899998865432 234578889999999999999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+++|.+++.. ....+++..++.++.|++.|++|||+.+ ++|+||+|+||++++++.++|+|||++.........
T Consensus 89 ~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd05033 89 NGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT 162 (266)
T ss_pred CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence 9999999965 3357899999999999999999999999 999999999999999999999999998764322222
Q ss_pred ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccC
Q 021526 156 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
.......++..|+|||.+.+..++.++|+||||+++|+|++ |..||....... .. ..+....
T Consensus 163 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~--------------~~~~~~~ 225 (266)
T cd05033 163 YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VI--------------KAVEDGY 225 (266)
T ss_pred eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HH--------------HHHHcCC
Confidence 12222334568999999988889999999999999999997 888885322110 00 0000000
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l 274 (311)
....+..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 226 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1112234567799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=286.33 Aligned_cols=239 Identities=27% Similarity=0.361 Sum_probs=190.1
Q ss_pred eeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhc-CCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 4 CYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSL-LHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
.+|.|+||.||++.. +++.||+|.+.... ....+.+..|..++.. .+||||+++++++..+...++||||+.++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 689999999999998 67899999987542 2233455667777654 48999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++....... ..
T Consensus 82 ~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 82 DLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 99999843 457899999999999999999999999 9999999999999999999999999986432211 22
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCC
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 237 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
.....|+..|+|||++.+..++.++|+|||||++|+|++|..||....... ... .+.. ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~----------~~~------~i~~--~~~~ 214 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE----------LFD------SILN--DRPH 214 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH----------HHH------HHHc--CCCC
Confidence 234568999999999988889999999999999999999999996432110 000 0000 0112
Q ss_pred CcHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 021526 238 YPRRCLNYAVAVTAMCLNEEANFRPLIN-DIVV 269 (311)
Q Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~RPs~~-~l~~ 269 (311)
++...+.++.+++.+||+.+|++||++. ++++
T Consensus 215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 3344567789999999999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=293.47 Aligned_cols=241 Identities=27% Similarity=0.272 Sum_probs=195.1
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
+++|+|+||.||.+.. +++.||+|.+.... ......+.+|+++++.++||||+++++++..+...++||||+.++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4689999999999988 78999999987542 223356778999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
+|.+++. ....+++..+..++.|++.||+|||+ .+ ++|+||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~ 151 (325)
T cd05594 81 ELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GA 151 (325)
T ss_pred cHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCC--Cc
Confidence 9999884 34578999999999999999999997 78 999999999999999999999999988632111 11
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......|+..|+|||++.+..++.++|+||||+++|+|++|..||........ .... ... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~------~~~i----------~~~--~~ 213 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FELI----------LME--EI 213 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH------HHHH----------hcC--CC
Confidence 22234689999999999888999999999999999999999999963321100 0000 000 11
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVVA 270 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~l~~~ 270 (311)
.++...+.++.+++.+||+.||++|+ ++.++++.
T Consensus 214 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 214 RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 23344567799999999999999996 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=283.31 Aligned_cols=246 Identities=26% Similarity=0.347 Sum_probs=196.2
Q ss_pred eeeceeccEEEEEE--CCeEEEEEEeccCCcc---chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 5 YLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 5 ~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
+|+|+||.||.+.. +++.||+|.+...... ..+.+..|+++++.++|+||+++.+++..+...+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 58999999999988 7899999998654322 235677899999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
.+++.........+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC--cccc
Confidence 9888654445667999999999999999999999999 9999999999999999999999999986432221 1122
Q ss_pred eccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 160 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
...|+..|+|||.+.+..++.++|+||||+++|+|++|..||......... .. . ........ ..++
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~----~------~~~~~~~~--~~~~ 221 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KE----L------KQRILNDS--VTYP 221 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HH----H------HHhhcccC--CCCc
Confidence 346788999999999999999999999999999999999999643321110 00 0 00011110 1233
Q ss_pred HHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 269 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RP-----s~~~l~~ 269 (311)
...+..+.+++.+||+.||++|| +++++++
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 45677899999999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=284.99 Aligned_cols=260 Identities=20% Similarity=0.207 Sum_probs=195.7
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
...+|+|++|.||++.. +++.||+|.+.... ....+.+.+|+++++.++||||+++++++..+...++||||+.++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 85 (287)
T cd07848 6 LGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKN 85 (287)
T ss_pred EEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCC
Confidence 56799999999999999 68899999986542 233467889999999999999999999999999999999999887
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
.+..+.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 86 ~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 157 (287)
T cd07848 86 MLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-AN 157 (287)
T ss_pred HHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccc-cc
Confidence 6655442 3457899999999999999999999999 99999999999999999999999999875422211 11
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCcccccc-chhcch-------hhhhcccchhhh
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWSR-------PFLKDQKKFVHL 229 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~-------~~~~~~~~~~~~ 229 (311)
.....++..|+|||++.+..++.++|+||||+++|+|++|.+||.......... ...... ..+.........
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 223457889999999988889999999999999999999999996543211100 000000 000000000000
Q ss_pred cCccCC------CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 230 VDPLLH------GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 230 ~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..+... ..+....+..+.+++.+||+.||++|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 001000 1112235677999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=277.58 Aligned_cols=254 Identities=21% Similarity=0.264 Sum_probs=204.6
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
...+|.|++|.||++.. +++.|++|.+.... ......+.+|+++++.++|++++++++++..+...+++|||+.+
T Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (267)
T cd08224 7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADA 86 (267)
T ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCC
Confidence 46789999999999999 68999999886432 23356788999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.........+++..++.++.+++.++++||+.+ ++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 87 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~--~ 161 (267)
T cd08224 87 GDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--T 161 (267)
T ss_pred CCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCCC--c
Confidence 9999998765445667899999999999999999999999 9999999999999999999999999876432211 1
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......++..|.|||.+.+..++.++|+||||+++|+|++|..||...... ....... .......
T Consensus 162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-----------~~~~~~~ 226 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKK-----------IEKCDYP 226 (267)
T ss_pred ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHhh-----------hhcCCCC
Confidence 122345778899999988888999999999999999999999998533211 0000000 0000111
Q ss_pred CCcH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 021526 237 RYPR-RCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 275 (311)
Q Consensus 237 ~~~~-~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~ 275 (311)
..+. ..+..+.++|.+||..+|++||++.+|++.|+.+.
T Consensus 227 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 227 PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1222 45678999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=285.44 Aligned_cols=259 Identities=24% Similarity=0.274 Sum_probs=194.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
+..+|.|+||.||++.. +++.||+|.+..... .....+.+|+++++.++||||+++++++.++...++|||++++ +
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~ 88 (288)
T cd07871 10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-D 88 (288)
T ss_pred eeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-C
Confidence 46899999999999998 689999999865432 2345678999999999999999999999999999999999975 8
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
|.+++.. ....+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++....... ...
T Consensus 89 l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--~~~ 160 (288)
T cd07871 89 LKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--KTY 160 (288)
T ss_pred HHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC--ccc
Confidence 9998854 3456788999999999999999999999 9999999999999999999999999986432211 112
Q ss_pred eeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCccccccch-hc----chhhhh---cccchhhh
Q 021526 159 TRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-SW----SRPFLK---DQKKFVHL 229 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~----~~~~~~---~~~~~~~~ 229 (311)
....++..|+|||++.+ ..++.++|+||||+++|+|++|..||............ .. ....+. ....+...
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY 240 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence 23456889999998765 56889999999999999999999999654322111000 00 000000 01111111
Q ss_pred cCccCCCC----CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 230 VDPLLHGR----YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 230 ~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..+..... .....+.+..++|.+||+.||.+|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 11111000 01234567899999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=285.50 Aligned_cols=247 Identities=29% Similarity=0.347 Sum_probs=195.7
Q ss_pred CeeeeeeceeccEEEEEE--CCeEEEEEEeccCCc--------------cchhHHHHHHHHHhcCCCCcccceeEEEEe-
Q 021526 1 MLCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL--------------QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS- 63 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 63 (311)
|...+|+|.||+|-+++. .++.||||++.+... ...+...+|+.++++++||||++++++.++
T Consensus 101 l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP 180 (576)
T KOG0585|consen 101 LIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDP 180 (576)
T ss_pred hhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCc
Confidence 356789999999999999 899999999976411 122578899999999999999999999865
Q ss_pred -CCeeEEEEecCCCCCHHHHhcccCCCCCC-CCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEe
Q 021526 64 -GDQRLLVYEYMPMGSLEDHLYDLEPDQEP-LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 141 (311)
Q Consensus 64 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~ 141 (311)
.+.+|+|+|||..|.+... ...+. +.+.++++++..++.||+|||.+| |+||||||.|+|++++|.|||+
T Consensus 181 ~s~~~YlVley~s~G~v~w~-----p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 181 ESDKLYLVLEYCSKGEVKWC-----PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred ccCceEEEEEeccCCccccC-----CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEee
Confidence 4578999999987766332 23344 999999999999999999999999 9999999999999999999999
Q ss_pred ecCCCccCCCC---CCcceeeeccccccccCCccccCC----CCCccccchhHHHHHHHHHhCCCCccccCccccccchh
Q 021526 142 DFGLAKLGPVG---DNTHVSTRVMGTYGYCAPEYAMSG----KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS 214 (311)
Q Consensus 142 Df~~~~~~~~~---~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 214 (311)
|||.+...... .....-....||+.|+|||...++ ..+.+.||||+|+++|.|+.|+.||.....
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~-------- 324 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE-------- 324 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--------
Confidence 99998643222 111112336799999999988763 235789999999999999999999952221
Q ss_pred cchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 021526 215 WSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 271 (311)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L 271 (311)
...+.++++..+...-.++..+.+.+||.+||+.||+.|.++.+|....
T Consensus 325 --------~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 325 --------LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred --------HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 1223334444443333445678899999999999999999999997643
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=294.88 Aligned_cols=241 Identities=29% Similarity=0.363 Sum_probs=204.4
Q ss_pred eeeeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHHHH
Q 021526 3 CCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDH 82 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 82 (311)
.-+|+|+-|.||.|.+.++.||||+++ +.-..++.-|++|+||||+.+.++|...--+|||||||..|-|...
T Consensus 130 eWlGSGaQGAVF~Grl~netVAVKKV~-------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V 202 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLHNETVAVKKVR-------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV 202 (904)
T ss_pred hhhccCcccceeeeeccCceehhHHHh-------hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence 458999999999999999999999875 2223468889999999999999999999999999999999999999
Q ss_pred hcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeeecc
Q 021526 83 LYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 162 (311)
Q Consensus 83 l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~~~ 162 (311)
|. .+..+.......|..+|+.++.|||... |+|||||.-||||+.+..|||+|||.++..... ..+-...
T Consensus 203 Lk----a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFa 272 (904)
T KOG4721|consen 203 LK----AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFA 272 (904)
T ss_pred Hh----ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhh
Confidence 94 5678888999999999999999999998 999999999999999999999999998753222 2233467
Q ss_pred ccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCcHHH
Q 021526 163 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRC 242 (311)
Q Consensus 163 ~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (311)
||..|||||++.+.+.+.|.||||||+++|||+||..||..-+. ...+.-.-...+.-..|-.|
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----------------sAIIwGVGsNsL~LpvPstc 336 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----------------SAIIWGVGSNSLHLPVPSTC 336 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----------------heeEEeccCCcccccCcccC
Confidence 99999999999999999999999999999999999999952111 11112222334444567788
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 021526 243 LNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 276 (311)
Q Consensus 243 ~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~ 276 (311)
+..+.-|+++||+..|.+||++.+++..|+-+.+
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 9999999999999999999999999999976554
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=287.08 Aligned_cols=240 Identities=27% Similarity=0.351 Sum_probs=193.7
Q ss_pred eeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 4 CYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
++|.|+||.||++.. +++.||+|.+.+.. ......+.+|.+++..+ +||||+++++++.+....++||||+.++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 689999999999999 67899999987542 23345677888888877 6999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|.+++.. ...+++..+..++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 82 ~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (318)
T cd05570 82 DLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVT 152 (318)
T ss_pred CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcC--CCc
Confidence 99998843 457899999999999999999999999 999999999999999999999999988632111 111
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCC
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 237 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
.....|+..|+|||++.+..++.++|+|||||++|+|++|..||...... ..... +... ...
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~------~~~~~----------i~~~--~~~ 214 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED------ELFQS----------ILED--EVR 214 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH------HHHHH----------HHcC--CCC
Confidence 22345789999999999999999999999999999999999999633211 00000 0000 112
Q ss_pred CcHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 021526 238 YPRRCLNYAVAVTAMCLNEEANFRPLI-----NDIVVA 270 (311)
Q Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~RPs~-----~~l~~~ 270 (311)
++...+..+.++|.+||..||++||++ .++++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 234456789999999999999999999 777653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=280.92 Aligned_cols=252 Identities=29% Similarity=0.418 Sum_probs=197.5
Q ss_pred eeeeeeceeccEEEEEE------CCeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWL------CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
...+|+|+||.||+|.. .++.|++|.+..... .....+.+|+++++.++||||+++++++..+...+++|||+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 89 (283)
T cd05090 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYL 89 (283)
T ss_pred eeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcC
Confidence 46789999999999985 457899999864433 23357889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEe
Q 021526 75 PMGSLEDHLYDLEP-------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 141 (311)
Q Consensus 75 ~~~~L~~~l~~~~~-------------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~ 141 (311)
.+++|.+++..... ....+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~~kl~ 166 (283)
T cd05090 90 NQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKIS 166 (283)
T ss_pred CCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCcEEec
Confidence 99999999853211 1235788899999999999999999999 9999999999999999999999
Q ss_pred ecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhh
Q 021526 142 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFL 220 (311)
Q Consensus 142 Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 220 (311)
|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||...... ...
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~------- 236 (283)
T cd05090 167 DLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVI------- 236 (283)
T ss_pred cccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHH-------
Confidence 9999875432222222233345667999999888889999999999999999998 88888532210 000
Q ss_pred hcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 021526 221 KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 273 (311)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~ 273 (311)
+.+........+..++..+.+++.+||+.+|++||++.+|++.|..
T Consensus 237 -------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 -------EMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -------HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 0000000011223456779999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=276.31 Aligned_cols=245 Identities=29% Similarity=0.406 Sum_probs=200.4
Q ss_pred eeeeeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHHH
Q 021526 2 LCCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (311)
...+|.|++|.||++...++.|++|.+..... ..+++.+|+.+++.++|+|++++++++.++...+++||++.+++|.+
T Consensus 11 ~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~ 89 (256)
T cd05039 11 GATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVD 89 (256)
T ss_pred eeeeecCCCceEEEEEecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHH
Confidence 46789999999999999999999999875543 55789999999999999999999999988899999999999999999
Q ss_pred HhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeeec
Q 021526 82 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 161 (311)
Q Consensus 82 ~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~~ 161 (311)
++.. .....+++..++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 90 ~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-----~~~ 159 (256)
T cd05039 90 YLRS--RGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-----DSG 159 (256)
T ss_pred HHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc-----ccC
Confidence 9964 22346899999999999999999999999 9999999999999999999999999987542111 122
Q ss_pred cccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCcH
Q 021526 162 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPR 240 (311)
Q Consensus 162 ~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (311)
..+..|.|||.+....++.++|+||||++++++++ |..||....... +...+........+.
T Consensus 160 ~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~ 222 (256)
T cd05039 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----------------VVPHVEKGYRMEAPE 222 (256)
T ss_pred CCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-----------------HHHHHhcCCCCCCcc
Confidence 34567999999888888999999999999999997 888885322110 000111111112234
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 021526 241 RCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274 (311)
Q Consensus 241 ~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l 274 (311)
.++..+.+++.+||..+|++||++.++++.|+.+
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 223 GCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 4567899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=289.25 Aligned_cols=236 Identities=25% Similarity=0.251 Sum_probs=187.3
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHHH-HHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEVL-MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+++|.|+||.||++.. +++.||+|.+.+... .....+.+|.. +++.++||||+++++++.+....++||||+.+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999999 689999999865422 22234555544 57889999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|..++. ....+.+..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++..... ...
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~ 151 (321)
T cd05603 81 GELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEE 151 (321)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCC
Confidence 99998884 3467888999999999999999999999 99999999999999999999999998864211 111
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......|+..|+|||++.+..++.++|+|||||++|+|++|..||...+. ...... +.... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~----------i~~~~--~ 213 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQMYDN----------ILHKP--L 213 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------HHHHHH----------HhcCC--C
Confidence 22334588999999999888899999999999999999999999964321 000001 11111 1
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLIN 265 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~ 265 (311)
..+...+..+.+++.+||+.+|.+||++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 22344566799999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=278.95 Aligned_cols=262 Identities=25% Similarity=0.273 Sum_probs=199.1
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCC-----eeEEEEecCC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD-----QRLLVYEYMP 75 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~ 75 (311)
.++|.|+||+||++.+ .++.||||..-.... --.+|+++|+.+.||||+++.-+|.... ...+||||+.
T Consensus 30 ~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP 105 (364)
T KOG0658|consen 30 RLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP 105 (364)
T ss_pred EEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch
Confidence 5799999999999999 679999998754432 2336899999999999999988875432 2369999994
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCC-CceEEeecCCCccCCCCCC
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-FNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~-~~vkl~Df~~~~~~~~~~~ 154 (311)
.+|.+++...-..+..++...+.-+.+||.+||+|||+.| ||||||||.|+|+|.+ |.+||+|||.+........
T Consensus 106 -~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep 181 (364)
T KOG0658|consen 106 -ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP 181 (364)
T ss_pred -HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence 5999999765556788998999999999999999999999 9999999999999876 8899999999986543332
Q ss_pred cceeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCccccc-------------cchhcchhhh
Q 021526 155 THVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-------------NLVSWSRPFL 220 (311)
Q Consensus 155 ~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-------------~~~~~~~~~~ 220 (311)
. ..-..+..|.|||++.+. .|+.+.||||.||++.||+.|++.|.+.+..... ++..+.-.+.
T Consensus 182 n---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~ 258 (364)
T KOG0658|consen 182 N---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYT 258 (364)
T ss_pred c---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccc
Confidence 2 223467889999988875 7999999999999999999999999765432111 1110000000
Q ss_pred hcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHhhhc
Q 021526 221 KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV--ALDYLVSQ 277 (311)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~--~L~~l~~~ 277 (311)
.....++....+...+....+.++.+|+.++|..+|.+|.++.+++. +++.+...
T Consensus 259 --~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 259 --EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred --cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 11111111112212234566788999999999999999999999997 57776655
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=289.76 Aligned_cols=234 Identities=26% Similarity=0.322 Sum_probs=189.4
Q ss_pred eeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 4 CYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
++|+|+||.||++.. +++.||+|.+.+.. ......+..|..++..+ +||||+++++++.+....++||||+.++
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 689999999999998 68899999987542 23345677788888766 6999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++...... ...
T Consensus 82 ~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~ 152 (320)
T cd05590 82 DLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKT 152 (320)
T ss_pred hHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCc
Confidence 99998843 456899999999999999999999999 999999999999999999999999987642111 112
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCC
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 237 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
.....|++.|+|||++.+..++.++|+||||+++|+|++|..||....... ..... .... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i----------~~~~--~~ 214 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD------LFEAI----------LNDE--VV 214 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH------HHHHH----------hcCC--CC
Confidence 233568999999999988889999999999999999999999996332110 00001 1000 12
Q ss_pred CcHHHHHHHHHHHHHhhccCCCCCCCH
Q 021526 238 YPRRCLNYAVAVTAMCLNEEANFRPLI 264 (311)
Q Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~RPs~ 264 (311)
++...+..+.+++.+||+.||++||++
T Consensus 215 ~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 215 YPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 233456778999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=288.84 Aligned_cols=247 Identities=26% Similarity=0.331 Sum_probs=194.3
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
.++|+|+||.||++.. +++.||+|.+.+.. ......+.+|+.++..+ +||||+++++++..+...++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3689999999999998 68899999987642 22335577888888766 799999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|..++. ....+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++..... ...
T Consensus 81 ~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~ 151 (329)
T cd05618 81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGD 151 (329)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCC
Confidence 99998884 3467899999999999999999999999 99999999999999999999999999864211 111
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccc--cchhcchhhhhcccchhhhcCccC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ--NLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
......|+..|+|||++.+..++.++|+||||+++|+|++|..||......... ....+... .....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~---------~i~~~-- 220 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ---------VILEK-- 220 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHH---------HHhcC--
Confidence 223356899999999999989999999999999999999999999643221111 00111000 01111
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCCH------HHHHH
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRPLI------NDIVV 269 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~------~~l~~ 269 (311)
....|...+..+.+++.+||+.||++||++ .++++
T Consensus 221 ~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 221 QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 112345567789999999999999999984 56654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=291.68 Aligned_cols=239 Identities=22% Similarity=0.242 Sum_probs=195.3
Q ss_pred eeeeeeceeccEEEEEE---CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL---CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~---~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
...+|.|+||.||++.. .+..||+|.+.... ....+.+.+|+++++.++||||+++++++.++...+++|||+.
T Consensus 35 ~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~ 114 (340)
T PTZ00426 35 IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVI 114 (340)
T ss_pred EEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCC
Confidence 56899999999999986 23689999986442 2334578899999999999999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||++.....
T Consensus 115 ~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~---- 183 (340)
T PTZ00426 115 GGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT---- 183 (340)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC----
Confidence 9999999953 457899999999999999999999999 99999999999999999999999999874321
Q ss_pred ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 156 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
......|++.|+|||++.+..++.++|+|||||++|+|++|..||........ . ..+....
T Consensus 184 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~------~----------~~i~~~~-- 244 (340)
T PTZ00426 184 -RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI------Y----------QKILEGI-- 244 (340)
T ss_pred -CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH------H----------HHHhcCC--
Confidence 12234689999999999888899999999999999999999999963321100 0 0011111
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVVA 270 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~l~~~ 270 (311)
..++...+..+.++|.+||+.+|.+|+ +++++++.
T Consensus 245 ~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 245 IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 123344566789999999999999995 88888764
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=289.84 Aligned_cols=241 Identities=26% Similarity=0.293 Sum_probs=193.6
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
.++|+|+||.||++.. .++.||+|.+.... ......+..|.+++..+ +||||+++++++.++...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3689999999999998 57899999987542 23335677888888765 799999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|..++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--~~ 151 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GV 151 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccC--Cc
Confidence 999998843 456889999999999999999999999 999999999999999999999999988642211 11
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......|+..|+|||++.+..++.++|+||||+++|+|++|..||........ .... .... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~------~~~i----------~~~~--~ 213 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL------FESI----------LHDD--V 213 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH------HHHH----------HcCC--C
Confidence 22334588999999999888999999999999999999999999964331110 0001 0000 1
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCC-------CHHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRP-------LINDIVVA 270 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RP-------s~~~l~~~ 270 (311)
.++...+.++.+++.+||+.||++|| +++++++.
T Consensus 214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 12334567899999999999999999 78888764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=276.84 Aligned_cols=249 Identities=30% Similarity=0.395 Sum_probs=203.2
Q ss_pred eeeeceeccEEEEEEC-----CeEEEEEEeccCCccc-hhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 4 CYLSCKFYNVGLVWLC-----DQLVAIKQLNHEGLQG-HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~~-----~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
.+|.|+||.||.+... +..|++|.+....... ...+.+|++.++.++|+|++++++++.++...+++|||+.++
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG 81 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence 6899999999999993 8899999987654333 578899999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCC-----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCC
Q 021526 78 SLEDHLYDLEPD-----QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 78 ~L~~~l~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~ 152 (311)
+|.+++...... ...+++..++.++.|++.||++||+++ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999763222 478999999999999999999999999 999999999999999999999999998764433
Q ss_pred CCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcC
Q 021526 153 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231 (311)
Q Consensus 153 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
..........++..|+|||.+....++.++|+||||+++|+|++ |..||...... . .. +.+.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~----~~-------~~~~ 221 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE------E----VL-------EYLR 221 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH------H----HH-------HHHH
Confidence 22222333456788999999988889999999999999999999 58888643210 0 00 0010
Q ss_pred ccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 021526 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 272 (311)
Q Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~ 272 (311)
.......+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 222 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 222 KGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred cCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 01122334456788999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=282.05 Aligned_cols=254 Identities=28% Similarity=0.374 Sum_probs=200.3
Q ss_pred eeeeeeceeccEEEEEEC-------CeEEEEEEeccCC-ccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWLC-------DQLVAIKQLNHEG-LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~-------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 72 (311)
.+.+|+|++|.||++... ...+++|.+.... ......+.+|+++++.+ +|+||+++++++..+...+++||
T Consensus 17 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e 96 (293)
T cd05053 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVE 96 (293)
T ss_pred eeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEE
Confidence 567899999999999872 3689999886542 23345688999999999 79999999999999999999999
Q ss_pred cCCCCCHHHHhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEE
Q 021526 73 YMPMGSLEDHLYDLE------------PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 140 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~------------~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl 140 (311)
|+.+++|.+++.... .....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|
T Consensus 97 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~~~~~kL 173 (293)
T cd05053 97 YAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKI 173 (293)
T ss_pred eCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcCCCeEEe
Confidence 999999999996432 23457889999999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhh
Q 021526 141 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPF 219 (311)
Q Consensus 141 ~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 219 (311)
+|||++................++..|+|||.+.+..++.++|+||||+++|++++ |..||........
T Consensus 174 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---------- 243 (293)
T cd05053 174 ADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL---------- 243 (293)
T ss_pred CccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH----------
Confidence 99999875432221111222234567999999888889999999999999999997 8888753221100
Q ss_pred hhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 021526 220 LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 275 (311)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~ 275 (311)
............+..++..+.+++.+||..+|++|||+.++++.|+.+.
T Consensus 244 -------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 -------FKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -------HHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 0001111111223455678999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=302.24 Aligned_cols=249 Identities=22% Similarity=0.198 Sum_probs=199.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeCC--------eeEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD--------QRLL 69 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~~~l 69 (311)
..++|+|+||.||.+.. +++.||||.+..... .....+.+|+..+..++|+|+++++..+.... ..++
T Consensus 37 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~l 116 (496)
T PTZ00283 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIAL 116 (496)
T ss_pred EEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEE
Confidence 46899999999999988 789999999865532 33456788999999999999999887764322 3679
Q ss_pred EEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccC
Q 021526 70 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 149 (311)
Q Consensus 70 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~ 149 (311)
||||+.+++|.+++.........+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||+++..
T Consensus 117 V~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFGls~~~ 193 (496)
T PTZ00283 117 VLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMY 193 (496)
T ss_pred EEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEecccCeec
Confidence 99999999999999765545677999999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhh
Q 021526 150 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 229 (311)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
.............|++.|+|||++.+..++.++||||||+++|+|++|..||..... .......
T Consensus 194 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~~~~---------- 257 (496)
T PTZ00283 194 AATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVMHKT---------- 257 (496)
T ss_pred cccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHH----------
Confidence 332222233345689999999999998999999999999999999999999963221 0000000
Q ss_pred cCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 230 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 230 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.. ......+..++..+.+++.+||..+|.+||++.++++.
T Consensus 258 ~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 LA-GRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred hc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 00 01112344567789999999999999999999999863
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=285.32 Aligned_cols=239 Identities=26% Similarity=0.335 Sum_probs=191.3
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhc-CCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSL-LHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+++|+|+||.||.+.. +++.||+|.+.... ......+..|..++.. .+||+|+++++++.+++..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4689999999999999 68899999987542 2234556777777765 4899999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ...+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++...... ..
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 151 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DN 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CC
Confidence 999999843 457889999999999999999999999 999999999999999999999999988632111 11
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......|+..|+|||++.+..++.++|+||||+++|+|++|..||...... ........ . ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~------~~~~~~~~--------~----~~ 213 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED------ELFESIRV--------D----TP 213 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHh--------C----CC
Confidence 223456899999999999989999999999999999999999999643211 00000000 0 01
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLIN-DIV 268 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~-~l~ 268 (311)
.++...+.++.++|.+||+.||++||++. +++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 214 HYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 22334567799999999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=281.24 Aligned_cols=255 Identities=24% Similarity=0.344 Sum_probs=201.2
Q ss_pred eeeeeeceeccEEEEEEC-------CeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWLC-------DQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~-------~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
...+|.|+||.||++... ...+++|.+..... ....++.+|+++++.++||||+++++.+..+...++++||
T Consensus 5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (290)
T cd05045 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEY 84 (290)
T ss_pred cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEe
Confidence 467899999999999872 25789998765432 2346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEc
Q 021526 74 MPMGSLEDHLYDLEP--------------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD 133 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~--------------------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~ 133 (311)
+.+++|.+++..... ....+++..++.++.|++.+|+|||+.+ ++|+||+|+||+++
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~nill~ 161 (290)
T cd05045 85 AKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVA 161 (290)
T ss_pred cCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheEEEc
Confidence 999999999864321 1235788999999999999999999999 99999999999999
Q ss_pred CCCceEEeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccc
Q 021526 134 NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNL 212 (311)
Q Consensus 134 ~~~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~ 212 (311)
+++.++|+|||++................++..|+|||...+..++.++|+||||+++++|++ |..||......
T Consensus 162 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----- 236 (290)
T cd05045 162 EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE----- 236 (290)
T ss_pred CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-----
Confidence 999999999999865322222111222345668999999888889999999999999999998 88888532211
Q ss_pred hhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 021526 213 VSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 276 (311)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~ 276 (311)
.+.+..........+..++..+.+++.+||+.+|++||++.++++.|+++..
T Consensus 237 ------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 237 ------------RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred ------------HHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 0111111111222234456789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=280.51 Aligned_cols=244 Identities=23% Similarity=0.281 Sum_probs=191.7
Q ss_pred eeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 5 YLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 5 ~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
+|.|+||.||++.. +|+.||+|.+..... .....+..|+++++.++||||+++++++.++...+++|||+.+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 58999999999998 689999999864322 1234566799999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
.+++.. .....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..... .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~---~~~~~ 152 (277)
T cd05607 81 KYHIYN--VGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTIT 152 (277)
T ss_pred HHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCC---Cceee
Confidence 988854 23445888999999999999999999999 99999999999999999999999998864322 11223
Q ss_pred eccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 160 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
...++..|+|||.+.+..++.++|+||||+++|+|++|..||........ ....... ....... ...
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~----------~~~~~~~-~~~ 219 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRR----------TLEDEVK-FEH 219 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHH----------hhccccc-ccc
Confidence 34678899999999888899999999999999999999999863321111 0000000 0000000 001
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
...+.++.+++.+||+.||++||+++|+++
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 234667899999999999999999977654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=275.61 Aligned_cols=246 Identities=25% Similarity=0.356 Sum_probs=195.1
Q ss_pred eeeeceeccEEEEEE----CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 4 CYLSCKFYNVGLVWL----CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~----~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
.+|.|+||.||++.. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++. +...+++||++.++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999865 578999999864432 23467889999999999999999999875 45678999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|.+++.. ...+++..+..++.|++.||++||+++ ++|+||+|.||+++.++.++|+|||.+...........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999943 456889999999999999999999999 99999999999999999999999999875432221111
Q ss_pred -eeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 158 -STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 158 -~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
.....++..|+|||.+....++.++|+||||+++|+|++ |..||....... +...+.....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----------------~~~~i~~~~~ 216 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE-----------------VTQMIESGER 216 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHHHCCCC
Confidence 111233578999999888888999999999999999998 899986332110 0111111111
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l 274 (311)
...+..++.++.++|.+||+.||++||++.+|.+.|+.+
T Consensus 217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 223445678899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=281.57 Aligned_cols=252 Identities=27% Similarity=0.354 Sum_probs=198.4
Q ss_pred eeeeeeceeccEEEEEEC-------CeEEEEEEeccCCcc-chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWLC-------DQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~-------~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
...+|.|+||.||++... ++.||+|.+...... ....+.+|..++..++||||+++++++......+++++|
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~ 89 (283)
T cd05091 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSY 89 (283)
T ss_pred HHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEc
Confidence 356899999999999872 478999998754322 235688899999999999999999999999999999999
Q ss_pred CCCCCHHHHhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEe
Q 021526 74 MPMGSLEDHLYDLE------------PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 141 (311)
Q Consensus 74 ~~~~~L~~~l~~~~------------~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~ 141 (311)
+.+++|.+++.... .....+++..++.++.|++.||.|||+.+ ++|+||||.||++++++.+||+
T Consensus 90 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~kl~ 166 (283)
T cd05091 90 CSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKIS 166 (283)
T ss_pred CCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCceEec
Confidence 99999999985311 12345888889999999999999999999 9999999999999999999999
Q ss_pred ecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhh
Q 021526 142 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFL 220 (311)
Q Consensus 142 Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 220 (311)
|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||...... ..
T Consensus 167 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~----- 235 (283)
T cd05091 167 DLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------DV----- 235 (283)
T ss_pred ccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH------HH-----
Confidence 9999875332222222223345678999999888889999999999999999998 77787532211 00
Q ss_pred hcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 021526 221 KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 273 (311)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~ 273 (311)
.+.+........+..++..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 236 ------~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 ------IEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ------HHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11111111112345677889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=284.79 Aligned_cols=241 Identities=28% Similarity=0.329 Sum_probs=192.7
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCC-cccceeEEEEeCCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHD-NLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
+..+|+|+||.||++.. +++.||+|++.+.. ....+.+..|.+++..++|+ +|+++++++.+.+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 84 (324)
T cd05587 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 84 (324)
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCC
Confidence 57899999999999998 57899999987542 23445677899999888765 58888999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+++|.+++.. ...+++..+..++.|++.||+|||+++ ++|+||||+|||++.++.++|+|||++...... .
T Consensus 85 ~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~--~ 155 (324)
T cd05587 85 GGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG--G 155 (324)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC--C
Confidence 9999999843 456889999999999999999999999 999999999999999999999999987632111 1
Q ss_pred ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 156 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
.......|+..|+|||++.+..++.++|+|||||++|+|++|..||........ ... +.. ..
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~------~~~----------i~~--~~ 217 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL------FQS----------IME--HN 217 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH------HHH----------HHc--CC
Confidence 122345689999999999988899999999999999999999999963321100 000 000 01
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRPLI-----NDIVV 269 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~-----~~l~~ 269 (311)
..++...+..+.+++.+||..||.+|++. +++++
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 218 VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 12344556779999999999999999976 56654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=274.37 Aligned_cols=247 Identities=26% Similarity=0.336 Sum_probs=197.9
Q ss_pred eeeeeceeccEEEEEE-CCeEEEEEEeccCCcc-chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 3 CCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
+++|.|++|.||.+.. .++.|++|.+...... ....+.+|+++++.++|+||+++++++......++++|++.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 4689999999999998 5899999998765443 4568899999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++.. ....+++..+..++.+++.+|++||+++ ++|+||+|+||+++.++.++|+|||.+..............
T Consensus 81 ~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 99954 2346788999999999999999999999 99999999999999999999999999864321111111112
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
...+..|+|||.+.+..++.++|+||||+++|+|++ |..||......... ...........+
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~-----------------~~~~~~~~~~~~ 217 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR-----------------ERIESGYRMPAP 217 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH-----------------HHHhcCCCCCCC
Confidence 233567999999888889999999999999999998 77888533321110 001111111223
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 272 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~ 272 (311)
...+..+.+++.+||..+|++||++.++++.|+
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 345678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=281.47 Aligned_cols=258 Identities=25% Similarity=0.351 Sum_probs=202.8
Q ss_pred eeeeeeceeccEEEEEE---------CCeEEEEEEeccCC-ccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEE
Q 021526 2 LCCYLSCKFYNVGLVWL---------CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLV 70 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 70 (311)
...+|.|+||.||.+.. .+..|++|.+.... ......+.+|+.+++.+ +||||+++++++..+...+++
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 99 (304)
T cd05101 20 GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 99 (304)
T ss_pred cceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEE
Confidence 36799999999999974 23579999986442 23446788999999999 799999999999999999999
Q ss_pred EecCCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCce
Q 021526 71 YEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 138 (311)
Q Consensus 71 ~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~v 138 (311)
|||+.+++|.+++..... ....+++..+..++.|++.||.|||+.| ++|+||+|+||+++.++.+
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili~~~~~~ 176 (304)
T cd05101 100 VEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVTENNVM 176 (304)
T ss_pred EecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEEcCCCcE
Confidence 999999999999976432 1245788889999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcch
Q 021526 139 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSR 217 (311)
Q Consensus 139 kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 217 (311)
+|+|||.+................++..|+|||++.+..++.++|+||||+++|+|++ |..||...... ....
T Consensus 177 kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~ 250 (304)
T cd05101 177 KIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE------ELFK 250 (304)
T ss_pred EECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH------HHHH
Confidence 9999999875433222222222345678999999988889999999999999999998 77777432211 0000
Q ss_pred hhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 021526 218 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 279 (311)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~ 279 (311)
.+........+..++..+.+++.+||..+|++||++.++++.|+++.....
T Consensus 251 -----------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 251 -----------LLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred -----------HHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 000011111234567789999999999999999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=279.48 Aligned_cols=251 Identities=25% Similarity=0.369 Sum_probs=195.1
Q ss_pred eeeeeeceeccEEEEEEC-------CeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWLC-------DQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~-------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
...+|+|++|.||.+... +..||+|.+.... .....++.+|+.+++.++||||+++++++..+...+++|||
T Consensus 11 ~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~ 90 (277)
T cd05062 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 90 (277)
T ss_pred eeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEec
Confidence 467999999999998862 4679999876432 23445788999999999999999999999998999999999
Q ss_pred CCCCCHHHHhcccCCC------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 74 MPMGSLEDHLYDLEPD------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~------~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
+.+++|.+++...... ...+.+..+..++.|++.||+|||+.+ ++|+||+|.||++++++.++|+|||++.
T Consensus 91 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~dfg~~~ 167 (277)
T cd05062 91 MTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR 167 (277)
T ss_pred CCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEECCCCCcc
Confidence 9999999999653321 234677888999999999999999999 9999999999999999999999999986
Q ss_pred cCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccch
Q 021526 148 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 226 (311)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
...............++..|+|||.+.+..++.++|+||||+++|+|++ |..||....... ... .... .
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~~---~~~~-~--- 237 (277)
T cd05062 168 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VLR---FVME-G--- 237 (277)
T ss_pred ccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH---HHHc-C---
Confidence 4322222111122334678999999988889999999999999999998 678885332110 000 0000 0
Q ss_pred hhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 021526 227 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 272 (311)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~ 272 (311)
.....+..++..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 238 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 238 -------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred -------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 001123345667999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=283.57 Aligned_cols=258 Identities=22% Similarity=0.227 Sum_probs=191.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
+..+|.|+||.||.+.. +++.||+|.+..... .....+.+|+++++.++||||+++++++.++...++||||+. ++
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~ 88 (303)
T cd07869 10 LEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TD 88 (303)
T ss_pred eeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cC
Confidence 57899999999999999 689999999875533 233467889999999999999999999999999999999995 58
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++...... ....
T Consensus 89 l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~ 160 (303)
T cd07869 89 LCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP--SHTY 160 (303)
T ss_pred HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC--CccC
Confidence 8888754 3466888999999999999999999999 999999999999999999999999988642211 1112
Q ss_pred eeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcc-------hhhhhcccchhhhc
Q 021526 159 TRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS-------RPFLKDQKKFVHLV 230 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~ 230 (311)
....++..|+|||++.+ ..++.++|+|||||++|+|++|..||......... +.... ...+..........
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ-LERIFLVLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH-HHHHHHHhCCCChhhccchhhccccc
Confidence 23457889999998765 45788999999999999999999999643211000 00000 00000000000000
Q ss_pred CccCCCCCc---------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 231 DPLLHGRYP---------RRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 231 ~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
........+ ...+..+.+++.+||+.||++|||++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000000 012356889999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=277.89 Aligned_cols=264 Identities=29% Similarity=0.416 Sum_probs=199.8
Q ss_pred eeeeeeceeccEEEEEE------CCeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeC--CeeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL------CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 72 (311)
+..+|.|+||.||.+.. .++.||+|.+..... .....+.+|+++++.++||||+++++++... ...+++||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (283)
T cd05080 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIME 88 (283)
T ss_pred ceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEec
Confidence 46799999999987653 577899999865432 2446788999999999999999999987653 45789999
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCC
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~ 152 (311)
++.+++|.+++.. ..+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 89 ~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 89 YVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred CCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 9999999999943 45899999999999999999999999 999999999999999999999999998754322
Q ss_pred CCcc-eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcC
Q 021526 153 DNTH-VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231 (311)
Q Consensus 153 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
.... ......++..|+|||...+..++.++|+||||+++++|++|..|+......... ........ .....+.+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~ 238 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-MIGPKQGQ-MTVVRLIELLE 238 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh-hhcccccc-cchhhhhhhhh
Confidence 2111 111223456799999988888899999999999999999999997533211100 00000000 00111112222
Q ss_pred ccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 021526 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 275 (311)
Q Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~ 275 (311)
.......+..++..+.+++.+||+.+|++|||++++++.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 22222334456788999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=289.42 Aligned_cols=242 Identities=21% Similarity=0.246 Sum_probs=188.5
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
+..+|.|+||.||++.. +++.||||.+..... .....+.+|+++++.++|+||+++++++..+...+++|||+++++
T Consensus 79 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 158 (353)
T PLN00034 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS 158 (353)
T ss_pred hhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCc
Confidence 35789999999999998 689999999865432 234678899999999999999999999999999999999999998
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
|.+.. ...+..+..++.||+.||+|||+.+ ++|+||||+|||++.++.+||+|||++...... ....
T Consensus 159 L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~ 225 (353)
T PLN00034 159 LEGTH--------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQT--MDPC 225 (353)
T ss_pred ccccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccc--cccc
Confidence 85432 3456778889999999999999999 999999999999999999999999998753221 1112
Q ss_pred eeccccccccCCccccC-----CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 159 TRVMGTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
....|+..|+|||.+.. ...+.++|||||||++|+|++|..||............. .. ...
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~~-----------~~~ 291 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC---AI-----------CMS 291 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH---HH-----------hcc
Confidence 23468899999998743 234568999999999999999999997322111100000 00 000
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.....+..++.++.++|.+||..||++||++.|+++.
T Consensus 292 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 292 QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111233556789999999999999999999999874
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=279.12 Aligned_cols=251 Identities=30% Similarity=0.411 Sum_probs=198.4
Q ss_pred eeeeeeceeccEEEEEE-------CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWL-------CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
...+|.|+||.||.+.. .+..+++|.+..........+.+|+++++.++|+||+++++++.++...+++|||+
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (280)
T cd05092 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYM 89 (280)
T ss_pred ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecC
Confidence 45789999999999864 46789999887665555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeec
Q 021526 75 PMGSLEDHLYDLEPD-----------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 143 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~-----------~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df 143 (311)
.+++|.+++...... ...+++..++.++.|++.|++|||+.+ ++|+||+|+||++++++.++|+||
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~kL~df 166 (280)
T cd05092 90 RHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDF 166 (280)
T ss_pred CCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEEECCC
Confidence 999999999653211 135888999999999999999999999 999999999999999999999999
Q ss_pred CCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhc
Q 021526 144 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKD 222 (311)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 222 (311)
|++................++..|+|||.+.+..++.++|+||||+++|+|++ |.+||........ .
T Consensus 167 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~--------- 234 (280)
T cd05092 167 GMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA---I--------- 234 (280)
T ss_pred CceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---H---------
Confidence 98864322221111222334678999999988889999999999999999998 8888853221110 0
Q ss_pred ccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 021526 223 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 272 (311)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~ 272 (311)
... ........+..++..+.+++.+||..+|.+||++++|++.|+
T Consensus 235 ----~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 235 ----ECI-TQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ----HHH-HcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 000 000011122345677999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=284.57 Aligned_cols=247 Identities=26% Similarity=0.279 Sum_probs=194.3
Q ss_pred eeeeeeceeccEEEEEE-----CCeEEEEEEeccCC----ccchhHHHHHHHHHhcCC-CCcccceeEEEEeCCeeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL-----CDQLVAIKQLNHEG----LQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-----~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 71 (311)
...+|+|+||.||.+.. .++.||+|++.+.. ....+.+.+|+++++.++ ||+|+++++++..+...+++|
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (332)
T cd05614 5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLIL 84 (332)
T ss_pred EEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEE
Confidence 57899999999999886 57899999986432 223456788999999994 899999999999999999999
Q ss_pred ecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCC
Q 021526 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 151 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~ 151 (311)
||+.+++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++.....
T Consensus 85 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 85 DYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 99999999999943 456899999999999999999999999 99999999999999999999999999864322
Q ss_pred CCCcceeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhc
Q 021526 152 GDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 230 (311)
Q Consensus 152 ~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (311)
.. ........|+..|+|||++.+. .++.++||||||+++|+|++|..||.......... ........
T Consensus 158 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~~~~--------- 225 (332)
T cd05614 158 EE-KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVSRRILK--------- 225 (332)
T ss_pred cC-CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHHHHHhc---------
Confidence 11 1112234689999999988765 47889999999999999999999996433211110 00000000
Q ss_pred CccCCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 021526 231 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVVA 270 (311)
Q Consensus 231 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~l~~~ 270 (311)
....++...+..+.+++.+||+.||++|| +++++++.
T Consensus 226 ---~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 ---CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 01122344567789999999999999999 77788763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=263.15 Aligned_cols=241 Identities=24% Similarity=0.309 Sum_probs=205.8
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
..||.|+||+||.++. ++--||+|++.+.. .....++.+|+++-..|+||||+++|++|.++...|+++||...|
T Consensus 28 r~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~g 107 (281)
T KOG0580|consen 28 RPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRG 107 (281)
T ss_pred ccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCc
Confidence 4689999999999999 78899999987653 234468899999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
++...++. +....+++...+.++.|++.|+.|+|.++ ++||||||+|+|++..+.+|++|||.+-..+ ...
T Consensus 108 el~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p----~~k 178 (281)
T KOG0580|consen 108 ELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP----SNK 178 (281)
T ss_pred hHHHHHHh--cccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC----CCC
Confidence 99999965 45677999999999999999999999999 9999999999999999999999999986422 334
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCC
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 237 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
..+.+||..|++||...+...+...|+|++|++.|+++.|.+||+..... +...++. .++..
T Consensus 179 R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~----------------etYkrI~--k~~~~ 240 (281)
T KOG0580|consen 179 RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS----------------ETYKRIR--KVDLK 240 (281)
T ss_pred ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH----------------HHHHHHH--Hcccc
Confidence 45678999999999999999999999999999999999999999744321 1111111 11224
Q ss_pred CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 238 YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
+|...+...+++|.+||..+|.+|.+..|++..
T Consensus 241 ~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 241 FPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred CCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 456778889999999999999999999998764
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=286.17 Aligned_cols=258 Identities=22% Similarity=0.258 Sum_probs=194.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
...+|.|+||.||++.. ++..+|+|.+..... .....+.+|+++++.++||||+++++++.+++..+++|||+.+++
T Consensus 10 ~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 89 (333)
T cd06650 10 ISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 89 (333)
T ss_pred eccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCc
Confidence 46789999999999999 688999998765432 334678899999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~-~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
|.+++.. .+.+++..+..++.+++.||.|||+. + ++|+||+|+||+++.++.++|+|||++...... .
T Consensus 90 L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~----~ 158 (333)
T cd06650 90 LDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----M 158 (333)
T ss_pred HHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh----c
Confidence 9999953 45688899999999999999999974 6 999999999999999999999999998643211 1
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchh------c--------chh-----
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS------W--------SRP----- 218 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------~--------~~~----- 218 (311)
.....++..|+|||++.+..++.++|+|||||++|+|++|..||............. . ...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (333)
T cd06650 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL 238 (333)
T ss_pred cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchh
Confidence 223457889999999988889999999999999999999999986432210000000 0 000
Q ss_pred --h---hhcccchhhhcCccCCCC---C-cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 219 --F---LKDQKKFVHLVDPLLHGR---Y-PRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 219 --~---~~~~~~~~~~~~~~~~~~---~-~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
. .................. . ....+.++.+|+.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred hhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0 000000000000000000 0 11235678999999999999999999999863
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=279.16 Aligned_cols=247 Identities=25% Similarity=0.336 Sum_probs=197.7
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
..++|.|+||.||++.. +++.||+|.+..... .....+.+|+++++.++||||+++++.+..+...+++|||+.+
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05605 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCC
Confidence 46899999999999998 689999999865432 2234577899999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. .....+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++...... .
T Consensus 85 ~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---~ 156 (285)
T cd05605 85 GDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG---E 156 (285)
T ss_pred CcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC---C
Confidence 999988854 23456899999999999999999999999 999999999999999999999999998753211 1
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......|+..|+|||++.+..++.++|+||+|+++|+|++|..||......... ......+. ....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~-------------~~~~~~~~-~~~~ 222 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR-------------EEVERRVK-EDQE 222 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH-------------HHHHHHhh-hccc
Confidence 122345788999999998888999999999999999999999999643221100 00000010 0111
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVVA 270 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~l~~~ 270 (311)
.++...+..+.+++.+||..||++|| +++++++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 23445677899999999999999999 88888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=281.75 Aligned_cols=259 Identities=27% Similarity=0.366 Sum_probs=201.9
Q ss_pred eeeeeeceeccEEEEEEC---------CeEEEEEEeccCC-ccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEE
Q 021526 2 LCCYLSCKFYNVGLVWLC---------DQLVAIKQLNHEG-LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLV 70 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~---------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 70 (311)
...+|+|+||.||.+... +..+|+|.+.... ......+.+|+++++.+ +||||+++++++..+...+++
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 102 (307)
T cd05098 23 GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 102 (307)
T ss_pred eeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 467899999999999862 2469999987543 23345788899999999 799999999999999999999
Q ss_pred EecCCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCce
Q 021526 71 YEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 138 (311)
Q Consensus 71 ~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~v 138 (311)
|||+.+++|.+++..... ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+
T Consensus 103 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~ 179 (307)
T cd05098 103 VEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVM 179 (307)
T ss_pred EecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEcCCCcE
Confidence 999999999999975332 1235888999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcch
Q 021526 139 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSR 217 (311)
Q Consensus 139 kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 217 (311)
+|+|||.+................++..|+|||.+.+..++.++|+||||+++|+|++ |..||...... .
T Consensus 180 kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~------~--- 250 (307)
T cd05098 180 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE------E--- 250 (307)
T ss_pred EECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH------H---
Confidence 9999999864322111111111223467999999988889999999999999999998 77887532210 0
Q ss_pred hhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCC
Q 021526 218 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 280 (311)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~ 280 (311)
+...+........+..++..+.+++.+||..+|++||++.++++.|+.+.+....
T Consensus 251 --------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~~ 305 (307)
T cd05098 251 --------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSN 305 (307)
T ss_pred --------HHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhhc
Confidence 0000111111123345677899999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=275.94 Aligned_cols=254 Identities=24% Similarity=0.321 Sum_probs=197.7
Q ss_pred CeeeeeeceeccEEEEEEC-----CeEEEEEEeccCCcc--chhHHHHHHHHHhcCCCCcccceeEEEEeCCe------e
Q 021526 1 MLCCYLSCKFYNVGLVWLC-----DQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ------R 67 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~~-----~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~ 67 (311)
+...+|+|+||.||.+... +..||+|.+...... ....+.+|++.++.++||||+++++++..... .
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence 3467899999999999872 378999998754332 33578899999999999999999998765444 7
Q ss_pred EEEEecCCCCCHHHHhcccCC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCC
Q 021526 68 LLVYEYMPMGSLEDHLYDLEP--DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 145 (311)
Q Consensus 68 ~lv~e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~ 145 (311)
++++||+.+++|..++..... ....+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||+
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCccc
Confidence 899999999999999855322 2346899999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhccc
Q 021526 146 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQK 224 (311)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 224 (311)
++................+..|+|||.+.+..++.++|+||||+++|+|++ |..||....... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~---------- 226 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYD---------- 226 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----------
Confidence 875432222111122234567999999888889999999999999999999 888885322110 000
Q ss_pred chhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 021526 225 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274 (311)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l 274 (311)
.+........+..++..+.+++.+||+.||++||++.++++.|+++
T Consensus 227 ----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 227 ----YLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ----HHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000011122345677899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=276.40 Aligned_cols=255 Identities=22% Similarity=0.252 Sum_probs=203.1
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
...+|+|++|.||++.. +++.+++|.+..... ....++.+|+.+++.++||||+++++++..+...++++|++.+
T Consensus 7 ~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~ 86 (267)
T cd08229 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA 86 (267)
T ss_pred hhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCC
Confidence 35689999999999997 889999998765432 2335788999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.........+++..++.++.|++.+++|||+++ ++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--~ 161 (267)
T cd08229 87 GDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--T 161 (267)
T ss_pred CCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccCC--c
Confidence 9999998654444567899999999999999999999999 9999999999999999999999999876432211 1
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......++..|+|||...+..++.++|+||||+++|+|++|..||...... ...... .......+.
T Consensus 162 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~-------~~~~~~~~~--- 227 (267)
T cd08229 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCK-------KIEQCDYPP--- 227 (267)
T ss_pred ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhh-------hhhcCCCCC---
Confidence 122345788899999998888999999999999999999999998532211 000000 000000000
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 275 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~ 275 (311)
..+...+..+.+++.+||..+|++|||+.+|.+.+.++.
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 228 LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 011245678999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=287.19 Aligned_cols=247 Identities=21% Similarity=0.199 Sum_probs=195.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
...+|.|+||.||++.. +++.||+|.+..... .....+.+|+.+++.++||||+++++++.++...++||||+++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (330)
T cd05601 6 KSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPG 85 (330)
T ss_pred EEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCC
Confidence 46899999999999998 789999999875432 2345678899999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.........
T Consensus 86 ~~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~- 158 (330)
T cd05601 86 GDLLSLLNR---YEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV- 158 (330)
T ss_pred CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCce-
Confidence 999999965 3357899999999999999999999999 999999999999999999999999998754322211
Q ss_pred eeeeccccccccCCcccc------CCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhc
Q 021526 157 VSTRVMGTYGYCAPEYAM------SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 230 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~------~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (311)
......++..|+|||++. ...++.++|+||||+++|+|++|..||........ ...... .
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~~-~------- 224 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNNIMN-F------- 224 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHHHHc-C-------
Confidence 223346889999999886 45678899999999999999999999964322110 000000 0
Q ss_pred CccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 231 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 231 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
............+..+.+++.+||. +|++||+++++++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 225 QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0001111112356778999999998 99999999999863
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=274.58 Aligned_cols=248 Identities=27% Similarity=0.399 Sum_probs=195.9
Q ss_pred eeeeeceeccEEEEEE--CC---eEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 3 CCYLSCKFYNVGLVWL--CD---QLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~---~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
.++|+|++|.||++.. .+ ..|++|.+..... ...+.+.+|+++++.++|||++++++++. ....+++||++.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 3689999999999987 22 6899999875543 24467889999999999999999999876 4568999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ...+++..++.++.|++.++++||+.+ ++|+||+|+||+++.++.++|+|||.+..........
T Consensus 80 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 999999954 347899999999999999999999999 9999999999999999999999999987543222111
Q ss_pred e-eeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccC
Q 021526 157 V-STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 157 ~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
. .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||....... ... .+....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~--------------~~~~~~ 215 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIA--------------MLESGE 215 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHH--------------HHHcCC
Confidence 1 111223457999999988889999999999999999998 899986332110 000 000011
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 275 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~ 275 (311)
....+..++..+.+++.+||..+|++||++.+|++.|+.+.
T Consensus 216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 11233455678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=276.30 Aligned_cols=252 Identities=26% Similarity=0.350 Sum_probs=195.5
Q ss_pred eeeeeeceeccEEEEEE--CCe----EEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQ----LVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~----~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
+..+|.|+||.||++.. +++ +|++|.+..... .....+..|+..+..++||||+++++++. +...++++|++
T Consensus 12 ~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~ 90 (279)
T cd05111 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLS 90 (279)
T ss_pred ccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeC
Confidence 46799999999999988 444 578888753322 23356777888899999999999999875 44578899999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
.+++|.+++.. ....+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 91 ~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T cd05111 91 PLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164 (279)
T ss_pred CCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence 99999999964 3457899999999999999999999999 99999999999999999999999999875433222
Q ss_pred cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 155 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
........++..|++||.+.+..++.++|+||||+++|++++ |..||........ .+.+...
T Consensus 165 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-----------------~~~~~~~ 227 (279)
T cd05111 165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-----------------PDLLEKG 227 (279)
T ss_pred ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-----------------HHHHHCC
Confidence 222223446678999999988889999999999999999998 9889864321110 0001000
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 277 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~ 277 (311)
.....+..+...+.+++.+||..+|.+|||+.|+++.|..+...
T Consensus 228 ~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 228 ERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 00011122455688999999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=285.43 Aligned_cols=242 Identities=27% Similarity=0.323 Sum_probs=192.3
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
.++|+|+||.||.+.. +++.||+|++.+... ...+.+.+|..++..+ +||+|+++++++.+....++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3689999999999998 688999999875432 2335677899988887 699999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|..++. ....+++..+..++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++..... ...
T Consensus 81 ~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~ 151 (327)
T cd05617 81 GDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGD 151 (327)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccC--CCC
Confidence 99999884 3457999999999999999999999999 99999999999999999999999998864211 112
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......|+..|+|||++.+..++.++|+||||+++|+|++|..||................... ... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~---------~~~--~~ 220 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI---------LEK--PI 220 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH---------HhC--CC
Confidence 2234568999999999998899999999999999999999999996433222211111111110 111 11
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLI 264 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~ 264 (311)
..|...+..+.+++.+||+.||++|+++
T Consensus 221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 221 RIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 2344456778999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=282.79 Aligned_cols=259 Identities=25% Similarity=0.346 Sum_probs=201.1
Q ss_pred eeeeeeceeccEEEEEE---------CCeEEEEEEeccCC-ccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEE
Q 021526 2 LCCYLSCKFYNVGLVWL---------CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLV 70 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 70 (311)
...+|.|+||.||.+.. .+..||+|.+.... ......+.+|+++++.+ +||||+++++++..+...+++
T Consensus 17 ~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 96 (334)
T cd05100 17 GKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVL 96 (334)
T ss_pred cceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEE
Confidence 45789999999999975 12378999876443 23346788999999999 799999999999999999999
Q ss_pred EecCCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCce
Q 021526 71 YEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 138 (311)
Q Consensus 71 ~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~v 138 (311)
+||+.+++|.+++..... ....+.+..+..++.|++.||+|||+++ ++|+||+|+||+++.++.+
T Consensus 97 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~~~~~~ 173 (334)
T cd05100 97 VEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVTEDNVM 173 (334)
T ss_pred EecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcE
Confidence 999999999999965321 2245788889999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcch
Q 021526 139 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSR 217 (311)
Q Consensus 139 kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 217 (311)
+|+|||+++...............++..|+|||.+.+..++.++|+||||+++|+|++ |..||....... ...
T Consensus 174 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~ 247 (334)
T cd05100 174 KIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE------LFK 247 (334)
T ss_pred EECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH------HHH
Confidence 9999999864322211111122233467999999988889999999999999999998 788875322111 000
Q ss_pred hhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCC
Q 021526 218 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 280 (311)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~ 280 (311)
. +........+..++..+.+++.+||+.+|++||++.++++.|+++......
T Consensus 248 ~-----------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~ 299 (334)
T cd05100 248 L-----------LKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299 (334)
T ss_pred H-----------HHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC
Confidence 0 000111122334567899999999999999999999999999999865554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=288.03 Aligned_cols=261 Identities=22% Similarity=0.268 Sum_probs=191.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccC--CccchhHHHHHHHHHhcCCCCcccceeEEEEeC-----CeeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG-----DQRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e 72 (311)
...+|.|++|.||.+.. +++.||+|.+... .......+.+|+++++.++||||+++++++... ...+++||
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e 84 (338)
T cd07859 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE 84 (338)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEe
Confidence 46899999999999998 6899999998643 223345688999999999999999999987533 24799999
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCC
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~ 152 (311)
|+. ++|.+++. ....+++..+..++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||++......
T Consensus 85 ~~~-~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 85 LME-SDLHQVIK----ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred cCC-CCHHHHHH----hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 995 68998884 3456899999999999999999999999 999999999999999999999999998743221
Q ss_pred CCc-ceeeeccccccccCCccccC--CCCCccccchhHHHHHHHHHhCCCCccccCccccccchh---------cchhhh
Q 021526 153 DNT-HVSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS---------WSRPFL 220 (311)
Q Consensus 153 ~~~-~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---------~~~~~~ 220 (311)
... .......++..|+|||++.+ ..++.++|||||||++|+|++|.+||............. ......
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 111 11123458899999998875 578899999999999999999999996443211100000 000000
Q ss_pred h-cccchhhhcCccCCCCCc---HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 221 K-DQKKFVHLVDPLLHGRYP---RRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 221 ~-~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
. .................+ +..+..+.+++.+||+.||++||+++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0 000000000000000000 1235668899999999999999999999973
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=284.60 Aligned_cols=239 Identities=29% Similarity=0.372 Sum_probs=190.9
Q ss_pred eeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhc-CCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 4 CYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSL-LHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
.+|+|+||.||++.. .++.||+|.+.... .........|..++.. ++||||+++++++.++...++||||+.++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 689999999999998 57899999987542 2233456677777765 48999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 82 ~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05619 82 DLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK 152 (316)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence 99999943 456888999999999999999999999 9999999999999999999999999886421111 12
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCC
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 237 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
.....|+..|+|||++.+..++.++|+|||||++|+|++|..||....... ..... .... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~~~~i--------~~~~----~~ 214 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE------LFQSI--------RMDN----PC 214 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH------HHHHH--------HhCC----CC
Confidence 233468899999999988899999999999999999999999996432110 00000 0000 11
Q ss_pred CcHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 021526 238 YPRRCLNYAVAVTAMCLNEEANFRPLIN-DIVV 269 (311)
Q Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~RPs~~-~l~~ 269 (311)
++...+.++.+++.+||+.+|++||++. ++++
T Consensus 215 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 215 YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 2334567789999999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=284.93 Aligned_cols=256 Identities=26% Similarity=0.344 Sum_probs=197.5
Q ss_pred eeeeeeceeccEEEEEE-------CCeEEEEEEeccCCc-cchhHHHHHHHHHhcC-CCCcccceeEEEEe-CCeeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL-------CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTS-GDQRLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~~lv~ 71 (311)
...+|.|+||.||.++. .++.||+|++..... ...+.+.+|++++..+ +|+||+++++++.. +...++++
T Consensus 12 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ 91 (337)
T cd05054 12 GKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 91 (337)
T ss_pred hcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEE
Confidence 46799999999999975 247899999864432 2335678899999999 79999999998754 45688999
Q ss_pred ecCCCCCHHHHhcccCCC---------------------------------------------------------CCCCC
Q 021526 72 EYMPMGSLEDHLYDLEPD---------------------------------------------------------QEPLS 94 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~---------------------------------------------------------~~~l~ 94 (311)
||+.+++|.+++...... ...++
T Consensus 92 ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 171 (337)
T cd05054 92 EYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLT 171 (337)
T ss_pred ecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCC
Confidence 999999999998542210 13678
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeeeccccccccCCcccc
Q 021526 95 WNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 174 (311)
Q Consensus 95 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 174 (311)
+..+..++.|++.||+|||+++ ++|+||||.||+++.++.++|+|||++................++..|+|||.+.
T Consensus 172 ~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 248 (337)
T cd05054 172 LEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIF 248 (337)
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhc
Confidence 8999999999999999999999 9999999999999999999999999987543222111122334567899999999
Q ss_pred CCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHh
Q 021526 175 SGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMC 253 (311)
Q Consensus 175 ~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 253 (311)
+..++.++|+|||||++|+|++ |..||........ +...+........+.....++.+++.+|
T Consensus 249 ~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~~c 312 (337)
T cd05054 249 DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE----------------FCRRLKEGTRMRAPEYATPEIYSIMLDC 312 (337)
T ss_pred CCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH----------------HHHHHhccCCCCCCccCCHHHHHHHHHH
Confidence 9999999999999999999997 9999853211100 0000011111112334567799999999
Q ss_pred hccCCCCCCCHHHHHHHHHHhhh
Q 021526 254 LNEEANFRPLINDIVVALDYLVS 276 (311)
Q Consensus 254 l~~~p~~RPs~~~l~~~L~~l~~ 276 (311)
|+.+|++||++.++++.|..+.+
T Consensus 313 l~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 313 WHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred ccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=291.13 Aligned_cols=247 Identities=24% Similarity=0.222 Sum_probs=197.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
...+|.|++|.||++.. +++.||+|.+.... ......+.+|++++..++||||+++++++.++...++||||+.+
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (350)
T cd05573 6 IKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPG 85 (350)
T ss_pred EEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCC
Confidence 57899999999999999 59999999987542 23445788899999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCC---
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD--- 153 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~--- 153 (311)
++|.+++.. ...+++..+..++.|++.||+|||+.| ++|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 86 GDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 999999954 367899999999999999999999999 9999999999999999999999999987543222
Q ss_pred ------------------------CcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCcccc
Q 021526 154 ------------------------NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE 209 (311)
Q Consensus 154 ------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 209 (311)
.........|+..|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 238 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence 00112234588999999999999999999999999999999999999964331110
Q ss_pred ccchhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 021526 210 QNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-INDIVVA 270 (311)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs-~~~l~~~ 270 (311)
...... .. ...........+..+.++|.+||. +|.+||+ ++++++.
T Consensus 239 ------~~~i~~----~~----~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 239 ------YNKIIN----WK----ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred ------HHHHhc----cC----CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 000000 00 000001111246789999999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=273.52 Aligned_cols=244 Identities=27% Similarity=0.361 Sum_probs=195.5
Q ss_pred eeeeeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEE-EeCCeeEEEEecCCCCCHH
Q 021526 2 LCCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC-TSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~ 80 (311)
...+|.|++|.||++...++.|++|.+... ...+.+.+|+.+++.++|+|++++++++ ..+...++++|++.+++|.
T Consensus 11 ~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~ 88 (256)
T cd05082 11 LQTIGKGEFGDVMLGDYRGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 88 (256)
T ss_pred eeeecccCCCeEEEEEEcCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHH
Confidence 467899999999999999999999997533 2346788999999999999999999875 4556789999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++.. .....+++..++.++.|++.+|++||+++ ++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 89 ~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-----~~~ 158 (256)
T cd05082 89 DYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDT 158 (256)
T ss_pred HHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecccc-----CCC
Confidence 99865 23345889999999999999999999999 999999999999999999999999988643221 112
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
..++..|+|||.+.+..++.++|+||||+++|+|++ |..||...... ... ..+........+
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~------~~~-----------~~~~~~~~~~~~ 221 (256)
T cd05082 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------DVV-----------PRVEKGYKMDAP 221 (256)
T ss_pred CccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH------HHH-----------HHHhcCCCCCCC
Confidence 234567999999988889999999999999999997 88888522110 000 000001111223
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l 274 (311)
..++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 222 DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 45677899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=285.71 Aligned_cols=236 Identities=24% Similarity=0.246 Sum_probs=187.6
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHHH-HHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEVL-MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+++|.|+||.||.+.. +++.||+|++.+... .....+..|.. +++.++||||+++++++..+...+++|||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3689999999999998 789999999865422 22334555554 46778999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|..++. ....+++..+..++.||+.||+|||+.| ++|+||||+||+++.++.++|+|||++..... ...
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~ 151 (325)
T cd05604 81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSD 151 (325)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCC
Confidence 99998884 3567899999999999999999999999 99999999999999999999999999864211 111
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......|+..|+|||++.+..++.++|+|||||++|+|++|..||....... ..... .....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~~~~~----------~~~~~-- 213 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE------MYDNI----------LHKPL-- 213 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH------HHHHH----------HcCCc--
Confidence 2234568999999999999899999999999999999999999996432110 00011 11111
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLIN 265 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~ 265 (311)
..++..+..+.+++.+||+.+|.+||++.
T Consensus 214 ~~~~~~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 214 VLRPGASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred cCCCCCCHHHHHHHHHHhccCHHhcCCCC
Confidence 11234566788999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=273.36 Aligned_cols=247 Identities=24% Similarity=0.322 Sum_probs=194.2
Q ss_pred eeeeceeccEEEEEE----CCeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 4 CYLSCKFYNVGLVWL----CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
.+|.|+||.||.+.. .+..||+|.+..... ...+.+.+|+++++.++||||+++++++.. ...++||||+.+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 379999999999976 345799999865532 234568899999999999999999998754 56899999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce-
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV- 157 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~- 157 (311)
|.+++.. ....+++..++.++.|++.|+++||+++ ++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9999854 3457899999999999999999999999 99999999999999999999999999864322221111
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
.....++..|+|||.+....++.++|+||||+++|++++ |..||....... ....+......
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----------------~~~~~~~~~~~ 217 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-----------------VMSFIEQGKRL 217 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-----------------HHHHHHCCCCC
Confidence 111223568999999888889999999999999999996 999986332110 00111111112
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l 274 (311)
..+..++.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 23445678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=273.61 Aligned_cols=246 Identities=26% Similarity=0.356 Sum_probs=194.5
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
+..+|.|.+|.||.+.. ++..||+|.+.... ...+.+.+|+++++.++||||+++++++......+++|||+.+++|.
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 87 (256)
T cd05113 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLL 87 (256)
T ss_pred eeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHH
Confidence 46789999999999988 55579999876443 34467899999999999999999999999888899999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++.. ....+++..++.++.|++.||+|||+.+ ++|+||+|.||+++.++.++|+|||.+........ .....
T Consensus 88 ~~i~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~~ 160 (256)
T cd05113 88 NYLRE---HGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSSVG 160 (256)
T ss_pred HHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce-eecCC
Confidence 99964 2346899999999999999999999999 99999999999999999999999998864322211 11111
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
..++..|++||...+..++.++|+||||+++|+|++ |..||........ .. .. .. ......+
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~---~~----------~~-~~~~~~~ 223 (256)
T cd05113 161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET---VE---KV----------SQ-GLRLYRP 223 (256)
T ss_pred CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HH---HH----------hc-CCCCCCC
Confidence 234567999999988889999999999999999998 8888853321100 00 00 00 0001112
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 272 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~ 272 (311)
...+..+.+++.+||..+|.+||++.+|++.|+
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 234677999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=273.96 Aligned_cols=245 Identities=27% Similarity=0.332 Sum_probs=194.8
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
...+|.|.+|.||.+.. .+..+++|.+... ......+.+|+++++.++||||+++++++......+++||++.+++|.
T Consensus 9 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 87 (256)
T cd05059 9 LKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLL 87 (256)
T ss_pred hhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHH
Confidence 35789999999999988 5678999987543 233457888999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++.. ....+++..++.++.|++.++++||+.+ ++|+||+|+||+++.++.++|+|||.++..... .......
T Consensus 88 ~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~-~~~~~~~ 160 (256)
T cd05059 88 NYLRE---RKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD-QYTSSQG 160 (256)
T ss_pred HHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccc-cccccCC
Confidence 99964 2347899999999999999999999999 999999999999999999999999988643221 1111111
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
..++..|+|||.+.+..++.++|+||||+++|+|++ |..||........ . ..+........+
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----------~-------~~~~~~~~~~~~ 223 (256)
T cd05059 161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV----------V-------ESVSAGYRLYRP 223 (256)
T ss_pred CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH----------H-------HHHHcCCcCCCC
Confidence 223457999999988889999999999999999998 7888863321100 0 000011111223
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 271 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L 271 (311)
..++..+.+++.+||..+|++|||+.++++.|
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 34677899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=279.17 Aligned_cols=251 Identities=25% Similarity=0.338 Sum_probs=197.8
Q ss_pred eeeeeceeccEEEEEE-------CCeEEEEEEeccCC-ccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEec
Q 021526 3 CCYLSCKFYNVGLVWL-------CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~-------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
..+|.|+||.||.+.. .+..||+|.+.... ....+.+.+|+++++.+ +||||+++++++......+++|||
T Consensus 41 ~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 120 (302)
T cd05055 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEY 120 (302)
T ss_pred ceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEc
Confidence 4689999999999875 34589999886543 23345788999999999 799999999999999999999999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 153 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~ 153 (311)
+.+++|.+++.. .....+++..+..++.+++.+|+|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 121 ~~~~~L~~~i~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 195 (302)
T cd05055 121 CCYGDLLNFLRR--KRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDS 195 (302)
T ss_pred CCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccccccCCC
Confidence 999999999964 22344899999999999999999999999 9999999999999999999999999987543222
Q ss_pred CcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCc
Q 021526 154 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 232 (311)
Q Consensus 154 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
.........++..|+|||.+.+..++.++|+||||+++|+|++ |..||........ +......
T Consensus 196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~----------------~~~~~~~ 259 (302)
T cd05055 196 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK----------------FYKLIKE 259 (302)
T ss_pred ceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH----------------HHHHHHc
Confidence 2112222345678999999988889999999999999999998 8999853322110 0001111
Q ss_pred cCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 021526 233 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274 (311)
Q Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l 274 (311)
......+...+..+.+++.+||..+|++||++.++++.|.++
T Consensus 260 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 260 GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 111111223456799999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=277.86 Aligned_cols=251 Identities=26% Similarity=0.376 Sum_probs=198.6
Q ss_pred eeeeeeceeccEEEEEEC-------CeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWLC-------DQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~-------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
...+|.|+||.||.+... ++.|++|.+.... ......+.+|+++++.++||||+++++++..+...+++||+
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 90 (277)
T cd05032 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMEL 90 (277)
T ss_pred EeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEec
Confidence 467899999999999873 3789999976443 23345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcccCC------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 74 MPMGSLEDHLYDLEP------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
+.+++|.+++..... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~dfg~~~ 167 (277)
T cd05032 91 MAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTR 167 (277)
T ss_pred CCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECCcccch
Confidence 999999999965332 1234788899999999999999999999 9999999999999999999999999986
Q ss_pred cCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccch
Q 021526 148 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 226 (311)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
...............++..|+|||.+.+..++.++|+||||+++|++++ |..||........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~----------------- 230 (277)
T cd05032 168 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV----------------- 230 (277)
T ss_pred hhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH-----------------
Confidence 5332222122223345678999999988889999999999999999998 8888853221110
Q ss_pred hhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 021526 227 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 272 (311)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~ 272 (311)
.+..........+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 231 LKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 0011111111233445778999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=273.87 Aligned_cols=245 Identities=23% Similarity=0.237 Sum_probs=198.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
...+|.|++|.||.+.. +++.+++|.+.... ....+.+.+|+.+++.++|+|++++++.+.++...++++||+.+++
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 84 (255)
T cd08219 5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGD 84 (255)
T ss_pred EEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCc
Confidence 46899999999999988 78999999986432 3445678899999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
|.+++.. .....+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+...... ....
T Consensus 85 l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--~~~~ 157 (255)
T cd08219 85 LMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP--GAYA 157 (255)
T ss_pred HHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccc--cccc
Confidence 9998854 23456889999999999999999999999 999999999999999999999999998653221 1122
Q ss_pred eeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCC
Q 021526 159 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRY 238 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
....++..|+|||++.+..++.++|+||||+++|+|++|..||....... ..... . .......
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~----------~-~~~~~~~ 220 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN------LILKV----------C-QGSYKPL 220 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH------HHHHH----------h-cCCCCCC
Confidence 23457888999999988889999999999999999999999996322100 00000 0 0001112
Q ss_pred cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 239 PRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 239 ~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
+...+..+.+++.+||+.+|++||++.+++..
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 34456679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=288.97 Aligned_cols=244 Identities=22% Similarity=0.230 Sum_probs=193.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
..++|.|+||.||++.. +++.||+|.+.+.. ......+.+|+.+++.++||||+++++++.++...++||||+.+
T Consensus 48 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~g 127 (370)
T cd05596 48 IKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPG 127 (370)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCC
Confidence 56899999999999998 68999999986432 22334577899999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||++........ .
T Consensus 128 g~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~-~ 198 (370)
T cd05596 128 GDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-V 198 (370)
T ss_pred CcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc-c
Confidence 999999843 45788889999999999999999999 99999999999999999999999999865322111 1
Q ss_pred eeeeccccccccCCccccCC----CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCc
Q 021526 157 VSTRVMGTYGYCAPEYAMSG----KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 232 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~----~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
......|++.|+|||++.+. .++.++|+|||||++|+|++|..||........ ...+...
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~----------------~~~i~~~ 262 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT----------------YSKIMDH 262 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH----------------HHHHHcC
Confidence 12235689999999988653 478899999999999999999999964332100 0111110
Q ss_pred cCCCCCc--HHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 021526 233 LLHGRYP--RRCLNYAVAVTAMCLNEEANF--RPLINDIVVA 270 (311)
Q Consensus 233 ~~~~~~~--~~~~~~l~~li~~~l~~~p~~--RPs~~~l~~~ 270 (311)
.....++ ...+..+.++|.+||+.+|++ ||+++++++.
T Consensus 263 ~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 263 KNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0001111 235678999999999999988 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=276.56 Aligned_cols=251 Identities=26% Similarity=0.337 Sum_probs=196.0
Q ss_pred eeeeeeceeccEEEEEEC-------CeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWLC-------DQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~-------~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
...+|+|++|.||++... +..|++|.+..... .....+.+|+.+++.++|+||+++++++.+....+++||+
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 90 (277)
T cd05036 11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLEL 90 (277)
T ss_pred eeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEec
Confidence 467899999999999983 47899998764432 2335688999999999999999999999888889999999
Q ss_pred CCCCCHHHHhcccCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCC---ceEEeecCCCc
Q 021526 74 MPMGSLEDHLYDLEP---DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF---NPKLSDFGLAK 147 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~---~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~---~vkl~Df~~~~ 147 (311)
+.+++|.+++..... ....+++..++.++.|++.+|+|||+++ ++|+||+|+||+++.++ .++|+|||.+.
T Consensus 91 ~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~ 167 (277)
T cd05036 91 MAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167 (277)
T ss_pred CCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEeccCcccc
Confidence 999999999965332 1235889999999999999999999999 99999999999998765 58999999987
Q ss_pred cCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccch
Q 021526 148 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 226 (311)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
................+..|+|||.+.+..++.++|+|||||++|+|++ |..||........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~----------------- 230 (277)
T cd05036 168 DIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV----------------- 230 (277)
T ss_pred ccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-----------------
Confidence 5422111111112223467999999988889999999999999999997 8889863322110
Q ss_pred hhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 021526 227 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 272 (311)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~ 272 (311)
...+........+..++..+.+++.+||+.+|++||++.+|++.|.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 231 MEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0111111112234455678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=271.62 Aligned_cols=245 Identities=27% Similarity=0.345 Sum_probs=195.4
Q ss_pred eeeeceeccEEEEEE-CCeEEEEEEeccCCcc-chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHHH
Q 021526 4 CYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (311)
++|+|++|.||++.. +++.||+|.+...... ....+.+|+++++.++||||+++++++......+++|||+.+++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 689999999999988 7889999998654332 23468899999999999999999999999999999999999999999
Q ss_pred HhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeeec
Q 021526 82 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 161 (311)
Q Consensus 82 ~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~~ 161 (311)
++.. ....+.+..++.++.+++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 82 ~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~ 154 (250)
T cd05085 82 FLRK---KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLK 154 (250)
T ss_pred HHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCC
Confidence 9854 3346889999999999999999999999 99999999999999999999999998864322111 111122
Q ss_pred cccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCcH
Q 021526 162 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPR 240 (311)
Q Consensus 162 ~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (311)
.++..|+|||.+.+..++.++|+||||+++|++++ |..||........ . ...........+.
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~------~-----------~~~~~~~~~~~~~ 217 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA------R-----------EQVEKGYRMSCPQ 217 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH------H-----------HHHHcCCCCCCCC
Confidence 34567999999988889999999999999999998 8889853321100 0 0000011112234
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 021526 241 RCLNYAVAVTAMCLNEEANFRPLINDIVVALD 272 (311)
Q Consensus 241 ~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~ 272 (311)
.++..+.+++.+||..+|++||++.++++.|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 45678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=287.88 Aligned_cols=250 Identities=23% Similarity=0.332 Sum_probs=209.3
Q ss_pred eeeeeeceeccEEEEEEC----C--eEEEEEEeccC-CccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWLC----D--QLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~----~--~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
-+++|.|-||.||+|++. | -.||||..+.. .+++.+.|..|+.+++.++||||+++++++.+ ...|+|||.+
T Consensus 394 ~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL~ 472 (974)
T KOG4257|consen 394 KRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMELA 472 (974)
T ss_pred HHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEecc
Confidence 468999999999999992 2 36888887653 45667889999999999999999999999864 5899999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
.-|.|..|++. ....++......++.||+.||+|||+.. +|||||...||||....-|||+|||+++.......
T Consensus 473 ~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 473 PLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY 546 (974)
T ss_pred cchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence 99999999965 6678999999999999999999999999 99999999999999999999999999997644433
Q ss_pred cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 155 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
...+ ...-+..|+|||-+.-..++.++|||.||+++||+++ |..||..-.. ...--.+...
T Consensus 547 YkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN-----------------sDVI~~iEnG 608 (974)
T KOG4257|consen 547 YKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN-----------------SDVIGHIENG 608 (974)
T ss_pred hhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc-----------------cceEEEecCC
Confidence 3332 3445778999999988999999999999999999976 7889863221 1111122333
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 276 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~ 276 (311)
-+-..|+.|+..|..++.+||.++|.+||.+.++...|..+..
T Consensus 609 eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 609 ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 4446788999999999999999999999999999998877766
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=272.85 Aligned_cols=248 Identities=28% Similarity=0.402 Sum_probs=197.4
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
..++|+|+||.||.+.. +++.||+|.+.... ....++.+|+++++.++|+|++++++++. +...+++||++.+++|.
T Consensus 11 ~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 88 (260)
T cd05067 11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLV 88 (260)
T ss_pred eeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHH
Confidence 56899999999999998 78999999986443 34568899999999999999999999874 45689999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++.. ..+..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 89 ~~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~~ 162 (260)
T cd05067 89 DFLKT--PEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE-YTAREG 162 (260)
T ss_pred HHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC-cccccC
Confidence 99854 23457889999999999999999999999 9999999999999999999999999986532111 111122
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
..++..|+|||.+....++.++|+||||+++|++++ |..||........ .. .. ........+
T Consensus 163 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~----~~----------~~~~~~~~~ 225 (260)
T cd05067 163 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---IQ----NL----------ERGYRMPRP 225 (260)
T ss_pred CcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---HH----HH----------HcCCCCCCC
Confidence 335678999999988889999999999999999998 9999863321100 00 00 000111122
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l 274 (311)
...+.++.+++.+||+.+|++||+++++++.|+.+
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 226 DNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 34466799999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=275.08 Aligned_cols=247 Identities=25% Similarity=0.266 Sum_probs=194.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
.+.+|+|+||.||++.. +++.||+|.+..........+.+|+.+++.++||||+++++++..+...+++|||+.+++|
T Consensus 14 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L 93 (267)
T cd06646 14 IQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSL 93 (267)
T ss_pred hheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcH
Confidence 46799999999999998 7899999998765555556788999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
.+++.. ...+++..+..++.|++.++.|||+.+ ++|+||+|.||+++.++.++|+|||++....... ....
T Consensus 94 ~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~~ 164 (267)
T cd06646 94 QDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI--AKRK 164 (267)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc--cccC
Confidence 998843 456889999999999999999999999 9999999999999999999999999987532211 1112
Q ss_pred eccccccccCCcccc---CCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 160 RVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
...++..|+|||.+. ...++.++|+||+|+++|+|++|..||.......... ... ... ...+..
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--~~~------~~~---~~~~~~-- 231 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--LMS------KSN---FQPPKL-- 231 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--eee------cCC---CCCCCC--
Confidence 235778899999874 3457789999999999999999999985332111100 000 000 000000
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
......+..+.+++.+||..+|++||+++++++.
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 0112345679999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=273.29 Aligned_cols=248 Identities=27% Similarity=0.387 Sum_probs=198.4
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
...+|.|++|.||++.. +++.|++|.+... .....++.+|+++++.++|+|++++++++..+...+++||++++++|.
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 89 (261)
T cd05034 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLL 89 (261)
T ss_pred eeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHH
Confidence 45789999999999988 6688999998644 344567999999999999999999999999888999999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++.. .....+++..+..++.+++.|+.+||+++ ++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 90 ~~i~~--~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~ 163 (261)
T cd05034 90 DFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE-YTAREG 163 (261)
T ss_pred HHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh-hhhhhc
Confidence 99965 23457899999999999999999999999 9999999999999999999999999986533211 111112
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
...+..|+|||.+.+..++.++|+||||++++++++ |+.||....... ... .. ........+
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~---~~-----------~~~~~~~~~ 226 (261)
T cd05034 164 AKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLE---QV-----------ERGYRMPRP 226 (261)
T ss_pred cCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---HH-----------HcCCCCCCC
Confidence 224567999999988889999999999999999998 899985322110 000 00 000111122
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 273 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~ 273 (311)
...+..+.+++.+||..+|++||+++++.+.|+.
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 3346779999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=274.85 Aligned_cols=253 Identities=25% Similarity=0.323 Sum_probs=194.4
Q ss_pred eeeeeeceeccEEEEEE--CC--eEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeC------CeeEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CD--QLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG------DQRLL 69 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~--~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~l 69 (311)
-..+|.|+||.||++.. .+ ..||+|.+.... ....+.+.+|+++++.++||||+++++++... ...++
T Consensus 4 ~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 83 (272)
T cd05075 4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVV 83 (272)
T ss_pred ccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEE
Confidence 35789999999999998 23 369999876542 23346788899999999999999999876432 24689
Q ss_pred EEecCCCCCHHHHhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 70 VYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 70 v~e~~~~~~L~~~l~~~~--~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
++||+.+++|.+++.... .....+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++.
T Consensus 84 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 84 ILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred EEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCccc
Confidence 999999999999875322 23356899999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccch
Q 021526 148 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 226 (311)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
...............++..|++||...+..++.++|+||||+++|+|++ |..||....... .. .......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~----~~~~~~~-- 231 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IY----DYLRQGN-- 231 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHHcCC--
Confidence 5432221111222345678999999988889999999999999999999 788886322110 00 0011000
Q ss_pred hhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 021526 227 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274 (311)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l 274 (311)
....+..++..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 232 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 --------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0112334566799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=290.55 Aligned_cols=247 Identities=23% Similarity=0.225 Sum_probs=194.1
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+..+|.|+||.||.+.. .++.||||++.... ......+.+|++++..++||||+++++++.++...++||||+.+
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 85 (364)
T cd05599 6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPG 85 (364)
T ss_pred EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCC
Confidence 57899999999999998 68999999987542 22335678899999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||||+|||++.++.++|+|||++..........
T Consensus 86 g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 86 GDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred cHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 999999953 456899999999999999999999999 9999999999999999999999999876432111000
Q ss_pred ------------------------------------eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCC
Q 021526 157 ------------------------------------VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 200 (311)
Q Consensus 157 ------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 200 (311)
......|++.|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 00123589999999999988999999999999999999999999
Q ss_pred ccccCccccccchhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 021526 201 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL---INDIVVA 270 (311)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs---~~~l~~~ 270 (311)
|........ ...... .. ..+........+..+.++|.+|+. +|.+|++ +.++++.
T Consensus 239 f~~~~~~~~------~~~i~~-~~-------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 239 FCSDNPQET------YRKIIN-WK-------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCHHHH------HHHHHc-CC-------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 964332110 000000 00 000000011345678999999996 9999998 8888773
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=282.98 Aligned_cols=240 Identities=23% Similarity=0.290 Sum_probs=203.2
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCcc--chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
.-+|+|+|..|-.+.. .|.+||||++.+...+ ...++.+|++.++.++||||+++|++.++...+|+|+|.-++|+
T Consensus 24 kTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GD 103 (864)
T KOG4717|consen 24 KTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGD 103 (864)
T ss_pred hhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCch
Confidence 3589999999988887 9999999999876544 33589999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE-cCCCceEEeecCCCccCCCCCCcce
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL-DNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~-~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
|.+||-+ ....+.++.+.+++.||+.|+.|+|+.. +||+|+||+|+.+ .+-|-|||.|||++..+.+ ...
T Consensus 104 l~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P---G~k 174 (864)
T KOG4717|consen 104 LFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP---GKK 174 (864)
T ss_pred HHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC---cch
Confidence 9999965 6688999999999999999999999998 9999999999876 5678899999999875432 233
Q ss_pred eeeccccccccCCccccCCCCC-ccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 158 STRVMGTYGYCAPEYAMSGKLT-LKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
-.+.+|...|.|||++.+..|+ ++.||||||+++|.|++|++||+..+..+. +.-+.+-. .
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET----------------LTmImDCK--Y 236 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET----------------LTMIMDCK--Y 236 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh----------------hhhhhccc--c
Confidence 4457899999999999998887 899999999999999999999974443222 22222111 1
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..|...+.+.++||..||..||++|.++++|..
T Consensus 237 tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 237 TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 346678889999999999999999999999874
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=288.27 Aligned_cols=253 Identities=21% Similarity=0.177 Sum_probs=190.1
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
+..+|.|+||.||.+.. .++.||+|... ...+.+|+++++.++||||+++++++..+...++++|++. ++|
T Consensus 97 ~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L 169 (391)
T PHA03212 97 LETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDL 169 (391)
T ss_pred EEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCH
Confidence 56889999999999999 78999999743 2357789999999999999999999999999999999985 688
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
..++.. ...+++..++.++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++....... .....
T Consensus 170 ~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~~~ 241 (391)
T PHA03212 170 YCYLAA----KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANKYY 241 (391)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-ccccc
Confidence 888843 456889999999999999999999999 9999999999999999999999999986422111 11222
Q ss_pred eccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccc-----cchhcchh-------hh-hcccch
Q 021526 160 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-----NLVSWSRP-------FL-KDQKKF 226 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-----~~~~~~~~-------~~-~~~~~~ 226 (311)
...|++.|+|||++.+..++.++|+|||||++|+|++|..||......... .+...... +. .....+
T Consensus 242 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~ 321 (391)
T PHA03212 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL 321 (391)
T ss_pred cccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHH
Confidence 356899999999998889999999999999999999999876432211100 00000000 00 000000
Q ss_pred hh----hc-----CccCCCCC--cHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 227 VH----LV-----DPLLHGRY--PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 227 ~~----~~-----~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.. .. .+..+... ....+.++.++|.+||..||.+|||++|+++
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 322 DEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00 00 00000000 0134667999999999999999999999986
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=290.01 Aligned_cols=248 Identities=24% Similarity=0.232 Sum_probs=192.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+..+|+|+||.||++.. +++.||+|++..... .....+.+|+++++.++||||+++++++.++...++||||+.+
T Consensus 6 ~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~g 85 (381)
T cd05626 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG 85 (381)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence 67899999999999998 788999999875432 2335688999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc-
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT- 155 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~- 155 (311)
++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.........
T Consensus 86 g~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 86 GDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 999999853 456889999999999999999999999 999999999999999999999999986432100000
Q ss_pred --------------------------------------------ceeeeccccccccCCccccCCCCCccccchhHHHHH
Q 021526 156 --------------------------------------------HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 191 (311)
Q Consensus 156 --------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l 191 (311)
.......|+..|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 000123589999999999888899999999999999
Q ss_pred HHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhh--ccCCCCCCCHHHHHH
Q 021526 192 LELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCL--NEEANFRPLINDIVV 269 (311)
Q Consensus 192 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l--~~~p~~RPs~~~l~~ 269 (311)
|+|++|..||......... ..... . ............+.++.++|.+|+ ..+|..||++.++++
T Consensus 239 ~elltG~~Pf~~~~~~~~~------~~i~~-~-------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQ------LKVIN-W-------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred HHHHhCCCCCcCCCHHHHH------HHHHc-c-------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 9999999999643321100 00000 0 000001111234667889998854 556666999999987
Q ss_pred H
Q 021526 270 A 270 (311)
Q Consensus 270 ~ 270 (311)
.
T Consensus 305 h 305 (381)
T cd05626 305 H 305 (381)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=272.00 Aligned_cols=245 Identities=24% Similarity=0.286 Sum_probs=198.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
...+|.|++|.||++.. +++.|++|.+.... ......+.+|+++++.++|||++++++++.++...++++||+.++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08529 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENG 84 (256)
T ss_pred eEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCC
Confidence 46799999999999998 78999999986542 334567889999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|.+++... ....+++..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 85 ~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~--~~ 157 (256)
T cd08529 85 DLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--NF 157 (256)
T ss_pred cHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc--ch
Confidence 999999652 3467899999999999999999999999 9999999999999999999999999887533221 12
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCC
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 237 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
.....++..|+|||...+..++.++|+||||+++++|++|..||........ . ..... .....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~----------~~~~~-~~~~~ 220 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL------I----------LKIIR-GVFPP 220 (256)
T ss_pred hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH------H----------HHHHc-CCCCC
Confidence 2234578889999999888899999999999999999999999964331100 0 00000 01111
Q ss_pred CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 238 YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.+...+..+.+++.+||+.+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 223456779999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=276.94 Aligned_cols=266 Identities=27% Similarity=0.378 Sum_probs=197.8
Q ss_pred eeeeeeceeccEEEEEE------CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEe--CCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL------CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS--GDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~ 73 (311)
+..+|.|+||.||.+.. +++.|++|.+........+.+.+|+++++.++||||+++++++.. ....++++||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 88 (284)
T cd05081 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEY 88 (284)
T ss_pred eeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEe
Confidence 56799999999999874 578999999876655556788999999999999999999987643 3467899999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 153 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~ 153 (311)
+.+++|.+++.. ....+++..++.++.|++.||+|||++| ++|+||+|+||+++.++.++|+|||++.......
T Consensus 89 ~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 162 (284)
T cd05081 89 LPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162 (284)
T ss_pred cCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence 999999999954 2356899999999999999999999999 9999999999999999999999999987543222
Q ss_pred Ccce-eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCc
Q 021526 154 NTHV-STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 232 (311)
Q Consensus 154 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
.... .....++..|+|||...+..++.++|+||||+++++|++|..++................. ......+.+.+..
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 241 (284)
T cd05081 163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQG-QMIVYHLIELLKN 241 (284)
T ss_pred cceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccccccc-ccchHHHHHHHhc
Confidence 1111 1112234569999999888899999999999999999998766532211000000000000 0000001111111
Q ss_pred cCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 021526 233 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274 (311)
Q Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l 274 (311)
......+..++..+.+++.+||..+|++|||+.+|++.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 242 NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111122334567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=272.35 Aligned_cols=247 Identities=29% Similarity=0.407 Sum_probs=195.8
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
+..+|.|++|.||++.. .+..|++|.+..... ..+.+.+|+.+++.++|++++++++++. +...+++||++.+++|.
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~ 88 (260)
T cd05070 11 IKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLL 88 (260)
T ss_pred hheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHH
Confidence 46899999999999988 667899999865433 4567899999999999999999999875 45678999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++.. .....+++..++.++.+++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+......... ....
T Consensus 89 ~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~ 162 (260)
T cd05070 89 DFLKD--GEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-ARQG 162 (260)
T ss_pred HHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc-cccC
Confidence 99964 23456889999999999999999999999 999999999999999999999999998643221111 1111
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
..++..|+|||...+..++.++|+||||+++|+|++ |..||....... ... ..........+
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~--------------~~~~~~~~~~~ 225 (260)
T cd05070 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLE--------------QVERGYRMPCP 225 (260)
T ss_pred CCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHH--------------HHHcCCCCCCC
Confidence 234567999999888889999999999999999999 888885322110 000 00111111223
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 273 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~ 273 (311)
...+..+.+++.+||..+|++|||+.++.+.|++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 226 QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 4556789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=284.04 Aligned_cols=237 Identities=25% Similarity=0.276 Sum_probs=187.4
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHH-HHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEV-LMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
..+|+|+||.||++.. +++.||+|++..... .....+..|. .+++.++||||+++++++..+...+++|||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 3689999999999999 678899999865421 2223444444 356788999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ...+.+..+..++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++..... ...
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~ 151 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNG 151 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccccc--CCC
Confidence 999999943 456888889999999999999999999 99999999999999999999999999864211 111
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......|++.|+|||++.+..++.++|+|||||++|+|++|..||....... ..... .....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i----------~~~~~-- 213 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MYDNI----------LNKPL-- 213 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH------HHHHH----------HhCCc--
Confidence 2334568999999999999899999999999999999999999996332110 00001 00001
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLIND 266 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~ 266 (311)
..+...+..+.+++.+||+.+|.+||++.+
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 214 QLKPNITNSARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 123345677999999999999999998874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=265.53 Aligned_cols=260 Identities=22% Similarity=0.227 Sum_probs=202.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc-ch-hHHHHHHHHHhcCCCCcccceeEEEEe--CCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ-GH-QEFIVEVLMLSLLHHDNLVTLIGYCTS--GDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~-~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~ 75 (311)
+|.++.|.||.||++.. .++-||+|.++.+... .. -...+|+.+|.+.+||||+.+..+... -+..|+|||||+
T Consensus 81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E 160 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE 160 (419)
T ss_pred HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence 57889999999999999 7999999999866432 22 357799999999999999999988653 346899999997
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
. +|...+.. -...|....+.-+..|++.|++|||++. |+|||+|++|+|++..|.+|++|||+++.++.. .
T Consensus 161 h-DLksl~d~---m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp--~ 231 (419)
T KOG0663|consen 161 H-DLKSLMET---MKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP--L 231 (419)
T ss_pred h-hHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC--c
Confidence 6 89999976 3478889999999999999999999998 999999999999999999999999999875433 2
Q ss_pred ceeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCccccccc----------hhcc---hhhhh
Q 021526 156 HVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL----------VSWS---RPFLK 221 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~----------~~~~---~~~~~ 221 (311)
........|.+|.|||++.+. .|+...|+||+||++.+|+++.+.|.+.+.....+. ..|. .-...
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~ 311 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV 311 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence 333445679999999998875 689999999999999999999999876554222110 0010 00000
Q ss_pred cccchhhhcCccCCCCCcHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 222 DQKKFVHLVDPLLHGRYPRR-CLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
....+.+.....++..++.. .++.-.+|+..+|..||.+|.|+++.++.
T Consensus 312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 11222233333344444333 45778899999999999999999999874
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=277.84 Aligned_cols=243 Identities=24% Similarity=0.269 Sum_probs=197.5
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
+..+|+|.+|.||++.. +++.|++|.+........+.+.+|+.+++.++|||++++++.+..+...++||||+.+++|
T Consensus 25 ~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L 104 (296)
T cd06654 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (296)
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCH
Confidence 45789999999999997 7899999998776666667889999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 105 ~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~~~~ 174 (296)
T cd06654 105 TDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRS 174 (296)
T ss_pred HHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc--cccC
Confidence 999843 45788899999999999999999999 9999999999999999999999999876432211 1112
Q ss_pred eccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 160 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
...++..|+|||.+.+..++.++|+||||+++|+|++|..||......... . .... ........+
T Consensus 175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~----~~~~---------~~~~~~~~~ 239 (296)
T cd06654 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--Y----LIAT---------NGTPELQNP 239 (296)
T ss_pred cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--H----HHhc---------CCCCCCCCc
Confidence 235788999999998888899999999999999999999999633221100 0 0000 000000113
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
...+..+.+++.+||..+|++||++.++++
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred cccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 345667899999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=279.57 Aligned_cols=260 Identities=26% Similarity=0.345 Sum_probs=202.0
Q ss_pred eeeeeeceeccEEEEEE---------CCeEEEEEEeccCC-ccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEE
Q 021526 2 LCCYLSCKFYNVGLVWL---------CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLV 70 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 70 (311)
...+|.|++|.||.+.. ....||+|.+.... ......+.+|+++++.+ +||||+++++++..+...+++
T Consensus 17 ~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 96 (314)
T cd05099 17 GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVI 96 (314)
T ss_pred eeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEE
Confidence 46799999999999875 34679999986443 23345788899999999 699999999999988899999
Q ss_pred EecCCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCce
Q 021526 71 YEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 138 (311)
Q Consensus 71 ~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~v 138 (311)
|||+.+++|.+++..... ....+++..+..++.|++.||.|||++| ++|+||+|+||+++.++.+
T Consensus 97 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~ 173 (314)
T cd05099 97 VEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVM 173 (314)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEcCCCcE
Confidence 999999999999965321 2346888999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcch
Q 021526 139 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSR 217 (311)
Q Consensus 139 kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 217 (311)
+|+|||.+................++..|+|||.+.+..++.++|+||||+++|+|++ |..||........ .
T Consensus 174 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~---- 246 (314)
T cd05099 174 KIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL---F---- 246 (314)
T ss_pred EEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH---H----
Confidence 9999999875332211111112223457999999988889999999999999999998 7888753221100 0
Q ss_pred hhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCC
Q 021526 218 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSH 281 (311)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~~ 281 (311)
+..........+..++..+.+++.+||..+|++||++.++++.|+++.......
T Consensus 247 ----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~ 300 (314)
T cd05099 247 ----------KLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEE 300 (314)
T ss_pred ----------HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcCC
Confidence 000001111223455678999999999999999999999999999987755443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=275.16 Aligned_cols=256 Identities=23% Similarity=0.319 Sum_probs=201.0
Q ss_pred eeeeeeceeccEEEEEE-C-----CeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEe-CCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL-C-----DQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS-GDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~-----~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~ 73 (311)
..++|.|.||.||.|.. . +..|++|.+.... ......+.+|+++++.++|||++++++++.. +...++++++
T Consensus 11 ~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~ 90 (280)
T cd05043 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPY 90 (280)
T ss_pred eeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEc
Confidence 35789999999999998 3 5899999876432 2334678899999999999999999998665 5678999999
Q ss_pred CCCCCHHHHhcccCCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccC
Q 021526 74 MPMGSLEDHLYDLEPD----QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 149 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~ 149 (311)
+.+++|.+++...... ...+++..++.++.+++.||+|||+.+ ++|+||+|+||++++++.++|+|||+++..
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~g~~~~~ 167 (280)
T cd05043 91 MNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDL 167 (280)
T ss_pred CCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCCCCcccc
Confidence 9999999999654322 256899999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhh
Q 021526 150 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 228 (311)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
.............++..|+|||.+.+..++.++|+||||+++|++++ |..||....... ... ...
T Consensus 168 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~----~~~------- 233 (280)
T cd05043 168 FPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAA----YLK------- 233 (280)
T ss_pred cCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHH----HHH-------
Confidence 33222222222345667999999988889999999999999999998 999986332211 000 000
Q ss_pred hcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 021526 229 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 277 (311)
Q Consensus 229 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~ 277 (311)
.......+..++..+.+++.+||..+|++|||+.++++.|..+...
T Consensus 234 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 234 ---DGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred ---cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 0011111233566799999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=271.09 Aligned_cols=248 Identities=27% Similarity=0.345 Sum_probs=196.0
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
...+|.|++|.||.+.. ++..|++|.+.... .....+.+|+++++.++||||+++++++.. ...+++||++.+++|.
T Consensus 11 ~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~ 88 (262)
T cd05071 11 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 88 (262)
T ss_pred eeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHH
Confidence 46789999999999988 55689999987533 344678999999999999999999998754 5679999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++.. .....+++..++.++.|++.||++||+.+ ++|+||+|.||++++++.++|+|||.+........ .....
T Consensus 89 ~~~~~--~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~~~~~ 162 (262)
T cd05071 89 DFLKG--EMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQG 162 (262)
T ss_pred HHHhh--ccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc-ccccC
Confidence 99964 23456788999999999999999999999 99999999999999999999999999865432221 11122
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
..++..|++||...+..++.++|+||||+++|+|++ |..||........ .... ........+
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~------~~~~-----------~~~~~~~~~ 225 (262)
T cd05071 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV------LDQV-----------ERGYRMPCP 225 (262)
T ss_pred CcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH------HHHH-----------hcCCCCCCc
Confidence 335667999999888889999999999999999999 7778853321100 0000 000111223
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l 274 (311)
..++..+.+++.+||+.+|++||++.++++.|+..
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 226 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 45667899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=287.93 Aligned_cols=255 Identities=25% Similarity=0.322 Sum_probs=199.1
Q ss_pred eeeeeeceeccEEEEEE-------CCeEEEEEEeccCCcc-chhHHHHHHHHHhcCC-CCcccceeEEEEeCCeeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL-------CDQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e 72 (311)
...+|+|+||.||++.. .++.||+|++...... ..+.+.+|+.++..+. ||||+++++++..+...++|+|
T Consensus 42 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E 121 (401)
T cd05107 42 GRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITE 121 (401)
T ss_pred hhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEe
Confidence 35799999999999986 3468999999754322 3357889999999997 9999999999999999999999
Q ss_pred cCCCCCHHHHhcccCC----------------------------------------------------------------
Q 021526 73 YMPMGSLEDHLYDLEP---------------------------------------------------------------- 88 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~---------------------------------------------------------------- 88 (311)
|+.+++|.+++.....
T Consensus 122 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (401)
T cd05107 122 YCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKY 201 (401)
T ss_pred ccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhh
Confidence 9999999999964321
Q ss_pred ------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCce
Q 021526 89 ------------------------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 138 (311)
Q Consensus 89 ------------------------------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~v 138 (311)
....+.+..++.++.|++.||+|||+.+ ++|+||+|.||++++++.+
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~~~~~~ 278 (401)
T cd05107 202 ADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLICEGKLV 278 (401)
T ss_pred hhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEeCCCEE
Confidence 1124677788899999999999999998 9999999999999999999
Q ss_pred EEeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcch
Q 021526 139 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSR 217 (311)
Q Consensus 139 kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 217 (311)
+|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||........
T Consensus 279 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~-------- 350 (401)
T cd05107 279 KICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ-------- 350 (401)
T ss_pred EEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH--------
Confidence 9999999874322211111222345678999999988889999999999999999998 8888753221100
Q ss_pred hhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 021526 218 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 275 (311)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~ 275 (311)
....+....+...+..++.++.+++.+||..+|.+||++.+|++.|+.+.
T Consensus 351 --------~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 --------FYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred --------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 00111111111233455778999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=273.61 Aligned_cols=249 Identities=27% Similarity=0.349 Sum_probs=194.4
Q ss_pred eeeeceeccEEEEEE--CC--eEEEEEEeccCC-ccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 4 CYLSCKFYNVGLVWL--CD--QLVAIKQLNHEG-LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~--~~--~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
++|.|++|.||++.. ++ ..+++|.+.... ....+.+.+|++++..+ +||||+++++++......+++|||+.++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 589999999999998 33 357888876432 33446788999999999 7999999999999999999999999999
Q ss_pred CHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCC
Q 021526 78 SLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 145 (311)
Q Consensus 78 ~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~ 145 (311)
+|.+++..... ....+++..++.++.|++.|++|||+.+ ++|+||+|+||++++++.++|+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCC
Confidence 99999965321 1235889999999999999999999999 99999999999999999999999998
Q ss_pred CccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhccc
Q 021526 146 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQK 224 (311)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 224 (311)
+.... ..........+..|+|||.+....++.++|+||||+++|+|++ |..||........ ...
T Consensus 159 ~~~~~---~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~------~~~------ 223 (270)
T cd05047 159 SRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YEK------ 223 (270)
T ss_pred ccccc---hhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH------HHH------
Confidence 75211 1111111223557999999888889999999999999999997 9999853221100 000
Q ss_pred chhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 021526 225 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 275 (311)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~ 275 (311)
.........+..++..+.+++.+||..+|.+|||+.++++.|..+.
T Consensus 224 -----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 224 -----LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -----HhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0000111122335567899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=274.13 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=197.2
Q ss_pred eeeeeeceeccEEEEEE--CCe----EEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQ----LVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~----~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
+..+|.|++|.||++.. +++ +||+|.+..... .....+.+|+.+++.++||||+++++++.. ...+++++++
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~ 90 (279)
T cd05109 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLM 90 (279)
T ss_pred eeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcC
Confidence 46799999999999986 444 589999865432 334678899999999999999999999865 4578999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
.+++|.+++.. ....+++..++.++.|++.||+|||+++ ++|+||+|+||++++++.++|+|||++........
T Consensus 91 ~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~ 164 (279)
T cd05109 91 PYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164 (279)
T ss_pred CCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence 99999999854 3456899999999999999999999999 99999999999999999999999999875432222
Q ss_pred cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 155 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
........++..|++||...+..++.++|+||||+++|+|++ |..||+....... ...+...
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-----------------~~~~~~~ 227 (279)
T cd05109 165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI-----------------PDLLEKG 227 (279)
T ss_pred eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-----------------HHHHHCC
Confidence 111122234567999999988889999999999999999998 8888863221110 0001011
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 278 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~ 278 (311)
.....+..++..+.+++.+||+.||++||++.++++.|..+....
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 228 ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 111112345667899999999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=278.84 Aligned_cols=255 Identities=26% Similarity=0.343 Sum_probs=197.5
Q ss_pred eeeeeeceeccEEEEEE--CCe--EEEEEEeccCC-ccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQ--LVAIKQLNHEG-LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~--~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
...+|.|+||.||++.. ++. .+++|.+.... ......+.+|++++..+ +||||+++++++..+...++++||+.
T Consensus 12 ~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 91 (303)
T cd05088 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 91 (303)
T ss_pred eeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCC
Confidence 35789999999999997 443 46777765432 22345788899999999 89999999999999999999999999
Q ss_pred CCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeec
Q 021526 76 MGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 143 (311)
Q Consensus 76 ~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df 143 (311)
+++|.+++..... ....+++..++.++.|++.|++|||++| ++|+||+|+||+++.++.++|+||
T Consensus 92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~kl~df 168 (303)
T cd05088 92 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF 168 (303)
T ss_pred CCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcEEeCcc
Confidence 9999999965321 2246889999999999999999999999 999999999999999999999999
Q ss_pred CCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhc
Q 021526 144 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKD 222 (311)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 222 (311)
|++.... .........++..|+|||.+.+..++.++|+||||+++|+|++ |..||........ ...
T Consensus 169 g~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~---- 235 (303)
T cd05088 169 GLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YEK---- 235 (303)
T ss_pred ccCcccc---hhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH------HHH----
Confidence 9985211 1111111223567999999888888999999999999999998 9999853322110 000
Q ss_pred ccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 021526 223 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 279 (311)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~ 279 (311)
.........+...+..+.+++.+||..+|++||+++++++.|..+.....
T Consensus 236 -------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 236 -------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred -------HhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 00001111222345678999999999999999999999999988776654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=280.45 Aligned_cols=241 Identities=27% Similarity=0.320 Sum_probs=192.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
++.+|+|+||.||++.. +++.||+|.+.+... .....+..|..++..+ +|++|+++++++.+....++||||+.
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 84 (323)
T cd05616 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVN 84 (323)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCC
Confidence 67899999999999998 678999999875422 2234566778888776 58899999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||++...... .
T Consensus 85 ~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~--~ 155 (323)
T cd05616 85 GGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD--G 155 (323)
T ss_pred CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC--C
Confidence 9999999843 456889999999999999999999999 999999999999999999999999998642211 1
Q ss_pred ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 156 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
.......|++.|+|||++.+..++.++|+|||||++|+|++|..||....... .... +... .
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~------~~~~----------i~~~--~ 217 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------LFQS----------IMEH--N 217 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH------HHHH----------HHhC--C
Confidence 12233568999999999999999999999999999999999999996432110 0000 1110 1
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRPLI-----NDIVV 269 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~-----~~l~~ 269 (311)
..++...+.++.+++.+||+.+|++|++. .++.+
T Consensus 218 ~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 218 VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 12344567789999999999999999984 56654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=277.66 Aligned_cols=259 Identities=22% Similarity=0.233 Sum_probs=189.0
Q ss_pred eeeeeeceeccEEEEEE---CCeEEEEEEeccCCc--cchhHHHHHHHHHhcC---CCCcccceeEEEE-----eCCeeE
Q 021526 2 LCCYLSCKFYNVGLVWL---CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLL---HHDNLVTLIGYCT-----SGDQRL 68 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~---~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~-----~~~~~~ 68 (311)
...+|+|+||.||++.. +++.||+|.+..... .....+.+|+.+++.+ +||||+++++++. .+...+
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~ 85 (290)
T cd07862 6 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 85 (290)
T ss_pred eeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEE
Confidence 56899999999999987 468899998865432 2234566677776655 6999999999875 345689
Q ss_pred EEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCcc
Q 021526 69 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 148 (311)
Q Consensus 69 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~ 148 (311)
++||++. ++|.+++.. .....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++..
T Consensus 86 lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 86 LVFEHVD-QDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred EEEccCC-CCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 9999996 589999865 23456899999999999999999999999 99999999999999999999999999875
Q ss_pred CCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccc-cchhcch----hhhhcc
Q 021526 149 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLVSWSR----PFLKDQ 223 (311)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~----~~~~~~ 223 (311)
.... .......++..|+|||.+.+..++.++|+||||+++|+|++|.+||......... .+..... ..+...
T Consensus 160 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 160 YSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred ccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 3222 2223345789999999998888999999999999999999999999754321110 0000000 000000
Q ss_pred cch-hhhcCccCCC---CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 224 KKF-VHLVDPLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 224 ~~~-~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
... .....+.... ...+..+..+.+++.+||+.||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 0000000000 011234667899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=272.06 Aligned_cols=247 Identities=28% Similarity=0.364 Sum_probs=196.9
Q ss_pred eeeeceeccEEEEEE---CC--eEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 4 CYLSCKFYNVGLVWL---CD--QLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~---~~--~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
.+|+|++|.||++.. ++ ..||+|.+..... ...+.+.+|++.++.++||||+++++++.. ...++++|+++++
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~ 80 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG 80 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence 689999999999987 22 3699999877665 456789999999999999999999999887 8899999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc-
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH- 156 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~- 156 (311)
+|.+++.... ...+++..++.++.|++.||++||+++ ++|+||+|+||+++.++.++|+|||.+..........
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 81 SLLDRLRKDA--LGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred cHHHHHHhcc--cccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 9999996522 157899999999999999999999999 9999999999999999999999999987543322111
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
......++..|+|||.+.+..++.++|+||||+++|+|++ |..||....... . ...... ....
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~---~~~~~~----------~~~~ 219 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---I---LKKIDK----------EGER 219 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---H---HHHHHh----------cCCc
Confidence 1122346678999999888889999999999999999998 999985322110 0 000000 0011
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 272 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~ 272 (311)
...+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 1122345677999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=289.83 Aligned_cols=247 Identities=21% Similarity=0.199 Sum_probs=191.6
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+..+|.|+||.||++.. +++.||+|.+.+.. ......+.+|+++++.++||||+++++++.++...++||||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~g 85 (377)
T cd05629 6 VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPG 85 (377)
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCC
Confidence 57899999999999988 78999999986432 22335678899999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc-
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT- 155 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~- 155 (311)
++|.+++.. ...+++..+..++.|++.||+|||+.| ++|+||||+||+++.++.++|+|||++.........
T Consensus 86 g~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 86 GDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 999999953 457889999999999999999999999 999999999999999999999999988532110000
Q ss_pred -----------c---------------------------------eeeeccccccccCCccccCCCCCccccchhHHHHH
Q 021526 156 -----------H---------------------------------VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 191 (311)
Q Consensus 156 -----------~---------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l 191 (311)
. ......|+..|+|||++.+..++.++|+|||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 0 00013588999999999888999999999999999
Q ss_pred HHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCC---CCHHHHH
Q 021526 192 LELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFR---PLINDIV 268 (311)
Q Consensus 192 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R---Ps~~~l~ 268 (311)
|+|++|..||........ ...... ... .+........+.++.++|.+||. +|.+| +++.+++
T Consensus 239 ~elltG~~Pf~~~~~~~~------~~~i~~----~~~----~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l 303 (377)
T cd05629 239 FECLIGWPPFCSENSHET------YRKIIN----WRE----TLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK 303 (377)
T ss_pred hhhhcCCCCCCCCCHHHH------HHHHHc----cCC----ccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence 999999999964332110 000000 000 00000011345678999999998 66665 5999988
Q ss_pred HH
Q 021526 269 VA 270 (311)
Q Consensus 269 ~~ 270 (311)
+.
T Consensus 304 ~h 305 (377)
T cd05629 304 SH 305 (377)
T ss_pred cC
Confidence 74
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=276.91 Aligned_cols=258 Identities=26% Similarity=0.383 Sum_probs=198.3
Q ss_pred eeeeeeceeccEEEEEEC------------------CeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWLC------------------DQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCT 62 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~------------------~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 62 (311)
...+|.|+||.||.+... +..||+|.+..... ...+.+.+|+++++.++||||+++++++.
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 89 (296)
T cd05051 10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCT 89 (296)
T ss_pred cccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 467999999999998872 25689999875532 34567889999999999999999999999
Q ss_pred eCCeeEEEEecCCCCCHHHHhcccCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCC
Q 021526 63 SGDQRLLVYEYMPMGSLEDHLYDLEP-------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 135 (311)
Q Consensus 63 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~ 135 (311)
.+...++++|++.+++|.+++..... ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.+
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Nili~~~ 166 (296)
T cd05051 90 VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKN 166 (296)
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhceeecCC
Confidence 99999999999999999999965331 1236899999999999999999999999 9999999999999999
Q ss_pred CceEEeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh--CCCCccccCccccccch
Q 021526 136 FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT--GRKAMDLSKGQGEQNLV 213 (311)
Q Consensus 136 ~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~--g~~p~~~~~~~~~~~~~ 213 (311)
+.++|+|||.+................++..|+|||.+.+..++.++||||||+++|+|++ +..||....... ..
T Consensus 167 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~---~~ 243 (296)
T cd05051 167 YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ---VI 243 (296)
T ss_pred CceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH---HH
Confidence 9999999999875333222222333445678999999888889999999999999999998 566764322110 00
Q ss_pred hcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 021526 214 SWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 272 (311)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~ 272 (311)
........ ..........+..++.++.+++.+||+.+|++||++.+|++.|+
T Consensus 244 ~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 244 ENAGHFFR-------DDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHhccc-------cccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 00000000 00011111123345678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=283.74 Aligned_cols=246 Identities=22% Similarity=0.217 Sum_probs=191.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+..+|+|+||.||.+.. +++.||+|++.+.. ......+.+|+.++..++||||+++++.+.++...++||||+.+
T Consensus 6 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~g 85 (363)
T cd05628 6 LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPG 85 (363)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCC
Confidence 57899999999999988 68999999986542 22335678899999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc-
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT- 155 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~- 155 (311)
++|.+++.. ...+++..+..++.|++.||+|||++| |+||||||+|||++.++.++|+|||++.........
T Consensus 86 g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 86 GDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 999999953 467899999999999999999999999 999999999999999999999999998643211000
Q ss_pred --------------------------------ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccc
Q 021526 156 --------------------------------HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDL 203 (311)
Q Consensus 156 --------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 203 (311)
.......|+..|+|||++.+..++.++|+|||||++|+|++|..||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 001124689999999999988999999999999999999999999964
Q ss_pred cCccccccchhcchhhhhcccchhhhcCccCCCCCc--HHHHHHHHHHHHHhhc--cCCCCCCCHHHHHHH
Q 021526 204 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP--RRCLNYAVAVTAMCLN--EEANFRPLINDIVVA 270 (311)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~--~~p~~RPs~~~l~~~ 270 (311)
...... ...... . .....++ ...+.++.++|.+|+. .++..||++++|++.
T Consensus 239 ~~~~~~------~~~i~~----~------~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 239 ETPQET------YKKVMN----W------KETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCHHHH------HHHHHc----C------cCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 332110 000000 0 0000011 1245678888888664 233456899999885
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=271.24 Aligned_cols=246 Identities=24% Similarity=0.291 Sum_probs=196.0
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc-----chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ-----GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
...+|.|.+|.||.+.. +++.|++|.+...... ....+.+|+++++.++||||+++++++.++...++++|++
T Consensus 7 ~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 86 (263)
T cd06625 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM 86 (263)
T ss_pred cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEEC
Confidence 35789999999999987 6899999988644221 2356888999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
.+++|.+++.. ...+++..+..++.|++.||++||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 87 ~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 87 PGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred CCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 99999999854 356888999999999999999999999 99999999999999999999999999864322111
Q ss_pred cce-eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 155 THV-STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 155 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
... .....++..|+|||...+..++.++|+||||+++|+|++|..||........ ........
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----------------~~~~~~~~ 223 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA----------------IFKIATQP 223 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH----------------HHHHhccC
Confidence 111 1223467789999999988899999999999999999999999853211100 00011111
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.....+...+..+.+++.+||..+|++||++.++++.
T Consensus 224 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1112344567789999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=276.38 Aligned_cols=255 Identities=26% Similarity=0.341 Sum_probs=198.1
Q ss_pred eeeeeeceeccEEEEEE--CC--eEEEEEEeccC-CccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CD--QLVAIKQLNHE-GLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~--~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
..++|.|+||.||+++. ++ ..+++|.+... .....+.+.+|++++.++ +||||+++++++......++++||+.
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 86 (297)
T cd05089 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAP 86 (297)
T ss_pred eeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecC
Confidence 46799999999999988 33 35788887632 233446788999999999 79999999999998889999999999
Q ss_pred CCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeec
Q 021526 76 MGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 143 (311)
Q Consensus 76 ~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df 143 (311)
+++|.+++..... ....+++..++.++.|++.||++||+.+ ++|+||+|+||+++.++.+||+||
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~df 163 (297)
T cd05089 87 YGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADF 163 (297)
T ss_pred CCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEEECCc
Confidence 9999999964221 1235889999999999999999999999 999999999999999999999999
Q ss_pred CCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhc
Q 021526 144 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKD 222 (311)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 222 (311)
|++..... .........+..|+|||...+..++.++|+||||+++|+|++ |..||....... ..
T Consensus 164 g~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~------~~------ 228 (297)
T cd05089 164 GLSRGEEV---YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE------LY------ 228 (297)
T ss_pred CCCccccc---eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------HH------
Confidence 98853111 101111223456999999888889999999999999999997 999985332110 00
Q ss_pred ccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 021526 223 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 279 (311)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~ 279 (311)
...........+..++..+.+++.+||+.+|.+||+++++++.|..+.....
T Consensus 229 -----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 229 -----EKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred -----HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 0001111112233456789999999999999999999999999998886553
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=272.62 Aligned_cols=250 Identities=24% Similarity=0.345 Sum_probs=196.7
Q ss_pred eeeeeeceeccEEEEEE--CC---eEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CD---QLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~---~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
...+|+|++|.||++.. ++ ..|++|.+.... ......+.+|+.+++.++||||+++++++.++...+++||++.
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T cd05065 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFME 88 (269)
T ss_pred EeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCC
Confidence 46799999999999998 23 369999986542 3345688999999999999999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+++|.+++.. ..+.+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 89 ~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 162 (269)
T cd05065 89 NGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 162 (269)
T ss_pred CCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCccc
Confidence 9999999964 3456889999999999999999999999 999999999999999999999999988643222111
Q ss_pred cee-eecc--ccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcC
Q 021526 156 HVS-TRVM--GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231 (311)
Q Consensus 156 ~~~-~~~~--~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
... .... .+..|++||.+.+..++.++|+||||+++|++++ |..||...... ....+. .
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i--------------~ 225 (269)
T cd05065 163 PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAI--------------E 225 (269)
T ss_pred cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHH--------------H
Confidence 111 1111 1347999999988889999999999999999886 99998533211 000000 0
Q ss_pred ccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 021526 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274 (311)
Q Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l 274 (311)
.......+..++..+.+++.+||..+|++||++++|++.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 226 QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred cCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011112234567789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=274.63 Aligned_cols=249 Identities=27% Similarity=0.356 Sum_probs=196.8
Q ss_pred eeeeceeccEEEEEEC--------CeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 4 CYLSCKFYNVGLVWLC--------DQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~~--------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
.+|+|++|.||.+... ++.|++|.+.... ......+.+|+++++.++||||+++++++..+...+++||++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 6899999999999873 2679999876543 234567889999999999999999999999888999999999
Q ss_pred CCCCHHHHhcccCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCC-----ceEEeecCCC
Q 021526 75 PMGSLEDHLYDLEP---DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-----NPKLSDFGLA 146 (311)
Q Consensus 75 ~~~~L~~~l~~~~~---~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~-----~vkl~Df~~~ 146 (311)
.+++|.+++..... ....+++..++.++.|++.+|+|||+.+ ++|+||+|+||+++.++ .++|+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99999999965322 2345788999999999999999999999 99999999999999877 8999999998
Q ss_pred ccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccc
Q 021526 147 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKK 225 (311)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
................++..|+|||.+.+..++.++|+||||+++|+|++ |..||....... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~----------- 224 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQ----------- 224 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHH-----------
Confidence 65432222222223345678999999988889999999999999999998 899985322110 000
Q ss_pred hhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 021526 226 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 272 (311)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~ 272 (311)
.+........+...+..+.++|.+||..+|++||++.++++.|+
T Consensus 225 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 225 ---HVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ---HHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 00001111223455778999999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=276.86 Aligned_cols=258 Identities=26% Similarity=0.368 Sum_probs=194.5
Q ss_pred eeeeeeceeccEEEEEEC----------------CeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeC
Q 021526 2 LCCYLSCKFYNVGLVWLC----------------DQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG 64 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~----------------~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 64 (311)
...+|+|+||.||.++.. ...||+|.+..... .....+.+|+++++.++|||++++++++..+
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 89 (295)
T cd05097 10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSD 89 (295)
T ss_pred hhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCC
Confidence 467999999999998762 23589999865432 2345788999999999999999999999999
Q ss_pred CeeEEEEecCCCCCHHHHhcccCC--------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCC
Q 021526 65 DQRLLVYEYMPMGSLEDHLYDLEP--------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF 136 (311)
Q Consensus 65 ~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~ 136 (311)
...+++|||+.+++|.+++..... ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nill~~~~ 166 (295)
T cd05097 90 DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHY 166 (295)
T ss_pred CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEEEcCCC
Confidence 999999999999999999854211 1124788889999999999999999999 99999999999999999
Q ss_pred ceEEeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh--CCCCccccCccccccchh
Q 021526 137 NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT--GRKAMDLSKGQGEQNLVS 214 (311)
Q Consensus 137 ~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~--g~~p~~~~~~~~~~~~~~ 214 (311)
.+||+|||++................++..|+|||...+..++.++|+||||+++++|++ +..||....... ...
T Consensus 167 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~---~~~ 243 (295)
T cd05097 167 TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ---VIE 243 (295)
T ss_pred cEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH---HHH
Confidence 999999999864322222112222334678999999888889999999999999999998 556665322111 000
Q ss_pred cchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 021526 215 WSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 272 (311)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~ 272 (311)
...... ...........+...+..+.+++.+||..+|++||++++|++.|.
T Consensus 244 ~~~~~~-------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 244 NTGEFF-------RNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHhh-------hhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 000000 000001111112335678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=266.67 Aligned_cols=261 Identities=21% Similarity=0.212 Sum_probs=197.5
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCcc--chhHHHHHHHHHhcCCCCc-ccceeEEEEeCC------eeEEEE
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDN-LVTLIGYCTSGD------QRLLVY 71 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~------~~~lv~ 71 (311)
.++|.|.||.||+|+. +|+.||+|.+...... ......+|+.+++.++|+| |+.+++++.+++ ..++|+
T Consensus 17 eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvf 96 (323)
T KOG0594|consen 17 EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVF 96 (323)
T ss_pred HHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEE
Confidence 5689999999999999 8899999998766432 3346789999999999999 999999998877 789999
Q ss_pred ecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCC
Q 021526 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 151 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~ 151 (311)
|+++. +|..++.........++...+..+++||+.||+|||+++ |+||||||.||+++++|.+||+|||+++....
T Consensus 97 e~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~i 172 (323)
T KOG0594|consen 97 EFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLARAFSI 172 (323)
T ss_pred Eeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHHHhcC
Confidence 99955 999999764433357888899999999999999999999 99999999999999999999999999985432
Q ss_pred CCCcceeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCccc----------cccchhcchhhh
Q 021526 152 GDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQG----------EQNLVSWSRPFL 220 (311)
Q Consensus 152 ~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~----------~~~~~~~~~~~~ 220 (311)
. ........+|.+|.|||++.+. .|+...||||+||++.||+++++.|....... ..+...|.....
T Consensus 173 p--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~ 250 (323)
T KOG0594|consen 173 P--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSS 250 (323)
T ss_pred C--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccc
Confidence 2 2223445678899999999887 78999999999999999999998886554310 011111111000
Q ss_pred hcccchhhhcCccCCCCCc---HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 221 KDQKKFVHLVDPLLHGRYP---RRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
...... ..........+. +.......+++.+||+.+|.+|.|+..+++.
T Consensus 251 ~~~~k~-~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 251 LPDYKA-PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cccccc-cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 000000 000000000001 1112468899999999999999999999875
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=271.06 Aligned_cols=250 Identities=26% Similarity=0.339 Sum_probs=197.3
Q ss_pred eeeeeeceeccEEEEEE--CC---eEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CD---QLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~---~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
...+|.|++|.||++.. ++ ..+++|.+.... ....+.+.+|+++++.++|||++++.+++......+++||++.
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (268)
T cd05063 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYME 89 (268)
T ss_pred eeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCC
Confidence 35799999999999998 33 379999886442 3345678899999999999999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+++|.+++.. ....+++..+..++.+++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 90 ~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 163 (268)
T cd05063 90 NGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG 163 (268)
T ss_pred CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence 9999999854 3457899999999999999999999999 999999999999999999999999998654322111
Q ss_pred cee-eeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 156 HVS-TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 156 ~~~-~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
... .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...... ...... ...
T Consensus 164 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~~~~~i-----------~~~ 226 (268)
T cd05063 164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------EVMKAI-----------NDG 226 (268)
T ss_pred ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHH-----------hcC
Confidence 111 11122457999999988888999999999999999997 99998532211 000000 001
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l 274 (311)
.....+..++..+.+++.+||..+|++||++.+|++.|+++
T Consensus 227 ~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11112234567789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=276.02 Aligned_cols=252 Identities=25% Similarity=0.358 Sum_probs=196.7
Q ss_pred eeeeeeceeccEEEEEE-------CCeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL-------CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
...+|.|+||.||.+.. .+..|++|.+..... .....+.+|+.+++.++||||+++++++.++...++++|+
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (288)
T cd05050 10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEY 89 (288)
T ss_pred cccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEec
Confidence 46789999999999986 368999999865432 3346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcccC------------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCC
Q 021526 74 MPMGSLEDHLYDLE------------------PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 135 (311)
Q Consensus 74 ~~~~~L~~~l~~~~------------------~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~ 135 (311)
+.+++|.+++.... .....+++..++.++.|++.||++||+++ ++|+||+|.||+++.+
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~nil~~~~ 166 (288)
T cd05050 90 MAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGEN 166 (288)
T ss_pred CCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhheEecCC
Confidence 99999999996422 11235788889999999999999999999 9999999999999999
Q ss_pred CceEEeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchh
Q 021526 136 FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVS 214 (311)
Q Consensus 136 ~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~ 214 (311)
+.++|+|||.+.................+..|+|||.+.+..++.++|+||||+++|+|++ |..||...... .
T Consensus 167 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~------~ 240 (288)
T cd05050 167 MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE------E 240 (288)
T ss_pred CceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------H
Confidence 9999999998864332222112222234567999999888889999999999999999997 77787422211 0
Q ss_pred cchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 021526 215 WSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 273 (311)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~ 273 (311)
... ..... .. ...+..++..+.+++.+||+.+|++||++.|+++.|++
T Consensus 241 ~~~-~~~~~---------~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 VIY-YVRDG---------NV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHH-HHhcC---------CC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 000 00000 00 01123456779999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=273.57 Aligned_cols=254 Identities=26% Similarity=0.386 Sum_probs=196.1
Q ss_pred eeeeeeceeccEEEEEE-------CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL-------CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
...+|.|+||.||+|.. .+..||+|.+.... ......+.+|+..++.++||||+++++++......+++|||
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 90 (288)
T cd05061 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMEL 90 (288)
T ss_pred eeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeC
Confidence 56899999999999875 24589999876443 22334678899999999999999999999988899999999
Q ss_pred CCCCCHHHHhcccCC------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 74 MPMGSLEDHLYDLEP------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
+.+++|.+++..... .........+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||+++
T Consensus 91 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~Dfg~~~ 167 (288)
T cd05061 91 MAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTR 167 (288)
T ss_pred CCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEECcCCccc
Confidence 999999999965321 1234567788999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccch
Q 021526 148 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 226 (311)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
...............++..|+|||.+.+..++.++|+||||+++|+|++ |..||....... .. . ..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~---~-~~------ 234 (288)
T cd05061 168 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VL---K-FV------ 234 (288)
T ss_pred cccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH---H-HH------
Confidence 4322222121222334667999999988889999999999999999998 677875322110 00 0 00
Q ss_pred hhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 021526 227 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 275 (311)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~ 275 (311)
... .....+..++..+.+++.+||+.+|++|||+.++++.|+...
T Consensus 235 ---~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 235 ---MDG-GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred ---HcC-CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 000 001112344578999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=274.33 Aligned_cols=265 Identities=28% Similarity=0.394 Sum_probs=201.9
Q ss_pred eeeeeeceeccEEEEEE------CCeEEEEEEeccCCcc-chhHHHHHHHHHhcCCCCcccceeEEEEe--CCeeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL------CDQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTS--GDQRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 72 (311)
+..+|.|+||.||++.. .++.||+|.+...... ..+.+.+|+++++.++||||+++++++.. ....+++||
T Consensus 9 ~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 88 (284)
T cd05038 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIME 88 (284)
T ss_pred heeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEe
Confidence 45789999999999986 2689999998755443 45789999999999999999999999876 557899999
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCC
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~ 152 (311)
|+.+++|.+++.. ....+++..++.++.|++.||++||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 89 ~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 89 YLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred cCCCCCHHHHHHh---CccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 9999999999964 2346899999999999999999999999 999999999999999999999999998754322
Q ss_pred CCcc-eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcC
Q 021526 153 DNTH-VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231 (311)
Q Consensus 153 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
.... ......++..|++||...+..++.++|+||||+++++|++|..|+.............. ........+.+.+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 240 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIA--QGQMIVTRLLELLK 240 (284)
T ss_pred CcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccc--cccccHHHHHHHHH
Confidence 1111 11122345679999998888899999999999999999999998753221110000000 00000111111111
Q ss_pred ccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 021526 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274 (311)
Q Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l 274 (311)
.......+..++..+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 2222222345567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=273.44 Aligned_cols=246 Identities=22% Similarity=0.294 Sum_probs=194.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
+..+|.|.+|.||++.. .+..+++|.+........+.+.+|+++++.++|||++++++++..+...++++||+.+++|
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l 89 (282)
T cd06643 10 IGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV 89 (282)
T ss_pred HhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcH
Confidence 35689999999999999 5788999998765555567788999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
..++.. ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++...... .....
T Consensus 90 ~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~~ 161 (282)
T cd06643 90 DAVMLE---LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRD 161 (282)
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc--ccccc
Confidence 988754 3457899999999999999999999999 999999999999999999999999988643211 11122
Q ss_pred eccccccccCCcccc-----CCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccC
Q 021526 160 RVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
...++..|+|||.+. +..++.++|+||+|+++|+|++|.+||........ .. .... ...+..
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~----~~~~-------~~~~~~ 228 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LL----KIAK-------SEPPTL 228 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HH----HHhh-------cCCCCC
Confidence 345788999999874 34577899999999999999999999853221000 00 0000 000000
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
..+..++..+.++|.+||+.+|.+||++.++++.
T Consensus 229 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 229 --AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred --CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1123456789999999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=284.39 Aligned_cols=192 Identities=27% Similarity=0.304 Sum_probs=164.6
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCC-C-----CcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-H-----DNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
+.++|+|.||.|.+++. .++.||||+++.. +.-..+...|+.+|..++ | -|+++++++|...++.|||+|.
T Consensus 191 ~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfEL 269 (586)
T KOG0667|consen 191 LEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFEL 269 (586)
T ss_pred EEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehh
Confidence 57899999999999999 7999999998643 555677888999999887 3 3899999999999999999999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCC--ceEEeecCCCccCCC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF--NPKLSDFGLAKLGPV 151 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~--~vkl~Df~~~~~~~~ 151 (311)
+ ..+|.+++.. ..-..++...+..++.||+.+|.+||..+ |+|+||||+|||+...+ .||++|||.+.....
T Consensus 270 L-~~NLYellK~--n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q 343 (586)
T KOG0667|consen 270 L-STNLYELLKN--NKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ 343 (586)
T ss_pred h-hhhHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccccCC
Confidence 8 5699999976 34556999999999999999999999999 99999999999996544 699999999975433
Q ss_pred CCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccC
Q 021526 152 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 205 (311)
Q Consensus 152 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 205 (311)
....+ .-...|.|||++.+.+|+.+.|||||||++.||++|.+.|.+.+
T Consensus 344 ~vytY-----iQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 344 RVYTY-----IQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred cceee-----eeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 33222 23567999999999999999999999999999999988776544
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=287.39 Aligned_cols=246 Identities=22% Similarity=0.220 Sum_probs=191.1
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+..+|+|+||.||++.. +++.||+|.+.+... .....+.+|+.+++.++||||+++++.+.++...++||||+.+
T Consensus 6 ~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~g 85 (382)
T cd05625 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 85 (382)
T ss_pred EEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCC
Confidence 67899999999999998 789999999875432 2345788899999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC--
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN-- 154 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~-- 154 (311)
++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.++|+|||++........
T Consensus 86 g~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 86 GDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 999999853 356889999999999999999999999 99999999999999999999999998642110000
Q ss_pred -------------------------------------------cceeeeccccccccCCccccCCCCCccccchhHHHHH
Q 021526 155 -------------------------------------------THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 191 (311)
Q Consensus 155 -------------------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l 191 (311)
........|++.|+|||++.+..++.++|+|||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 0001123588999999999988999999999999999
Q ss_pred HHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCC---HHHHH
Q 021526 192 LELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL---INDIV 268 (311)
Q Consensus 192 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs---~~~l~ 268 (311)
|+|++|..||......... ..... . ............+.+..++|.+|+ .+|.+|++ +++++
T Consensus 239 ~elltG~~Pf~~~~~~~~~------~~i~~----~----~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 303 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQ------MKVIN----W----QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIK 303 (382)
T ss_pred HHHHhCCCCCCCCCHHHHH------HHHHc----c----CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence 9999999999643221000 00000 0 000000111234567888888876 59999987 88776
Q ss_pred H
Q 021526 269 V 269 (311)
Q Consensus 269 ~ 269 (311)
+
T Consensus 304 ~ 304 (382)
T cd05625 304 A 304 (382)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=288.27 Aligned_cols=246 Identities=23% Similarity=0.245 Sum_probs=193.0
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+..+|.|+||.||++.. .++.||+|.+.+.. ......+.+|+++++.++||||+++++.+.+++..++||||+.+
T Consensus 6 ~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 85 (376)
T cd05598 6 IKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG 85 (376)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCC
Confidence 57899999999999998 68999999986542 22345688999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC--
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN-- 154 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~-- 154 (311)
++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 86 g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 86 GDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 999999943 456888999999999999999999999 99999999999999999999999998742110000
Q ss_pred ---------------------------------------cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHH
Q 021526 155 ---------------------------------------THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 195 (311)
Q Consensus 155 ---------------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~ 195 (311)
........|++.|+|||++.+..++.++|||||||++|+|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 00001235889999999999989999999999999999999
Q ss_pred hCCCCccccCccccc-cchhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCC---CHHHHHHH
Q 021526 196 TGRKAMDLSKGQGEQ-NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP---LINDIVVA 270 (311)
Q Consensus 196 ~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP---s~~~l~~~ 270 (311)
+|..||......... .+..|. ...........+..+.++|.+|+ .+|.+|+ ++.++++.
T Consensus 239 ~G~~Pf~~~~~~~~~~~i~~~~---------------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 239 VGQPPFLADTPAETQLKVINWE---------------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hCCCCCCCCCHHHHHHHHhccC---------------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999644321110 000000 00000111234567888898876 5999999 89999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=277.08 Aligned_cols=259 Identities=24% Similarity=0.273 Sum_probs=193.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
+..+|+|+||.||++.. .++.||+|.+..... .....+.+|+++++.++||||+++++++..+...+++|||+.+ +
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 89 (309)
T cd07872 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-D 89 (309)
T ss_pred EEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-C
Confidence 56899999999999988 688999999865432 2334677899999999999999999999999999999999975 8
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 90 l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~ 161 (309)
T cd07872 90 LKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT--KTY 161 (309)
T ss_pred HHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc--ccc
Confidence 8888854 3456888999999999999999999999 9999999999999999999999999986432211 112
Q ss_pred eeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCccccccchh-c----chhhhhccc---chhhh
Q 021526 159 TRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS-W----SRPFLKDQK---KFVHL 229 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~----~~~~~~~~~---~~~~~ 229 (311)
....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||............. . ....+.... .....
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07872 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY 241 (309)
T ss_pred ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence 23456889999998765 467899999999999999999999996543221110000 0 000000000 00000
Q ss_pred cCccCC----CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 230 VDPLLH----GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 230 ~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
-.+... .......+.++.++|.+||+.||.+|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000 0011234667899999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=293.46 Aligned_cols=263 Identities=23% Similarity=0.248 Sum_probs=191.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeC--------CeeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--------DQRLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~ 71 (311)
..++|+|+||.||++.. .++.||||.+.... ....+|+.+++.++||||+++++++... ..++++|
T Consensus 71 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvm 146 (440)
T PTZ00036 71 GNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVM 146 (440)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEE
Confidence 46799999999999998 68999999875332 3455799999999999999999876432 2467999
Q ss_pred ecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCC-ceEEeecCCCccCC
Q 021526 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-NPKLSDFGLAKLGP 150 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~-~vkl~Df~~~~~~~ 150 (311)
||+.+ +|.+++.........+++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||++....
T Consensus 147 E~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~ 222 (440)
T PTZ00036 147 EFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL 222 (440)
T ss_pred ecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccchhcc
Confidence 99964 788777654445678999999999999999999999999 99999999999998665 69999999997532
Q ss_pred CCCCcceeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCccccc-cchhcch----hhhh-cc
Q 021526 151 VGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLVSWSR----PFLK-DQ 223 (311)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~----~~~~-~~ 223 (311)
... ......+++.|+|||++.+. .++.++|+|||||++|+|++|.+||......... .+..... ..+. ..
T Consensus 223 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 299 (440)
T PTZ00036 223 AGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN 299 (440)
T ss_pred CCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhc
Confidence 211 12224578899999987654 6899999999999999999999999644321110 0000000 0000 00
Q ss_pred cchhhh-----cCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHHhh
Q 021526 224 KKFVHL-----VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA--LDYLV 275 (311)
Q Consensus 224 ~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~--L~~l~ 275 (311)
..+... ....+...++...+.++.+||.+||+.||.+|||+.++++. ++.+.
T Consensus 300 ~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 300 PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred hhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 000000 00011111233456789999999999999999999999963 55543
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=274.94 Aligned_cols=259 Identities=25% Similarity=0.390 Sum_probs=195.9
Q ss_pred eeeeeeceeccEEEEEE------------------CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL------------------CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 62 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~------------------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 62 (311)
...+|.|+||.||.+.. ++..||+|.+.... ......+.+|+++++.++|+||+++++++.
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~ 89 (296)
T cd05095 10 KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCI 89 (296)
T ss_pred eeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 46789999999998753 24578999986543 234467899999999999999999999999
Q ss_pred eCCeeEEEEecCCCCCHHHHhcccCCC-------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCC
Q 021526 63 SGDQRLLVYEYMPMGSLEDHLYDLEPD-------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 135 (311)
Q Consensus 63 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~ 135 (311)
++...+++||++.+++|.+++...... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.+
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Nili~~~ 166 (296)
T cd05095 90 TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKN 166 (296)
T ss_pred cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheEEEcCC
Confidence 999999999999999999999653211 234778889999999999999999999 9999999999999999
Q ss_pred CceEEeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh--CCCCccccCccccccch
Q 021526 136 FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT--GRKAMDLSKGQGEQNLV 213 (311)
Q Consensus 136 ~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~--g~~p~~~~~~~~~~~~~ 213 (311)
+.++|+|||.+................++..|++||...+..++.++|+||||+++|+|++ |..||........ .
T Consensus 167 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~---~ 243 (296)
T cd05095 167 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV---I 243 (296)
T ss_pred CCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH---H
Confidence 9999999999864322221122222334568999998888889999999999999999998 6677753221110 0
Q ss_pred hcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 021526 214 SWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 273 (311)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~ 273 (311)
.......... ........+..++..+.+++.+||+.||++||++.+|++.|++
T Consensus 244 ~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 244 ENTGEFFRDQ-------GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHhhc-------cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0000000000 0001111223456789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=271.70 Aligned_cols=253 Identities=25% Similarity=0.298 Sum_probs=189.8
Q ss_pred eeeeceeccEEEEEE----CCeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 4 CYLSCKFYNVGLVWL----CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
.+|+|+||.||+|.. .+..+++|.+..... .....+.+|+.+++.++||||+++++++.+....+++|||+.+++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 589999999999986 346799998765432 233578889999999999999999999998888999999999999
Q ss_pred HHHHhcccCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 79 LEDHLYDLEP-DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 79 L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
|.+++..... .....++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||.+...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 9999965332 2235667778889999999999999999 99999999999999999999999999864322221111
Q ss_pred eeeccccccccCCccccCC-------CCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhh
Q 021526 158 STRVMGTYGYCAPEYAMSG-------KLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 229 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~-------~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
.....++..|+|||++.+. .++.++|+||||+++|+|++ |..||......... .. .. .......
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~---~~---~~--~~~~~~~ 230 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL---TY---TV--REQQLKL 230 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH---HH---Hh--hcccCCC
Confidence 2234467789999987642 35789999999999999996 99999643221110 00 00 0000111
Q ss_pred cCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 021526 230 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 272 (311)
Q Consensus 230 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~ 272 (311)
..+.. ....+..+.+++.+|| .+|++|||+++|++.|.
T Consensus 231 ~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111 1234556889999999 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=284.58 Aligned_cols=244 Identities=22% Similarity=0.224 Sum_probs=191.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+..+|+|+||.||.+.. +++.||+|.+.+.. ......+.+|+.+++.++||||+++++++.++...++||||+.+
T Consensus 48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~g 127 (370)
T cd05621 48 VKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPG 127 (370)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCC
Confidence 56899999999999998 68899999986432 22335677899999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 128 g~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~-~~ 198 (370)
T cd05621 128 GDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MV 198 (370)
T ss_pred CcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCC-ce
Confidence 999999943 35788899999999999999999999 9999999999999999999999999987532211 11
Q ss_pred eeeeccccccccCCccccCC----CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCc
Q 021526 157 VSTRVMGTYGYCAPEYAMSG----KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 232 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~----~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
......|++.|+|||++.+. .++.++|+|||||++|+|++|..||........ . ..+...
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~------~----------~~i~~~ 262 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT------Y----------SKIMDH 262 (370)
T ss_pred ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH------H----------HHHHhC
Confidence 12345689999999988754 377899999999999999999999964322110 0 111110
Q ss_pred cCCCCCc--HHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 021526 233 LLHGRYP--RRCLNYAVAVTAMCLNEEANF--RPLINDIVVA 270 (311)
Q Consensus 233 ~~~~~~~--~~~~~~l~~li~~~l~~~p~~--RPs~~~l~~~ 270 (311)
.....++ ...+..+.+++..||..++.+ |+++.++++.
T Consensus 263 ~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 263 KNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0001111 234677899999999866544 8999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=279.90 Aligned_cols=240 Identities=25% Similarity=0.201 Sum_probs=204.0
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCcc---chhHHHHHHHHHhcCC-CCcccceeEEEEeCCeeEEEEecCCC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
..||.|.||.|+.+.. +|+.+|+|.+.+.... +.+.+.+|+++|+++. ||||+.++++|++....++|||++.|
T Consensus 41 ~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~G 120 (382)
T KOG0032|consen 41 RELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEG 120 (382)
T ss_pred hhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCC
Confidence 5799999999999999 6999999999877554 3468999999999998 99999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCC----CceEEeecCCCccCCCC
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND----FNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~----~~vkl~Df~~~~~~~~~ 152 (311)
|.|.+.+... .+++..+..++.|++.+++|||+.| ++|+|+||+|+|+... +.++++|||++.....
T Consensus 121 GeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~- 191 (382)
T KOG0032|consen 121 GELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP- 191 (382)
T ss_pred chHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC-
Confidence 9999999763 3999999999999999999999999 9999999999999433 4799999999986433
Q ss_pred CCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCc
Q 021526 153 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 232 (311)
Q Consensus 153 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
.......+|++.|+|||++....++...|+||+|+++|.|++|.+||.......... .+...
T Consensus 192 --~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~----------------~i~~~ 253 (382)
T KOG0032|consen 192 --GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL----------------AILRG 253 (382)
T ss_pred --CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH----------------HHHcC
Confidence 445667889999999999998999999999999999999999999997544322211 11110
Q ss_pred --cCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 233 --LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 233 --~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.+....-+..+..+.++|.+||..||..|+|+.++++
T Consensus 254 ~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 254 DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1111222456788999999999999999999999998
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=274.45 Aligned_cols=243 Identities=25% Similarity=0.294 Sum_probs=197.5
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
+..+|.|.+|.||++.. +++.|++|.+........+.+.+|+.+++.++|||++++++++..+...++++||+.+++|
T Consensus 24 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 103 (296)
T cd06655 24 YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL 103 (296)
T ss_pred EEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcH
Confidence 45789999999999987 7899999998766555667888999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
..++.. ..+++..+..++.+++.++++||+.+ ++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 104 ~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~ 173 (296)
T cd06655 104 TDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRS 173 (296)
T ss_pred HHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc--cCC
Confidence 999843 46889999999999999999999999 99999999999999999999999998764322211 122
Q ss_pred eccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 160 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
...++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..... ..... . ..+.+ ..+
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~------~~~~~--~-----~~~~~--~~~ 238 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIAT--N-----GTPEL--QNP 238 (296)
T ss_pred CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHh--c-----CCccc--CCc
Confidence 345788999999998888999999999999999999999999643321100 00000 0 00000 112
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..++..+.++|.+||..+|++||++.++++
T Consensus 239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 345667999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=271.35 Aligned_cols=257 Identities=24% Similarity=0.303 Sum_probs=196.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEecc--CCccchhHHHHHHHHHhcCCCCcccceeEEEEe-----CCeeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS-----GDQRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e 72 (311)
+..+|.|++|.|-.+.. +|+.||||.+.. ......++..+|+.+|+.++|+||+.+++++.. -+..|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 35689999999999999 899999999873 345566889999999999999999999998754 356799999
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCC
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~ 152 (311)
++ ..+|...+. .+..+..+.+..++.|++.||+|+|+.+ ++|||+||.|++++.+..+|++|||+++.....
T Consensus 107 lM-etDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 107 LM-ETDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred HH-hhHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeecccc
Confidence 99 458888883 4556999999999999999999999999 999999999999999999999999999865332
Q ss_pred CCcceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCccccccch-------------hc---
Q 021526 153 DNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-------------SW--- 215 (311)
Q Consensus 153 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------------~~--- 215 (311)
........-.-|.+|.|||++.+ ..|+.+.||||+||++.||++|++.|.+.+......+. ..
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~ 258 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSE 258 (359)
T ss_pred CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccH
Confidence 11222223346889999998765 57999999999999999999999999765532211111 00
Q ss_pred -chhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 216 -SRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 216 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.+.++.... ......+...+ +...+...+|+++||..||.+|+|++|.++.
T Consensus 259 ~ar~yi~slp---~~p~~~f~~~f-p~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 259 KARPYIKSLP---QIPKQPFSSIF-PNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHHhCC---CCCCCCHHHHc-CCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 001111000 00000000111 2456778899999999999999999999974
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=270.55 Aligned_cols=252 Identities=21% Similarity=0.293 Sum_probs=198.4
Q ss_pred eeeeeeceeccEEEEEEC-----CeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWLC-----DQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~-----~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
..++|.|++|.||++... ...|++|...... ....+.+.+|+++++.++||||+++++++.+ ...+++||++.
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~ 89 (270)
T cd05056 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAP 89 (270)
T ss_pred eeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCC
Confidence 357899999999999872 2478999876554 3445688999999999999999999998865 45789999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+++|.+++.. ....+++..++.++.+++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 90 ~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 162 (270)
T cd05056 90 LGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY- 162 (270)
T ss_pred CCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccccc-
Confidence 9999999954 2346899999999999999999999999 99999999999999999999999998864322211
Q ss_pred ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccC
Q 021526 156 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
.......++..|+|||.+....++.++|+||||++++++++ |..||......... . ... ...
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~---~----~~~----------~~~ 225 (270)
T cd05056 163 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI---G----RIE----------NGE 225 (270)
T ss_pred eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---H----HHH----------cCC
Confidence 11112234467999999888889999999999999999986 99998643321110 0 000 001
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 278 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~ 278 (311)
+...+..++..+.+++.+||..+|++|||+.+++..|+++....
T Consensus 226 ~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 226 RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 11223456678999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=269.19 Aligned_cols=250 Identities=26% Similarity=0.342 Sum_probs=196.8
Q ss_pred eeeeeeceeccEEEEEE--C---CeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL--C---DQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~---~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
...+|.|.||.||.+.. + +..+++|.+..... .....+.+|+++++.++||||+++++++.++...+++||++.
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (267)
T cd05066 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYME 88 (267)
T ss_pred eeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCC
Confidence 35789999999999987 2 34799998865432 234678899999999999999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+++|.+++.. ....+++..++.++.|++.|+++||+.+ ++|+||+|+||+++.++.++|+|||.+.........
T Consensus 89 ~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd05066 89 NGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162 (267)
T ss_pred CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence 9999999964 3356889999999999999999999999 999999999999999999999999998754322111
Q ss_pred cee-eeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 156 HVS-TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 156 ~~~-~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
... ....++..|++||.+.+..++.++|+||||+++|++++ |..||........ .. .. . ..
T Consensus 163 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~---~~-~----------~~ 225 (267)
T cd05066 163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IK---AI-E----------EG 225 (267)
T ss_pred eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HH---HH-h----------CC
Confidence 111 11223457999999988889999999999999999886 9999863322110 00 00 0 00
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l 274 (311)
.+...+..++..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 01111234567789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=270.40 Aligned_cols=252 Identities=26% Similarity=0.348 Sum_probs=198.5
Q ss_pred eeeeeeceeccEEEEEE--CC----eEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWL--CD----QLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~----~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
...+|.|+||.||++.. .+ ..|++|.+..... .....+.+|+++++.++|||++++++++.. ...++++|++
T Consensus 12 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 90 (279)
T cd05057 12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLM 90 (279)
T ss_pred cceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecC
Confidence 45789999999999987 23 3689998765543 334678899999999999999999999876 7889999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
.+++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 91 ~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 164 (279)
T cd05057 91 PLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK 164 (279)
T ss_pred CCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccCccc
Confidence 99999999964 3456899999999999999999999998 99999999999999999999999999875432221
Q ss_pred cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 155 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
........++..|++||.+....++.++|+||||+++|++++ |..||....... +...+...
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----------------~~~~~~~~ 227 (279)
T cd05057 165 EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-----------------IPDLLEKG 227 (279)
T ss_pred ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-----------------HHHHHhCC
Confidence 111111223567999999888889999999999999999998 999986332110 00111111
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 277 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~ 277 (311)
.....+..++..+.+++.+||..+|++||++.++++.|..+...
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 228 ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 11122334556789999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=272.80 Aligned_cols=248 Identities=31% Similarity=0.400 Sum_probs=196.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchh--HHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQ--EFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~--~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
..++|+|++|.||++.. +++.||+|.+......... ...+|+.+++.++||||+++++++.++...+++||++.++
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~ 83 (260)
T PF00069_consen 4 VKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGG 83 (260)
T ss_dssp EEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTE
T ss_pred eEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccccc
Confidence 57899999999999999 6778999999866543332 3456999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|.+++. ....+++..++.++.|++.||++||+.+ ++|+||+|+||+++.++.++|+|||.+... ......
T Consensus 84 ~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~ 154 (260)
T PF00069_consen 84 SLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNEN 154 (260)
T ss_dssp BHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSE
T ss_pred ccccccc----cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc--cccccc
Confidence 9999995 3567899999999999999999999999 999999999999999999999999998642 122233
Q ss_pred eeeccccccccCCcccc-CCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 158 STRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
.....++..|.|||++. +..++.++|+||||+++++|++|..||............. .... ........
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~---~~~~-----~~~~~~~~-- 224 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE---KILK-----RPLPSSSQ-- 224 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH---HHHH-----THHHHHTT--
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh---hccc-----cccccccc--
Confidence 34456788999999988 7889999999999999999999999987441111110000 0000 00000000
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
........+.+++.+||+.||++||++.++++
T Consensus 225 -~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 -QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp -SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred -ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111378999999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=267.11 Aligned_cols=247 Identities=26% Similarity=0.274 Sum_probs=198.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
...+|.|+++.||.+.. +++.+++|.+........+.+.+|+++++.++||||+++++++.++...+++||++.+++|
T Consensus 8 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l 87 (262)
T cd06613 8 IQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSL 87 (262)
T ss_pred EEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcH
Confidence 35789999999999998 6789999999876666677899999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
.+++.. ....+++..++.++.|++.+++|||+.+ ++|+||+|+||+++.++.++|+|||.+...... .....
T Consensus 88 ~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--~~~~~ 159 (262)
T cd06613 88 QDIYQV---TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTAT--IAKRK 159 (262)
T ss_pred HHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhh--hhccc
Confidence 999854 2367889999999999999999999999 999999999999999999999999988643221 11122
Q ss_pred eccccccccCCccccCC---CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 160 RVMGTYGYCAPEYAMSG---KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~~~---~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
...++..|+|||.+.+. .++.++|+||||+++|+|++|..||......... .. .. .. ...... .
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~--~~----~~--~~---~~~~~~--~ 226 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL--FL----IS--KS---NFPPPK--L 226 (262)
T ss_pred cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HH----HH--hc---cCCCcc--c
Confidence 34567789999998776 7889999999999999999999998632211100 00 00 00 000001 1
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..+...+..+.+++.+||..+|.+||++.+++.
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 123455678999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=272.78 Aligned_cols=265 Identities=23% Similarity=0.356 Sum_probs=197.8
Q ss_pred eeeeeeceeccEEEEEE------CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeC--CeeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL------CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 72 (311)
+..+|+|+||.||.+.. +++.|++|.+.... ......+.+|+++++.++|||++++++++... ...+++||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (284)
T cd05079 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 88 (284)
T ss_pred ceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEE
Confidence 56799999999999874 57899999986543 33446788999999999999999999988765 56789999
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCC
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~ 152 (311)
|+++++|.+++.. ....+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 89 ~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 89 FLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred ccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccccccC
Confidence 9999999999854 2346899999999999999999999999 999999999999999999999999998754322
Q ss_pred CCc-ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcC
Q 021526 153 DNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231 (311)
Q Consensus 153 ~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
... .......++..|+|||.+.+..++.++|+||||+++|+|+++..|.................... .........
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 240 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMT--VTRLVRVLE 240 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccccccccc--HHHHHHHHH
Confidence 211 11223446678999999888889999999999999999999876542111000000000000000 000000111
Q ss_pred ccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 021526 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274 (311)
Q Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l 274 (311)
.......+..++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111122334567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=270.32 Aligned_cols=242 Identities=25% Similarity=0.280 Sum_probs=197.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
+..+|+|.+|.||.+.. +++.||+|.+.... ......+.+|+.+++.++||||+++++.+.++...++||||+.+++
T Consensus 9 ~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (277)
T cd06640 9 LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGS 88 (277)
T ss_pred hhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCc
Confidence 45789999999999998 68999999987543 2344678899999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
|.+++.. ..+++..+..++.|++.++++||+.+ ++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 89 L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 158 (277)
T cd06640 89 ALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKR 158 (277)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc--ccc
Confidence 9999843 46888999999999999999999999 9999999999999999999999999986532221 112
Q ss_pred eeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCC
Q 021526 159 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRY 238 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||......... ...........
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-----------------~~~~~~~~~~~ 221 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-----------------FLIPKNNPPTL 221 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-----------------hhhhcCCCCCC
Confidence 2235677899999988888999999999999999999999998633211100 00000111123
Q ss_pred cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 239 PRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 239 ~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
+..++..+.+++.+||+.+|++||++.++++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 34567789999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=267.10 Aligned_cols=247 Identities=28% Similarity=0.377 Sum_probs=194.0
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
...+|.|++|.||.+.. .+..|++|.+... ....+.+.+|+++++.++|||++++++++. +...+++||++.+++|.
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 88 (260)
T cd05069 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLL 88 (260)
T ss_pred eeeecCcCCCeEEEEEEcCCceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHH
Confidence 35789999999999988 5567999987543 234467889999999999999999998875 45678999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++.. .....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+........ .....
T Consensus 89 ~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 162 (260)
T cd05069 89 DFLKE--GDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TARQG 162 (260)
T ss_pred HHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc-cccCC
Confidence 99965 23445888999999999999999999999 99999999999999999999999999864322211 11112
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
..++..|+|||...+..++.++|+||||+++|+|++ |..||....... ... . .. .......+
T Consensus 163 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~---~-~~----------~~~~~~~~ 225 (260)
T cd05069 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLE---Q-VE----------RGYRMPCP 225 (260)
T ss_pred CccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---H-HH----------cCCCCCCC
Confidence 234567999998888889999999999999999999 888886322110 000 0 00 00111223
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 273 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~ 273 (311)
...+..+.+++.+||..+|++||++++|++.|++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 3456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=272.54 Aligned_cols=245 Identities=23% Similarity=0.289 Sum_probs=194.7
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
+..+|.|++|.||++.. +++.|++|.+........+.+.+|+++++.++|||++++++.+..+...+++|||+.+++|
T Consensus 17 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 96 (292)
T cd06644 17 IGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAV 96 (292)
T ss_pred hheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcH
Confidence 46799999999999998 6899999998766656667888999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
..++.. ....+++..++.++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+...... .....
T Consensus 97 ~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~~~~ 168 (292)
T cd06644 97 DAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQRRD 168 (292)
T ss_pred HHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc--ccccc
Confidence 888754 3456899999999999999999999999 999999999999999999999999987642211 11122
Q ss_pred eccccccccCCcccc-----CCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccC
Q 021526 160 RVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
...++..|+|||.+. ...++.++|+||||+++|+|++|..||........ .. .... ...+..
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~----~~~~-------~~~~~~ 235 (292)
T cd06644 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LL----KIAK-------SEPPTL 235 (292)
T ss_pred eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--HH----HHhc-------CCCccC
Confidence 345678899999874 34567899999999999999999999853221100 00 0000 000000
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..+..++..+.++|.+||..+|++||+++++++
T Consensus 236 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 236 --SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred --CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 112344567899999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=273.40 Aligned_cols=246 Identities=26% Similarity=0.344 Sum_probs=196.0
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc---chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
..++|+|+||.||.+.. .++.||+|.+...... ....+.+|+.+++.++|++++++++.+.++...+++|||+.+
T Consensus 5 ~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g 84 (285)
T cd05630 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred eEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCC
Confidence 46799999999999999 6899999998654322 224577899999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. .....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--- 156 (285)
T cd05630 85 GDLKFHIYH--MGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--- 156 (285)
T ss_pred CcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc---
Confidence 999998854 23346889999999999999999999999 9999999999999999999999999886432111
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||.......... ....... ....
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~-------------~~~~~~~-~~~~ 222 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE-------------EVERLVK-EVQE 222 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH-------------HHHhhhh-hhhh
Confidence 1123468899999999988889999999999999999999999996432211000 0000000 0011
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 269 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs-----~~~l~~ 269 (311)
.++...+..+.+++.+||+.||++||| ++++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 123345667899999999999999999 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=267.77 Aligned_cols=246 Identities=26% Similarity=0.372 Sum_probs=194.9
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
...+|+|++|.||++.. +++.+++|.+... ......+.+|+++++.++||+++++++++......++++|++.+++|.
T Consensus 9 ~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 87 (256)
T cd05112 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLS 87 (256)
T ss_pred EeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHH
Confidence 46789999999999988 5889999987643 334467899999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++.. ....+++..++.++.+++.++++||+.+ ++|+||+|.||+++.++.++|+|||.+....... ......
T Consensus 88 ~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~ 160 (256)
T cd05112 88 DYLRA---QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSSTG 160 (256)
T ss_pred HHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCc-ccccCC
Confidence 99854 3346888999999999999999999999 9999999999999999999999999886432211 111112
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
..++..|+|||.+.+..++.++|+||||+++|+|++ |..||....... .... +....+...+
T Consensus 161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~----------~~~~-------~~~~~~~~~~ 223 (256)
T cd05112 161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE----------VVET-------INAGFRLYKP 223 (256)
T ss_pred CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH----------HHHH-------HhCCCCCCCC
Confidence 234568999999988889999999999999999998 888986322110 0000 0000010112
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 272 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~ 272 (311)
...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 224 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 224 RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 224567999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=270.40 Aligned_cols=245 Identities=25% Similarity=0.278 Sum_probs=193.6
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
..+|+|++|.||.+.. +++.|++|.+..........+.+|+.+++.++||||+++++++..+...++++||+.+++|.
T Consensus 15 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (267)
T cd06645 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQ 94 (267)
T ss_pred HHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHH
Confidence 5689999999999998 78999999987655555567888999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++. ..+.+++..++.++.|++.++.|||+.| ++|+||+|+||+++.++.++|+|||++...... ......
T Consensus 95 ~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~ 165 (267)
T cd06645 95 DIYH----VTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAKRKS 165 (267)
T ss_pred HHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc--cccccc
Confidence 9984 3457899999999999999999999999 999999999999999999999999998643221 112233
Q ss_pred ccccccccCCcccc---CCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCC
Q 021526 161 VMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 237 (311)
Q Consensus 161 ~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
..|+..|+|||.+. ...++.++|+||||+++|+|++|..||......... . .... .. ...+...
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~--~----~~~~--~~---~~~~~~~-- 232 (267)
T cd06645 166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--F----LMTK--SN---FQPPKLK-- 232 (267)
T ss_pred ccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH--H----hhhc--cC---CCCCccc--
Confidence 45788999999874 456788999999999999999999998533211110 0 0000 00 0000000
Q ss_pred CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 238 YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
....++..+.++|.+||..+|++||++++|++
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 233 DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 01124556899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=273.85 Aligned_cols=260 Identities=26% Similarity=0.326 Sum_probs=198.7
Q ss_pred eeeeeeceeccEEEEEE--CCe----EEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQ----LVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~----~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
+..+|+|++|.||++.. .+. .||+|.+..... .....+.+|+.+++.++||||+++++++... ..+++++++
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~ 90 (303)
T cd05110 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLM 90 (303)
T ss_pred ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehhc
Confidence 45799999999999987 443 578998764432 2234688899999999999999999998654 467999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
.+++|.+++.. ....+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.+||+|||++........
T Consensus 91 ~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 164 (303)
T cd05110 91 PHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164 (303)
T ss_pred CCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCccc
Confidence 99999999854 3446888999999999999999999999 99999999999999999999999999875432221
Q ss_pred cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 155 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
........++..|++||...+..++.++|+||||+++|+|++ |..||........ . .... ..
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~---~----~~~~----------~~ 227 (303)
T cd05110 165 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI---P----DLLE----------KG 227 (303)
T ss_pred ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---H----HHHH----------CC
Confidence 111122334668999999988889999999999999999997 8888853221110 0 0111 00
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCCCCC
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSR 285 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~~~~~~ 285 (311)
.....+..++..+.+++.+||..+|++||++.++++.|..+.......-...
T Consensus 228 ~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~ 279 (303)
T cd05110 228 ERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYLVIQ 279 (303)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchhhheeec
Confidence 0011123345678999999999999999999999999999876554443333
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=267.83 Aligned_cols=250 Identities=27% Similarity=0.369 Sum_probs=190.0
Q ss_pred eeeeceeccEEEEEE-----CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEE-eCCeeEEEEecCCC
Q 021526 4 CYLSCKFYNVGLVWL-----CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCT-SGDQRLLVYEYMPM 76 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~ 76 (311)
++|+|+||.||++.. .+..||+|.+.... ....+.+.+|+.+++.++|||++++++++. .+...++++||+.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 81 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence 689999999999986 24679999875432 334567888999999999999999999765 45567899999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ......+..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 82 ~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 82 GDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 999999964 2345677778889999999999999999 9999999999999999999999999986432211111
Q ss_pred e--eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhC-CCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 157 V--STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG-RKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 157 ~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
. .....++..|+|||.+.+..++.++|+||||+++|+|++| .+||...... ........ .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~------~~~~~~~~-~---------- 218 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF------DITVYLLQ-G---------- 218 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHhc-C----------
Confidence 1 1122346689999998888899999999999999999995 5555422110 00000000 0
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 276 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~ 276 (311)
.....+...+..+.+++.+||..+|++||++.++++.|+++..
T Consensus 219 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 219 RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0001122345679999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=278.48 Aligned_cols=256 Identities=25% Similarity=0.324 Sum_probs=195.3
Q ss_pred eeeeeeceeccEEEEEE-------CCeEEEEEEeccCCc-cchhHHHHHHHHHhcC-CCCcccceeEEEEe-CCeeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL-------CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTS-GDQRLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~~lv~ 71 (311)
...+|+|+||.||++.. .++.||||.+..... .....+.+|+.++..+ +||||+++++++.. +...+++|
T Consensus 12 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ 91 (343)
T cd05103 12 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 91 (343)
T ss_pred cccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEE
Confidence 46799999999999973 568999999865432 2345688999999999 68999999998754 45678999
Q ss_pred ecCCCCCHHHHhcccCC---------------------------------------------------------------
Q 021526 72 EYMPMGSLEDHLYDLEP--------------------------------------------------------------- 88 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~--------------------------------------------------------------- 88 (311)
||+++++|.+++.....
T Consensus 92 ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (343)
T cd05103 92 EFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDL 171 (343)
T ss_pred eccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhh
Confidence 99999999999864211
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeeecccccccc
Q 021526 89 DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 168 (311)
Q Consensus 89 ~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (311)
....+++..+..++.|++.||+|||+++ ++|+||+|.||+++.++.++|+|||++................++..|+
T Consensus 172 ~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 248 (343)
T cd05103 172 YKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 248 (343)
T ss_pred hhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceE
Confidence 0124677888999999999999999999 9999999999999999999999999987532222111122233566799
Q ss_pred CCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCcHHHHHHHH
Q 021526 169 APEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAV 247 (311)
Q Consensus 169 aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 247 (311)
|||.+.+..++.++|+||||+++|+|++ |..||........ .. ..+........+...+..+.
T Consensus 249 aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-----~~-----------~~~~~~~~~~~~~~~~~~~~ 312 (343)
T cd05103 249 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-----FC-----------RRLKEGTRMRAPDYTTPEMY 312 (343)
T ss_pred CcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-----HH-----------HHHhccCCCCCCCCCCHHHH
Confidence 9999888889999999999999999997 8888853221100 00 00000011111223456789
Q ss_pred HHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 021526 248 AVTAMCLNEEANFRPLINDIVVALDYLVS 276 (311)
Q Consensus 248 ~li~~~l~~~p~~RPs~~~l~~~L~~l~~ 276 (311)
+++.+||+.+|++||++.+|++.|+.+.+
T Consensus 313 ~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 313 QTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=267.23 Aligned_cols=248 Identities=25% Similarity=0.356 Sum_probs=195.8
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
...+|+|++|.||.+.. .+..+++|.+... ......+.+|+++++.++|+|++++++++.. ...+++|||+.+++|.
T Consensus 11 ~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~ 88 (260)
T cd05073 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLL 88 (260)
T ss_pred EeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHH
Confidence 46799999999999987 6678999987643 3344678899999999999999999999877 6789999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++.. .....+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+........ .....
T Consensus 89 ~~~~~--~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 162 (260)
T cd05073 89 DFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREG 162 (260)
T ss_pred HHHHh--CCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc-ccccC
Confidence 99965 23456788899999999999999999999 99999999999999999999999998864322111 11122
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
..++..|+|||.+....++.++|+||||+++|++++ |..||....... .... .. .......+
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~----~~----------~~~~~~~~ 225 (260)
T cd05073 163 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRA----LE----------RGYRMPRP 225 (260)
T ss_pred CcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHH----Hh----------CCCCCCCc
Confidence 234567999999988889999999999999999998 888986332110 0000 00 00011112
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l 274 (311)
...+..+.+++.+||+.+|++||++.++.+.|+.+
T Consensus 226 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 226 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 34566799999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=273.98 Aligned_cols=243 Identities=24% Similarity=0.265 Sum_probs=197.5
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
+..+|.|++|.||++.. +++.||+|.+........+.+.+|+.+++.++|||++++++++..+...++||||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 103 (297)
T cd06656 24 FEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 103 (297)
T ss_pred eeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCH
Confidence 45789999999999997 7899999998766555567788999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
.+++.. ..+++..+..++.|++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 104 ~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 173 (297)
T cd06656 104 TDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRS 173 (297)
T ss_pred HHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc--cCcC
Confidence 999843 45788899999999999999999999 9999999999999999999999999886432221 1122
Q ss_pred eccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 160 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
...++..|++||.+.+..++.++|+||||+++|++++|..||...+...... .. .. ........+
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~--~~----~~---------~~~~~~~~~ 238 (297)
T cd06656 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--LI----AT---------NGTPELQNP 238 (297)
T ss_pred cccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee--ee----cc---------CCCCCCCCc
Confidence 3457788999999988889999999999999999999999996433211100 00 00 000000123
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
...+..+.+++.+||..+|++||++.++++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 345667899999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=270.08 Aligned_cols=244 Identities=20% Similarity=0.242 Sum_probs=191.7
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
+.++|+|++|.||++.. +++.||+|.+.... ......+.+|+++++.++||||+++++++..+...+++|||+++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 85 (279)
T cd06619 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGS 85 (279)
T ss_pred eeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCC
Confidence 46799999999999998 78999999986542 2334578899999999999999999999999999999999999998
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
|..+. .+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 86 l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~~ 150 (279)
T cd06619 86 LDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IA 150 (279)
T ss_pred hHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc----cc
Confidence 86542 4677888999999999999999999 999999999999999999999999998643211 12
Q ss_pred eeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCcccccc-chhcchhhhhcccchhhhcCccCCCC
Q 021526 159 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWSRPFLKDQKKFVHLVDPLLHGR 237 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||.......... ..... ....+......
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~----------~~~~~~~~~~~ 220 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL----------QCIVDEDPPVL 220 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHH----------HHHhccCCCCC
Confidence 23457889999999988889999999999999999999999986432111100 00000 00000000000
Q ss_pred CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 238 YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.....+.++.+++.+||+.+|++||+++++++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 112345678999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=268.67 Aligned_cols=244 Identities=23% Similarity=0.273 Sum_probs=193.1
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
.++|.|++|.||++.. ++..|++|.+........+.+.+|+++++.++|+||+++++++..+...++++|++.+++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 5789999999999997 67889999987665556678999999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCCC--CHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcC-CCceEEeecCCCccCCCCCCcce
Q 021526 81 DHLYDLEPDQEPL--SWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-DFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 81 ~~l~~~~~~~~~l--~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~-~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+++... ...+ ++..+..++.|++.||+|||+.+ ++|+||+|+||+++. ++.++|+|||.+....... ..
T Consensus 94 ~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~--~~ 165 (268)
T cd06624 94 ALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN--PC 165 (268)
T ss_pred HHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCC--Cc
Confidence 999642 2334 77888899999999999999999 999999999999976 6789999999886432211 11
Q ss_pred eeeccccccccCCccccCC--CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 158 STRVMGTYGYCAPEYAMSG--KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|..||......... .+. .......
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~------------~~~~~~~ 230 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFK------------VGMFKIH 230 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhh------------hhhhccC
Confidence 2223478899999988654 3788999999999999999999998532211000 000 0000011
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
...+......+.+++.+||..+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 231 PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 1234456677999999999999999999999975
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=301.98 Aligned_cols=248 Identities=22% Similarity=0.276 Sum_probs=192.1
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEe--CCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS--GDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~ 75 (311)
+..+|.|+||.||++.. .++.||+|.+..... .....+..|+.+++.++||||++++++|.+ ...+++||||+.
T Consensus 18 l~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~ 97 (1021)
T PTZ00266 18 IKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCD 97 (1021)
T ss_pred EEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCC
Confidence 57899999999999999 788999999865432 234678899999999999999999998854 456899999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC----CCeeecCCCCCcEEEcC-----------------
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN----PPVIYRDLKSANILLDN----------------- 134 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~----~~i~H~di~p~nil~~~----------------- 134 (311)
+++|.+++.........+++..++.++.||+.||+|||+.+. ..|+|+||||+|||++.
T Consensus 98 gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng 177 (1021)
T PTZ00266 98 AGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177 (1021)
T ss_pred CCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCC
Confidence 999999997654455689999999999999999999998431 22999999999999954
Q ss_pred CCceEEeecCCCccCCCCCCcceeeeccccccccCCccccC--CCCCccccchhHHHHHHHHHhCCCCccccCccccccc
Q 021526 135 DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 212 (311)
Q Consensus 135 ~~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~ 212 (311)
.+.+||+|||++...... .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 178 ~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~----- 249 (1021)
T PTZ00266 178 RPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF----- 249 (1021)
T ss_pred CCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH-----
Confidence 234899999998743221 12233468999999998854 45789999999999999999999999632211
Q ss_pred hhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 213 VSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
......... . +.+ .....+..+.+||.+||..+|.+||++.++++
T Consensus 250 ~qli~~lk~-~--------p~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 250 SQLISELKR-G--------PDL---PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHHHHHhc-C--------CCC---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 010000000 0 000 01123567999999999999999999999985
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=277.79 Aligned_cols=269 Identities=18% Similarity=0.186 Sum_probs=194.7
Q ss_pred Ceeeeeec--eeccEEEEEE--CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 1 MLCCYLSC--KFYNVGLVWL--CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 1 ~~~~~~~g--~~~~v~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
+++++|+| +|+.||.+.. +|+.||+|.+..... .....+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 6889999988 789999999875532 22356778999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
.+++|.+++... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+++.||+..........
T Consensus 82 ~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999999999542 2345889999999999999999999999 99999999999999999999999986432211111
Q ss_pred c-----ceeeeccccccccCCccccC--CCCCccccchhHHHHHHHHHhCCCCccccCccccc------cchhcch----
Q 021526 155 T-----HVSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ------NLVSWSR---- 217 (311)
Q Consensus 155 ~-----~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~------~~~~~~~---- 217 (311)
. .......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||......... .......
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence 0 01112345667999999875 46889999999999999999999999632211000 0000000
Q ss_pred --hhh-------------hcccc---hhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHh
Q 021526 218 --PFL-------------KDQKK---FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV--ALDYL 274 (311)
Q Consensus 218 --~~~-------------~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~--~L~~l 274 (311)
... ..... ............+....+..+.+++.+||+.||++|||++++++ .+.++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 000 00000 00000000001112234667999999999999999999999997 35444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=283.98 Aligned_cols=256 Identities=21% Similarity=0.195 Sum_probs=192.9
Q ss_pred eeeeeeceeccEEEEEE----CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL----CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~----~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
+..+|.|++|.||.+.. .+..|++|.+... ....+|+++++.++||||+++++++..+...+++||++. +
T Consensus 97 ~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 170 (392)
T PHA03207 97 LSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-C 170 (392)
T ss_pred EEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-C
Confidence 46799999999999876 3578999987543 245689999999999999999999999999999999985 6
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|.+++. ....+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++...........
T Consensus 171 ~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~ 243 (392)
T PHA03207 171 DLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243 (392)
T ss_pred CHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccccccc
Confidence 8888883 4567899999999999999999999999 99999999999999999999999999865433322222
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhh---------cccchhh
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK---------DQKKFVH 228 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~ 228 (311)
.....|+..|+|||++.+..++.++|+|||||++|+|++|..||.................... ....+..
T Consensus 244 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 323 (392)
T PHA03207 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCK 323 (392)
T ss_pred ccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHH
Confidence 2345689999999999988999999999999999999999999865443211100000000000 0000000
Q ss_pred ---hcCccCCCCCc-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 229 ---LVDPLLHGRYP-------RRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 229 ---~~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
......+..+. .....++.++|.+||..||++||++.+++..
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 324 HFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000010000 1234568899999999999999999999864
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=267.40 Aligned_cols=243 Identities=25% Similarity=0.256 Sum_probs=197.1
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
...+|.|.+|.||++.. +++.|++|.+..... .+++.+|+++++.++||||+++++++..+...++++|++.+++|
T Consensus 8 ~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 85 (256)
T cd06612 8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSV 85 (256)
T ss_pred hhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcH
Confidence 35689999999999999 479999999864432 67899999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
.+++.. ....+++..++.++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 86 ~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~~ 157 (256)
T cd06612 86 SDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--AKRN 157 (256)
T ss_pred HHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc--cccc
Confidence 999854 3467899999999999999999999999 9999999999999999999999999987543221 1222
Q ss_pred eccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 160 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
...++..|+|||.+.+..++.++|+||||+++|+|++|..||......... .. ..... ......+
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~---------~~----~~~~~--~~~~~~~ 222 (256)
T cd06612 158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI---------FM----IPNKP--PPTLSDP 222 (256)
T ss_pred cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh---------hh----hccCC--CCCCCch
Confidence 344678899999998888999999999999999999999998633221110 00 00000 0011123
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
......+.++|.+||+.+|++||++.++++
T Consensus 223 ~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 223 EKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 345677999999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=270.19 Aligned_cols=247 Identities=25% Similarity=0.320 Sum_probs=195.7
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc---chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
..++|.|+||.||.+.. +++.||+|.+...... ....+.+|+++++.++|++++++.+.+..++..+++|||+.+
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05632 5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccC
Confidence 46799999999999999 6899999998654322 234577899999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. .....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++...... .
T Consensus 85 ~~L~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~---~ 156 (285)
T cd05632 85 GDLKFHIYN--MGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG---E 156 (285)
T ss_pred ccHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC---C
Confidence 999988864 23456999999999999999999999999 999999999999999999999999988643221 1
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||......... .... ...... ..
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~--~~~~-------~~~~~~-----~~ 222 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR--EEVD-------RRVLET-----EE 222 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHH-------Hhhhcc-----cc
Confidence 112345789999999998888999999999999999999999999633211000 0000 000000 01
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVVA 270 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs-----~~~l~~~ 270 (311)
.++...+..+.+++.+||+.||++||+ +.+++..
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 123345667899999999999999999 6777763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=272.92 Aligned_cols=238 Identities=23% Similarity=0.285 Sum_probs=186.8
Q ss_pred eeeeeceeccEEEEEEC--------------------------CeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccc
Q 021526 3 CCYLSCKFYNVGLVWLC--------------------------DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVT 56 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~~--------------------------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 56 (311)
|++|+|+||.||+|... ...|++|.+..........+.+|+.+++.++||||++
T Consensus 1 ~~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 1 AHLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CCcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeee
Confidence 57999999999999851 2468999886554444567888999999999999999
Q ss_pred eeEEEEeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCC
Q 021526 57 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF 136 (311)
Q Consensus 57 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~ 136 (311)
+++++..+...++||||+++++|..++.. ..+.+++..+..++.|++.||+|||+++ ++|+||+|+||+++..+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccC
Confidence 99999999999999999999999999854 3457889999999999999999999999 99999999999997643
Q ss_pred -------ceEEeecCCCccCCCCCCcceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHH-hCCCCccccCcc
Q 021526 137 -------NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELI-TGRKAMDLSKGQ 207 (311)
Q Consensus 137 -------~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~-~g~~p~~~~~~~ 207 (311)
.++++|||.+...... ....++..|+|||.+.+ ..++.++|+||||+++|+|+ +|..||......
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 228 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS 228 (274)
T ss_pred cccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence 3799999987532111 12245677999998865 56889999999999999984 688888633221
Q ss_pred ccccchhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 021526 208 GEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 271 (311)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L 271 (311)
... ..... . ...+......+.++|.+||+.+|++|||+.++++.|
T Consensus 229 ~~~-------~~~~~----------~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 229 EKE-------RFYEK----------K--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHH-------HHHHh----------c--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 110 00000 0 011112235689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=272.09 Aligned_cols=246 Identities=24% Similarity=0.291 Sum_probs=196.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
+..+|.|.+|.||.+.. +++.|++|.+........+.+.+|+++++.++||||+++++++..+...+++|||+++++|
T Consensus 10 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (280)
T cd06611 10 IGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGAL 89 (280)
T ss_pred HHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcH
Confidence 45689999999999998 6899999998766555667888999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
.+++.. ....+++..+..++.|++.++.|||+++ ++|+||+|+||+++.++.++|+|||.+...... .....
T Consensus 90 ~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--~~~~~ 161 (280)
T cd06611 90 DSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--LQKRD 161 (280)
T ss_pred HHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc--ccccc
Confidence 999854 3457999999999999999999999999 999999999999999999999999987643221 11222
Q ss_pred eccccccccCCcccc-----CCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccC
Q 021526 160 RVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
...++..|++||.+. ...++.++|+||||+++|+|++|..||........ .. .. .....+.+
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~----~~-------~~~~~~~~ 228 (280)
T cd06611 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LL----KI-------LKSEPPTL 228 (280)
T ss_pred eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HH----HH-------hcCCCCCc
Confidence 345788899999875 34567899999999999999999999864321100 00 00 00000011
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
..+..++..+.+++.+||+.+|.+||+++++++.
T Consensus 229 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 229 --DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred --CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 1123456779999999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=293.07 Aligned_cols=267 Identities=24% Similarity=0.347 Sum_probs=224.0
Q ss_pred eeeeeceeccEEEEEE-----CCeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 3 CCYLSCKFYNVGLVWL-----CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
.++|+|.||.|+.|.+ ....||||.++.... +...+|..|+.++-+++||||+++.++.+......||+|||++
T Consensus 635 ~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMEN 714 (996)
T KOG0196|consen 635 KVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMEN 714 (996)
T ss_pred EEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhC
Confidence 4789999999999999 247899999976543 4556899999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
|+|..+|+. ..+.|...++..++..|+.+++||-+.| +|||||...||||+.+..+|+.|||+++....+...
T Consensus 715 GsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~- 787 (996)
T KOG0196|consen 715 GSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA- 787 (996)
T ss_pred CcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCCCc-
Confidence 999999976 4566999999999999999999999999 999999999999999999999999999865333322
Q ss_pred eeeec--cccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 157 VSTRV--MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 157 ~~~~~--~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
..... .-+.+|.|||.+...+++.++||||+|++|||.++ |..||..... ....+-+...
T Consensus 788 ~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-----------------QdVIkaIe~g 850 (996)
T KOG0196|consen 788 AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-----------------QDVIKAIEQG 850 (996)
T ss_pred cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-----------------HHHHHHHHhc
Confidence 22222 23679999999999999999999999999999866 7889863321 2222333344
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCCCCCCCCCCCCC
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSRNAGARGVP 293 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~~~~~~~~~~~~~~ 293 (311)
.+-.-|.+|+..|.+|+..||+.|-.+||.+.+|+..|+++.+...+-+...+.+...+.
T Consensus 851 yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~~~~r~s~ 910 (996)
T KOG0196|consen 851 YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAPESPRPSQ 910 (996)
T ss_pred cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCCCCCCCcc
Confidence 445667899999999999999999999999999999999999988877777666555433
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=273.40 Aligned_cols=258 Identities=22% Similarity=0.262 Sum_probs=195.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
.+.+|.|+||.||++.. ++..+++|.+..... ....++.+|+++++.++||||+++++.+..+...+++|||+++++
T Consensus 6 ~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~ 85 (308)
T cd06615 6 LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 85 (308)
T ss_pred EeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCc
Confidence 46899999999999998 688899998865432 233568899999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
|.+++.. ...+++..+..++.|++.+|+|||+ .+ ++|+||+|+||+++.++.++|+|||.+...... .
T Consensus 86 L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~ 154 (308)
T cd06615 86 LDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----M 154 (308)
T ss_pred HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc----c
Confidence 9999954 3668899999999999999999997 57 999999999999999999999999987642211 1
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhc---------------
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD--------------- 222 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------- 222 (311)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||.....................
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence 22345788999999988888899999999999999999999998643321111100000000000
Q ss_pred -ccchhhhcCccC---CCCCc-HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 223 -QKKFVHLVDPLL---HGRYP-RRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 223 -~~~~~~~~~~~~---~~~~~-~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.....+..+... ....+ ...+.++.+++.+||..+|++||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000 00001 1245679999999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=274.35 Aligned_cols=249 Identities=19% Similarity=0.164 Sum_probs=191.0
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+..+|.|+||.||.+.. +++.||+|++.+.. ....+.+.+|..++..++|+||+++++++.++...++||||+.+
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (331)
T cd05597 6 LKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVG 85 (331)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCC
Confidence 56899999999999998 68999999986432 22335678899999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ....+++..+..++.|++.||+|||+++ ++|+||||+|||++.++.++|+|||++........ .
T Consensus 86 ~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 158 (331)
T cd05597 86 GDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-V 158 (331)
T ss_pred CcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCC-c
Confidence 999999954 3457899999999999999999999999 99999999999999999999999999864322211 1
Q ss_pred eeeeccccccccCCccccC-----CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcC
Q 021526 157 VSTRVMGTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
......|+..|+|||++.. ..++.++|+|||||++|+|++|..||...... .......... .....
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------~~~~~i~~~~-~~~~~-- 229 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHK-EHFQF-- 229 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------HHHHHHHcCC-CcccC--
Confidence 1222458999999998863 45788999999999999999999999632211 0000011000 00000
Q ss_pred ccCCCCCcHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 021526 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANF--RPLINDIVVA 270 (311)
Q Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~--RPs~~~l~~~ 270 (311)
. ......+..+.+++.+||..++++ ||+++++++.
T Consensus 230 ---~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 ---P-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ---C-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 011235677899999988654443 7899999885
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=284.78 Aligned_cols=252 Identities=26% Similarity=0.334 Sum_probs=213.4
Q ss_pred CeeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 1 MLCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
|-.+||-|.||.||.|++ -.-.||||.++ ++.-..++|..|+.+++.++|||+++++++|+.+-..|||+|||..|+
T Consensus 271 MkhKLGGGQYGeVYeGvWKkyslTvAVKtLK-EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGN 349 (1157)
T KOG4278|consen 271 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGN 349 (1157)
T ss_pred eeeccCCCcccceeeeeeeccceeeehhhhh-hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCcc
Confidence 446899999999999999 56789999984 566677899999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
|.+|+.. -....++...++.++.||.+|++||..++ ++|+||...|+||.++..||++|||+++.+..+.+.. .
T Consensus 350 LLdYLRe--cnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA-H 423 (1157)
T KOG4278|consen 350 LLDYLRE--CNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA-H 423 (1157)
T ss_pred HHHHHHH--hchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceec-c
Confidence 9999976 34566777888999999999999999999 9999999999999999999999999998754433222 2
Q ss_pred eeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCC
Q 021526 159 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 237 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
.-......|.|||-+....++.++|||+||+++||+.| |-.||..-+ ..+.-.++.+..+-+
T Consensus 424 AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-----------------lSqVY~LLEkgyRM~ 486 (1157)
T KOG4278|consen 424 AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-----------------LSQVYGLLEKGYRMD 486 (1157)
T ss_pred cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-----------------HHHHHHHHhcccccc
Confidence 22345778999999999999999999999999999988 445774211 233334555555566
Q ss_pred CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 021526 238 YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 276 (311)
Q Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~ 276 (311)
-|..|++.+.+|++.||+++|.+||++.|+.+.|+.+..
T Consensus 487 ~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 487 GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 677899999999999999999999999999999976654
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=267.38 Aligned_cols=243 Identities=26% Similarity=0.356 Sum_probs=194.9
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCccc---------hhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEE
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQG---------HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 71 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 71 (311)
..+|.|++|.||.+.. +++.|++|.+....... .+.+.+|+++++.++||||+++++++..+...++++
T Consensus 6 ~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (267)
T cd06628 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFL 85 (267)
T ss_pred ceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEE
Confidence 5789999999999998 67999999886543322 146788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCC
Q 021526 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 151 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~ 151 (311)
||+.+++|.+++.. ...+++..+..++.|++.||++||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 86 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 86 EYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred EecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 99999999999953 356888899999999999999999999 99999999999999999999999998875432
Q ss_pred CCC----cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchh
Q 021526 152 GDN----THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 227 (311)
Q Consensus 152 ~~~----~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (311)
... ........++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---------~~~----~~~ 225 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ---------AIF----KIG 225 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH---------HHH----HHh
Confidence 111 111122346788999999988888999999999999999999999996322110 000 000
Q ss_pred hhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 228 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
. ......+...+..+.++|.+||+.+|++||++.++++
T Consensus 226 ~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 E----NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred c----cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0 1111223456778999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=265.61 Aligned_cols=247 Identities=30% Similarity=0.388 Sum_probs=196.1
Q ss_pred eeeeeeceeccEEEEEECC------eEEEEEEeccCCcc-chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWLCD------QLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~~------~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
...+|.|+||.||.+.... ..||+|.+...... ....+.+|++.++.++|+||+++++++.+++..+++||++
T Consensus 4 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~ 83 (258)
T smart00219 4 GKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYM 83 (258)
T ss_pred cceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEecc
Confidence 4578999999999999943 88999998655433 5678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
.+++|.+++... ....+++..++.++.|++.||++||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 84 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 84 EGGDLLDYLRKN--RPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred CCCCHHHHHHhh--hhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 999999999641 1222899999999999999999999999 99999999999999999999999999875433211
Q ss_pred cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 155 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
.... ...++..|++||...+..++.++|+|+||+++++|++ |..||...... . ... .....
T Consensus 159 ~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~------~----~~~-------~~~~~ 220 (258)
T smart00219 159 YKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE------E----VLE-------YLKKG 220 (258)
T ss_pred cccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH------H----HHH-------HHhcC
Confidence 1111 1236678999999888889999999999999999998 77887532110 0 000 00000
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 271 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L 271 (311)
.....+...+.++.+++.+||..+|++|||+.++++.|
T Consensus 221 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 221 YRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 01112233577899999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=270.98 Aligned_cols=241 Identities=25% Similarity=0.286 Sum_probs=194.3
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
..+|+|.+|.||.+.. +++.||+|.+.... ....+.+.+|+++++.++||||+++++++..+...++|+||+.+++|
T Consensus 10 ~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (277)
T cd06642 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSA 89 (277)
T ss_pred HHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcH
Confidence 4679999999999988 68899999986443 23345788999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
.+++. ...+.+..+..++.+++.|+.|||+++ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 90 ~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~ 159 (277)
T cd06642 90 LDLLK-----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRN 159 (277)
T ss_pred HHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc--hhhh
Confidence 99884 356888999999999999999999999 9999999999999999999999999986432211 1112
Q ss_pred eccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 160 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
...++..|+|||.+.+..++.++|+||||+++|+|++|..|+......... . ..........+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~--------------~~~~~~~~~~~ 222 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---F--------------LIPKNSPPTLE 222 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH---h--------------hhhcCCCCCCC
Confidence 234678899999998888999999999999999999999998532211100 0 00000011112
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
...+..+.+++.+||..+|++||++.++++.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 223 GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 3456679999999999999999999999983
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=266.21 Aligned_cols=241 Identities=28% Similarity=0.387 Sum_probs=193.3
Q ss_pred eeeeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHHHH
Q 021526 3 CCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDH 82 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 82 (311)
..+|+|+||.||.+...++.|++|.+.... ..+.+.+|+.+++.++|||++++++++..+ ..+++|||+.+++|.++
T Consensus 12 ~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~ 88 (254)
T cd05083 12 EIIGEGEFGAVLQGEYTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNF 88 (254)
T ss_pred eeeccCCCCceEecccCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHH
Confidence 578999999999999999999999985432 346788999999999999999999998654 47999999999999999
Q ss_pred hcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeeecc
Q 021526 83 LYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 162 (311)
Q Consensus 83 l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~~~ 162 (311)
+.. .....+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+...... .....
T Consensus 89 l~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----~~~~~ 158 (254)
T cd05083 89 LRT--RGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----VDNSK 158 (254)
T ss_pred HHh--cCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc-----CCCCC
Confidence 965 23446889999999999999999999999 999999999999999999999999988643211 11223
Q ss_pred ccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCcHH
Q 021526 163 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRR 241 (311)
Q Consensus 163 ~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (311)
.+..|+|||.+.+..++.++|+||||+++|+|++ |..||........ . ...........+..
T Consensus 159 ~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~------~-----------~~~~~~~~~~~~~~ 221 (254)
T cd05083 159 LPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV------K-----------ECVEKGYRMEPPEG 221 (254)
T ss_pred CCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH------H-----------HHHhCCCCCCCCCc
Confidence 3567999999888889999999999999999997 8888863322110 0 00001111112234
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 021526 242 CLNYAVAVTAMCLNEEANFRPLINDIVVALDY 273 (311)
Q Consensus 242 ~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~ 273 (311)
++..+.+++.+||+.+|++||++.++++.|+.
T Consensus 222 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 222 CPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 56778999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=282.43 Aligned_cols=245 Identities=22% Similarity=0.225 Sum_probs=191.5
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+..+|+|+||.||.+.. .++.||+|++.... ......+.+|+.++..++||+|+++++.+.++...++||||+.+
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~g 85 (360)
T cd05627 6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPG 85 (360)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence 57899999999999998 68999999986532 23345778899999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc-
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT- 155 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~- 155 (311)
++|.+++. ....+++..+..++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++.........
T Consensus 86 g~L~~~l~----~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 86 GDMMTLLM----KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred ccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 99999994 3457899999999999999999999999 999999999999999999999999987643211000
Q ss_pred --------------------------------ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccc
Q 021526 156 --------------------------------HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDL 203 (311)
Q Consensus 156 --------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 203 (311)
.......|+..|+|||++.+..++.++|+|||||++|+|++|..||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 001124589999999999999999999999999999999999999964
Q ss_pred cCccccccchhcchhhhhcccchhhhcCccCCCCCc--HHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 021526 204 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP--RRCLNYAVAVTAMCLNEEANFRPL---INDIVVA 270 (311)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~RPs---~~~l~~~ 270 (311)
...... ... +........++ ...+.++.++|.+|+ .+|.+|++ ++++++.
T Consensus 239 ~~~~~~------~~~----------i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 239 ETPQET------YRK----------VMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCHHHH------HHH----------HHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 332111 000 00000000111 124567889998876 59999985 5666653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=283.98 Aligned_cols=256 Identities=20% Similarity=0.167 Sum_probs=189.5
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
...+|.|++|.||++.. .++.||||... ...+.+|+++++.++|+||+++++++..+...+++|+++. ++|
T Consensus 174 ~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L 246 (461)
T PHA03211 174 HRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDL 246 (461)
T ss_pred EEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCH
Confidence 45789999999999999 57899999632 2346789999999999999999999999999999999995 688
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
.+++.. ....+++..++.++.|++.||.|||++| |+|+||||+|||++.++.++|+|||++.............
T Consensus 247 ~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 320 (461)
T PHA03211 247 YTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320 (461)
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence 888854 3357999999999999999999999999 9999999999999999999999999987533222222222
Q ss_pred eccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCcccc-ccchhcchhhhhcc----cch--------
Q 021526 160 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE-QNLVSWSRPFLKDQ----KKF-------- 226 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~----~~~-------- 226 (311)
...|+..|+|||++.+..++.++|||||||++|+|++|..|+........ ..........+... ..+
T Consensus 321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l 400 (461)
T PHA03211 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL 400 (461)
T ss_pred ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence 35689999999999998999999999999999999998876532221111 10000000000000 000
Q ss_pred h-hhcC---ccCCCCCc-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 227 V-HLVD---PLLHGRYP-------RRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 227 ~-~~~~---~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
. .... ........ ......+.+||.+||+.||.+|||+.|+++.
T Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 0000 00000000 0223468899999999999999999999863
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=276.32 Aligned_cols=236 Identities=26% Similarity=0.319 Sum_probs=189.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCC-CCcccceeEEEEeCCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
+..+|+|+||.||++.. +++.||+|++.+.. ....+.+..|..++..+. |++|+++++++.++...++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~ 84 (323)
T cd05615 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVN 84 (323)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCC
Confidence 46899999999999998 68999999987542 223356778888888776 5778889999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+++|.+++. ....+++..+..++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++...... .
T Consensus 85 ~g~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~--~ 155 (323)
T cd05615 85 GGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD--G 155 (323)
T ss_pred CCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC--C
Confidence 999999984 3457899999999999999999999999 999999999999999999999999988642211 1
Q ss_pred ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 156 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
.......|+..|+|||++.+..++.++|+||||+++|+|++|..||...... ..... +... .
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------~~~~~----------i~~~--~ 217 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED------ELFQS----------IMEH--N 217 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHH----------HHhC--C
Confidence 1223345889999999998888999999999999999999999999643211 00001 1110 1
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCCCH
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRPLI 264 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~ 264 (311)
..++...+..+.+++.+||+.+|.+|++.
T Consensus 218 ~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 12344556778999999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=265.41 Aligned_cols=245 Identities=23% Similarity=0.287 Sum_probs=195.3
Q ss_pred CeeeeeeceeccEEEEEE--CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEe-CCeeEEEEecCC
Q 021526 1 MLCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS-GDQRLLVYEYMP 75 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~ 75 (311)
+++.+|.|++|.||.+.. +++.|++|.+..... ...+.+.+|+++++.++|+|++++++.+.. +...++++|++.
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (257)
T cd08223 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCE 83 (257)
T ss_pred EEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccC
Confidence 367899999999999998 678999999865432 344578899999999999999999988764 446799999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+++|.+++.. .....+++..++.++.+++.++++||+.+ ++|+||+|+||+++.++.++|+|||++...... .
T Consensus 84 ~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~--~ 156 (257)
T cd08223 84 GGDLYHKLKE--QKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ--C 156 (257)
T ss_pred CCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEeccc--C
Confidence 9999999965 23456899999999999999999999999 999999999999999999999999988643221 1
Q ss_pred ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 156 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
.......++..|+|||...+..++.++|+||||+++++|++|..||...+.. ........ ...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~~~~----------~~~- 219 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYRIIE----------GKL- 219 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHh----------cCC-
Confidence 1223345788999999998888999999999999999999999998632210 00000100 000
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
...+...+..+.+++.+||+.+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1123456678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=281.48 Aligned_cols=238 Identities=25% Similarity=0.253 Sum_probs=184.9
Q ss_pred eeeceeccEEEEEE--CCeEEEEEEeccCCcc---chhHHHHHHHHHhcC---CCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 5 YLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLL---HHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 5 ~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+|+|+||.||++.. +++.||+|++.+.... .......|..++... +||||++++.++.++...++||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 68999999999998 6899999998654222 223445566666544 699999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++. ....+++..+..++.|++.||+|||+++ ++|+||||+|||++.++.++|+|||++...... ..
T Consensus 81 g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~--~~ 151 (330)
T cd05586 81 GELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTD--NK 151 (330)
T ss_pred ChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCC--CC
Confidence 99999884 3567899999999999999999999999 999999999999999999999999998642111 11
Q ss_pred eeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
......|+..|+|||++.+. .++.++|+||||+++|+|++|..||...... ........ ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~------~~~~~i~~----------~~~- 214 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ------QMYRNIAF----------GKV- 214 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH------HHHHHHHc----------CCC-
Confidence 22345689999999988754 5789999999999999999999998632211 00000000 000
Q ss_pred CCCc-HHHHHHHHHHHHHhhccCCCCCC----CHHHHHH
Q 021526 236 GRYP-RRCLNYAVAVTAMCLNEEANFRP----LINDIVV 269 (311)
Q Consensus 236 ~~~~-~~~~~~l~~li~~~l~~~p~~RP----s~~~l~~ 269 (311)
.++ ...+..+.+++.+||+.||++|| ++.++++
T Consensus 215 -~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 215 -RFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -CCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 111 12456789999999999999998 5677765
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=297.05 Aligned_cols=258 Identities=22% Similarity=0.295 Sum_probs=199.5
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
..++|+|++|.||++.. +++.||+|.+..... ...+.+.+|+++++.++||||+++++++.+++..+++|||+++
T Consensus 7 i~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eG 86 (932)
T PRK13184 7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEG 86 (932)
T ss_pred EEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCC
Confidence 56899999999999998 689999999865422 2235788999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCC-------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccC
Q 021526 77 GSLEDHLYDLEPD-------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 149 (311)
Q Consensus 77 ~~L~~~l~~~~~~-------~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~ 149 (311)
++|.+++...... ...++...++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++...
T Consensus 87 GSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGLAk~i 163 (932)
T PRK13184 87 YTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFK 163 (932)
T ss_pred CCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCcceec
Confidence 9999998643211 234566778899999999999999999 999999999999999999999999998754
Q ss_pred CCCCC----------------cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccch
Q 021526 150 PVGDN----------------THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV 213 (311)
Q Consensus 150 ~~~~~----------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 213 (311)
..... ........|++.|+|||.+.+..++.++|+|||||++|+|++|..||.........
T Consensus 164 ~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~--- 240 (932)
T PRK13184 164 KLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS--- 240 (932)
T ss_pred ccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh---
Confidence 11100 00111245899999999999989999999999999999999999999642211100
Q ss_pred hcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHhhhc
Q 021526 214 SWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-LINDIVVALDYLVSQ 277 (311)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-s~~~l~~~L~~l~~~ 277 (311)
.. .. ...+... ......+..+.+++.+||..||++|| +++++++.|+.+...
T Consensus 241 -~~-~~---------i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 241 -YR-DV---------ILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred -hh-hh---------ccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 00 00 0000000 00123456789999999999999995 677788888777654
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=277.06 Aligned_cols=184 Identities=23% Similarity=0.301 Sum_probs=157.5
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
+..+|.|++|.||++.. .++.||+|..... ....|+.+++.++||||+++++++..+...++|++++. ++|
T Consensus 71 ~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l 143 (357)
T PHA03209 71 IKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDL 143 (357)
T ss_pred EEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcH
Confidence 57899999999999999 5679999974322 33568999999999999999999999999999999995 588
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
.+++.. ....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++..... .....
T Consensus 144 ~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---~~~~~ 214 (357)
T PHA03209 144 YTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---APAFL 214 (357)
T ss_pred HHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccccc---Ccccc
Confidence 888854 4567899999999999999999999999 99999999999999999999999999863211 11122
Q ss_pred eccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCc
Q 021526 160 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 201 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 201 (311)
...|+..|+|||++.+..++.++|+|||||++|+|+++..|+
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 345889999999999889999999999999999999866554
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=284.31 Aligned_cols=260 Identities=22% Similarity=0.250 Sum_probs=192.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccC--CccchhHHHHHHHHHhcCCCCcccceeEEEEeCC-----eeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD-----QRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e 72 (311)
...+|.|+||.||++.. +++.||+|.+... .......+.+|+++++.++||||+++++++.... ..++++|
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 84 (372)
T cd07853 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTE 84 (372)
T ss_pred cceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEee
Confidence 57899999999999997 7899999998643 2234467889999999999999999999987766 7899999
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCC
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~ 152 (311)
|+. ++|.+.+. ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 85 ~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 85 LMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred ccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 996 57888773 4567899999999999999999999999 999999999999999999999999998753222
Q ss_pred CCcceeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCccccccch-hcc-----hhhhhcccc
Q 021526 153 DNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-SWS-----RPFLKDQKK 225 (311)
Q Consensus 153 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~-----~~~~~~~~~ 225 (311)
.. .......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||............ ... .........
T Consensus 157 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 157 ES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred cc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 11 111223467889999988764 5789999999999999999999999654321110000 000 000000000
Q ss_pred hhhhc-CccCC-------CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 226 FVHLV-DPLLH-------GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 226 ~~~~~-~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
....+ ..... .......+.++.++|.+||+.||++|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000 00000 01112346678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=278.49 Aligned_cols=256 Identities=22% Similarity=0.254 Sum_probs=188.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeCC------eeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD------QRLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~ 71 (311)
+..+|+|+||.||.+.. .++.||+|.+.... ......+.+|+.+++.++||||+++++++.... ..+++|
T Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 105 (359)
T cd07876 26 LKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105 (359)
T ss_pred EEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEE
Confidence 46799999999999988 68999999986442 233457889999999999999999999886443 469999
Q ss_pred ecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCC
Q 021526 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 151 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~ 151 (311)
||+++ +|.+.+. ..++...+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 106 e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 106 ELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred eCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 99965 6666662 24788889999999999999999999 99999999999999999999999999864221
Q ss_pred CCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCcccccc-c--------hhc-------
Q 021526 152 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-L--------VSW------- 215 (311)
Q Consensus 152 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~--------~~~------- 215 (311)
........++..|+|||++.+..++.++|+||||+++|+|++|..||...+...... . ..+
T Consensus 176 ---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (359)
T cd07876 176 ---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252 (359)
T ss_pred ---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence 111223457889999999999899999999999999999999999997443211000 0 000
Q ss_pred chhhhhcccc-----hhhhcCccC---CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 216 SRPFLKDQKK-----FVHLVDPLL---HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 216 ~~~~~~~~~~-----~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
...+...... +.+...... ...........+.++|.+||..||++|||+.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000000 000000000 000111235678999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=264.02 Aligned_cols=245 Identities=22% Similarity=0.309 Sum_probs=198.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
+..+|.|++|.|+.+.. +++.+++|.+.... ......+.+|+++++.++|+||+++++++.++...+++|||+.++
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (256)
T cd08221 5 IRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGG 84 (256)
T ss_pred eeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCC
Confidence 56899999998888888 78999999886553 344567889999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|.+++... ....+++..+..++.|++.++++||+.+ ++|+||+|+||++++++.++|+|||.+........ .
T Consensus 85 ~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~ 157 (256)
T cd08221 85 TLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--M 157 (256)
T ss_pred cHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc--c
Confidence 999999652 2457899999999999999999999999 99999999999999999999999998865422221 2
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCC
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 237 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
.....++..|.|||...+..++.++|+||||+++++|++|..||....... ...... .... ..
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~----------~~~~-~~ 220 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN------LVVKIV----------QGNY-TP 220 (256)
T ss_pred ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHH----------cCCC-CC
Confidence 223457889999999888888999999999999999999999986322110 000000 0000 11
Q ss_pred CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 238 YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.+...+.++.+++.+||..+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 123456779999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=265.78 Aligned_cols=244 Identities=22% Similarity=0.246 Sum_probs=197.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
+..+|+|.+|.+|.+.. +++.|++|.+.... ......+.+|+.+++.++||||+++++++..+...++++|++.++
T Consensus 5 ~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08218 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGG 84 (256)
T ss_pred EEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCC
Confidence 57899999999999998 78999999986543 234457899999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|.+++.. .....+++..++.++.|++.++++||+.+ ++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 85 ~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 157 (256)
T cd08218 85 DLYKKINA--QRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--EL 157 (256)
T ss_pred cHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch--hh
Confidence 99999864 23346788999999999999999999999 9999999999999999999999999886432211 11
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCC
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 237 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
.....++..|+|||...+..++.++|+||||+++++|++|..||....... .. ...... ....
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~----------~~~~~~-~~~~ 220 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN------LV----------LKIIRG-SYPP 220 (256)
T ss_pred hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH------HH----------HHHhcC-CCCC
Confidence 222346788999999988888999999999999999999999986322110 00 000000 0111
Q ss_pred CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 238 YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.+...+..+.++|.+||+.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 23455778999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=270.98 Aligned_cols=259 Identities=20% Similarity=0.200 Sum_probs=188.1
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc--chhHHHHHHHHHhcC---CCCcccceeEEEEe-----CCeeEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLL---HHDNLVTLIGYCTS-----GDQRLL 69 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~~~~l 69 (311)
...+|.|++|.||++.. +++.||+|.+...... ....+.+|+++++.+ +||||+++++++.. ....++
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~l 84 (288)
T cd07863 5 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTL 84 (288)
T ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEE
Confidence 46899999999999998 6899999998654322 223566677776655 79999999998754 345799
Q ss_pred EEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccC
Q 021526 70 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 149 (311)
Q Consensus 70 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~ 149 (311)
++|++.+ +|.+++.. .....+++..+..++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||++...
T Consensus 85 v~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 85 VFEHVDQ-DLRTYLDK--VPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred EEccccc-CHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccccc
Confidence 9999974 89888854 23356899999999999999999999999 999999999999999999999999998753
Q ss_pred CCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccc-cchhcc----hhhhhc-c
Q 021526 150 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLVSWS----RPFLKD-Q 223 (311)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~----~~~~~~-~ 223 (311)
... .......++..|+|||++.+..++.++|+|||||++|+|++|.+||......... .+.... ...+.. .
T Consensus 159 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 159 SCQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred cCc---ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 221 1112245688999999998888999999999999999999999998643321110 000000 000000 0
Q ss_pred cchhhhcCccCC---CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 224 KKFVHLVDPLLH---GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 224 ~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
........+... ....+..+..+.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000000000 0111235667899999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=273.21 Aligned_cols=246 Identities=22% Similarity=0.182 Sum_probs=191.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
...+|+|+||.||.+.. .++.||+|.+.+.. ......+.+|+.++..++|++|+++++.+.++...++||||+.+
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~ 85 (332)
T cd05623 6 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVG 85 (332)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCC
Confidence 57899999999999998 67899999986432 22234577899999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... ..
T Consensus 86 g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~-~~ 158 (332)
T cd05623 86 GDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TV 158 (332)
T ss_pred CcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCC-cc
Confidence 999999954 3456899999999999999999999999 9999999999999999999999999886432211 11
Q ss_pred eeeeccccccccCCcccc-----CCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcC
Q 021526 157 VSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
......|+..|+|||++. ...++.++|+||||+++|+|++|..||....... ...... .
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~----------~ 222 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIM----------N 222 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH------HHHHHh----------C
Confidence 222346899999999876 3467889999999999999999999996332110 000010 0
Q ss_pred ccCCCCCc---HHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 021526 232 PLLHGRYP---RRCLNYAVAVTAMCLNEEANF--RPLINDIVVA 270 (311)
Q Consensus 232 ~~~~~~~~---~~~~~~l~~li~~~l~~~p~~--RPs~~~l~~~ 270 (311)
......++ ..++..+.+++.+||..++++ |++++++++.
T Consensus 223 ~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 223 HKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00000111 235677899999999765544 6899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=267.68 Aligned_cols=253 Identities=24% Similarity=0.275 Sum_probs=187.7
Q ss_pred eeeeceeccEEEEEE----CCeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 4 CYLSCKFYNVGLVWL----CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
.+|.|+||.||.|.. ....+++|.+..... .....+.+|++.++.++||||+++++.+.+....+++|||+.+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 589999999999976 345788888754432 233567889999999999999999999999999999999999999
Q ss_pred HHHHhcccCCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 79 LEDHLYDLEPD-QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 79 L~~~l~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
|.+++...... ....++..+..++.|++.|++|||+++ ++|+||||+||+++.++.++|+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999764322 234567788899999999999999999 99999999999999999999999999864322211111
Q ss_pred eeeccccccccCCccccC-------CCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhh
Q 021526 158 STRVMGTYGYCAPEYAMS-------GKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 229 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~-------~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
.....++..|+|||+... ..++.++|+||||+++|+|++ |..||........ ...... ......
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------~~~~~~--~~~~~~ 230 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV------LKQVVR--EQDIKL 230 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH------HHHHhh--ccCccC
Confidence 222345667999998642 356789999999999999999 6778753221100 000000 011111
Q ss_pred cCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 021526 230 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 272 (311)
Q Consensus 230 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~ 272 (311)
..+.. +...+..+.+++..|| .||++||++++|++.|.
T Consensus 231 ~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11211 2345666788999998 59999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=273.05 Aligned_cols=244 Identities=23% Similarity=0.294 Sum_probs=196.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
+..+|+|++|.||.+.. .++.||||.+........+.+.+|+..++.++|+|++++++.+..+...+++||++.+++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 35689999999999998 6899999998765555566788999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
.+++.. ..+++..++.++.|++.+++|||+.+ ++|+||+|+||+++.++.++|+|||++...... .....
T Consensus 107 ~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--~~~~~ 176 (292)
T cd06658 107 TDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE--VPKRK 176 (292)
T ss_pred HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccc--cccCc
Confidence 998832 45888999999999999999999999 999999999999999999999999988643221 11122
Q ss_pred eccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 160 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
...++..|+|||.+.+..++.++|+||||+++|+|++|..||........ . ............ ..
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~-------~~~~~~~~~~~~--~~ 241 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA------M-------RRIRDNLPPRVK--DS 241 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------H-------HHHHhcCCCccc--cc
Confidence 34578899999999888899999999999999999999999863221100 0 000011111111 11
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
...+..+.+++.+||..+|++|||++++++.
T Consensus 242 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 242 HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 2345678999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=267.59 Aligned_cols=241 Identities=26% Similarity=0.285 Sum_probs=195.5
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
...+|.|++|.||++.. +++.|++|.+.... ......+.+|+++++.++|+|++++++++.++...++++|++.+++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (274)
T cd06609 6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGS 85 (274)
T ss_pred hhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCc
Confidence 35689999999999998 78999999987553 3344678899999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
|.+++.. ..+++..++.++.|++.++.+||+.+ ++|+||+|+||++++++.++|+|||++....... ...
T Consensus 86 L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~ 155 (274)
T cd06609 86 CLDLLKP-----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKR 155 (274)
T ss_pred HHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc--ccc
Confidence 9999954 37899999999999999999999999 9999999999999999999999999987543221 112
Q ss_pred eeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCC
Q 021526 159 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRY 238 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
....++..|++||.+.+..++.++|+||||+++|+|++|..||........ .... .....+.+
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~------~~~~-------~~~~~~~~---- 218 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV------LFLI-------PKNNPPSL---- 218 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH------HHHh-------hhcCCCCC----
Confidence 234567789999999888899999999999999999999999963321100 0000 00000111
Q ss_pred cHH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 239 PRR-CLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 239 ~~~-~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
+.. ++..+.+++.+||..+|++||+++++++
T Consensus 219 ~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 219 EGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred cccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111 5667999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=267.10 Aligned_cols=244 Identities=25% Similarity=0.286 Sum_probs=190.6
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcC-CCCcccceeEEEEeC------CeeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSG------DQRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~------~~~~lv~e 72 (311)
...+|+|++|.||.+.. .++.||+|.+... ......+.+|+.+++.+ +|||++++++++... ...+++||
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e 89 (272)
T cd06637 11 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME 89 (272)
T ss_pred HHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEE
Confidence 35689999999999988 7889999998644 34456788999999888 699999999998653 46799999
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCC
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~ 152 (311)
|+.+++|.+++.. .....+++..+..++.|++.|++|||+++ ++|+||+|+||++++++.++|+|||++......
T Consensus 90 ~~~~~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~ 164 (272)
T cd06637 90 FCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 164 (272)
T ss_pred cCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCceecccc
Confidence 9999999999965 23456889999999999999999999999 999999999999999999999999998643211
Q ss_pred CCcceeeeccccccccCCcccc-----CCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchh
Q 021526 153 DNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 227 (311)
Q Consensus 153 ~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (311)
........|+..|+|||++. ...++.++|+||+|+++|+|++|..||......... ..
T Consensus 165 --~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~--------~~------- 227 (272)
T cd06637 165 --VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL--------FL------- 227 (272)
T ss_pred --cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH--------HH-------
Confidence 11223355788999999875 335788999999999999999999998532211100 00
Q ss_pred hhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 228 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.............++..+.+++.+||..+|.+|||+.++++
T Consensus 228 -~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 228 -IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -HhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00000111112234567899999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=268.83 Aligned_cols=261 Identities=20% Similarity=0.199 Sum_probs=193.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
+..+|.|++|.||++.. +++.||+|.+..... .....+.+|+.+++.++|||++++++++.++...++||||+. +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (285)
T cd07861 5 IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-M 83 (285)
T ss_pred eeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-C
Confidence 46799999999999998 689999999865432 233578899999999999999999999999999999999997 5
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|.+++.... .+..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 84 ~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~ 157 (285)
T cd07861 84 DLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VRV 157 (285)
T ss_pred CHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCC--ccc
Confidence 8988886532 2467899999999999999999999999 999999999999999999999999998643221 111
Q ss_pred eeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCcccccc-chh----cchhhhhccc---chhh
Q 021526 158 STRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVS----WSRPFLKDQK---KFVH 228 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~----~~~~~~~~~~---~~~~ 228 (311)
.....++..|+|||.+.+. .++.++|+||||+++++|++|++||.......... ... .....+.... ....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 2223467889999987654 57889999999999999999999996443211100 000 0000000000 0000
Q ss_pred hcCccCC---CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 229 LVDPLLH---GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 229 ~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
....... .......+.++.++|.+||+.||++|||+.+|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 0011235677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=273.83 Aligned_cols=246 Identities=20% Similarity=0.168 Sum_probs=190.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+..+|+|+||.||.+.. +++.||+|.+.+.. ......+.+|..++..++|++|+++++++.+++..++||||+.+
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~g 85 (331)
T cd05624 6 IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVG 85 (331)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence 57899999999999998 68899999986432 22234577889999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++........ .
T Consensus 86 g~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~ 158 (331)
T cd05624 86 GDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-V 158 (331)
T ss_pred CcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCc-e
Confidence 999999964 2457889999999999999999999999 99999999999999999999999999865322211 1
Q ss_pred eeeeccccccccCCccccC-----CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcC
Q 021526 157 VSTRVMGTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
......|+..|+|||++.+ ..++.++|+||||+++|+|++|..||....... ..... ..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~i----------~~ 222 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKI----------MN 222 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------HHHHH----------Hc
Confidence 1223468999999998865 467889999999999999999999996332110 00000 00
Q ss_pred ccCCCCCc---HHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 021526 232 PLLHGRYP---RRCLNYAVAVTAMCLNEEANF--RPLINDIVVA 270 (311)
Q Consensus 232 ~~~~~~~~---~~~~~~l~~li~~~l~~~p~~--RPs~~~l~~~ 270 (311)
...+..++ ...+..+.+++.+||..++++ |++++++++.
T Consensus 223 ~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 223 HEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00000111 234677999999999876654 4688888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=279.87 Aligned_cols=246 Identities=21% Similarity=0.190 Sum_probs=190.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
...+|.|+||.||.+.. +++.||+|.+.+.. ......+.+|+.+++.++||||+++++.+.++...++||||+.+
T Consensus 48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~g 127 (371)
T cd05622 48 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG 127 (371)
T ss_pred EEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence 46899999999999999 68899999986432 22334577899999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++....... ..
T Consensus 128 g~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~-~~ 198 (371)
T cd05622 128 GDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MV 198 (371)
T ss_pred CcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC-cc
Confidence 999999843 35788889999999999999999999 9999999999999999999999999987542211 11
Q ss_pred eeeeccccccccCCccccCC----CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCc
Q 021526 157 VSTRVMGTYGYCAPEYAMSG----KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 232 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~----~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
......|++.|+|||++.+. .++.++|+|||||++|+|++|..||....... ..........
T Consensus 199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~~~-------- 264 (371)
T cd05622 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMNHKN-------- 264 (371)
T ss_pred cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH------HHHHHHcCCC--------
Confidence 12345689999999988754 37889999999999999999999996433210 0001110000
Q ss_pred cCCCCCcHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 021526 233 LLHGRYPRRCLNYAVAVTAMCLNEEANF--RPLINDIVVA 270 (311)
Q Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~--RPs~~~l~~~ 270 (311)
..........+..+.++|.+||..++.+ |++++++++.
T Consensus 265 ~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 265 SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 0000112245777999999999844443 7899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=265.59 Aligned_cols=253 Identities=21% Similarity=0.271 Sum_probs=187.5
Q ss_pred eeeeceeccEEEEEE-CC---eEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 4 CYLSCKFYNVGLVWL-CD---QLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~-~~---~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
.+|+|+||.||++.. ++ ..+++|.+.... ....+.+.+|+..++.++||||+++++.+......+++|||+.+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999976 32 356677765443 2344688999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
|.+++.........++...++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999764333456777788899999999999999999 999999999999999999999999987532111111122
Q ss_pred eeccccccccCCccccC-------CCCCccccchhHHHHHHHHHhC-CCCccccCccccccchhcchhhhhcccchhhhc
Q 021526 159 TRVMGTYGYCAPEYAMS-------GKLTLKSDIYSFGVVLLELITG-RKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 230 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~-------~~~~~~~Dv~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (311)
....++..|+|||+... ..++.++|+||||+++|+|+++ ..||....... ....... .......
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~--~~~~~~~ 230 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE------VLNHVIK--DQQVKLF 230 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHh--hcccccC
Confidence 23456788999998743 2457899999999999999974 56774322110 0000010 1111112
Q ss_pred CccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 021526 231 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 272 (311)
Q Consensus 231 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~ 272 (311)
.+... ......+.+++..|| .+|++||++++|++.|.
T Consensus 231 ~~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 22222 224566888999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=267.37 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=196.4
Q ss_pred eeeeeeceeccEEEEEE-------CCeEEEEEEeccCCcc-chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL-------CDQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
+..+|.|+||.||.+.. ..+.|++|.+...... ....+.+|+++++.++|+||+++++++.+....+++||+
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (275)
T cd05046 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEY 89 (275)
T ss_pred eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEe
Confidence 45789999999999996 3568999987654433 346789999999999999999999999988899999999
Q ss_pred CCCCCHHHHhcccCCC-----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCcc
Q 021526 74 MPMGSLEDHLYDLEPD-----QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 148 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~ 148 (311)
+++++|.+++...... ...+++..++.++.|++.+|+|||+.+ ++|+||+|+||+++.++.++++|||.+..
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~~~~~~ 166 (275)
T cd05046 90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKD 166 (275)
T ss_pred cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcccccccc
Confidence 9999999999653321 126899999999999999999999999 99999999999999999999999998763
Q ss_pred CCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchh
Q 021526 149 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 227 (311)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (311)
.... .........++..|++||...+..++.++|+||||+++|+|++ |..||....... .. .
T Consensus 167 ~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~-------------~ 229 (275)
T cd05046 167 VYNS-EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VL-------------N 229 (275)
T ss_pred cCcc-cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HH-------------H
Confidence 2211 1111222345667999999888888999999999999999998 777885221110 00 0
Q ss_pred hhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 021526 228 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 272 (311)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~ 272 (311)
...........+..++..+.+++.+||..+|++||++.++++.|.
T Consensus 230 ~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 230 RLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 011111111223345678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=272.26 Aligned_cols=242 Identities=22% Similarity=0.260 Sum_probs=195.5
Q ss_pred eeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHHH
Q 021526 4 CYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (311)
.+|.|+||.||.+.. +++.|++|.+........+.+.+|+.++..++|||++++++++..+...++++||+++++|.+
T Consensus 28 ~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~ 107 (297)
T cd06659 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTD 107 (297)
T ss_pred hcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHH
Confidence 579999999999988 689999999876555556778899999999999999999999999999999999999999999
Q ss_pred HhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeeec
Q 021526 82 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 161 (311)
Q Consensus 82 ~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~~ 161 (311)
++. ...+++..++.++.|++.||++||+.+ ++|+||+|.||+++.++.++|+|||++....... ......
T Consensus 108 ~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~ 177 (297)
T cd06659 108 IVS-----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSL 177 (297)
T ss_pred HHh-----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--ccccce
Confidence 873 356889999999999999999999999 9999999999999999999999999886432211 112234
Q ss_pred cccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCcHH
Q 021526 162 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRR 241 (311)
Q Consensus 162 ~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (311)
.++..|+|||.+.+..++.++|+||||+++++|++|..||......... ..... ...... .....
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------~~~~~-------~~~~~~--~~~~~ 242 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM------KRLRD-------SPPPKL--KNAHK 242 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHhc-------cCCCCc--cccCC
Confidence 5788999999998888999999999999999999999998633221110 00000 000000 11123
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 242 CLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 242 ~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.+..+.+++.+||+.+|++||+++++++.
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 45678999999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=272.51 Aligned_cols=247 Identities=26% Similarity=0.262 Sum_probs=196.1
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc---chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+..+|.|.+|.||.+.. +++.||+|.+...... ....+.+|+++++.++||||+++++.+.++...+++||++.+
T Consensus 6 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (316)
T cd05574 6 IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPG 85 (316)
T ss_pred eeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCC
Confidence 56899999999999999 5899999998765433 345788999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. .....+++..+..++.|++.+|+|||+.+ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 86 ~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 86 GELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred CCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999864 23467899999999999999999999999 9999999999999999999999999876432211100
Q ss_pred ---------------------------eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCcccc
Q 021526 157 ---------------------------VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE 209 (311)
Q Consensus 157 ---------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~ 209 (311)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 240 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence 01123467889999999888899999999999999999999999863332110
Q ss_pred ccchhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCC----HHHHHH
Q 021526 210 QNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL----INDIVV 269 (311)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs----~~~l~~ 269 (311)
+.+..............+..+.+++.+||..+|++||+ ++++++
T Consensus 241 ----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 241 ----------------FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred ----------------HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 01111111110111125678999999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=272.08 Aligned_cols=259 Identities=23% Similarity=0.274 Sum_probs=193.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
+..+|.|++|.||++.. +++.||+|.+.... ......+.+|+++++.++||||+++++++..+...+++|||+. ++
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~ 89 (301)
T cd07873 11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KD 89 (301)
T ss_pred eeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cC
Confidence 46799999999999988 68999999986543 2233567889999999999999999999999999999999996 58
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 90 l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~ 161 (301)
T cd07873 90 LKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KTY 161 (301)
T ss_pred HHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--Ccc
Confidence 9888854 3456889999999999999999999999 9999999999999999999999999986432211 111
Q ss_pred eeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCccccccc-hhc----chhhhh---cccchhhh
Q 021526 159 TRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-VSW----SRPFLK---DQKKFVHL 229 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~----~~~~~~---~~~~~~~~ 229 (311)
....++..|+|||.+.+. .++.++|+||||+++|+|++|.+||........... ... ....+. ........
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (301)
T cd07873 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY 241 (301)
T ss_pred cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccc
Confidence 223467889999987654 578899999999999999999999975432111000 000 000000 00000000
Q ss_pred cCccCCCC----CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 230 VDPLLHGR----YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 230 ~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..+..... .....+..+.++|.+||+.||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00100000 11234667899999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=283.85 Aligned_cols=243 Identities=25% Similarity=0.295 Sum_probs=203.9
Q ss_pred eeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHHH
Q 021526 4 CYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (311)
++|.|.+|.||.|+. +...+|||-+........+.+..|+..-++++|.||+++++.+..++..-++||-+.||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 689999999999999 778899999877777777889999999999999999999999999999999999999999999
Q ss_pred HhcccCCCCCCC--CHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEc-CCCceEEeecCCCccCCCCCCccee
Q 021526 82 HLYDLEPDQEPL--SWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 82 ~l~~~~~~~~~l--~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~-~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
.+...+ +++ .+...-.+..||++||+|||++. |||||||-+|+||+ -.|.+||.|||.+.+.. +...++
T Consensus 662 LLrskW---GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~T 733 (1226)
T KOG4279|consen 662 LLRSKW---GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPCT 733 (1226)
T ss_pred HHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhc--cCCccc
Confidence 997643 344 56777889999999999999998 99999999999995 56789999999988743 344556
Q ss_pred eeccccccccCCccccCC--CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 159 TRVMGTYGYCAPEYAMSG--KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
.+..||.-|||||++..+ .|..++|||||||++.||.||++||-..+.... .+.+..--..+-
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---------------AMFkVGmyKvHP 798 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---------------AMFKVGMYKVHP 798 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---------------hhhhhcceecCC
Confidence 678899999999999865 688999999999999999999999953332111 111111112223
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..|...+++.+.+|.+|+.++|.+||++.++++
T Consensus 799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 457788999999999999999999999999987
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=262.97 Aligned_cols=243 Identities=26% Similarity=0.301 Sum_probs=195.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
+..+|.|.+|.||.+.. +++.+++|.+.... ......+.+|+++++.++|||++++++.+..+...++++|++.++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08220 5 IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGG 84 (256)
T ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCC
Confidence 56899999999999888 78999999987553 234467889999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCC-ceEEeecCCCccCCCCCCcc
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-NPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~-~vkl~Df~~~~~~~~~~~~~ 156 (311)
+|.+++.. .....+++..++.++.+++.++++||+++ ++|+||+|+||+++.++ .++|+|||.+...... .
T Consensus 85 ~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---~ 156 (256)
T cd08220 85 TLAEYIQK--RCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---S 156 (256)
T ss_pred CHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC---c
Confidence 99999965 23456899999999999999999999999 99999999999997654 5799999998754322 1
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||........ ..... . ....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~------~~~~~----------~-~~~~ 219 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL------VLKIM----------S-GTFA 219 (256)
T ss_pred cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH------HHHHH----------h-cCCC
Confidence 12234578889999999888889999999999999999999999864322110 00000 0 0011
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..+...+..+.+++.+||..+|++|||+.++++
T Consensus 220 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 220 PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 122345677999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=279.30 Aligned_cols=256 Identities=22% Similarity=0.255 Sum_probs=189.6
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeC------CeeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG------DQRLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~ 71 (311)
+..+|.|+||.||.+.. .++.||+|.+.... ......+.+|+.+++.++||||+++++++... ...+++|
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 101 (355)
T cd07874 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 101 (355)
T ss_pred EEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEh
Confidence 56899999999999988 68999999986542 22345778899999999999999999987543 3469999
Q ss_pred ecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCC
Q 021526 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 151 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~ 151 (311)
|++++ ++.+.+. ..++...+..++.|++.||+|||+.| ++|+||||+||+++.++.+||+|||++.....
T Consensus 102 e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 102 ELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred hhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 99965 6777663 24788889999999999999999999 99999999999999999999999999874322
Q ss_pred CCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCcccccc-ch---------------hc
Q 021526 152 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LV---------------SW 215 (311)
Q Consensus 152 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~---------------~~ 215 (311)
. .......++..|+|||++.+..++.++|+|||||++|+|++|..||.......... .. ..
T Consensus 172 ~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (355)
T cd07874 172 S---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_pred c---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence 1 11223457889999999988899999999999999999999999996443211100 00 00
Q ss_pred chhhhhcccchhhhc------CccC--CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 216 SRPFLKDQKKFVHLV------DPLL--HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 216 ~~~~~~~~~~~~~~~------~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
...+........... +... ....+......+.++|.+||..||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000000000 0000 001112235678999999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=266.74 Aligned_cols=237 Identities=22% Similarity=0.278 Sum_probs=186.0
Q ss_pred eeeeceeccEEEEEEC--------------CeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEE
Q 021526 4 CYLSCKFYNVGLVWLC--------------DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 69 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~~--------------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 69 (311)
.+|.|++|.||++... ...|++|.+..........+.+|+.++..++||||+++++++..+...++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 5799999999999862 23689998765554455678889999999999999999999998889999
Q ss_pred EEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCc-------eEEee
Q 021526 70 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN-------PKLSD 142 (311)
Q Consensus 70 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~-------vkl~D 142 (311)
+|||+++++|..++.. ....+++..++.++.|++.|++|||+++ ++|+||+|+||+++.++. ++++|
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 82 VEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 9999999999988854 3456899999999999999999999999 999999999999987664 89999
Q ss_pred cCCCccCCCCCCcceeeeccccccccCCcccc-CCCCCccccchhHHHHHHHHH-hCCCCccccCccccccchhcchhhh
Q 021526 143 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELI-TGRKAMDLSKGQGEQNLVSWSRPFL 220 (311)
Q Consensus 143 f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~~l~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~ 220 (311)
||++..... .....++..|+|||.+. +..++.++||||||+++|+|+ .|..|+......... ...
T Consensus 156 ~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-------~~~ 222 (262)
T cd05077 156 PGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-------RFY 222 (262)
T ss_pred CCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-------HHH
Confidence 998864321 11234677899999876 466889999999999999997 577777532211000 000
Q ss_pred hcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 021526 221 KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 271 (311)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L 271 (311)
. ... .........+.+++.+||+.||++||++.+|++.|
T Consensus 223 ~----------~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 223 E----------GQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred h----------cCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0 000 01112346789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=272.57 Aligned_cols=198 Identities=25% Similarity=0.276 Sum_probs=159.2
Q ss_pred eeeeeeceeccEEEEEE----CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEe--CCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL----CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS--GDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~----~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~ 75 (311)
.+.+|.|+||.||++.. .++.||+|.+.... ....+.+|+++++.++||||+++++++.. +...++++|++.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 36899999999999986 45789999986432 23567889999999999999999998854 456789999985
Q ss_pred CCCHHHHhcccCC-----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE----cCCCceEEeecCCC
Q 021526 76 MGSLEDHLYDLEP-----DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL----DNDFNPKLSDFGLA 146 (311)
Q Consensus 76 ~~~L~~~l~~~~~-----~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~----~~~~~vkl~Df~~~ 146 (311)
++|.+++..... ....+++..+..++.|++.||.|||+++ ++|+||||+|||+ +..+.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 488887753221 2235899999999999999999999999 9999999999999 45678999999998
Q ss_pred ccCCCCCC-cceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccC
Q 021526 147 KLGPVGDN-THVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSK 205 (311)
Q Consensus 147 ~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 205 (311)
........ ........++..|+|||++.+ ..++.++|+||+||++|+|++|.+||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 75432211 111223467889999998876 458899999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=265.23 Aligned_cols=246 Identities=26% Similarity=0.289 Sum_probs=198.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEE--eCCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCT--SGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~ 75 (311)
+..+|.|++|.||++.. +++.|++|.+..... ...+.+.+|+++++.++||||+++++++. .+...++++||+.
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~ 84 (265)
T cd08217 5 LETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCE 84 (265)
T ss_pred eeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhcc
Confidence 56799999999999988 778999998865432 33457888999999999999999998775 3456799999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHh-----hCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCC
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH-----CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 150 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh-----~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~ 150 (311)
+++|.+++.........+++..++.++.+++.+|++|| +.+ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 85 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~~~~~ 161 (265)
T cd08217 85 GGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLAKILG 161 (265)
T ss_pred CCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccccccc
Confidence 99999999765555678999999999999999999999 777 9999999999999999999999999987543
Q ss_pred CCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhc
Q 021526 151 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 230 (311)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (311)
.... ......++..|++||.+.+..++.++|+||||+++++|++|..||....... +. +..
T Consensus 162 ~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~--------------~~~ 222 (265)
T cd08217 162 HDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LA--------------SKI 222 (265)
T ss_pred CCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HH--------------HHH
Confidence 3221 1223457889999999988888999999999999999999999987433110 00 001
Q ss_pred CccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 231 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 231 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
........+...+..+.+++.+||+.+|++||++.+|++
T Consensus 223 ~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 223 KEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred hcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 111111234456778999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=265.52 Aligned_cols=245 Identities=25% Similarity=0.314 Sum_probs=194.0
Q ss_pred eeeeeceeccEEEEEE-CCeEEEEEEeccCCc------cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCC
Q 021526 3 CCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGL------QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
..+|.|.||.||.+.. +++.+|+|.+..... .....+.+|+++++.++|+||+++++++.++...++++||+.
T Consensus 6 ~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (265)
T cd06631 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVP 85 (265)
T ss_pred ceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCC
Confidence 5789999999999988 788999998764421 123568889999999999999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCC--
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD-- 153 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~-- 153 (311)
+++|.+++.+ ...+++..+..++.|++.++++||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 86 ~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 86 GGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 9999999943 356889999999999999999999999 9999999999999999999999999876432111
Q ss_pred --CcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcC
Q 021526 154 --NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231 (311)
Q Consensus 154 --~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
.........++..|+|||.+.+..++.++|+||||+++++|++|..||......... . . .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~--~----~-~~~~~------- 224 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM--F----Y-IGAHR------- 224 (265)
T ss_pred ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH--H----H-hhhcc-------
Confidence 111122345788999999998888899999999999999999999999633211100 0 0 00000
Q ss_pred ccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
......+...+..+.++|++||..+|++||++.++++
T Consensus 225 -~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 -GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0001123345677899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=263.80 Aligned_cols=236 Identities=25% Similarity=0.354 Sum_probs=185.9
Q ss_pred eeeeceeccEEEEEEC--C----------eEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEE
Q 021526 4 CYLSCKFYNVGLVWLC--D----------QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 71 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~~--~----------~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 71 (311)
.+|+|+||.||++... + ..|++|.+...... ...+.+|+.+++.++||||+++++++.. ...++++
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 6899999999999993 2 24888877544333 6788899999999999999999999877 6789999
Q ss_pred ecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCC-------ceEEeecC
Q 021526 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-------NPKLSDFG 144 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~-------~vkl~Df~ 144 (311)
||+.+++|.+++.. ....+++..+..++.|++.||+|||+++ ++|+||+|+||+++.++ .++|+|||
T Consensus 80 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 80 EYVKFGPLDVFLHR---EKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EcCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999965 2237889999999999999999999999 99999999999998887 79999999
Q ss_pred CCccCCCCCCcceeeeccccccccCCccccCC--CCCccccchhHHHHHHHHHhC-CCCccccCccccccchhcchhhhh
Q 021526 145 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG--KLTLKSDIYSFGVVLLELITG-RKAMDLSKGQGEQNLVSWSRPFLK 221 (311)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~ 221 (311)
++..... .....+...|+|||.+... .++.++|+||||+++|+|++| ..||.......... ...
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-------~~~ 220 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-------FYQ 220 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-------HHh
Confidence 9874322 2223356679999998776 788999999999999999994 66765332111100 000
Q ss_pred cccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 021526 222 DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 272 (311)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~ 272 (311)
.. ...+......+.+++.+||..+|++||++.++++.|+
T Consensus 221 ~~------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 DQ------------HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cC------------CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 0011111267899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=265.16 Aligned_cols=253 Identities=22% Similarity=0.249 Sum_probs=197.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeC--CeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~ 76 (311)
++.+|.|.+|.||.+.. .++.+|+|.+..... .....+.+|+++++.++||||+++++++... ...+++|||+++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 85 (287)
T cd06621 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEG 85 (287)
T ss_pred EEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCC
Confidence 57899999999999999 689999999875433 3446789999999999999999999987543 468999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.........++...+..++.|++.+|+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 86 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--- 159 (287)
T cd06621 86 GSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL--- 159 (287)
T ss_pred CCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccccc---
Confidence 9999988654455677899999999999999999999999 9999999999999999999999999976432211
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
.....++..|++||...+..++.++|+|+||+++|+|++|..||......... ..... ....... .+.+..
T Consensus 160 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~-~~~~~~~------~~~~~~ 230 (287)
T cd06621 160 -AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG-PIELL-SYIVNMP------NPELKD 230 (287)
T ss_pred -cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC-hHHHH-HHHhcCC------chhhcc
Confidence 11234677899999998888999999999999999999999999744321110 01110 0000000 000100
Q ss_pred CCc--HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 237 RYP--RRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 237 ~~~--~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
... ...+..+.+++.+||..+|++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 231 EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 000 124667999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=267.57 Aligned_cols=255 Identities=22% Similarity=0.312 Sum_probs=200.5
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
++.+|+|++|.||++.. +++.||+|.+.... ......+.+|+++++.++||||+++++++......++|+||+.+++
T Consensus 10 ~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (284)
T cd06620 10 ISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGS 89 (284)
T ss_pred HHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCC
Confidence 46799999999999998 58999999876543 3345688999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
|.+++.. .+.+++..+..++.+++.+|.|||+ .+ ++|+||+|+||+++.++.++|+|||++...... .
T Consensus 90 L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~----~ 158 (284)
T cd06620 90 LDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS----I 158 (284)
T ss_pred HHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh----c
Confidence 9998843 4568999999999999999999997 57 999999999999999999999999987542111 1
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccc-----cchhcchhhhhcccchhhhcCc
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-----NLVSWSRPFLKDQKKFVHLVDP 232 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
.....++..|+|||.+.+..++.++|+||||+++|++++|..||......... ............ ..+
T Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~ 231 (284)
T cd06620 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-------PPP 231 (284)
T ss_pred cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-------cCC
Confidence 22345788999999988888999999999999999999999999744332110 011111111100 000
Q ss_pred cCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 021526 233 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 277 (311)
Q Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~ 277 (311)
.+ ....++..+.+++.+||+.||++||++.|+++..-.++..
T Consensus 232 ~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 232 RL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred CC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 01 0112566799999999999999999999999875544443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=264.35 Aligned_cols=247 Identities=21% Similarity=0.285 Sum_probs=196.4
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCcc------chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ------GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
..+|+|++|.||.+.. +++.||+|.+...... ..+.+.+|+.+++.++|+|++++++++.++...++++||+
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~ 85 (268)
T cd06630 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWM 85 (268)
T ss_pred ceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEecc
Confidence 5789999999999987 7899999998654321 2357889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCC-ceEEeecCCCccCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-NPKLSDFGLAKLGPVGD 153 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~-~vkl~Df~~~~~~~~~~ 153 (311)
.+++|.+++.. ...+++..++.++.|++.||++||+++ ++|+||+|.||+++.++ .++|+|||.+.......
T Consensus 86 ~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 86 AGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred CCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999853 456889999999999999999999999 99999999999998776 59999999986543221
Q ss_pred C--cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcC
Q 021526 154 N--THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231 (311)
Q Consensus 154 ~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
. ........++..|+|||.+.+..++.++|+|+||+++++|++|..||.......... .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-------------~~~~~~~ 225 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA-------------LIFKIAS 225 (268)
T ss_pred ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH-------------HHHHHhc
Confidence 1 111223457889999999988888999999999999999999999985322111100 0001111
Q ss_pred ccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.......+...+..+.+++.+||..+|++||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 226 ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 11122344566788999999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=262.99 Aligned_cols=241 Identities=25% Similarity=0.308 Sum_probs=194.6
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCc-----cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL-----QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
..+|+|++|.||++.. +++.|++|.+..... +..+.+.+|+++++.++|+||+++++++..+...++++||+.
T Consensus 6 ~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (258)
T cd06632 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVP 85 (258)
T ss_pred ceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecC
Confidence 4689999999999998 689999998865432 234678899999999999999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+++|.+++.. ...+++..++.++.|++.++++||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 86 ~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 86 GGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence 9999999953 346889999999999999999999999 9999999999999999999999999886432221
Q ss_pred ceeeeccccccccCCccccCCC-CCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccC
Q 021526 156 HVSTRVMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
......++..|++||.+.... ++.++|+||||+++|+|++|..||........ .. .......
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~---------~~-------~~~~~~~ 219 (258)
T cd06632 157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA---------VF-------KIGRSKE 219 (258)
T ss_pred -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH---------HH-------HHHhccc
Confidence 223355788899999887665 88999999999999999999999863321000 00 0000000
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
....+......+.+++.+||..+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 220 LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11223445677899999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=266.42 Aligned_cols=245 Identities=23% Similarity=0.285 Sum_probs=189.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc-cchhHHHHHHHH-HhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL-QGHQEFIVEVLM-LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
...+|.|+||.||++.. +++.||+|.+..... .....+..|+.. ++.++|||++++++++..+...+++|||++ +
T Consensus 6 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~ 84 (283)
T cd06617 6 IEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-T 84 (283)
T ss_pred EEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-c
Confidence 45789999999999998 689999999875432 233455666665 566789999999999999999999999996 5
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~-~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
+|.+++.........+++..++.++.|++.||+|||++ + ++|+||+|+||+++.++.+||+|||.+...... .
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~---~ 158 (283)
T cd06617 85 SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS---V 158 (283)
T ss_pred cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccccc---c
Confidence 88888866544557899999999999999999999987 8 999999999999999999999999998643211 1
Q ss_pred eeeeccccccccCCccccC----CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCc
Q 021526 157 VSTRVMGTYGYCAPEYAMS----GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 232 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~----~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||........ ........
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---------------~~~~~~~~ 223 (283)
T cd06617 159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ---------------QLKQVVEE 223 (283)
T ss_pred ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH---------------HHHHHHhc
Confidence 1122346788999998765 3468899999999999999999999853221100 00000000
Q ss_pred cCCCCC-cHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 233 LLHGRY-PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 233 ~~~~~~-~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.. ... ...++.++.++|.+||..+|++||++.++++
T Consensus 224 ~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 224 PS-PQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CC-CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 011 1234677999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=267.21 Aligned_cols=246 Identities=24% Similarity=0.312 Sum_probs=194.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccC-CccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
++.+|.|++|.||++.. +++.||+|.+... .......+.+|+++++.++||||+++++.+..+...+++|||+++++
T Consensus 6 ~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (286)
T cd06622 6 LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGS 85 (286)
T ss_pred hhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCC
Confidence 57899999999999999 6899999988654 22334678899999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
|.+++.... ....+++..+..++.+++.+|.|||+ .+ ++|+||+|+||+++.++.++|+|||.+...... .
T Consensus 86 l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~ 157 (286)
T cd06622 86 LDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS----L 157 (286)
T ss_pred HHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC----c
Confidence 999885421 23478999999999999999999996 47 999999999999999999999999988643211 1
Q ss_pred eeeccccccccCCccccCC------CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcC
Q 021526 158 STRVMGTYGYCAPEYAMSG------KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~------~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|..||........ . ..+.....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~----------~~~~~~~~ 224 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI---F----------AQLSAIVD 224 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH---H----------HHHHHHhh
Confidence 2223467789999987543 347899999999999999999999863221110 0 00011111
Q ss_pred ccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
......+..++.++.+++.+||+.+|++||+++++++
T Consensus 225 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 225 -GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred -cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1111234457788999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=267.06 Aligned_cols=238 Identities=24% Similarity=0.357 Sum_probs=187.8
Q ss_pred eeeeceeccEEEEEEC---------CeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 4 CYLSCKFYNVGLVWLC---------DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
.+|.|+||.||++... ...|++|.+........+.+.+|..+++.++|||++++++++..+...++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 5899999999999872 3358888876554445567889999999999999999999999988999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCc--------eEEeecCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN--------PKLSDFGLA 146 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~--------vkl~Df~~~ 146 (311)
++++|.+++.. ....+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++. ++++|||.+
T Consensus 82 ~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 82 KFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999964 3346889999999999999999999999 999999999999987765 699999987
Q ss_pred ccCCCCCCcceeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCC-CCccccCccccccchhcchhhhhccc
Q 021526 147 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGR-KAMDLSKGQGEQNLVSWSRPFLKDQK 224 (311)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 224 (311)
..... .....++..|+|||.+.+. .++.++|+||||+++|+|++|. .|+......... ....
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-------~~~~--- 219 (258)
T cd05078 156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-------QFYE--- 219 (258)
T ss_pred cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-------HHHH---
Confidence 64221 1223467789999988764 5789999999999999999985 555422111000 0000
Q ss_pred chhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 021526 225 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 272 (311)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~ 272 (311)
. ....+......+.+++.+||+.+|++|||++++++.|+
T Consensus 220 -------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 220 -------D--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -------c--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 11223334567899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=277.83 Aligned_cols=257 Identities=26% Similarity=0.366 Sum_probs=210.2
Q ss_pred eeeeeceeccEEEEEECC-eEEEEEEeccCCccch-hHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 3 CCYLSCKFYNVGLVWLCD-QLVAIKQLNHEGLQGH-QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~~~-~~vaiK~~~~~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
..+|+|.||.|..=...+ .+||+|++........ .+|.+|+.+|.+++||||+.++++|..++.+++++||++.|+|.
T Consensus 544 ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLn 623 (807)
T KOG1094|consen 544 EKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLN 623 (807)
T ss_pred hhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHH
Confidence 468999999999988854 9999999987655444 78999999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++.+.. .+.+.......++.||+.|++||.+.+ ++||||.+.|+|+++++++|++|||.++-....+.......
T Consensus 624 qFl~ahe--apt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr 698 (807)
T KOG1094|consen 624 QFLSAHE--LPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGR 698 (807)
T ss_pred HHHHhcc--CcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCceeeecc
Confidence 9997632 233455556779999999999999999 99999999999999999999999999987666777777777
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHh--CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCC
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT--GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRY 238 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
..-+.+|+|+|.+..++++.++|+|+||+++||+++ ...||.....+ +.......+...-.....-..
T Consensus 699 ~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e----------~vven~~~~~~~~~~~~~l~~ 768 (807)
T KOG1094|consen 699 AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE----------QVVENAGEFFRDQGRQVVLSR 768 (807)
T ss_pred eeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH----------HHHHhhhhhcCCCCcceeccC
Confidence 777899999999999999999999999999999866 45677522110 011111111111112222234
Q ss_pred cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 021526 239 PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274 (311)
Q Consensus 239 ~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l 274 (311)
|+-|+..+.+++.+||..+-++||+++++...|++.
T Consensus 769 P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 769 PPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 678899999999999999999999999999988764
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=264.46 Aligned_cols=247 Identities=26% Similarity=0.294 Sum_probs=193.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcC-CCCcccceeEEEEeCC------eeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGD------QRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~------~~~lv~e 72 (311)
...+|+|++|.||.+.. +++.+++|.+.... ...+.+.+|+++++.+ +|+||+++++++.... ..+++||
T Consensus 11 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e 89 (275)
T cd06608 11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVME 89 (275)
T ss_pred eeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEE
Confidence 46789999999999999 67899999986543 3446789999999998 6999999999986544 4899999
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCC
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~ 152 (311)
|+++++|.+++......+..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 166 (275)
T cd06608 90 LCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST 166 (275)
T ss_pred cCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccceecccc
Confidence 99999999998764444678999999999999999999999999 999999999999999999999999988643221
Q ss_pred CCcceeeeccccccccCCccccC-----CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchh
Q 021526 153 DNTHVSTRVMGTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 227 (311)
Q Consensus 153 ~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (311)
........++..|+|||.+.. ..++.++|+||||+++++|++|..||....... .... . .
T Consensus 167 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~----~-------~ 231 (275)
T cd06608 167 --LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--ALFK----I-------P 231 (275)
T ss_pred --hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--HHHH----h-------h
Confidence 111223457888999998753 346788999999999999999999985321110 0000 0 0
Q ss_pred hhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 228 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
....+ ....+...+..+.++|.+||..||++|||+.++++
T Consensus 232 ~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 RNPPP--TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ccCCC--CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00000 11122345678999999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=263.77 Aligned_cols=252 Identities=24% Similarity=0.351 Sum_probs=193.2
Q ss_pred eeeeeceeccEEEEEE-----CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeCC------eeEE
Q 021526 3 CCYLSCKFYNVGLVWL-----CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD------QRLL 69 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~l 69 (311)
..+|+|++|.||++.. .++.||+|.+.... ....+++.+|+++++.++||||+++++++.... ..++
T Consensus 5 ~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 84 (273)
T cd05074 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMV 84 (273)
T ss_pred hcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEE
Confidence 4689999999999986 36899999986543 234467889999999999999999999876432 2368
Q ss_pred EEecCCCCCHHHHhcccCC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 70 VYEYMPMGSLEDHLYDLEP--DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 70 v~e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
+++++.+++|.+++..... ....++...++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 85 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg~~~ 161 (273)
T cd05074 85 ILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSK 161 (273)
T ss_pred EEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcccccc
Confidence 8999999999988753221 2235788999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccch
Q 021526 148 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 226 (311)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
...............++..|++||......++.++|+||||+++|+|++ |.+||....... ... ......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~----~~~~~~-- 232 (273)
T cd05074 162 KIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYN----YLIKGN-- 232 (273)
T ss_pred cccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHH----HHHcCC--
Confidence 5432221111122334567999999888888999999999999999999 788875322110 000 000000
Q ss_pred hhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 021526 227 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274 (311)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l 274 (311)
....+...+..+.+++.+||..+|++||++.++++.|+++
T Consensus 233 --------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 --------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred --------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011234556899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=263.04 Aligned_cols=241 Identities=26% Similarity=0.301 Sum_probs=195.9
Q ss_pred eeeceeccEEEEEEC--CeEEEEEEeccCCc---cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 5 YLSCKFYNVGLVWLC--DQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 5 ~~~g~~~~v~~~~~~--~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
+|.|.+|.||.+... ++.|++|.+..... ...+.+.+|+++++.++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 588999999999994 89999999875432 2346788999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
.+++.+ ...+++..+..++.|++.+|++||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~ 150 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW 150 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence 999954 345889999999999999999999999 9999999999999999999999999987543221 122
Q ss_pred eccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 160 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
...++..|++||.+.+..++.++|+|+||+++|+|++|..||....... . ..............++
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~----------~~~~~~~~~~~~~~~~ 216 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----M----------EIYNDILKGNGKLEFP 216 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----H----------HHHHHHhccCCCCCCC
Confidence 3457888999999888888999999999999999999999996443210 0 0011111111222344
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 269 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs-----~~~l~~ 269 (311)
...+..+.+++.+||..+|++||+ ++|+++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 455778999999999999999999 787775
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=266.68 Aligned_cols=248 Identities=25% Similarity=0.270 Sum_probs=191.6
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcC-CCCcccceeEEEE-----eCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCT-----SGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-----~~~~~~lv~e~ 73 (311)
++.+|+|++|.||++.. .++.+++|.+... ......+.+|+.+++.+ +||||+++++++. .+...+++|||
T Consensus 23 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 101 (286)
T cd06638 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLEL 101 (286)
T ss_pred eeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEee
Confidence 57899999999999988 7889999987543 22235678899999998 6999999999873 44568999999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 153 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~ 153 (311)
+++++|.+++.........+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 178 (286)
T cd06638 102 CNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 178 (286)
T ss_pred cCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCceeecccCC
Confidence 9999999988654445567899999999999999999999999 9999999999999999999999999986532211
Q ss_pred CcceeeeccccccccCCccccC-----CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhh
Q 021526 154 NTHVSTRVMGTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 228 (311)
Q Consensus 154 ~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
.......++..|+|||.+.. ..++.++|+||||+++|+|++|..||........ .... ..
T Consensus 179 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~--~~~~-------~~---- 243 (286)
T cd06638 179 --LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA--LFKI-------PR---- 243 (286)
T ss_pred --CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH--Hhhc-------cc----
Confidence 11223457889999998753 4578899999999999999999999863321110 0000 00
Q ss_pred hcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 229 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 229 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
...+.. ..+..++..+.+++.+||+.+|++||++.|+++.
T Consensus 244 ~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 244 NPPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred cCCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 000000 0122245679999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=268.44 Aligned_cols=258 Identities=19% Similarity=0.190 Sum_probs=191.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
+..+|.|.+|.||++.. +|+.|++|.+..... .....+.+|+++++.++|||++++++++.+....++++||++ +
T Consensus 5 ~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 83 (284)
T cd07839 5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-Q 83 (284)
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-C
Confidence 46789999999999999 789999999865432 223567889999999999999999999999999999999996 4
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 84 ~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~ 155 (284)
T cd07839 84 DLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--RC 155 (284)
T ss_pred CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC--CC
Confidence 88887754 3456899999999999999999999999 9999999999999999999999999987432211 11
Q ss_pred eeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcch-------hhhhcccchhhh
Q 021526 158 STRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR-------PFLKDQKKFVHL 229 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~ 229 (311)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|..|+........ ....... ..+.........
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HHHHHHHHhCCCChHHhHHhhhcccc
Confidence 1223467889999987764 468999999999999999999988643222110 0000000 000000000000
Q ss_pred -cCccCC-----CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 230 -VDPLLH-----GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 230 -~~~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..+... ....+..+..+.+++.+||+.||.+|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000 0112345678899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=276.74 Aligned_cols=256 Identities=23% Similarity=0.269 Sum_probs=189.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeC------CeeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG------DQRLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~ 71 (311)
...+|+|+||.||.+.. .++.||||.+.... ......+.+|+.+++.++||||+++++++... ...++||
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~ 108 (364)
T cd07875 29 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM 108 (364)
T ss_pred EEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEE
Confidence 46799999999999998 68999999986542 23346788899999999999999999887543 3579999
Q ss_pred ecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCC
Q 021526 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 151 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~ 151 (311)
||+++ +|.+.+. ..+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 109 e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 109 ELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred eCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 99965 7777773 24778889999999999999999999 99999999999999999999999999874322
Q ss_pred CCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCcccccc-ch--------hc-------
Q 021526 152 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LV--------SW------- 215 (311)
Q Consensus 152 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~--------~~------- 215 (311)
. .......++..|+|||++.+..++.++|+|||||++|+|++|..||.......... +. .+
T Consensus 179 ~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (364)
T cd07875 179 S---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255 (364)
T ss_pred C---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence 1 11223457889999999999899999999999999999999999996443211100 00 00
Q ss_pred chhhhhcccc-----hhhhcCccC---CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 216 SRPFLKDQKK-----FVHLVDPLL---HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 216 ~~~~~~~~~~-----~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
...+..+... ......... ...........+.++|.+||+.||.+|||+.++++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000000 000000000 000111234568999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=263.37 Aligned_cols=249 Identities=24% Similarity=0.301 Sum_probs=192.7
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc----------chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ----------GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 69 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 69 (311)
...+|.|++|.||+|.. +++.||+|.+...... ..+.+.+|+++++.++|||++++++++......++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI 85 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence 35799999999999987 7899999987542111 12357789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccC
Q 021526 70 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 149 (311)
Q Consensus 70 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~ 149 (311)
|+|++.+++|.+++.. ...+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 86 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 86 FLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred EEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 9999999999999954 357888999999999999999999999 999999999999999999999999998643
Q ss_pred CCCCCcceeeeccccccccCCccccCCC--CCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchh
Q 021526 150 PVGDNTHVSTRVMGTYGYCAPEYAMSGK--LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 227 (311)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (311)
.............++..|+|||.+.... ++.++|+||||++++++++|..||........ ......
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---------~~~~~~--- 226 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA---------MFKLGN--- 226 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH---------HHHhhc---
Confidence 2211111122345788899999887654 78999999999999999999999852221100 000000
Q ss_pred hhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 228 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..............++..+.+++.+||..+|++||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 227 KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 000011111122345678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=280.29 Aligned_cols=239 Identities=28% Similarity=0.366 Sum_probs=198.0
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccch---hHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
|+.+|.|+||.||.++. +.+.||||.+.-...... +++.+|+..|.+++|||++.+.+.|..+.+.|+|||||-
T Consensus 31 LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl- 109 (948)
T KOG0577|consen 31 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL- 109 (948)
T ss_pred HHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-
Confidence 45789999999999999 889999999865544433 578999999999999999999999999999999999995
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
|+-.|.+.. ..+++.+..+..++.+.+.||+|||+.+ .+|+|||..|||+++.|.|||+|||.+.+..+
T Consensus 110 GSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----- 178 (948)
T KOG0577|consen 110 GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP----- 178 (948)
T ss_pred ccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc-----
Confidence 477777754 6689999999999999999999999999 99999999999999999999999999865322
Q ss_pred eeeeccccccccCCcccc---CCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 157 VSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
-....||+.|||||++. .+.|+-+.||||||++..++.-.++|+.-.+.... ...+..--.|.
T Consensus 179 -AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA-------------LYHIAQNesPt 244 (948)
T KOG0577|consen 179 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------------LYHIAQNESPT 244 (948)
T ss_pred -hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH-------------HHHHHhcCCCC
Confidence 23456999999999764 57899999999999999999999999752221110 00011111222
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
+. .++++..+..|+..||+.-|.+|||.++++.
T Consensus 245 Lq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 245 LQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 22 4678889999999999999999999998876
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=262.96 Aligned_cols=242 Identities=25% Similarity=0.265 Sum_probs=194.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
+..+|.|+||.||++.. +++.||+|.+.... ......+.+|+.+++.++||||+++++++..+...++|+||+++++
T Consensus 9 ~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 88 (277)
T cd06641 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS 88 (277)
T ss_pred heeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCc
Confidence 46789999999999987 68999999876443 2334678899999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
|.+++. ...+++..+..++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 89 l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~ 158 (277)
T cd06641 89 ALDLLE-----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KR 158 (277)
T ss_pred HHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh--hh
Confidence 999984 346889999999999999999999999 99999999999999999999999998864322111 11
Q ss_pred eeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCC
Q 021526 159 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRY 238 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
....++..|++||.+.+..++.++|+||||+++|+|++|..||........ ... .. .......
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~------~~~-~~----------~~~~~~~ 221 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV------LFL-IP----------KNNPPTL 221 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH------HHH-Hh----------cCCCCCC
Confidence 223467789999998888889999999999999999999999863221100 000 00 0000112
Q ss_pred cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 239 PRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 239 ~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
+..++..+.+++.+||..+|.+||++.++++.
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 23456779999999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=259.83 Aligned_cols=246 Identities=24% Similarity=0.313 Sum_probs=201.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
...+|.|++|.||.+.. +++.|++|.+..... .....+.+|++.++.++|||++++.+.+..+...++++|+++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~ 84 (258)
T cd08215 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGG 84 (258)
T ss_pred EeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCC
Confidence 46789999999999999 589999999876543 45567889999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|.+++.........+++..++.++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 159 (258)
T cd08215 85 DLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--DL 159 (258)
T ss_pred cHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc--ce
Confidence 999999764444678999999999999999999999999 9999999999999999999999999887533222 22
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCC
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 237 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
.....++..|+|||...+..++.++|+|++|+++++|++|..||....... ..... . ......
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~----------~-~~~~~~ 222 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE------LALKI----------L-KGQYPP 222 (258)
T ss_pred ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH------HHHHH----------h-cCCCCC
Confidence 333467888999999888889999999999999999999999986433110 00000 0 000112
Q ss_pred CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 238 YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.+...+..+.+++.+||..+|++||++.++++
T Consensus 223 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 223 IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 23355678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=261.17 Aligned_cols=246 Identities=23% Similarity=0.289 Sum_probs=200.1
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
...+|.|+++.||++.. .++.|++|.+..... .....+.+|++.+..++|+|++++++++..+...++++|++++++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (264)
T cd06623 6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGS 85 (264)
T ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCc
Confidence 46789999999999999 589999999876544 445789999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
|.+++.. ...+++..++.++.|++.++++||+ .+ ++|+||+|+||+++.++.++|+|||.+.........
T Consensus 86 L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-- 156 (264)
T cd06623 86 LADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-- 156 (264)
T ss_pred HHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc--
Confidence 9999954 3678999999999999999999999 98 999999999999999999999999988754322211
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCC
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 237 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
.....++..|+|||.+.+..++.++|+|+||+++|+|++|..||............ ... .. .....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~---~~~----------~~-~~~~~ 222 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM---QAI----------CD-GPPPS 222 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH---HHH----------hc-CCCCC
Confidence 12345778899999998888899999999999999999999998644321100000 000 00 00011
Q ss_pred CcHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 238 YPRR-CLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 238 ~~~~-~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.+.. .+..+.++|.+||..+|++||++.++++.
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1223 56789999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=262.07 Aligned_cols=243 Identities=24% Similarity=0.308 Sum_probs=189.7
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCc-----cchhHHHHHHHHHhcCCCCcccceeEEEEe--CCeeEEEEec
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL-----QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS--GDQRLLVYEY 73 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~ 73 (311)
..+|.|.+|.||++.. .++.|++|.+..... .....+.+|+++++.++||||+++++++.+ +...++++|+
T Consensus 8 ~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~ 87 (266)
T cd06651 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEY 87 (266)
T ss_pred ceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeC
Confidence 5789999999999998 689999998764421 123468889999999999999999998865 3567899999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 153 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~ 153 (311)
+.+++|.+++.. ...+++..++.++.|++.+|++||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 88 MPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 999999999953 345888999999999999999999999 9999999999999999999999999886432111
Q ss_pred -CcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCc
Q 021526 154 -NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 232 (311)
Q Consensus 154 -~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
.........++..|+|||.+.+..++.++|+||+|+++|+|++|..||....... ........
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~----------------~~~~~~~~ 224 (266)
T cd06651 161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA----------------AIFKIATQ 224 (266)
T ss_pred ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH----------------HHHHHhcC
Confidence 1111122347788999999988889999999999999999999999986321110 00111111
Q ss_pred cCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 233 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
......+......+.+++ +||..+|++||++++|++
T Consensus 225 ~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 225 PTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 111223445567788888 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=265.97 Aligned_cols=244 Identities=25% Similarity=0.288 Sum_probs=196.5
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
+..+|+|++|.||++.. +++.|++|.+........+.+.+|+.+++.++|||++++++++..+...++|+||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L 103 (293)
T cd06647 24 FEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSL 103 (293)
T ss_pred eeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcH
Confidence 35789999999999987 7889999998765555567889999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
.+++.. ..+++..+..++.|++.++.+||+++ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 104 ~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~--~~~~ 173 (293)
T cd06647 104 TDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRS 173 (293)
T ss_pred HHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc--cccc
Confidence 999943 45788899999999999999999999 9999999999999999999999999876432221 1122
Q ss_pred eccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 160 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
...++..|++||.+.+..++.++|+||||+++|++++|..||.......... . ... . ..+.. ..+
T Consensus 174 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~--~----~~~-~------~~~~~--~~~ 238 (293)
T cd06647 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--L----IAT-N------GTPEL--QNP 238 (293)
T ss_pred cccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee--e----hhc-C------CCCCC--CCc
Confidence 2357788999999888888999999999999999999999996432211100 0 000 0 00001 112
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
...+..+.++|++||..+|++||++.+++..
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2345679999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=265.70 Aligned_cols=238 Identities=27% Similarity=0.338 Sum_probs=195.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
...+|+|.+|.||.+.. +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.++...+++|||+.+
T Consensus 6 ~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 85 (290)
T cd05580 6 IKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPG 85 (290)
T ss_pred EEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCC
Confidence 56899999999999998 68999999986542 23346788999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ...+++..+..++.|++.||++||+.+ ++|+||+|.||+++.++.++|+|||++......
T Consensus 86 ~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 86 GELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 999999954 467899999999999999999999999 999999999999999999999999998753222
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
.....++..|+|||.+.+...+.++|+||||+++|+|++|..||....... . ....... ..
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----------~------~~~~~~~--~~ 215 (290)
T cd05580 155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ----------I------YEKILEG--KV 215 (290)
T ss_pred -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH----------H------HHHHhcC--Cc
Confidence 223457889999999888888899999999999999999999986333100 0 0000000 11
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 269 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~l~~ 269 (311)
..+...+..+.++|.+||..+|.+|+ +++++++
T Consensus 216 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 216 RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 22334567899999999999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=264.42 Aligned_cols=247 Identities=25% Similarity=0.260 Sum_probs=191.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcC-CCCcccceeEEEEeC-----CeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSG-----DQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-----~~~~lv~e~ 73 (311)
...+|+|.+|.||++.. +++.+|+|.+.... .....+.+|+.+++.+ +|||++++++++... ...++++||
T Consensus 27 ~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey 105 (291)
T cd06639 27 IETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLEL 105 (291)
T ss_pred EEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEE
Confidence 46789999999999998 68899999985432 2345677899999888 799999999988643 357999999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 153 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~ 153 (311)
+++++|.+++.........+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 106 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 182 (291)
T cd06639 106 CNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182 (291)
T ss_pred CCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeecccchhccccc
Confidence 9999999998654445677899999999999999999999999 9999999999999999999999999886432211
Q ss_pred CcceeeeccccccccCCccccCC-----CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhh
Q 021526 154 NTHVSTRVMGTYGYCAPEYAMSG-----KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 228 (311)
Q Consensus 154 ~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
. ......++..|+|||.+... .++.++|+||||+++|+|++|..||........ +.. ....
T Consensus 183 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~~----~~~~------ 248 (291)
T cd06639 183 L--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LFK----IPRN------ 248 (291)
T ss_pred c--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HHH----HhcC------
Confidence 1 11224577889999987543 367899999999999999999999863321110 000 0000
Q ss_pred hcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 229 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 229 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..+.. ..+......+.++|.+||+.+|++||++.++++
T Consensus 249 -~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 249 -PPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred -CCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00000 112334567999999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=260.97 Aligned_cols=251 Identities=27% Similarity=0.329 Sum_probs=198.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
...+|.|++|.||++.. ++..+++|.+.... ....+.+.+|++.++.++|+|++++++.+..+...++++|++.+++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~ 85 (267)
T cd06610 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGS 85 (267)
T ss_pred eeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCc
Confidence 46789999999999998 78899999986543 2355788999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc--
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH-- 156 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~-- 156 (311)
|.+++..... ...+++..+..++.|++.|+++||+.+ ++|+||+|+||++++++.++|+|||++..........
T Consensus 86 l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~ 161 (267)
T cd06610 86 LLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRK 161 (267)
T ss_pred HHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccccc
Confidence 9999965221 356899999999999999999999999 9999999999999999999999999886543322221
Q ss_pred eeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
......++..|++||.+... .++.++|+||||+++++|++|..||......... . ..... ..+...
T Consensus 162 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~--~----~~~~~-------~~~~~~ 228 (267)
T cd06610 162 VRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL--M----LTLQN-------DPPSLE 228 (267)
T ss_pred ccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH--H----HHhcC-------CCCCcC
Confidence 22334578899999988776 7889999999999999999999998633221110 0 00000 000111
Q ss_pred CC-CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 236 GR-YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 236 ~~-~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.. .....+..+.+++.+||..||++||++.+|++
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 229 TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00 01245677999999999999999999999985
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=264.17 Aligned_cols=245 Identities=26% Similarity=0.320 Sum_probs=196.2
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
..+|.|.+|.||++.. +++.|++|.+.... ......+.+|+++++.++||||+++++++..+...++++|++.+++|
T Consensus 7 ~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 86 (265)
T cd06605 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSL 86 (265)
T ss_pred HHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcH
Confidence 4689999999999999 58999999987653 23446788999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
.+++.. ....+++..+..++.|++.++++||+ .+ ++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 87 ~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~----~ 156 (265)
T cd06605 87 DKILKE---VQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL----A 156 (265)
T ss_pred HHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH----h
Confidence 999965 22678999999999999999999999 88 9999999999999999999999999876432111 1
Q ss_pred eeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCC
Q 021526 159 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRY 238 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
....++..|+|||.+.+..++.++|+||||+++++|++|..||......... .......... ...+ ..
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~-------~~~~----~~ 224 (265)
T cd06605 157 KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IFELLQYIVN-------EPPP----RL 224 (265)
T ss_pred hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HHHHHHHHhc-------CCCC----CC
Confidence 1155778899999998889999999999999999999999998644321111 1111101100 0001 11
Q ss_pred cHH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 239 PRR-CLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 239 ~~~-~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
+.. .+..+.++|.+||..+|++|||+.+++.
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 225 PSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 222 5677999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=259.29 Aligned_cols=245 Identities=27% Similarity=0.312 Sum_probs=195.7
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc--chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
.+.+|.|.++.||.+.. +++.|++|.+...... ..+.+.+|+++++.++|+||+++++++.+....++++||+.++
T Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (264)
T cd06626 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGG 84 (264)
T ss_pred eeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCC
Confidence 47899999999999998 7899999998766543 5578999999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|.+++.. ...+++..+..++.+++.++++||+.+ ++|+||+|+||+++.++.++|+|||++...........
T Consensus 85 ~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 85 TLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred cHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 99999943 455788999999999999999999999 99999999999999999999999999875432222111
Q ss_pred --eeeccccccccCCccccCCC---CCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCc
Q 021526 158 --STRVMGTYGYCAPEYAMSGK---LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 232 (311)
Q Consensus 158 --~~~~~~~~~~~aPE~~~~~~---~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
.....++..|++||.+.+.. ++.++|+|+||++++++++|..||........ ..... . .
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-------~~~~~-~----~---- 221 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-------IMFHV-G----A---- 221 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-------HHHHH-h----c----
Confidence 11245678999999988765 78999999999999999999999963321100 00000 0 0
Q ss_pred cCCCCCcH--HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 233 LLHGRYPR--RCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 233 ~~~~~~~~--~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
......+. ..+..+.+++.+||+.+|++||++.+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 222 GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00001112 23677889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=268.14 Aligned_cols=197 Identities=24% Similarity=0.284 Sum_probs=157.9
Q ss_pred eeeeeceeccEEEEEE----CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEE--eCCeeEEEEecCCC
Q 021526 3 CCYLSCKFYNVGLVWL----CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT--SGDQRLLVYEYMPM 76 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~----~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~ 76 (311)
+.+|.|+||.||++.. .+..||+|.+.... ....+.+|+++++.++||||+++++++. .+...++++||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 6799999999999997 34789999876432 2346788999999999999999999874 35678999999864
Q ss_pred CCHHHHhcccC-----CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE----cCCCceEEeecCCCc
Q 021526 77 GSLEDHLYDLE-----PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL----DNDFNPKLSDFGLAK 147 (311)
Q Consensus 77 ~~L~~~l~~~~-----~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~----~~~~~vkl~Df~~~~ 147 (311)
+|.+++.... .....+++..++.++.|++.||.|||+.+ ++|+||||+||++ +.++.+||+|||++.
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 7877774321 12345889999999999999999999999 9999999999999 556789999999987
Q ss_pred cCCCCCCc-ceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccC
Q 021526 148 LGPVGDNT-HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSK 205 (311)
Q Consensus 148 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 205 (311)
........ .......++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 54322111 11223457889999998876 457899999999999999999999996443
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=260.66 Aligned_cols=244 Identities=24% Similarity=0.268 Sum_probs=190.6
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc-----cchhHHHHHHHHHhcCCCCcccceeEEEEeC--CeeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL-----QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 72 (311)
..++|+|.+|.||.+.. +++.|++|.+..... ...+.+.+|+++++.++||||+++++++.+. ...+++||
T Consensus 7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (265)
T cd06652 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86 (265)
T ss_pred eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEE
Confidence 46799999999999998 689999998754321 1235678899999999999999999988653 46789999
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCC
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~ 152 (311)
++.+++|.+++.. ...+++..+..++.|++.+|++||+.+ ++|+||+|.||+++.++.++|+|||.+......
T Consensus 87 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 87 HMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred ecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 9999999999853 345788889999999999999999999 999999999999999999999999988643211
Q ss_pred CC-cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcC
Q 021526 153 DN-THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231 (311)
Q Consensus 153 ~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
.. ........++..|+|||.+.+..++.++|+||||+++|+|++|..||....... .......
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----------------~~~~~~~ 223 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA----------------AIFKIAT 223 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH----------------HHHHHhc
Confidence 11 111122347888999999988888999999999999999999999985221110 0011111
Q ss_pred ccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.......+......+.+++.+||. +|++||+++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 224 QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 111122345566778999999995 9999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=283.42 Aligned_cols=254 Identities=19% Similarity=0.260 Sum_probs=181.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCC------CcccceeEEEEeC-CeeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHH------DNLVTLIGYCTSG-DQRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~-~~~~lv~e 72 (311)
+.++|.|+||.||+++. .++.||||++... .........|++++..++| .+++++++++..+ ...++||+
T Consensus 134 ~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~ 212 (467)
T PTZ00284 134 LSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMP 212 (467)
T ss_pred EEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEe
Confidence 46799999999999998 6889999998643 2223445667777766654 4588888888654 57899999
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeecCCCCCcEEEcCCC---------------
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDF--------------- 136 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~di~p~nil~~~~~--------------- 136 (311)
++ +++|.+++.. ...+++..+..++.||+.||.|||+ .| |+|+||||+|||++.++
T Consensus 213 ~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 213 KY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred cc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 88 7789888843 4578999999999999999999998 58 99999999999998765
Q ss_pred -ceEEeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccch--
Q 021526 137 -NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-- 213 (311)
Q Consensus 137 -~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-- 213 (311)
.+||+|||.+.... .......|+..|+|||++.+..++.++|||||||++|+|++|+.||............
T Consensus 285 ~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 359 (467)
T PTZ00284 285 CRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK 359 (467)
T ss_pred ceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 49999999875321 1123356899999999999999999999999999999999999999754421111000
Q ss_pred -------hcch--------hhhhcccchhhhcCc-----cCCCC-C-cHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 214 -------SWSR--------PFLKDQKKFVHLVDP-----LLHGR-Y-PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 214 -------~~~~--------~~~~~~~~~~~~~~~-----~~~~~-~-~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.|.. ..+.....+.....+ ..... . .......+.+||.+||+.||++|||++|+++
T Consensus 360 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 360 TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 0000 000000000000000 00000 0 0012355789999999999999999999997
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=264.86 Aligned_cols=244 Identities=24% Similarity=0.271 Sum_probs=189.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcC-CCCcccceeEEEE------eCCeeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCT------SGDQRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~------~~~~~~lv~e 72 (311)
...+|.|+||.||.+.. .++.||+|.+.... .....+..|+.+++.+ +|+|++++++++. .+...+++||
T Consensus 21 ~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e 99 (282)
T cd06636 21 VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVME 99 (282)
T ss_pred heeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEE
Confidence 45789999999999999 78999999986442 3345688899999888 6999999999874 3457899999
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCC
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~ 152 (311)
|+.+++|.+++.. .....+++..++.++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 100 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~ 174 (282)
T cd06636 100 FCGAGSVTDLVKN--TKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 174 (282)
T ss_pred eCCCCcHHHHHHH--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchhhhhcc
Confidence 9999999999965 23456888889999999999999999999 999999999999999999999999987643211
Q ss_pred CCcceeeeccccccccCCcccc-----CCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchh
Q 021526 153 DNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 227 (311)
Q Consensus 153 ~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (311)
........++..|+|||.+. ...++.++|+||||+++|+|++|..||..........
T Consensus 175 --~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~---------------- 236 (282)
T cd06636 175 --VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF---------------- 236 (282)
T ss_pred --ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh----------------
Confidence 11122345788899999875 3467889999999999999999999985322111100
Q ss_pred hhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 228 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..............++..+.++|.+||..||.+||++.+|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000000001112235678999999999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=265.39 Aligned_cols=242 Identities=21% Similarity=0.263 Sum_probs=194.7
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
-.+|.|++|.||.+.. +++.|++|.+........+.+.+|+.+++.++|||++++++++..+...++++|++.+++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~ 104 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence 4689999999999987 68899999886554455567889999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++.. ..+++..+..++.|++.++++||+.+ ++|+||+|.||+++.++.++|+|||.+...... ......
T Consensus 105 ~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~--~~~~~~ 174 (285)
T cd06648 105 DIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--VPRRKS 174 (285)
T ss_pred HHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccC--Cccccc
Confidence 99843 56888999999999999999999999 999999999999999999999999987643221 111223
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCcH
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPR 240 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (311)
..++..|+|||...+..++.++|+||||+++++|++|..||...... ....... ....+.. ..+.
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~~~-------~~~~~~~--~~~~ 239 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKRIR-------DNLPPKL--KNLH 239 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHH-------hcCCCCC--cccc
Confidence 45788999999988888899999999999999999999998532210 0000000 0000111 1122
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 241 RCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 241 ~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..+..+.+++.+||..+|++||++.++++
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 240 KVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 35567999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=266.30 Aligned_cols=260 Identities=22% Similarity=0.276 Sum_probs=194.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
...+|.|.+|.||++.. +++.|++|.+.... ....+.+.+|+++++.++|+||+++++++..+...++++||+.++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~ 85 (288)
T cd07833 6 LGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERT 85 (288)
T ss_pred EEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCC
Confidence 46789999999999998 68899999886542 334467899999999999999999999999999999999999886
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
.+..+.. ....+++..++.++.|++.++++||+.+ ++|+||+|+||++++++.++|+|||++........ ..
T Consensus 86 ~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~ 157 (288)
T cd07833 86 LLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SP 157 (288)
T ss_pred HHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-cc
Confidence 6665552 3456899999999999999999999999 99999999999999999999999999875433221 11
Q ss_pred eeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCccccccch-hc----ch---hhhhccc----
Q 021526 158 STRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-SW----SR---PFLKDQK---- 224 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~----~~---~~~~~~~---- 224 (311)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|.+||............ .. .. ..+....
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 2224467889999998887 7889999999999999999999998643321110000 00 00 0000000
Q ss_pred -chhhhcCc-cCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 225 -KFVHLVDP-LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 225 -~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.+...... .....++..++..+.++|.+||..+|++||+++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000000 0001123344788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=279.95 Aligned_cols=248 Identities=24% Similarity=0.334 Sum_probs=210.6
Q ss_pred CeeeeeeceeccEEEEEE---CC--eEEEEEEeccCCcc-chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 1 MLCCYLSCKFYNVGLVWL---CD--QLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~---~~--~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
|.++||.|.||.|.+|.+ +| -.||||++...... ...+|.+|+.++..|+|+|++++|++..+ ....+|||.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 356899999999999999 33 57999998765443 55799999999999999999999999876 7889999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
.+|+|.+.|.+ .....|....+..++.||+.|+.||.+++ +||||+...|+++-....|||+|||+++-......
T Consensus 193 plGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 193 PLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred ccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 99999999987 56678888999999999999999999999 99999999999999999999999999987665555
Q ss_pred cceee-eccccccccCCccccCCCCCccccchhHHHHHHHHHhC-CCCccccCccccccchhcchhhhhcccchhhhcCc
Q 021526 155 THVST-RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG-RKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 232 (311)
Q Consensus 155 ~~~~~-~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
.+... ...-...|+|||.+....++-++|+|++|++||||+++ ..||.... ...+.+.++.
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~-----------------g~qIL~~iD~ 330 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR-----------------GIQILKNIDA 330 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC-----------------HHHHHHhccc
Confidence 44433 23456789999999999999999999999999999984 45764322 3344455555
Q ss_pred cCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 021526 233 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 271 (311)
Q Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L 271 (311)
..+-..|..|++.+.+++..||..+|.+||++..|.+.+
T Consensus 331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 555667889999999999999999999999999998544
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=263.57 Aligned_cols=259 Identities=23% Similarity=0.224 Sum_probs=193.0
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
...+|+|++|.||++.. +++.||+|.+.... ....+.+.+|+++++.++|||++++++++..+...+++|||++++
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 85 (286)
T cd07847 6 LSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHT 85 (286)
T ss_pred eeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCcc
Confidence 46789999999999998 68999999886442 223356789999999999999999999999999999999999988
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|..++. ....+++..+..++.|++.+|+|||+.+ ++|+||+|.||++++++.++|+|||++........ .
T Consensus 86 ~l~~~~~----~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~ 156 (286)
T cd07847 86 VLNELEK----NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--D 156 (286)
T ss_pred HHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc--c
Confidence 8877763 3456899999999999999999999999 99999999999999999999999999875432211 1
Q ss_pred eeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCcccccc-chhcchhhhhc------ccch-hh
Q 021526 158 STRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWSRPFLKD------QKKF-VH 228 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~------~~~~-~~ 228 (311)
.....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.......... ........... .... ..
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence 122346778999998765 457889999999999999999999996443221100 00000000000 0000 00
Q ss_pred hcCccCCCCC-----cHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 229 LVDPLLHGRY-----PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 229 ~~~~~~~~~~-----~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
...+...... -...+..+.+++.+||+.+|++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000000000 0123577899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=274.30 Aligned_cols=255 Identities=22% Similarity=0.277 Sum_probs=186.6
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeC------CeeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG------DQRLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~ 71 (311)
+..+|.|+||.||++.. +++.||+|.+..... .....+.+|+++++.++||||+++++++... ...++++
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~ 99 (343)
T cd07878 20 LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVT 99 (343)
T ss_pred heecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEe
Confidence 45789999999999988 678999999865422 2335677899999999999999999887533 3468999
Q ss_pred ecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCC
Q 021526 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 151 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~ 151 (311)
+++ +++|.+++. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 100 ~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 100 NLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred ecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 987 778988873 356899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCcceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCcccccc-chhcc----hhhhhc--c
Q 021526 152 GDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWS----RPFLKD--Q 223 (311)
Q Consensus 152 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~----~~~~~~--~ 223 (311)
. .....++..|+|||++.+ ..++.++|+|||||++|+|++|..||.......... +.... ...... .
T Consensus 171 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 171 E-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred C-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence 1 122357889999998876 568899999999999999999999996433210000 00000 000000 0
Q ss_pred cchhhhcCcc--CCC----CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 224 KKFVHLVDPL--LHG----RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 224 ~~~~~~~~~~--~~~----~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.......... ... .........+.+++.+||..||.+|||+.++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 000 0001123457899999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=264.94 Aligned_cols=259 Identities=24% Similarity=0.247 Sum_probs=189.6
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc-chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
.+.+|.|.+|.||++.. +++.|++|.+...... ....+.+|+++++.++|+||+++++++.++...++||||+.+ +
T Consensus 10 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~ 88 (291)
T cd07844 10 LDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-D 88 (291)
T ss_pred EEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-C
Confidence 46899999999999998 6899999998654322 224577899999999999999999999999999999999975 8
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 89 L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--~~~ 160 (291)
T cd07844 89 LKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS--KTY 160 (291)
T ss_pred HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC--ccc
Confidence 9998854 2347889999999999999999999999 9999999999999999999999999886432111 111
Q ss_pred eeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCcccccc--chhc----chhhhhcccchhhhcC
Q 021526 159 TRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN--LVSW----SRPFLKDQKKFVHLVD 231 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~--~~~~----~~~~~~~~~~~~~~~~ 231 (311)
....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.......... .... ....+...........
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP 240 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence 12235778999998765 457899999999999999999999996433110000 0000 0000000000000000
Q ss_pred --------ccCCCCCc-HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 232 --------PLLHGRYP-RRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 232 --------~~~~~~~~-~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..+....+ ......+.+++.+||+.+|++||++.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000000 011267889999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=265.39 Aligned_cols=259 Identities=22% Similarity=0.195 Sum_probs=192.7
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc-----chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ-----GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
+..+|.|.+|.||++.. +++.|++|.+...... ....+.+|+++++.++|+||+++++++.++...++|||++
T Consensus 5 ~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (298)
T cd07841 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM 84 (298)
T ss_pred eeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc
Confidence 56799999999999998 6899999998755432 2345778999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
+++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 -~~~L~~~i~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~- 156 (298)
T cd07841 85 -ETDLEKVIKD---KSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN- 156 (298)
T ss_pred -CCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCC-
Confidence 8899999954 2237999999999999999999999999 9999999999999999999999999987543221
Q ss_pred cceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCcccccc-chhc----chhhhhcccchhh
Q 021526 155 THVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSW----SRPFLKDQKKFVH 228 (311)
Q Consensus 155 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~ 228 (311)
.......++..|+|||.+.+ ..++.++|+||||+++++|++|.+||.......... .... ....+........
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 157 -RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred -ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence 11122345678999998765 467899999999999999999977775332211000 0000 0000000000000
Q ss_pred hcCccCCCC-----CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 229 LVDPLLHGR-----YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 229 ~~~~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
......... .....+..+.++|.+||..+|++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 000000000 11234677999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=261.77 Aligned_cols=249 Identities=24% Similarity=0.322 Sum_probs=195.3
Q ss_pred eeeeeeceeccEEEEEE---CCeEEEEEEeccCCc----------cchhHHHHHHHHHhc-CCCCcccceeEEEEeCCee
Q 021526 2 LCCYLSCKFYNVGLVWL---CDQLVAIKQLNHEGL----------QGHQEFIVEVLMLSL-LHHDNLVTLIGYCTSGDQR 67 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~---~~~~vaiK~~~~~~~----------~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~ 67 (311)
...+|.|.+|.||.+.. .++.+++|.+..... .....+.+|+.++.. ++||||+++++++..+...
T Consensus 5 ~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 84 (269)
T cd08528 5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRL 84 (269)
T ss_pred hhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeE
Confidence 35689999999999999 368999998754321 122456678887764 7999999999999999999
Q ss_pred EEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeecCCCCCcEEEcCCCceEEeecCCC
Q 021526 68 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFNPKLSDFGLA 146 (311)
Q Consensus 68 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~ 146 (311)
+++|||+.+++|.+++.........+++..++.++.|++.++.+||+ .+ ++|+||+|+||+++.++.++|+|||.+
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~ 161 (269)
T cd08528 85 YIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDFGLA 161 (269)
T ss_pred EEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecccce
Confidence 99999999999999986544456779999999999999999999996 67 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccch
Q 021526 147 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 226 (311)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
....... ......++..|++||.+.+..++.++|+||||+++|+|++|..||....... .....
T Consensus 162 ~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~------~~~~~------- 225 (269)
T cd08528 162 KQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS------LATKI------- 225 (269)
T ss_pred eeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH------HHHHH-------
Confidence 7543221 2233457888999999988889999999999999999999999985322110 00000
Q ss_pred hhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 021526 227 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 272 (311)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~ 272 (311)
.............+..+.+++.+||+.||++||++.|+...+.
T Consensus 226 ---~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 226 ---VEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ---hhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0000000001134567999999999999999999999998774
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=262.65 Aligned_cols=243 Identities=25% Similarity=0.312 Sum_probs=192.1
Q ss_pred eeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 5 YLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 5 ~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
+|.|.||.||.+.. +++.|++|.+.... ......+.+|+++++.++||||+++++++......+++|||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 58899999999987 68999999986543 22344667899999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
.+++... ....+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||.+..... .....
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~ 152 (277)
T cd05577 81 KYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIK 152 (277)
T ss_pred HHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccc
Confidence 9999652 2346899999999999999999999999 99999999999999999999999998864322 11122
Q ss_pred eccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 160 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
...++..|++||.+.+..++.++|+||||+++++|++|..||.......... .+..... .....++
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------------~~~~~~~-~~~~~~~ 218 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE-------------ELKRRTL-EMAVEYP 218 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH-------------HHHhccc-cccccCC
Confidence 2346778999999888888999999999999999999999996433211100 0000000 0111233
Q ss_pred HHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 269 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RP-----s~~~l~~ 269 (311)
...+..+.++|.+||+.+|.+|| ++.++++
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 44577899999999999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=266.66 Aligned_cols=259 Identities=24% Similarity=0.289 Sum_probs=192.7
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc--chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
+..+|+|.+|.||++.. +++.||+|.+...... ..+.+.+|+++++.++||||+++++++..+...++++||++++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 85 (286)
T cd07846 6 LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHT 85 (286)
T ss_pred eeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCcc
Confidence 57899999999999999 5899999987654322 3457889999999999999999999999999999999999998
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|..+.. ....+++..++.++.|++.+|+|||+.+ ++|+||+|+||++++++.++|+|||++....... ..
T Consensus 86 ~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~~ 156 (286)
T cd07846 86 VLDDLEK----YPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EV 156 (286)
T ss_pred HHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--cc
Confidence 8887763 3445899999999999999999999999 9999999999999999999999999886432221 11
Q ss_pred eeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCccccc-cchhcchh-------hhhcccchhh
Q 021526 158 STRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLVSWSRP-------FLKDQKKFVH 228 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~-------~~~~~~~~~~ 228 (311)
.....++..|+|||.+.+ ..++.++|+||||+++++|++|.+||......... ........ ..........
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 222346788999998875 35678999999999999999999988633321100 00000000 0000000000
Q ss_pred hcCccCCC-----CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 229 LVDPLLHG-----RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 229 ~~~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
...+.... ...+..+..+.+++.+||+.+|++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000000 011245677999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=262.94 Aligned_cols=242 Identities=24% Similarity=0.276 Sum_probs=197.6
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
...+|.|+++.||.+.. +++.|++|.+..... ...+.+.+|+++++.++||||+++++.+.++...++++||+.+
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (258)
T cd05578 5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLG 84 (258)
T ss_pred EEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCC
Confidence 45789999999999999 589999999875432 3456888999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 85 ~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--- 154 (258)
T cd05578 85 GDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--- 154 (258)
T ss_pred CCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc---
Confidence 999999954 357889999999999999999999999 9999999999999999999999999987543221
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||............ ..... ...
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~--------------~~~~~-~~~ 219 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR--------------AKQET-ADV 219 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH--------------HHhcc-ccc
Confidence 223345778899999998888999999999999999999999998744432110000 00000 112
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCH--HHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLI--NDIV 268 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~--~~l~ 268 (311)
..+...+..+.++|.+||..+|.+||++ +|++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 2344556889999999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=256.08 Aligned_cols=244 Identities=28% Similarity=0.353 Sum_probs=198.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
...+|+|++|.||++.. +++.+++|.+..........+.+|+++++.++|++++++++.+..+...++++|++++++|
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 84 (253)
T cd05122 5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSL 84 (253)
T ss_pred eeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcH
Confidence 46789999999999999 5899999998766555667899999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
.+++.. ....+++..+..++.|++.++++||+.+ ++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 85 ~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~ 155 (253)
T cd05122 85 KDLLKS---TNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RN 155 (253)
T ss_pred HHHHhh---cCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc---cc
Confidence 999854 2267899999999999999999999998 99999999999999999999999998875433221 23
Q ss_pred eccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 160 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
...++..|++||...+..++.++|+||||+++++|++|..||........ ... ......+.. ..+
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---------~~~----~~~~~~~~~--~~~ 220 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA---------LFK----IATNGPPGL--RNP 220 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH---------HHH----HHhcCCCCc--Ccc
Confidence 34578889999998888889999999999999999999999863321000 000 000000000 111
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..++..+.++|.+||+.+|++|||+.++++
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 123667999999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=267.09 Aligned_cols=250 Identities=22% Similarity=0.235 Sum_probs=193.7
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+..+|.|.++.||++.. .++.|++|.+..... .....+.+|+++++.++||||+++++.+..+...+++||++.+
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (305)
T cd05609 6 IKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEG 85 (305)
T ss_pred eeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence 56899999999999998 678999998865432 2335678899999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc-
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT- 155 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~- 155 (311)
++|.+++.. ...+++..+..++.|++.|++|||+.+ ++|+||+|.||+++.++.++|+|||.+.........
T Consensus 86 ~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 86 GDCATLLKN----IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 999999943 356899999999999999999999999 999999999999999999999999987531111000
Q ss_pred ------------ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcc
Q 021526 156 ------------HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 223 (311)
Q Consensus 156 ------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 223 (311)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~~~~-- 230 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQVIS-- 230 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh--
Confidence 0011234677899999988888999999999999999999999998532211 00000000
Q ss_pred cchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 021526 224 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 273 (311)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~ 273 (311)
.....+. .....+.++.+++.+||+.+|++||+..++.+.|+.
T Consensus 231 ---~~~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 231 ---DDIEWPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ---cccCCCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 0000000 012356778999999999999999997666555543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=253.24 Aligned_cols=257 Identities=23% Similarity=0.253 Sum_probs=198.0
Q ss_pred eeeeceeccEEEEEE--CCeEEEEEEeccCC----ccch----hHHHHHHHHHhcCC-CCcccceeEEEEeCCeeEEEEe
Q 021526 4 CYLSCKFYNVGLVWL--CDQLVAIKQLNHEG----LQGH----QEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYE 72 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~----~~~~----~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e 72 (311)
++|.|..+.|-+-.. .|+..|+|++.-.. .... +...+|+.+|+++. ||+|+++.++|+.+...++|+|
T Consensus 24 ilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFd 103 (411)
T KOG0599|consen 24 ILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFD 103 (411)
T ss_pred HhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhh
Confidence 467777666655555 68888999874321 1111 34557999999985 9999999999999999999999
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCC
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~ 152 (311)
.+..|.|.|++ ....++++.....++.|+..+++|||.++ |+|+|+||+|||++++-+++|.|||.+.....
T Consensus 104 l~prGELFDyL----ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l~~- 175 (411)
T KOG0599|consen 104 LMPRGELFDYL----TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQLEP- 175 (411)
T ss_pred hcccchHHHHh----hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeeccCC-
Confidence 99999999999 45778999999999999999999999999 99999999999999999999999999985433
Q ss_pred CCcceeeeccccccccCCccccC------CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccch
Q 021526 153 DNTHVSTRVMGTYGYCAPEYAMS------GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 226 (311)
Q Consensus 153 ~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
...-...+||++|+|||.+.. ..|+...|+|++|+++|-++.|.+||....+..- .+.++...
T Consensus 176 --GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlM------LR~ImeGk--- 244 (411)
T KOG0599|consen 176 --GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLM------LRMIMEGK--- 244 (411)
T ss_pred --chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHH------HHHHHhcc---
Confidence 233445789999999998764 4678899999999999999999999963221100 00001000
Q ss_pred hhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHhhhccCCCCCC
Q 021526 227 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV--ALDYLVSQRDSHPVS 284 (311)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~--~L~~l~~~~~~~~~~ 284 (311)
.+...+.+ .+.+....++|.+||+.||.+|.|++|++. .+.++...+.....+
T Consensus 245 yqF~speW-----adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r~msP 299 (411)
T KOG0599|consen 245 YQFRSPEW-----ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQARQMSP 299 (411)
T ss_pred cccCCcch-----hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcccccCC
Confidence 01111111 356778999999999999999999999998 466666655554433
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=261.89 Aligned_cols=243 Identities=26% Similarity=0.279 Sum_probs=195.7
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
..++.|.+|.||.+.. .++.|++|.+..... ..+.+.+|++.++.++|+|++++++.+..+...++++|++++++|.
T Consensus 25 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 103 (286)
T cd06614 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLT 103 (286)
T ss_pred HhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHH
Confidence 4689999999999999 589999999875544 5677889999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++.. ....+++..++.++.+++.+|++||+.| ++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 104 ~~l~~---~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--~~~~~ 175 (286)
T cd06614 104 DIITQ---NFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK--SKRNS 175 (286)
T ss_pred HHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch--hhhcc
Confidence 99965 2247999999999999999999999999 9999999999999999999999999876432211 11122
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCcH
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPR 240 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (311)
..++..|++||.+.+..++.++|+||||+++|+|++|..||......... . .... ........+.
T Consensus 176 ~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~--~----~~~~---------~~~~~~~~~~ 240 (286)
T cd06614 176 VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL--F----LITT---------KGIPPLKNPE 240 (286)
T ss_pred ccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH--H----HHHh---------cCCCCCcchh
Confidence 34677899999988888899999999999999999999998632211000 0 0000 0000011122
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 241 RCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 241 ~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.++..+.++|.+||+.+|.+||++.++++
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 241 KWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred hCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 35678999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=257.20 Aligned_cols=246 Identities=26% Similarity=0.283 Sum_probs=200.0
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeC--CeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~ 75 (311)
...+|+|++|.||++.. +++.|++|.+..... ...+.+.+|++.++.++||||+++++.+... ...++++|++.
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 84 (260)
T cd06606 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS 84 (260)
T ss_pred eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence 35789999999999999 589999999865543 3457888999999999999999999999888 88999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+++|.+++.. ...+++..++.++.+++.++++||+.+ ++|+||+|+||+++.++.++|+|||.+.........
T Consensus 85 ~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 85 GGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 9999999954 338899999999999999999999999 999999999999999999999999998754333221
Q ss_pred ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 156 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
.......++..|++||.+.....+.++|+|+||+++++|++|..||....... ............
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---------------~~~~~~~~~~~~ 222 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM---------------AALYKIGSSGEP 222 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH---------------HHHHhccccCCC
Confidence 11334557889999999988889999999999999999999999986443100 000011111111
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
...+...+..+.++|.+||+.+|++||++.++++
T Consensus 223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 2234455788999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=271.83 Aligned_cols=246 Identities=23% Similarity=0.244 Sum_probs=197.1
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEecc--CCccchhHHHHHHHHHhcCC-CCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
+..+|.|+-+.||++.. +.+-+|+|.+.. .+.....-|.+|+..|.+++ |.+|+.+++|-..++.+|+|||+- ..
T Consensus 366 lk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~ 444 (677)
T KOG0596|consen 366 LKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DI 444 (677)
T ss_pred HHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cc
Confidence 45789999999999999 567778876543 34555678999999999996 899999999988899999999986 45
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|...|.. .....+...+..++.|++.|+.++|..| |||.||||.|+++ -.|.+||+|||.+.-.......-.
T Consensus 445 DL~kiL~k---~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTsI~ 517 (677)
T KOG0596|consen 445 DLNKILKK---KKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTSIV 517 (677)
T ss_pred cHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEE-EeeeEEeeeechhcccCcccccee
Confidence 99999965 3344444578889999999999999999 9999999999998 457899999999976555444445
Q ss_pred eeeccccccccCCccccCC-----------CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccch
Q 021526 158 STRVMGTYGYCAPEYAMSG-----------KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 226 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~-----------~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
.....||..||+||.+... +.+.++|||||||++|+|+.|++||. .+......+
T Consensus 518 kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~---------------~~~n~~aKl 582 (677)
T KOG0596|consen 518 KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG---------------QIINQIAKL 582 (677)
T ss_pred eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH---------------HHHHHHHHH
Confidence 5668899999999987532 35678999999999999999999996 222234445
Q ss_pred hhhcCccCCCCCcHHHHHH-HHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 227 VHLVDPLLHGRYPRRCLNY-AVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~-l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
..+.++...-+||..-... +.+++..||..||++||++.+|++.
T Consensus 583 ~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 583 HAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 5555554444454433333 9999999999999999999999973
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=263.33 Aligned_cols=260 Identities=21% Similarity=0.222 Sum_probs=195.1
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
...+|.|.+|.||++.. +++.|++|.+..... .....+.+|+.+++.++|||++++++++..+...++|+|++ ++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~ 83 (286)
T cd07832 5 LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PS 83 (286)
T ss_pred EeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CC
Confidence 46789999999999998 789999999876542 23467889999999999999999999999999999999999 99
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|.+++.. ....+++..++.++.|++.+|+|||+.+ ++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 84 ~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~ 156 (286)
T cd07832 84 DLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RL 156 (286)
T ss_pred CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Cc
Confidence 99999865 3367999999999999999999999999 99999999999999999999999998875433221 11
Q ss_pred eeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCcccccc-chhcc----hhhhhcc---cchhh
Q 021526 158 STRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWS----RPFLKDQ---KKFVH 228 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~----~~~~~~~---~~~~~ 228 (311)
.....++..|+|||.+.+. .++.++|+||+|+++++|++|.+||.......... ..... ...+... .....
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK 236 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhc
Confidence 2234578899999988654 46899999999999999999988775433211000 00000 0000000 00000
Q ss_pred hcCccCC----CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 229 LVDPLLH----GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 229 ~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
...+... ..........+.++|.+||..+|.+||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000000 0001234578999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=258.65 Aligned_cols=244 Identities=22% Similarity=0.272 Sum_probs=195.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
...+|+|++|.||++.. +++.||+|.+.... ....+.+.+|+++++.++|+||+++++.+..+...++++||+.++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (257)
T cd08225 5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGG 84 (257)
T ss_pred EEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCC
Confidence 46789999999999999 68999999986542 234467889999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCc-eEEeecCCCccCCCCCCcc
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN-PKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~-vkl~Df~~~~~~~~~~~~~ 156 (311)
+|.+++.. .....+++..+..++.+++.+++|||+.+ ++|+||+|+||++++++. ++|+|||.+...... ..
T Consensus 85 ~L~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~--~~ 157 (257)
T cd08225 85 DLMKRINR--QRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS--ME 157 (257)
T ss_pred cHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC--cc
Confidence 99999965 23346789999999999999999999999 999999999999988864 699999988654322 11
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......++..|+|||.+.+..++.++|+||||+++++|++|..||...... .... ....... .
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~----------~~~~~~~-~ 220 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVL----------KICQGYF-A 220 (257)
T ss_pred cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHH----------HHhcccC-C
Confidence 222345788899999988888999999999999999999999998532211 0000 0011011 1
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..++..+..+.+++.+||..+|++|||+.++++
T Consensus 221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 221 PISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 112344667999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=259.59 Aligned_cols=242 Identities=26% Similarity=0.285 Sum_probs=192.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCC---CCcccceeEEEEeCCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLH---HDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
+..+|.|++|.||++.. +++.|++|.+.... .....++.+|+.+++.++ |||++++++++..+...+++|||+.
T Consensus 6 ~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06917 6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAE 85 (277)
T ss_pred hhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCC
Confidence 35789999999999998 78999999986543 334467888999998886 9999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+++|.+++.. ..+++..++.++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 86 ~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06917 86 GGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-- 155 (277)
T ss_pred CCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--
Confidence 9999999843 37889999999999999999999999 9999999999999999999999999887543322
Q ss_pred ceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccC
Q 021526 156 HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
.......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.......... .......+.+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-------------~~~~~~~~~~ 222 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-------------LIPKSKPPRL 222 (277)
T ss_pred cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-------------ccccCCCCCC
Confidence 11223457788999998765 456889999999999999999999996332211100 0000000111
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.. ...+.++.+++.+||+.+|++||++.++++
T Consensus 223 ~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 223 ED---NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred Cc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 10 114567999999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=262.27 Aligned_cols=241 Identities=24% Similarity=0.262 Sum_probs=187.0
Q ss_pred eeeeceeccEEEEEE--CCeEEEEEEeccCCcc---chhHHHHHHHHH---hcCCCCcccceeEEEEeCCeeEEEEecCC
Q 021526 4 CYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ---GHQEFIVEVLML---SLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~---~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
++|.|+||.||++.. +++.||+|.+...... ....+.+|..++ ...+||+++.+++++..++..++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 479999999999998 6899999988654321 122334444333 34479999999999998899999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+++|.+++.. .+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 9999998843 456999999999999999999999999 9999999999999999999999999986432211
Q ss_pred ceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccC
Q 021526 156 HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
.....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||............. . ....
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~--------------~-~~~~ 214 (279)
T cd05633 152 --PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR--------------M-TLTV 214 (279)
T ss_pred --ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH--------------H-hhcC
Confidence 122357889999998764 567899999999999999999999996443211110000 0 0011
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVVA 270 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~l~~~ 270 (311)
....+...+.++.++|.+||..||++|| +++++++.
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1223455677899999999999999999 59888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=258.42 Aligned_cols=245 Identities=24% Similarity=0.302 Sum_probs=200.0
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
+..+|.|+++.||.+.. +++.+++|.+..... .....+.+|+++++.++|+||+++++++..+...++++|++.++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd08530 5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFG 84 (256)
T ss_pred eeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCC
Confidence 46789999999999987 788999999875432 33457788999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|.+++.........+++..++.++.+++.|+++||+.| ++|+||+|+||+++.++.++|+|||++...... .
T Consensus 85 ~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~----~ 157 (256)
T cd08530 85 DLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN----M 157 (256)
T ss_pred CHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC----C
Confidence 999998664444577899999999999999999999999 999999999999999999999999998754332 2
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCC
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 237 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
.....++..|++||.+.+..++.++|+||||+++++|++|..||...+... ............
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-----------------~~~~~~~~~~~~ 220 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-----------------LRYKVQRGKYPP 220 (256)
T ss_pred cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----------------HHHHHhcCCCCC
Confidence 223457788999999988889999999999999999999999986433210 000000111112
Q ss_pred CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 238 YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.+...+.++.+++.+||..+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 221 IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 234567789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=273.87 Aligned_cols=240 Identities=27% Similarity=0.324 Sum_probs=204.0
Q ss_pred CeeeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 1 MLCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
++..+|.|.|+.|..++. .+..||||.+.+.. +...+.+.+|+++++.++||||++++.+.+....+++||||+.+
T Consensus 60 i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ 139 (596)
T KOG0586|consen 60 IIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASG 139 (596)
T ss_pred eeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccC
Confidence 456899999999999999 89999999987663 34446688999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
+.+.+|+.+ .+.+.+..+...+.|++.|++|+|+++ |+|+|||++|+|++.+-++||+|||++.. .....
T Consensus 140 ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~---~~~~~ 209 (596)
T KOG0586|consen 140 GELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTF---FDYGL 209 (596)
T ss_pred chhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeecccccee---ecccc
Confidence 999999954 556666888999999999999999999 99999999999999999999999999984 33555
Q ss_pred eeeeccccccccCCccccCCCCC-ccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLT-LKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
.....+|.+.|.|||++++..++ ++.|+|++|+++|.|+.|..||+... +.++-...++
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~--------------------lk~Lr~rvl~ 269 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN--------------------LKELRPRVLR 269 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc--------------------cccccchhee
Confidence 66778999999999999987764 89999999999999999999998433 2222222232
Q ss_pred CC--CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 236 GR--YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 236 ~~--~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
+. .+.-.+.+..++|+++|..+|.+|++.+++.+.
T Consensus 270 gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 270 GKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 22 233456668899999999999999999998763
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=263.19 Aligned_cols=241 Identities=22% Similarity=0.269 Sum_probs=193.1
Q ss_pred eeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHHH
Q 021526 4 CYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (311)
.+|.|++|.||.+.. +++.|++|.+..........+.+|+.+++.++|+|++++++.+..+...+++|||+.+++|.+
T Consensus 27 ~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 106 (292)
T cd06657 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD 106 (292)
T ss_pred HcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHH
Confidence 589999999999988 789999999865544555678999999999999999999999999999999999999999999
Q ss_pred HhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeeec
Q 021526 82 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 161 (311)
Q Consensus 82 ~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~~ 161 (311)
++.. ..+++..+..++.|++.++++||+.+ ++|+||+|.||+++.++.++|+|||.+....... ......
T Consensus 107 ~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 176 (292)
T cd06657 107 IVTH-----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSL 176 (292)
T ss_pred HHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--cccccc
Confidence 8732 45788999999999999999999999 9999999999999999999999999876432211 112224
Q ss_pred cccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCcHH
Q 021526 162 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRR 241 (311)
Q Consensus 162 ~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (311)
.++..|++||...+..++.++|+||+|+++|+|++|..||........ .. . ........+. ....
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~~---~-------~~~~~~~~~~--~~~~ 241 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MK---M-------IRDNLPPKLK--NLHK 241 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH---H-------HHhhCCcccC--Cccc
Confidence 567889999988888889999999999999999999999863221100 00 0 0000001110 0123
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 242 CLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 242 ~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.+..+.+++.+||+.+|.+||++.++++
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 4566899999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=260.47 Aligned_cols=242 Identities=25% Similarity=0.318 Sum_probs=192.6
Q ss_pred eeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 5 YLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 5 ~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
+|.|.+|.||.+.. +++.|++|.+..... .....+.+|+++++.++|||++++++.+..+...++++|++.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 58899999999999 589999999865543 3446788999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC-----
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN----- 154 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~----- 154 (311)
.+++.+ ...+++..++.++.|++.+|++||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLEN----VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 999954 237899999999999999999999999 99999999999999999999999998864322211
Q ss_pred -cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 155 -THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 155 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
........++..|++||.......+.++|+||||++++++++|..||........ . .......
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~----------~------~~~~~~~ 217 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI----------F------QNILNGK 217 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH----------H------HHHhcCC
Confidence 0122234567789999998888889999999999999999999999863331100 0 0000000
Q ss_pred CCCCCcHH--HHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 021526 234 LHGRYPRR--CLNYAVAVTAMCLNEEANFRPLINDIVVAL 271 (311)
Q Consensus 234 ~~~~~~~~--~~~~l~~li~~~l~~~p~~RPs~~~l~~~L 271 (311)
...+.. .+..+.+++.+||+.+|++||++.++.+.|
T Consensus 218 --~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 218 --IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred --cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 011112 267799999999999999999995555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=263.57 Aligned_cols=264 Identities=20% Similarity=0.199 Sum_probs=193.1
Q ss_pred eeeeeeceeccEEEEEE----CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeC--CeeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL----CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~----~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 72 (311)
+..+|+|++|.||++.. .++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+. ...++|||
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 84 (316)
T cd07842 5 EGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFD 84 (316)
T ss_pred EEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEe
Confidence 56799999999999999 46999999987643 33446788899999999999999999999887 78999999
Q ss_pred cCCCCCHHHHhcccCCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcC----CCceEEeecCCCc
Q 021526 73 YMPMGSLEDHLYDLEPDQ-EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN----DFNPKLSDFGLAK 147 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~----~~~vkl~Df~~~~ 147 (311)
++.+ ++.+.+....... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. ++.+||+|||++.
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 85 YAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred CCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 9965 7777775433333 47899999999999999999999999 999999999999999 8999999999887
Q ss_pred cCCCCCC-cceeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCccccccc-------hhcchh
Q 021526 148 LGPVGDN-THVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-------VSWSRP 218 (311)
Q Consensus 148 ~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-------~~~~~~ 218 (311)
....... ........++..|+|||.+.+. .++.++|+||||+++++|++|.+||........... ......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence 5322211 1112223567889999987664 578999999999999999999999975443221000 000000
Q ss_pred ----------hhhcccchhhhcCccCCCCCc---------H--HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 219 ----------FLKDQKKFVHLVDPLLHGRYP---------R--RCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 219 ----------~~~~~~~~~~~~~~~~~~~~~---------~--~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
...................++ . .....+.+++.+||+.||++|||+.++++
T Consensus 241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000000000000011111 0 33456899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=262.56 Aligned_cols=259 Identities=22% Similarity=0.240 Sum_probs=192.5
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc--chhHHHHHHHHHhcCCCCcccceeEEEEeC--CeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~ 75 (311)
...+|.|.+|.||++.. +++.+++|.+...... ....+.+|+++++.++||||+++++++..+ ...++++||+.
T Consensus 10 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~ 89 (293)
T cd07843 10 LNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE 89 (293)
T ss_pred hhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC
Confidence 35789999999999999 5889999998654322 223567899999999999999999998777 88999999997
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+ +|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 90 ~-~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-- 160 (293)
T cd07843 90 H-DLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-- 160 (293)
T ss_pred c-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc--
Confidence 4 89988854 2346899999999999999999999999 9999999999999999999999999887543221
Q ss_pred ceeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCccccccc-hh-cc---hhhhhc-------
Q 021526 156 HVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-VS-WS---RPFLKD------- 222 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~-~~---~~~~~~------- 222 (311)
.......++..|+|||.+.+. .++.++|+||||+++++|++|.+||........... .. +. ...+..
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA 240 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence 112223467789999988754 468899999999999999999999864432111000 00 00 000000
Q ss_pred -ccchhhhcCccCCCCCcHH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 223 -QKKFVHLVDPLLHGRYPRR-CLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 223 -~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
...........+...++.. .+..+.++|.+||+.+|++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0001111111112222222 4677899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=261.13 Aligned_cols=244 Identities=25% Similarity=0.281 Sum_probs=205.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
+.+||.|+||.|+++.. +|+.||||.+. ...+.+++.+|+.++++...|+++++|+.|-....+|+|||||..|++
T Consensus 38 ~~KLGEGSYGSV~KAIH~EsG~v~AIK~VP--V~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSi 115 (502)
T KOG0574|consen 38 VGKLGEGSYGSVHKAIHRESGHVLAIKKVP--VDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSI 115 (502)
T ss_pred HHHhcCCcchHHHHHHHhccCcEEEEEecC--ccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcH
Confidence 45789999999999999 89999999974 345678999999999999999999999999899999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
.+.++. +++++.+..+..++...+++|.|||... -+|||||..|||++.+|..||+|||.+...+ +......
T Consensus 116 SDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLT--DTMAKRN 187 (502)
T KOG0574|consen 116 SDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLT--DTMAKRN 187 (502)
T ss_pred HHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhh--hhHHhhC
Confidence 999965 7799999999999999999999999998 9999999999999999999999999986533 2233345
Q ss_pred eccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 160 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
+..||+.|+|||++..-.|+.++||||||++..+|.-|++||..-- ..+..+.-+ .-.-+.+ +.|
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH---------PMRAIFMIP----T~PPPTF--~KP 252 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIH---------PMRAIFMIP----TKPPPTF--KKP 252 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccc---------ccceeEecc----CCCCCCC--CCh
Confidence 5679999999999999999999999999999999999999985110 011111100 0111122 335
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
...+.++.+++++||-.+|++|-|+-.+++.
T Consensus 253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 253 EEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 6778899999999999999999999988874
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=261.68 Aligned_cols=258 Identities=21% Similarity=0.225 Sum_probs=191.7
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
+..+|.|++|.||++.. +++.|+||.+.... ......+.+|+++++.++||||+++++++.++...+++|||+. +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (284)
T cd07860 5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-Q 83 (284)
T ss_pred eeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-c
Confidence 46789999999999988 78999999886443 2233578899999999999999999999999999999999995 5
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|..++.. .....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 84 ~l~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--~~ 156 (284)
T cd07860 84 DLKKFMDA--SPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RT 156 (284)
T ss_pred CHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc--cc
Confidence 89888854 23467899999999999999999999999 9999999999999999999999999886432211 11
Q ss_pred eeeccccccccCCccccCCC-CCccccchhHHHHHHHHHhCCCCccccCccccccchhcchh-------hh---hcccch
Q 021526 158 STRVMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP-------FL---KDQKKF 226 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------~~---~~~~~~ 226 (311)
.....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||........ ....... .+ ......
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhhhhHHHHH
Confidence 22234577899999876644 58899999999999999999999864332110 0000000 00 000000
Q ss_pred hhhcCccCCC---CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 227 VHLVDPLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 227 ~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.......... ...+..+.++.++|.+||+.||++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000 001234567889999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=261.73 Aligned_cols=240 Identities=28% Similarity=0.349 Sum_probs=189.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+..+|+|.+|.||.+.. +++.|++|.+..... ...+.+.+|+++++.++|||++++.+++.++...++|+||+.
T Consensus 20 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~- 98 (307)
T cd06607 20 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL- 98 (307)
T ss_pred heeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-
Confidence 46799999999999998 689999998864432 233568899999999999999999999999999999999996
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
+++.+++.. ....+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 99 g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---- 168 (307)
T cd06607 99 GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---- 168 (307)
T ss_pred CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC----
Confidence 577777743 3356899999999999999999999999 999999999999999999999999988643211
Q ss_pred eeeeccccccccCCcccc---CCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 157 VSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
....++..|+|||.+. ...++.++|+||||+++|+|++|..||......... .......
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~----------------~~~~~~~ 230 (307)
T cd06607 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL----------------YHIAQND 230 (307)
T ss_pred --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH----------------HHHhcCC
Confidence 2234677899999874 356788999999999999999999998532211100 0000000
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.....+..++..+.+++.+||..+|++||++.+++..
T Consensus 231 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 231 SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0001122356779999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=255.05 Aligned_cols=243 Identities=21% Similarity=0.183 Sum_probs=195.4
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccC--CccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
.++|+|.|+.|++-.. .|+.+|+|+++.+ ...+.+.+.+|+.+.+.++||||+++.+.+..+...++|+|+++|++
T Consensus 17 e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~d 96 (355)
T KOG0033|consen 17 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE 96 (355)
T ss_pred HHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchH
Confidence 4689999999998777 7999999988755 34467899999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEc---CCCceEEeecCCCccCCCCCCc
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD---NDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~---~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
|...+.. ...+++..+-.++.||+++|.|+|.++ |+|||++|.|+++- ...-+||+|||++.... ..
T Consensus 97 l~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~---~g 166 (355)
T KOG0033|consen 97 LFEDIVA----REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN---DG 166 (355)
T ss_pred HHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC---Cc
Confidence 9888854 356777788899999999999999999 99999999999993 44569999999998654 22
Q ss_pred ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 156 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
..-.-..|++.|+|||++...+|+..+|||+.|+++|-++.|.+||...++..- ..++.... -- ..
T Consensus 167 ~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl------ye~I~~g~----yd----~~ 232 (355)
T KOG0033|consen 167 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL------YEQIKAGA----YD----YP 232 (355)
T ss_pred cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH------HHHHhccc----cC----CC
Confidence 233345689999999999999999999999999999999999999974322110 00010000 00 00
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..+=+...++..+|+++||..||.+|.|+.|.++
T Consensus 233 ~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 233 SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 1111345778999999999999999999988764
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=253.77 Aligned_cols=242 Identities=27% Similarity=0.327 Sum_probs=197.7
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
...+|+|.+|.+|.+.. .++.|++|.+..... ...+.+.+|+++++.++|||++++++++.++...++++|+++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (254)
T cd06627 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENG 84 (254)
T ss_pred eeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCC
Confidence 46789999999999988 678999999876654 35568899999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|.+++.. ...+++..++.++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 85 ~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 155 (254)
T cd06627 85 SLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--D 155 (254)
T ss_pred cHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc--c
Confidence 99999954 367899999999999999999999999 99999999999999999999999999875433221 1
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCC
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 237 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
.....++..|++||...+..++.++|+|+||+++++|++|..||...... . .... .. ......
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-----~----~~~~-------~~-~~~~~~ 218 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-----A----ALFR-------IV-QDDHPP 218 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-----H----HHHH-------Hh-ccCCCC
Confidence 22345788899999988777889999999999999999999998632210 0 0000 00 001112
Q ss_pred CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 238 YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.+...+..+.+++.+||..+|++||++.+++.
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 23445678999999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=266.58 Aligned_cols=238 Identities=25% Similarity=0.312 Sum_probs=199.7
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
+++|+|+||.|+--.. .|+.+|+|.+.+++. .......+|.++|..++.++|+.+--.|++.+.+|+|+..|+||
T Consensus 191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG 270 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG 270 (591)
T ss_pred EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence 6899999999997776 899999999887643 34567889999999999999999988899999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|.-+|+. ..++.|++..+..++.+|+.+|.+||+.+ ||+||+||+|||+|+.|+|+|+|+|++...... ..
T Consensus 271 DLkfHiyn--~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g---~~ 342 (591)
T KOG0986|consen 271 DLKFHIYN--HGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG---KP 342 (591)
T ss_pred ceeEEeec--cCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC---Cc
Confidence 99999976 44578999999999999999999999999 999999999999999999999999999754332 23
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCC
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 237 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
.....||..|||||++++..|+...|.|+|||++|+|+.|+.||......... +.+.. ........
T Consensus 343 ~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~-------------eEvdr-r~~~~~~e 408 (591)
T KOG0986|consen 343 IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR-------------EEVDR-RTLEDPEE 408 (591)
T ss_pred cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH-------------HHHHH-HHhcchhh
Confidence 33347999999999999999999999999999999999999999633322111 00000 01112235
Q ss_pred CcHHHHHHHHHHHHHhhccCCCCCC
Q 021526 238 YPRRCLNYAVAVTAMCLNEEANFRP 262 (311)
Q Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~RP 262 (311)
|+...+++..++++..|..||++|-
T Consensus 409 y~~kFS~eakslc~~LL~Kdp~~RL 433 (591)
T KOG0986|consen 409 YSDKFSEEAKSLCEGLLTKDPEKRL 433 (591)
T ss_pred cccccCHHHHHHHHHHHccCHHHhc
Confidence 6778899999999999999999996
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=261.84 Aligned_cols=250 Identities=23% Similarity=0.279 Sum_probs=190.1
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc-cchhHHHHHHHHHhcCC-CCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
.+.+|.|++|.||.+.. +++.||+|.+..... .....+.+|+.++..+. |+||+++++++..+...+++||++. +
T Consensus 9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~ 87 (288)
T cd06616 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-I 87 (288)
T ss_pred HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-C
Confidence 35789999999999998 689999999875432 33457888999998886 9999999999988889999999985 4
Q ss_pred CHHHHhccc-CCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 78 SLEDHLYDL-EPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 78 ~L~~~l~~~-~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~-~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
++.++.... ......+++..+..++.+++.||+|||+. + ++|+||+|+||+++.++.++|+|||++.......
T Consensus 88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 162 (288)
T cd06616 88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI-- 162 (288)
T ss_pred CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccCC--
Confidence 655543221 12346799999999999999999999975 7 9999999999999999999999999986432211
Q ss_pred ceeeeccccccccCCccccCC---CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCc
Q 021526 156 HVSTRVMGTYGYCAPEYAMSG---KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 232 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~---~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
......++..|+|||.+.+. .++.++|+||||+++|+|++|..||..... .......... ...+
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~-------~~~~ 229 (288)
T cd06616 163 -AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK-------GDPP 229 (288)
T ss_pred -ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC-------CCCC
Confidence 11223477889999988765 688999999999999999999999864321 0000000000 0001
Q ss_pred cCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 233 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.+....+..++..+.+++.+||+.+|++|||+++|++.
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11112223467789999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=277.40 Aligned_cols=244 Identities=22% Similarity=0.286 Sum_probs=199.3
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
-.||-|+||+||++.. .+-.-|-|++........++|.-|+++|....||+|+++++.|..++.+|++.|||.||-+.
T Consensus 38 GELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVD 117 (1187)
T KOG0579|consen 38 GELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVD 117 (1187)
T ss_pred hhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHh
Confidence 4689999999999999 44556778887777777889999999999999999999999999999999999999999888
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
..+-. -+..+.+..+.-++.|++.||.|||+++ |+|+|+|..|||++-+|.++|+|||.+.. ..........
T Consensus 118 aimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAK--n~~t~qkRDs 189 (1187)
T KOG0579|consen 118 AIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAK--NKSTRQKRDS 189 (1187)
T ss_pred HHHHH---hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeeccccccc--chhHHhhhcc
Confidence 87744 5678999999999999999999999999 99999999999999999999999998864 2333334455
Q ss_pred ccccccccCCccccC-----CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 161 VMGTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
..||+.|||||+.+. .+|+.++||||||+++.+|..+.+|...... ++..+. +..---+.+
T Consensus 190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp---------MRVllK----iaKSePPTL- 255 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP---------MRVLLK----IAKSEPPTL- 255 (1187)
T ss_pred ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch---------HHHHHH----HhhcCCCcc-
Confidence 779999999998764 5789999999999999999999998642111 101100 000001111
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
--|..++..+.+|+.+||..||..||++.++++
T Consensus 256 -lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 256 -LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred -cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 114467888999999999999999999999987
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=262.68 Aligned_cols=261 Identities=19% Similarity=0.216 Sum_probs=191.2
Q ss_pred eeeceeccEEEEEECCeEEEEEEeccC--CccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHHHH
Q 021526 5 YLSCKFYNVGLVWLCDQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDH 82 (311)
Q Consensus 5 ~~~g~~~~v~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 82 (311)
+|.|+++.++++..+++.||+|.+... .......+.+|+++++.++|+||+++++++..+...+++|||+.+++|.++
T Consensus 10 ~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~ 89 (314)
T cd08216 10 FEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDL 89 (314)
T ss_pred hcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHH
Confidence 344566667776668999999998755 234456899999999999999999999999999999999999999999999
Q ss_pred hcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc-----ce
Q 021526 83 LYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT-----HV 157 (311)
Q Consensus 83 l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~-----~~ 157 (311)
+... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+||+.+......... ..
T Consensus 90 l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (314)
T cd08216 90 LKTH--FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164 (314)
T ss_pred HHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccc
Confidence 9652 3456889999999999999999999999 999999999999999999999999987643221111 11
Q ss_pred eeeccccccccCCccccC--CCCCccccchhHHHHHHHHHhCCCCccccCccccc------cchhcch--hhhhcccchh
Q 021526 158 STRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ------NLVSWSR--PFLKDQKKFV 227 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~------~~~~~~~--~~~~~~~~~~ 227 (311)
.....++..|+|||.+.. ..++.++|+||+|+++|+|++|..||......... ....+.. ..........
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (314)
T cd08216 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMS 244 (314)
T ss_pred cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcC
Confidence 122345678999998865 35788999999999999999999999643211000 0000000 0000000000
Q ss_pred h--------hcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 228 H--------LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 228 ~--------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
. .........+.......+.+++.+||+.||++|||++++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0 000011112233456789999999999999999999999973
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=262.57 Aligned_cols=268 Identities=29% Similarity=0.360 Sum_probs=205.5
Q ss_pred CeeeeeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhc--CCCCcccceeEEEEeCC----eeEEEEecC
Q 021526 1 MLCCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSL--LHHDNLVTLIGYCTSGD----QRLLVYEYM 74 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~----~~~lv~e~~ 74 (311)
|+.++|+|+||.||+|.+.++.||||+|. ..+++.+.+|.++++. ++|+||+++++.-.... .++||++|.
T Consensus 214 l~eli~~Grfg~V~KaqL~~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh 290 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLDNRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH 290 (534)
T ss_pred hHHHhhcCccceeehhhccCceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence 46688999999999999999999999997 4456788888888865 47999999998865444 789999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC------CCCeeecCCCCCcEEEcCCCceEEeecCCCcc
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA------NPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 148 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~------~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~ 148 (311)
+.|+|.+|| ....++|.....++..++.||+|||+.- +++|+|||||.+||||.+++...|+|||++.+
T Consensus 291 ~kGsL~dyL-----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 291 PKGSLCDYL-----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred cCCcHHHHH-----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 999999999 4578999999999999999999999632 57799999999999999999999999999988
Q ss_pred CCCCCCcceeeeccccccccCCccccCCC-C-----CccccchhHHHHHHHHHhCCCCccccCccccccc----------
Q 021526 149 GPVGDNTHVSTRVMGTYGYCAPEYAMSGK-L-----TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL---------- 212 (311)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~-----~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---------- 212 (311)
...+..........||.+|||||++.+.. + -.+.||||+|.++|||++...-++........-.
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 77666655555578999999999988752 2 2478999999999999996654432111100000
Q ss_pred hhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCC
Q 021526 213 VSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 280 (311)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~ 280 (311)
.+-++...-..+....+.+.-.. .....-+.+.++.||+.||+-|-|+.=+.+.+.++......
T Consensus 446 ~e~mq~~VV~kK~RP~~p~~W~~----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 446 LEEMQELVVRKKQRPKIPDAWRK----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred HHHHHHHHHhhccCCCChhhhhc----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 00011111111111111111111 12355689999999999999999999999999999887766
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=277.46 Aligned_cols=241 Identities=21% Similarity=0.281 Sum_probs=187.0
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEecc----CCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCe--eEEEEecC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNH----EGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ--RLLVYEYM 74 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~lv~e~~ 74 (311)
.++|+|+|.+||+|.. .|..||=-.++. ..+...+.+..|+.+|+.|+||||++++++|.+... ..+|+|.+
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 4789999999999999 555555322211 234556789999999999999999999999987665 78999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCC-CceEEeecCCCccCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-FNPKLSDFGLAKLGPVGD 153 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~-~~vkl~Df~~~~~~~~~~ 153 (311)
..|+|..|+.+ -+.+....+..|+.||++||.|||++ .++|+|||||-+||||+++ |.|||+|+|+++......
T Consensus 126 TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 126 TSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred cCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 99999999954 45677788999999999999999999 6789999999999999765 789999999998643221
Q ss_pred CcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 154 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 154 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
-....||+.|||||++. ..|+...||||||++++||+|+..||.-.... .+..+... ...
T Consensus 201 ----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~-----AQIYKKV~----------SGi 260 (632)
T KOG0584|consen 201 ----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP-----AQIYKKVT----------SGI 260 (632)
T ss_pred ----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH-----HHHHHHHH----------cCC
Confidence 12256999999999775 88999999999999999999999999633321 00000000 000
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
....+..--.+++++||.+||.. .++|||+.|+++
T Consensus 261 KP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 261 KPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred CHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 00000111145689999999999 999999999987
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=257.96 Aligned_cols=259 Identities=22% Similarity=0.229 Sum_probs=188.5
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccc-hhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQG-HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
+..+|.|.+|.||.+.. +++.|++|.+....... ...+.+|+++++.++|+||+++++++..+...++++|++. ++
T Consensus 10 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~ 88 (291)
T cd07870 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TD 88 (291)
T ss_pred EEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CC
Confidence 56799999999999987 68999999986553322 3467889999999999999999999999999999999995 67
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
+.+++.. ....+.+..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 89 l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~ 160 (291)
T cd07870 89 LAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS--QTY 160 (291)
T ss_pred HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC--CCC
Confidence 7777643 3356778888999999999999999999 9999999999999999999999999886432211 111
Q ss_pred eeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcc------hhhhhcccchhhhcC
Q 021526 159 TRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS------RPFLKDQKKFVHLVD 231 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~ 231 (311)
....++..|+|||.+.+. .++.++|+||||+++|+|++|..||.......+.....+. ...+...........
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP 240 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence 223467889999988754 5788999999999999999999999643321110000000 000000000000000
Q ss_pred ccCCC----CC-----cHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 232 PLLHG----RY-----PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 232 ~~~~~----~~-----~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..... .. .......+.+++.+||..||++|||+.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000 00 0012456889999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=260.94 Aligned_cols=245 Identities=27% Similarity=0.342 Sum_probs=192.1
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+..+|+|+||.||++.. ++..|++|.+..... .....+.+|+++++.++|||++++++++.++...+++|||+.+
T Consensus 30 ~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g 109 (317)
T cd06635 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG 109 (317)
T ss_pred hheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC
Confidence 35689999999999998 789999999864422 2335788899999999999999999999999999999999964
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++.+.+.. ....+++..+..++.+++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 110 -~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----- 177 (317)
T cd06635 110 -SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP----- 177 (317)
T ss_pred -CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence 77777743 3456899999999999999999999999 99999999999999999999999998764321
Q ss_pred eeeeccccccccCCcccc---CCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 157 VSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
.....++..|+|||.+. ...++.++|+||||+++|+|++|..||........ ........
T Consensus 178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~----------------~~~~~~~~ 240 (317)
T cd06635 178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----------------LYHIAQNE 240 (317)
T ss_pred -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH----------------HHHHHhcc
Confidence 12235778899999873 45678999999999999999999999853211000 00000000
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 275 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~ 275 (311)
.........+..+.+++.+||+.+|.+||++.++++.+-.+.
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 241 SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 000112235667999999999999999999999998654433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=257.39 Aligned_cols=256 Identities=20% Similarity=0.184 Sum_probs=187.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc-cchhHHHHHHHHHhcCC-CCcccceeEEEEeC--CeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSG--DQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e~~~ 75 (311)
+..+|.|.+|.||++.. +++.||+|.+..... .......+|+..+..+. |+|++++++++.++ +..++++||+.
T Consensus 4 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (282)
T cd07831 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD 83 (282)
T ss_pred EeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC
Confidence 46789999999999998 789999999865422 22234557888888885 99999999999877 88999999996
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
++|.+.+.. ....+++..++.++.|++.||++||+.+ ++|+||+|+||+++. +.++|+|||++........
T Consensus 84 -~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 84 -MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred -ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 588888754 3357899999999999999999999999 999999999999999 9999999999875322211
Q ss_pred ceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCcccccc-chhcc-------hhhhhcccch
Q 021526 156 HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWS-------RPFLKDQKKF 226 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~-------~~~~~~~~~~ 226 (311)
.....++..|+|||.+.. ..++.++|+||||+++|+|++|..||...+...... ..... ........ .
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 231 (282)
T cd07831 155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR-H 231 (282)
T ss_pred --cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc-c
Confidence 112346788999997654 557889999999999999999999996543211100 00000 00000000 0
Q ss_pred hhhcCccCCC----CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 227 VHLVDPLLHG----RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 227 ~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.....+.... ......+..+.++|.+||..+|++||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000000000 001235788999999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=259.98 Aligned_cols=262 Identities=19% Similarity=0.166 Sum_probs=189.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCC-CCcccceeEEEEeCCe-----eEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQ-----RLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~-----~~lv~ 71 (311)
.+.+|.|.+|.||++.. +++.||+|.+..... .....+.+|+.+++.++ ||||+++++++..... .+++|
T Consensus 6 ~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~ 85 (295)
T cd07837 6 LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF 85 (295)
T ss_pred eeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEe
Confidence 56899999999999998 689999998765432 23357888999999995 6999999999876655 79999
Q ss_pred ecCCCCCHHHHhcccCCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcC-CCceEEeecCCCccC
Q 021526 72 EYMPMGSLEDHLYDLEPD-QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-DFNPKLSDFGLAKLG 149 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~-~~~vkl~Df~~~~~~ 149 (311)
||+++ +|.+++...... ...+++..++.++.||+.||.|||+.+ ++|+||+|+||+++. ++.++|+|||.+...
T Consensus 86 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~ 161 (295)
T cd07837 86 EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161 (295)
T ss_pred eccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecccceec
Confidence 99975 898888653322 456899999999999999999999999 999999999999998 889999999988643
Q ss_pred CCCCCcceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCcccccc-chhcc----hhhhhcc
Q 021526 150 PVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWS----RPFLKDQ 223 (311)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~----~~~~~~~ 223 (311)
..... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.......... +.... ...+...
T Consensus 162 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 162 SIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred CCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 22211 1112245778999998765 457899999999999999999999986433211100 00000 0000000
Q ss_pred cchhhhc-CccCC----CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 224 KKFVHLV-DPLLH----GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 224 ~~~~~~~-~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
....... .+... ....+..+..+.++|.+||..||.+||++.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000 00000 0011235677999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=257.85 Aligned_cols=260 Identities=20% Similarity=0.187 Sum_probs=192.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
+..+|.|.+|.||++.. +|+.|++|.+..... .....+.+|+++++.++|||++++++++.++...++++||++ +
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~ 82 (283)
T cd07835 4 VEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-L 82 (283)
T ss_pred heEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-c
Confidence 56899999999999998 799999999875432 233568889999999999999999999999999999999995 6
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|.+++... ....+++..++.++.|++.+|+|||+.+ ++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 83 ~l~~~~~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~ 155 (283)
T cd07835 83 DLKKYMDSS--PLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--RT 155 (283)
T ss_pred CHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--cc
Confidence 899988542 2247899999999999999999999999 9999999999999999999999999986432211 11
Q ss_pred eeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCccccc-cchhcch----hhhhcccchhhhcC
Q 021526 158 STRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLVSWSR----PFLKDQKKFVHLVD 231 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~----~~~~~~~~~~~~~~ 231 (311)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|..||......... ....... ..+.......+...
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 1222457789999987654 5688999999999999999999998643321110 0000000 00000000000000
Q ss_pred c------cCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 232 P------LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 232 ~------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
. ..........+..+.++|.+||+.+|++||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 0000112234567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=256.56 Aligned_cols=240 Identities=23% Similarity=0.252 Sum_probs=186.1
Q ss_pred eeeeceeccEEEEEE--CCeEEEEEEeccCCccc---hhHHHHHHH---HHhcCCCCcccceeEEEEeCCeeEEEEecCC
Q 021526 4 CYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQG---HQEFIVEVL---MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~---~~~~~~e~~---~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
++|.|+||.||.+.. +++.||+|.+....... ...+..|.. .+....||+|+++++++..+...++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 479999999999988 68899999987653221 122333433 3445579999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+++|.+++. ..+.+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--- 150 (278)
T cd05606 81 GGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--- 150 (278)
T ss_pred CCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc---
Confidence 999999884 3457999999999999999999999999 999999999999999999999999988643211
Q ss_pred ceeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccC
Q 021526 156 HVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
......|+..|+|||.+.+. .++.++|+||+|+++|+|++|..||............ .. ....
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~--------------~~-~~~~ 214 (278)
T cd05606 151 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--------------RM-TLTM 214 (278)
T ss_pred -CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH--------------HH-hhcc
Confidence 11234578899999998754 6889999999999999999999999643221110000 00 0001
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 269 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~l~~ 269 (311)
....+...+..+.+++.+||..+|.+|| ++.++++
T Consensus 215 ~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 215 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1122334567899999999999999999 9999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=263.60 Aligned_cols=269 Identities=21% Similarity=0.228 Sum_probs=195.1
Q ss_pred eeeec--eeccEEEEEE--CCeEEEEEEeccCCcc--chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 4 CYLSC--KFYNVGLVWL--CDQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 4 ~~~~g--~~~~v~~~~~--~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
.+|.| +++.||.+.. .++.||+|.+...... ..+.+.+|+.+++.++||||+++++++..+...++++|++.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 45666 8889999988 7999999998754322 3367888999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC-cc
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN-TH 156 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~-~~ 156 (311)
++.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++++||+.......... ..
T Consensus 85 ~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 85 SANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 9999986532 346889999999999999999999999 99999999999999999999999975432111110 00
Q ss_pred e----eeeccccccccCCccccCC--CCCccccchhHHHHHHHHHhCCCCccccCccccc-cc------hhcchhhh---
Q 021526 157 V----STRVMGTYGYCAPEYAMSG--KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NL------VSWSRPFL--- 220 (311)
Q Consensus 157 ~----~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~------~~~~~~~~--- 220 (311)
. .....++..|++||++.+. .++.++|+|||||++|+|++|..||......... .. ..+.....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 0 0112245679999998763 4789999999999999999999999643211000 00 00000000
Q ss_pred ----hc---------------ccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHhhhc
Q 021526 221 ----KD---------------QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV--ALDYLVSQ 277 (311)
Q Consensus 221 ----~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~--~L~~l~~~ 277 (311)
.. ...........+....+..++..+.+++.+||+.||++|||+.++++ .+..+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 00 00000111111222223456788999999999999999999999987 45665554
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=260.53 Aligned_cols=259 Identities=22% Similarity=0.227 Sum_probs=188.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc--chhHHHHHHHHHhcCCCCcccceeEEEEeC--CeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~ 75 (311)
++.+|.|++|.||++.. +++.||+|.+...... ....+.+|+.+++.++|+|++++++++... ...++|||++.
T Consensus 12 ~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 91 (309)
T cd07845 12 LNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE 91 (309)
T ss_pred eeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC
Confidence 56899999999999998 6899999998654322 223567899999999999999999998654 46899999996
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+ +|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 92 ~-~l~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~-- 162 (309)
T cd07845 92 Q-DLASLLDN---MPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-- 162 (309)
T ss_pred C-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCcc--
Confidence 4 88888864 2367899999999999999999999999 9999999999999999999999999987543221
Q ss_pred ceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCcccccc-chhcc----hhhhhcccch---
Q 021526 156 HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWS----RPFLKDQKKF--- 226 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~----~~~~~~~~~~--- 226 (311)
.......++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||...+...... +.... ...+......
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07845 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV 242 (309)
T ss_pred CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence 11112234678999998765 467899999999999999999999996433211100 00000 0000000000
Q ss_pred h--hhcCccCC--CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 227 V--HLVDPLLH--GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 227 ~--~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
. ........ .......+..+.++|.+||+.||++|||+++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 00000000 0000123667889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=254.20 Aligned_cols=242 Identities=23% Similarity=0.208 Sum_probs=186.5
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCccc---hhHHHHHHHHH-hcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQG---HQEFIVEVLML-SLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~---~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
..+|.|.+|.||++.. +++.||+|.+....... ...+..|..++ ...+|+|++++++++..++..++++||+.+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5689999999999998 68999999986543222 12334454443 455899999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999943 456889999999999999999999999 99999999999999999999999998864221
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
.....++..|++||.+.+..++.++|+||||+++|+|++|..||....... ......... .....
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~--------~~~~~ 214 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA------VFDNILSRR--------INWPE 214 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhcc--------cCCCC
Confidence 223346788999999888788999999999999999999999996332110 000000000 00011
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 271 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L 271 (311)
.....++..+.+++.+||+.+|++||++.++.+.|
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 11224567899999999999999999776554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=264.43 Aligned_cols=256 Identities=23% Similarity=0.257 Sum_probs=190.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccC--CccchhHHHHHHHHHhcCCCCcccceeEEEEeC------CeeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG------DQRLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~ 71 (311)
+..+|+|++|.||.+.. .++.||+|.+... .......+.+|+.+++.++||||+++++++... ...++||
T Consensus 21 ~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 100 (353)
T cd07850 21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVM 100 (353)
T ss_pred EEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEE
Confidence 46789999999999998 7899999998643 233445677899999999999999999987543 3569999
Q ss_pred ecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCC
Q 021526 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 151 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~ 151 (311)
|++. ++|.+.+.. .++...+..++.|++.||++||+.| ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 101 e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 101 ELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred eccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 9995 488888743 2888899999999999999999999 99999999999999999999999999875322
Q ss_pred CCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCcccccc-c--------hhc-------
Q 021526 152 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-L--------VSW------- 215 (311)
Q Consensus 152 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~--------~~~------- 215 (311)
. .......++..|+|||.+.+..++.++|+||||+++++|++|..||...+...... + ..+
T Consensus 171 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T cd07850 171 S---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT 247 (353)
T ss_pred C---CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh
Confidence 1 11222346788999999999899999999999999999999999996443211000 0 000
Q ss_pred chhhhhcc-----cchhhhcCc----cCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 216 SRPFLKDQ-----KKFVHLVDP----LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 216 ~~~~~~~~-----~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
........ ..+.+.... ......+...+..+.++|.+||+.||++|||+.++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 000011100 00001122346678999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=257.33 Aligned_cols=240 Identities=27% Similarity=0.330 Sum_probs=189.0
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+..+|.|++|.||++.. +++.|++|.+..... .....+.+|+++++.++|||++++++++.++...+++|||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL- 104 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence 35689999999999998 789999999865432 233567889999999999999999999999999999999995
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
+++.+++.. ....+++..++.++.|++.+++|||+.| ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 105 ~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----- 173 (313)
T cd06633 105 GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP----- 173 (313)
T ss_pred CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence 578777743 3456889999999999999999999999 99999999999999999999999998753211
Q ss_pred eeeeccccccccCCcccc---CCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 157 VSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
.....++..|+|||.+. ...++.++|+||||+++|+|++|..||.......... .. ....
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~------~~----------~~~~ 236 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HI----------AQND 236 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH------HH----------HhcC
Confidence 12345778899999874 4567889999999999999999999985332111100 00 0000
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.........+..+.+++.+||+.+|.+||++.+++..
T Consensus 237 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 237 SPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001112345568999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=251.59 Aligned_cols=244 Identities=23% Similarity=0.261 Sum_probs=191.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC-----ccchhHHHHHHHHHhcCCCCcccceeEEEEeC--CeeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG-----LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 72 (311)
..++|+|++|.||.+.. +++.|++|.+.... ......+.+|+++++.++|+||+++++.+.+. ...++++|
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (264)
T cd06653 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVE 86 (264)
T ss_pred eeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEE
Confidence 46799999999999998 68999999875321 22335788999999999999999999988654 45789999
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCC
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~ 152 (311)
++.+++|.+++.. ...+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 87 YMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred eCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 9999999999843 345888999999999999999999999 999999999999999999999999998743221
Q ss_pred CC-cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcC
Q 021526 153 DN-THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231 (311)
Q Consensus 153 ~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
.. ........++..|+|||.+.+..++.++|+||||+++++|++|..||...... ........
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~~~ 223 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM----------------AAIFKIAT 223 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH----------------HHHHHHHc
Confidence 11 11112234788899999998888899999999999999999999998522110 01111111
Q ss_pred ccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.......+......+.+++.+||. +|..||++.+++.
T Consensus 224 ~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 224 QPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 111223455667889999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=256.86 Aligned_cols=260 Identities=23% Similarity=0.244 Sum_probs=192.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeC--CeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~ 75 (311)
+..+|.|++|.||++.. +++.+++|.+.... ......+.+|+++++.++|||++++++++... ...++++||+.
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (287)
T cd07840 4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD 83 (287)
T ss_pred eEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc
Confidence 46789999999999998 57999999987653 33345788999999999999999999999887 78999999996
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+ +|.+++.. ....+++..++.++.|++.||++||+.+ ++|+||+|+||++++++.++|+|||.+.........
T Consensus 84 ~-~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 84 H-DLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred c-cHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 4 88888854 2357899999999999999999999999 999999999999999999999999998754332211
Q ss_pred ceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCcccccc-chhcc----hhhhhcccch---
Q 021526 156 HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWS----RPFLKDQKKF--- 226 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~----~~~~~~~~~~--- 226 (311)
......++..|+|||.+.+ ..++.++|+|+||+++|+|++|..||.......... +.... ...+......
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 157 -DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred -cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence 1122345778999997764 467899999999999999999999986443211100 00000 0000000000
Q ss_pred -----hhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 227 -----VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 227 -----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.......+...+...++..+.+++++||..+|++||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000000011113677999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=255.63 Aligned_cols=261 Identities=20% Similarity=0.255 Sum_probs=193.5
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
+..+|.|.+|.||++.. +++.||+|.+..... .....+.+|+++++.++||||+++++++.+++..+++||++.+ +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~ 83 (284)
T cd07836 5 LEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-D 83 (284)
T ss_pred eeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-c
Confidence 46789999999999999 689999999876533 2345778899999999999999999999999999999999975 8
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++...... ....
T Consensus 84 l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~--~~~~ 157 (284)
T cd07836 84 LKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIP--VNTF 157 (284)
T ss_pred HHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCC--cccc
Confidence 888885422 2356899999999999999999999999 999999999999999999999999988643221 1111
Q ss_pred eeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCcccccc-chhc----chhhhhcccchhhhcCc
Q 021526 159 TRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSW----SRPFLKDQKKFVHLVDP 232 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~ 232 (311)
....++..|++||.+.+. .++.++|+|+||+++|+|++|..||.......... .... ....+............
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence 223467789999987654 56889999999999999999999986443211100 0000 00000000000000000
Q ss_pred cC------CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 233 LL------HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 233 ~~------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.. .....+..+..+.+++.+||+.+|.+||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 00111234677899999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=271.36 Aligned_cols=265 Identities=26% Similarity=0.284 Sum_probs=200.7
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccC-CccchhHHHHHHHHHhcCCCCcccceeEEEEeCC------eeEEEEec
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD------QRLLVYEY 73 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~ 73 (311)
..+|+|+||.||+++. .|+.||||.++.. .....+...+|++++++++|+||++++++=++.. .-.++|||
T Consensus 19 e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEy 98 (732)
T KOG4250|consen 19 ERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEY 98 (732)
T ss_pred hhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEee
Confidence 5789999999999997 8999999998765 3556688999999999999999999998854433 34799999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEc----CCCceEEeecCCCccC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD----NDFNPKLSDFGLAKLG 149 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~----~~~~vkl~Df~~~~~~ 149 (311)
|.||+|...+.+.. ....+++..++.++.++..|+.|||.+| |+||||||.||++- +.-..||+|||.++-.
T Consensus 99 C~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 99 CSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred cCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 99999999997643 4567999999999999999999999999 99999999999993 2234799999999853
Q ss_pred CCCCCcceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcch-----------
Q 021526 150 PVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR----------- 217 (311)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----------- 217 (311)
+.........||..|++||++.. ..|+...|.|||||++|+++||..||....++.......|..
T Consensus 175 ---~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~ 251 (732)
T KOG4250|consen 175 ---DDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG 251 (732)
T ss_pred ---CCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence 33335566789999999999985 788999999999999999999999997665543211111110
Q ss_pred --hhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCC--CHHHHHHHHHHhhh
Q 021526 218 --PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP--LINDIVVALDYLVS 276 (311)
Q Consensus 218 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP--s~~~l~~~L~~l~~ 276 (311)
.....+..+...+ |. ....+......+...+..+|+.+|.+|. .+.+.-..++.|..
T Consensus 252 ~~~~eNgpv~~s~~l-P~-p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 252 AQEEENGPVEWSSTL-PQ-PNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred eecccCCceeeeccC-CC-cccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 0000011111111 11 1112233445567778889999999998 66666666655554
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=254.13 Aligned_cols=241 Identities=27% Similarity=0.302 Sum_probs=204.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccch---hHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
|.+||+|.||+|-..+. .++.+|+|+++++..-.. .....|-++|+..+||++..+.-.|.....+|+||||.+|
T Consensus 173 LKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanG 252 (516)
T KOG0690|consen 173 LKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANG 252 (516)
T ss_pred HHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccC
Confidence 56899999999999888 899999999988754333 4566788999999999999998889999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
|.|.-++ .+...+++.+...+-..|+.||.|||+++ |+++|+|.+|+|+|.+|.+||.|||++.. ......
T Consensus 253 GeLf~HL----srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE--~I~~g~ 323 (516)
T KOG0690|consen 253 GELFFHL----SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKE--EIKYGD 323 (516)
T ss_pred ceEeeeh----hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchh--cccccc
Confidence 9999998 45678999999999999999999999999 99999999999999999999999999975 233445
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
...+.+||+.|+|||++....|..+.|.|.+|+++|+|++|+.||.-.+ ...+.+++... .-
T Consensus 324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d-----------------h~kLFeLIl~e-d~ 385 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD-----------------HEKLFELILME-DL 385 (516)
T ss_pred eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc-----------------hhHHHHHHHhh-hc
Confidence 5677899999999999999999999999999999999999999995222 33333333211 12
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 269 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~l~~ 269 (311)
++|...+++...|+.-.|..||.+|- .+.||.+
T Consensus 386 kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 386 KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 56778888899999999999999995 4555544
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=255.02 Aligned_cols=259 Identities=20% Similarity=0.202 Sum_probs=194.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc--chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
...+|.|.+|.||++.. +++.+++|.+...... ....+.+|+++++.++|+||+++++++..+...++++||+.+
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~- 82 (283)
T cd05118 4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT- 82 (283)
T ss_pred ceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-
Confidence 35789999999999998 7899999998655332 346788899999999999999999999999999999999965
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|.+++.. ....+++..++.++.|++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 83 ~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~ 154 (283)
T cd05118 83 DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP 154 (283)
T ss_pred CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence 88888854 3367899999999999999999999999 9999999999999999999999999886543322 11
Q ss_pred eeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCccccccc-hh-cch---hhhhcccch-----
Q 021526 158 STRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-VS-WSR---PFLKDQKKF----- 226 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~-~~~---~~~~~~~~~----- 226 (311)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+....... .. ... ..+......
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 2223467789999988776 788999999999999999999999864332111000 00 000 000000000
Q ss_pred hhhcC--ccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 227 VHLVD--PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 227 ~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..... ...........+.++.++|.+||+.||.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000 00000112345778999999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=257.88 Aligned_cols=261 Identities=25% Similarity=0.264 Sum_probs=186.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc--chhHHHHHHHHHhcCCCCcccceeEEEEeCC--------eeEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD--------QRLL 69 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~~~l 69 (311)
...+|.|++|.||++.. +++.||+|.+...... ....+.+|+++++.++||||+++++++.... ..++
T Consensus 17 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l 96 (310)
T cd07865 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYL 96 (310)
T ss_pred EEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEE
Confidence 46899999999999998 7899999988654322 2345678999999999999999999876543 4599
Q ss_pred EEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccC
Q 021526 70 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 149 (311)
Q Consensus 70 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~ 149 (311)
+||++. ++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 97 v~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 97 VFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred EEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 999995 488888743 3457899999999999999999999999 999999999999999999999999998653
Q ss_pred CCCCCc--ceeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcch-----hhhh
Q 021526 150 PVGDNT--HVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR-----PFLK 221 (311)
Q Consensus 150 ~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~ 221 (311)
...... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||................ ..+.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP 249 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 222111 111223457789999987654 46889999999999999999999986543221111000000 0000
Q ss_pred cccc---hhhhcCccC-CCCC-----cHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 222 DQKK---FVHLVDPLL-HGRY-----PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 222 ~~~~---~~~~~~~~~-~~~~-----~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.... ......+.. .... +......+.++|.+||..||.+|||++++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000 000000000 0000 0012345789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=250.82 Aligned_cols=235 Identities=29% Similarity=0.333 Sum_probs=191.1
Q ss_pred eeeceeccEEEEEE--CCeEEEEEEeccCCcc---chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 5 YLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 5 ~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
+|+|.+|.||.+.. +++.+++|.+...... ....+.+|+++++.++|||++++++.+..+...+++||++.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 58999999999998 5899999998765432 345788999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
.+++.. ...+++..++.++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~ 151 (250)
T cd05123 81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTN 151 (250)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--Cccc
Confidence 999954 346899999999999999999999999 9999999999999999999999999986532221 1223
Q ss_pred eccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 160 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
...++..|++||...+...+.++|+|+||+++|++++|..||...+.. . .. ..... .....+
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~----~~------~~~~~--~~~~~~ 213 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK------E----IY------EKILK--DPLRFP 213 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------H----HH------HHHhc--CCCCCC
Confidence 345678899999998888899999999999999999999999633320 0 00 00000 111233
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHH
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLIND 266 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~ 266 (311)
...+..+.+++.+||..||++||++.+
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 344677899999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=261.33 Aligned_cols=263 Identities=22% Similarity=0.258 Sum_probs=193.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccC--CccchhHHHHHHHHHhcCCCCcccceeEEEEeC-----CeeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG-----DQRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e 72 (311)
+..+|.|++|.||.+.. .++.||+|.+... .......+.+|+.+++.++|+||+++++++... ...++++|
T Consensus 10 ~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e 89 (337)
T cd07858 10 IKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE 89 (337)
T ss_pred EEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEe
Confidence 56899999999999998 6899999988653 233445678899999999999999999887543 34799999
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCC
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~ 152 (311)
|+. ++|.+++. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 90 ~~~-~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 90 LMD-TDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred CCC-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 995 68888884 3467999999999999999999999999 999999999999999999999999998754322
Q ss_pred CCcceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCccccccchh-cch----hhh--hccc
Q 021526 153 DNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS-WSR----PFL--KDQK 224 (311)
Q Consensus 153 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~----~~~--~~~~ 224 (311)
. .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+......... ... ..+ ....
T Consensus 162 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 162 G--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239 (337)
T ss_pred c--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence 1 11222346788999998765 468899999999999999999999996433211000000 000 000 0000
Q ss_pred chhhh---cCccCC---CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHHh
Q 021526 225 KFVHL---VDPLLH---GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA--LDYL 274 (311)
Q Consensus 225 ~~~~~---~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~--L~~l 274 (311)
...+. ...... ....+.++..+.+++.+||+.+|++|||++++++. +..+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00000 000000 00112456778999999999999999999999986 5544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=252.89 Aligned_cols=264 Identities=23% Similarity=0.269 Sum_probs=198.3
Q ss_pred CeeeeeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcC--CCCcccceeEEEEeC----CeeEEEEecC
Q 021526 1 MLCCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLL--HHDNLVTLIGYCTSG----DQRLLVYEYM 74 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~----~~~~lv~e~~ 74 (311)
|...+|+|.||+|++|.+.|+.||||+|.. .+.+.+.+|.++++.+ +|+||+.+++.-..+ ..+|||++|.
T Consensus 215 L~e~IGkGRyGEVwrG~wrGe~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYH 291 (513)
T KOG2052|consen 215 LQEIIGKGRFGEVWRGRWRGEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYH 291 (513)
T ss_pred EEEEecCccccceeeccccCCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecc
Confidence 567899999999999999999999999973 3456788999999764 899999999874322 3579999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHh-----hCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH-----CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 149 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh-----~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~ 149 (311)
+.|+|.|||. ..+++.+..++++..+++||++|| .+|++.|.|||||.+||||.+++.+.|+|+|++-..
T Consensus 292 e~GSL~DyL~-----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h 366 (513)
T KOG2052|consen 292 EHGSLYDYLN-----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 366 (513)
T ss_pred cCCcHHHHHh-----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEe
Confidence 9999999994 478999999999999999999999 467889999999999999999999999999998654
Q ss_pred CCC-CCcc-eeeeccccccccCCccccCCC------CCccccchhHHHHHHHHHhC----------CCCccccCcccccc
Q 021526 150 PVG-DNTH-VSTRVMGTYGYCAPEYAMSGK------LTLKSDIYSFGVVLLELITG----------RKAMDLSKGQGEQN 211 (311)
Q Consensus 150 ~~~-~~~~-~~~~~~~~~~~~aPE~~~~~~------~~~~~Dv~slG~~l~~l~~g----------~~p~~~~~~~~~~~ 211 (311)
... +... ......||-+|||||++...- .-..+||||||+++||++-. +.||...-+... +
T Consensus 367 ~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP-s 445 (513)
T KOG2052|consen 367 DSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP-S 445 (513)
T ss_pred cccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC-C
Confidence 332 1111 123467999999999987642 13479999999999999762 334421111000 0
Q ss_pred chhcchhhhhcccchhhhcCccCCCC-CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 021526 212 LVSWSRPFLKDQKKFVHLVDPLLHGR-YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 279 (311)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~ 279 (311)
.. .+.+..-. +.+.|..... .+......+.++++.||..||.-|-|+=-+.+.|.++....+
T Consensus 446 ~e-----eMrkVVCv-~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~e 508 (513)
T KOG2052|consen 446 FE-----EMRKVVCV-QKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSDE 508 (513)
T ss_pred HH-----HHhcceee-cccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChh
Confidence 00 00000000 0111111111 234567789999999999999999999999999999886443
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=256.40 Aligned_cols=241 Identities=27% Similarity=0.329 Sum_probs=189.0
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+..+|.|++|.||.+.. +++.|++|.+..... ....++.+|+++++.++|+|++++++++..+...++|+||+.
T Consensus 20 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~- 98 (308)
T cd06634 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL- 98 (308)
T ss_pred HHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-
Confidence 35689999999999998 788999998864322 233567889999999999999999999999999999999996
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
+++.+.+.. ....+++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 99 ~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----- 167 (308)
T cd06634 99 GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167 (308)
T ss_pred CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC-----
Confidence 588777743 3456889999999999999999999999 99999999999999999999999998764321
Q ss_pred eeeeccccccccCCcccc---CCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 157 VSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
.....++..|+|||.+. ...++.++|+||||+++|+|++|..||........ . .......
T Consensus 168 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~----------~~~~~~~ 230 (308)
T cd06634 168 -ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------L----------YHIAQNE 230 (308)
T ss_pred -cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH------H----------HHHhhcC
Confidence 12234678899999874 34678899999999999999999999853211100 0 0000000
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 271 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L 271 (311)
.....+...+..+.++|.+||..+|++||+++++++..
T Consensus 231 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 231 SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred CCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 00011234567799999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=260.90 Aligned_cols=271 Identities=25% Similarity=0.269 Sum_probs=200.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeCC-----eeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD-----QRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e 72 (311)
...+|.|.+|.||++.. +++.|++|.+.... ....+.+.+|+++++.++||||+++++++.... ..+++|+
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e 84 (330)
T cd07834 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTE 84 (330)
T ss_pred eeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEec
Confidence 46799999999999998 58999999987543 334567889999999999999999999987765 7899999
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCC
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~ 152 (311)
++. ++|.+++.. ...+++..++.++.+++.||++||+.| ++|+||+|.||+++.++.++|+|||.+......
T Consensus 85 ~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 85 LME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred chh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 996 488888843 448999999999999999999999999 999999999999999999999999998754332
Q ss_pred CCc-ceeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCcccccc-chhcc----hhhh--hcc
Q 021526 153 DNT-HVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWS----RPFL--KDQ 223 (311)
Q Consensus 153 ~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~----~~~~--~~~ 223 (311)
... .......++..|+|||.+.+. .++.++|+||||+++++|++|.+||.......... +.... ...+ ...
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 210 112223467889999999887 78999999999999999999999996443211000 00000 0000 000
Q ss_pred cchhhhcCccC------CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHHhhhccCC
Q 021526 224 KKFVHLVDPLL------HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA--LDYLVSQRDS 280 (311)
Q Consensus 224 ~~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~--L~~l~~~~~~ 280 (311)
......+.... .....+..+..+.++|.+||+.+|.+||+++++++. |+.+......
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~ 301 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDE 301 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccC
Confidence 00000000000 000112346779999999999999999999999984 6665554333
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=256.40 Aligned_cols=243 Identities=25% Similarity=0.305 Sum_probs=196.1
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHHHHHhcCC-CCcccceeEEEEeCCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
...+|+|++|.||++.. +++.|++|++..... .....+.+|+++++.++ ||||+++++++.++...+++||++.
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd05581 6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP 85 (280)
T ss_pred eeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCC
Confidence 45789999999999998 789999999865322 23457888999999998 9999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+++|.+++.. ...+++..++.++.|++.+|++||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 86 ~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 86 NGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 9999999954 347999999999999999999999999 999999999999999999999999988754322210
Q ss_pred ------------------ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcch
Q 021526 156 ------------------HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR 217 (311)
Q Consensus 156 ------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 217 (311)
.......++..|++||......++.++|+|+||++++++++|..||........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------- 230 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT-------- 230 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH--------
Confidence 112223467889999998888889999999999999999999999863331000
Q ss_pred hhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCH----HHHHH
Q 021526 218 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI----NDIVV 269 (311)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~----~~l~~ 269 (311)
+.... ......+...+..+.+++.+||+.+|++||++ +++++
T Consensus 231 --------~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 --------FQKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --------HHHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 00000 11112334457779999999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=293.36 Aligned_cols=243 Identities=26% Similarity=0.295 Sum_probs=195.9
Q ss_pred eeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 4 CYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
.+|.|.||.||.++. +|...|+|-+.... ....+.+.+|..++..++|||+++++++=.+.+..+|+||||++|+|
T Consensus 1242 ~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsL 1321 (1509)
T KOG4645|consen 1242 FIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSL 1321 (1509)
T ss_pred ccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcH
Confidence 578999999999999 89999999776543 34447889999999999999999999998888999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc--ce
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT--HV 157 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~--~~ 157 (311)
.+.+ ..+...++.....+..|++.|++|||..| |||+||||.||+++.+|.+|++|||.+......... ..
T Consensus 1322 a~ll----~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1322 ASLL----EHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred HHHH----HhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence 9999 45666777777889999999999999999 999999999999999999999999998764333111 11
Q ss_pred eeeccccccccCCccccCCC---CCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccC
Q 021526 158 STRVMGTYGYCAPEYAMSGK---LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~---~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
-....||+.|||||++.+.. -..++|||||||++.||+||+.||.-.+. +|...+ .+...-
T Consensus 1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy---------~V~~gh 1458 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMY---------HVAAGH 1458 (1509)
T ss_pred HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHh---------HHhccC
Confidence 12356999999999998754 45789999999999999999999852221 111111 111111
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.-..|...+.+-.++|++||+.||++|.++.++++
T Consensus 1459 ~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1459 KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 11235567888999999999999999999987765
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=250.23 Aligned_cols=233 Identities=23% Similarity=0.290 Sum_probs=181.9
Q ss_pred eeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhc-CCCCcccceeEEEEeCCeeEEEEecCCCCCHHH
Q 021526 5 YLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSL-LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81 (311)
Q Consensus 5 ~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (311)
+|.|.||.||.+.. ++..+++|.+........ |...... .+|||++++++.+..+...++||||+.+++|.+
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~ 98 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD 98 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence 59999999999998 788999999865432211 2222222 279999999999999999999999999999999
Q ss_pred HhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCC-ceEEeecCCCccCCCCCCcceeee
Q 021526 82 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-NPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 82 ~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~-~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
++.. ...+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++ .++|+|||.+...... ..
T Consensus 99 ~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------~~ 165 (267)
T PHA03390 99 LLKK----EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------SC 165 (267)
T ss_pred HHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC------cc
Confidence 9954 348899999999999999999999999 99999999999999988 9999999988643211 12
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCcH
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPR 240 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (311)
..++..|+|||.+.+..++.++|+||+|+++|+|++|..||....... .....+. ..... ....+.
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~-----------~~~~~--~~~~~~ 231 (267)
T PHA03390 166 YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLL-----------KRQQK--KLPFIK 231 (267)
T ss_pred CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHH-----------Hhhcc--cCCccc
Confidence 347889999999988889999999999999999999999997332211 1111110 00000 011223
Q ss_pred HHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 021526 241 RCLNYAVAVTAMCLNEEANFRPL-INDIVV 269 (311)
Q Consensus 241 ~~~~~l~~li~~~l~~~p~~RPs-~~~l~~ 269 (311)
..+..+.++|.+||+.+|.+||+ ++++++
T Consensus 232 ~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 232 NVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 56778999999999999999996 688874
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=254.84 Aligned_cols=260 Identities=20% Similarity=0.206 Sum_probs=189.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
+..+|.|.+|.||++.. +++.|++|.+..... .....+.+|+++++.++||||+++++++..+...++||||++ +
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 85 (294)
T PLN00009 7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-L 85 (294)
T ss_pred EEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-c
Confidence 56789999999999998 688999998865432 233568899999999999999999999999999999999995 5
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcC-CCceEEeecCCCccCCCCCCcc
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-DFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~-~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
+|.+++.. .....+++..++.++.|++.||+|||+++ ++|+||+|+||+++. ++.+||+|||++...... ..
T Consensus 86 ~l~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~--~~ 158 (294)
T PLN00009 86 DLKKHMDS--SPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP--VR 158 (294)
T ss_pred cHHHHHHh--CCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC--cc
Confidence 88888744 23344678888999999999999999999 999999999999985 557999999998643221 11
Q ss_pred eeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCcccccc-chhc----chhhhhcccchhhhc
Q 021526 157 VSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSW----SRPFLKDQKKFVHLV 230 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~ 230 (311)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.......... .... ....+.....+....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 1122346788999998765 457899999999999999999999996443211100 0000 000000000000000
Q ss_pred C--ccCCC----CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 231 D--PLLHG----RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 231 ~--~~~~~----~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
. +.... ...+..+..+.+++.+||+.+|++||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00000 011234667899999999999999999999986
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=261.80 Aligned_cols=261 Identities=21% Similarity=0.246 Sum_probs=191.1
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEE----eCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCT----SGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~lv~e~ 73 (311)
...+|.|++|.||.+.. +++.|++|.+.... ......+.+|+.+++.++||||+++++++. .....++++||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 89 (334)
T cd07855 10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDL 89 (334)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEeh
Confidence 45789999999999998 68999999987543 234467788999999999999999998875 33567999999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 153 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~ 153 (311)
+. ++|.+++. ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 90 ~~-~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 90 ME-SDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred hh-hhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 95 58988884 3456999999999999999999999999 9999999999999999999999999986533222
Q ss_pred Cc--ceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcc-----hhhhh--cc
Q 021526 154 NT--HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS-----RPFLK--DQ 223 (311)
Q Consensus 154 ~~--~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~--~~ 223 (311)
.. .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+........... ...+. ..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~ 241 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence 11 11123457888999998765 46789999999999999999999999643321100000000 00000 00
Q ss_pred cchhhhcCcc-CCCC-----CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 224 KKFVHLVDPL-LHGR-----YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 224 ~~~~~~~~~~-~~~~-----~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.......... .... ..+..+..+.++|.+||+.+|++||++.+++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000000 0000 112346789999999999999999999998873
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=289.29 Aligned_cols=257 Identities=28% Similarity=0.446 Sum_probs=197.6
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
.++|+|+||.||+|.. ++..||+|.+..... ....|++.+++++||||+++++++.++...++||||+++++|.
T Consensus 696 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~ 771 (968)
T PLN00113 696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLS 771 (968)
T ss_pred cEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHH
Confidence 4689999999999997 789999998864322 2234688899999999999999999999999999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++. .+++..+..++.+++.|++|||....++++|+||||+||+++.++..++. ++....... ...
T Consensus 772 ~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~ 837 (968)
T PLN00113 772 EVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTK 837 (968)
T ss_pred HHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCC
Confidence 9993 37889999999999999999994422339999999999999988887765 544332111 112
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCC--C
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR--Y 238 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 238 (311)
..++..|+|||.+.+..++.++||||||+++|||++|+.||+..... ......|.+.... ........++.+... .
T Consensus 838 ~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 915 (968)
T PLN00113 838 CFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYS-DCHLDMWIDPSIRGDVSV 915 (968)
T ss_pred ccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcC-ccchhheeCccccCCCCc
Confidence 24678999999999889999999999999999999999998543221 2233334332221 122333444444322 3
Q ss_pred cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 021526 239 PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 279 (311)
Q Consensus 239 ~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~ 279 (311)
+.....++.+++.+||+.+|++||++.++++.|+++.+..+
T Consensus 916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 34566778899999999999999999999999998766433
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=250.91 Aligned_cols=259 Identities=20% Similarity=0.219 Sum_probs=188.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc--chhHHHHHHHHHhcC---CCCcccceeEEEEeCCe-----eEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLL---HHDNLVTLIGYCTSGDQ-----RLL 69 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~-----~~l 69 (311)
...+|.|.+|.||++.. +++.||+|.+...... ....+.+|+.+++.+ +|||++++++++..... .++
T Consensus 4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l 83 (287)
T cd07838 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL 83 (287)
T ss_pred EEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEE
Confidence 46789999999999999 5899999998754322 224566777766555 69999999999887766 899
Q ss_pred EEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccC
Q 021526 70 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 149 (311)
Q Consensus 70 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~ 149 (311)
+||++.+ +|.+++... ....+++..++.++.|++.||++||+.+ ++|+||+|+||+++.++.++|+|||.+...
T Consensus 84 ~~e~~~~-~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 84 VFEHVDQ-DLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred Eehhccc-CHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcceec
Confidence 9999964 898888552 2346899999999999999999999999 999999999999999999999999988654
Q ss_pred CCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCcccccc-chhcc----hhhhhccc
Q 021526 150 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWS----RPFLKDQK 224 (311)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~----~~~~~~~~ 224 (311)
..... .....++..|+|||.+.+..++.++|+||||+++|+|++|.+||.......... +.... ...+....
T Consensus 158 ~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 158 SFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred cCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 32211 122346778999999988889999999999999999999999986433211000 00000 00000000
Q ss_pred c-hhhhcCccCC---CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 225 K-FVHLVDPLLH---GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 225 ~-~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
. .......... .......+..+.++|.+||+.||++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 0000000000 1111244677899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=260.91 Aligned_cols=261 Identities=21% Similarity=0.251 Sum_probs=189.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeC-----CeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG-----DQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~ 73 (311)
..++|.|++|.||.+.. +++.||+|.+.... ......+.+|+.+++.++||||+++++++... ...++++|+
T Consensus 10 ~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 89 (336)
T cd07849 10 LSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQEL 89 (336)
T ss_pred EEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehh
Confidence 46899999999999988 78999999986432 23445688899999999999999999876543 357999999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 153 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~ 153 (311)
+. ++|.+.+. ...+++..++.++.|++.||++||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 90 ~~-~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 90 ME-TDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred cc-cCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 96 48887773 356899999999999999999999999 9999999999999999999999999886532211
Q ss_pred Cc-ceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhc--ccchhhh
Q 021526 154 NT-HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD--QKKFVHL 229 (311)
Q Consensus 154 ~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 229 (311)
.. .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||......... ......... ...+..+
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL---NLILGVLGTPSQEDLNCI 237 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCCHHHHHHh
Confidence 11 11122457888999997654 56889999999999999999999999643221100 000000000 0000000
Q ss_pred cCc---------cCCCC-----CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHHh
Q 021526 230 VDP---------LLHGR-----YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA--LDYL 274 (311)
Q Consensus 230 ~~~---------~~~~~-----~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~--L~~l 274 (311)
... ..... ..+..+..+.+++.+||+.+|++||++.++++. +...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 000 00000 011235678999999999999999999999875 4443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=242.83 Aligned_cols=245 Identities=27% Similarity=0.351 Sum_probs=190.5
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCC-CCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
-.+|.|..|.|.+.+. .|.-.|||.+.... .++.+++.+.+.++..-+ +|+|++.+++|..+...++.||.+. ..
T Consensus 98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~C 176 (391)
T KOG0983|consen 98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-TC 176 (391)
T ss_pred HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-HH
Confidence 4689999999999999 67999999876553 345567777777765554 8999999999999999999999873 24
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
+..++.. ..+++++..+-++...+++||.||..+. +|+|||+||.|||+|+.|++||+|||.+-+.. .....
T Consensus 177 ~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlv---dSkAh 248 (391)
T KOG0983|consen 177 AEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLV---DSKAH 248 (391)
T ss_pred HHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceee---ccccc
Confidence 4444433 4567999999999999999999998654 39999999999999999999999999987432 23334
Q ss_pred eeccccccccCCccccC---CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 159 TRVMGTYGYCAPEYAMS---GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
....|-+.|+|||.+.. ..|+.++||||||++++||.||+.||...+.+-+. .. .+.+-.-+.+.
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~--lt----------kvln~ePP~L~ 316 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV--LT----------KVLNEEPPLLP 316 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH--HH----------HHHhcCCCCCC
Confidence 45678899999998874 47899999999999999999999999865543221 10 00000112222
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
. ....+..+.+++..||+.|+.+||.+.++++.
T Consensus 317 ~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 317 G--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred c--ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1 12367789999999999999999999999874
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=253.61 Aligned_cols=250 Identities=26% Similarity=0.287 Sum_probs=194.1
Q ss_pred eeeeeeceeccEEEEEE-----CCeEEEEEEeccCC----ccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL-----CDQLVAIKQLNHEG----LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-----~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 71 (311)
...+|.|++|.||.+.. .++.||+|.+.... ....+.+.+|++++..+ +||+|+++++.+..+...++||
T Consensus 5 ~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 84 (288)
T cd05583 5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLIL 84 (288)
T ss_pred EEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEE
Confidence 56799999999999885 46789999986432 22335678899999999 5999999999999999999999
Q ss_pred ecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCC
Q 021526 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 151 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~ 151 (311)
||+.+++|.+++.. ...+++..+..++.|++.+|.+||+.+ ++|+||+|.||+++.++.++|+|||++.....
T Consensus 85 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 85 DYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred ecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 99999999999843 456888999999999999999999999 99999999999999999999999998865322
Q ss_pred CCCcceeeeccccccccCCccccCCC--CCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhh
Q 021526 152 GDNTHVSTRVMGTYGYCAPEYAMSGK--LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 229 (311)
Q Consensus 152 ~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
... .......++..|++||...+.. .+.++|+||||+++++|++|..||........ ..........
T Consensus 158 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~-------- 226 (288)
T cd05583 158 EEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILK-------- 226 (288)
T ss_pred ccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHc--------
Confidence 211 1112235788999999887654 68899999999999999999999863321110 0000000000
Q ss_pred cCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 021526 230 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 273 (311)
Q Consensus 230 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~ 273 (311)
.....+...+..+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 227 ----~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 227 ----SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ----cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0112233456778999999999999999999888776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=273.34 Aligned_cols=264 Identities=19% Similarity=0.200 Sum_probs=180.6
Q ss_pred eeeeeeceeccEEEEEE---CCeEEEEE--------------Eecc---CCccchhHHHHHHHHHhcCCCCcccceeEEE
Q 021526 2 LCCYLSCKFYNVGLVWL---CDQLVAIK--------------QLNH---EGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC 61 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~---~~~~vaiK--------------~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 61 (311)
+..+|+|+||.||.+.. .+..+++| .+.+ ........+.+|+++++.++||||+++++++
T Consensus 153 i~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 232 (501)
T PHA03210 153 IDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEIL 232 (501)
T ss_pred EeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEeEEE
Confidence 57899999999998765 12222222 1111 1112334678999999999999999999999
Q ss_pred EeCCeeEEEEecCCCCCHHHHhcccCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEE
Q 021526 62 TSGDQRLLVYEYMPMGSLEDHLYDLEP-DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 140 (311)
Q Consensus 62 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl 140 (311)
..+...+++++++. ++|.+++..... .........+..++.|++.||.|||+++ |+|+||||+|||++.++.+||
T Consensus 233 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~~~~vkL 308 (501)
T PHA03210 233 RSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVL 308 (501)
T ss_pred EECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence 99999999999984 577777643221 1223345667889999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCC-CccccCccccccchhcchh-
Q 021526 141 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK-AMDLSKGQGEQNLVSWSRP- 218 (311)
Q Consensus 141 ~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~-p~~~~~~~~~~~~~~~~~~- 218 (311)
+|||++....... ........|+..|+|||++.+..++.++|||||||++|+|++|.. |+..........+......
T Consensus 309 ~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~ 387 (501)
T PHA03210 309 GDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSL 387 (501)
T ss_pred EeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhc
Confidence 9999987542211 112223568999999999999899999999999999999999875 4432222111111110000
Q ss_pred ------hhhcccchhhhcCccC----CCCCc-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 219 ------FLKDQKKFVHLVDPLL----HGRYP-----RRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 219 ------~~~~~~~~~~~~~~~~----~~~~~-----~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
+......+.+.+.... ....+ ...+..+.++|.+||+.||++|||+.|+++.
T Consensus 388 ~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 388 SVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred ccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000000011110000 00000 1134567888999999999999999999873
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=258.80 Aligned_cols=259 Identities=21% Similarity=0.223 Sum_probs=189.5
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCccc--------------hhHHHHHHHHHhcCCCCcccceeEEEEeCCe
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQG--------------HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 66 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 66 (311)
..+|.|++|.||++.. .++.||+|.+....... ...+.+|+++++.++|+||+++++++..+..
T Consensus 15 ~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 94 (335)
T PTZ00024 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDF 94 (335)
T ss_pred hcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCc
Confidence 4689999999999997 78999999886542221 1247789999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCC
Q 021526 67 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 146 (311)
Q Consensus 67 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~ 146 (311)
.+++||++. ++|.+++. ....+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+
T Consensus 95 ~~lv~e~~~-~~l~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 95 INLVMDIMA-SDLKKVVD----RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred EEEEEeccc-cCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCccce
Confidence 999999996 58999884 3456899999999999999999999999 999999999999999999999999988
Q ss_pred ccCCCCCC------------cceeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCcccccc-c
Q 021526 147 KLGPVGDN------------THVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-L 212 (311)
Q Consensus 147 ~~~~~~~~------------~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~ 212 (311)
........ ........++..|+|||.+.+. .++.++|+||||+++|+|++|..||.......... +
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i 246 (335)
T PTZ00024 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI 246 (335)
T ss_pred eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 65431110 0111123357789999988764 46889999999999999999999996443211100 0
Q ss_pred hhcch----hhhhcccchhh--hcCccCCC---CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 213 VSWSR----PFLKDQKKFVH--LVDPLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 213 ~~~~~----~~~~~~~~~~~--~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..... ..+........ ........ ......+..+.+++.+||+.+|++||++++++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 247 FELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 00000 00000000000 00000000 001234567899999999999999999999985
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=258.12 Aligned_cols=260 Identities=24% Similarity=0.270 Sum_probs=189.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccC--CccchhHHHHHHHHHhcC-CCCcccceeEEEEe--CCeeEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHE--GLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTS--GDQRLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~e~~ 74 (311)
...+|.|.+|.||++.. +++.|++|.+... .......+.+|+.+++.+ +||||+++++++.. ....++|||++
T Consensus 12 ~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~ 91 (337)
T cd07852 12 LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM 91 (337)
T ss_pred hHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEeccc
Confidence 35789999999999998 6899999987543 233445677899999999 99999999998754 34689999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
. ++|.+++.. ..+.+..++.++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||.+........
T Consensus 92 ~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 92 E-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred c-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 6 599988843 27788889999999999999999999 99999999999999999999999998875433221
Q ss_pred c---ceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCccccccc-hhcch----hhhh--cc
Q 021526 155 T---HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-VSWSR----PFLK--DQ 223 (311)
Q Consensus 155 ~---~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~----~~~~--~~ 223 (311)
. .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||........... ..... ..+. ..
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07852 163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS 242 (337)
T ss_pred cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence 1 12223357888999998765 4578899999999999999999999864332111000 00000 0000 00
Q ss_pred cchhhhcCccCC------CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 224 KKFVHLVDPLLH------GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 224 ~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
............ ....+.++.++.++|.+||+.+|++|||+.++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000000 00111256789999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=252.43 Aligned_cols=245 Identities=25% Similarity=0.343 Sum_probs=186.2
Q ss_pred eeeeeeceeccEEEEEEC--CeEEEEEEeccCCc-cchhHHHHHHHHHhcCC-CCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWLC--DQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~--~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
...+|.|.+|.||++... ++.||+|.+..... .....+.+|+.++.... ||||+++++++..+...+++||++. +
T Consensus 20 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~ 98 (296)
T cd06618 20 LGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-T 98 (296)
T ss_pred eeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-c
Confidence 467999999999999994 99999999875432 23355667777666664 9999999999999999999999984 4
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++.+.+.. ....+++..+..++.+++.+++|||+ .+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 99 ~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~--- 169 (296)
T cd06618 99 CLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK--- 169 (296)
T ss_pred CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCC---
Confidence 77777644 23478899999999999999999997 57 9999999999999999999999999886432211
Q ss_pred eeeeccccccccCCccccCCC----CCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCc
Q 021526 157 VSTRVMGTYGYCAPEYAMSGK----LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 232 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~----~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||........ ......... .+
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----~~~~~~~~~-------~~ 237 (296)
T cd06618 170 AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE-----VLTKILQEE-------PP 237 (296)
T ss_pred cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH-----HHHHHhcCC-------CC
Confidence 112234677899999887543 78899999999999999999999863221100 000000000 00
Q ss_pred cCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 233 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.. .....++.++.+++.+||..+|++||+++++++.
T Consensus 238 ~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 238 SL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 0011345679999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=251.18 Aligned_cols=246 Identities=26% Similarity=0.299 Sum_probs=191.3
Q ss_pred eeeeeeceeccEEEEEE-----CCeEEEEEEeccCC----ccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL-----CDQLVAIKQLNHEG----LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-----~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 71 (311)
...+|.|.+|.||.+.. +|+.||+|.+.... ....+.+.+|+++++.+ +|++|+++++.+..+...++++
T Consensus 5 ~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (290)
T cd05613 5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLIL 84 (290)
T ss_pred eeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEE
Confidence 56899999999999987 57899999986532 22345678899999999 5899999999999999999999
Q ss_pred ecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCC
Q 021526 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 151 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~ 151 (311)
|++.+++|.+++.. ...+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 85 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 85 DYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 99999999999953 456888999999999999999999999 99999999999999999999999998864322
Q ss_pred CCCcceeeeccccccccCCccccCC--CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhh
Q 021526 152 GDNTHVSTRVMGTYGYCAPEYAMSG--KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 229 (311)
Q Consensus 152 ~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
.. ........++..|++||.+.+. .++.++|+||||+++|+|++|..||........ ..........
T Consensus 158 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~-------- 226 (290)
T cd05613 158 DE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILK-------- 226 (290)
T ss_pred cc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhc--------
Confidence 11 1112234578889999988653 467899999999999999999999863221110 0000000000
Q ss_pred cCccCCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 021526 230 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 269 (311)
Q Consensus 230 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~l~~ 269 (311)
....++..+...+.+++.+||..+|++|| ++++++.
T Consensus 227 ----~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 227 ----SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ----cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 01123344567899999999999999997 7777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=250.65 Aligned_cols=259 Identities=24% Similarity=0.233 Sum_probs=190.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc-cchhHHHHHHHHHhcCC-CCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
...+|.|++|.||+|.. +++.|+||.+..... .......+|+..++.++ |||++++++++..+...+++||++ ++
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 82 (283)
T cd07830 4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EG 82 (283)
T ss_pred heeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CC
Confidence 45789999999999999 678999999865432 22234567899999998 999999999999999999999999 77
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|.+++.. ..+..+++..+..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 83 ~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~---~ 154 (283)
T cd07830 83 NLYQLMKD--RKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---P 154 (283)
T ss_pred CHHHHHHh--cccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC---C
Confidence 99988855 22357899999999999999999999999 9999999999999999999999999986432211 1
Q ss_pred eeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCccccccc-hhc----chhhhhcccchhhhcC
Q 021526 158 STRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-VSW----SRPFLKDQKKFVHLVD 231 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~ 231 (311)
.....++..|+|||.+.. ..++.++|+||||+++++|++|.+||........... ... ....+...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 122346778999998754 4678999999999999999999999864432211100 000 0000000000000000
Q ss_pred ccCC-------CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 232 PLLH-------GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 232 ~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.... ..........+.++|++||+.+|++||+++|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000 0001122567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=249.73 Aligned_cols=245 Identities=24% Similarity=0.246 Sum_probs=191.1
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC-----ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG-----LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
...+|.|++|.||++.. .+..+++|.+.... .....++..|+.+++.++||||+++++++.+....++++||+
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (260)
T cd08222 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYC 84 (260)
T ss_pred eeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeC
Confidence 46799999999999988 34556666654321 223346778999999999999999999998888999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
.+++|.+++.........+++..++.++.|++.|+.+||+.+ ++|+||+|+||+++. +.++|+|||.+......
T Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~-- 158 (260)
T cd08222 85 EGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS-- 158 (260)
T ss_pred CCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCCC--
Confidence 999999998765455678999999999999999999999999 999999999999975 56999999988643221
Q ss_pred cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccC
Q 021526 155 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
........++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ...... ... ..
T Consensus 159 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~----------~~~-~~ 221 (260)
T cd08222 159 CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLR----------IVE-GP 221 (260)
T ss_pred cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHH----------HHc-CC
Confidence 1122234567889999998888888999999999999999999999852211 000000 000 00
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
....+..++..+.++|.+||..+|++||++.++++
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11123456778999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=252.34 Aligned_cols=259 Identities=24% Similarity=0.232 Sum_probs=188.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeCC----------ee
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD----------QR 67 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----------~~ 67 (311)
...+|.|.+|.||++.. .++.|++|.+..... .....+.+|+++++.++|||++++++++.+.. ..
T Consensus 12 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 91 (302)
T cd07864 12 IGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAF 91 (302)
T ss_pred eeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcE
Confidence 45789999999999999 689999999875432 23356778999999999999999999886554 78
Q ss_pred EEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 68 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 68 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
++++|++++ ++.+.+.. ....+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.
T Consensus 92 ~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~ 164 (302)
T cd07864 92 YLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLAR 164 (302)
T ss_pred EEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCcccccc
Confidence 999999976 77777744 3457899999999999999999999999 9999999999999999999999999887
Q ss_pred cCCCCCCcceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCccccccc-hhcc----hhhhh
Q 021526 148 LGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-VSWS----RPFLK 221 (311)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~----~~~~~ 221 (311)
....... .......++..|++||.+.+ ..++.++|+||||+++++|++|++||........... .... ...+.
T Consensus 165 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (302)
T cd07864 165 LYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWP 243 (302)
T ss_pred cccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence 5432221 11112234668999998765 3568899999999999999999999964332111000 0000 00000
Q ss_pred cccchhhh--------cCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 222 DQKKFVHL--------VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 222 ~~~~~~~~--------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
........ .....+.. ....+..+.+++.+||+.+|++||++.+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 244 DVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred cccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000000 00000000 1123667999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=250.66 Aligned_cols=258 Identities=24% Similarity=0.250 Sum_probs=193.1
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
...+|.|.+|.||.+.. +++.|++|.+.... ....+.+.+|+++++.++|+|++++++++.+....++++|++. +
T Consensus 4 ~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~ 82 (282)
T cd07829 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-M 82 (282)
T ss_pred ehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-c
Confidence 45789999999999999 58999999987653 3344678889999999999999999999999899999999997 5
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|.+++.. ....+++..++.++.+++.+|++||+.+ ++|+||+|+||++++++.++|+|||.+........ .
T Consensus 83 ~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~ 154 (282)
T cd07829 83 DLKKYLDK---RPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T 154 (282)
T ss_pred CHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence 89999964 2257999999999999999999999999 99999999999999999999999998865322211 1
Q ss_pred eeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCcccccc-chhc----chhhhhcccch-----
Q 021526 158 STRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSW----SRPFLKDQKKF----- 226 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~----~~~~~~~~~~~----- 226 (311)
.....++..|+|||.+.+. .++.++|+||||+++++|++|.+||.......... .... ....+......
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 1223346679999988766 78899999999999999999999986443211100 0000 00000000000
Q ss_pred --hhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 227 --VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 227 --~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
............ +..+..+.++|++||..+|++||++++++.
T Consensus 235 ~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 235 TFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000000001 123567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=254.08 Aligned_cols=251 Identities=25% Similarity=0.315 Sum_probs=195.2
Q ss_pred CeeeeeeceeccEEEEEE--CCeEEEEEEeccCC------cc-chhHHHHHHHHHhcCCCCcccceeEEEE-eCCeeEEE
Q 021526 1 MLCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG------LQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCT-SGDQRLLV 70 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~------~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv 70 (311)
||.+||+|+|+.||+++. .++.||+|+-.... .. -.+...+|+.+-+.|.||.|+++|++|. +....|-|
T Consensus 467 lLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTV 546 (775)
T KOG1151|consen 467 LLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTV 546 (775)
T ss_pred HHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceee
Confidence 578999999999999999 89999999854331 11 1246789999999999999999999986 44567899
Q ss_pred EecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE---cCCCceEEeecCCCc
Q 021526 71 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAK 147 (311)
Q Consensus 71 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~---~~~~~vkl~Df~~~~ 147 (311)
+|||+|-+|.-|+ ...+.+++..+..++.||+.||.||... +++|+|-|+||.|||+ +..|.+||.|||++.
T Consensus 547 LEYceGNDLDFYL----KQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 547 LEYCEGNDLDFYL----KQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred eeecCCCchhHHH----HhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 9999999999999 4677899999999999999999999988 6779999999999999 345779999999998
Q ss_pred cCCCCCCcc-----eeeeccccccccCCccccCC----CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchh
Q 021526 148 LGPVGDNTH-----VSTRVMGTYGYCAPEYAMSG----KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP 218 (311)
Q Consensus 148 ~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~----~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 218 (311)
+........ ......||.+|++||.+.-+ +++.+.||||+|+++|+++.|+.||.....+..
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd--------- 692 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD--------- 692 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH---------
Confidence 755433332 23446789999999988643 568899999999999999999999964332111
Q ss_pred hhhcccchhhhcC-ccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 219 FLKDQKKFVHLVD-PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 219 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
++... .++. ..+....-+..+.+...||++||.+.-++|.+..++..
T Consensus 693 ILqeN----TIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 693 ILQEN----TILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred HHhhh----chhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 01000 0010 01111122346778999999999999999988887754
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=249.27 Aligned_cols=253 Identities=14% Similarity=0.073 Sum_probs=177.5
Q ss_pred eeeeeeceeccEEEEEE--C---CeEEEEEEeccCCccch-----------hHHHHHHHHHhcCCCCcccceeEEEEeCC
Q 021526 2 LCCYLSCKFYNVGLVWL--C---DQLVAIKQLNHEGLQGH-----------QEFIVEVLMLSLLHHDNLVTLIGYCTSGD 65 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~---~~~vaiK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 65 (311)
..++|+|+||.||++.. + +..+++|.......... .....++..+..++|++++++++.+....
T Consensus 17 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 96 (294)
T PHA02882 17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKR 96 (294)
T ss_pred eeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEec
Confidence 45799999999999998 2 45677776433221111 11223344556778999999998754433
Q ss_pred ----eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEe
Q 021526 66 ----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 141 (311)
Q Consensus 66 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~ 141 (311)
..+++++.+. .++.+.+.. ....++..+..++.|++.||+|||+.+ ++||||||+|||++.++.++|+
T Consensus 97 ~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~l~ 168 (294)
T PHA02882 97 CRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYII 168 (294)
T ss_pred CCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEEEE
Confidence 3367777763 466666633 233567888999999999999999999 9999999999999999999999
Q ss_pred ecCCCccCCCCCCc-----ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcc
Q 021526 142 DFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS 216 (311)
Q Consensus 142 Df~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 216 (311)
|||+++........ .......|+..|+|||++.+..++.++||||||+++++|++|..||......... ....
T Consensus 169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~--~~~~ 246 (294)
T PHA02882 169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL--IHAA 246 (294)
T ss_pred EcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH--HHHh
Confidence 99998754221111 1112245899999999999999999999999999999999999999754321110 0000
Q ss_pred hhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 021526 217 RPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 272 (311)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~ 272 (311)
.. .-...+..... ....++..+.+++..||..+|++||+++++++.|+
T Consensus 247 ~~-----~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 247 KC-----DFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HH-----HHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 00 00011111100 12234677999999999999999999999998763
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=252.29 Aligned_cols=261 Identities=22% Similarity=0.232 Sum_probs=186.5
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccc--hhHHHHHHHHHhcCCCCcccceeEEEEeC--------CeeEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLIGYCTSG--------DQRLL 69 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~l 69 (311)
...+|.|++|.||.+.. +++.|++|.+....... ...+.+|+++++.++||||+++++++... ...++
T Consensus 13 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~l 92 (311)
T cd07866 13 LGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYM 92 (311)
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEE
Confidence 46789999999999998 68999999886543322 34678899999999999999999886433 34699
Q ss_pred EEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccC
Q 021526 70 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 149 (311)
Q Consensus 70 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~ 149 (311)
+++|+.+ ++...+.. ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 93 v~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 93 VTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred EEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 9999864 67777743 3457999999999999999999999999 999999999999999999999999988653
Q ss_pred CCCCCcce---------eeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCcccccc-chhcch-
Q 021526 150 PVGDNTHV---------STRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWSR- 217 (311)
Q Consensus 150 ~~~~~~~~---------~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~- 217 (311)
........ .....++..|+|||.+.+. .++.++|+||||+++|+|++|.+||.......... +.....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT 245 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 32211111 1112456789999987654 57899999999999999999999986443221100 000000
Q ss_pred ---hhhhcccchhhhcCccCCCCCc-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 218 ---PFLKDQKKFVHLVDPLLHGRYP-------RRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 218 ---~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..+..................+ ......+.++|.+||+.+|++|||+.+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000000000000000000011 123367899999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=258.05 Aligned_cols=259 Identities=23% Similarity=0.252 Sum_probs=187.5
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeC--------------C
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--------------D 65 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------------~ 65 (311)
...+|.|++|.||.+.. +++.|++|.+........+.+.+|+++++.++||||+++++++... .
T Consensus 10 ~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (342)
T cd07854 10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89 (342)
T ss_pred EEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccc
Confidence 46789999999999998 6899999998776666667889999999999999999999776543 3
Q ss_pred eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcC-CCceEEeecC
Q 021526 66 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-DFNPKLSDFG 144 (311)
Q Consensus 66 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~-~~~vkl~Df~ 144 (311)
..++++||+. ++|.+++. ...+++..++.++.|++.||.|||+.| ++|+||+|+||+++. ++.++|+|||
T Consensus 90 ~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 90 SVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred eEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCcc
Confidence 5789999996 58888873 346889999999999999999999999 999999999999974 5578999999
Q ss_pred CCccCCCCCCc-ceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCccccccchh--cchhhh
Q 021526 145 LAKLGPVGDNT-HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS--WSRPFL 220 (311)
Q Consensus 145 ~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~ 220 (311)
.+......... .......++..|.|||.+.. ..++.++|+|||||++|+|++|..||............. ......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 98653221111 11122346778999997654 567889999999999999999999996443211100000 000000
Q ss_pred hcccch----hhhcC-ccCCCC-----CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 221 KDQKKF----VHLVD-PLLHGR-----YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 221 ~~~~~~----~~~~~-~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
...... ..... ...... .....+.++.+++.+||+.||++||++.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000000 00000 000000 01134567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=253.40 Aligned_cols=253 Identities=23% Similarity=0.265 Sum_probs=188.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEe-CCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS-GDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~ 76 (311)
...+|.|++|.||++.. +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.. +...++++|++ +
T Consensus 15 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~ 93 (328)
T cd07856 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-G 93 (328)
T ss_pred EEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-c
Confidence 45789999999999987 78999999876432 2344678899999999999999999998865 56789999998 5
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++. ...+++..+..++.|++.||++||+.+ ++|+||+|.||+++.++.++|+|||.+......
T Consensus 94 ~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~---- 161 (328)
T cd07856 94 TDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQ---- 161 (328)
T ss_pred cCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCC----
Confidence 68988883 346788888999999999999999999 999999999999999999999999988643211
Q ss_pred eeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCccccccc-h--------hcchhhhhcccch
Q 021526 157 VSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-V--------SWSRPFLKDQKKF 226 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~--------~~~~~~~~~~~~~ 226 (311)
.....++..|+|||.+.+ ..++.++|+||||+++++|++|..||........... . .+...... . ..
T Consensus 162 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~ 238 (328)
T cd07856 162 -MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS-E-NT 238 (328)
T ss_pred -cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc-h-hh
Confidence 112345778999998765 5688999999999999999999999964432111000 0 00000000 0 00
Q ss_pred hhhcCcc-CCCCCc-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 227 VHLVDPL-LHGRYP-----RRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 227 ~~~~~~~-~~~~~~-----~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.+..... .....+ +..+..+.++|.+||+.+|++||++++++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0010000 011111 1245789999999999999999999999764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=243.13 Aligned_cols=218 Identities=24% Similarity=0.210 Sum_probs=174.9
Q ss_pred ceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHHHHhcc
Q 021526 8 CKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYD 85 (311)
Q Consensus 8 g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 85 (311)
|.++.||.++. +++.||+|.+.... ...+|...+....|||++++++++.++...+++|||+.+++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999999 78999999986543 233455555566799999999999999999999999999999999854
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeeeccccc
Q 021526 86 LEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 165 (311)
Q Consensus 86 ~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~ 165 (311)
...+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+...... .....++.
T Consensus 79 ----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~ 146 (237)
T cd05576 79 ----FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVEN 146 (237)
T ss_pred ----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCc
Confidence 345899999999999999999999999 999999999999999999999999977543221 11223466
Q ss_pred cccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCcHHHHHH
Q 021526 166 GYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNY 245 (311)
Q Consensus 166 ~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
.|+|||...+..++.++|+||+|+++|+|++|..|+........ .......+...+..
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~ 204 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN----------------------THTTLNIPEWVSEE 204 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc----------------------cccccCCcccCCHH
Confidence 79999998888889999999999999999999988742211000 00001223445677
Q ss_pred HHHHHHHhhccCCCCCCCH
Q 021526 246 AVAVTAMCLNEEANFRPLI 264 (311)
Q Consensus 246 l~~li~~~l~~~p~~RPs~ 264 (311)
+.++|.+||+.||++||++
T Consensus 205 ~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHHHccCCHHHhcCC
Confidence 9999999999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=253.00 Aligned_cols=260 Identities=20% Similarity=0.199 Sum_probs=186.2
Q ss_pred eeeeeeceeccEEEEEE--C--CeEEEEEEeccCC--ccchhHHHHHHHHHhcC-CCCcccceeEEEEe----CCeeEEE
Q 021526 2 LCCYLSCKFYNVGLVWL--C--DQLVAIKQLNHEG--LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTS----GDQRLLV 70 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~--~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~~~lv 70 (311)
...+|+|++|.||.+.. . +..||+|.+.... ....+.+.+|+++++.+ +||||+++++.+.. ....+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 84 (332)
T cd07857 5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLY 84 (332)
T ss_pred EEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEE
Confidence 46789999999999999 3 6799999876432 22345788899999998 59999999986432 2456888
Q ss_pred EecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCC
Q 021526 71 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 150 (311)
Q Consensus 71 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~ 150 (311)
++++. ++|.+++. ....+++..++.++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||.+....
T Consensus 85 ~e~~~-~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 85 EELME-ADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred Eeccc-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 99885 68988884 3567899999999999999999999999 9999999999999999999999999987533
Q ss_pred CCCCc--ceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCcccccc-c--------hhcchh
Q 021526 151 VGDNT--HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-L--------VSWSRP 218 (311)
Q Consensus 151 ~~~~~--~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~--------~~~~~~ 218 (311)
..... .......++..|+|||.+.+ ..++.++|+||+|+++|+|++|.+||...+...... . ......
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 21111 11122357889999997765 468899999999999999999999986443210000 0 000000
Q ss_pred hhhc-ccchhhhcCccCCCC---CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 219 FLKD-QKKFVHLVDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 219 ~~~~-~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.... ............... ..+..+..+.+++.+||+.||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000 000000000000000 01123567999999999999999999999986
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=240.68 Aligned_cols=239 Identities=22% Similarity=0.219 Sum_probs=186.6
Q ss_pred eeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcC-CCCcccceeEEEEeC----CeeEEEEecCCC
Q 021526 4 CYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSG----DQRLLVYEYMPM 76 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~----~~~~lv~e~~~~ 76 (311)
++|.|--|+|-.-+. .++++|+|++. +.+...+|++.--.. .||||+.++++|++. .-+.+|||.++|
T Consensus 69 vLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meG 143 (400)
T KOG0604|consen 69 VLGAGINGKVVQCVHKRTQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEG 143 (400)
T ss_pred hhccccCCceEEEEeccchhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccc
Confidence 578888888877666 78999999875 225667777765434 599999999998643 345799999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCC---CceEEeecCCCccCCCCC
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND---FNPKLSDFGLAKLGPVGD 153 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~---~~vkl~Df~~~~~~~~~~ 153 (311)
|.|.+.++. .....+++..+-.++.||..|+.|||+.+ |.||||||+|+|.+.. ..+||+|||++... .
T Consensus 144 GeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t---~ 215 (400)
T KOG0604|consen 144 GELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET---Q 215 (400)
T ss_pred hHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccccccc---C
Confidence 999999976 45678999999999999999999999999 9999999999999643 45899999999742 2
Q ss_pred CcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 154 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 154 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
......+.+.|+.|.|||++...+|+...|+||+|+++|-|++|.+||...-.. .+..-++ ..+...
T Consensus 216 ~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~---aispgMk---------~rI~~g- 282 (400)
T KOG0604|consen 216 EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---AISPGMK---------RRIRTG- 282 (400)
T ss_pred CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc---cCChhHH---------hHhhcc-
Confidence 233345577899999999999999999999999999999999999999533221 0000000 001000
Q ss_pred CCCCCc----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 234 LHGRYP----RRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 234 ~~~~~~----~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
+..+| ...++...++|+.+|..+|.+|.|+++++.
T Consensus 283 -qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 283 -QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred -CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 11222 246778999999999999999999999874
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=254.06 Aligned_cols=259 Identities=24% Similarity=0.282 Sum_probs=187.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeCC------eeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD------QRLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~ 71 (311)
...+|+|++|.||++.. .++.||+|.+.... ......+.+|+.+++.++||||+++++++.... ..++++
T Consensus 20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 99 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99 (342)
T ss_pred EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence 46789999999999997 68999999986542 222356889999999999999999999886542 458999
Q ss_pred ecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCC
Q 021526 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 151 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~ 151 (311)
+++. .+|.++. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 100 e~~~-~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 100 PYMQ-TDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred cccc-cCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 9985 4676655 235888999999999999999999999 99999999999999999999999999864321
Q ss_pred CCCcceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCccccccc-hhc---ch----hhhhc
Q 021526 152 GDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-VSW---SR----PFLKD 222 (311)
Q Consensus 152 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~---~~----~~~~~ 222 (311)
. .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||........... ... .. .....
T Consensus 170 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 170 E-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred C-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 1 112345778999998766 4688999999999999999999999974432111000 000 00 00000
Q ss_pred c--cchhhhcCccCCCCC---cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHHhh
Q 021526 223 Q--KKFVHLVDPLLHGRY---PRRCLNYAVAVTAMCLNEEANFRPLINDIVVA--LDYLV 275 (311)
Q Consensus 223 ~--~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~--L~~l~ 275 (311)
. ...........+... .+..+..+.++|.+||+.||++||++++++.. ++.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0 000000000000000 01245668899999999999999999999964 66654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=275.59 Aligned_cols=243 Identities=25% Similarity=0.266 Sum_probs=181.6
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEe---------------
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS--------------- 63 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------------- 63 (311)
|.+||+|+||.|++++. +|..+|||++.... ......+.+|+..|..|+||||++++..|.+
T Consensus 484 L~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~ 563 (1351)
T KOG1035|consen 484 LELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDS 563 (1351)
T ss_pred HHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccch
Confidence 46899999999999999 99999999987653 3344678899999999999999999765420
Q ss_pred --------------------------------------------------------------------------------
Q 021526 64 -------------------------------------------------------------------------------- 63 (311)
Q Consensus 64 -------------------------------------------------------------------------------- 63 (311)
T Consensus 564 ~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d 643 (1351)
T KOG1035|consen 564 ESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILD 643 (1351)
T ss_pred hhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccC
Confidence
Q ss_pred ----------------C--------CeeEEEEecCCCCCHHHHhcccCCCCCCC-CHHHHHHHHHHHHHHHHHHhhCCCC
Q 021526 64 ----------------G--------DQRLLVYEYMPMGSLEDHLYDLEPDQEPL-SWNTRMKIAVGAARGLEYLHCKANP 118 (311)
Q Consensus 64 ----------------~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l-~~~~~~~~~~~i~~~l~~Lh~~~~~ 118 (311)
+ ..+||-||||+..++.+++.+ +... .....|.++.+|++||+|+|++|
T Consensus 644 ~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~----N~~~~~~d~~wrLFreIlEGLaYIH~~g-- 717 (1351)
T KOG1035|consen 644 DTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR----NHFNSQRDEAWRLFREILEGLAYIHDQG-- 717 (1351)
T ss_pred cchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh----cccchhhHHHHHHHHHHHHHHHHHHhCc--
Confidence 0 134788999988777777743 2222 56788999999999999999999
Q ss_pred CeeecCCCCCcEEEcCCCceEEeecCCCccCC----C------------CCCcceeeeccccccccCCccccCC---CCC
Q 021526 119 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGP----V------------GDNTHVSTRVMGTYGYCAPEYAMSG---KLT 179 (311)
Q Consensus 119 ~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~----~------------~~~~~~~~~~~~~~~~~aPE~~~~~---~~~ 179 (311)
++||||||.|||++.++.|||+|||++.... . ...........||.-|.|||++.+. +|+
T Consensus 718 -iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn 796 (1351)
T KOG1035|consen 718 -IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN 796 (1351)
T ss_pred -eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence 9999999999999999999999999987511 0 0001112235689999999999865 499
Q ss_pred ccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCC--CcHHHHHHHHHHHHHhhccC
Q 021526 180 LKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR--YPRRCLNYAVAVTAMCLNEE 257 (311)
Q Consensus 180 ~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~ 257 (311)
.|.|+||||++++||+. ||...+.. ...+..+.+..+... +.......=+.+|++|++.|
T Consensus 797 ~KiDmYSLGIVlFEM~y---PF~TsMER---------------a~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hd 858 (1351)
T KOG1035|consen 797 SKIDMYSLGIVLFEMLY---PFGTSMER---------------ASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHD 858 (1351)
T ss_pred chhhhHHHHHHHHHHhc---cCCchHHH---------------HHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCC
Confidence 99999999999999997 45422211 111111111111111 11222334578999999999
Q ss_pred CCCCCCHHHHHH
Q 021526 258 ANFRPLINDIVV 269 (311)
Q Consensus 258 p~~RPs~~~l~~ 269 (311)
|.+|||+.|+++
T Consensus 859 P~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 859 PSKRPTATELLN 870 (1351)
T ss_pred CccCCCHHHHhh
Confidence 999999999986
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=252.99 Aligned_cols=255 Identities=22% Similarity=0.286 Sum_probs=186.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeC------CeeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG------DQRLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~ 71 (311)
+..+|+|+||.||.+.. +++.||+|.+.... ....+.+.+|+++++.++||||+++++++... ...++++
T Consensus 22 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 101 (345)
T cd07877 22 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 101 (345)
T ss_pred EEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEe
Confidence 45799999999999987 78999999986532 22345678899999999999999999987543 3467888
Q ss_pred ecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCC
Q 021526 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 151 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~ 151 (311)
+++ +++|.+.+. ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 102 ~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 102 HLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172 (345)
T ss_pred hhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEecccccccccc
Confidence 877 779988873 246889999999999999999999999 99999999999999999999999999874321
Q ss_pred CCCcceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCcccccc-chhcc----hhhhh---c
Q 021526 152 GDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWS----RPFLK---D 222 (311)
Q Consensus 152 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~----~~~~~---~ 222 (311)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.......... ..... ..... .
T Consensus 173 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T cd07877 173 -----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247 (345)
T ss_pred -----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence 1122356788999998766 467889999999999999999999985433211100 00000 00000 0
Q ss_pred --ccchhhhcCccCCCCC---cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 223 --QKKFVHLVDPLLHGRY---PRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 223 --~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.......+.......+ ....+..+.++|.+||+.+|.+||++.+++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000000000000 01235668999999999999999999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=256.80 Aligned_cols=255 Identities=23% Similarity=0.294 Sum_probs=188.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCe------eEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ------RLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~ 71 (311)
...+|.|.+|.||.+.. +++.||+|.+.... ......+.+|+.+++.++|||++++++++..+.. .++++
T Consensus 20 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07851 20 LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVT 99 (343)
T ss_pred EEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEE
Confidence 46789999999999999 68899999886532 2334567889999999999999999988765544 89999
Q ss_pred ecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCC
Q 021526 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 151 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~ 151 (311)
|++ +++|.+++.. ..+++..++.++.|++.||.+||+.| ++|+||+|+||+++.++.++|+|||++.....
T Consensus 100 e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 100 HLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred ecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 998 6699998843 56999999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCcceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCcccccc-chhcc----hhhhh----
Q 021526 152 GDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWS----RPFLK---- 221 (311)
Q Consensus 152 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~----~~~~~---- 221 (311)
. .....++..|+|||...+ ..++.++|+||||+++|+|++|..||.......... +.+.. .....
T Consensus 171 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (343)
T cd07851 171 E-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245 (343)
T ss_pred c-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence 1 122346778999998765 367899999999999999999999996433211100 00000 00000
Q ss_pred -cccchhhhcCccCCCCCc---HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 222 -DQKKFVHLVDPLLHGRYP---RRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 222 -~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
....+........+..+. ...+..+.++|.+||+.+|++|||+.+|++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000000000000000111 1236779999999999999999999999863
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=251.97 Aligned_cols=259 Identities=24% Similarity=0.267 Sum_probs=189.1
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeCC------eeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD------QRLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~ 71 (311)
+..+|.|++|.||.+.. +++.||+|.+.... ......+.+|+++++.++||||+++++++..+. ..++++
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07880 20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM 99 (343)
T ss_pred EEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEE
Confidence 45789999999999988 78999999985432 222356889999999999999999999886554 358999
Q ss_pred ecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCC
Q 021526 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 151 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~ 151 (311)
+++ +++|.+++. ...+++..++.++.|++.||+|||+.+ ++|+||+|.||+++.++.++|+|||.+.....
T Consensus 100 e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 100 PFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred ecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 998 778988883 356899999999999999999999999 99999999999999999999999999874322
Q ss_pred CCCcceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCccccc-cch--------hcchhhhh
Q 021526 152 GDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLV--------SWSRPFLK 221 (311)
Q Consensus 152 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~--------~~~~~~~~ 221 (311)
. .....++..|++||.+.+ ..++.++|+||||+++|++++|..||......... ... .+......
T Consensus 171 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07880 171 E-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245 (343)
T ss_pred C-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence 1 122346788999998875 45789999999999999999999999643321100 000 00000000
Q ss_pred -cccchhhhcCccCCC---CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHh
Q 021526 222 -DQKKFVHLVDPLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV--ALDYL 274 (311)
Q Consensus 222 -~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~--~L~~l 274 (311)
........+...... ......+..+.++|.+||+.||++|||+.+++. .++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 000000000000000 011234556899999999999999999999985 34443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=265.19 Aligned_cols=251 Identities=26% Similarity=0.331 Sum_probs=213.0
Q ss_pred eeeeeceeccEEEEEE--C----CeEEEEEEeccC-CccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCC
Q 021526 3 CCYLSCKFYNVGLVWL--C----DQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
.++|+|+||.||+|.+ . +-+||||++... ..+...++..|+.++..++|||++++++++..+. +-||++|+.
T Consensus 702 kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP 780 (1177)
T KOG1025|consen 702 KVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMP 780 (1177)
T ss_pred ceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcc
Confidence 4799999999999999 3 468999987644 4556689999999999999999999999987665 889999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
.|+|.+|++. ....+.....+.|..||++|+.|||.++ ++||||-.+|+||..-..||+.|||++.........
T Consensus 781 ~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 781 LGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred cchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 9999999976 6678888999999999999999999998 999999999999999999999999999876655555
Q ss_pred ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccC
Q 021526 156 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
.......-.+.|+|-|.+....++.++||||+|+++||++| |..|++.... ..+.+++....
T Consensus 855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~-----------------~eI~dlle~ge 917 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA-----------------EEIPDLLEKGE 917 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH-----------------HHhhHHHhccc
Confidence 44444556778999999999999999999999999999988 7788863332 23333444444
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 277 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~ 277 (311)
+-.-|+.|+.++.-++.+||-.|++.||+++++...+....+.
T Consensus 918 RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 918 RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 4456889999999999999999999999999999998776653
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=239.73 Aligned_cols=255 Identities=20% Similarity=0.270 Sum_probs=198.0
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCC-CCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
.+||.|+++.|-..+. +|..+|||++.+.......++.+|++++.+.+ |+||+.++++|+++...|+|||.+.||.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 4689999999988777 89999999999887778889999999999986 99999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCc---eEEeecCCCccCCCCCCc-
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN---PKLSDFGLAKLGPVGDNT- 155 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~---vkl~Df~~~~~~~~~~~~- 155 (311)
.++|. ....|.+..+..+...|+.||.+||.+| |.|+|+||+|||....+. |||+||++..-.......
T Consensus 164 LshI~----~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 164 LSHIQ----KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred HHHHH----HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 99994 5678999999999999999999999999 999999999999966554 799999986432111111
Q ss_pred ----ceeeeccccccccCCccccC-----CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhh--hccc
Q 021526 156 ----HVSTRVMGTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFL--KDQK 224 (311)
Q Consensus 156 ----~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~ 224 (311)
..-.+..|...|||||+..- ..|+.+.|.||||+++|-|+.|.+||...=... ..|-+... .-+.
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d----CGWdrGe~Cr~CQ~ 312 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD----CGWDRGEVCRVCQN 312 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc----CCccCCCccHHHHH
Confidence 11124578889999997652 368999999999999999999999996432210 01110000 0011
Q ss_pred chhhhcCccCCCCCcH----HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 225 KFVHLVDPLLHGRYPR----RCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 225 ~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.+.+.+... ...+|. ..+.+..++|...|..++.+|-++..+++
T Consensus 313 ~LFesIQEG-kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 313 KLFESIQEG-KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHhcc-CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 111111111 112333 45777899999999999999999888876
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=240.10 Aligned_cols=280 Identities=21% Similarity=0.167 Sum_probs=199.5
Q ss_pred eeeeeceeccEEEEEE----C--CeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEe-CCeeEEEEec
Q 021526 3 CCYLSCKFYNVGLVWL----C--DQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS-GDQRLLVYEY 73 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~----~--~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~ 73 (311)
-.+|+|.+|.||+++- . ++.+|||.|+.+.. .......+|+.+++.++|||++.+..+|.+ +...++++||
T Consensus 30 g~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdY 109 (438)
T KOG0666|consen 30 GKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDY 109 (438)
T ss_pred ceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehh
Confidence 4589999999999966 2 34789999876532 333678999999999999999999998866 8889999999
Q ss_pred CCCCCHHHHhcccCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCC----CceEEeecCCCcc
Q 021526 74 MPMGSLEDHLYDLEP-DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND----FNPKLSDFGLAKL 148 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~----~~vkl~Df~~~~~ 148 (311)
.+. +|.+.|.-.+. ....++...+..+++||+.++.|||++= ++|||+||.||||..+ |+|||+|||+++.
T Consensus 110 AEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~ 185 (438)
T KOG0666|consen 110 AEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADLGLARL 185 (438)
T ss_pred hhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecccHHHH
Confidence 976 78777754332 3467999999999999999999999997 9999999999999888 8999999999987
Q ss_pred CCCCC-CcceeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCcccccc----chhcc------
Q 021526 149 GPVGD-NTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN----LVSWS------ 216 (311)
Q Consensus 149 ~~~~~-~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~------ 216 (311)
....- ..........|.+|.|||++.+. .|+.+.|+|++||++.||++-.+.|.......+.. ..+..
T Consensus 186 ~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vL 265 (438)
T KOG0666|consen 186 FNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVL 265 (438)
T ss_pred hhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHc
Confidence 54322 12223345578999999999886 68999999999999999999998886554322211 00000
Q ss_pred ----hhhhhcccchhhh---cCccCCCCC-cH---H-------HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 021526 217 ----RPFLKDQKKFVHL---VDPLLHGRY-PR---R-------CLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 278 (311)
Q Consensus 217 ----~~~~~~~~~~~~~---~~~~~~~~~-~~---~-------~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~ 278 (311)
...|.+..++.+. +...-+..+ +. . -+..-.+|+.+||+.||.+|.|+++.++..-......
T Consensus 266 G~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~l 345 (438)
T KOG0666|consen 266 GTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPL 345 (438)
T ss_pred CCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCCC
Confidence 0001111111100 000000000 00 0 1222678999999999999999999998654444444
Q ss_pred CCCCCCCC
Q 021526 279 DSHPVSRN 286 (311)
Q Consensus 279 ~~~~~~~~ 286 (311)
...+.+.+
T Consensus 346 pp~pt~~~ 353 (438)
T KOG0666|consen 346 PPLPTSDN 353 (438)
T ss_pred CCCcccce
Confidence 43333333
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=264.42 Aligned_cols=254 Identities=24% Similarity=0.351 Sum_probs=207.2
Q ss_pred eeeeceeccEEEEEEC---------CeEEEEEEeccCC-ccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEe
Q 021526 4 CYLSCKFYNVGLVWLC---------DQLVAIKQLNHEG-LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYE 72 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~~---------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 72 (311)
.+|.|.||.|+++... ...||||.+.... ..+.+.+..|+++++.+ .|+||+.+++.+...+..++|+|
T Consensus 303 ~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~E 382 (609)
T KOG0200|consen 303 YLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVE 382 (609)
T ss_pred eeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEE
Confidence 6899999999999872 4689999987543 34567899999999988 59999999999999999999999
Q ss_pred cCCCCCHHHHhcccC---CC-C--------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEE
Q 021526 73 YMPMGSLEDHLYDLE---PD-Q--------EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 140 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~---~~-~--------~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl 140 (311)
|+..|+|..++...+ .. . ..+....++.+++||+.|++||++.. ++|||+..+|||+.++..+|+
T Consensus 383 y~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~~~~~~kI 459 (609)
T KOG0200|consen 383 YAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLITKNKVIKI 459 (609)
T ss_pred eccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEecCCCEEEE
Confidence 999999999998755 10 1 23889999999999999999999998 999999999999999999999
Q ss_pred eecCCCccCCCCCCcceeeec-cccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchh
Q 021526 141 SDFGLAKLGPVGDNTHVSTRV-MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRP 218 (311)
Q Consensus 141 ~Df~~~~~~~~~~~~~~~~~~-~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 218 (311)
+|||+++.............. .-+..|+|||.+....|+.++||||+|+++|||++ |..||..-
T Consensus 460 aDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~-------------- 525 (609)
T KOG0200|consen 460 ADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI-------------- 525 (609)
T ss_pred ccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC--------------
Confidence 999999854333322222111 13557999999999999999999999999999998 56787420
Q ss_pred hhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 021526 219 FLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 276 (311)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~ 276 (311)
.....+.+.+...-+-..|..|..++.+++..||+.+|++||++.++.+.|.....
T Consensus 526 --~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 526 --PPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred --CcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 00122233444455556677889999999999999999999999999999988544
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=255.18 Aligned_cols=242 Identities=22% Similarity=0.252 Sum_probs=196.3
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
.+||+|-||.||-|.. +|+.||||++.+.+ +....++.+|..+|+.+.||.|+.+-..|++.+..++|||.+.|.-
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM 649 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM 649 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence 4689999999999999 89999999998764 4455789999999999999999999999999999999999997655
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCC---CceEEeecCCCccCCCCCCc
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND---FNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~---~~vkl~Df~~~~~~~~~~~~ 155 (311)
|...+. +..+.+++.....++.||+.||.|||.+| |+|+|+||+|+|+... ..+||+|||.+++. .+.
T Consensus 650 LEMILS---sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiI---gEk 720 (888)
T KOG4236|consen 650 LEMILS---SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARII---GEK 720 (888)
T ss_pred HHHHHH---hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeec---chh
Confidence 555554 36788999999999999999999999999 9999999999999544 46999999999954 344
Q ss_pred ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 156 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
.......||+.|+|||++.+..|...-|+||+|+++|.-+.|..||+....-.+ ++++.. ++.....+
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd-QIQNAa--FMyPp~PW--------- 788 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND-QIQNAA--FMYPPNPW--------- 788 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH-Hhhccc--cccCCCch---------
Confidence 455567899999999999999999999999999999999999999974332111 011100 01101111
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.+.+.+..++|...|++.-.+|-|.+.-+.
T Consensus 789 ----~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 789 ----SEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred ----hhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 134666789999999999999988776543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=235.44 Aligned_cols=235 Identities=31% Similarity=0.368 Sum_probs=189.7
Q ss_pred eeccEEEEEE--CCeEEEEEEeccCCccc-hhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHHHHhcc
Q 021526 9 KFYNVGLVWL--CDQLVAIKQLNHEGLQG-HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYD 85 (311)
Q Consensus 9 ~~~~v~~~~~--~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 85 (311)
+||.||++.. +++.+++|.+....... .+.+.+|++.++.++|+|++++++.+..+...++++|++.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 4789999999 57999999987665544 67899999999999999999999999998999999999999999999854
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeeeccccc
Q 021526 86 LEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 165 (311)
Q Consensus 86 ~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~ 165 (311)
...++...++.++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+....... ......++.
T Consensus 81 ----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 81 ----RGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred ----ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 223889999999999999999999999 9999999999999999999999999987543321 223345778
Q ss_pred cccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCcHH--HH
Q 021526 166 GYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRR--CL 243 (311)
Q Consensus 166 ~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 243 (311)
.|++||.+.+..++.++|+|+||++++++++|..||...... ....+............. .+
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~ 214 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL----------------LELFKKIGKPKPPFPPPEWKIS 214 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH----------------HHHHHHHhccCCCCccccccCC
Confidence 899999998888899999999999999999999998642110 000001100000000011 56
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 244 NYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 244 ~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..+.+++.+||..+|++||++.++++
T Consensus 215 ~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 215 PEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHHHccCCchhccCHHHHhh
Confidence 78999999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=244.87 Aligned_cols=255 Identities=19% Similarity=0.217 Sum_probs=190.5
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCC--CCc----ccceeEEEEeCCeeEEEEecC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH--HDN----LVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--h~~----i~~~~~~~~~~~~~~lv~e~~ 74 (311)
.++|.|.||.|-+.+. .+..||||++.. ...-.+..+-|+++|.+++ .|+ ++.+.++|+..++.|+|+|.+
T Consensus 95 ~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell 173 (415)
T KOG0671|consen 95 DLLGEGTFGKVVECWDRETKEHVALKIIKN-VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL 173 (415)
T ss_pred hhhcCCcccceEEEeecCCCceehHHHHHH-HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc
Confidence 5789999999999998 679999999753 2334456677999999884 232 667778899999999999998
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEc--------------------C
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD--------------------N 134 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~--------------------~ 134 (311)
|.++.+++.. ..-.+++...+..+++|++.++++||+.+ ++|.|+||+||++. .
T Consensus 174 -G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~k 247 (415)
T KOG0671|consen 174 -GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLK 247 (415)
T ss_pred -ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccceeccCC
Confidence 6699999965 34567999999999999999999999999 99999999999983 1
Q ss_pred CCceEEeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchh
Q 021526 135 DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS 214 (311)
Q Consensus 135 ~~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 214 (311)
+..|+++|||.++.. .. .......|..|.|||++.+-.++..+||||+||+++|+++|...|+..+..++..+.+
T Consensus 248 s~~I~vIDFGsAtf~---~e--~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMe 322 (415)
T KOG0671|consen 248 STAIKVIDFGSATFD---HE--HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMME 322 (415)
T ss_pred CcceEEEecCCccee---cc--CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHH
Confidence 345899999999742 22 1244567899999999999999999999999999999999999998776433221111
Q ss_pred -----cchhhhhcc----------------------cchhhhcCccCCC-CCcHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 021526 215 -----WSRPFLKDQ----------------------KKFVHLVDPLLHG-RYPRRCLNYAVAVTAMCLNEEANFRPLIND 266 (311)
Q Consensus 215 -----~~~~~~~~~----------------------~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~RPs~~~ 266 (311)
.....+... ....+...+.-.. .-......+|.+|+++||..||.+|+|+.|
T Consensus 323 rIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~E 402 (415)
T KOG0671|consen 323 RILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLRE 402 (415)
T ss_pred HhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHH
Confidence 111111100 0000000000000 001234566999999999999999999999
Q ss_pred HHH
Q 021526 267 IVV 269 (311)
Q Consensus 267 l~~ 269 (311)
+++
T Consensus 403 AL~ 405 (415)
T KOG0671|consen 403 ALS 405 (415)
T ss_pred Hhc
Confidence 986
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=269.18 Aligned_cols=253 Identities=24% Similarity=0.246 Sum_probs=199.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccC---CccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHE---GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+.++|+|+||.|..++. .++.+|+|++++- .......|..|-.++..-+.+=|+.++-.|.++.++|+||||+.|
T Consensus 80 lKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pG 159 (1317)
T KOG0612|consen 80 LKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPG 159 (1317)
T ss_pred HHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccC
Confidence 45789999999999999 7899999998763 223335677888888888888999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
|+|-..+.+ -..++++.+..++..|+.||..+|+.| +|||||||+|||+|..|.+||+|||.+......+. -
T Consensus 160 GDlltLlSk----~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~-V 231 (1317)
T KOG0612|consen 160 GDLLTLLSK----FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT-V 231 (1317)
T ss_pred chHHHHHhh----cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCCc-E
Confidence 999999954 237999999999999999999999999 99999999999999999999999999876543333 3
Q ss_pred eeeeccccccccCCccccC-----CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcC
Q 021526 157 VSTRVMGTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
......|||.|.+||++.. +.|++.+|.||+|+++|+|+.|..||.-... ......+.+
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl----------------veTY~KIm~ 295 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL----------------VETYGKIMN 295 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH----------------HHHHHHHhc
Confidence 3456789999999998862 5789999999999999999999999952221 111112221
Q ss_pred ccCCCCCc--HHHHHHHHHHHHHhhccCCCCCCC---HHHHHHHHHHhhhccCCCCCCCCCCCC
Q 021526 232 PLLHGRYP--RRCLNYAVAVTAMCLNEEANFRPL---INDIVVALDYLVSQRDSHPVSRNAGAR 290 (311)
Q Consensus 232 ~~~~~~~~--~~~~~~l~~li~~~l~~~p~~RPs---~~~l~~~L~~l~~~~~~~~~~~~~~~~ 290 (311)
-.-...+| ...+....+||++.+ -+|+.|-. ++++. +++.+.+-+|.
T Consensus 296 hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik-----------~HpFF~g~~W~ 347 (1317)
T KOG0612|consen 296 HKESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIK-----------NHPFFEGIDWD 347 (1317)
T ss_pred hhhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHH-----------hCccccCCChh
Confidence 11111233 356888999999776 47888877 77664 45555555553
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=253.57 Aligned_cols=230 Identities=23% Similarity=0.266 Sum_probs=186.9
Q ss_pred eeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 4 CYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
.+|.|+|+.+-.... +++..++|++.+.. .+..+|..++... +|||++++.+++.++.+.|+|||.++++-+.
T Consensus 329 ~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell 404 (612)
T KOG0603|consen 329 ELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELL 404 (612)
T ss_pred ccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHH
Confidence 368899999988888 78999999987652 3344567655444 7999999999999999999999999999998
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE-cCCCceEEeecCCCccCCCCCCcceee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL-DNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~-~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
+.+.. .+.+. ..+..|+.+|+.|+.|||++| ++|||+||+|||+ ++.+.++|+|||........ ..
T Consensus 405 ~ri~~----~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~ 471 (612)
T KOG0603|consen 405 RRIRS----KPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----CD 471 (612)
T ss_pred HHHHh----cchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh-----hc
Confidence 88844 22232 677789999999999999999 9999999999999 58889999999998754322 22
Q ss_pred eccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 160 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
..+.|..|.|||+.....+++++|+||||+++|+|++|+.||...... .++........++
T Consensus 472 tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------------------~ei~~~i~~~~~s 532 (612)
T KOG0603|consen 472 TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------------------IEIHTRIQMPKFS 532 (612)
T ss_pred ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------------------HHHHHhhcCCccc
Confidence 345688999999999999999999999999999999999999744332 1222222333344
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
...+...++|+.+||+.||.+||++.++..
T Consensus 533 ~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 533 ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 677888999999999999999999999975
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=263.27 Aligned_cols=139 Identities=28% Similarity=0.283 Sum_probs=124.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc---chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+..+|.|+||.||+++. .++.||||++...... ....+.+|+.+++.++||||++++.++......++||||+.+
T Consensus 9 ~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g 88 (669)
T cd05610 9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIG 88 (669)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCC
Confidence 57899999999999999 5899999998754322 235688899999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
++|.+++.. ...+++..++.++.||+.||.|||..+ |+|+||||+|||++.++.++|+|||+++
T Consensus 89 ~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 89 GDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999953 346888999999999999999999999 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=236.67 Aligned_cols=250 Identities=23% Similarity=0.263 Sum_probs=188.7
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCc-cchhHHHHHHHHHhc-CCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSL-LHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
-.+|.|+||.|++-.. +|+..|||.+..... .+.+++..|.+...+ -++|||+++++..-.++..|+.||.++- +
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-S 148 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-S 148 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-h
Confidence 4689999999999998 899999999976654 455678888876644 4799999999998899999999999953 5
Q ss_pred HHHHhccc-CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 79 LEDHLYDL-EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 79 L~~~l~~~-~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
|.-+.... ......+++..+-.+....+.||.||...-+ |+|||+||+|||++..|.|||||||.+... ...-.
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqL---v~SiA 223 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQL---VDSIA 223 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhH---HHHHH
Confidence 54433221 1356678988888999999999999986433 999999999999999999999999998632 12222
Q ss_pred eeeccccccccCCccccCC--CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 158 STRVMGTYGYCAPEYAMSG--KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
.....|-.-|+|||.+... .|+.++|+||||+++||+.||..||..++...+ -...... .. -+.+.
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfe-----ql~~Vv~--gd-----pp~l~ 291 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFE-----QLCQVVI--GD-----PPILL 291 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHH-----HHHHHHc--CC-----CCeec
Confidence 3345677889999988753 589999999999999999999999974443111 0001110 00 01111
Q ss_pred CC-CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 236 GR-YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 236 ~~-~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.. -..+.+..+..+|..||..|.++||.+.++.++
T Consensus 292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11 112457779999999999999999999999874
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=251.92 Aligned_cols=244 Identities=25% Similarity=0.308 Sum_probs=200.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcC-CCCcccceeEEEE-----eCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCT-----SGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-----~~~~~~lv~e~ 73 (311)
...+|.|.+|+||++.. +++.+|+|+.... .+..+++..|+++|+.. .|||+..++++|. .++.+||||||
T Consensus 24 ~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEf 102 (953)
T KOG0587|consen 24 IEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEF 102 (953)
T ss_pred EEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeec
Confidence 46789999999999998 8999999997533 44556788899999887 5999999999985 46688999999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 153 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~ 153 (311)
|.+|+..|++.... +..+.+..+..++..++.|+.+||..- ++|+|||-.|||++.++.|||+|||.+.....
T Consensus 103 C~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQlds-- 175 (953)
T KOG0587|consen 103 CGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS-- 175 (953)
T ss_pred cCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeeeeec--
Confidence 99999999998855 888999999999999999999999998 99999999999999999999999999876332
Q ss_pred CcceeeeccccccccCCccccCC-----CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchh-
Q 021526 154 NTHVSTRVMGTYGYCAPEYAMSG-----KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV- 227 (311)
Q Consensus 154 ~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 227 (311)
......+..||+.|||||+.... .|+..+|+||||++..||.-|.+|+-..-. ...+.
T Consensus 176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP----------------mraLF~ 239 (953)
T KOG0587|consen 176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP----------------MRALFL 239 (953)
T ss_pred ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch----------------hhhhcc
Confidence 23334556799999999988743 467899999999999999999999741110 11111
Q ss_pred hhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 228 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
-..+|.....-|...+..+.++|..||..|..+||+..++++
T Consensus 240 IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 240 IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 112233333346678899999999999999999999999886
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=240.18 Aligned_cols=234 Identities=29% Similarity=0.344 Sum_probs=194.6
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
+-++|.|+||+|-.+.- ..+.+|||++++... ++.+.-+.|-++|... +-|+++.++..|.+-+.+|+||||+.
T Consensus 354 l~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvn 433 (683)
T KOG0696|consen 354 LMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVN 433 (683)
T ss_pred EEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEec
Confidence 56899999999999988 678999999987643 2334566778887665 46788899998988899999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
||+|--.+ ++-+.+.+..+..++..|+-+|-+||++| |++||+|.+|+|++.+|.+||+|||.+..- .-..
T Consensus 434 GGDLMyhi----QQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn--i~~~ 504 (683)
T KOG0696|consen 434 GGDLMYHI----QQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN--IFDG 504 (683)
T ss_pred CchhhhHH----HHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc--ccCC
Confidence 99998888 45678888899999999999999999999 999999999999999999999999998742 2233
Q ss_pred ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 156 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
..+.+.+||+.|+|||++...+|+...|.||+|+++|||+.|++||+..+...- +..+.+..
T Consensus 505 ~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el----------------F~aI~ehn-- 566 (683)
T KOG0696|consen 505 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL----------------FQAIMEHN-- 566 (683)
T ss_pred cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH----------------HHHHHHcc--
Confidence 445678999999999999999999999999999999999999999985543211 11111111
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCC
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRP 262 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RP 262 (311)
-.||...+.+..+++...|..+|.+|-
T Consensus 567 vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 567 VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 256778888999999999999999994
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=250.85 Aligned_cols=242 Identities=26% Similarity=0.289 Sum_probs=202.7
Q ss_pred eeeeeeceeccEEEEEECCeE--EEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWLCDQL--VAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~~~~--vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+.-||-|+||.|=.+..+++. +|+|++++.. ....+++..|-+++...+.|+|+++|..|.++...|++||-|-|
T Consensus 425 iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG 504 (732)
T KOG0614|consen 425 IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG 504 (732)
T ss_pred hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence 356899999999999997766 7999887764 34556788999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
|.|...+ ...+.|+......++..+++|++|||++| |++||+||+|++++.+|-+||+|||.+.... ...
T Consensus 505 GElWTiL----rdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~---~g~ 574 (732)
T KOG0614|consen 505 GELWTIL----RDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG---SGR 574 (732)
T ss_pred chhhhhh----hhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhc---cCC
Confidence 9999999 45788999999999999999999999999 9999999999999999999999999998543 334
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
.+-+.+||+.|.|||++.+...+.+.|.||||+++|||++|.+||...++....+.+ +...-.-
T Consensus 575 KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I----------------LkGid~i 638 (732)
T KOG0614|consen 575 KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI----------------LKGIDKI 638 (732)
T ss_pred ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH----------------Hhhhhhh
Confidence 455678999999999999999999999999999999999999999866554332221 1111122
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 269 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs-----~~~l~~ 269 (311)
.+|........++|++.-..+|.+|-- +.+|.+
T Consensus 639 ~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 639 EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 345566777889999999999999964 555544
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=207.69 Aligned_cols=259 Identities=19% Similarity=0.191 Sum_probs=194.3
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
.++|.|.+|.|++++. ..+-||+|.+...+. .......+|+-+|+.++|.||++++++...+..+.+|+|+|+. +
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-d 86 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-D 86 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-H
Confidence 5789999999999999 789999998875532 2335789999999999999999999999999999999999954 8
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
|..|... -++.++.+.+..++.|++.++.+.|+.+ +.|+|+||.|++++.+|.+||+|||+++- ++......
T Consensus 87 lkkyfds---lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglara--fgipvrcy 158 (292)
T KOG0662|consen 87 LKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARA--FGIPVRCY 158 (292)
T ss_pred HHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhh--cCCceEee
Confidence 8888865 6788999999999999999999999999 99999999999999999999999999986 33444455
Q ss_pred eeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCC-ccccCccccccchhcchhh--hhcccchhhhcCccC
Q 021526 159 TRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKA-MDLSKGQGEQNLVSWSRPF--LKDQKKFVHLVDPLL 234 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p-~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 234 (311)
.....|.+|.+|.++-+. -|+...|+||.||++.|+.....| |...+.......+-+.... ......+..+.+-..
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence 555678999999998876 578999999999999999876555 4333221110000000000 000011111111111
Q ss_pred CCCCc---------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 235 HGRYP---------RRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 235 ~~~~~---------~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.--|| +.....-++++.+.|.-+|..|.++++.++.
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 11111 2334446789999999999999999988763
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=232.29 Aligned_cols=258 Identities=21% Similarity=0.257 Sum_probs=208.9
Q ss_pred CeeeeeeceeccEEEEEE-------CCeEEEEEEeccC-CccchhHHHHHHHHHhcCCCCcccceeEEEEe-CCeeEEEE
Q 021526 1 MLCCYLSCKFYNVGLVWL-------CDQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS-GDQRLLVY 71 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~-------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 71 (311)
|+|++-.|.||.||.|.+ +.+.|.+|.++.. +.-+...+..|.-.+..+.|||++.+.++..+ ....+.++
T Consensus 288 l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y 367 (563)
T KOG1024|consen 288 LSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLY 367 (563)
T ss_pred chhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEE
Confidence 578888999999999965 4567788876533 23344567888888888999999999998754 45678899
Q ss_pred ecCCCCCHHHHhcccCC----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 72 EYMPMGSLEDHLYDLEP----DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~----~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
++..-|+|..++...+. ....+....+..++.|++.|+++||+.+ ++|.||..+|++|++...|||+|-.+++
T Consensus 368 ~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsaLSR 444 (563)
T KOG1024|consen 368 PATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSALSR 444 (563)
T ss_pred eccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccchhcc
Confidence 99989999999974332 2345777788899999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccch
Q 021526 148 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 226 (311)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
..-+.+..-......++..|++||.+.+..|+.++|+||||+++|||++ |+.|+..- ++..+
T Consensus 445 DLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI-----------------DPfEm 507 (563)
T KOG1024|consen 445 DLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI-----------------DPFEM 507 (563)
T ss_pred ccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc-----------------CHHHH
Confidence 7666555555555567889999999999999999999999999999988 67787411 12333
Q ss_pred hhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 021526 227 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 278 (311)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~ 278 (311)
...+....+-.-|.+|+.+|..++.-||...|++||+++++.+-|.++..+.
T Consensus 508 ~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 508 EHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred HHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 3333334444457789999999999999999999999999999998886643
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-33 Score=252.35 Aligned_cols=242 Identities=26% Similarity=0.266 Sum_probs=181.7
Q ss_pred eeeeceec-cEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEecCCCCCHHH
Q 021526 4 CYLSCKFY-NVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81 (311)
Q Consensus 4 ~~~~g~~~-~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (311)
++|.|+-| .||+|...++.||||.+-.+ ...-+.+|+..|+.- +||||+++++.-.+....|+..|.|.+ +|.+
T Consensus 516 ilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~d 591 (903)
T KOG1027|consen 516 ILGYGSNGTVVFRGVYEGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQD 591 (903)
T ss_pred HcccCCCCcEEEEEeeCCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hHHH
Confidence 35566654 58999999999999987533 345778999999887 599999999998889999999999954 9999
Q ss_pred HhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcC---C--CceEEeecCCCccCCCCCCcc
Q 021526 82 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN---D--FNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 82 ~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~---~--~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++...............+..+.|+++||++||+.+ |+|||+||.||||+. + .+++|.|||++.....+....
T Consensus 592 lie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~ 668 (903)
T KOG1027|consen 592 LIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSF 668 (903)
T ss_pred HHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCcchh
Confidence 99763111111111345788999999999999999 999999999999965 2 468999999998765543322
Q ss_pred e-eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhC-CCCccccCccccccchhcchhhhhcccchhhhcCccC
Q 021526 157 V-STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG-RKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 157 ~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
. .....|+.+|+|||++.....+.+.|||||||++||.++| ..||...-.... ++......+..+
T Consensus 669 ~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--------NIl~~~~~L~~L----- 735 (903)
T KOG1027|consen 669 SRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--------NILTGNYTLVHL----- 735 (903)
T ss_pred hcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--------hhhcCccceeee-----
Confidence 2 2346789999999999998888899999999999999997 679852211100 111111111111
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.-..++ +..+||.+|++.+|..||++.+|+.
T Consensus 736 --~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 736 --EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred --ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 001122 7889999999999999999999985
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=225.80 Aligned_cols=242 Identities=26% Similarity=0.344 Sum_probs=195.7
Q ss_pred CeeeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEecC
Q 021526 1 MLCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
||.++|+|++.+|-.+.+ ..+-+|+|+++++-. ++.+....|..+..+. +||+++-++..|.++..+++|.||+
T Consensus 254 ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv 333 (593)
T KOG0695|consen 254 LLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYV 333 (593)
T ss_pred eeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEe
Confidence 688999999999999999 678999999987632 3344566677777665 7999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
+||+|--++ ++...++++.+..+...|+.||.|||++| |+++|+|.+|+|++..|.+||.|+|.+.. ....
T Consensus 334 ~ggdlmfhm----qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke--~l~~ 404 (593)
T KOG0695|consen 334 NGGDLMFHM----QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE--GLGP 404 (593)
T ss_pred cCcceeeeh----hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhc--CCCC
Confidence 999997777 45678999999999999999999999999 99999999999999999999999999875 3334
Q ss_pred cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCcc-ccccchhcchhhhhcccchhhhcCcc
Q 021526 155 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQ-GEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
...+.+.+||+.|.|||++.+..|....|.|+||+++++|+.|+.||+.-.-+ .+.+-.++. +.-++.+.
T Consensus 405 gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedyl---------fqvilekq 475 (593)
T KOG0695|consen 405 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYL---------FQVILEKQ 475 (593)
T ss_pred CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHH---------HHHHhhhc
Confidence 45567789999999999999999999999999999999999999999754321 111211111 11112222
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCC
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRP 262 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RP 262 (311)
. +.|...+.....++..-|+.||++|-
T Consensus 476 i--riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 476 I--RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred c--cccceeehhhHHHHHHhhcCCcHHhc
Confidence 2 33445556677888889999999985
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-33 Score=222.51 Aligned_cols=261 Identities=24% Similarity=0.290 Sum_probs=189.2
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCC-cc-chhHHHHHHHHHhcCCCCcccceeEEEE--------eCCeeEEE
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG-LQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCT--------SGDQRLLV 70 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~-~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~--------~~~~~~lv 70 (311)
.++|+|.||.||+++. .+++||+|++-.+. .. --....+|+.+|..++|+|++.+++.|. +....++|
T Consensus 23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV 102 (376)
T KOG0669|consen 23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV 102 (376)
T ss_pred HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence 4789999999999999 67889999754432 22 2357889999999999999998887653 23457999
Q ss_pred EecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCC
Q 021526 71 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 150 (311)
Q Consensus 71 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~ 150 (311)
|++|+. +|.-.+.. ....++...+.+++.++..+|.|+|+.. |+|||+|+.|+||+.+|.++|+|||+++...
T Consensus 103 f~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~fs 175 (376)
T KOG0669|consen 103 FDFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARAFS 175 (376)
T ss_pred HHHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccccccee
Confidence 999976 78888854 4467899999999999999999999998 9999999999999999999999999997543
Q ss_pred CCCCcce--eeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcc-----hhhhhc
Q 021526 151 VGDNTHV--STRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS-----RPFLKD 222 (311)
Q Consensus 151 ~~~~~~~--~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~ 222 (311)
....... ......|.+|.+||.+.+. .+++..|+|+.||++.+|+++.+.++....+.....+... ...|..
T Consensus 176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~ 255 (376)
T KOG0669|consen 176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPN 255 (376)
T ss_pred cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCC
Confidence 3322221 1223458899999988764 7899999999999999999999988765543221111100 000110
Q ss_pred c---cchhhhc-CccCCCCC--------cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 223 Q---KKFVHLV-DPLLHGRY--------PRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 223 ~---~~~~~~~-~~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
. .-+..+- .+...+.+ |.--..+..++++++|..||.+|+++.+++..
T Consensus 256 ~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 256 VDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 0 0011110 00111110 00113357799999999999999999988763
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=243.04 Aligned_cols=254 Identities=18% Similarity=0.138 Sum_probs=159.3
Q ss_pred eeeeeeceeccEEEEEE--C----CeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEE------EEeCCeeEE
Q 021526 2 LCCYLSCKFYNVGLVWL--C----DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGY------CTSGDQRLL 69 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~------~~~~~~~~l 69 (311)
...+|+|+||.||+++. + +..||+|.+..... .+...++ .+....+.++..+... ...+...++
T Consensus 137 ~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 212 (566)
T PLN03225 137 GKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWL 212 (566)
T ss_pred eEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEE
Confidence 46899999999999999 4 68999998753321 1111111 1112222222221111 245667899
Q ss_pred EEecCCCCCHHHHhcccCC----------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEc
Q 021526 70 VYEYMPMGSLEDHLYDLEP----------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD 133 (311)
Q Consensus 70 v~e~~~~~~L~~~l~~~~~----------------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~ 133 (311)
++||+.+++|.+++..... .........+..++.|++.||+|||+++ |+|+||||+|||++
T Consensus 213 V~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~NILl~ 289 (566)
T PLN03225 213 VWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFS 289 (566)
T ss_pred EEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHHHEEEe
Confidence 9999999999998854210 0111223446679999999999999999 99999999999998
Q ss_pred C-CCceEEeecCCCccCCCCCCcceeeeccccccccCCccccCC----------------------CCCccccchhHHHH
Q 021526 134 N-DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG----------------------KLTLKSDIYSFGVV 190 (311)
Q Consensus 134 ~-~~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----------------------~~~~~~Dv~slG~~ 190 (311)
. ++.+||+|||++....... ........+++.|+|||.+... .+..++|||||||+
T Consensus 290 ~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGvi 368 (566)
T PLN03225 290 EGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 368 (566)
T ss_pred CCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHH
Confidence 5 5789999999997432221 1222335678899999965432 23346699999999
Q ss_pred HHHHHhCCCCccccCccccccchhcchhhhhc---ccchhhhcCccCCC------CCcHHHHHHHHHHHHHhhccCCCCC
Q 021526 191 LLELITGRKAMDLSKGQGEQNLVSWSRPFLKD---QKKFVHLVDPLLHG------RYPRRCLNYAVAVTAMCLNEEANFR 261 (311)
Q Consensus 191 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~R 261 (311)
+|+|+++..+++... ..+....... ...+.....+.... ...........+||.+||+.||++|
T Consensus 369 L~el~~~~~~~~~~~-------~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 369 FLQMAFPNLRSDSNL-------IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHhCcCCCchHH-------HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 999999766543110 0000000000 00111111111000 0001122345689999999999999
Q ss_pred CCHHHHHHH
Q 021526 262 PLINDIVVA 270 (311)
Q Consensus 262 Ps~~~l~~~ 270 (311)
||+.++++.
T Consensus 442 ~ta~e~L~H 450 (566)
T PLN03225 442 ISAKAALAH 450 (566)
T ss_pred CCHHHHhCC
Confidence 999999863
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=234.02 Aligned_cols=238 Identities=23% Similarity=0.257 Sum_probs=185.7
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccc---hhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQG---HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
|.-+|=|+||+|-.++. ....+|.|.+.+++.-. ....+.|-.||....++-|+++|-.|.+.+.+|+||+|+.|
T Consensus 634 ik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPG 713 (1034)
T KOG0608|consen 634 IKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 713 (1034)
T ss_pred EeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCC
Confidence 45688999999999988 56789999998775433 34677889999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCC--CCCC
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP--VGDN 154 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~--~~~~ 154 (311)
|++-.+|. +.+.|.++.+..++..+.+|+++.|..| ++||||||+|||||.+|.+||.|||+++-.. ....
T Consensus 714 GDmMSLLI----rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 714 GDMMSLLI----RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred ccHHHHHH----HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceeccccc
Confidence 99999884 5678999999999999999999999999 9999999999999999999999999986211 1000
Q ss_pred ccee--------------------------------------eeccccccccCCccccCCCCCccccchhHHHHHHHHHh
Q 021526 155 THVS--------------------------------------TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196 (311)
Q Consensus 155 ~~~~--------------------------------------~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~ 196 (311)
.+.. ....||..|+|||++....++..+|.|+.|+++|+|+.
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence 0000 02458999999999999999999999999999999999
Q ss_pred CCCCccccCccccc-cchhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCC
Q 021526 197 GRKAMDLSKGQGEQ-NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 262 (311)
Q Consensus 197 g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP 262 (311)
|++||-.....+.. .+. ++...++-.-++.++.++...+..|++ +++.|-
T Consensus 867 g~~pf~~~tp~~tq~kv~-----------nw~~~l~~~~~~~ls~e~~~li~kLc~-----sad~RL 917 (1034)
T KOG0608|consen 867 GQPPFLADTPGETQYKVI-----------NWRNFLHIPYQGNLSKEALDLIQKLCC-----SADSRL 917 (1034)
T ss_pred CCCCccCCCCCcceeeee-----------ehhhccccccccccCHHHHHHHHHHhc-----Chhhhh
Confidence 99999644433222 223 333444444455555555544444433 455553
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=209.13 Aligned_cols=209 Identities=35% Similarity=0.456 Sum_probs=180.4
Q ss_pred eeeceeccEEEEEEC--CeEEEEEEeccCCcc-chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHHH
Q 021526 5 YLSCKFYNVGLVWLC--DQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81 (311)
Q Consensus 5 ~~~g~~~~v~~~~~~--~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (311)
+|.|.+|.||++... ++.+++|.+...... ..+.+.+|++.++.++|++++++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 578999999999995 899999998755432 34689999999999999999999999999899999999999899999
Q ss_pred HhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcC-CCceEEeecCCCccCCCCCCcceeee
Q 021526 82 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-DFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 82 ~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~-~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
++... ...++...++.++.+++.++++||+.+ ++|+||+|.||+++. ++.++|+||+.+........ ....
T Consensus 81 ~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 81 LLKEN---EGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 99542 157889999999999999999999999 999999999999999 89999999999875322211 1223
Q ss_pred ccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 161 VMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
..+...|.+||..... ..+.+.|+|++|+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 4467789999988777 788999999999999998
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
..+.+++.+|+..+|++||++.++++.
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 347899999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-32 Score=207.58 Aligned_cols=199 Identities=23% Similarity=0.271 Sum_probs=163.1
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc-cchhHHHHHHHHHhc-CCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSL-LHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
++.+|+|++|.|-+-++ +|.-.|+|.+...-. +...+..+|+.+... ..+|+++++++.+..+...++.||.++-
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t- 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT- 129 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-
Confidence 46799999998877777 999999999875543 233467777777644 4699999999998899999999999954
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|.-+.......++.+++..+-+++..++.||.|||++-+ ++|||+||.|||++..|.||+||||.+-...... .
T Consensus 130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi---A 204 (282)
T KOG0984|consen 130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGYLVDSI---A 204 (282)
T ss_pred hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccceeehhhh---H
Confidence 7777766655688999999999999999999999998643 9999999999999999999999999986532211 1
Q ss_pred eeeccccccccCCccccC----CCCCccccchhHHHHHHHHHhCCCCccccCc
Q 021526 158 STRVMGTYGYCAPEYAMS----GKLTLKSDIYSFGVVLLELITGRKAMDLSKG 206 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~----~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 206 (311)
.....|-.-|+|||.... ..|+.++||||||+++.||.+++.||+.+..
T Consensus 205 kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 205 KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 222456778999998764 3689999999999999999999999975443
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=231.92 Aligned_cols=259 Identities=19% Similarity=0.142 Sum_probs=171.2
Q ss_pred eeeeeeceeccEEEEEE------------------CCeEEEEEEeccCCccchhH--------------HHHHHHHHhcC
Q 021526 2 LCCYLSCKFYNVGLVWL------------------CDQLVAIKQLNHEGLQGHQE--------------FIVEVLMLSLL 49 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~------------------~~~~vaiK~~~~~~~~~~~~--------------~~~e~~~l~~l 49 (311)
.+++|+|+||.||+|.. .++.||||.+........++ ...|+.++..+
T Consensus 150 ~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l 229 (507)
T PLN03224 150 RDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKI 229 (507)
T ss_pred eeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHh
Confidence 47899999999999974 34689999986543222222 33466666666
Q ss_pred CCCc-----ccceeEEEEe--------CCeeEEEEecCCCCCHHHHhcccCC--------------------CCCCCCHH
Q 021526 50 HHDN-----LVTLIGYCTS--------GDQRLLVYEYMPMGSLEDHLYDLEP--------------------DQEPLSWN 96 (311)
Q Consensus 50 ~h~~-----i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~l~~~ 96 (311)
+|.+ +++++++|.. ....++|+||+.+++|.+++..... ....+++.
T Consensus 230 ~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~ 309 (507)
T PLN03224 230 KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDIN 309 (507)
T ss_pred hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHH
Confidence 6554 3566666542 3467999999999999999864211 11235667
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeeeccccccccCCccccCC
Q 021526 97 TRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG 176 (311)
Q Consensus 97 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 176 (311)
.+..++.|++.+|.|||+.+ ++|+||||.||+++.++.++|+|||++........ .......+++.|+|||++...
T Consensus 310 ~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aPE~l~~~ 385 (507)
T PLN03224 310 VIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPPEELVMP 385 (507)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeChhhhcCC
Confidence 78899999999999999999 99999999999999999999999999864322111 111122347899999987542
Q ss_pred CC----------------------CccccchhHHHHHHHHHhCCC-CccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 177 KL----------------------TLKSDIYSFGVVLLELITGRK-AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 177 ~~----------------------~~~~Dv~slG~~l~~l~~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
.. ..+.|+||+||++++|+++.. |+........ ... ..-.+...+.......
T Consensus 386 ~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~-~~~----~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 386 QSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT-ELR----QYDNDLNRWRMYKGQK 460 (507)
T ss_pred CCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh-HHh----hccchHHHHHhhcccC
Confidence 21 124699999999999999875 6642111000 000 0000000011111111
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCC---CCCCCHHHHHH
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEA---NFRPLINDIVV 269 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p---~~RPs~~~l~~ 269 (311)
.........+....+++.+||..+| .+|+|++|+++
T Consensus 461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 1111123456778999999999766 68999999985
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=227.36 Aligned_cols=191 Identities=24% Similarity=0.206 Sum_probs=158.0
Q ss_pred eeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCC------CcccceeEEEEeCCeeEEEEecCC
Q 021526 4 CYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHH------DNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
..|+|-|++|-.+.. .|..||||+|.... .-++.=..|+++|++|+. -|+++++-.|.+.+++|+|+|.+
T Consensus 439 ~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L- 516 (752)
T KOG0670|consen 439 YTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL- 516 (752)
T ss_pred ccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-
Confidence 468999999988887 67899999987542 233445679999999963 37999999999999999999988
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCC-ceEEeecCCCccCCCCCC
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-NPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~-~vkl~Df~~~~~~~~~~~ 154 (311)
..+|.+.+.++. .+..+....+..++.|+..||..|-..| ++|.||||+||||++.. .+||||||.+... ..
T Consensus 517 slNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~---~e 589 (752)
T KOG0670|consen 517 SLNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSASFA---SE 589 (752)
T ss_pred hchHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCcccccc---cc
Confidence 569999997754 5567888899999999999999999999 99999999999998765 4799999998632 22
Q ss_pred cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCcccc
Q 021526 155 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 204 (311)
Q Consensus 155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 204 (311)
....+.. ....|.|||++.+.+|+...|+||+||++|||+||+..|.+.
T Consensus 590 neitPYL-VSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 590 NEITPYL-VSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred ccccHHH-HHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 2222221 345799999999999999999999999999999999888643
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=204.71 Aligned_cols=252 Identities=16% Similarity=0.222 Sum_probs=185.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCC-CCcccceeEEEEeC--CeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSG--DQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e~~~~ 76 (311)
...+|+|+++.|+.|.. ++++++||++++ ...+.+.+|+.+|..+. +|||++++++..+. ....+++|++++
T Consensus 43 vrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n 119 (338)
T KOG0668|consen 43 VRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNN 119 (338)
T ss_pred HHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhcc
Confidence 35789999999999997 899999999863 34568999999999998 99999999987543 456899999988
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCC-CceEEeecCCCccCCCCCCc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-FNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~-~~vkl~Df~~~~~~~~~~~~ 155 (311)
.+..... ++++...+..++.+++.||.|+|+.| |.|+|+||.|++++.. ..++|+|+|++...-....
T Consensus 120 ~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e- 188 (338)
T KOG0668|consen 120 TDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE- 188 (338)
T ss_pred ccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCce-
Confidence 7776665 56777888999999999999999999 9999999999999855 5699999999974433332
Q ss_pred ceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCccccc-----------cchhcchhh-hhc
Q 021526 156 HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-----------NLVSWSRPF-LKD 222 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-----------~~~~~~~~~-~~~ 222 (311)
.........|--||++.. ..|+..-|+|||||++..|+..+.||..+.....+ .+......+ +.-
T Consensus 189 --YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 189 --YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred --eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence 233344567888998765 46788999999999999999999998644322111 000010000 011
Q ss_pred ccchhhhcCccCCCCCc--------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 223 QKKFVHLVDPLLHGRYP--------RRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 223 ~~~~~~~~~~~~~~~~~--------~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
...+..++....+.... .-..++..+++.+.|..|-++|+|+.|...
T Consensus 267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 11111111111111110 112467889999999999999999999876
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=201.44 Aligned_cols=239 Identities=20% Similarity=0.298 Sum_probs=177.0
Q ss_pred eeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCC-CCcccceeEE-EEeCCeeEEEEecCCCCCH
Q 021526 4 CYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGY-CTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~-~~~~~~~~lv~e~~~~~~L 79 (311)
.+|.|.||.+-.+.. ++..+++|.+..+- ....+|.+|+..--.|. |.||+..|++ |++.+.+.+++|++.-|+|
T Consensus 31 ~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL 109 (378)
T KOG1345|consen 31 QLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDL 109 (378)
T ss_pred HhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchh
Confidence 579999999999999 78999999986553 34468999998776774 8899988875 6777788999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEc--CCCceEEeecCCCccCCCCCCcce
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD--NDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~--~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
.+.+. ...+.+.....++.|+++||.|||+++ +||||||.+||||- +.-+|||+|||+++..+...
T Consensus 110 ~snv~-----~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV---- 177 (378)
T KOG1345|consen 110 RSNVE-----AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV---- 177 (378)
T ss_pred hhhcC-----cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCcee----
Confidence 99984 367888888999999999999999999 99999999999993 33489999999997533221
Q ss_pred eeeccccccccCCccccC---C--CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCc
Q 021526 158 STRVMGTYGYCAPEYAMS---G--KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 232 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~---~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
.......-|.+||+... + ...+.+|+|.||+++|++++|.+||+....... ....|. .+.....+
T Consensus 178 -~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~-~Y~~~~--------~w~~rk~~ 247 (378)
T KOG1345|consen 178 -KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK-PYWEWE--------QWLKRKNP 247 (378)
T ss_pred -hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc-hHHHHH--------HHhcccCc
Confidence 11223556899997653 2 346789999999999999999999983332222 122221 11111111
Q ss_pred cCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 021526 233 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLIND 266 (311)
Q Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~ 266 (311)
.+...+ ...++.+..++++-|..++++|=-..+
T Consensus 248 ~~P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~ 280 (378)
T KOG1345|consen 248 ALPKKF-NPFSEKALRLFKKSLTPRFKDRCKIWT 280 (378)
T ss_pred cCchhh-cccCHHHHHHHHHhcCCcccccchhHH
Confidence 221111 123556888999999999999933333
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-30 Score=228.94 Aligned_cols=247 Identities=24% Similarity=0.263 Sum_probs=200.0
Q ss_pred CeeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 1 MLCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
|+-.+|+|.+|.||+++. +++..|+|+++.+...+..-+.+|+-+++..+||||+.+++.+.....+|+.||||.+|+
T Consensus 19 llqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggs 98 (829)
T KOG0576|consen 19 LLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGS 98 (829)
T ss_pred heeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCc
Confidence 456789999999999999 899999999998888888889999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
|.+-. .-.+.+.+.++..++...+.+++|||+.+ -+|||||-.||++++.|.||+.|||.+-.++.. ....
T Consensus 99 lQdiy----~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat--i~Kr 169 (829)
T KOG0576|consen 99 LQDIY----HVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IAKR 169 (829)
T ss_pred cccee----eecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh--hhhh
Confidence 98876 35788999999999999999999999999 999999999999999999999999987653322 2223
Q ss_pred eeccccccccCCcccc---CCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 159 TRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
....|++.|+|||+.. ...|...+|+|++|+...++.-.++|....-+ ++..+. -.....++.-.
T Consensus 170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp---------mr~l~L---mTkS~~qpp~l 237 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP---------MRALFL---MTKSGFQPPTL 237 (829)
T ss_pred hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch---------HHHHHH---hhccCCCCCcc
Confidence 4467999999999764 45788999999999999999988887531110 000000 00000111111
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
+-.....+.+.+|++.+|..+|++||+++.+++
T Consensus 238 -kDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 238 -KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred -cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 112345777999999999999999999998876
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=221.95 Aligned_cols=190 Identities=24% Similarity=0.283 Sum_probs=163.6
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc----ch----hHHHHHHHHHhcCC---CCcccceeEEEEeCCeeE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ----GH----QEFIVEVLMLSLLH---HDNLVTLIGYCTSGDQRL 68 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~----~~----~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~ 68 (311)
+-.+|.|+||.|..++. +...|+||++.+++.- -+ -.+-.|+++|..++ |+||++++++|++++.+|
T Consensus 566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy 645 (772)
T KOG1152|consen 566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY 645 (772)
T ss_pred eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence 45789999999999999 7789999999876421 11 12557999999997 999999999999999999
Q ss_pred EEEecC-CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 69 LVYEYM-PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 69 lv~e~~-~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
++||.- ++.+|.+++ ...+.+++..+..++.|++.++++||++| |+|||||-+|+.++.+|-+||+|||.+.
T Consensus 646 l~te~hg~gIDLFd~I----E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 646 LETEVHGEGIDLFDFI----EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred EEecCCCCCcchhhhh----hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccchh
Confidence 999975 567999999 46788999999999999999999999999 9999999999999999999999999986
Q ss_pred cCCCCCCcceeeeccccccccCCccccCCCCC-ccccchhHHHHHHHHHhCCCCcc
Q 021526 148 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT-LKSDIYSFGVVLLELITGRKAMD 202 (311)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~ 202 (311)
....+ ......||..|.|||++.+.+|- ..-|||+||+++|-++....||.
T Consensus 719 ~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 719 YTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 43222 23456799999999999988774 67899999999999998888873
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-31 Score=211.24 Aligned_cols=258 Identities=22% Similarity=0.250 Sum_probs=185.9
Q ss_pred eeeceeccEEEEEE--CCeEEEEEEeccC--CccchhHHHHHHHHHhcCCCCcccceeEEEEeCC-----eeEEEEecCC
Q 021526 5 YLSCKFYNVGLVWL--CDQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD-----QRLLVYEYMP 75 (311)
Q Consensus 5 ~~~g~~~~v~~~~~--~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~ 75 (311)
+|-|+||.||.+.. +|+.|++|++..- +....+.+.+|+.+|+..+|.|++..++...-.. .+|+++|.+.
T Consensus 61 IGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQ 140 (449)
T KOG0664|consen 61 IGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQ 140 (449)
T ss_pred ccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHH
Confidence 67899999999998 8999999987543 3345578899999999999999998887653222 3467777773
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
.+|...+ .....++.+.+.-++.||+.+|+|||+.+ |.||||||.|++++.+-.+||+|||+++.......
T Consensus 141 -SDLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~- 211 (449)
T KOG0664|consen 141 -SDLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR- 211 (449)
T ss_pred -hhhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhhh-
Confidence 3555555 56788999999999999999999999999 99999999999999999999999999985433222
Q ss_pred ceeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcch------hhhhcccchhh
Q 021526 156 HVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR------PFLKDQKKFVH 228 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------~~~~~~~~~~~ 228 (311)
........|..|.|||++++. .|+.+.||||.||++.|++..+..|+-.+.....+++.... .....-+....
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~ 291 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN 291 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence 222334568899999999986 68999999999999999999888886554322221111000 00000000000
Q ss_pred -hcCc--------cCCC-CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 021526 229 -LVDP--------LLHG-RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 271 (311)
Q Consensus 229 -~~~~--------~~~~-~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L 271 (311)
++.. .+.. ..+..-..+-..+..++|..+|++|.+.++.+..+
T Consensus 292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 0000 0000 01123345567888999999999999999887754
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=208.68 Aligned_cols=125 Identities=23% Similarity=0.308 Sum_probs=105.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCC-----C---CcccceeEEEE----eCCee
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-----H---DNLVTLIGYCT----SGDQR 67 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~~i~~~~~~~~----~~~~~ 67 (311)
.++||=|+|++|+.+|. +.+.||+|+.+... .-.+....|+.+|++++ | .+|+++++.|. ++.+.
T Consensus 83 ~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HV 161 (590)
T KOG1290|consen 83 QRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHV 161 (590)
T ss_pred EEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEE
Confidence 46899999999999999 88999999976432 22255778999998884 2 36999999986 46789
Q ss_pred EEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE
Q 021526 68 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL 132 (311)
Q Consensus 68 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~ 132 (311)
|+|+|++ |.+|..+|.+ ..-..++...+.+++.||+.||.|||...+ |+|.||||+|||+
T Consensus 162 CMVfEvL-GdnLLklI~~--s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl 221 (590)
T KOG1290|consen 162 CMVFEVL-GDNLLKLIKY--SNYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLL 221 (590)
T ss_pred EEEehhh-hhHHHHHHHH--hCCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeee
Confidence 9999998 7799999976 456789999999999999999999998653 9999999999998
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-27 Score=196.96 Aligned_cols=194 Identities=34% Similarity=0.361 Sum_probs=166.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc-chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
...++.|.++.||++.. +++.+++|.+...... ..+.+.+|++.++.++|+|++++++++......++++|++.+++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 83 (225)
T smart00221 4 GKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGD 83 (225)
T ss_pred eeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCC
Confidence 35689999999999999 4799999998866554 56789999999999999999999999998899999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
|.+++.... ..+++..++.++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+........ ...
T Consensus 84 L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~ 156 (225)
T smart00221 84 LFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALL 156 (225)
T ss_pred HHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccc
Confidence 999996522 12888999999999999999999998 99999999999999999999999998875433210 122
Q ss_pred eeccccccccCCccc-cCCCCCccccchhHHHHHHHHHhCCCCcc
Q 021526 159 TRVMGTYGYCAPEYA-MSGKLTLKSDIYSFGVVLLELITGRKAMD 202 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~-~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 202 (311)
....+...|++||.+ ....++.++|+|+||+++++|++|+.||.
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 234567789999988 66677889999999999999999999995
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=201.07 Aligned_cols=239 Identities=25% Similarity=0.303 Sum_probs=175.2
Q ss_pred CCeEEEEEEeccC--CccchhHHHHHHHHHhcCCCCcccceeEEEEeC------CeeEEEEecCCCCCHHHHhcccCCCC
Q 021526 19 CDQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG------DQRLLVYEYMPMGSLEDHLYDLEPDQ 90 (311)
Q Consensus 19 ~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~ 90 (311)
.+++|++|....+ .....++..+|+..+..++|+|+++++.+|+-. ...|+|||+++ .+|.+.+.
T Consensus 40 ~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~------ 112 (369)
T KOG0665|consen 40 LGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVIL------ 112 (369)
T ss_pred ccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHH------
Confidence 6899999987655 223346788999999999999999999998643 34689999995 48888884
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeeeccccccccCC
Q 021526 91 EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 170 (311)
Q Consensus 91 ~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aP 170 (311)
-.++-+.+..++.|++.|+.+||+.| |+|||+||+||++..+..+|+.|||+++..... ........+..|.||
T Consensus 113 ~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrap 186 (369)
T KOG0665|consen 113 MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAP 186 (369)
T ss_pred HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcc---cccCchhheeeccCc
Confidence 45566788999999999999999999 999999999999999999999999999743222 223334568889999
Q ss_pred ccccCCCCCccccchhHHHHHHHHHhCCCCccccCcccc----------------ccchhcchhhhhcc-----cchhhh
Q 021526 171 EYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE----------------QNLVSWSRPFLKDQ-----KKFVHL 229 (311)
Q Consensus 171 E~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~-----~~~~~~ 229 (311)
|+..+-.+.+..||||+||++.+|++|...|.+.+.-.. .++..-.+.+.... ..+.++
T Consensus 187 evil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~ 266 (369)
T KOG0665|consen 187 EVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSEL 266 (369)
T ss_pred hheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhh
Confidence 999888899999999999999999999988863321000 00111111111100 001111
Q ss_pred -cCccCCCC--CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 230 -VDPLLHGR--YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 230 -~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.+..+... .++.......+++.+||-.||++|-|++++++.
T Consensus 267 fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 267 FPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred CCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 11111111 112345668899999999999999999999874
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=184.90 Aligned_cols=169 Identities=24% Similarity=0.188 Sum_probs=125.1
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
|+|.+++.. .+..+++..++.++.|++.||.|||+.+ ||+||+++.++.+++ ||.+......
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~---- 62 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE---- 62 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc----
Confidence 588898854 3567999999999999999999999875 999999999999999 9988643221
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
...|+..|+|||++.+..++.++|||||||++|+|++|..||........ .......... . ..+.. .
T Consensus 63 ---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-----~~~~~~~~~~---~-~~~~~-~ 129 (176)
T smart00750 63 ---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-----ILEILLNGMP---A-DDPRD-R 129 (176)
T ss_pred ---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-----HHHHHHHHhc---c-CCccc-c
Confidence 12578999999999999999999999999999999999999853321110 0000000000 0 00000 0
Q ss_pred CCcHHHHH--HHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 021526 237 RYPRRCLN--YAVAVTAMCLNEEANFRPLINDIVVALDYLVS 276 (311)
Q Consensus 237 ~~~~~~~~--~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~ 276 (311)
..+..... .+.+++.+||..+|.+||++.++++.+..+..
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 11223333 69999999999999999999999998876654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-27 Score=226.51 Aligned_cols=196 Identities=15% Similarity=0.204 Sum_probs=134.7
Q ss_pred cCCC-CcccceeEEE-------EeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 021526 48 LLHH-DNLVTLIGYC-------TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 119 (311)
Q Consensus 48 ~l~h-~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~ 119 (311)
.++| +||..++++| ..+...++++|++ +++|.+++.. ....+++..++.++.||+.||+|||++|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 4445 4677777766 2234567788887 6699999964 3456999999999999999999999999
Q ss_pred eeecCCCCCcEEEcCCCceEEe-------------------ecCCCccCCCCCCc--------------ceeeecccccc
Q 021526 120 VIYRDLKSANILLDNDFNPKLS-------------------DFGLAKLGPVGDNT--------------HVSTRVMGTYG 166 (311)
Q Consensus 120 i~H~di~p~nil~~~~~~vkl~-------------------Df~~~~~~~~~~~~--------------~~~~~~~~~~~ 166 (311)
|+||||||+|||++..+.++++ |||+++........ .......|++.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 9999999999999765555555 55544321000000 00011346788
Q ss_pred ccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCcHHHHHHH
Q 021526 167 YCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYA 246 (311)
Q Consensus 167 ~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (311)
|+|||++.+..++.++|||||||++|||++|.+|+..... .... . . .....+. ........
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~----~-~-----~~~~~~~-----~~~~~~~~ 241 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSS----L-R-----HRVLPPQ-----ILLNWPKE 241 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHH----H-H-----HhhcChh-----hhhcCHHH
Confidence 9999999998999999999999999999998887641110 0000 0 0 0000000 01113345
Q ss_pred HHHHHHhhccCCCCCCCHHHHHH
Q 021526 247 VAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 247 ~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..++.+||+.+|.+||++.++++
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhh
Confidence 68889999999999999999976
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=196.87 Aligned_cols=257 Identities=23% Similarity=0.243 Sum_probs=188.4
Q ss_pred eeeeeeceeccEEEEEE-----CCeEEEEEEeccCCccchhHHHHHHHHHhcCC-CCcccceeEEEEeCCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL-----CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
.+++|.|+|+.||++.+ .++.||+|.+... .....+.+|+++|..+. +.||+++.+.+..++..++|+||++
T Consensus 41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~ 118 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFE 118 (418)
T ss_pred hccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccC
Confidence 57899999999999998 3689999987643 34467999999999986 8899999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEc-CCCceEEeecCCCccCCCCC-
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAKLGPVGD- 153 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~-~~~~vkl~Df~~~~~~~~~~- 153 (311)
+....++.. .++...+..+++.++.||+++|.+| |+|+||||.|++.+ ..++-.|+|||++.......
T Consensus 119 H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 119 HDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred ccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence 988888883 3557888999999999999999999 99999999999996 45678999999987200000
Q ss_pred -------------C----------------------------cceeeeccccccccCCccccCC-CCCccccchhHHHHH
Q 021526 154 -------------N----------------------------THVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVL 191 (311)
Q Consensus 154 -------------~----------------------------~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l 191 (311)
. ........||++|.|||++... ..+++.||||.|+++
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence 0 0000124589999999988764 568899999999999
Q ss_pred HHHHhCCCCccccCcccccc---------------------chhcc-hhh---hhcccchhhh----cCc-----cCCCC
Q 021526 192 LELITGRKAMDLSKGQGEQN---------------------LVSWS-RPF---LKDQKKFVHL----VDP-----LLHGR 237 (311)
Q Consensus 192 ~~l~~g~~p~~~~~~~~~~~---------------------~~~~~-~~~---~~~~~~~~~~----~~~-----~~~~~ 237 (311)
..+++++.||......-..- +.-|. ... ......+..+ +.+ .....
T Consensus 269 Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~ 348 (418)
T KOG1167|consen 269 LSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREI 348 (418)
T ss_pred ehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecc
Confidence 99999999985433211100 00011 000 0000111111 111 11111
Q ss_pred CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 238 YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.....+..+.+++.+||+.||.+|.|+++.++.
T Consensus 349 ~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 349 GSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 122345578999999999999999999999873
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-26 Score=212.56 Aligned_cols=243 Identities=22% Similarity=0.198 Sum_probs=180.9
Q ss_pred eeeeeceeccEEEEEECCeEEEEEEeccCCc-cchhHHHHHHHHH--hcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 3 CCYLSCKFYNVGLVWLCDQLVAIKQLNHEGL-QGHQEFIVEVLML--SLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l--~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
.-+|+++|-++.++......|+||++-+..+ -....+.++++.+ ..+++||++++..+...+...|+|-+|..+ +|
T Consensus 29 ~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nL 107 (1431)
T KOG1240|consen 29 ENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NL 107 (1431)
T ss_pred cccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh-hh
Confidence 3579999999999999666699999877653 3345555554444 455899999998887788888899888854 88
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCC-----CCCC
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP-----VGDN 154 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~-----~~~~ 154 (311)
.|.+ .-.+-+..-++.++++|++.||..+|..| |+|||||.+||||+.-+.++|.||....... +.+.
T Consensus 108 yDRl----STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf 180 (1431)
T KOG1240|consen 108 YDRL----STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADF 180 (1431)
T ss_pred hhhh----ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCcccc
Confidence 8888 45677888889999999999999999999 9999999999999999999999998775422 2222
Q ss_pred cceeeeccccccccCCccccCC----------C-CCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhc
Q 021526 155 THVSTRVMGTYGYCAPEYAMSG----------K-LTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKD 222 (311)
Q Consensus 155 ~~~~~~~~~~~~~~aPE~~~~~----------~-~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 222 (311)
.....+.....+|.|||.+... . .+++.||||+||++.|+++ |++||.+..- ..+......+
T Consensus 181 ~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL------~aYr~~~~~~ 254 (1431)
T KOG1240|consen 181 TFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL------LAYRSGNADD 254 (1431)
T ss_pred eEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH------HhHhccCccC
Confidence 3333445567799999988641 1 5788999999999999988 5777763221 1111110111
Q ss_pred ccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 223 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.+...+.+. ...++.+|..|++.||++|-++++.++.
T Consensus 255 ~e~~Le~Ie-----------d~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 255 PEQLLEKIE-----------DVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHHHhCc-----------CccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111111111 1247899999999999999999999986
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-24 Score=169.45 Aligned_cols=257 Identities=20% Similarity=0.147 Sum_probs=194.8
Q ss_pred CeeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCC-CcccceeEEEEeCCeeEEEEecCCCC
Q 021526 1 MLCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHH-DNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
++..+|.|+||.+|.+.. +|..||||+-.. .....++..|..++..+++ ..|..+..+..+...-.+||+.+ |.
T Consensus 19 lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~--~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GP 95 (341)
T KOG1163|consen 19 LVRKIGSGSFGDIYLGISITSGEEVAIKLESS--KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GP 95 (341)
T ss_pred EEEeecCCchhheeeeeeccCCceEEEEeecc--cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-Cc
Confidence 468899999999999999 999999998542 3345688889999999974 67777787888888889999988 77
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEc---CCCceEEeecCCCccCCCCCC
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD---NDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~---~~~~vkl~Df~~~~~~~~~~~ 154 (311)
+|.+.++- ....++..+++.++.|++.-++|+|.++ ++|+||||+|+|+. ...++.|+|||++..+.....
T Consensus 96 sLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t 169 (341)
T KOG1163|consen 96 SLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT 169 (341)
T ss_pred cHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence 99998865 4567888999999999999999999999 99999999999994 345689999999986544332
Q ss_pred cc-----eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhh
Q 021526 155 TH-----VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 229 (311)
Q Consensus 155 ~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
.. ......||.+|.+--...+...+.+.|+-|+|.++.++--|..||+........+....+..... ..
T Consensus 170 ~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~------s~ 243 (341)
T KOG1163|consen 170 RQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM------ST 243 (341)
T ss_pred cccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc------CC
Confidence 22 22346688888887766677778899999999999999999999986554433322221111110 11
Q ss_pred cCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 021526 230 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 276 (311)
Q Consensus 230 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~ 276 (311)
.-..++.. .+.++.-.+..|-...-++-|+...+.+.+.-|..
T Consensus 244 ~ie~LC~G----~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 244 PIEVLCKG----FPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred CHHHHhCC----CcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 11122223 35567777778888888888998888887755544
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.3e-23 Score=178.02 Aligned_cols=258 Identities=21% Similarity=0.150 Sum_probs=193.0
Q ss_pred eeeeeeceeccEEEEEECC---eEEEEEEeccCCccchhHHHHHHHHHhcCC----CCcccceeEEE-EeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWLCD---QLVAIKQLNHEGLQGHQEFIVEVLMLSLLH----HDNLVTLIGYC-TSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~~---~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~----h~~i~~~~~~~-~~~~~~~lv~e~ 73 (311)
...+|.|+||.||.+.... ..+|+|............+..|..++..+. .+++..+++.. ..+...++||+.
T Consensus 23 ~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l 102 (322)
T KOG1164|consen 23 GKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSL 102 (322)
T ss_pred eeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEec
Confidence 4579999999999999832 479999876554333337788888888876 25888888888 477788999998
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCC-----CceEEeecCCCc-
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-----FNPKLSDFGLAK- 147 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~-----~~vkl~Df~~~~- 147 (311)
+ |.+|.+...... ...++...+..++.|++.+|.+||+.| ++||||||.|+++... ..++|.|||+++
T Consensus 103 ~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~ 176 (322)
T KOG1164|consen 103 L-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR 176 (322)
T ss_pred c-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence 7 889999875422 678999999999999999999999999 9999999999999754 469999999998
Q ss_pred -cCCCCCCc---ce---eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhh
Q 021526 148 -LGPVGDNT---HV---STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFL 220 (311)
Q Consensus 148 -~~~~~~~~---~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 220 (311)
........ .. .....||..|.++....+...+.+.|+||++.++.+++.|..||..........
T Consensus 177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~--------- 247 (322)
T KOG1164|consen 177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS--------- 247 (322)
T ss_pred ccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHH---------
Confidence 32222211 11 122458999999999999999999999999999999999999985433221110
Q ss_pred hcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 021526 221 KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 278 (311)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~ 278 (311)
.+.+..............+..+.++...+-..+...+|....+...|.+.....
T Consensus 248 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 248 ----KFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred ----HHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 000000000000022234556777777777789999999999999988877665
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.3e-23 Score=168.70 Aligned_cols=257 Identities=18% Similarity=0.125 Sum_probs=198.1
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCC-CCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
.++|.|+||.++.|.. ++++||||.-. ......++..|+..++.|. .++|..++-+-..+-+-.+|+|.+ |-+|
T Consensus 34 kKIGeGsFG~lf~G~Nl~nne~VAIKfEP--rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSL 110 (449)
T KOG1165|consen 34 KKIGEGSFGVLFLGKNLYNNEPVAIKFEP--RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSL 110 (449)
T ss_pred cccccCcceeeecccccccCceEEEEecc--ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCH
Confidence 3689999999999999 99999999843 4455678889999999886 789999887777777778999988 7788
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCC-----CceEEeecCCCccCCCCCC
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-----FNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~-----~~vkl~Df~~~~~~~~~~~ 154 (311)
.|++.- .+..|+...+..++.|++.-++++|++. +++|||||+|+||... ..+.++|||.+..+.....
T Consensus 111 EDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T 184 (449)
T KOG1165|consen 111 EDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT 184 (449)
T ss_pred HHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence 888854 5678999999999999999999999999 9999999999999543 3589999999986554443
Q ss_pred cce-----eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhh
Q 021526 155 THV-----STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 229 (311)
Q Consensus 155 ~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
... .....||.+||+--...+...+.+.|+-|||=++++.+-|..||+...........+.+-...+ ...+..+
T Consensus 185 kqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr-~T~i~~L 263 (449)
T KOG1165|consen 185 KQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKR-STPIEVL 263 (449)
T ss_pred cccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccc-cCCHHHH
Confidence 322 2346799999998888889999999999999999999999999986654322211111000000 0111111
Q ss_pred cCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 021526 230 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 278 (311)
Q Consensus 230 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~ 278 (311)
....+.++...++-.-..+-.+-|+.+.+...+..+....
T Consensus 264 ---------c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 264 ---------CEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred ---------HhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 1234667777777777788889999999999887776543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-24 Score=172.65 Aligned_cols=243 Identities=20% Similarity=0.282 Sum_probs=190.1
Q ss_pred eeeeceeccEEEEEECCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHHH
Q 021526 4 CYLSCKFYNVGLVWLCDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (311)
++.....|..++|++.|..++.|++.-... ....+|..|.-.|+...||||+++++.|...-++.++..|+..++|..
T Consensus 197 kl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslyn 276 (448)
T KOG0195|consen 197 KLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYN 276 (448)
T ss_pred hhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHH
Confidence 445566789999999999999998865533 233678899999999999999999999999999999999999999999
Q ss_pred HhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEE--eecCCCccCCCCCCcceee
Q 021526 82 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL--SDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 82 ~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl--~Df~~~~~~~~~~~~~~~~ 159 (311)
.+.. +.+...+..++..++.+++.+++|||+.. +-|.--.++...+++|++...+| +|--.+.. ..
T Consensus 277 vlhe--~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfq---------e~ 344 (448)
T KOG0195|consen 277 VLHE--QTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---------EV 344 (448)
T ss_pred HHhc--CccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeee---------cc
Confidence 9965 44555777788999999999999999985 33555568899999998876555 33322211 11
Q ss_pred eccccccccCCccccCCCC---CccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 160 RVMGTYGYCAPEYAMSGKL---TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~~~~~---~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
.....+.|++||.++..+- -.++|+|||++++||+.|...||..... .+.-.++....++-
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp----------------mecgmkialeglrv 408 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP----------------MECGMKIALEGLRV 408 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc----------------hhhhhhhhhccccc
Confidence 1234678999999887654 3579999999999999999999963322 12222333445555
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l 274 (311)
..|+..+..+..++.-|++.||.+||.+..++-.|++.
T Consensus 409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 67888899999999999999999999999999888875
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-22 Score=175.00 Aligned_cols=157 Identities=18% Similarity=0.075 Sum_probs=119.0
Q ss_pred eeeeeeceeccEEEEEE---CCeEEEEEEeccCC-----ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL---CDQLVAIKQLNHEG-----LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~---~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
...+|+|+||.||++.. +++.||||.+.... ......+.+|+++++.++|+|+++.+.. ....++||||
T Consensus 23 ~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE~ 99 (365)
T PRK09188 23 TAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRGW 99 (365)
T ss_pred ccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEEc
Confidence 46799999999999987 46778999865331 1224568999999999999999853322 2457999999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCC-CCCcEEEcCCCceEEeecCCCccCCCC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL-KSANILLDNDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di-~p~nil~~~~~~vkl~Df~~~~~~~~~ 152 (311)
+.|++|.. +. ... ...++.+++.+|+|||+.| ++|||| ||.|||++.++.++|+|||+++.....
T Consensus 100 ~~G~~L~~-~~---~~~-------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~ 165 (365)
T PRK09188 100 TEGVPLHL-AR---PHG-------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRR 165 (365)
T ss_pred cCCCCHHH-hC---ccc-------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceecccC
Confidence 99999963 21 111 1467889999999999999 999999 999999999999999999999864432
Q ss_pred CCccee------eeccccccccCCccccC
Q 021526 153 DNTHVS------TRVMGTYGYCAPEYAMS 175 (311)
Q Consensus 153 ~~~~~~------~~~~~~~~~~aPE~~~~ 175 (311)
...... ....++..|.+||.+..
T Consensus 166 ~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 166 GALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 211111 23456778999998764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-23 Score=195.02 Aligned_cols=250 Identities=20% Similarity=0.172 Sum_probs=177.3
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccC--Cccchh----HHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHE--GLQGHQ----EFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~--~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
.++|.|++|.|+.... ..+..+.|.+... ...... .+..|+.+=..++|||++..+..+.+.....-+||||
T Consensus 324 ~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~ 403 (601)
T KOG0590|consen 324 RVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYC 403 (601)
T ss_pred ceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhcc
Confidence 4678888886666655 3444455543211 111111 2444666667789999877766554444444449999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
+. +|...+.. ...+....+.-++.|++.|+.|+|+.| +.|+|+|++|++++.+|.+|++|||.+........
T Consensus 404 ~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 404 PY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred cH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 98 99999943 457888888999999999999999999 99999999999999999999999998865333333
Q ss_pred c--ceeeeccccccccCCccccCCCCCc-cccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcC
Q 021526 155 T--HVSTRVMGTYGYCAPEYAMSGKLTL-KSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231 (311)
Q Consensus 155 ~--~~~~~~~~~~~~~aPE~~~~~~~~~-~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
. .......|...|+|||++.+..|++ ..||||.|+++..|++|+.||.........................
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~----- 550 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGP----- 550 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccCh-----
Confidence 2 3344567888999999999999885 6899999999999999999997665443321000000000000000
Q ss_pred ccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.......+...+.+|.+||+.+|.+|.|+++|++
T Consensus 551 ----~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 551 ----NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ----HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0111245667889999999999999999999986
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.6e-21 Score=165.47 Aligned_cols=259 Identities=32% Similarity=0.369 Sum_probs=193.2
Q ss_pred eeeeeeceeccEEEEEECCeEEEEEEeccCCcc---chhHHHHHHHHHhcCCCC-cccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHD-NLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
...+|.|.|+.||.+... ..+++|.+...... ....+.+|+..+..+.|+ +++++.+++......+++++++.++
T Consensus 5 ~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 83 (384)
T COG0515 5 LRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGG 83 (384)
T ss_pred EEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCC
Confidence 457889999999999998 88899988766433 356899999999999988 7999999997777789999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCC-ceEEeecCCCccCCCCCCcc
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-NPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~-~vkl~Df~~~~~~~~~~~~~ 156 (311)
++.+++...... ..+.......++.|++.++.++|+.+ ++|+|++|+||+++..+ .++++|||.+..........
T Consensus 84 ~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (384)
T COG0515 84 SLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTS 159 (384)
T ss_pred cHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccc
Confidence 999777442111 37889999999999999999999999 99999999999999988 79999999987433322221
Q ss_pred ----eeeeccccccccCCccccC---CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhh
Q 021526 157 ----VSTRVMGTYGYCAPEYAMS---GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 229 (311)
Q Consensus 157 ----~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
......++..|.+||...+ .......|+|++|+++++++.|..||...... ................ .
T Consensus 160 ~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~---~ 234 (384)
T COG0515 160 SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS--SATSQTLKIILELPTP---S 234 (384)
T ss_pred cccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc--ccHHHHHHHHHhcCCc---c
Confidence 2355678999999999887 57889999999999999999999996543321 0000000000000000 0
Q ss_pred cCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 230 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 230 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
................+.+++..|+..+|..|.+..+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000001223578899999999999999998887764
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=185.37 Aligned_cols=243 Identities=16% Similarity=0.135 Sum_probs=178.3
Q ss_pred eeeeeceeccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCC---CCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 3 CCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH---HDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
.++|.|++|.||.|.. +|+.||+|+-....+.+.- --.+++.+|+ -+.|.++...+...+..++|++|.+.|+
T Consensus 704 ~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfY---I~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gt 780 (974)
T KOG1166|consen 704 KEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFY---ICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGT 780 (974)
T ss_pred eeeccccceEEEEeecCCCcEEEEEeecCCCceeee---ehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecccccc
Confidence 4689999999999999 8999999997766555332 1222222232 3456676666666778899999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEc-------CCCceEEeecCCCccCCC
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD-------NDFNPKLSDFGLAKLGPV 151 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~-------~~~~vkl~Df~~~~~~~~ 151 (311)
|.+++. ..+.+++..++.+..|++..++.||..+ |+||||||+|+|+. .+-.++|+|||.+..+..
T Consensus 781 lld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~l 853 (974)
T KOG1166|consen 781 LLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKL 853 (974)
T ss_pred HHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecccceeeeE
Confidence 999995 6788999999999999999999999999 99999999999993 234589999999876554
Q ss_pred CCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcC
Q 021526 152 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231 (311)
Q Consensus 152 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
..........+++..+-.+|+..+.+++.+.|.|.|+.+++.|+.|...- ..+ .....+.
T Consensus 854 fp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-~~~-------------------g~~~~~~ 913 (974)
T KOG1166|consen 854 FPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-VKN-------------------GSSWMVK 913 (974)
T ss_pred cCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-hcC-------------------Ccceecc
Confidence 44443444567888999999999999999999999999999999997532 000 0000011
Q ss_pred ccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 021526 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 278 (311)
Q Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~ 278 (311)
..++. ...-.-+.+++..+|+.|-..=|.+.+|...|+......
T Consensus 914 ~~~~R---y~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 914 TNFPR---YWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred ccchh---hhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 00100 011223567788888844444478888887776655443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.1e-22 Score=165.33 Aligned_cols=228 Identities=20% Similarity=0.222 Sum_probs=142.7
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCC---C-------cccceeEEE------
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHH---D-------NLVTLIGYC------ 61 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h---~-------~i~~~~~~~------ 61 (311)
..+|.|+++.||.+.. .++.+++|++.... ....+++.+|.-....+.+ | .++..++..
T Consensus 18 ~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~ 97 (288)
T PF14531_consen 18 RIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKP 97 (288)
T ss_dssp EEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-
T ss_pred cccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCC
Confidence 4689999999999999 68999999876543 2233566666655544322 1 222222221
Q ss_pred ---EeC---C-----eeEEEEecCCCCCHHHHhcccC---CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCC
Q 021526 62 ---TSG---D-----QRLLVYEYMPMGSLEDHLYDLE---PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 127 (311)
Q Consensus 62 ---~~~---~-----~~~lv~e~~~~~~L~~~l~~~~---~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p 127 (311)
... + +.+++|+-+ .++|.+.+.... +....+.....+.+..|+++.+++||+.| ++|+||+|
T Consensus 98 ~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~~ 173 (288)
T PF14531_consen 98 PFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIKP 173 (288)
T ss_dssp SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-SG
T ss_pred cceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccce
Confidence 111 1 236788877 458877764321 11222434445667799999999999999 99999999
Q ss_pred CcEEEcCCCceEEeecCCCccCCCCCCcceeeeccccccccCCccccC--------CCCCccccchhHHHHHHHHHhCCC
Q 021526 128 ANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS--------GKLTLKSDIYSFGVVLLELITGRK 199 (311)
Q Consensus 128 ~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Dv~slG~~l~~l~~g~~ 199 (311)
+|++++.+|.++|+||+.....+. ... ....+..|.+||.... ..++.+.|.|+||+++|.|+++..
T Consensus 174 ~nfll~~~G~v~Lg~F~~~~r~g~----~~~-~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 174 ENFLLDQDGGVFLGDFSSLVRAGT----RYR-CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp GGEEE-TTS-EEE--GGGEEETTE----EEE-GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred eeEEEcCCCCEEEcChHHHeecCc----eee-ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 999999999999999987653211 111 1334567889986643 246788999999999999999999
Q ss_pred CccccCccccccchhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCC
Q 021526 200 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFR 261 (311)
Q Consensus 200 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 261 (311)
||........... .-..+. +.++.++.||+.+|+.||.+|
T Consensus 249 Pf~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPEW---------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSGG---------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccccc---------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9974433222110 011223 778899999999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=156.79 Aligned_cols=138 Identities=17% Similarity=0.062 Sum_probs=108.1
Q ss_pred CeeeeeeceeccEEEEEE-CCeEEEEEEeccCCcc--c-------h-----------------hHHHHHHHHHhcCCCCc
Q 021526 1 MLCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQ--G-------H-----------------QEFIVEVLMLSLLHHDN 53 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~--~-------~-----------------~~~~~e~~~l~~l~h~~ 53 (311)
+.+++|+|++|.||.+.. +|+.||+|++...... . . ....+|++.+..+.+++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 1 INGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467899999999999998 7999999998754221 1 1 12234999999998877
Q ss_pred ccceeEEEEeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeeecCCCCCcEEE
Q 021526 54 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL-HCKANPPVIYRDLKSANILL 132 (311)
Q Consensus 54 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~L-h~~~~~~i~H~di~p~nil~ 132 (311)
+.....+... ..++||||+.++++..... ....++...+..++.|++.+|.++ |+.| ++|+||||.||++
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli 151 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLY 151 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEE
Confidence 6444333222 2389999998876655431 235688899999999999999999 7999 9999999999999
Q ss_pred cCCCceEEeecCCCcc
Q 021526 133 DNDFNPKLSDFGLAKL 148 (311)
Q Consensus 133 ~~~~~vkl~Df~~~~~ 148 (311)
+ ++.++|+|||++..
T Consensus 152 ~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 152 H-DGKLYIIDVSQSVE 166 (190)
T ss_pred E-CCcEEEEEcccccc
Confidence 8 47899999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.2e-22 Score=159.97 Aligned_cols=165 Identities=13% Similarity=0.144 Sum_probs=125.7
Q ss_pred eeeeeeceeccEEEEEECCeEEEEEEeccCCccchhH---------HHHHHHHHhcCCCCcccceeEEEEeC--------
Q 021526 2 LCCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQE---------FIVEVLMLSLLHHDNLVTLIGYCTSG-------- 64 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~---------~~~e~~~l~~l~h~~i~~~~~~~~~~-------- 64 (311)
+.+++.|+||.|+....+++.+|+|.+.......... +.+|++.+.+++|++|..+.+++...
T Consensus 36 ~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~ 115 (232)
T PRK10359 36 IKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYA 115 (232)
T ss_pred EEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccccccccc
Confidence 5689999999999976688899999997654333322 67899999999999999998886533
Q ss_pred CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecC
Q 021526 65 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 144 (311)
Q Consensus 65 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~ 144 (311)
...+++|||++|.+|.++.. +++ ....+++.++..+|+.| ++|+|++|.||+++.+| ++|+|||
T Consensus 116 ~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDfg 179 (232)
T PRK10359 116 HTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDLS 179 (232)
T ss_pred CCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEECC
Confidence 35789999999999988741 222 24568999999999999 99999999999999888 9999999
Q ss_pred CCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh
Q 021526 145 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196 (311)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~ 196 (311)
........... . .......+..++|+|+||+++..+..
T Consensus 180 ~~~~~~e~~a~---d-----------~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 180 GKRCTAQRKAK---D-----------RIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred CcccccchhhH---H-----------HHHHHhHhcccccccceeEeehHHHH
Confidence 87643111100 0 02233445678999999998776543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.4e-22 Score=178.89 Aligned_cols=224 Identities=25% Similarity=0.268 Sum_probs=182.9
Q ss_pred eeeeceeccEEEEEE-----CCeEEEEEEeccCCcc--chhHHHHHHHHHhcCC-CCcccceeEEEEeCCeeEEEEecCC
Q 021526 4 CYLSCKFYNVGLVWL-----CDQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
.+|.|.+|+|+.+.. .++.+++|...++... .......|-.++...+ ||+++++.-.+..+...+++.++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 368899999988776 5788888887765322 2235667888888887 9999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
++.|...+. ....+.+.....+...++.+++.+|+.+ ++|+|+|++||+++.+|.+++.|||+++......
T Consensus 81 gg~lft~l~----~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~-- 151 (612)
T KOG0603|consen 81 GGDLFTRLS----KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK-- 151 (612)
T ss_pred cchhhhccc----cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh--
Confidence 999998883 4667888888899999999999999999 9999999999999999999999999987432111
Q ss_pred ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 156 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
..+|+..|+|||+.. ....+.|.|++|+++++|++|..||.. +....++.. .
T Consensus 152 ----~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--------------------~~~~~Il~~--~ 203 (612)
T KOG0603|consen 152 ----IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--------------------DTMKRILKA--E 203 (612)
T ss_pred ----hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--------------------HHHHHHhhh--c
Confidence 117899999999987 567889999999999999999999973 111122211 1
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCCCH
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRPLI 264 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~ 264 (311)
-.+|...+....+++..++..+|.+|--.
T Consensus 204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 204 LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 24577889999999999999999999644
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.3e-20 Score=147.09 Aligned_cols=137 Identities=18% Similarity=0.074 Sum_probs=108.3
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCccc--------------------------hhHHHHHHHHHhcCCCCcc
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQG--------------------------HQEFIVEVLMLSLLHHDNL 54 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h~~i 54 (311)
+..+|+|++|.||++.. +|+.||||++....... .....+|++.+..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999998 69999999987653210 1123578899999999887
Q ss_pred cceeEEEEeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeecCCCCCcEEEc
Q 021526 55 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLD 133 (311)
Q Consensus 55 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~di~p~nil~~ 133 (311)
.....+... ..++||||++++++..... ....++...+..++.|++.++.++|+ .| ++|+||||.||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE
Confidence 554444333 2489999998875544321 23456778889999999999999999 98 99999999999998
Q ss_pred CCCceEEeecCCCcc
Q 021526 134 NDFNPKLSDFGLAKL 148 (311)
Q Consensus 134 ~~~~vkl~Df~~~~~ 148 (311)
++.++|+|||++..
T Consensus 153 -~~~~~liDFG~a~~ 166 (190)
T cd05145 153 -DGKPYIIDVSQAVE 166 (190)
T ss_pred -CCCEEEEEccccee
Confidence 78999999999874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.9e-20 Score=155.89 Aligned_cols=198 Identities=22% Similarity=0.187 Sum_probs=142.9
Q ss_pred CCCcccceeEEEEe---------------------------CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHH
Q 021526 50 HHDNLVTLIGYCTS---------------------------GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 102 (311)
Q Consensus 50 ~h~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~ 102 (311)
+||||+.+..+|.+ ...+|+||..++. +|.+|+.. ...+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-----CCCchHHHHHHH
Confidence 59999999877642 3567999999855 99999954 344556677899
Q ss_pred HHHHHHHHHHhhCCCCCeeecCCCCCcEEE--cC--CCceEEeecCCCccCCC----CCCcceeeeccccccccCCcccc
Q 021526 103 VGAARGLEYLHCKANPPVIYRDLKSANILL--DN--DFNPKLSDFGLAKLGPV----GDNTHVSTRVMGTYGYCAPEYAM 174 (311)
Q Consensus 103 ~~i~~~l~~Lh~~~~~~i~H~di~p~nil~--~~--~~~vkl~Df~~~~~~~~----~~~~~~~~~~~~~~~~~aPE~~~ 174 (311)
.|+++|+.+||.+| +.|+|+|.+|||+ ++ -..+.+.|||++.-... -..........|+-..+|||+..
T Consensus 348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 99999999999999 9999999999999 33 33579999998753211 11112223456788999999876
Q ss_pred CC--C----CCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHH
Q 021526 175 SG--K----LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVA 248 (311)
Q Consensus 175 ~~--~----~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 248 (311)
.- + .-.++|.|+.|.+.||+++...||...... ..+. ....+--.+ ..|..++..+++
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~-----------r~Yqe~qLP----alp~~vpp~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDT-----------RTYQESQLP----ALPSRVPPVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eech-----------hhhhhhhCC----CCcccCChHHHH
Confidence 32 1 135899999999999999999999642211 1111 111111111 235567778999
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHH
Q 021526 249 VTAMCLNEEANFRPLINDIVVALD 272 (311)
Q Consensus 249 li~~~l~~~p~~RPs~~~l~~~L~ 272 (311)
++...|+.||++|++..-....|+
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHH
Confidence 999999999999999877666653
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-19 Score=144.85 Aligned_cols=183 Identities=21% Similarity=0.114 Sum_probs=136.8
Q ss_pred eeeeeceeccEEEEEECCeEEEEEEeccCCccchh-----HHHHHHHHHhcCC-CCcccceeEEEEeCCeeEEEEecCCC
Q 021526 3 CCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQ-----EFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~-----~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
..+++|.||.|+.+.-.+.+++.+.+... +.... .+.+|+++|+++. ++++.+++++ +..+++|+|+.|
T Consensus 8 ~~l~~~~f~~v~~~~~~~~k~~~~~l~~~-~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G 82 (218)
T PRK12274 8 EPLKSDTFGRILLVRGGERKFVRRDLSAA-PWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAG 82 (218)
T ss_pred eeecCCCcceEEEeecCCceeeecccccc-hhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecC
Confidence 46899999999987778999998887644 33222 5789999999996 5788888876 346899999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCC-CCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL-KSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di-~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
.+|.+... . . ...++.|++.+|.++|+.| ++|+|| +|.||+++.++.++|+|||++.........
T Consensus 83 ~~L~~~~~----~-~------~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 83 AAMYQRPP----R-G------DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred ccHHhhhh----h-h------hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 88865441 1 1 1347789999999999999 999999 799999999999999999999753322210
Q ss_pred ----ce-------eeeccccccccCCccccCC-CCC-ccccchhHHHHHHHHHhCCCCcccc
Q 021526 156 ----HV-------STRVMGTYGYCAPEYAMSG-KLT-LKSDIYSFGVVLLELITGRKAMDLS 204 (311)
Q Consensus 156 ----~~-------~~~~~~~~~~~aPE~~~~~-~~~-~~~Dv~slG~~l~~l~~g~~p~~~~ 204 (311)
.. ......++.+++|+...-- ..+ ...+.++.|+.+|.++|+..++...
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 00 1122346667777643321 333 6778899999999999999886543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.9e-20 Score=162.87 Aligned_cols=220 Identities=27% Similarity=0.383 Sum_probs=164.3
Q ss_pred HhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe-eecC
Q 021526 46 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV-IYRD 124 (311)
Q Consensus 46 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i-~H~d 124 (311)
|+.+.|.|+.++++.+.++...+.|.++|..|+|.+.+.. ....+++.....++.+++.+++|||... + .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeee
Confidence 4678999999999999999999999999999999999965 5677888889999999999999999876 5 9999
Q ss_pred CCCCcEEEcCCCceEEeecCCCccCCCCCCcceeeeccccccccCCccccCCC-------CCccccchhHHHHHHHHHhC
Q 021526 125 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK-------LTLKSDIYSFGVVLLELITG 197 (311)
Q Consensus 125 i~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-------~~~~~Dv~slG~~l~~l~~g 197 (311)
++..|++++....+||.|||+.................-...|.|||++.... .+.++|+||+|++++++++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999999999999999999986542211111122223456799999887631 46679999999999999999
Q ss_pred CCCccccCccccc-cchhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 021526 198 RKAMDLSKGQGEQ-NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 276 (311)
Q Consensus 198 ~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~ 276 (311)
..||......... .+... ..+ .....+.|.+... ....+++..++.+||..+|.+||+++.+...+..+..
T Consensus 155 ~~~~~~~~~~~~~~eii~~----~~~--~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILR----VKK--GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cCccccccccCChHHHHHH----HHh--cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9999754332221 11111 010 0111111111100 1334479999999999999999999999998888776
Q ss_pred ccC
Q 021526 277 QRD 279 (311)
Q Consensus 277 ~~~ 279 (311)
...
T Consensus 227 ~~~ 229 (484)
T KOG1023|consen 227 GGS 229 (484)
T ss_pred ccc
Confidence 543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-18 Score=142.49 Aligned_cols=134 Identities=19% Similarity=0.167 Sum_probs=113.5
Q ss_pred eeeeeeceeccEEEEEECCeEEEEEEeccCCccc--------hhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQG--------HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
++.+|+|++|.||.+...+..|++|......... ...+.+|++++..++|+++.....++......+++|||
T Consensus 1 ~~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred CcccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4689999999999999999999999865443221 13577899999999999988777777777788999999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
++|++|.+.+... . . ....++.+++.+++++|+.+ ++|+|++|.||+++ ++.++|+|||.+.
T Consensus 81 ~~G~~L~~~~~~~----~---~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~ 142 (211)
T PRK14879 81 IEGEPLKDLINSN----G---M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAE 142 (211)
T ss_pred eCCcCHHHHHHhc----c---H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCccc
Confidence 9999999998431 1 1 77889999999999999999 99999999999998 7889999999886
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.7e-19 Score=142.38 Aligned_cols=133 Identities=17% Similarity=0.106 Sum_probs=104.1
Q ss_pred eeeeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcC-----CCCcccceeEEEEeCC---e-eEEEEec
Q 021526 3 CCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-----HHDNLVTLIGYCTSGD---Q-RLLVYEY 73 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~---~-~~lv~e~ 73 (311)
.++|+|+++.||.....+.. +||++........+.+.+|+.+++.+ +||||++++++++++. . ..+|+||
T Consensus 8 ~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~ 86 (210)
T PRK10345 8 SPLGTGRHRKCYAHPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADF 86 (210)
T ss_pred ceecCCCceEEEECCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecC
Confidence 47999999999973334444 79988765555567899999999999 5799999999998874 3 3378999
Q ss_pred --CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHH-HHHhhCCCCCeeecCCCCCcEEEcC----CCceEEeecCCC
Q 021526 74 --MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL-EYLHCKANPPVIYRDLKSANILLDN----DFNPKLSDFGLA 146 (311)
Q Consensus 74 --~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l-~~Lh~~~~~~i~H~di~p~nil~~~----~~~vkl~Df~~~ 146 (311)
+.+++|.+++.. ..+++. ..++.+++.++ +|||+.+ |+|+||||+||+++. ++.++|+|++.+
T Consensus 87 ~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 87 DGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred CCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 457899999943 235555 35677888777 9999999 999999999999974 337999995444
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.8e-18 Score=136.47 Aligned_cols=129 Identities=22% Similarity=0.207 Sum_probs=106.2
Q ss_pred eeeeceeccEEEEEECCeEEEEEEeccCCcc--------chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCC
Q 021526 4 CYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQ--------GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
++|+|++|.||++...+..|++|........ ....+.+|++++..++++++.....++..+...+++||+++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 4799999999999999999999986543211 12456789999999988876655555556667799999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
|++|.+.+.. ... .++.+++.+|++||+.+ ++|+|++|.||+++ ++.++++|||++.
T Consensus 81 g~~l~~~~~~----~~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~ 137 (199)
T TIGR03724 81 GKPLKDVIEE----GND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGK 137 (199)
T ss_pred CccHHHHHhh----cHH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCc
Confidence 9999988743 110 78999999999999999 99999999999999 8899999999886
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=5e-17 Score=134.90 Aligned_cols=136 Identities=17% Similarity=0.074 Sum_probs=104.0
Q ss_pred eeeeeeceeccEEEEE--E-CCeEEEEEEeccCCcc------------------------chhHHHHHHHHHhcCCCCc-
Q 021526 2 LCCYLSCKFYNVGLVW--L-CDQLVAIKQLNHEGLQ------------------------GHQEFIVEVLMLSLLHHDN- 53 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~--~-~~~~vaiK~~~~~~~~------------------------~~~~~~~e~~~l~~l~h~~- 53 (311)
...+|.|++|.||.++ . +|+.||+|.+...... ....+.+|++.+..+.+.+
T Consensus 33 ~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i 112 (237)
T smart00090 33 GGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGV 112 (237)
T ss_pred CCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 4679999999999999 3 8999999998754211 0123567999999987532
Q ss_pred -ccceeEEEEeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE
Q 021526 54 -LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL 132 (311)
Q Consensus 54 -i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~ 132 (311)
+.++++. . ..++|||++.+.+|..... ....+....+..++.|++.++.+||+.|. ++|+||+|+||++
T Consensus 113 ~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~NIli 182 (237)
T smart00090 113 PVPKPIAW---R-RNVLVMEFIGGDGLPAPRL----KDVEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEYNILV 182 (237)
T ss_pred CCCeeeEe---c-CceEEEEEecCCccccccc----ccCCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChhhEEE
Confidence 3344432 2 3589999999988766542 23345566678899999999999998763 9999999999999
Q ss_pred cCCCceEEeecCCCcc
Q 021526 133 DNDFNPKLSDFGLAKL 148 (311)
Q Consensus 133 ~~~~~vkl~Df~~~~~ 148 (311)
+ ++.++|+|||.+..
T Consensus 183 ~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 183 H-DGKVVIIDVSQSVE 197 (237)
T ss_pred E-CCCEEEEEChhhhc
Confidence 9 88999999998863
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=1e-16 Score=149.00 Aligned_cols=131 Identities=20% Similarity=0.176 Sum_probs=108.7
Q ss_pred eeeeeeceeccEEEEEECCeEEEEEEeccCCcc--------chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQ--------GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
..++|+|++|.||++...+..+++|........ ..+.+.+|+++++.++|+++.....++..+...+++|||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~ 417 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEY 417 (535)
T ss_pred cceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEe
Confidence 357899999999999997766776654322111 124578899999999999998877777677778999999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCcc
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 148 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~ 148 (311)
+++++|.+++. ....++.+++.+|.+||+.+ ++|+||+|.||++ .++.++|+|||++..
T Consensus 418 ~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 418 IGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred cCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999883 34678999999999999999 9999999999999 678899999999863
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.5e-17 Score=155.96 Aligned_cols=202 Identities=24% Similarity=0.290 Sum_probs=138.0
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
+.++..|++|.||.++. ..+++|+|+ +++. .+.+. ++....+|+++ |+-
T Consensus 88 IklisngAygavylvrh~~trqrfa~ki-Nkq~-----lilRn--ilt~a~npfvv---------------------gDc 138 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-----LILRN--ILTFAGNPFVV---------------------GDC 138 (1205)
T ss_pred eEeeccCCCCceeeeeccccccchhhcc-cccc-----hhhhc--cccccCCccee---------------------chh
Confidence 56788999999999988 478888843 3332 11111 33444455544 222
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc----
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT---- 155 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~---- 155 (311)
...+ ...+.++.+. +.+++|||+.+ |+|+|+||+|.+|+.-|.+|+.|||++.........
T Consensus 139 ~tll----k~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~e 203 (1205)
T KOG0606|consen 139 ATLL----KNIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKE 203 (1205)
T ss_pred hhhc----ccCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhh
Confidence 3333 1234444332 78899999999 999999999999999999999999998753221111
Q ss_pred --------ceee-eccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccch
Q 021526 156 --------HVST-RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 226 (311)
Q Consensus 156 --------~~~~-~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
+... ..+||+.|.|||+.....|..-.|+|++|+++|+.+.|..||.....+.-.. ..+.+...+
T Consensus 204 g~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg------~visd~i~w 277 (1205)
T KOG0606|consen 204 GHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG------QVISDDIEW 277 (1205)
T ss_pred cchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh------hhhhhhccc
Confidence 1111 2479999999999999999999999999999999999999997654322110 111111111
Q ss_pred hhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCC
Q 021526 227 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 262 (311)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP 262 (311)
.+- -...+.+.+++|.+.|+.+|..|-
T Consensus 278 pE~---------dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 278 PEE---------DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ccc---------CcCCCHHHHHHHHHHHHhChHhhc
Confidence 110 112356789999999999999994
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=9e-18 Score=147.16 Aligned_cols=170 Identities=25% Similarity=0.323 Sum_probs=126.0
Q ss_pred eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCC
Q 021526 66 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 145 (311)
Q Consensus 66 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~ 145 (311)
.+++.|++|.-.+|.+++...+ ....-++.....++.|++.++.| ++ .+|+|++|.||+...+..+||+|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 4689999999999999996433 34556777889999999999999 77 99999999999999999999999999
Q ss_pred CccCCCCC----CcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhh
Q 021526 146 AKLGPVGD----NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFL 220 (311)
Q Consensus 146 ~~~~~~~~----~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 220 (311)
.+...... .........|+..|++||++.+..|+.+.|||+||+++++++. -...++
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e------------------ 464 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE------------------ 464 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH------------------
Confidence 87543332 1122345679999999999999999999999999999999988 222221
Q ss_pred hcccchhhhcCccCCCCCcHHH---HHHHHHHHHHhhccCCCCCCCHH
Q 021526 221 KDQKKFVHLVDPLLHGRYPRRC---LNYAVAVTAMCLNEEANFRPLIN 265 (311)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~~p~~RPs~~ 265 (311)
....+.++.+. .+|+.. -+.=..|+.+++...|.+||++.
T Consensus 465 -r~~t~~d~r~g----~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 465 -RIATLTDIRDG----IIPPEFLQDYPEEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred -HHHhhhhhhcC----CCChHHhhcCcHHHHHHHHhcCCCcccCchHH
Confidence 01111111111 112111 11235889999999999999443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=5e-16 Score=126.00 Aligned_cols=130 Identities=18% Similarity=0.018 Sum_probs=101.7
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCcc----------------------chhHHHHHHHHHhcCCCCc--ccc
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQ----------------------GHQEFIVEVLMLSLLHHDN--LVT 56 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~~--i~~ 56 (311)
...+|.|++|.||++.. +|+.||||.+...... .......|+.++..+.+++ +..
T Consensus 20 ~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~ 99 (198)
T cd05144 20 GNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPK 99 (198)
T ss_pred CCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCc
Confidence 35689999999999998 7999999987643210 0113567888888887763 444
Q ss_pred eeEEEEeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCC
Q 021526 57 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF 136 (311)
Q Consensus 57 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~ 136 (311)
.++ ....+++|||+++++|...... .....++.+++.++.++|..+ ++|+||+|.||++++++
T Consensus 100 ~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 100 PID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDE 162 (198)
T ss_pred eee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCC
Confidence 443 2345899999999888765421 234678899999999999999 99999999999999999
Q ss_pred ceEEeecCCCcc
Q 021526 137 NPKLSDFGLAKL 148 (311)
Q Consensus 137 ~vkl~Df~~~~~ 148 (311)
.++|+|||.+..
T Consensus 163 ~~~liDfg~~~~ 174 (198)
T cd05144 163 KIYIIDWPQMVS 174 (198)
T ss_pred cEEEEECCcccc
Confidence 999999999863
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.5e-15 Score=126.23 Aligned_cols=133 Identities=21% Similarity=0.121 Sum_probs=103.8
Q ss_pred eee-eceeccEEEEEECCeEEEEEEeccCCc-------------cchhHHHHHHHHHhcCCCCcc--cceeEEEEeCC--
Q 021526 4 CYL-SCKFYNVGLVWLCDQLVAIKQLNHEGL-------------QGHQEFIVEVLMLSLLHHDNL--VTLIGYCTSGD-- 65 (311)
Q Consensus 4 ~~~-~g~~~~v~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~~-- 65 (311)
.+| .|+-|.|+.+...+..++||.+..... .....+.+|++++..++|+++ +..+++...+.
T Consensus 38 ~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~ 117 (239)
T PRK01723 38 VVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGL 117 (239)
T ss_pred eeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCc
Confidence 566 788899999999999999998854211 122467889999999998774 66666643322
Q ss_pred --eeEEEEecCCC-CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEee
Q 021526 66 --QRLLVYEYMPM-GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 142 (311)
Q Consensus 66 --~~~lv~e~~~~-~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~D 142 (311)
..++|||++++ .+|.+++.. ..++.. .+.+++.++.+||+.| |+|+||+|.|||++.++.++|+|
T Consensus 118 ~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 118 FYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred ceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEE
Confidence 23599999987 689888843 334443 3568999999999999 99999999999999989999999
Q ss_pred cCCCcc
Q 021526 143 FGLAKL 148 (311)
Q Consensus 143 f~~~~~ 148 (311)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998863
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.7e-15 Score=115.93 Aligned_cols=133 Identities=21% Similarity=0.113 Sum_probs=110.8
Q ss_pred eeeeeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcCCC--CcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHH--DNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
...++.|.++.||++...++.+++|....... ...+.+|+..++.+++ .++.+++.+...++..++++||+.+..+
T Consensus 3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred ceecccccccceEEEEecCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 45789999999999999889999999764432 4678899999999976 5888888888777789999999988666
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
..+ +......++.+++.+++.||......++|+|++|.||++++.+.++++||+.+.
T Consensus 81 ~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 81 DEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred ccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 433 445667789999999999998532339999999999999998999999999886
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=6.4e-16 Score=128.18 Aligned_cols=203 Identities=25% Similarity=0.320 Sum_probs=142.3
Q ss_pred HHHhcCCCCcccceeEEEEeCC-----eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 021526 44 LMLSLLHHDNLVTLIGYCTSGD-----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 118 (311)
Q Consensus 44 ~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~ 118 (311)
..|-++.|.|+++++.+|.+.. ...+++||+..|++.++|++.+...+.+....+.+|+.||+.||.|||+. .+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 3445667999999999986543 46799999999999999998877888899999999999999999999999 57
Q ss_pred CeeecCCCCCcEEEcCCCceEEeecCCCc--cCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh
Q 021526 119 PVIYRDLKSANILLDNDFNPKLSDFGLAK--LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196 (311)
Q Consensus 119 ~i~H~di~p~nil~~~~~~vkl~Df~~~~--~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~ 196 (311)
+++|+++.-+.|++..+|-+|++--.-.. ...............+.+.|.+||-=.....+.++|||++|++..+|..
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 79999999999999998888875322111 0001111112233456788999995444456778999999999999988
Q ss_pred CCCC-ccccC-ccccccchhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 197 GRKA-MDLSK-GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 197 g~~p-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
+..- .+... ...+.+.. .....+-+.+ =++++.+|++.+|..||++.+++-
T Consensus 278 lEiq~tnseS~~~~ee~ia----------~~i~~len~l------------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIA----------NVIIGLENGL------------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred heeccCCCcceeehhhhhh----------hheeeccCcc------------ccCcCcccccCCCCCCcchhhhhc
Confidence 7642 21110 00000000 0000111111 136788899999999999998765
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=8.2e-15 Score=117.78 Aligned_cols=133 Identities=20% Similarity=0.065 Sum_probs=95.0
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCccch--hH----------------------HHHHHHHHhcCCCCc--c
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQGH--QE----------------------FIVEVLMLSLLHHDN--L 54 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~--~~----------------------~~~e~~~l~~l~h~~--i 54 (311)
...+|+|++|.||.+.. +++.||||.+........ .. ...|.+.+..+.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46789999999999999 599999999865422111 11 134555555554432 3
Q ss_pred cceeEEEEeCCeeEEEEecCCCCCHHH-HhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeecCCCCCcEEE
Q 021526 55 VTLIGYCTSGDQRLLVYEYMPMGSLED-HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILL 132 (311)
Q Consensus 55 ~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~di~p~nil~ 132 (311)
.+++.. ...+++|||+.++.+.. .+.. .... ..+..++.+++.++.++|. .+ ++|+||+|+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~-----~~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKD-----VRLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhh-----hhhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEE
Confidence 444433 24689999998854321 1111 0001 5567899999999999999 88 9999999999999
Q ss_pred cCCCceEEeecCCCcc
Q 021526 133 DNDFNPKLSDFGLAKL 148 (311)
Q Consensus 133 ~~~~~vkl~Df~~~~~ 148 (311)
+ ++.++|+|||.+..
T Consensus 149 ~-~~~~~liDfg~a~~ 163 (187)
T cd05119 149 D-DGKVYIIDVPQAVE 163 (187)
T ss_pred E-CCcEEEEECccccc
Confidence 9 88999999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=3e-14 Score=128.70 Aligned_cols=164 Identities=16% Similarity=0.145 Sum_probs=126.7
Q ss_pred CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHH
Q 021526 19 CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTR 98 (311)
Q Consensus 19 ~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 98 (311)
.+.+|.|+..............+.+..|+.++||||++++..++.+...|+|+|.+. -|..++.. +....+
T Consensus 36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~~v 106 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKEEV 106 (690)
T ss_pred cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHHHH
Confidence 788999998765544455678899999999999999999999999999999999884 46677743 236777
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeeeccccccccCCccccCCCC
Q 021526 99 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL 178 (311)
Q Consensus 99 ~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 178 (311)
...++||+.||.|||+.++ ++|+||.-..++|+..|..||++|.++........ ..........|..|+......
T Consensus 107 ~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc-
Confidence 8899999999999985443 99999999999999999999999998754322211 111122233466666543332
Q ss_pred CccccchhHHHHHHHHHhC
Q 021526 179 TLKSDIYSFGVVLLELITG 197 (311)
Q Consensus 179 ~~~~Dv~slG~~l~~l~~g 197 (311)
-..|.|.|||++++++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 346999999999999998
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.5e-16 Score=147.88 Aligned_cols=249 Identities=24% Similarity=0.247 Sum_probs=182.1
Q ss_pred eeeeeceeccEEEEEE---CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCC-CCcccceeEEEEeCCeeEEEEecCCC
Q 021526 3 CCYLSCKFYNVGLVWL---CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
.-+|+|+++.+-.... ....++.|.+.... .....++..|..+-+.+. |+|++++++...+....++++++.++
T Consensus 26 ~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g 105 (601)
T KOG0590|consen 26 RSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDG 105 (601)
T ss_pred ccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccc
Confidence 3467888888877666 34455666554332 223344555777777776 99999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeeecCCCCCcEEEcCCC-ceEEeecCCCccCCC-CC
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH-CKANPPVIYRDLKSANILLDNDF-NPKLSDFGLAKLGPV-GD 153 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh-~~~~~~i~H~di~p~nil~~~~~-~vkl~Df~~~~~~~~-~~ 153 (311)
+++.+.+.. ......+...+-.++.|+..++.|+| ..+ +.|+||+|+|.+++.++ .+++.||+++..... ..
T Consensus 106 ~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g 180 (601)
T KOG0590|consen 106 GSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNG 180 (601)
T ss_pred ccccccccc--CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccccccCC
Confidence 999888831 23335666777889999999999999 888 99999999999999999 999999999987655 34
Q ss_pred Ccceeeeccc-cccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcC
Q 021526 154 NTHVSTRVMG-TYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231 (311)
Q Consensus 154 ~~~~~~~~~~-~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
.........| +..|.|||...+. ...+..|+||.|+++.-+++|..|++........ ...|... .. .
T Consensus 181 ~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~----~~----~-- 249 (601)
T KOG0590|consen 181 AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSN----KG----R-- 249 (601)
T ss_pred cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeeccc----cc----c--
Confidence 4444455667 9999999988874 5568899999999999999999998644432211 0111100 00 0
Q ss_pred ccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..............+++.+++..+|..|.+.+++..
T Consensus 250 --~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 250 --FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred --cccCccccCChhhhhcccccccCCchhccccccccc
Confidence 000111233445778899999999999999998753
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.8e-14 Score=126.63 Aligned_cols=240 Identities=23% Similarity=0.190 Sum_probs=176.8
Q ss_pred eee--ceeccEEEEEE----CCeEEEEEEec--cCCccchhHHHHHHHHHhcCC-CCcccceeEEEEeCCeeEEEEecCC
Q 021526 5 YLS--CKFYNVGLVWL----CDQLVAIKQLN--HEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 5 ~~~--g~~~~v~~~~~----~~~~vaiK~~~--~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
+|. |.+|.++.+.+ ++..+|+|.=. ...+.....-.+|+...+.++ |++.++.+..++..+..++-+|.+.
T Consensus 122 ~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~ 201 (524)
T KOG0601|consen 122 TGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG 201 (524)
T ss_pred cccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeecccc
Confidence 566 89999999988 57889998732 223344455566777777775 8999998899999999999999994
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHH----HHHHHhhCCCCCeeecCCCCCcEEEcCC-CceEEeecCCCccCC
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR----GLEYLHCKANPPVIYRDLKSANILLDND-FNPKLSDFGLAKLGP 150 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~----~l~~Lh~~~~~~i~H~di~p~nil~~~~-~~vkl~Df~~~~~~~ 150 (311)
.+|.++... ....++...++..+.+... |+..+|+.+ ++|-|++|.||+...+ ..++++||++.....
T Consensus 202 -~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~ 274 (524)
T KOG0601|consen 202 -ESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGLVSKIS 274 (524)
T ss_pred -chhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcceeEEcc
Confidence 688888754 4455777888888888888 999999999 9999999999999998 889999999987654
Q ss_pred CCCCccee---eeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchh
Q 021526 151 VGDNTHVS---TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 227 (311)
Q Consensus 151 ~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (311)
........ ....+...|++||.. +.-++...|+|+||.++.+...+..+........ +.
T Consensus 275 ~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-----------------W~ 336 (524)
T KOG0601|consen 275 DGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-----------------WS 336 (524)
T ss_pred CCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCC-----------------cc
Confidence 44433222 223577889999954 5667889999999999999998876654331111 11
Q ss_pred hhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 228 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
++....+..++.......+...+.+|++.+|-.|++.+.+..
T Consensus 337 ~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 337 QLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 111111222222233455677999999999999998887654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.45 E-value=7.7e-13 Score=119.38 Aligned_cols=136 Identities=21% Similarity=0.104 Sum_probs=92.8
Q ss_pred eeeeceeccEEEEEE-CCeEEEEEEeccCCccch----------------------------------------hHHHHH
Q 021526 4 CYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQGH----------------------------------------QEFIVE 42 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~----------------------------------------~~~~~e 42 (311)
-+++|++|.||++++ +|+.||||+..+...... -++.+|
T Consensus 124 plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~E 203 (437)
T TIGR01982 124 PLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRRE 203 (437)
T ss_pred ceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHH
Confidence 378999999999999 899999999754311100 023344
Q ss_pred HHHHhcC----C-CCcccceeEE-EEeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHH-HHHHHhhC
Q 021526 43 VLMLSLL----H-HDNLVTLIGY-CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR-GLEYLHCK 115 (311)
Q Consensus 43 ~~~l~~l----~-h~~i~~~~~~-~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~-~l~~Lh~~ 115 (311)
+..+..+ + ++++ .+-.+ +...+..+++|||++|.+|.+..... ..... ...++..++. .+..+|..
T Consensus 204 a~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~---~~~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 204 AANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALD---EAGLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHH---hcCCC---HHHHHHHHHHHHHHHHHhC
Confidence 4444433 2 2332 22222 23345578999999999998876421 11122 2345555555 47888999
Q ss_pred CCCCeeecCCCCCcEEEcCCCceEEeecCCCccC
Q 021526 116 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 149 (311)
Q Consensus 116 ~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~ 149 (311)
| ++|+|++|.||+++.++.++++|||.+...
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 8 999999999999999999999999998653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.44 E-value=9.3e-13 Score=104.01 Aligned_cols=129 Identities=16% Similarity=0.037 Sum_probs=95.4
Q ss_pred eeeeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCccc-ceeEEEEeCCeeEEEEecCCCCCHHH
Q 021526 3 CCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLV-TLIGYCTSGDQRLLVYEYMPMGSLED 81 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (311)
..++.|.++.+|.+...++.|++|...... .....+.+|+.+++.+.+.+++ +++.+ .....++||||++|.++.+
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGT-ELLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEeCCCCc-ccccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcccc
Confidence 456789999999999999999999965432 1234567899999888655544 44443 2334689999999977654
Q ss_pred HhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 82 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA--NPPVIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 82 ~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~--~~~i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
.- ......+.+++.+++.||..+ ...++|+|++|.||+++ ++.++++||+.+.
T Consensus 81 ~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 81 ED------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cc------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 20 011345678999999999887 11249999999999998 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.9e-11 Score=94.18 Aligned_cols=142 Identities=18% Similarity=0.124 Sum_probs=108.6
Q ss_pred eeeeeeceeccEEEEEECCeEEEEEEeccCC---cc-----chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWLCDQLVAIKQLNHEG---LQ-----GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~---~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
+.++.||+=+.|+.+...|+..+||.-..+. +. ...+..+|+..|.++.--.|.-..-++.+.+.-.++|||
T Consensus 12 l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred ceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 4578899999999999999999999643331 11 224567899999888765666555566777888999999
Q ss_pred CCC-CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCc---eEEeecCCCcc
Q 021526 74 MPM-GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN---PKLSDFGLAKL 148 (311)
Q Consensus 74 ~~~-~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~---vkl~Df~~~~~ 148 (311)
++| .++.+++.... ...........++..+-..+.-||..+ ++|||+..+||++..++. +.++|||++..
T Consensus 92 ~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 92 IDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred ccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 977 47888887622 233333444788999999999999999 999999999999965543 58999999864
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.35 E-value=5.9e-11 Score=102.42 Aligned_cols=263 Identities=16% Similarity=0.106 Sum_probs=164.1
Q ss_pred eeeeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhc-CCCCcccceeEE-----E--EeCCeeEEEEecC
Q 021526 3 CCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSL-LHHDNLVTLIGY-----C--TSGDQRLLVYEYM 74 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~-----~--~~~~~~~lv~e~~ 74 (311)
.-||+|+=+-+|..-.-+..| -|+.....+....+. ...|.. -.||-+-.-+.+ + ..+....+.|+.+
T Consensus 17 r~LgqGgea~ly~l~e~~d~V-AKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~v 92 (637)
T COG4248 17 RPLGQGGEADLYTLGEVRDQV-AKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPKV 92 (637)
T ss_pred ccccCCccceeeecchhhchh-heeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecccC
Confidence 346777777776644434444 466554443322222 222322 245533221111 1 1223367899988
Q ss_pred CCCC-HHHHhcc--cCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCC
Q 021526 75 PMGS-LEDHLYD--LEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 151 (311)
Q Consensus 75 ~~~~-L~~~l~~--~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~ 151 (311)
.+.. +.+++.. .++.-+...|..++..+..++.+.+.||..| .+-||++++|+||++++.|.|+|-+.....
T Consensus 93 ~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~-- 167 (637)
T COG4248 93 SGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQIN-- 167 (637)
T ss_pred CCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeec--
Confidence 7643 3333321 2234567889999999999999999999999 999999999999999999999998876542
Q ss_pred CCCcceeeeccccccccCCccccC-----CCCCccccchhHHHHHHHHHhC-CCCccccCc------cccccchhcchhh
Q 021526 152 GDNTHVSTRVMGTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLELITG-RKAMDLSKG------QGEQNLVSWSRPF 219 (311)
Q Consensus 152 ~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~~l~~l~~g-~~p~~~~~~------~~~~~~~~~~~~~ 219 (311)
..........|...|.+||...- ..-+..+|.|.||+++++++.| +.||..-.. ..+..+....-.+
T Consensus 168 -~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~y 246 (637)
T COG4248 168 -ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAY 246 (637)
T ss_pred -cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeee
Confidence 23333445668899999997652 2346789999999999999887 789863221 1121222111001
Q ss_pred hhcccchhhhcCccCCCCCc-HHHHHHHHHHHHHhhcc--CCCCCCCHHHHHHHHHHhhhccC
Q 021526 220 LKDQKKFVHLVDPLLHGRYP-RRCLNYAVAVTAMCLNE--EANFRPLINDIVVALDYLVSQRD 279 (311)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~--~p~~RPs~~~l~~~L~~l~~~~~ 279 (311)
..+ ........+ ...| ...+..+..++.+|+.. ++.-|||++..+..|..+..+..
T Consensus 247 a~~-~~~g~~p~P---~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 247 ASD-QRRGLKPPP---RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred chh-ccCCCCCCC---CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 000 000000000 0111 13466788999999986 36789999999999988877654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.30 E-value=4.7e-11 Score=95.33 Aligned_cols=132 Identities=15% Similarity=0.061 Sum_probs=94.6
Q ss_pred eeeeceeccEEEEEEC--------CeEEEEEEeccC-------------C---------ccchhHHH----HHHHHHhcC
Q 021526 4 CYLSCKFYNVGLVWLC--------DQLVAIKQLNHE-------------G---------LQGHQEFI----VEVLMLSLL 49 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~~--------~~~vaiK~~~~~-------------~---------~~~~~~~~----~e~~~l~~l 49 (311)
.+|.|+=++||.+... +..+|||+.... + ......+. +|+..|+++
T Consensus 4 ~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl 83 (197)
T cd05146 4 CISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRM 83 (197)
T ss_pred ccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 5788999999999873 379999987542 0 00112233 788888888
Q ss_pred CC--CcccceeEEEEeCCeeEEEEecCCCCCHHH-HhcccCCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeeecCC
Q 021526 50 HH--DNLVTLIGYCTSGDQRLLVYEYMPMGSLED-HLYDLEPDQEPLSWNTRMKIAVGAARGLEYL-HCKANPPVIYRDL 125 (311)
Q Consensus 50 ~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~L-h~~~~~~i~H~di 125 (311)
.. -++..++++ ..-++|||++.+..+.. .+ ....++...+..+..+++.++..| |..| ++|||+
T Consensus 84 ~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L-----kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 84 QKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL-----KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh-----hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 53 355566654 45689999997643321 22 122344456677889999999988 8898 999999
Q ss_pred CCCcEEEcCCCceEEeecCCCcc
Q 021526 126 KSANILLDNDFNPKLSDFGLAKL 148 (311)
Q Consensus 126 ~p~nil~~~~~~vkl~Df~~~~~ 148 (311)
++.||+++ ++.++|+||+.+..
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCcee
Confidence 99999996 46899999998853
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=6.3e-11 Score=91.70 Aligned_cols=130 Identities=21% Similarity=0.186 Sum_probs=101.1
Q ss_pred eeeeeceeccEEEEEECCeEEEEEEeccCCcc--------chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 3 CCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQ--------GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
.++.+|+=..++.+.+-|.++++|.-.++.-. ......+|+.++.+++--.|.-..-+..+.....++|||+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 35678888899999887777888875444211 1134567999998887656655555556777888999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
+|..|.+++... ...++..+-..+.-||..| |+|||+.++||++.+.+ +.++|||++.
T Consensus 82 ~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 82 EGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred CChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccc
Confidence 999999999652 2556777888899999999 99999999999997665 9999999986
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.5e-10 Score=102.22 Aligned_cols=167 Identities=18% Similarity=0.189 Sum_probs=126.1
Q ss_pred ccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEE----eCCeeEEEEecCCC-CCHHHHh
Q 021526 11 YNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT----SGDQRLLVYEYMPM-GSLEDHL 83 (311)
Q Consensus 11 ~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~lv~e~~~~-~~L~~~l 83 (311)
.+-|+++. +|..+++|++...+.........-+++++++.|+|++++.++|. .+..+++|++|+.+ .+|.++.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 45677777 79999999985444333334556788999999999999998876 45578999999865 5777755
Q ss_pred cccC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCC
Q 021526 84 YDLE-----------PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 84 ~~~~-----------~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~ 152 (311)
-... ..+...++..+|-++.|++.||.++|+.| +.-+-+.|.+|+++++.+++|..+|..-..-..
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 3211 23456888999999999999999999999 999999999999999999999888766432111
Q ss_pred CCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCC
Q 021526 153 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 199 (311)
Q Consensus 153 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 199 (311)
. . +.+ .--.+-|.=.||.+++.|.+|..
T Consensus 447 ~--------------~--~~l---e~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 447 P--------------T--EPL---ESQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred C--------------C--cch---hHHhhhhHHHHHHHHHHHhhccc
Confidence 1 0 001 11235688999999999999854
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.2e-12 Score=116.17 Aligned_cols=136 Identities=17% Similarity=0.100 Sum_probs=87.0
Q ss_pred eeeeceeccEEEEEE-C-CeEEEEEEeccCCccc----------------------------------h------hHHHH
Q 021526 4 CYLSCKFYNVGLVWL-C-DQLVAIKQLNHEGLQG----------------------------------H------QEFIV 41 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~-~-~~~vaiK~~~~~~~~~----------------------------------~------~~~~~ 41 (311)
-+++|++|.|+.+++ + |+.||||+..+..... . -++.+
T Consensus 126 PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~ 205 (537)
T PRK04750 126 PLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMR 205 (537)
T ss_pred hhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHH
Confidence 378999999999999 5 9999999986441100 0 12334
Q ss_pred HHHHHhcCC----CCcccceeEEE-EeCCeeEEEEecCCCCCHHHHh--cccCCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 021526 42 EVLMLSLLH----HDNLVTLIGYC-TSGDQRLLVYEYMPMGSLEDHL--YDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 114 (311)
Q Consensus 42 e~~~l~~l~----h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l--~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~ 114 (311)
|+..+.+++ +...+.+-.++ +..+..++||||++|+.+.+.- .........+....+..++.|+ ..
T Consensus 206 Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f~ 278 (537)
T PRK04750 206 EAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------FR 278 (537)
T ss_pred HHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------Hh
Confidence 444443332 33333333333 2345678999999999997742 1110011123333333344443 45
Q ss_pred CCCCCeeecCCCCCcEEEcCCC----ceEEeecCCCccC
Q 021526 115 KANPPVIYRDLKSANILLDNDF----NPKLSDFGLAKLG 149 (311)
Q Consensus 115 ~~~~~i~H~di~p~nil~~~~~----~vkl~Df~~~~~~ 149 (311)
.| ++|+|++|.||+++.++ +++++|||.+...
T Consensus 279 ~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 279 DG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred CC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 77 99999999999999888 9999999998754
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.16 E-value=9.7e-10 Score=92.61 Aligned_cols=132 Identities=17% Similarity=0.095 Sum_probs=96.1
Q ss_pred ccEEEEEECCeEEEEEEeccCCcc-ch----------hHHHHHHHHHhcCCCCc--ccceeEEEEe-----CCeeEEEEe
Q 021526 11 YNVGLVWLCDQLVAIKQLNHEGLQ-GH----------QEFIVEVLMLSLLHHDN--LVTLIGYCTS-----GDQRLLVYE 72 (311)
Q Consensus 11 ~~v~~~~~~~~~vaiK~~~~~~~~-~~----------~~~~~e~~~l~~l~h~~--i~~~~~~~~~-----~~~~~lv~e 72 (311)
..|.....+|+.+.||........ .. ..+.+|+..+..+...+ +..++++.+. ....++|||
T Consensus 36 rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 36 RRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred ceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 346677778999999976433211 01 13778888887775333 3344555543 235689999
Q ss_pred cCCCC-CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcC-------CCceEEeecC
Q 021526 73 YMPMG-SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-------DFNPKLSDFG 144 (311)
Q Consensus 73 ~~~~~-~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~-------~~~vkl~Df~ 144 (311)
++++. +|.+++..+. ...........++.+++..++.||..| ++|+|+++.|||++. +..+.|+||+
T Consensus 116 ~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~ 190 (268)
T PRK15123 116 DLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLH 190 (268)
T ss_pred eCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence 99875 8999885422 234456677789999999999999999 999999999999975 4679999999
Q ss_pred CCc
Q 021526 145 LAK 147 (311)
Q Consensus 145 ~~~ 147 (311)
.+.
T Consensus 191 r~~ 193 (268)
T PRK15123 191 RAQ 193 (268)
T ss_pred ccc
Confidence 875
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.16 E-value=5.3e-10 Score=92.12 Aligned_cols=140 Identities=19% Similarity=0.182 Sum_probs=102.7
Q ss_pred eeeeeceeccEEEEEECC-eEEEEEEeccCCc-cchhHHHHHHHHHhcCCCC--cccceeEEEEeC---CeeEEEEecCC
Q 021526 3 CCYLSCKFYNVGLVWLCD-QLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHD--NLVTLIGYCTSG---DQRLLVYEYMP 75 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~~~-~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~---~~~~lv~e~~~ 75 (311)
..++.|..+.+|++...+ +.+++|....... .....+.+|+++++.+++. .+.+++.+.... +..+++||+++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 347889999999999854 8999998654332 2456788999999998753 456677765543 25689999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC---------------------------------------
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA--------------------------------------- 116 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~--------------------------------------- 116 (311)
|.++.+.+. ...++......++.+++.+|+.||+..
T Consensus 84 G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 987766552 134555666667777777777777421
Q ss_pred --------------CCCeeecCCCCCcEEEcC--CCceEEeecCCCc
Q 021526 117 --------------NPPVIYRDLKSANILLDN--DFNPKLSDFGLAK 147 (311)
Q Consensus 117 --------------~~~i~H~di~p~nil~~~--~~~vkl~Df~~~~ 147 (311)
...++|+|++|.||+++. ++.+.++||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 123799999999999988 5668999999876
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.16 E-value=4.5e-11 Score=107.18 Aligned_cols=241 Identities=20% Similarity=0.150 Sum_probs=165.5
Q ss_pred eeeeeeceeccEEEEEE---CCeEEEEEEeccCCccchhH--HHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL---CDQLVAIKQLNHEGLQGHQE--FIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~---~~~~vaiK~~~~~~~~~~~~--~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
+-.+|.|.|+.++.... ++..+++|.....-.....+ -..|..+...+ .|.+++.....|......++-.|||+
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE 349 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence 45678888888888766 57788888765543332222 22344444444 47788887777777778889999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCC-CceEEeecCCCccCCCCCC
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-FNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~-~~vkl~Df~~~~~~~~~~~ 154 (311)
++++.... .-...+.+..++.+..|++.++.++|+.. ++|.|++|.||++..+ +..+++||+.........
T Consensus 350 ~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~- 421 (524)
T KOG0601|consen 350 GGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS- 421 (524)
T ss_pred Ccchhhhh----HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccceec-
Confidence 98887766 34567888889999999999999999998 9999999999999876 778999999876422211
Q ss_pred cceeeeccccccc-cCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 155 THVSTRVMGTYGY-CAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 155 ~~~~~~~~~~~~~-~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
......+..| .++.+.....+..+.|+++||..+.+.+++...-.... ++..+....
T Consensus 422 ---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-------------------~~~~i~~~~ 479 (524)
T KOG0601|consen 422 ---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-------------------QSLTIRSGD 479 (524)
T ss_pred ---ccccccccccccchhhccccccccccccccccccccccccCcccCcccc-------------------cceeeeccc
Confidence 1112223333 35555555677899999999999999999875321100 000110000
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l 274 (311)
. ...+.....+..+...+...++..||.+.++....+..
T Consensus 480 ~--p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 480 T--PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred c--cCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 0 01122236688888999999999999999887655443
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.08 E-value=4e-09 Score=84.49 Aligned_cols=137 Identities=16% Similarity=0.117 Sum_probs=103.6
Q ss_pred eeceeccEEEEEECCeEEEEEEeccC------CccchhHHHHHHHHHhcCCCCc--ccceeEEEE-e----CCeeEEEEe
Q 021526 6 LSCKFYNVGLVWLCDQLVAIKQLNHE------GLQGHQEFIVEVLMLSLLHHDN--LVTLIGYCT-S----GDQRLLVYE 72 (311)
Q Consensus 6 ~~g~~~~v~~~~~~~~~vaiK~~~~~------~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~-~----~~~~~lv~e 72 (311)
++|+.+.|+.....|+.+-+|.-... .+-....+.+|+..|..+..-+ +.++. ++. . ....+||+|
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTE 105 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEE
Confidence 56899999998888888999975411 1445678999999998886432 44444 322 1 223579999
Q ss_pred cCCC-CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCc--eEEeecCCCcc
Q 021526 73 YMPM-GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN--PKLSDFGLAKL 148 (311)
Q Consensus 73 ~~~~-~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~--vkl~Df~~~~~ 148 (311)
-+.+ .+|.+++... .....+...+..++.+++.+++-||+.| +.|+|+.+.||+++.++. +.++||..++.
T Consensus 106 ~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 106 DMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred eCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 7754 6888888441 2234566777889999999999999999 999999999999986777 99999988764
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.1e-09 Score=87.06 Aligned_cols=123 Identities=21% Similarity=0.132 Sum_probs=78.6
Q ss_pred cEEEEEE-CCeEEEEEEeccC---------------C------c-cc----hhHHHHHHHHHhcCCCC--cccceeEEEE
Q 021526 12 NVGLVWL-CDQLVAIKQLNHE---------------G------L-QG----HQEFIVEVLMLSLLHHD--NLVTLIGYCT 62 (311)
Q Consensus 12 ~v~~~~~-~~~~vaiK~~~~~---------------~------~-~~----~~~~~~e~~~l~~l~h~--~i~~~~~~~~ 62 (311)
.||.|.. ++..||+|+.... + . .. .....+|++.|..+..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4889998 8999999987542 1 0 00 12456899999999765 456666552
Q ss_pred eCCeeEEEEecCC--CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHH-HHHhhCCCCCeeecCCCCCcEEEcCCCceE
Q 021526 63 SGDQRLLVYEYMP--MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL-EYLHCKANPPVIYRDLKSANILLDNDFNPK 139 (311)
Q Consensus 63 ~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l-~~Lh~~~~~~i~H~di~p~nil~~~~~~vk 139 (311)
.-.+||||++ |..+...... .+.......++.+++..+ ..+|..| ++|||+++.||+++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEE
Confidence 3469999998 5444443321 111233456677777744 4467898 9999999999999887 899
Q ss_pred EeecCCCcc
Q 021526 140 LSDFGLAKL 148 (311)
Q Consensus 140 l~Df~~~~~ 148 (311)
++||+.+..
T Consensus 147 iIDf~qav~ 155 (188)
T PF01163_consen 147 IIDFGQAVD 155 (188)
T ss_dssp E--GTTEEE
T ss_pred EEecCccee
Confidence 999998763
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=2e-10 Score=104.67 Aligned_cols=155 Identities=19% Similarity=0.255 Sum_probs=107.5
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee-------eccccccccCCc
Q 021526 99 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST-------RVMGTYGYCAPE 171 (311)
Q Consensus 99 ~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~-------~~~~~~~~~aPE 171 (311)
..-+.+++.|+.++|...+ +||++|.|++|.++.++.+||+.|+.+............. .......|.|||
T Consensus 102 f~nl~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE 179 (700)
T KOG2137|consen 102 FANLGNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPE 179 (700)
T ss_pred hhhhhcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccch
Confidence 3344556699999997654 9999999999999999999999999875432211111111 123456799999
Q ss_pred cccCCCCCccccchhHHHHHHHHH-hCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHH
Q 021526 172 YAMSGKLTLKSDIYSFGVVLLELI-TGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVT 250 (311)
Q Consensus 172 ~~~~~~~~~~~Dv~slG~~l~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 250 (311)
...+...+.++|+||+|+++|.+. .|+..+...+...... .....+..-...++.+.+.++.+=+
T Consensus 180 ~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~--------------~~~~~~~~~~~~~s~~~p~el~~~l 245 (700)
T KOG2137|consen 180 YLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS--------------FSRNLLNAGAFGYSNNLPSELRESL 245 (700)
T ss_pred hhccccccccccceeeeeEEEEEecCCcchhhccCCcchhh--------------hhhcccccccccccccCcHHHHHHH
Confidence 998888889999999999999999 4544444322211110 0111111122234467788999999
Q ss_pred HHhhccCCCCCCCHHHHHH
Q 021526 251 AMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 251 ~~~l~~~p~~RPs~~~l~~ 269 (311)
.+++..++..||++.++..
T Consensus 246 ~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 246 KKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHHhcCCcccCcchhhhhc
Confidence 9999999999998777654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.96 E-value=9.6e-09 Score=83.67 Aligned_cols=123 Identities=23% Similarity=0.173 Sum_probs=90.2
Q ss_pred CCeEEEEEEeccCCc-------cchhHHHHHHHHHhcCCCC--cccceeEEEEeC----CeeEEEEecCCC-CCHHHHhc
Q 021526 19 CDQLVAIKQLNHEGL-------QGHQEFIVEVLMLSLLHHD--NLVTLIGYCTSG----DQRLLVYEYMPM-GSLEDHLY 84 (311)
Q Consensus 19 ~~~~vaiK~~~~~~~-------~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~----~~~~lv~e~~~~-~~L~~~l~ 84 (311)
.++.+.+|.....-. -......+|+..+..+..- .+.+++++.+.. ...++|+|.+++ .+|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 566677775433211 2334677888887777533 345556665442 245899999987 47999885
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCC---ceEEeecCCCcc
Q 021526 85 DLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF---NPKLSDFGLAKL 148 (311)
Q Consensus 85 ~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~---~vkl~Df~~~~~ 148 (311)
.. ...+......++.+++..++.||..| ++|+|+++.|||++.++ .+.|+||+.+..
T Consensus 111 ~~----~~~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 111 QW----EQLDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred hh----cccchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 42 22566677889999999999999999 99999999999998887 899999998763
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=6.8e-10 Score=105.40 Aligned_cols=194 Identities=24% Similarity=0.223 Sum_probs=135.6
Q ss_pred CCCCcccceeEEEEeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCC
Q 021526 49 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 128 (311)
Q Consensus 49 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~ 128 (311)
.++|.++.....+.-....++++++..+++|...++. .+....+...-.+..+..++.+||... +.|+|++|.
T Consensus 861 p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~ 933 (1205)
T KOG0606|consen 861 PRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPD 933 (1205)
T ss_pred CCCCceecccCCCCCCCCcchhhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhccccch---hhccccccc
Confidence 3445555444334445677899999999999998854 334555555667778889999999997 999999999
Q ss_pred cEEEcCCCceEEeecCCCccCCCC----C-------------------------CcceeeeccccccccCCccccCCCCC
Q 021526 129 NILLDNDFNPKLSDFGLAKLGPVG----D-------------------------NTHVSTRVMGTYGYCAPEYAMSGKLT 179 (311)
Q Consensus 129 nil~~~~~~vkl~Df~~~~~~~~~----~-------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~ 179 (311)
|++...++..++.||+........ + .........+++.|.+||...+....
T Consensus 934 ~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hg 1013 (1205)
T KOG0606|consen 934 SLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHG 1013 (1205)
T ss_pred chhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCC
Confidence 999999999999999733221110 0 00111234578999999999999999
Q ss_pred ccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC-CCcHHHHHHHHHHHHHhhccCC
Q 021526 180 LKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG-RYPRRCLNYAVAVTAMCLNEEA 258 (311)
Q Consensus 180 ~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p 258 (311)
..+|+|++|+++++.++|.+||+-...+... ..++..-... .-+.......++++...+..+|
T Consensus 1014 s~ad~~~~g~~l~e~l~g~pp~na~tpq~~f----------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~ 1077 (1205)
T KOG0606|consen 1014 SAADWWSSGVCLFEVLTGIPPFNAETPQQIF----------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEP 1077 (1205)
T ss_pred CcchhhhhhhhhhhhhcCCCCCCCcchhhhh----------------hccccCCCCCCCCccccChhhhhhhhhhhccCc
Confidence 9999999999999999999999633322111 1111100000 1123445668899999999999
Q ss_pred CCCCCHH
Q 021526 259 NFRPLIN 265 (311)
Q Consensus 259 ~~RPs~~ 265 (311)
.+|-.+.
T Consensus 1078 ~qr~~a~ 1084 (1205)
T KOG0606|consen 1078 TQRLGAK 1084 (1205)
T ss_pred hhccCcc
Confidence 9997665
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=5.9e-08 Score=79.87 Aligned_cols=129 Identities=18% Similarity=0.053 Sum_probs=94.2
Q ss_pred eeeeeceeccEEEEEE-CCeEEEEEEeccCC------------------cc----chhHHHHHHHHHhcCCCC--cccce
Q 021526 3 CCYLSCKFYNVGLVWL-CDQLVAIKQLNHEG------------------LQ----GHQEFIVEVLMLSLLHHD--NLVTL 57 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~------------------~~----~~~~~~~e~~~l~~l~h~--~i~~~ 57 (311)
..+|-|+=+.||.+.. +|.+++||.-.... .. ......+|+++|..+... .|.+.
T Consensus 97 ~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P 176 (304)
T COG0478 97 TKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKP 176 (304)
T ss_pred cccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCc
Confidence 4578888899999999 79999999643211 00 112466899999888654 67777
Q ss_pred eEEEEeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCc
Q 021526 58 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 137 (311)
Q Consensus 58 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~ 137 (311)
+++ +.-.+|||+++|..|...- +.....-.++..|+.-+..+-..| ++|||+++-||+++++|.
T Consensus 177 ~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 177 IAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGD 240 (304)
T ss_pred ccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCC
Confidence 755 4567999999885443221 123344556666666666666788 999999999999999999
Q ss_pred eEEeecCCCc
Q 021526 138 PKLSDFGLAK 147 (311)
Q Consensus 138 vkl~Df~~~~ 147 (311)
++++||-.+.
T Consensus 241 ~~vIDwPQ~v 250 (304)
T COG0478 241 IVVIDWPQAV 250 (304)
T ss_pred EEEEeCcccc
Confidence 9999998765
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=5.1e-08 Score=89.02 Aligned_cols=137 Identities=19% Similarity=0.140 Sum_probs=86.7
Q ss_pred eeeceeccEEEEEE-CCeEEEEEEeccCCcc---------------------c-------------------hhHHHHHH
Q 021526 5 YLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQ---------------------G-------------------HQEFIVEV 43 (311)
Q Consensus 5 ~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~---------------------~-------------------~~~~~~e~ 43 (311)
+++++.|.|+++++ +|+.||||+..+.-.. . .-++.+|+
T Consensus 133 iAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA 212 (517)
T COG0661 133 IASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRREA 212 (517)
T ss_pred hhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHHH
Confidence 35789999999999 6999999997652100 0 00122333
Q ss_pred HHHhcCC-----CCcccceeEEEEeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 021526 44 LMLSLLH-----HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 118 (311)
Q Consensus 44 ~~l~~l~-----h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~ 118 (311)
..+.+++ .+.+.-..=+++-.+...++|||++|..+.+...- ....++...+.....++. +..+-..|
T Consensus 213 ~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l---~~~g~d~k~ia~~~~~~f--~~q~~~dg-- 285 (517)
T COG0661 213 ANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL---KSAGIDRKELAELLVRAF--LRQLLRDG-- 285 (517)
T ss_pred HHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHH---HhcCCCHHHHHHHHHHHH--HHHHHhcC--
Confidence 3333331 23332222234455677899999999888877422 123344333332222221 33334466
Q ss_pred CeeecCCCCCcEEEcCCCceEEeecCCCccC
Q 021526 119 PVIYRDLKSANILLDNDFNPKLSDFGLAKLG 149 (311)
Q Consensus 119 ~i~H~di~p~nil~~~~~~vkl~Df~~~~~~ 149 (311)
+.|+|.+|.||+++.+|++.+.|||.....
T Consensus 286 -ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 286 -FFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred -ccccCCCccceEEecCCcEEEEcCcceecC
Confidence 999999999999999999999999998653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.66 E-value=7.7e-07 Score=73.47 Aligned_cols=139 Identities=9% Similarity=-0.041 Sum_probs=84.2
Q ss_pred eeeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCc--ccceeEEEEeCCeeEEEEecCCCCC-HH
Q 021526 4 CYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN--LVTLIGYCTSGDQRLLVYEYMPMGS-LE 80 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~-L~ 80 (311)
.+++|..+.||+. .+..+++|...... ......+|++++..+..-+ +.+++.+.+.++..+++|++++|.+ +.
T Consensus 8 ~i~~G~t~~~y~~--~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~ 83 (226)
T TIGR02172 8 QTGEGGNGESYTH--KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFS 83 (226)
T ss_pred eecCCCCcceeEe--cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchh
Confidence 5789999999983 35567889875322 3456788999998886433 4677888777788899999998863 11
Q ss_pred HHh------------------cccCCC-CCCCCHHHHHHHH-HH----------HHH-HHHHHhhC-CCCCeeecCCCCC
Q 021526 81 DHL------------------YDLEPD-QEPLSWNTRMKIA-VG----------AAR-GLEYLHCK-ANPPVIYRDLKSA 128 (311)
Q Consensus 81 ~~l------------------~~~~~~-~~~l~~~~~~~~~-~~----------i~~-~l~~Lh~~-~~~~i~H~di~p~ 128 (311)
..+ .....- ...........-. .+ +.. ...+|... +...++|+|++|.
T Consensus 84 ~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~ 163 (226)
T TIGR02172 84 RIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIG 163 (226)
T ss_pred hhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCC
Confidence 111 001110 0111111111100 00 001 12222211 1234899999999
Q ss_pred cEEEcCCCceEEeecCCCc
Q 021526 129 NILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 129 nil~~~~~~vkl~Df~~~~ 147 (311)
||++++++ +.++||+.+.
T Consensus 164 Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 164 NLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cEEEcCCC-cEEEechhcC
Confidence 99999888 9999998775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.62 E-value=3.3e-07 Score=73.85 Aligned_cols=122 Identities=14% Similarity=0.110 Sum_probs=78.6
Q ss_pred eccEEEEEECCeEEEEEEeccCCccchhH---------HHHHHHHHhcCCCC---cccceeEE-----EEeCCeeEEEEe
Q 021526 10 FYNVGLVWLCDQLVAIKQLNHEGLQGHQE---------FIVEVLMLSLLHHD---NLVTLIGY-----CTSGDQRLLVYE 72 (311)
Q Consensus 10 ~~~v~~~~~~~~~vaiK~~~~~~~~~~~~---------~~~e~~~l~~l~h~---~i~~~~~~-----~~~~~~~~lv~e 72 (311)
-..|..-..+|+.+++|....+.....+. ..+++..+..++.. ....++.+ +......+++||
T Consensus 44 r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~E 123 (229)
T PF06176_consen 44 RNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLME 123 (229)
T ss_pred ccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEE
Confidence 34566666689999999876543322222 22444444444322 22222222 222345578999
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
|++|..|.+... +++ .+...+..++..+|..| +.|||++|.|++++++ .++++||+..+
T Consensus 124 YIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 124 YIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred EecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cEEEEECcccc
Confidence 999987766541 222 24456778899999999 9999999999999855 49999997664
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.59 E-value=5.9e-07 Score=73.29 Aligned_cols=135 Identities=20% Similarity=0.143 Sum_probs=91.0
Q ss_pred CeeeeeeceeccEEEEEE-CCeEEEEEEeccCCcc-------------------ch-----hHHHHHHHHHhcCCC--Cc
Q 021526 1 MLCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQ-------------------GH-----QEFIVEVLMLSLLHH--DN 53 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~-------------------~~-----~~~~~e~~~l~~l~h--~~ 53 (311)
|.+.+.+|+-.+||.+.. ++..||+|++...... +. ....+|+..|+.+.. -.
T Consensus 52 ~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 52 LVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred eEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 457788999999999998 7999999998653111 11 113356666666643 23
Q ss_pred ccceeEEEEeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeecCCCCCcEEE
Q 021526 54 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILL 132 (311)
Q Consensus 54 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~di~p~nil~ 132 (311)
+.+.+.+. .-.++||++... . ..........+.......+..+++..+.-|-. .+ +||+|++..|||+
T Consensus 132 vP~Pi~~~----~nVLvMEfIg~~--g--~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~ 200 (268)
T COG1718 132 VPEPIAFR----NNVLVMEFIGDD--G--LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILV 200 (268)
T ss_pred CCCceeec----CCeEEEEeccCC--C--CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEE
Confidence 44555543 346999998432 1 11111122233333566677788888888876 66 9999999999999
Q ss_pred cCCCceEEeecCCCc
Q 021526 133 DNDFNPKLSDFGLAK 147 (311)
Q Consensus 133 ~~~~~vkl~Df~~~~ 147 (311)
. ++.++++||+.+.
T Consensus 201 ~-~~~p~iID~~QaV 214 (268)
T COG1718 201 H-DGEPYIIDVSQAV 214 (268)
T ss_pred E-CCeEEEEECcccc
Confidence 8 8889999999875
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.41 E-value=3.3e-06 Score=69.93 Aligned_cols=78 Identities=18% Similarity=0.128 Sum_probs=55.7
Q ss_pred eeeeeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcCCCC--cccceeEEEE---eCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHD--NLVTLIGYCT---SGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~---~~~~~~lv~e~~~~ 76 (311)
+..++.|....+|.+...++.+++|..... .....+.+|..+++.+... .+.+++.... .....+++|++++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 356788888899999997789999996543 4556788888888877533 3456665432 23346899999998
Q ss_pred CCHHH
Q 021526 77 GSLED 81 (311)
Q Consensus 77 ~~L~~ 81 (311)
..+..
T Consensus 80 ~~~~~ 84 (239)
T PF01636_consen 80 RPLDD 84 (239)
T ss_dssp EEHHH
T ss_pred ccccc
Confidence 87777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=3.8e-06 Score=64.96 Aligned_cols=125 Identities=17% Similarity=0.071 Sum_probs=90.0
Q ss_pred eeeeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCccc-ceeEEEEeCCeeEEEEecCCCCCHHH
Q 021526 3 CCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLV-TLIGYCTSGDQRLLVYEYMPMGSLED 81 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (311)
..++.|..+.||.+.+.|..+|+|.-... .-...+..|+++|..++--++- +++.+- ..++.|||++|..|.+
T Consensus 28 ~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L~~ 101 (201)
T COG2112 28 KELAKGTTSVVYLGEWRGGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPLGK 101 (201)
T ss_pred hhhhcccccEEEEeeccCceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcchhh
Confidence 35789999999999999999999985433 3446788999999988866654 444442 2335599999988877
Q ss_pred HhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCC-CCcEEEcCCCceEEeecCCCc
Q 021526 82 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK-SANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 82 ~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~-p~nil~~~~~~vkl~Df~~~~ 147 (311)
.... . + .+-+..++++.--|-..| |-|+.|+ |...++.+++.+.|+||..++
T Consensus 102 ~~~~-----~--~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 102 LEIG-----G--D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhhc-----c--c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchh
Confidence 6632 1 2 223344556655666777 9999998 555555566699999999886
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.36 E-value=8.8e-06 Score=68.13 Aligned_cols=134 Identities=17% Similarity=0.058 Sum_probs=81.1
Q ss_pred ccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcCC-CCcccceeEEEEeCCeeEEEEecCCCCCHHHHhc-----
Q 021526 11 YNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLY----- 84 (311)
Q Consensus 11 ~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----- 84 (311)
..||+....+..+++|...... ...+.+|+++++.+. +--+.+++.+...++..++||++++|.++.....
T Consensus 13 ~~v~~~~~~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~~~~ 89 (244)
T cd05150 13 ATVYRLDGKNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEELEPE 89 (244)
T ss_pred CeEEEEcCCCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhcccCHH
Confidence 6788887777889999865432 346778888888774 3345577777666667899999999877664321
Q ss_pred -----------ccCCC---CCCCCHH--HHHHHHH--------------------HHHHHHHHHhh----CCCCCeeecC
Q 021526 85 -----------DLEPD---QEPLSWN--TRMKIAV--------------------GAARGLEYLHC----KANPPVIYRD 124 (311)
Q Consensus 85 -----------~~~~~---~~~l~~~--~~~~~~~--------------------~i~~~l~~Lh~----~~~~~i~H~d 124 (311)
..... ...+... ....... .+...+..|-. ...+.++|+|
T Consensus 90 ~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD 169 (244)
T cd05150 90 RLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVTHGD 169 (244)
T ss_pred HHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEECCC
Confidence 00110 0011100 0000000 01111222211 1123499999
Q ss_pred CCCCcEEEcCCCceEEeecCCCc
Q 021526 125 LKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 125 i~p~nil~~~~~~vkl~Df~~~~ 147 (311)
+.|.||++++++.+.|+||+.+.
T Consensus 170 ~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 170 ACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CCCccEEEeCCcEEEEEEccccc
Confidence 99999999997778899998775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.24 E-value=2.2e-07 Score=84.61 Aligned_cols=179 Identities=18% Similarity=0.104 Sum_probs=122.0
Q ss_pred eeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCc-ccceeEEEEeCCeeEEEEecCCCC-CHHHH
Q 021526 5 YLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN-LVTLIGYCTSGDQRLLVYEYMPMG-SLEDH 82 (311)
Q Consensus 5 ~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~ 82 (311)
|++++++++++.+- .|-|.+..+-........-++++|.+++||| .+..++.++.+...++.++++.++ +....
T Consensus 250 fvK~altknpKkRp----taeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~ 325 (829)
T KOG0576|consen 250 FVKGALTKNPKKRP----TAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALE 325 (829)
T ss_pred HHHHHhcCCCccCC----ChhhheeceeeccchhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccccc
Confidence 55667777777554 3334333332333356667899999999999 666666677777889999998765 22211
Q ss_pred hcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeeecc
Q 021526 83 LYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 162 (311)
Q Consensus 83 l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~~~ 162 (311)
... ....+...........-++.++++|+.. -+|+| ||+..+ +.+++.||+....+.... ......
T Consensus 326 ~~~---se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~ 391 (829)
T KOG0576|consen 326 MTV---SEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAI 391 (829)
T ss_pred CCh---hhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc---ccccCC
Confidence 111 1122333333445555667899999875 57887 666544 679999999876443322 334456
Q ss_pred ccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCc
Q 021526 163 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 201 (311)
Q Consensus 163 ~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 201 (311)
+++.+++||+.....+....|.|++|.-..++.-|.+|-
T Consensus 392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 899999999999999999999999998877888877764
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.7e-05 Score=66.87 Aligned_cols=137 Identities=14% Similarity=-0.025 Sum_probs=78.2
Q ss_pred eeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcc-cceeEEEEeCCeeEEEEecCCCCCHHHH--
Q 021526 6 LSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNL-VTLIGYCTSGDQRLLVYEYMPMGSLEDH-- 82 (311)
Q Consensus 6 ~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~~~-- 82 (311)
..|-...+|+...+++.+++|........-..+..+|+++++.+...++ .+++... + .++|++|++|..+...
T Consensus 5 ~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~~~~ 80 (256)
T TIGR02721 5 SGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITLDQF 80 (256)
T ss_pred CCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccccccc
Confidence 4567778888888888999997543322211245778888888864333 3444332 2 3689999988654321
Q ss_pred ------------hcccC---CCCCCCCHHH-HHHHHHHH---------HHHHHHHhhC-----CCCCeeecCCCCCcEEE
Q 021526 83 ------------LYDLE---PDQEPLSWNT-RMKIAVGA---------ARGLEYLHCK-----ANPPVIYRDLKSANILL 132 (311)
Q Consensus 83 ------------l~~~~---~~~~~l~~~~-~~~~~~~i---------~~~l~~Lh~~-----~~~~i~H~di~p~nil~ 132 (311)
+.+.. .....+.... +..+..++ ...+..+-.. ....++|+|+.|.||++
T Consensus 81 ~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~ 160 (256)
T TIGR02721 81 VALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVV 160 (256)
T ss_pred cCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEE
Confidence 11111 1112222221 11111111 1112222211 01238999999999999
Q ss_pred cCCCceEEeecCCCc
Q 021526 133 DNDFNPKLSDFGLAK 147 (311)
Q Consensus 133 ~~~~~vkl~Df~~~~ 147 (311)
++++ +.|+||+.+.
T Consensus 161 ~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 161 TPQG-LKLIDWEYAS 174 (256)
T ss_pred eCCC-CEEEeccccC
Confidence 8876 8999999876
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.15 E-value=2.1e-05 Score=76.64 Aligned_cols=193 Identities=22% Similarity=0.199 Sum_probs=130.0
Q ss_pred HHHHHHhcCCCCcccceeEEEEeCCee----EEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 021526 41 VEVLMLSLLHHDNLVTLIGYCTSGDQR----LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 116 (311)
Q Consensus 41 ~e~~~l~~l~h~~i~~~~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~ 116 (311)
-|++.+..+.|+|+..++.|....... .+..+++...++...+ +.-..++....+.+..+..++++++|+..
T Consensus 231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~----q~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL----QSVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH----hhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 466677788999999998886543333 2445667777777777 34567888899999999999999999986
Q ss_pred CCCeeecCCCCC---cEEEcCCCceEEe--ecCCCccCCCCCCcceeeeccccccccCCccccCCCCC--ccccchhHHH
Q 021526 117 NPPVIYRDLKSA---NILLDNDFNPKLS--DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT--LKSDIYSFGV 189 (311)
Q Consensus 117 ~~~i~H~di~p~---nil~~~~~~vkl~--Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~--~~~Dv~slG~ 189 (311)
+.|.-+... +.-++..+.+... ||+.+....... ..........+.++|........ ...|+|.+|.
T Consensus 307 ---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~---~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 307 ---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE---KSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred ---cceeEEecccccccccCccceeecchhhhcccccCCCcc---cchhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 666655554 4445566667766 888776433221 11122234457777776665544 4479999999
Q ss_pred HHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 190 VLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 190 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
....+..|..+-.... ....++. ..+...+.+...+|+..++++|+++.+++.
T Consensus 381 l~~~~~~~~~i~~~~~-------------------~~~~~l~--------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSA-------------------VPVSLLD--------VLSTSELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HHhhhhhcCccccccc-------------------chhhhhc--------cccchhhhhhhhhhcchhhhhccchhhhhh
Confidence 9999988776432111 0011111 111115778899999999999999999987
Q ss_pred H
Q 021526 270 A 270 (311)
Q Consensus 270 ~ 270 (311)
.
T Consensus 434 ~ 434 (1351)
T KOG1035|consen 434 H 434 (1351)
T ss_pred c
Confidence 5
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.14 E-value=6.8e-05 Score=64.66 Aligned_cols=75 Identities=15% Similarity=0.060 Sum_probs=55.6
Q ss_pred eeeeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcCCC---CcccceeEEEEe---CCeeEEEEecCCC
Q 021526 3 CCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHH---DNLVTLIGYCTS---GDQRLLVYEYMPM 76 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~---~~~~~lv~e~~~~ 76 (311)
+-++.|.++.||.....+.++++|.... ......+.+|++.|+.+.. -.+.++++++.. .+..++|||++++
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGNPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG 97 (297)
T ss_pred eecCCccceeEEEEEcCCCCEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence 4678899999999988666788888432 1133588899999988853 357788877654 3568999999988
Q ss_pred CCH
Q 021526 77 GSL 79 (311)
Q Consensus 77 ~~L 79 (311)
.++
T Consensus 98 ~~~ 100 (297)
T PRK10593 98 VSV 100 (297)
T ss_pred Eec
Confidence 654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.12 E-value=6.7e-05 Score=60.34 Aligned_cols=128 Identities=18% Similarity=0.071 Sum_probs=87.6
Q ss_pred eeeeeceeccEEEEEECCeEEEEEEeccCC----------------ccchhHHHHHHHHHhcCC------CCcccceeEE
Q 021526 3 CCYLSCKFYNVGLVWLCDQLVAIKQLNHEG----------------LQGHQEFIVEVLMLSLLH------HDNLVTLIGY 60 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~~i~~~~~~ 60 (311)
..+++|+--.+|..= .+....||+..... .....+..+|+..+..+. +.+|.+++++
T Consensus 7 ~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 357778877777643 44556888876654 223456666776665554 7789999999
Q ss_pred EEeCCeeEEEEecCCC------CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcC
Q 021526 61 CTSGDQRLLVYEYMPM------GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN 134 (311)
Q Consensus 61 ~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~ 134 (311)
.+++.-..+|+|.+.. .+|.+++. .+.++. ...+.+ -.-..+|-+.+ |+.+|++|.||++..
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~-~~~~~L---~~f~~~l~~~~---Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLK-----EGGLTE-ELRQAL---DEFKRYLLDHH---IVIRDLNPHNIVVQR 153 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHH-----cCCccH-HHHHHH---HHHHHHHHHcC---CeecCCCcccEEEEe
Confidence 9999999999998632 47888883 244554 333333 34456667777 999999999999943
Q ss_pred CC----ceEEeec
Q 021526 135 DF----NPKLSDF 143 (311)
Q Consensus 135 ~~----~vkl~Df 143 (311)
.. .+.|+|-
T Consensus 154 ~~~~~~~lvlIDG 166 (199)
T PF10707_consen 154 RDSGEFRLVLIDG 166 (199)
T ss_pred cCCCceEEEEEeC
Confidence 32 4667663
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.11 E-value=0.0002 Score=57.23 Aligned_cols=103 Identities=28% Similarity=0.296 Sum_probs=79.0
Q ss_pred HHHHHHHhcCCC-CcccceeEEEEeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 021526 40 IVEVLMLSLLHH-DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 118 (311)
Q Consensus 40 ~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~ 118 (311)
.+|.-+++.+++ +++.+++|+| ..+++.|+...+++...... ..+--.-+|..+.+++.+++..+.+|+..-..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~-l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRP-LSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccc-cccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 357888888875 6899999997 34678899876554321000 01223468899999999999999999985544
Q ss_pred CeeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 119 PVIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 119 ~i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
.+.-.|++++|+-+++++++|++|.+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcc
Confidence 48999999999999999999999998765
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.09 E-value=9e-05 Score=72.87 Aligned_cols=76 Identities=14% Similarity=0.156 Sum_probs=52.8
Q ss_pred eeeeeceeccEEEEEECC----eEEEEEEeccCC-ccchhHHHHHHHHHhcCC-CCcc--cceeEEEEeC---CeeEEEE
Q 021526 3 CCYLSCKFYNVGLVWLCD----QLVAIKQLNHEG-LQGHQEFIVEVLMLSLLH-HDNL--VTLIGYCTSG---DQRLLVY 71 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~~~----~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~---~~~~lv~ 71 (311)
..++.|.....|.....+ ..+++|+..... ......+.+|+++++.+. |.++ .+++.++.+. +..++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 346677788888877733 467788754322 223457889999999985 6654 6777776654 3578999
Q ss_pred ecCCCCC
Q 021526 72 EYMPMGS 78 (311)
Q Consensus 72 e~~~~~~ 78 (311)
|+++|..
T Consensus 124 E~v~G~~ 130 (822)
T PLN02876 124 EYLEGRI 130 (822)
T ss_pred EecCCcc
Confidence 9998764
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.09 E-value=2.2e-05 Score=71.85 Aligned_cols=134 Identities=20% Similarity=0.130 Sum_probs=82.0
Q ss_pred eeeceeccEEEEEE-CCeEEEEEEeccCCccc-------------------------------------hhHHHHHHHHH
Q 021526 5 YLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQG-------------------------------------HQEFIVEVLML 46 (311)
Q Consensus 5 ~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~-------------------------------------~~~~~~e~~~l 46 (311)
+++.+++.|+++++ +|+.||||+=.+.-... .-+|.+|++..
T Consensus 169 iaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Na 248 (538)
T KOG1235|consen 169 IAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNA 248 (538)
T ss_pred hhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhH
Confidence 46778899999999 89999999854320000 00122333322
Q ss_pred hcC----CCCc------ccceeEEEEeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 021526 47 SLL----HHDN------LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 116 (311)
Q Consensus 47 ~~l----~h~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~ 116 (311)
.+. .|-+ |.+++ ++......|+|||++|..+.+.-.- ....++...+...+.+.. +..+-..|
T Consensus 249 e~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~~~l~~~~--~~qIf~~G 321 (538)
T KOG1235|consen 249 ERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAI---DKRGISPHDILNKLVEAY--LEQIFKTG 321 (538)
T ss_pred HHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHH---HHcCCCHHHHHHHHHHHH--HHHHHhcC
Confidence 221 2222 33333 3344578899999999866654321 234455444433333322 23333456
Q ss_pred CCCeeecCCCCCcEEEcC----CCceEEeecCCCcc
Q 021526 117 NPPVIYRDLKSANILLDN----DFNPKLSDFGLAKL 148 (311)
Q Consensus 117 ~~~i~H~di~p~nil~~~----~~~vkl~Df~~~~~ 148 (311)
++|+|-+|.||+++. ++.+.+.|||+...
T Consensus 322 ---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 322 ---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred ---CccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 999999999999983 66799999999864
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00013 Score=60.55 Aligned_cols=71 Identities=17% Similarity=0.141 Sum_probs=45.3
Q ss_pred eeeeceeccEEEEEEC---CeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcc-cceeEEEEeCCeeEEEEecCCCCCH
Q 021526 4 CYLSCKFYNVGLVWLC---DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNL-VTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~~---~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
.+..|-...+|+.... ++.|++|+.... .....+..+|+.+++.+...++ .+++..+. ..++|||++|.++
T Consensus 5 ~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~-~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l 79 (235)
T cd05157 5 RFTGGITNKLVKVSNKEDNQDAVLVRVYGNK-TELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL 79 (235)
T ss_pred EcCCcccceEEEEEcCCCCCCeEEEEEccCC-ccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence 4555667788888775 578999976533 2222344578888888854333 34443322 2489999988665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00012 Score=60.92 Aligned_cols=72 Identities=13% Similarity=-0.021 Sum_probs=42.5
Q ss_pred eeeeceecc-EEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcCCCC---cccceeEEEEeC---CeeEEEEecCCC
Q 021526 4 CYLSCKFYN-VGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHD---NLVTLIGYCTSG---DQRLLVYEYMPM 76 (311)
Q Consensus 4 ~~~~g~~~~-v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~---~~~~lv~e~~~~ 76 (311)
-++.|+..+ ||.. +..+++|.... ......+.+|++.+..+... .+..++...... ...+++|++++|
T Consensus 4 ~~~~gG~~n~vy~~---~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G 78 (235)
T cd05155 4 PVDSGGTDNATFRL---GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEG 78 (235)
T ss_pred eccCCCcccceEEc---CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecC
Confidence 345566554 7764 34567787442 22345788999999877532 233444433222 234789999988
Q ss_pred CCHH
Q 021526 77 GSLE 80 (311)
Q Consensus 77 ~~L~ 80 (311)
.++.
T Consensus 79 ~~l~ 82 (235)
T cd05155 79 ETAT 82 (235)
T ss_pred CCCC
Confidence 6653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00018 Score=61.49 Aligned_cols=71 Identities=17% Similarity=0.097 Sum_probs=46.8
Q ss_pred eeeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcCC---CCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 4 CYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH---HDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
-++.|.+..+|....+++.+++|+-. ......+..|++-|+.|. .-.+.+++++...++..++++||++.+
T Consensus 24 ~v~GG~i~~a~~~~~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 24 PVSGGDINEAYRLDTDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EE--SSSSEEEEEETTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred ecCCCChhheEEEECCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 35668888888888899999999854 333467888998888873 345778888887777789999998765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00073 Score=58.94 Aligned_cols=140 Identities=12% Similarity=0.086 Sum_probs=72.8
Q ss_pred eeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCc--ccceeE------EEEeCCeeEEEEecCCC
Q 021526 5 YLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN--LVTLIG------YCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 5 ~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~------~~~~~~~~~lv~e~~~~ 76 (311)
+..|....+|....++..+++|++. . .....+..++..+..+...+ +.+++. +...++..+++++|++|
T Consensus 30 l~~G~~n~~y~v~t~~g~~vLK~~~-~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l~G 106 (319)
T PRK05231 30 IAEGIENSNFFLTTTQGEYVLTLFE-R--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFLEG 106 (319)
T ss_pred hccccccceEEEEeCCCcEEEEEec-c--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEecCC
Confidence 3445556788888766789999875 2 12234444555555543211 333332 12335567899999988
Q ss_pred CCHH-----------HHhcccCCCCC----------CCCH-HHHH------------HHHHH-HHHHHHHHhhC----CC
Q 021526 77 GSLE-----------DHLYDLEPDQE----------PLSW-NTRM------------KIAVG-AARGLEYLHCK----AN 117 (311)
Q Consensus 77 ~~L~-----------~~l~~~~~~~~----------~l~~-~~~~------------~~~~~-i~~~l~~Lh~~----~~ 117 (311)
..+. ..+-+...... .+.+ .... ..+.+ +...+..+... -.
T Consensus 107 ~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~lp 186 (319)
T PRK05231 107 KWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPALP 186 (319)
T ss_pred CCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccccCC
Confidence 6431 11111110000 1111 1100 01111 11122222211 12
Q ss_pred CCeeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 118 PPVIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 118 ~~i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
..+||+|++|.||+++++...-++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 239999999999999866556899999875
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00033 Score=60.42 Aligned_cols=140 Identities=16% Similarity=0.091 Sum_probs=79.5
Q ss_pred eeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCc--ccceeE------EEEeCCeeEEEEecCCC
Q 021526 5 YLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN--LVTLIG------YCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 5 ~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~------~~~~~~~~~lv~e~~~~ 76 (311)
+..|....+|.....+..+++|.... .....+..|++++..+...+ +.+++. +...++..++++++++|
T Consensus 22 i~~G~~n~~y~v~~~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G 98 (296)
T cd05153 22 ISAGIENTNYFVTTDSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAG 98 (296)
T ss_pred ccCccccceEEEEeCCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCC
Confidence 33455567888777777899998754 33456777888777774322 334332 12334566899999988
Q ss_pred CCHHH-----------Hhcc-------cCCC---CCCCCHHHH----------HHHHHHHHHHHHHHhhC----CCCCee
Q 021526 77 GSLED-----------HLYD-------LEPD---QEPLSWNTR----------MKIAVGAARGLEYLHCK----ANPPVI 121 (311)
Q Consensus 77 ~~L~~-----------~l~~-------~~~~---~~~l~~~~~----------~~~~~~i~~~l~~Lh~~----~~~~i~ 121 (311)
..+.. .+.. .... .....+... ......+..++.++... -...++
T Consensus 99 ~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 178 (296)
T cd05153 99 EHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVI 178 (296)
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCC
Confidence 65421 0100 0000 000011100 00111123334444431 122399
Q ss_pred ecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 122 YRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 122 H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
|+|++|.|+++++++.+.|+||+.+.
T Consensus 179 HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 179 HADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred ccCcCcccEEEeCCceEEEeehhhhc
Confidence 99999999999987777899998875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00051 Score=59.64 Aligned_cols=141 Identities=16% Similarity=0.072 Sum_probs=76.8
Q ss_pred eeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCc--ccceeEE------EEeCCeeEEEEecCCC
Q 021526 5 YLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN--LVTLIGY------CTSGDQRLLVYEYMPM 76 (311)
Q Consensus 5 ~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~------~~~~~~~~lv~e~~~~ 76 (311)
++.|....+|....++..+++|+..... ....+..|.+++..+...+ +.+++.. ...++..+++++|++|
T Consensus 30 ~~~G~~n~~y~v~t~~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i~G 107 (307)
T TIGR00938 30 IAEGVENSNYLLTTDVGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFLQG 107 (307)
T ss_pred cCCccccceEEEEeCCCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeCCC
Confidence 4445556788887766678889865421 2345556777776664222 3343331 1224567899999988
Q ss_pred CCHH-----------HHhcccCCCCCC--------CCHHHHH---------------HHHHHHHHHHHHHhh----CCCC
Q 021526 77 GSLE-----------DHLYDLEPDQEP--------LSWNTRM---------------KIAVGAARGLEYLHC----KANP 118 (311)
Q Consensus 77 ~~L~-----------~~l~~~~~~~~~--------l~~~~~~---------------~~~~~i~~~l~~Lh~----~~~~ 118 (311)
..+. ..+......... ....... .....+...+.++.. .-..
T Consensus 108 ~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~~~ 187 (307)
T TIGR00938 108 LSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDLPR 187 (307)
T ss_pred CCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 5431 111100000000 0001000 001112334444432 1123
Q ss_pred CeeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 119 PVIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 119 ~i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
.++|+|+++.|+++++++.+.++||+.+.
T Consensus 188 ~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 188 GVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred ccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 39999999999999988777899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.0028 Score=56.63 Aligned_cols=73 Identities=15% Similarity=-0.039 Sum_probs=50.5
Q ss_pred eeeeeceeccEEEEEEC-C-eEEEEEEeccC------C-ccchhHHHHHHHHHhcCC---CCcccceeEEEEeCCeeEEE
Q 021526 3 CCYLSCKFYNVGLVWLC-D-QLVAIKQLNHE------G-LQGHQEFIVEVLMLSLLH---HDNLVTLIGYCTSGDQRLLV 70 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~~-~-~~vaiK~~~~~------~-~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv 70 (311)
..+|.|.+..||.+... | +.|+||.-... . +-..+....|.+.|+.+. ..++.+++.+ +....++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 35788899999999994 3 48999984321 1 123456777888887763 2356677766 44567899
Q ss_pred EecCCCC
Q 021526 71 YEYMPMG 77 (311)
Q Consensus 71 ~e~~~~~ 77 (311)
||++++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9998763
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00093 Score=58.07 Aligned_cols=135 Identities=18% Similarity=0.084 Sum_probs=87.6
Q ss_pred eeeeceeccEEEEEE-CCeEEEEEEeccCC--ccc------------------------hhHHHHHHHHHhcCCCCcccc
Q 021526 4 CYLSCKFYNVGLVWL-CDQLVAIKQLNHEG--LQG------------------------HQEFIVEVLMLSLLHHDNLVT 56 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~--~~~------------------------~~~~~~e~~~l~~l~h~~i~~ 56 (311)
++..|+=.+||.+.. +|..+|||+++... ..+ ......|++-|+.++...|.-
T Consensus 151 CiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~ 230 (520)
T KOG2270|consen 151 CISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPC 230 (520)
T ss_pred ccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 467788899999998 88999999875420 000 012446777777776555322
Q ss_pred eeEEEEeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCC
Q 021526 57 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF 136 (311)
Q Consensus 57 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~ 136 (311)
.--... ..-.|||+++.... ..........+....+..+-.+++.-+.-|..... +||.||+--|+|+ .+|
T Consensus 231 PePIlL--k~hVLVM~FlGrdg----w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Ly-hdG 301 (520)
T KOG2270|consen 231 PEPILL--KNHVLVMEFLGRDG----WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLY-HDG 301 (520)
T ss_pred CCceee--ecceEeeeeccCCC----CcCcccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheE-ECC
Confidence 111111 12368999984211 11111234456666777777777777777765443 9999999999999 567
Q ss_pred ceEEeecCCCc
Q 021526 137 NPKLSDFGLAK 147 (311)
Q Consensus 137 ~vkl~Df~~~~ 147 (311)
.++++|.+.+-
T Consensus 302 ~lyiIDVSQSV 312 (520)
T KOG2270|consen 302 KLYIIDVSQSV 312 (520)
T ss_pred EEEEEEccccc
Confidence 89999998764
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0021 Score=55.63 Aligned_cols=72 Identities=18% Similarity=0.122 Sum_probs=45.6
Q ss_pred eeeeceeccEEEEEEC--------CeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcc-cceeEEEEeCCeeEEEEecC
Q 021526 4 CYLSCKFYNVGLVWLC--------DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNL-VTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~ 74 (311)
.+..|-.-.+|+.... ++.+++|+.... .....+..+|++++..+...++ .+++.++. ..+|++|+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~-~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~i 79 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQS-VELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEFI 79 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCC-CcceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhee
Confidence 3444556678887774 478999996543 2333566788888888754333 34455443 24688998
Q ss_pred CCCCHH
Q 021526 75 PMGSLE 80 (311)
Q Consensus 75 ~~~~L~ 80 (311)
+|..+.
T Consensus 80 ~G~~l~ 85 (302)
T cd05156 80 PSRTLT 85 (302)
T ss_pred CCCcCC
Confidence 876654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0052 Score=49.30 Aligned_cols=120 Identities=23% Similarity=0.231 Sum_probs=79.7
Q ss_pred eeeeeecee-ccEEEEEECCeEEEEEEecc---CCcc------------------chhHHHHHHHHH---hcCCCCcc--
Q 021526 2 LCCYLSCKF-YNVGLVWLCDQLVAIKQLNH---EGLQ------------------GHQEFIVEVLML---SLLHHDNL-- 54 (311)
Q Consensus 2 ~~~~~~g~~-~~v~~~~~~~~~vaiK~~~~---~~~~------------------~~~~~~~e~~~l---~~l~h~~i-- 54 (311)
+..+|.|.= |.|+++...|+.+|+|++.. ..+. ....|..|-+.+ +.+.+.++
T Consensus 42 lefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~A 121 (207)
T PF13095_consen 42 LEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGLWA 121 (207)
T ss_pred eeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCceE
Confidence 578899999 99999999999999999321 1111 112345555544 44455566
Q ss_pred cceeEEEEeC------------------CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 021526 55 VTLIGYCTSG------------------DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 116 (311)
Q Consensus 55 ~~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~ 116 (311)
++++++..-. ....||.||..... .+. ..-+.+|.+-+..+|..|
T Consensus 122 vkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~----~~~~~~~~~dl~~~~k~g 184 (207)
T PF13095_consen 122 VKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ----IRDIPQMLRDLKILHKLG 184 (207)
T ss_pred EEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc----hhHHHHHHHHHHHHHHCC
Confidence 7888876211 11246666654321 222 334566777889999999
Q ss_pred CCCeeecCCCCCcEEEcCCCceEEeecCCC
Q 021526 117 NPPVIYRDLKSANILLDNDFNPKLSDFGLA 146 (311)
Q Consensus 117 ~~~i~H~di~p~nil~~~~~~vkl~Df~~~ 146 (311)
|+-+|+++.|.. .=+|+||+.+
T Consensus 185 ---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 185 ---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred ---eeeccCcccccc-----CCEEEecccC
Confidence 999999999984 2488999864
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0093 Score=53.29 Aligned_cols=78 Identities=17% Similarity=0.034 Sum_probs=51.2
Q ss_pred eeeeceeccEEEEEECCeEEEEEEeccC----C---ccchhHHHHHHHHHhcCC---CCcccceeEEEEeCCeeEEEEec
Q 021526 4 CYLSCKFYNVGLVWLCDQLVAIKQLNHE----G---LQGHQEFIVEVLMLSLLH---HDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~~~~~vaiK~~~~~----~---~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
.+|-|..-.||.....++.++||.-... . +....+...|++.|+.+. -.++.+++.++. ...+++||+
T Consensus 39 eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvME~ 116 (418)
T PLN02756 39 EVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGMRY 116 (418)
T ss_pred EcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEEee
Confidence 4677778889998887778999974311 1 113445566777776664 246777887755 456788999
Q ss_pred CCC--CCHHHHh
Q 021526 74 MPM--GSLEDHL 83 (311)
Q Consensus 74 ~~~--~~L~~~l 83 (311)
+++ ..+.+.+
T Consensus 117 L~~~~~ilr~~L 128 (418)
T PLN02756 117 LEPPHIILRKGL 128 (418)
T ss_pred cCCcceehhhhh
Confidence 976 3444444
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0086 Score=51.74 Aligned_cols=120 Identities=20% Similarity=0.251 Sum_probs=74.4
Q ss_pred CCeEEEEEEecc--CCccchhHHHHHHHHHhcCCC--CcccceeEEEEeCC--eeEEEEecCCCCCHHHHhcccCCCCCC
Q 021526 19 CDQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLHH--DNLVTLIGYCTSGD--QRLLVYEYMPMGSLEDHLYDLEPDQEP 92 (311)
Q Consensus 19 ~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~ 92 (311)
.+++++++ ... ..........+|+.+++.+.- --+...++.+.++. ..++||+|++|..+.+.+.. ..
T Consensus 47 ~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~-----~~ 120 (321)
T COG3173 47 TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPP-----ES 120 (321)
T ss_pred CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCc-----cc
Confidence 47778888 331 233455667788888877643 23445566666655 66999999988533322211 00
Q ss_pred CCHHHHHHHH-HHHHHHHHHHhh--------------------------------------------------CC-----
Q 021526 93 LSWNTRMKIA-VGAARGLEYLHC--------------------------------------------------KA----- 116 (311)
Q Consensus 93 l~~~~~~~~~-~~i~~~l~~Lh~--------------------------------------------------~~----- 116 (311)
.. .+.+ ..++..|+.||+ ..
T Consensus 121 ~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~ 196 (321)
T COG3173 121 LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAG 196 (321)
T ss_pred ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCC
Confidence 00 0111 244444444442 11
Q ss_pred CCCeeecCCCCCcEEEcCCCceEEeecCCCcc
Q 021526 117 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 148 (311)
Q Consensus 117 ~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~ 148 (311)
...++|||+++.|++++..+.+=++||+.+..
T Consensus 197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred CceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 14599999999999999998899999999874
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0059 Score=53.00 Aligned_cols=67 Identities=12% Similarity=0.084 Sum_probs=40.7
Q ss_pred eeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcCCCC--cccceeEE------EEeCCeeEEEEecCCCCCH
Q 021526 9 KFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHD--NLVTLIGY------CTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 9 ~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~------~~~~~~~~lv~e~~~~~~L 79 (311)
..-.||....++..+++|.+... ...+..+...+..+... .+.+++.. ...++..+++++|++|..+
T Consensus 8 ~~~~v~~v~t~~g~~~LK~~~~~----~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~ 82 (313)
T TIGR02906 8 PLRNVYKVETDSGNKCLKKINYP----PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGREC 82 (313)
T ss_pred CCccEEEEEeCCCCeEEEEcCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCC
Confidence 34468888886678899987422 23455566666665432 23333321 2335678899999987543
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0022 Score=51.92 Aligned_cols=104 Identities=13% Similarity=0.056 Sum_probs=68.3
Q ss_pred eEEEEEEeccCCcc-chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHH
Q 021526 21 QLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRM 99 (311)
Q Consensus 21 ~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~ 99 (311)
.+..+|++..-... ...-+.+++.++..+. .|+++..- +...+.++.|.|..... .. .
T Consensus 86 G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-------------~~----~ 144 (308)
T PF07387_consen 86 GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-------------NF----S 144 (308)
T ss_pred chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------------ch----h
Confidence 34556665544443 4456788888887664 46666632 55567899998843211 11 1
Q ss_pred HHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCC
Q 021526 100 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 146 (311)
Q Consensus 100 ~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~ 146 (311)
.++..=+++|..+|+.. ...+|||..|+|||-|+.|.+||.|=+..
T Consensus 145 N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 145 NFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhh
Confidence 11222246788888653 33999999999999999999999997653
|
The function of this family is unknown. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0035 Score=51.17 Aligned_cols=28 Identities=39% Similarity=0.493 Sum_probs=20.6
Q ss_pred eeecCCCCCcEEE-cCCCceEEeecCCCc
Q 021526 120 VIYRDLKSANILL-DNDFNPKLSDFGLAK 147 (311)
Q Consensus 120 i~H~di~p~nil~-~~~~~vkl~Df~~~~ 147 (311)
++|+|+.+.||++ +.++.++|+||..+.
T Consensus 145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 145 FCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred EeeccCccccEEeccCCCeEEEecHHHHh
Confidence 8999999999999 889999999999875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.011 Score=48.10 Aligned_cols=70 Identities=23% Similarity=0.209 Sum_probs=48.8
Q ss_pred ceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcCC---CCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 8 CKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH---HDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 8 g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
|.+-..|....+..++++|.=. ......|..|+.-|..+. .-.+.+++.+-....+.++|++|++.+.+.
T Consensus 27 G~inea~~v~dg~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 27 GDINEAWRLRDGTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred ccccceeEeecCCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 4444555555588999999832 223356777777776663 456778888888889999999998765443
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.016 Score=50.37 Aligned_cols=30 Identities=17% Similarity=0.222 Sum_probs=27.2
Q ss_pred CeeecCCCCCcEEEcCCCceEEeecCCCcc
Q 021526 119 PVIYRDLKSANILLDNDFNPKLSDFGLAKL 148 (311)
Q Consensus 119 ~i~H~di~p~nil~~~~~~vkl~Df~~~~~ 148 (311)
.+||+|+.++|+++++++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 399999999999999999999999998763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.00095 Score=57.06 Aligned_cols=126 Identities=13% Similarity=-0.011 Sum_probs=84.9
Q ss_pred eeeceeccEEEEEE-CCeEEEEEEeccCCcc------------------c----hhHHHHHHHHHhcCC-CCc-ccceeE
Q 021526 5 YLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQ------------------G----HQEFIVEVLMLSLLH-HDN-LVTLIG 59 (311)
Q Consensus 5 ~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~------------------~----~~~~~~e~~~l~~l~-h~~-i~~~~~ 59 (311)
+|=|+=+.||.+.. .|++.++|.-...++. + .-...+|+..++.+. |.+ |.+.++
T Consensus 100 IGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpVPkpiD 179 (465)
T KOG2268|consen 100 IGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPVPKPID 179 (465)
T ss_pred cccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCCCCccc
Confidence 46677778999988 6999999853221110 1 112446777777774 322 344443
Q ss_pred EEEeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceE
Q 021526 60 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 139 (311)
Q Consensus 60 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vk 139 (311)
+ +.-++||+++++..|.+.-.- .....+...+...+.-|-..| ++|||++-=||++++++.++
T Consensus 180 ~----~RH~Vvmelv~g~Pl~~v~~v----------~d~~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 180 H----NRHCVVMELVDGYPLRQVRHV----------EDPPTLYDDLMGLIVRLANHG---LIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred c----cceeeHHHhhcccceeeeeec----------CChHHHHHHHHHHHHHHHHcC---ceecccchheeEEecCCCEE
Confidence 3 456899999988666543311 112334455566677788888 99999999999999999999
Q ss_pred EeecCCCc
Q 021526 140 LSDFGLAK 147 (311)
Q Consensus 140 l~Df~~~~ 147 (311)
++||-.+.
T Consensus 243 vIDFPQmv 250 (465)
T KOG2268|consen 243 VIDFPQMV 250 (465)
T ss_pred EeechHhh
Confidence 99998654
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.016 Score=51.20 Aligned_cols=135 Identities=16% Similarity=0.163 Sum_probs=74.2
Q ss_pred ceeccEEEEEEC------CeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcc-cceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 8 CKFYNVGLVWLC------DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNL-VTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 8 g~~~~v~~~~~~------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
|-.-.+|+.... ++.|++|+.... ....-+-.+|..+++.+...++ .++++.+..+ .|.+|+++.++.
T Consensus 47 GlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~-t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~~l~ 121 (344)
T PLN02236 47 AMTNEVFQIKWPTKEGNLGRKVLVRIYGEG-VELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHARTLS 121 (344)
T ss_pred cccceeEEEEeCCCCCCCCCeEEEEEccCC-CCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCCCCC
Confidence 455667776642 368999987544 2333344678888888864443 3555555332 578888776553
Q ss_pred HH--------------hcccCCC---C-C-CCCHHHHHHHHHHH-----------------HHHHHHH----hhCC-CCC
Q 021526 81 DH--------------LYDLEPD---Q-E-PLSWNTRMKIAVGA-----------------ARGLEYL----HCKA-NPP 119 (311)
Q Consensus 81 ~~--------------l~~~~~~---~-~-~l~~~~~~~~~~~i-----------------~~~l~~L----h~~~-~~~ 119 (311)
.. +.+.... . . ...+..+..+..++ ...+..| .... ..-
T Consensus 122 ~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~~~ 201 (344)
T PLN02236 122 AADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQEIG 201 (344)
T ss_pred HHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCCce
Confidence 21 1111111 1 1 11122222332211 1111112 1111 223
Q ss_pred eeecCCCCCcEEEcC-CCceEEeecCCCc
Q 021526 120 VIYRDLKSANILLDN-DFNPKLSDFGLAK 147 (311)
Q Consensus 120 i~H~di~p~nil~~~-~~~vkl~Df~~~~ 147 (311)
++|+|+++.||++++ ++.++++||..+.
T Consensus 202 ~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 202 FCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred EEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 899999999999986 4679999998875
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.012 Score=51.67 Aligned_cols=28 Identities=25% Similarity=0.344 Sum_probs=25.0
Q ss_pred eeecCCCCCcEEEcC-CCceEEeecCCCc
Q 021526 120 VIYRDLKSANILLDN-DFNPKLSDFGLAK 147 (311)
Q Consensus 120 i~H~di~p~nil~~~-~~~vkl~Df~~~~ 147 (311)
++|+|+.+.||++++ ++.++++||..+.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 899999999999975 5789999999875
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.027 Score=49.52 Aligned_cols=78 Identities=12% Similarity=-0.053 Sum_probs=48.5
Q ss_pred eeeeceeccEEEEEECC--eEEEEEEeccC------C-ccchhHHHHHHHHHhcCC--CC-cccceeEEEEeCCeeEEEE
Q 021526 4 CYLSCKFYNVGLVWLCD--QLVAIKQLNHE------G-LQGHQEFIVEVLMLSLLH--HD-NLVTLIGYCTSGDQRLLVY 71 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~~~--~~vaiK~~~~~------~-~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~lv~ 71 (311)
.+|-|....||++...+ +.|+||.-... + +-...+...|.+.|+... .| .+.+++.+ +.....++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 46778889999999843 68999964321 1 223355667888886654 34 34455544 455667999
Q ss_pred ecCCC-CCHHHHh
Q 021526 72 EYMPM-GSLEDHL 83 (311)
Q Consensus 72 e~~~~-~~L~~~l 83 (311)
|++.. ..+...+
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 98743 3343444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.01 Score=52.77 Aligned_cols=72 Identities=15% Similarity=0.020 Sum_probs=47.4
Q ss_pred eeeeeceeccEEEEEEC--CeEEEEEEeccC-----C-ccchhHHHHHHHHHhcCC--CC-cccceeEEEEeCCeeEEEE
Q 021526 3 CCYLSCKFYNVGLVWLC--DQLVAIKQLNHE-----G-LQGHQEFIVEVLMLSLLH--HD-NLVTLIGYCTSGDQRLLVY 71 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~~--~~~vaiK~~~~~-----~-~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~lv~ 71 (311)
..+|-|....||+++.. ++.|+||.-... + +-..++...|.+.|+... .| ++.+++.+ +.....+||
T Consensus 35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~vM 112 (409)
T PRK12396 35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCVM 112 (409)
T ss_pred eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHHH
Confidence 35688888999999974 678999963221 1 223456777888887664 45 45555544 455667888
Q ss_pred ecCCC
Q 021526 72 EYMPM 76 (311)
Q Consensus 72 e~~~~ 76 (311)
|++..
T Consensus 113 EdL~~ 117 (409)
T PRK12396 113 EDLSD 117 (409)
T ss_pred HhCcc
Confidence 88743
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.00018 Score=72.43 Aligned_cols=152 Identities=14% Similarity=0.015 Sum_probs=105.3
Q ss_pred cCCCCcccceeEEEE--eCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeeec
Q 021526 48 LLHHDNLVTLIGYCT--SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA--NPPVIYR 123 (311)
Q Consensus 48 ~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~--~~~i~H~ 123 (311)
...|+++.....=.. .+...+..++++.+|.+.+.+.+--...+.+....+...-.+.+....-.|+.. +...+|.
T Consensus 1285 ~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~ 1364 (2724)
T KOG1826|consen 1285 EAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSK 1364 (2724)
T ss_pred hhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhh
Confidence 345666544433221 334568899999999999999764434444444444333333355555555443 3448899
Q ss_pred CCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCc
Q 021526 124 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 201 (311)
Q Consensus 124 di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 201 (311)
++++.|-++..+-+++++++|+.++..+ .....+...+++.|+.|++...-.++.++|+|..|+.+|....|..+|
T Consensus 1365 ~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1365 SLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred hhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 9999999999999999999999873221 122223345677888999888888888899999999999999888776
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.054 Score=46.20 Aligned_cols=29 Identities=34% Similarity=0.479 Sum_probs=24.8
Q ss_pred CeeecCCCCCcEEEcCCCc-eEEeecCCCc
Q 021526 119 PVIYRDLKSANILLDNDFN-PKLSDFGLAK 147 (311)
Q Consensus 119 ~i~H~di~p~nil~~~~~~-vkl~Df~~~~ 147 (311)
.++|+|++|.||+++++++ .-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 3899999999999987555 4699999876
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.055 Score=47.25 Aligned_cols=134 Identities=22% Similarity=0.298 Sum_probs=75.6
Q ss_pred cEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcc---cc---eeE--EEEeCC--eeEEEEecCCCCCHHH
Q 021526 12 NVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNL---VT---LIG--YCTSGD--QRLLVYEYMPMGSLED 81 (311)
Q Consensus 12 ~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i---~~---~~~--~~~~~~--~~~lv~e~~~~~~L~~ 81 (311)
.+|+....++.+++|+.... ....++..|+..+..+.-.++ .+ .-+ ...-.. ..+-+++|++|..+..
T Consensus 40 ~~f~~~~~~g~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~~~~ 117 (331)
T COG2334 40 SNFRVQTEDGRYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRPLER 117 (331)
T ss_pred ceEEEEecCCCeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcCcCC
Confidence 46777775556699987654 556778888888887742211 11 111 111223 6778899998876662
Q ss_pred ------------Hh-------cccC---CC-CCCCCHHH-------------HHHHHHHHHHHHHHHhhCC----C---C
Q 021526 82 ------------HL-------YDLE---PD-QEPLSWNT-------------RMKIAVGAARGLEYLHCKA----N---P 118 (311)
Q Consensus 82 ------------~l-------~~~~---~~-~~~l~~~~-------------~~~~~~~i~~~l~~Lh~~~----~---~ 118 (311)
++ .... .. .....|.. -.....++...++.+.+.- . .
T Consensus 118 ~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~~~~ 197 (331)
T COG2334 118 DDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPALGD 197 (331)
T ss_pred CCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCcccc
Confidence 00 0110 00 01112210 0112333334444444211 1 2
Q ss_pred CeeecCCCCCcEEEcCCCc-eEEeecCCCc
Q 021526 119 PVIYRDLKSANILLDNDFN-PKLSDFGLAK 147 (311)
Q Consensus 119 ~i~H~di~p~nil~~~~~~-vkl~Df~~~~ 147 (311)
.++|+|+.|+||+++.+.. +-++||+-+.
T Consensus 198 ~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 198 QIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 2899999999999998885 8999998775
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.15 Score=44.71 Aligned_cols=68 Identities=13% Similarity=-0.008 Sum_probs=41.3
Q ss_pred eccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCc--cccee---E--EEEeCCeeEEEEecCCCCC
Q 021526 10 FYNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN--LVTLI---G--YCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 10 ~~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~---~--~~~~~~~~~lv~e~~~~~~ 78 (311)
--.||.... +++.+++|+.... ......+..|.+.+..+.... ++... + +...++..+.++++++|..
T Consensus 38 eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 38 ENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 345788777 5778999987533 235566777888777664221 22211 1 2233556788999987753
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.055 Score=47.37 Aligned_cols=86 Identities=22% Similarity=0.247 Sum_probs=58.6
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeeeccccccccCC
Q 021526 91 EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 170 (311)
Q Consensus 91 ~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aP 170 (311)
+.....++..++++.+..+.-+..+- +.-|+|+.-.||+++ .|+|-|+||.+++..... . ......+-.|
T Consensus 316 k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl~~~q--~-----~isy~rldhp 385 (488)
T COG5072 316 KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRLSYSQ--G-----IISYNRLDHP 385 (488)
T ss_pred ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeecccCC--c-----eeeccccCch
Confidence 34456788889999988888887654 389999999999999 999999999999732111 1 1122334556
Q ss_pred ccccCCCCCccccchhH
Q 021526 171 EYAMSGKLTLKSDIYSF 187 (311)
Q Consensus 171 E~~~~~~~~~~~Dv~sl 187 (311)
..+.+.. +.+=|||-+
T Consensus 386 ~lF~G~d-d~QFeIYrl 401 (488)
T COG5072 386 DLFNGVD-DYQFEIYRL 401 (488)
T ss_pred hhhcCcc-ceeeeHHHH
Confidence 6555332 444555544
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.33 E-value=0.31 Score=44.51 Aligned_cols=27 Identities=30% Similarity=0.381 Sum_probs=23.4
Q ss_pred eeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 120 VIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 120 i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
++|+|+.+.||+.+++ .++|+||..+.
T Consensus 286 fCHNDl~~~NiL~~~~-~l~LIDfEYAg 312 (442)
T PTZ00296 286 FCHNDLQENNIINTNK-CLRLIDFEYSG 312 (442)
T ss_pred EEeCCCCccceeecCC-CEEEEeecccc
Confidence 8999999999987654 49999998875
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.25 E-value=0.26 Score=44.11 Aligned_cols=27 Identities=33% Similarity=0.197 Sum_probs=23.4
Q ss_pred eeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 120 VIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 120 i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
.||.|+.+.||+.++ +.++++||..+.
T Consensus 229 fCHNDL~~gNIL~~~-~~l~lID~EYA~ 255 (383)
T PTZ00384 229 FCHNDLFFTNILDFN-QGIYFIDFDFAG 255 (383)
T ss_pred eeeccCCcccEEecC-CCEEEEEecccc
Confidence 899999999998754 569999998875
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.06 E-value=0.099 Score=46.52 Aligned_cols=61 Identities=18% Similarity=0.106 Sum_probs=42.6
Q ss_pred eEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeecCCCCCcEEEcCC
Q 021526 67 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDND 135 (311)
Q Consensus 67 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~di~p~nil~~~~ 135 (311)
..++=+|..|.++..++ ..+..++....+++.-.+.|+-.+-- .+ ++|.|++|.||++..+
T Consensus 320 ~vl~E~~~~Gl~v~~~v-----~~~~~pe~l~kkva~lg~~AllkMl~vDN---FvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFV-----KWKSQPEALVKKVAKLGVNALLKMLIVDN---FVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhh-----hcccChHHHHHHHHHHHHHHHHHHHHhhc---ceecccCCCcEEEEec
Confidence 35666677788888888 34555655666666666666554443 44 9999999999999543
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=95.04 E-value=0.049 Score=46.21 Aligned_cols=46 Identities=24% Similarity=0.165 Sum_probs=33.8
Q ss_pred HHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 101 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 101 ~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
.+..+-.++.-.+.. ..-+||+|+.|.|++.++.+.++|+||..+.
T Consensus 137 ~~~~l~~~l~~~~~~-~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg 182 (269)
T COG0510 137 KLKELRRALEEVPKD-DLVPCHNDLNPGNLLLTDKGGLFLIDWEYAG 182 (269)
T ss_pred HHHHHHHHhhhcCCC-ceeeecCCCCccceEEcCCCcEEEEecccCC
Confidence 344444444444433 0139999999999999999999999999885
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 311 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-49 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-49 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-45 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-44 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-38 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-38 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-37 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-36 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-24 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-24 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-23 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-23 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-23 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-23 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-23 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-23 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-23 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-23 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-23 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-23 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-23 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-23 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-23 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-22 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-21 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-21 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-18 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-18 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-18 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-18 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-18 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-17 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-17 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 9e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-15 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-15 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 9e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-08 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 9e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 9e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 9e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 9e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-04 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-04 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-04 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-04 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-04 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-04 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-04 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-04 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-04 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-04 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-04 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-04 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-04 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-04 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-04 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-04 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-04 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-04 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-04 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 8e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-04 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 448 bits (1155), Expect = e-160
Identities = 101/264 (38%), Positives = 149/264 (56%), Gaps = 12/264 (4%)
Query: 17 WLCDQLVAIKQL----NHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 72
++ + VA+K+L + + Q+F E+ +++ H+NLV L+G+ + GD LVY
Sbjct: 51 YVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110
Query: 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL 132
YMP GSL D L L+ PLSW+ R KIA GAA G+ +LH I+RD+KSANILL
Sbjct: 111 YMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILL 166
Query: 133 DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLL 192
D F K+SDFGLA+ T +++R++GT Y APE + G++T KSDIYSFGVVLL
Sbjct: 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLL 225
Query: 193 ELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAM 252
E+ITG A+D + Q L+ ++K +D + + +V +
Sbjct: 226 EIITGLPAVDEH--REPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQ 282
Query: 253 CLNEEANFRPLINDIVVALDYLVS 276
CL+E+ N RP I + L + +
Sbjct: 283 CLHEKKNKRPDIKKVQQLLQEMTA 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 442 bits (1139), Expect = e-158
Identities = 106/266 (39%), Positives = 153/266 (57%), Gaps = 5/266 (1%)
Query: 17 WLCD-QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75
L D VA+K+ E QG +EF E+ LS H +LV+LIG+C ++ +L+Y+YM
Sbjct: 59 VLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYME 118
Query: 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 135
G+L+ HLY + +SW R++I +GAARGL YLH +I+RD+KS NILLD +
Sbjct: 119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDEN 175
Query: 136 FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 195
F PK++DFG++K G D TH+ST V GT GY PEY + G+LT KSD+YSFGVVL E++
Sbjct: 176 FVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235
Query: 196 TGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLN 255
R A+ S + NL W+ + +VDP L + L CL
Sbjct: 236 CARSAIVQSLPREMVNLAEWAVESHN-NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLA 294
Query: 256 EEANFRPLINDIVVALDYLVSQRDSH 281
+ RP + D++ L+Y + ++S
Sbjct: 295 LSSEDRPSMGDVLWKLEYALRLQESV 320
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 423 bits (1091), Expect = e-150
Identities = 110/255 (43%), Positives = 157/255 (61%), Gaps = 5/255 (1%)
Query: 21 QLVAIKQLNHEGLQGHQ-EFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79
LVA+K+L E QG + +F EV M+S+ H NL+ L G+C + +RLLVY YM GS+
Sbjct: 55 TLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 114
Query: 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 139
L + Q PL W R +IA+G+ARGL YLH +P +I+RD+K+ANILLD +F
Sbjct: 115 ASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174
Query: 140 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 199
+ DFGLAKL D THV+T V GT G+ APEY +GK + K+D++ +GV+LLELITG++
Sbjct: 175 VGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 233
Query: 200 AMDLSKGQGEQ--NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEE 257
A DL++ + L+ W + LK+ KK LVD L G Y + + V +C
Sbjct: 234 AFDLARLANDDDVMLLDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSS 292
Query: 258 ANFRPLINDIVVALD 272
RP ++++V L+
Sbjct: 293 PMERPKMSEVVRMLE 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 8e-82
Identities = 75/290 (25%), Positives = 116/290 (40%), Gaps = 30/290 (10%)
Query: 14 GLVW---LCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD----Q 66
G VW L ++ VA+K + Q + EV L + H+N++ IG G
Sbjct: 38 GCVWKAQLLNEYVAVKIFPIQDKQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96
Query: 67 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH-------CKANPP 119
L+ + GSL D L +SWN IA ARGL YLH P
Sbjct: 97 LWLITAFHEKGSLSDFLK-----ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA 151
Query: 120 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG--- 176
+ +RD+KS N+LL N+ ++DFGLA G + + +GT Y APE
Sbjct: 152 ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINF 211
Query: 177 --KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS--WSRPFLKDQKKFV--HLV 230
L+ D+Y+ G+VL EL + A D + P L+D ++ V
Sbjct: 212 QRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKK 271
Query: 231 DPLLHGRYPRRCLNYAVAVTAM-CLNEEANFRPLINDIVVALDYLVSQRD 279
P+L + + + T C + +A R + + + +
Sbjct: 272 RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLTN 321
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 2e-65
Identities = 79/280 (28%), Positives = 115/280 (41%), Gaps = 37/280 (13%)
Query: 14 GLVWL---CDQLVAIKQLNHEGLQGH--QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 68
G V VA+K L + EF+ EV ++ L H N+V +G T
Sbjct: 51 GTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110
Query: 69 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 128
+V EY+ GSL L+ +E L R+ +A A+G+ YLH + NPP+++R+LKS
Sbjct: 111 IVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSP 168
Query: 129 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFG 188
N+L+D + K+ DFGL++L S GT + APE KSD+YSFG
Sbjct: 169 NLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFG 226
Query: 189 VVLLELITGR------KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRC 242
V+L EL T + + G + R + PR
Sbjct: 227 VILWELATLQQPWGNLNPAQVVAAVGFKCK----RLEI------------------PRNL 264
Query: 243 LNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHP 282
A+ C E RP I+ L L+ P
Sbjct: 265 NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 203 bits (517), Expect = 1e-63
Identities = 69/308 (22%), Positives = 118/308 (38%), Gaps = 49/308 (15%)
Query: 14 GLVW---LCDQLVAIKQLNHEGLQGHQEFI--VEVLMLSLLHHDNLVTLIGYCTSGD--- 65
G V+ L ++ VA+K + Q FI + + L+ HDN+ I
Sbjct: 27 GAVYKGSLDERPVAVKVFS---FANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADG 83
Query: 66 --QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH------CKAN 117
+ LLV EY P GSL +L W + ++A RGL YLH
Sbjct: 84 RMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYK 138
Query: 118 PPVIYRDLKSANILLDNDFNPKLSDFGLAK------LGPVGDNTHVSTRVMGTYGYCAPE 171
P + +RDL S N+L+ ND +SDFGL+ L G+ + + +GT Y APE
Sbjct: 139 PAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPE 198
Query: 172 YAMS-------GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL----VSWSRPFL 220
+ D+Y+ G++ E+ + + E + + P
Sbjct: 199 VLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTF 258
Query: 221 KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAM------CLNEEANFRPLINDIVVALDYL 274
+D + V ++P ++AV ++ C +++A R + L
Sbjct: 259 EDMQVLV--SREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316
Query: 275 VSQRDSHP 282
+ + +
Sbjct: 317 MMIWERNK 324
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 9e-62
Identities = 64/190 (33%), Positives = 94/190 (49%), Gaps = 14/190 (7%)
Query: 14 GLVWL---CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 70
G+V + VAIKQ+ E + + FIVE+ LS ++H N+V L G C + LV
Sbjct: 22 GVVCKAKWRAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL--NPVCLV 77
Query: 71 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANI 130
EY GSL + L+ EP + M + ++G+ YLH +I+RDLK N+
Sbjct: 78 MEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNL 136
Query: 131 LLDNDFN-PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGV 189
LL K+ DFG A D T G+ + APE + K D++S+G+
Sbjct: 137 LLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGI 191
Query: 190 VLLELITGRK 199
+L E+IT RK
Sbjct: 192 ILWEVITRRK 201
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 5e-60
Identities = 78/288 (27%), Positives = 125/288 (43%), Gaps = 60/288 (20%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGH-------QEFIVEVLMLSLLHHDNLVTLIGYC 61
GLV +VAIK L +G QEF EV ++S L+H N+V L G
Sbjct: 33 GLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92
Query: 62 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 121
+ +V E++P G L L D P+ W+ ++++ + A G+EY+ + NPP++
Sbjct: 93 H--NPPRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ-NPPIV 146
Query: 122 YRDLKSANILLDN-----DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE--YAM 174
+RDL+S NI L + K++DFGL++ + H + ++G + + APE A
Sbjct: 147 HRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAPETIGAE 201
Query: 175 SGKLTLKSDIYSFGVVLLELITGRK--------AMDLSKGQGEQNLVSWSRPFLKDQKKF 226
T K+D YSF ++L ++TG + E+ L RP +
Sbjct: 202 EESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL----RPTI------ 251
Query: 227 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274
P C V +C + + RP + IV L L
Sbjct: 252 ------------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 6e-60
Identities = 59/276 (21%), Positives = 107/276 (38%), Gaps = 50/276 (18%)
Query: 14 GLVWL---CDQLVAIKQLNHEGLQGH--QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 68
G +W + +K L ++F E L + H N++ ++G C S
Sbjct: 24 GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83
Query: 69 L--VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 126
+ +MP GSL + L++ + + +K A+ ARG+ +LH P + L
Sbjct: 84 PTLITHWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALN 140
Query: 127 SANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK----LTLKS 182
S ++++D D ++S + + S M + APE A+ K +
Sbjct: 141 SRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPE-ALQKKPEDTNRRSA 192
Query: 183 DIYSFGVVLLELITGR------KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236
D++SF V+L EL+T M++ + L RP +
Sbjct: 193 DMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL----RPTI---------------- 232
Query: 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 272
P + + +C+NE+ RP + IV L+
Sbjct: 233 --PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 4e-59
Identities = 70/280 (25%), Positives = 112/280 (40%), Gaps = 52/280 (18%)
Query: 14 GLVWL---CDQLVAIKQLNHEGLQGH----QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 66
G V+ VA+K H+ + + E + ++L H N++ L G C
Sbjct: 21 GKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80
Query: 67 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 126
LV E+ G L L + + + + AV ARG+ YLH +A P+I+RDLK
Sbjct: 81 LCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLK 135
Query: 127 SANILLDNDFNP--------KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL 178
S+NIL+ K++DFGLA+ T + G Y + APE +
Sbjct: 136 SSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAA-GAYAWMAPEVIRASMF 191
Query: 179 TLKSDIYSFGVVLLELITGR------KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 232
+ SD++S+GV+L EL+TG + ++ G L +
Sbjct: 192 SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL----ALPI------------ 235
Query: 233 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 272
P C + C N + + RP +I+ L
Sbjct: 236 ------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 4e-56
Identities = 62/275 (22%), Positives = 109/275 (39%), Gaps = 33/275 (12%)
Query: 19 CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78
+++ +K+L + + F+ EV ++ L H N++ IG + + EY+ G+
Sbjct: 34 TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGT 93
Query: 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 138
L + ++ W+ R+ A A G+ YLH +I+RDL S N L+ + N
Sbjct: 94 LRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNV 147
Query: 139 KLSDFGLAKL------------GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYS 186
++DFGLA+L + V+G + APE K D++S
Sbjct: 148 VVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFS 207
Query: 187 FGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYA 246
FG+VL E+I A + + + F + + F+ P C
Sbjct: 208 FGIVLCEIIGRVNADP--------DYLPRTMDFGLNVRGFLDR--YC-----PPNCPPSF 252
Query: 247 VAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSH 281
+T C + + RP + L+ L H
Sbjct: 253 FPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH 287
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 5e-56
Identities = 64/181 (35%), Positives = 91/181 (50%), Gaps = 12/181 (6%)
Query: 23 VAIKQLNHEGLQGH--QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
VA+K LN Q F EV +L H N++ +GY T Q +V ++ SL
Sbjct: 49 VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLY 107
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 140
HL+ E + IA ARG++YLH K +I+RDLKS NI L D K+
Sbjct: 108 HHLHASET---KFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKI 161
Query: 141 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE---YAMSGKLTLKSDIYSFGVVLLELITG 197
DFGLA +H ++ G+ + APE S + +SD+Y+FG+VL EL+TG
Sbjct: 162 GDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG 221
Query: 198 R 198
+
Sbjct: 222 Q 222
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 1e-54
Identities = 45/190 (23%), Positives = 75/190 (39%), Gaps = 21/190 (11%)
Query: 23 VAIKQLNHEGLQGH--QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
VAI+ ++ E + F EV+ H+N+V +G C S ++ +L
Sbjct: 58 VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLY 117
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 140
+ D + L N +IA +G+ YLH K ++++DLKS N+ DN +
Sbjct: 118 SVVRDAKI---VLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYDNG-KVVI 170
Query: 141 SDFGLAKL---GPVGDNTHVSTRVMGTYGYCAPEYAMSGKL---------TLKSDIYSFG 188
+DFGL + G G + APE + SD+++ G
Sbjct: 171 TDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALG 230
Query: 189 VVLLELITGR 198
+ EL
Sbjct: 231 TIWYELHARE 240
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 3e-54
Identities = 64/292 (21%), Positives = 109/292 (37%), Gaps = 34/292 (11%)
Query: 14 GLVW---LCDQLVAIKQLNHEGLQGHQEFI--VEVLMLSLLHHDNLVTLIGYCTSGD--- 65
G VW + VA+K + E+ L+ H+N++ I G
Sbjct: 51 GEVWMGKWRGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107
Query: 66 -QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH-----CKANPP 119
Q L+ +Y GSL D+L L + +K+A + GL +LH + P
Sbjct: 108 TQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA 162
Query: 120 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH--VSTRVMGTYGYCAPE------ 171
+ +RDLKS NIL+ + ++D GLA N +GT Y PE
Sbjct: 163 IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL 222
Query: 172 YAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKG-QGEQNLVSWSRPFLKDQKKFVHLV 230
+ + +D+YSFG++L E+ + + + Q + + S P +D ++ V +
Sbjct: 223 NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIK 282
Query: 231 D---PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 279
+ CL + C R + L + +D
Sbjct: 283 KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 4e-53
Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 30/206 (14%)
Query: 14 GLVW---LCDQLVAIKQLNHEGLQGHQEFI--VEVLMLSLLHHDNLVTLIGYCTSGD--- 65
G VW + VA+K + + + + E+ +L H+N++ I +
Sbjct: 22 GEVWRGSWQGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78
Query: 66 -QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH-----CKANPP 119
Q L+ Y MGSL D+L L + ++I + A GL +LH + P
Sbjct: 79 TQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA 133
Query: 120 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV--STRVMGTYGYCAPE------ 171
+ +RDLKS NIL+ + ++D GLA + N + +GT Y APE
Sbjct: 134 IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETI 193
Query: 172 YAMSGKLTLKSDIYSFGVVLLELITG 197
+ DI++FG+VL E+
Sbjct: 194 QVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 6e-51
Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 32/207 (15%)
Query: 14 GLVW---LCDQLVAIKQLNHEGLQGHQEFI--VEVLMLSLLHHDNLVTLIGYCTSGD--- 65
G VW + VA+K + + + + E+ +L H+N++ I +
Sbjct: 56 GEVWRGKWRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112
Query: 66 -QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH-----CKANPP 119
Q LV +Y GSL D+L ++ ++ +K+A+ A GL +LH + P
Sbjct: 113 TQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 167
Query: 120 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH--VSTRVMGTYGYCAPEYAMSGK 177
+ +RDLKS NIL+ + ++D GLA +T +GT Y APE +
Sbjct: 168 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE-VLDDS 226
Query: 178 L-------TLKSDIYSFGVVLLELITG 197
+ ++DIY+ G+V E+
Sbjct: 227 INMKHFESFKRADIYAMGLVFWEIARR 253
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-37
Identities = 66/199 (33%), Positives = 99/199 (49%), Gaps = 26/199 (13%)
Query: 14 GLVWLC---------DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG 64
G V +C ++VA+K+L H + ++F E+ +L L HDN+V G C S
Sbjct: 24 GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83
Query: 65 DQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 122
+R L+ EY+P GSL D+L +E + ++ +G+EYL K I+
Sbjct: 84 GRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR---YIH 137
Query: 123 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----YCAPEYAMSGK 177
RDL + NIL++N+ K+ DFGL K+ P G + APE K
Sbjct: 138 RDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK----EPGESPIFWYAPESLTESK 193
Query: 178 LTLKSDIYSFGVVLLELIT 196
++ SD++SFGVVL EL T
Sbjct: 194 FSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-37
Identities = 82/287 (28%), Positives = 130/287 (45%), Gaps = 41/287 (14%)
Query: 14 GLVWLC---------DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG 64
G V +C ++VA+K+L H + ++F E+ +L L HDN+V G C S
Sbjct: 55 GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114
Query: 65 DQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 122
+R L+ EY+P GSL D+L +E + ++ +G+EYL K I+
Sbjct: 115 GRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR---YIH 168
Query: 123 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----YCAPEYAMSGK 177
RDL + NIL++N+ K+ DFGL K+ P + G + APE K
Sbjct: 169 RDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK----EPGESPIFWYAPESLTESK 224
Query: 178 LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 237
++ SD++SFGVVL EL T + + + + + Q HL++ L +
Sbjct: 225 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI--GNDKQ--GQMIVFHLIELLKNNG 280
Query: 238 ---YPRRCLN--YAVAVTAM--CLNEEANFRPLINDIVVALDYLVSQ 277
P C + Y + M C N N RP D+ + +D + Q
Sbjct: 281 RLPRPDGCPDEIYMI----MTECWNNNVNQRPSFRDLALRVDQIRDQ 323
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-37
Identities = 65/199 (32%), Positives = 98/199 (49%), Gaps = 26/199 (13%)
Query: 14 GLVWLC---------DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG 64
G V LC LVA+KQL H G ++F E+ +L LH D +V G
Sbjct: 37 GSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96
Query: 65 DQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 122
++ LV EY+P G L D L L + + + +G+EYL + ++
Sbjct: 97 GRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYLGSRR---CVH 150
Query: 123 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----YCAPEYAMSGK 177
RDL + NIL++++ + K++DFGLAKL P+ + +V G + APE
Sbjct: 151 RDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR----EPGQSPIFWYAPESLSDNI 206
Query: 178 LTLKSDIYSFGVVLLELIT 196
+ +SD++SFGVVL EL T
Sbjct: 207 FSRQSDVWSFGVVLYELFT 225
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-36
Identities = 52/186 (27%), Positives = 85/186 (45%), Gaps = 11/186 (5%)
Query: 14 GLVWLCDQLVAIKQLN-HEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 72
G + + LVA+K +F+ E +L H N+V LIG CT +V E
Sbjct: 133 GRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192
Query: 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL 132
+ G L + L T +++ AA G+EYL K I+RDL + N L+
Sbjct: 193 LVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLV 246
Query: 133 DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY--CAPEYAMSGKLTLKSDIYSFGVV 190
K+SDFG+++ D + ++ + APE G+ + +SD++SFG++
Sbjct: 247 TEKNVLKISDFGMSRE--EADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGIL 304
Query: 191 LLELIT 196
L E +
Sbjct: 305 LWETFS 310
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-35
Identities = 78/288 (27%), Positives = 119/288 (41%), Gaps = 39/288 (13%)
Query: 14 GLVWLC---------DQLVAIKQL-NHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 63
G V L ++VA+K L G Q + E+ +L L+H++++ G C
Sbjct: 45 GKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED 104
Query: 64 GDQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 121
LV EY+P+GSL D+L + + + A G+ YLH + I
Sbjct: 105 AGAASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLHAQH---YI 156
Query: 122 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----YCAPEYAMSG 176
+RDL + N+LLDND K+ DFGLAK P G + + G + APE
Sbjct: 157 HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFWYAPECLKEY 212
Query: 177 KLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235
K SD++SFGV L EL+T + E + Q + L + L
Sbjct: 213 KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI----AQ--GQMTVLRLTELLER 266
Query: 236 GRY---PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 280
G P +C + C EA+FRP +++ L + +
Sbjct: 267 GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-35
Identities = 55/189 (29%), Positives = 96/189 (50%), Gaps = 14/189 (7%)
Query: 14 GLVWL-----CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 68
G V+ VA+K L E +EF+ E ++ + H NLV L+G CT
Sbjct: 234 GEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 292
Query: 69 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 128
++ E+M G+L D+L + + +S + +A + +EYL K I+R+L +
Sbjct: 293 IITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAAR 347
Query: 129 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG-TYGYCAPEYAMSGKLTLKSDIYSF 187
N L+ + K++DFGL++L + +T+ + + APE K ++KSD+++F
Sbjct: 348 NCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 405
Query: 188 GVVLLELIT 196
GV+L E+ T
Sbjct: 406 GVLLWEIAT 414
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-35
Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 27/200 (13%)
Query: 14 GLVWLC---------DQLVAIKQL-NHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 63
G V LC + VA+K L G + E+ +L L+H+N+V G CT
Sbjct: 35 GKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE 94
Query: 64 GDQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 121
L+ E++P GSL+++L ++ ++ ++K AV +G++YL + +
Sbjct: 95 DGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSRQ---YV 148
Query: 122 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----YCAPEYAMSG 176
+RDL + N+L++++ K+ DFGL K + + APE M
Sbjct: 149 HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK----DDRDSPVFWYAPECLMQS 204
Query: 177 KLTLKSDIYSFGVVLLELIT 196
K + SD++SFGV L EL+T
Sbjct: 205 KFYIASDVWSFGVTLHELLT 224
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-35
Identities = 52/188 (27%), Positives = 87/188 (46%), Gaps = 15/188 (7%)
Query: 16 VWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75
W VA+K + EG EF E + L H LV G C+ +V EY+
Sbjct: 28 KWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86
Query: 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 135
G L ++L + L + +++ G+ +L I+RDL + N L+D D
Sbjct: 87 NGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRD 140
Query: 136 FNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLTLKSDIYSFGVVLL 192
K+SDFG+ + V D+ + +GT + APE K + KSD+++FG+++
Sbjct: 141 LCVKVSDFGMTRY--VLDDQY--VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMW 196
Query: 193 ELIT-GRK 199
E+ + G+
Sbjct: 197 EVFSLGKM 204
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 9e-35
Identities = 53/185 (28%), Positives = 81/185 (43%), Gaps = 17/185 (9%)
Query: 21 QLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS---GDQRLLVY-EYM 74
VA +L L Q F E ML L H N+V S G + +++ E M
Sbjct: 52 VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 111
Query: 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD- 133
G+L+ +L + + +GL++LH + PP+I+RDLK NI +
Sbjct: 112 TSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITG 166
Query: 134 NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLE 193
+ K+ D GLA L + V+GT + APE K D+Y+FG+ +LE
Sbjct: 167 PTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLE 221
Query: 194 LITGR 198
+ T
Sbjct: 222 MATSE 226
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-34
Identities = 58/188 (30%), Positives = 91/188 (48%), Gaps = 15/188 (7%)
Query: 16 VWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75
WL VAIK + EG ++FI E ++ L H LV L G C LV E+M
Sbjct: 28 YWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86
Query: 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 135
G L D+L + + T + + + G+ YL VI+RDL + N L+ +
Sbjct: 87 HGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGEN 140
Query: 136 FNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLTLKSDIYSFGVVLL 192
K+SDFG+ + V D+ + T GT + +PE + + KSD++SFGV++
Sbjct: 141 QVIKVSDFGMTRF--VLDDQY--TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMW 196
Query: 193 ELIT-GRK 199
E+ + G+
Sbjct: 197 EVFSEGKI 204
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-34
Identities = 57/191 (29%), Positives = 97/191 (50%), Gaps = 18/191 (9%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 68
G V+ VA+K L E +EF+ E ++ + H NLV L+G CT
Sbjct: 27 GEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85
Query: 69 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 128
++ E+M G+L D+L + + +S + +A + +EYL K I+RDL +
Sbjct: 86 IITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAAR 140
Query: 129 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLTLKSDIY 185
N L+ + K++DFGL++L + +T+ + G + APE K ++KSD++
Sbjct: 141 NCLVGENHLVKVADFGLSRL--MTGDTYTAHA--GAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 186 SFGVVLLELIT 196
+FGV+L E+ T
Sbjct: 197 AFGVLLWEIAT 207
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-34
Identities = 56/276 (20%), Positives = 102/276 (36%), Gaps = 43/276 (15%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC----TSG 64
V L A+K++ Q +E E M L +H N++ L+ YC +
Sbjct: 43 SYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102
Query: 65 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 124
+ L+ + G+L + + L+ L+ + + + +G RGLE +H +RD
Sbjct: 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRD 159
Query: 125 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-------GTYGYCAPE------ 171
LK NILL ++ P L D G + + T Y APE
Sbjct: 160 LKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQS 219
Query: 172 YAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231
+ + + ++D++S G VL ++ G D+ +G+ L Q +
Sbjct: 220 HCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA-------LAVQNQL----S 265
Query: 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 267
R+ + + + + RP I +
Sbjct: 266 IPQSPRHSSALWQ----LLNSMMTVDPHQRPHIPLL 297
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-34
Identities = 60/184 (32%), Positives = 95/184 (51%), Gaps = 14/184 (7%)
Query: 16 VWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75
+ VA+K L +G F+ E ++ L H LV L T + ++ EYM
Sbjct: 33 YYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90
Query: 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 135
GSL D L P L+ N + +A A G+ ++ + I+RDL++ANIL+ +
Sbjct: 91 NGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDT 145
Query: 136 FNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLTLKSDIYSFGVVLL 192
+ K++DFGLA+L + DN + T G + APE G T+KSD++SFG++L
Sbjct: 146 LSCKIADFGLARL--IEDNEY--TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLT 201
Query: 193 ELIT 196
E++T
Sbjct: 202 EIVT 205
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-34
Identities = 56/184 (30%), Positives = 91/184 (49%), Gaps = 14/184 (7%)
Query: 16 VWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75
W VAIK + EG EFI E ++ L H+ LV L G CT ++ EYM
Sbjct: 44 KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 102
Query: 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 135
G L ++L ++ +++ +EYL K ++RDL + N L+++
Sbjct: 103 NGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQ 156
Query: 136 FNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLTLKSDIYSFGVVLL 192
K+SDFGL++ V D+ + T +G+ + PE M K + KSDI++FGV++
Sbjct: 157 GVVKVSDFGLSRY--VLDDEY--TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMW 212
Query: 193 ELIT 196
E+ +
Sbjct: 213 EIYS 216
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-34
Identities = 47/182 (25%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 23 VAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
VAIK+L + ++E + E +++ + + ++ L+G C L+ + MP G L D
Sbjct: 47 VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLD 105
Query: 82 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYL---HCKANPPVIYRDLKSANILLDNDFNP 138
++ + ++ + + V A+G+ YL ++RDL + N+L+ +
Sbjct: 106 YVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRRL------VHRDLAARNVLVKTPQHV 156
Query: 139 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-G 197
K++DFGLAKL + + + + A E + T +SD++S+GV + EL+T G
Sbjct: 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 216
Query: 198 RK 199
K
Sbjct: 217 SK 218
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-34
Identities = 59/181 (32%), Positives = 90/181 (49%), Gaps = 8/181 (4%)
Query: 16 VWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75
W VAIK L G + F+ E ++ L H+ LV L + + +V EYM
Sbjct: 204 TWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 261
Query: 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 135
GSL D L + L + +A A G+ Y+ ++RDL++ANIL+ +
Sbjct: 262 KGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGEN 316
Query: 136 FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 195
K++DFGLA+L + T + APE A+ G+ T+KSD++SFG++L EL
Sbjct: 317 LVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 375
Query: 196 T 196
T
Sbjct: 376 T 376
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 1e-33
Identities = 59/181 (32%), Positives = 90/181 (49%), Gaps = 8/181 (4%)
Query: 16 VWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75
W VAIK L G + F+ E ++ L H+ LV L + + +V EYM
Sbjct: 287 TWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 344
Query: 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 135
GSL D L + L + +A A G+ Y+ ++RDL++ANIL+ +
Sbjct: 345 KGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGEN 399
Query: 136 FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 195
K++DFGLA+L + T + APE A+ G+ T+KSD++SFG++L EL
Sbjct: 400 LVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 458
Query: 196 T 196
T
Sbjct: 459 T 459
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-33
Identities = 54/184 (29%), Positives = 91/184 (49%), Gaps = 14/184 (7%)
Query: 16 VWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75
+ VA+K + G + F+ E ++ L HD LV L T + ++ E+M
Sbjct: 208 TYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMA 265
Query: 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 135
GSL D L + + + A G+ ++ + I+RDL++ANIL+
Sbjct: 266 KGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSAS 320
Query: 136 FNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLTLKSDIYSFGVVLL 192
K++DFGLA++ + DN + T G + APE G T+KSD++SFG++L+
Sbjct: 321 LVCKIADFGLARV--IEDNEY--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLM 376
Query: 193 ELIT 196
E++T
Sbjct: 377 EIVT 380
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-33
Identities = 62/214 (28%), Positives = 91/214 (42%), Gaps = 43/214 (20%)
Query: 14 GLVWLC----------DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 63
G V+L LVA+K L L ++F E +L+ L H+++V G C
Sbjct: 29 GKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGD 88
Query: 64 GDQRLLVYEYMPMGSLEDHLYDLEPDQE------------PLSWNTRMKIAVGAARGLEY 111
GD ++V+EYM G L L PD L + + IA A G+ Y
Sbjct: 89 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVY 148
Query: 112 L---HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV------M 162
L H ++RDL + N L+ + K+ DFG+++ D V M
Sbjct: 149 LASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 202
Query: 163 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
PE M K T +SD++SFGV+L E+ T
Sbjct: 203 ------PPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-33
Identities = 55/179 (30%), Positives = 91/179 (50%), Gaps = 9/179 (5%)
Query: 23 VAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
V IK + + G Q Q +L + L H ++V L+G C G LV +Y+P+GSL D
Sbjct: 45 VCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLD 103
Query: 82 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 141
H+ + L + V A+G+ YL +++R+L + N+LL + +++
Sbjct: 104 HVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVA 157
Query: 142 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRK 199
DFG+A L P D + + + A E GK T +SD++S+GV + EL+T G +
Sbjct: 158 DFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 6e-33
Identities = 60/184 (32%), Positives = 85/184 (46%), Gaps = 16/184 (8%)
Query: 23 VAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79
VA+K L + L + +FI EV + L H NL+ L G +V E P+GSL
Sbjct: 49 VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSL 107
Query: 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 139
D L Q T + AV A G+ YL K I+RDL + N+LL K
Sbjct: 108 LDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVK 161
Query: 140 LSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
+ DFGL + P D+ +V + +CAPE + + SD + FGV L E+ T
Sbjct: 162 IGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
Query: 197 -GRK 199
G++
Sbjct: 220 YGQE 223
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 64/213 (30%), Positives = 91/213 (42%), Gaps = 42/213 (19%)
Query: 14 GLVWLC----------DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 63
G V+L LVA+K L Q+F E +L++L H ++V G CT
Sbjct: 55 GKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE 114
Query: 64 GDQRLLVYEYMPMGSLEDHLYDLEPDQE-----------PLSWNTRMKIAVGAARGLEYL 112
G L+V+EYM G L L PD + PL + +A A G+ YL
Sbjct: 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL 174
Query: 113 ---HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV------MG 163
H ++RDL + N L+ K+ DFG+++ D V R M
Sbjct: 175 AGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM- 227
Query: 164 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
PE + K T +SD++SFGVVL E+ T
Sbjct: 228 -----PPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-32
Identities = 57/266 (21%), Positives = 100/266 (37%), Gaps = 35/266 (13%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQE---FIVEVLMLSLLHHDNLVTLIGYCTSGD 65
V+ VA+K++ L + I E+ +L L+H N++ +
Sbjct: 46 SEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN 105
Query: 66 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 125
+ +V E G L + + + + T K V LE++H + V++RD+
Sbjct: 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDI 162
Query: 126 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIY 185
K AN+ + KL D GL + T + ++GT Y +PE KSDI+
Sbjct: 163 KPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIW 220
Query: 186 SFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNY 245
S G +L E+ + PF D+ L + YP ++
Sbjct: 221 SLGCLLYEMAALQ------------------SPFYGDKMNLYSLCKKIEQCDYPPLPSDH 262
Query: 246 ----AVAVTAMCLNEEANFRPLINDI 267
+ MC+N + RP + +
Sbjct: 263 YSEELRQLVNMCINPDPEKRPDVTYV 288
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-32
Identities = 63/268 (23%), Positives = 105/268 (39%), Gaps = 36/268 (13%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIG-YCTSGD 65
G +++ K+L++ + Q + EV +L L H N+V +
Sbjct: 20 GRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN 79
Query: 66 QRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP--VIY 122
L +V EY G L + +++ L +++ L+ H +++ V++
Sbjct: 80 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLH 139
Query: 123 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKS 182
RDLK AN+ LD N KL DFGLA++ + +T + +GT Y +PE KS
Sbjct: 140 RDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKS 197
Query: 183 DIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRC 242
DI+S G +L EL PF L + G++ R
Sbjct: 198 DIWSLGCLLYELCALM------------------PPF--TAFSQKELAGKIREGKFRRIP 237
Query: 243 LNY---AVAVTAMCLNEEANFRPLINDI 267
Y + LN + RP + +I
Sbjct: 238 YRYSDELNEIITRMLNLKDYHRPSVEEI 265
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-32
Identities = 53/187 (28%), Positives = 95/187 (50%), Gaps = 15/187 (8%)
Query: 19 CDQLVAIKQLNHEGLQGHQ--EFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76
+ VAIK L G Q +F+ E ++ H N++ L G + +++ EYM
Sbjct: 72 KEVPVAIKTLK-AGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMEN 130
Query: 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF 136
G+L+ L + + + S + + G A G++YL ++RDL + NIL++++
Sbjct: 131 GALDKFLREKDGE---FSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNL 184
Query: 137 NPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLTLKSDIYSFGVVLLE 193
K+SDFGL+++ + D+ + G + APE K T SD++SFG+V+ E
Sbjct: 185 VCKVSDFGLSRV--LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWE 242
Query: 194 LIT-GRK 199
++T G +
Sbjct: 243 VMTYGER 249
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-32
Identities = 55/184 (29%), Positives = 91/184 (49%), Gaps = 15/184 (8%)
Query: 20 DQLVAIKQLNHEGLQGHQEFIV----EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75
+ VAIK + + +E + EV S L H N+V++I D LV EY+
Sbjct: 36 NIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIE 94
Query: 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 135
+L +++ PLS +T + G+++ H +++RD+K NIL+D++
Sbjct: 95 GPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAH-DMR--IVHRDIKPQNILIDSN 147
Query: 136 FNPKLSDFGLAKLGPVGDNTHVST-RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLEL 194
K+ DFG+AK + + + T V+GT Y +PE A +DIYS G+VL E+
Sbjct: 148 KTLKIFDFGIAKA--LSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEM 205
Query: 195 ITGR 198
+ G
Sbjct: 206 LVGE 209
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-32
Identities = 47/179 (26%), Positives = 92/179 (51%), Gaps = 9/179 (5%)
Query: 23 VAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
VAIK+L + ++E + E +++ + + ++ L+G C L+ + MP G L D
Sbjct: 47 VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLD 105
Query: 82 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 141
++ + ++ + + V A+G+ YL + +++RDL + N+L+ + K++
Sbjct: 106 YVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKIT 159
Query: 142 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRK 199
DFGLAKL + + + + A E + T +SD++S+GV + EL+T G K
Sbjct: 160 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-32
Identities = 53/183 (28%), Positives = 88/183 (48%), Gaps = 15/183 (8%)
Query: 23 VAIKQLNHEGLQGHQ--EFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
VAIK L G Q +F+ E ++ H N++ L G T G ++V EYM GSL+
Sbjct: 80 VAIKALK-AGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLD 138
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 140
L + + + G G+ YL ++RDL + N+L+D++ K+
Sbjct: 139 TFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKV 192
Query: 141 SDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT- 196
SDFGL+++ + D+ + G + APE + SD++SFGVV+ E++
Sbjct: 193 SDFGLSRV--LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAY 250
Query: 197 GRK 199
G +
Sbjct: 251 GER 253
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 9e-32
Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 24/191 (12%)
Query: 14 GLVW---LCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL-L 69
G V VA+K + ++ Q F+ E +++ L H NLV L+G L +
Sbjct: 207 GDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264
Query: 70 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 129
V EYM GSL D+L + L + +K ++ +EYL ++RDL + N
Sbjct: 265 VTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARN 319
Query: 130 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV----MGTYGYCAPEYAMSGKLTLKSDIY 185
+L+ D K+SDFGL K +T + ++ APE K + KSD++
Sbjct: 320 VLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------APEALREKKFSTKSDVW 370
Query: 186 SFGVVLLELIT 196
SFG++L E+ +
Sbjct: 371 SFGILLWEIYS 381
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 53/183 (28%), Positives = 91/183 (49%), Gaps = 15/183 (8%)
Query: 23 VAIKQLNHEGLQGHQ--EFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
VAIK L G Q +F+ E ++ H N++ L G T ++V EYM GSL+
Sbjct: 76 VAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 140
L + + + + G A G++YL ++RDL + NIL++++ K+
Sbjct: 135 SFLRKHDAQ---FTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKV 188
Query: 141 SDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT- 196
SDFGL ++ + D+ + G + +PE K T SD++S+G+VL E+++
Sbjct: 189 SDFGLGRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY 246
Query: 197 GRK 199
G +
Sbjct: 247 GER 249
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-31
Identities = 51/189 (26%), Positives = 88/189 (46%), Gaps = 28/189 (14%)
Query: 23 VAIKQLNHEGLQGHQ--EFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
VAIK L +G + E + E ++ L + +V LIG C + +LV E G L
Sbjct: 40 VAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLH 97
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL---HCKANPPVIYRDLKSANILLDNDFN 137
L +E + + ++ + G++YL + ++RDL + N+LL N
Sbjct: 98 KFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKNF------VHRDLAARNVLLVNRHY 148
Query: 138 PKLSDFGLAKLGPVGDNTHVSTRVMGTYG------YCAPEYAMSGKLTLKSDIYSFGVVL 191
K+SDFGL+K D+ + + + APE K + +SD++S+GV +
Sbjct: 149 AKISDFGLSKALGADDSYYTARS-----AGKWPLKWYAPECINFRKFSSRSDVWSYGVTM 203
Query: 192 LELIT-GRK 199
E ++ G+K
Sbjct: 204 WEALSYGQK 212
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-31
Identities = 52/190 (27%), Positives = 87/190 (45%), Gaps = 22/190 (11%)
Query: 20 DQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78
+ VAIK +N ++ EF+ E ++ + ++V L+G + G L++ E M G
Sbjct: 55 ETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGD 114
Query: 79 LEDHL------YDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL 132
L+ +L P P S + +++A A G+ YL+ ++RDL + N ++
Sbjct: 115 LKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 171
Query: 133 DNDFNPKLSDFGLAKLGPVGDNTHVSTRV------MGTYGYCAPEYAMSGKLTLKSDIYS 186
DF K+ DFG+ + D + M +PE G T SD++S
Sbjct: 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM------SPESLKDGVFTTYSDVWS 225
Query: 187 FGVVLLELIT 196
FGVVL E+ T
Sbjct: 226 FGVVLWEIAT 235
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-31
Identities = 58/195 (29%), Positives = 90/195 (46%), Gaps = 25/195 (12%)
Query: 14 GLVW---LCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL-L 69
G V VA+K + Q F+ E +++ L H NLV L+G L +
Sbjct: 35 GDVMLGDYRGNKVAVKCIK-NDAT-AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 92
Query: 70 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 129
V EYM GSL D+L + L + +K ++ +EYL ++RDL + N
Sbjct: 93 VTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARN 147
Query: 130 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV----MGTYGYCAPEYAMSGKLTLKSDIY 185
+L+ D K+SDFGL K +T + ++ APE K + KSD++
Sbjct: 148 VLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------APEALREKKFSTKSDVW 198
Query: 186 SFGVVLLELIT-GRK 199
SFG++L E+ + GR
Sbjct: 199 SFGILLWEIYSFGRV 213
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-31
Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 28/189 (14%)
Query: 23 VAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
VA+K L +E E + E ++ L + +V +IG C + +LV E +G L
Sbjct: 47 VAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLN 105
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL---HCKANPPVIYRDLKSANILLDNDFN 137
+L + +++ + G++YL + ++RDL + N+LL
Sbjct: 106 KYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESNF------VHRDLAARNVLLVTQHY 155
Query: 138 PKLSDFGLAKLGPVGDNTHVSTRVMGTYG------YCAPEYAMSGKLTLKSDIYSFGVVL 191
K+SDFGL+K +N + + + APE K + KSD++SFGV++
Sbjct: 156 AKISDFGLSKALRADENYYKAQT-----HGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 210
Query: 192 LELIT-GRK 199
E + G+K
Sbjct: 211 WEAFSYGQK 219
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-31
Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 46/216 (21%)
Query: 14 GLVWLC----------DQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYC 61
G V+ Q VAIK L + +EF E ++ + L H N+V L+G
Sbjct: 23 GKVYKGHLFGPAPGEQTQAVAIKTLK-DKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV 81
Query: 62 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQE------------PLSWNTRMKIAVGAARGL 109
T +++ Y G L + L P + L + + A G+
Sbjct: 82 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGM 141
Query: 110 EYL---HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST------R 160
EYL H +++DL + N+L+ + N K+SD GL + D + R
Sbjct: 142 EYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIR 195
Query: 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
M APE M GK ++ SDI+S+GVVL E+ +
Sbjct: 196 WM------APEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-31
Identities = 42/185 (22%), Positives = 82/185 (44%), Gaps = 22/185 (11%)
Query: 23 VAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
VA+K + L ++F+ E +++ L H ++V LIG + ++ E P G L
Sbjct: 43 VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE-EEPTWIIMELYPYGELGH 101
Query: 82 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 141
+L + L T + ++ + + YL ++RD+ NIL+ + KL
Sbjct: 102 YLERNKNS---LKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLG 155
Query: 142 DFGLAKLGPVGDNTHVSTRVMGTYG------YCAPEYAMSGKLTLKSDIYSFGVVLLELI 195
DFGL++ + D + + +PE + T SD++ F V + E++
Sbjct: 156 DFGLSRY--IEDEDYYKAS-----VTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEIL 208
Query: 196 T-GRK 199
+ G++
Sbjct: 209 SFGKQ 213
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-31
Identities = 48/190 (25%), Positives = 84/190 (44%), Gaps = 28/190 (14%)
Query: 23 VAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDH 82
V +K L+ + F M+S L H +LV G C GD+ +LV E++ GSL+ +
Sbjct: 43 VLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTY 102
Query: 83 LYDLEPDQEPLSWNTRMKIAVGAARGLEYL---HCKANPPVIYRDLKSANILLDNDFNP- 138
L ++ ++ ++++A A + +L I+ ++ + NILL + +
Sbjct: 103 LKK---NKNCINILWKLEVAKQLAAAMHFLEENTL------IHGNVCAKNILLIREEDRK 153
Query: 139 -------KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVV 190
KLSD G++ V + R+ PE + K L +D +SFG
Sbjct: 154 TGNPPFIKLSDPGISIT--VLPKDILQERIPWV----PPECIENPKNLNLATDKWSFGTT 207
Query: 191 LLELIT-GRK 199
L E+ + G K
Sbjct: 208 LWEICSGGDK 217
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-31
Identities = 58/264 (21%), Positives = 104/264 (39%), Gaps = 37/264 (14%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGH--QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 66
G L + IK++N + +E EV +L+ + H N+V
Sbjct: 38 GKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGS 97
Query: 67 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 126
+V +Y G L + + + + V L+++H + +++RD+K
Sbjct: 98 LYIVMDYCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIK 152
Query: 127 SANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYS 186
S NI L D +L DFG+A++ + ++ +GT Y +PE + KSDI++
Sbjct: 153 SQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGTPYYLSPEICENKPYNNKSDIWA 210
Query: 187 FGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNY- 245
G VL EL T + F + +LV ++ G +P L+Y
Sbjct: 211 LGCVLYELCTLK------------------HAF--EAGSMKNLVLKIISGSFPPVSLHYS 250
Query: 246 --AVAVTAMCLNEEANFRPLINDI 267
++ + RP +N I
Sbjct: 251 YDLRSLVSQLFKRNPRDRPSVNSI 274
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 9e-31
Identities = 53/187 (28%), Positives = 81/187 (43%), Gaps = 16/187 (8%)
Query: 20 DQLVAIKQLN-HEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78
VA+K L Q +F++E L++S +H N+V IG R ++ E M G
Sbjct: 60 PLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGD 119
Query: 79 LEDHLYDLEPDQE---PLSWNTRMKIAVGAARGLEYL---HCKANPPVIYRDLKSANILL 132
L+ L + P L+ + +A A G +YL H I+RD+ + N LL
Sbjct: 120 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF------IHRDIAARNCLL 173
Query: 133 DN---DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGV 189
K+ DFG+A+ M + PE M G T K+D +SFGV
Sbjct: 174 TCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGV 233
Query: 190 VLLELIT 196
+L E+ +
Sbjct: 234 LLWEIFS 240
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 1e-30
Identities = 52/193 (26%), Positives = 84/193 (43%), Gaps = 29/193 (15%)
Query: 23 VAIKQLNHEG--LQGHQEFIVEV-LMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79
VA+K L + + E+ +M L H+N+V L+G CT G L++ EY G L
Sbjct: 79 VAVKMLK-STAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 80 EDHL----------YDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 129
+ L S + + A+G+ +L K I+RD+ + N
Sbjct: 138 LNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARN 194
Query: 130 ILLDNDFNPKLSDFGLAKLGPVGDNTHVST------RVMGTYGYCAPEYAMSGKLTLKSD 183
+LL N K+ DFGLA+ N V + M APE T++SD
Sbjct: 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWM------APESIFDCVYTVQSD 248
Query: 184 IYSFGVVLLELIT 196
++S+G++L E+ +
Sbjct: 249 VWSYGILLWEIFS 261
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 44/212 (20%), Positives = 89/212 (41%), Gaps = 34/212 (16%)
Query: 14 GLVWLC---DQLVAIKQLNHEGLQGHQEFIV-----------------EVLMLSLLHHDN 53
+ LC ++ A+K+ L+ ++F E+ +++ + ++
Sbjct: 45 NKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY 104
Query: 54 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR----GL 109
+T G T+ D+ ++YEYM S+ + + +++ +
Sbjct: 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSF 164
Query: 110 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 169
Y+H + N + +RD+K +NIL+D + KLSDFG ++ + + GTY +
Sbjct: 165 SYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV---DKKIKG-SRGTYEFMP 218
Query: 170 PEYAMSGKLT---LKSDIYSFGVVLLELITGR 198
PE S + + K DI+S G+ L +
Sbjct: 219 PE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-30
Identities = 47/186 (25%), Positives = 80/186 (43%), Gaps = 24/186 (12%)
Query: 23 VAIKQLNHEGLQGHQ--EFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
VAIK +F+ E L + H ++V LIG T + ++ E +G L
Sbjct: 46 VAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELR 103
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 140
L + L + + A + L YL K ++RD+ + N+L+ ++ KL
Sbjct: 104 SFLQVRKYS---LDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKL 157
Query: 141 SDFGLAKLGPVGDNTHVSTRVMGTYG------YCAPEYAMSGKLTLKSDIYSFGVVLLEL 194
DFGL++ + D+T+ + APE + T SD++ FGV + E+
Sbjct: 158 GDFGLSRY--MEDSTYYKAS-----KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 210
Query: 195 IT-GRK 199
+ G K
Sbjct: 211 LMHGVK 216
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-30
Identities = 48/192 (25%), Positives = 83/192 (43%), Gaps = 30/192 (15%)
Query: 23 VAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR-----LLVYEYMP 75
VA+K + + + +EF+ E + H N++ L+G C + +++ +M
Sbjct: 65 VAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMK 124
Query: 76 MGSLEDHLYDLEPDQEP--LSWNTRMKIAVGAARGLEYL---HCKANPPVIYRDLKSANI 130
G L +L + P + T +K V A G+EYL + ++RDL + N
Sbjct: 125 YGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNF------LHRDLAARNC 178
Query: 131 LLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV------MGTYGYCAPEYAMSGKLTLKSDI 184
+L +D ++DFGL+K GD + A E T KSD+
Sbjct: 179 MLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI------AIESLADRVYTSKSDV 232
Query: 185 YSFGVVLLELIT 196
++FGV + E+ T
Sbjct: 233 WAFGVTMWEIAT 244
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-30
Identities = 54/187 (28%), Positives = 89/187 (47%), Gaps = 28/187 (14%)
Query: 23 VAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD-QRLLVYEYMPMGSLE 80
AIK L+ +Q + F+ E L++ L+H N++ LIG + ++ YM G L
Sbjct: 52 CAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLL 111
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL---HCKANPPVIYRDLKSANILLDNDFN 137
+ + + + + + ARG+EYL ++RDL + N +LD F
Sbjct: 112 QFIRSPQRN---PTVKDLISFGLQVARGMEYLAEQKF------VHRDLAARNCMLDESFT 162
Query: 138 PKLSDFGLAKLGPVGDNTHVSTRVMG--------TYGYCAPEYAMSGKLTLKSDIYSFGV 189
K++DFGLA+ + D + S + T A E + + T KSD++SFGV
Sbjct: 163 VKVADFGLARD--ILDREYYSVQQHRHARLPVKWT----ALESLQTYRFTTKSDVWSFGV 216
Query: 190 VLLELIT 196
+L EL+T
Sbjct: 217 LLWELLT 223
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-30
Identities = 51/195 (26%), Positives = 90/195 (46%), Gaps = 31/195 (15%)
Query: 23 VAIKQLNHEG--LQGHQEFIVEV-LMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79
VA+K L + + + + E+ +M + H N++ L+G CT ++ EY G+L
Sbjct: 70 VAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 80 EDHL------------YDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 127
++L +E +++ + ARG+EYL + I+RDL +
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAA 185
Query: 128 ANILLDNDFNPKLSDFGLAKLGPVGDNTHVST------RVMGTYGYCAPEYAMSGKLTLK 181
N+L+ + K++DFGLA+ D +T + M APE T +
Sbjct: 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM------APEALFDRVYTHQ 239
Query: 182 SDIYSFGVVLLELIT 196
SD++SFGV++ E+ T
Sbjct: 240 SDVWSFGVLMWEIFT 254
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-30
Identities = 72/271 (26%), Positives = 115/271 (42%), Gaps = 58/271 (21%)
Query: 20 DQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78
+ VAIK++N E Q + ++ E+ +S HH N+V+ D+ LV + + GS
Sbjct: 40 KEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGS 99
Query: 79 LEDHLYDLEPDQEPLSWN-TRMKIAV---GAARGLEYLHCKANPPVIYRDLKSANILLDN 134
+ D + + E S IA GLEYLH I+RD+K+ NILL
Sbjct: 100 VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGE 156
Query: 135 DFNPKLSDFGL-AKLGPVGDNTHVSTR--VMGTYGYCAPEYAMSGKL-TLKSDIYSFGVV 190
D + +++DFG+ A L GD T R +GT + APE + K+DI+SFG+
Sbjct: 157 DGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGIT 216
Query: 191 LLELITGR---------KAMDL----------SKGQGEQNLVSWSRPFLKDQKKFVHLVD 231
+EL TG K + L + Q ++ L + + F +K +
Sbjct: 217 AIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSF----RKMI---- 268
Query: 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 262
++CL ++ RP
Sbjct: 269 -------------------SLCLQKDPEKRP 280
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-30
Identities = 56/197 (28%), Positives = 88/197 (44%), Gaps = 33/197 (16%)
Query: 23 VAIKQLNHEG--LQGHQEFIVEV-LMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79
VA+K L L + + E+ ++ L +H N+V L+G CT G L++ EY G L
Sbjct: 56 VAVKMLK-PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDL 114
Query: 80 EDHL--------------YDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 125
+ L +E D+ L + + A+G+ +L K I+RDL
Sbjct: 115 LNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDL 171
Query: 126 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST------RVMGTYGYCAPEYAMSGKLT 179
+ NILL + K+ DFGLA+ N V + M APE + T
Sbjct: 172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWM------APESIFNCVYT 225
Query: 180 LKSDIYSFGVVLLELIT 196
+SD++S+G+ L EL +
Sbjct: 226 FESDVWSYGIFLWELFS 242
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 6e-30
Identities = 50/182 (27%), Positives = 87/182 (47%), Gaps = 14/182 (7%)
Query: 23 VAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
VAIK L +E + E ++ L + +V LIG C + +LV E G L
Sbjct: 366 VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHK 424
Query: 82 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 141
L + +E + + ++ + G++YL K ++R+L + N+LL N K+S
Sbjct: 425 FL--VGKREE-IPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKIS 478
Query: 142 DFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-G 197
DFGL+K D+ + + + APE K + +SD++S+GV + E ++ G
Sbjct: 479 DFGLSKALGADDSYYTARS--AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG 536
Query: 198 RK 199
+K
Sbjct: 537 QK 538
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-30
Identities = 53/187 (28%), Positives = 81/187 (43%), Gaps = 16/187 (8%)
Query: 20 DQLVAIKQLN-HEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78
VA+K L Q +F++E L++S +H N+V IG R ++ E M G
Sbjct: 101 PLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 160
Query: 79 LEDHLYDLEPDQE---PLSWNTRMKIAVGAARGLEYL---HCKANPPVIYRDLKSANILL 132
L+ L + P L+ + +A A G +YL H I+RD+ + N LL
Sbjct: 161 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF------IHRDIAARNCLL 214
Query: 133 DN---DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGV 189
K+ DFG+A+ M + PE M G T K+D +SFGV
Sbjct: 215 TCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGV 274
Query: 190 VLLELIT 196
+L E+ +
Sbjct: 275 LLWEIFS 281
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-30
Identities = 61/276 (22%), Positives = 100/276 (36%), Gaps = 57/276 (20%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGY-------- 60
G V+ + IK++ + + +E V L+ L H N+V G
Sbjct: 25 GQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVHYNGCWDGFDYDP 80
Query: 61 -------CTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 112
S + L + E+ G+LE + E L +++ +G++Y+
Sbjct: 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYI 138
Query: 113 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 172
H K +I RDLK +NI L + K+ DFGL N TR GT Y +PE
Sbjct: 139 HSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVT---SLKNDGKRTRSKGTLRYMSPEQ 192
Query: 173 AMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231
S + D+Y+ G++L EL+ A + SK
Sbjct: 193 ISSQDYGKEVDLYALGLILAELLHVCDTAFETSK-----------------------FFT 229
Query: 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 267
L G + L+++ RP ++I
Sbjct: 230 DLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEI 265
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 9e-30
Identities = 55/196 (28%), Positives = 86/196 (43%), Gaps = 32/196 (16%)
Query: 21 QLVAIKQLNHE-GLQGHQEFIVEV-LMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78
AIK++ H++F E+ ++ L HH N++ L+G C L EY P G+
Sbjct: 53 MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN 112
Query: 79 LEDHL------------YDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 126
L D L LS + A ARG++YL K I+RDL
Sbjct: 113 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLA 169
Query: 127 SANILLDNDFNPKLSDFGLAKLGPVGDNTHVST------RVMGTYGYCAPEYAMSGKLTL 180
+ NIL+ ++ K++DFGL++ + T R M A E T
Sbjct: 170 ARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRWM------AIESLNYSVYTT 220
Query: 181 KSDIYSFGVVLLELIT 196
SD++S+GV+L E+++
Sbjct: 221 NSDVWSYGVLLWEIVS 236
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 51/195 (26%), Positives = 90/195 (46%), Gaps = 31/195 (15%)
Query: 23 VAIKQLNHEG--LQGHQEFIVEV-LMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79
VA+K L + + + + E+ +M + H N++ L+G CT ++ EY G+L
Sbjct: 116 VAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 174
Query: 80 EDHL------------YDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 127
++L +E +++ + ARG+EYL + I+RDL +
Sbjct: 175 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAA 231
Query: 128 ANILLDNDFNPKLSDFGLAKLGPVGDNTHVST------RVMGTYGYCAPEYAMSGKLTLK 181
N+L+ + K++DFGLA+ D +T + M APE T +
Sbjct: 232 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM------APEALFDRVYTHQ 285
Query: 182 SDIYSFGVVLLELIT 196
SD++SFGV++ E+ T
Sbjct: 286 SDVWSFGVLMWEIFT 300
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 49/182 (26%), Positives = 80/182 (43%), Gaps = 16/182 (8%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
A+K++ E + E E++ + L +V L G G + E + GSL
Sbjct: 84 FQCAVKKVRLEVFR--VE---ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLG 138
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP-K 139
+ + E + + A GLEYLH + +++ D+K+ N+LL +D +
Sbjct: 139 QLIKQMGCLPEDRA----LYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAA 191
Query: 140 LSDFGLAK-LGPVGDNTHVSTR--VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
L DFG A L P G + T + GT + APE M K DI+S ++L ++
Sbjct: 192 LCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN 251
Query: 197 GR 198
G
Sbjct: 252 GC 253
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-29
Identities = 55/262 (20%), Positives = 85/262 (32%), Gaps = 38/262 (14%)
Query: 14 GLVWLC-----DQLVAIKQLN--HEGLQGHQEFIVEV-LMLSLLHHDNLVTLIGYCTSGD 65
G V+ +L A+K+ G + + EV + H V L G
Sbjct: 71 GEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130
Query: 66 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 125
L E SL+ H L L +LH + +++ D+
Sbjct: 131 ILYLQTELCG-PSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDV 183
Query: 126 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIY 185
K ANI L KL DFGL +G + G Y APE + G +D++
Sbjct: 184 KPANIFLGPRGRCKLGDFGLLVE--LGTAGAGEVQE-GDPRYMAPE-LLQGSYGTAADVF 239
Query: 186 SFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNY 245
S G+ +LE+ + G+G Q L Q L + +
Sbjct: 240 SLGLTILEVACNMELP--HGGEGWQQLR---------QGY--------LPPEFTAGLSSE 280
Query: 246 AVAVTAMCLNEEANFRPLINDI 267
+V M L + R +
Sbjct: 281 LRSVLVMMLEPDPKLRATAEAL 302
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-29
Identities = 46/193 (23%), Positives = 79/193 (40%), Gaps = 31/193 (16%)
Query: 23 VAIKQL--NHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR------LLVYEYM 74
VA+K L + +EF+ E + H ++ L+G + +++ +M
Sbjct: 54 VAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFM 113
Query: 75 PMGSLEDHLYDLEPDQEP--LSWNTRMKIAVGAARGLEYL---HCKANPPVIYRDLKSAN 129
G L L + P L T ++ V A G+EYL + I+RDL + N
Sbjct: 114 KHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNF------IHRDLAARN 167
Query: 130 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV------MGTYGYCAPEYAMSGKLTLKSD 183
+L D ++DFGL++ GD + A E T+ SD
Sbjct: 168 CMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL------ALESLADNLYTVHSD 221
Query: 184 IYSFGVVLLELIT 196
+++FGV + E++T
Sbjct: 222 VWAFGVTMWEIMT 234
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 38/202 (18%)
Query: 23 VAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
VA+K L E ++ + E +L ++H +++ L G C+ LL+ EY GSL
Sbjct: 56 VAVKMLK-ENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLR 114
Query: 81 DHL--------------------YDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 120
L PD+ L+ + A ++G++YL +
Sbjct: 115 GFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---L 171
Query: 121 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST------RVMGTYGYCAPEYAM 174
++RDL + NIL+ K+SDFGL++ D+ + + M A E
Sbjct: 172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWM------AIESLF 225
Query: 175 SGKLTLKSDIYSFGVVLLELIT 196
T +SD++SFGV+L E++T
Sbjct: 226 DHIYTTQSDVWSFGVLLWEIVT 247
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-29
Identities = 52/191 (27%), Positives = 91/191 (47%), Gaps = 23/191 (12%)
Query: 20 DQLVAIKQLNHEGLQGHQEFIV----EVLMLSLLHHDNLVTL--IGYCTSGDQRLLVY-- 71
+ VA+K L L F + E + L+H +V + G L Y
Sbjct: 37 HRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG-EAETPAGPLPYIV 94
Query: 72 -EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANI 130
EY+ +L D ++ + P++ +++ A + L + H + +I+RD+K ANI
Sbjct: 95 MEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSH-QNG--IIHRDVKPANI 147
Query: 131 LLDNDFNPKLSDFGLAKLGPVGDNTHVSTR---VMGTYGYCAPEYAMSGKLTLKSDIYSF 187
++ K+ DFG+A+ + D+ + T+ V+GT Y +PE A + +SD+YS
Sbjct: 148 MISATNAVKVMDFGIAR--AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 188 GVVLLELITGR 198
G VL E++TG
Sbjct: 206 GCVLYEVLTGE 216
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-29
Identities = 60/262 (22%), Positives = 98/262 (37%), Gaps = 52/262 (19%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIG-YCTSGDQR 67
G V + AIK++ H + + EV++L+ L+H +V + +
Sbjct: 20 GQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVRYYAAWLERRNFV 78
Query: 68 L------------LVYEYMPMGSLEDHLYDL-EPDQEPLSWNTRMKIAVGAARGLEYLHC 114
+ EY G+L D ++ Q W +I L Y+H
Sbjct: 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL----EALSYIHS 134
Query: 115 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL-------------GPVGDNTHVSTRV 161
+ +I+RDLK NI +D N K+ DFGLAK G + ++++ +
Sbjct: 135 QG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI 191
Query: 162 MGTYGYCAPE-YAMSGKLTLKSDIYSFGVVLLELITG-RKAMDLSK-----GQGEQNLVS 214
GT Y A E +G K D+YS G++ E+I M+
Sbjct: 192 -GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVSIEFPP 250
Query: 215 W-SRPFLKDQKKFVHL---VDP 232
+K +KK + L DP
Sbjct: 251 DFDDNKMKVEKKIIRLLIDHDP 272
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-29
Identities = 48/184 (26%), Positives = 79/184 (42%), Gaps = 15/184 (8%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
+AIK++ + Q E+ + L H N+V +G + + E +P GSL
Sbjct: 48 VRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107
Query: 81 D---HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-DF 136
+ D E +I GL+YLH +++RD+K N+L++
Sbjct: 108 ALLRSKWGPLKDNEQTIGFYTKQI----LEGLKYLHDNQ---IVHRDIKGDNVLINTYSG 160
Query: 137 NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL--TLKSDIYSFGVVLLEL 194
K+SDFG +K + + GT Y APE G +DI+S G ++E+
Sbjct: 161 VLKISDFGTSKR--LAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEM 218
Query: 195 ITGR 198
TG+
Sbjct: 219 ATGK 222
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-29
Identities = 68/256 (26%), Positives = 106/256 (41%), Gaps = 54/256 (21%)
Query: 21 QLVAIKQLNHEGLQGH-QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79
++VAIK ++ E + ++ E+ +LS + G + ++ EY+ GS
Sbjct: 48 KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA 107
Query: 80 EDHLYDLEPDQEPLSWNTRMKIAV---GAARGLEYLHCKANPPVIYRDLKSANILLDNDF 136
D L + P E +IA +GL+YLH + I+RD+K+AN+LL
Sbjct: 108 LD-LLEPGPLDET-------QIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHG 156
Query: 137 NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
KL+DFG+A G + D +GT + APE K+DI+S G+ +EL
Sbjct: 157 EVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAR 214
Query: 197 GR---------KAMDLSKGQGEQNLVS-WSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYA 246
G K + L L +S+P K+FV
Sbjct: 215 GEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPL----KEFV------------------- 251
Query: 247 VAVTAMCLNEEANFRP 262
CLN+E +FRP
Sbjct: 252 ----EACLNKEPSFRP 263
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 5e-29
Identities = 47/197 (23%), Positives = 76/197 (38%), Gaps = 29/197 (14%)
Query: 14 GLVWLC------DQLVAIKQLNHEGLQGHQE-FIVEVLMLSLLHHDNLVTLIGYCTSGDQ 66
G ++L + V +K L H G Q + E L+ + H ++V + + D+
Sbjct: 94 GWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR 153
Query: 67 RL-----LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 121
+V EY+ SL+ + L + + L YLH + ++
Sbjct: 154 HGDPVGYIVMEYVGGQSLKRSK------GQKLPVAEAIAYLLEILPALSYLH---SIGLV 204
Query: 122 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK 181
Y DLK NI+L + KL D G + + GT G+ APE T+
Sbjct: 205 YNDLKPENIMLTEE-QLKLIDLGAVS--RINS----FGYLYGTPGFQAPEIVR-TGPTVA 256
Query: 182 SDIYSFGVVLLELITGR 198
+DIY+ G L L
Sbjct: 257 TDIYTVGRTLAALTLDL 273
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-29
Identities = 58/195 (29%), Positives = 89/195 (45%), Gaps = 31/195 (15%)
Query: 23 VAIKQLNHEG--LQGHQEFIVEV-LMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79
VA+K L + + I E+ +M + H N++ L+G CT ++ EY G+L
Sbjct: 104 VAVKMLK-SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 162
Query: 80 EDHL------------YDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 127
++L +E LS + A ARG+EYL K I+RDL +
Sbjct: 163 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAA 219
Query: 128 ANILLDNDFNPKLSDFGLAKLGPVGDNTHVST------RVMGTYGYCAPEYAMSGKLTLK 181
N+L+ D K++DFGLA+ D +T + M APE T +
Sbjct: 220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM------APEALFDRIYTHQ 273
Query: 182 SDIYSFGVVLLELIT 196
SD++SFGV+L E+ T
Sbjct: 274 SDVWSFGVLLWEIFT 288
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-29
Identities = 47/184 (25%), Positives = 70/184 (38%), Gaps = 15/184 (8%)
Query: 20 DQLVAIKQLNHEGLQGHQEFIV----EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75
+++VA+K + E L F E L ++V + + Q + +
Sbjct: 59 ERIVALKLM-SETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLIN 117
Query: 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 135
L L Q PL+ + I L+ H A +RD+K NIL+ D
Sbjct: 118 GVDLAAML----RRQGPLAPPRAVAIVRQIGSALDAAH-AAG--ATHRDVKPENILVSAD 170
Query: 136 FNPKLSDFGLAKLGPVGDNTHVST-RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLEL 194
L DFG+A D +GT Y APE T ++DIY+ VL E
Sbjct: 171 DFAYLVDFGIASA--TTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYEC 228
Query: 195 ITGR 198
+TG
Sbjct: 229 LTGS 232
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 45/176 (25%), Positives = 80/176 (45%), Gaps = 11/176 (6%)
Query: 23 VAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
VAIK + ++F+ E L + H ++V LIG T + ++ E +G L
Sbjct: 421 VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRS 479
Query: 82 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 141
L + L + + A + L YL K ++RD+ + N+L+ ++ KL
Sbjct: 480 FLQVRKF---SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLG 533
Query: 142 DFGLAKLGPVGDNTHVSTRVMGT-YGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
DFGL++ + D+T+ + APE + T SD++ FGV + E++
Sbjct: 534 DFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-28
Identities = 50/185 (27%), Positives = 87/185 (47%), Gaps = 24/185 (12%)
Query: 23 VAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD-QRLLVYEYMPMGSLE 80
A+K LN + +F+ E +++ H N+++L+G C + L+V YM G L
Sbjct: 56 CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 115
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL---HCKANPPVIYRDLKSANILLDNDFN 137
+ + + + + + + A+G++YL ++RDL + N +LD F
Sbjct: 116 NFIRNETHN---PTVKDLIGFGLQVAKGMKYLASKKF------VHRDLAARNCMLDEKFT 166
Query: 138 PKLSDFGLAKLGPVGDNTHVSTRVMG------TYGYCAPEYAMSGKLTLKSDIYSFGVVL 191
K++DFGLA+ + V + A E + K T KSD++SFGV+L
Sbjct: 167 VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM----ALESLQTQKFTTKSDVWSFGVLL 222
Query: 192 LELIT 196
EL+T
Sbjct: 223 WELMT 227
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 55/211 (26%), Positives = 88/211 (41%), Gaps = 28/211 (13%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIVEV-LMLSLLHHDNLVTLIGYCTSGDQR 67
V+ + A+K+L + ++ I EV M L H N+V + G +
Sbjct: 42 AFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101
Query: 68 -------LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 120
L+ + G L + L +E + PLS +T +KI R ++++H + PP+
Sbjct: 102 SDTGQAEFLLLTELCKGQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPI 159
Query: 121 IYRDLKSANILLDNDFNPKLSDFGLA---KLGPVGDNTHVSTRVM-------GTYGYCAP 170
I+RDLK N+LL N KL DFG A P + ++ T Y P
Sbjct: 160 IHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTP 219
Query: 171 E--YAMSGK-LTLKSDIYSFGVVLLELITGR 198
E S + K DI++ G +L L +
Sbjct: 220 EIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-28
Identities = 52/196 (26%), Positives = 91/196 (46%), Gaps = 32/196 (16%)
Query: 23 VAIKQLNHEG--LQGHQEFIVEV-LMLSLLHHDNLVTLIGYCTSGDQ-RLLVYEYMPMGS 78
VA+K L EG H+ + E+ +++ + HH N+V L+G CT +++ E+ G+
Sbjct: 60 VAVKMLK-EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 118
Query: 79 LEDHL------------YDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 126
L +L + ++ L+ + + A+G+E+L + I+RDL
Sbjct: 119 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 175
Query: 127 SANILLDNDFNPKLSDFGLAKLGPVGDNTHVST------RVMGTYGYCAPEYAMSGKLTL 180
+ NILL K+ DFGLA+ + + M APE T+
Sbjct: 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM------APETIFDRVYTI 229
Query: 181 KSDIYSFGVVLLELIT 196
+SD++SFGV+L E+ +
Sbjct: 230 QSDVWSFGVLLWEIFS 245
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-28
Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 38/202 (18%)
Query: 23 VAIKQLNHEG--LQGHQEFIVEV-LMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79
VA+K L E + + E+ +M L H+N+V L+G CT L++EY G L
Sbjct: 78 VAVKMLK-EKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDL 136
Query: 80 EDHL-------------------YDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 120
++L + E D L++ + A A+G+E+L K+
Sbjct: 137 LNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---C 193
Query: 121 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST------RVMGTYGYCAPEYAM 174
++RDL + N+L+ + K+ DFGLA+ N V + M APE
Sbjct: 194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWM------APESLF 247
Query: 175 SGKLTLKSDIYSFGVVLLELIT 196
G T+KSD++S+G++L E+ +
Sbjct: 248 EGIYTIKSDVWSYGILLWEIFS 269
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-28
Identities = 49/185 (26%), Positives = 87/185 (47%), Gaps = 24/185 (12%)
Query: 23 VAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD-QRLLVYEYMPMGSLE 80
A+K LN + +F+ E +++ H N+++L+G C + L+V YM G L
Sbjct: 120 CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 179
Query: 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL---HCKANPPVIYRDLKSANILLDNDFN 137
+ + + + + + + A+G+++L ++RDL + N +LD F
Sbjct: 180 NFIRNETHN---PTVKDLIGFGLQVAKGMKFLASKKF------VHRDLAARNCMLDEKFT 230
Query: 138 PKLSDFGLAKLGPVGDNTHVSTRVMG------TYGYCAPEYAMSGKLTLKSDIYSFGVVL 191
K++DFGLA+ + V + A E + K T KSD++SFGV+L
Sbjct: 231 VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM----ALESLQTQKFTTKSDVWSFGVLL 286
Query: 192 LELIT 196
EL+T
Sbjct: 287 WELMT 291
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-28
Identities = 54/223 (24%), Positives = 88/223 (39%), Gaps = 52/223 (23%)
Query: 14 GLVWLC----------DQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 62
G V+ +VA+K L E +F E +++ + N+V L+G C
Sbjct: 61 GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120
Query: 63 SGDQRLLVYEYMPMGSLEDHLYDLEPDQE--------------------PLSWNTRMKIA 102
G L++EYM G L + L + P PLS ++ IA
Sbjct: 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIA 180
Query: 103 VGAARGLEYL---HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159
A G+ YL ++RDL + N L+ + K++DFGL++ D
Sbjct: 181 RQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADG 234
Query: 160 RV------MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
M PE + T +SD++++GVVL E+ +
Sbjct: 235 NDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 58/233 (24%), Positives = 101/233 (43%), Gaps = 41/233 (17%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
+ VA+K ++ Q + EV+++ H N+V + G++ ++ E++ G+L
Sbjct: 71 RQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT 130
Query: 81 DHLYDLEPDQEPLSWNTRMKIAV---GAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 137
D + E +IA + L YLH + VI+RD+KS +ILL D
Sbjct: 131 D-IVSQVRLNEE-------QIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGR 179
Query: 138 PKLSDFGL-AKLGPVGDNTHVSTR--VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLEL 194
KLSDFG A++ + V R ++GT + APE + DI+S G++++E+
Sbjct: 180 VKLSDFGFCAQI-----SKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEM 234
Query: 195 ITGR---------KAMDLSKGQGE---QNLVSWSRPFLKDQKKFVHL---VDP 232
+ G +AM + +N S + F+ DP
Sbjct: 235 VDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVL----RDFLERMLVRDP 283
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 42/193 (21%), Positives = 73/193 (37%), Gaps = 24/193 (12%)
Query: 20 DQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77
+ V ++++N E E+ + L +H N+V + ++ +V +M G
Sbjct: 52 GEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG 111
Query: 78 SLEDHLYDLEPD--QEPLSWNTRMKIAV---GAARGLEYLHCKANPPVIYRDLKSANILL 132
S +D + D E IA G + L+Y+H ++R +K+++IL+
Sbjct: 112 SAKDLICTHFMDGMNELA-------IAYILQGVLKALDYIHHMG---YVHRSVKASHILI 161
Query: 133 DNDFNPKLSDFG-LAKLGPVGDNTHV----STRVMGTYGYCAPEYAMSGKL--TLKSDIY 185
D LS + G V + + +PE KSDIY
Sbjct: 162 SVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIY 221
Query: 186 SFGVVLLELITGR 198
S G+ EL G
Sbjct: 222 SVGITACELANGH 234
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-27
Identities = 69/233 (29%), Positives = 105/233 (45%), Gaps = 41/233 (17%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
Q VAI+Q+N + + I E+L++ + N+V + GD+ +V EY+ GSL
Sbjct: 46 QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105
Query: 81 DHLYDLEPDQEPLSWNTRMKIAV---GAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 137
D + E +IA + LE+LH VI+RD+KS NILL D +
Sbjct: 106 D-VVTETCMDEG-------QIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGS 154
Query: 138 PKLSDFGL-AKLGPVGD--NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLEL 194
KL+DFG A++ P +T V GT + APE K DI+S G++ +E+
Sbjct: 155 VKLTDFGFCAQITPEQSKRSTMV-----GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEM 209
Query: 195 ITGR---------KAMDLSKGQGE---QNLVSWSRPFLKDQKKFVHL---VDP 232
I G +A+ L G QN S F + F++ +D
Sbjct: 210 IEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF----RDFLNRCLEMDV 258
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-27
Identities = 58/285 (20%), Positives = 102/285 (35%), Gaps = 57/285 (20%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIGY------- 60
G+V+ D AIK++ + +E ++ EV L+ L H +V
Sbjct: 19 GVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT 78
Query: 61 --CTSGDQRLLVY---EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 115
++ +Y + +L+D + +E + + I + A +E+LH K
Sbjct: 79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER-ERSVCLHIFLQIAEAVEFLHSK 137
Query: 116 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL----------GPVGDNTHVSTRVMGTY 165
+++RDLK +NI D K+ DFGL T +GT
Sbjct: 138 G---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTK 194
Query: 166 GYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 225
Y +PE + K DI+S G++L EL+ PF ++
Sbjct: 195 LYMSPEQIHGNSYSHKVDIFSLGLILFELLY---------------------PFSTQMER 233
Query: 226 FVHLVDPLLHGRYPRRCLNY---AVAVTAMCLNEEANFRPLINDI 267
L D + + ++P + L+ RP +I
Sbjct: 234 VRTLTD-VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-27
Identities = 59/195 (30%), Positives = 88/195 (45%), Gaps = 27/195 (13%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 68
G V+ Q+VAIKQ+ E QE I E+ ++ ++V G
Sbjct: 43 GSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100
Query: 69 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV---GAARGLEYLHCKANPPVIYRDL 125
+V EY GS+ D + L L T +IA +GLEYLH I+RD+
Sbjct: 101 IVMEYCGAGSVSD-IIRLRNK--TL---TEDEIATILQSTLKGLEYLHFMR---KIHRDI 151
Query: 126 KSANILLDNDFNPKLSDFGL-AKLGPVGD--NTHVSTRVMGTYGYCAPEYAMSGKLTLKS 182
K+ NILL+ + + KL+DFG+ +L NT + GT + APE +
Sbjct: 152 KAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-----GTPFWMAPEVIQEIGYNCVA 206
Query: 183 DIYSFGVVLLELITG 197
DI+S G+ +E+ G
Sbjct: 207 DIWSLGITAIEMAEG 221
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 9e-27
Identities = 47/188 (25%), Positives = 88/188 (46%), Gaps = 25/188 (13%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
L A K + + + +++IVE+ +L+ H +V L+G + ++ E+ P G+++
Sbjct: 45 ALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVD 104
Query: 81 DHLYDLEPDQEPLSWNTRMKIAV---GAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 137
+ L T +I V L +LH K +I+RDLK+ N+L+ + +
Sbjct: 105 AI---MLELDRGL---TEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGD 155
Query: 138 PKLSDFGLAKLGPVGDNTHVSTR---VMGTYGYCAPEYAMSGKLT-----LKSDIYSFGV 189
+L+DFG++ N + +GT + APE M + K+DI+S G+
Sbjct: 156 IRLADFGVS-----AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGI 210
Query: 190 VLLELITG 197
L+E+
Sbjct: 211 TLIEMAQI 218
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 9e-27
Identities = 47/205 (22%), Positives = 76/205 (37%), Gaps = 27/205 (13%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIGYCTSGDQR 67
V+ L AIK N+ + + E +L L+H N+V L R
Sbjct: 23 ANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82
Query: 68 L--LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 125
L+ E+ P GSL L + L + + + G+ +L +++R++
Sbjct: 83 HKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNI 138
Query: 126 KSANILL----DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE--------YA 173
K NI+ D KL+DFG A+ + D+ + GT Y P+
Sbjct: 139 KPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY-GTEEYLHPDMYERAVLRKD 195
Query: 174 MSGKLTLKSDIYSFGVVLLELITGR 198
K D++S GV TG
Sbjct: 196 HQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 1e-26
Identities = 51/181 (28%), Positives = 78/181 (43%), Gaps = 14/181 (7%)
Query: 21 QLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77
++A+K L L+ + EV + S L H N++ L GY + L+ EY P+G
Sbjct: 35 FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG 94
Query: 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 137
++ L L E + A L Y H K VI+RD+K N+LL +
Sbjct: 95 TVYRELQKLSKFDEQRT----ATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGE 147
Query: 138 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 197
K++DFG + P + GT Y PE K D++S GV+ E + G
Sbjct: 148 LKIADFGWSVHAP--SSRRTDL--CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203
Query: 198 R 198
+
Sbjct: 204 K 204
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-26
Identities = 45/193 (23%), Positives = 74/193 (38%), Gaps = 24/193 (12%)
Query: 21 QLVAIKQLNHEGLQGH--QEFIVEVLMLSLL--HHDNLVTLIGYCTSGDQRLLVYEYMPM 76
Q+ AIK +N E + E+ L+ L H D ++ L Y + +V E
Sbjct: 34 QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN- 92
Query: 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF 136
L L ++ + R + +H +++ DLK AN L+ +
Sbjct: 93 IDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG- 144
Query: 137 NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-----------YAMSGKLTLKSDIY 185
KL DFG+A + V +GT Y PE K++ KSD++
Sbjct: 145 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 204
Query: 186 SFGVVLLELITGR 198
S G +L + G+
Sbjct: 205 SLGCILYYMTYGK 217
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 45/193 (23%), Positives = 74/193 (38%), Gaps = 24/193 (12%)
Query: 21 QLVAIKQLNHEGLQGH--QEFIVEVLMLSLL--HHDNLVTLIGYCTSGDQRLLVYEYMPM 76
Q+ AIK +N E + E+ L+ L H D ++ L Y + +V E
Sbjct: 53 QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN- 111
Query: 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF 136
L L ++ + R + +H +++ DLK AN L+ +
Sbjct: 112 IDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG- 163
Query: 137 NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-----------YAMSGKLTLKSDIY 185
KL DFG+A + V +GT Y PE K++ KSD++
Sbjct: 164 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 223
Query: 186 SFGVVLLELITGR 198
S G +L + G+
Sbjct: 224 SLGCILYYMTYGK 236
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-26
Identities = 47/205 (22%), Positives = 80/205 (39%), Gaps = 27/205 (13%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIGY--CTSGD 65
V+ L AIK N+ + + E +L L+H N+V L T+
Sbjct: 23 ANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82
Query: 66 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 125
++L+ E+ P GSL L + + L + + + G+ +L +++R++
Sbjct: 83 HKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNI 138
Query: 126 KSANILL----DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE--------YA 173
K NI+ D KL+DFG A+ + D+ + GT Y P+
Sbjct: 139 KPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY-GTEEYLHPDMYERAVLRKD 195
Query: 174 MSGKLTLKSDIYSFGVVLLELITGR 198
K D++S GV TG
Sbjct: 196 HQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-26
Identities = 40/347 (11%), Positives = 84/347 (24%), Gaps = 82/347 (23%)
Query: 14 GLVWLC-----DQLVAIKQL----------------------------NHEGLQGHQEFI 40
+ + N + + H FI
Sbjct: 92 YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 151
Query: 41 VEVLMLSLLHHDNLVTLIGYCTSGD--QRLLVYEYM--PMGSLEDHLYDLEPDQEPLSWN 96
++ ++ + R +Y M + + + L + L +
Sbjct: 152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHH 211
Query: 97 TRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156
R+++ + R L LH +++ L+ +I+LD L+ F G
Sbjct: 212 ARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV--RDGA--- 263
Query: 157 VSTRVMGTYGYCAPEY----------AMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKG 206
S G+ PE +T D ++ G+ + +
Sbjct: 264 -SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD-------- 314
Query: 207 QGEQNLVSWSRPFLKDQKKFVHLVDPLLHG--RYPRRCLNYAVAVTAMCLNEEANFRPLI 264
P D + + + P+ A+ L R L
Sbjct: 315 ----------LPNTDDAA--LGGSEWIFRSCKNIPQ----PVRALLEGFLRYPKEDRLLP 358
Query: 265 NDIVVALDYLVSQRDSHPVSRNAGARGVPTSASDVSQGSNSRRSSSA 311
+ +Y + + G PT S+ +
Sbjct: 359 LQAMETPEYEQLRTELSAALPLYQTDGEPTREGGAPPSGTSQPDEAG 405
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-26
Identities = 58/200 (29%), Positives = 80/200 (40%), Gaps = 22/200 (11%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLI------GYC 61
G V + VAIKQ E ++E E+ ++ L+H N+V+
Sbjct: 28 GYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL 87
Query: 62 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 121
D LL EY G L +L E + L + + L YLH +I
Sbjct: 88 APNDLPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHENR---II 143
Query: 122 YRDLKSANILLD---NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL 178
+RDLK NI+L K+ D G AK + + V GT Y APE K
Sbjct: 144 HRDLKPENIVLQPGPQRLIHKIIDLGYAKE--LDQGELCTEFV-GTLQYLAPELLEQKKY 200
Query: 179 TLKSDIYSFGVVLLELITGR 198
T+ D +SFG + E ITG
Sbjct: 201 TVTVDYWSFGTLAFECITGF 220
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 27/185 (14%), Positives = 58/185 (31%), Gaps = 24/185 (12%)
Query: 29 NHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM----GSLEDHLY 84
N + + H FI ++ ++ + + Y M + + L
Sbjct: 135 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 194
Query: 85 DLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 144
+ L + R+++ + R L LH +++ L+ +I+LD L+ F
Sbjct: 195 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFE 251
Query: 145 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-----------GKLTLKSDIYSFGVVLLE 193
G + G+ PE +T D ++ G+V+
Sbjct: 252 HLV--RDGA----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305
Query: 194 LITGR 198
+
Sbjct: 306 IWCAD 310
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 53/195 (27%), Positives = 96/195 (49%), Gaps = 20/195 (10%)
Query: 12 NVGLVWLC-----DQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIGYCTSGD 65
N G+V+ ++A K ++ E + I+ E+ +L + +V G S
Sbjct: 45 NGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG 104
Query: 66 QRLLVYEYMPMGSLEDHLYDLEPDQEP-LSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 124
+ + E+M GSL+ L E L K+++ +GL YL K +++RD
Sbjct: 105 EISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLREKHK--IMHRD 157
Query: 125 LKSANILLDNDFNPKLSDFGLA-KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSD 183
+K +NIL+++ KL DFG++ +L ++ ++ V GT Y +PE +++SD
Sbjct: 158 VKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV-GTRSYMSPERLQGTHYSVQSD 212
Query: 184 IYSFGVVLLELITGR 198
I+S G+ L+E+ GR
Sbjct: 213 IWSMGLSLVEMAVGR 227
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 44/193 (22%), Positives = 73/193 (37%), Gaps = 24/193 (12%)
Query: 21 QLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHH--DNLVTLIGYCTSGDQRLLVYEYMPM 76
Q+ AIK +N E Q + E+ L+ L D ++ L Y + +V E
Sbjct: 81 QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN- 139
Query: 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF 136
L L ++ + R + +H +++ DLK AN L+ +
Sbjct: 140 IDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG- 191
Query: 137 NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-----------YAMSGKLTLKSDIY 185
KL DFG+A + V +G Y PE K++ KSD++
Sbjct: 192 MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 251
Query: 186 SFGVVLLELITGR 198
S G +L + G+
Sbjct: 252 SLGCILYYMTYGK 264
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-25
Identities = 24/223 (10%), Positives = 50/223 (22%), Gaps = 46/223 (20%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQE---FIVEVLMLSLLHHDNLVTLIGYC---- 61
+V+L + A+K E + L ++
Sbjct: 76 SVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLL 135
Query: 62 ----------------------TSGDQRLLVYEYMP--MGSLEDHLYDLEPDQEPLSWNT 97
+ LL+ + L L + +
Sbjct: 136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILA 195
Query: 98 RMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157
+ R L K +++ N+ + D L D VG
Sbjct: 196 LHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW--KVGTRGPA 250
Query: 158 STRVMGTYGYCAPEYAMSGKL--TLKSDIYSFGVVLLELITGR 198
S+ Y E+ + T + + G+ + +
Sbjct: 251 SS---VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 9e-25
Identities = 47/183 (25%), Positives = 72/183 (39%), Gaps = 18/183 (9%)
Query: 21 QLVAIK-----QLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75
++A+K QL EG++ E+ + S L H N++ + Y + L+ E+ P
Sbjct: 40 FIMALKVLFKSQLEKEGVEHQ--LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAP 97
Query: 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 135
G L L E S A L Y H + VI+RD+K N+L+
Sbjct: 98 RGELYKELQKHGRFDEQRS----ATFMEELADALHYCHERK---VIHRDIKPENLLMGYK 150
Query: 136 FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 195
K++DFG + P GT Y PE K D++ GV+ E +
Sbjct: 151 GELKIADFGWSVHAP-SLRRRTMC---GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFL 206
Query: 196 TGR 198
G
Sbjct: 207 VGM 209
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 49/198 (24%), Positives = 85/198 (42%), Gaps = 21/198 (10%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIV---EVLMLSLLHHDNLVTLIGYCTSGD 65
G+V Q++A+K++ Q+ ++ ++ M + VT G
Sbjct: 21 GVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM-RTVDCPFTVTFYGALFREG 79
Query: 66 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 125
+ E M SL+ + + + + KIAV + LE+LH K + VI+RD+
Sbjct: 80 DVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDV 136
Query: 126 KSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTRVMGTYGYCAPE----YAMSGKLTL 180
K +N+L++ K+ DFG+ L + G Y APE ++
Sbjct: 137 KPSNVLINALGQVKMCDFGISGYL----VDDVAKDIDAGCKPYMAPERINPELNQKGYSV 192
Query: 181 KSDIYSFGVVLLELITGR 198
KSDI+S G+ ++EL R
Sbjct: 193 KSDIWSLGITMIELAILR 210
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 73/263 (27%), Positives = 106/263 (40%), Gaps = 65/263 (24%)
Query: 21 QLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77
++VAIK++++ G Q + Q+ I EV L L H N + G LV EY G
Sbjct: 80 EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-G 138
Query: 78 SLEDHLYDLEPDQEPLSWNTRMKIAV---GAARGLEYLHCKANPPVIYRDLKSANILLDN 134
S D LE ++PL ++IA GA +GL YLH +I+RD+K+ NILL
Sbjct: 139 SASD---LLEVHKKPL---QEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSE 189
Query: 135 DFNPKLSDFGL-AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT---LKSDIYSFGVV 190
KL DFG + + P N+ +GT + APE ++ K D++S G+
Sbjct: 190 PGLVKLGDFGSASIMAP--ANS-----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 242
Query: 191 LLELITGR---------KAMDLSKGQGEQNLVS--WSRPFLKDQKKFVHLVDPLLHGRYP 239
+EL + A+ L S WS F + FV
Sbjct: 243 CIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF----RNFV------------ 286
Query: 240 RRCLNYAVAVTAMCLNEEANFRP 262
CL + RP
Sbjct: 287 -----------DSCLQKIPQDRP 298
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 27/190 (14%), Positives = 56/190 (29%), Gaps = 15/190 (7%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
Q +K + L + + +LV E G+L
Sbjct: 96 QKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLL 155
Query: 81 DHLYDL-EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP- 138
+ + ++ + + A+ +E +H +I+ D+K N +L N F
Sbjct: 156 NAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQ 212
Query: 139 ----------KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFG 188
L D G + + + T T G+ E + + D +
Sbjct: 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVA 272
Query: 189 VVLLELITGR 198
+ ++ G
Sbjct: 273 ATVYCMLFGT 282
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-24
Identities = 70/271 (25%), Positives = 100/271 (36%), Gaps = 70/271 (25%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLS-LLHHDNLVTLIG-----YCTSGDQRL-LVYEY 73
QL AIK ++ G +E E+ ML HH N+ T G D +L LV E+
Sbjct: 50 QLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF 108
Query: 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAV---GAARGLEYLHCKANPPVIYRDLKSANI 130
GS+ D L L IA RGL +LH VI+RD+K N+
Sbjct: 109 CGAGSVTD-LIKNTKGN-TL---KEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNV 160
Query: 131 LLDNDFNPKLSDFGLAKLGPVGDNTHVSTR---VMGTYGYCAPEYAMSGKLT-----LKS 182
LL + KL DFG++ R +GT + APE + KS
Sbjct: 161 LLTENAEVKLVDFGVS-----AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKS 215
Query: 183 DIYSFGVVLLELITGR---------KAMDLSKGQGEQNLVS--WSRPFLKDQKKFVHLVD 231
D++S G+ +E+ G +A+ L L S WS+ F + F+
Sbjct: 216 DLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKF----QSFI---- 267
Query: 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 262
CL + + RP
Sbjct: 268 -------------------ESCLVKNHSQRP 279
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 61/195 (31%), Positives = 92/195 (47%), Gaps = 17/195 (8%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLIGYCTSGD 65
G V+ C +L A K+LN + L+ + + +VE +L+ +H +V+L Y
Sbjct: 199 GEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETK 257
Query: 66 QRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEYLHCKANPPVIYR 123
L LV M G + H+Y+++ D R GLE+LH + +IYR
Sbjct: 258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYTAQIVSGLEHLHQRN---IIYR 313
Query: 124 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSD 183
DLK N+LLD+D N ++SD GLA G GT G+ APE + + D
Sbjct: 314 DLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA-GTPGFMAPELLLGEEYDFSVD 371
Query: 184 IYSFGVVLLELITGR 198
++ GV L E+I R
Sbjct: 372 YFALGVTLYEMIAAR 386
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-24
Identities = 49/186 (26%), Positives = 82/186 (44%), Gaps = 15/186 (8%)
Query: 21 QLVAIKQLNHEGLQGHQEFIV---EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77
Q++A+K++ + Q+ ++ +V+M +V G + E M
Sbjct: 48 QIMAVKRIRSTVDEKEQKQLLMDLDVVM-RSSDCPYIVQFYGALFREGDCWICMELMSTS 106
Query: 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 137
+ + Y + + KI + + L +L +I+RD+K +NILLD N
Sbjct: 107 FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGN 164
Query: 138 PKLSDFGL-AKLGPVGDNTHVSTRVMGTYGYCAPE----YAMSGKLTLKSDIYSFGVVLL 192
KL DFG+ +L ++ TR G Y APE A ++SD++S G+ L
Sbjct: 165 IKLCDFGISGQL----VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLY 220
Query: 193 ELITGR 198
EL TGR
Sbjct: 221 ELATGR 226
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-23
Identities = 41/213 (19%), Positives = 69/213 (32%), Gaps = 37/213 (17%)
Query: 14 GLVWLC-----DQLVAIKQLNHE--GLQGHQEFIVEV-LMLSLLHHDNLVTLIGYCTSGD 65
G V+ C + AIK+ G Q + EV L H ++V D
Sbjct: 25 GSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD 84
Query: 66 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 125
L+ EY GSL D + + + + RGL Y+H + +++ D+
Sbjct: 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDI 141
Query: 126 KSANILLDNDFNP-------------------KLSDFGLAKLGPVGDNTHVSTRVMGTYG 166
K +NI + P K+ D G + V G
Sbjct: 142 KPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT---RISSPQVEE---GDSR 195
Query: 167 YCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 198
+ A E K+DI++ + ++
Sbjct: 196 FLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 1e-23
Identities = 60/197 (30%), Positives = 90/197 (45%), Gaps = 24/197 (12%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLIGYCTSGD 65
G V C ++ A K+L + ++ + + E +L ++ +V+L Y
Sbjct: 198 GEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA-YAYETK 256
Query: 66 QRL-LVYEYMPMGSLEDHLYDLEPDQ--EPLSWNTRMKI-AVGAARGLEYLHCKANPPVI 121
L LV M G L+ H+Y + E R A GLE LH + ++
Sbjct: 257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEA-----RAVFYAAEICCGLEDLHRER---IV 308
Query: 122 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK 181
YRDLK NILLD+ + ++SD GLA P G RV GT GY APE + + T
Sbjct: 309 YRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV-GTVGYMAPEVVKNERYTFS 365
Query: 182 SDIYSFGVVLLELITGR 198
D ++ G +L E+I G+
Sbjct: 366 PDWWALGCLLYEMIAGQ 382
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 2e-23
Identities = 36/164 (21%), Positives = 65/164 (39%), Gaps = 17/164 (10%)
Query: 47 SLLHHDNLVTLIGYCTSGDQRLLVY---EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 103
+ + +G ++ +Y + +L+D + ++ + I +
Sbjct: 113 RRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR-EHGVCLHIFI 171
Query: 104 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK----------LGPVGD 153
A +E+LH K +++RDLK +NI D K+ DFGL +
Sbjct: 172 QIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 228
Query: 154 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 197
T +GT Y +PE + K DI+S G++L EL+
Sbjct: 229 AYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 4e-23
Identities = 44/188 (23%), Positives = 76/188 (40%), Gaps = 20/188 (10%)
Query: 20 DQLVAIKQLNHEGLQG-HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78
++ VA+K++ E +E V++L H N++ + + E +
Sbjct: 48 NRDVAVKRILPECFSFADRE--VQLLR-ESDEHPNVIRYFCTEKDRQFQYIAIELCA-AT 103
Query: 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN---- 134
L++++ + L + + GL +LH +++RDLK NIL+
Sbjct: 104 LQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAH 157
Query: 135 -DFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEY---AMSGKLTLKSDIYSFGV 189
+SDFGL K L + + V GT G+ APE T DI+S G
Sbjct: 158 GKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGC 217
Query: 190 VLLELITG 197
V +I+
Sbjct: 218 VFYYVISE 225
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-22
Identities = 52/202 (25%), Positives = 83/202 (41%), Gaps = 27/202 (13%)
Query: 12 NVGLVWLC-----DQLVAIKQLNHEGLQGHQEFIV---EVLMLSLLHHDNLVTLIGYCTS 63
G VW ++A+KQ+ G + + I+ +V++ +V G +
Sbjct: 37 TCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVL-KSHDCPYIVQCFGTFIT 95
Query: 64 GDQRLLVYEYMPMGSLEDHLYDLEPDQEP-LSWNTRMKIAVGAARGLEYLHCKANPPVIY 122
+ E M + + P E L K+ V + L YL K VI+
Sbjct: 96 NTDVFIAMELMGTCAEKLKKRMQGPIPERILG-----KMTVAIVKALYYLKEKHG--VIH 148
Query: 123 RDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTRVMGTYGYCAPE-----YAMSG 176
RD+K +NILLD KL DFG+ +L + R G Y APE
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISGRL----VDDKAKDRSAGCAAYMAPERIDPPDPTKP 204
Query: 177 KLTLKSDIYSFGVVLLELITGR 198
+++D++S G+ L+EL TG+
Sbjct: 205 DYDIRADVWSLGISLVELATGQ 226
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 2e-22
Identities = 61/199 (30%), Positives = 91/199 (45%), Gaps = 27/199 (13%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHDN---LVTLIGYCT 62
G V+ C ++ A+K L+ + ++ Q + E +MLSL+ + +V + Y
Sbjct: 203 GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS-YAF 261
Query: 63 SGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEYLHCKANPPV 120
+L + + M G L HL E M+ A GLE++H + V
Sbjct: 262 HTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRFYAAEIILGLEHMHNRF---V 313
Query: 121 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTL 180
+YRDLK ANILLD + ++SD GLA H V GT+GY APE G
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPH--ASV-GTHGYMAPEVLQKGVAYD 369
Query: 181 KS-DIYSFGVVLLELITGR 198
S D +S G +L +L+ G
Sbjct: 370 SSADWFSLGCMLFKLLRGH 388
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-22
Identities = 46/182 (25%), Positives = 76/182 (41%), Gaps = 14/182 (7%)
Query: 21 QLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77
++ A K + L ++ +E+ + L H ++V G+ D +V E
Sbjct: 67 EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRR 126
Query: 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 137
SL + + EP + G +YLH VI+RDLK N+ L+ D
Sbjct: 127 SLLELHKRRKALTEPEAR----YYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLE 179
Query: 138 PKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
K+ DFGLA +V+ GT Y APE + + D++S G ++ L+
Sbjct: 180 VKIGDFGLATKVEYDGERK---KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV 236
Query: 197 GR 198
G+
Sbjct: 237 GK 238
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 5e-22
Identities = 46/182 (25%), Positives = 76/182 (41%), Gaps = 14/182 (7%)
Query: 21 QLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77
++ A K + L ++ +E+ + L H ++V G+ D +V E
Sbjct: 41 EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRR 100
Query: 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 137
SL + + EP + G +YLH VI+RDLK N+ L+ D
Sbjct: 101 SLLELHKRRKALTEPEAR----YYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLE 153
Query: 138 PKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
K+ DFGLA +V+ GT Y APE + + D++S G ++ L+
Sbjct: 154 VKIGDFGLATKVEYDGERK---KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV 210
Query: 197 GR 198
G+
Sbjct: 211 GK 212
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-21
Identities = 55/195 (28%), Positives = 83/195 (42%), Gaps = 21/195 (10%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIV--EVLMLSLLHHDNLVTLIGYCTSGDQ 66
G V LC AIK + + + EV +L LL H N++ L +
Sbjct: 51 GEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRN 110
Query: 67 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 126
LV E G L D + + + I G+ YLH +++RDLK
Sbjct: 111 YYLVMECYKGGELFDEII----HRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLK 163
Query: 127 SANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSD 183
N+LL++ D K+ DFGL+ + + + R+ GT Y APE + K K D
Sbjct: 164 PENLLLESKEKDALIKIVDFGLSAV--FENQKKMKERL-GTAYYIAPE-VLRKKYDEKCD 219
Query: 184 IYSFGVVLLELITGR 198
++S GV+L L+ G
Sbjct: 220 VWSIGVILFILLAGY 234
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-21
Identities = 52/182 (28%), Positives = 84/182 (46%), Gaps = 13/182 (7%)
Query: 21 QLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77
VAIK ++ + + Q EV + L H +++ L Y + LV E G
Sbjct: 37 LEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNG 96
Query: 78 SLEDHLYDLE-PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF 136
+ +L + P E + + +I G+ YLH +++RDL +N+LL +
Sbjct: 97 EMNRYLKNRVKPFSENEARHFMHQII----TGMLYLHSHG---ILHRDLTLSNLLLTRNM 149
Query: 137 NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
N K++DFGLA + H T + GT Y +PE A L+SD++S G + L+
Sbjct: 150 NIKIADFGLATQLKMPHEKH-YT-LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLI 207
Query: 197 GR 198
GR
Sbjct: 208 GR 209
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 5e-21
Identities = 51/196 (26%), Positives = 88/196 (44%), Gaps = 22/196 (11%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQG---HQEFIVEVLMLSLLHHDNLVTLIGYCTSGD 65
G V LC Q A+K ++ ++ + + EV +L L H N++ L +
Sbjct: 40 GEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG 99
Query: 66 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 125
LV E G L D + + E + ++ + + Y+H +++RDL
Sbjct: 100 YFYLVGEVYTGGELFDEIISRKRFSEVDAARI-IRQVLSG---ITYMHKNK---IVHRDL 152
Query: 126 KSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKS 182
K N+LL++ D N ++ DFGL+ + + +GT Y APE + G K
Sbjct: 153 KPENLLLESKSKDANIRIIDFGLST---HFEASKKMKDKIGTAYYIAPE-VLHGTYDEKC 208
Query: 183 DIYSFGVVLLELITGR 198
D++S GV+L L++G
Sbjct: 209 DVWSTGVILYILLSGC 224
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 5e-21
Identities = 56/225 (24%), Positives = 95/225 (42%), Gaps = 40/225 (17%)
Query: 20 DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS-GDQRL-LVYEYMPMG 77
D+ A+KQ+ G+ E+ +L L H N+++L S D+++ L+++Y
Sbjct: 48 DKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA--- 102
Query: 78 SLEDHLYDLEP--DQEPLSWNTRMKIAVGAA----------RGLEYLHCKANPPVIYRDL 125
+H DL S + + + G+ YLH V++RDL
Sbjct: 103 ---EH--DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDL 154
Query: 126 KSANILLDNDFNP----KLSDFGLAKL--GPVGDNTHVSTRVMGTYGYCAPEYAMSGKL- 178
K ANIL+ + K++D G A+L P+ + V+ T+ Y APE + +
Sbjct: 155 KPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYRAPELLLGARHY 213
Query: 179 TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 223
T DI++ G + EL+T Q + S P+ DQ
Sbjct: 214 TKAIDIWAIGCIFAELLTSEPIF-----HCRQEDIKTSNPYHHDQ 253
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 6e-21
Identities = 46/205 (22%), Positives = 78/205 (38%), Gaps = 35/205 (17%)
Query: 20 DQLVAIKQLNHEGLQGHQEFIVEV-LMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78
+ VA+K++ + ++E+ L+ H N++ T+ + E +
Sbjct: 39 GRPVAVKRML---IDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LN 94
Query: 79 LEDHLYDLEPDQEPLSWNTRMKIAV---GAARGLEYLHCKANPPVIYRDLKSANILLDN- 134
L+D + E L A G+ +LH +I+RDLK NIL+
Sbjct: 95 LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTS 151
Query: 135 ------------DFNPKLSDFGLAKL---GPVGDNTHVSTRVMGTYGYCAPE-------Y 172
+ +SDFGL K G T+++ GT G+ APE
Sbjct: 152 SRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS-GTSGWRAPELLEESNNL 210
Query: 173 AMSGKLTLKSDIYSFGVVLLELITG 197
+LT DI+S G V +++
Sbjct: 211 QTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 7e-21
Identities = 51/194 (26%), Positives = 81/194 (41%), Gaps = 17/194 (8%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLIGYCTSGD 65
V L + AIK L + + E ++S L H V L +
Sbjct: 44 STVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE 103
Query: 66 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA-VGAARGLEYLHCKANPPVIYRD 124
+ Y G L ++ + E TR A + +A LEYLH K +I+RD
Sbjct: 104 KLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAEIVSA--LEYLHGKG---IIHRD 155
Query: 125 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDI 184
LK NILL+ D + +++DFG AK+ + +GT Y +PE SD+
Sbjct: 156 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDL 215
Query: 185 YSFGVVLLELITGR 198
++ G ++ +L+ G
Sbjct: 216 WALGCIIYQLVAGL 229
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-20
Identities = 51/189 (26%), Positives = 86/189 (45%), Gaps = 27/189 (14%)
Query: 21 QLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79
+ VA+K ++ + E I E+ + +L+H+N+V G+ G+ + L EY G L
Sbjct: 33 EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 92
Query: 80 EDHLYDLEPDQEPLSWNTRMKIAVGAAR--------GLEYLHCKANPPVIYRDLKSANIL 131
D + + M A+ G+ YLH + +RD+K N+L
Sbjct: 93 FDRIEP----------DIGMPEPD--AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLL 137
Query: 132 LDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL--TLKSDIYSFGV 189
LD N K+SDFGLA + + + ++ GT Y APE + + D++S G+
Sbjct: 138 LDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE-LLKRREFHAEPVDVWSCGI 196
Query: 190 VLLELITGR 198
VL ++ G
Sbjct: 197 VLTAMLAGE 205
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-20
Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 32/206 (15%)
Query: 14 GLVWLC-----DQLVAIKQLN-------------HEGLQGHQEFIVEVLMLSLLHHDNLV 55
G V LC AIK + + H+E E+ +L L H N++
Sbjct: 50 GEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNII 109
Query: 56 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 115
L LV E+ G L + + + E + N MK + + YLH
Sbjct: 110 KLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI-MKQILSG---ICYLHKH 165
Query: 116 ANPPVIYRDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 172
+++RD+K NILL+N N K+ DFGL+ + +GT Y APE
Sbjct: 166 N---IVHRDIKPENILLENKNSLLNIKIVDFGLSS---FFSKDYKLRDRLGTAYYIAPE- 218
Query: 173 AMSGKLTLKSDIYSFGVVLLELITGR 198
+ K K D++S GV++ L+ G
Sbjct: 219 VLKKKYNEKCDVWSCGVIMYILLCGY 244
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 4e-20
Identities = 51/189 (26%), Positives = 86/189 (45%), Gaps = 27/189 (14%)
Query: 21 QLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79
+ VA+K ++ + E I E+ + +L+H+N+V G+ G+ + L EY G L
Sbjct: 33 EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 92
Query: 80 EDHLYDLEPDQEPLSWNTRMKIAVGAAR--------GLEYLHCKANPPVIYRDLKSANIL 131
D + + M A+ G+ YLH + +RD+K N+L
Sbjct: 93 FDRIEP----------DIGMPEPD--AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLL 137
Query: 132 LDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL--TLKSDIYSFGV 189
LD N K+SDFGLA + + + ++ GT Y APE + + D++S G+
Sbjct: 138 LDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE-LLKRREFHAEPVDVWSCGI 196
Query: 190 VLLELITGR 198
VL ++ G
Sbjct: 197 VLTAMLAGE 205
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-20
Identities = 54/190 (28%), Positives = 85/190 (44%), Gaps = 31/190 (16%)
Query: 21 QLVAIKQLNHEGLQGHQEFIV--EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78
+ VAIK ++ L + EV ++ +L+H N+V L + L+ EY G
Sbjct: 41 REVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGE 100
Query: 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAAR--------GLEYLHCKANPPVIYRDLKSANI 130
+ D+L + RMK AR ++Y H K +++RDLK+ N+
Sbjct: 101 VFDYLVA----------HGRMKEKE--ARSKFRQIVSAVQYCHQKR---IVHRDLKAENL 145
Query: 131 LLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL--TLKSDIYSFG 188
LLD D N K++DFG + + G Y APE GK + D++S G
Sbjct: 146 LLDADMNIKIADFGFSNE--FTVGGKLDAFC-GAPPYAAPE-LFQGKKYDGPEVDVWSLG 201
Query: 189 VVLLELITGR 198
V+L L++G
Sbjct: 202 VILYTLVSGS 211
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 9e-20
Identities = 55/195 (28%), Positives = 85/195 (43%), Gaps = 21/195 (10%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 66
G V C Q A+K +N + + EV +L L H N++ L
Sbjct: 36 GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95
Query: 67 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 126
+V E G L D + + E + +K + Y+H +++RDLK
Sbjct: 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARI-IKQVFSG---ITYMHKHN---IVHRDLK 148
Query: 127 SANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSD 183
NILL++ D + K+ DFGL+ NT + R+ GT Y APE + G K D
Sbjct: 149 PENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRI-GTAYYIAPE-VLRGTYDEKCD 204
Query: 184 IYSFGVVLLELITGR 198
++S GV+L L++G
Sbjct: 205 VWSAGVILYILLSGT 219
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-19
Identities = 58/196 (29%), Positives = 84/196 (42%), Gaps = 22/196 (11%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIGYCTSGDQR 67
G V L IK +N + Q E I E+ +L L H N++ +
Sbjct: 36 GDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNM 95
Query: 68 LLVYEYMPMGSLEDHLYDLEPDQEPLSWN---TRMKIAVGAARGLEYLHCKANPPVIYRD 124
+V E G L + + + + LS MK + A L Y H + V+++D
Sbjct: 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA---LAYFHSQH---VVHKD 149
Query: 125 LKSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK 181
LK NIL + K+ DFGLA+L + H + GT Y APE +T K
Sbjct: 150 LKPENILFQDTSPHSPIKIIDFGLAEL--FKSDEHSTNAA-GTALYMAPE-VFKRDVTFK 205
Query: 182 SDIYSFGVVLLELITG 197
DI+S GVV+ L+TG
Sbjct: 206 CDIWSAGVVMYFLLTG 221
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 1e-19
Identities = 43/197 (21%), Positives = 82/197 (41%), Gaps = 28/197 (14%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 68
G+V C ++ K +N E+ +++ LHH L+ L + +
Sbjct: 65 GVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 124
Query: 69 LVYEYMPMGSL------EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 122
L+ E++ G L ED+ E + M+ A GL+++H + +++
Sbjct: 125 LILEFLSGGELFDRIAAEDYKMS-EAEVINY-----MRQACE---GLKHMHEHS---IVH 172
Query: 123 RDLKSANILLDNDFNP--KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTL 180
D+K NI+ + K+ DFGLA + + V T + APE +
Sbjct: 173 LDIKPENIMCETKKASSVKIIDFGLATK--LNPDEIVKVTT-ATAEFAAPEIVDREPVGF 229
Query: 181 KSDIYSFGVVLLELITG 197
+D+++ GV+ L++G
Sbjct: 230 YTDMWAIGVLGYVLLSG 246
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-19
Identities = 48/194 (24%), Positives = 76/194 (39%), Gaps = 30/194 (15%)
Query: 21 QLVAIKQLNHEGLQGHQEFIV----EVLMLSLLHHDNLVTL--IGYCTSGDQRLLVYEYM 74
A+K L + L+ E+ +L L H N++ L + Y + +V EY
Sbjct: 31 CRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYC 90
Query: 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR--------GLEYLHCKANPPVIYRDLK 126
G E + D P++ R + A GLEYLH + ++++D+K
Sbjct: 91 VCGMQE--MLDSVPEK-------RFPVCQ--AHGYFCQLIDGLEYLHSQG---IVHKDIK 136
Query: 127 SANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL--TLKSDI 184
N+LL K+S G+A+ G+ + PE A K DI
Sbjct: 137 PGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDI 196
Query: 185 YSFGVVLLELITGR 198
+S GV L + TG
Sbjct: 197 WSAGVTLYNITTGL 210
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 2e-19
Identities = 53/238 (22%), Positives = 81/238 (34%), Gaps = 57/238 (23%)
Query: 14 GLVWLC-----DQLVAIK-----QLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 63
G+V + + AIK ++ + + EV ++ LHH N+ L
Sbjct: 40 GVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99
Query: 64 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG------------------- 104
LV E G L D L D +K +
Sbjct: 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRE 159
Query: 105 ----------AAR-------GLEYLHCKANPPVIYRDLKSANILL--DNDFNPKLSDFGL 145
+ L YLH + + +RD+K N L + F KL DFGL
Sbjct: 160 SLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGL 216
Query: 146 AKL---GPVGDNTHVSTRVMGTYGYCAPE--YAMSGKLTLKSDIYSFGVVLLELITGR 198
+K G+ ++T+ GT + APE + K D +S GV+L L+ G
Sbjct: 217 SKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-19
Identities = 47/186 (25%), Positives = 73/186 (39%), Gaps = 19/186 (10%)
Query: 14 GLVWLCD-----QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 68
G V + A K++ ++ F E+ ++ L H N++ L
Sbjct: 23 GEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY 82
Query: 69 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 128
LV E G L + + +E + MK + A + Y H V +RDLK
Sbjct: 83 LVMELCTGGELFERVVHKRVFRESDAARI-MKDVLSA---VAYCHKLN---VAHRDLKPE 135
Query: 129 NILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIY 185
N L D KL DFGLA + T+V GT Y +P+ + G + D +
Sbjct: 136 NFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKV-GTPYYVSPQ-VLEGLYGPECDEW 191
Query: 186 SFGVVL 191
S GV++
Sbjct: 192 SAGVMM 197
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 3e-19
Identities = 49/190 (25%), Positives = 82/190 (43%), Gaps = 27/190 (14%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 68
V+L +L A+K + E+ +L + H+N+VTL S
Sbjct: 23 SEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYY 82
Query: 69 LVYEYMPMGSLEDHLYDL----EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 124
LV + + G L D + + E D + ++ + A ++YLH +++RD
Sbjct: 83 LVMQLVSGGELFDRILERGVYTEKDASLV-----IQQVLSA---VKYLHENG---IVHRD 131
Query: 125 LKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK 181
LK N+L + + ++DFGL+K + N +ST GT GY APE +
Sbjct: 132 LKPENLLYLTPEENSKIMITDFGLSK---MEQNGIMSTAC-GTPGYVAPEVLAQKPYSKA 187
Query: 182 SDIYSFGVVL 191
D +S GV+
Sbjct: 188 VDCWSIGVIT 197
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-19
Identities = 51/197 (25%), Positives = 84/197 (42%), Gaps = 28/197 (14%)
Query: 14 GLVWLCD-----QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 68
G V C+ +A K + G++ +E E+ +++ L H NL+ L S + +
Sbjct: 103 GQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIV 162
Query: 69 LVYEYMPMGSL------EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 122
LV EY+ G L E + E D MK G+ ++H +++
Sbjct: 163 LVMEYVDGGELFDRIIDESYNLT-ELDTILF-----MKQICE---GIRHMHQMY---ILH 210
Query: 123 RDLKSANILLDNDFNP--KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTL 180
DLK NIL N K+ DFGLA+ + GT + APE ++
Sbjct: 211 LDLKPENILCVNRDAKQIKIIDFGLARR--YKPREKLKVNF-GTPEFLAPEVVNYDFVSF 267
Query: 181 KSDIYSFGVVLLELITG 197
+D++S GV+ L++G
Sbjct: 268 PTDMWSVGVIAYMLLSG 284
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 5e-19
Identities = 55/198 (27%), Positives = 87/198 (43%), Gaps = 25/198 (12%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLIGYCTSGD 65
G V + ++ A+K +N + E E+ ++ L H LV L Y +
Sbjct: 29 GKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW-YSFQDE 87
Query: 66 QRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA-VGAARGLEYLHCKANPPVIYR 123
+ + +V + + G L HL +E ++ I + A L+YL + +I+R
Sbjct: 88 EDMFMVVDLLLGGDLRYHLQQNVHFKEET---VKLFICELVMA--LDYLQNQR---IIHR 139
Query: 124 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKS- 182
D+K NILLD + ++DF +A + P T + GT Y APE S K S
Sbjct: 140 DMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMAPEMFSSRKGAGYSF 196
Query: 183 --DIYSFGVVLLELITGR 198
D +S GV EL+ GR
Sbjct: 197 AVDWWSLGVTAYELLRGR 214
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 5e-19
Identities = 50/208 (24%), Positives = 82/208 (39%), Gaps = 41/208 (19%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIV--------EVLMLSLLHHDNLVTLIGY 60
G VW ++ V +K + E + E+ +LS + H N++ ++
Sbjct: 38 GFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDI 97
Query: 61 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR--------GLEYL 112
+ LV E G L+ L+ + + R+ + A + YL
Sbjct: 98 FENQGFFQLVMEKHGSG-LD--LFAF------IDRHPRLDEPL--ASYIFRQLVSAVGYL 146
Query: 113 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 172
K +I+RD+K NI++ DF KL DFG A G + GT YCAPE
Sbjct: 147 RLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIEYCAPE- 199
Query: 173 AMSGKLTL--KSDIYSFGVVLLELITGR 198
+ G + +++S GV L L+
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 6e-19
Identities = 57/190 (30%), Positives = 85/190 (44%), Gaps = 29/190 (15%)
Query: 20 DQLVAIKQLNHEGLQGHQEFIVEVLM----LSLLHHDNLVTLIGYCTSGDQRL-LVYEYM 74
QL A+K L L+ V M L ++H +V L Y + +L L+ +++
Sbjct: 52 RQLYAMKVLKKATLKVRDR--VRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFL 108
Query: 75 PMGSLEDHLYDLEPDQEPLSWNTRMK-----IAVGAARGLEYLHCKANPPVIYRDLKSAN 129
G L L E +K +A+ L++LH +IYRDLK N
Sbjct: 109 RGGDLFTRLSKEVMFTEE-----DVKFYLAELALA----LDHLHSLG---IIYRDLKPEN 156
Query: 130 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPEYAMSGKLTLKSDIYSFG 188
ILLD + + KL+DFGL+K + GT Y APE T +D +SFG
Sbjct: 157 ILLDEEGHIKLTDFGLSKESIDHEKK---AYSFCGTVEYMAPEVVNRRGHTQSADWWSFG 213
Query: 189 VVLLELITGR 198
V++ E++TG
Sbjct: 214 VLMFEMLTGT 223
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-18
Identities = 56/189 (29%), Positives = 84/189 (44%), Gaps = 25/189 (13%)
Query: 21 QLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIGYCTSGDQRL------LVYEY 73
+LVAIK++ LQ + F E+ ++ L H N+V L + S ++ LV +Y
Sbjct: 80 ELVAIKKV----LQ-DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 134
Query: 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD 133
+P ++ ++ L R L Y+H + +RD+K N+LLD
Sbjct: 135 VPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFG--ICHRDIKPQNLLLD 190
Query: 134 NDFNP-KLSDFGLAK-LGPVGDNTH-VSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGV 189
D KL DFG AK L N + +R Y Y APE T D++S G
Sbjct: 191 PDTAVLKLCDFGSAKQLVRGEPNVSYICSR----Y-YRAPELIFGATDYTSSIDVWSAGC 245
Query: 190 VLLELITGR 198
VL EL+ G+
Sbjct: 246 VLAELLLGQ 254
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 1e-18
Identities = 59/184 (32%), Positives = 79/184 (42%), Gaps = 15/184 (8%)
Query: 20 DQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLIGYCTSGDQRL-LVYEYMP 75
+ A+K L E + E + E +L H L L Y RL V EY
Sbjct: 173 GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYAN 231
Query: 76 MGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEYLHCKANPPVIYRDLKSANILLDN 134
G L HL E R + L+YLH + N V+YRDLK N++LD
Sbjct: 232 GGELFFHLSRERVFSED-----RARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDK 284
Query: 135 DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLEL 194
D + K++DFGL K G + D + T GT Y APE D + GVV+ E+
Sbjct: 285 DGHIKITDFGLCKEG-IKDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 342
Query: 195 ITGR 198
+ GR
Sbjct: 343 MCGR 346
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 48/195 (24%), Positives = 79/195 (40%), Gaps = 24/195 (12%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 68
G+V A K + + E+ +S+L H LV L ++ +
Sbjct: 171 GVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230
Query: 69 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR----GLEYLHCKANPPVIYRD 124
++YE+M G L + + D + +S AV R GL ++H ++ D
Sbjct: 231 MIYEFMSGGELFEKVAD---EHNKMS----EDEAVEYMRQVCKGLCHMHENN---YVHLD 280
Query: 125 LKSANILLDNDFNP--KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKS 182
LK NI+ + KL DFGL + V GT + APE A + +
Sbjct: 281 LKPENIMFTTKRSNELKLIDFGLTAH--LDPKQSVKVTT-GTAEFAAPEVAEGKPVGYYT 337
Query: 183 DIYSFGVVLLELITG 197
D++S GV+ L++G
Sbjct: 338 DMWSVGVLSYILLSG 352
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-18
Identities = 54/192 (28%), Positives = 80/192 (41%), Gaps = 29/192 (15%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIV--EVLMLSLLHHDNLVTLIGYCTSGDQ 66
G V C Q A+K +N + + EV +L L H N++ L
Sbjct: 36 GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95
Query: 67 RLLVYEYMPMGSLEDHLYDL----EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 122
+V E G L D + E D + +K + Y+H +++
Sbjct: 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARI-----IKQVFSG---ITYMHKHN---IVH 144
Query: 123 RDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT 179
RDLK NILL + D + K+ DFGL+ NT + R+ GT Y APE + G
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRI-GTAYYIAPE-VLRGTYD 200
Query: 180 LKSDIYSFGVVL 191
K D++S GV+L
Sbjct: 201 EKCDVWSAGVIL 212
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-18
Identities = 54/194 (27%), Positives = 80/194 (41%), Gaps = 22/194 (11%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGL--QGHQEFIV-EVLMLSLLHHDNLVTLIGYCTSGD 65
G V L A+K L+ + + E + E +L ++ LV L
Sbjct: 55 GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 66 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA-VGAARGLEYLHCKANPPVIYRD 124
+V EY+ G + HL + EP R A + EYLH +IYRD
Sbjct: 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPH---ARFYAAQIVLT--FEYLHSLD---LIYRD 166
Query: 125 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDI 184
LK N+L+D +++DFG AK V T T + GT APE +S D
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKR--VKGRTW--T-LCGTPEALAPEIILSKGYNKAVDW 221
Query: 185 YSFGVVLLELITGR 198
++ GV++ E+ G
Sbjct: 222 WALGVLIYEMAAGY 235
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-18
Identities = 44/194 (22%), Positives = 76/194 (39%), Gaps = 24/194 (12%)
Query: 14 GLVWLC-----DQLVAIK-----QLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 63
+V C Q A+K + ++ E + +L H ++V L+ +S
Sbjct: 38 SVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS 97
Query: 64 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWN---TRMKIAVGAARGLEYLHCKANPPV 120
+V+E+M L + S M+ + A L Y H +
Sbjct: 98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA---LRYCHDNN---I 151
Query: 121 IYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK 177
I+RD+K +LL +N KL FG+A +G++ V+ +GT + APE
Sbjct: 152 IHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGTPHFMAPEVVKREP 209
Query: 178 LTLKSDIYSFGVVL 191
D++ GV+L
Sbjct: 210 YGKPVDVWGCGVIL 223
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-18
Identities = 49/203 (24%), Positives = 86/203 (42%), Gaps = 30/203 (14%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIV--------EVLMLSLLHHDNLVTLIGY 60
G V L + VAI+ ++ E+ +L L+H ++ + +
Sbjct: 149 GEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF 208
Query: 61 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 120
+ D +V E M G L D + + +E ++ ++YLH +
Sbjct: 209 FDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM----LLAVQYLHENG---I 260
Query: 121 IYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE---YAM 174
I+RDLK N+LL + D K++DFG +K+ +G+ + + T GT Y APE
Sbjct: 261 IHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLC-GTPTYLAPEVLVSVG 317
Query: 175 SGKLTLKSDIYSFGVVLLELITG 197
+ D +S GV+L ++G
Sbjct: 318 TAGYNRAVDCWSLGVILFICLSG 340
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-18
Identities = 53/193 (27%), Positives = 88/193 (45%), Gaps = 36/193 (18%)
Query: 21 QLVAIK-----QLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75
VA+K ++ + G + E+ L L H +++ L ++ +V EY+
Sbjct: 37 HKVAVKILNRQKIRSLDVVGKIK--REIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVS 94
Query: 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR--------GLEYLHCKANPPVIYRDLKS 127
G L D++ + R++ AR ++Y H V++RDLK
Sbjct: 95 GGELFDYI----------CKHGRVEEME--ARRLFQQILSAVDYCHRHM---VVHRDLKP 139
Query: 128 ANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL--TLKSDIY 185
N+LLD N K++DFGL+ + G+ S G+ Y APE +SG+L + DI+
Sbjct: 140 ENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPE-VISGRLYAGPEVDIW 195
Query: 186 SFGVVLLELITGR 198
S GV+L L+ G
Sbjct: 196 SCGVILYALLCGT 208
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 5e-18
Identities = 55/196 (28%), Positives = 84/196 (42%), Gaps = 23/196 (11%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIV--EVLMLSLLHHDNLVTLIGYCTSGDQ 66
G+V+ C Q+VAIK+ + I E+ ML L H NLV L+ +
Sbjct: 17 GVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRR 76
Query: 67 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 126
LV+EY L++L+ Q + + I + + + H I+RD+K
Sbjct: 77 LHLVFEYCDH----TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVK 129
Query: 127 SANILLDNDFNPKLSDFGLAKL--GPVGDNTH-VSTRVMGTYGYCAPEYAMSGKLTLKS- 182
NIL+ KL DFG A+L GP V+TR Y +PE +
Sbjct: 130 PENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYRSPELLVGDTQYGPPV 184
Query: 183 DIYSFGVVLLELITGR 198
D+++ G V EL++G
Sbjct: 185 DVWAIGCVFAELLSGV 200
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 8e-18
Identities = 51/189 (26%), Positives = 86/189 (45%), Gaps = 22/189 (11%)
Query: 20 DQLVAIKQLNHEGLQGHQEF----IVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75
VA+K++ + +G I E+ ++ L H+N+V L + ++ LV+E+M
Sbjct: 30 GVYVALKEVKLDSEEG---TPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD 86
Query: 76 M---GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL 132
++ P L N +GL + H +++RDLK N+L+
Sbjct: 87 NDLKKYMDSRTVGNTP--RGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLI 141
Query: 133 DNDFNPKLSDFGLAKL--GPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGV 189
+ KL DFGLA+ PV + V+ T Y AP+ M + + DI+S G
Sbjct: 142 NKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TLWYRAPDVLMGSRTYSTSIDIWSCGC 197
Query: 190 VLLELITGR 198
+L E+ITG+
Sbjct: 198 ILAEMITGK 206
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 8e-18
Identities = 48/192 (25%), Positives = 73/192 (38%), Gaps = 28/192 (14%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 66
+V C A K +N + L Q+ E + L H N+V L
Sbjct: 20 SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF 79
Query: 67 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR----GLEYLHCKANPPVIY 122
LV++ + G L + + E E A + + Y H +++
Sbjct: 80 HYLVFDLVTGGELFEDIVAREFYSE--------ADASHCIQQILESIAYCHSNG---IVH 128
Query: 123 RDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT 179
R+LK N+LL KL+DFGLA V D+ GT GY +PE +
Sbjct: 129 RNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEAWHGFA-GTPGYLSPEVLKKDPYS 185
Query: 180 LKSDIYSFGVVL 191
DI++ GV+L
Sbjct: 186 KPVDIWACGVIL 197
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 9e-18
Identities = 51/193 (26%), Positives = 75/193 (38%), Gaps = 33/193 (17%)
Query: 20 DQLVAIKQLNHEGLQGHQEFIVEVLM----LSLLHHDNLVTLIGYCTSGDQRL-LVYEYM 74
++ A+K L + + + L + H +V LI Y +L L+ EY+
Sbjct: 45 GKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYL 103
Query: 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR--------GLEYLHCKANPPVIYRDLK 126
G L L E A L +LH K +IYRDLK
Sbjct: 104 SGGELFMQLEREGIFMEDT------------ACFYLAEISMALGHLHQKG---IIYRDLK 148
Query: 127 SANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPEYAMSGKLTLKSDIY 185
NI+L++ + KL+DFGL K T GT Y APE M D +
Sbjct: 149 PENIMLNHQGHVKLTDFGLCKESIHDGTV---THTFCGTIEYMAPEILMRSGHNRAVDWW 205
Query: 186 SFGVVLLELITGR 198
S G ++ +++TG
Sbjct: 206 SLGALMYDMLTGA 218
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 9e-18
Identities = 46/192 (23%), Positives = 72/192 (37%), Gaps = 23/192 (11%)
Query: 20 DQLVAIKQLNHEGLQGHQE---FIVEVLMLSLLHHDNLVTLIGYCTSGDQRL-LVYEYMP 75
Q+ A+K +N + E F E +L + L + + L LV EY
Sbjct: 86 GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYV 144
Query: 76 MGSLEDHLYDLEPDQEPLSWNTRMKIA--VGAARGLEYLHCKANPPVIYRDLKSANILLD 133
G L L ++ P R +A V A ++ +H ++RD+K NILLD
Sbjct: 145 GGDLLTLLSKFG-ERIPAEM-ARFYLAEIVMA---IDSVHRLG---YVHRDIKPDNILLD 196
Query: 134 NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIY-------S 186
+ +L+DFG V GT Y +PE + + Y +
Sbjct: 197 RCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWA 255
Query: 187 FGVVLLELITGR 198
GV E+ G+
Sbjct: 256 LGVFAYEMFYGQ 267
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 9e-18
Identities = 48/192 (25%), Positives = 73/192 (38%), Gaps = 28/192 (14%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 66
+V C A K +N + L Q+ E + L H N+V L
Sbjct: 43 SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF 102
Query: 67 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR----GLEYLHCKANPPVIY 122
LV++ + G L + + E E A + + Y H +++
Sbjct: 103 HYLVFDLVTGGELFEDIVAREFYSE--------ADASHCIQQILESIAYCHSNG---IVH 151
Query: 123 RDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT 179
R+LK N+LL KL+DFGLA V D+ GT GY +PE +
Sbjct: 152 RNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEAWHGFA-GTPGYLSPEVLKKDPYS 208
Query: 180 LKSDIYSFGVVL 191
DI++ GV+L
Sbjct: 209 KPVDIWACGVIL 220
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-17
Identities = 53/187 (28%), Positives = 81/187 (43%), Gaps = 25/187 (13%)
Query: 23 VAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIGYCTSGDQRL------LVYEYMP 75
VAIK++ LQ + F E+ ++ ++ H N+V L + S + LV EY+P
Sbjct: 67 VAIKKV----LQ-DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP 121
Query: 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 135
++ ++ + R L Y+H + +RD+K N+LLD
Sbjct: 122 E-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH-SIG--ICHRDIKPQNLLLDPP 177
Query: 136 FNP-KLSDFGLAK-LGPVGDNTH-VSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVL 191
KL DFG AK L N + +R Y Y APE T DI+S G V+
Sbjct: 178 SGVLKLIDFGSAKILIAGEPNVSYICSR----Y-YRAPELIFGATNYTTNIDIWSTGCVM 232
Query: 192 LELITGR 198
EL+ G+
Sbjct: 233 AELMQGQ 239
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-17
Identities = 53/188 (28%), Positives = 81/188 (43%), Gaps = 19/188 (10%)
Query: 20 DQLVAIKQLNHEGLQGHQEFIVEVLM-----LSLLHHDNLVTLIGYCTSGDQRL-LVYEY 73
+L A+K L + + + LVTL Y + +L L+ +Y
Sbjct: 82 GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDY 140
Query: 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIA-VGAARGLEYLHCKANPPVIYRDLKSANILL 132
+ G L HL E E ++ + + A LE+LH +IYRD+K NILL
Sbjct: 141 INGGELFTHLSQRERFTEHE---VQIYVGEIVLA--LEHLHKLG---IIYRDIKLENILL 192
Query: 133 DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL--TLKSDIYSFGVV 190
D++ + L+DFGL+K + GT Y AP+ G D +S GV+
Sbjct: 193 DSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMAPDIVRGGDSGHDKAVDWWSLGVL 251
Query: 191 LLELITGR 198
+ EL+TG
Sbjct: 252 MYELLTGA 259
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-17
Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 17/163 (10%)
Query: 42 EVLMLSLLHHDNLVTLIG-YCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRM 99
E+ +L L H N+V L+ + L +V+E + G + + P +PLS +
Sbjct: 86 EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV-----PTLKPLSEDQAR 140
Query: 100 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159
+G+EYLH + +I+RD+K +N+L+ D + K++DFG++ G + +S
Sbjct: 141 FYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNE-FKGSDALLSN 196
Query: 160 RVMGTYGYCAPEYAMSGKLTL----KSDIYSFGVVLLELITGR 198
V GT + APE ++S + D+++ GV L + G+
Sbjct: 197 TV-GTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-17
Identities = 49/206 (23%), Positives = 82/206 (39%), Gaps = 45/206 (21%)
Query: 14 GLVWLC-----DQLVAIKQLN--------HEGLQGHQEFI---VEVLMLSLLHHDNLVTL 57
+V C + A+K ++ E +Q +E V++L + H N++ L
Sbjct: 31 SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR-KVSGHPNIIQL 89
Query: 58 IGYCTSGDQRLLVYEYMPMGSLED------HLYDLEPDQEPLSWNTRMKIAVGAARGLEY 111
+ LV++ M G L D L E + + M+ + +
Sbjct: 90 KDTYETNTFFFLVFDLMKKGELFDYLTEKVTLS--EKETRKI-----MRALLEV---ICA 139
Query: 112 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 171
LH +++RDLK NILLD+D N KL+DFG + + + GT Y APE
Sbjct: 140 LHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGEKLREVC-GTPSYLAPE 193
Query: 172 ------YAMSGKLTLKSDIYSFGVVL 191
+ D++S GV++
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-17
Identities = 49/204 (24%), Positives = 81/204 (39%), Gaps = 42/204 (20%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIVEVL---------MLSLLHHDNLVTLIG 59
+V C A+K + + E + EV + + H +++TLI
Sbjct: 108 SVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167
Query: 60 YCTSGDQRLLVYEYMPMGSLED------HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 113
S LV++ M G L D L E + + M+ + A + +LH
Sbjct: 168 SYESSSFMFLVFDLMRKGELFDYLTEKVALS--EKETRSI-----MRSLLEA---VSFLH 217
Query: 114 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-- 171
+++RDLK NILLD++ +LSDFG + + + GT GY APE
Sbjct: 218 ANN---IVHRDLKPENILLDDNMQIRLSDFGFSCH--LEPGEKLRELC-GTPGYLAPEIL 271
Query: 172 ----YAMSGKLTLKSDIYSFGVVL 191
+ D+++ GV+L
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVIL 295
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-17
Identities = 54/202 (26%), Positives = 83/202 (41%), Gaps = 35/202 (17%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIV--EVLMLSLLHHDNLVTLIGYCTSGDQ 66
G+V C ++VAIK+ + I E+ +L L H+NLV L+ C +
Sbjct: 39 GMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR 98
Query: 67 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 126
LV+E++ L DLE L + K G+ + H +I+RD+K
Sbjct: 99 WYLVFEFVDH----TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIK 151
Query: 127 SANILLDNDFNPKLSDFGLAKL--GPVGDNTH-VSTRVMGTYGYCAPE-------YAMSG 176
NIL+ KL DFG A+ P V+TR Y APE Y +
Sbjct: 152 PENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR-----WYRAPELLVGDVKYGKA- 205
Query: 177 KLTLKSDIYSFGVVLLELITGR 198
D+++ G ++ E+ G
Sbjct: 206 -----VDVWAIGCLVTEMFMGE 222
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-17
Identities = 57/185 (30%), Positives = 76/185 (41%), Gaps = 18/185 (9%)
Query: 20 DQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLIGYCTSGDQRL-LVYEYMP 75
+ A+K L E + E + E +L H L L Y RL V EY
Sbjct: 30 GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYAN 88
Query: 76 MGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEYLHCKANPPVIYRDLKSANILLDN 134
G L HL E R + LEYLH + V+YRD+K N++LD
Sbjct: 89 GGELFFHLSRERVFTEE-----RARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDK 140
Query: 135 DFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLE 193
D + K++DFGL K G T + GT Y APE D + GVV+ E
Sbjct: 141 DGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 197
Query: 194 LITGR 198
++ GR
Sbjct: 198 MMCGR 202
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 4e-17
Identities = 52/190 (27%), Positives = 79/190 (41%), Gaps = 21/190 (11%)
Query: 20 DQLVAIKQLNHEGLQGHQE---FIVEVLMLSLLHHDNLVTLIGYCTSGDQRL-LVYEYMP 75
D++ A+K LN + E F E +L + TL Y D L LV +Y
Sbjct: 99 DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYV 157
Query: 76 MGSLEDHLYDLEPDQEPLSWNTRMKIA--VGAARGLEYLHCKANPPVIYRDLKSANILLD 133
G L L E D+ P R +A V A ++ +H ++RD+K NIL+D
Sbjct: 158 GGDLLTLLSKFE-DRLPEEM-ARFYLAEMVIA---IDSVHQLH---YVHRDIKPDNILMD 209
Query: 134 NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKS-----DIYSFG 188
+ + +L+DFG S V GT Y +PE + + D +S G
Sbjct: 210 MNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLG 268
Query: 189 VVLLELITGR 198
V + E++ G
Sbjct: 269 VCMYEMLYGE 278
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 4e-17
Identities = 55/191 (28%), Positives = 88/191 (46%), Gaps = 32/191 (16%)
Query: 21 QLVAIKQLNHEGLQGHQEFIV---EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77
VA+K LN + ++ E+ L L H +++ L ++ +V EY+ G
Sbjct: 42 HKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGG 101
Query: 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAAR--------GLEYLHCKANPPVIYRDLKSAN 129
L D++ N R+ +R G++Y H V++RDLK N
Sbjct: 102 ELFDYI----------CKNGRLDEKE--SRRLFQQILSGVDYCHRHM---VVHRDLKPEN 146
Query: 130 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL--TLKSDIYSF 187
+LLD N K++DFGL+ + G+ S G+ Y APE +SG+L + DI+S
Sbjct: 147 VLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPE-VISGRLYAGPEVDIWSS 202
Query: 188 GVVLLELITGR 198
GV+L L+ G
Sbjct: 203 GVILYALLCGT 213
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 4e-17
Identities = 61/195 (31%), Positives = 94/195 (48%), Gaps = 24/195 (12%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLIGYCTSGD 65
G V L + A+K L E + ++ E LMLS++ H ++ +
Sbjct: 20 GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW-GTFQDA 78
Query: 66 QRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA-VGAARGLEYLHCKANPPVIYR 123
Q++ ++ +Y+ G L L + P+ + A V A LEYLH K +IYR
Sbjct: 79 QQIFMIMDYIEGGELFSLLRKSQRFPNPV---AKFYAAEVCLA--LEYLHSKD---IIYR 130
Query: 124 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSD 183
DLK NILLD + + K++DFG AK V D T+ T + GT Y APE + D
Sbjct: 131 DLKPENILLDKNGHIKITDFGFAKY--VPDVTY--T-LCGTPDYIAPEVVSTKPYNKSID 185
Query: 184 IYSFGVVLLELITGR 198
+SFG+++ E++ G
Sbjct: 186 WWSFGILIYEMLAGY 200
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 4e-17
Identities = 54/203 (26%), Positives = 81/203 (39%), Gaps = 33/203 (16%)
Query: 14 GLVWLCD-----QLVAIKQLN------HEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 62
+V C A K + +E EV +L + H N++TL
Sbjct: 26 AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE 85
Query: 63 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR----GLEYLHCKANP 118
+ +L+ E + G L D L E E + A + G+ YLH K
Sbjct: 86 NRTDVVLILELVSGGELFDFLAQKESLSE--------EEATSFIKQILDGVNYLHTKK-- 135
Query: 119 PVIYRDLKSANILLDNDFNP----KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 174
+ + DLK NI+L + P KL DFGLA + D GT + APE
Sbjct: 136 -IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIF-GTPEFVAPEIVN 191
Query: 175 SGKLTLKSDIYSFGVVLLELITG 197
L L++D++S GV+ L++G
Sbjct: 192 YEPLGLEADMWSIGVITYILLSG 214
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-17
Identities = 48/191 (25%), Positives = 77/191 (40%), Gaps = 29/191 (15%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 68
+ C + A+K ++ +E +E+ +L H N++TL G
Sbjct: 36 SVCKRCIHKATNMEFAVKIIDKSKRDPTEE--IEI-LLRYGQHPNIITLKDVYDDGKYVY 92
Query: 69 LVYEYMPMGSLEDHLYDL----EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 124
+V E M G L D + E + + + +EYLH + V++RD
Sbjct: 93 VVTELMKGGELLDKILRQKFFSEREASAV-----LFTITKT---VEYLHAQG---VVHRD 141
Query: 125 LKSANILL----DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTL 180
LK +NIL N + ++ DFG AK +N + T T + APE
Sbjct: 142 LKPSNILYVDESGNPESIRICDFGFAKQLR-AENGLLMTPC-YTANFVAPEVLERQGYDA 199
Query: 181 KSDIYSFGVVL 191
DI+S GV+L
Sbjct: 200 ACDIWSLGVLL 210
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 6e-17
Identities = 33/126 (26%), Positives = 59/126 (46%), Gaps = 3/126 (2%)
Query: 71 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANI 130
E + +E+ + ++ L+ + + A+G+E+L + I+RDL + NI
Sbjct: 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI 224
Query: 131 LLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVV 190
LL K+ DFGLA+ + + APE T++SD++SFGV+
Sbjct: 225 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 284
Query: 191 LLELIT 196
L E+ +
Sbjct: 285 LWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 8e-06
Identities = 20/74 (27%), Positives = 37/74 (50%), Gaps = 3/74 (4%)
Query: 23 VAIKQLNHE-GLQGHQEFIVEV-LMLSLLHHDNLVTLIGYCT-SGDQRLLVYEYMPMGSL 79
VA+K L H+ + E+ +++ + HH N+V L+G CT G +++ E+ G+L
Sbjct: 55 VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 114
Query: 80 EDHLYDLEPDQEPL 93
+L + P
Sbjct: 115 STYLRSKRNEFVPY 128
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 6e-17
Identities = 45/190 (23%), Positives = 82/190 (43%), Gaps = 24/190 (12%)
Query: 21 QLVAIK-----QLNHEGLQGHQEFI-VEVLMLSLLHHD--NLVTLIGYCTSGDQRLLVYE 72
VAIK +++ G + + +EV++L + ++ L+ + D +L+ E
Sbjct: 69 LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE 128
Query: 73 Y-MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANIL 131
P+ L D + + QE L+ R + + H V++RD+K NIL
Sbjct: 129 RPEPVQDLFDFITERGALQEELA---R-SFFWQVLEAVRHCHNCG---VLHRDIKDENIL 181
Query: 132 LD-NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL--TLKSDIYSFG 188
+D N KL DFG L +T + GT Y PE+ + + ++S G
Sbjct: 182 IDLNRGELKLIDFGSGALLK---DTVYTDFD-GTRVYSPPEW-IRYHRYHGRSAAVWSLG 236
Query: 189 VVLLELITGR 198
++L +++ G
Sbjct: 237 ILLYDMVCGD 246
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-17
Identities = 53/190 (27%), Positives = 84/190 (44%), Gaps = 29/190 (15%)
Query: 20 DQLVAIKQLNHEGLQGHQEF----IVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75
D LVA+K++ E +G I EV +L L H N+VTL + LV+EY+
Sbjct: 27 DNLVALKEIRLEHEEG---APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 83
Query: 76 MGSLEDHLYDL----EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANIL 131
DL + ++ + RGL Y H + V++RDLK N+L
Sbjct: 84 K--------DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLL 132
Query: 132 LDNDFNPKLSDFGLAKL--GPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFG 188
++ KL+DFGLA+ P + V+ T Y P+ + + + D++ G
Sbjct: 133 INERGELKLADFGLARAKSIPTKTYDN---EVV-TLWYRPPDILLGSTDYSTQIDMWGVG 188
Query: 189 VVLLELITGR 198
+ E+ TGR
Sbjct: 189 CIFYEMATGR 198
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 7e-17
Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 37/193 (19%)
Query: 21 QLVAIK-----QLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75
Q VA+K L + E E+ L LL H +++ L T+ ++V EY
Sbjct: 35 QKVALKFISRQLLKKSDMHMRVE--REISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAG 92
Query: 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR--------GLEYLHCKANPPVIYRDLKS 127
G L D++ RM R +EY H +++RDLK
Sbjct: 93 -GELFDYI----------VEKKRMTEDE--GRRFFQQIICAIEYCHRHK---IVHRDLKP 136
Query: 128 ANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL--TLKSDIY 185
N+LLD++ N K++DFGL+ + G+ S G+ Y APE ++GKL + D++
Sbjct: 137 ENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE-VINGKLYAGPEVDVW 192
Query: 186 SFGVVLLELITGR 198
S G+VL ++ GR
Sbjct: 193 SCGIVLYVMLVGR 205
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 8e-17
Identities = 54/192 (28%), Positives = 89/192 (46%), Gaps = 29/192 (15%)
Query: 20 DQLVAIKQLNHEGLQGHQE-----FIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74
+Q+VAIK++ ++ + E+ +L L H N++ L+ LV+++M
Sbjct: 35 NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 94
Query: 75 PMGSLEDHLYDL----EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANI 130
DL + + L+ + + +GLEYLH +++RDLK N+
Sbjct: 95 ET--------DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNL 143
Query: 131 LLDNDFNPKLSDFGLAKL--GPVGDNTH-VSTRVMGTYGYCAPEYAMSGKL-TLKSDIYS 186
LLD + KL+DFGLAK P TH V TR Y APE ++ + D+++
Sbjct: 144 LLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR-----WYRAPELLFGARMYGVGVDMWA 198
Query: 187 FGVVLLELITGR 198
G +L EL+
Sbjct: 199 VGCILAELLLRV 210
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 8e-17
Identities = 47/192 (24%), Positives = 75/192 (39%), Gaps = 27/192 (14%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 66
+V C Q A +N + L HQ+ E + LL H N+V L +
Sbjct: 25 SVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGH 84
Query: 67 RLLVYEYMPMGSLEDHLYDL----EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 122
L+++ + G L + + E D ++ + A + + H V++
Sbjct: 85 HYLIFDLVTGGELFEDIVAREYYSEADASHC-----IQQILEA---VLHCHQMG---VVH 133
Query: 123 RDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT 179
R+LK N+LL KL+DFGLA V GT GY +PE
Sbjct: 134 RNLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQQAWFGFAGTPGYLSPEVLRKDPYG 191
Query: 180 LKSDIYSFGVVL 191
D+++ GV+L
Sbjct: 192 KPVDLWACGVIL 203
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 8e-17
Identities = 55/194 (28%), Positives = 82/194 (42%), Gaps = 29/194 (14%)
Query: 21 QLVAIKQLNHEGLQGHQEF----IVEVLMLSLLHHDNLVTLIGYCTSGDQR-------LL 69
VAIK++ +Q F + + L++LHH N+V L Y + +R +
Sbjct: 49 MSVAIKKV----IQ-DPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNV 103
Query: 70 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSA 128
V EY+P +L + Q R + LH N V +RD+K
Sbjct: 104 VMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPH 160
Query: 129 NILLD-NDFNPKLSDFGLAK-LGPVGDNTH-VSTRVMGTYGYCAPEYAMSGKL-TLKSDI 184
N+L++ D KL DFG AK L P N + +R Y Y APE + T DI
Sbjct: 161 NVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR----Y-YRAPELIFGNQHYTTAVDI 215
Query: 185 YSFGVVLLELITGR 198
+S G + E++ G
Sbjct: 216 WSVGCIFAEMMLGE 229
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 77.9 bits (193), Expect = 8e-17
Identities = 47/189 (24%), Positives = 84/189 (44%), Gaps = 20/189 (10%)
Query: 20 DQLVAIKQL----NHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75
++VA+K++ + EG+ + E+ +L L H N+V L S + LV+E+
Sbjct: 27 HEIVALKRVRLDDDDEGV--PSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD 84
Query: 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 135
L+ + L +GL + H + V++RDLK N+L++ +
Sbjct: 85 Q-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRN 137
Query: 136 FNPKLSDFGLAKL--GPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLL 192
KL++FGLA+ PV + V+ T Y P+ KL + D++S G +
Sbjct: 138 GELKLANFGLARAFGIPVRCYSA---EVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFA 193
Query: 193 ELITGRKAM 201
EL + +
Sbjct: 194 ELANAGRPL 202
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 9e-17
Identities = 54/203 (26%), Positives = 81/203 (39%), Gaps = 33/203 (16%)
Query: 14 GLVWLCD-----QLVAIKQLN------HEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 62
+V C A K + +E EV +L + H N++TL
Sbjct: 26 AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE 85
Query: 63 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR----GLEYLHCKANP 118
+ +L+ E + G L D L E E + A + G+ YLH K
Sbjct: 86 NRTDVVLILELVSGGELFDFLAQKESLSE--------EEATSFIKQILDGVNYLHTKK-- 135
Query: 119 PVIYRDLKSANILLDNDFNP----KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 174
+ + DLK NI+L + P KL DFGLA + D GT + APE
Sbjct: 136 -IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIF-GTPEFVAPEIVN 191
Query: 175 SGKLTLKSDIYSFGVVLLELITG 197
L L++D++S GV+ L++G
Sbjct: 192 YEPLGLEADMWSIGVITYILLSG 214
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 9e-17
Identities = 44/199 (22%), Positives = 80/199 (40%), Gaps = 27/199 (13%)
Query: 14 GLVWLC-----DQLVAIKQLN--HEGLQGHQEFIVEV-LMLSLLHHDNLVTLIGYCTSGD 65
+V C Q A K L G E + E+ ++ ++ L +
Sbjct: 43 AVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102
Query: 66 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR----GLEYLHCKANPPVI 121
+ +L+ EY G + L E +S + + G+ YLH ++
Sbjct: 103 EIILILEYAAGGEIFSLC--LPELAEMVS----ENDVIRLIKQILEGVYYLHQNN---IV 153
Query: 122 YRDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL 178
+ DLK NILL + + K+ DFG+++ +G + + GT Y APE +
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRK--IGHACELREIM-GTPEYLAPEILNYDPI 210
Query: 179 TLKSDIYSFGVVLLELITG 197
T +D+++ G++ L+T
Sbjct: 211 TTATDMWNIGIIAYMLLTH 229
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 49/190 (25%), Positives = 80/190 (42%), Gaps = 28/190 (14%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 68
+V+ C + A+K L + E+ +L L H N++ L + +
Sbjct: 67 SIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124
Query: 69 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR----GLEYLHCKANPPVIYRD 124
LV E + G L D + + E + A A + + YLH +++RD
Sbjct: 125 LVLELVTGGELFDRIVEKGYYSE--------RDAADAVKQILEAVAYLHENG---IVHRD 173
Query: 125 LKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK 181
LK N+L D K++DFGL+K+ V + T GT GYCAPE +
Sbjct: 174 LKPENLLYATPAPDAPLKIADFGLSKI--VEHQVLMKTVC-GTPGYCAPEILRGCAYGPE 230
Query: 182 SDIYSFGVVL 191
D++S G++
Sbjct: 231 VDMWSVGIIT 240
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-16
Identities = 51/203 (25%), Positives = 82/203 (40%), Gaps = 42/203 (20%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIV--------EVLMLSLLHHDNLVTLIGY 60
G V L + VAIK ++ E+ +L L+H ++ + +
Sbjct: 24 GEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF 83
Query: 61 CTSGDQRLLVYEYMPMGSLED------HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 114
+ D +V E M G L D L E + + A ++YLH
Sbjct: 84 FDAEDY-YIVLELMEGGELFDKVVGNKRLK--EATCKLY-----FYQMLLA---VQYLHE 132
Query: 115 KANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 171
+I+RDLK N+LL + D K++DFG +K+ +G+ + + T GT Y APE
Sbjct: 133 NG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLC-GTPTYLAPE 186
Query: 172 ---YAMSGKLTLKSDIYSFGVVL 191
+ D +S GV+L
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-16
Identities = 58/189 (30%), Positives = 92/189 (48%), Gaps = 26/189 (13%)
Query: 20 DQLVAIKQLNHEGLQGHQEF-------IVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 72
++VA+K++ + E I E+ +L LHH N+V+LI S LV+E
Sbjct: 45 GRIVALKRIRLD-----AEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99
Query: 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL 132
+M L+ L + + L + RG+ + H +++RDLK N+L+
Sbjct: 100 FMEK-DLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLI 152
Query: 133 DNDFNPKLSDFGLAKL--GPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGV 189
++D KL+DFGLA+ PV TH V+ T Y AP+ M K + DI+S G
Sbjct: 153 NSDGALKLADFGLARAFGIPVRSYTH---EVV-TLWYRAPDVLMGSKKYSTSVDIWSIGC 208
Query: 190 VLLELITGR 198
+ E+ITG+
Sbjct: 209 IFAEMITGK 217
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 57/201 (28%), Positives = 85/201 (42%), Gaps = 29/201 (14%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQE---FIVEVLMLSLLHHDNLVTLIGYCTSGD 65
G V L ++ A+K L+ + + F E +++ + +V L Y D
Sbjct: 83 GEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDD 141
Query: 66 QRL-LVYEYMPMGSLEDHL--YDLEPDQEPLSWNTRMKIA-VGAARGLEYLHCKANPPVI 121
+ L +V EYMP G L + + YD+ R A V A L+ +H I
Sbjct: 142 RYLYMVMEYMPGGDLVNLMSNYDVPEKW------ARFYTAEVVLA--LDAIHSMG---FI 190
Query: 122 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS----GK 177
+RD+K N+LLD + KL+DFG T V GT Y +PE S G
Sbjct: 191 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGY 249
Query: 178 LTLKSDIYSFGVVLLELITGR 198
+ D +S GV L E++ G
Sbjct: 250 YGRECDWWSVGVFLYEMLVGD 270
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 2e-16
Identities = 51/187 (27%), Positives = 87/187 (46%), Gaps = 22/187 (11%)
Query: 20 DQLVAIKQLNHEGLQGHQE-----FIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74
+ A+K++ L+ E I E+ +L L H N+V L + + +LV+E++
Sbjct: 26 GETFALKKIR---LEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82
Query: 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN 134
L+ L + L T + G+ Y H + V++RDLK N+L++
Sbjct: 83 DQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINR 135
Query: 135 DFNPKLSDFGLAKL--GPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVL 191
+ K++DFGLA+ PV TH ++ T Y AP+ M K + DI+S G +
Sbjct: 136 EGELKIADFGLARAFGIPVRKYTH---EIV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIF 191
Query: 192 LELITGR 198
E++ G
Sbjct: 192 AEMVNGT 198
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-16
Identities = 47/192 (24%), Positives = 73/192 (38%), Gaps = 36/192 (18%)
Query: 21 QLVAIKQLNHEGLQGHQEFIV--EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78
+LVA+K + V E++ L H N+V + ++ EY G
Sbjct: 46 ELVAVKYIERGAAIDEN---VQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGE 102
Query: 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAAR--------GLEYLHCKANPPVIYRDLKSANI 130
L + + + R AR G+ Y H + +RDLK N
Sbjct: 103 LYERICN----------AGRFSEDE--ARFFFQQLLSGVSYCHSMQ---ICHRDLKLENT 147
Query: 131 LLDNDFNP--KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL--TLKSDIYS 186
LLD P K+ DFG +K + + V GT Y APE + + +D++S
Sbjct: 148 LLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPAYIAPE-VLLRQEYDGKIADVWS 203
Query: 187 FGVVLLELITGR 198
GV L ++ G
Sbjct: 204 CGVTLYVMLVGA 215
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-16
Identities = 60/187 (32%), Positives = 85/187 (45%), Gaps = 21/187 (11%)
Query: 20 DQLVAIKQLNHEGLQGHQEF---IVE--VLMLSLLHHDNLVTLIGYCTSGDQRL-LVYEY 73
+Q AIK L + + + +VE VL L+ H L + + L V EY
Sbjct: 42 NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-EHPFLTHMF-CTFQTKENLFFVMEY 99
Query: 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEYLHCKANPPVIYRDLKSANILL 132
+ G L H+ R A GL++LH K ++YRDLK NILL
Sbjct: 100 LNGGDLMYHIQSCHKFDLS-----RATFYAAEIILGLQFLHSKG---IVYRDLKLDNILL 151
Query: 133 DNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPEYAMSGKLTLKSDIYSFGVVL 191
D D + K++DFG+ K +GD T GT Y APE + K D +SFGV+L
Sbjct: 152 DKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLL 208
Query: 192 LELITGR 198
E++ G+
Sbjct: 209 YEMLIGQ 215
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 3e-16
Identities = 52/203 (25%), Positives = 81/203 (39%), Gaps = 33/203 (16%)
Query: 14 GLVWLC-----DQLVAIKQLN------HEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 62
+V C + A K + +E EV +L + H N++TL
Sbjct: 19 AIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE 78
Query: 63 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR----GLEYLHCKANP 118
+ +L+ E + G L D L + E E A + G+ YLH K
Sbjct: 79 NKTDVVLILELVSGGELFDFLAEKESLTE--------DEATQFLKQILDGVHYLHSKR-- 128
Query: 119 PVIYRDLKSANILLDNDFNP----KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 174
+ + DLK NI+L + P KL DFG+A + GT + APE
Sbjct: 129 -IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEFKNIF-GTPEFVAPEIVN 184
Query: 175 SGKLTLKSDIYSFGVVLLELITG 197
L L++D++S GV+ L++G
Sbjct: 185 YEPLGLEADMWSIGVITYILLSG 207
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-16
Identities = 50/202 (24%), Positives = 82/202 (40%), Gaps = 36/202 (17%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIVEV-LMLSLLHHDNLVTLIGYCTSGDQR 67
V C Q A+K + + EV ++ H N++ LI + D+
Sbjct: 27 ARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF 86
Query: 68 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTR-----MKIAVGAARGLEYLHCKANPPVIY 122
LV+E M GS+ H+ + +N ++ A L++LH K + +
Sbjct: 87 YLVFEKMRGGSILSHI------HKRRHFNELEASVVVQDVASA---LDFLHNKG---IAH 134
Query: 123 RDLKSANILL---DNDFNPKLSDFGLAK-LGPVGDNTHVSTRVM----GTYGYCAPE--- 171
RDLK NIL + K+ DF L + GD + +ST + G+ Y APE
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 172 --YAMSGKLTLKSDIYSFGVVL 191
+ + D++S GV+L
Sbjct: 195 AFSEEASIYDKRCDLWSLGVIL 216
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-16
Identities = 49/148 (33%), Positives = 64/148 (43%), Gaps = 15/148 (10%)
Query: 54 LVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEY 111
LV L + +L V +Y+ G L HL EP R + A A L Y
Sbjct: 101 LVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP-----RARFYAAEIASALGY 154
Query: 112 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAP 170
LH ++YRDLK NILLD+ + L+DFGL K ++T T GT Y AP
Sbjct: 155 LHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEYLAP 208
Query: 171 EYAMSGKLTLKSDIYSFGVVLLELITGR 198
E D + G VL E++ G
Sbjct: 209 EVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-16
Identities = 47/191 (24%), Positives = 77/191 (40%), Gaps = 29/191 (15%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIVEV-LMLSLLHHDNLVTLIGYCTSGDQR 67
+ C +Q A+K ++ Q+ E+ + H N+V L
Sbjct: 25 SICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVFHDQLHT 81
Query: 68 LLVYEYMPMGSLEDHLYDL----EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 123
LV E + G L + + E + + M+ V A + ++H V++R
Sbjct: 82 FLVMELLNGGELFERIKKKKHFSETEASYI-----MRKLVSA---VSHMHDVG---VVHR 130
Query: 124 DLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTL 180
DLK N+L +++ K+ DFG A+L P DN + T T Y APE
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKP-PDNQPLKTPC-FTLHYAAPELLNQNGYDE 188
Query: 181 KSDIYSFGVVL 191
D++S GV+L
Sbjct: 189 SCDLWSLGVIL 199
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 5e-16
Identities = 48/148 (32%), Positives = 65/148 (43%), Gaps = 15/148 (10%)
Query: 54 LVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEY 111
L L C RL V E++ G L H+ E R + A L +
Sbjct: 86 LTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA-----RARFYAAEIISALMF 139
Query: 112 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAP 170
LH K +IYRDLK N+LLD++ + KL+DFG+ K G T T GT Y AP
Sbjct: 140 LHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDYIAP 193
Query: 171 EYAMSGKLTLKSDIYSFGVVLLELITGR 198
E D ++ GV+L E++ G
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 5e-16
Identities = 42/166 (25%), Positives = 74/166 (44%), Gaps = 25/166 (15%)
Query: 42 EVLMLSLLHHDNLVTLIGYCTSGDQRL------LVYEYMPMGSLEDHLYDL-EPDQEPLS 94
E++++ ++H N+++L+ T LV E M +L + Q L
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA--------NLCQVIQMELD 162
Query: 95 WNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154
+ G+++LH A +I+RDLK +NI++ +D K+ DFGLA+
Sbjct: 163 HERMSYLLYQMLCGIKHLH-SAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 219
Query: 155 T--HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 198
+V TR Y APE + DI+S G ++ E++ +
Sbjct: 220 MTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 5e-16
Identities = 48/148 (32%), Positives = 69/148 (46%), Gaps = 15/148 (10%)
Query: 54 LVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEY 111
L L C RL V EY+ G L H+ + +EP A A GL +
Sbjct: 83 LTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-----HAVFYAAEIAIGLFF 136
Query: 112 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAP 170
L K +IYRDLK N++LD++ + K++DFG+ K T T+ GT Y AP
Sbjct: 137 LQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIAP 190
Query: 171 EYAMSGKLTLKSDIYSFGVVLLELITGR 198
E D ++FGV+L E++ G+
Sbjct: 191 EIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 6e-16
Identities = 50/203 (24%), Positives = 80/203 (39%), Gaps = 33/203 (16%)
Query: 14 GLVWLC-----DQLVAIKQLN------HEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 62
+V C A K + ++ EV +L + H N++TL
Sbjct: 25 AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE 84
Query: 63 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR----GLEYLHCKANP 118
+ +L+ E + G L D L + E E + A + G+ YLH
Sbjct: 85 NKTDVILILELVAGGELFDFLAEKESLTE--------EEATEFLKQILNGVYYLHSLQ-- 134
Query: 119 PVIYRDLKSANILLDNDFNP----KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 174
+ + DLK NI+L + P K+ DFGLA + GT + APE
Sbjct: 135 -IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNIF-GTPEFVAPEIVN 190
Query: 175 SGKLTLKSDIYSFGVVLLELITG 197
L L++D++S GV+ L++G
Sbjct: 191 YEPLGLEADMWSIGVITYILLSG 213
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 7e-16
Identities = 33/200 (16%), Positives = 77/200 (38%), Gaps = 35/200 (17%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 68
G+V C + K + +G E+ +L++ H N++ L S ++ +
Sbjct: 19 GIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELV 77
Query: 69 LVYEYMPMGSLEDHLYDL-----EPDQEPLSWNTRMKIAVGAAR----GLEYLHCKANPP 119
+++E++ + + + E + V L++LH
Sbjct: 78 MIFEFISGLDIFERINTSAFELNERE------------IVSYVHQVCEALQFLHSHN--- 122
Query: 120 VIYRDLKSANILLDNDFNP--KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK 177
+ + D++ NI+ + K+ +FG A+ + + Y APE
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ--LKPGDNFRLLF-TAPEYYAPEVHQHDV 179
Query: 178 LTLKSDIYSFGVVLLELITG 197
++ +D++S G ++ L++G
Sbjct: 180 VSTATDMWSLGTLVYVLLSG 199
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 77.0 bits (189), Expect = 7e-16
Identities = 56/187 (29%), Positives = 82/187 (43%), Gaps = 21/187 (11%)
Query: 20 DQLVAIKQLNHEGLQGHQEFIVEVLM------LSLLHHDNLVTLIGYCTSGDQRL-LVYE 72
D+L A+K L + + + VE M L L C RL V E
Sbjct: 366 DELYAVKILKKDVVIQDDD--VECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVME 422
Query: 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL 132
Y+ G L H+ + +EP A A GL +L K +IYRDLK N++L
Sbjct: 423 YVNGGDLMYHIQQVGRFKEPH---AVFYAA-EIAIGLFFLQSKG---IIYRDLKLDNVML 475
Query: 133 DNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPEYAMSGKLTLKSDIYSFGVVL 191
D++ + K++DFG+ K T T+ GT Y APE D ++FGV+L
Sbjct: 476 DSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 532
Query: 192 LELITGR 198
E++ G+
Sbjct: 533 YEMLAGQ 539
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 9e-16
Identities = 42/175 (24%), Positives = 72/175 (41%), Gaps = 43/175 (24%)
Query: 42 EVLMLSLLHHDNLVTLIGYCTSGDQRL------LVYEYMP--------MGSLEDH----L 83
E++++ ++H N++ L+ T +V E M M + L
Sbjct: 74 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL 133
Query: 84 YDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 143
Y + G+++LH A +I+RDLK +NI++ +D K+ DF
Sbjct: 134 YQM-------------------LCGIKHLH-SAG--IIHRDLKPSNIVVKSDCTLKILDF 171
Query: 144 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 198
GLA + + T + T Y APE + DI+S G ++ E+I G
Sbjct: 172 GLA---RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 49/147 (33%), Positives = 69/147 (46%), Gaps = 13/147 (8%)
Query: 54 LVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 112
LV L C + RL V EY+ G L H+ E R A + L YL
Sbjct: 72 LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH---ARFYSAE-ISLALNYL 126
Query: 113 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPE 171
H + +IYRDLK N+LLD++ + KL+D+G+ K G +T T GT Y APE
Sbjct: 127 HERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPE 180
Query: 172 YAMSGKLTLKSDIYSFGVVLLELITGR 198
D ++ GV++ E++ GR
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-15
Identities = 29/193 (15%), Positives = 54/193 (27%), Gaps = 46/193 (23%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD 65
W D+ VA+ ++ +G+ QE + L LS + + ++ +
Sbjct: 45 LQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA 104
Query: 66 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 125
L+V E++ GSL++ S ++ A + H V
Sbjct: 105 GGLVVAEWIRGGSLQEVA------DTSPSPVGAIRAMQSLAAAADAAHRA---GVALSID 155
Query: 126 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIY 185
+ + + D G L + DI
Sbjct: 156 HPSRVRVSID--------GDVVLA--------------YPATMPDA-------NPQDDIR 186
Query: 186 SFGVVLLELITGR 198
G L L+ R
Sbjct: 187 GIGASLYALLVNR 199
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 3e-15
Identities = 52/213 (24%), Positives = 82/213 (38%), Gaps = 45/213 (21%)
Query: 14 GLVWLC----DQLVAIKQLNHEGLQGHQEFIV-----------EVLMLSLLHHDNLVTLI 58
G V VAIK++ + G I+ E+ +L+ HH N++ L
Sbjct: 36 GAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLR 95
Query: 59 GYCTSGDQRL-----LVYEYMPMGSLEDHLYDLE----PDQEPLSWNTRMK-IAVGAARG 108
++ LV E M DL + +S ++ G
Sbjct: 96 DIFVHFEEPAMHKLYLVTELMR--------TDLAQVIHDQRIVIS-PQHIQYFMYHILLG 146
Query: 109 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT--HVSTRVMGTYG 166
L LH +A V++RDL NILL ++ + + DF LA+ N +V+ R
Sbjct: 147 LHVLH-EAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW----- 198
Query: 167 YCAPEYAMS-GKLTLKSDIYSFGVVLLELITGR 198
Y APE M T D++S G V+ E+ +
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 4e-15
Identities = 49/147 (33%), Positives = 69/147 (46%), Gaps = 13/147 (8%)
Query: 54 LVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 112
LV L C + RL V EY+ G L H+ E R A + L YL
Sbjct: 115 LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH---ARFYSAE-ISLALNYL 169
Query: 113 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPE 171
H + +IYRDLK N+LLD++ + KL+D+G+ K G +T T GT Y APE
Sbjct: 170 HERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPE 223
Query: 172 YAMSGKLTLKSDIYSFGVVLLELITGR 198
D ++ GV++ E++ GR
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 4e-15
Identities = 46/197 (23%), Positives = 76/197 (38%), Gaps = 38/197 (19%)
Query: 20 DQLVAIKQLNHEGLQGHQEF-------IVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 72
++ VAIK++ E E I EV +L L H N++ L + L++E
Sbjct: 59 NETVAIKRIRLE-----HEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFE 113
Query: 73 YMPMGSLEDHLYDLEP---DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 129
Y DL+ +S G+ + H + ++RDLK N
Sbjct: 114 YAEN--------DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQN 162
Query: 130 ILLDNDFNP-----KLSDFGLAKL--GPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLK 181
+LL K+ DFGLA+ P+ TH ++ T Y PE + + +
Sbjct: 163 LLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EII-TLWYRPPEILLGSRHYSTS 218
Query: 182 SDIYSFGVVLLELITGR 198
DI+S + E++
Sbjct: 219 VDIWSIACIWAEMLMKT 235
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 7e-15
Identities = 46/190 (24%), Positives = 81/190 (42%), Gaps = 26/190 (13%)
Query: 23 VAIKQLN------HEGLQGHQEFIVEVLMLSLLH----HDNLVTLIGYCTSGDQRLLVYE 72
VAIK + L +EV +L + H ++ L+ + + + +LV E
Sbjct: 59 VAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLE 118
Query: 73 Y-MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANIL 131
+P L D++ + P E S R +++ H + V++RD+K NIL
Sbjct: 119 RPLPAQDLFDYITEKGPLGEGPS---R-CFFGQVVAAIQHCHSRG---VVHRDIKDENIL 171
Query: 132 LDNDFNP-KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL--TLKSDIYSFG 188
+D KL DFG L + + GT Y PE+ +S L + ++S G
Sbjct: 172 IDLRRGCAKLIDFGSGALLH---DEPYTDFD-GTRVYSPPEW-ISRHQYHALPATVWSLG 226
Query: 189 VVLLELITGR 198
++L +++ G
Sbjct: 227 ILLYDMVCGD 236
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 8e-15
Identities = 42/172 (24%), Positives = 74/172 (43%), Gaps = 26/172 (15%)
Query: 42 EVLMLSLLHHDNLVTLIGYCTSGDQRL--------LVYEYMPMGSLEDHLYDL----EPD 89
E+ +L LL H+N+V LI C + LV+++ +H DL
Sbjct: 66 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC------EH--DLAGLLSNV 117
Query: 90 QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL- 148
+ + ++ GL Y+H +++RD+K+AN+L+ D KL+DFGLA+
Sbjct: 118 LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAF 174
Query: 149 -GPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 198
+ T + T Y PE + + D++ G ++ E+ T
Sbjct: 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 2e-14
Identities = 49/193 (25%), Positives = 81/193 (41%), Gaps = 24/193 (12%)
Query: 20 DQLVAIKQ--LNHEGLQGHQEF----IVEV---LMLSLLHHDNLVTLI----GYCTSGDQ 66
VA+K + + G G + EV L H N+V L+ T +
Sbjct: 34 GHFVALKSVRVPNGG-GGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREI 92
Query: 67 RL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 125
++ LV+E++ L +L L T + RGL++LH +++RDL
Sbjct: 93 KVTLVFEHVDQ-DLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDL 146
Query: 126 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIY 185
K NIL+ + KL+DFGLA+ ++ V+ T Y APE + D++
Sbjct: 147 KPENILVTSGGTVKLADFGLAR--IYSYQMALTPVVV-TLWYRAPEVLLQSTYATPVDMW 203
Query: 186 SFGVVLLELITGR 198
S G + E+ +
Sbjct: 204 SVGCIFAEMFRRK 216
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 44/196 (22%), Positives = 72/196 (36%), Gaps = 37/196 (18%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIVEV-LMLSLLHHDNLVTLIGYCTSGDQR 67
G V C Q A+K L EV ++V ++ +
Sbjct: 43 GKVLECFHRRTGQKCALKLLYDSPKARQ-----EVDHHWQASGGPHIVCILDVYENMHHG 97
Query: 68 ----LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTR-----MKIAVGAARGLEYLHCKANP 118
L++ E M G L + + + ++ R M+ A +++LH
Sbjct: 98 KRCLLIIMECMEGGELFSRIQE----RGDQAFTEREAAEIMRDIGTA---IQFLHSHN-- 148
Query: 119 PVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS 175
+ +RD+K N+L + D KL+DFG AK + T T Y APE
Sbjct: 149 -IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK---ETTQNALQTPC-YTPYYVAPEVLGP 203
Query: 176 GKLTLKSDIYSFGVVL 191
K D++S GV++
Sbjct: 204 EKYDKSCDMWSLGVIM 219
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 3e-14
Identities = 47/221 (21%), Positives = 82/221 (37%), Gaps = 57/221 (25%)
Query: 21 QLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIGYCTSGDQRL----------- 68
+ A+K++ LQ + E+ ++ +L H N++ L+ Y +
Sbjct: 33 KRFALKKV----LQ-DPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHN 87
Query: 69 ---------------------------LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI 101
++ EY+P +L L + N
Sbjct: 88 KLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIY 146
Query: 102 AVGAARGLEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAK-LGPVGDNTH-VS 158
R + ++H + +RD+K N+L++ D KL DFG AK L P + +
Sbjct: 147 IYQLFRAVGFIHS-LG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYIC 203
Query: 159 TRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 198
+R + Y APE + T D++S G V ELI G+
Sbjct: 204 SR----F-YRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-14
Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 21/164 (12%)
Query: 42 EVLMLSLLHHDNLVTLIGYCTSGDQRL------LVYEYMPMGSLEDHLYDLEPDQEPLSW 95
E+ +L + H+N++ L+ T + LV +M L L + L
Sbjct: 74 ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHE-KLGE 127
Query: 96 NTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155
+ + +GL Y+H A +I+RDLK N+ ++ D K+ DFGLA+
Sbjct: 128 DRIQFLVYQMLKGLRYIH-AAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG 184
Query: 156 HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGR 198
+V TR Y APE ++ + T DI+S G ++ E+ITG+
Sbjct: 185 YVVTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-14
Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 57/220 (25%)
Query: 14 GLVW-----LCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 68
GLV+ CD+ VAIK++ Q + + E+ ++ L HDN+V + +L
Sbjct: 25 GLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84
Query: 69 --------------LVYEYMP--------MGSL-EDH----LYDLEPDQEPLSWNTRMKI 101
+V EYM G L E+H +Y L
Sbjct: 85 TDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQL--------------- 129
Query: 102 AVGAARGLEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAK-LGPVGDNTHVST 159
RGL+Y+H AN V++RDLK AN+ ++ D K+ DFGLA+ + P + +
Sbjct: 130 ----LRGLKYIH-SAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 160 RVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 198
+ T Y +P +S T D+++ G + E++TG+
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-13
Identities = 47/196 (23%), Positives = 75/196 (38%), Gaps = 36/196 (18%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIVEV-LMLSLLHHDNLVTLIG-YCTSGDQ 66
G V + A+K L + EV L ++V ++ Y
Sbjct: 76 GKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAG 130
Query: 67 R---LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTR-----MKIAVGAARGLEYLHCKANP 118
R L+V E + G L + D + ++ R MK A ++YLH
Sbjct: 131 RKCLLIVMECLDGGELFSRIQD----RGDQAFTEREASEIMKSIGEA---IQYLHSIN-- 181
Query: 119 PVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS 175
+ +RD+K N+L + KL+DFG AK + ++T T Y APE
Sbjct: 182 -IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLTTPC-YTPYYVAPEVLGP 237
Query: 176 GKLTLKSDIYSFGVVL 191
K D++S GV++
Sbjct: 238 EKYDKSCDMWSLGVIM 253
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 56/201 (27%), Positives = 90/201 (44%), Gaps = 47/201 (23%)
Query: 21 QLVAIKQLN---HEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL-----LVYE 72
VAIK+++ H+ Q + E+ +L H+N++ + + +V +
Sbjct: 53 VRVAIKKISPFEHQTYC--QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQD 110
Query: 73 YMP--------MGSL-EDH----LYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 119
M L DH LY + RGL+Y+H AN
Sbjct: 111 LMETDLYKLLKTQHLSNDHICYFLYQI-------------------LRGLKYIH-SAN-- 148
Query: 120 VIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL 178
V++RDLK +N+LL+ + K+ DFGLA+ P D+T T + T Y APE ++ K
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 179 -TLKSDIYSFGVVLLELITGR 198
T DI+S G +L E+++ R
Sbjct: 209 YTKSIDIWSVGCILAEMLSNR 229
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 3e-13
Identities = 46/165 (27%), Positives = 71/165 (43%), Gaps = 24/165 (14%)
Query: 44 LMLSLLHHDNLVTLI----GYCTSGDQRL-LVYEYMPMGSLEDHLYDLEP--DQEPLSWN 96
L H N+V L T + +L LV+E++ D DL D+ P
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV------DQ--DLTTYLDKVPEPGV 117
Query: 97 TRMKIAVGAA---RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 153
I RGL++LH V++RDLK NIL+ + KL+DFGLA+
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR--IYSF 172
Query: 154 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 198
+++ V+ T Y APE + D++S G + E+ +
Sbjct: 173 QMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 3e-13
Identities = 41/195 (21%), Positives = 81/195 (41%), Gaps = 37/195 (18%)
Query: 20 DQLVAIKQLNHEGLQGHQEFIVEVLML-SLLHHDNLVTLIGYCTSGDQR--LLVYEYMPM 76
++ V +K L ++ E+ +L +L N++TL R LV+E++
Sbjct: 61 NEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 117
Query: 77 GSLEDHLYDLEPDQ------EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANI 130
+ L E L + L+Y H +++RD+K N+
Sbjct: 118 TDFKQLYQTLTDYDIRFYMYEIL-------------KALDYCHSMG---IMHRDVKPHNV 161
Query: 131 LLDNDF-NPKLSDFGLAKLGPVGD--NTHVSTRVMGTYGYCAPEYAMSGKLTLKS-DIYS 186
++D++ +L D+GLA+ G N V++R + PE + ++ S D++S
Sbjct: 162 MIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGPELLVDYQMYDYSLDMWS 216
Query: 187 FGVVLLELITGRKAM 201
G +L +I ++
Sbjct: 217 LGCMLASMIFRKEPF 231
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-13
Identities = 45/176 (25%), Positives = 75/176 (42%), Gaps = 46/176 (26%)
Query: 42 EVLMLSLLHHDNLVTLIGYCTSGDQRL------LVYEYMP--------MGSLEDH----L 83
E+L+L + H+N++ L+ T LV +M + E+ +
Sbjct: 73 ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLV 132
Query: 84 YDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 143
Y + +GL+Y+H A V++RDLK N+ ++ D K+ DF
Sbjct: 133 YQML-------------------KGLKYIH-SAG--VVHRDLKPGNLAVNEDCELKILDF 170
Query: 144 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGR 198
GLA+ +V TR Y APE +S DI+S G ++ E++TG+
Sbjct: 171 GLARHADAEMTGYVVTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-13
Identities = 47/164 (28%), Positives = 78/164 (47%), Gaps = 21/164 (12%)
Query: 42 EVLMLSLLHHDNLVTLIGYCTSGDQRL------LVYEYMPMGSLEDHLYDLEPDQEPLSW 95
E+ +L + H+N++ L+ T LV M L ++ Q L+
Sbjct: 78 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQ-KLTD 131
Query: 96 NTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155
+ + RGL+Y+H A+ +I+RDLK +N+ ++ D K+ DFGLA+
Sbjct: 132 DHVQFLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG 188
Query: 156 HVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 198
+V+TR Y APE ++ DI+S G ++ EL+TGR
Sbjct: 189 YVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 6e-13
Identities = 47/218 (21%), Positives = 84/218 (38%), Gaps = 55/218 (25%)
Query: 14 GLVWLC-----DQLVAIKQLN-HEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 67
G+V ++VAIK++ + + E+ +L H+N++T+
Sbjct: 25 GVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFE 84
Query: 68 L-----LVYEYMP--------MGSL-EDH----LYDLEPDQEPLSWNTRMKIAVGAARGL 109
++ E M L +DH +Y R +
Sbjct: 85 NFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQT-------------------LRAV 125
Query: 110 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA----KLGPVGDNTHVSTRVMGTY 165
+ LH +N VI+RDLK +N+L++++ + K+ DFGLA + M +
Sbjct: 126 KVLH-GSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 166 ----GYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 198
Y APE ++ + D++S G +L EL R
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 4e-11
Identities = 62/275 (22%), Positives = 97/275 (35%), Gaps = 87/275 (31%)
Query: 14 GLVWLC-----DQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 66
G V+L ++ VAIK++N E L + + E+ +L+ L D ++ L D
Sbjct: 40 GYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL 99
Query: 67 RL-----LVYEYM----------PMGSLEDH----LYDLEPDQEPLSWNTRMKIAVGAAR 107
+V E P+ E+H LY+L L
Sbjct: 100 LKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNL------L-------------L 140
Query: 108 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT------------ 155
G ++H ++ +I+RDLK AN LL+ D + K+ DFGLA+ +T
Sbjct: 141 GENFIH-ESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 156 -------------HVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAM 201
HV TR Y APE + + T DI+S G + EL+ ++
Sbjct: 198 GPHNKNLKKQLTSHVVTR-----WYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252
Query: 202 DLS--------KGQGEQNLVSWSRPFLKDQKKFVH 228
G L +K
Sbjct: 253 INDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRD 287
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 51/249 (20%), Positives = 87/249 (34%), Gaps = 78/249 (31%)
Query: 14 GLVWLC-----DQLVAIKQLN----HEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG 64
G V ++VAIK++ + + E+ +L+ L+HD++V ++
Sbjct: 67 GHVCEAYDKLEKRVVAIKKILRVFEDLIDC--KRILREIAILNRLNHDHVVKVLDIVIPK 124
Query: 65 DQRL-----LVYEYMPM---------GSL-EDH----LYDLEPDQEPLSWNTRMKIAVGA 105
D +V E L E H LY+L
Sbjct: 125 DVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNL------------------- 165
Query: 106 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 165
G++Y+H A +++RDLK AN L++ D + K+ DFGLA+ +N + +
Sbjct: 166 LVGVKYVH-SAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222
Query: 166 G-------------------------YCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRK 199
Y APE + + T D++S G + EL+ K
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282
Query: 200 AMDLSKGQG 208
Sbjct: 283 ENVAYHADR 291
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 43/214 (20%), Positives = 87/214 (40%), Gaps = 43/214 (20%)
Query: 14 GLVWLC-----DQLVAIKQL-NHEGLQGHQEFIVEVLMLSLLH-----------HDNLVT 56
VWL + VA+K + + + E+ +L ++ ++++
Sbjct: 33 STVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90
Query: 57 LIGY----CTSGDQRLLVYEYMPMGSLEDHLYDL--EPDQEPLSWNTRMKIAVGAARGLE 110
L+ + +G ++V+E +G +L L + + + +I+ GL+
Sbjct: 91 LLDHFNHKGPNGVHVVMVFE--VLGE---NLLALIKKYEHRGIPLIYVKQISKQLLLGLD 145
Query: 111 YLHCKANPPVIYRDLKSANILLD------NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 164
Y+H + +I+ D+K N+L++ N K++D G A + TR
Sbjct: 146 YMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE--- 200
Query: 165 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 198
Y +PE + +DI+S ++ ELITG
Sbjct: 201 --YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-09
Identities = 45/193 (23%), Positives = 82/193 (42%), Gaps = 58/193 (30%)
Query: 42 EVLMLSLLH-HDNLVTLIGYCTSGDQR--LLVYEYMP--------MGSLED-H----LYD 85
E+++L+ L H+N+V L+ + + R LV++YM LE H +Y
Sbjct: 58 EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQ 117
Query: 86 LEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 145
L + ++YLH +++RD+K +NILL+ + + K++DFGL
Sbjct: 118 L-------------------IKVIKYLH-SGG--LLHRDMKPSNILLNAECHVKVADFGL 155
Query: 146 A---------------KLGPVGDNTHVSTRVMGTY----GYCAPEYAMSGKL-TLKSDIY 185
+ + +N ++ Y Y APE + T D++
Sbjct: 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMW 215
Query: 186 SFGVVLLELITGR 198
S G +L E++ G+
Sbjct: 216 SLGCILGEILCGK 228
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 6e-08
Identities = 49/197 (24%), Positives = 82/197 (41%), Gaps = 40/197 (20%)
Query: 20 DQLVAIKQL-NHEGLQGHQEFIVEVLMLSLLH-HD-----NLVTLIGY-------CTSGD 65
Q VA+K + N + H++ E+ +L L D N++ ++ C
Sbjct: 122 HQHVALKMVRNEKRF--HRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC---- 175
Query: 66 QRLLVYEYMPMGSLEDHLYDL--EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 123
+ +E L +LY+L + + S K A + L+ LH +I+
Sbjct: 176 ---MTFE-----LLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHC 224
Query: 124 DLKSANILLDNDFNP--KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK 181
DLK NILL K+ DFG + T++ +R Y APE + + +
Sbjct: 225 DLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-----YRAPEVILGARYGMP 279
Query: 182 SDIYSFGVVLLELITGR 198
D++S G +L EL+TG
Sbjct: 280 IDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 53/197 (26%), Positives = 81/197 (41%), Gaps = 38/197 (19%)
Query: 20 DQLVAIKQL-NHEGLQGHQEFIVEVLMLSLL-HHD-----NLVTLIGY-------CTSGD 65
+ VAIK + N + + +EV +L L+ HD +V L + C
Sbjct: 79 QEWVAIKIIKNKKAF--LNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC---- 132
Query: 66 QRLLVYEYMPMGSLEDHLYDL--EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 123
LV+E L +LYDL + +S N K A L +L +I+
Sbjct: 133 ---LVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHC 183
Query: 124 DLKSANILLDNDFNP--KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK 181
DLK NILL N K+ DFG + ++ +R Y +PE + L
Sbjct: 184 DLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YRSPEVLLGMPYDLA 238
Query: 182 SDIYSFGVVLLELITGR 198
D++S G +L+E+ TG
Sbjct: 239 IDMWSLGCILVEMHTGE 255
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 1e-07
Identities = 36/180 (20%), Positives = 53/180 (29%), Gaps = 61/180 (33%)
Query: 69 LVYEYMPMG-SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 127
+V+E +G L + PL KI +GL+YLH K +I+ D+K
Sbjct: 122 MVFE--VLGHHLLKWIIKSNYQGLPLP--CVKKIIQQVLQGLDYLHTKCR--IIHTDIKP 175
Query: 128 ANILL-------------------------------------------------DNDFNP 138
NILL
Sbjct: 176 ENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKV 235
Query: 139 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 198
K++D G A + TR Y + E + +DI+S + EL TG
Sbjct: 236 KIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-07
Identities = 33/153 (21%), Positives = 52/153 (33%), Gaps = 35/153 (22%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIVEV-LMLSLLHHDNLVTLIG-YCTSGDQ 66
G V + A+K L + EV L ++V ++ Y
Sbjct: 32 GKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAG 86
Query: 67 RLLVY---EYMPMGSLED------HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 117
R + E + G L E + + MK A ++YLH
Sbjct: 87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI-----MKSIGEA---IQYLHSIN- 137
Query: 118 PPVIYRDLKSANILL---DNDFNPKLSDFGLAK 147
+ +RD+K N+L + KL+DFG AK
Sbjct: 138 --IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 3e-07
Identities = 49/191 (25%), Positives = 76/191 (39%), Gaps = 24/191 (12%)
Query: 21 QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHH-DNLVTLIGYCTSGDQRLLVYEYMPMG-S 78
+ VAIK + + +E L D + + + G +V E + G S
Sbjct: 35 EYVAIKLEPMK--SRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL--GPS 90
Query: 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 138
LED L+DL S T + IA+ +EY+H K +IYRD+K N L+ N
Sbjct: 91 LED-LFDLCDRT--FSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNK 144
Query: 139 K-----LSDFGLAKL-GPVGDNTHVSTR----VMGTYGYCAPEYAMSGK-LTLKSDIYSF 187
+ DF LAK H+ R + GT Y GK + + D+ +
Sbjct: 145 TQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY-MSINTHLGKEQSRRDDLEAL 203
Query: 188 GVVLLELITGR 198
G + + + G
Sbjct: 204 GHMFMYFLRGS 214
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 49.6 bits (118), Expect = 6e-07
Identities = 48/189 (25%), Positives = 82/189 (43%), Gaps = 20/189 (10%)
Query: 20 DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYMPMGS 78
++ VAIK N + H + + E + +L + + + GD +LV + + S
Sbjct: 32 NEEVAIKLENVK--TKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGP-S 88
Query: 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 138
LED L++ LS T + +A +E++H K+ ++RD+K N L+
Sbjct: 89 LED-LFNFCS--RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRA 142
Query: 139 K---LSDFGLAKL-GPVGDNTHVSTR----VMGTYGYCAPEYAMSGK-LTLKSDIYSFGV 189
+ DFGLAK + H+ R + GT Y A G + + D+ S G
Sbjct: 143 NQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-ASVNTHLGIEQSRRDDLESLGY 201
Query: 190 VLLELITGR 198
VL+ + G
Sbjct: 202 VLMYFLRGS 210
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-06
Identities = 43/191 (22%), Positives = 72/191 (37%), Gaps = 22/191 (11%)
Query: 20 DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHH-DNLVTLIGYCTSGDQRLLVYEYMPMGS 78
+Q VAIK + E LL + + + G +LV + + S
Sbjct: 35 NQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGP-S 91
Query: 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 138
LED L DL + S T A ++ +H K+ ++YRD+K N L+ +
Sbjct: 92 LED-LLDLCGRK--FSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSK 145
Query: 139 K-----LSDFGLAKL-GPVGDNTHVSTR----VMGTYGYCAPEYAMSGK-LTLKSDIYSF 187
+ DFG+ K H+ R + GT Y G+ + + D+ +
Sbjct: 146 NANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY-MSINTHLGREQSRRDDLEAL 204
Query: 188 GVVLLELITGR 198
G V + + G
Sbjct: 205 GHVFMYFLRGS 215
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 49/190 (25%), Positives = 79/190 (41%), Gaps = 22/190 (11%)
Query: 20 DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHH-DNLVTLIGYCTSGDQRLLVYEYMPMG- 77
+ VAIK + H + +E + ++ + T+ GD ++V E + G
Sbjct: 34 GEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL--GP 89
Query: 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 137
SLED L++ + S T + +A +EY+H K I+RD+K N L+
Sbjct: 90 SLED-LFNFCSRK--FSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKK 143
Query: 138 PK---LSDFGLAKL-GPVGDNTHVSTR----VMGTYGYCAPEYAMSGK-LTLKSDIYSFG 188
+ DFGLAK + H+ R + GT Y A G + + D+ S G
Sbjct: 144 GNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY-ASINTHLGIEQSRRDDLESLG 202
Query: 189 VVLLELITGR 198
VL+ G
Sbjct: 203 YVLMYFNLGS 212
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 4e-06
Identities = 28/142 (19%), Positives = 55/142 (38%), Gaps = 21/142 (14%)
Query: 20 DQLVAIK------QLNHEGL----QGHQEFIVEVLMLSLLHHDNLVTLIGY-CTSGDQRL 68
Q ++K +L +E + + L + T +G+ R
Sbjct: 75 KQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRF 134
Query: 69 LVYEYMPMG-SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 127
LV + G SL+ D+ P LS + +++A LE+LH ++ ++ +
Sbjct: 135 LVLPSL--GRSLQS-ALDVSPKH-VLSERSVLQVACRLLDALEFLHENE---YVHGNVTA 187
Query: 128 ANILLDNDFNPK--LSDFGLAK 147
NI +D + + L+ +G A
Sbjct: 188 ENIFVDPEDQSQVTLAGYGFAF 209
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 8e-06
Identities = 32/187 (17%), Positives = 56/187 (29%), Gaps = 23/187 (12%)
Query: 63 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 122
DQ +V E+ G + + + S T I L +
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQM-----RTKLSSLATAKSILHQLTASLAVAEASLR--FEH 185
Query: 123 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP--EYAMSGKLTL 180
RDL N+LL KL K + + + G +Y +S
Sbjct: 186 RDLHWGNVLLKKTSLKKLHYTLNGK-----------SSTIPSCGLQVSIIDYTLSRLERD 234
Query: 181 KSDIYSFGVVLLELITGRKAM--DLSKGQGEQNLVSWSRPFLKDQKKFVH-LVDPLLHGR 237
++ + +L TG D+ + ++N W ++H L D +L
Sbjct: 235 GIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQM 294
Query: 238 YPRRCLN 244
+ N
Sbjct: 295 TFKTKCN 301
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 1e-04
Identities = 39/206 (18%), Positives = 74/206 (35%), Gaps = 39/206 (18%)
Query: 20 DQLVAIK-------QLNHEG----LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 68
D +K L E E I + + L + + G
Sbjct: 65 DAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGK 124
Query: 69 LVYEYMPM---G-SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 124
Y +M M G L+ +Y+ + S T +++++ LEY+H ++ D
Sbjct: 125 S-YRFMIMDRFGSDLQK-IYEANAKR--FSRKTVLQLSLRILDILEYIHEHE---YVHGD 177
Query: 125 LKSANILLDNDFNPK--LSDFGLAKL-GPVGDNTHVSTR----VMGTYGYCAPEYA---- 173
+K++N+LL+ + L D+GLA P G + + GT E+
Sbjct: 178 IKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGT-----IEFTSIDA 232
Query: 174 -MSGKLTLKSDIYSFGVVLLELITGR 198
+ + D+ G +++ +TG
Sbjct: 233 HNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 20/90 (22%), Positives = 39/90 (43%), Gaps = 5/90 (5%)
Query: 60 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 119
+ + Y +M M L L + +T +++ + LEY+H
Sbjct: 115 GSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--- 171
Query: 120 VIYRDLKSANILLDNDFNPK--LSDFGLAK 147
++ D+K+AN+LL + L+D+GL+
Sbjct: 172 YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 311 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.39 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.18 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.14 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.84 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.71 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.52 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.5 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.5 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.48 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.39 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.21 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.15 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.06 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.97 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.96 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.74 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.57 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.5 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.5 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.35 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.33 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.22 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.19 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.12 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.01 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.71 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.7 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 88.14 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 88.12 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.87 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-56 Score=384.97 Aligned_cols=256 Identities=29% Similarity=0.392 Sum_probs=206.4
Q ss_pred eeeeeeceeccEEEEEE-------CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWL-------CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
..++|+|+||.||+|.+ +++.||||.+........++|.+|++++++++||||+++++++.++...++||||+
T Consensus 46 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~ 125 (329)
T 4aoj_A 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYM 125 (329)
T ss_dssp EEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred EEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 36799999999999986 37899999998766666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeec
Q 021526 75 PMGSLEDHLYDLEP-----------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 143 (311)
Q Consensus 75 ~~~~L~~~l~~~~~-----------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df 143 (311)
++|+|.+++..... ....+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 126 ~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~Ki~DF 202 (329)
T 4aoj_A 126 RHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDF 202 (329)
T ss_dssp TTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCC
T ss_pred CCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcEEEccc
Confidence 99999999976432 2356999999999999999999999999 999999999999999999999999
Q ss_pred CCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhc
Q 021526 144 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKD 222 (311)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 222 (311)
|+++...............||+.|+|||++.+..++.++|||||||++|||+| |+.||....... + ....
T Consensus 203 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---~---~~~i--- 273 (329)
T 4aoj_A 203 GMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---A---IDCI--- 273 (329)
T ss_dssp C----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---H---HHHH---
T ss_pred ccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---H---HHHH---
Confidence 99986443333333445678999999999999999999999999999999999 899996332110 0 0000
Q ss_pred ccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 021526 223 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 277 (311)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~ 277 (311)
....+-..|..++.++.+|+.+||+.||++|||+.||++.|+.+.+.
T Consensus 274 --------~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 274 --------TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp --------HHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --------HcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 01112234566788899999999999999999999999999998765
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-56 Score=383.86 Aligned_cols=256 Identities=27% Similarity=0.360 Sum_probs=210.6
Q ss_pred eeeeeeceeccEEEEEE-------CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWL-------CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
...+|+|+||.||+|.+ ++..||||.+........+++.+|++++++++||||+++++++.+++..++||||+
T Consensus 18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~ 97 (299)
T 4asz_A 18 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYM 97 (299)
T ss_dssp EEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred eeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcC
Confidence 46799999999999986 36889999998666666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccC---------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCC
Q 021526 75 PMGSLEDHLYDLE---------PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 145 (311)
Q Consensus 75 ~~~~L~~~l~~~~---------~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~ 145 (311)
++|+|.+++.... .....+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 98 ~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki~DFGl 174 (299)
T 4asz_A 98 KHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGM 174 (299)
T ss_dssp TTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSC
T ss_pred CCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEECCccc
Confidence 9999999996532 23467999999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhccc
Q 021526 146 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQK 224 (311)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 224 (311)
++...............||+.|+|||++.+..++.++|||||||++|||+| |+.||...... +.....
T Consensus 175 a~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~------~~~~~i----- 243 (299)
T 4asz_A 175 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------EVIECI----- 243 (299)
T ss_dssp HHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHH-----
T ss_pred ceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHH-----
Confidence 975433322222333468999999999999999999999999999999998 89999643211 000001
Q ss_pred chhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 021526 225 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 277 (311)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~ 277 (311)
........|..++.++.+|+.+||+.||++|||+++|.+.|+.+...
T Consensus 244 ------~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 244 ------TQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp ------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------HcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 01111234566788899999999999999999999999999988754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-56 Score=385.03 Aligned_cols=244 Identities=22% Similarity=0.256 Sum_probs=198.1
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
+..+|+|+||.||++.. +|+.||||++.+... ...+.+.+|+++++.++||||+++++++.+++..|+|||||+||
T Consensus 29 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg 108 (350)
T 4b9d_A 29 LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGG 108 (350)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCC
Confidence 57899999999999998 799999999976543 34467899999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|.+++.. .....+++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+++.... ....
T Consensus 109 ~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~~ 181 (350)
T 4b9d_A 109 DLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVEL 181 (350)
T ss_dssp BHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCH--HHHH
T ss_pred cHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecC--Cccc
Confidence 99999965 34566899999999999999999999999 99999999999999999999999999975321 1122
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCC
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 237 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
.....||+.|+|||++.+..|+.++|||||||++|+|++|..||...... ......... .. ..
T Consensus 182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~~~----------~~-~~ 244 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK------NLVLKIISG----------SF-PP 244 (350)
T ss_dssp HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHT----------CC-CC
T ss_pred ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHcC----------CC-CC
Confidence 23457999999999999999999999999999999999999999643211 111111110 00 12
Q ss_pred CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 238 YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.+..++.++.+||.+||+.||++|||++|+++
T Consensus 245 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 245 VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 23456778999999999999999999999987
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=379.78 Aligned_cols=253 Identities=28% Similarity=0.378 Sum_probs=209.0
Q ss_pred eeeeeeceeccEEEEEE-------CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL-------CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
+..+|+|+||.||+|.+ .++.||||.+.... ....++|.+|+.++++++||||+++++++.++...++||||
T Consensus 31 ~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey 110 (308)
T 4gt4_A 31 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSY 110 (308)
T ss_dssp EEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEc
Confidence 57899999999999986 45899999986543 33457899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEe
Q 021526 74 MPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 141 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~ 141 (311)
+++|+|.+++..... ....+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+
T Consensus 111 ~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~Ki~ 187 (308)
T 4gt4_A 111 CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKIS 187 (308)
T ss_dssp CSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEEC
T ss_pred CCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCEEEC
Confidence 999999999965321 1356999999999999999999999999 9999999999999999999999
Q ss_pred ecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhh
Q 021526 142 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFL 220 (311)
Q Consensus 142 Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 220 (311)
|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |..||...... .+
T Consensus 188 DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~---~~-------- 256 (308)
T 4gt4_A 188 DLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DV-------- 256 (308)
T ss_dssp CSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH---HH--------
T ss_pred CcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH---HH--------
Confidence 9999975433333333445678999999999999999999999999999999998 88999643211 01
Q ss_pred hcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 021526 221 KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274 (311)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l 274 (311)
...+........|..++..+.+++.+||+.||++|||+.+|++.|+++
T Consensus 257 ------~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 257 ------VEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ------HHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111111112234667888999999999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-55 Score=374.90 Aligned_cols=257 Identities=27% Similarity=0.373 Sum_probs=202.0
Q ss_pred eeeeeeceeccEEEEEECCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWLCDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
...+|+|+||.||+|.+.+ .||||+++... ....+.+.+|++++++++||||+++++++.+ +..++||||+++|+|
T Consensus 41 ~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL 118 (307)
T 3omv_A 41 STRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSL 118 (307)
T ss_dssp EEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBH
T ss_pred eeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCH
Confidence 4679999999999998865 59999986543 2344679999999999999999999998764 568999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++............
T Consensus 119 ~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~ 192 (307)
T 3omv_A 119 YKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVE 192 (307)
T ss_dssp HHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----------
T ss_pred HHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeec
Confidence 999965 4467999999999999999999999999 9999999999999999999999999997643333333344
Q ss_pred eccccccccCCccccC---CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 160 RVMGTYGYCAPEYAMS---GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
...||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ........ ...+.. .
T Consensus 193 ~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~------~~~~~~~~-----~~~p~~-~ 260 (307)
T 3omv_A 193 QPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ------IIFMVGRG-----YASPDL-S 260 (307)
T ss_dssp -CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHTT-----CCCCCS-T
T ss_pred ccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH------HHHHHhcC-----CCCCCc-c
Confidence 5679999999999864 4689999999999999999999999964322110 00000000 011111 1
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 278 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~ 278 (311)
..+..++..+.+|+.+||+.||++|||+.+|++.|+.|+...
T Consensus 261 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 261 KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 234567788999999999999999999999999999987654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-55 Score=379.13 Aligned_cols=243 Identities=21% Similarity=0.262 Sum_probs=205.5
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
+..+|+|+||.||++.. +|+.||||++........+.+.+|+++++.++||||++++++|.+++.+|+|||||++|+|
T Consensus 79 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 158 (346)
T 4fih_A 79 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 158 (346)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEH
T ss_pred eEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcH
Confidence 56799999999999999 7999999999877666777899999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
.+++.. ..+++..+..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||++..... ......
T Consensus 159 ~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~~ 228 (346)
T 4fih_A 159 TDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRK 228 (346)
T ss_dssp HHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS--SSCCBC
T ss_pred HHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCC--CCCccc
Confidence 999954 46999999999999999999999999 99999999999999999999999999975432 222334
Q ss_pred eccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 160 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
...||+.|+|||++.+..|+.++|||||||++|+|++|.+||....... ...... ....+ ....+
T Consensus 229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~~i~-------~~~~~--~~~~~ 293 (346)
T 4fih_A 229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK------AMKMIR-------DNLPP--RLKNL 293 (346)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHH-------HSSCC--CCSCG
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHH-------cCCCC--CCCcc
Confidence 5679999999999999999999999999999999999999996332110 000010 00111 11223
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..++.++.+||.+||+.||++|||++|+++
T Consensus 294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 294 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 456788999999999999999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=375.80 Aligned_cols=252 Identities=20% Similarity=0.188 Sum_probs=205.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
...+|+|+||.||++.. +|+.||||++..+.. ..+|+.+++.++||||+++++++.++...|+||||++||+|
T Consensus 63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 137 (336)
T 4g3f_A 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred CcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence 35799999999999998 689999999975432 24699999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCC-ceEEeecCCCccCCCCCCcc--
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-NPKLSDFGLAKLGPVGDNTH-- 156 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~-~vkl~Df~~~~~~~~~~~~~-- 156 (311)
.+++.. .+.+++..+..++.||+.||+|||+++ |+||||||+|||++.+| .+||+|||+++.........
T Consensus 138 ~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~ 210 (336)
T 4g3f_A 138 GQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210 (336)
T ss_dssp HHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence 999954 457999999999999999999999999 99999999999999887 69999999997643322111
Q ss_pred -eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 157 -VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 157 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.......- ...........
T Consensus 211 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~i~~~~~~~--------- 275 (336)
T 4g3f_A 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL------CLKIASEPPPI--------- 275 (336)
T ss_dssp ---CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC------HHHHHHSCCGG---------
T ss_pred ecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH------HHHHHcCCCCc---------
Confidence 12335799999999999999999999999999999999999999964332111 11111111110
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCC
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 280 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~ 280 (311)
...+..++..+.++|.+||+.||++|||+.||++.|.........
T Consensus 276 ~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~ 320 (336)
T 4g3f_A 276 REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG 320 (336)
T ss_dssp GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence 123456678899999999999999999999999999887765543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-55 Score=375.90 Aligned_cols=260 Identities=21% Similarity=0.216 Sum_probs=214.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+.++|+|+||.||++.. +++.||||++.+.. ....+.+.+|+++++.++||||++++++|.+++..|+||||++|
T Consensus 37 ~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~g 116 (311)
T 4aw0_A 37 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 116 (311)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence 57899999999999999 79999999997542 33456799999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
|+|.+++.. .+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 117 G~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 117 GELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp EEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 999999954 467999999999999999999999999 9999999999999999999999999998654443334
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
.....+||+.|+|||++.+..++.++|+|||||++|+|++|..||...+.. ......... .-
T Consensus 190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~~i~~~------------~~ 251 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG------LIFAKIIKL------------EY 251 (311)
T ss_dssp CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHT------------CC
T ss_pred cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcC------------CC
Confidence 445678999999999999999999999999999999999999999643211 111111110 01
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCCCCCCCCCCC
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSRNAGARG 291 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~~~~~~~~~~~~ 291 (311)
.+|...+.++.+||.+||+.||++|||++|++..- ....+++.++.+|..
T Consensus 252 ~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~-----~i~~Hp~F~~idw~~ 301 (311)
T 4aw0_A 252 DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYG-----PLKAHPFFESVTWEN 301 (311)
T ss_dssp CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHH-----HHHTSGGGTTCCCTT
T ss_pred CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCH-----HHHCCCCcCCCCHHH
Confidence 23445677899999999999999999999875321 112467777666544
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-54 Score=380.89 Aligned_cols=243 Identities=21% Similarity=0.271 Sum_probs=205.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
+..+|+|+||.||++.. +|+.||||++........+.+.+|+.+++.++||||++++++|.+++.+|+|||||+||+|
T Consensus 156 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L 235 (423)
T 4fie_A 156 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 235 (423)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred eeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcH
Confidence 57899999999999999 7999999999877767778899999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
.+++.. ..+++..+..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||++..... ......
T Consensus 236 ~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~~ 305 (423)
T 4fie_A 236 TDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRK 305 (423)
T ss_dssp HHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCS--SCCCBC
T ss_pred HHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCC--CCcccc
Confidence 999953 46999999999999999999999999 99999999999999999999999999975432 222334
Q ss_pred eccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 160 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
..+||+.|+|||++.+..|+.++|||||||++|+|++|.+||...... ....... ....+.+ ...
T Consensus 306 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~~i~-------~~~~~~~--~~~ 370 (423)
T 4fie_A 306 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAMKMIR-------DNLPPRL--KNL 370 (423)
T ss_dssp CCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHH-------HSCCCCC--SCT
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHH-------cCCCCCC--ccc
Confidence 567999999999999999999999999999999999999999633211 0000110 0011111 122
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..++.++.+||.+||+.||++|||++|+++
T Consensus 371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 371 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 356778999999999999999999999976
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-54 Score=360.99 Aligned_cols=239 Identities=24% Similarity=0.283 Sum_probs=188.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+..+|+|+||.||++.. +|+.||||++.+.. ......+.+|+++++.++||||+++++++.+++..++||||+ +
T Consensus 18 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~ 96 (275)
T 3hyh_A 18 VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-G 96 (275)
T ss_dssp EEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-C
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-C
Confidence 57899999999999998 79999999997653 233467899999999999999999999999999999999999 6
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
|+|.+++.. .+.+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.... ..
T Consensus 97 g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---~~ 166 (275)
T 3hyh_A 97 NELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD---GN 166 (275)
T ss_dssp EEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC---CC
Confidence 799999954 467999999999999999999999999 99999999999999999999999999975322 22
Q ss_pred eeeeccccccccCCccccCCCC-CccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
......||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... ...........
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~------~~~~~~i~~~~------------ 228 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI------PVLFKNISNGV------------ 228 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTC------------
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHcCC------------
Confidence 3345679999999999988776 5799999999999999999999963221 11111111100
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..++...+.++.++|.+||+.||++|||++|+++
T Consensus 229 ~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 229 YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1234456778999999999999999999999987
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-53 Score=359.89 Aligned_cols=242 Identities=25% Similarity=0.315 Sum_probs=193.5
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEe----CCeeEEEEecC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS----GDQRLLVYEYM 74 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~ 74 (311)
.++|+|+||.||++.. .+..||+|.+.... ....+.+.+|+++++.++||||++++++|.+ +..+++||||+
T Consensus 32 ~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~ 111 (290)
T 3fpq_A 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 111 (290)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCC
Confidence 3699999999999999 68999999987543 2334678999999999999999999999865 34579999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcC-CCceEEeecCCCccCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-DFNPKLSDFGLAKLGPVGD 153 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~-~~~vkl~Df~~~~~~~~~~ 153 (311)
++|+|.+++.+ ...+++..+..++.||+.||+|||+++ ++|+||||||+|||++. ++.+||+|||+++....
T Consensus 112 ~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-- 184 (290)
T 3fpq_A 112 TSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-- 184 (290)
T ss_dssp CSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT--
T ss_pred CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC--
Confidence 99999999954 467999999999999999999999874 34999999999999974 78999999999974321
Q ss_pred CcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 154 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 154 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||....... ...... ....
T Consensus 185 --~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-----~~~~~i----------~~~~ 246 (290)
T 3fpq_A 185 --SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIYRRV----------TSGV 246 (290)
T ss_dssp --TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HHHHHH----------TTTC
T ss_pred --CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-----HHHHHH----------HcCC
Confidence 22345679999999998865 68999999999999999999999996322110 000000 0000
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.....+..+++++.+||.+||+.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 247 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001122334567999999999999999999999985
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-53 Score=370.15 Aligned_cols=257 Identities=25% Similarity=0.298 Sum_probs=209.6
Q ss_pred eeeeeeceeccEEEEEEC-------CeEEEEEEeccCCc-cchhHHHHHHHHHhcCCC-CcccceeEEEEeC-CeeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWLC-------DQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHH-DNLVTLIGYCTSG-DQRLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~-------~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~-~~~~lv~ 71 (311)
...+|+|+||.||+|... ++.||||.+..... ...+.+.+|++++.+++| |||++++++|.++ ..+++||
T Consensus 69 ~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~ 148 (353)
T 4ase_A 69 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 148 (353)
T ss_dssp EEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEE
T ss_pred eeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEE
Confidence 468999999999999872 36899999875543 334679999999999975 8999999998664 5689999
Q ss_pred ecCCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceE
Q 021526 72 EYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 139 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vk 139 (311)
|||++|+|.+++..... ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+|
T Consensus 149 Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~vK 225 (353)
T 4ase_A 149 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVK 225 (353)
T ss_dssp ECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceeeCCCCCEE
Confidence 99999999999965321 2356899999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchh
Q 021526 140 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRP 218 (311)
Q Consensus 140 l~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 218 (311)
|+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |..||.......
T Consensus 226 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~---------- 295 (353)
T 4ase_A 226 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---------- 295 (353)
T ss_dssp ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH----------
T ss_pred ECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH----------
Confidence 999999986544433334445678999999999999999999999999999999998 899996432211
Q ss_pred hhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 021526 219 FLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 277 (311)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~ 277 (311)
.+...+....+-..|..++.++.+++.+||+.||++|||+.+|++.|+.+.+.
T Consensus 296 ------~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 296 ------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp ------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 01111111122234566788899999999999999999999999999988764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=364.46 Aligned_cols=242 Identities=26% Similarity=0.273 Sum_probs=193.9
Q ss_pred CeeeeeeceeccEEEEEE-----CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEec
Q 021526 1 MLCCYLSCKFYNVGLVWL-----CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
++..+|+|+||.||++.. .++.||+|++.+... .....+.+|+++++.++||||+++++++.+++..|+||||
T Consensus 28 i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 107 (304)
T 3ubd_A 28 LLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDF 107 (304)
T ss_dssp EEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECC
T ss_pred EEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEc
Confidence 367899999999999987 468999999876532 2345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 153 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~ 153 (311)
++||+|.+++.+ .+.+++..+..++.|++.||+|||++| |+||||||+|||++.+|.+||+|||+++.....
T Consensus 108 ~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 179 (304)
T 3ubd_A 108 LRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH- 179 (304)
T ss_dssp CTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCC-
Confidence 999999999954 457999999999999999999999999 999999999999999999999999999753221
Q ss_pred CcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 154 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 154 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
........||+.|+|||++.+..++.++|||||||++|+|++|..||...+.. ........ .
T Consensus 180 -~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~~----------~- 241 (304)
T 3ubd_A 180 -EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK------ETMTMILK----------A- 241 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH----------C-
T ss_pred -CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH------HHHHHHHc----------C-
Confidence 22233467999999999999999999999999999999999999999643211 11111111 0
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLI-----NDIVV 269 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~-----~~l~~ 269 (311)
.-.+|..++.++.+||.+||+.||++|||+ +|+++
T Consensus 242 -~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 242 -KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 112345567889999999999999999984 56654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-52 Score=357.39 Aligned_cols=269 Identities=23% Similarity=0.251 Sum_probs=196.3
Q ss_pred eeeeeeceeccEEEEEECCeEEEEEEeccCCccchhHHH--HHHHHHhcCCCCcccceeEEEEeCC----eeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFI--VEVLMLSLLHHDNLVTLIGYCTSGD----QRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~--~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~ 75 (311)
-..+|+|+||.||+|.+.|+.||||++.... ...+. .|+..+..++||||+++++++.+++ .+++||||++
T Consensus 8 ~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~ 84 (303)
T 3hmm_A 8 QESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 84 (303)
T ss_dssp EEEEEECSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred EEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCC
Confidence 4689999999999999999999999986432 23333 4555567889999999999987654 5799999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeeecCCCCCcEEEcCCCceEEeecCCCccCC
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA-----NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 150 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~-----~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~ 150 (311)
+|+|.+++.. ..+++..+..++.|++.||+|||++. .++|+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 85 HGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp TCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 9999999954 46899999999999999999999871 1129999999999999999999999999987543
Q ss_pred CCCCcc--eeeeccccccccCCccccCC------CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhc
Q 021526 151 VGDNTH--VSTRVMGTYGYCAPEYAMSG------KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 222 (311)
Q Consensus 151 ~~~~~~--~~~~~~~~~~~~aPE~~~~~------~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 222 (311)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||.......... ..........
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~-~~~~~~~~~~ 238 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-YDLVPSDPSV 238 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT-TTTSCSSCCH
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc-hhcccccchH
Confidence 222211 12235699999999998754 36789999999999999999998875433211100 0000000000
Q ss_pred ccchhhhcCccCCCCCc-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 021526 223 QKKFVHLVDPLLHGRYP-----RRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 279 (311)
Q Consensus 223 ~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~ 279 (311)
...........++-..| ..++..+.+|+.+||+.||++|||+.+|++.|++|..++.
T Consensus 239 ~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~ 300 (303)
T 3hmm_A 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcC
Confidence 00000111112221222 3466789999999999999999999999999999987643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=346.21 Aligned_cols=242 Identities=22% Similarity=0.272 Sum_probs=183.6
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc-chhHHHHHHHHHhcCCCCcccceeEEEEeCC------------e
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD------------Q 66 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------------~ 66 (311)
+..+|+|+||.||+++. +|+.||||.+...... ..+.+.+|+++++.++||||++++++|.+.+ .
T Consensus 10 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~ 89 (299)
T 4g31_A 10 IQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVY 89 (299)
T ss_dssp EEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEE
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcE
Confidence 57899999999999998 7999999998755433 3467899999999999999999999986544 3
Q ss_pred eEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCC
Q 021526 67 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 146 (311)
Q Consensus 67 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~ 146 (311)
+|++||||++++|.+++.... .....++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++
T Consensus 90 l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFGla 165 (299)
T 4g31_A 90 LYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLV 165 (299)
T ss_dssp EEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCCCC
T ss_pred EEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccCccc
Confidence 689999999999999996522 2234566778899999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCcc----------eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcc
Q 021526 147 KLGPVGDNTH----------VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS 216 (311)
Q Consensus 147 ~~~~~~~~~~----------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 216 (311)
+......... ......||+.|+|||++.+..++.++|||||||++|+|++ ||..... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~-----~~--- 234 (299)
T 4g31_A 166 TAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME-----RV--- 234 (299)
T ss_dssp --------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH-----HH---
T ss_pred eecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH-----HH---
Confidence 7543322111 1123469999999999999999999999999999999996 6642110 00
Q ss_pred hhhhhcccchhhhcCccCCCCCc---HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 217 RPFLKDQKKFVHLVDPLLHGRYP---RRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..+.... ...+| ...++.+.+||.+||+.||++|||+.|+++
T Consensus 235 -------~~~~~~~----~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 235 -------RTLTDVR----NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -------HHHHHHH----TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------HHHHHHh----cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0000000 11222 234456789999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=335.60 Aligned_cols=274 Identities=39% Similarity=0.625 Sum_probs=230.3
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
...+|.|+||.||++.. +++.||+|.+........+.+.+|+++++.++||||+++++++.++...++||||+++++|.
T Consensus 44 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 123 (321)
T 2qkw_B 44 KFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123 (321)
T ss_dssp CCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTG
T ss_pred cceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHH
Confidence 46799999999999998 68999999987766666788999999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++.........+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.+||+|||++..............
T Consensus 124 ~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 200 (321)
T 2qkw_B 124 RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV 200 (321)
T ss_dssp GGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCC
T ss_pred HHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccccccccccccccc
Confidence 999765444567999999999999999999999999 99999999999999999999999999875433333333334
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCcH
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPR 240 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (311)
..|+..|+|||++.+..++.++||||||+++|+|++|..||.............|..... ....+...+++......+.
T Consensus 201 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 279 (321)
T 2qkw_B 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH-NNGQLEQIVDPNLADKIRP 279 (321)
T ss_dssp CEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH-TTTCCCSSSSSSCTTCSCH
T ss_pred cCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc-ccccHHHhcChhhccccCH
Confidence 558999999999988899999999999999999999999997655444333333332221 2334445556666666778
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 021526 241 RCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 279 (311)
Q Consensus 241 ~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~ 279 (311)
.++..+.+++.+||+.||++|||+.++++.|+.+....+
T Consensus 280 ~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 280 ESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp HHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred HHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 899999999999999999999999999999999887654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=346.40 Aligned_cols=260 Identities=20% Similarity=0.230 Sum_probs=194.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEe------CCeeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS------GDQRLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~ 71 (311)
+..+|+|+||.||+++. +|+.||||++..... ...+.+.+|+++|+.++||||+++++++.. ...+|+||
T Consensus 59 ~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivm 138 (398)
T 4b99_A 59 IETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVL 138 (398)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEE
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEE
Confidence 57899999999999999 799999999975532 334578899999999999999999998753 35789999
Q ss_pred ecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCC
Q 021526 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 151 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~ 151 (311)
||++ |+|.+++. ..+.+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++....
T Consensus 139 E~~~-g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 139 DLME-SDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp ECCS-EEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred eCCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 9996 68999994 4568999999999999999999999999 99999999999999999999999999975432
Q ss_pred CC--CcceeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCccccccchh-cc----hhhhh--
Q 021526 152 GD--NTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS-WS----RPFLK-- 221 (311)
Q Consensus 152 ~~--~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~----~~~~~-- 221 (311)
.. .........||+.|+|||++.+. .++.++||||+||++|+|++|.+||...+......... .. ...+.
T Consensus 211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~ 290 (398)
T 4b99_A 211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV 290 (398)
T ss_dssp -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC--
T ss_pred CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhh
Confidence 21 12223346799999999998775 56899999999999999999999997543211100000 00 00000
Q ss_pred cccchhhh---cCccCCCC---CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 222 DQKKFVHL---VDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 222 ~~~~~~~~---~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
........ ..+..... ..+..+.++.+||.+||+.||++|||++|+++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000 00000000 01134567899999999999999999999987
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=358.75 Aligned_cols=245 Identities=20% Similarity=0.199 Sum_probs=204.1
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
+..+|+|+||.||++.. +|+.||+|.+........+.+.+|+++|+.++||||++++++|.++..+++||||++||+|
T Consensus 162 ~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L 241 (573)
T 3uto_A 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 241 (573)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBH
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcH
Confidence 57899999999999999 7999999999876666667899999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCC--CceEEeecCCCccCCCCCCcce
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND--FNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~--~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||++..... ...
T Consensus 242 ~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~---~~~ 312 (573)
T 3uto_A 242 FEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---KQS 312 (573)
T ss_dssp HHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT---TSE
T ss_pred HHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccC---CCc
Confidence 999954 4467999999999999999999999999 9999999999999754 8899999999986432 233
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCC
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 237 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
.....||+.|+|||++.+..++.++|||||||++|+|++|.+||........ ........ ......
T Consensus 313 ~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~------~~~i~~~~--------~~~~~~ 378 (573)
T 3uto_A 313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET------LRNVKSCD--------WNMDDS 378 (573)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHTTC--------CCCCSG
T ss_pred eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------HHHHHhCC--------CCCCcc
Confidence 3456799999999999999999999999999999999999999964332110 00000000 001111
Q ss_pred CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 238 YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
....++.++.+||.+||+.||.+|||+.|+++
T Consensus 379 ~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 379 AFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12345677999999999999999999999987
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=334.17 Aligned_cols=191 Identities=24% Similarity=0.273 Sum_probs=162.7
Q ss_pred eeeeeeceeccEEEEEE-----CCeEEEEEEeccCCccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL-----CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
...+|+|+||.||+++. .++.||+|.+... .....+.+|+++++.+ +||||++++++|.+++..++||||++
T Consensus 26 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~ 103 (361)
T 4f9c_A 26 EDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLE 103 (361)
T ss_dssp EEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCC
T ss_pred EEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCC
Confidence 57899999999999986 3689999988643 2345788999999988 69999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCC-CceEEeecCCCccCCCCCC
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-FNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~-~~vkl~Df~~~~~~~~~~~ 154 (311)
+++|.+++. .+++..+..++.|++.||+|||++| |+||||||+|||++.+ +.+||+|||+++.......
T Consensus 104 g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~ 173 (361)
T 4f9c_A 104 HESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI 173 (361)
T ss_dssp CCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred cccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence 999999992 4889999999999999999999999 9999999999999876 7999999999974322111
Q ss_pred c--------------------------ceeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCcccc
Q 021526 155 T--------------------------HVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLS 204 (311)
Q Consensus 155 ~--------------------------~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 204 (311)
. .......||+.|+|||++.+. .++.++||||+||++|+|++|+.||...
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 0 111234699999999998775 5899999999999999999999999643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=353.98 Aligned_cols=243 Identities=24% Similarity=0.256 Sum_probs=196.9
Q ss_pred CeeeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHH---HHHHHHhcCCCCcccceeEEEEeCCeeEEEEe
Q 021526 1 MLCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFI---VEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 72 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~---~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 72 (311)
++.++|+|+||.||.+.. +|+.||||++.+... ....... +++.+++.++||||++++++|.+++.+|+|||
T Consensus 193 i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmE 272 (689)
T 3v5w_A 193 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 272 (689)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEe
Confidence 357899999999999999 799999999975421 2223333 34667778899999999999999999999999
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCC
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~ 152 (311)
|+.||+|.+++.. .+.+++..+..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||++......
T Consensus 273 y~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 273 LMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp CCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 9999999999954 467999999999999999999999999 999999999999999999999999999754322
Q ss_pred CCcceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcC
Q 021526 153 DNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231 (311)
Q Consensus 153 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
.....+||+.|+|||++.+ ..|+.++|+|||||++|+|++|.+||..........+ ......
T Consensus 346 ----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i---~~~i~~---------- 408 (689)
T 3v5w_A 346 ----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRMTLT---------- 408 (689)
T ss_dssp ----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHH---HHHHHH----------
T ss_pred ----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHhhcC----------
Confidence 1234679999999999864 5799999999999999999999999964332211100 000110
Q ss_pred ccCCCCCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 021526 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 269 (311)
Q Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs-----~~~l~~ 269 (311)
....+|...+.++.+||.+||+.||.+|++ ++||++
T Consensus 409 --~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 409 --MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp --CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred --CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 011345566788999999999999999998 678776
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=324.58 Aligned_cols=258 Identities=24% Similarity=0.303 Sum_probs=210.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
..++|+|+||.||++.. +++.||+|.+........+.+.+|+++++.++||||+++++++.++...++||||+++++|
T Consensus 15 ~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 94 (310)
T 3s95_A 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL 94 (310)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred cceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcH
Confidence 46899999999999999 6899999998766666677899999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc---
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH--- 156 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~--- 156 (311)
.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++..........
T Consensus 95 ~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 168 (310)
T 3s95_A 95 RGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168 (310)
T ss_dssp HHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---------
T ss_pred HHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccccccc
Confidence 999965 3567999999999999999999999999 9999999999999999999999999987543222111
Q ss_pred ---------eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchh
Q 021526 157 ---------VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 227 (311)
Q Consensus 157 ---------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (311)
......|++.|+|||++.+..++.++||||||+++|+|++|..|+............. ..
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-----------~~ 237 (310)
T 3s95_A 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-----------VR 237 (310)
T ss_dssp -----------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-----------HH
T ss_pred ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-----------hh
Confidence 0113568999999999999999999999999999999999999986433221111000 00
Q ss_pred hhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCC
Q 021526 228 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 280 (311)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~ 280 (311)
..... ..+..++..+.+++.+||+.||++|||+.++++.|+.+......
T Consensus 238 ~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 238 GFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp HHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred ccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 00000 11334556799999999999999999999999999999876543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=324.03 Aligned_cols=270 Identities=41% Similarity=0.630 Sum_probs=221.9
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCcc-chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
..++|+|+||.||++.. +++.||+|.+...... ....+.+|+++++.++||||+++++++.++...++||||+.+++|
T Consensus 35 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 114 (326)
T 3uim_A 35 KNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 114 (326)
T ss_dssp TTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBH
T ss_pred ceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCH
Confidence 46799999999999988 7899999998765432 334789999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhC---CCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK---ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~---~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
.+++.........+++..++.++.|++.||+|||+. + ++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 115 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 190 (326)
T 3uim_A 115 ASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK-DTH 190 (326)
T ss_dssp HHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCCEEECCCSSCEECCSS-SSC
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCCEEeccCccccccCcc-ccc
Confidence 999987665667799999999999999999999999 8 999999999999999999999999999754322 222
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCcc--ccccchhcchhhhhcccchhhhcCccC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQ--GEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
......|+..|+|||++.+..++.++||||||+++|+|++|..||+..... .......|...... ........+...
T Consensus 191 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 269 (326)
T 3uim_A 191 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK-EKKLEALVDVDL 269 (326)
T ss_dssp EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS-SCCSTTSSCTTC
T ss_pred ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh-chhhhhhcChhh
Confidence 333455899999999998888999999999999999999999999643221 11222223222222 344455566666
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 276 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~ 276 (311)
...++...+..+.+++.+||+.||.+|||+.+|++.|+....
T Consensus 270 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 270 QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred ccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 677788899999999999999999999999999999986433
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=324.51 Aligned_cols=267 Identities=25% Similarity=0.301 Sum_probs=204.4
Q ss_pred eeeeeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCC----eeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD----QRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~ 77 (311)
..++|+|+||.||++...++.||||++.... .......+|+.+++.++||||+++++++.... ..++||||++++
T Consensus 29 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g 107 (322)
T 3soc_A 29 LEVKARGRFGCVWKAQLLNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKG 107 (322)
T ss_dssp EEEEECSTTCEEEEEEETTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred hheecccCceEEEEEEECCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCC
Confidence 5789999999999999999999999986442 33345666888899999999999999988744 369999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhC----------CCCCeeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK----------ANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~----------~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
+|.+++.. ..+++..++.++.|++.||+|||+. + ++|+||||+||+++.++.+||+|||++.
T Consensus 108 ~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~a~ 179 (322)
T 3soc_A 108 SLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFGLAL 179 (322)
T ss_dssp BHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccCCccc
Confidence 99999954 4589999999999999999999998 8 9999999999999999999999999997
Q ss_pred cCCCCCCcceeeeccccccccCCccccCC-----CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhc
Q 021526 148 LGPVGDNTHVSTRVMGTYGYCAPEYAMSG-----KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 222 (311)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 222 (311)
...............|+..|+|||++.+. .++.++||||||+++|+|++|..||................... .
T Consensus 180 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~-~ 258 (322)
T 3soc_A 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP-S 258 (322)
T ss_dssp EECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC-C
T ss_pred ccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC-c
Confidence 54433332223335689999999998763 45678899999999999999999997544322211111000000 0
Q ss_pred ccchhh-hcCccCCCCC-----cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 021526 223 QKKFVH-LVDPLLHGRY-----PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 278 (311)
Q Consensus 223 ~~~~~~-~~~~~~~~~~-----~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~ 278 (311)
...+.. .......... ...++..+.++|.+||+.||++|||+.++++.|++|....
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 000001 1111111111 1245677999999999999999999999999999987643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=318.72 Aligned_cols=243 Identities=24% Similarity=0.259 Sum_probs=203.6
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
...+|+|+||.||++.. +++.||+|.+........+.+.+|+.+++.++||||+++++++..+...++||||+++++|
T Consensus 25 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (297)
T 3fxz_A 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (297)
T ss_dssp CEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred eeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCH
Confidence 57899999999999987 7899999999877666678899999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
.+++.. ..+++..++.++.|++.||+|||++| ++|+||+|+||+++.++.+||+|||++....... ....
T Consensus 105 ~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~ 174 (297)
T 3fxz_A 105 TDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRS 174 (297)
T ss_dssp HHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CCBC
T ss_pred HHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc--cccC
Confidence 999954 36899999999999999999999999 9999999999999999999999999987543222 2233
Q ss_pred eccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 160 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
...|++.|+|||++.+..++.++||||||+++|+|++|..||......... ..... . .......+
T Consensus 175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------~~~~~-------~--~~~~~~~~ 239 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL------YLIAT-------N--GTPELQNP 239 (297)
T ss_dssp CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHH-------H--CSCCCSCG
T ss_pred CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHh-------C--CCCCCCCc
Confidence 456899999999999999999999999999999999999999633211100 00000 0 00111234
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..++..+.++|.+||+.||++|||+.++++
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 556778999999999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=322.69 Aligned_cols=259 Identities=25% Similarity=0.337 Sum_probs=206.7
Q ss_pred eeeeeeceeccEEEEEE-----CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL-----CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
..++|+|+||.||.+.. .+..||||.+.... ....+.+.+|+.+++.++||||+++++++.++...++||||++
T Consensus 54 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 133 (325)
T 3kul_A 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYME 133 (325)
T ss_dssp EEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCT
T ss_pred eeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCC
Confidence 46899999999999998 34569999987543 3344678999999999999999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 134 ~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 207 (325)
T 3kul_A 134 NGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA 207 (325)
T ss_dssp TCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC----C
T ss_pred CCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccCccc
Confidence 9999999964 4467999999999999999999999999 999999999999999999999999999764332221
Q ss_pred c-eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 156 H-VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 156 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
. ......++..|+|||++.+..++.++||||||+++|+|++ |..||....... ....+...
T Consensus 208 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----------------~~~~~~~~ 270 (325)
T 3kul_A 208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-----------------VISSVEEG 270 (325)
T ss_dssp CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-----------------HHHHHHTT
T ss_pred eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH-----------------HHHHHHcC
Confidence 1 1222345778999999988899999999999999999999 999985332110 00111111
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCCC
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPV 283 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~~~~ 283 (311)
.....+..++..+.+++.+||..||++|||+.+|++.|+.+.....+...
T Consensus 271 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~~~ 320 (325)
T 3kul_A 271 YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRA 320 (325)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC----
T ss_pred CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccccc
Confidence 12233456678899999999999999999999999999999876555443
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=319.72 Aligned_cols=260 Identities=29% Similarity=0.357 Sum_probs=200.8
Q ss_pred eeeeeeceeccEEEEEECCeEEEEEEeccCCcc--chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
...+|+|+||.||++...++.||+|++...... ..+.+.+|+++++.++||||+++++++.++...++||||+++++|
T Consensus 42 ~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 121 (309)
T 3p86_A 42 KEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL 121 (309)
T ss_dssp EEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBH
T ss_pred eeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcH
Confidence 468999999999999999999999998765432 335788999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
.+++.... ....+++..++.++.|++.||+|||+.+ .+++|+||||+||+++.++.+||+|||++..... ......
T Consensus 122 ~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--~~~~~~ 197 (309)
T 3p86_A 122 YRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLSSK 197 (309)
T ss_dssp HHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---------------
T ss_pred HHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccc--cccccc
Confidence 99996411 1224899999999999999999999875 3499999999999999999999999999864222 112223
Q ss_pred eccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 160 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
...|+..|+|||++.+..++.++||||||+++|+|++|..||........ .............+
T Consensus 198 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~----------------~~~~~~~~~~~~~~ 261 (309)
T 3p86_A 198 SAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV----------------VAAVGFKCKRLEIP 261 (309)
T ss_dssp ----CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH----------------HHHHHHSCCCCCCC
T ss_pred cCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----------------HHHHHhcCCCCCCC
Confidence 45689999999999999999999999999999999999999963321100 00000011112334
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCC
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSH 281 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~~ 281 (311)
..++..+.++|.+||..||.+|||+.++++.|+.+......+
T Consensus 262 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 262 RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 566778999999999999999999999999999998765443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=325.72 Aligned_cols=259 Identities=25% Similarity=0.352 Sum_probs=209.4
Q ss_pred eeeeeeceeccEEEEEE---------CCeEEEEEEeccCCc-cchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEE
Q 021526 2 LCCYLSCKFYNVGLVWL---------CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLV 70 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~---------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 70 (311)
...+|+|+||.||.+.. .+..||+|.+..... ...+.+.+|+++++.+ +||||+++++++.++...++|
T Consensus 86 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv 165 (370)
T 2psq_A 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 165 (370)
T ss_dssp EEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEE
Confidence 45799999999999986 245799999875532 3346789999999999 899999999999999999999
Q ss_pred EecCCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCce
Q 021526 71 YEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 138 (311)
Q Consensus 71 ~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~v 138 (311)
|||+.+++|.+++..... ....+++..++.++.|++.||+|||+++ ++|+||||+|||++.++.+
T Consensus 166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~ 242 (370)
T 2psq_A 166 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVM 242 (370)
T ss_dssp EECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCE
T ss_pred EEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEECCCCCE
Confidence 999999999999976432 1346899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcch
Q 021526 139 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSR 217 (311)
Q Consensus 139 kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 217 (311)
||+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 243 kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--------- 313 (370)
T 2psq_A 243 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------- 313 (370)
T ss_dssp EECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---------
T ss_pred EEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---------
Confidence 9999999975433322222333456788999999999999999999999999999999 999986432111
Q ss_pred hhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCC
Q 021526 218 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 280 (311)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~ 280 (311)
+...+........+..++.++.++|.+||..||.+||++.++++.|+.+......
T Consensus 314 --------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~ 368 (370)
T 2psq_A 314 --------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368 (370)
T ss_dssp --------HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred --------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 0011111112233456678899999999999999999999999999998875443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=320.34 Aligned_cols=247 Identities=23% Similarity=0.292 Sum_probs=198.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
...+|+|+||.||++.. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.++...++||||+++++
T Consensus 12 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~ 91 (323)
T 3tki_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91 (323)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred eeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCc
Confidence 57899999999999998 789999999875543 334678899999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
|.+++. ....+++..++.++.|++.||+|||+.| ++|+||||+||+++.++.+||+|||++............
T Consensus 92 L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 164 (323)
T 3tki_A 92 LFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (323)
T ss_dssp GGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred HHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence 999994 4557999999999999999999999999 999999999999999999999999999754322222223
Q ss_pred eeccccccccCCccccCCCC-CccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCC
Q 021526 159 TRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 237 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
....|++.|+|||++.+..+ +.++||||||+++|+|++|..||......... .. ..........
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~--------------~~~~~~~~~~ 229 (323)
T 3tki_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YS--------------DWKEKKTYLN 229 (323)
T ss_dssp CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HH--------------HHHTTCTTST
T ss_pred CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HH--------------HHhcccccCC
Confidence 34578999999999987765 78999999999999999999999643321110 00 0000011111
Q ss_pred CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 238 YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
....++..+.++|.+||+.||++|||++|+++.
T Consensus 230 ~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 230 PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 123456778999999999999999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=331.04 Aligned_cols=253 Identities=26% Similarity=0.306 Sum_probs=206.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
...+|+|+||.||++.. +++.||+|.+..... ...+.+.+|+++++.++||||+++++++.++...++||||+++++
T Consensus 119 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~ 198 (377)
T 3cbl_A 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 198 (377)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred eeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCC
Confidence 46899999999999999 689999999865432 234578899999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
|.+++.. .+..+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.+||+|||++............
T Consensus 199 L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~ 272 (377)
T 3cbl_A 199 FLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASG 272 (377)
T ss_dssp HHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCS
T ss_pred HHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecC
Confidence 9999964 3456899999999999999999999999 999999999999999999999999998753221111111
Q ss_pred eeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCC
Q 021526 159 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 237 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
....++..|+|||++.+..++.++||||||+++|+|++ |..||....... ..+.+....+..
T Consensus 273 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-----------------~~~~~~~~~~~~ 335 (377)
T 3cbl_A 273 GLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-----------------TREFVEKGGRLP 335 (377)
T ss_dssp SCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-----------------HHHHHHTTCCCC
T ss_pred CCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHHHcCCCCC
Confidence 12235678999999988889999999999999999998 899986432110 011111111223
Q ss_pred CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 021526 238 YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 277 (311)
Q Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~ 277 (311)
.+..++..+.+++.+||+.||++|||+++|++.|+.+...
T Consensus 336 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 336 CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 3455677899999999999999999999999999998764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=310.36 Aligned_cols=251 Identities=25% Similarity=0.340 Sum_probs=206.4
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
...+|+|+||.||++.. +++.||+|.+... ....+.+.+|+++++.++||||+++++++.++...++||||+++++|.
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (269)
T 4hcu_A 15 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 93 (269)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHH
T ss_pred eheecCCCccEEEEEEecCCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHH
Confidence 57899999999999999 8899999998754 344577999999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++.. ....+++..++.++.|++.||++||+.+ ++|+||+|+||+++.++.++|+|||++...... .......
T Consensus 94 ~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~ 166 (269)
T 4hcu_A 94 DYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSSTG 166 (269)
T ss_dssp HHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH-HHHSTTS
T ss_pred HHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccc-ccccccC
Confidence 99965 4467999999999999999999999999 999999999999999999999999998743221 1111222
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
..++..|+|||++.+..++.++|+||||+++|+|++ |..||........ . ..+........+
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~------~-----------~~~~~~~~~~~~ 229 (269)
T 4hcu_A 167 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV------V-----------EDISTGFRLYKP 229 (269)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------H-----------HHHHTTCCCCCC
T ss_pred cccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH------H-----------HHHhcCccCCCC
Confidence 345678999999998899999999999999999999 8999863321100 0 000011111223
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 277 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~ 277 (311)
...+..+.+++.+||+.||++||++.++++.|+++...
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 230 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 44567799999999999999999999999999998754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=310.49 Aligned_cols=266 Identities=38% Similarity=0.544 Sum_probs=214.5
Q ss_pred eeeeeceeccEEEEEECCeEEEEEEeccCC----ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 3 CCYLSCKFYNVGLVWLCDQLVAIKQLNHEG----LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
..+|+|+||.||++..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.++...+++||++++++
T Consensus 37 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 116 (307)
T 2nru_A 37 NKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGS 116 (307)
T ss_dssp CEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred CccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCc
Confidence 579999999999999999999999986532 2234678899999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++............
T Consensus 117 L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 192 (307)
T 2nru_A 117 LLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192 (307)
T ss_dssp HHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEEC
T ss_pred HHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcEEEeecccccccccccccccc
Confidence 999996422 3456999999999999999999999999 999999999999999999999999998754333333333
Q ss_pred eeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCC
Q 021526 159 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRY 238 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
....|+..|+|||++.+ .++.++|+||||+++|+|++|..||........ ...+..........+...+++.. ...
T Consensus 193 ~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~ 268 (307)
T 2nru_A 193 SRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LLDIKEEIEDEEKTIEDYIDKKM-NDA 268 (307)
T ss_dssp SSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--TTHHHHHHHTTSCCHHHHSCSSC-SCC
T ss_pred cccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--HHHHHHHhhhhhhhhhhhccccc-ccc
Confidence 34568999999998764 578999999999999999999999975443221 11111222222233334444433 234
Q ss_pred cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 021526 239 PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 276 (311)
Q Consensus 239 ~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~ 276 (311)
+...+..+.+++.+||..||.+|||+.++++.|+++.+
T Consensus 269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred chHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 67788999999999999999999999999999998864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=321.38 Aligned_cols=241 Identities=25% Similarity=0.312 Sum_probs=200.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
+..+|+|+||.||.+.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++.++...++||||++++
T Consensus 20 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~ 99 (328)
T 3fe3_A 20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGG 99 (328)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCC
Confidence 57899999999999998 89999999987553 234467889999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|.+++.. ...+++..++.++.|++.||+|||+.| ++||||||+||+++.++.+||+|||++...... ..
T Consensus 100 ~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~---~~ 169 (328)
T 3fe3_A 100 EVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GK 169 (328)
T ss_dssp BHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS---CG
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC---Cc
Confidence 99999954 356999999999999999999999999 999999999999999999999999998754322 22
Q ss_pred eeeccccccccCCccccCCCCC-ccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 158 STRVMGTYGYCAPEYAMSGKLT-LKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
.....|++.|+|||++.+..+. .++||||||+++|+|++|..||...... ........ . ..
T Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~i~~----------~--~~ 231 (328)
T 3fe3_A 170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK------ELRERVLR----------G--KY 231 (328)
T ss_dssp GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH----------C--CC
T ss_pred cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHh----------C--CC
Confidence 3345689999999999887765 8999999999999999999999643311 10101111 0 11
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
..|...+..+.+++.+||..||.+|||++++++.
T Consensus 232 ~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 2334456779999999999999999999999863
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=317.38 Aligned_cols=270 Identities=28% Similarity=0.390 Sum_probs=206.4
Q ss_pred eeeeeeceeccEEEEEE------CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEe--CCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL------CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS--GDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~ 73 (311)
+..+|+|+||.||++.. +++.||+|.+........+.+.+|+++++.++||||+++++++.. ....++||||
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 94 (295)
T 3ugc_A 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY 94 (295)
T ss_dssp EEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEEC
T ss_pred hheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEe
Confidence 57899999999999984 689999999986665566789999999999999999999999854 3568999999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 153 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~ 153 (311)
+++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 95 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (295)
T 3ugc_A 95 LPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168 (295)
T ss_dssp CTTCBHHHHHHH---CGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC------
T ss_pred CCCCCHHHHHHh---cccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccccCCc
Confidence 999999999965 3446999999999999999999999999 9999999999999999999999999997543222
Q ss_pred Cc-ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCc
Q 021526 154 NT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 232 (311)
Q Consensus 154 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
.. .......++..|+|||++.+..++.++||||||+++|+|++|..|+................... ......+.+..
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 247 (295)
T 3ugc_A 169 EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM-IVFHLIELLKN 247 (295)
T ss_dssp -------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHH-HHHHHHHHHHT
T ss_pred ceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccch-hHHHHHHHHhc
Confidence 11 12223446778999999998999999999999999999999999875322110000000000000 00011111222
Q ss_pred cCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 021526 233 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 278 (311)
Q Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~ 278 (311)
......+..++..+.+++.+||..||++|||+.++++.|+.+....
T Consensus 248 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 248 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 2223345567788999999999999999999999999999987654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=323.11 Aligned_cols=264 Identities=28% Similarity=0.361 Sum_probs=213.1
Q ss_pred eeeeeeceeccEEEEEEC---------CeEEEEEEeccCCc-cchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEE
Q 021526 2 LCCYLSCKFYNVGLVWLC---------DQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLV 70 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~---------~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 70 (311)
...+|+|+||.||++... +..||+|++..... .....+.+|+++++.+ +||||+++++++.++...++|
T Consensus 74 ~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv 153 (382)
T 3tt0_A 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 153 (382)
T ss_dssp EEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEE
Confidence 467999999999999962 26899999875532 3346788999999999 899999999999999999999
Q ss_pred EecCCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCce
Q 021526 71 YEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 138 (311)
Q Consensus 71 ~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~v 138 (311)
||++++++|.+++..... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+
T Consensus 154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~ 230 (382)
T 3tt0_A 154 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVM 230 (382)
T ss_dssp EECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCE
T ss_pred EEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEEcCCCcE
Confidence 999999999999976432 1346999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcch
Q 021526 139 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSR 217 (311)
Q Consensus 139 kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 217 (311)
||+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 231 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~---------- 300 (382)
T 3tt0_A 231 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---------- 300 (382)
T ss_dssp EECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----------
T ss_pred EEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----------
Confidence 9999999976543333233334557889999999999999999999999999999999 99998633211
Q ss_pred hhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCCCCC
Q 021526 218 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSR 285 (311)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~~~~~~ 285 (311)
.+...+........+..++..+.+++.+||+.||++|||+.+|++.|+.+...........
T Consensus 301 -------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~ 361 (382)
T 3tt0_A 301 -------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGY 361 (382)
T ss_dssp -------HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC---
T ss_pred -------HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCC
Confidence 0111111111222344567789999999999999999999999999999998776655444
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=308.84 Aligned_cols=252 Identities=23% Similarity=0.298 Sum_probs=204.9
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
+..+|+|+||.||.+.. ++..||+|.+... ....+.+.+|+++++.++||||+++++++.++...++|||++++++|.
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (268)
T 3sxs_A 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLL 91 (268)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECBT-TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHH
T ss_pred eeeeccCCCceEEEEEecCceeEEEEEeccC-CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHH
Confidence 57899999999999998 6778999998644 334577999999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++.. ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 92 ~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~ 164 (268)
T 3sxs_A 92 NYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-YVSSVG 164 (268)
T ss_dssp HHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-EEECCS
T ss_pred HHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh-hhcccC
Confidence 99965 3456999999999999999999999999 9999999999999999999999999987543221 111222
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
..++..|+|||++.+..++.++|+||||+++|+|++ |..||......... ... ........+
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------~~~-----------~~~~~~~~~ 227 (268)
T 3sxs_A 165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV------LKV-----------SQGHRLYRP 227 (268)
T ss_dssp CCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH------HHH-----------HTTCCCCCC
T ss_pred CCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH------HHH-----------HcCCCCCCC
Confidence 345678999999988889999999999999999999 99998643321110 000 000111123
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 278 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~ 278 (311)
...+..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 228 HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 344667999999999999999999999999999987653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=314.62 Aligned_cols=257 Identities=25% Similarity=0.329 Sum_probs=208.4
Q ss_pred eeeeeeceeccEEEEEE-------CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL-------CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
...+|.|+||.||++.. +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.++...++||||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 107 (314)
T 2ivs_A 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEY 107 (314)
T ss_dssp EEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEee
Confidence 46799999999999987 34899999987543 33446788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEc
Q 021526 74 MPMGSLEDHLYDLEP--------------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD 133 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~--------------------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~ 133 (311)
+++++|.+++..... ....+++..++.++.|++.||+|||+++ ++|+||+|+||+++
T Consensus 108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp~NIli~ 184 (314)
T 2ivs_A 108 AKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVA 184 (314)
T ss_dssp CTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEE
T ss_pred cCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---CcccccchheEEEc
Confidence 999999999976432 1234899999999999999999999999 99999999999999
Q ss_pred CCCceEEeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccc
Q 021526 134 NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNL 212 (311)
Q Consensus 134 ~~~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~ 212 (311)
.++.++|+|||++................++..|+|||++.+..++.++|+||||+++|+|++ |..||........
T Consensus 185 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--- 261 (314)
T 2ivs_A 185 EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL--- 261 (314)
T ss_dssp TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---
T ss_pred CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---
Confidence 999999999999875433332222333456788999999988889999999999999999999 9999864332110
Q ss_pred hhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 021526 213 VSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 278 (311)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~ 278 (311)
...+........+..++..+.+++.+||..||++||++.++++.|+++....
T Consensus 262 --------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 313 (314)
T 2ivs_A 262 --------------FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313 (314)
T ss_dssp --------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred --------------HHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhhc
Confidence 0111111112234456778999999999999999999999999999987653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=327.51 Aligned_cols=247 Identities=28% Similarity=0.359 Sum_probs=204.4
Q ss_pred eeeeeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCC-eeEEEEecCCCCCHH
Q 021526 2 LCCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD-QRLLVYEYMPMGSLE 80 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~ 80 (311)
...+|+|+||.||++...++.||||.+.... ..+.+.+|+++++.++||||+++++++..+. ..++||||+.+++|.
T Consensus 198 ~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~ 275 (450)
T 1k9a_A 198 LQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 275 (450)
T ss_dssp EEEEEECSSEEEEEEEETTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHH
T ss_pred EeeecCcCCeeEEEEEecCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHH
Confidence 5689999999999999999999999987543 4578999999999999999999999987655 789999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++... ....+++..++.++.|++.||+|||+++ ++|+||+|+|||++.++.+||+|||++...... ...
T Consensus 276 ~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~~~ 345 (450)
T 1k9a_A 276 DYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDT 345 (450)
T ss_dssp HHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----------
T ss_pred HHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-----ccC
Confidence 999752 2345789999999999999999999999 999999999999999999999999998743211 122
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
..++..|+|||++.+..++.++||||||+++|+|++ |..||........ . ..+....+...+
T Consensus 346 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~--------------~~i~~~~~~~~p 408 (450)
T 1k9a_A 346 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---V--------------PRVEKGYKMDAP 408 (450)
T ss_dssp -CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH---H--------------HHHHTTCCCCCC
T ss_pred CCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---H--------------HHHHcCCCCCCC
Confidence 356788999999999999999999999999999998 9999964322110 0 011111122345
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 277 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~ 277 (311)
..++..+.++|.+||..||.+|||+.++++.|+.+...
T Consensus 409 ~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 409 DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 56778899999999999999999999999999998754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=326.85 Aligned_cols=262 Identities=25% Similarity=0.316 Sum_probs=209.1
Q ss_pred eeeeeeceeccEEEEEE-------CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL-------CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
...+|+|+||.||++.. .++.||||.+.... ......+.+|+.+++.++||||+++++++.++...++||||
T Consensus 76 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 155 (367)
T 3l9p_A 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 155 (367)
T ss_dssp EEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEe
Confidence 56799999999999994 46789999986442 33445788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcccCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCC---ceEEeecCCCc
Q 021526 74 MPMGSLEDHLYDLEP---DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF---NPKLSDFGLAK 147 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~---~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~---~vkl~Df~~~~ 147 (311)
+++++|.+++..... ....+++..++.++.|++.||+|||++| ++||||||+|||++.++ .+||+|||++.
T Consensus 156 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~ 232 (367)
T 3l9p_A 156 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232 (367)
T ss_dssp CTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHH
T ss_pred CCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECCCcccc
Confidence 999999999976432 2356999999999999999999999999 99999999999998555 49999999986
Q ss_pred cCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccch
Q 021526 148 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 226 (311)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
...............++..|+|||++.+..++.++|||||||++|+|++ |..||....... .
T Consensus 233 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~-----------------~ 295 (367)
T 3l9p_A 233 DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-----------------V 295 (367)
T ss_dssp HHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----------------H
T ss_pred ccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------H
Confidence 4222222222334557889999999988899999999999999999998 999986432110 0
Q ss_pred hhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCCC
Q 021526 227 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPV 283 (311)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~~~~ 283 (311)
...+........+..++..+.+++.+||+.||++|||+.+|++.|+.+.........
T Consensus 296 ~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~~~~ 352 (367)
T 3l9p_A 296 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINT 352 (367)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHHTC
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhhccC
Confidence 111111111223445677899999999999999999999999999998876654333
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=316.65 Aligned_cols=253 Identities=23% Similarity=0.339 Sum_probs=199.3
Q ss_pred eeeeeeceeccEEEEEE--CCe----EEEEEEeccC-CccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQ----LVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
+.++|+|+||.||++.. +++ +|++|.+... .....+.+.+|+.+++.++||||+++++++..+. .+++++++
T Consensus 20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~ 98 (327)
T 3lzb_A 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLM 98 (327)
T ss_dssp EEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCC
T ss_pred EEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEec
Confidence 57899999999999998 444 4577776543 3445678999999999999999999999988654 78999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
.+++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~ 172 (327)
T 3lzb_A 99 PFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp SSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence 99999999965 4567999999999999999999999999 99999999999999999999999999976433333
Q ss_pred cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 155 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
........++..|+|||++.+..++.++||||||+++|+|++ |..||....... +...+...
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----------------~~~~~~~~ 235 (327)
T 3lzb_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----------------ISSILEKG 235 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----------------HHHHHHTT
T ss_pred cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-----------------HHHHHHcC
Confidence 333333456778999999999999999999999999999999 999996433211 11111111
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 278 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~ 278 (311)
.....+..++..+.+++.+||..||.+||++.++++.|+.+....
T Consensus 236 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 236 ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 122334556778999999999999999999999999999988654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=323.57 Aligned_cols=257 Identities=26% Similarity=0.342 Sum_probs=197.4
Q ss_pred eeeeeeceeccEEEEEE-----CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL-----CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
...+|+|+||.||++.. .+..||||.+.... ....+.+.+|+.+++.++||||+++++++.++...++||||++
T Consensus 50 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 129 (373)
T 2qol_A 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYME 129 (373)
T ss_dssp CEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCC
Confidence 46899999999999987 36789999987543 2344678999999999999999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 130 ~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 203 (373)
T 2qol_A 130 NGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA 203 (373)
T ss_dssp TCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred CCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccCCcc
Confidence 9999999964 4467999999999999999999999999 999999999999999999999999998754322111
Q ss_pred c-eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 156 H-VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 156 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
. ......++..|+|||++.+..++.++||||||+++|+|++ |..||....... ....+...
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-----------------~~~~i~~~ 266 (373)
T 2qol_A 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-----------------VIKAVDEG 266 (373)
T ss_dssp ----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-----------------HHHHHHTT
T ss_pred ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHHHcC
Confidence 1 1112234678999999998899999999999999999998 999986332110 00011111
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCC
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSH 281 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~~ 281 (311)
.....+..++..+.+++.+||+.||.+||++.+|++.|+.+.......
T Consensus 267 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~~ 314 (373)
T 2qol_A 267 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSL 314 (373)
T ss_dssp EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGGGG
T ss_pred CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcccc
Confidence 111223456778999999999999999999999999999998765433
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=309.68 Aligned_cols=243 Identities=22% Similarity=0.253 Sum_probs=202.1
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
..+|+|+||.||++.. +|+.||||++........+.+.+|+.+++.++||||+++++++..+...++||||+++++|.
T Consensus 51 ~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 130 (321)
T 2c30_A 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT 130 (321)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHH
T ss_pred EEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHH
Confidence 5789999999999998 69999999998776666778999999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++...... ......
T Consensus 131 ~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~ 200 (321)
T 2c30_A 131 DIVS-----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKS 200 (321)
T ss_dssp HHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS--SCCBCC
T ss_pred HHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccC--cccccc
Confidence 9984 356999999999999999999999999 999999999999999999999999998754322 112234
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCcH
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPR 240 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (311)
..|+..|+|||++.+..++.++|+||||+++|+|++|..||....... .... +.....+.. ..+.
T Consensus 201 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~------~~~~-------~~~~~~~~~--~~~~ 265 (321)
T 2c30_A 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ------AMKR-------LRDSPPPKL--KNSH 265 (321)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHH-------HHHSSCCCC--TTGG
T ss_pred ccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-------HhcCCCCCc--Cccc
Confidence 568999999999999899999999999999999999999996432110 0000 001111111 1233
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 241 RCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 241 ~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
..+..+.+++.+||+.||++|||+.++++.
T Consensus 266 ~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 266 KVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 456789999999999999999999999863
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=315.79 Aligned_cols=242 Identities=26% Similarity=0.293 Sum_probs=201.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccC---CccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHE---GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+..+|+|+||.||.+.. +++.||+|++.+. .......+.+|+.+++.++||||+++++++.+....++||||+++
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~g 89 (337)
T 1o6l_A 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 57899999999999999 6899999998754 233456788999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ...+++..++.++.||+.||+|||++| ++||||||+||+++.++.+||+|||++...... ..
T Consensus 90 g~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~~ 160 (337)
T 1o6l_A 90 GELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GA 160 (337)
T ss_dssp CBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT--TC
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC--CC
Confidence 999999954 457899999999999999999999999 999999999999999999999999998742221 22
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......|++.|+|||++.+..++.++|+||||+++|+|++|..||...... ........ . ..
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~----------~--~~ 222 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILM----------E--EI 222 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH----------C--CC
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH------HHHHHHHc----------C--CC
Confidence 234457899999999999999999999999999999999999999633211 00001110 0 11
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVVA 270 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~l~~~ 270 (311)
.++...+.++.++|.+||+.||++|| +++++++.
T Consensus 223 ~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 23455677899999999999999999 89999874
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=319.51 Aligned_cols=258 Identities=24% Similarity=0.340 Sum_probs=205.9
Q ss_pred eeeeeeceeccEEEEEECC-------eEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWLCD-------QLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~~-------~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
...+|+|+||.||++...+ +.||+|.+..... ...+.+.+|+.+++.++||||+++++++.++...++||||
T Consensus 52 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 131 (343)
T 1luf_A 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEY 131 (343)
T ss_dssp EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEec
Confidence 4679999999999999843 8999999875533 3346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcccCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEc
Q 021526 74 MPMGSLEDHLYDLEPD--------------------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD 133 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~--------------------~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~ 133 (311)
+++++|.+++...... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++
T Consensus 132 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~ 208 (343)
T 1luf_A 132 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVG 208 (343)
T ss_dssp CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred CCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEC
Confidence 9999999999763221 267999999999999999999999999 99999999999999
Q ss_pred CCCceEEeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccc
Q 021526 134 NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNL 212 (311)
Q Consensus 134 ~~~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~ 212 (311)
.++.+||+|||++................++..|+|||++.+..++.++|+||||+++|+|++ |..||.......
T Consensus 209 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---- 284 (343)
T 1luf_A 209 ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE---- 284 (343)
T ss_dssp GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH----
T ss_pred CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHH----
Confidence 999999999999865332222222334567889999999988889999999999999999999 999986332110
Q ss_pred hhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 021526 213 VSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 279 (311)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~ 279 (311)
..... .. ......+..++..+.+++.+||..||++||++.++++.|+++.....
T Consensus 285 --~~~~~----------~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 285 --VIYYV----------RD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp --HHHHH----------HT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred --HHHHH----------hC-CCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 00000 00 01112344567789999999999999999999999999999876544
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=316.31 Aligned_cols=244 Identities=25% Similarity=0.237 Sum_probs=199.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc------chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ------GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
...+|+|+||.||++.. +|+.||+|.+...... ..+.+.+|+.+++.++||||+++++++.++...++||||
T Consensus 17 ~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~ 96 (361)
T 2yab_A 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILEL 96 (361)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEc
Confidence 46899999999999999 6899999998765432 346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCC----ceEEeecCCCccC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF----NPKLSDFGLAKLG 149 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~----~vkl~Df~~~~~~ 149 (311)
+.+++|.+++. ....+++..++.++.||+.||.|||+.| ++|+||||+||+++.++ .+||+|||++...
T Consensus 97 ~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 97 VSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp CCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred CCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 99999999994 4567999999999999999999999999 99999999999998777 7999999999754
Q ss_pred CCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhh
Q 021526 150 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 229 (311)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
... .......|++.|+|||++.+..++.++|+||||+++|+|++|..||........ ..........
T Consensus 170 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~------~~~i~~~~~~---- 236 (361)
T 2yab_A 170 EDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LANITAVSYD---- 236 (361)
T ss_dssp CTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHTTCCC----
T ss_pred CCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhcCCC----
Confidence 322 222345689999999999988999999999999999999999999964322110 0000000000
Q ss_pred cCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 230 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 230 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
....+....+..+.++|.+||..||.+|||+.++++
T Consensus 237 ----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 237 ----FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp ----CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000011234677999999999999999999999985
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=318.12 Aligned_cols=254 Identities=26% Similarity=0.367 Sum_probs=202.5
Q ss_pred eeeeeeceeccEEEEEE--CCe----EEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQ----LVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
+.++|+|+||.||++.. +++ +|++|.+.... ......+.+|+.+++.++||||+++++++. +...++||||+
T Consensus 18 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 96 (325)
T 3kex_A 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYL 96 (325)
T ss_dssp EEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECC
T ss_pred eeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeC
Confidence 57899999999999998 444 38888875443 334467888999999999999999999986 45689999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
.+++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||++........
T Consensus 97 ~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 170 (325)
T 3kex_A 97 PLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170 (325)
T ss_dssp TTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred CCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence 99999999964 3457888999999999999999999999 99999999999999999999999999986544443
Q ss_pred cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 155 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
........++..|+|||++.+..++.++||||||+++|+|++ |..||........ ...+...
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-----------------~~~~~~~ 233 (325)
T 3kex_A 171 QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV-----------------PDLLEKG 233 (325)
T ss_dssp CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH-----------------HHHHHTT
T ss_pred cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH-----------------HHHHHcC
Confidence 333445567889999999998899999999999999999999 9999964332111 0111111
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 279 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~ 279 (311)
.....+..++..+.+++.+||..||.+||++.++++.|+.+....+
T Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~ 279 (325)
T 3kex_A 234 ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPP 279 (325)
T ss_dssp CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHH
T ss_pred CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 1112233455568899999999999999999999999999876543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=309.54 Aligned_cols=252 Identities=24% Similarity=0.321 Sum_probs=203.4
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
+..+|+|+||.||.+.. ++..||+|.+... ....+.+.+|+++++.++||||+++++++.++...++|||++++++|.
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (283)
T 3gen_A 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 107 (283)
T ss_dssp EEECC---CEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHH
T ss_pred HhhcCCCCCceEEEEEEcCCCeEEEEEecCC-CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHH
Confidence 46899999999999999 6779999998754 334577999999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++.. ....+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++...... .......
T Consensus 108 ~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~ 180 (283)
T 3gen_A 108 NYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVG 180 (283)
T ss_dssp HHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH-HHHSTTS
T ss_pred HHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccc-ccccccC
Confidence 99964 3456999999999999999999999999 999999999999999999999999998753221 1111222
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
..++..|+|||++.+..++.++|+||||+++|+|++ |..||........ ...+........+
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~-----------------~~~~~~~~~~~~~ 243 (283)
T 3gen_A 181 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-----------------AEHIAQGLRLYRP 243 (283)
T ss_dssp TTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-----------------HHHHHTTCCCCCC
T ss_pred CccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH-----------------HHHHhcccCCCCC
Confidence 345678999999998899999999999999999998 9999864332110 0001111111223
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 278 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~ 278 (311)
...+..+.+++.+||+.+|.+|||+.++++.|.++..++
T Consensus 244 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 244 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 445678999999999999999999999999999987654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=316.63 Aligned_cols=253 Identities=23% Similarity=0.338 Sum_probs=200.0
Q ss_pred eeeeeeceeccEEEEEE--CCe----EEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQ----LVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
+.++|+|+||.||++.. +++ +||+|.+.... ....+.+.+|+.+++.++||||+++++++.++. .+++++++
T Consensus 20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~ 98 (327)
T 3poz_A 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLM 98 (327)
T ss_dssp EEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECC
T ss_pred ceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEec
Confidence 57899999999999997 443 46888875432 345578999999999999999999999998754 78999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
.+++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 172 (327)
T 3poz_A 99 PFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp TTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccCCcc
Confidence 99999999965 4567999999999999999999999999 99999999999999999999999999875433333
Q ss_pred cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 155 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
........++..|+|||.+.+..++.++||||||+++|+|++ |..||....... +...+...
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----------------~~~~~~~~ 235 (327)
T 3poz_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----------------ISSILEKG 235 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----------------HHHHHHTT
T ss_pred cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-----------------HHHHHHcC
Confidence 333333456789999999999999999999999999999999 999996433211 11111111
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 278 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~ 278 (311)
.....+..++..+.+++.+||+.||.+||++.++++.|+.+....
T Consensus 236 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 280 (327)
T 3poz_A 236 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence 222334556778999999999999999999999999999987654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=317.58 Aligned_cols=260 Identities=24% Similarity=0.339 Sum_probs=205.0
Q ss_pred eeeeeeceeccEEEEEE-------CCeEEEEEEeccCC-ccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL-------CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 72 (311)
...+|.|+||.||++.. .+..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++..+...++|||
T Consensus 50 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 129 (344)
T 1rjb_A 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 129 (344)
T ss_dssp EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEe
Confidence 46899999999999996 45689999987543 33457899999999999 89999999999999999999999
Q ss_pred cCCCCCHHHHhcccCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEc
Q 021526 73 YMPMGSLEDHLYDLEPD-------------------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD 133 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~-------------------~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~ 133 (311)
|+++++|.+++...... ...+++..++.++.|++.||+|||+.| ++|+||+|+||+++
T Consensus 130 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~ 206 (344)
T 1rjb_A 130 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVT 206 (344)
T ss_dssp CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEE
T ss_pred cCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEEc
Confidence 99999999999763321 134899999999999999999999999 99999999999999
Q ss_pred CCCceEEeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccc
Q 021526 134 NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNL 212 (311)
Q Consensus 134 ~~~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~ 212 (311)
.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||........
T Consensus 207 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--- 283 (344)
T 1rjb_A 207 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN--- 283 (344)
T ss_dssp TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH---
T ss_pred CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHH---
Confidence 999999999999875433333333334556788999999988899999999999999999998 9999964332110
Q ss_pred hhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCC
Q 021526 213 VSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 280 (311)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~ 280 (311)
....+........+..++..+.+++.+||..||.+|||+.++++.|+.+......
T Consensus 284 -------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 338 (344)
T 1rjb_A 284 -------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE 338 (344)
T ss_dssp -------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred -------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence 0011111112223445677899999999999999999999999999998776543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=309.81 Aligned_cols=258 Identities=24% Similarity=0.279 Sum_probs=202.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc---chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
...+|+|+||.||++.. .++.||+|.+...... ..+.+.+|+.+++.++||||+++++++.++...++||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 95 (294)
T 4eqm_A 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEG 95 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCC
Confidence 57899999999999998 7899999998654332 335788999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ...+++..++.++.|++.||+|||+.| ++|+||||+||+++.++.+||+|||++....... ..
T Consensus 96 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 167 (294)
T 4eqm_A 96 PTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-LT 167 (294)
T ss_dssp CBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccccc-cc
Confidence 999999954 357999999999999999999999999 9999999999999999999999999987542221 11
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......|++.|+|||++.+..++.++|+||||+++|+|++|..||........ ........ . +....
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~--~-----~~~~~ 234 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQDS--V-----PNVTT 234 (294)
T ss_dssp -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHSSC--C-----CCHHH
T ss_pred ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhhcc--C-----CCcch
Confidence 22335689999999999999999999999999999999999999964332110 00000000 0 00000
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHhhhccCC
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRP-LINDIVVALDYLVSQRDS 280 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RP-s~~~l~~~L~~l~~~~~~ 280 (311)
..+..++..+.++|.+||+.||.+|| +++++.+.|..+......
T Consensus 235 ~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~ 279 (294)
T 4eqm_A 235 DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA 279 (294)
T ss_dssp HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence 11234567799999999999999998 999999999887665443
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=313.39 Aligned_cols=261 Identities=23% Similarity=0.294 Sum_probs=204.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEe----CCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS----GDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~ 75 (311)
...+|+|+||.||++.. +++.||+|.+........+.+.+|+++++.++||||+++++++.. ....++|||++.
T Consensus 34 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~ 113 (317)
T 2buj_A 34 IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFK 113 (317)
T ss_dssp EEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCT
T ss_pred EEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCC
Confidence 56899999999999998 789999999876666666789999999999999999999999862 346799999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+++|.+++.........+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+.........
T Consensus 114 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~ 190 (317)
T 2buj_A 114 RGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190 (317)
T ss_dssp TCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEESCEEEES
T ss_pred CCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhccccccc
Confidence 99999999765556778999999999999999999999999 999999999999999999999999988643211100
Q ss_pred ce-------eeeccccccccCCccccCCC---CCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccc
Q 021526 156 HV-------STRVMGTYGYCAPEYAMSGK---LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 225 (311)
Q Consensus 156 ~~-------~~~~~~~~~~~aPE~~~~~~---~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
.. .....|+..|+|||++.+.. ++.++||||||+++|+|++|..||........ .
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---------------~ 255 (317)
T 2buj_A 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD---------------S 255 (317)
T ss_dssp HHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS---------------C
T ss_pred ccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc---------------h
Confidence 00 01234688999999887554 68899999999999999999999863211110 0
Q ss_pred hhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCC
Q 021526 226 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 280 (311)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~ 280 (311)
.............+..++..+.++|.+||+.||.+|||+.++++.|+.+....++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 256 VALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred hhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 0000000111122234567899999999999999999999999999998755444
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=314.16 Aligned_cols=261 Identities=21% Similarity=0.301 Sum_probs=194.3
Q ss_pred eeeeeeceeccEEEEEE--CCe---EEEEEEeccC--CccchhHHHHHHHHHhcCCCCcccceeEEEEeCCee------E
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQ---LVAIKQLNHE--GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR------L 68 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~---~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------~ 68 (311)
...+|+|+||.||++.. .++ .||+|.+... .....+.+.+|+++++.++||||+++++++...... +
T Consensus 28 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 107 (323)
T 3qup_A 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPM 107 (323)
T ss_dssp EEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEE
T ss_pred eceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccE
Confidence 56899999999999998 232 8999998755 234457899999999999999999999999876655 9
Q ss_pred EEEecCCCCCHHHHhcccCC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCC
Q 021526 69 LVYEYMPMGSLEDHLYDLEP--DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 146 (311)
Q Consensus 69 lv~e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~ 146 (311)
++|||+.+++|.+++..... ....+++..++.++.|++.||+|||++| ++|+||||+||+++.++.+||+|||++
T Consensus 108 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl~Dfg~a 184 (323)
T 3qup_A 108 VILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLS 184 (323)
T ss_dssp EEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred EEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEEeecccc
Confidence 99999999999999965322 2336999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccc
Q 021526 147 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKK 225 (311)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
................++..|+|||.+.+..++.++||||||+++|+|++ |..||.........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~--------------- 249 (323)
T 3qup_A 185 RKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY--------------- 249 (323)
T ss_dssp ----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---------------
T ss_pred ccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH---------------
Confidence 75433332222333456778999999999999999999999999999999 89998643321110
Q ss_pred hhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCC
Q 021526 226 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHP 282 (311)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~~~ 282 (311)
..+........+..++..+.+++.+||..||++|||+.++++.|+++.....-..
T Consensus 250 --~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 250 --NYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp --HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred --HHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 0000011112344567789999999999999999999999999999987654333
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=311.79 Aligned_cols=259 Identities=25% Similarity=0.345 Sum_probs=209.9
Q ss_pred eeeeeeceeccEEEEEE-------CCeEEEEEEeccCCc-cchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL-------CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 72 (311)
...+|+|+||.||++.. .++.||+|.+..... ...+.+.+|+.+++.+ +||||+++++++.++...++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 107 (313)
T 1t46_A 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE 107 (313)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEe
Confidence 46799999999999985 468999999875533 3446788999999999 89999999999999999999999
Q ss_pred cCCCCCHHHHhcccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCce
Q 021526 73 YMPMGSLEDHLYDLEP--------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 138 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~--------------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~v 138 (311)
++++++|.+++..... ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 184 (313)
T 1t46_A 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRIT 184 (313)
T ss_dssp CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEE
T ss_pred cCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEcCCCCE
Confidence 9999999999976331 1235899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcch
Q 021526 139 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSR 217 (311)
Q Consensus 139 kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 217 (311)
||+|||++................++..|+|||++.+..++.++|+||||+++|+|++ |..||........
T Consensus 185 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------- 256 (313)
T 1t46_A 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-------- 256 (313)
T ss_dssp EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--------
T ss_pred EEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH--------
Confidence 9999999876544333333334556788999999988899999999999999999998 9999864332111
Q ss_pred hhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 021526 218 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 279 (311)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~ 279 (311)
.............+..++..+.+++.+||..||.+|||+.++++.|+++.....
T Consensus 257 --------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 257 --------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp --------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred --------HHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 000111111112234556789999999999999999999999999999887644
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=306.70 Aligned_cols=271 Identities=20% Similarity=0.196 Sum_probs=207.5
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCC--eeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD--QRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~ 76 (311)
..++|+|+||.||++.. +++.||||++.... ....+.+.+|+++++.++||||+++++++.... ..++||||+++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 93 (319)
T 4euu_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93 (319)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTT
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCC
Confidence 57899999999999999 58999999987543 344567889999999999999999999987655 77999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE----cCCCceEEeecCCCccCCCC
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL----DNDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~----~~~~~vkl~Df~~~~~~~~~ 152 (311)
++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+||++ +.++.+||+|||++......
T Consensus 94 ~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~ 169 (319)
T 4euu_A 94 GSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD 169 (319)
T ss_dssp CBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTT
T ss_pred CCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCceecCCC
Confidence 99999997532 2334999999999999999999999999 9999999999999 78888999999999754322
Q ss_pred CCcceeeeccccccccCCcccc--------CCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhh-cc
Q 021526 153 DNTHVSTRVMGTYGYCAPEYAM--------SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK-DQ 223 (311)
Q Consensus 153 ~~~~~~~~~~~~~~~~aPE~~~--------~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~ 223 (311)
. ......|+..|+|||++. +..++.++||||||+++|+|++|..||......... ......... ..
T Consensus 170 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~p 244 (319)
T 4euu_A 170 E---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKIITGKP 244 (319)
T ss_dssp C---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHHHHHHHHHCC
T ss_pred C---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHHHHhcCCC
Confidence 1 223356899999999876 567899999999999999999999999744332111 000001100 00
Q ss_pred cc----hhhh--------cCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCC
Q 021526 224 KK----FVHL--------VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSH 281 (311)
Q Consensus 224 ~~----~~~~--------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~~ 281 (311)
.. .... ........++...+..+.+++.+||+.||++|||++|+++..........++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~~~~~ 314 (319)
T 4euu_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRGNSH 314 (319)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-----
T ss_pred cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhcCCcc
Confidence 00 0000 0011122445788899999999999999999999999999988766555444
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=304.69 Aligned_cols=248 Identities=28% Similarity=0.369 Sum_probs=193.8
Q ss_pred eeeeeeceeccEEEEEECCeEEEEEEeccCCc----cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWLCDQLVAIKQLNHEGL----QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
...+|+|+||.||++...++.||+|++..... ...+.+.+|+++++.++||||+++++++.++...++||||++++
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (271)
T 3dtc_A 12 EEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGG 91 (271)
T ss_dssp EEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTE
T ss_pred eeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCC
Confidence 46899999999999999999999999865432 23467889999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcC--------CCceEEeecCCCccC
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN--------DFNPKLSDFGLAKLG 149 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~--------~~~vkl~Df~~~~~~ 149 (311)
+|.+++. ...+++..++.++.|++.||+|||+++..+++|+||+|+||+++. ++.++|+|||.+...
T Consensus 92 ~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~ 166 (271)
T 3dtc_A 92 PLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW 166 (271)
T ss_dssp EHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC----
T ss_pred CHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccc
Confidence 9999993 457999999999999999999999987444789999999999986 678999999998743
Q ss_pred CCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhh
Q 021526 150 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 229 (311)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||........ ....
T Consensus 167 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----------------~~~~ 226 (271)
T 3dtc_A 167 HRT----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV----------------AYGV 226 (271)
T ss_dssp -------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH----------------HHHH
T ss_pred ccc----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----------------HHhh
Confidence 221 12234689999999999988999999999999999999999999963321100 0111
Q ss_pred cCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 021526 230 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274 (311)
Q Consensus 230 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l 274 (311)
.........+..++..+.+++.+||..||++|||+.++++.|+.|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 227 AMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred hcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111122233455677899999999999999999999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=320.01 Aligned_cols=257 Identities=25% Similarity=0.317 Sum_probs=205.6
Q ss_pred eeeeeeceeccEEEEEE-------CCeEEEEEEeccCCc-cchhHHHHHHHHHhcC-CCCcccceeEEEEeCCe-eEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL-------CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQ-RLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~-~~lv~ 71 (311)
...+|+|+||.||++.. .++.||||.+..... ...+.+.+|++++..+ +||||+++++++.+... .++||
T Consensus 27 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~ 106 (359)
T 3vhe_A 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 106 (359)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred ceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEE
Confidence 56899999999999984 458999999975433 3346789999999999 78999999999877554 89999
Q ss_pred ecCCCCCHHHHhcccCCC--------------------------------------------------------------
Q 021526 72 EYMPMGSLEDHLYDLEPD-------------------------------------------------------------- 89 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~-------------------------------------------------------------- 89 (311)
||+++++|.+++......
T Consensus 107 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (359)
T 3vhe_A 107 EFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLY 186 (359)
T ss_dssp ECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CTT
T ss_pred EecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchh
Confidence 999999999999764321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeeeccccccccC
Q 021526 90 QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 169 (311)
Q Consensus 90 ~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~a 169 (311)
...+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++................++..|+|
T Consensus 187 ~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~a 263 (359)
T 3vhe_A 187 KDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 263 (359)
T ss_dssp TTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCC
T ss_pred ccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEC
Confidence 122899999999999999999999999 99999999999999999999999999975433333333444567889999
Q ss_pred CccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHH
Q 021526 170 PEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVA 248 (311)
Q Consensus 170 PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 248 (311)
||++.+..++.++||||||+++|+|++ |..||........ .............+..++..+.+
T Consensus 264 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~l~~ 327 (359)
T 3vhe_A 264 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----------------FCRRLKEGTRMRAPDYTTPEMYQ 327 (359)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH----------------HHHHHHHTCCCCCCTTCCHHHHH
T ss_pred hhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH----------------HHHHHHcCCCCCCCCCCCHHHHH
Confidence 999998999999999999999999998 9999964332110 00001111112234456678999
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 021526 249 VTAMCLNEEANFRPLINDIVVALDYLVSQ 277 (311)
Q Consensus 249 li~~~l~~~p~~RPs~~~l~~~L~~l~~~ 277 (311)
++.+||..||.+|||+.++++.|+.+...
T Consensus 328 li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 328 TMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 99999999999999999999999988754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=307.65 Aligned_cols=259 Identities=18% Similarity=0.161 Sum_probs=206.0
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
...+|.|+||.||++.. +++.||||.+.... ..+.+.+|+++++.+ +||||+++++++..+...++|||++ +++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (330)
T 2izr_A 14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPS 90 (330)
T ss_dssp EEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCC
Confidence 57899999999999997 79999999986543 335788999999999 8999999999999999999999999 899
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCc-----eEEeecCCCccCCCCC
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN-----PKLSDFGLAKLGPVGD 153 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~-----vkl~Df~~~~~~~~~~ 153 (311)
|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++. +||+|||++.......
T Consensus 91 L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~ 164 (330)
T 2izr_A 91 LEDLFDL---CDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164 (330)
T ss_dssp HHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred HHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence 9999965 2568999999999999999999999999 999999999999998887 9999999997543322
Q ss_pred Ccc-----eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhh
Q 021526 154 NTH-----VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 228 (311)
Q Consensus 154 ~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
... ......|+..|+|||++.+..++.++|+||||+++|+|++|..||.............. ...... .
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~---i~~~~~---~ 238 (330)
T 2izr_A 165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQK---IGDTKR---A 238 (330)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHH---HHHHHH---H
T ss_pred CCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHH---HHhhhc---c
Confidence 211 12345689999999999999999999999999999999999999975432211111110 000000 0
Q ss_pred hcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCC
Q 021526 229 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 280 (311)
Q Consensus 229 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~ 280 (311)
.....+. ..++ .+.+++.+||..||.+||++++|.+.|+.+......
T Consensus 239 ~~~~~~~----~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~ 285 (330)
T 2izr_A 239 TPIEVLC----ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY 285 (330)
T ss_dssp SCHHHHT----TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CCHHHHh----ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 0000000 1134 899999999999999999999999999988776543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=311.08 Aligned_cols=245 Identities=15% Similarity=0.151 Sum_probs=199.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
...+|+|+||.||++.. +++.||+|.+... ......+.+|+++++.++||||+++++++.+....++||||+++++|
T Consensus 10 ~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L 88 (321)
T 1tki_A 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI 88 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBH
T ss_pred eeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCH
Confidence 56899999999999999 6899999998643 33446788999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcC--CCceEEeecCCCccCCCCCCcce
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN--DFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~--~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
.+++.. ....+++..++.++.|++.||.|||+.| ++|+||||+||+++. ++.+||+|||++..... ...
T Consensus 89 ~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~---~~~ 159 (321)
T 1tki_A 89 FERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDN 159 (321)
T ss_dssp HHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT---TCE
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC---CCc
Confidence 999954 3457999999999999999999999999 999999999999987 78999999999975432 223
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCC
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 237 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
.....+++.|+|||++.+..++.++|+||||+++|+|++|..||....... ............ ...
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~~~~--------~~~ 225 (321)
T 1tki_A 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNAEYTF--------DEE 225 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTCCCC--------CHH
T ss_pred cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH------HHHHHHcCCCCC--------Chh
Confidence 344568999999999998889999999999999999999999996432210 000111100000 000
Q ss_pred CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 238 YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.....+.++.++|.+||..||.+|||+.++++.
T Consensus 226 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 012346779999999999999999999999983
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=308.48 Aligned_cols=260 Identities=26% Similarity=0.339 Sum_probs=206.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEE--EEEEeccC-CccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLV--AIKQLNHE-GLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~v--aiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
...+|.|+||.||++.. ++..+ ++|.+... .....+.+.+|+++++.+ +||||+++++++.++...++|||+++
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 109 (327)
T 1fvr_A 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 109 (327)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred eeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCC
Confidence 46899999999999998 56644 99988643 234556799999999999 89999999999999999999999999
Q ss_pred CCCHHHHhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeec
Q 021526 76 MGSLEDHLYDLE------------PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 143 (311)
Q Consensus 76 ~~~L~~~l~~~~------------~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df 143 (311)
+++|.+++.... .....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+||
T Consensus 110 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kL~Df 186 (327)
T 1fvr_A 110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF 186 (327)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCT
T ss_pred CCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeEEEccc
Confidence 999999997633 23457999999999999999999999999 999999999999999999999999
Q ss_pred CCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhc
Q 021526 144 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKD 222 (311)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 222 (311)
|++.... .........++..|+|||++.+..++.++|+||||+++|+|++ |..||........
T Consensus 187 g~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~------------- 250 (327)
T 1fvr_A 187 GLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------------- 250 (327)
T ss_dssp TCEESSC---EECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------------
T ss_pred CcCcccc---ccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH-------------
Confidence 9986321 1111223446778999999988889999999999999999998 9999963321100
Q ss_pred ccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCCCC
Q 021526 223 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVS 284 (311)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~~~~~ 284 (311)
...+........+..++..+.++|.+||..||.+|||+.++++.|+.+..........
T Consensus 251 ----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~ 308 (327)
T 1fvr_A 251 ----YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNT 308 (327)
T ss_dssp ----HHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBCC
T ss_pred ----HHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCcccc
Confidence 0001111112234456778999999999999999999999999999999877654433
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=329.81 Aligned_cols=251 Identities=24% Similarity=0.332 Sum_probs=207.7
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
...+|+|+||.||++.. .+..||||.+... ....+.+.+|+++++.++||||+++++++.++...++||||+.+++|
T Consensus 225 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L 303 (495)
T 1opk_A 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 303 (495)
T ss_dssp EEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred eeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCH
Confidence 46899999999999999 4899999998644 34567899999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
.+++.. .....+++..++.++.|++.||+|||+++ ++|+||+|+|||++.++.+||+|||++....... .....
T Consensus 304 ~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~ 377 (495)
T 1opk_A 304 LDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHA 377 (495)
T ss_dssp HHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-EECCT
T ss_pred HHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc-eeecC
Confidence 999965 23456899999999999999999999999 9999999999999999999999999997543211 11112
Q ss_pred eccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCC
Q 021526 160 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRY 238 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
...++..|+|||++....++.++||||||+++|+|++ |..||....... ..+.+....+...
T Consensus 378 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~ 440 (495)
T 1opk_A 378 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----------------VYELLEKDYRMER 440 (495)
T ss_dssp TCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----------------HHHHHHTTCCCCC
T ss_pred CCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHHHcCCCCCC
Confidence 2345678999999998899999999999999999999 889986433110 1111111222234
Q ss_pred cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 021526 239 PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 276 (311)
Q Consensus 239 ~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~ 276 (311)
+..++..+.++|.+||+.||++|||+.+|++.|+.+..
T Consensus 441 ~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 441 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 55677889999999999999999999999999988754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=313.94 Aligned_cols=240 Identities=24% Similarity=0.279 Sum_probs=198.5
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
...+|+|+||.||++.. +++.||+|++.... ......+.+|+.+++.++||||+++++++.++...++||||+ +
T Consensus 14 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~ 92 (336)
T 3h4j_B 14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-G 92 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-C
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-C
Confidence 57899999999999998 78999999986542 233457899999999999999999999999999999999999 6
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ...+++..++.++.|++.||.|||+.| ++|+||||+||+++.++.+||+|||++...... .
T Consensus 93 g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~---~ 162 (336)
T 3h4j_B 93 GELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG---N 162 (336)
T ss_dssp EEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS---B
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC---c
Confidence 799998854 457999999999999999999999999 999999999999999999999999998754322 2
Q ss_pred eeeeccccccccCCccccCCCC-CccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
......|++.|+|||++.+..+ +.++||||||+++|+|++|..||........... +. ...
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~-----------------i~-~~~ 224 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK-----------------VN-SCV 224 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC-----------------CC-SSC
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH-----------------HH-cCC
Confidence 2334568999999999988776 6899999999999999999999964322111000 00 001
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
...+...+..+.++|.+||..||.+|||++|+++.
T Consensus 225 ~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 225 YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 12344567789999999999999999999999873
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=316.31 Aligned_cols=243 Identities=24% Similarity=0.319 Sum_probs=199.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+..+|+|+||.||.+.. +++.||+|.+.+.. ......+.+|+++++.++||||+++++++.+....++||||+.+
T Consensus 20 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~g 99 (384)
T 4fr4_A 20 LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLG 99 (384)
T ss_dssp EEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCC
Confidence 57899999999999999 68999999986542 33456788999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++. ....+++..+..++.|++.||+|||+.| |+|+||||+||+++.++.++|+|||++..... ..
T Consensus 100 g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~---~~ 169 (384)
T 4fr4_A 100 GDLRYHLQ----QNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR---ET 169 (384)
T ss_dssp EEHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT---TC
T ss_pred CcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC---CC
Confidence 99999995 3567999999999999999999999999 99999999999999999999999999975432 22
Q ss_pred eeeeccccccccCCccccC---CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 157 VSTRVMGTYGYCAPEYAMS---GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
......|++.|+|||++.. ..++.++|+|||||++|+|++|..||............. ....
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~---~~~~------------ 234 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH---TFET------------ 234 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHH---HHHH------------
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHH---HHhh------------
Confidence 2344679999999999864 458899999999999999999999996443222111110 0000
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPL-INDIVV 269 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs-~~~l~~ 269 (311)
....++..++..+.++|.+||+.||.+||+ ++++++
T Consensus 235 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 235 TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 011234556788999999999999999998 777665
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=308.90 Aligned_cols=264 Identities=21% Similarity=0.220 Sum_probs=199.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
...+|.|+||.||++.. +++.||+|.+.... ......+.+|+.+++.++||||+++++++..+...+++||++++
T Consensus 37 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 116 (310)
T 2wqm_A 37 EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA 116 (310)
T ss_dssp EEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCS
T ss_pred EEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCC
Confidence 46899999999999998 78999999987543 23346788999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 117 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~--~~ 191 (310)
T 2wqm_A 117 GDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TT 191 (310)
T ss_dssp CBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------------
T ss_pred CCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecCC--Cc
Confidence 9999999754445677999999999999999999999999 999999999999999999999999998653221 11
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......++..|+|||++.+..++.++|+||||+++|+|++|..||...... ......... .. ....
T Consensus 192 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~-------~~---~~~~ 257 (310)
T 2wqm_A 192 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIE-------QC---DYPP 257 (310)
T ss_dssp -------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHHHH-------TT---CSCC
T ss_pred cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHHhh-------cc---cCCC
Confidence 223345788999999999889999999999999999999999998633211 001000000 00 0000
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCCCC
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVS 284 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~~~~~ 284 (311)
..+..++..+.+++.+||..||++|||+.++++.|+++.+....++..
T Consensus 258 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~~ 305 (310)
T 2wqm_A 258 LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEH 305 (310)
T ss_dssp CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-----
T ss_pred CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhhh
Confidence 112345678999999999999999999999999999999887776654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=306.53 Aligned_cols=253 Identities=25% Similarity=0.334 Sum_probs=209.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
...+|+|++|.||.+.. .+..||+|.+... ....+.+.+|+++++.++||||+++++++.++...++|||++++++|
T Consensus 18 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 96 (288)
T 3kfa_A 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 96 (288)
T ss_dssp EEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEH
T ss_pred EeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcH
Confidence 46899999999999999 5899999998643 44557899999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
.+++.. .....+++..++.++.|++.||++||+.+ ++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 97 ~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~ 170 (288)
T 3kfa_A 97 LDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHA 170 (288)
T ss_dssp HHHHHH--CCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-SEEET
T ss_pred HHHHHh--cccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc-ccccc
Confidence 999965 34466999999999999999999999999 9999999999999999999999999987543222 22223
Q ss_pred eccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCC
Q 021526 160 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRY 238 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
...++..|+|||++.+..++.++|+||||+++|+|++ |..||....... ..+.+........
T Consensus 171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~ 233 (288)
T 3kfa_A 171 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----------------VYELLEKDYRMER 233 (288)
T ss_dssp TEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----------------HHHHHHTTCCCCC
T ss_pred CCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHHhccCCCCC
Confidence 3446778999999998899999999999999999999 889986432211 1111111122233
Q ss_pred cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 021526 239 PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 278 (311)
Q Consensus 239 ~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~ 278 (311)
+..++..+.+++.+||..||.+|||+.++++.|+.+....
T Consensus 234 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 234 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 4456778999999999999999999999999998877653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=315.84 Aligned_cols=248 Identities=21% Similarity=0.192 Sum_probs=199.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC-----ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG-----LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
...+|+|+||.||++.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.++...++||||+
T Consensus 29 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 108 (351)
T 3c0i_A 29 CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFM 108 (351)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCC
Confidence 56899999999999998 68999999986432 224577999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCc---eEEeecCCCccCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN---PKLSDFGLAKLGPV 151 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~---vkl~Df~~~~~~~~ 151 (311)
++++|.+++.........+++..++.++.|++.||+|||+++ ++|+||||+||+++.++. +||+|||++.....
T Consensus 109 ~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~ 185 (351)
T 3c0i_A 109 DGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE 185 (351)
T ss_dssp SSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTCEECCT
T ss_pred CCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcceeEecC
Confidence 999999888654444567899999999999999999999999 999999999999976655 99999999975432
Q ss_pred CCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcC
Q 021526 152 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231 (311)
Q Consensus 152 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
. ........|++.|+|||++.+..++.++||||||+++|+|++|..||...... . ........... .
T Consensus 186 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~---~~~i~~~~~~~----~ 252 (351)
T 3c0i_A 186 S--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER----L---FEGIIKGKYKM----N 252 (351)
T ss_dssp T--SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH----H---HHHHHHTCCCC----C
T ss_pred C--CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH----H---HHHHHcCCCCC----C
Confidence 2 12233456899999999999989999999999999999999999999642210 0 00000000000 0
Q ss_pred ccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
+ ......+..+.++|.+||..||++|||+.++++
T Consensus 253 ~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 253 P----RQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp H----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred c----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 000134677999999999999999999999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=309.52 Aligned_cols=244 Identities=23% Similarity=0.239 Sum_probs=199.1
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc------chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ------GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
...+|.|+||.||++.. +++.||+|.+...... ..+.+.+|+.+++.++||||+++++++.++...++|||+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 95 (326)
T 2y0a_A 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95 (326)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEc
Confidence 46899999999999999 6899999998765322 356789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCC----ceEEeecCCCccC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF----NPKLSDFGLAKLG 149 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~----~vkl~Df~~~~~~ 149 (311)
+.+++|.+++. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++ .+||+|||++...
T Consensus 96 ~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 96 VAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp CCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred CCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 99999999994 3567999999999999999999999999 99999999999998887 7999999999754
Q ss_pred CCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhh
Q 021526 150 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 229 (311)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
.... ......|++.|+|||++.+..++.++|+||||+++|+|++|..||........ ........
T Consensus 169 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~~~~~~------ 233 (326)
T 2y0a_A 169 DFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LANVSAVN------ 233 (326)
T ss_dssp CTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHHTC------
T ss_pred CCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH------HHHHHhcC------
Confidence 3221 22335689999999999988999999999999999999999999964321110 00000000
Q ss_pred cCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 230 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 230 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
...........+..+.++|.+||..||++|||+.++++
T Consensus 234 --~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 234 --YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp --CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000011234677999999999999999999999987
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=315.13 Aligned_cols=272 Identities=27% Similarity=0.360 Sum_probs=209.6
Q ss_pred eeeeeeceeccEEEEEE------CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEE--eCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL------CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT--SGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~ 73 (311)
+..+|.|+||.||++.. .++.||+|.+........+.+.+|+++++.++||||+++++++. +....++||||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 107 (327)
T 3lxl_A 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEY 107 (327)
T ss_dssp EEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEEC
T ss_pred hhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEee
Confidence 57899999999999984 68999999998776666678999999999999999999999886 45678999999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 153 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~ 153 (311)
+++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 108 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 181 (327)
T 3lxl_A 108 LPSGCLRDFLQR---HRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181 (327)
T ss_dssp CTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECCTTC
T ss_pred cCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceecccCC
Confidence 999999999965 2346999999999999999999999999 9999999999999999999999999997643322
Q ss_pred Ccc-eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCc
Q 021526 154 NTH-VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 232 (311)
Q Consensus 154 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
... ......++..|+|||++.+..++.++||||||+++|+|++|..||............ . ................
T Consensus 182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~ 259 (327)
T 3lxl_A 182 DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG-C-ERDVPALSRLLELLEE 259 (327)
T ss_dssp SEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CCHHHHHHHHHHT
T ss_pred ccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc-c-ccccccHHHHHHHhhc
Confidence 211 122345778899999999888999999999999999999999998633221000000 0 0000001111222222
Q ss_pred cCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCC
Q 021526 233 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSH 281 (311)
Q Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~~ 281 (311)
......+..++..+.++|.+||+.||++|||+.++++.|+.+.......
T Consensus 260 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 308 (327)
T 3lxl_A 260 GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308 (327)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-------
T ss_pred ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCc
Confidence 2333445667888999999999999999999999999999987655433
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=304.23 Aligned_cols=259 Identities=24% Similarity=0.291 Sum_probs=210.4
Q ss_pred eeeeceeccEEEEEE----CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 4 CYLSCKFYNVGLVWL----CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~----~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
.+|+|+||.||++.. .+..||+|.+.... ....+.+.+|+++++.++||||+++++++ .+...++|||++.+++
T Consensus 17 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~ 95 (287)
T 1u59_A 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP 95 (287)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEE
T ss_pred cccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCC
Confidence 799999999999986 57889999987643 33456789999999999999999999998 5567899999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc-e
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH-V 157 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~-~ 157 (311)
|.+++.. ....+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.......... .
T Consensus 96 L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 169 (287)
T 1u59_A 96 LHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 169 (287)
T ss_dssp HHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECC
T ss_pred HHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCcceeec
Confidence 9999954 4567999999999999999999999999 9999999999999999999999999987543322211 1
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
.....++..|+|||++.+..++.++|+||||+++|+|++ |..||........ . ..+......
T Consensus 170 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~--------------~~i~~~~~~ 232 (287)
T 1u59_A 170 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---M--------------AFIEQGKRM 232 (287)
T ss_dssp CCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH---H--------------HHHHTTCCC
T ss_pred cccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH---H--------------HHHhcCCcC
Confidence 222345788999999988889999999999999999998 9999964332110 0 000011112
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCCCCCC
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSRN 286 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~~~~~~~ 286 (311)
..+..++..+.++|.+||..||.+||++.++++.|+.+........+...
T Consensus 233 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~~ 282 (287)
T 1u59_A 233 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH 282 (287)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSCC
T ss_pred CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCCc
Confidence 33456678899999999999999999999999999999887776665543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=305.30 Aligned_cols=252 Identities=22% Similarity=0.302 Sum_probs=194.1
Q ss_pred eeeeeeceeccEEEEEE-----CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL-----CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
...+|+|+||.||++.. .+..||+|.+.... ....+.+.+|+.+++.++||||+++++++. ++..++|||+++
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~ 98 (281)
T 1mp8_A 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCT 98 (281)
T ss_dssp EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred EeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCC
Confidence 46899999999999998 24579999986543 233467889999999999999999999974 567899999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++....... .
T Consensus 99 ~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 171 (281)
T 1mp8_A 99 LGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-Y 171 (281)
T ss_dssp TEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCccc-c
Confidence 9999999965 3457999999999999999999999999 9999999999999999999999999987542221 1
Q ss_pred ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccC
Q 021526 156 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
.......+++.|+|||++.+..++.++|+||||+++|+|++ |..||........ .. . + ....
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~---~----------i-~~~~ 234 (281)
T 1mp8_A 172 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IG---R----------I-ENGE 234 (281)
T ss_dssp -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HH---H----------H-HTTC
T ss_pred cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HH---H----------H-HcCC
Confidence 11223446778999999988899999999999999999996 8899864322110 00 0 0 0011
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 278 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~ 278 (311)
....+..++..+.+++.+||..||++|||+.++++.|+++....
T Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 235 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 11234556788999999999999999999999999999987654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=304.57 Aligned_cols=242 Identities=21% Similarity=0.256 Sum_probs=190.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc--------------------------chhHHHHHHHHHhcCCCCc
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ--------------------------GHQEFIVEVLMLSLLHHDN 53 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~~ 53 (311)
...+|+|+||.||++.. +++.||+|.+...... ..+.+.+|+++++.++|||
T Consensus 18 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 97 (298)
T 2zv2_A 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPN 97 (298)
T ss_dssp EEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTT
T ss_pred EeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCC
Confidence 56899999999999998 7899999998654321 2356889999999999999
Q ss_pred ccceeEEEEe--CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEE
Q 021526 54 LVTLIGYCTS--GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANIL 131 (311)
Q Consensus 54 i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil 131 (311)
|+++++++.+ +...++|||++++++|.+++ ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+
T Consensus 98 iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil 169 (298)
T 2zv2_A 98 VVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLL 169 (298)
T ss_dssp BCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred CCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEE
Confidence 9999999986 56889999999999998765 3457999999999999999999999999 999999999999
Q ss_pred EcCCCceEEeecCCCccCCCCCCcceeeeccccccccCCccccCCC---CCccccchhHHHHHHHHHhCCCCccccCccc
Q 021526 132 LDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK---LTLKSDIYSFGVVLLELITGRKAMDLSKGQG 208 (311)
Q Consensus 132 ~~~~~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 208 (311)
++.++.+||+|||++...... ........|++.|+|||++.+.. ++.++|+||||+++|+|++|..||......
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~- 246 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM- 246 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH-
T ss_pred ECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH-
Confidence 999999999999998754322 12233456899999999987654 478899999999999999999999632210
Q ss_pred cccchhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 209 EQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
........ ..........++..+.++|.+||+.||++|||+.++++
T Consensus 247 -----~~~~~~~~----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 247 -----CLHSKIKS----------QALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp -----HHHHHHHH----------CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -----HHHHHHhc----------ccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 00000000 00111112345677999999999999999999999875
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=316.97 Aligned_cols=248 Identities=26% Similarity=0.354 Sum_probs=199.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
+.++|+|+||.||++.. +++.||+|++.+... .....+.+|..++..+ +||||+++++++.++...++||||++
T Consensus 57 ~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~ 136 (396)
T 4dc2_A 57 LRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 136 (396)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCC
Confidence 57899999999999999 689999999976532 2335688899999876 89999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+++|.+++.. ...+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++..... ..
T Consensus 137 gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~--~~ 207 (396)
T 4dc2_A 137 GGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PG 207 (396)
T ss_dssp TCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--TT
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeeccc--CC
Confidence 9999999954 457999999999999999999999999 99999999999999999999999999874221 22
Q ss_pred ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCcccccc--chhcchhhhhcccchhhhcCcc
Q 021526 156 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN--LVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
.......||+.|+|||++.+..++.++|+||||+++|+|++|..||.......... ..... ...+...
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~---------~~~i~~~- 277 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL---------FQVILEK- 277 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHH---------HHHHHHC-
T ss_pred CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHH---------HHHHhcc-
Confidence 23445679999999999999999999999999999999999999996443221110 00000 0001111
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCH------HHHHH
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLI------NDIVV 269 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~------~~l~~ 269 (311)
...+|...+..+.++|.+||+.||++||++ +++++
T Consensus 278 -~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 278 -QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred -ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 113455667789999999999999999985 56665
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=302.65 Aligned_cols=251 Identities=25% Similarity=0.335 Sum_probs=205.4
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
...+|+|++|.||.+.. +++.||+|.+.... ...+.+.+|+++++.++||||+++++++.++...+++||++++++|.
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (267)
T 3t9t_A 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLS 91 (267)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHH
T ss_pred eeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHH
Confidence 46799999999999999 78899999987543 34578999999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++.. ....+++..++.++.|++.||++||+.+ ++|+||+|+||+++.++.++|+|||++...... .......
T Consensus 92 ~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~ 164 (267)
T 3t9t_A 92 DYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSSTG 164 (267)
T ss_dssp HHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-HHHSTTS
T ss_pred HHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccc-ccccccc
Confidence 99965 3457899999999999999999999999 999999999999999999999999998753221 1111122
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
..++..|+|||++.+..++.++|+||||+++|+|++ |..||........ .... ........+
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~i-----------~~~~~~~~~ 227 (267)
T 3t9t_A 165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV------VEDI-----------STGFRLYKP 227 (267)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHHH-----------HTTCCCCCC
T ss_pred ccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH------HHHH-----------hcCCcCCCC
Confidence 346778999999988889999999999999999999 8999863321100 0000 001111223
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 277 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~ 277 (311)
...+..+.+++.+||+.||++||++.++++.|+++...
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 34567899999999999999999999999999998753
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=310.15 Aligned_cols=259 Identities=25% Similarity=0.340 Sum_probs=202.3
Q ss_pred eeeeeeceeccEEEEEEC------CeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWLC------DQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~------~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
..++|+|+||.||++... +..||+|.+..... .....+.+|+.+++.++||||+++++++.+....++|||++
T Consensus 49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 128 (333)
T 1mqb_A 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 128 (333)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCC
Confidence 367999999999999872 24699999875432 33457889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 129 ~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 202 (333)
T 1mqb_A 129 ENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 202 (333)
T ss_dssp TTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred CCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhccccc
Confidence 99999999965 3467999999999999999999999999 99999999999999999999999999875432211
Q ss_pred cc-eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCc
Q 021526 155 TH-VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 232 (311)
Q Consensus 155 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
.. ......++..|+|||++.+..++.++|+||||+++|+|++ |..||....... ....+..
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-----------------~~~~~~~ 265 (333)
T 1mqb_A 203 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-----------------VMKAIND 265 (333)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----------------HHHHHHT
T ss_pred cccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH-----------------HHHHHHC
Confidence 11 1122345778999999998899999999999999999998 999985322110 0000001
Q ss_pred cCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCCC
Q 021526 233 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPV 283 (311)
Q Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~~~~ 283 (311)
......+..++..+.+++.+||+.||++||++.++++.|+++.........
T Consensus 266 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~~~ 316 (333)
T 1mqb_A 266 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKT 316 (333)
T ss_dssp TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGGS
T ss_pred CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhhhh
Confidence 111122345677899999999999999999999999999998876555433
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=307.89 Aligned_cols=266 Identities=24% Similarity=0.347 Sum_probs=205.4
Q ss_pred eeeeeeceeccEEEEEE------CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeC--CeeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL------CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 72 (311)
...+|.|+||.||.+.. .++.||+|.+.... ....+.+.+|+++++.++||||+++++++..+ ...+++||
T Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 105 (302)
T 4e5w_A 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 105 (302)
T ss_dssp EEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEE
T ss_pred hhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEE
Confidence 46899999999999984 68999999987543 34457899999999999999999999999876 66899999
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCC
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~ 152 (311)
++++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 106 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 106 FLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp CCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred eCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccccccCC
Confidence 9999999999965 3456999999999999999999999999 999999999999999999999999998764332
Q ss_pred CCc-ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcC
Q 021526 153 DNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231 (311)
Q Consensus 153 ~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
... .......++..|+|||++.+..++.++|+||||+++|+|++|..|+............... . ............
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~ 257 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH-G-QMTVTRLVNTLK 257 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCC-G-GGHHHHHHHHHH
T ss_pred CcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcc-c-ccCHHHHHHHHh
Confidence 221 2233455788899999999888999999999999999999999986422110000000000 0 000111111222
Q ss_pred ccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 021526 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 275 (311)
Q Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~ 275 (311)
.......+..++..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 258 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 258 EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 22223345567788999999999999999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=300.75 Aligned_cols=260 Identities=17% Similarity=0.102 Sum_probs=207.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
...+|+|++|.||++.. +++.||+|.+.... ..+.+.+|+.+++.+ +|++++++++++.++...+++||++ +++
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 91 (298)
T 1csn_A 15 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPS 91 (298)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCC
Confidence 46899999999999997 89999999986432 345788999999999 7999999999999999999999999 999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCc-----eEEeecCCCccCCCCC
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN-----PKLSDFGLAKLGPVGD 153 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~-----vkl~Df~~~~~~~~~~ 153 (311)
|.+++.. .+..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++. ++|+|||++.......
T Consensus 92 L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~ 165 (298)
T 1csn_A 92 LEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165 (298)
T ss_dssp HHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred HHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence 9999965 3456999999999999999999999999 999999999999987776 9999999987543322
Q ss_pred Cc-----ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhh
Q 021526 154 NT-----HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 228 (311)
Q Consensus 154 ~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
.. .......|+..|+|||++.+..++.++||||||+++|+|++|..||.................... ......
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~ 244 (298)
T 1csn_A 166 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ-STPLRE 244 (298)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-HSCHHH
T ss_pred ccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc-CccHHH
Confidence 21 112345689999999999998999999999999999999999999975432222111110000000 000000
Q ss_pred hcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCC
Q 021526 229 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 280 (311)
Q Consensus 229 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~ 280 (311)
. ...++..+.+++.+||+.||++||++++|++.|+++......
T Consensus 245 ~---------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 245 L---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp H---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred H---------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 0 123467899999999999999999999999999999876544
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=305.54 Aligned_cols=255 Identities=28% Similarity=0.321 Sum_probs=199.8
Q ss_pred eeeeeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHHH
Q 021526 2 LCCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (311)
...+|+|+||.||++...++.||+|.+... ...+.+.+|+++++.++||||+++++++. +..++||||+++++|.+
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~ 88 (307)
T 2eva_A 13 EEVVGRGAFGVVCKAKWRAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYN 88 (307)
T ss_dssp EEEEECCSSSEEEEEEETTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHHH
T ss_pred eeEeecCCCceEEEEEECCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHH
Confidence 468999999999999999999999998533 34567899999999999999999999876 34799999999999999
Q ss_pred HhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh---CCCCCeeecCCCCCcEEEcCCCc-eEEeecCCCccCCCCCCcce
Q 021526 82 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC---KANPPVIYRDLKSANILLDNDFN-PKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 82 ~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~---~~~~~i~H~di~p~nil~~~~~~-vkl~Df~~~~~~~~~~~~~~ 157 (311)
++.... ....+....++.++.|++.||+|||+ ++ ++|+||+|+||+++.++. +||+|||++..... .
T Consensus 89 ~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~-----~ 159 (307)
T 2eva_A 89 VLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----H 159 (307)
T ss_dssp HHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC------------
T ss_pred HHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEccccccccccc-----c
Confidence 996522 22357889999999999999999999 67 999999999999998886 79999999864321 1
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCC
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 237 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
.....|+..|+|||++.+..++.++||||||+++|+|++|..||......... ..... .......
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~~~~~-----------~~~~~~~ 224 (307)
T 2eva_A 160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR----IMWAV-----------HNGTRPP 224 (307)
T ss_dssp -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH----HHHHH-----------HTTCCCC
T ss_pred cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH----HHHHH-----------hcCCCCC
Confidence 22345899999999999989999999999999999999999999643221100 00000 0001112
Q ss_pred CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCCCC
Q 021526 238 YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVS 284 (311)
Q Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~~~~~ 284 (311)
.+..++..+.+++.+||+.||++|||++++++.|+.+.........+
T Consensus 225 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~ 271 (307)
T 2eva_A 225 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271 (307)
T ss_dssp CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSC
T ss_pred cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCc
Confidence 23445677999999999999999999999999999998876654443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=326.87 Aligned_cols=253 Identities=24% Similarity=0.347 Sum_probs=205.1
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
...+|+|+||.||++.. ++..||||.+... ....+.+.+|+++++.++||||+++++++. +...++|||++.+++|.
T Consensus 193 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~ 270 (454)
T 1qcf_A 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLL 270 (454)
T ss_dssp EEEEECCSSEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHH
T ss_pred EEEcccCCceEEEEEEECCccEEEEEEecCC-CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHH
Confidence 46899999999999999 6889999998754 345678999999999999999999999986 66789999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++... ....+++..++.++.|++.||+|||+++ ++|+||+|+|||++.++.+||+|||+++..... .......
T Consensus 271 ~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~-~~~~~~~ 344 (454)
T 1qcf_A 271 DFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN-EYTAREG 344 (454)
T ss_dssp HHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH-HHHTTCS
T ss_pred HHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC-ceeccCC
Confidence 999641 2346888999999999999999999999 999999999999999999999999999753221 1111122
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
..++..|+|||++....++.++||||||+++|+|++ |..||....... +. ..+....+...+
T Consensus 345 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~---~~--------------~~i~~~~~~~~~ 407 (454)
T 1qcf_A 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VI--------------RALERGYRMPRP 407 (454)
T ss_dssp SSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HH--------------HHHHHTCCCCCC
T ss_pred CcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH---HH--------------HHHHcCCCCCCC
Confidence 345778999999988899999999999999999999 999996332110 00 000011112234
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 279 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~ 279 (311)
..++..+.++|.+||..||++|||+++|++.|+.+.....
T Consensus 408 ~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~ 447 (454)
T 1qcf_A 408 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447 (454)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence 5667889999999999999999999999999999876443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=314.08 Aligned_cols=246 Identities=19% Similarity=0.188 Sum_probs=201.7
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
+..+|+|+||.||++.. +++.||+|.+..........+.+|+++++.++||||+++++++.++...++||||+.+++|
T Consensus 56 ~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L 135 (387)
T 1kob_A 56 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL 135 (387)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBH
T ss_pred EEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcH
Confidence 56899999999999999 6899999999766555567889999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcC--CCceEEeecCCCccCCCCCCcce
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN--DFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~--~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
.+++.. ....+++..++.++.|++.||+|||+.| ++|+||||+||+++. .+.+||+|||++...... ..
T Consensus 136 ~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~---~~ 206 (387)
T 1kob_A 136 FDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD---EI 206 (387)
T ss_dssp HHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT---SC
T ss_pred HHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC---cc
Confidence 999954 3457999999999999999999999999 999999999999974 567999999999754322 22
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCC
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 237 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
.....|++.|+|||++.+..++.++|||||||++|+|++|..||........ ....... .......
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~------~~~i~~~--------~~~~~~~ 272 (387)
T 1kob_A 207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET------LQNVKRC--------DWEFDED 272 (387)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHHC--------CCCCCSS
T ss_pred eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH------HHHHHhC--------CCCCCcc
Confidence 3345689999999999999999999999999999999999999964322100 0000000 0001111
Q ss_pred CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 238 YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.....+..+.++|.+||..||++|||+.++++.
T Consensus 273 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 273 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 123456789999999999999999999999863
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=324.43 Aligned_cols=253 Identities=27% Similarity=0.358 Sum_probs=201.7
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
...+|+|+||.||++.. ++..||||.+.... ...+.+.+|+++++.++||||+++++++.+ ...++||||+.+++|.
T Consensus 189 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~ 266 (452)
T 1fmk_A 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 266 (452)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHH
T ss_pred eeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHH
Confidence 46799999999999999 56789999987543 345789999999999999999999999865 6789999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++.. ..+..+++..++.++.|++.||+|||+++ ++|+||+|+|||++.++.+||+|||++....... ......
T Consensus 267 ~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~ 340 (452)
T 1fmk_A 267 DFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQG 340 (452)
T ss_dssp HHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred HHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc-eecccC
Confidence 99954 12356899999999999999999999999 9999999999999999999999999997543211 111223
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
..++..|+|||++.+..++.++||||||+++|+|++ |..||....... ....+....+...+
T Consensus 341 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-----------------~~~~i~~~~~~~~~ 403 (452)
T 1fmk_A 341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----------------VLDQVERGYRMPCP 403 (452)
T ss_dssp --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----------------HHHHHHTTCCCCCC
T ss_pred CcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHHHcCCCCCCC
Confidence 346778999999988899999999999999999999 899986332110 00011111122335
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 279 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~ 279 (311)
..++..+.++|.+||..||++|||+++|++.|+.+.....
T Consensus 404 ~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 5677889999999999999999999999999998875543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=311.16 Aligned_cols=259 Identities=25% Similarity=0.348 Sum_probs=207.3
Q ss_pred eeeeeeceeccEEEEEE---------CCeEEEEEEeccCCc-cchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEE
Q 021526 2 LCCYLSCKFYNVGLVWL---------CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLV 70 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~---------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 70 (311)
...+|.|+||.||++.. .+..||+|.+..... .....+.+|+++++.+ +||||+++++++.++...++|
T Consensus 40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 119 (334)
T 2pvf_A 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 119 (334)
T ss_dssp EEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEE
T ss_pred eeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEE
Confidence 46899999999999986 357899999875432 3446788999999999 899999999999999999999
Q ss_pred EecCCCCCHHHHhcccCCC------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCce
Q 021526 71 YEYMPMGSLEDHLYDLEPD------------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 138 (311)
Q Consensus 71 ~e~~~~~~L~~~l~~~~~~------------~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~v 138 (311)
||++++++|.+++...... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+
T Consensus 120 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~ 196 (334)
T 2pvf_A 120 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVM 196 (334)
T ss_dssp EECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred EECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEEcCCCCE
Confidence 9999999999999764321 235899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcch
Q 021526 139 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSR 217 (311)
Q Consensus 139 kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 217 (311)
||+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||....... ..
T Consensus 197 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~- 269 (334)
T 2pvf_A 197 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------LF- 269 (334)
T ss_dssp EECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HH-
T ss_pred EEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH------HH-
Confidence 9999999875443322222333456788999999988889999999999999999999 999986332110 00
Q ss_pred hhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCC
Q 021526 218 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 280 (311)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~ 280 (311)
..+........+..++..+.+++.+||..+|.+||++.++++.|+.+......
T Consensus 270 ----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 270 ----------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp ----------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred ----------HHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 00000111123445677899999999999999999999999999999876554
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=310.52 Aligned_cols=269 Identities=28% Similarity=0.400 Sum_probs=210.4
Q ss_pred eeeeeeceeccEEEEEE------CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEe--CCeeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL------CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS--GDQRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 72 (311)
+..+|+|+||.||.+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+ ....++|||
T Consensus 36 ~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 115 (318)
T 3lxp_A 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVME 115 (318)
T ss_dssp EEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEEC
T ss_pred hheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEe
Confidence 57899999999998865 68999999987553 2345678999999999999999999999987 467899999
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCC
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~ 152 (311)
++++++|.+++.. ..+++..++.++.|++.||++||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 116 ~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 116 YVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp CCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred cccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 9999999999954 34899999999999999999999999 999999999999999999999999999764332
Q ss_pred CCc-ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcC
Q 021526 153 DNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231 (311)
Q Consensus 153 ~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
... .......++..|+|||++.+..++.++|+||||+++|+|++|..||......... ...+..... ....+.+.+.
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~ 265 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE-LIGIAQGQM-TVLRLTELLE 265 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HHCSCCHHH-HHHHHHHHHH
T ss_pred ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh-hhcccccch-hHHHHHHHHh
Confidence 221 1223345788899999999888999999999999999999999998633211000 000000000 0112222223
Q ss_pred ccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCC
Q 021526 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 280 (311)
Q Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~ 280 (311)
.......+..++..+.++|.+||+.||++|||+.++++.|+.+.....+
T Consensus 266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 3333344566778899999999999999999999999999998876543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=313.78 Aligned_cols=245 Identities=20% Similarity=0.174 Sum_probs=198.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
...+|.|+||.||++.. +++.||+|++..... ...+.+.+|+++++.++||||+++++++.++...++|||++.++
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg 113 (362)
T 2bdw_A 34 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 113 (362)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCC
Confidence 46899999999999999 689999999976533 33467889999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCC---ceEEeecCCCccCCCCCC
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF---NPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~---~vkl~Df~~~~~~~~~~~ 154 (311)
+|.+++. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++ .+||+|||++......
T Consensus 114 ~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~-- 184 (362)
T 2bdw_A 114 ELFEDIV----AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-- 184 (362)
T ss_dssp BHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC--
T ss_pred CHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecCC--
Confidence 9999994 3467999999999999999999999999 99999999999997654 5999999999754322
Q ss_pred cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccC
Q 021526 155 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
.......|++.|+|||++.+..++.++||||||+++|+|++|..||....... .......... ..
T Consensus 185 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~------~~~~i~~~~~--------~~ 249 (362)
T 2bdw_A 185 -EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR------LYAQIKAGAY--------DY 249 (362)
T ss_dssp -CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCC--------CC
T ss_pred -cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhCCC--------CC
Confidence 22234568999999999998899999999999999999999999996432110 0000000000 00
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.......++..+.++|.+||..||++||++.++++.
T Consensus 250 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 001112456789999999999999999999998763
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=303.82 Aligned_cols=256 Identities=23% Similarity=0.276 Sum_probs=193.7
Q ss_pred eeeeeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhc--CCCCcccceeEEEEe----CCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSL--LHHDNLVTLIGYCTS----GDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~----~~~~~lv~e~~~ 75 (311)
...+|+|+||.||++..+++.||||++... ....+.+|.+++.. ++||||+++++++.. ....++||||++
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~ 89 (301)
T 3q4u_A 13 LECVGKGRYGEVWRGSWQGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHE 89 (301)
T ss_dssp EEEEEECSSEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCT
T ss_pred EEeeccCCCcEEEEEEECCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhcc
Confidence 578999999999999999999999998643 34556667776655 799999999998654 345799999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH--------CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh--------~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
+++|.+++. ...+++..++.++.|++.||+||| +.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 90 ~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 161 (301)
T 3q4u_A 90 MGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLGLAV 161 (301)
T ss_dssp TCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCCCee
Confidence 999999993 357999999999999999999999 888 9999999999999999999999999986
Q ss_pred cCCCCCCcce--eeeccccccccCCccccCC------CCCccccchhHHHHHHHHHhC----------CCCccccCcccc
Q 021526 148 LGPVGDNTHV--STRVMGTYGYCAPEYAMSG------KLTLKSDIYSFGVVLLELITG----------RKAMDLSKGQGE 209 (311)
Q Consensus 148 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~------~~~~~~Dv~slG~~l~~l~~g----------~~p~~~~~~~~~ 209 (311)
.......... .....|+..|+|||++.+. .++.++||||||+++|+|++| ..||........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~ 241 (301)
T 3q4u_A 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241 (301)
T ss_dssp EEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred ecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCc
Confidence 4322222111 1224689999999998876 455799999999999999999 666643221111
Q ss_pred ccchhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 021526 210 QNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274 (311)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l 274 (311)
. ... .......... ........++..++..+.+++.+||+.||++|||+.++++.|++|
T Consensus 242 ~-~~~-~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 242 S-FED-MRKVVCVDQQ----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp C-HHH-HHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred c-hhh-hhHHHhccCC----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 0 000 0000000000 000000112345778899999999999999999999999999986
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=307.73 Aligned_cols=239 Identities=27% Similarity=0.343 Sum_probs=200.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+..+|+|+||.||.+.. +++.||+|++.+.. ....+.+.+|..+++.++||||+++++++.++...++||||+++
T Consensus 11 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~g 90 (318)
T 1fot_A 11 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG 90 (318)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCC
Confidence 57899999999999999 78999999987542 23456788999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ...+++..+..++.|++.||+|||++| ++|+||||+||+++.++.+||+|||++.....
T Consensus 91 g~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~----- 158 (318)
T 1fot_A 91 GELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD----- 158 (318)
T ss_dssp CBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS-----
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC-----
Confidence 999999954 457899999999999999999999999 99999999999999999999999999975322
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......|++.|+|||++.+..++.++|+||||+++|+|++|..||...... ... ..+.... .
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~----------~~i~~~~--~ 220 (318)
T 1fot_A 159 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTY----------EKILNAE--L 220 (318)
T ss_dssp CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHH----------HHHHHCC--C
T ss_pred ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHH----------HHHHhCC--C
Confidence 123456899999999999999999999999999999999999999633211 000 1111111 1
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVVA 270 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~l~~~ 270 (311)
.++...+.++.++|.+||..||++|| +++++++.
T Consensus 221 ~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 221 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 23455677899999999999999999 89999863
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=316.48 Aligned_cols=241 Identities=25% Similarity=0.316 Sum_probs=196.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
+.++|+|+||.||++.. +++.||+|++.+.. ......+.+|..++..+ +||||+++++++.++...++||||++
T Consensus 28 ~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~ 107 (353)
T 3txo_A 28 IRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVN 107 (353)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCC
Confidence 57899999999999998 68999999987542 23446688899999887 69999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+++|.+++.. ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++..... ..
T Consensus 108 gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~--~~ 178 (353)
T 3txo_A 108 GGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC--NG 178 (353)
T ss_dssp SCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeeccc--CC
Confidence 9999999954 457999999999999999999999999 99999999999999999999999999874221 22
Q ss_pred ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 156 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
.......|++.|+|||++.+..++.++|+||||+++|+|++|..||....... ....... . .
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~----------~--~ 240 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD------LFEAILN----------D--E 240 (353)
T ss_dssp -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH----------C--C
T ss_pred ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH------HHHHHHc----------C--C
Confidence 22344679999999999988889999999999999999999999996433210 0111111 1 1
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCCCH------HHHHH
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRPLI------NDIVV 269 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~------~~l~~ 269 (311)
..++...+..+.++|.+||+.||.+||++ +++++
T Consensus 241 ~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 241 VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 12344567789999999999999999998 77776
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=305.54 Aligned_cols=258 Identities=23% Similarity=0.299 Sum_probs=195.4
Q ss_pred eeeeeeceeccEEEEEE-----CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeCCe-----eEE
Q 021526 2 LCCYLSCKFYNVGLVWL-----CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ-----RLL 69 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~~l 69 (311)
...+|.|+||.||++.. .+..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+... .++
T Consensus 39 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 118 (313)
T 3brb_A 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMV 118 (313)
T ss_dssp EEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEE
T ss_pred ccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEE
Confidence 46799999999999987 235899999875532 234678899999999999999999999876543 499
Q ss_pred EEecCCCCCHHHHhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 70 VYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 70 v~e~~~~~~L~~~l~~~~--~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
+||++.+++|.+++.... .....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 119 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~ 195 (313)
T 3brb_A 119 ILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSK 195 (313)
T ss_dssp EEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEECSCSCC-
T ss_pred EEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEeecCcce
Confidence 999999999999985432 34567999999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccch
Q 021526 148 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 226 (311)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
...............++..|+|||.+.+..++.++|+||||+++|+|++ |..||........
T Consensus 196 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~----------------- 258 (313)
T 3brb_A 196 KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM----------------- 258 (313)
T ss_dssp ---------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-----------------
T ss_pred ecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-----------------
Confidence 5433322222333456788999999999999999999999999999999 8888864332110
Q ss_pred hhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 021526 227 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 279 (311)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~ 279 (311)
............+..++..+.++|.+||..||.+|||+.++++.|+.+....+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 259 YDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp HHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 00000011122344567789999999999999999999999999999877543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=305.01 Aligned_cols=255 Identities=29% Similarity=0.398 Sum_probs=191.3
Q ss_pred eeeeeeceeccEEEEEECCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWLCDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
...+|+|+||.||++...+ .||+|.+..... ...+.+.+|+++++.++||||++++++. .+...++|||++++++|
T Consensus 29 ~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L 106 (289)
T 3og7_A 29 GQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSL 106 (289)
T ss_dssp EEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEH
T ss_pred eeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcH
Confidence 4689999999999998765 499999875533 3346789999999999999999999964 55678999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.............
T Consensus 107 ~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 180 (289)
T 3og7_A 107 YHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE 180 (289)
T ss_dssp HHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------------
T ss_pred HHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccccccccc
Confidence 999954 4567999999999999999999999999 9999999999999999999999999987543322223334
Q ss_pred eccccccccCCcccc---CCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 160 RVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
...|+..|+|||++. +..++.++||||||+++|+|++|..||........ .. ...... ...+. ..
T Consensus 181 ~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~----~~~~~~-----~~~~~-~~ 248 (289)
T 3og7_A 181 QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--II----EMVGRG-----SLSPD-LS 248 (289)
T ss_dssp ---CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HH----HHHHHT-----SCCCC-TT
T ss_pred ccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HH----HHhccc-----ccCcc-hh
Confidence 456899999999886 56788899999999999999999999964322110 00 000000 00000 01
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 276 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~ 276 (311)
.....++..+.+++.+||..||.+|||+.++++.|+.+..
T Consensus 249 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1223556789999999999999999999999999998864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=317.96 Aligned_cols=246 Identities=20% Similarity=0.171 Sum_probs=197.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
...+|+|+||.||++.. +++.||+|.+..... ...+.+.+|+++++.++||||+++++++.++...++|||++.++
T Consensus 16 ~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 95 (444)
T 3soa_A 16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGG 95 (444)
T ss_dssp EEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCC
T ss_pred EEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCC
Confidence 57899999999999998 799999999876543 23457889999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEc---CCCceEEeecCCCccCCCCCC
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD---NDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~---~~~~vkl~Df~~~~~~~~~~~ 154 (311)
+|.+++.. ...+++..+..++.|++.||+|||++| |+|+||||+||+++ .++.+||+|||++......
T Consensus 96 ~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~-- 166 (444)
T 3soa_A 96 ELFEDIVA----REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-- 166 (444)
T ss_dssp BHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT--
T ss_pred CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC--
Confidence 99999954 457999999999999999999999999 99999999999998 5678999999999754322
Q ss_pred cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccC
Q 021526 155 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
........|++.|+|||++.+..++.++||||||+++|+|++|.+||........ ......... . .
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~~~~---~-----~ 232 (444)
T 3soa_A 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL------YQQIKAGAY---D-----F 232 (444)
T ss_dssp CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHTCC---C-----C
T ss_pred CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH------HHHHHhCCC---C-----C
Confidence 2222345689999999999998999999999999999999999999963321100 000100000 0 0
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.......++..+.++|.+||+.||++|||+.++++.
T Consensus 233 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 233 PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 001112456779999999999999999999999873
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=314.55 Aligned_cols=244 Identities=22% Similarity=0.236 Sum_probs=195.5
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
.++|+|+||.||++.. +++.||+|++........+.+.+|+++++.++||||+++++++.++...++||||+++++|.
T Consensus 95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~ 174 (373)
T 2x4f_A 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174 (373)
T ss_dssp EECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEH
T ss_pred eEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHH
Confidence 4699999999999998 68999999998766566678999999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE--cCCCceEEeecCCCccCCCCCCccee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL--DNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~--~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
+++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+|||+ +.++.+||+|||++....... ..
T Consensus 175 ~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~ 245 (373)
T 2x4f_A 175 DRIID---ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KL 245 (373)
T ss_dssp HHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---BC
T ss_pred HHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---cc
Confidence 98864 3456899999999999999999999999 9999999999999 567889999999997543221 22
Q ss_pred eeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCC
Q 021526 159 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRY 238 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
....|++.|+|||++.+..++.++|||||||++|+|++|..||........ .......... .....
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------~~~i~~~~~~--------~~~~~ 311 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET------LNNILACRWD--------LEDEE 311 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHTCCC--------SCSGG
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhccCC--------CChhh
Confidence 334689999999999888999999999999999999999999964332110 0011110000 00011
Q ss_pred cHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 239 PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 239 ~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
....+.++.+||.+||+.||.+|||+.++++
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1245678999999999999999999999998
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=303.53 Aligned_cols=259 Identities=23% Similarity=0.223 Sum_probs=195.0
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
+..+|.|+||.||++.. +++.||+|.+..... .....+.+|+++++.++||||+++++++.++...++||||+++ +
T Consensus 26 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~ 104 (311)
T 3niz_A 26 LEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-D 104 (311)
T ss_dssp EEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-E
T ss_pred hhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-C
Confidence 57899999999999999 889999999865432 2336788999999999999999999999999999999999975 8
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
|.+++.. ....+++..++.++.|++.||+|||+.| ++|+||||+||+++.++.+||+|||++...... ....
T Consensus 105 l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~~ 176 (311)
T 3niz_A 105 LKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP--VRSY 176 (311)
T ss_dssp HHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC--CC--
T ss_pred HHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC--cccc
Confidence 8888854 4466999999999999999999999999 999999999999999999999999999754221 2223
Q ss_pred eeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCccccccc-hhcc----hhhhhcccchhhhcC-
Q 021526 159 TRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-VSWS----RPFLKDQKKFVHLVD- 231 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~- 231 (311)
....++..|+|||++.+ ..++.++||||||+++|+|++|..||........... .... ...+...........
T Consensus 177 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 256 (311)
T 3niz_A 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQR 256 (311)
T ss_dssp -CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSC
T ss_pred cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhc
Confidence 33467999999998876 5689999999999999999999999975443221100 0000 000000000000000
Q ss_pred --ccCCC----CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 232 --PLLHG----RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 232 --~~~~~----~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..... .....++.++.++|.+||+.||++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 257 TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp CCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000 011234567899999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=299.62 Aligned_cols=248 Identities=29% Similarity=0.457 Sum_probs=198.6
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccch-------hHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGH-------QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 72 (311)
...+|+|+||.||++.. +++.||+|.+........ +.+.+|+++++.++||||+++++++.+.. ++|||
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e 101 (287)
T 4f0f_A 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVME 101 (287)
T ss_dssp EEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEE
T ss_pred hhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEE
Confidence 46899999999999999 789999999865433221 57889999999999999999999986554 79999
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCc-----eEEeecCCCc
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN-----PKLSDFGLAK 147 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~-----vkl~Df~~~~ 147 (311)
++++++|.+++.. ....+++..++.++.|++.||+|||+.+ .+++|+||+|+||+++.++. +||+|||++.
T Consensus 102 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~ 177 (287)
T 4f0f_A 102 FVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177 (287)
T ss_dssp CCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCB
T ss_pred ecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCccc
Confidence 9999999998864 4567999999999999999999999875 34999999999999988776 9999999987
Q ss_pred cCCCCCCcceeeeccccccccCCcccc--CCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccc
Q 021526 148 LGPVGDNTHVSTRVMGTYGYCAPEYAM--SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 225 (311)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
.... ......++..|+|||++. ...++.++|+||||+++|+|++|..||......... ..
T Consensus 178 ~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~--------- 239 (287)
T 4f0f_A 178 QSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK----FI--------- 239 (287)
T ss_dssp CCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH----HH---------
T ss_pred cccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH----HH---------
Confidence 4221 233456899999999884 456789999999999999999999999643321110 00
Q ss_pred hhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 021526 226 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274 (311)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l 274 (311)
............+..++..+.+++.+||+.||.+|||++++++.|++|
T Consensus 240 -~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 240 -NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp -HHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred -HHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 001111122233456677899999999999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=301.94 Aligned_cols=258 Identities=19% Similarity=0.188 Sum_probs=196.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc--chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
+..+|+|+||.||++.. +++.||+|.+...... ....+.+|+.+++.++||||+++++++.++...++|||++++
T Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 85 (292)
T 3o0g_A 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85 (292)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred eeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-
Confidence 57899999999999999 6899999998755432 336788999999999999999999999999999999999975
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
++.+++.. ....+++..++.++.|++.||+|||++| ++|+||||+||+++.++.+||+|||++..... ....
T Consensus 86 ~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~ 157 (292)
T 3o0g_A 86 DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRC 157 (292)
T ss_dssp EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCS--CCSC
T ss_pred CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCC--cccc
Confidence 66666643 4567999999999999999999999999 99999999999999999999999999975322 2222
Q ss_pred eeeccccccccCCccccCCC-CCccccchhHHHHHHHHHhCCCCccccCccccccchhcch-------hhhhcccchhh-
Q 021526 158 STRVMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR-------PFLKDQKKFVH- 228 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~- 228 (311)
.....++..|+|||++.+.. ++.++|+||||+++|+|++|..|+......... ...... ..+........
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH-HHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH-HHHHHHHhCCCChhhhhhhcccccc
Confidence 33456799999999987765 799999999999999999988886432211100 000000 00000000000
Q ss_pred -----hcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 229 -----LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 229 -----~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..............+..+.++|.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00001111222346778999999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=302.18 Aligned_cols=254 Identities=26% Similarity=0.389 Sum_probs=203.4
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
...+|+|++|.||.+.. +++.||+|.+... ....+.+.+|+++++.++||||+++++++. ++..+++||++.+++|.
T Consensus 18 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 95 (279)
T 1qpc_A 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLV 95 (279)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHH
T ss_pred eeeecCCCCeEEEEEEEcCCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHH
Confidence 57899999999999999 6679999998644 345678999999999999999999999976 45689999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++.. .....+++..++.++.|++.||++||+.| ++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 96 ~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 169 (279)
T 1qpc_A 96 DFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREG 169 (279)
T ss_dssp HHTTS--HHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EECCTT
T ss_pred HHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcc-cccccC
Confidence 99954 11236899999999999999999999999 9999999999999999999999999987543211 111222
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
..++..|+|||++.+..++.++|+||||+++|+|++ |..||....... ..... ........+
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~~~-----------~~~~~~~~~ 232 (279)
T 1qpc_A 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------VIQNL-----------ERGYRMVRP 232 (279)
T ss_dssp CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHH-----------HTTCCCCCC
T ss_pred CCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH------HHHHH-----------hcccCCCCc
Confidence 345778999999988889999999999999999999 899986332110 00000 001111223
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCC
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 280 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~ 280 (311)
..++..+.+++.+||..||++|||+.++++.|+.+......
T Consensus 233 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 45667899999999999999999999999999998876544
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=300.07 Aligned_cols=258 Identities=25% Similarity=0.282 Sum_probs=204.3
Q ss_pred eeeeeceeccEEEEEE--CC---eEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCee-EEEEecCC
Q 021526 3 CCYLSCKFYNVGLVWL--CD---QLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR-LLVYEYMP 75 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~---~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~lv~e~~~ 75 (311)
.++|+|+||.||++.. ++ ..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.... +++||++.
T Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~ 106 (298)
T 3pls_A 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMC 106 (298)
T ss_dssp EEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCT
T ss_pred ceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEeccc
Confidence 6799999999999987 22 3799999875433 3446788999999999999999999999766655 99999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC-
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN- 154 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~- 154 (311)
+++|.+++.. ....+++..++.++.|++.||+|||+.| ++|+||||+||+++.++.+||+|||++........
T Consensus 107 ~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 180 (298)
T 3pls_A 107 HGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180 (298)
T ss_dssp TCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred CCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence 9999999965 4567899999999999999999999999 99999999999999999999999999875432211
Q ss_pred -cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 155 -THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 155 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
........++..|+|||.+.+..++.++|+||||+++|+|++|..|+........ ........
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~----------------~~~~~~~~ 244 (298)
T 3pls_A 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD----------------LTHFLAQG 244 (298)
T ss_dssp CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG----------------HHHHHHTT
T ss_pred ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH----------------HHHHhhcC
Confidence 1122334578899999999999999999999999999999996655432211100 00111111
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCC
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHP 282 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~~~ 282 (311)
.....+..++..+.+++.+||..||.+|||+.++++.|+++.....+..
T Consensus 245 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 245 RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 1112234456789999999999999999999999999999988765543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=299.00 Aligned_cols=249 Identities=21% Similarity=0.268 Sum_probs=201.9
Q ss_pred eeeeeeceeccEEEEEECCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeC--CeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWLCDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~ 77 (311)
...+|+|++|.||++...++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.+. ...+++||+++++
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~ 94 (271)
T 3kmu_A 15 LTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYG 94 (271)
T ss_dssp EEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTC
T ss_pred HHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCC
Confidence 56899999999999999999999999876532 3345789999999999999999999999876 7789999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|.+++.. .....+++..++.++.|++.||+|||+.+ ..++|+||+|+||+++.++.++|.||++......
T Consensus 95 ~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~------ 165 (271)
T 3kmu_A 95 SLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS------ 165 (271)
T ss_dssp BHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC------
T ss_pred cHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc------
Confidence 99999965 23346999999999999999999999874 3499999999999999999999998887653211
Q ss_pred eeeccccccccCCccccCCCCCc---cccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccC
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTL---KSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~---~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
....+++.|+|||++.+..++. ++||||||+++|+|++|..||....... ..........
T Consensus 166 -~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----------------~~~~~~~~~~ 228 (271)
T 3kmu_A 166 -PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME----------------IGMKVALEGL 228 (271)
T ss_dssp -TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH----------------HHHHHHHSCC
T ss_pred -cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH----------------HHHHHHhcCC
Confidence 1235788999999988765544 7999999999999999999996332110 0011111112
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 276 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~ 276 (311)
....+..++..+.+++.+||+.||++|||++++++.|+.+..
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 229 RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 223345567789999999999999999999999999998864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=310.17 Aligned_cols=238 Identities=24% Similarity=0.241 Sum_probs=200.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+..+|+|+||.||.+.. +++.||+|++.+.. ....+.+.+|+++++.++||||+++++++.++...++||||+.+
T Consensus 46 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 125 (350)
T 1rdq_E 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence 57899999999999999 68999999986542 23456788999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ...+++..++.++.|++.||+|||++| ++||||||+||+++.++.+||+|||++......
T Consensus 126 g~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~---- 194 (350)
T 1rdq_E 126 GEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---- 194 (350)
T ss_dssp CBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC----
Confidence 999999954 356899999999999999999999999 999999999999999999999999999754221
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
.....|++.|+|||++.+..++.++|+||||+++|+|++|..||...... ........ . ..
T Consensus 195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~----------~--~~ 255 (350)
T 1rdq_E 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIYEKIVS----------G--KV 255 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH----------C--CC
T ss_pred -cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH------HHHHHHHc----------C--CC
Confidence 23356899999999999999999999999999999999999999633211 00101111 1 11
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 269 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs-----~~~l~~ 269 (311)
.++..++..+.++|.+||+.||.+||+ +++|++
T Consensus 256 ~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 234456778999999999999999998 888876
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=307.17 Aligned_cols=252 Identities=23% Similarity=0.303 Sum_probs=198.6
Q ss_pred eeeeeeceeccEEEEEE--CC-------eEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL--CD-------QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~-------~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 72 (311)
...+|+|+||.||++.. .+ ..||+|.+........+.+.+|+++++.++||||+++++++.++...++|||
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 92 (289)
T 4fvq_A 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQE 92 (289)
T ss_dssp EEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEE
T ss_pred eeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEE
Confidence 56899999999999998 23 5799999976666667889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCc--------eEEeecC
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN--------PKLSDFG 144 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~--------vkl~Df~ 144 (311)
|+++++|.+++.. ....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++. ++|+|||
T Consensus 93 ~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg 166 (289)
T 4fvq_A 93 FVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG 166 (289)
T ss_dssp CCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEECCCC
T ss_pred CCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeeccCc
Confidence 9999999999965 3345899999999999999999999999 999999999999988887 9999999
Q ss_pred CCccCCCCCCcceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCC-CccccCccccccchhcchhhhhc
Q 021526 145 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRK-AMDLSKGQGEQNLVSWSRPFLKD 222 (311)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~-p~~~~~~~~~~~~~~~~~~~~~~ 222 (311)
.+..... .....++..|+|||++.+ ..++.++||||||+++|+|++|.. |+......... .....
T Consensus 167 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-------~~~~~ 233 (289)
T 4fvq_A 167 ISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-------QFYED 233 (289)
T ss_dssp SCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-------HHHHT
T ss_pred ccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-------HHhhc
Confidence 9864211 123457888999999887 678999999999999999999654 44322111000 00000
Q ss_pred ccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCCCC
Q 021526 223 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVS 284 (311)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~~~~~ 284 (311)
....+...+..+.+++.+||+.||++|||+.++++.|+.+.....++++.
T Consensus 234 ------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~~~ 283 (289)
T 4fvq_A 234 ------------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGS 283 (289)
T ss_dssp ------------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---------
T ss_pred ------------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCCCc
Confidence 01112223456899999999999999999999999999988755554443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=302.68 Aligned_cols=248 Identities=27% Similarity=0.364 Sum_probs=196.8
Q ss_pred eeeeeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeC-CeeEEEEecCCCCCHH
Q 021526 2 LCCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG-DQRLLVYEYMPMGSLE 80 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~ 80 (311)
...+|.|++|.||.+...++.||+|.+... ...+.+.+|+++++.++||||+++++++.++ ...+++||++++++|.
T Consensus 26 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~ 103 (278)
T 1byg_A 26 LQTIGKGEFGDVMLGDYRGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 103 (278)
T ss_dssp EEEEEECSSCEEEEEEETTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHH
T ss_pred EeEEecCCCceEEEEEEcCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHH
Confidence 568999999999999999999999998643 3457789999999999999999999986544 4789999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++... ....+++..++.++.|++.||++||+.+ ++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 104 ~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-----~~~ 173 (278)
T 1byg_A 104 DYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDT 173 (278)
T ss_dssp HHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------------
T ss_pred HHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc-----ccC
Confidence 999641 1223788999999999999999999999 999999999999999999999999998643221 223
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
..++..|+|||++.+..++.++|+||||+++|+|++ |..||....... ....+........+
T Consensus 174 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~ 236 (278)
T 1byg_A 174 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----------------VVPRVEKGYKMDAP 236 (278)
T ss_dssp --CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-----------------HHHHHTTTCCCCCC
T ss_pred CCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHHhcCCCCCCc
Confidence 356788999999988899999999999999999998 999986332110 00011111122334
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 278 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~ 278 (311)
..++..+.++|.+||..||.+|||+.++++.|+++....
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 237 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 556778999999999999999999999999999987643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=311.87 Aligned_cols=246 Identities=20% Similarity=0.212 Sum_probs=189.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
+..+|+|+||.||.+.. +++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.++...++||||+.+++|
T Consensus 25 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L 103 (361)
T 3uc3_A 25 VKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGEL 103 (361)
T ss_dssp EEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCH
Confidence 57899999999999999 78999999986543 3346788999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCc--eEEeecCCCccCCCCCCcce
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN--PKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~--vkl~Df~~~~~~~~~~~~~~ 157 (311)
.+++.. .+.+++..++.++.|++.||+|||++| ++|+||||+||+++.++. +||+|||++.... ....
T Consensus 104 ~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~---~~~~ 173 (361)
T 3uc3_A 104 YERICN----AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV---LHSQ 173 (361)
T ss_dssp HHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----------
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccc---ccCC
Confidence 999954 456999999999999999999999999 999999999999987765 9999999986321 1222
Q ss_pred eeeccccccccCCccccCCCCCcc-ccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLK-SDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
.....|++.|+|||++.+..++.+ +|||||||++|+|++|..||......... .... ..........
T Consensus 174 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~~----------~~~~~~~~~~ 241 (361)
T 3uc3_A 174 PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKTI----------QRILSVKYSI 241 (361)
T ss_dssp -------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHHH----------HHHHTTCCCC
T ss_pred CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHHH----------HHHhcCCCCC
Confidence 234568999999999988777655 89999999999999999999643322111 0000 0111111111
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
......+..+.+||.+||..||.+|||+.++++.
T Consensus 242 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 242 PDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 1112346778999999999999999999999874
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=297.28 Aligned_cols=246 Identities=23% Similarity=0.304 Sum_probs=198.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
...+|.|++|.||.+.. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.++...++|||++++++
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 91 (276)
T 2yex_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91 (276)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred EEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCc
Confidence 56899999999999999 68999999987543 3344678999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
|.+++. ....+++..++.++.|++.||.+||+.| ++|+||+|+||+++.++.++|+|||.+............
T Consensus 92 L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 164 (276)
T 2yex_A 92 LFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (276)
T ss_dssp GGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred HHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence 999984 3457999999999999999999999999 999999999999999999999999998753322222223
Q ss_pred eeccccccccCCccccCCCC-CccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCC
Q 021526 159 TRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 237 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
....++..|+|||++.+..+ +.++|+||||+++|+|++|..||......... ... .. .......
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~----~~----------~~~~~~~ 229 (276)
T 2yex_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSD----WK----------EKKTYLN 229 (276)
T ss_dssp CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HHH----HH----------TTCTTST
T ss_pred cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHH----hh----------hcccccC
Confidence 34568999999999887665 68999999999999999999999643321110 000 00 0000011
Q ss_pred CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 238 YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.....+..+.++|.+||..||++|||++++++
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 230 PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 12345677999999999999999999999975
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=312.99 Aligned_cols=241 Identities=28% Similarity=0.344 Sum_probs=198.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
...+|+|+||.||.+.. +++.||+|.+.+.. ......+.+|..++..+ +||||+++++++.++...++||||++
T Consensus 22 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~ 101 (345)
T 1xjd_A 22 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 101 (345)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCC
Confidence 57899999999999999 68999999987542 23456778899999876 89999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+++|.+++.. ...+++..+..++.|++.||+|||++| ++||||||+||+++.++.+||+|||++...... .
T Consensus 102 gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~ 172 (345)
T 1xjd_A 102 GGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--D 172 (345)
T ss_dssp TCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--T
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcccC--C
Confidence 9999999954 356899999999999999999999999 999999999999999999999999998743221 1
Q ss_pred ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 156 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
.......|++.|+|||++.+..++.++|+||||+++|+|++|..||....... ....... . .
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~~----------~--~ 234 (345)
T 1xjd_A 173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------LFHSIRM----------D--N 234 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH----------C--C
T ss_pred CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHHh----------C--C
Confidence 22344678999999999999999999999999999999999999996432110 0001100 0 1
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRPLIN-DIVV 269 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~~-~l~~ 269 (311)
..++...+..+.++|.+||..||++||++. ++++
T Consensus 235 ~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 235 PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 123445677899999999999999999997 6654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=309.42 Aligned_cols=270 Identities=28% Similarity=0.394 Sum_probs=208.0
Q ss_pred eeeeeeceeccEEEEEE------CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCC--eeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL------CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD--QRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~ 73 (311)
+..+|.|++|.||.+.. +++.||+|.+........+.+.+|+++++.++||||+++++++.... ..++|||+
T Consensus 46 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 125 (326)
T 2w1i_A 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY 125 (326)
T ss_dssp EEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECC
T ss_pred eeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEEC
Confidence 57899999999999984 68999999998766566678999999999999999999999886543 67999999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 153 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~ 153 (311)
+++++|.+++.. ....+++..++.++.|++.||++||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 126 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~ 199 (326)
T 2w1i_A 126 LPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199 (326)
T ss_dssp CTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCSSC
T ss_pred CCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhccccc
Confidence 999999999965 3456899999999999999999999999 9999999999999999999999999987643322
Q ss_pred Ccc-eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCc
Q 021526 154 NTH-VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 232 (311)
Q Consensus 154 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
... ......++..|+|||++.+..++.++||||||+++|+|++|..|+.................... ...+.+.+..
T Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 278 (326)
T 2w1i_A 200 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI-VFHLIELLKN 278 (326)
T ss_dssp SEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHH-HHHHHHHHHT
T ss_pred cccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhh-HHHHHHHhhc
Confidence 211 12224467789999999888899999999999999999999998753211000000000000000 0011111211
Q ss_pred cCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 021526 233 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 278 (311)
Q Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~ 278 (311)
......+..++..+.++|.+||..||++|||+.+|++.|+++....
T Consensus 279 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 279 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 2222334567788999999999999999999999999999987653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=307.37 Aligned_cols=255 Identities=22% Similarity=0.229 Sum_probs=192.0
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccc---hhHHHHHHHHHhcCCCCcccceeEEEEeCCe----eEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQG---HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ----RLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e 72 (311)
...+|+|+||.||++.. +++.||+|++....... ...+.+|+++++.++||||+++++++..... .++|||
T Consensus 17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e 96 (311)
T 3ork_A 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 96 (311)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred EEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEe
Confidence 56899999999999997 78999999997653332 3568899999999999999999999876543 399999
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCC
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~ 152 (311)
|+++++|.+++.. ...+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.+||+|||++......
T Consensus 97 ~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 97 YVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp CCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred cCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 9999999999954 356899999999999999999999999 999999999999999999999999998754322
Q ss_pred CCc-ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcC
Q 021526 153 DNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231 (311)
Q Consensus 153 ~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
... .......|+..|+|||++.+..++.++||||||+++|+|++|..||........ .............
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~~~~~~--- 240 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPIPPS--- 240 (311)
T ss_dssp ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCCCCHH---
T ss_pred ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhcCCCCCcc---
Confidence 111 122334589999999999999999999999999999999999999964332110 0000000000000
Q ss_pred ccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHH-HHHHHHhhhc
Q 021526 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI-VVALDYLVSQ 277 (311)
Q Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l-~~~L~~l~~~ 277 (311)
.....++..+.++|.+||+.||++||+..++ ...|..+...
T Consensus 241 -----~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 241 -----ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp -----HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred -----cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 0012356779999999999999999966554 4556665443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=308.80 Aligned_cols=250 Identities=27% Similarity=0.360 Sum_probs=198.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc---chhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
+..+|+|+||.||.+.. +++.||+|++.+.... ..+.+.+|..++..+ +||||+++++++.++...++||||+.
T Consensus 14 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~ 93 (345)
T 3a8x_A 14 LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 93 (345)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCC
Confidence 57899999999999999 6899999999765332 335678899999887 89999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+++|.+++.. ...+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++..... ..
T Consensus 94 gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~--~~ 164 (345)
T 3a8x_A 94 GGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PG 164 (345)
T ss_dssp SCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC--TT
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC--CC
Confidence 9999999954 357999999999999999999999999 99999999999999999999999999874221 12
Q ss_pred ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 156 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
.......|++.|+|||++.+..++.++|+|||||++|+|++|..||............. . ... ...+... .
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~-~-~~~-----~~~i~~~--~ 235 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT-E-DYL-----FQVILEK--Q 235 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------C-H-HHH-----HHHHHHC--C
T ss_pred CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccccc-H-HHH-----HHHHHcC--C
Confidence 22344578999999999999999999999999999999999999996433221110000 0 000 0001111 1
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCCCH------HHHHH
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRPLI------NDIVV 269 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~------~~l~~ 269 (311)
..+|...+..+.++|.+||+.||++||++ +++++
T Consensus 236 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 236 IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 12345567789999999999999999995 56665
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=302.89 Aligned_cols=259 Identities=19% Similarity=0.133 Sum_probs=195.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc---chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
...+|.|+||.||++.. +++.||+|.+...... ..+.+.+|+.+++.++||||+++++++..+...+++||++++
T Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 118 (309)
T 2h34_A 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLING 118 (309)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCC
T ss_pred EEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCC
Confidence 56899999999999998 6899999998755332 236788999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 119 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~ 190 (309)
T 2h34_A 119 VDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEK-LT 190 (309)
T ss_dssp EEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccccc-cc
Confidence 999999954 356899999999999999999999999 9999999999999999999999999986533221 11
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......++..|+|||++.+..++.++|+||||+++|+|++|..||...... ........... ...
T Consensus 191 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~--------~~~ 255 (309)
T 2h34_A 191 QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIP--------RPS 255 (309)
T ss_dssp ------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCC--------CGG
T ss_pred cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCC--------Ccc
Confidence 222345889999999999889999999999999999999999999633211 00000000000 000
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHhhhccCCCCC
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRP-LINDIVVALDYLVSQRDSHPV 283 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RP-s~~~l~~~L~~l~~~~~~~~~ 283 (311)
..+..++..+.++|.+||+.||++|| +++++++.|+++........+
T Consensus 256 ~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~~~ 303 (309)
T 2h34_A 256 TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDRA 303 (309)
T ss_dssp GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-------
T ss_pred ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcccch
Confidence 12334566799999999999999999 999999999987766554443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=310.95 Aligned_cols=245 Identities=24% Similarity=0.272 Sum_probs=193.8
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCcc--chhHHHHHHHHHhcCCC--CcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHH--DNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+..+|+|+||.||++.. +++.||+|.+...... ..+.+.+|+.+++.++| |||+++++++.++...++||| +.+
T Consensus 14 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~ 92 (343)
T 3dbq_A 14 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 92 (343)
T ss_dssp EEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCS
T ss_pred EEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCC
Confidence 57899999999999988 7889999998755332 33678899999999986 999999999999999999999 457
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||||+|||++ ++.+||+|||++..........
T Consensus 93 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 164 (343)
T 3dbq_A 93 IDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 164 (343)
T ss_dssp EEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-------
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcccccc
Confidence 899999954 467899999999999999999999999 99999999999997 5789999999997643333222
Q ss_pred eeeeccccccccCCccccC-----------CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccc
Q 021526 157 VSTRVMGTYGYCAPEYAMS-----------GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 225 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~-----------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
......|++.|+|||++.+ ..++.++||||||+++|+|++|..||...... ...
T Consensus 165 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---------------~~~ 229 (343)
T 3dbq_A 165 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---------------ISK 229 (343)
T ss_dssp -----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---------------HHH
T ss_pred cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH---------------HHH
Confidence 3344578999999998864 67889999999999999999999999522110 111
Q ss_pred hhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 226 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
+....++.....++...+..+.+++.+||+.||.+|||+.++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 230 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 222233333334455556789999999999999999999999874
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=317.95 Aligned_cols=240 Identities=25% Similarity=0.318 Sum_probs=199.6
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
...+|.|+||.||.+.. +|+.||||++.... ......+.+|+.+++.++||||+++++++.+....++||||+.+
T Consensus 21 ~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~g 100 (476)
T 2y94_A 21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSG 100 (476)
T ss_dssp EEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 56899999999999999 69999999986542 23346788999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++...... .
T Consensus 101 g~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~---~ 170 (476)
T 2y94_A 101 GELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---E 170 (476)
T ss_dssp EEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT---C
T ss_pred CcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc---c
Confidence 99999994 4567999999999999999999999999 999999999999999999999999999754322 2
Q ss_pred eeeeccccccccCCccccCCCC-CccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
......|++.|+|||++.+..+ +.++|+||||+++|+|++|..||...... ... ..+.....
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~------~~~----------~~i~~~~~- 233 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP------TLF----------KKICDGIF- 233 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH------HHH----------HHHHTTCC-
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH------HHH----------HHHhcCCc-
Confidence 2334568999999999988765 68999999999999999999999633211 000 01111111
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..+...+..+.++|.+||+.||.+|||++++++
T Consensus 234 -~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 -YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 223345677999999999999999999999997
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=309.49 Aligned_cols=242 Identities=26% Similarity=0.305 Sum_probs=199.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
+.++|+|+||.||.+.. +++.||+|++.+.. ....+.+.+|..++..+ +||+|+++++++.+....++||||++
T Consensus 25 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~ 104 (353)
T 2i0e_A 25 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 104 (353)
T ss_dssp EEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCC
Confidence 57899999999999999 57899999987542 23456788899999887 79999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+++|.+++.. ...+++..++.++.|++.||.|||++| ++||||||+||+++.++.+||+|||++..... ..
T Consensus 105 gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~ 175 (353)
T 2i0e_A 105 GGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW--DG 175 (353)
T ss_dssp SCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--TT
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccccc--CC
Confidence 9999999954 356999999999999999999999999 99999999999999999999999999874221 12
Q ss_pred ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 156 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
.......|++.|+|||++.+..++.++|+||||+++|+|++|..||...... ........ . .
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~----------~--~ 237 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIME----------H--N 237 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH----------C--C
T ss_pred cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH------HHHHHHHh----------C--C
Confidence 2234467899999999999999999999999999999999999999643211 00111111 1 1
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVVA 270 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RPs-----~~~l~~~ 270 (311)
..++...+..+.++|.+||..||.+||+ ++++++.
T Consensus 238 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 238 VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1234556788999999999999999995 5777653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=327.08 Aligned_cols=253 Identities=24% Similarity=0.302 Sum_probs=203.1
Q ss_pred eeeeceeccEEEEEE----CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 4 CYLSCKFYNVGLVWL----CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~----~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
.+|+|+||.||++.. ++..||||.+.... ....+.+.+|+++++.++||||+++++++.. ...++||||+.+++
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 689999999999987 45679999987653 3356789999999999999999999999876 56899999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc-ce
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT-HV 157 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~-~~ 157 (311)
|.+++.. ....+++..++.++.|++.||+|||+++ |+|+||||+|||++.++.+||+|||++......... ..
T Consensus 422 L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 422 LHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp HHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred HHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 9999954 4567999999999999999999999999 999999999999999999999999999754322211 11
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
.....++..|+|||++.+..++.++||||||+++|+|++ |..||....... ....+....+.
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-----------------~~~~i~~~~~~ 558 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-----------------VMAFIEQGKRM 558 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-----------------HHHHHHTTCCC
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-----------------HHHHHHcCCCC
Confidence 122335678999999998899999999999999999998 999996433211 00111111122
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCC
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 280 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~ 280 (311)
..+..++..+.++|.+||..||++||++.+|++.|+.+......
T Consensus 559 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 559 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 34556788899999999999999999999999999988765544
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=309.44 Aligned_cols=261 Identities=24% Similarity=0.253 Sum_probs=190.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCC-CCcccceeEEEE--------eCCeeEEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCT--------SGDQRLLV 70 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--------~~~~~~lv 70 (311)
..++|.|+||.||++.. +++.||+|.+..........+.+|+.+++.+. ||||+++++++. .....+++
T Consensus 33 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv 112 (337)
T 3ll6_A 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLL 112 (337)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEE
T ss_pred EEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEE
Confidence 57899999999999999 88999999987666566678899999999996 999999999984 34457999
Q ss_pred EecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCC
Q 021526 71 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 150 (311)
Q Consensus 71 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~ 150 (311)
||++. ++|.+++.... ....+++..++.++.|++.||+|||+.+ ++++|+||+|+||+++.++.+||+|||++....
T Consensus 113 ~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 189 (337)
T 3ll6_A 113 TELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTIS 189 (337)
T ss_dssp EECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCS
T ss_pred EEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccceecc
Confidence 99995 69999886422 3456999999999999999999999874 349999999999999999999999999997543
Q ss_pred CCCCcc----------eeeeccccccccCCccc---cCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcch
Q 021526 151 VGDNTH----------VSTRVMGTYGYCAPEYA---MSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR 217 (311)
Q Consensus 151 ~~~~~~----------~~~~~~~~~~~~aPE~~---~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 217 (311)
...... ......++..|+|||++ .+..++.++||||||+++|+|++|..||.......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--------- 260 (337)
T 3ll6_A 190 HYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--------- 260 (337)
T ss_dssp SCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------------
T ss_pred ccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH---------
Confidence 322111 11134588999999988 46678899999999999999999999996322110
Q ss_pred hhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCCCCC
Q 021526 218 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSR 285 (311)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~~~~~~ 285 (311)
..........+...+..+.+++.+||+.||.+|||+.++++.|+.+.......+...
T Consensus 261 -----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~~ 317 (337)
T 3ll6_A 261 -----------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSP 317 (337)
T ss_dssp ----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTSC
T ss_pred -----------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCcc
Confidence 000011111112233458899999999999999999999999999988765554443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=307.07 Aligned_cols=255 Identities=24% Similarity=0.332 Sum_probs=204.1
Q ss_pred eeeeeeceeccEEEEEEC-------CeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWLC-------DQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~-------~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
...+|+|+||.||++... ++.||+|.+..... .....+.+|+.+++.++||||+++++++.++...++|||+
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 109 (322)
T 1p4o_A 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 109 (322)
T ss_dssp EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEe
Confidence 468999999999999863 68899999875432 3445788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcccC------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 74 MPMGSLEDHLYDLE------PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 74 ~~~~~L~~~l~~~~------~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
+++++|.+++.... .....+++..++.++.|++.||.|||++| ++|+||+|+||+++.++.+||+|||++.
T Consensus 110 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl~Dfg~~~ 186 (322)
T 1p4o_A 110 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR 186 (322)
T ss_dssp CTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCC
T ss_pred CCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEECcCcccc
Confidence 99999999996522 12256789999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccch
Q 021526 148 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 226 (311)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
...............++..|+|||++.+..++.++|+||||+++|+|++ |..||........ .....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------~~~~~------ 254 (322)
T 1p4o_A 187 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV------LRFVM------ 254 (322)
T ss_dssp GGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH------HHHHH------
T ss_pred ccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH------HHHHH------
Confidence 5332222222223446788999999988889999999999999999999 8888863321100 00000
Q ss_pred hhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 021526 227 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 276 (311)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~ 276 (311)
. ......+..++..+.++|.+||..||.+|||+.++++.|+++..
T Consensus 255 ----~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 255 ----E-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp ----T-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ----c-CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 0 00112234567789999999999999999999999999988755
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=308.53 Aligned_cols=243 Identities=21% Similarity=0.210 Sum_probs=183.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
...+|.|+||.||++.. .++.||+|.+.... ..+.+.+|+++++.++||||+++++++.++...++||||+++++|
T Consensus 58 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 135 (349)
T 2w4o_A 58 ESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL 135 (349)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred eeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCH
Confidence 46899999999999999 57899999987542 345688899999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcC---CCceEEeecCCCccCCCCCCcc
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~---~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
.+++. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. ++.+||+|||++..... ..
T Consensus 136 ~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~---~~ 205 (349)
T 2w4o_A 136 FDRIV----EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH---QV 205 (349)
T ss_dssp HHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred HHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCc---cc
Confidence 99994 3566999999999999999999999999 999999999999975 88999999999874322 12
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......|++.|+|||++.+..++.++||||||+++|+|++|..||........ ......... .....
T Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~~i~~~~--------~~~~~ 272 (349)
T 2w4o_A 206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF-----MFRRILNCE--------YYFIS 272 (349)
T ss_dssp -------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH-----HHHHHHTTC--------CCCCT
T ss_pred ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH-----HHHHHHhCC--------CccCC
Confidence 22345689999999999998999999999999999999999999863322110 000000000 00001
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
......+..+.++|.+||..||++|||+.++++
T Consensus 273 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 273 PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112345678999999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=300.40 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=200.9
Q ss_pred eeeeceeccEEEEEE----CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 4 CYLSCKFYNVGLVWL----CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~----~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
.+|+|+||.||++.. .++.||+|.+..... ...+.+.+|+++++.++||||+++++++ .+...++|||++.++
T Consensus 24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 102 (291)
T 1xbb_A 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELG 102 (291)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCC
Confidence 799999999999965 468999999875532 2346789999999999999999999998 566789999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc-
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH- 156 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~- 156 (311)
+|.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 103 ~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 175 (291)
T 1xbb_A 103 PLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 175 (291)
T ss_dssp EHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCccc
Confidence 99999954 456899999999999999999999999 9999999999999999999999999987543322211
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
......++..|+|||.+.+..++.++|+||||+++|+|++ |..||....... ....+.....
T Consensus 176 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----------------~~~~~~~~~~ 238 (291)
T 1xbb_A 176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----------------VTAMLEKGER 238 (291)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----------------HHHHHHTTCC
T ss_pred ccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-----------------HHHHHHcCCC
Confidence 1122345688999999988889999999999999999999 999986432211 0001111111
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 279 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~ 279 (311)
...+..++..+.++|.+||..||++||++.++++.|+.+.....
T Consensus 239 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 239 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 22345667889999999999999999999999999999876544
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=300.69 Aligned_cols=262 Identities=23% Similarity=0.242 Sum_probs=196.6
Q ss_pred eeeeeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcC--CCCcccceeEEEEeC----CeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLL--HHDNLVTLIGYCTSG----DQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~----~~~~lv~e~~~ 75 (311)
...+|+|+||.||++...++.||+|++... ......+|.+++..+ +||||+++++++... ...++||||++
T Consensus 42 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 118 (337)
T 3mdy_A 42 VKQIGKGRYGEVWMGKWRGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHE 118 (337)
T ss_dssp EEEEEEETTEEEEEEEETTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCT
T ss_pred EeEeecCCCeEEEEEEECCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccC
Confidence 578999999999999999999999998533 234555666666554 899999999999877 78899999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhC--------CCCCeeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK--------ANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~--------~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
+++|.+++.. ..+++..++.++.|++.||+|||+. + ++|+||||+||+++.++.+||+|||++.
T Consensus 119 ~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 190 (337)
T 3mdy_A 119 NGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAV 190 (337)
T ss_dssp TCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEEEEeCCCce
Confidence 9999999954 4689999999999999999999998 8 9999999999999999999999999986
Q ss_pred cCCCCCCcce--eeeccccccccCCccccCCCCCcc------ccchhHHHHHHHHHhCCCCccccCcccccc--c--hhc
Q 021526 148 LGPVGDNTHV--STRVMGTYGYCAPEYAMSGKLTLK------SDIYSFGVVLLELITGRKAMDLSKGQGEQN--L--VSW 215 (311)
Q Consensus 148 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~------~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~--~--~~~ 215 (311)
.......... .....|+..|+|||++.+...... +||||||+++|+|++|..|+.......... . ...
T Consensus 191 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~ 270 (337)
T 3mdy_A 191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP 270 (337)
T ss_dssp ECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred eeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC
Confidence 5432221111 123468999999999987766554 999999999999999955442111100000 0 000
Q ss_pred chhhhhcccchhhhcCccCCCCC-----cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 021526 216 SRPFLKDQKKFVHLVDPLLHGRY-----PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 279 (311)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~ 279 (311)
...... ............ +..++..+.+++.+||+.||++|||+.++++.|+.+....+
T Consensus 271 ~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 271 SYEDMR-----EIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp CHHHHH-----HHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred chhhhH-----HHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 000000 000111111122 23678889999999999999999999999999999988764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=312.17 Aligned_cols=258 Identities=25% Similarity=0.324 Sum_probs=206.1
Q ss_pred eeeeeeceeccEEEEEEC--C-----eEEEEEEeccCCc-cchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWLC--D-----QLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~--~-----~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 72 (311)
...+|.|+||.||++... + +.||+|.+..... ...+.+.+|+.+++.+ +||||+++++++.++...++|||
T Consensus 51 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 130 (333)
T 2i1m_A 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE 130 (333)
T ss_dssp EEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEe
Confidence 467999999999999982 2 4899999875532 3446788999999999 89999999999999999999999
Q ss_pred cCCCCCHHHHhcccCC----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEee
Q 021526 73 YMPMGSLEDHLYDLEP----------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 142 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~----------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~D 142 (311)
++++++|.+++..... ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 131 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~D 207 (333)
T 2i1m_A 131 YCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGD 207 (333)
T ss_dssp CCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGGEEEBCC
T ss_pred cCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCCeEEECc
Confidence 9999999999864211 1456899999999999999999999999 99999999999999999999999
Q ss_pred cCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhh
Q 021526 143 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLK 221 (311)
Q Consensus 143 f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 221 (311)
||++................++..|+|||++.+..++.++||||||+++|+|++ |..||........
T Consensus 208 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~------------ 275 (333)
T 2i1m_A 208 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK------------ 275 (333)
T ss_dssp CGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH------------
T ss_pred cccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH------------
Confidence 999875433333223334456788999999988899999999999999999998 8889864322110
Q ss_pred cccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 021526 222 DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 278 (311)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~ 278 (311)
.............+..++..+.+++.+||+.||.+|||+.++++.|+++....
T Consensus 276 ----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 276 ----FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp ----HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----HHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 00111111111223445678999999999999999999999999999887643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=300.05 Aligned_cols=244 Identities=24% Similarity=0.280 Sum_probs=199.7
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEe----------------
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS---------------- 63 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---------------- 63 (311)
...+|+|++|.||++.. +++.||+|.+.... ..+.+|+++++.++||||+++++++..
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (284)
T 2a19_B 16 IELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSK 91 (284)
T ss_dssp EEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCE
T ss_pred eeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccC
Confidence 56899999999999999 69999999986543 467789999999999999999998754
Q ss_pred CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeec
Q 021526 64 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 143 (311)
Q Consensus 64 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df 143 (311)
....+++|||+++++|.+++.. .....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+||
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Df 166 (284)
T 2a19_B 92 TKCLFIQMEFCDKGTLEQWIEK--RRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDF 166 (284)
T ss_dssp EEEEEEEECCCCSCBHHHHHHH--GGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCC
T ss_pred cceEEEEEeccCCCCHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEECcc
Confidence 4457999999999999999965 23467899999999999999999999999 999999999999999999999999
Q ss_pred CCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcc
Q 021526 144 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 223 (311)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 223 (311)
|++....... ......++..|+|||++.+..++.++|+||||+++|+|++|..|+.... ..
T Consensus 167 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------------~~---- 227 (284)
T 2a19_B 167 GLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS------------KF---- 227 (284)
T ss_dssp TTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH------------HH----
T ss_pred hhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH------------HH----
Confidence 9987543322 1223458999999999998899999999999999999999998874110 00
Q ss_pred cchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 021526 224 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 279 (311)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~ 279 (311)
...+... ..+..++..+.++|.+||..||.+|||+.++++.|..+.....
T Consensus 228 --~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 228 --FTDLRDG----IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp --HHHHHTT----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred --HHHhhcc----cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 0011111 1223445678999999999999999999999999999876544
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=297.09 Aligned_cols=242 Identities=24% Similarity=0.284 Sum_probs=179.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
...+|+|++|.||++.. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.++...+++||++++
T Consensus 16 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 95 (278)
T 3cok_A 16 GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHN 95 (278)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCC
Confidence 46899999999999998 78999999986542 22346788999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 96 ~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~--~ 167 (278)
T 3cok_A 96 GEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH--E 167 (278)
T ss_dssp EEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred CcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCC--C
Confidence 999999964 3467999999999999999999999999 9999999999999999999999999987543221 1
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......++..|+|||++.+..++.++|+||||+++|+|++|..||.......... ..... ..
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----------------~~~~~--~~ 229 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN----------------KVVLA--DY 229 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------CCSS--CC
T ss_pred cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH----------------HHhhc--cc
Confidence 1223468899999999988889999999999999999999999996433211100 00000 01
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..+...+..+.++|.+||+.||++|||++++++
T Consensus 230 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 223445678999999999999999999999985
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=306.65 Aligned_cols=245 Identities=20% Similarity=0.214 Sum_probs=178.0
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCC-CCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
..+|.|+||.||++.. +++.||+|++... ....+.+|+.+++.+. ||||+++++++.++...++|||++++++|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 4699999999999999 6899999998643 3467888999999997 99999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCC---ceEEeecCCCccCCCCCCcc
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF---NPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~---~vkl~Df~~~~~~~~~~~~~ 156 (311)
.+++.. ...+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++ .+||+|||++...... ..
T Consensus 94 ~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~~ 164 (325)
T 3kn6_A 94 FERIKK----KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQ 164 (325)
T ss_dssp HHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC--CC
Confidence 999954 467999999999999999999999999 99999999999997766 7999999999753222 22
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCcccccc-chhcchhhhhcccchhhhcCccCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
......++..|+|||++.+..++.++||||||+++|+|++|..||.......... ..... ..+......
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~----------~~i~~~~~~ 234 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM----------KKIKKGDFS 234 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHH----------HHHTTTCCC
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHH----------HHHHcCCCC
Confidence 2334567999999999999999999999999999999999999997543321110 01100 011111110
Q ss_pred --CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 236 --GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 236 --~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
......++.++.++|.+||+.||.+|||++++++
T Consensus 235 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 0011235778999999999999999999999874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=300.41 Aligned_cols=257 Identities=26% Similarity=0.341 Sum_probs=201.4
Q ss_pred eeeeeeceeccEEEEEEC-----CeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEE-EeCCeeEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWLC-----DQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYC-TSGDQRLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~-----~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~ 74 (311)
...+|+|+||.||++... ...||+|.+.... ....+.+.+|+.+++.++||||+++++++ ..+...+++||++
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 109 (298)
T 3f66_A 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 109 (298)
T ss_dssp EEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECC
T ss_pred cceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCC
Confidence 468999999999999972 2368999987543 23446788999999999999999999985 4556789999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
++++|.+++.. ....+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.+||+|||++........
T Consensus 110 ~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 110 KHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp TTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred CCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 99999999964 4567899999999999999999999999 99999999999999999999999999875432221
Q ss_pred c--ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcC
Q 021526 155 T--HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231 (311)
Q Consensus 155 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
. .......++..|+|||.+.+..++.++|+||||+++|+|++ |.+||......... .....
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~------~~~~~---------- 247 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT------VYLLQ---------- 247 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH------HHHHT----------
T ss_pred hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH------HHHhc----------
Confidence 1 11223456788999999998899999999999999999999 45565432211110 00000
Q ss_pred ccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCC
Q 021526 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSH 281 (311)
Q Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~~ 281 (311)
......+..++..+.+++.+||..||++|||+.++++.|+.+.....+.
T Consensus 248 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~ 296 (298)
T 3f66_A 248 -GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296 (298)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred -CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 0011123345677999999999999999999999999999998876554
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=300.09 Aligned_cols=251 Identities=21% Similarity=0.279 Sum_probs=199.4
Q ss_pred eeeeeeceeccEEEEEEC-----CeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWLC-----DQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~-----~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
...+|+|++|.||++... +..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+ ...+++||++.
T Consensus 17 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 95 (281)
T 3cc6_A 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYP 95 (281)
T ss_dssp EEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred EEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCC
Confidence 468999999999999872 3469999987553 3345678999999999999999999999765 45789999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 96 ~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 168 (281)
T 3cc6_A 96 YGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY- 168 (281)
T ss_dssp TCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC------
T ss_pred CCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccccccc-
Confidence 9999999965 3456899999999999999999999999 99999999999999999999999999875432211
Q ss_pred ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccC
Q 021526 156 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
.......++..|+|||++.+..++.++|+||||+++|+|++ |..||......... .... ...
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~-------~~~~----------~~~ 231 (281)
T 3cc6_A 169 YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI-------GVLE----------KGD 231 (281)
T ss_dssp ----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH-------HHHH----------HTC
T ss_pred cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH-------HHHh----------cCC
Confidence 11223446788999999988899999999999999999998 99998633221110 0000 001
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 277 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~ 277 (311)
....+..++..+.+++.+||..||++||++.++++.|+.+...
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 232 RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 1122344567799999999999999999999999999988654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=302.76 Aligned_cols=245 Identities=22% Similarity=0.223 Sum_probs=191.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCC-------------
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD------------- 65 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------------- 65 (311)
...+|+|+||.||++.. +++.||||++.... ....+.+.+|+++++.++||||+++++++.+..
T Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~ 90 (332)
T 3qd2_B 11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWL 90 (332)
T ss_dssp EEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC---
T ss_pred eeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhh
Confidence 57899999999999999 78999999987544 334578999999999999999999999986543
Q ss_pred --------------------------------------------eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHH
Q 021526 66 --------------------------------------------QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI 101 (311)
Q Consensus 66 --------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~ 101 (311)
..+++|||+++++|.+++.... ......+..++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i 169 (332)
T 3qd2_B 91 KDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREHGVCLHI 169 (332)
T ss_dssp -----------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCHHHHHHH
T ss_pred ccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-CccchhhHHHHHH
Confidence 3799999999999999997633 3345667778999
Q ss_pred HHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc----------ceeeeccccccccCCc
Q 021526 102 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT----------HVSTRVMGTYGYCAPE 171 (311)
Q Consensus 102 ~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~----------~~~~~~~~~~~~~aPE 171 (311)
+.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++......... .......|++.|+|||
T Consensus 170 ~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 246 (332)
T 3qd2_B 170 FIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246 (332)
T ss_dssp HHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHH
T ss_pred HHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChH
Confidence 999999999999999 999999999999999999999999998764332211 1122346899999999
Q ss_pred cccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHH
Q 021526 172 YAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTA 251 (311)
Q Consensus 172 ~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (311)
++.+..++.++|+||||+++|+|++|..|+.... ........... .......+..+.++|.
T Consensus 247 ~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~------------------~~~~~~~~~~~-~~~~~~~~~~~~~li~ 307 (332)
T 3qd2_B 247 QIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV------------------RIITDVRNLKF-PLLFTQKYPQEHMMVQ 307 (332)
T ss_dssp HHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH------------------HHHHHHHTTCC-CHHHHHHCHHHHHHHH
T ss_pred HhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH------------------HHHHHhhccCC-CcccccCChhHHHHHH
Confidence 9999999999999999999999999877653100 00000000000 0112345567899999
Q ss_pred HhhccCCCCCCCHHHHHH
Q 021526 252 MCLNEEANFRPLINDIVV 269 (311)
Q Consensus 252 ~~l~~~p~~RPs~~~l~~ 269 (311)
+||+.||++|||+.++++
T Consensus 308 ~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 308 DMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHCSSGGGSCCHHHHHH
T ss_pred HHccCCCCcCCCHHHHhh
Confidence 999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=298.65 Aligned_cols=246 Identities=26% Similarity=0.262 Sum_probs=194.1
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
...+|+|+||.||++.. ++..||+|.+.... ....+.+.+|+++++.++||||+++++++.+....++|||++++++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 106 (285)
T 3is5_A 27 KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGE 106 (285)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCB
T ss_pred cceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCc
Confidence 46899999999999998 68999999987654 3345789999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE---cCCCceEEeecCCCccCCCCCCc
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~---~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
|.+++.........+++..++.++.|++.||+|||+.+ ++|+||+|+||++ +.++.++|+|||++..... .
T Consensus 107 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~---~ 180 (285)
T 3is5_A 107 LLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS---D 180 (285)
T ss_dssp HHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------
T ss_pred HHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecCC---c
Confidence 99999654444578999999999999999999999999 9999999999999 4567899999999974322 2
Q ss_pred ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 156 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
.......++..|+|||++. ..++.++|+||||+++|+|++|..||......... ..... ......
T Consensus 181 ~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~------~~~~~--------~~~~~~ 245 (285)
T 3is5_A 181 EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ------QKATY--------KEPNYA 245 (285)
T ss_dssp ------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHH--------CCCCCC
T ss_pred ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH------hhhcc--------CCcccc
Confidence 2233456899999999875 56789999999999999999999999643311100 00000 000000
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
......+..+.+++.+||+.||++|||+.|+++
T Consensus 246 -~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 246 -VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001123567889999999999999999999985
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=302.38 Aligned_cols=244 Identities=25% Similarity=0.234 Sum_probs=198.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc------chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ------GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
...+|.|+||.||++.. +++.||+|.+...... ..+.+.+|+.+++.++||||+++++++.++...++|||+
T Consensus 17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 96 (321)
T 2a2a_A 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILEL 96 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEc
Confidence 46899999999999999 6899999998765332 346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCC----ceEEeecCCCccC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF----NPKLSDFGLAKLG 149 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~----~vkl~Df~~~~~~ 149 (311)
+.+++|.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++ .++|+|||++...
T Consensus 97 ~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 97 VSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp CCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 999999999953 467899999999999999999999999 99999999999999887 7999999998754
Q ss_pred CCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhh
Q 021526 150 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 229 (311)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
... .......|++.|+|||++.+..++.++|+||||+++|+|++|..||........ .........
T Consensus 170 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~i~~~~~----- 235 (321)
T 2a2a_A 170 EDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LANITSVSY----- 235 (321)
T ss_dssp CTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHTTCC-----
T ss_pred Ccc---ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhccc-----
Confidence 322 122334689999999999988999999999999999999999999964321110 000000000
Q ss_pred cCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 230 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 230 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..........+..+.++|.+||..||++|||+.++++
T Consensus 236 ---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 ---DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp ---CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ---ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000011234667999999999999999999999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=312.42 Aligned_cols=267 Identities=17% Similarity=0.189 Sum_probs=199.4
Q ss_pred eeeeeec--eeccEEEEEE--CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCC
Q 021526 2 LCCYLSC--KFYNVGLVWL--CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g--~~~~v~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
..++|.| +||.||++.. +++.||||.+..... ...+.+.+|+.+++.++||||+++++++.++...++||||++
T Consensus 30 ~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 109 (389)
T 3gni_B 30 LTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 109 (389)
T ss_dssp EEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred EecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccC
Confidence 5789999 9999999999 699999999876532 233678889999999999999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC-
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN- 154 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~- 154 (311)
+++|.+++.. .....+++..+..++.||+.||+|||+++ |+|+||||+|||++.++.+||+|||.+........
T Consensus 110 ~~~L~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~ 184 (389)
T 3gni_B 110 YGSAKDLICT--HFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR 184 (389)
T ss_dssp TCBHHHHHHH--TCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEETTEE
T ss_pred CCCHHHHHhh--hcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeecccccc
Confidence 9999999965 23456999999999999999999999999 99999999999999999999999998753211111
Q ss_pred ----cceeeeccccccccCCccccC--CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhc------
Q 021526 155 ----THVSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD------ 222 (311)
Q Consensus 155 ----~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 222 (311)
........|+..|+|||++.+ ..++.++|||||||++|+|++|..||......... ..........
T Consensus 185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~ 262 (389)
T 3gni_B 185 QRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPCLLDTST 262 (389)
T ss_dssp CSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--HHC-------------
T ss_pred ccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHhcCCCCccccccc
Confidence 111122367889999999887 57899999999999999999999999643322110 0000000000
Q ss_pred --cc-------------chhhhc---------CccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHHhh
Q 021526 223 --QK-------------KFVHLV---------DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA--LDYLV 275 (311)
Q Consensus 223 --~~-------------~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~--L~~l~ 275 (311)
.. ...... .......++..++..+.+||.+||+.||++|||+.++++. |+.+.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 00 000000 0000111234456779999999999999999999999874 44443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=305.27 Aligned_cols=235 Identities=23% Similarity=0.267 Sum_probs=196.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc--------chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ--------GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 71 (311)
...+|+|+||.||++.. +++.||+|.+...... ....+.+|+.+++.++||||+++++++.++...++||
T Consensus 29 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 108 (335)
T 3dls_A 29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVM 108 (335)
T ss_dssp EEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEE
Confidence 46899999999999998 7999999998765321 3346788999999999999999999999999999999
Q ss_pred ecCCCC-CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCC
Q 021526 72 EYMPMG-SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 150 (311)
Q Consensus 72 e~~~~~-~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~ 150 (311)
|++.++ +|.+++. ....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++....
T Consensus 109 e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 109 EKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp ECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 998666 9999995 3457999999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCCcceeeeccccccccCCccccCCCC-CccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhh
Q 021526 151 VGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 229 (311)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
.. .......|++.|+|||++.+..+ +.++||||||+++|+|++|..||......
T Consensus 182 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------------- 236 (335)
T 3dls_A 182 RG---KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------------- 236 (335)
T ss_dssp TT---CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------------
T ss_pred CC---CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------------
Confidence 22 22234568999999999988776 78999999999999999999999531110
Q ss_pred cCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 230 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 230 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
..... ..+..++..+.++|.+||+.||++|||++++++.
T Consensus 237 ~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 VEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp TTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred Hhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 1122356679999999999999999999999874
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=305.97 Aligned_cols=258 Identities=26% Similarity=0.316 Sum_probs=205.5
Q ss_pred eeeeeeceeccEEEEEE-------CCeEEEEEEeccCCc-cchhHHHHHHHHHhcC-CCCcccceeEEEEeCC-eeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL-------CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGD-QRLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~lv~ 71 (311)
...+|+|+||.||++.. +++.||+|.+..... .....+.+|+.++..+ +||||+++++++.... ..+++|
T Consensus 32 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~ 111 (316)
T 2xir_A 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 111 (316)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEE
T ss_pred eeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEE
Confidence 46899999999999985 458999999875533 2345788999999999 6899999999987654 489999
Q ss_pred ecCCCCCHHHHhcccCCC------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceE
Q 021526 72 EYMPMGSLEDHLYDLEPD------------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 139 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~------------~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vk 139 (311)
||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+|
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~k 188 (316)
T 2xir_A 112 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVK 188 (316)
T ss_dssp ECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEE
Confidence 999999999999763321 223889999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchh
Q 021526 140 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRP 218 (311)
Q Consensus 140 l~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 218 (311)
|+|||++................++..|+|||++.+..++.++|+||||+++|+|++ |..||........ .. .
T Consensus 189 l~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~-----~~-~ 262 (316)
T 2xir_A 189 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-----FC-R 262 (316)
T ss_dssp ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH-----HH-H
T ss_pred ECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH-----HH-H
Confidence 999999875433333333334557889999999988899999999999999999998 9999864332110 00 0
Q ss_pred hhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 021526 219 FLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 278 (311)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~ 278 (311)
... .......+..++..+.+++.+||..||.+|||+.++++.|+.+....
T Consensus 263 ~~~----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 263 RLK----------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp HHH----------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred Hhc----------cCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 000 01111223445677999999999999999999999999999987644
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=303.56 Aligned_cols=246 Identities=21% Similarity=0.201 Sum_probs=196.3
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCC-CCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
..+|+|+||.||++.. +++.||+|.+..... .....+.+|+.+++.+. ||||+++++++.++...++||||+.++
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (327)
T 3lm5_A 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG 114 (327)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCC
Confidence 6799999999999999 699999999875432 34568889999999885 699999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcC---CCceEEeecCCCccCCCCCC
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN---DFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~---~~~vkl~Df~~~~~~~~~~~ 154 (311)
+|.+++.. .....+++..++.++.|++.||+|||+.| ++|+||+|+||+++. ++.+||+|||++......
T Consensus 115 ~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~-- 187 (327)
T 3lm5_A 115 EIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA-- 187 (327)
T ss_dssp EGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-----
T ss_pred cHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCccccccCCc--
Confidence 99999854 34567999999999999999999999999 999999999999987 789999999999754322
Q ss_pred cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccC
Q 021526 155 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
.......|++.|+|||++.+..++.++|+||||+++|+|++|..||......... ..... .....
T Consensus 188 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~i~~--------~~~~~ 252 (327)
T 3lm5_A 188 -CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY------LNISQ--------VNVDY 252 (327)
T ss_dssp -------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHH--------TCCCC
T ss_pred -cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH------HHHHh--------ccccc
Confidence 1223356899999999999999999999999999999999999999643321110 00000 00011
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.......++..+.++|.+||+.||.+|||++++++.
T Consensus 253 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 253 SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 111223456779999999999999999999999863
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=310.48 Aligned_cols=258 Identities=25% Similarity=0.326 Sum_probs=196.4
Q ss_pred eeeeeeceeccEEEEEE--C---CeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEE-eCCeeEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWL--C---DQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCT-SGDQRLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~---~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~ 74 (311)
..++|+|+||.||++.. + +..||+|.+.... ....+.+.+|+.+++.++||||+++++++. .+...++||||+
T Consensus 94 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~ 173 (373)
T 3c1x_A 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 173 (373)
T ss_dssp EEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECC
T ss_pred CcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECC
Confidence 35799999999999987 2 2468999986432 344568899999999999999999999864 456789999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
++++|.+++.. ....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++........
T Consensus 174 ~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 174 KHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred CCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccccccc
Confidence 99999999964 4567889999999999999999999999 99999999999999999999999999875422211
Q ss_pred cc--eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcC
Q 021526 155 TH--VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231 (311)
Q Consensus 155 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
.. ......++..|+|||++.+..++.++||||||+++|+|++ |.+||........ .. ....
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~~---~~~~---------- 311 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TV---YLLQ---------- 311 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---HH---HHHT----------
T ss_pred ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---HH---HHHc----------
Confidence 11 1122346778999999998999999999999999999999 6677753322111 00 0000
Q ss_pred ccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCC
Q 021526 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHP 282 (311)
Q Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~~~ 282 (311)
......+..++..+.+++.+||..||++|||+.++++.|+.+........
T Consensus 312 -~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~ 361 (373)
T 3c1x_A 312 -GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361 (373)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred -CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence 00112234566789999999999999999999999999999988766543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=297.26 Aligned_cols=239 Identities=20% Similarity=0.193 Sum_probs=198.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
...+|+|+||.||++.. ++..||+|.+........+.+.+|+++++.++||||+++++++.++...++||||+++++|
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 93 (277)
T 3f3z_A 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL 93 (277)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred eeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcH
Confidence 46899999999999999 6779999999877666778899999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE---cCCCceEEeecCCCccCCCCCCcc
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~---~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
.+++.. ...+++..++.++.|++.||+|||+++ ++|+||+|+||++ +.++.++|+|||++...... .
T Consensus 94 ~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~---~ 163 (277)
T 3f3z_A 94 FERVVH----KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG---K 163 (277)
T ss_dssp HHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT---S
T ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc---c
Confidence 999854 456899999999999999999999999 9999999999999 78889999999998754322 2
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......+++.|+|||++.+. ++.++|+||||+++|+|++|..||........ ...... ...
T Consensus 164 ~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~----------~~~-- 224 (277)
T 3f3z_A 164 MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV------MLKIRE----------GTF-- 224 (277)
T ss_dssp CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHH----------CCC--
T ss_pred chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHH------HHHHHh----------CCC--
Confidence 23345689999999987654 89999999999999999999999964322110 000000 000
Q ss_pred CCcH----HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 237 RYPR----RCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 237 ~~~~----~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..+. .++..+.++|.+||+.||++|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 225 TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 34677999999999999999999999986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=302.19 Aligned_cols=238 Identities=21% Similarity=0.165 Sum_probs=187.0
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc--chhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+.++|.|+||.||++.. +++.||||++...... .......|+..+..+ +||||+++++++.++...++|||++ +
T Consensus 62 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~ 140 (311)
T 3p1a_A 62 LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-G 140 (311)
T ss_dssp EEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-C
T ss_pred eheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-C
Confidence 46899999999999999 6999999998654322 223455555555444 8999999999999999999999999 6
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. .+..+++..++.++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||++..... ..
T Consensus 141 ~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~---~~ 211 (311)
T 3p1a_A 141 PSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT---AG 211 (311)
T ss_dssp CBHHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc---CC
Confidence 699998865 3467999999999999999999999999 99999999999999999999999999875322 22
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......|++.|+|||++.+ .++.++||||||+++|+|++|..|+..... ...+.......
T Consensus 212 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-------------------~~~~~~~~~~~ 271 (311)
T 3p1a_A 212 AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-------------------WQQLRQGYLPP 271 (311)
T ss_dssp ---CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-------------------HHHHTTTCCCH
T ss_pred CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-------------------HHHHhccCCCc
Confidence 2334568999999998876 789999999999999999999766532110 00011111111
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.++..++..+.++|.+||+.||++|||++++++
T Consensus 272 ~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 272 EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 112345678999999999999999999999985
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=312.62 Aligned_cols=245 Identities=24% Similarity=0.270 Sum_probs=193.7
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCC--CCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLH--HDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+..+|+|+||.||++.. .++.||||++..... ...+.+.+|+++++.++ ||||+++++++..+...++||| +.+
T Consensus 61 ~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~ 139 (390)
T 2zmd_A 61 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 139 (390)
T ss_dssp EEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCS
T ss_pred EEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCC
Confidence 56899999999999998 688999999875533 33467899999999996 5999999999999999999999 567
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ...+++..++.++.||+.||+|||+.+ |+|+||||+|||++ ++.+||+|||++..........
T Consensus 140 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 140 IDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp EEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence 899999964 347888999999999999999999999 99999999999995 5889999999997543322222
Q ss_pred eeeeccccccccCCccccC-----------CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccc
Q 021526 157 VSTRVMGTYGYCAPEYAMS-----------GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 225 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~-----------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
......|++.|+|||++.+ ..++.++|||||||++|+|++|..||...... ...
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---------------~~~ 276 (390)
T 2zmd_A 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---------------ISK 276 (390)
T ss_dssp --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---------------HHH
T ss_pred cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH---------------HHH
Confidence 2344579999999998865 36889999999999999999999999632210 011
Q ss_pred hhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 226 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
+...+++.....++...+..+.++|.+||+.||++|||+.++++.
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 277 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 122222223333444456789999999999999999999999874
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=305.62 Aligned_cols=241 Identities=25% Similarity=0.261 Sum_probs=190.4
Q ss_pred eeeeeeceeccEEEEEE-----CCeEEEEEEeccCC----ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL-----CDQLVAIKQLNHEG----LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-----~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 72 (311)
+..+|+|+||.||.+.. .++.||+|++.+.. ......+.+|+++++.++||||+++++++.++...++|||
T Consensus 22 ~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 101 (327)
T 3a62_A 22 LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILE 101 (327)
T ss_dssp EEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred EEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEe
Confidence 57899999999999997 68999999987653 2234567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCC
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~ 152 (311)
|+++++|.+++.. ...+++..++.++.|++.||.|||++| ++|+||||+||+++.++.+||+|||++......
T Consensus 102 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 174 (327)
T 3a62_A 102 YLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD 174 (327)
T ss_dssp CCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC------
T ss_pred CCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccccccC
Confidence 9999999999954 456889999999999999999999999 999999999999999999999999998642211
Q ss_pred CCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCc
Q 021526 153 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 232 (311)
Q Consensus 153 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
........|++.|+|||++.+..++.++|+||||+++|+|++|..||....... ....... .
T Consensus 175 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~----------~ 236 (327)
T 3a62_A 175 --GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK------TIDKILK----------C 236 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHH----------T
T ss_pred --CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHh----------C
Confidence 122234568999999999998889999999999999999999999996432110 0001111 0
Q ss_pred cCCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 021526 233 LLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 269 (311)
Q Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~l~~ 269 (311)
...++...+..+.++|.+||..||.+|| ++.++++
T Consensus 237 --~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 237 --KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp --CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred --CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 1123445677899999999999999999 7888876
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=299.87 Aligned_cols=258 Identities=21% Similarity=0.232 Sum_probs=193.8
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
+..+|.|+||.||++.. .++.||+|.+..... .....+.+|+++++.++||||+++++++.++...++|||++++ +
T Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 85 (288)
T 1ob3_A 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-D 85 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-E
T ss_pred hhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-C
Confidence 57899999999999999 689999999865532 2346788999999999999999999999999999999999975 9
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
|.+++.. ....+++..+..++.|++.||+|||++| ++|+||||+||+++.++.+||+|||++...... ....
T Consensus 86 l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~ 157 (288)
T 1ob3_A 86 LKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRKY 157 (288)
T ss_dssp HHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred HHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc--cccc
Confidence 9998864 3467899999999999999999999999 999999999999999999999999998643211 1122
Q ss_pred eeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCcccccc-chhc----chhhhhcccchhhhcCc
Q 021526 159 TRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSW----SRPFLKDQKKFVHLVDP 232 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~ 232 (311)
....++..|+|||++.+. .++.++|+||||+++|+|++|..||.......... +... ....+........ .++
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 236 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK-YDP 236 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT-CCT
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc-ccc
Confidence 234578999999998764 58999999999999999999999996443211100 0000 0000000000000 000
Q ss_pred cC-------CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 233 LL-------HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 233 ~~-------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.. ........+..+.++|.+||+.||++|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 00112235677899999999999999999999985
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=307.98 Aligned_cols=262 Identities=25% Similarity=0.319 Sum_probs=203.7
Q ss_pred eeeeeeceeccEEEEEE-------CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL-------CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
...+|.|+||.||++.. +++.||+|.+.... ......+.+|+.+++.++||||+++++++.++...++|||+
T Consensus 35 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 114 (327)
T 2yfx_A 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMEL 114 (327)
T ss_dssp EEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred EEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEec
Confidence 56899999999999983 56789999986443 23446788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcccCCC---CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCC---CceEEeecCCCc
Q 021526 74 MPMGSLEDHLYDLEPD---QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND---FNPKLSDFGLAK 147 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~---~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~---~~vkl~Df~~~~ 147 (311)
+++++|.+++...... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.+ ..++|+|||++.
T Consensus 115 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~ 191 (327)
T 2yfx_A 115 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191 (327)
T ss_dssp CTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHH
T ss_pred CCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEECcccccc
Confidence 9999999999764322 256899999999999999999999999 9999999999999844 459999999886
Q ss_pred cCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccch
Q 021526 148 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 226 (311)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
...............++..|+|||++.+..++.++|+||||+++|+|++ |..||....... .
T Consensus 192 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~-------------- 254 (327)
T 2yfx_A 192 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---V-------------- 254 (327)
T ss_dssp HHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---H--------------
T ss_pred ccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH---H--------------
Confidence 4322222222334557889999999988899999999999999999998 888986332110 0
Q ss_pred hhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCCC
Q 021526 227 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPV 283 (311)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~~~~ 283 (311)
...+........+..++..+.++|.+||..||.+||++.++++.|..+.........
T Consensus 255 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~~ 311 (327)
T 2yfx_A 255 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINT 311 (327)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHHTC
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHHhcc
Confidence 000000111122345667899999999999999999999999999998876554433
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=302.96 Aligned_cols=258 Identities=21% Similarity=0.258 Sum_probs=189.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
+..+|+|+||.||++.. +++.||+|.+..... .....+.+|+++++.++||||+++++++.+++..++||||++ ++
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~ 88 (317)
T 2pmi_A 10 LEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-ND 88 (317)
T ss_dssp ---------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CB
T ss_pred eeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CC
Confidence 56899999999999988 689999999875532 344678899999999999999999999999999999999997 59
Q ss_pred HHHHhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 79 LEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 79 L~~~l~~~~--~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
|.+++.... .....+++..+..++.|++.||+|||+.| ++|+||||+||+++.++.+||+|||++...... ..
T Consensus 89 L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~~ 163 (317)
T 2pmi_A 89 LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP--VN 163 (317)
T ss_dssp HHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTSC--CC
T ss_pred HHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCCC--cc
Confidence 999886532 12346899999999999999999999999 999999999999999999999999998754221 11
Q ss_pred eeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCccccccc-hhc----chhhhhcc-------
Q 021526 157 VSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-VSW----SRPFLKDQ------- 223 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~----~~~~~~~~------- 223 (311)
......++..|+|||++.+. .++.++|||||||++|+|++|..||........... ... ....+...
T Consensus 164 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 243 (317)
T 2pmi_A 164 TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYN 243 (317)
T ss_dssp CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCC
T ss_pred cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcc
Confidence 22334679999999998764 689999999999999999999999965432111000 000 00000000
Q ss_pred --------cchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 224 --------KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 224 --------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..+.+.+.+.. +...+..+.++|.+||+.||++|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 244 PNIQQRPPRDLRQVLQPHT----KEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp TTCCCCCCCCSHHHHGGGC----SSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccchhHHHhhcccc----cccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00001111111 1134567999999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=326.85 Aligned_cols=253 Identities=27% Similarity=0.356 Sum_probs=204.6
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
...+|+|+||.||++.. .+..||||.+.... ...+.+.+|+++++.++||||+++++++.+ ...++||||+.+++|.
T Consensus 272 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~ 349 (535)
T 2h8h_A 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 349 (535)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHH
T ss_pred heecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHH
Confidence 46799999999999999 56789999987543 345789999999999999999999999865 6789999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++.. .....+++..++.++.||+.||+|||+++ ++|+||+|+|||++.++.+||+|||++...... .......
T Consensus 350 ~~l~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~ 423 (535)
T 2h8h_A 350 DFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQG 423 (535)
T ss_dssp HHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH-HHHTTCS
T ss_pred HHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC-ceecccC
Confidence 99954 12356899999999999999999999999 999999999999999999999999999753211 1111122
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
..++..|+|||++.+..++.++||||||+++|+|++ |..||....... ....+....+...+
T Consensus 424 ~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-----------------~~~~i~~~~~~~~~ 486 (535)
T 2h8h_A 424 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----------------VLDQVERGYRMPCP 486 (535)
T ss_dssp TTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-----------------HHHHHHTTCCCCCC
T ss_pred CcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHHHcCCCCCCC
Confidence 345778999999988899999999999999999999 899986332110 00011111122334
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 279 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~ 279 (311)
..++..+.+||.+||+.||++|||+++|++.|+.+.....
T Consensus 487 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 487 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 5677889999999999999999999999999998865443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=297.25 Aligned_cols=246 Identities=24% Similarity=0.253 Sum_probs=196.6
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
.++|.|+||.||++.. +++.||+|.+........+.+.+|+.+++.++||||+++++++.++...++|||++.+++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 4799999999999998 78899999998766666678999999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcC-CCceEEeecCCCccCCCCCCcceee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-DFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~-~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
+++.... ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++. ++.++|+|||.+...... .....
T Consensus 108 ~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~--~~~~~ 181 (295)
T 2clq_A 108 ALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI--NPCTE 181 (295)
T ss_dssp HHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------C
T ss_pred HHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCC--CCccc
Confidence 9997522 3345778899999999999999999999 999999999999987 899999999998753221 11223
Q ss_pred eccccccccCCccccCCC--CCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCC
Q 021526 160 RVMGTYGYCAPEYAMSGK--LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 237 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~~~~--~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
...++..|+|||++.+.. ++.++|+||||+++|+|++|..||......... ... .........
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--------~~~-------~~~~~~~~~ 246 (295)
T 2clq_A 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA--------MFK-------VGMFKVHPE 246 (295)
T ss_dssp CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH--------HHH-------HHHHCCCCC
T ss_pred ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH--------HHh-------hcccccccc
Confidence 456889999999987643 789999999999999999999999633211100 000 000011112
Q ss_pred CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 238 YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.+..++..+.++|.+||+.||++||++.++++
T Consensus 247 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 247 IPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 34456778999999999999999999999986
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=315.58 Aligned_cols=249 Identities=21% Similarity=0.175 Sum_probs=198.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+.++|+|+||.||++.. +++.||+|++.+.. ......+.+|..++..++||||+++++++.++...++||||+.+
T Consensus 79 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~g 158 (437)
T 4aw2_A 79 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVG 158 (437)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCC
Confidence 57899999999999999 68999999987532 22334588999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 159 g~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~-~~ 231 (437)
T 4aw2_A 159 GDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TV 231 (437)
T ss_dssp CBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-CE
T ss_pred CcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccCC-Cc
Confidence 999999964 3467999999999999999999999999 9999999999999999999999999997543221 22
Q ss_pred eeeeccccccccCCcccc-----CCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcC
Q 021526 157 VSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
......||+.|+|||++. ...++.++|+|||||++|+|++|..||........ ........ .....
T Consensus 232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~------~~~i~~~~---~~~~~ 302 (437)
T 4aw2_A 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHK---ERFQF 302 (437)
T ss_dssp ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHTHH---HHCCC
T ss_pred ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH------HHhhhhcc---ccccC
Confidence 223357999999999987 56789999999999999999999999964332111 00111000 00000
Q ss_pred ccCCCCCcHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 021526 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANF--RPLINDIVVA 270 (311)
Q Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~--RPs~~~l~~~ 270 (311)
+. .....+..+.+||.+||..+|++ ||+++|+++.
T Consensus 303 p~----~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 303 PT----QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp CS----SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred Cc----ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 00 11235677999999999988888 9999999873
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=314.88 Aligned_cols=246 Identities=21% Similarity=0.199 Sum_probs=198.0
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+.++|+|+||.||++.. +++.||+|++.+.. ......+.+|..+++.++||||+++++++.++...++||||+.+
T Consensus 74 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g 153 (410)
T 3v8s_A 74 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG 153 (410)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 57899999999999999 68999999986532 23345688999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ..+++..+..++.|++.||+|||++| |+||||||+|||++.++.+||+|||++....... ..
T Consensus 154 g~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~-~~ 224 (410)
T 3v8s_A 154 GDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MV 224 (410)
T ss_dssp EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-EE
T ss_pred CcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccCC-cc
Confidence 999999954 46899999999999999999999999 9999999999999999999999999997543221 11
Q ss_pred eeeeccccccccCCccccCCC----CCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCc
Q 021526 157 VSTRVMGTYGYCAPEYAMSGK----LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 232 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~----~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
......|++.|+|||++.+.. ++.++|+||||+++|+|++|..||........ ......... .
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~~~~---~---- 291 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIMNHKN---S---- 291 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHTHHH---H----
T ss_pred cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH------HHHHHhccc---c----
Confidence 223467999999999988655 78999999999999999999999964332110 001110000 0
Q ss_pred cCCCCCcHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 021526 233 LLHGRYPRRCLNYAVAVTAMCLNEEANF--RPLINDIVVA 270 (311)
Q Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~--RPs~~~l~~~ 270 (311)
+........+..+.+||.+||..+|.+ ||+++||++.
T Consensus 292 -~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 292 -LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp -CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred -ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 000111235678999999999999988 9999999874
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=318.91 Aligned_cols=249 Identities=26% Similarity=0.345 Sum_probs=204.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+.++|+|+||.||.+.. +|+.||+|++.+.. ......+.+|+++++.++||||+++++++.+....++||||+++
T Consensus 190 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~g 269 (543)
T 3c4z_A 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNG 269 (543)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccC
Confidence 46799999999999999 69999999987543 23446788999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.........+++..++.++.||+.||.|||++| |+|+||||+|||++.+|.+||+|||++....... .
T Consensus 270 g~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~--~ 344 (543)
T 3c4z_A 270 GDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--T 344 (543)
T ss_dssp CBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTC--C
T ss_pred CCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccCCC--c
Confidence 9999999765545678999999999999999999999999 9999999999999999999999999997543221 1
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......||+.|+|||++.+..++.++|+|||||++|+|++|..||......... ......... . ..
T Consensus 345 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~--~~~~~~i~~----------~--~~ 410 (543)
T 3c4z_A 345 KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQRVLE----------Q--AV 410 (543)
T ss_dssp CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH--HHHHHHHHH----------C--CC
T ss_pred ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH--HHHHHHHhh----------c--cc
Confidence 223347899999999999999999999999999999999999999754321110 111111111 1 11
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLI-----NDIVV 269 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~-----~~l~~ 269 (311)
.++...+..+.++|.+||+.||++||++ ++|++
T Consensus 411 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 411 TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 3345667889999999999999999965 66664
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=305.53 Aligned_cols=251 Identities=23% Similarity=0.170 Sum_probs=193.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccC-----CccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHE-----GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
...+|+|+||.||.+.. +++.||+|.+... .....+.+.+|+++++.++||||+++++++.++...++||||+
T Consensus 31 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 110 (345)
T 3hko_A 31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELC 110 (345)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCC
Confidence 56899999999999999 7889999998654 2345578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCC------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 021526 75 PMGSLEDHLYDLEPD------------------------------------QEPLSWNTRMKIAVGAARGLEYLHCKANP 118 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~------------------------------------~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~ 118 (311)
++++|.+++...... ...+++..++.++.|++.||+|||+.+
T Consensus 111 ~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-- 188 (345)
T 3hko_A 111 HGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG-- 188 (345)
T ss_dssp CSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred CCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--
Confidence 999999999532111 223467778899999999999999999
Q ss_pred CeeecCCCCCcEEEcCCC--ceEEeecCCCccCCCCCC--cceeeeccccccccCCccccC--CCCCccccchhHHHHHH
Q 021526 119 PVIYRDLKSANILLDNDF--NPKLSDFGLAKLGPVGDN--THVSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLL 192 (311)
Q Consensus 119 ~i~H~di~p~nil~~~~~--~vkl~Df~~~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~~l~ 192 (311)
++|+||+|+||+++.++ .+||+|||++........ ........|++.|+|||++.+ ..++.++||||||+++|
T Consensus 189 -ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~ 267 (345)
T 3hko_A 189 -ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLH 267 (345)
T ss_dssp -EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHH
T ss_pred -ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHH
Confidence 99999999999998776 899999999875322111 112234568999999999875 67889999999999999
Q ss_pred HHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 193 ELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 193 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
+|++|..||........ ......... ..........+..+.++|.+||+.||.+||++.++++
T Consensus 268 el~~g~~pf~~~~~~~~------~~~~~~~~~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 268 LLLMGAVPFPGVNDADT------ISQVLNKKL--------CFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHSSCSSCCSSHHHH------HHHHHHCCC--------CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHCCCCCCCCChHHH------HHHHHhccc--------ccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 99999999964332110 001111000 0000111235678999999999999999999999987
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=296.99 Aligned_cols=243 Identities=25% Similarity=0.266 Sum_probs=200.7
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
+..+|.|++|.||++.. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.++...++||||+++++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 106 (303)
T 3a7i_A 27 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS 106 (303)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred hhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCc
Confidence 46899999999999998 68999999987654 3445789999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
|.+++. ...+++..++.++.|++.||.+||+.| ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 107 L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~ 176 (303)
T 3a7i_A 107 ALDLLE-----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKR 176 (303)
T ss_dssp HHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--CCB
T ss_pred HHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc--ccc
Confidence 999994 357899999999999999999999999 9999999999999999999999999987543221 122
Q ss_pred eeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCC
Q 021526 159 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRY 238 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
....++..|+|||++.+..++.++|+||||+++|+|++|..||........ . ... ... .....
T Consensus 177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~-~~~------~~~----~~~~~ 239 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV------L-FLI------PKN----NPPTL 239 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------H-HHH------HHS----CCCCC
T ss_pred CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH------H-HHh------hcC----CCCCC
Confidence 335688999999999998999999999999999999999999863321100 0 000 000 01112
Q ss_pred cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 021526 239 PRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 271 (311)
Q Consensus 239 ~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L 271 (311)
+..++..+.+++.+||..||.+|||+.++++..
T Consensus 240 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 240 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred ccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 334566799999999999999999999998853
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=309.78 Aligned_cols=268 Identities=20% Similarity=0.184 Sum_probs=207.6
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCC--eeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD--QRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~ 76 (311)
..++|+|+||.||++.. +++.||||.+.... ....+.+.+|+++++.++||||+++++++.... ..++||||+++
T Consensus 14 ~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~ 93 (396)
T 4eut_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93 (396)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTT
T ss_pred EEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCC
Confidence 57899999999999999 58999999987543 334567889999999999999999999988655 67999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE----cCCCceEEeecCCCccCCCC
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL----DNDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~----~~~~~vkl~Df~~~~~~~~~ 152 (311)
++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+||++ +.++.+||+|||++......
T Consensus 94 g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~ 169 (396)
T 4eut_A 94 GSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD 169 (396)
T ss_dssp EEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCG
T ss_pred CCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceEccCC
Confidence 99999996522 2234999999999999999999999999 9999999999999 77888999999999753221
Q ss_pred CCcceeeeccccccccCCccccC--------CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhc-c
Q 021526 153 DNTHVSTRVMGTYGYCAPEYAMS--------GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD-Q 223 (311)
Q Consensus 153 ~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~ 223 (311)
.......|+..|+|||++.+ ..++.++||||||+++|+|++|..||.......... ......... +
T Consensus 170 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~--~~~~~~~~~~p 244 (396)
T 4eut_A 170 ---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK--EVMYKIITGKP 244 (396)
T ss_dssp ---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH--HHHHHHHHSCC
T ss_pred ---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH--HHHHHHhcCCC
Confidence 22233568999999998765 467789999999999999999999997543321110 000001000 0
Q ss_pred cc----hhhh--------cCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 021526 224 KK----FVHL--------VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 278 (311)
Q Consensus 224 ~~----~~~~--------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~ 278 (311)
.. .... .........+......+.+++.+||+.||++||++.++++.++.+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 00 0000 0001122345678899999999999999999999999999998887753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=319.23 Aligned_cols=241 Identities=27% Similarity=0.292 Sum_probs=190.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccC---CccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHE---GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+.++|.|+||.||++.. +++.||+|++... .......+.+|+.+++.++||||+++++++.++...++||||+++
T Consensus 153 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 232 (446)
T 4ejn_A 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 232 (446)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSS
T ss_pred eEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCC
Confidence 56899999999999998 7899999998754 233445678899999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
++|.+++.. ...+++..+..++.|++.||+|||+ .| |+|+||||+|||++.++.+||+|||++..... ..
T Consensus 233 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~--~~ 303 (446)
T 4ejn_A 233 GELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DG 303 (446)
T ss_dssp CBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccC--CC
Confidence 999999954 4578999999999999999999998 88 99999999999999999999999999874222 22
Q ss_pred ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 156 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
.......|++.|+|||++.+..++.++||||||+++|+|++|..||....... ....... . .
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~~----------~--~ 365 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILM----------E--E 365 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH----------C--C
T ss_pred cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH------HHHHHHh----------C--C
Confidence 22344678999999999999999999999999999999999999996332210 0001111 0 1
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 269 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~l~~ 269 (311)
..++...+..+.++|.+||+.||.+|| +++++++
T Consensus 366 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 366 IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 123445677899999999999999999 9999987
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=296.04 Aligned_cols=240 Identities=25% Similarity=0.344 Sum_probs=196.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
...+|+|++|.||++.. +++.||+|.+.... ......+.+|+.+++.++||||+++++++.++...+++|||+++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 93 (279)
T 3fdn_A 14 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 93 (279)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred eeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCC
Confidence 56899999999999999 67899999986542 22346788999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ...+++..++.++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||++..... .
T Consensus 94 ~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~----~ 162 (279)
T 3fdn_A 94 GTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS----S 162 (279)
T ss_dssp EEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-------
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc----c
Confidence 999999954 356899999999999999999999999 99999999999999999999999998754222 1
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......++..|+|||++.+..++.++|+||||+++|+|++|..||........ ...... ...
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~------------~~~ 224 (279)
T 3fdn_A 163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISR------------VEF 224 (279)
T ss_dssp -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHH------------TCC
T ss_pred cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH------HHHHHh------------CCC
Confidence 22335689999999999998999999999999999999999999963321110 000000 111
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
..+...+..+.++|.+||+.||.+|||+.++++.
T Consensus 225 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 2344456779999999999999999999999984
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=291.91 Aligned_cols=260 Identities=20% Similarity=0.185 Sum_probs=204.6
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEE-EeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC-TSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~ 78 (311)
...+|.|++|.||++.. +++.||+|.+.... ..+.+.+|+.+++.++|++++..+..+ ..+...+++||++ +++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (296)
T 3uzp_A 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS 90 (296)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCC
Confidence 56899999999999997 89999999986543 335788999999999988866666554 6777889999999 889
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE---cCCCceEEeecCCCccCCCCCCc
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~---~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
|.+++.. ....+++..++.++.|++.||+|||+++ ++|+||+|+||++ +.++.+||+|||++.........
T Consensus 91 L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (296)
T 3uzp_A 91 LEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp HHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred HHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence 9999964 3457999999999999999999999999 9999999999999 58889999999998754333221
Q ss_pred c-----eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcc-hhhhhcccchhhh
Q 021526 156 H-----VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS-RPFLKDQKKFVHL 229 (311)
Q Consensus 156 ~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 229 (311)
. ......|+..|+|||++.+..++.++||||||+++|+|++|..||............... ..... .
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------~ 237 (296)
T 3uzp_A 165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-------T 237 (296)
T ss_dssp CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH-------S
T ss_pred cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC-------C
Confidence 1 123456899999999999989999999999999999999999999754432221111110 00000 0
Q ss_pred cCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCC
Q 021526 230 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSH 281 (311)
Q Consensus 230 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~~ 281 (311)
..+.+ +..++..+.+++.+||+.||++|||+.++++.|+++.......
T Consensus 238 ~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 238 PIEVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp CHHHH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred chHHH----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 00000 1234567999999999999999999999999999998876554
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=328.08 Aligned_cols=249 Identities=24% Similarity=0.348 Sum_probs=200.3
Q ss_pred eeeeceeccEEEEEE----CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 4 CYLSCKFYNVGLVWL----CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~----~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
.+|+|+||.||++.+ .++.||||++..... ...+.+.+|+++++.++||||+++++++.. ...++||||+.++
T Consensus 376 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g 454 (635)
T 4fl3_A 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELG 454 (635)
T ss_dssp EEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTE
T ss_pred EeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCC
Confidence 699999999999976 468999999875432 335789999999999999999999999864 4688999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc-c
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT-H 156 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~-~ 156 (311)
+|.+++.. ...+++..++.++.||+.||+|||+++ |+|+||||+|||++.++.+||+|||++......... .
T Consensus 455 ~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 455 PLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999953 467899999999999999999999999 999999999999999999999999998754332211 1
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
......++..|+|||++.+..++.++||||||+++|+|++ |..||....... ....+.....
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-----------------~~~~i~~~~~ 590 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----------------VTAMLEKGER 590 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----------------HHHHHHTTCC
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHHHcCCC
Confidence 2223346788999999999899999999999999999998 999996433211 1111111122
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 277 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~ 277 (311)
...+..++.++.++|.+||..||++||++.+|++.|+.+...
T Consensus 591 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 591 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 234556778899999999999999999999999999987654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=307.67 Aligned_cols=245 Identities=20% Similarity=0.175 Sum_probs=187.0
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHH-hcCCCCcccceeEEEEe----CCeeEEEEecCC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLML-SLLHHDNLVTLIGYCTS----GDQRLLVYEYMP 75 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~ 75 (311)
.++|.|+||.||.+.. +++.||||++.. ...+.+|++++ +..+||||+++++++.. +...++||||++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 4799999999999999 689999999853 24677888887 45589999999999875 567899999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcC---CCceEEeecCCCccCCCC
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN---DFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~---~~~vkl~Df~~~~~~~~~ 152 (311)
+++|.+++.. .....+++..++.++.|++.||.|||+.+ |+|+||||+|||++. ++.+||+|||++.....
T Consensus 143 gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~- 216 (400)
T 1nxk_A 143 GGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS- 216 (400)
T ss_dssp SEEHHHHHHC--C---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred CCcHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccCC-
Confidence 9999999965 23456999999999999999999999999 999999999999987 78899999999975322
Q ss_pred CCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCc
Q 021526 153 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 232 (311)
Q Consensus 153 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
........|+..|+|||++.+..++.++|||||||++|+|++|..||........... ..........
T Consensus 217 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--~~~~i~~~~~-------- 284 (400)
T 1nxk_A 217 --HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--MKTRIRMGQY-------- 284 (400)
T ss_dssp ------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS--HHHHHHHTCC--------
T ss_pred --CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH--HHHHHHcCcc--------
Confidence 1222345689999999999999999999999999999999999999964432211100 0000000000
Q ss_pred cCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 233 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.........++.++.+||.+||..||++|||+.++++.
T Consensus 285 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 285 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000112456779999999999999999999999984
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=292.00 Aligned_cols=259 Identities=20% Similarity=0.189 Sum_probs=203.0
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEE-EeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC-TSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~ 78 (311)
...+|+|+||.||++.. +++.||+|++.... ..+.+.+|+.+++.++|++++..+..+ ..+...+++||++ +++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (296)
T 4hgt_A 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS 90 (296)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred eeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCC
Confidence 56899999999999997 89999999865443 235688999999999988777666554 6778889999999 899
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE---cCCCceEEeecCCCccCCCCCCc
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~---~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+||++ +.++.+||+|||++.........
T Consensus 91 L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~ 164 (296)
T 4hgt_A 91 LEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp HHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred HHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccC
Confidence 9999964 3456999999999999999999999999 9999999999999 78899999999999754332221
Q ss_pred -----ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcc-hhhhhcccchhhh
Q 021526 156 -----HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS-RPFLKDQKKFVHL 229 (311)
Q Consensus 156 -----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 229 (311)
.......|+..|+|||++.+..++.++||||||+++|+|++|..||............... .......
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------ 238 (296)
T 4hgt_A 165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP------ 238 (296)
T ss_dssp CBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC------
T ss_pred ccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch------
Confidence 1223456899999999999999999999999999999999999999754433222111110 0000000
Q ss_pred cCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCC
Q 021526 230 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 280 (311)
Q Consensus 230 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~ 280 (311)
.... ...++..+.+++.+||+.||++|||+.++++.|+++......
T Consensus 239 -~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 239 -IEVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp -HHHH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred -hhhh----hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 0000 112356799999999999999999999999999999877654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=301.00 Aligned_cols=268 Identities=23% Similarity=0.291 Sum_probs=194.8
Q ss_pred eeeeeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHH--HhcCCCCcccceeEEEEe-----CCeeEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLM--LSLLHHDNLVTLIGYCTS-----GDQRLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~--l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~ 74 (311)
...+|+|+||.||++..+++.||||++... ....+..|.++ +..++||||+++++.+.. ....++||||+
T Consensus 18 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 94 (336)
T 3g2f_A 18 LELIGRGRYGAVYKGSLDERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYY 94 (336)
T ss_dssp EEEEEECSSEEEEEEEETTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCC
T ss_pred eeecccCCCeEEEEEEECCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecC
Confidence 568999999999999999999999998643 23444445554 455899999999976532 23568999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhC---------CCCCeeecCCCCCcEEEcCCCceEEeecCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK---------ANPPVIYRDLKSANILLDNDFNPKLSDFGL 145 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~---------~~~~i~H~di~p~nil~~~~~~vkl~Df~~ 145 (311)
++++|.+++.. ...++..++.++.|++.||+|||+. + ++|+||||+|||++.++.+||+|||+
T Consensus 95 ~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~DFG~ 166 (336)
T 3g2f_A 95 PNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISDFGL 166 (336)
T ss_dssp TTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECCCTT
T ss_pred CCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEeeccc
Confidence 99999999954 3448889999999999999999999 8 99999999999999999999999999
Q ss_pred CccCCCCCC------cceeeeccccccccCCccccC-------CCCCccccchhHHHHHHHHHhCCCCccccCccccccc
Q 021526 146 AKLGPVGDN------THVSTRVMGTYGYCAPEYAMS-------GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 212 (311)
Q Consensus 146 ~~~~~~~~~------~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~ 212 (311)
+........ ........|+..|+|||++.+ ..++.++||||||+++|+|++|..|+...........
T Consensus 167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~ 246 (336)
T 3g2f_A 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246 (336)
T ss_dssp CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence 975432211 111223468999999999876 3556789999999999999999877654333222111
Q ss_pred hhcchhhhhcc---cchhh-hcCccCCCCC------cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCC
Q 021526 213 VSWSRPFLKDQ---KKFVH-LVDPLLHGRY------PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHP 282 (311)
Q Consensus 213 ~~~~~~~~~~~---~~~~~-~~~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~~~ 282 (311)
.. ....... ..... ......+..+ ...++..+.++|.+||+.||++|||+.++++.|+++........
T Consensus 247 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 247 AF--QTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324 (336)
T ss_dssp TT--HHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred hh--hcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence 00 0000000 00000 0011111111 22467789999999999999999999999999999986554443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=305.79 Aligned_cols=266 Identities=15% Similarity=0.101 Sum_probs=200.6
Q ss_pred eeeeeeceeccEEEEEE-C------CeEEEEEEeccCCccc-----------hhHHHHHHHHHhcCCCCcccceeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL-C------DQLVAIKQLNHEGLQG-----------HQEFIVEVLMLSLLHHDNLVTLIGYCTS 63 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~------~~~vaiK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 63 (311)
...+|+|+||.||++.. . ++.||+|.+....... ...+..|+..+..++||||+++++++..
T Consensus 40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 119 (364)
T 3op5_A 40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLH 119 (364)
T ss_dssp EEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEE
T ss_pred EEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeee
Confidence 46899999999999998 2 4789999986543211 1223345566777889999999999876
Q ss_pred C----CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEc--CCCc
Q 021526 64 G----DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD--NDFN 137 (311)
Q Consensus 64 ~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~--~~~~ 137 (311)
+ ...++||||+ +++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+|||++ .++.
T Consensus 120 ~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 120 DKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSCTTC
T ss_pred ccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCCCCe
Confidence 4 4579999999 9999999965 4467999999999999999999999999 99999999999999 8899
Q ss_pred eEEeecCCCccCCCCCCc-----ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccc
Q 021526 138 PKLSDFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 212 (311)
Q Consensus 138 vkl~Df~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~ 212 (311)
+||+|||++......... .......|+..|+|||++.+..++.++||||||+++|+|++|..||........ .
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~--~ 270 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK--Y 270 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH--H
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH--H
Confidence 999999999654322111 111234589999999999998999999999999999999999999974322111 0
Q ss_pred hhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCC
Q 021526 213 VSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSH 281 (311)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~~ 281 (311)
........ ...+..++++.+. ...++.++.+++.+||..+|.+||++.+|++.|+.+.......
T Consensus 271 ~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 271 VRDSKIRY--RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp HHHHHHHH--HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHh--hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 10000000 1112222222221 1234677999999999999999999999999999988765433
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=304.02 Aligned_cols=240 Identities=28% Similarity=0.333 Sum_probs=194.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc---chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+..+|+|+||.||++.. +++.||||.+...... ..+.+.+|+++++.++||||+++++++.++...++||||+.
T Consensus 59 ~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~- 137 (348)
T 1u5q_A 59 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL- 137 (348)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred eeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-
Confidence 46799999999999997 7999999998754332 23568899999999999999999999999999999999997
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 138 g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~----- 206 (348)
T 1u5q_A 138 GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 206 (348)
T ss_dssp EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC-----
Confidence 588888854 3467999999999999999999999999 99999999999999999999999999875322
Q ss_pred eeeeccccccccCCcccc---CCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 157 VSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
.....|++.|+|||++. ...++.++||||||+++|+|++|..||........ ...... ...+.
T Consensus 207 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------~~~~~~-------~~~~~ 272 (348)
T 1u5q_A 207 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQ-------NESPA 272 (348)
T ss_dssp -BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHH-------SCCCC
T ss_pred -CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHh-------cCCCC
Confidence 12346899999999884 56789999999999999999999999863321100 000000 00011
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
..+..++..+.++|.+||+.||++|||++++++.
T Consensus 273 ---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 273 ---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1123456779999999999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=305.90 Aligned_cols=245 Identities=21% Similarity=0.240 Sum_probs=194.5
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
...+|.|+||.||++.. +++.||+|++.+... ...+|++++..+ +||||+++++++.++...++||||+++++
T Consensus 27 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~ 102 (342)
T 2qr7_A 27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGE 102 (342)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCc
Confidence 56899999999999999 689999999875532 345688888777 79999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCC----CceEEeecCCCccCCCCCC
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND----FNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~----~~vkl~Df~~~~~~~~~~~ 154 (311)
|.+++.. ...+++..+..++.|++.||+|||+.| ++|+||||+||++... +.+||+|||++.......
T Consensus 103 L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~- 174 (342)
T 2qr7_A 103 LLDKILR----QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN- 174 (342)
T ss_dssp HHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT-
T ss_pred HHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC-
Confidence 9999953 457999999999999999999999999 9999999999998443 359999999987543221
Q ss_pred cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccC
Q 021526 155 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
.......+++.|+|||++.+..++.++|+||||+++|+|++|..||..........+.. ..... ....
T Consensus 175 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~---~i~~~--------~~~~ 242 (342)
T 2qr7_A 175 -GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA---RIGSG--------KFSL 242 (342)
T ss_dssp -CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHH---HHHHC--------CCCC
T ss_pred -CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHH---HHccC--------Cccc
Confidence 22334568999999999988888999999999999999999999997432211111110 11000 0011
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
...+....+..+.++|.+||..||++||++.++++.
T Consensus 243 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 243 SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 112234567789999999999999999999999873
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=296.10 Aligned_cols=239 Identities=18% Similarity=0.173 Sum_probs=193.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+..+|+|++|.||++.. +++.||+|.+.... ......+.+|+..+..+ +||||+++++++.++...++|||++++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 95 (289)
T 1x8b_A 16 LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNG 95 (289)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred hhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCC
Confidence 57899999999999999 69999999987643 23446788899999888 899999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCC-------------------Cc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-------------------FN 137 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~-------------------~~ 137 (311)
++|.+++.........+++..++.++.|++.||+|||+++ ++|+||+|+||+++.+ ..
T Consensus 96 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (289)
T 1x8b_A 96 GSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 172 (289)
T ss_dssp CBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------------------CCC
T ss_pred CcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccccCCceE
Confidence 9999999764333467999999999999999999999999 9999999999999844 47
Q ss_pred eEEeecCCCccCCCCCCcceeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcc
Q 021526 138 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS 216 (311)
Q Consensus 138 vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 216 (311)
++|+|||.+...... ....++..|+|||++.+. .++.++||||||+++|+|++|.+|+.....
T Consensus 173 ~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---------- 236 (289)
T 1x8b_A 173 FKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---------- 236 (289)
T ss_dssp EEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----------
T ss_pred EEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----------
Confidence 999999998754321 123489999999998766 566899999999999999999877532110
Q ss_pred hhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 217 RPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
...+... .....+..++..+.++|.+||..||++|||+.++++
T Consensus 237 ---------~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 ---------WHEIRQG-RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ---------HHHHHTT-CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---------HHHHHcC-CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 0000000 011233455678999999999999999999999985
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=310.08 Aligned_cols=237 Identities=24% Similarity=0.250 Sum_probs=187.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHHHH-HhcCCCCcccceeEEEEeCCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEVLM-LSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
+..+|+|+||.||++.. +++.||+|++.+... .....+.+|..+ ++.++||||+++++++.++...++||||++
T Consensus 43 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~ 122 (373)
T 2r5t_A 43 LKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 122 (373)
T ss_dssp EEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCC
Confidence 57899999999999999 688999999976532 233456667776 467899999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+++|.+++.. ...+++..++.++.||+.||+|||++| ++||||||+|||++.++.+||+|||++...... .
T Consensus 123 gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~--~ 193 (373)
T 2r5t_A 123 GGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--N 193 (373)
T ss_dssp SCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC--C
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccC--C
Confidence 9999999954 457889999999999999999999999 999999999999999999999999998742211 1
Q ss_pred ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 156 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
.......|++.|+|||++.+..++.++|+||||+++|+|++|..||...... ...... ....
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i----------~~~~-- 255 (373)
T 2r5t_A 194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNI----------LNKP-- 255 (373)
T ss_dssp CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH------HHHHHH----------HHSC--
T ss_pred CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHH----------Hhcc--
Confidence 2234467899999999999999999999999999999999999999633211 001111 1111
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCCCHH
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRPLIN 265 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~~ 265 (311)
..++...+..+.++|.+||+.||.+||++.
T Consensus 256 ~~~~~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 256 LQLKPNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp CCCCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred cCCCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 123445677899999999999999999974
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=300.46 Aligned_cols=256 Identities=23% Similarity=0.243 Sum_probs=200.3
Q ss_pred eeeeeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhc--CCCCcccceeEEEEeCC----eeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSL--LHHDNLVTLIGYCTSGD----QRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~----~~~lv~e~~~ 75 (311)
...+|+|+||.||++...++.||||.+... ....+.+|.+++.. ++||||+++++++..+. ..++|||+++
T Consensus 47 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~ 123 (342)
T 1b6c_B 47 QESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 123 (342)
T ss_dssp EEEEEEETTEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCT
T ss_pred EeeecCCCCcEEEEEEEcCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecC
Confidence 468999999999999999999999998633 34567788888876 78999999999998776 7899999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH--------CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh--------~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
+++|.+++.. ..+++..++.++.|++.||+||| +.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 124 ~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~ 195 (342)
T 1b6c_B 124 HGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAV 195 (342)
T ss_dssp TCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEECCCce
Confidence 9999999954 46899999999999999999999 888 9999999999999999999999999986
Q ss_pred cCCCCCCcc--eeeeccccccccCCccccCCC------CCccccchhHHHHHHHHHhC----------CCCccccCcccc
Q 021526 148 LGPVGDNTH--VSTRVMGTYGYCAPEYAMSGK------LTLKSDIYSFGVVLLELITG----------RKAMDLSKGQGE 209 (311)
Q Consensus 148 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~------~~~~~Dv~slG~~l~~l~~g----------~~p~~~~~~~~~ 209 (311)
......... ......|+..|+|||++.+.. ++.++||||||+++|+|++| ..||........
T Consensus 196 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~ 275 (342)
T 1b6c_B 196 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 275 (342)
T ss_dssp EEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred eccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcc
Confidence 543322111 123346899999999987652 34689999999999999999 556543221110
Q ss_pred ccchhcchhhhhcccchhhhcCccCCCCC-----cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 021526 210 QNLVSWSRPFLKDQKKFVHLVDPLLHGRY-----PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 279 (311)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~ 279 (311)
. ...+. ........+... +..++..+.+++.+||+.||++|||+.+|++.|+.+.....
T Consensus 276 ~-~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 276 S-VEEMR----------KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 339 (342)
T ss_dssp C-HHHHH----------HHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred c-HHHHH----------HHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence 0 00000 001111111112 23667889999999999999999999999999999987654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=298.81 Aligned_cols=243 Identities=22% Similarity=0.272 Sum_probs=196.1
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
...+|.|++|.||.+.. +++.||+|.+..........+.+|+.+++.++||||+++++++.++...+++||++++++|
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 93 (304)
T 2jam_A 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL 93 (304)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred eeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccH
Confidence 56899999999999998 6999999999866555556788999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE---cCCCceEEeecCCCccCCCCCCcc
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~---~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
.+++.. ...+++..++.++.|++.||.|||+.| ++|+||+|+||++ +.++.++|+|||++......
T Consensus 94 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~---- 162 (304)
T 2jam_A 94 FDRILE----RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---- 162 (304)
T ss_dssp HHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB----
T ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC----
Confidence 999854 356899999999999999999999999 9999999999999 78889999999998643211
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......++..|+|||++.+..++.++|+||||+++|+|++|..||....... .......... ....
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~i~~~~~--------~~~~ 228 (304)
T 2jam_A 163 IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK------LFEKIKEGYY--------EFES 228 (304)
T ss_dssp TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHCCC--------CCCT
T ss_pred ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHcCCC--------CCCc
Confidence 1223458899999999999899999999999999999999999996332110 0000100000 0111
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
......+..+.++|.+||..||++|||+.++++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 229 PFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 122345678999999999999999999999987
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=319.20 Aligned_cols=247 Identities=26% Similarity=0.322 Sum_probs=202.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+.++|+|+||.||.+.. +|+.||+|.+.+.. ......+.+|+++++.++||||+++++++.++...++||||+.+
T Consensus 189 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~g 268 (576)
T 2acx_A 189 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 268 (576)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCC
Confidence 57899999999999999 79999999986542 23446788999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. .....+++..++.++.||+.||+|||++| |+|+||||+|||++.++.+||+|||++...... .
T Consensus 269 g~L~~~l~~--~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~---~ 340 (576)
T 2acx_A 269 GDLKFHIYH--MGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG---Q 340 (576)
T ss_dssp CBHHHHHHS--SSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTT---C
T ss_pred CcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccC---c
Confidence 999999965 23445999999999999999999999999 999999999999999999999999999754322 2
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......|++.|+|||++.+..++.++|+||||+++|+|++|..||......... ......... ...
T Consensus 341 ~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~--~~i~~~i~~------------~~~ 406 (576)
T 2acx_A 341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEVERLVKE------------VPE 406 (576)
T ss_dssp CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH--HHHHHHHHH------------CCC
T ss_pred cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH--HHHHHHhhc------------ccc
Confidence 223457999999999999989999999999999999999999999744321110 000000000 111
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVVA 270 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~l~~~ 270 (311)
.++...+..+.++|.+||+.||.+|| +++|+++.
T Consensus 407 ~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 407 EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 23455677899999999999999999 78888863
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=300.45 Aligned_cols=257 Identities=22% Similarity=0.229 Sum_probs=194.1
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
.++|+|+||.||++.. +++.||||++..........+.+|++++.++ +||||+++++++.++...++|||++++++|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 4689999999999997 7899999999876666677899999999885 799999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCc---eEEeecCCCccCCCCCC--
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN---PKLSDFGLAKLGPVGDN-- 154 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~---vkl~Df~~~~~~~~~~~-- 154 (311)
.+++.. ...+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++. +||+|||++........
T Consensus 99 ~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 171 (316)
T 2ac3_A 99 LSHIHK----RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171 (316)
T ss_dssp HHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---------
T ss_pred HHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccc
Confidence 999954 356899999999999999999999999 999999999999988776 99999999864322111
Q ss_pred ---cceeeeccccccccCCccccC-----CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccch
Q 021526 155 ---THVSTRVMGTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 226 (311)
Q Consensus 155 ---~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
........|+..|+|||++.+ ..++.++||||||+++|+|++|..||................... .....
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~ 250 (316)
T 2ac3_A 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC-QNMLF 250 (316)
T ss_dssp ----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH-HHHHH
T ss_pred cccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH-HHHHH
Confidence 111123458999999998875 457899999999999999999999997544321100000000000 00000
Q ss_pred hhhcCccCCCCCc----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 227 VHLVDPLLHGRYP----RRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 227 ~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..+..... .++ ...+..+.++|.+||..||++|||+.++++
T Consensus 251 ~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 251 ESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 00000000 112 134677999999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=303.22 Aligned_cols=259 Identities=24% Similarity=0.275 Sum_probs=190.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc-chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
+..+|+|+||.||++.. +++.||+|.+...... ....+.+|+++++.++||||+++++++.++...++||||++ ++
T Consensus 7 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 85 (324)
T 3mtl_A 7 LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KD 85 (324)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EE
T ss_pred EEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cC
Confidence 57899999999999999 6899999998755332 22355679999999999999999999999999999999997 59
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
|.+++.. ....+++..+..++.|++.||+|||+.| ++|+||+|+||+++.++.+||+|||++...... ....
T Consensus 86 l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~~ 157 (324)
T 3mtl_A 86 LKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP--TKTY 157 (324)
T ss_dssp HHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred HHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC--cccc
Confidence 9998865 4567999999999999999999999999 999999999999999999999999998643221 1222
Q ss_pred eeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCccccccch-hc----chhhhh---cccchhhh
Q 021526 159 TRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-SW----SRPFLK---DQKKFVHL 229 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~----~~~~~~---~~~~~~~~ 229 (311)
....++..|+|||++.+ ..++.++||||||+++|+|++|..||............ .. ....+. ........
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence 33467999999998876 56899999999999999999999999754321110000 00 000000 00000000
Q ss_pred cCccCCCC----CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 230 VDPLLHGR----YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 230 ~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..+..... .....+..+.+||.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000000 01234667899999999999999999999997
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=294.72 Aligned_cols=245 Identities=20% Similarity=0.173 Sum_probs=197.7
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
...+|.|++|.||++.. +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.++...+++||++.++
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 90 (284)
T 3kk8_A 11 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 90 (284)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred hhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCC
Confidence 46899999999999998 689999999875532 23467889999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCc---eEEeecCCCccCCCCCC
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN---PKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~---vkl~Df~~~~~~~~~~~ 154 (311)
+|.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++. ++|+|||.+......
T Consensus 91 ~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~-- 161 (284)
T 3kk8_A 91 ELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-- 161 (284)
T ss_dssp BHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS--
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC--
Confidence 99998854 456899999999999999999999999 999999999999976665 999999998753322
Q ss_pred cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccC
Q 021526 155 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
.......+++.|+|||++.+..++.++|+||||+++|+|++|..||........ ......... ..
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~~--------~~ 226 (284)
T 3kk8_A 162 -EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL------YAQIKAGAY--------DY 226 (284)
T ss_dssp -CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHTCC--------CC
T ss_pred -ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH------HHHHHhccc--------cC
Confidence 222335689999999999999999999999999999999999999963321110 000000000 00
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.......++..+.+++.+||+.||++|||+.++++.
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 227 PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 001112446779999999999999999999999873
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=298.78 Aligned_cols=260 Identities=21% Similarity=0.208 Sum_probs=193.5
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc--chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
+..+|+|++|.||++.. +++.||+|.+...... ..+.+.+|+++++.++||||+++++++.++...++|||+++++
T Consensus 8 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (311)
T 4agu_A 8 IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHT 87 (311)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred eeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCc
Confidence 57899999999999999 5899999998655332 2456789999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|.+++. ....+++..+..++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus 88 ~l~~~~~----~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~ 158 (311)
T 4agu_A 88 VLHELDR----YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP--SDY 158 (311)
T ss_dssp HHHHHHH----TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred hHHHHHh----hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc--ccc
Confidence 9988884 3466999999999999999999999999 999999999999999999999999998753321 122
Q ss_pred eeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhc--------chhhhhcccchhh
Q 021526 158 STRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSW--------SRPFLKDQKKFVH 228 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~ 228 (311)
.....++..|+|||++.+ ..++.++|+||||+++|+|++|..||.............. ....+........
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 234568899999998876 5679999999999999999999999965443211100000 0000000000000
Q ss_pred h--cCccCCCCC---cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 229 L--VDPLLHGRY---PRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 229 ~--~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
. .++...... ....+..+.+++.+||+.||++|||++++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 000000000 02356678999999999999999999999863
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=304.46 Aligned_cols=262 Identities=16% Similarity=0.098 Sum_probs=194.2
Q ss_pred eeeeeeceeccEEEEEE-----CCeEEEEEEeccCCcc-----------chhHHHHHHHHHhcCCCCcccceeEEEEe--
Q 021526 2 LCCYLSCKFYNVGLVWL-----CDQLVAIKQLNHEGLQ-----------GHQEFIVEVLMLSLLHHDNLVTLIGYCTS-- 63 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-----~~~~vaiK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 63 (311)
...+|+|+||.||++.. .+..||+|.+...... ....+.+|+..++.++||||+++++++..
T Consensus 42 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~ 121 (345)
T 2v62_A 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEF 121 (345)
T ss_dssp EEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEES
T ss_pred EeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccccccc
Confidence 46899999999999999 4689999998755321 12346678888999999999999999887
Q ss_pred --CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCC--ceE
Q 021526 64 --GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF--NPK 139 (311)
Q Consensus 64 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~--~vk 139 (311)
+...++|||++ +++|.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++ .+|
T Consensus 122 ~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 122 KGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp SSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTSEE
T ss_pred CCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCcEE
Confidence 67889999999 9999999954 338999999999999999999999999 99999999999998887 999
Q ss_pred EeecCCCccCCCCCCc-----ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchh
Q 021526 140 LSDFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS 214 (311)
Q Consensus 140 l~Df~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 214 (311)
|+|||++......... .......|+..|+|||++.+..++.++||||||+++|+|++|..||......... ...
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~-~~~ 272 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA-VQT 272 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH-HHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH-HHH
Confidence 9999999754321111 1113346899999999999999999999999999999999999999632211110 000
Q ss_pred cchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 021526 215 WSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 278 (311)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~ 278 (311)
........ ......... ....++..+.+++.+||..||++||++++|++.|+.+....
T Consensus 273 ~~~~~~~~---~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 330 (345)
T 2v62_A 273 AKTNLLDE---LPQSVLKWA---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPL 330 (345)
T ss_dssp HHHHHHHT---TTHHHHHHS---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCC
T ss_pred HHHhhccc---ccHHHHhhc---cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcc
Confidence 00011000 000000000 01135667999999999999999999999999999866533
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=295.91 Aligned_cols=243 Identities=25% Similarity=0.287 Sum_probs=195.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
+..+|.|+||.||.+.. +++.||+|.+.... ..+.+.+|+.+++.++||||+++++++.++...++|||++++++|
T Consensus 34 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 111 (314)
T 3com_A 34 LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSV 111 (314)
T ss_dssp EEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred heeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCH
Confidence 46899999999999999 58999999986542 456789999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
.+++.. ....+++..++.++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||.+...... .....
T Consensus 112 ~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~ 183 (314)
T 3com_A 112 SDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT--MAKRN 183 (314)
T ss_dssp HHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT--BSCBC
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh--ccccC
Confidence 999953 3567999999999999999999999999 999999999999999999999999998653322 11223
Q ss_pred eccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 160 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
...++..|+|||++.+..++.++|+||||+++|+|++|..||........ .. ..... .......+
T Consensus 184 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------~~----~~~~~--~~~~~~~~ 248 (314)
T 3com_A 184 TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA---------IF----MIPTN--PPPTFRKP 248 (314)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH---------HH----HHHHS--CCCCCSSG
T ss_pred ccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH---------HH----HHhcC--CCcccCCc
Confidence 34688999999999988899999999999999999999999963321100 00 00000 00111223
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..++..+.++|.+||..||.+|||+.++++
T Consensus 249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 249 ELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 455778999999999999999999999987
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=297.14 Aligned_cols=259 Identities=20% Similarity=0.207 Sum_probs=192.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc-----cchhHHHHHHHHHhcC---CCCcccceeEEEEeCC-----e
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL-----QGHQEFIVEVLMLSLL---HHDNLVTLIGYCTSGD-----Q 66 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~-----~ 66 (311)
...+|+|+||.||++.. +++.||+|.+..... .....+.+|+++++.+ +||||+++++++.... .
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~ 93 (308)
T 3g33_A 14 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIK 93 (308)
T ss_dssp EEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEE
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCcee
Confidence 57899999999999997 789999999864321 1234667777777666 4999999999987765 5
Q ss_pred eEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCC
Q 021526 67 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 146 (311)
Q Consensus 67 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~ 146 (311)
.+++||++. ++|.+++.. .....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++
T Consensus 94 ~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 94 VTLVFEHVD-QDLRTYLDK--APPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp EEEEEECCC-CBHHHHHHT--CCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred EEEEehhhh-cCHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 799999996 599999965 23345999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCcccccc-chhcc----hhhhh
Q 021526 147 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWS----RPFLK 221 (311)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~----~~~~~ 221 (311)
..... ........+++.|+|||++.+..++.++|||||||++|+|++|..||.......... +.... ...+.
T Consensus 168 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (308)
T 3g33_A 168 RIYSY---QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244 (308)
T ss_dssp TTSTT---CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred cccCC---CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 75322 222234568999999999999999999999999999999999999996443211100 00000 00000
Q ss_pred cccchhh-hcCccCCC---CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 222 DQKKFVH-LVDPLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 222 ~~~~~~~-~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
....... ...+.... ...+..+..+.++|.+||+.||++|||+.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp SSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0000000 00000000 001235677999999999999999999999985
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=292.59 Aligned_cols=253 Identities=23% Similarity=0.245 Sum_probs=200.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc------chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ------GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
...+|.|+||.||++.. +++.||+|.+...... ..+.+.+|+.+++.++||||+++++++.++...+++||+
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 89 (283)
T 3bhy_A 10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILEL 89 (283)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred HHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEee
Confidence 56899999999999999 6899999998755322 356789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCC----ceEEeecCCCccC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF----NPKLSDFGLAKLG 149 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~----~vkl~Df~~~~~~ 149 (311)
+++++|.+++.. ...+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++ .++|+|||.+...
T Consensus 90 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 90 VSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 999999999954 457899999999999999999999999 99999999999998877 7999999998753
Q ss_pred CCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhh
Q 021526 150 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 229 (311)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
... .......++..|+|||++.+..++.++|+||||+++|+|++|..||........ ........
T Consensus 163 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~------ 227 (283)
T 3bhy_A 163 EAG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET------LTNISAVN------ 227 (283)
T ss_dssp C-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHTTC------
T ss_pred cCC---CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH------HHHhHhcc------
Confidence 221 122334588999999999988999999999999999999999999964322110 00000000
Q ss_pred cCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHhhhcc
Q 021526 230 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV--ALDYLVSQR 278 (311)
Q Consensus 230 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~--~L~~l~~~~ 278 (311)
...........+..+.+++.+||..||++||++.++++ .++.+....
T Consensus 228 --~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 228 --YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp --CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred --cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence 00000011234667999999999999999999999998 466665443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=310.96 Aligned_cols=248 Identities=22% Similarity=0.163 Sum_probs=196.7
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+.++|+|+||.||.+.. +++.||+|++.+.. ......+.+|..++..++||||+++++++.++...++||||+.+
T Consensus 66 ~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~g 145 (412)
T 2vd5_A 66 LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVG 145 (412)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCC
Confidence 57899999999999999 69999999987532 22335688999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. .+..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 146 g~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~-~~ 218 (412)
T 2vd5_A 146 GDLLTLLSK---FGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG-TV 218 (412)
T ss_dssp CBHHHHHHH---HSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-CE
T ss_pred CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCCC-cc
Confidence 999999965 2357999999999999999999999999 9999999999999999999999999997543221 11
Q ss_pred eeeeccccccccCCcccc-------CCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhh
Q 021526 157 VSTRVMGTYGYCAPEYAM-------SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 229 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~-------~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
......||+.|+|||++. ...++.++|+|||||++|+|++|..||........ ........ ...
T Consensus 219 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~i~~~~---~~~ 289 (412)
T 2vd5_A 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET------YGKIVHYK---EHL 289 (412)
T ss_dssp ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHTHH---HHC
T ss_pred ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH------HHHHHhcc---cCc
Confidence 223357999999999887 35689999999999999999999999964332110 00010000 000
Q ss_pred cCccCCCCCcHHHHHHHHHHHHHhhccCCCCC---CCHHHHHHH
Q 021526 230 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFR---PLINDIVVA 270 (311)
Q Consensus 230 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R---Ps~~~l~~~ 270 (311)
..+. .+..++.++.++|.+||. +|.+| |+++|+++.
T Consensus 290 ~~p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 290 SLPL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp CCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred CCCc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 0011 123456789999999999 99998 689998763
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=302.24 Aligned_cols=250 Identities=16% Similarity=0.121 Sum_probs=202.1
Q ss_pred eeeeeeceeccEEEEE-----E--CCeEEEEEEeccCCccchhHHHHHHHHHhcCC---CCcccceeEEEEeCCeeEEEE
Q 021526 2 LCCYLSCKFYNVGLVW-----L--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH---HDNLVTLIGYCTSGDQRLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~-----~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~ 71 (311)
.+++|+|+||.||+++ . .++.||+|.+... ....+.+|.++++.++ |+||+++++++..++..++||
T Consensus 70 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~ 146 (365)
T 3e7e_A 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVG 146 (365)
T ss_dssp EEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEE
T ss_pred EEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEE
Confidence 4689999999999994 2 7899999998644 3456777777777776 899999999999999999999
Q ss_pred ecCCCCCHHHHhcccCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcC-----------CCceE
Q 021526 72 EYMPMGSLEDHLYDLEP-DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-----------DFNPK 139 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~-----------~~~vk 139 (311)
||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+|
T Consensus 147 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~~~~~~k 223 (365)
T 3e7e_A 147 ELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLA 223 (365)
T ss_dssp CCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC------CTTEE
T ss_pred eccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccccccCCEE
Confidence 99999999999965332 3567999999999999999999999999 999999999999988 89999
Q ss_pred EeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhh
Q 021526 140 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF 219 (311)
Q Consensus 140 l~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 219 (311)
|+|||++................||..|+|||++.+..++.++||||||+++|+|++|..||........
T Consensus 224 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---------- 293 (365)
T 3e7e_A 224 LIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC---------- 293 (365)
T ss_dssp ECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE----------
T ss_pred EeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce----------
Confidence 9999999654333333344556799999999999999999999999999999999999999853322110
Q ss_pred hhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCC-CCHHHHHHHHHHhhhccC
Q 021526 220 LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFR-PLINDIVVALDYLVSQRD 279 (311)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R-Ps~~~l~~~L~~l~~~~~ 279 (311)
. ....+. .+ .....+.+++..||+.+|.+| |+++++.+.|+.+.....
T Consensus 294 -----~----~~~~~~-~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 294 -----K----PEGLFR-RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp -----E----ECSCCT-TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred -----e----echhcc-cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 0 000010 11 125668899999999999999 688888888888776543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=298.75 Aligned_cols=252 Identities=23% Similarity=0.271 Sum_probs=198.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEe--CCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS--GDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~ 75 (311)
+..+|+|++|.||++.. +++.||+|.+..... ...+.+.+|+++++.++||||+++++++.+ +...++||||++
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 90 (279)
T 2w5a_A 11 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE 90 (279)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCT
T ss_pred ehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCC
Confidence 56899999999999999 789999999875532 344678899999999999999999998743 678899999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCC
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA--NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 153 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~--~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~ 153 (311)
+++|.+++.........+++..++.++.|++.||+|||+.+ ..+++|+||+|+||+++.++.++|+|||.+......
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~- 169 (279)
T 2w5a_A 91 GGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD- 169 (279)
T ss_dssp TEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC----
T ss_pred CCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccc-
Confidence 99999999764445566999999999999999999999875 234999999999999999999999999998653221
Q ss_pred CcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 154 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 154 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
........++..|+|||++.+..++.++|+||||+++|+|++|..||....... ....... .
T Consensus 170 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~i~~-----------~ 231 (279)
T 2w5a_A 170 -TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------LAGKIRE-----------G 231 (279)
T ss_dssp -CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH-----------T
T ss_pred -cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH------HHHHHhh-----------c
Confidence 111223457889999999998899999999999999999999999986432110 0000000 0
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 272 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~ 272 (311)
.....+..++..+.++|.+||+.||++||++.+|++.+.
T Consensus 232 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 232 KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred ccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 011223456778999999999999999999999987543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=307.64 Aligned_cols=244 Identities=22% Similarity=0.242 Sum_probs=184.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC--------ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--------LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 71 (311)
...+|+|+||.||+++. +++.||+|++.... ......+.+|+++++.++||||+++++++. ....++||
T Consensus 140 ~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~ 218 (419)
T 3i6u_A 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVL 218 (419)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEEE
T ss_pred EeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEEE
Confidence 46799999999999999 68999999987542 112235889999999999999999999975 45689999
Q ss_pred ecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCC---ceEEeecCCCcc
Q 021526 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF---NPKLSDFGLAKL 148 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~---~vkl~Df~~~~~ 148 (311)
||+.+++|.+++. ....+++..++.++.|++.||+|||+++ ++|+||||+|||++.++ .+||+|||++..
T Consensus 219 e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 219 ELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp ECCTTCBGGGGTS----SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred EcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 9999999999884 4567999999999999999999999999 99999999999997554 499999999975
Q ss_pred CCCCCCcceeeeccccccccCCccccC---CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccc
Q 021526 149 GPVGDNTHVSTRVMGTYGYCAPEYAMS---GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 225 (311)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
... ........|++.|+|||++.+ ..++.++|+||||+++|+|++|..||........ ... ........
T Consensus 292 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~---~i~~~~~~ 363 (419)
T 3i6u_A 292 LGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD---QITSGKYN 363 (419)
T ss_dssp CC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHH---HHHTTCCC
T ss_pred cCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHH---HHhcCCCC
Confidence 322 222334568999999998853 5678899999999999999999999964322111 000 00000000
Q ss_pred hhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 226 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
. ........+..+.++|.+||+.||++|||++++++
T Consensus 364 ~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 364 F--------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp C--------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred C--------CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0 00001234677999999999999999999999987
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=314.04 Aligned_cols=244 Identities=23% Similarity=0.253 Sum_probs=195.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
.+.+|+|+||.||++.. +++.||+|++.... ......+.+|+++++.++||||+++++++.+....++|||++.++
T Consensus 27 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~ 106 (486)
T 3mwu_A 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG 106 (486)
T ss_dssp EEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCC
Confidence 57899999999999999 68999999986542 345578999999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEc---CCCceEEeecCCCccCCCCCC
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD---NDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~---~~~~vkl~Df~~~~~~~~~~~ 154 (311)
+|.+++.. ...+++..++.++.|++.||.|||++| |+|+||||+||+++ .++.+||+|||++......
T Consensus 107 ~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-- 177 (486)
T 3mwu_A 107 ELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-- 177 (486)
T ss_dssp BHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC--
Confidence 99999854 357999999999999999999999999 99999999999995 4567999999998753222
Q ss_pred cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccC
Q 021526 155 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
.......|++.|+|||++.+ .++.++||||||+++|+|++|..||........ ......... ..
T Consensus 178 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~i~~~~~--------~~ 241 (486)
T 3mwu_A 178 -TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI------LKRVETGKY--------AF 241 (486)
T ss_dssp -----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHTCC--------CS
T ss_pred -CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCC--------CC
Confidence 22334568999999998876 589999999999999999999999964322100 000000000 00
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.......++..+.++|.+||+.||.+|||+.++++.
T Consensus 242 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 242 DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 001113456789999999999999999999999974
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=293.70 Aligned_cols=245 Identities=22% Similarity=0.204 Sum_probs=195.1
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC----ccchhHHHHHHHHHhcCCCCcccceeEEE--EeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG----LQGHQEFIVEVLMLSLLHHDNLVTLIGYC--TSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e~ 73 (311)
...+|+|+||.||++.. +++.||+|.+.... ......+.+|+++++.++||||+++++++ .+....++||||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (305)
T 2wtk_C 10 GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEY 89 (305)
T ss_dssp CCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEEC
T ss_pred eeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehh
Confidence 56899999999999999 78899999987542 23456789999999999999999999998 445578999999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 153 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~ 153 (311)
++++ |.+++.. .....+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 90 ~~~~-l~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 90 CVCG-MQEMLDS--VPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp CSEE-HHHHHHH--STTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred ccCC-HHHHHHh--CcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 9875 7777755 23567999999999999999999999999 9999999999999999999999999987644333
Q ss_pred CcceeeeccccccccCCccccCCC--CCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcC
Q 021526 154 NTHVSTRVMGTYGYCAPEYAMSGK--LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231 (311)
Q Consensus 154 ~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
.........++..|+|||++.+.. ++.++|+||||+++|+|++|..||...... ........
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~i~~---------- 227 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY------KLFENIGK---------- 227 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHH----------
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH------HHHHHHhc----------
Confidence 333344556899999999887643 478999999999999999999999643211 00000000
Q ss_pred ccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
. ....+..++..+.++|.+||..||.+|||++++++.
T Consensus 228 ~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 228 G--SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp C--CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred C--CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 012234556789999999999999999999999974
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=292.89 Aligned_cols=239 Identities=22% Similarity=0.262 Sum_probs=198.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
...+|.|++|.||.+.. +++.||+|.+.... ......+.+|+++++.++||||+++++++.++...+++||++++
T Consensus 19 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 98 (284)
T 2vgo_A 19 GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR 98 (284)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred eheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCC
Confidence 46799999999999999 68899999986542 22346788999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 99 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~---- 167 (284)
T 2vgo_A 99 GELYKELQK----HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL---- 167 (284)
T ss_dssp EEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS----
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc----
Confidence 999999954 346899999999999999999999999 999999999999999999999999998643221
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......++..|+|||++.+..++.++|+||||+++|+|++|..||........ . ..+... ..
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~----------~~~~~~--~~ 229 (284)
T 2vgo_A 168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET------H----------RRIVNV--DL 229 (284)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------H----------HHHHTT--CC
T ss_pred ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH------H----------HHHhcc--cc
Confidence 12335689999999999998999999999999999999999999964321110 0 000000 11
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.++...+..+.++|.+||..||.+||+++++++
T Consensus 230 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 230 KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 234456678999999999999999999999987
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=296.94 Aligned_cols=246 Identities=22% Similarity=0.230 Sum_probs=183.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc-ch-hHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ-GH-QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~-~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
...+|+|+||.||++.. +++.||+|.+...... .. ..+.++...++.++||||+++++++.++...++|||++++
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~- 90 (290)
T 3fme_A 12 IMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT- 90 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSE-
T ss_pred HHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhcc-
Confidence 57899999999999999 8999999998755322 22 2344455557888999999999999999999999999974
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~-~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
+|.+++.........+++..++.++.|++.||+|||++ + ++|+||+|+||+++.++.+||+|||++..... ..
T Consensus 91 ~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---~~ 164 (290)
T 3fme_A 91 SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLVD---DV 164 (290)
T ss_dssp EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------------
T ss_pred chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccccc---cc
Confidence 88888765444567899999999999999999999998 9 99999999999999999999999999874322 12
Q ss_pred eeeeccccccccCCccc----cCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCc
Q 021526 157 VSTRVMGTYGYCAPEYA----MSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 232 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~----~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
......++..|+|||++ .+..++.++|+||||+++|+|++|..||........ . .......
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~-----------~~~~~~~ 229 (290)
T 3fme_A 165 AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ----Q-----------LKQVVEE 229 (290)
T ss_dssp -----CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH----H-----------HHHHHHS
T ss_pred cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH----H-----------HHHHhcc
Confidence 22334689999999986 456788999999999999999999999963221110 0 0000001
Q ss_pred cCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 233 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
......+..++..+.+++.+||+.||++|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 230 PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1111112345677999999999999999999999988
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=294.46 Aligned_cols=242 Identities=22% Similarity=0.276 Sum_probs=199.7
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
...+|+|+||.||++.. +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.++...+++||++++
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 99 (294)
T 2rku_A 20 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 99 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCC
Confidence 46899999999999999 588999999875532 3346788999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 100 ~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~ 170 (294)
T 2rku_A 100 RSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--E 170 (294)
T ss_dssp CBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTT--C
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCc--c
Confidence 999998854 457899999999999999999999999 9999999999999999999999999987543221 2
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......++..|+|||++.+..++.++|+||||+++|+|++|..||........ . ...... ..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~----------~~~~~~--~~ 232 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------Y----------LRIKKN--EY 232 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------H----------HHHHTT--CC
T ss_pred ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------H----------HHHhhc--cC
Confidence 22335688999999999888899999999999999999999999964321100 0 000000 01
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
..+...+..+.+++.+||+.||++|||++++++.
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 SIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 2234556779999999999999999999999874
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=302.05 Aligned_cols=256 Identities=18% Similarity=0.176 Sum_probs=186.7
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc--chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
+..+|+|+||.||++.. +++.||+|.+...... ....+.+|+++++.++||||+++++++.++...++||||+++
T Consensus 39 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 117 (329)
T 3gbz_A 39 ITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN- 117 (329)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred EEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCC-
Confidence 57899999999999998 7999999998755332 235678999999999999999999999999999999999975
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEc-----CCCceEEeecCCCccCCCC
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD-----NDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~-----~~~~vkl~Df~~~~~~~~~ 152 (311)
+|.+++.. ...+++..++.++.|++.||+|||+++ ++|+||||+||+++ ..+.+||+|||++......
T Consensus 118 ~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~ 190 (329)
T 3gbz_A 118 DLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190 (329)
T ss_dssp EHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred CHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence 99999954 456999999999999999999999999 99999999999994 4556999999998653221
Q ss_pred CCcceeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchh-------hhhcc-
Q 021526 153 DNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP-------FLKDQ- 223 (311)
Q Consensus 153 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~- 223 (311)
........++..|+|||++.+. .++.++||||||+++|+|++|..||......... ...... .+...
T Consensus 191 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 266 (329)
T 3gbz_A 191 --IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL--FKIFEVLGLPDDTTWPGVT 266 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCTTTSTTGG
T ss_pred --ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHH--HHHHHHhCCCchhhhhhhh
Confidence 1122334578999999998874 5899999999999999999999999644321110 000000 00000
Q ss_pred --cchhhhc----CccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 224 --KKFVHLV----DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 224 --~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..+.... ...+....+...+..+.+||.+||+.||++|||++|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000000 000000011224677899999999999999999999985
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=302.07 Aligned_cols=259 Identities=22% Similarity=0.315 Sum_probs=195.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc--chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
+.++|.|+||.||++.. +++.||+|.+...... ..+.+.+|+.+++.++||||+++++++.++...++|||+++++
T Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 109 (331)
T 4aaa_A 30 LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHT 109 (331)
T ss_dssp EEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred eeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcc
Confidence 56899999999999999 5899999998655332 2356789999999999999999999999999999999999998
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
+|.+++. ....+++..++.++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 110 ~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~ 180 (331)
T 4aaa_A 110 ILDDLEL----FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GEV 180 (331)
T ss_dssp HHHHHHH----STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred hHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC--ccc
Confidence 8888763 3457999999999999999999999999 999999999999999999999999998753221 122
Q ss_pred eeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCccccccc-h-------hcchhhhhcccchhh
Q 021526 158 STRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-V-------SWSRPFLKDQKKFVH 228 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~-------~~~~~~~~~~~~~~~ 228 (311)
.....++..|+|||++.+. .++.++|+||||+++|+|++|..||........... . ......+........
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence 2345688999999998775 788999999999999999999999965442211000 0 000000111111111
Q ss_pred hcCccCCCCCc-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 229 LVDPLLHGRYP-----RRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 229 ~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
...+......+ +.++..+.++|.+||+.||++|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 11111111111 235778999999999999999999999987
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=295.70 Aligned_cols=254 Identities=27% Similarity=0.309 Sum_probs=192.3
Q ss_pred eeeeeeceeccEEEEEE---CC--eEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL---CD--QLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~---~~--~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
...+|.|++|.||++.. ++ ..||+|.+.... ....+.+.+|+++++.++||||+++++++.++. .++++|+
T Consensus 23 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~ 101 (291)
T 1u46_A 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTEL 101 (291)
T ss_dssp EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEEC
T ss_pred eeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEec
Confidence 56899999999999986 22 369999886542 334567889999999999999999999987654 8999999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 153 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~ 153 (311)
+.+++|.+++.. ....+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 102 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 175 (291)
T 1u46_A 102 APLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175 (291)
T ss_dssp CTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred ccCCCHHHHHHh---ccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccccccc
Confidence 999999999965 2356899999999999999999999999 9999999999999999999999999987643322
Q ss_pred Ccc-eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcC
Q 021526 154 NTH-VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231 (311)
Q Consensus 154 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
... ......++..|+|||++.+..++.++|+||||+++|+|++ |..||....... .. .....
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~----------~~~~~ 239 (291)
T 1u46_A 176 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------IL----------HKIDK 239 (291)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HH----------HHHHT
T ss_pred cchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH------HH----------HHHHc
Confidence 211 1223456778999999988888999999999999999999 999986432210 00 01111
Q ss_pred ccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 021526 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 278 (311)
Q Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~ 278 (311)
.......+..++..+.+++.+||..||++|||+.++++.|+++....
T Consensus 240 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 240 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred cCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 11111223456778999999999999999999999999999876543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=310.52 Aligned_cols=256 Identities=22% Similarity=0.247 Sum_probs=189.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccC--CccchhHHHHHHHHHhcCCCCcccceeEEEEeC------CeeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG------DQRLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~ 71 (311)
+..+|+|+||.||.+.. .++.||||++... .....+.+.+|+.+++.++||||+++++++... ...++||
T Consensus 67 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~ 146 (464)
T 3ttj_A 67 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 146 (464)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred EEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEE
Confidence 56899999999999998 7899999998754 233446788999999999999999999998654 3579999
Q ss_pred ecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCC
Q 021526 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 151 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~ 151 (311)
||+++ +|.+.+. ..+++..+..++.|++.||+|||+.| |+||||||+|||++.++.+||+|||+++....
T Consensus 147 E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 147 ELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp ECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred eCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 99976 5777773 24889999999999999999999999 99999999999999999999999999975322
Q ss_pred CCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCcccccc-chh---------------c
Q 021526 152 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVS---------------W 215 (311)
Q Consensus 152 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~---------------~ 215 (311)
........|++.|+|||++.+..++.++|||||||++|+|++|..||...+...... +.. .
T Consensus 217 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~ 293 (464)
T 3ttj_A 217 ---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 293 (464)
T ss_dssp ---CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHH
T ss_pred ---CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchh
Confidence 222334568999999999999999999999999999999999999997543211000 000 0
Q ss_pred chhhhhcc-----cchhhhcCccC-CC--CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 216 SRPFLKDQ-----KKFVHLVDPLL-HG--RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 216 ~~~~~~~~-----~~~~~~~~~~~-~~--~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
...+.... ..+........ .. ......+..+.+||.+||+.||++|||++|+++.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 00000000000 00 0011236779999999999999999999999874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=301.83 Aligned_cols=242 Identities=22% Similarity=0.260 Sum_probs=199.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
...+|+|+||.||++.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.++...+++|||+++
T Consensus 46 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 125 (335)
T 2owb_A 46 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 125 (335)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCC
Confidence 46899999999999999 68899999987543 23446788999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ...+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 126 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~ 196 (335)
T 2owb_A 126 RSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--E 196 (335)
T ss_dssp CBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTT--C
T ss_pred CCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCc--c
Confidence 999999854 457899999999999999999999999 9999999999999999999999999987543221 2
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......++..|+|||++.+..++.++|+||||+++|+|++|..||........ ...... . ..
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~----------~--~~ 258 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLRIKK----------N--EY 258 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHH----------T--CC
T ss_pred cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH------HHHHhc----------C--CC
Confidence 22345689999999999988899999999999999999999999964321100 000000 0 01
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
..+..++..+.++|.+||+.||++||+++++++.
T Consensus 259 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 SIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1234456779999999999999999999999873
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=291.52 Aligned_cols=241 Identities=24% Similarity=0.271 Sum_probs=190.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
...+|.|++|.||.+.. +++.||+|.+.... ......+.+|+++++.++||||+++++++.++...+++||++.+
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 95 (276)
T 2h6d_A 16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG 95 (276)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCC
Confidence 46899999999999998 68999999986542 23446788999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ...+++..++.++.|++.||++||+.+ ++|+||+|+||+++.++.++|+|||++...... .
T Consensus 96 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~---~ 165 (276)
T 2h6d_A 96 GELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---E 165 (276)
T ss_dssp CBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred CcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC---c
Confidence 999999954 356899999999999999999999999 999999999999999999999999998753221 2
Q ss_pred eeeeccccccccCCccccCCCC-CccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
......++..|+|||.+.+..+ +.++|+||||+++|+|++|..||...... ........ . .
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~----------~--~ 227 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP------TLFKKIRG----------G--V 227 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH----------C--C
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHHHHhhc----------C--c
Confidence 2233467899999999887765 68999999999999999999999632211 00000000 0 0
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
...+...+..+.++|.+||+.||++|||+.++++.
T Consensus 228 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 228 FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11233456779999999999999999999999873
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=297.52 Aligned_cols=245 Identities=20% Similarity=0.247 Sum_probs=193.5
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
...+|.|+||.||.+.. +++.||+|.+........+.+.+|+++++.++||||+++++++.++...++|||++++++|
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 103 (302)
T 2j7t_A 24 VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV 103 (302)
T ss_dssp EEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEH
T ss_pred cceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcH
Confidence 46799999999999999 5899999999877666778899999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
.+++.. ....+++..++.++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||++..... ......
T Consensus 104 ~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~ 175 (302)
T 2j7t_A 104 DAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--TLQKRD 175 (302)
T ss_dssp HHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHH--HHHC--
T ss_pred HHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccc--cccccc
Confidence 999864 3466999999999999999999999999 99999999999999999999999998642110 011122
Q ss_pred eccccccccCCccc-----cCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccC
Q 021526 160 RVMGTYGYCAPEYA-----MSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 160 ~~~~~~~~~aPE~~-----~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
...++..|+|||++ ....++.++|+||||+++|+|++|..||........ ...... . ...
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~-------~--~~~ 240 (302)
T 2j7t_A 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAK-------S--DPP 240 (302)
T ss_dssp ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHH-------S--CCC
T ss_pred cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH------HHHHhc-------c--CCc
Confidence 34578999999987 356788999999999999999999999864332100 000000 0 000
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
....+..++..+.++|.+||..||++|||+.++++
T Consensus 241 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 241 TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11123456778999999999999999999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=313.69 Aligned_cols=248 Identities=23% Similarity=0.249 Sum_probs=194.0
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
+..+|+|+||.||++.. ++..||+|++.... ......+.+|+.+++.++||||+++++++.+....++||||+.++
T Consensus 42 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 121 (494)
T 3lij_A 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG 121 (494)
T ss_dssp EEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred eeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCC
Confidence 56899999999999999 78999999987653 334567899999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCC---CceEEeecCCCccCCCCCC
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND---FNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~---~~vkl~Df~~~~~~~~~~~ 154 (311)
+|.+++.. ...+++..++.++.|++.||+|||++| ++|+||||+||+++.. +.+||+|||++......
T Consensus 122 ~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~-- 192 (494)
T 3lij_A 122 ELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-- 192 (494)
T ss_dssp BHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT--
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC--
Confidence 99998854 356899999999999999999999999 9999999999999764 44999999998754322
Q ss_pred cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccC
Q 021526 155 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
.......|++.|+|||++. ..++.++|||||||++|+|++|..||........ .......... ...
T Consensus 193 -~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~i~~~~~~---~~~--- 258 (494)
T 3lij_A 193 -KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI------LRKVEKGKYT---FDS--- 258 (494)
T ss_dssp -BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHTCCC---CCS---
T ss_pred -ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCCC---CCc---
Confidence 2233456899999999875 5689999999999999999999999964332110 0000000000 000
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHHh
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA--LDYL 274 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~--L~~l 274 (311)
......+..+.++|.+||+.||.+|||+.++++. +...
T Consensus 259 --~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 259 --PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp --GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred --hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 0012346779999999999999999999999973 4443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=295.13 Aligned_cols=244 Identities=23% Similarity=0.263 Sum_probs=189.6
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc--------cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL--------QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 71 (311)
...+|.|+||.||++.. +++.||||.+..... .....+.+|+++++.++||||+++++++..+. .++||
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~ 93 (322)
T 2ycf_A 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVL 93 (322)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEE
T ss_pred eeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEE
Confidence 56899999999999999 689999999865421 22346889999999999999999999987654 89999
Q ss_pred ecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCc---eEEeecCCCcc
Q 021526 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN---PKLSDFGLAKL 148 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~---vkl~Df~~~~~ 148 (311)
|++++++|.+++. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++. +||+|||++..
T Consensus 94 e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 94 ELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp ECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 9999999999994 4567999999999999999999999999 999999999999987665 99999999875
Q ss_pred CCCCCCcceeeeccccccccCCcccc---CCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccc
Q 021526 149 GPVGDNTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 225 (311)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
... ........|+..|+|||++. ...++.++|+||||+++|+|++|..||........ +.. ........
T Consensus 167 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~---~~~~~~~~ 238 (322)
T 2ycf_A 167 LGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD---QITSGKYN 238 (322)
T ss_dssp CCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHH---HHHHTCCC
T ss_pred ccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHH---HHHhCccc
Confidence 322 11223346899999999864 46788999999999999999999999964332211 000 00000000
Q ss_pred hhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 226 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
. .+ .....++..+.++|.+||..||++||++.++++
T Consensus 239 ~----~~----~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 239 F----IP----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp C----CH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred c----Cc----hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 0 00 001234677999999999999999999999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=306.25 Aligned_cols=259 Identities=20% Similarity=0.182 Sum_probs=202.5
Q ss_pred CeeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCC-CcccceeEEEEeCCeeEEEEecCCCC
Q 021526 1 MLCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHH-DNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
+..++|.|+||.||++.. +++.||||++.... ....+.+|+++++.++| +++..+..++..+...++|||++ ++
T Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~ 87 (483)
T 3sv0_A 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GP 87 (483)
T ss_dssp CCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CC
Confidence 357899999999999998 69999999876443 23568899999999987 45556666667888899999999 89
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE---cCCCceEEeecCCCccCCCCCC
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~---~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
+|.+++.. ....+++..++.++.||+.||+|||+++ |+|+||||+|||+ +.++.+||+|||++........
T Consensus 88 sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 88 SLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp BHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred CHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence 99999964 3467999999999999999999999999 9999999999999 6889999999999976443322
Q ss_pred cc-----eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhh
Q 021526 155 TH-----VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 229 (311)
Q Consensus 155 ~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
.. ......|+..|+|||++.+..++.++|||||||++|+|++|..||.................... ......+
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-~~~~~~l 240 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-ATSIEAL 240 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH-HSCHHHH
T ss_pred ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc-cccHHHH
Confidence 11 12245689999999999999999999999999999999999999975443222111111000000 0000000
Q ss_pred cCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 021526 230 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 278 (311)
Q Consensus 230 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~ 278 (311)
...++.++.+++.+||..+|++||++.+|++.|+.+....
T Consensus 241 ---------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 241 ---------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp ---------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ---------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 1234567999999999999999999999999999886543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=302.74 Aligned_cols=192 Identities=25% Similarity=0.280 Sum_probs=167.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCC-----CCcccceeEEEEeCCeeEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-----HDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
+..+|.|+||.||++.. +++.||||++... ......+..|+++++.++ ||||+++++++......++|||++
T Consensus 40 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 118 (360)
T 3llt_A 40 IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL 118 (360)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC
T ss_pred EEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC
Confidence 57899999999999999 7899999998632 334456778999998886 999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcC--------------------
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-------------------- 134 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~-------------------- 134 (311)
+++|.+++.. .....+++..++.++.||+.||+|||+.+ ++|+||||+|||++.
T Consensus 119 -~~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~ 192 (360)
T 3llt_A 119 -GPSLYEIITR--NNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192 (360)
T ss_dssp -CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEE
T ss_pred -CCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhccccccccc
Confidence 8899999975 33456999999999999999999999999 999999999999975
Q ss_pred -----CCceEEeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccC
Q 021526 135 -----DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 205 (311)
Q Consensus 135 -----~~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 205 (311)
++.+||+|||++...... .....|++.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 193 ~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 193 IYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp EEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence 788999999999753221 223568999999999999999999999999999999999999996543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=315.36 Aligned_cols=244 Identities=23% Similarity=0.250 Sum_probs=198.1
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
...+|+|+||.||++.. +++.||||++.... ......+.+|+++++.++||||+++++++.+....++|||++.+
T Consensus 31 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 110 (484)
T 3nyv_A 31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 110 (484)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred eeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCC
Confidence 46899999999999999 78999999987553 33557899999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE---cCCCceEEeecCCCccCCCCC
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGD 153 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~---~~~~~vkl~Df~~~~~~~~~~ 153 (311)
++|.+++.. ...+++..++.++.|++.||+|||+++ ++|+||||+||++ +.++.+||+|||++.......
T Consensus 111 ~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 183 (484)
T 3nyv_A 111 GELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183 (484)
T ss_dssp CBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc
Confidence 999999953 467999999999999999999999999 9999999999999 567889999999987543221
Q ss_pred CcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 154 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 154 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
......|++.|+|||++.+ .++.++||||||+++|+|++|.+||........ ......... .
T Consensus 184 ---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~i~~~~~--------~ 245 (484)
T 3nyv_A 184 ---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI------LKKVEKGKY--------T 245 (484)
T ss_dssp ---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCC--------C
T ss_pred ---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHcCCC--------C
Confidence 2233568999999998866 689999999999999999999999964332110 000000000 0
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.........+..+.++|.+||+.||.+|||+.++++.
T Consensus 246 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 246 FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0001113456789999999999999999999999973
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=301.99 Aligned_cols=263 Identities=15% Similarity=0.120 Sum_probs=202.6
Q ss_pred eeeeeeceeccEEEEEEC----------CeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccc---------------
Q 021526 2 LCCYLSCKFYNVGLVWLC----------DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVT--------------- 56 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~----------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~--------------- 56 (311)
...+|+|+||.||++... ++.||+|.+... ..+.+|+++++.++||||++
T Consensus 47 ~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~ 121 (352)
T 2jii_A 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPT 121 (352)
T ss_dssp EEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCC
T ss_pred EEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCccc
Confidence 468999999999999982 789999998644 47889999999999999887
Q ss_pred eeEEEEe-CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCC
Q 021526 57 LIGYCTS-GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 135 (311)
Q Consensus 57 ~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~ 135 (311)
+++++.. +...++|||++ +++|.+++... ....+++..++.++.|++.||+|||+++ ++|+||+|+||+++.+
T Consensus 122 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~~~ 195 (352)
T 2jii_A 122 CMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPE 195 (352)
T ss_dssp CCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEEETT
T ss_pred hhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEcCC
Confidence 5667665 77889999999 99999999652 2467999999999999999999999999 9999999999999999
Q ss_pred C--ceEEeecCCCccCCCCCCc-----ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccc
Q 021526 136 F--NPKLSDFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQG 208 (311)
Q Consensus 136 ~--~vkl~Df~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 208 (311)
+ .++|+|||++......... .......|+..|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 275 (352)
T 2jii_A 196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT 275 (352)
T ss_dssp EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCH
Confidence 8 8999999999754321111 11123468999999999999899999999999999999999999997543211
Q ss_pred cccchhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCC
Q 021526 209 EQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHP 282 (311)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~~~ 282 (311)
. .+............ .+.... .....++..+.+++.+||..||++||++++|++.|+++........
T Consensus 276 ~-~~~~~~~~~~~~~~---~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~ 342 (352)
T 2jii_A 276 E-DIMKQKQKFVDKPG---PFVGPC---GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSP 342 (352)
T ss_dssp H-HHHHHHHHHHHSCC---CEECTT---SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCT
T ss_pred H-HHHHHHHhccCChh---hhhhhc---cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCc
Confidence 1 11111111111010 011000 0112346779999999999999999999999999999988765443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=306.81 Aligned_cols=260 Identities=22% Similarity=0.297 Sum_probs=184.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccC--CccchhHHHHHHHHHhcCC-CCcccceeEEEEeCC--eeEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGD--QRLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~--~~~lv~e~~ 74 (311)
+..+|+|+||.||.+.. +++.||||.+... .......+.+|+.+++.+. ||||+++++++..++ ..++||||+
T Consensus 14 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 93 (388)
T 3oz6_A 14 VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM 93 (388)
T ss_dssp EEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECC
T ss_pred EEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEeccc
Confidence 57899999999999998 7899999998644 2334467889999999997 999999999997544 689999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCC-
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD- 153 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~- 153 (311)
+ ++|.+++.. ..+++..+..++.|++.||+|||+.| ++||||||+|||++.++.+||+|||+++......
T Consensus 94 ~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 94 E-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp S-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred C-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 7 589999854 47899999999999999999999999 9999999999999999999999999987532211
Q ss_pred ------------------CcceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCccccccch-
Q 021526 154 ------------------NTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV- 213 (311)
Q Consensus 154 ------------------~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~- 213 (311)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~ 244 (388)
T 3oz6_A 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII 244 (388)
T ss_dssp CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 1111233468999999999876 57899999999999999999999999754321110000
Q ss_pred h----------------cchhhhhcccchhhhcCccCCCCC------------cHHHHHHHHHHHHHhhccCCCCCCCHH
Q 021526 214 S----------------WSRPFLKDQKKFVHLVDPLLHGRY------------PRRCLNYAVAVTAMCLNEEANFRPLIN 265 (311)
Q Consensus 214 ~----------------~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~l~~li~~~l~~~p~~RPs~~ 265 (311)
. +......................+ ...++..+.+|+.+||+.||++|||++
T Consensus 245 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~ 324 (388)
T 3oz6_A 245 GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAN 324 (388)
T ss_dssp HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHH
Confidence 0 000000000000000000000000 013456799999999999999999999
Q ss_pred HHHHH
Q 021526 266 DIVVA 270 (311)
Q Consensus 266 ~l~~~ 270 (311)
|+++.
T Consensus 325 e~l~H 329 (388)
T 3oz6_A 325 DALKH 329 (388)
T ss_dssp HHTTS
T ss_pred HHhCC
Confidence 99864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=311.44 Aligned_cols=188 Identities=24% Similarity=0.301 Sum_probs=147.5
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEe-----CCeeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS-----GDQRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e 72 (311)
+.++|.|+||.||++.. +++.||||++.... ....+.+.+|+++++.++||||+++++++.. ....++|||
T Consensus 58 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 137 (458)
T 3rp9_A 58 RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLE 137 (458)
T ss_dssp CCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEC
T ss_pred eeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEe
Confidence 56899999999999988 78999999986542 2344678899999999999999999999843 356899999
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCC
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~ 152 (311)
++ +++|.+++. ....+++..+..++.||+.||+|||+.| |+||||||+|||++.++.+||+|||+++.....
T Consensus 138 ~~-~~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 138 IA-DSDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp CC-SEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred cc-ccchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 98 568999984 3567999999999999999999999999 999999999999999999999999999764322
Q ss_pred CCc-------------------------ceeeeccccccccCCccc-cCCCCCccccchhHHHHHHHHHhC
Q 021526 153 DNT-------------------------HVSTRVMGTYGYCAPEYA-MSGKLTLKSDIYSFGVVLLELITG 197 (311)
Q Consensus 153 ~~~-------------------------~~~~~~~~~~~~~aPE~~-~~~~~~~~~Dv~slG~~l~~l~~g 197 (311)
... .......||+.|+|||++ ....++.++|||||||++|+|++|
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 111 112234679999999976 456799999999999999999994
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=305.64 Aligned_cols=258 Identities=21% Similarity=0.206 Sum_probs=198.0
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
+..+|+|+||.||++.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.++...++||||+++++
T Consensus 38 ~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 117 (360)
T 3eqc_A 38 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 117 (360)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred eeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCC
Confidence 56899999999999999 58999999987653 3344678999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~-~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
|.+++.. ...+++..+..++.|++.||+|||+. + ++|+||+|+||+++.++.++|+|||++..... ..
T Consensus 118 L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~----~~ 186 (360)
T 3eqc_A 118 LDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SM 186 (360)
T ss_dssp HHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH----HC
T ss_pred HHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc----cc
Confidence 9999954 34689999999999999999999996 8 99999999999999999999999999853211 11
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhc-------------------ch-
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSW-------------------SR- 217 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-------------------~~- 217 (311)
.....|+..|+|||++.+..++.++||||||+++|+|++|..||.............. ..
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (360)
T 3eqc_A 187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266 (360)
T ss_dssp ----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------------
T ss_pred ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccc
Confidence 2234689999999999999999999999999999999999999965432111000000 00
Q ss_pred --hhhhcccchhh----hcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 218 --PFLKDQKKFVH----LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 218 --~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
..........+ ..........+..++..+.+||.+||+.||++|||++++++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp -------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00000000000 000011111112356679999999999999999999999983
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=291.34 Aligned_cols=243 Identities=24% Similarity=0.303 Sum_probs=192.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEe----CCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS----GDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~ 73 (311)
...+|+|+||.||++.. ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.. +...++||||
T Consensus 31 ~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 110 (290)
T 1t4h_A 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred eeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEe
Confidence 35799999999999999 68899999987543 2344678899999999999999999999865 3568999999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEc-CCCceEEeecCCCccCCCC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~-~~~~vkl~Df~~~~~~~~~ 152 (311)
+++++|.+++.. ...+++..++.++.|++.||+|||+.+ .+++|+||+|+||+++ .++.++|+|||++......
T Consensus 111 ~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~ 185 (290)
T 1t4h_A 111 MTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred cCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc
Confidence 999999999954 356899999999999999999999874 3399999999999997 7889999999998643221
Q ss_pred CCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCc
Q 021526 153 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 232 (311)
Q Consensus 153 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
......++..|+|||++. ..++.++|+||||+++|+|++|..||........ .. ......
T Consensus 186 ----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~----------~~~~~~ 245 (290)
T 1t4h_A 186 ----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IY----------RRVTSG 245 (290)
T ss_dssp ----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----HH----------HHHTTT
T ss_pred ----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH-----HH----------HHHhcc
Confidence 223456899999999876 4589999999999999999999999963221110 00 000000
Q ss_pred cCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 233 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
......+...+..+.++|.+||+.||.+|||+.++++
T Consensus 246 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 246 VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0011112234567999999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=300.07 Aligned_cols=258 Identities=21% Similarity=0.231 Sum_probs=198.2
Q ss_pred eeeeeeceeccEEEEEECCeEEEEEEeccCCccch-----------------hHHHHHHHHHhcCCCCcccceeEEEEeC
Q 021526 2 LCCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGH-----------------QEFIVEVLMLSLLHHDNLVTLIGYCTSG 64 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~-----------------~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 64 (311)
...+|+|+||.||.+..+++.||+|.+........ +.+.+|+++++.++||||+++++++.++
T Consensus 36 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 115 (348)
T 2pml_X 36 IRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNY 115 (348)
T ss_dssp EEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESS
T ss_pred EEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence 46899999999999999999999999875432211 7899999999999999999999999999
Q ss_pred CeeEEEEecCCCCCHHHH------hcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeecCCCCCcEEEcCCCc
Q 021526 65 DQRLLVYEYMPMGSLEDH------LYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFN 137 (311)
Q Consensus 65 ~~~~lv~e~~~~~~L~~~------l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~di~p~nil~~~~~~ 137 (311)
...++||||+++++|.++ +.. .....+++..++.++.|++.||+|||+ .| ++|+||+|+||+++.++.
T Consensus 116 ~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~~~~ 190 (348)
T 2pml_X 116 DEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDKNGR 190 (348)
T ss_dssp SEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECTTSC
T ss_pred CeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcCCCc
Confidence 999999999999999998 432 226789999999999999999999999 98 999999999999999999
Q ss_pred eEEeecCCCccCCCCCCcceeeeccccccccCCccccCC-CCCc-cccchhHHHHHHHHHhCCCCccccCccccccchhc
Q 021526 138 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTL-KSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSW 215 (311)
Q Consensus 138 vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~-~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 215 (311)
++|+|||.+...... ......++..|+|||++.+. .++. ++|+||||+++|+|++|..||......... ....
T Consensus 191 ~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~i 265 (348)
T 2pml_X 191 VKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL-FNNI 265 (348)
T ss_dssp EEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH-HHHH
T ss_pred EEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHH
Confidence 999999998753222 23445689999999999877 5665 999999999999999999999754331100 0000
Q ss_pred chhhhhcc---cchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 216 SRPFLKDQ---KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 216 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
........ ..................++..+.++|.+||+.||.+|||+.++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 266 RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000000 0000000000000111345778999999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=299.23 Aligned_cols=242 Identities=22% Similarity=0.246 Sum_probs=194.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc--------chhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ--------GHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLV 70 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 70 (311)
...+|+|++|.||++.. +|+.||||++...... ..+.+.+|+.+++.+ +||||+++++++......++|
T Consensus 99 ~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 178 (365)
T 2y7j_A 99 KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178 (365)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEE
T ss_pred ceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEE
Confidence 36899999999999999 6899999998754321 134677899999998 799999999999999999999
Q ss_pred EecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCC
Q 021526 71 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 150 (311)
Q Consensus 71 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~ 150 (311)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||++....
T Consensus 179 ~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 179 FDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp ECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 999999999999953 457999999999999999999999999 9999999999999999999999999987543
Q ss_pred CCCCcceeeeccccccccCCccccC------CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhccc
Q 021526 151 VGDNTHVSTRVMGTYGYCAPEYAMS------GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 224 (311)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 224 (311)
.. .......|++.|+|||++.+ ..++.++||||||+++|+|++|..||....... .......
T Consensus 252 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~------~~~~i~~--- 319 (365)
T 2y7j_A 252 PG---EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL------MLRMIME--- 319 (365)
T ss_dssp TT---CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH---
T ss_pred CC---cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHh---
Confidence 22 12234568999999998863 357889999999999999999999996332110 0000000
Q ss_pred chhhhcCccCCCCCc--HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 225 KFVHLVDPLLHGRYP--RRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 225 ~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.......+ ...+..+.++|.+||+.||++|||+.++++
T Consensus 320 -------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 320 -------GQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp -------TCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -------CCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00000000 123567999999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=296.06 Aligned_cols=261 Identities=23% Similarity=0.259 Sum_probs=193.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc--chhHHHHHHHHHhcCCCCcccceeEEEEe--------CCeeEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTS--------GDQRLL 69 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~~~~~l 69 (311)
+..+|+|+||.||++.. +++.||+|.+...... ....+.+|+++++.++||||+++++++.. ++..++
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l 101 (351)
T 3mi9_A 22 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL 101 (351)
T ss_dssp EEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEE
T ss_pred EEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEE
Confidence 56899999999999999 7899999998655332 34578899999999999999999999876 456899
Q ss_pred EEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccC
Q 021526 70 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 149 (311)
Q Consensus 70 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~ 149 (311)
||||+++ +|.+.+.. ....+++..++.++.|++.||+|||++| ++|+||||+||+++.++.+||+|||++...
T Consensus 102 v~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 102 VFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp EEECCSE-EHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEeccCC-CHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 9999975 77777754 4456999999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCCc--ceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhc-----chhhhh
Q 021526 150 PVGDNT--HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSW-----SRPFLK 221 (311)
Q Consensus 150 ~~~~~~--~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~~ 221 (311)
...... .......|++.|+|||++.+ ..++.++||||||+++|+|++|..||.............. ....+.
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 254 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 254 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence 322211 12233567999999998876 4679999999999999999999999975432211100000 000000
Q ss_pred ccc--chhhhcCccCCCC--CcH-----HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 222 DQK--KFVHLVDPLLHGR--YPR-----RCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 222 ~~~--~~~~~~~~~~~~~--~~~-----~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
... ............. ... ..+..+.+||.+||+.||++|||++|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 255 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 000 0000000000000 001 11456889999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=312.99 Aligned_cols=242 Identities=24% Similarity=0.262 Sum_probs=193.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc-------------cchhHHHHHHHHHhcCCCCcccceeEEEEeCCe
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL-------------QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 66 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 66 (311)
...+|+|+||.||++.. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.++..
T Consensus 41 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 120 (504)
T 3q5i_A 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120 (504)
T ss_dssp EEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred EeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 57899999999999999 689999999875432 234678899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCC---ceEEeec
Q 021526 67 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF---NPKLSDF 143 (311)
Q Consensus 67 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~---~vkl~Df 143 (311)
.++||||+.+++|.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++ .+||+||
T Consensus 121 ~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 121 FYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 9999999999999999954 456999999999999999999999999 99999999999998776 6999999
Q ss_pred CCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcc
Q 021526 144 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 223 (311)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 223 (311)
|++...... .......|++.|+|||++. ..++.++||||||+++|+|++|..||........ ......
T Consensus 194 g~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~i~~-- 261 (504)
T 3q5i_A 194 GLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI------IKKVEK-- 261 (504)
T ss_dssp TTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHH--
T ss_pred CCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHc--
Confidence 999754322 2233456899999999876 4689999999999999999999999964332110 000000
Q ss_pred cchhhhcCccCCCCC--cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 224 KKFVHLVDPLLHGRY--PRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 224 ~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
....... ....+..+.++|.+||+.||.+|||++++++.
T Consensus 262 --------~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 262 --------GKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp --------CCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --------CCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0000000 02346779999999999999999999999873
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=295.17 Aligned_cols=244 Identities=25% Similarity=0.273 Sum_probs=190.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcC-CCCcccceeEEEEe------CCeeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTS------GDQRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~~~~~lv~e 72 (311)
...+|.|+||.||++.. +++.||+|.+... ......+.+|+.+++.+ +||||+++++++.. +...++|||
T Consensus 29 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e 107 (326)
T 2x7f_A 29 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME 107 (326)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEE
T ss_pred EEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEE
Confidence 56899999999999999 7899999998644 34457889999999998 79999999999876 567899999
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCC
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~ 152 (311)
++++++|.+++... ....+++..++.++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||++......
T Consensus 108 ~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 182 (326)
T 2x7f_A 108 FCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182 (326)
T ss_dssp CCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC-----
T ss_pred cCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCceecCcC
Confidence 99999999999652 3467899999999999999999999999 999999999999999999999999998753221
Q ss_pred CCcceeeeccccccccCCcccc-----CCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchh
Q 021526 153 DNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 227 (311)
Q Consensus 153 ~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (311)
........++..|+|||++. +..++.++|+||||+++|+|++|..||........ ......
T Consensus 183 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~------ 248 (326)
T 2x7f_A 183 --VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA------LFLIPR------ 248 (326)
T ss_dssp ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHH------
T ss_pred --ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH------HHHhhc------
Confidence 11223346899999999886 45688999999999999999999999853321100 000000
Q ss_pred hhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 228 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
...+. ..+..++..+.++|.+||..||.+||++.++++
T Consensus 249 -~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 249 -NPAPR---LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp -SCCCC---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -Ccccc---CCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000 112344677999999999999999999999987
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=298.49 Aligned_cols=260 Identities=22% Similarity=0.210 Sum_probs=193.6
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc-----chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ-----GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
...+|.|+||.||.+.. +++.||+|.+...... ....+.+|+++++.++||||+++++++.++...++|||++
T Consensus 15 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 94 (346)
T 1ua2_A 15 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 94 (346)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred EeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcC
Confidence 57899999999999999 6899999998654221 2346889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
++ +|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 95 ~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-- 165 (346)
T 1ua2_A 95 ET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-- 165 (346)
T ss_dssp SE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC--
T ss_pred CC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceeccCC--
Confidence 76 89888854 4457888999999999999999999999 999999999999999999999999998754222
Q ss_pred cceeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCcccccc-chhc----chhhhhcccchhh
Q 021526 155 THVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSW----SRPFLKDQKKFVH 228 (311)
Q Consensus 155 ~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~ 228 (311)
........+++.|+|||++.+. .++.++|+||||+++|+|++|.+||.......... +... ....+.+.....+
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 245 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence 2223345689999999988654 57899999999999999999999986443211100 0000 0000000000000
Q ss_pred hcCccCCCCCc-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 229 LVDPLLHGRYP-----RRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 229 ~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
..........+ ...+..+.++|.+||..||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000000001 2345789999999999999999999999874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=321.76 Aligned_cols=241 Identities=27% Similarity=0.314 Sum_probs=200.6
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccC---CccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHE---GLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
+.++|+|+||.||++.. +++.||||++.+. .....+.+..|..++..+ +||+|+++++++.+....++||||++
T Consensus 346 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~ 425 (674)
T 3pfq_A 346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 425 (674)
T ss_dssp EEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCC
T ss_pred EEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcC
Confidence 57899999999999999 6889999998754 233456788899999887 69999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...... .
T Consensus 426 gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~--~ 496 (674)
T 3pfq_A 426 GGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--G 496 (674)
T ss_dssp SCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCT--T
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccC--C
Confidence 9999999964 357999999999999999999999999 999999999999999999999999998743221 2
Q ss_pred ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 156 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
.......||+.|+|||++.+..++.++|+||||+++|+|++|..||...+.. . .+..+....
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~------~----------~~~~i~~~~-- 558 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------E----------LFQSIMEHN-- 558 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H----------HHHHHHSSC--
T ss_pred cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH------H----------HHHHHHhCC--
Confidence 2234567999999999999999999999999999999999999999643221 0 111111111
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRPLI-----NDIVV 269 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~-----~~l~~ 269 (311)
..+|...+.++.+||.+||+.||++||++ ++|++
T Consensus 559 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 559 VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 13455677889999999999999999997 77765
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=294.18 Aligned_cols=245 Identities=24% Similarity=0.269 Sum_probs=191.7
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCC--CCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLH--HDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+..+|+|+||.||++.. +++.||+|.+..... ...+.+.+|+++++.++ ||||+++++++.++...+++|| +.+
T Consensus 33 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~ 111 (313)
T 3cek_A 33 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 111 (313)
T ss_dssp EEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCS
T ss_pred EEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCC
Confidence 57899999999999998 788999999875533 34467889999999997 5999999999999999999999 557
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||+|+||++++ +.+||+|||++..........
T Consensus 112 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~ 183 (313)
T 3cek_A 112 IDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSV 183 (313)
T ss_dssp EEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--------
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccCccccc
Confidence 899999964 457899999999999999999999999 999999999999965 889999999987543332222
Q ss_pred eeeeccccccccCCccccC-----------CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccc
Q 021526 157 VSTRVMGTYGYCAPEYAMS-----------GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 225 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~-----------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
......|+..|+|||++.+ ..++.++|+||||+++|+|++|..||...... ...
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---------------~~~ 248 (313)
T 3cek_A 184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---------------ISK 248 (313)
T ss_dssp ------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---------------HHH
T ss_pred cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH---------------HHH
Confidence 2334568999999998865 46788999999999999999999999632211 011
Q ss_pred hhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 226 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
......+.....++...+..+.++|.+||..||++||++.++++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 249 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 122222223333444456789999999999999999999999874
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=306.98 Aligned_cols=193 Identities=26% Similarity=0.289 Sum_probs=160.6
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeC-----CeeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG-----DQRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e 72 (311)
...+|+|+||.||++.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++... ...++|||
T Consensus 31 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e 110 (432)
T 3n9x_A 31 KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLE 110 (432)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEE
T ss_pred EEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEe
Confidence 57899999999999998 78999999987542 23446788999999999999999999998766 56899999
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCC
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~ 152 (311)
+++ ++|.+++. ....+++..+..++.||+.||+|||+.| ++||||||+|||++.++.+||+|||+++.....
T Consensus 111 ~~~-~~L~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 111 IAD-SDLKKLFK----TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp CCS-EEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred cCC-cCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 986 59999994 3567999999999999999999999999 999999999999999999999999999764332
Q ss_pred CCc--------------------ceeeeccccccccCCccc-cCCCCCccccchhHHHHHHHHHhCCCCcc
Q 021526 153 DNT--------------------HVSTRVMGTYGYCAPEYA-MSGKLTLKSDIYSFGVVLLELITGRKAMD 202 (311)
Q Consensus 153 ~~~--------------------~~~~~~~~~~~~~aPE~~-~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 202 (311)
... .......||+.|+|||++ ....++.++|||||||++|+|++|..||.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 211 112345689999999986 45678999999999999999998666553
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=293.69 Aligned_cols=252 Identities=17% Similarity=0.219 Sum_probs=194.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCC-CCcccceeEEEEe--CCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTS--GDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~ 76 (311)
...+|+|+||.||++.. +++.||+|++.. ...+.+.+|+++++.++ ||||+++++++.+ ....+++||++.+
T Consensus 41 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 117 (330)
T 3nsz_A 41 VRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 117 (330)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCC
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCc
Confidence 56899999999999998 789999999863 34578899999999997 9999999999987 6678999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCC-ceEEeecCCCccCCCCCCc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-NPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~-~vkl~Df~~~~~~~~~~~~ 155 (311)
++|.+++. .+++..+..++.|++.||+|||+.| ++|+||||+||+++.++ .+||+|||++.......
T Consensus 118 ~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-- 185 (330)
T 3nsz_A 118 TDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-- 185 (330)
T ss_dssp CCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC--
T ss_pred hhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC--
Confidence 99999983 3888999999999999999999999 99999999999999776 89999999997543222
Q ss_pred ceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCcccccc-----------chhcchhh-hhc
Q 021526 156 HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-----------LVSWSRPF-LKD 222 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-----------~~~~~~~~-~~~ 222 (311)
......++..|+|||++.+ ..++.++||||||+++|+|++|..||.......... ...+.... ...
T Consensus 186 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 264 (330)
T 3nsz_A 186 -EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264 (330)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred -ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence 2233468889999999877 678999999999999999999999995332211100 00000000 000
Q ss_pred ccchhhh--------cCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 223 QKKFVHL--------VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 223 ~~~~~~~--------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
...+... .........+...+..+.+||.+||+.||++|||++++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 0111112223346788999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=297.32 Aligned_cols=255 Identities=21% Similarity=0.228 Sum_probs=194.0
Q ss_pred eeeeeeceeccEEEEEECCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWLCDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
...+|+|+||.||++...+ .||+|.+.... ....+.+.+|+.+++.++||||+++++++.++...+++||++++++|
T Consensus 38 ~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L 116 (319)
T 2y4i_B 38 GELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTL 116 (319)
T ss_dssp CCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEH
T ss_pred eeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcH
Confidence 4689999999999999865 48999986543 23346788899999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCC---Ccc
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD---NTH 156 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~---~~~ 156 (311)
.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++ ++.++|+|||++....... ...
T Consensus 117 ~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~ 189 (319)
T 2y4i_B 117 YSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRED 189 (319)
T ss_dssp HHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----------CC
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccccccccccc
Confidence 999954 3457899999999999999999999999 99999999999997 6799999999876432111 111
Q ss_pred eeeeccccccccCCccccC---------CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchh
Q 021526 157 VSTRVMGTYGYCAPEYAMS---------GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 227 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~---------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (311)
......|+..|+|||++.. ..++.++||||||+++|+|++|..||........ .....
T Consensus 190 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~------- 256 (319)
T 2y4i_B 190 KLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI------IWQMG------- 256 (319)
T ss_dssp SCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH------HHHHH-------
T ss_pred ccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHhc-------
Confidence 2223458899999998864 3578899999999999999999999963321100 00000
Q ss_pred hhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCC
Q 021526 228 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 280 (311)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~ 280 (311)
....+.. .+..++..+.+++.+||..||++|||+.++++.|+.+......
T Consensus 257 ~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 257 TGMKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp TTCCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred cCCCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 0000111 1123455689999999999999999999999999998876543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=298.88 Aligned_cols=255 Identities=24% Similarity=0.276 Sum_probs=188.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeCC------eeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD------QRLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~ 71 (311)
+..+|+|+||.||.+.. +|+.||||.+..... ...+.+.+|+++++.++||||+++++++..+. ..++||
T Consensus 30 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~ 109 (367)
T 1cm8_A 30 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM 109 (367)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred eEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEE
Confidence 56799999999999998 789999999865422 23467889999999999999999999987653 459999
Q ss_pred ecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCC
Q 021526 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 151 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~ 151 (311)
|++ +++|.+++.. ..+++..+..++.|++.||+|||+.| ++|+||||+||+++.++.+||+|||+++....
T Consensus 110 e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 110 PFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp ECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 999 7899999954 46899999999999999999999999 99999999999999999999999999975322
Q ss_pred CCCcceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCcccccc-chhc----chhhhhc---
Q 021526 152 GDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSW----SRPFLKD--- 222 (311)
Q Consensus 152 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~----~~~~~~~--- 222 (311)
. .....++..|+|||++.+ ..++.++|+|||||++++|++|..||.......... +... ....+..
T Consensus 181 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 181 E-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp S-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred c-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 1 223457899999998877 678999999999999999999999997543211100 0000 0000000
Q ss_pred --ccchhhhcCccCCC---CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 223 --QKKFVHLVDPLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 223 --~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.......+...... ......+..+.+++.+||..||++|||++++++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 00000000000000 1123456789999999999999999999999873
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=296.60 Aligned_cols=256 Identities=22% Similarity=0.264 Sum_probs=187.1
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeCC------eeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD------QRLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~ 71 (311)
+..+|+|+||.||++.. +++.||||.+.... ......+.+|+.+++.++||||+++++++.... ..++||
T Consensus 30 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~ 109 (371)
T 2xrw_A 30 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM 109 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEE
T ss_pred eeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEE
Confidence 46899999999999998 78999999987542 233457889999999999999999999987654 789999
Q ss_pred ecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCC
Q 021526 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 151 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~ 151 (311)
|++++ +|.+++. ..+++..+..++.|++.||+|||++| ++|+||||+||+++.++.+||+|||++.....
T Consensus 110 e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 110 ELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp ECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred EcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 99975 7888884 34889999999999999999999999 99999999999999999999999999874322
Q ss_pred CCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCcccccc-chh--------c-------
Q 021526 152 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVS--------W------- 215 (311)
Q Consensus 152 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~--------~------- 215 (311)
........|+..|+|||++.+..++.++|||||||++|+|++|..||.......... +.. +
T Consensus 180 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 256 (371)
T 2xrw_A 180 ---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256 (371)
T ss_dssp -------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred ---ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 112233568999999999999899999999999999999999999997543211000 000 0
Q ss_pred chhhhhcc-----cchhhhcCccCC---CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 216 SRPFLKDQ-----KKFVHLVDPLLH---GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 216 ~~~~~~~~-----~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
........ ..+......... ...+...+..+.+||.+||+.||++|||++++++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000000 000000000000 00112347789999999999999999999999983
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=309.02 Aligned_cols=242 Identities=14% Similarity=0.119 Sum_probs=186.6
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccC---CccchhHHHHHHH---HHhcCCCCccccee-------EEEEeCCe
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHE---GLQGHQEFIVEVL---MLSLLHHDNLVTLI-------GYCTSGDQ 66 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~---~~~~~~~~~~e~~---~l~~l~h~~i~~~~-------~~~~~~~~ 66 (311)
...+|+|+||.||++.. +++.||||++... .....+.+.+|+. .++.++||||++++ +++.+++.
T Consensus 78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 157 (377)
T 3byv_A 78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157 (377)
T ss_dssp EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence 46899999999999997 6999999998743 3334567889994 55566899999998 67665532
Q ss_pred -----------------eEEEEecCCCCCHHHHhcccCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCC
Q 021526 67 -----------------RLLVYEYMPMGSLEDHLYDLEP---DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 126 (311)
Q Consensus 67 -----------------~~lv~e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~ 126 (311)
.+++|||+ +|+|.+++..... ....+++..++.++.|++.||+|||+.+ |+|+|||
T Consensus 158 ~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDik 233 (377)
T 3byv_A 158 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLR 233 (377)
T ss_dssp CSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCC
T ss_pred ccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 78999999 6799999965211 1123445788899999999999999999 9999999
Q ss_pred CCcEEEcCCCceEEeecCCCccCCCCCCcceeeeccccccccCCccccCC-----------CCCccccchhHHHHHHHHH
Q 021526 127 SANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-----------KLTLKSDIYSFGVVLLELI 195 (311)
Q Consensus 127 p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~Dv~slG~~l~~l~ 195 (311)
|+|||++.++.+||+|||++.... .......| ..|+|||++.+. .++.++||||||+++|+|+
T Consensus 234 p~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ell 307 (377)
T 3byv_A 234 PVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307 (377)
T ss_dssp GGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHH
T ss_pred HHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHH
Confidence 999999999999999999987421 12334456 899999999877 8999999999999999999
Q ss_pred hCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHH
Q 021526 196 TGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV--ALDY 273 (311)
Q Consensus 196 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~--~L~~ 273 (311)
+|..||......... ..... ....++..+.++|.+||+.||++|||+.++++ .+..
T Consensus 308 tg~~Pf~~~~~~~~~----------------~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 308 CADLPITKDAALGGS----------------EWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HSSCCC------CCS----------------GGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HCCCCCcccccccch----------------hhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 999999643321110 00000 01234567999999999999999999999997 4554
Q ss_pred hh
Q 021526 274 LV 275 (311)
Q Consensus 274 l~ 275 (311)
+.
T Consensus 366 ~~ 367 (377)
T 3byv_A 366 LR 367 (377)
T ss_dssp HH
T ss_pred HH
Confidence 44
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=289.36 Aligned_cols=244 Identities=23% Similarity=0.207 Sum_probs=196.0
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc---------cchhHHHHHHHHHhcCC-CCcccceeEEEEeCCeeEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---------QGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLL 69 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 69 (311)
...+|.|++|.||++.. +++.||+|.+..... ...+.+.+|+++++.+. ||||+++++++.++...++
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l 101 (298)
T 1phk_A 22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101 (298)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred eeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEE
Confidence 46899999999999999 689999999875431 12356778999999995 9999999999999999999
Q ss_pred EEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccC
Q 021526 70 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 149 (311)
Q Consensus 70 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~ 149 (311)
|||++++++|.+++.. ...+++..++.++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||.+...
T Consensus 102 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 102 VFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 9999999999999954 457899999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCCcceeeeccccccccCCcccc------CCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcc
Q 021526 150 PVGDNTHVSTRVMGTYGYCAPEYAM------SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 223 (311)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 223 (311)
... .......++..|+|||++. ...++.++|+||||+++|+|++|..||....... .........
T Consensus 175 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~ 245 (298)
T 1phk_A 175 DPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------MLRMIMSGN 245 (298)
T ss_dssp CTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTC
T ss_pred CCC---cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH------HHHHHhcCC
Confidence 322 1223356889999999875 4567899999999999999999999996332110 000000000
Q ss_pred cchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 224 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..........++..+.+++.+||..||.+|||+.++++
T Consensus 246 --------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 246 --------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp --------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred --------cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 00011112356778999999999999999999999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=317.84 Aligned_cols=252 Identities=22% Similarity=0.304 Sum_probs=200.1
Q ss_pred eeeeeeceeccEEEEEE-----CCeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL-----CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
...+|+|+||.||++.. .+..||+|.+..... ...+.+.+|+.+++.++||||+++++++. ++..++||||++
T Consensus 395 ~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~ 473 (656)
T 2j0j_A 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCT 473 (656)
T ss_dssp EEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred eeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCC
Confidence 46799999999999998 246799999765432 33467889999999999999999999985 457899999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||++....... .
T Consensus 474 ~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~-~ 546 (656)
T 2j0j_A 474 LGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-Y 546 (656)
T ss_dssp TCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----
T ss_pred CCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCCCc-c
Confidence 9999999965 3456899999999999999999999999 9999999999999999999999999997543221 1
Q ss_pred ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccC
Q 021526 156 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
.......++..|+|||++.+..++.++||||||+++|+|++ |..||....... .. ... ....
T Consensus 547 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~---~~i-----------~~~~ 609 (656)
T 2j0j_A 547 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VI---GRI-----------ENGE 609 (656)
T ss_dssp -------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH---HHH-----------HHTC
T ss_pred eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HH---HHH-----------HcCC
Confidence 11223446788999999988899999999999999999997 889986332110 00 000 0011
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 278 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~ 278 (311)
....+..++..+.+++.+||..||.+|||+.+|++.|+.+....
T Consensus 610 ~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 610 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 11234566788999999999999999999999999999987543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=300.19 Aligned_cols=247 Identities=27% Similarity=0.294 Sum_probs=197.0
Q ss_pred eeeeeeceeccEEEEEE-----CCeEEEEEEeccCC----ccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL-----CDQLVAIKQLNHEG----LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-----~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 71 (311)
+..+|+|+||.||++.. .++.||||++.... ....+.+.+|+++++.+ +||||+++++++..+...++||
T Consensus 59 ~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 138 (355)
T 1vzo_A 59 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL 138 (355)
T ss_dssp EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEe
Confidence 56899999999999998 68999999986542 23445677899999999 6999999999999999999999
Q ss_pred ecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCC
Q 021526 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 151 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~ 151 (311)
||+++++|.+++.. ...+++..++.++.|++.||+|||+++ ++|+||||+|||++.++.+||+|||++.....
T Consensus 139 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 211 (355)
T 1vzo_A 139 DYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 211 (355)
T ss_dssp CCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence 99999999999954 356899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCcceeeeccccccccCCccccC--CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhh
Q 021526 152 GDNTHVSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 229 (311)
Q Consensus 152 ~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
. .........|+..|+|||++.+ ..++.++||||||+++|+|++|..||......... .........
T Consensus 212 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~-------- 280 (355)
T 1vzo_A 212 D-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILK-------- 280 (355)
T ss_dssp G-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHH--------
T ss_pred C-CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHhc--------
Confidence 1 1112233568999999999885 35789999999999999999999999644322111 111111110
Q ss_pred cCccCCCCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 021526 230 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVVA 270 (311)
Q Consensus 230 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~l~~~ 270 (311)
....++..++..+.++|.+||..||.+|| +++++++.
T Consensus 281 ----~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 281 ----SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp ----CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ----cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 01123455677899999999999999999 99999874
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=301.32 Aligned_cols=264 Identities=20% Similarity=0.258 Sum_probs=195.0
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEe----------------
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS---------------- 63 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---------------- 63 (311)
...+|+|+||.||++.. +++.||||.+.... ....+|+++++.++||||+++++++..
T Consensus 12 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 87 (383)
T 3eb0_A 12 GKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHN 87 (383)
T ss_dssp EEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC---------------
T ss_pred EEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccc
Confidence 57899999999999998 78999999986442 223479999999999999999999843
Q ss_pred ----------------------CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCee
Q 021526 64 ----------------------GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 121 (311)
Q Consensus 64 ----------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~ 121 (311)
+...++||||+. ++|.+.+.........+++..++.++.|++.||+|||+.| ++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---i~ 163 (383)
T 3eb0_A 88 KLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---IC 163 (383)
T ss_dssp ----------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EE
T ss_pred cccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc---Cc
Confidence 334789999997 5888877654456778999999999999999999999999 99
Q ss_pred ecCCCCCcEEEc-CCCceEEeecCCCccCCCCCCcceeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCC
Q 021526 122 YRDLKSANILLD-NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRK 199 (311)
Q Consensus 122 H~di~p~nil~~-~~~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~ 199 (311)
|+||||+||+++ .++.+||+|||++....... ......++..|+|||++.+. .++.++|||||||++|+|++|..
T Consensus 164 H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 240 (383)
T 3eb0_A 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240 (383)
T ss_dssp CSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence 999999999997 68899999999997542222 22334578899999988765 58999999999999999999999
Q ss_pred CccccCcccccc-chhc-----chhhhhcccchhhhcCcc-----CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 021526 200 AMDLSKGQGEQN-LVSW-----SRPFLKDQKKFVHLVDPL-----LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 268 (311)
Q Consensus 200 p~~~~~~~~~~~-~~~~-----~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~ 268 (311)
||.......... +... ................+. +...++...+..+.++|.+||..||++|||+.|++
T Consensus 241 pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 320 (383)
T 3eb0_A 241 LFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAM 320 (383)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 997543211100 0000 000000000000000001 11112334567799999999999999999999999
Q ss_pred H--HHHHhhh
Q 021526 269 V--ALDYLVS 276 (311)
Q Consensus 269 ~--~L~~l~~ 276 (311)
+ .++.+..
T Consensus 321 ~hp~f~~~~~ 330 (383)
T 3eb0_A 321 AHPFFDHLRN 330 (383)
T ss_dssp TSGGGHHHHH
T ss_pred cCHHHHHHHh
Confidence 7 3555544
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=296.37 Aligned_cols=257 Identities=25% Similarity=0.312 Sum_probs=180.7
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
...+|.|++|.||.+.. +++.||+|.+.... ....+.+.+|+++++.++||||+++++++..+...++|||++++++
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 99 (303)
T 2vwi_A 20 QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGS 99 (303)
T ss_dssp EEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCB
T ss_pred hheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCc
Confidence 56899999999999987 78999999986543 2345678899999999999999999999999999999999999999
Q ss_pred HHHHhcccC----CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC
Q 021526 79 LEDHLYDLE----PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 79 L~~~l~~~~----~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
|.+++.... .....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 100 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 176 (303)
T 2vwi_A 100 VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD 176 (303)
T ss_dssp HHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHHCC----
T ss_pred hHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchheeccCCC
Confidence 999986421 13456999999999999999999999999 99999999999999999999999998764322211
Q ss_pred ---cceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhc
Q 021526 155 ---THVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 230 (311)
Q Consensus 155 ---~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (311)
........++..|+|||++.+ ..++.++|+||||+++|+|++|..||.......... .... .......
T Consensus 177 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~~--~~~~~~~ 248 (303)
T 2vwi_A 177 ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM------LTLQ--NDPPSLE 248 (303)
T ss_dssp -----------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH------HHHT--SSCCCTT
T ss_pred ccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH------HHhc--cCCCccc
Confidence 111233468899999998865 568899999999999999999999996443221100 0000 0000000
Q ss_pred CccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 231 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 231 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
...........++..+.+++.+||+.||.+||++.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 249 TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 000011112234567999999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=300.68 Aligned_cols=246 Identities=11% Similarity=-0.044 Sum_probs=176.0
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHH---HHHhcCCCCccccee-------EEEEeC--
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEV---LMLSLLHHDNLVTLI-------GYCTSG-- 64 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~---~~l~~l~h~~i~~~~-------~~~~~~-- 64 (311)
...+|+|+||.||++.. +++.||+|.+..... ...+.+.+|+ ..|+. +||||++++ +++..+
T Consensus 67 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~~ 145 (371)
T 3q60_A 67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQSQ 145 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEETTS
T ss_pred eeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecCCC
Confidence 46899999999999998 789999999987543 2334567774 45555 799987754 455433
Q ss_pred ---------------CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHH------HHHHHHHHHHHHHHhhCCCCCeeec
Q 021526 65 ---------------DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTR------MKIAVGAARGLEYLHCKANPPVIYR 123 (311)
Q Consensus 65 ---------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~------~~~~~~i~~~l~~Lh~~~~~~i~H~ 123 (311)
...++||||++ ++|.+++... +..+....+ +.++.|++.||+|||+++ ++|+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivHr 218 (371)
T 3q60_A 146 PPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHG 218 (371)
T ss_dssp CSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred CCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---CccC
Confidence 33799999998 7999999752 223344444 677799999999999999 9999
Q ss_pred CCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeeeccccccccCCccccC--CCCCccccchhHHHHHHHHHhCCCCc
Q 021526 124 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGRKAM 201 (311)
Q Consensus 124 di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~ 201 (311)
||||+|||++.++.+||+|||++.... .......++..|+|||++.+ ..++.++||||||+++|+|++|..||
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETT-----CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred cCCHHHEEECCCCCEEEEecceeeecC-----CCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999997532 11223456799999999987 67899999999999999999999999
Q ss_pred cccCccccccchhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 202 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.............. .................++..+.++|.+||+.||++|||+.++++
T Consensus 294 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 294 GLVTPGIKGSWKRP---------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TBCCTTCTTCCCBC---------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCcCcccccchhhh---------hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 75432211111000 000000111111112355778999999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=299.67 Aligned_cols=256 Identities=20% Similarity=0.209 Sum_probs=194.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCC--------CCcccceeEEEE----eCCee
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH--------HDNLVTLIGYCT----SGDQR 67 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~----~~~~~ 67 (311)
..++|+|+||.||+++. +++.||||++... ....+.+.+|+++++.++ |+||+++++++. ++...
T Consensus 42 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~ 120 (397)
T 1wak_A 42 IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHI 120 (397)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEE
T ss_pred EEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceE
Confidence 56899999999999998 7899999998643 334467889999998885 788999999987 55678
Q ss_pred EEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeecCCCCCcEEEcCCC----------
Q 021526 68 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLDNDF---------- 136 (311)
Q Consensus 68 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~-~~~~i~H~di~p~nil~~~~~---------- 136 (311)
++|||++ +++|.+++.. .....+++..++.++.||+.||+|||++ | ++|+||||+|||++.++
T Consensus 121 ~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 121 CMVFEVL-GHHLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp EEEECCC-CCBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred EEEEecc-CccHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhhhhhh
Confidence 9999999 5677777654 2346799999999999999999999998 9 99999999999998775
Q ss_pred ---------------------------------------ceEEeecCCCccCCCCCCcceeeeccccccccCCccccCCC
Q 021526 137 ---------------------------------------NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK 177 (311)
Q Consensus 137 ---------------------------------------~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 177 (311)
.+||+|||++...... .....|+..|+|||++.+..
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~ 269 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIGSG 269 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHTSC
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhcCCC
Confidence 7999999998753221 22346899999999999999
Q ss_pred CCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhh-----------h----------hcccchhhhcCc----
Q 021526 178 LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF-----------L----------KDQKKFVHLVDP---- 232 (311)
Q Consensus 178 ~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------~----------~~~~~~~~~~~~---- 232 (311)
++.++|||||||++|+|++|..||.................. + .....+......
T Consensus 270 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (397)
T 1wak_A 270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG 349 (397)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCC
T ss_pred CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcc
Confidence 999999999999999999999999755432211100000000 0 000000000000
Q ss_pred -----cCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 233 -----LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 233 -----~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
......+...+..+.+||.+||+.||++|||+.++++
T Consensus 350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 350 LFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred hhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0011235677888999999999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=285.19 Aligned_cols=243 Identities=23% Similarity=0.247 Sum_probs=194.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
...+|.|++|.||++.. +++.||+|.+.... ......+.+|+++++.++||||+++++++.++...++++|++.++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 106 (287)
T 2wei_A 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG 106 (287)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCC
Confidence 57899999999999999 68999999986543 345578899999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCC---ceEEeecCCCccCCCCCC
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF---NPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~---~vkl~Df~~~~~~~~~~~ 154 (311)
+|.+++.. ...+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++ .++|+|||++.......
T Consensus 107 ~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~- 178 (287)
T 2wei_A 107 ELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT- 178 (287)
T ss_dssp BHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS-
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCCC-
Confidence 99998854 346899999999999999999999999 99999999999997644 69999999987532221
Q ss_pred cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccC
Q 021526 155 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
......++..|+|||++.+ .++.++|+||||+++|+|++|..||....... .......... ..
T Consensus 179 --~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~~--------~~ 241 (287)
T 2wei_A 179 --KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD------ILKRVETGKY--------AF 241 (287)
T ss_dssp --SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCC--------CC
T ss_pred --ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHcCCC--------CC
Confidence 1223457889999998765 48899999999999999999999996432110 0000000000 00
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.......++..+.++|.+||..||++|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 242 DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00001234677999999999999999999999997
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=285.26 Aligned_cols=245 Identities=22% Similarity=0.300 Sum_probs=187.1
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEe-------------CCe
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS-------------GDQ 66 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------------~~~ 66 (311)
+..+|.|+||.||.+.. +++.||+|.+... ....+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (303)
T 1zy4_A 11 IAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKST 89 (303)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEE
T ss_pred hheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCc
Confidence 57899999999999998 7899999998542 3345678899999999999999999998765 356
Q ss_pred eEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCC
Q 021526 67 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 146 (311)
Q Consensus 67 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~ 146 (311)
.++|||++++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~ 163 (303)
T 1zy4_A 90 LFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLA 163 (303)
T ss_dssp EEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCcch
Confidence 7999999999999999965 3456788999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCC------------cceeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCccccccch
Q 021526 147 KLGPVGDN------------THVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV 213 (311)
Q Consensus 147 ~~~~~~~~------------~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 213 (311)
........ ........++..|+|||++.+. .++.++|+||||+++|+|++ ||...... .
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~-----~ 235 (303)
T 1zy4_A 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER-----V 235 (303)
T ss_dssp SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH-----H
T ss_pred hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH-----H
Confidence 75432110 1112334588999999998765 68899999999999999998 44311100 0
Q ss_pred hcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 214 SWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
...... . .........++...+..+.++|.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~-------~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 236 NILKKL-------R-SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHH-------H-STTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhc-------c-ccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 000000 0 01111222334556677999999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=302.49 Aligned_cols=260 Identities=25% Similarity=0.252 Sum_probs=191.1
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeC------CeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG------DQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~ 73 (311)
..++|.|+||.||++.. +++.||||.+.... ....+|+++++.++||||+++++++... ...++||||
T Consensus 59 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~ 134 (420)
T 1j1b_A 59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 134 (420)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEEC
T ss_pred eeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhc
Confidence 46899999999999999 68999999986432 2334799999999999999999987532 236799999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCC-CceEEeecCCCccCCCC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-FNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~-~~vkl~Df~~~~~~~~~ 152 (311)
+.+ ++.+.+.........+++..++.++.||+.||+|||+.+ |+|+||||+|||++.+ +.+||+|||+++.....
T Consensus 135 ~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~ 210 (420)
T 1j1b_A 135 VPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210 (420)
T ss_dssp CCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred ccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhcccC
Confidence 975 677666543345678999999999999999999999999 9999999999999965 56899999999754222
Q ss_pred CCcceeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchh-------hhh-cc
Q 021526 153 DNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP-------FLK-DQ 223 (311)
Q Consensus 153 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------~~~-~~ 223 (311)
. ......++..|+|||++.+. .++.++|||||||++|+|++|..||........ +...... .+. ..
T Consensus 211 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~i~~~lg~p~~~~~~~~~ 285 (420)
T 1j1b_A 211 E---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQIREMN 285 (420)
T ss_dssp C---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCSCCHHHHHHHC
T ss_pred C---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHHhhC
Confidence 1 12234679999999988764 789999999999999999999999975432111 0000000 000 00
Q ss_pred cchhhhcCccCCC-----CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHHh
Q 021526 224 KKFVHLVDPLLHG-----RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA--LDYL 274 (311)
Q Consensus 224 ~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~--L~~l 274 (311)
....+...+.... .++...+.++.+||.+||..||.+||++.|+++. ++.+
T Consensus 286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 0000000011000 0223456789999999999999999999999873 4444
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=290.42 Aligned_cols=249 Identities=22% Similarity=0.277 Sum_probs=175.1
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc-cchhHHHHHHH-HHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL-QGHQEFIVEVL-MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
+..+|.|+||.||++.. +++.||||.+..... .....+.+|+. +++.++||||+++++++.++...++|||++.+
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~- 105 (327)
T 3aln_A 27 LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST- 105 (327)
T ss_dssp -CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-
T ss_pred hheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-
Confidence 56799999999999999 599999999875532 23345556665 67788999999999999999999999999975
Q ss_pred CHHHHhcccC-CCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 78 SLEDHLYDLE-PDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 78 ~L~~~l~~~~-~~~~~l~~~~~~~~~~~i~~~l~~Lh~~-~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+|.+++.... .....+++..++.++.|++.||.|||+. + ++|+||+|+||+++.++.+||+|||++......
T Consensus 106 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--- 179 (327)
T 3aln_A 106 SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS--- 179 (327)
T ss_dssp EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-------
T ss_pred ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecccc---
Confidence 8887775311 2356799999999999999999999998 9 999999999999999999999999998753221
Q ss_pred ceeeeccccccccCCccc----cCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcC
Q 021526 156 HVSTRVMGTYGYCAPEYA----MSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~----~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
.......|+..|+|||++ .+..++.++|+||||+++|+|++|..||......... ... . .....
T Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~----~-------~~~~~ 247 (327)
T 3aln_A 180 IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-LTQ----V-------VKGDP 247 (327)
T ss_dssp --------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------CC----C-------CCSCC
T ss_pred cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-HHH----H-------hcCCC
Confidence 122234688999999998 4567889999999999999999999999643221110 000 0 00000
Q ss_pred ccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
+.+.......++..+.+++.+||..||++||++.++++
T Consensus 248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11111112345677999999999999999999999987
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=301.12 Aligned_cols=192 Identities=24% Similarity=0.269 Sum_probs=164.7
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcC------CCCcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLL------HHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
+.++|+|+||.||++.. .++.||||++... ......+.+|+.+++.+ +|+||+++++++......+++||+
T Consensus 102 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 180 (429)
T 3kvw_A 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFEL 180 (429)
T ss_dssp EEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECC
T ss_pred EEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEec
Confidence 57899999999999998 6899999998643 33345677788877766 577999999999999999999999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCc--eEEeecCCCccCCC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN--PKLSDFGLAKLGPV 151 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~--vkl~Df~~~~~~~~ 151 (311)
+. ++|.+++.. .....+++..++.++.||+.||+|||+.+ |+|+||||+|||++.++. +||+|||++.....
T Consensus 181 ~~-~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~ 254 (429)
T 3kvw_A 181 LS-MNLYELIKK--NKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ 254 (429)
T ss_dssp CC-CBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred cC-CCHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccceecCC
Confidence 95 599999866 23456999999999999999999999999 999999999999999887 99999999864322
Q ss_pred CCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccC
Q 021526 152 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 205 (311)
Q Consensus 152 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 205 (311)
. .....+++.|+|||++.+..++.++|||||||++|+|++|.+||....
T Consensus 255 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 255 R-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp C-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred c-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 1 223468899999999999999999999999999999999999996543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=296.07 Aligned_cols=259 Identities=22% Similarity=0.236 Sum_probs=193.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeC-----CeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG-----DQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~ 73 (311)
+..+|.|+||.||++.. +++.||+|.+..... ...+.+.+|+++++.++||||+++++++... ...+++||+
T Consensus 32 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~ 111 (364)
T 3qyz_A 32 LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL 111 (364)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred EEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcc
Confidence 56899999999999998 789999999875432 2336788999999999999999999998654 368999999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 153 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~ 153 (311)
+. ++|.+++.. ..+++..++.++.|++.||+|||++| ++|+||+|+||+++.++.+||+|||++.......
T Consensus 112 ~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 112 ME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp CS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred cC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 96 499999854 46999999999999999999999999 9999999999999999999999999997543221
Q ss_pred Ccc-eeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCccccccch-hc----chhhhhccc--
Q 021526 154 NTH-VSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-SW----SRPFLKDQK-- 224 (311)
Q Consensus 154 ~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~----~~~~~~~~~-- 224 (311)
... ......|++.|+|||++.+ ..++.++||||||+++|+|++|..||............ .. ....+....
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 262 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 111 1233468999999998654 45899999999999999999999999654322111000 00 000000000
Q ss_pred chhhhc-CccCCCC-----CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 225 KFVHLV-DPLLHGR-----YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 225 ~~~~~~-~~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
...... ....... .....+..+.++|.+||+.||++|||+.++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 0000000 01234667999999999999999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=296.31 Aligned_cols=258 Identities=22% Similarity=0.184 Sum_probs=187.4
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCccc-----------hhHHHHHHHHHhcCCCCcccceeEEEEe-----C
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQG-----------HQEFIVEVLMLSLLHHDNLVTLIGYCTS-----G 64 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 64 (311)
...+|+|+||.||.+.. .++.||||.+....... .+.+.+|+++++.++||||+++++++.. .
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 106 (362)
T 3pg1_A 27 QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAM 106 (362)
T ss_dssp EEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTC
T ss_pred eEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCc
Confidence 57899999999999988 78999999986543221 2678899999999999999999999854 3
Q ss_pred CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecC
Q 021526 65 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 144 (311)
Q Consensus 65 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~ 144 (311)
...++|||++. ++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 107 ~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 179 (362)
T 3pg1_A 107 HKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFN 179 (362)
T ss_dssp CEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCTT
T ss_pred ceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEEEecC
Confidence 36799999997 588888864 4567999999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCCcceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCcccccc-chhcc-----h
Q 021526 145 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWS-----R 217 (311)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~-----~ 217 (311)
++..... ........++..|+|||++.+ ..++.++|+||||+++|+|++|..||.......... +.... .
T Consensus 180 ~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 256 (362)
T 3pg1_A 180 LAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE 256 (362)
T ss_dssp C------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChH
Confidence 9874222 222333567889999998876 678999999999999999999999997543211100 00000 0
Q ss_pred h-hhhcccchhhhcCccCCC-------CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 218 P-FLKDQKKFVHLVDPLLHG-------RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 218 ~-~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
. .................. ......+..+.++|.+||+.||++|||+.++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 0 000000000111011000 011234667999999999999999999999987
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=287.48 Aligned_cols=258 Identities=23% Similarity=0.272 Sum_probs=193.6
Q ss_pred eeeeeeceeccEEEEEE---CCeEEEEEEeccCCc--cchhHHHHHHHHHhcC---CCCcccceeEEEE-----eCCeeE
Q 021526 2 LCCYLSCKFYNVGLVWL---CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLL---HHDNLVTLIGYCT-----SGDQRL 68 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~---~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~-----~~~~~~ 68 (311)
...+|+|+||.||++.. +++.||+|.+..... .....+.+|+.+++.+ +||||+++++++. .....+
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 95 (326)
T 1blx_A 16 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 95 (326)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred eeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEE
Confidence 56899999999999998 578999999865432 2234667787777666 8999999999987 556789
Q ss_pred EEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCcc
Q 021526 69 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 148 (311)
Q Consensus 69 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~ 148 (311)
+|||+++ ++|.+++.. .....+++..++.++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||++..
T Consensus 96 lv~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 169 (326)
T 1blx_A 96 LVFEHVD-QDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI 169 (326)
T ss_dssp EEEECCS-CBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred EEEecCC-CCHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCccccc
Confidence 9999997 599999965 23456899999999999999999999999 99999999999999999999999999874
Q ss_pred CCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCcccccc-c---------hhcchh
Q 021526 149 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-L---------VSWSRP 218 (311)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~---------~~~~~~ 218 (311)
... ........++..|+|||++.+..++.++|+||||+++|+|++|..||.......... + ..|...
T Consensus 170 ~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (326)
T 1blx_A 170 YSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246 (326)
T ss_dssp CCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred ccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccc
Confidence 321 122334567899999999998899999999999999999999999997543211100 0 000000
Q ss_pred hhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 219 FLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.......+.. ........+...++..+.++|.+||..||++|||+.++++
T Consensus 247 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 247 VALPRQAFHS-KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CSSCGGGSCC-CCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccchhhhcc-cCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000000 0000001122345678999999999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=297.47 Aligned_cols=255 Identities=23% Similarity=0.274 Sum_probs=177.5
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeC------CeeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG------DQRLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~ 71 (311)
+..+|+|+||.||++.. +|+.||||.+.... ......+.+|+.+++.++||||+++++++... ...++++
T Consensus 34 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~ 113 (367)
T 2fst_X 34 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113 (367)
T ss_dssp EEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred eeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEe
Confidence 56899999999999998 78999999986542 23446788999999999999999999998654 5679999
Q ss_pred ecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCC
Q 021526 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 151 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~ 151 (311)
+++ +++|.+++.. ..+++..+..++.|++.||+|||+.| ++|+||||+||+++.++.+||+|||+++....
T Consensus 114 e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 114 HLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp ECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---------
T ss_pred ccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 998 6789888842 57999999999999999999999999 99999999999999999999999999875321
Q ss_pred CCCcceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCccccccc-hhcc----hhhhhc--c
Q 021526 152 GDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-VSWS----RPFLKD--Q 223 (311)
Q Consensus 152 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~----~~~~~~--~ 223 (311)
......++..|+|||++.+ ..++.++|||||||++|+|++|..||........... .... ...+.. .
T Consensus 185 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 185 -----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred -----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 1223468999999999877 6789999999999999999999999965432111000 0000 000000 0
Q ss_pred cchhhhc---CccCCCCC---cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 224 KKFVHLV---DPLLHGRY---PRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 224 ~~~~~~~---~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
......+ ...-...+ ....+..+.+||.+||..||++|||+.++++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000000 00000000 01235678999999999999999999999873
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=288.85 Aligned_cols=257 Identities=17% Similarity=0.197 Sum_probs=195.8
Q ss_pred eeeeeeceeccEEEEEE---CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCC------cccceeEEEEeCCeeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL---CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHD------NLVTLIGYCTSGDQRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e 72 (311)
...+|.|+||.||++.. +++.||+|++... ....+.+.+|+++++.++|+ +++++++++.++...++|||
T Consensus 19 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 97 (339)
T 1z57_A 19 VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE 97 (339)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEE
T ss_pred EEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEc
Confidence 56899999999999987 6899999998643 33446788899999888655 49999999999999999999
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcC------------------
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN------------------ 134 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~------------------ 134 (311)
++ +++|.+++.. .....+++..++.++.|++.||+|||+++ ++|+||||+||+++.
T Consensus 98 ~~-~~~l~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~ 171 (339)
T 1z57_A 98 LL-GLSTYDFIKE--NGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171 (339)
T ss_dssp CC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CEEEEE
T ss_pred CC-CCCHHHHHHh--cCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccccccc
Confidence 99 8899999965 23346899999999999999999999999 999999999999987
Q ss_pred -CCceEEeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccch
Q 021526 135 -DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV 213 (311)
Q Consensus 135 -~~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 213 (311)
++.++|+|||++..... ......|+..|+|||++.+..++.++|+||||+++|+|++|..||............
T Consensus 172 ~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 246 (339)
T 1z57_A 172 INPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMM 246 (339)
T ss_dssp SCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHH
T ss_pred cCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 66799999999875322 122346899999999999989999999999999999999999999754322111000
Q ss_pred hc-----chhhhhccc--------------------chhhhcCccC-CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 021526 214 SW-----SRPFLKDQK--------------------KFVHLVDPLL-HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 267 (311)
Q Consensus 214 ~~-----~~~~~~~~~--------------------~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l 267 (311)
.. ......... .......+.. ....+...+..+.++|.+||+.||.+|||+.|+
T Consensus 247 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el 326 (339)
T 1z57_A 247 ERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREA 326 (339)
T ss_dssp HHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHH
Confidence 00 000000000 0000000000 011234567889999999999999999999999
Q ss_pred HHH
Q 021526 268 VVA 270 (311)
Q Consensus 268 ~~~ 270 (311)
++.
T Consensus 327 l~h 329 (339)
T 1z57_A 327 LKH 329 (339)
T ss_dssp TTS
T ss_pred hcC
Confidence 863
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=289.74 Aligned_cols=259 Identities=22% Similarity=0.250 Sum_probs=187.6
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEE--------------eCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT--------------SGD 65 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--------------~~~ 65 (311)
+..+|+|++|.||++.. .++.||+|.+........+.+.+|+++++.++||||+++++++. +..
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~ 95 (320)
T 2i6l_A 16 LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELN 95 (320)
T ss_dssp EEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCS
T ss_pred EEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccC
Confidence 56899999999999999 58999999987666666678999999999999999999999873 346
Q ss_pred eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEc-CCCceEEeecC
Q 021526 66 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFG 144 (311)
Q Consensus 66 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~-~~~~vkl~Df~ 144 (311)
..++|||+++ ++|.+++. ...+++..++.++.|++.||+|||+.| ++|+||+|+||+++ +++.+||+|||
T Consensus 96 ~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg 166 (320)
T 2i6l_A 96 SVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFG 166 (320)
T ss_dssp EEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred ceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccCc
Confidence 7899999997 59999994 356899999999999999999999999 99999999999997 56789999999
Q ss_pred CCccCCCCCC-cceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCcccccc-chhcc-hhhh
Q 021526 145 LAKLGPVGDN-THVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWS-RPFL 220 (311)
Q Consensus 145 ~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~-~~~~ 220 (311)
++........ ........++..|+|||++.+ ..++.++|+||||+++|+|++|..||.......... +.... ....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (320)
T 2i6l_A 167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHE 246 (320)
T ss_dssp TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCH
T ss_pred cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCch
Confidence 9875422111 111223456888999998765 678999999999999999999999997543211100 00000 0000
Q ss_pred hcccchhhh----cCccCC-C-----CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 221 KDQKKFVHL----VDPLLH-G-----RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 221 ~~~~~~~~~----~~~~~~-~-----~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
......... ...... . .....++..+.++|.+||+.||++|||++++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 247 EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 000000000 000000 0 011235678999999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=297.40 Aligned_cols=258 Identities=22% Similarity=0.235 Sum_probs=188.2
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCe------eEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ------RLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~ 74 (311)
..++|.|+||.||.+.. .+..||+|.+.... ....+|+++++.++||||+++++++..... .++||||+
T Consensus 45 ~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~ 120 (394)
T 4e7w_A 45 CKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV 120 (394)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECC
T ss_pred eEEEeeCCCeEEEEEEECCCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeecc
Confidence 46899999999999999 66779999876432 223369999999999999999999865433 78999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEc-CCCceEEeecCCCccCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAKLGPVGD 153 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~-~~~~vkl~Df~~~~~~~~~~ 153 (311)
.+ ++.+.+.........+++..++.++.|++.||+|||+.| ++||||||+||+++ .++.+||+|||++.......
T Consensus 121 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~ 196 (394)
T 4e7w_A 121 PE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196 (394)
T ss_dssp SE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred Cc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC
Confidence 76 444444332234678999999999999999999999999 99999999999999 79999999999997542221
Q ss_pred CcceeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCcccccc-chhcc----hhhh-hcccch
Q 021526 154 NTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWS----RPFL-KDQKKF 226 (311)
Q Consensus 154 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~----~~~~-~~~~~~ 226 (311)
......+++.|+|||++.+. .++.++|||||||++|+|++|..||.......... +.... ...+ ......
T Consensus 197 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 273 (394)
T 4e7w_A 197 ---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY 273 (394)
T ss_dssp ---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGG
T ss_pred ---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence 22234578999999988765 58999999999999999999999997543211100 00000 0000 000000
Q ss_pred hhhcCccCC-----CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 227 VHLVDPLLH-----GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 227 ~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.....+... ..++...+.++.+||.+||+.||.+|||+.++++.
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 274 MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp SSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000000000 01122356789999999999999999999999873
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=292.17 Aligned_cols=256 Identities=18% Similarity=0.194 Sum_probs=192.6
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCC-----------CCcccceeEEEEeCC---
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-----------HDNLVTLIGYCTSGD--- 65 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~~~--- 65 (311)
...+|+|+||.||++.. +++.||||.+... ......+.+|+.+++.++ ||||+++++++....
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 102 (373)
T 1q8y_A 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG 102 (373)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTE
T ss_pred EEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCC
Confidence 57899999999999998 7999999998643 334467888999888776 789999999987654
Q ss_pred -eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeecCCCCCcEEEc------CCCc
Q 021526 66 -QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLD------NDFN 137 (311)
Q Consensus 66 -~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~-~~~~i~H~di~p~nil~~------~~~~ 137 (311)
..+++||++ +++|.+++.. .....+++..++.++.||+.||+|||++ | ++|+||||+|||++ ..+.
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~~~~ 176 (373)
T 1q8y_A 103 VHVVMVFEVL-GENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQ 176 (373)
T ss_dssp EEEEEEECCC-CEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEE
T ss_pred ceEEEEEecC-CCCHHHHHHH--hhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcCcce
Confidence 789999999 8899999976 2345699999999999999999999998 9 99999999999994 3447
Q ss_pred eEEeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcch
Q 021526 138 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR 217 (311)
Q Consensus 138 vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 217 (311)
+||+|||++...... .....++..|+|||++.+..++.++||||||+++|+|++|..||................
T Consensus 177 ~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 251 (373)
T 1q8y_A 177 IKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251 (373)
T ss_dssp EEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred EEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHH
Confidence 999999998753221 223468999999999999999999999999999999999999997544221110000000
Q ss_pred hh-----------hhcccchhhhcC------c-------------cCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 021526 218 PF-----------LKDQKKFVHLVD------P-------------LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 267 (311)
Q Consensus 218 ~~-----------~~~~~~~~~~~~------~-------------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l 267 (311)
.. +........... . .....++...+..+.+||.+||+.||++|||+.++
T Consensus 252 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 331 (373)
T 1q8y_A 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 331 (373)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHH
Confidence 00 000000000000 0 00113456788999999999999999999999999
Q ss_pred HH
Q 021526 268 VV 269 (311)
Q Consensus 268 ~~ 269 (311)
++
T Consensus 332 l~ 333 (373)
T 1q8y_A 332 VN 333 (373)
T ss_dssp HT
T ss_pred hh
Confidence 87
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=292.97 Aligned_cols=254 Identities=22% Similarity=0.273 Sum_probs=190.0
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc--chhHHHHHHHHHhcCCCCcccceeEEEEeCCee------EEEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR------LLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------~lv~ 71 (311)
...+|+|+||.||++.. +++.||+|.+...... ....+.+|+.+++.++||||+++++++...... ++||
T Consensus 47 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 126 (371)
T 4exu_A 47 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 126 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEE
T ss_pred EeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEE
Confidence 46799999999999998 7999999998754322 346788999999999999999999999876655 9999
Q ss_pred ecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCC
Q 021526 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 151 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~ 151 (311)
|++. ++|.+++. ..+++..+..++.|++.||+|||+.| ++|+||+|+||+++.++.+||+|||++.....
T Consensus 127 e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 127 PFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp ECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred cccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 9996 58888873 34899999999999999999999999 99999999999999999999999999874322
Q ss_pred CCCcceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCcccccc-chhcc----hhhhhc---
Q 021526 152 GDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWS----RPFLKD--- 222 (311)
Q Consensus 152 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~----~~~~~~--- 222 (311)
......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||.......... +.... ......
T Consensus 197 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 271 (371)
T 4exu_A 197 -----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 271 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred -----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence 1233467899999998877 678999999999999999999999997443211100 00000 000000
Q ss_pred --ccchhhhcCccCCCC---CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 223 --QKKFVHLVDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 223 --~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
............... ....++..+.+||.+||+.||++|||+.++++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 272 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000000000000001 012346789999999999999999999999873
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=292.37 Aligned_cols=259 Identities=21% Similarity=0.187 Sum_probs=183.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCe-------eEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ-------RLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-------~~lv~e 72 (311)
...+|.|+||.||++.. +++.||||.+... ........++++.+..++||||+++++++..... .++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e 106 (360)
T 3e3p_A 28 ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVME 106 (360)
T ss_dssp C----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEee
Confidence 46799999999999998 6899999988543 3344567788888899999999999999865433 789999
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHh--hCCCCCeeecCCCCCcEEEcC-CCceEEeecCCCccC
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH--CKANPPVIYRDLKSANILLDN-DFNPKLSDFGLAKLG 149 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh--~~~~~~i~H~di~p~nil~~~-~~~vkl~Df~~~~~~ 149 (311)
|+.+ +|.+.+.........+++..++.++.|++.||.||| +.+ ++|+||||+||+++. ++.+||+|||++...
T Consensus 107 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~ 182 (360)
T 3e3p_A 107 YVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182 (360)
T ss_dssp CCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEECCCTTCBCC
T ss_pred cccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEeeCCCceec
Confidence 9976 666555443346678999999999999999999999 898 999999999999996 899999999999754
Q ss_pred CCCCCcceeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhh
Q 021526 150 PVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 228 (311)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
... .......|+..|+|||++.+. .++.++||||||+++|+|++|..||......... ................
T Consensus 183 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~ 257 (360)
T 3e3p_A 183 SPS---EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL--HEIVRVLGCPSREVLR 257 (360)
T ss_dssp CTT---SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCHHHHH
T ss_pred CCC---CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHH--HHHHHHcCCCCHHHHH
Confidence 322 222335679999999988665 4899999999999999999999999754321110 0000000000000000
Q ss_pred hcCc----------------cCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 229 LVDP----------------LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 229 ~~~~----------------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
...+ ......+...+..+.+||.+||+.||.+|||+.|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 258 KLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred hcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000 00011122357789999999999999999999999873
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=287.55 Aligned_cols=243 Identities=20% Similarity=0.175 Sum_probs=167.7
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHH-HHHhcCCCCcccceeEEEEe----CCeeEEEEecCC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEV-LMLSLLHHDNLVTLIGYCTS----GDQRLLVYEYMP 75 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~ 75 (311)
.++|.|+||.||++.. +++.||+|++... ....+|+ ..++.++||||+++++++.. +...++||||++
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 109 (336)
T 3fhr_A 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME 109 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred eeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence 3689999999999999 6999999998643 2223333 34567799999999999876 445899999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCC---CceEEeecCCCccCCCC
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND---FNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~---~~vkl~Df~~~~~~~~~ 152 (311)
+++|.+++.. .....+++..++.++.|++.||+|||++| ++|+||+|+||+++.+ +.+||+|||++.....
T Consensus 110 gg~L~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~- 183 (336)
T 3fhr_A 110 GGELFSRIQE--RGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ- 183 (336)
T ss_dssp TEEHHHHHHT--C-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---
T ss_pred CCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccceeccc-
Confidence 9999999975 23457999999999999999999999999 9999999999999764 4599999999875322
Q ss_pred CCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCc
Q 021526 153 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 232 (311)
Q Consensus 153 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
.......+++.|+|||++.+..++.++|+||||+++|+|++|..||............ ..... ....
T Consensus 184 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~--------~~~~ 250 (336)
T 3fhr_A 184 ---NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM--KRRIR--------LGQY 250 (336)
T ss_dssp -----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------------
T ss_pred ---cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH--HHhhh--------cccc
Confidence 1223356799999999998888999999999999999999999999643322110000 00000 0000
Q ss_pred cCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 233 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.........++..+.++|.+||..||.+|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 251 GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0001111345677999999999999999999999998
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=298.19 Aligned_cols=262 Identities=20% Similarity=0.189 Sum_probs=178.7
Q ss_pred eeeeeceeccEEEEEE----CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEe--CCeeEEEEecCCC
Q 021526 3 CCYLSCKFYNVGLVWL----CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS--GDQRLLVYEYMPM 76 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~----~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 76 (311)
+++|+|+||.||++.. .++.||+|.+.... ....+.+|+.+++.++||||+++++++.. +...++||||+.+
T Consensus 27 ~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~ 104 (405)
T 3rgf_A 27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 104 (405)
T ss_dssp CCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE
T ss_pred cEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC
Confidence 5799999999999996 47899999986442 33578899999999999999999999954 6789999999964
Q ss_pred CCHHHHhcccC-----CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE----cCCCceEEeecCCCc
Q 021526 77 GSLEDHLYDLE-----PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL----DNDFNPKLSDFGLAK 147 (311)
Q Consensus 77 ~~L~~~l~~~~-----~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~----~~~~~vkl~Df~~~~ 147 (311)
+|.+++.... .....+++..++.++.||+.||+|||+.+ |+|+||||+|||+ +.++.+||+|||++.
T Consensus 105 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 180 (405)
T 3rgf_A 105 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 180 (405)
T ss_dssp -EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC
T ss_pred -CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCce
Confidence 8888775321 12335999999999999999999999999 9999999999999 677899999999997
Q ss_pred cCCCCCC-cceeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCccccccc---hhcchhh---
Q 021526 148 LGPVGDN-THVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL---VSWSRPF--- 219 (311)
Q Consensus 148 ~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~--- 219 (311)
....... ........|++.|+|||++.+. .++.++|||||||++|+|++|..||........... .......
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~ 260 (405)
T 3rgf_A 181 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 260 (405)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHH
T ss_pred ecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHh
Confidence 5432111 1222345689999999998874 589999999999999999999999965433211000 0000000
Q ss_pred --------hhcc------cchh-hhcCccCCCC--------CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 220 --------LKDQ------KKFV-HLVDPLLHGR--------YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 220 --------~~~~------~~~~-~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
+... .... .......... .....+..+.+||.+||+.||.+|||++|+++.
T Consensus 261 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 261 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000 0000 0000000000 000114568899999999999999999999974
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=290.18 Aligned_cols=259 Identities=20% Similarity=0.220 Sum_probs=191.5
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeC-----CeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG-----DQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~ 73 (311)
...+|.|+||.||++.. +++.||||.+.... ......+.+|+++++.++||||+++++++..+ ...+++||+
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 95 (353)
T 2b9h_A 16 KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL 95 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECC
T ss_pred eeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEec
Confidence 56899999999999999 59999999986443 23345788999999999999999999987654 678999999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 153 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~ 153 (311)
+. ++|.+++.. ..+++..++.++.|++.||+|||+.| ++|+||+|+||+++.++.+||+|||++.......
T Consensus 96 ~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (353)
T 2b9h_A 96 MQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166 (353)
T ss_dssp CS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred cC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence 96 589999854 46899999999999999999999999 9999999999999999999999999987543221
Q ss_pred Ccc--------eeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCccccccch-hcc-----hh
Q 021526 154 NTH--------VSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-SWS-----RP 218 (311)
Q Consensus 154 ~~~--------~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~-----~~ 218 (311)
... ......|+..|+|||++.+ ..++.++|+||||+++|+|++|..||............ ... ..
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T 2b9h_A 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246 (353)
T ss_dssp -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTT
T ss_pred ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhc
Confidence 111 1122457999999998764 67899999999999999999999999754321100000 000 00
Q ss_pred hhh--cccchhhhcCccC---CC---CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 219 FLK--DQKKFVHLVDPLL---HG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 219 ~~~--~~~~~~~~~~~~~---~~---~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
... ......+...... .. .....++..+.++|.+||..||++|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp TTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000 0000000000000 00 001245677999999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=285.74 Aligned_cols=253 Identities=22% Similarity=0.272 Sum_probs=189.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeCCe------eEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ------RLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~ 71 (311)
...+|.|+||.||.+.. +|+.||||.+..... .....+.+|+.+++.++||||+++++++..... .+++|
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 108 (353)
T 3coi_A 29 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 108 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred eeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEe
Confidence 46799999999999998 699999999865432 234578899999999999999999999877654 49999
Q ss_pred ecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCC
Q 021526 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 151 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~ 151 (311)
|++. ++|.+++. ..+++..++.++.|++.||+|||+.| ++|+||+|+||+++.++.+||+|||++.....
T Consensus 109 e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 109 PFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp ECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred cccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 9996 58877773 34899999999999999999999999 99999999999999999999999999874321
Q ss_pred CCCcceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCcccccc-chhc----chhhhhc--c
Q 021526 152 GDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSW----SRPFLKD--Q 223 (311)
Q Consensus 152 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~----~~~~~~~--~ 223 (311)
......++..|+|||++.+ ..++.++|+||||+++|+|++|..||.......... +... ....... .
T Consensus 179 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 179 -----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred -----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 1223457899999998876 678899999999999999999999997543211000 0000 0000000 0
Q ss_pred ---cchhhhcCccCC---CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 224 ---KKFVHLVDPLLH---GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 224 ---~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
............ .......+..+.++|.+||+.||++|||+.++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000000000 1122356778999999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=294.17 Aligned_cols=247 Identities=20% Similarity=0.209 Sum_probs=181.1
Q ss_pred eeeeeceeccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 3 CCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
.++|.|+||.|+.... +|+.||||.+... ..+.+.+|+++++.+ +||||+++++++.++...++|||++. ++|.
T Consensus 21 ~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~ 96 (434)
T 2rio_A 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ 96 (434)
T ss_dssp EEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHH
T ss_pred CeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHH
Confidence 5799999999965544 8999999998643 345678899999876 89999999999999999999999996 5999
Q ss_pred HHhcccCCCCCC---CCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCC-------------CceEEeecC
Q 021526 81 DHLYDLEPDQEP---LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-------------FNPKLSDFG 144 (311)
Q Consensus 81 ~~l~~~~~~~~~---l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~-------------~~vkl~Df~ 144 (311)
+++......... ..+..++.++.|++.||+|||+.+ ++|+||||+|||++.+ +.+||+|||
T Consensus 97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG 173 (434)
T 2rio_A 97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173 (434)
T ss_dssp HHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence 999653322111 123345789999999999999999 9999999999999754 479999999
Q ss_pred CCccCCCCCCcc--eeeeccccccccCCccccC-------CCCCccccchhHHHHHHHHHh-CCCCccccCccccccchh
Q 021526 145 LAKLGPVGDNTH--VSTRVMGTYGYCAPEYAMS-------GKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVS 214 (311)
Q Consensus 145 ~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~-------~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~ 214 (311)
++.......... ......|++.|+|||++.+ ..++.++|||||||++|+|++ |..||........
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~----- 248 (434)
T 2rio_A 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES----- 248 (434)
T ss_dssp TCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH-----
T ss_pred cceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH-----
Confidence 997643322111 1223568999999999865 568899999999999999999 8999853321110
Q ss_pred cchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 215 WSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
........ .+..........+.++.++|.+||+.||.+|||+.++++
T Consensus 249 ---~i~~~~~~-----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 ---NIIRGIFS-----LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ---HHHHTCCC-----CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHhcCCCC-----cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 01110000 001111123567889999999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=284.76 Aligned_cols=233 Identities=22% Similarity=0.265 Sum_probs=192.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc------chhHHHHHHHHHhcCC--CCcccceeEEEEeCCeeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ------GHQEFIVEVLMLSLLH--HDNLVTLIGYCTSGDQRLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~ 71 (311)
...+|+|+||.||++.. +++.||||.+...... ....+.+|+.+++.++ ||||+++++++.++...++++
T Consensus 48 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~ 127 (320)
T 3a99_A 48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 127 (320)
T ss_dssp EEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEE
Confidence 46899999999999998 7899999998765332 2356778999999996 599999999999999999999
Q ss_pred ecCCC-CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEc-CCCceEEeecCCCccC
Q 021526 72 EYMPM-GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAKLG 149 (311)
Q Consensus 72 e~~~~-~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~-~~~~vkl~Df~~~~~~ 149 (311)
|++.+ ++|.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++ +++.+||+|||++...
T Consensus 128 e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~ 200 (320)
T 3a99_A 128 ERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL 200 (320)
T ss_dssp ECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCcccccc
Confidence 99976 899999954 457899999999999999999999999 99999999999999 7889999999998754
Q ss_pred CCCCCcceeeeccccccccCCccccCCCC-CccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhh
Q 021526 150 PVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 228 (311)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
... ......|+..|+|||++.+..+ +.++|+||||+++|+|++|..||..... .....
T Consensus 201 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------------~~~~~----- 259 (320)
T 3a99_A 201 KDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQ----- 259 (320)
T ss_dssp CSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHHCC-----
T ss_pred ccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------------hhccc-----
Confidence 321 1223458999999998876665 6889999999999999999999853210 00000
Q ss_pred hcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 229 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 229 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..++..++..+.++|.+||+.||++|||++++++
T Consensus 260 -------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 260 -------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0112334667999999999999999999999986
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=272.95 Aligned_cols=234 Identities=15% Similarity=0.074 Sum_probs=179.7
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc---chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
...+|.|+||.||+++. .++.||||.+...... ..+.+.+|+..+..++||||+++++++.+++..++||||+++
T Consensus 36 ~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 115 (286)
T 3uqc_A 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRG 115 (286)
T ss_dssp EEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCE
T ss_pred EEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCC
Confidence 46899999999999999 4899999999765433 236788999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. . .....+..++.|++.||+|||++| ++|+||||+||+++.++.++|++++.
T Consensus 116 ~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~----------- 175 (286)
T 3uqc_A 116 GSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPAT----------- 175 (286)
T ss_dssp EEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCC-----------
T ss_pred CCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEeccc-----------
Confidence 999999943 2 355678889999999999999999 99999999999999999999984432
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
++ .++.++||||||+++|+|++|..||............. ...........
T Consensus 176 -----------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---~~~~~~~~~~~-------- 226 (286)
T 3uqc_A 176 -----------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---RDTAGQPIEPA-------- 226 (286)
T ss_dssp -----------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---BCTTSCBCCHH--------
T ss_pred -----------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---HHhccCCCChh--------
Confidence 22 36889999999999999999999997544322110000 00000000000
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCCCCCC
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSR 285 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~~~~~~ 285 (311)
.....++..+.++|.+||+.||++| |+.++++.|+++...........
T Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~~~~~~ 274 (286)
T 3uqc_A 227 DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVADRTEVLG 274 (286)
T ss_dssp HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---------
T ss_pred hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCCccCCCC
Confidence 0112456779999999999999999 99999999999887665444443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=286.20 Aligned_cols=192 Identities=26% Similarity=0.259 Sum_probs=161.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCC-CC-----cccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HD-----NLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~~~~~~~~~lv~e~ 73 (311)
..++|+|+||.||++.. +++.||||++... ......+.+|+.+++.++ |+ +++++++++..+...++|||+
T Consensus 59 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 137 (382)
T 2vx3_A 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEM 137 (382)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEec
Confidence 46899999999999998 6899999998643 233456777888887775 44 499999999999999999999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh--CCCCCeeecCCCCCcEEEc--CCCceEEeecCCCccC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC--KANPPVIYRDLKSANILLD--NDFNPKLSDFGLAKLG 149 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~--~~~~~i~H~di~p~nil~~--~~~~vkl~Df~~~~~~ 149 (311)
+. ++|.+++.. .....+++..+..++.|++.||.|||+ .+ |+|+||||+|||++ .++.+||+|||++...
T Consensus 138 ~~-~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~ 211 (382)
T 2vx3_A 138 LS-YNLYDLLRN--TNFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 211 (382)
T ss_dssp CC-CBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred CC-CCHHHHHhh--cCcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence 96 599999976 233568999999999999999999994 66 99999999999994 5778999999999754
Q ss_pred CCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccC
Q 021526 150 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 205 (311)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 205 (311)
... .....+++.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 212 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 212 GQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp TCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 221 223468899999999999999999999999999999999999997543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=283.30 Aligned_cols=256 Identities=16% Similarity=0.174 Sum_probs=192.2
Q ss_pred eeeeeeceeccEEEEEE--C-CeEEEEEEeccCCccchhHHHHHHHHHhcCCCCc------ccceeEEEEeCCeeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL--C-DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN------LVTLIGYCTSGDQRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~~~~~~~lv~e 72 (311)
...+|+|+||.||++.. . ++.||+|++... ....+.+.+|+++++.++|++ ++.+++++......++|||
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e 102 (355)
T 2eu9_A 24 VGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFE 102 (355)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEE
T ss_pred EEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEe
Confidence 56899999999999998 3 479999998643 334567888999998887654 8899999999999999999
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEE-------------------c
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL-------------------D 133 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~-------------------~ 133 (311)
++ ++++.+++.. .....+++..++.++.|++.||+|||+.+ ++|+||||+||++ +
T Consensus 103 ~~-~~~l~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~ 176 (355)
T 2eu9_A 103 LL-GKNTFEFLKE--NNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176 (355)
T ss_dssp CC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCEEEE
T ss_pred cc-CCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccccccccc
Confidence 99 6677777754 23357999999999999999999999999 9999999999999 6
Q ss_pred CCCceEEeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccch
Q 021526 134 NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV 213 (311)
Q Consensus 134 ~~~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 213 (311)
.++.+||+|||++...... .....|+..|+|||++.+..++.++|+||||+++|+|++|..||............
T Consensus 177 ~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 251 (355)
T 2eu9_A 177 KNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMM 251 (355)
T ss_dssp SCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 6789999999998753221 23346899999999999999999999999999999999999999754322110000
Q ss_pred hc-----chhhhhccc--------------------chhhhcCccC-CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 021526 214 SW-----SRPFLKDQK--------------------KFVHLVDPLL-HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 267 (311)
Q Consensus 214 ~~-----~~~~~~~~~--------------------~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l 267 (311)
.. ......... .......+.. ........+..+.++|.+||+.||++|||+.++
T Consensus 252 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~ 331 (355)
T 2eu9_A 252 EKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEA 331 (355)
T ss_dssp HHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHH
Confidence 00 000000000 0000000000 001123456789999999999999999999999
Q ss_pred HH
Q 021526 268 VV 269 (311)
Q Consensus 268 ~~ 269 (311)
++
T Consensus 332 l~ 333 (355)
T 2eu9_A 332 LL 333 (355)
T ss_dssp TT
T ss_pred hc
Confidence 85
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=292.30 Aligned_cols=243 Identities=21% Similarity=0.188 Sum_probs=179.6
Q ss_pred eeeeeeceecc-EEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYN-VGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~-v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
..++|.|+||. ++.+..+++.||||.+.... ...+.+|+++++.+ +||||+++++++.++...++|||++. ++|
T Consensus 29 ~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L 104 (432)
T 3p23_A 29 KDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATL 104 (432)
T ss_dssp EEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEH
T ss_pred CCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCH
Confidence 36899999998 45555589999999986433 23467899999998 79999999999999999999999996 599
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcC-----CCceEEeecCCCccCCCCCC
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-----DFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~-----~~~vkl~Df~~~~~~~~~~~ 154 (311)
.+++... ...+....++.++.|++.||+|||+.+ |+|+||||+||+++. ...++|+|||++........
T Consensus 105 ~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 105 QEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp HHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred HHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 9999652 233444456789999999999999999 999999999999943 23578999999875432211
Q ss_pred c-ceeeeccccccccCCccccC---CCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhh
Q 021526 155 T-HVSTRVMGTYGYCAPEYAMS---GKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 229 (311)
Q Consensus 155 ~-~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
. .......|++.|+|||++.+ ..++.++|||||||++|+|++ |..||........ ........
T Consensus 179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~--------~~~~~~~~---- 246 (432)
T 3p23_A 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA--------NILLGACS---- 246 (432)
T ss_dssp -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH--------HHHTTCCC----
T ss_pred ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH--------HHHhccCC----
Confidence 1 12233568999999999873 567789999999999999999 8889852221100 00000000
Q ss_pred cCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 230 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 230 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.............+.++|.+||+.||.+|||+.++++
T Consensus 247 ---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 247 ---LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ---CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0000112345667899999999999999999999984
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=279.65 Aligned_cols=244 Identities=25% Similarity=0.287 Sum_probs=174.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc-ch-hHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ-GH-QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~-~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
+..+|.|+||.||++.. +++.||||.+...... .. +.+.++..+++.++||||+++++++.++...++|||++ +.
T Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 108 (318)
T 2dyl_A 30 LGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GT 108 (318)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SE
T ss_pred cceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CC
Confidence 46799999999999999 6899999998755332 22 23444555678889999999999999999999999999 55
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~-~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
.+...... ....+++..++.++.|++.||.|||++ | ++|+||+|+||+++.++.++|+|||++...... .
T Consensus 109 ~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~---~ 179 (318)
T 2dyl_A 109 CAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD---K 179 (318)
T ss_dssp EHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred cHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCC---c
Confidence 55555533 246789999999999999999999995 8 999999999999999999999999998643221 1
Q ss_pred eeeeccccccccCCcccc-----CCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcC
Q 021526 157 VSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
......++..|+|||++. ...++.++||||||+++|+|++|..||........ ......... .
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~~~-------~ 247 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE-----VLTKVLQEE-------P 247 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-----HHHHHHHSC-------C
T ss_pred cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH-----HHHHHhccC-------C
Confidence 223346889999999984 45678899999999999999999999964221100 000111100 0
Q ss_pred ccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
+.. .....++..+.++|.+||..||.+||+++++++
T Consensus 248 ~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 PLL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 001 011234677999999999999999999999987
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=283.62 Aligned_cols=233 Identities=23% Similarity=0.306 Sum_probs=186.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc------chhHHHHHHHHHhcC----CCCcccceeEEEEeCCeeEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ------GHQEFIVEVLMLSLL----HHDNLVTLIGYCTSGDQRLL 69 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l----~h~~i~~~~~~~~~~~~~~l 69 (311)
...+|.|+||.||++.. +++.||+|.+...... ....+.+|+.++..+ +||||+++++++.+++..++
T Consensus 36 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~ 115 (312)
T 2iwi_A 36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFML 115 (312)
T ss_dssp EEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEE
T ss_pred eeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEE
Confidence 46899999999999988 7899999998755332 234566788888888 89999999999999899999
Q ss_pred EEec-CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEc-CCCceEEeecCCCc
Q 021526 70 VYEY-MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAK 147 (311)
Q Consensus 70 v~e~-~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~-~~~~vkl~Df~~~~ 147 (311)
++|+ +.+++|.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++ .++.++|+|||++.
T Consensus 116 v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg~~~ 188 (312)
T 2iwi_A 116 VLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGA 188 (312)
T ss_dssp EEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCCSSCE
T ss_pred EEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEcchhh
Confidence 9999 788999999954 346899999999999999999999999 99999999999999 88999999999987
Q ss_pred cCCCCCCcceeeeccccccccCCccccCCCCC-ccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccch
Q 021526 148 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT-LKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 226 (311)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
..... ......++..|+|||++.+..+. .++|+||||+++|+|++|..||..... ...
T Consensus 189 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------~~~----- 247 (312)
T 2iwi_A 189 LLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------------ILE----- 247 (312)
T ss_dssp ECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHH-----
T ss_pred hcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------------Hhh-----
Confidence 54322 12334588999999988766654 589999999999999999999862210 000
Q ss_pred hhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 227 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
. ...++..++..+.++|.+||..||++|||++++++
T Consensus 248 -----~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 248 -----A--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -----T--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----h--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 01123445677999999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=301.60 Aligned_cols=269 Identities=25% Similarity=0.222 Sum_probs=201.0
Q ss_pred CeeeeeeceeccEEEEEE--CCeEEEEEEeccC-CccchhHHHHHHHHHhcCCCCcccceeEEEEe------CCeeEEEE
Q 021526 1 MLCCYLSCKFYNVGLVWL--CDQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS------GDQRLLVY 71 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~ 71 (311)
+...+|.|+||.||.+.. +++.||||.+... .....+.+.+|+++++.++||||+++++++.. +...++||
T Consensus 18 i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVm 97 (676)
T 3qa8_A 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAM 97 (676)
T ss_dssp CCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEE
T ss_pred EEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEE
Confidence 357899999999999998 7899999998654 23345678899999999999999999998755 66789999
Q ss_pred ecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCc---eEEeecCCCcc
Q 021526 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN---PKLSDFGLAKL 148 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~---vkl~Df~~~~~ 148 (311)
||+++++|.+++.... ....+++..++.++.|++.||+|||+.| ++|+||+|+||+++.++. ++|+|||.+..
T Consensus 98 Ey~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~ 173 (676)
T 3qa8_A 98 EYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE 173 (676)
T ss_dssp ECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCCCCB
T ss_pred EeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccccccc
Confidence 9999999999997532 2346888999999999999999999999 999999999999987765 89999999975
Q ss_pred CCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccc--cchh------cchhhh
Q 021526 149 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ--NLVS------WSRPFL 220 (311)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--~~~~------~~~~~~ 220 (311)
.... .......|+..|+|||++.+..++.++|+||||+++|+|++|..||......... .... ......
T Consensus 174 ~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l 250 (676)
T 3qa8_A 174 LDQG---ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250 (676)
T ss_dssp TTSC---CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCC
T ss_pred cccc---cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhh
Confidence 4322 2223456899999999999999999999999999999999999999643211000 0000 000000
Q ss_pred hcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHH-----HHHHHHhhhcc
Q 021526 221 KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI-----VVALDYLVSQR 278 (311)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l-----~~~L~~l~~~~ 278 (311)
.....+.. ........+...+..+.++|.+||..||++|||+.++ .+.++.+....
T Consensus 251 ~g~~~~~~--~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 251 TGAVKFSS--VLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp SSSCCCCS--SSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred cccccccc--ccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 00000000 0011123445678899999999999999999999884 45566655544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=287.36 Aligned_cols=235 Identities=16% Similarity=0.124 Sum_probs=174.3
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHHHHHHHHhcCCC-Ccc---------ccee---------
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHH-DNL---------VTLI--------- 58 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h-~~i---------~~~~--------- 58 (311)
.++|+|+||.||++.. +|+.||||++..... ...+.+.+|+.+++.++| ++. +...
T Consensus 84 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (413)
T 3dzo_A 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 163 (413)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC--
T ss_pred cccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCC
Confidence 5799999999999998 699999999874332 235678899999999876 221 1111
Q ss_pred ---EEEEe-----CCeeEEEEecCCCCCHHHHhccc---CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCC
Q 021526 59 ---GYCTS-----GDQRLLVYEYMPMGSLEDHLYDL---EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 127 (311)
Q Consensus 59 ---~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p 127 (311)
.++.. ....+++|+.+ +++|.+++... ......+++..++.++.|++.||+|||+++ |+||||||
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDiKp 239 (413)
T 3dzo_A 164 KMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRP 239 (413)
T ss_dssp -------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCG
T ss_pred ccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCccc
Confidence 11111 22457777766 67999888522 223556788899999999999999999999 99999999
Q ss_pred CcEEEcCCCceEEeecCCCccCCCCCCcceeeeccccccccCCccc----------cCCCCCccccchhHHHHHHHHHhC
Q 021526 128 ANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA----------MSGKLTLKSDIYSFGVVLLELITG 197 (311)
Q Consensus 128 ~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~----------~~~~~~~~~Dv~slG~~l~~l~~g 197 (311)
+|||++.++.+||+|||++..... ......| ..|+|||++ .+..++.++|||||||++|+|++|
T Consensus 240 ~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg 313 (413)
T 3dzo_A 240 VDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313 (413)
T ss_dssp GGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHS
T ss_pred ceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHC
Confidence 999999999999999999874321 1334556 899999998 555688899999999999999999
Q ss_pred CCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 198 RKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 198 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..||......... ...+.. ...++..+.++|.+||+.||++||++.++++
T Consensus 314 ~~Pf~~~~~~~~~----------------~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 314 DLPNTDDAALGGS----------------EWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp SCCCCTTGGGSCS----------------GGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCcchhhhH----------------HHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999643321110 000100 0123467999999999999999999766654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=267.50 Aligned_cols=220 Identities=19% Similarity=0.223 Sum_probs=174.8
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHH-hcCCCCcccceeEEEEe----CCeeEEEEecCC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLML-SLLHHDNLVTLIGYCTS----GDQRLLVYEYMP 75 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~ 75 (311)
.++|.|+||.||.+.. +++.||+|.+.. ...+.+|++++ +..+||||+++++++.. +...++||||++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 98 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 98 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence 5699999999999999 789999999853 25677888888 66689999999999876 677899999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcC---CCceEEeecCCCccCCCC
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN---DFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~---~~~vkl~Df~~~~~~~~~ 152 (311)
+++|.+++.. .....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++. ++.++|+|||++...
T Consensus 99 ~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~--- 170 (299)
T 3m2w_A 99 GGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET--- 170 (299)
T ss_dssp SCBHHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC---
T ss_pred CCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccccccc---
Confidence 9999999976 23457999999999999999999999999 999999999999988 788999999988532
Q ss_pred CCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCc
Q 021526 153 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 232 (311)
Q Consensus 153 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
.+..++.++|+||||+++|+|++|..||............ . ......
T Consensus 171 ---------------------~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~--~----------~~~~~~ 217 (299)
T 3m2w_A 171 ---------------------TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--K----------TRIRMG 217 (299)
T ss_dssp ---------------------TTCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS--C----------CSSCTT
T ss_pred ---------------------ccccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH--H----------HHHhhc
Confidence 1245678999999999999999999999643321110000 0 000000
Q ss_pred cCCCCCc----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 233 LLHGRYP----RRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 233 ~~~~~~~----~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
....+ ..++..+.++|.+||..||.+|||+.++++.
T Consensus 218 --~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 218 --QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp --CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00111 2356789999999999999999999999973
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=298.90 Aligned_cols=234 Identities=21% Similarity=0.262 Sum_probs=186.5
Q ss_pred eeeeeeceeccEEEEEE---CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCe-----eEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL---CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ-----RLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~~lv~e 72 (311)
...+|.|+||.||+++. +++.||||.+.... ......+.+|+++++.++||||+++++++..... .++|||
T Consensus 85 ~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E 164 (681)
T 2pzi_A 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVME 164 (681)
T ss_dssp EEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEE
T ss_pred EEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEE
Confidence 46799999999999998 58999999986443 2344578899999999999999999999987655 799999
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCC
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~ 152 (311)
|+++++|.+++. ..+++..++.++.||+.+|.|||++| |+|+||||+|||++.+ .+||+|||++......
T Consensus 165 ~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 165 YVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp CCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred eCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 999999988763 26899999999999999999999999 9999999999999875 8999999998754322
Q ss_pred CCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCc
Q 021526 153 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 232 (311)
Q Consensus 153 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
....|++.|+|||++.+.. +.++||||||+++|+|++|.+||........
T Consensus 235 ------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------------------- 284 (681)
T 2pzi_A 235 ------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------------------- 284 (681)
T ss_dssp ------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----------------------
T ss_pred ------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc-----------------------
Confidence 3356899999999887654 8899999999999999999988752111000
Q ss_pred cCCCCCcHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHhhh
Q 021526 233 LLHGRYPRRCLNYAVAVTAMCLNEEANFRP-LINDIVVALDYLVS 276 (311)
Q Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-s~~~l~~~L~~l~~ 276 (311)
.........+..+.++|.+||+.||++|| +++++.+.|..+..
T Consensus 285 -~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 285 -PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp -CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred -cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 00001123456789999999999999999 56667766766543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=270.65 Aligned_cols=234 Identities=17% Similarity=0.092 Sum_probs=178.2
Q ss_pred eeeeeeceeccEEEEEECCeEEEEEEeccCCc--------cchhHHHHHHHHHhcCC---------CCcccceeEEE---
Q 021526 2 LCCYLSCKFYNVGLVWLCDQLVAIKQLNHEGL--------QGHQEFIVEVLMLSLLH---------HDNLVTLIGYC--- 61 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~---------h~~i~~~~~~~--- 61 (311)
...+|+|+||.||++..+++.||||.+..... ...+.+.+|+.+++.++ ||||+++.+++
T Consensus 25 ~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~ 104 (336)
T 2vuw_A 25 CEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQ 104 (336)
T ss_dssp CEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEE
T ss_pred eeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEec
Confidence 57899999999999999999999999876532 23367889999888875 66666666653
Q ss_pred --------------Ee-------------CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHh-
Q 021526 62 --------------TS-------------GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH- 113 (311)
Q Consensus 62 --------------~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh- 113 (311)
.+ +...++||||+++|++.+.+. ...+++..++.++.||+.||+|||
T Consensus 105 ~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~~aL~~lH~ 179 (336)
T 2vuw_A 105 GSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLTASLAVAEA 179 (336)
T ss_dssp SSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH
Confidence 22 678999999999998777773 256899999999999999999999
Q ss_pred hCCCCCeeecCCCCCcEEEcCCC--------------------ceEEeecCCCccCCCCCCcceeeeccccccccCCccc
Q 021526 114 CKANPPVIYRDLKSANILLDNDF--------------------NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 173 (311)
Q Consensus 114 ~~~~~~i~H~di~p~nil~~~~~--------------------~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 173 (311)
+.+ |+||||||+|||++.++ .+||+|||+++.... ....|++.|+|||++
T Consensus 180 ~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 180 SLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDEDLF 249 (336)
T ss_dssp HHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSGGG
T ss_pred hCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChhhh
Confidence 899 99999999999999887 899999999975322 134689999999999
Q ss_pred cCCCCCccccchhHHHH-HHHHHhCCCCccccCccccccchhcchhhhhcccchhhh--cCccCCCCCcHHHHHHHHHHH
Q 021526 174 MSGKLTLKSDIYSFGVV-LLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL--VDPLLHGRYPRRCLNYAVAVT 250 (311)
Q Consensus 174 ~~~~~~~~~Dv~slG~~-l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li 250 (311)
.+.. +.++|||||+++ .++++.|..||... .|...... .+... .........+...+.++.+||
T Consensus 250 ~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~~~~---~~~~~~~~~~~~~~~~~~~~s~~~~dli 316 (336)
T 2vuw_A 250 TGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHYLTD---KMLKQMTFKTKCNTPAMKQIKRKIQEFH 316 (336)
T ss_dssp CCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHHHHH---HHHHTCCCSSCCCSHHHHHHHHHHHHHH
T ss_pred cCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhHHHH---hhhhhhccCcccchhhhhhcCHHHHHHH
Confidence 8766 889999998777 77788898888410 01000000 00000 000111112346788999999
Q ss_pred HHhhccCCCCCCCHHHHH
Q 021526 251 AMCLNEEANFRPLINDIV 268 (311)
Q Consensus 251 ~~~l~~~p~~RPs~~~l~ 268 (311)
.+||+.| |++|++
T Consensus 317 ~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 317 RTMLNFS-----SATDLL 329 (336)
T ss_dssp HHGGGSS-----SHHHHH
T ss_pred HHHhccC-----CHHHHH
Confidence 9999976 898887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=246.66 Aligned_cols=183 Identities=16% Similarity=0.087 Sum_probs=128.4
Q ss_pred eeceeccEEEEEE--CCeEEEEEEeccCCc----------cchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEe
Q 021526 6 LSCKFYNVGLVWL--CDQLVAIKQLNHEGL----------QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYE 72 (311)
Q Consensus 6 ~~g~~~~v~~~~~--~~~~vaiK~~~~~~~----------~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 72 (311)
++|+.+.++.++- .|+.+++|.+.+... ...+++.+|+++|+++ .|+||++++++++++...|||||
T Consensus 243 ~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVME 322 (569)
T 4azs_A 243 YAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVME 322 (569)
T ss_dssp C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEE
T ss_pred ccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEe
Confidence 3444555554443 689999999875421 1235689999999999 69999999999999999999999
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCC
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~ 152 (311)
|++|++|.+++.. .+.++.. +++.||+.||+|+|++| |+||||||+|||++.+|.+||+|||+++.....
T Consensus 323 yv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 323 KLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp CCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred cCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 9999999999954 4566654 47899999999999999 999999999999999999999999998753222
Q ss_pred CCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCc
Q 021526 153 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 201 (311)
Q Consensus 153 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 201 (311)
........||+.|+|||++.+ .+..++|+|++|++++.+.++..++
T Consensus 393 --~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 393 --CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred --CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 222334679999999998865 4567899999999988776665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.5e-27 Score=217.10 Aligned_cols=182 Identities=18% Similarity=0.158 Sum_probs=144.2
Q ss_pred eeeeeceeccEEEEEECCeEEEEEEeccCCccc--------hhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 3 CCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQG--------HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
.++|+|+||.||++...++.+++|......... .+.+.+|+++++.++||||+++..++..+...++||||+
T Consensus 342 ~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~ 421 (540)
T 3en9_A 342 HLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYI 421 (540)
T ss_dssp ------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECC
T ss_pred CEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECC
Confidence 478999999999998899999999865432221 234789999999999999996666666777889999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
++++|.+++.. +..++.|++.+|.|||+++ |+|+||||+|||++. .+||+|||+++.......
T Consensus 422 ~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 422 NGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp CSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred CCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 99999999953 4689999999999999999 999999999999998 999999999986432211
Q ss_pred cc-----eeeeccccccccCCccccC--CCCCccccchhHHHHHHHHHhCCCCc
Q 021526 155 TH-----VSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGRKAM 201 (311)
Q Consensus 155 ~~-----~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~ 201 (311)
.. ......||+.|+|||++.. ..|+...|+|+..+-..+-+-++.+|
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 11 1134578999999999987 56788899999998888887776655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4e-23 Score=175.62 Aligned_cols=126 Identities=11% Similarity=-0.019 Sum_probs=104.3
Q ss_pred eeeeeceeccEEEEEE-CCeEEEEEEeccCCcc------------------chhHHHHHHHHHhcCCCCcccceeEEEEe
Q 021526 3 CCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQ------------------GHQEFIVEVLMLSLLHHDNLVTLIGYCTS 63 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~------------------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 63 (311)
..+|+|++|.||.+.. +|+.||+|.+...... ....+.+|+++++.++ | +++.+++..
T Consensus 96 ~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~ 172 (282)
T 1zar_A 96 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW 172 (282)
T ss_dssp EEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE
T ss_pred CEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec
Confidence 7899999999999999 7899999998643221 2356889999999998 4 666665544
Q ss_pred CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeec
Q 021526 64 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 143 (311)
Q Consensus 64 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df 143 (311)
+..++||||+++++|.+ +.. .....++.|++.||.+||+.| ++|+||||+|||++ ++.++|+||
T Consensus 173 -~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 173 -EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp -ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECCC
T ss_pred -cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEEC
Confidence 45699999999999988 521 123569999999999999999 99999999999999 999999999
Q ss_pred CCCc
Q 021526 144 GLAK 147 (311)
Q Consensus 144 ~~~~ 147 (311)
|++.
T Consensus 237 G~a~ 240 (282)
T 1zar_A 237 PQSV 240 (282)
T ss_dssp TTCE
T ss_pred CCCe
Confidence 9986
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=6.6e-19 Score=147.72 Aligned_cols=131 Identities=17% Similarity=0.010 Sum_probs=101.4
Q ss_pred eeeeeeceeccEEEEEE--CCeE--EEEEEeccCCccc------------------------hhHHHHHHHHHhcCCCCc
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQL--VAIKQLNHEGLQG------------------------HQEFIVEVLMLSLLHHDN 53 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~--vaiK~~~~~~~~~------------------------~~~~~~e~~~l~~l~h~~ 53 (311)
...+|+|++|.||.+.. +|+. ||||++....... ...+.+|+..+..++|++
T Consensus 52 ~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 131 (258)
T 1zth_A 52 GGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAG 131 (258)
T ss_dssp EEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCC
Confidence 35799999999999998 8989 9999875432110 125788999999998876
Q ss_pred c--cceeEEEEeCCeeEEEEecCCC-C----CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeeecCC
Q 021526 54 L--VTLIGYCTSGDQRLLVYEYMPM-G----SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH-CKANPPVIYRDL 125 (311)
Q Consensus 54 i--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh-~~~~~~i~H~di 125 (311)
+ ..++.. ...++||||+.+ | +|.+.... .++..+..++.|++.++.+|| +.| ++|+||
T Consensus 132 i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDl 197 (258)
T 1zth_A 132 VSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE---LVHADL 197 (258)
T ss_dssp CCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSC
T ss_pred CCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCC
Confidence 4 333332 356899999932 3 67776532 123456789999999999999 999 999999
Q ss_pred CCCcEEEcCCCceEEeecCCCcc
Q 021526 126 KSANILLDNDFNPKLSDFGLAKL 148 (311)
Q Consensus 126 ~p~nil~~~~~~vkl~Df~~~~~ 148 (311)
||.|||++. .++|+|||++..
T Consensus 198 kp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEE
T ss_pred CHHHEEEcC--cEEEEECccccc
Confidence 999999988 899999999863
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=3.4e-16 Score=136.86 Aligned_cols=131 Identities=12% Similarity=0.025 Sum_probs=93.4
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCc-----c---------chh--------HHHHHHHHHhcCCCCccccee
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGL-----Q---------GHQ--------EFIVEVLMLSLLHHDNLVTLI 58 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~-----~---------~~~--------~~~~e~~~l~~l~h~~i~~~~ 58 (311)
...+|.|++|.||.+.. +|+.||||++..... . ... ...+|...|..+.+.++.-..
T Consensus 100 ~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~ 179 (397)
T 4gyi_A 100 GSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPE 179 (397)
T ss_dssp EEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCC
T ss_pred cCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCe
Confidence 46799999999999998 899999998753211 0 001 123466666666544432211
Q ss_pred EEEEeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCC--
Q 021526 59 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-- 136 (311)
Q Consensus 59 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~-- 136 (311)
-+... ..++||||++|.+|.+.... .....++.|++.++.+||..| ++||||||.|||+++++
T Consensus 180 p~~~~--~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 180 PIAQS--RHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp EEEEE--TTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECS
T ss_pred eeecc--CceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCc
Confidence 11112 23799999999888655421 123567899999999999999 99999999999998776
Q ss_pred --------ceEEeecCCCc
Q 021526 137 --------NPKLSDFGLAK 147 (311)
Q Consensus 137 --------~vkl~Df~~~~ 147 (311)
.+.++||+.+.
T Consensus 245 ~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp SCTTSEEEEEEECCCTTCE
T ss_pred ccccccccceEEEEeCCcc
Confidence 38999999775
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=2.4e-12 Score=107.83 Aligned_cols=135 Identities=13% Similarity=-0.018 Sum_probs=104.4
Q ss_pred eeeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcCC-CCcccceeEEEEeCCeeEEEEecCCCCCHHHH
Q 021526 4 CYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDH 82 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 82 (311)
..+.|+...||+....++.+++|............+.+|+++++.+. +..+.++++++.+++..+++||+++|.+|.+.
T Consensus 21 ~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 100 (263)
T 3tm0_A 21 DTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE 100 (263)
T ss_dssp CCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred eccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhc
Confidence 34556678899998888999999986532234457889999998885 66788899999888899999999999999876
Q ss_pred hcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC----------------------------------------------
Q 021526 83 LYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA---------------------------------------------- 116 (311)
Q Consensus 83 l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~---------------------------------------------- 116 (311)
+.. ......++.+++.+++.||+..
T Consensus 101 ~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 171 (263)
T 3tm0_A 101 YED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELY 171 (263)
T ss_dssp CCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHH
T ss_pred cCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHH
Confidence 411 0122467889999999999810
Q ss_pred ----------CCCeeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 117 ----------NPPVIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 117 ----------~~~i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
...++|+|++|.||++++++.+.|+||+.+.
T Consensus 172 ~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 172 DFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 0228999999999999876556799998774
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.18 E-value=1.5e-10 Score=101.39 Aligned_cols=140 Identities=13% Similarity=0.111 Sum_probs=103.6
Q ss_pred eeeeeceeccEEEEEECCeEEEEEEec--cCC-ccchhHHHHHHHHHhcCCC--CcccceeEEEEeC---CeeEEEEecC
Q 021526 3 CCYLSCKFYNVGLVWLCDQLVAIKQLN--HEG-LQGHQEFIVEVLMLSLLHH--DNLVTLIGYCTSG---DQRLLVYEYM 74 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~~~~~vaiK~~~--~~~-~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~---~~~~lv~e~~ 74 (311)
..++.|.+..+|.....+..+++|... ... ......+.+|+.+++.+.. ..+.+++.++.+. +..++|||++
T Consensus 44 ~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v 123 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFV 123 (359)
T ss_dssp EECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECC
T ss_pred EEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEec
Confidence 457788889999998878889999865 222 1234578889999988873 4577888887766 3478999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--------------------------------------
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA-------------------------------------- 116 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~-------------------------------------- 116 (311)
+|..+.+.. ...++......++.+++..|+.||+..
T Consensus 124 ~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 124 SGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp CCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred CCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 987664322 234677888889999999999999731
Q ss_pred -----------------CCCeeecCCCCCcEEEcCCCc--eEEeecCCCcc
Q 021526 117 -----------------NPPVIYRDLKSANILLDNDFN--PKLSDFGLAKL 148 (311)
Q Consensus 117 -----------------~~~i~H~di~p~nil~~~~~~--vkl~Df~~~~~ 148 (311)
...++|||+++.||+++.++. +.|+||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 133999999999999987653 68999998863
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.14 E-value=1.1e-10 Score=97.23 Aligned_cols=126 Identities=18% Similarity=0.106 Sum_probs=92.9
Q ss_pred eceeccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCc--ccceeEEEEeCCeeEEEEecCCCCCHHHHh
Q 021526 7 SCKFYNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN--LVTLIGYCTSGDQRLLVYEYMPMGSLEDHL 83 (311)
Q Consensus 7 ~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 83 (311)
.|..+.||.+.. +|+.+++|..... ....+.+|+.+++.+.+.+ +.+++.+...++..+++||+++|.++. .
T Consensus 30 gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~ 104 (264)
T 1nd4_A 30 GCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--S 104 (264)
T ss_dssp TTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--T
T ss_pred CCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--c
Confidence 455688999876 5678999996543 3356788999998885444 556888887777889999999998773 2
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----------------------------------------------
Q 021526 84 YDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA----------------------------------------------- 116 (311)
Q Consensus 84 ~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~----------------------------------------------- 116 (311)
.. .. ...++.+++..++.||+..
T Consensus 105 ~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (264)
T 1nd4_A 105 SH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 174 (264)
T ss_dssp SC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred Cc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence 11 11 1256677778888888642
Q ss_pred --------CCCeeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 117 --------NPPVIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 117 --------~~~i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
...++|+|++|.||++++++.+.|+||+.+.
T Consensus 175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999877666799999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.84 E-value=7.7e-10 Score=94.60 Aligned_cols=185 Identities=19% Similarity=0.158 Sum_probs=111.2
Q ss_pred eeeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcCC-CCc--ccceeEEEEeCC---eeEEEEecCCCC
Q 021526 4 CYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDN--LVTLIGYCTSGD---QRLLVYEYMPMG 77 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~--i~~~~~~~~~~~---~~~lv~e~~~~~ 77 (311)
.++.|....+|.. +..+++|.... ......+.+|++.++.+. +.. +.+++.....+. ..++||++++|.
T Consensus 27 ~~~~G~~n~v~~v---~~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~ 101 (304)
T 3sg8_A 27 ISGEGNDCIAYEI---NRDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGV 101 (304)
T ss_dssp EEEECSSEEEEES---TTSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCE
T ss_pred ecCCCCcceEEEE---CCEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCe
Confidence 3455655555553 46788998532 234467889999998773 332 334444433332 247899999998
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----------------------------------------
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA----------------------------------------- 116 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~----------------------------------------- 116 (311)
++.+... ..++......++.+++..++.||+..
T Consensus 102 ~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 102 PLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp ECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred ECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 7765332 23556666777788888888887511
Q ss_pred --------------CCCeeecCCCCCcEEEcC--CCceEEeecCCCccCCCCCCcceeeec---cc-------cccc--c
Q 021526 117 --------------NPPVIYRDLKSANILLDN--DFNPKLSDFGLAKLGPVGDNTHVSTRV---MG-------TYGY--C 168 (311)
Q Consensus 117 --------------~~~i~H~di~p~nil~~~--~~~vkl~Df~~~~~~~~~~~~~~~~~~---~~-------~~~~--~ 168 (311)
...++|+|++|.||+++. .+.+.++||+.+............... .+ ...| .
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~ 255 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK 255 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence 123899999999999988 556789999987642111000000000 00 0011 0
Q ss_pred C-CccccCCCCCccccchhHHHHHHHHHhCCCCc
Q 021526 169 A-PEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 201 (311)
Q Consensus 169 a-PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 201 (311)
. |+... ......+.|+++.++|.+.+|..+|
T Consensus 256 ~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 256 DIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 11100 0112258899999999999998876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=1.2e-06 Score=74.85 Aligned_cols=133 Identities=20% Similarity=0.143 Sum_probs=86.7
Q ss_pred eeeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcCCCC---cccceeEEEE-eCCeeEEEEecCCCCCH
Q 021526 4 CYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHD---NLVTLIGYCT-SGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~-~~~~~~lv~e~~~~~~L 79 (311)
.++.|....+|.. ++.+++|+- ........+.+|+++++.+.+. .+.+++.+.. .++..+++|++++|.++
T Consensus 26 ~l~~G~~n~v~~v---g~~~VlR~~--~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l 100 (306)
T 3tdw_A 26 SLGEGFRNYAILV---NGDWVFRFP--KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQIL 100 (306)
T ss_dssp EEEECSSEEEEEE---TTTEEEEEE--SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEEC
T ss_pred ecCCCcceeEEEE---CCEEEEEec--CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeEC
Confidence 4555666667766 677888884 2233446788999999988642 3556666653 34557899999999877
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-------------------------------------------
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA------------------------------------------- 116 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~------------------------------------------- 116 (311)
.+... ..++......++.++...|+.||+..
T Consensus 101 ~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 101 GEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp HHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred chhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 66321 11233344444444554444444321
Q ss_pred --------------CCCeeecCCCCCcEEEcC---CCc-eEEeecCCCc
Q 021526 117 --------------NPPVIYRDLKSANILLDN---DFN-PKLSDFGLAK 147 (311)
Q Consensus 117 --------------~~~i~H~di~p~nil~~~---~~~-vkl~Df~~~~ 147 (311)
...++|+|++|.||+++. ++. +.|+||+.+.
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 223799999999999987 455 4899998875
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=1.2e-06 Score=73.20 Aligned_cols=125 Identities=17% Similarity=0.106 Sum_probs=89.3
Q ss_pred cEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCC-CCcccceeEEEEeCCeeEEEEecCCCCCHHHHhcccCC
Q 021526 12 NVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP 88 (311)
Q Consensus 12 ~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 88 (311)
.||+... ++..+++|.-.. .....+.+|+..|+.+. +-.+.+++.++.+++..++||++++|.++.+.....
T Consensus 40 ~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~-- 114 (272)
T 4gkh_A 40 TIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY-- 114 (272)
T ss_dssp EEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC--
T ss_pred eEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC--
Confidence 4777665 467899998542 23456888999988775 333678888888999999999999998877655321
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhhCC----------------------------------------------------
Q 021526 89 DQEPLSWNTRMKIAVGAARGLEYLHCKA---------------------------------------------------- 116 (311)
Q Consensus 89 ~~~~l~~~~~~~~~~~i~~~l~~Lh~~~---------------------------------------------------- 116 (311)
......+..++...|+.||...
T Consensus 115 ------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 188 (272)
T 4gkh_A 115 ------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLP 188 (272)
T ss_dssp ------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCC
T ss_pred ------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhccc
Confidence 0122345556666666666421
Q ss_pred ---CCCeeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 117 ---NPPVIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 117 ---~~~i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
...++|||+++.||+++.++.+-|+||+.+.
T Consensus 189 ~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 189 FSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp CCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 0227999999999999987777899998875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=1.1e-06 Score=76.67 Aligned_cols=75 Identities=7% Similarity=-0.043 Sum_probs=50.8
Q ss_pred eeceeccEEEEEEC--------CeEEEEEEeccCC---ccchhHHHHHHHHHhcCCC---CcccceeEEEEeC---CeeE
Q 021526 6 LSCKFYNVGLVWLC--------DQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHH---DNLVTLIGYCTSG---DQRL 68 (311)
Q Consensus 6 ~~g~~~~v~~~~~~--------~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~---~~~~ 68 (311)
+.|....+|..... ++.+++|...... ......+.+|+.+++.+.. -.+.+++.+..++ ...+
T Consensus 30 ~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~ 109 (357)
T 3ats_A 30 STGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPF 109 (357)
T ss_dssp TTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCE
T ss_pred CCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCce
Confidence 55667778887765 7789999854322 1123567888888887742 3466777776554 3468
Q ss_pred EEEecCCCCCHH
Q 021526 69 LVYEYMPMGSLE 80 (311)
Q Consensus 69 lv~e~~~~~~L~ 80 (311)
++||+++|..+.
T Consensus 110 ~v~e~l~G~~l~ 121 (357)
T 3ats_A 110 FLMDYVEGVVPP 121 (357)
T ss_dssp EEEECCCCBCCC
T ss_pred EEEEecCCCChh
Confidence 999999886654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.21 E-value=5.3e-06 Score=71.64 Aligned_cols=71 Identities=14% Similarity=0.234 Sum_probs=41.4
Q ss_pred eeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcCC-----CCccccee-E--EEEeCCeeEEEEecCCC
Q 021526 5 YLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-----HDNLVTLI-G--YCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 5 ~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~-~--~~~~~~~~~lv~e~~~~ 76 (311)
++.|....+|....++..+++|..... ...+..|+.+++.+. .|.++... + +...++..+++++|++|
T Consensus 40 l~gG~~n~~~~v~~~~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~G 115 (346)
T 2q83_A 40 IQGNQMALVWKVHTDSGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIEG 115 (346)
T ss_dssp CC----CEEEEEEETTEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCCC
T ss_pred ccccccCcEEEEEeCCCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeecC
Confidence 444668889998887777999998642 234445555555443 23333311 0 12346678999999988
Q ss_pred CCH
Q 021526 77 GSL 79 (311)
Q Consensus 77 ~~L 79 (311)
.++
T Consensus 116 ~~~ 118 (346)
T 2q83_A 116 RPF 118 (346)
T ss_dssp BCC
T ss_pred ccC
Confidence 543
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.15 E-value=2.4e-05 Score=65.99 Aligned_cols=72 Identities=18% Similarity=0.146 Sum_probs=51.8
Q ss_pred eeeeeceeccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCC---cccceeEEEEeCCeeEEEEecCCCCC
Q 021526 3 CCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHD---NLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
..+|.|....||+..+ +|+.|++|+-..........+..|+..|+.+... .+.+++.+ . ..+++||++++..
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEeecccC
Confidence 3578888999999999 7899999986555444455788899999887422 34455544 2 3478999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.06 E-value=2.5e-05 Score=69.07 Aligned_cols=73 Identities=12% Similarity=-0.066 Sum_probs=47.5
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCCc-------cchhHHHHHHHHHhcCCC--Cc-ccceeEEEEeCCeeEEE
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL-------QGHQEFIVEVLMLSLLHH--DN-LVTLIGYCTSGDQRLLV 70 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~~-i~~~~~~~~~~~~~~lv 70 (311)
..+|.|..+.||++.. +++.|++|....... .....+..|.++++.+.. +. +.+++.+ +....++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 4578888999999965 578999998643211 123456788888877642 33 4455543 34556899
Q ss_pred EecCCCC
Q 021526 71 YEYMPMG 77 (311)
Q Consensus 71 ~e~~~~~ 77 (311)
||++.+.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.97 E-value=9.2e-05 Score=63.07 Aligned_cols=73 Identities=21% Similarity=0.103 Sum_probs=57.2
Q ss_pred eeeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcCC---CCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 4 CYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH---HDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
.++.|.+..+|....+++.+++|..... ....+..|++.|+.+. ...+.+++.+...++..+++||++++..+
T Consensus 43 ~l~gG~~n~~y~v~~~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 43 KLYSGEMNEIWLINDEVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EECCSSSSEEEEEESSSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EeCCccceeeeEEEECCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 4667778889998888889999986532 3567888999888774 35677888888777889999999988654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.96 E-value=6.1e-05 Score=59.85 Aligned_cols=103 Identities=16% Similarity=0.070 Sum_probs=68.9
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
.+|.+.|.. .+.++.++++|.++.|.+.+|..+-.+.. -...=+.|..|++..+|.|-+.+ ..+.
T Consensus 33 vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc---------
Confidence 478888865 67899999999999999999887732211 12233457999999999998864 1110
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 200 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 200 (311)
.....+.+||... ...+.+.-||+||+++|.-+-...|
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1233467888653 4456778899999999999876544
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00019 Score=63.86 Aligned_cols=28 Identities=18% Similarity=0.318 Sum_probs=25.5
Q ss_pred eeecCCCCCcEEEcCCCceEEeecCCCcc
Q 021526 120 VIYRDLKSANILLDNDFNPKLSDFGLAKL 148 (311)
Q Consensus 120 i~H~di~p~nil~~~~~~vkl~Df~~~~~ 148 (311)
++|||++|.||+++.++ ++++||+.+..
T Consensus 234 liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 234 LIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp EECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred EEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 99999999999998776 99999998864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00034 Score=59.22 Aligned_cols=69 Identities=7% Similarity=-0.042 Sum_probs=40.7
Q ss_pred eeeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcc-cceeEEEEeCCeeEEEEecC-CCCCH
Q 021526 4 CYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNL-VTLIGYCTSGDQRLLVYEYM-PMGSL 79 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~-~~~~L 79 (311)
.+..|....+|.. +.+++|+.... ........+|+..++.+...++ .+++.+ +....+++++|+ ++.++
T Consensus 25 ~l~gG~tN~~~~~----~~~vlR~~~~~-~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 25 ERLGGLTNLVFRA----GDLCLRIPGKG-TEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEESCSSEEEEEE----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred EcCCcccccccee----eeEEEECCCCC-ccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 4555667777777 67888987543 2222334567777776643233 355543 344567899999 66444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00047 Score=60.31 Aligned_cols=138 Identities=17% Similarity=0.133 Sum_probs=78.1
Q ss_pred eeeceeccEEEEEEC---------CeEEEEEEeccCCccchhHHHHHHHHHhcCC-CCcccceeEEEEeCCeeEEEEecC
Q 021526 5 YLSCKFYNVGLVWLC---------DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 5 ~~~g~~~~v~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
+..|-...+|+.... ++.+++|+... .........+|+.+++.+. +.-..++++.+.+ .+|++|+
T Consensus 58 lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i 132 (379)
T 3feg_A 58 VSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYI 132 (379)
T ss_dssp C-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECC
T ss_pred cCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEe
Confidence 344556667777763 47899998532 2334566778999998775 3223566665543 3999999
Q ss_pred CCCCHHH--------------HhcccCC----CCCCC--CHHHHHHHHHHHHH-------------------HHHH----
Q 021526 75 PMGSLED--------------HLYDLEP----DQEPL--SWNTRMKIAVGAAR-------------------GLEY---- 111 (311)
Q Consensus 75 ~~~~L~~--------------~l~~~~~----~~~~l--~~~~~~~~~~~i~~-------------------~l~~---- 111 (311)
+|.+|.. .+.+... ..... .+..+..|..++.. .+..
T Consensus 133 ~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~ 212 (379)
T 3feg_A 133 PSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKL 212 (379)
T ss_dssp SEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHH
T ss_pred cCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHH
Confidence 8754431 1111001 11112 23444445544321 1222
Q ss_pred HhhCC-CCCeeecCCCCCcEEEcCC----CceEEeecCCCc
Q 021526 112 LHCKA-NPPVIYRDLKSANILLDND----FNPKLSDFGLAK 147 (311)
Q Consensus 112 Lh~~~-~~~i~H~di~p~nil~~~~----~~vkl~Df~~~~ 147 (311)
|...+ ...++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 213 L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 213 LESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 22222 2239999999999999876 789999998875
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.50 E-value=0.0015 Score=55.57 Aligned_cols=141 Identities=13% Similarity=0.107 Sum_probs=73.8
Q ss_pred eeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCc--ccceeE------EEEeCCeeEEEEecCCC
Q 021526 5 YLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN--LVTLIG------YCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 5 ~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~------~~~~~~~~~lv~e~~~~ 76 (311)
++.|....+|.....+..+++|..... .....+..|+.++..+...+ +.+++. +...++..++++++++|
T Consensus 30 i~~G~~n~~~~v~~~~g~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G 107 (322)
T 2ppq_A 30 IAEGVENSNFLLHTTKDPLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLEG 107 (322)
T ss_dssp ECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCC
T ss_pred cCCCcccceEEEEeCCccEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCCC
Confidence 344555678888776668899987642 12345666777776653211 223331 12234567899999987
Q ss_pred CCHHH-----------H---hc----ccCCCC-CCCC---HHHHHH------------HHHHHHHHHHHHhhC----CCC
Q 021526 77 GSLED-----------H---LY----DLEPDQ-EPLS---WNTRMK------------IAVGAARGLEYLHCK----ANP 118 (311)
Q Consensus 77 ~~L~~-----------~---l~----~~~~~~-~~l~---~~~~~~------------~~~~i~~~l~~Lh~~----~~~ 118 (311)
..+.. . ++ ...... .... +...+. +...+...+..+... ...
T Consensus 108 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~ 187 (322)
T 2ppq_A 108 MWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPA 187 (322)
T ss_dssp BCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCE
T ss_pred cCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCCc
Confidence 54311 0 11 100000 0011 111000 001133344555421 122
Q ss_pred CeeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 119 PVIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 119 ~i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
.++|+|+++.||++++++.+.++||+.+.
T Consensus 188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 188 GVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 39999999999999887666899998774
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0018 Score=55.53 Aligned_cols=30 Identities=30% Similarity=0.348 Sum_probs=26.2
Q ss_pred CeeecCCCCCcEEEcCC----CceEEeecCCCcc
Q 021526 119 PVIYRDLKSANILLDND----FNPKLSDFGLAKL 148 (311)
Q Consensus 119 ~i~H~di~p~nil~~~~----~~vkl~Df~~~~~ 148 (311)
.++|||+++.||+++.+ +.+.++||+.+..
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 39999999999999874 6799999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00044 Score=61.71 Aligned_cols=68 Identities=18% Similarity=0.215 Sum_probs=43.8
Q ss_pred eeeceeccEEEEEEC---------CeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcc-cceeEEEEeCCeeEEEEecC
Q 021526 5 YLSCKFYNVGLVWLC---------DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNL-VTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 5 ~~~g~~~~v~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~ 74 (311)
++.|-...+|..... ++.+++|+.... .....+.+|+.+++.+...++ .++++.+.+ .+|++|+
T Consensus 81 l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l 154 (429)
T 1nw1_A 81 IKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYI 154 (429)
T ss_dssp ECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCC
T ss_pred eCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEe
Confidence 445556778888773 478999987432 122456679888887753333 566665432 3899998
Q ss_pred CCCC
Q 021526 75 PMGS 78 (311)
Q Consensus 75 ~~~~ 78 (311)
+|.+
T Consensus 155 ~G~~ 158 (429)
T 1nw1_A 155 PSRP 158 (429)
T ss_dssp CEEE
T ss_pred CCcc
Confidence 7643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0012 Score=57.63 Aligned_cols=69 Identities=13% Similarity=0.004 Sum_probs=41.1
Q ss_pred eeeceeccEEEEEECC----------eEEEEEEeccCCccchhHHHHHHHHHhcCCCCc-ccceeEEEEeCCeeEEEEec
Q 021526 5 YLSCKFYNVGLVWLCD----------QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN-LVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 5 ~~~g~~~~v~~~~~~~----------~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~ 73 (311)
++.|..-.+|.....+ +.+++|+.... .........|+++++.+...+ +.+++..+ + .+++++|
T Consensus 41 l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e~ 115 (369)
T 3c5i_A 41 ILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH-VDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEEW 115 (369)
T ss_dssp C----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT-GGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEEC
T ss_pred eCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC-ccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEEE
Confidence 4556667788887754 78899986532 222223467888887775333 34666543 2 3789999
Q ss_pred CCCCC
Q 021526 74 MPMGS 78 (311)
Q Consensus 74 ~~~~~ 78 (311)
++|.+
T Consensus 116 i~G~~ 120 (369)
T 3c5i_A 116 LYGDP 120 (369)
T ss_dssp CCSEE
T ss_pred ecCCc
Confidence 98754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0035 Score=56.26 Aligned_cols=71 Identities=13% Similarity=-0.056 Sum_probs=44.4
Q ss_pred eeeeceeccEEEEEECC--eEEEEEEeccCCccchhHHHHHHHHHhcCCCCcc-cceeEEEEeCCeeEEEEecCCCCCH
Q 021526 4 CYLSCKFYNVGLVWLCD--QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNL-VTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~~~--~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
.+..|-...+|.....+ +.+++|+.... .....+..+|+.+++.+...++ .++++.+. + .+|++|++|.+|
T Consensus 115 ~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~-~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 115 IINGGITNILIKVKDMSKQAKYLIRLYGPK-TDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EECC--CEEEEEEEETTTTEEEEEEEECC--CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EcCCCeEeEEEEEEECCCCceEEEEECCCC-hhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 34556667788888865 88999987433 2222233678888888864444 46666652 2 359999987443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0042 Score=53.42 Aligned_cols=29 Identities=17% Similarity=0.269 Sum_probs=26.1
Q ss_pred CeeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 119 PVIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 119 ~i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
.++|+|+.+.||+++.++.+.++||+.+.
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 39999999999999888889999998765
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.01 E-value=0.014 Score=49.66 Aligned_cols=70 Identities=10% Similarity=-0.016 Sum_probs=43.7
Q ss_pred ceeccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCc--ccceeEE-----EEeCCeeEEEEecCCCCC
Q 021526 8 CKFYNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN--LVTLIGY-----CTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 8 g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~-----~~~~~~~~lv~e~~~~~~ 78 (311)
|....+|.... +|+.+++|...... .....+..|..++..+.... +.+++.. ...++..++++++++|..
T Consensus 36 g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~~ 113 (328)
T 1zyl_A 36 SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 113 (328)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCCCC
Confidence 66667887776 46689999976332 23456777888777664212 3333332 223556688999998743
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0078 Score=53.39 Aligned_cols=70 Identities=11% Similarity=0.051 Sum_probs=43.9
Q ss_pred eeeceeccEEEEEEC---------CeEEEEEEeccCCccchhHHHHHHHHHhcCC-CCcccceeEEEEeCCeeEEEEecC
Q 021526 5 YLSCKFYNVGLVWLC---------DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 5 ~~~g~~~~v~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
+..|-.-.+|..... ++.+++|+.... ....-+..+|+.+++.+. +.-..++++.+ . .++|++|+
T Consensus 78 lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~-t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~efI 152 (424)
T 3mes_A 78 IFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH-VGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEFI 152 (424)
T ss_dssp ECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC-C-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEECC
T ss_pred cCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC-cchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEEe
Confidence 444556667887775 688999986432 233334567888887774 32244555533 2 37899999
Q ss_pred CCCCH
Q 021526 75 PMGSL 79 (311)
Q Consensus 75 ~~~~L 79 (311)
+|.+|
T Consensus 153 ~G~~l 157 (424)
T 3mes_A 153 DGEPL 157 (424)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 88653
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=88.14 E-value=1.8 Score=34.34 Aligned_cols=115 Identities=11% Similarity=0.093 Sum_probs=74.9
Q ss_pred CCCCcccceeEEEEeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHH-HHhhCCCCCeeecCCCC
Q 021526 49 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE-YLHCKANPPVIYRDLKS 127 (311)
Q Consensus 49 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~-~Lh~~~~~~i~H~di~p 127 (311)
..||++ -..+-.+++.+.+.++.-+++.=...+ ..++...+++++.+|+.... +++ . -+|--++|
T Consensus 47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~--~---r~tf~l~P 112 (219)
T 4ano_A 47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSA--R---RLIFIVCP 112 (219)
T ss_dssp GSCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCS--S---SEECCCCG
T ss_pred ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhh--C---ceeEEEeC
Confidence 357777 344546777777777765443333344 35677888999988877666 443 2 47889999
Q ss_pred CcEEEcCCCceEEeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccch-hHHHHHHHHHhCCCCcc
Q 021526 128 ANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIY-SFGVVLLELITGRKAMD 202 (311)
Q Consensus 128 ~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~-slG~~l~~l~~g~~p~~ 202 (311)
+|++++.++.+++.-.|... -++|..+ ...|.| .+=|++..++.++..|+
T Consensus 113 ~NL~f~~~~~p~i~hRGi~~-------------------~lpP~e~------~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVKE-------------------SLPPDEW------DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GGEEECTTCCEEESCCEETT-------------------TBSSCSC------CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred ceEEEeCCCcEEEEEcCCcc-------------------cCCCCCC------CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999998665432 2233311 112333 56778888888877664
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=88.12 E-value=1.2 Score=35.21 Aligned_cols=117 Identities=11% Similarity=0.133 Sum_probs=76.2
Q ss_pred cCCCCcccceeEEEEeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCC
Q 021526 48 LLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 127 (311)
Q Consensus 48 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p 127 (311)
...||+.+.. .+-.+++.+.+.++.-+.+.=...+ ..++...++.++.+|+....++++ -+|--++|
T Consensus 41 ~~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i-------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P 107 (215)
T 4ann_A 41 EQHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI-------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAP 107 (215)
T ss_dssp GSCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG-------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSG
T ss_pred hccCCcccce-EEEEcccEEEEEEEcCcccCCHHHH-------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEec
Confidence 3457888765 5556666666666654322112223 456778889999999887754432 37889999
Q ss_pred CcEEEcCCCceEEeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccc-hhHHHHHHHHHhCCCCcc
Q 021526 128 ANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDI-YSFGVVLLELITGRKAMD 202 (311)
Q Consensus 128 ~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv-~slG~~l~~l~~g~~p~~ 202 (311)
+|++++.++.+++.-.|.... ++|..+ ...|. -.+=|++..+++++..|+
T Consensus 108 ~NL~f~~~~~p~i~~RGik~~-------------------l~P~~~------~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 108 DELFFTRDGLPIAKTRGLQNV-------------------VDPLPV------SEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GGEEECTTSCEEESCCEETTT-------------------BSCCCC------CHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred ceEEEcCCCCEEEEEccCccC-------------------CCCCCC------CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999985554321 122211 11233 366788899999988875
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.87 E-value=0.29 Score=42.87 Aligned_cols=28 Identities=29% Similarity=0.347 Sum_probs=24.3
Q ss_pred eeecCCCCCcEEE------cCCCceEEeecCCCc
Q 021526 120 VIYRDLKSANILL------DNDFNPKLSDFGLAK 147 (311)
Q Consensus 120 i~H~di~p~nil~------~~~~~vkl~Df~~~~ 147 (311)
++|+|+.+.||++ ++...++++||..+.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6899999999999 345679999999885
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 311 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-66 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-56 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-56 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-55 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-55 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-54 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-54 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-54 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-53 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-52 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-52 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-52 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-52 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-51 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-51 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-51 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-51 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-49 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-47 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-46 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-46 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-45 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-44 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-44 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-41 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-40 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-36 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-35 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-34 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-34 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-34 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-33 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-33 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-33 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-32 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-31 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-31 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-27 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-27 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-25 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-25 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-11 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (529), Expect = 1e-66
Identities = 76/268 (28%), Positives = 118/268 (44%), Gaps = 26/268 (9%)
Query: 14 GLVWLC--DQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 69
G V+ VA+K LN Q Q F EV +L H N++ +GY T Q +
Sbjct: 22 GTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAI 80
Query: 70 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 129
V ++ SL HL+ +E + IA A+G++YLH K +I+RDLKS N
Sbjct: 81 VTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNN 134
Query: 130 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYS 186
I L D K+ DFGLA + +H ++ G+ + APE + +SD+Y+
Sbjct: 135 IFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYA 194
Query: 187 FGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYA 246
FG+VL EL+TG+ + + + D K C
Sbjct: 195 FGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV------------RSNCPKAM 242
Query: 247 VAVTAMCLNEEANFRPLINDIVVALDYL 274
+ A CL ++ + RPL I+ +++ L
Sbjct: 243 KRLMAECLKKKRDERPLFPQILASIELL 270
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 2e-56
Identities = 67/290 (23%), Positives = 113/290 (38%), Gaps = 30/290 (10%)
Query: 14 GLVWLC---DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD----Q 66
G VW + VA+K + + E+ +L H+N++ I + Q
Sbjct: 17 GEVWRGKWRGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75
Query: 67 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA-----NPPVI 121
LV +Y GSL D+L ++ ++ +K+A+ A GL +LH + P +
Sbjct: 76 LWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 130
Query: 122 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT--HVSTRVMGTYGYCAPEYAMS---- 175
+RDLKS NIL+ + ++D GLA +T +GT Y APE
Sbjct: 131 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 190
Query: 176 --GKLTLKSDIYSFGVVLLELITGRKAMDLSK-GQGEQNLVSWSRPFLKDQKKFV--HLV 230
+ ++DIY+ G+V E+ + + Q + S P +++ +K V +
Sbjct: 191 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL 250
Query: 231 DPLLHGRY-PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 279
P + R+ L + C R I L L Q
Sbjct: 251 RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 3e-56
Identities = 70/265 (26%), Positives = 113/265 (42%), Gaps = 32/265 (12%)
Query: 14 GLVWLC----DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 69
G VW+ VA+K L +G F+ E ++ L H LV L T + +
Sbjct: 27 GEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84
Query: 70 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 129
+ EYM GSL D L P L+ N + +A A G+ ++ + I+RDL++AN
Sbjct: 85 ITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAAN 139
Query: 130 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGV 189
IL+ + + K++DFGLA+L + + APE G T+KSD++SFG+
Sbjct: 140 ILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 198
Query: 190 VLLELITGRKA--MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAV 247
+L E++T + ++ + QNL R P C
Sbjct: 199 LLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------------------PDNCPEELY 240
Query: 248 AVTAMCLNEEANFRPLINDIVVALD 272
+ +C E RP + + L+
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 6e-56
Identities = 48/191 (25%), Positives = 89/191 (46%), Gaps = 16/191 (8%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQG-HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 67
G+V+ ++A K ++ E + I E+ +L + +V G S +
Sbjct: 20 GVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 79
Query: 68 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 127
+ E+M GSL+ L + K+++ +GL YL K +++RD+K
Sbjct: 80 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKP 133
Query: 128 ANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSF 187
+NIL+++ KL DFG++ ++ +GT Y +PE +++SDI+S
Sbjct: 134 SNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSM 189
Query: 188 GVVLLELITGR 198
G+ L+E+ GR
Sbjct: 190 GLSLVEMAVGR 200
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 5e-55
Identities = 64/263 (24%), Positives = 105/263 (39%), Gaps = 30/263 (11%)
Query: 14 GLVWLC----DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 69
G+V VAIK + EG EFI E ++ L H+ LV L G CT +
Sbjct: 18 GVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 76
Query: 70 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 129
+ EYM G L ++L + +++ +EYL K ++RDL + N
Sbjct: 77 ITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARN 130
Query: 130 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGV 189
L+++ K+SDFGL++ D S + PE M K + KSDI++FGV
Sbjct: 131 CLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGV 189
Query: 190 VLLELITGRKAMDLSKGQGEQNLVSWSRPF-LKDQKKFVHLVDPLLHGRYPRRCLNYAVA 248
++ E+ + K P+ + + L P
Sbjct: 190 LMWEIYSLGK-----------------MPYERFTNSETAEHIAQGLRLYRPHLASEKVYT 232
Query: 249 VTAMCLNEEANFRPLINDIVVAL 271
+ C +E+A+ RP ++ +
Sbjct: 233 IMYSCWHEKADERPTFKILLSNI 255
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 9e-55
Identities = 63/269 (23%), Positives = 102/269 (37%), Gaps = 36/269 (13%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 66
G +++ K+L++ + Q + EV +L L H N+V
Sbjct: 18 GRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN 77
Query: 67 RLL--VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK--ANPPVIY 122
L V EY G L + +++ L +++ L+ H + V++
Sbjct: 78 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLH 137
Query: 123 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKS 182
RDLK AN+ LD N KL DFGLA++ + +T + +GT Y +PE KS
Sbjct: 138 RDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKS 195
Query: 183 DIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRC 242
DI+S G +L EL PF L + G++ R
Sbjct: 196 DIWSLGCLLYELCALM------------------PPF--TAFSQKELAGKIREGKFRRIP 235
Query: 243 LNY---AVAVTAMCLNEEANFRPLINDIV 268
Y + LN + RP + +I+
Sbjct: 236 YRYSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 177 bits (450), Expect = 1e-54
Identities = 66/271 (24%), Positives = 116/271 (42%), Gaps = 28/271 (10%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 68
G V+ VA+K L + ++ +EF+ E ++ + H NLV L+G CT
Sbjct: 31 GEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89
Query: 69 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 128
++ E+M G+L D+L E +++ +S + +A + +EYL K I+RDL +
Sbjct: 90 IITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAAR 144
Query: 129 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFG 188
N L+ + K++DFGL++L GD + APE K ++KSD+++FG
Sbjct: 145 NCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 203
Query: 189 VVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVA 248
V+L E+ T + D + L++ P C
Sbjct: 204 VLLWEIATYGMSPYPG----------------IDLSQVYELLEKDYRMERPEGCPEKVYE 247
Query: 249 VTAMCLNEEANFRPLINDIVVALDYLVSQRD 279
+ C + RP +I A + + +
Sbjct: 248 LMRACWQWNPSDRPSFAEIHQAFETMFQESS 278
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 2e-54
Identities = 66/273 (24%), Positives = 108/273 (39%), Gaps = 34/273 (12%)
Query: 21 QLVAIKQLNHEGLQGH-QEFIVEVLMLS-LLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78
VA+K L + + E+ +LS L +H N+V L+G CT G L++ EY G
Sbjct: 54 MTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 113
Query: 79 LEDHLYD--------------LEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 124
L + L +E D+ L + + A+G+ +L K I+RD
Sbjct: 114 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRD 170
Query: 125 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDI 184
L + NILL + K+ DFGLA+ N V + APE + T +SD+
Sbjct: 171 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV 230
Query: 185 YSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLN 244
+S+G+ L EL + + P + KF ++ P
Sbjct: 231 WSYGIFLWELFSLGSSPY---------------PGMPVDSKFYKMIKEGFRMLSPEHAPA 275
Query: 245 YAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 277
+ C + + RP IV ++ +S+
Sbjct: 276 EMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 3e-54
Identities = 67/266 (25%), Positives = 107/266 (40%), Gaps = 28/266 (10%)
Query: 14 GLVWLC----DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 69
GLV L VAIK + EG ++FI E ++ L H LV L G C L
Sbjct: 19 GLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 77
Query: 70 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 129
V+E+M G L D+L + + T + + + G+ YL VI+RDL + N
Sbjct: 78 VFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARN 131
Query: 130 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGV 189
L+ + K+SDFG+ + D ST + +PE + + KSD++SFGV
Sbjct: 132 CLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGV 190
Query: 190 VLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAV 249
++ E+ + K ++ E V + PR + +
Sbjct: 191 LMWEVFSEGKIPYENRSNSEV----------------VEDISTGFRLYKPRLASTHVYQI 234
Query: 250 TAMCLNEEANFRPLINDIVVALDYLV 275
C E RP + ++ L +
Sbjct: 235 MNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 4e-54
Identities = 69/266 (25%), Positives = 111/266 (41%), Gaps = 34/266 (12%)
Query: 14 GLVWLC---DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL-L 69
G V L VA+K + ++ Q F+ E +++ L H NLV L+G L +
Sbjct: 21 GDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 78
Query: 70 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 129
V EYM GSL D+L + L + +K ++ +EYL ++RDL + N
Sbjct: 79 VTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARN 133
Query: 130 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGV 189
+L+ D K+SDFGL K +T + APE K + KSD++SFG+
Sbjct: 134 VLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREKKFSTKSDVWSFGI 188
Query: 190 VLLELITGRKAMDLSKGQGEQNLVSWSRPFLK-DQKKFVHLVDPLLHGRYPRRCLNYAVA 248
+L E+ + + P+ + K V V+ P C
Sbjct: 189 LLWEIYSFGR-----------------VPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 231
Query: 249 VTAMCLNEEANFRPLINDIVVALDYL 274
V C + +A RP + L+++
Sbjct: 232 VMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 1e-53
Identities = 63/273 (23%), Positives = 108/273 (39%), Gaps = 43/273 (15%)
Query: 23 VAIKQLNHEGLQGHQE-FIVEV-LMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80
VA+K L + +E + E+ +M L H+N+V L+G CT L++EY G L
Sbjct: 70 VAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLL 129
Query: 81 DHLY-------------------DLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 121
++L + E D L++ + A A+G+E+L K +
Sbjct: 130 NYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCV 186
Query: 122 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK 181
+RDL + N+L+ + K+ DFGLA+ N V + APE G T+K
Sbjct: 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK 246
Query: 182 SDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF--LKDQKKFVHLVDPLLHGRYP 239
SD++S+G++L E+ + P+ + F L+ P
Sbjct: 247 SDVWSYGILLWEIFSLGV-----------------NPYPGIPVDANFYKLIQNGFKMDQP 289
Query: 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 272
+ C ++ RP ++ L
Sbjct: 290 FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 173 bits (439), Expect = 6e-53
Identities = 61/276 (22%), Positives = 105/276 (38%), Gaps = 42/276 (15%)
Query: 21 QLVAIKQLNHEGLQGHQ-EFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79
+VA+K L E Q +F E +++ + N+V L+G C G L++EYM G L
Sbjct: 44 TMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDL 103
Query: 80 EDHLYD--------------------LEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 119
+ L P PLS ++ IA A G+ YL
Sbjct: 104 NEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RK 160
Query: 120 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT 179
++RDL + N L+ + K++DFGL++ D + PE + T
Sbjct: 161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT 220
Query: 180 LKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFL-KDQKKFVHLVDPLLHGRY 238
+SD++++GVVL E+ + +P+ ++ ++ V
Sbjct: 221 TESDVWAYGVVLWEIFSYGL-----------------QPYYGMAHEEVIYYVRDGNILAC 263
Query: 239 PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274
P C + +C ++ RP I L +
Sbjct: 264 PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 173 bits (439), Expect = 8e-53
Identities = 62/280 (22%), Positives = 116/280 (41%), Gaps = 36/280 (12%)
Query: 14 GLVWLC--------DQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG 64
G V + VAIK L + ++F+ E ++ H N++ L G T
Sbjct: 40 GEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99
Query: 65 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 124
+++ E+M GSL+ L + + + + G A G++YL ++RD
Sbjct: 100 TPVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRD 153
Query: 125 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV---MGTYGYCAPEYAMSGKLTLK 181
L + NIL++++ K+SDFGL++ + T + APE K T
Sbjct: 154 LAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSA 213
Query: 182 SDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFL-KDQKKFVHLVDPLLHGRYPR 240
SD++S+G+V+ E+++ + RP+ + ++ ++ P
Sbjct: 214 SDVWSYGIVMWEVMSYGE-----------------RPYWDMTNQDVINAIEQDYRLPPPM 256
Query: 241 RCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 280
C + + C ++ N RP IV LD ++ +S
Sbjct: 257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNS 296
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 1e-52
Identities = 58/261 (22%), Positives = 106/261 (40%), Gaps = 29/261 (11%)
Query: 14 GLVWLC-----DQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 67
G V L ++ VA+K ++ + + + E+ + +L+H+N+V G+ G+ +
Sbjct: 19 GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ 78
Query: 68 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 127
L EY G L D + + + G+ YLH + +RD+K
Sbjct: 79 YLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKP 131
Query: 128 ANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYS 186
N+LLD N K+SDFGLA + + + ++ GT Y APE + D++S
Sbjct: 132 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWS 191
Query: 187 FGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYA 246
G+VL ++ G D ++ + + + ++ +
Sbjct: 192 CGIVLTAMLAGELPWDQPSDSCQE---------------YSDWKEKKTYLNPWKKIDSAP 236
Query: 247 VAVTAMCLNEEANFRPLINDI 267
+A+ L E + R I DI
Sbjct: 237 LALLHKILVENPSARITIPDI 257
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 2e-52
Identities = 61/270 (22%), Positives = 102/270 (37%), Gaps = 43/270 (15%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 66
V+ VA +L L Q F E ML L H N+V S +
Sbjct: 23 KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 82
Query: 67 R----LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 122
+LV E M G+L+ +L + + +GL++LH + PP+I+
Sbjct: 83 GKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIH 137
Query: 123 RDLKSANILL-DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK 181
RDLK NI + + K+ D GLA L + V+GT + APE K
Sbjct: 138 RDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEM-YEEKYDES 192
Query: 182 SDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK---FVHLVDPLLHGRY 238
D+Y+FG+ +LE+ T P+ + Q + + + +
Sbjct: 193 VDVYAFGMCMLEMATSE------------------YPYSECQNAAQIYRRVTSGVKPASF 234
Query: 239 PRRCLNYAVAVTAMCLNEEANFRPLINDIV 268
+ + + C+ + + R I D++
Sbjct: 235 DKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 2e-52
Identities = 56/265 (21%), Positives = 106/265 (40%), Gaps = 35/265 (13%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 68
G V+ L A K ++ + + ++++VE+ +L+ H N+V L+ +
Sbjct: 26 GKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW 85
Query: 69 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 128
++ E+ G+++ + +LE PL+ + + L YLH +I+RDLK+
Sbjct: 86 ILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAG 139
Query: 129 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-----GKLTLKSD 183
NIL D + KL+DFG++ +GT + APE M K+D
Sbjct: 140 NILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKAD 197
Query: 184 IYSFGVVLLELITGRKA-MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRC 242
++S G+ L+E+ +L+ + + P L P R
Sbjct: 198 VWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA----------------QPSRW 241
Query: 243 LNYAVAVTAMCLNEEANFRPLINDI 267
+ CL + + R + +
Sbjct: 242 SSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 2e-52
Identities = 57/269 (21%), Positives = 104/269 (38%), Gaps = 36/269 (13%)
Query: 14 GLVWLC-------DQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLIGYCTSG 64
G V + VA+K L +E E + E ++ L + +V +IG C +
Sbjct: 21 GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA- 79
Query: 65 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 124
+ +LV E +G L +L + +++ + G++YL ++RD
Sbjct: 80 ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRD 132
Query: 125 LKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSD 183
L + N+LL K+SDFGL+K L + T + APE K + KSD
Sbjct: 133 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSD 192
Query: 184 IYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFL-KDQKKFVHLVDPLLHGRYPRRC 242
++SFGV++ E + + +P+ + +++ P C
Sbjct: 193 VWSFGVLMWEAFSYGQ-----------------KPYRGMKGSEVTAMLEKGERMGCPAGC 235
Query: 243 LNYAVAVTAMCLNEEANFRPLINDIVVAL 271
+ +C + RP + + L
Sbjct: 236 PREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 6e-52
Identities = 69/264 (26%), Positives = 111/264 (42%), Gaps = 30/264 (11%)
Query: 14 GLVWLC----DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 69
G VW+ VAIK L G + F+ E ++ L H+ LV L + + +
Sbjct: 31 GEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 88
Query: 70 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 129
V EYM GSL D L + L + +A A G+ Y+ ++RDL++AN
Sbjct: 89 VTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAAN 143
Query: 130 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGV 189
IL+ + K++DFGLA+L + + APE A+ G+ T+KSD++SFG+
Sbjct: 144 ILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 202
Query: 190 VLLELITGRKAMDLSKGQGEQNLVSWSRPF-LKDQKKFVHLVDPLLHGRYPRRCLNYAVA 248
+L EL T + P+ ++ + V+ P C
Sbjct: 203 LLTELTTKGR-----------------VPYPGMVNREVLDQVERGYRMPCPPECPESLHD 245
Query: 249 VTAMCLNEEANFRPLINDIVVALD 272
+ C +E RP + L+
Sbjct: 246 LMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 6e-52
Identities = 62/282 (21%), Positives = 109/282 (38%), Gaps = 38/282 (13%)
Query: 14 GLVWLC-------DQLVAIKQLNHEGLQGH-QEFIVEVLMLSLLHHDNLVTLIGYCTSGD 65
G V VAIK L + +E + E ++ L + +V LIG C +
Sbjct: 23 GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AE 81
Query: 66 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 125
+LV E G L L +E + + ++ + G++YL K ++RDL
Sbjct: 82 ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDL 135
Query: 126 KSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDI 184
+ N+LL N K+SDFGL+K LG + + APE K + +SD+
Sbjct: 136 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDV 195
Query: 185 YSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFL-KDQKKFVHLVDPLLHGRYPRRCL 243
+S+GV + E ++ + +P+ + + ++ P C
Sbjct: 196 WSYGVTMWEALSYGQ-----------------KPYKKMKGPEVMAFIEQGKRMECPPECP 238
Query: 244 NYAVAVTAMCLNEEANFRPLINDIVVALDY----LVSQRDSH 281
A+ + C + RP + + L S+ + H
Sbjct: 239 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 280
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 3e-51
Identities = 65/263 (24%), Positives = 116/263 (44%), Gaps = 24/263 (9%)
Query: 20 DQLVAIKQLNHEGLQGHQ-EFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78
+ VAIK L + + +F+ E ++ H N++ L G + +++ EYM G+
Sbjct: 36 EVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA 95
Query: 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 138
L+ L + S + + G A G++YL N ++RDL + NIL++++
Sbjct: 96 LDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVC 149
Query: 139 KLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 197
K+SDFGL++ L + T+ ++ + APE K T SD++SFG+V+ E++T
Sbjct: 150 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTY 209
Query: 198 RKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEE 257
+ + + + ++ P C + + C +E
Sbjct: 210 GERPY----------------WELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQE 253
Query: 258 ANFRPLINDIVVALDYLVSQRDS 280
RP DIV LD L+ DS
Sbjct: 254 RARRPKFADIVSILDKLIRAPDS 276
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 3e-51
Identities = 60/265 (22%), Positives = 99/265 (37%), Gaps = 41/265 (15%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD 65
G V+L ++A+K L L + EV + S L H N++ L GY
Sbjct: 20 GNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 79
Query: 66 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 125
+ L+ EY P+G++ L A L Y H K VI+RD+
Sbjct: 80 RVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDI 132
Query: 126 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIY 185
K N+LL + K++DFG + P + T + GT Y PE K D++
Sbjct: 133 KPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLW 188
Query: 186 SFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRY--PRRCL 243
S GV+ E + G+ PF + + + + P
Sbjct: 189 SLGVLCYEFLVGK------------------PPF--EANTYQETYKRISRVEFTFPDFVT 228
Query: 244 NYAVAVTAMCLNEEANFRPLINDIV 268
A + + L + RP++ +++
Sbjct: 229 EGARDLISRLLKHNPSQRPMLREVL 253
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (427), Expect = 6e-51
Identities = 63/267 (23%), Positives = 105/267 (39%), Gaps = 42/267 (15%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHHDNLVTLIGYCTSGD 65
G V+ ++VAIK++++ G Q + Q+ I EV L L H N + G
Sbjct: 29 GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 88
Query: 66 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 125
LV EY + + ++PL + GA +GL YLH +I+RD+
Sbjct: 89 TAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDV 141
Query: 126 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS---GKLTLKS 182
K+ NILL KL DFG A + + +GT + APE ++ G+ K
Sbjct: 142 KAGNILLSEPGLVKLGDFGSASI------MAPANSFVGTPYWMAPEVILAMDEGQYDGKV 195
Query: 183 DIYSFGVVLLELITGRKAM-DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRR 241
D++S G+ +EL + + +++ ++ P L+
Sbjct: 196 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ-----------------SGH 238
Query: 242 CLNYAVAVTAMCLNEEANFRPLINDIV 268
Y CL + RP ++
Sbjct: 239 WSEYFRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 7e-51
Identities = 66/290 (22%), Positives = 111/290 (38%), Gaps = 45/290 (15%)
Query: 14 GLVWLC-------DQLVAIKQLNHEGL-QGHQEFIVEV-LMLSLLHHDNLVTLIGYCTSG 64
G V AIK++ H++F E+ ++ L HH N++ L+G C
Sbjct: 24 GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 83
Query: 65 DQRLLVYEYMPMGSLEDHLYD------------LEPDQEPLSWNTRMKIAVGAARGLEYL 112
L EY P G+L D L LS + A ARG++YL
Sbjct: 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 143
Query: 113 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 172
I+RDL + NIL+ ++ K++DFGL++ V T + A E
Sbjct: 144 S---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIES 197
Query: 173 AMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFL-KDQKKFVHLVD 231
T SD++S+GV+L E+++ P+ + +
Sbjct: 198 LNYSVYTTNSDVWSYGVLLWEIVSLGG-----------------TPYCGMTCAELYEKLP 240
Query: 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSH 281
P C + + C E+ RP I+V+L+ ++ +R ++
Sbjct: 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 290
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 2e-50
Identities = 64/261 (24%), Positives = 113/261 (43%), Gaps = 26/261 (9%)
Query: 21 QLVAIKQLNHEGLQGH-QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR-LLVYEYMPMGS 78
A+K LN G +F+ E +++ H N+++L+G C + L+V YM G
Sbjct: 56 IHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGD 115
Query: 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 138
L + + + + + + A+G+++L K ++RDL + N +LD F
Sbjct: 116 LRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTV 169
Query: 139 KLSDFGLAKL--GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 196
K++DFGLA+ D+ H T + A E + K T KSD++SFGV+L EL+T
Sbjct: 170 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 229
Query: 197 GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNE 256
+ N + L+ ++ P C + V C +
Sbjct: 230 RGAPPY-----PDVNTFDITVYLLQGRRLL-----------QPEYCPDPLYEVMLKCWHP 273
Query: 257 EANFRPLINDIVVALDYLVSQ 277
+A RP +++V + + S
Sbjct: 274 KAEMRPSFSELVSRISAIFST 294
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-49
Identities = 53/263 (20%), Positives = 115/263 (43%), Gaps = 26/263 (9%)
Query: 23 VAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 81
VAIK+L + ++E + E +++ + + ++ L+G C + +L + + MP G L D
Sbjct: 41 VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLD 99
Query: 82 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 141
++ + ++ + + V A+G+ YL + +++RDL + N+L+ + K++
Sbjct: 100 YVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKIT 153
Query: 142 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 201
DFGLAKL + + + + A E + T +SD++S+GV + EL+T
Sbjct: 154 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS-- 211
Query: 202 DLSKGQGEQNLVSWSRPF-LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANF 260
+P+ + +++ P C + C +A+
Sbjct: 212 ---------------KPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADS 256
Query: 261 RPLINDIVVALDYLVSQRDSHPV 283
RP ++++ + + V
Sbjct: 257 RPKFRELIIEFSKMARDPQRYLV 279
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-49
Identities = 61/262 (23%), Positives = 107/262 (40%), Gaps = 36/262 (13%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 68
G V+ Q VAI+Q+N + + I E+L++ + N+V + GD+
Sbjct: 34 GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93
Query: 69 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 128
+V EY+ GSL D + + + + + LE+LH VI+RD+KS
Sbjct: 94 VVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSD 145
Query: 129 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFG 188
NILL D + KL+DFG + + ++GT + APE K DI+S G
Sbjct: 146 NILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 203
Query: 189 VVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD---QKKFVHLVDPLLHGRYPRRCLNY 245
++ +E+I G P+L + + ++ + + P +
Sbjct: 204 IMAIEMIEGE------------------PPYLNENPLRALYLIATNGTPELQNPEKLSAI 245
Query: 246 AVAVTAMCLNEEANFRPLINDI 267
CL+ + R ++
Sbjct: 246 FRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 8e-47
Identities = 61/260 (23%), Positives = 110/260 (42%), Gaps = 28/260 (10%)
Query: 20 DQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78
+ VAIK +N ++ EF+ E ++ + ++V L+G + G L++ E M G
Sbjct: 50 ETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGD 109
Query: 79 LEDHLYDLEPDQE------PLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL 132
L+ +L L P P S + +++A A G+ YL+ ++RDL + N ++
Sbjct: 110 LKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 166
Query: 133 DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLL 192
DF K+ DFG+ + D + + + +PE G T SD++SFGVVL
Sbjct: 167 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 226
Query: 193 ELITGRKAMDLSKGQGEQNLVSWSRPF-LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTA 251
E+ T + +P+ ++ + V P C + +
Sbjct: 227 EIATLAE-----------------QPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMR 269
Query: 252 MCLNEEANFRPLINDIVVAL 271
MC RP +I+ ++
Sbjct: 270 MCWQYNPKMRPSFLEIISSI 289
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 1e-46
Identities = 69/272 (25%), Positives = 102/272 (37%), Gaps = 38/272 (13%)
Query: 14 GLVWLC--------DQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCT 62
G+V VA+K L + L + +FI EV + L H NL+ L G
Sbjct: 22 GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 81
Query: 63 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 122
+ ++ V E P+GSL D L Q T + AV A G+ YL + I+
Sbjct: 82 TPPMKM-VTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIH 134
Query: 123 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV-STRVMGTYGYCAPEYAMSGKLTLK 181
RDL + N+LL K+ DFGL + P D+ +V + +CAPE + +
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA 194
Query: 182 SDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF--LKDQKKFVHLVDPLLHGRYP 239
SD + FGV L E+ T + P+ L + + P
Sbjct: 195 SDTWMFGVTLWEMFTYGQ-----------------EPWIGLNGSQILHKIDKEGERLPRP 237
Query: 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 271
C V C + RP + L
Sbjct: 238 EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 1e-46
Identities = 55/279 (19%), Positives = 90/279 (32%), Gaps = 42/279 (15%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD 65
V L + AIK L + E ++S L H V L +
Sbjct: 22 STVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE 81
Query: 66 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 125
+ Y G L ++ LEYLH +I+RDL
Sbjct: 82 KLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDL 134
Query: 126 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIY 185
K NILL+ D + +++DFG AK+ + +GT Y +PE SD++
Sbjct: 135 KPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLW 194
Query: 186 SFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRY--PRRCL 243
+ G ++ +L+ G PF + ++ Y P +
Sbjct: 195 ALGCIIYQLVAGL------------------PPF--RAGNEYLIFQKIIKLEYDFPEKFF 234
Query: 244 NYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHP 282
A + L +A R ++ +HP
Sbjct: 235 PKARDLVEKLLVLDATKRLGCEEMEGYGPLK-----AHP 268
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 6e-46
Identities = 69/271 (25%), Positives = 112/271 (41%), Gaps = 35/271 (12%)
Query: 21 QLVAIKQLNHEGLQGH-QEFIVEV-LMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78
VA+K L + + + I E+ +M + H N++ L+G CT ++ EY G+
Sbjct: 46 TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 105
Query: 79 LEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 126
L ++L P +E LS + A ARG+EYL + I+RDL
Sbjct: 106 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLA 162
Query: 127 SANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYS 186
+ N+L+ D K++DFGLA+ D +T + APE T +SD++S
Sbjct: 163 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 222
Query: 187 FGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFL-KDQKKFVHLVDPLLHGRYPRRCLNY 245
FGV+L E+ T P+ ++ L+ P C N
Sbjct: 223 FGVLLWEIFTLGG-----------------SPYPGVPVEELFKLLKEGHRMDKPSNCTNE 265
Query: 246 AVAVTAMCLNEEANFRPLINDIVVALDYLVS 276
+ C + + RP +V LD +V+
Sbjct: 266 LYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 2e-45
Identities = 62/270 (22%), Positives = 113/270 (41%), Gaps = 33/270 (12%)
Query: 21 QLVAIKQLNHEGLQG-HQEFIVEV-LMLSLLHHDNLVTLIGYCTS-GDQRLLVYEYMPMG 77
+ VA+K L H+ + E+ +++ + HH N+V L+G CT G +++ E+ G
Sbjct: 44 RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 103
Query: 78 SLEDHLYD------------LEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 125
+L +L + ++ L+ + + A+G+E+L + I+RDL
Sbjct: 104 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDL 160
Query: 126 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIY 185
+ NILL K+ DFGLA+ + + APE T++SD++
Sbjct: 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW 220
Query: 186 SFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNY 245
SFGV+L E+ + + P +K ++F + R P
Sbjct: 221 SFGVLLWEIFSLGASPY---------------PGVKIDEEFCRRLKEGTRMRAPDYTTPE 265
Query: 246 AVAVTAMCLNEEANFRPLINDIVVALDYLV 275
C + E + RP +++V L L+
Sbjct: 266 MYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 153 bits (387), Expect = 1e-44
Identities = 45/192 (23%), Positives = 79/192 (41%), Gaps = 16/192 (8%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 68
G+V A K + + E+ +S+L H LV L ++ +
Sbjct: 40 GVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 99
Query: 69 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 128
++YE+M G L + + D + +S + ++ +GL ++H ++ DLK
Sbjct: 100 MIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPE 153
Query: 129 NILLDNDFNP--KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYS 186
NI+ + KL DFGL D GT + APE A + +D++S
Sbjct: 154 NIMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWS 210
Query: 187 FGVVLLELITGR 198
GV+ L++G
Sbjct: 211 VGVLSYILLSGL 222
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 3e-44
Identities = 53/273 (19%), Positives = 101/273 (36%), Gaps = 33/273 (12%)
Query: 14 GLVWLC--------DQLVAIKQLNHEGLQGHQE-FIVEVLMLSLLHHDNLVTLIGYCTSG 64
G V VAIK + +E F+ E L + H ++V LIG T
Sbjct: 21 GDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE- 79
Query: 65 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 124
+ ++ E +G L L + L + + A + L YL + ++RD
Sbjct: 80 NPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLE---SKRFVHRD 133
Query: 125 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDI 184
+ + N+L+ ++ KL DFGL++ + +++ + APE + T SD+
Sbjct: 134 IAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRRFTSASDV 192
Query: 185 YSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLN 244
+ FGV + E++ + D + + L P C
Sbjct: 193 WMFGVCMWEILMHGVK-------------PFQGVKNNDVIGRIENGERL---PMPPNCPP 236
Query: 245 YAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 277
++ C + + RP ++ L ++ +
Sbjct: 237 TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 149 bits (376), Expect = 6e-43
Identities = 47/261 (18%), Positives = 93/261 (35%), Gaps = 30/261 (11%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 68
G+V C ++ K +N E+ +++ LHH L+ L + +
Sbjct: 43 GVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 102
Query: 69 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 128
L+ E++ G L D + + +S + A GL+++H +++ D+K
Sbjct: 103 LILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPE 156
Query: 129 NILLDNDFNP--KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYS 186
NI+ + K+ DFGLA + + T + APE + +D+++
Sbjct: 157 NIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWA 213
Query: 187 FGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYA 246
GV+ L++G ++ + + V D A
Sbjct: 214 IGVLGYVLLSGLSP--------------FAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 259
Query: 247 VAVTAMCLNEEANFRPLINDI 267
L +E R ++D
Sbjct: 260 KDFIKNLLQKEPRKRLTVHDA 280
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 5e-41
Identities = 35/192 (18%), Positives = 80/192 (41%), Gaps = 17/192 (8%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 68
G+V C + K + +G E+ +L++ H N++ L S ++ +
Sbjct: 19 GIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELV 77
Query: 69 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 128
+++E++ + + + L+ + L++LH + + D++
Sbjct: 78 MIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPE 131
Query: 129 NILLDNDFNP--KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYS 186
NI+ + K+ +FG A+ GDN + + Y APE ++ +D++S
Sbjct: 132 NIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDVVSTATDMWS 188
Query: 187 FGVVLLELITGR 198
G ++ L++G
Sbjct: 189 LGTLVYVLLSGI 200
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 5e-41
Identities = 68/258 (26%), Positives = 102/258 (39%), Gaps = 36/258 (13%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQE---FIVEVLMLSL-LHHDNLVTLIGYCTSG 64
G V+L +Q AIK L + + + +VE +LSL H L + +
Sbjct: 16 GKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 75
Query: 65 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 124
+ V EY+ G L H+ + A GL++LH K ++YRD
Sbjct: 76 ENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRD 128
Query: 125 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDI 184
LK NILLD D + K++DFG+ K +GD GT Y APE + K D
Sbjct: 129 LKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPEILLGQKYNHSVDW 186
Query: 185 YSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLN 244
+SFGV+L E++ G+ PF ++ + + + YPR
Sbjct: 187 WSFGVLLYEMLIGQ------------------SPFHGQDEEELFHSIRMDNPFYPRWLEK 228
Query: 245 YAVAVTAMCLNEEANFRP 262
A + E R
Sbjct: 229 EAKDLLVKLFVREPEKRL 246
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (358), Expect = 7e-41
Identities = 48/191 (25%), Positives = 77/191 (40%), Gaps = 13/191 (6%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQE-FIVEVLMLSLLHHDNLVTLIGYCTSGDQR 67
V L +LVAIK + + L+G + E+ +L + H N+V L SG
Sbjct: 23 SEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHL 82
Query: 68 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 127
L+ + + G L D + + + + ++ ++YLH +
Sbjct: 83 YLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENL 138
Query: 128 ANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSF 187
LD D +SDFGL+K+ D V + GT GY APE + D +S
Sbjct: 139 LYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSI 195
Query: 188 GVVLLELITGR 198
GV+ L+ G
Sbjct: 196 GVIAYILLCGY 206
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 142 bits (360), Expect = 1e-40
Identities = 59/218 (27%), Positives = 92/218 (42%), Gaps = 23/218 (10%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLH---HDNLVTLIGYCT 62
G V+ C ++ A+K L+ + + QG + E +MLSL+ +V +
Sbjct: 18 GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH 77
Query: 63 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 122
+ D+ + + M G L HL E A GLE++H N V+Y
Sbjct: 78 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR----FYAAEIILGLEHMH---NRFVVY 130
Query: 123 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK-LTLK 181
RDLK ANILLD + ++SD GLA +GT+GY APE G
Sbjct: 131 RDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMAPEVLQKGVAYDSS 186
Query: 182 SDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF 219
+D +S G +L +L+ G K + + + +
Sbjct: 187 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 224
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 138 bits (349), Expect = 9e-40
Identities = 51/198 (25%), Positives = 93/198 (46%), Gaps = 20/198 (10%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQG---HQEFIVEVLMLSLLHHDNLVTLIGYCTS-- 63
V L + VA+K L + + + F E + L+H +V + +
Sbjct: 21 SEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 80
Query: 64 --GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 121
G +V EY+ +L D ++ + P++ +++ A + L + H +I
Sbjct: 81 PAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSH---QNGII 133
Query: 122 YRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTL 180
+RD+K ANI++ K+ DFG+A+ + G++ + V+GT Y +PE A +
Sbjct: 134 HRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDA 193
Query: 181 KSDIYSFGVVLLELITGR 198
+SD+YS G VL E++TG
Sbjct: 194 RSDVYSLGCVLYEVLTGE 211
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 137 bits (347), Expect = 4e-39
Identities = 55/194 (28%), Positives = 86/194 (44%), Gaps = 20/194 (10%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQE---FIVEVLMLSLLHHDNLVTLIGYCTSGD 65
G V L + A+K L E + ++ E LMLS++ H ++ + G
Sbjct: 18 GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ 77
Query: 66 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 125
Q ++ +Y+ L+ L + A LEYLH + +IYRDL
Sbjct: 78 QIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDL 130
Query: 126 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIY 185
K NILLD + + K++DFG AK P V+ + GT Y APE + D +
Sbjct: 131 KPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYIAPEVVSTKPYNKSIDWW 185
Query: 186 SFGVVLLELITGRK 199
SFG+++ E++ G
Sbjct: 186 SFGILIYEMLAGYT 199
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 135 bits (340), Expect = 2e-38
Identities = 53/206 (25%), Positives = 85/206 (41%), Gaps = 31/206 (15%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGL---------QGHQEFIVEV-LMLSLLHHDNLVTLI 58
+V C + A+K ++ G + + + EV ++ + H N++ L
Sbjct: 17 SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 76
Query: 59 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 118
+ LV++ M G L D+L + + LS KI + LH
Sbjct: 77 DTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL--- 129
Query: 119 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-- 176
+++RDLK NILLD+D N KL+DFG + D V GT Y APE
Sbjct: 130 NIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGTPSYLAPEIIECSMN 186
Query: 177 ----KLTLKSDIYSFGVVLLELITGR 198
+ D++S GV++ L+ G
Sbjct: 187 DNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 2e-37
Identities = 54/275 (19%), Positives = 99/275 (36%), Gaps = 30/275 (10%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQG-----HQEFIVEVLMLSLLHHDNLVTLIGYCTS 63
V+ +Q+VAIK++ ++ + E+ +L L H N++ L+
Sbjct: 12 ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 71
Query: 64 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 123
LV+++M D ++ + L+ + + +GLEYLH +++R
Sbjct: 72 KSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHR 124
Query: 124 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKS 182
DLK N+LLD + KL+DFGLAK G T + T Y APE ++ +
Sbjct: 125 DLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGV 182
Query: 183 DIYSFGVVLLELITGRKAMD----------LSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 232
D+++ G +L EL+ + + + G W
Sbjct: 183 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 242
Query: 233 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 267
+ + + + R
Sbjct: 243 IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 4e-37
Identities = 62/275 (22%), Positives = 113/275 (41%), Gaps = 25/275 (9%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGH-QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 67
G+V VAIK+++ Q + Q + E+ +L H+N++ + +
Sbjct: 22 GMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 81
Query: 68 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 127
+ Y+ + LY L Q LS + RGL+Y+H V++RDLK
Sbjct: 82 QMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKP 137
Query: 128 ANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKS-DIY 185
+N+LL+ + K+ DFGLA+ P D+T T + T Y APE ++ K KS DI+
Sbjct: 138 SNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 197
Query: 186 SFGVVLLELITGR-------------KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 232
S G +L E+++ R + + +++L ++ + +
Sbjct: 198 SVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNK 257
Query: 233 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 267
+ R + A+ + L + R +
Sbjct: 258 VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 7e-37
Identities = 62/291 (21%), Positives = 103/291 (35%), Gaps = 46/291 (15%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGH------QEFIVEVLMLSLLHHDNLVTLIGYCT 62
+V C A K + + ++ EV +L + H N++TL
Sbjct: 24 AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE 83
Query: 63 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 122
+ +L+ E + G L+D ++E L+ + G+ YLH + + +
Sbjct: 84 NKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAH 136
Query: 123 RDLKSANILLDNDFNP----KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL 178
DLK NI+L + P K+ DFGLA D + + GT + APE L
Sbjct: 137 FDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPEIVNYEPL 193
Query: 179 TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRY 238
L++D++S GV+ L++G Q + V V+ Y
Sbjct: 194 GLEADMWSIGVITYILLSGASPFLGDTKQ--------------ETLANVSAVNYEFEDEY 239
Query: 239 PRRCLNYAVAVTAMCLNEEANFRPLINDIV-------VALDYLVSQRDSHP 282
A L ++ R I D + +S SHP
Sbjct: 240 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHP 290
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 1e-36
Identities = 57/277 (20%), Positives = 95/277 (34%), Gaps = 30/277 (10%)
Query: 14 GLVWLC------DQLVAIKQLNHEGLQGHQE--FIVEVLMLSLL---HHDNLVTLIGYCT 62
G V+ + VA+K++ + + I EV +L L H N+V L CT
Sbjct: 21 GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 80
Query: 63 SGDQRLLVYEYMPMGSLEDHLYDL--EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 120
+ ++ L + + + T + RGL++LH V
Sbjct: 81 VSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RV 137
Query: 121 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTL 180
++RDLK NIL+ + KL+DFGLA++ T V+ T Y APE +
Sbjct: 138 VHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPEVLLQSSYAT 194
Query: 181 KSDIYSFGVVLLELITGRKAMD----------LSKGQGEQNLVSWSRPFLKDQKKFVHLV 230
D++S G + E+ + + G W R ++ F H
Sbjct: 195 PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF-HSK 253
Query: 231 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 267
++ + CL R
Sbjct: 254 SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (320), Expect = 2e-35
Identities = 50/273 (18%), Positives = 94/273 (34%), Gaps = 33/273 (12%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC-TSGDQR 67
G ++L + VAIK + H + +E + ++ + I +C GD
Sbjct: 21 GDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 78
Query: 68 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 127
++V E + + + S T + +A +EY+H K I+RD+K
Sbjct: 79 VMVMELLGPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKP 131
Query: 128 ANIL---LDNDFNPKLSDFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAMSGKLT 179
N L + DFGLAK + + GT Y + + + +
Sbjct: 132 DNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS 191
Query: 180 LKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239
+ D+ S G VL+ G K ++ + + +K + +L YP
Sbjct: 192 RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK------YERISEKKMSTPIEVLCKGYP 245
Query: 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 272
Y C + + +P + +
Sbjct: 246 SEFATYL----NFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-34
Identities = 48/197 (24%), Positives = 80/197 (40%), Gaps = 22/197 (11%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR- 67
G+V+ +LVAIK++ + + E+ ++ L H N+V L + S ++
Sbjct: 34 GVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 89
Query: 68 -----LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 122
LV +Y+P + ++ L R L Y+H + +
Sbjct: 90 DEVYLNLVLDYVPETVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHSF---GICH 145
Query: 123 RDLKSANILLDND-FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK 181
RD+K N+LLD D KL DFG AK + + + Y + T
Sbjct: 146 RDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSYICSRYYRAPELIFGATDYTSS 203
Query: 182 SDIYSFGVVLLELITGR 198
D++S G VL EL+ G+
Sbjct: 204 IDVWSAGCVLAELLLGQ 220
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 3e-34
Identities = 49/267 (18%), Positives = 82/267 (30%), Gaps = 36/267 (13%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIVEV-LMLSLLHHDNLVTLIGYC----TS 63
G V + A+K L + EV L ++V ++
Sbjct: 26 GKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAG 80
Query: 64 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 123
L+V E + G L + D + + +I ++YLH + +R
Sbjct: 81 RKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN---IAHR 135
Query: 124 DLKSANILLDNDFNP---KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTL 180
D+K N+L + KL+DFG AK ++ T Y APE K
Sbjct: 136 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVLGPEKYDK 192
Query: 181 KSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPR 240
D++S GV++ L+ G L + + +P
Sbjct: 193 SCDMWSLGVIMYILLCGYPPF-----YSNHGLAISPGMKTRIRMGQYEFPNP-----EWS 242
Query: 241 RCLNYAVAVTAMCLNEEANFRPLINDI 267
+ L E R I +
Sbjct: 243 EVSEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 3e-34
Identities = 54/193 (27%), Positives = 75/193 (38%), Gaps = 17/193 (8%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQE---FIVEVLMLSLLHHDNLVTLIGYCTSGD 65
G V L + A+K L E + E + E +L H L L + D
Sbjct: 19 GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 78
Query: 66 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 125
+ V EY G L HL E + A + L + V+YRD+
Sbjct: 79 RLCFVMEYANGGELFFHLSRERVFTEE-------RARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 126 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIY 185
K N++LD D + K++DFGL K G T GT Y APE D +
Sbjct: 132 KLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEVLEDNDYGRAVDWW 189
Query: 186 SFGVVLLELITGR 198
GVV+ E++ GR
Sbjct: 190 GLGVVMYEMMCGR 202
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 3e-34
Identities = 42/192 (21%), Positives = 82/192 (42%), Gaps = 14/192 (7%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 66
G+V+ ++VA+K++ + I E+ +L L+H N+V L+ + ++
Sbjct: 16 GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 75
Query: 67 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 126
LV+E++ + + + +GL + H V++RDLK
Sbjct: 76 LYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLK 129
Query: 127 SANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYS 186
N+L++ + KL+DFGLA+ V + V+ + + DI+S
Sbjct: 130 PQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWS 188
Query: 187 FGVVLLELITGR 198
G + E++T R
Sbjct: 189 LGCIFAEMVTRR 200
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 122 bits (308), Expect = 1e-33
Identities = 38/285 (13%), Positives = 81/285 (28%), Gaps = 35/285 (12%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQR 67
G+++ +Q VAIK + E LL + + + G
Sbjct: 19 GVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 76
Query: 68 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 127
+LV + + L+ S T A ++ +H K ++YRD+K
Sbjct: 77 VLVIDLLGP----SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKP 129
Query: 128 ANILLDNDFNP-----KLSDFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAMSGK 177
N L+ + + DFG+ K + GT Y + + +
Sbjct: 130 DNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE 189
Query: 178 LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 237
+ + D+ + G V + + G K + ++
Sbjct: 190 QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY----------ERIGEKKQSTPLRE 239
Query: 238 YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHP 282
N + P + + ++ + ++
Sbjct: 240 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 284
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 1e-33
Identities = 44/200 (22%), Positives = 78/200 (39%), Gaps = 25/200 (12%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQE------FIVEVLMLSLLH--HDNLVTLIGY 60
G V+ + VAIK + + + E +EV++L + ++ L+ +
Sbjct: 18 GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 77
Query: 61 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 120
D +L+ E L+D ++ L + + H V
Sbjct: 78 FERPDSFVLILERPEPVQD---LFDFITERGALQEELARSFFWQVLEAVRHCHNC---GV 131
Query: 121 IYRDLKSANILLD-NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL- 178
++RD+K NIL+D N KL DFG L V T GT Y PE+ +
Sbjct: 132 LHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGTRVYSPPEWIRYHRYH 187
Query: 179 TLKSDIYSFGVVLLELITGR 198
+ ++S G++L +++ G
Sbjct: 188 GRSAAVWSLGILLYDMVCGD 207
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 121 bits (305), Expect = 2e-33
Identities = 52/271 (19%), Positives = 102/271 (37%), Gaps = 25/271 (9%)
Query: 14 GLVWLC----DQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 67
G+V+ + A+K++ E I E+ +L L H N+V L + +
Sbjct: 16 GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRL 75
Query: 68 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 127
+LV+E++ + + L T + G+ Y H + V++RDLK
Sbjct: 76 VLVFEHLDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKP 128
Query: 128 ANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSF 187
N+L++ + K++DFGLA+ + + ++ + S K + DI+S
Sbjct: 129 QNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVLMGSKKYSTTIDIWSV 187
Query: 188 GVVLLELITGRK----------AMDLSKGQGEQNLVSWSRPF-LKDQKKFVHLVDPLLHG 236
G + E++ G M + + G N +W L + +PL
Sbjct: 188 GCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWE 247
Query: 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDI 267
+ + + + + L + N R
Sbjct: 248 SFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 8e-32
Identities = 48/203 (23%), Positives = 87/203 (42%), Gaps = 25/203 (12%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 66
G V+ Q VA+K++ E + + E+ +L LL H+N+V LI C +
Sbjct: 24 GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 83
Query: 67 R--------LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 118
LV+++ L + + ++ GL Y+H
Sbjct: 84 PYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQMLLNGLYYIH---RN 136
Query: 119 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS--TRVMGTYGYCAPEYAMSG 176
+++RD+K+AN+L+ D KL+DFGLA+ + N+ + T + T Y PE +
Sbjct: 137 KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE 196
Query: 177 KL-TLKSDIYSFGVVLLELITGR 198
+ D++ G ++ E+ T
Sbjct: 197 RDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 1e-31
Identities = 41/192 (21%), Positives = 76/192 (39%), Gaps = 14/192 (7%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 66
G V VAIK+L + E+ +L + H+N++ L+ T +
Sbjct: 32 GAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 91
Query: 67 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 126
++ + E L + + +GL Y+H +RDLK
Sbjct: 92 LDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII---HRDLK 148
Query: 127 SANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYS 186
N+ ++ D K+ DFGLA+ ++ ++ V+ + + T DI+S
Sbjct: 149 PGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWS 204
Query: 187 FGVVLLELITGR 198
G ++ E+ITG+
Sbjct: 205 VGCIMAEMITGK 216
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 4e-31
Identities = 46/252 (18%), Positives = 93/252 (36%), Gaps = 15/252 (5%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 66
G V+ ++VA+K++ + + E+ +L L H N+V L S +
Sbjct: 16 GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK 75
Query: 67 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 126
LV+E+ D + L +GL + H + V++RDLK
Sbjct: 76 LTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLK 128
Query: 127 SANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYS 186
N+L++ + KL++FGLA+ + S V+ + + + D++S
Sbjct: 129 PQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWS 187
Query: 187 FGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYA 246
G + EL + + +Q + ++++ + + YP +
Sbjct: 188 AGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTS 247
Query: 247 VAVTAMCLNEEA 258
+ LN
Sbjct: 248 LVNVVPKLNATG 259
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 116 bits (292), Expect = 6e-31
Identities = 49/193 (25%), Positives = 75/193 (38%), Gaps = 20/193 (10%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQE---FIVEVLMLSLLHHDNLVTLIGYCTSGD 65
G V L A+K L+ + + ++ + E +L ++ LV L
Sbjct: 55 GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 66 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 125
+V EY+ G + HL S A EYLH +IYRDL
Sbjct: 115 NLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDL 167
Query: 126 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIY 185
K N+L+D +++DFG AK T + GT APE +S D +
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNKAVDWW 222
Query: 186 SFGVVLLELITGR 198
+ GV++ E+ G
Sbjct: 223 ALGVLIYEMAAGY 235
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 3e-27
Identities = 57/200 (28%), Positives = 87/200 (43%), Gaps = 23/200 (11%)
Query: 14 GLVWLC--------DQLVAIKQLNHEGL----QGHQEFIVEVLMLSLL-HHDNLVTLIGY 60
G V+L +L A+K L + + + E +L + LVTL
Sbjct: 38 GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 97
Query: 61 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 120
+ + L+ +Y+ G L HL +E + + LE+LH +
Sbjct: 98 FQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GI 150
Query: 121 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK--L 178
IYRD+K NILLD++ + L+DFGL+K V D T + GT Y AP+ G
Sbjct: 151 IYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGTIEYMAPDIVRGGDSGH 209
Query: 179 TLKSDIYSFGVVLLELITGR 198
D +S GV++ EL+TG
Sbjct: 210 DKAVDWWSLGVLMYELLTGA 229
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 106 bits (264), Expect = 5e-27
Identities = 36/206 (17%), Positives = 76/206 (36%), Gaps = 24/206 (11%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIVEV-LMLSLLHHDNLVTLIGYCTSGDQR 67
V+ ++ V +K L ++ E+ ++ +L N++TL R
Sbjct: 49 SEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSR 105
Query: 68 L--LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 125
LV+E++ + + L+ + L+Y H +++RD+
Sbjct: 106 TPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDV 155
Query: 126 KSANILLDNDFNP-KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDI 184
K N+++D++ +L D+GLA+ + RV Y D+
Sbjct: 156 KPHNVMIDHEHRKLRLIDWGLAEF--YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDM 213
Query: 185 YSFGVVLLELITGRKAMDLSKGQGEQ 210
+S G +L +I ++ +Q
Sbjct: 214 WSLGCMLASMIFRKEPFFHGHDNYDQ 239
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 2e-25
Identities = 47/198 (23%), Positives = 85/198 (42%), Gaps = 26/198 (13%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS--- 63
G+V D+ VAIK+L+ + E++++ ++H N+++L+ T
Sbjct: 31 GIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 90
Query: 64 ---GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 120
LV E M + Q L + G+++LH +
Sbjct: 91 LEEFQDVYLVMELMDANLCQVI-------QMELDHERMSYLLYQMLCGIKHLHS---AGI 140
Query: 121 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTL 180
I+RDLK +NI++ +D K+ DFGLA+ + + T + T Y APE +
Sbjct: 141 IHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILGMGYKE 197
Query: 181 KSDIYSFGVVLLELITGR 198
DI+S G ++ E++ +
Sbjct: 198 NVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 3e-25
Identities = 41/192 (21%), Positives = 78/192 (40%), Gaps = 14/192 (7%)
Query: 14 GLVWLC-----DQLVAIKQLN--HEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 66
G V VA+K+L+ + + + E+ +L + H+N++ L+ T
Sbjct: 32 GSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 91
Query: 67 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 126
+ + L + + L+ + + RGL+Y+H +RDLK
Sbjct: 92 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADII---HRDLK 148
Query: 127 SANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYS 186
+N+ ++ D K+ DFGLA+ + ++ V + DI+S
Sbjct: 149 PSNLAVNEDCELKILDFGLARH----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWS 204
Query: 187 FGVVLLELITGR 198
G ++ EL+TGR
Sbjct: 205 VGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 98.2 bits (243), Expect = 6e-24
Identities = 39/216 (18%), Positives = 78/216 (36%), Gaps = 21/216 (9%)
Query: 14 GLVWLC-----DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 68
VWL + VA+K + + + + E+ +L ++ + + +L
Sbjct: 27 STVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 85
Query: 69 LVYEYMPMGSL------------EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 116
L + + + + + +I+ GL+Y+H +
Sbjct: 86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC 145
Query: 117 NPPVIYRDLKSANILLD-NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS 175
+I+ D+K N+L++ D L +A LG T + T Y +PE +
Sbjct: 146 G--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLG 203
Query: 176 GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN 211
+DI+S ++ ELITG + +G
Sbjct: 204 APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 58.3 bits (140), Expect = 7e-11
Identities = 17/152 (11%), Positives = 38/152 (25%), Gaps = 33/152 (21%)
Query: 14 GLVWLC----DQLVAIKQLNHEGL----------QGHQEFIVEVLMLSLLHHDNLVTLIG 59
V+ C +K G F V + + L L G
Sbjct: 14 SAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG 73
Query: 60 YCTSG----DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 115
+ ++ E + L ++ + + +
Sbjct: 74 LAVPKVYAWEGNAVLMELIDAKELYRV-----------RVENPDEVLDMILEEVAKFYHR 122
Query: 116 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 147
+++ DL N+L+ + + DF +
Sbjct: 123 ---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 311 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.66 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.18 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.8 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.05 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.01 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.42 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-54 Score=361.37 Aligned_cols=246 Identities=23% Similarity=0.292 Sum_probs=199.6
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
+..+|+|+||.||++.. +|+.||||++..... ...+.+.+|+++++.++||||+++++++.+++..++||||+++++
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~ 89 (271)
T d1nvra_ 10 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 89 (271)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCc
Confidence 57899999999999998 689999999876543 344678999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
|.+++. ....+++..+..++.|++.||+|||++| |+||||||+|||+++++.+||+|||++............
T Consensus 90 L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~ 162 (271)
T d1nvra_ 90 LFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 162 (271)
T ss_dssp GGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred HHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence 999994 4567999999999999999999999999 999999999999999999999999999864333333334
Q ss_pred eeccccccccCCccccCCCC-CccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCC
Q 021526 159 TRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 237 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......... . ..........
T Consensus 163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-~--------------~~~~~~~~~~ 227 (271)
T d1nvra_ 163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-S--------------DWKEKKTYLN 227 (271)
T ss_dssp CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH-H--------------HHHTTCTTST
T ss_pred cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH-H--------------HHhcCCCCCC
Confidence 45679999999999988776 578999999999999999999996433211100 0 0000011111
Q ss_pred CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 238 YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.....+.++.+||.+||+.||++|||++|+++
T Consensus 228 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 228 PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 12345678899999999999999999999865
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-53 Score=360.89 Aligned_cols=244 Identities=24% Similarity=0.263 Sum_probs=205.0
Q ss_pred CeeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 1 MLCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
++..+|+|+||.||++.. +|+.||||++........+.+.+|+++++.++||||+++++++.+++..++||||+++++
T Consensus 24 ~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~ 103 (293)
T d1yhwa1 24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (293)
T ss_dssp SCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred EEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCc
Confidence 357899999999999998 699999999987766667889999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
|.+++.. ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++...... ....
T Consensus 104 L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~--~~~~ 173 (293)
T d1yhwa1 104 LTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKR 173 (293)
T ss_dssp HHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST--TCCB
T ss_pred HHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccc--cccc
Confidence 9998843 46999999999999999999999999 999999999999999999999999999764322 2233
Q ss_pred eeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCC
Q 021526 159 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRY 238 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
....||+.|+|||++.+..++.++|||||||++|+|++|..||........ ...... ........
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~~~~---------~~~~~~~~ 238 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIAT---------NGTPELQN 238 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHH---------HCSCCCSS
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH------HHHHHh---------CCCCCCCC
Confidence 445799999999999999999999999999999999999999963321100 000000 00111123
Q ss_pred cHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 239 PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 239 ~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
+..++..+.+||.+||+.||++|||++|+++
T Consensus 239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 4566788999999999999999999999975
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-53 Score=358.92 Aligned_cols=258 Identities=29% Similarity=0.397 Sum_probs=201.1
Q ss_pred CeeeeeeceeccEEEEEECCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 1 MLCCYLSCKFYNVGLVWLCDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
+...+|+|+||.||++...+ .||||++.... ....+.+.+|++++++++||||+++++++. +...++||||+++|+
T Consensus 12 ~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~ 89 (276)
T d1uwha_ 12 VGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSS 89 (276)
T ss_dssp CCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEE
T ss_pred EEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCC
Confidence 35689999999999998765 59999986543 344568899999999999999999999865 456899999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCccee
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 158 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~ 158 (311)
|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++............
T Consensus 90 L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~ 163 (276)
T d1uwha_ 90 LYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 163 (276)
T ss_dssp HHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC----------
T ss_pred HHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCcccc
Confidence 9999965 3457999999999999999999999999 999999999999999999999999999764433333334
Q ss_pred eeccccccccCCccccC---CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 159 TRVMGTYGYCAPEYAMS---GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 159 ~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||......... . ...... ...+..
T Consensus 164 ~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~--~----~~~~~~-----~~~p~~- 231 (276)
T d1uwha_ 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--I----FMVGRG-----YLSPDL- 231 (276)
T ss_dssp --CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--H----HHHHHT-----SCCCCG-
T ss_pred cccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH--H----HHHhcC-----CCCCcc-
Confidence 45678999999999864 35789999999999999999999999643221110 0 000000 000000
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 278 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~ 278 (311)
...+..++..+.+++.+||+.||++|||+++|++.|+.+.+..
T Consensus 232 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 1123456778999999999999999999999999999988643
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=355.88 Aligned_cols=250 Identities=24% Similarity=0.326 Sum_probs=198.4
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
+..+|+|+||.||++.. +++.||||.+... ....+++.+|+++++.++||||+++++++.+++..++||||+++|+|.
T Consensus 10 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~ 88 (263)
T d1sm2a_ 10 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 88 (263)
T ss_dssp EEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred EEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHH
Confidence 56899999999999999 7889999998643 445678999999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++.. ....+++..++.++.|++.||+|||+++ ++||||||+|||+++++.+||+|||+++...... ......
T Consensus 89 ~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-~~~~~~ 161 (263)
T d1sm2a_ 89 DYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTG 161 (263)
T ss_dssp HHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC----------------
T ss_pred HHhhc---cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC-ceeecc
Confidence 99865 4567899999999999999999999999 9999999999999999999999999997543222 122233
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHhCC-CCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR-KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
..|+..|+|||++.+..++.++||||||+++|||+++. +||..... .... ..+....+...|
T Consensus 162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~------~~~~-----------~~i~~~~~~~~p 224 (263)
T d1sm2a_ 162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVV-----------EDISTGFRLYKP 224 (263)
T ss_dssp ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH------HHHH-----------HHHHHTCCCCCC
T ss_pred eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH------HHHH-----------HHHHhcCCCCCc
Confidence 56889999999999999999999999999999999964 45432111 0000 011111122234
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 276 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~ 276 (311)
..++.++.+++.+||+.||++|||+++|++.|+++..
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 5567789999999999999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.5e-53 Score=359.23 Aligned_cols=253 Identities=24% Similarity=0.325 Sum_probs=209.6
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
...+|+|+||.||++.. +++.||||.+... ....+++.+|+++++.++||||+++++++.++...+++|||+++|+|
T Consensus 22 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l 100 (287)
T d1opja_ 22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 100 (287)
T ss_dssp EEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred eeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcch
Confidence 46799999999999999 6899999998643 45567899999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
.+++.. .....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++..... ......
T Consensus 101 ~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~-~~~~~~ 174 (287)
T d1opja_ 101 LDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHA 174 (287)
T ss_dssp HHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS-SSEEET
T ss_pred HHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCC-Cceeec
Confidence 999965 34568999999999999999999999999 999999999999999999999999999754322 222223
Q ss_pred eccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 160 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
...|+..|+|||++.+..++.++|||||||++|+|++|..|+...... ..+.+.+....+...+
T Consensus 175 ~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~----------------~~~~~~i~~~~~~~~~ 238 (287)
T d1opja_ 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----------------SQVYELLEKDYRMERP 238 (287)
T ss_dssp TEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH----------------HHHHHHHHTTCCCCCC
T ss_pred cccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH----------------HHHHHHHhcCCCCCCC
Confidence 345788999999999999999999999999999999977765322211 1111112222233445
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 277 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~ 277 (311)
..++..+.+|+.+||+.||++|||+++|++.|+.+...
T Consensus 239 ~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 56778899999999999999999999999999887543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-53 Score=354.56 Aligned_cols=239 Identities=25% Similarity=0.333 Sum_probs=202.0
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccC---CccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHE---GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
...+|+|+||.||++.. +++.||+|++.+. .....+.+.+|+++++.++||||+++++++.+++..++||||+++
T Consensus 11 ~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~ 90 (263)
T d2j4za1 11 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 90 (263)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence 56899999999999999 6899999998653 233456788999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
|+|.+++.. ...+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++..... .
T Consensus 91 g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~----~ 159 (263)
T d2j4za1 91 GTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS----S 159 (263)
T ss_dssp CBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC----C
T ss_pred CcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC----C
Confidence 999999954 457999999999999999999999999 99999999999999999999999999975322 1
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ...... .. ..
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~----------~~--~~ 221 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TYKRIS----------RV--EF 221 (263)
T ss_dssp CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHH----------TT--CC
T ss_pred cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH------HHHHHH----------cC--CC
Confidence 2344679999999999999999999999999999999999999996432110 000110 00 11
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.+|..++.++.++|.+||+.||++|||++|+++
T Consensus 222 ~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 234556788999999999999999999999986
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-53 Score=357.92 Aligned_cols=245 Identities=21% Similarity=0.269 Sum_probs=203.1
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
+..+|+|+||.||++.. +++.||+|++........+.+.+|+++++.++||||+++++++.+++..++||||+++++|
T Consensus 17 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L 96 (288)
T d2jfla1 17 IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred eEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcH
Confidence 57899999999999998 7899999999877777778899999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
.+++.. ....+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++..... ......
T Consensus 97 ~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~~~~~~ 168 (288)
T d2jfla1 97 DAVMLE---LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQRRD 168 (288)
T ss_dssp HHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH--HHHHHT
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC--Cccccc
Confidence 999854 3467999999999999999999999999 99999999999999999999999999864211 111223
Q ss_pred eccccccccCCcccc-----CCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccC
Q 021526 160 RVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
...||+.|+|||++. +..++.++|||||||++|+|++|..||........ ....... ...
T Consensus 169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~------~~~i~~~---------~~~ 233 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV------LLKIAKS---------EPP 233 (288)
T ss_dssp CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHHHHHS---------CCC
T ss_pred ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH------HHHHHcC---------CCC
Confidence 457899999999874 45678999999999999999999999964332110 0011100 001
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
....+..++.++.+||.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 234 TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11234566788999999999999999999999976
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-52 Score=357.82 Aligned_cols=254 Identities=24% Similarity=0.349 Sum_probs=198.2
Q ss_pred eeeeeeceeccEEEEEE--CC---eEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CD---QLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~---~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
..++|+|+||.||++.. ++ ..||||.+.... ....+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~ 110 (299)
T d1jpaa_ 31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFME 110 (299)
T ss_dssp EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecC
Confidence 35899999999999998 23 368999876543 3344679999999999999999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+|+|.+++.. ..+.+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++........
T Consensus 111 ~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 184 (299)
T d1jpaa_ 111 NGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184 (299)
T ss_dssp TEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred CCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCCCCc
Confidence 9999998864 4567999999999999999999999999 999999999999999999999999999754322211
Q ss_pred ce---eeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcC
Q 021526 156 HV---STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231 (311)
Q Consensus 156 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
.. .....+++.|+|||.+.+..++.++|||||||++|||++ |..||....... +. ..+.
T Consensus 185 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---~~--------------~~i~ 247 (299)
T d1jpaa_ 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD---VI--------------NAIE 247 (299)
T ss_dssp -----------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH--------------HHHH
T ss_pred ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH---HH--------------HHHH
Confidence 11 112347889999999999999999999999999999998 899986332110 00 1111
Q ss_pred ccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 021526 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 278 (311)
Q Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~ 278 (311)
...+...+..++..+.+++.+||+.||++|||+.+|++.|+++.+..
T Consensus 248 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 248 QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence 11122345567888999999999999999999999999999987654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-52 Score=352.17 Aligned_cols=251 Identities=24% Similarity=0.307 Sum_probs=204.6
Q ss_pred eeeeceeccEEEEEE----CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 4 CYLSCKFYNVGLVWL----CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~----~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
++|+|+||.||+|.. ++..||||.+.... ....+.+.+|++++++++||||+++++++.+ +..++||||+++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 489999999999987 35579999987543 3345689999999999999999999999865 46899999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc-e
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH-V 157 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~-~ 157 (311)
|.+++.. ....+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++......... .
T Consensus 95 L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 168 (285)
T d1u59a_ 95 LHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 168 (285)
T ss_dssp HHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECC
T ss_pred HHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccccccccc
Confidence 9999854 4567999999999999999999999999 9999999999999999999999999998654332221 1
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
.....|++.|+|||++....++.++|||||||++|||++ |..||...... .+. ..+....+-
T Consensus 169 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~--------------~~i~~~~~~ 231 (285)
T d1u59a_ 169 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVM--------------AFIEQGKRM 231 (285)
T ss_dssp CCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHH--------------HHHHTTCCC
T ss_pred ccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHH--------------HHHHcCCCC
Confidence 223457899999999998999999999999999999998 89999643211 000 111111122
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 278 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~ 278 (311)
..|..++.++.+||.+||..||++|||+.+|.+.|+.+....
T Consensus 232 ~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 232 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 345667888999999999999999999999999998766543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-52 Score=346.96 Aligned_cols=249 Identities=24% Similarity=0.324 Sum_probs=207.4
Q ss_pred CeeeeeeceeccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 1 MLCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
++..+|+|+||.||++.. +++.||||.++.. ....+++.+|+.++..++||||+++++++.++...++||||+++|+|
T Consensus 8 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l 86 (258)
T d1k2pa_ 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 86 (258)
T ss_dssp CCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEH
T ss_pred EeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcH
Confidence 357899999999999999 6789999998754 34557899999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceee
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 159 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~ 159 (311)
.+++.. ....+++..++.++.|++.||+|||+.| |+|+||+|+||+++.++.+||+|||+++....... ....
T Consensus 87 ~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~ 159 (258)
T d1k2pa_ 87 LNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSV 159 (258)
T ss_dssp HHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CCCC
T ss_pred HHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc-eeec
Confidence 999754 4567899999999999999999999999 99999999999999999999999999975433222 2223
Q ss_pred eccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCC
Q 021526 160 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRY 238 (311)
Q Consensus 160 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||.......- . ..+....+...
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~---~--------------~~i~~~~~~~~ 222 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET---A--------------EHIAQGLRLYR 222 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH---H--------------HHHHTTCCCCC
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH---H--------------HHHHhCCCCCC
Confidence 3568899999999999999999999999999999998 7889864432110 0 00111112233
Q ss_pred cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 021526 239 PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274 (311)
Q Consensus 239 ~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l 274 (311)
|..++..+.++|.+||+.||++|||+++|++.|..|
T Consensus 223 p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 455677899999999999999999999999988653
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-53 Score=354.79 Aligned_cols=249 Identities=24% Similarity=0.288 Sum_probs=191.5
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc--chhHHHHHHHHHhcCCCCcccceeEEEEe--CCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTS--GDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~ 75 (311)
+..+|+|+||.||++.. +|+.||+|.+...... ..+.+.+|+++++.++||||+++++++.+ +...++||||++
T Consensus 9 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~ 88 (269)
T d2java1 9 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE 88 (269)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCT
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCC
Confidence 57899999999999998 6899999998765432 34578899999999999999999999854 456899999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCC
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA--NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 153 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~--~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~ 153 (311)
+|+|.+++.+.......+++..++.++.|++.||.|||+++ ...|+||||||+|||++.++.+||+|||++......
T Consensus 89 ~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~- 167 (269)
T d2java1 89 GGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD- 167 (269)
T ss_dssp TEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC----
T ss_pred CCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccC-
Confidence 99999999764445678999999999999999999999864 233999999999999999999999999998754322
Q ss_pred CcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 154 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 154 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
........||+.|+|||++.+..++.++|||||||++|+|++|..||...... ........ ..
T Consensus 168 -~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~------~~~~~i~~----------~~ 230 (269)
T d2java1 168 -TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------ELAGKIRE----------GK 230 (269)
T ss_dssp ---------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHH----------TC
T ss_pred -CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH------HHHHHHHc----------CC
Confidence 22233467899999999999999999999999999999999999999633211 00001100 00
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
....+..++.++.++|.+||+.||++|||++|+++
T Consensus 231 -~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 231 -FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11234456778999999999999999999999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-53 Score=357.95 Aligned_cols=244 Identities=21% Similarity=0.227 Sum_probs=200.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
..++|+|+||.||++.. +++.||||++.+.. ....+.+.+|+++++.++||||+++++++.+++..++||||+++
T Consensus 13 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~g 92 (288)
T d1uu3a_ 13 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 92 (288)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCC
Confidence 57899999999999998 68999999987542 33446789999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
|+|.+++.. .+.+++..++.++.|++.||+|||++| |+||||||+|||+++++.+||+|||++..........
T Consensus 93 g~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 93 GELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp EEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred CCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 999999853 467999999999999999999999999 9999999999999999999999999998654433333
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.. ...... ... ..
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i----------~~~--~~ 227 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY------LIFQKI----------IKL--EY 227 (288)
T ss_dssp ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHH----------HTT--CC
T ss_pred ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH------HHHHHH----------HcC--CC
Confidence 344567999999999999999999999999999999999999999643211 000011 111 11
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.+|...+.++.+||.+||+.||++|||++|+++.
T Consensus 228 ~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 228 DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 2344567789999999999999999999998654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-52 Score=350.33 Aligned_cols=247 Identities=25% Similarity=0.347 Sum_probs=199.0
Q ss_pred eeeeceeccEEEEEE----CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 4 CYLSCKFYNVGLVWL----CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~----~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
.+|+|+||.||+|.. .++.||||++.... ....+.+.+|++++++++||||+++++++.++ ..++||||+++|
T Consensus 14 ~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g 92 (277)
T d1xbba_ 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELG 92 (277)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTTE
T ss_pred CcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCCC
Confidence 599999999999987 24689999986543 23346799999999999999999999998654 578999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc-
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH- 156 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~- 156 (311)
+|.+++.. ...+++..++.++.||+.||+|||+++ ++||||||+|||++.++.+||+|||+++.........
T Consensus 93 ~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 93 PLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred cHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999953 467999999999999999999999999 9999999999999999999999999997543322222
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
......|++.|+|||++.+..++.++||||||+++|||++ |..||...... .+...+....+
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-----------------~~~~~i~~~~~ 228 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----------------EVTAMLEKGER 228 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----------------HHHHHHHTTCC
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH-----------------HHHHHHHcCCC
Confidence 2233568899999999999999999999999999999997 89999633211 01111111122
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 275 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~ 275 (311)
-..|..++.++.+|+.+||+.||++|||+++|.+.|+.+-
T Consensus 229 ~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 2345567888999999999999999999999998887653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-52 Score=349.66 Aligned_cols=251 Identities=25% Similarity=0.378 Sum_probs=202.4
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
...+|+|+||.||+|.+ +++.||||++... ....+.+.+|++++++++||||+++++++.+ +..++||||+++|+|.
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~ 95 (272)
T d1qpca_ 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLV 95 (272)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHH
T ss_pred eEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHH
Confidence 46799999999999999 6789999998644 4455789999999999999999999998754 5679999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++.. .....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..... .......
T Consensus 96 ~~~~~--~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~-~~~~~~~ 169 (272)
T d1qpca_ 96 DFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREG 169 (272)
T ss_dssp HHTTS--HHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS-CEECCTT
T ss_pred HHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCC-ccccccc
Confidence 98854 23346899999999999999999999999 999999999999999999999999999864322 1122233
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCcH
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPR 240 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (311)
..|+..|+|||++.+..++.++||||||+++|+|++|..|+....... . ....+....+...|.
T Consensus 170 ~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-----~-----------~~~~i~~~~~~~~p~ 233 (272)
T d1qpca_ 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----E-----------VIQNLERGYRMVRPD 233 (272)
T ss_dssp CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----H-----------HHHHHHTTCCCCCCT
T ss_pred cCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-----H-----------HHHHHHhcCCCCCcc
Confidence 567889999999998899999999999999999999665543211110 0 000111112223345
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 021526 241 RCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 276 (311)
Q Consensus 241 ~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~ 276 (311)
.++.++.+|+.+||+.||++|||+++|++.|+.+-.
T Consensus 234 ~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 667889999999999999999999999999988754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-51 Score=353.61 Aligned_cols=244 Identities=23% Similarity=0.274 Sum_probs=186.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc-chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
..++|+|+||.||++.. +++.||||.+.+.... ....+.+|+.+++.++||||+++++++.+++..++||||+++++
T Consensus 14 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~ 93 (307)
T d1a06a_ 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGE 93 (307)
T ss_dssp EEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCc
Confidence 56899999999999998 6899999999765433 33567899999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEc---CCCceEEeecCCCccCCCCCCc
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD---NDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~---~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
|.+++. ....+++..+..++.||+.||+|||+++ ++||||||+||++. +++.+||+|||++..... .
T Consensus 94 L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~---~ 163 (307)
T d1a06a_ 94 LFDRIV----EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP---G 163 (307)
T ss_dssp HHHHHH----TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred HHHhhh----cccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccC---C
Confidence 999995 3567999999999999999999999999 99999999999994 578899999999974322 2
Q ss_pred ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 156 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ........ .....
T Consensus 164 ~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~~--------~~~~~ 229 (307)
T d1a06a_ 164 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK------LFEQILKA--------EYEFD 229 (307)
T ss_dssp ---------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHTT--------CCCCC
T ss_pred CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHhcc--------CCCCC
Confidence 22344679999999999999999999999999999999999999996322110 00011100 00111
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
...+..++.++.+||.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1223456778999999999999999999999987
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=356.34 Aligned_cols=252 Identities=25% Similarity=0.348 Sum_probs=203.2
Q ss_pred eeeeeeceeccEEEEEE--CC-----eEEEEEEeccC-CccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL--CD-----QLVAIKQLNHE-GLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~-----~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 72 (311)
...+|+|+||.||++.. .+ ..||+|.+... .......+.+|+.++.++ +||||+++++++.+++..++|||
T Consensus 42 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 121 (325)
T d1rjba_ 42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 121 (325)
T ss_dssp EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEE
Confidence 46799999999999998 22 37999998654 334456789999999988 89999999999999999999999
Q ss_pred cCCCCCHHHHhcccCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEc
Q 021526 73 YMPMGSLEDHLYDLEP-------------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD 133 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~-------------------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~ 133 (311)
|+++|+|.+++..... ....+++..++.++.|++.||+|||+++ |+||||||+||+++
T Consensus 122 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~Nill~ 198 (325)
T d1rjba_ 122 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVT 198 (325)
T ss_dssp CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEE
T ss_pred cCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchhccccc
Confidence 9999999999975331 1245899999999999999999999999 99999999999999
Q ss_pred CCCceEEeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccc
Q 021526 134 NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNL 212 (311)
Q Consensus 134 ~~~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~ 212 (311)
.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 199 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~---- 274 (325)
T d1rjba_ 199 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA---- 274 (325)
T ss_dssp TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH----
T ss_pred cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH----
Confidence 999999999999976444333333444567999999999999999999999999999999997 899996433211
Q ss_pred hhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 021526 213 VSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 272 (311)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~ 272 (311)
.+...+....+-..|..++.++.+||.+||+.||++|||++||++.|.
T Consensus 275 ------------~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 275 ------------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp ------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ------------HHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 111111122223445667888999999999999999999999999985
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.7e-51 Score=356.06 Aligned_cols=246 Identities=20% Similarity=0.194 Sum_probs=204.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
...+|+|+||.||++.. +|+.||||++........+.+.+|+++++.++||||+++++++.+++..++||||+++|+|
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L 110 (350)
T d1koaa2 31 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 110 (350)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBH
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCH
Confidence 57899999999999998 6999999999877666667899999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEc--CCCceEEeecCCCccCCCCCCcce
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD--NDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~--~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
.+++.. ....+++..+..++.||+.||+|||++| ++||||||+|||++ .++.+||+|||++..... ...
T Consensus 111 ~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~---~~~ 181 (350)
T d1koaa2 111 FEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---KQS 181 (350)
T ss_dssp HHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT---TSC
T ss_pred HHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccc---ccc
Confidence 999954 4467999999999999999999999999 99999999999995 467899999999975432 233
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCC
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 237 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...... .......... ......
T Consensus 182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~--------~~~~~~ 247 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVKSCD--------WNMDDS 247 (350)
T ss_dssp EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTC--------CCSCCG
T ss_pred cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC--------CCCCcc
Confidence 44567899999999999999999999999999999999999999643211 0011111100 001111
Q ss_pred CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 238 YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
....++.++.+||.+||..||++|||++|+++.
T Consensus 248 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 248 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 223456789999999999999999999999873
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-51 Score=346.84 Aligned_cols=255 Identities=25% Similarity=0.324 Sum_probs=200.9
Q ss_pred eeeeeeceeccEEEEEEC--C----eEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWLC--D----QLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~--~----~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
..++|+|+||.||+|... + ..||||.+..... ....++.+|++++++++||||+++++++.++...+++||++
T Consensus 12 ~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~ 91 (283)
T d1mqba_ 12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 91 (283)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEec
Confidence 357999999999999882 2 4799999865433 33457889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
.++++.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 92 ~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 165 (283)
T d1mqba_ 92 ENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 165 (283)
T ss_dssp TTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred ccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence 99999998865 4567999999999999999999999999 99999999999999999999999999975433222
Q ss_pred cc-eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 155 TH-VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 155 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
.. ......||..|+|||++.+..++.++||||||+++|||++|..|+...... ..+...+...
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~----------------~~~~~~i~~~ 229 (283)
T d1mqba_ 166 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----------------HEVMKAINDG 229 (283)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------------HHHHHHHHTT
T ss_pred cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH----------------HHHHHHHhcc
Confidence 11 222345789999999999999999999999999999999976655322111 0111111222
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhcc
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 278 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~ 278 (311)
.+...+..++..+.++|.+||+.||++|||+.+|++.|+.+....
T Consensus 230 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 233445567788999999999999999999999999999987653
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.6e-51 Score=354.73 Aligned_cols=245 Identities=19% Similarity=0.195 Sum_probs=204.5
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
+..+|+|+||.||++.. +|+.||||++..........+.+|+++++.++||||++++++|.++...++||||+++++|
T Consensus 34 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L 113 (352)
T d1koba_ 34 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL 113 (352)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBH
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChH
Confidence 57899999999999998 7999999999876666667889999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEc--CCCceEEeecCCCccCCCCCCcce
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD--NDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~--~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
.+++.. ....+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||++..... ...
T Consensus 114 ~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~---~~~ 184 (352)
T d1koba_ 114 FDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP---DEI 184 (352)
T ss_dssp HHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT---TSC
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCC---CCc
Confidence 998853 4567999999999999999999999999 99999999999997 678999999999986433 233
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCC
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 237 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
.....|++.|+|||++.+..++.++|||||||++|+|++|..||........ ...... ........
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~i~~--------~~~~~~~~ 250 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET------LQNVKR--------CDWEFDED 250 (352)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHH--------CCCCCCSS
T ss_pred eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHh--------CCCCCCcc
Confidence 4456789999999999999999999999999999999999999963322110 001111 00111112
Q ss_pred CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 238 YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.....+.++.+||.+||+.||.+|||++|+++
T Consensus 251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22356778999999999999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-51 Score=350.28 Aligned_cols=239 Identities=26% Similarity=0.291 Sum_probs=196.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc---chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+..+|+|+||.||++.. +++.||||.+...... ..+.+.+|+++++.++||||+++++++.+++..++||||+.+
T Consensus 20 l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~ 99 (309)
T d1u5ra_ 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG 99 (309)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCC
Confidence 57899999999999998 7899999998765433 235688999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|..++. ....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 100 g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----- 167 (309)
T d1u5ra_ 100 SASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167 (309)
T ss_dssp EHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred CchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-----
Confidence 98877663 3467999999999999999999999999 99999999999999999999999999975322
Q ss_pred eeeeccccccccCCccccC---CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 157 VSTRVMGTYGYCAPEYAMS---GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... ...... ...
T Consensus 168 -~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~------~~~~i~----------~~~ 230 (309)
T d1u5ra_ 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIA----------QNE 230 (309)
T ss_dssp -BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHH----------HSC
T ss_pred -CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH------HHHHHH----------hCC
Confidence 233569999999999864 468899999999999999999999996322110 000000 000
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.....+..++..+.+||.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 231 SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 111112345678999999999999999999999976
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-51 Score=343.91 Aligned_cols=242 Identities=25% Similarity=0.313 Sum_probs=192.6
Q ss_pred eeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEe----CCeeEEEEecC
Q 021526 3 CCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS----GDQRLLVYEYM 74 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~ 74 (311)
..+|+|+||.||++.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+ +...++||||+
T Consensus 15 ~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~ 94 (270)
T d1t4ha_ 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 94 (270)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCC
Confidence 4699999999999999 68899999987553 2344678999999999999999999999865 34579999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEc-CCCceEEeecCCCccCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAKLGPVGD 153 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~-~~~~vkl~Df~~~~~~~~~~ 153 (311)
++++|.+++.. ...+++..+..++.||+.||+|||+++ .+|+||||||+|||++ .++.+||+|||+++....
T Consensus 95 ~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~-- 167 (270)
T d1t4ha_ 95 TSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-- 167 (270)
T ss_dssp CSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT--
T ss_pred CCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC--
Confidence 99999999954 457999999999999999999999874 3499999999999996 578999999999974322
Q ss_pred CcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 154 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 154 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
.......||+.|+|||++.+ .++.++|||||||++|+|++|+.||........ ...... ...
T Consensus 168 --~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~-----~~~~i~----------~~~ 229 (270)
T d1t4ha_ 168 --SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IYRRVT----------SGV 229 (270)
T ss_dssp --TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----HHHHHT----------TTC
T ss_pred --CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH-----HHHHHH----------cCC
Confidence 22334679999999998865 589999999999999999999999963221110 000000 000
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
.....+...++++.++|.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 230 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 001112334567999999999999999999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=356.71 Aligned_cols=262 Identities=21% Similarity=0.215 Sum_probs=201.6
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC-ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
+..+|+|+||.||++.. +|+.||+|.+.... ......+.+|+.+++.++||||++++++|.++...++||||+++++
T Consensus 11 ~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~ 90 (322)
T d1s9ja_ 11 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 90 (322)
T ss_dssp EEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCc
Confidence 57899999999999998 78999999987653 3344678999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~-~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
|.+++.+ .+.+++..+..++.|++.||.|||++ + |+||||||+|||++.++.+||+|||++..... ..
T Consensus 91 L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~----~~ 159 (322)
T d1s9ja_ 91 LDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SM 159 (322)
T ss_dssp HHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH----HT
T ss_pred HHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC----Cc
Confidence 9999954 45699999999999999999999974 8 99999999999999999999999999874321 11
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchh-cchh------------------
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS-WSRP------------------ 218 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~------------------ 218 (311)
.....||+.|+|||++.+..++.++||||+||++|+|++|+.||............. ....
T Consensus 160 ~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239 (322)
T ss_dssp C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence 234579999999999999999999999999999999999999996543211100000 0000
Q ss_pred h---hhcccchhhh----cCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHHh
Q 021526 219 F---LKDQKKFVHL----VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV--ALDYL 274 (311)
Q Consensus 219 ~---~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~--~L~~l 274 (311)
. ........+. .............+.++.+||.+||+.||++|||++|+++ .++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 0 0000000000 0000000111224577999999999999999999999998 35543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=343.39 Aligned_cols=247 Identities=28% Similarity=0.368 Sum_probs=197.9
Q ss_pred eeeeeeceeccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEe-CCeeEEEEecCCCCCHH
Q 021526 2 LCCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS-GDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~ 80 (311)
...+|+|+||.||++...|+.||||.+... ...+.+.+|++++++++||||+++++++.+ +...++||||+++|+|.
T Consensus 12 ~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~ 89 (262)
T d1byga_ 12 LQTIGKGEFGDVMLGDYRGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 89 (262)
T ss_dssp EEEEEECSSCEEEEEEETTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHH
T ss_pred eEEEecCCCeEEEEEEECCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHH
Confidence 567999999999999999999999998643 345789999999999999999999999854 45689999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
+++.. .....+++..++.++.||+.||+|||+.+ ++|+||+|+||+++.++.+||+|||.+..... ....
T Consensus 90 ~~l~~--~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-----~~~~ 159 (262)
T d1byga_ 90 DYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDT 159 (262)
T ss_dssp HHHHH--HHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------------
T ss_pred HHHHh--cCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC-----CCcc
Confidence 99964 22345899999999999999999999999 99999999999999999999999999874322 1233
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCc
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 239 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
..++..|+|||.+.+..+++++||||||+++|||++ |.+||...... .+...+....+...+
T Consensus 160 ~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~-----------------~~~~~i~~~~~~~~~ 222 (262)
T d1byga_ 160 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----------------DVVPRVEKGYKMDAP 222 (262)
T ss_dssp --CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-----------------GHHHHHTTTCCCCCC
T ss_pred ccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH-----------------HHHHHHHcCCCCCCC
Confidence 457889999999998999999999999999999998 67777532211 111111122233445
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 021526 240 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 277 (311)
Q Consensus 240 ~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~ 277 (311)
..++..+.++|.+||..||++|||+.+|++.|++++..
T Consensus 223 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 66778899999999999999999999999999998753
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=343.16 Aligned_cols=252 Identities=26% Similarity=0.335 Sum_probs=200.4
Q ss_pred eeeeeeceeccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCHH
Q 021526 2 LCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 80 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (311)
.+.+|+|+||.||+|+. +++.||||.+... ....+.+.+|+.+++.++||||+++++++. ++..++||||+.+|+|.
T Consensus 22 ~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~ 99 (285)
T d1fmka3 22 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLL 99 (285)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHH
T ss_pred eeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCchh
Confidence 46799999999999999 6778999998643 455678999999999999999999999985 45689999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcceeee
Q 021526 81 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 160 (311)
Q Consensus 81 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~~~~ 160 (311)
.++.. .....+++..++.++.||+.||+|||+++ ++||||||+|||++.++.+||+|||+++..... .......
T Consensus 100 ~~~~~--~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~-~~~~~~~ 173 (285)
T d1fmka3 100 DFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQG 173 (285)
T ss_dssp HHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred hhhhh--cccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCC-Cceeecc
Confidence 99865 23456999999999999999999999999 999999999999999999999999999754322 2222334
Q ss_pred ccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCCCcH
Q 021526 161 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPR 240 (311)
Q Consensus 161 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (311)
..|++.|+|||.+....++.++||||||+++|+|++|..|+....... .....+....+...+.
T Consensus 174 ~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~----------------~~~~~i~~~~~~~~~~ 237 (285)
T d1fmka3 174 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----------------EVLDQVERGYRMPCPP 237 (285)
T ss_dssp --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----------------HHHHHHHTTCCCCCCT
T ss_pred ccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH----------------HHHHHHHhcCCCCCCc
Confidence 568999999999999999999999999999999999766653222110 0011111112223456
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 021526 241 RCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 277 (311)
Q Consensus 241 ~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~ 277 (311)
.++.++.++|.+||+.||++||++++|++.|+.+...
T Consensus 238 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 6788899999999999999999999999999886654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-50 Score=347.34 Aligned_cols=241 Identities=27% Similarity=0.288 Sum_probs=202.9
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+.++|.|+||.||++.. +|+.||||++.+.. ......+.+|+.+++.++||||+++++++.++...++||||+.+
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~g 89 (337)
T d1o6la_ 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCC
Confidence 57899999999999998 79999999987542 33456788999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
|+|.+++.. ...+++..++.++.|++.||+|||++| |+||||||+|||++.+|.+||+|||+++..... ..
T Consensus 90 g~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~--~~ 160 (337)
T d1o6la_ 90 GELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GA 160 (337)
T ss_dssp CBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT--TC
T ss_pred Cchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC--Cc
Confidence 999999954 567899999999999999999999999 999999999999999999999999999753222 22
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
......||+.|+|||++.+..++.++|+|||||++|+|++|.+||...+... ....... . .-
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~------~~~~i~~----------~--~~ 222 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELILM----------E--EI 222 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH----------C--CC
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH------HHHHHhc----------C--CC
Confidence 2344679999999999999999999999999999999999999997443211 0111111 0 11
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 269 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RPs-----~~~l~~ 269 (311)
.+|..++.++.+||.+||+.||.+||+ ++++++
T Consensus 223 ~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 234556778999999999999999995 888877
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=343.72 Aligned_cols=244 Identities=23% Similarity=0.235 Sum_probs=199.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc------cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL------QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
...+|+|+||.||++.. +|+.||||++.+... ...+.+.+|+++++.++||||+++++++.++...++||||
T Consensus 15 ~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (293)
T d1jksa_ 15 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 94 (293)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 57899999999999998 689999999875432 2346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCC----ceEEeecCCCccC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF----NPKLSDFGLAKLG 149 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~----~vkl~Df~~~~~~ 149 (311)
+++++|.+++.. .+.+++..++.++.|++.||+|||+++ ++||||||+||+++.++ .+||+|||++...
T Consensus 95 ~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 95 VAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred CCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 999999999954 457999999999999999999999999 99999999999998776 4999999999754
Q ss_pred CCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhh
Q 021526 150 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 229 (311)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
... .......+++.|+|||++.+..++.++|||||||++|+|++|..||........ .........
T Consensus 168 ~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~------~~~i~~~~~----- 233 (293)
T d1jksa_ 168 DFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LANVSAVNY----- 233 (293)
T ss_dssp TTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHTTCC-----
T ss_pred CCC---ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH------HHHHHhcCC-----
Confidence 322 223345689999999999999999999999999999999999999964322110 001100000
Q ss_pred cCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 230 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 230 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
......+..++..+.+||.+||+.||++|||++|+++
T Consensus 234 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 ---EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ---CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000112245677999999999999999999999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=348.03 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=201.5
Q ss_pred eeeeeeceeccEEEEEE--CCe----EEEEEEeccC-CccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQ----LVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
+.++|+|+||.||+|.. +|+ +||+|.+... .....+.+.+|++++++++||||+++++++.++ ..+++++++
T Consensus 14 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~ 92 (317)
T d1xkka_ 14 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM 92 (317)
T ss_dssp EEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECC
T ss_pred eeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEec
Confidence 57899999999999998 333 6899988644 344567899999999999999999999998765 567888999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
.+++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 93 ~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 93 PFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp TTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred cCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 99999998865 5678999999999999999999999999 99999999999999999999999999976544333
Q ss_pred cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 155 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
........||..|+|||++.+..++.++|||||||++|+|+| |.+||....... +...+...
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~-----------------~~~~i~~~ 229 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----------------ISSILEKG 229 (317)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-----------------HHHHHHHT
T ss_pred cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH-----------------HHHHHHcC
Confidence 333344568999999999999999999999999999999998 788886432211 11111111
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 277 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~ 277 (311)
.+-..+..++..+.+++.+||..||++|||+.+|++.|..+...
T Consensus 230 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 22234566788899999999999999999999999999888654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=340.78 Aligned_cols=254 Identities=22% Similarity=0.312 Sum_probs=196.5
Q ss_pred CeeeeeeceeccEEEEEEC-----CeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 1 MLCCYLSCKFYNVGLVWLC-----DQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~~-----~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
+...+|+|+||.||++... +..||||.+..... ...+.+.+|++++++++||||+++++++. ++..++||||+
T Consensus 11 l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~ 89 (273)
T d1mp8a_ 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELC 89 (273)
T ss_dssp EEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred EEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEec
Confidence 3578999999999999882 35689998865433 33467899999999999999999999985 56789999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
++++|.+++.. ....+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++......
T Consensus 90 ~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~- 162 (273)
T d1mp8a_ 90 TLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST- 162 (273)
T ss_dssp TTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------------
T ss_pred cCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCCc-
Confidence 99999998764 4567999999999999999999999999 9999999999999999999999999997543221
Q ss_pred cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 155 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
........|++.|+|||++.+..++.++||||||+++|+|++ |.+||....... +.. .. ...
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~---~i-----------~~~ 225 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIG---RI-----------ENG 225 (273)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH---HH-----------HTT
T ss_pred ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHH---HH-----------HcC
Confidence 222334567899999999999999999999999999999998 788886433211 000 00 011
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 279 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~ 279 (311)
.+...+..++..+.+||.+||..||++|||+++|++.|+.+....+
T Consensus 226 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k 271 (273)
T d1mp8a_ 226 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271 (273)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 1123455678889999999999999999999999999998876543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.8e-50 Score=342.74 Aligned_cols=240 Identities=27% Similarity=0.346 Sum_probs=201.9
Q ss_pred CeeeeeeceeccEEEEEE--CCeEEEEEEeccC---CccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCC
Q 021526 1 MLCCYLSCKFYNVGLVWL--CDQLVAIKQLNHE---GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
++..+|+|+||.||++.. +|+.||||++.+. .....+.+.+|+.+++.++||||+++++++.++...++||||+.
T Consensus 8 i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 87 (316)
T d1fota_ 8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE 87 (316)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecC
Confidence 367899999999999998 6899999998654 23445678999999999999999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
|++|..++. ....+++..+..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||++......
T Consensus 88 gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--- 157 (316)
T d1fota_ 88 GGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 157 (316)
T ss_dssp SCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred Ccccccccc----ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence 999999984 4567888999999999999999999999 999999999999999999999999999754322
Q ss_pred ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCC
Q 021526 156 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 235 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ........ . .
T Consensus 158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~i~~----------~--~ 217 (316)
T d1fota_ 158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKILN----------A--E 217 (316)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHH----------C--C
T ss_pred --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH------HHHHHHHc----------C--C
Confidence 23467999999999999999999999999999999999999999643211 00111111 1 1
Q ss_pred CCCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 021526 236 GRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVVA 270 (311)
Q Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~l~~~ 270 (311)
..++...+.++.+++.+||+.||.+|+ |++++++.
T Consensus 218 ~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 218 LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 123455677899999999999999996 89999873
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.2e-50 Score=342.21 Aligned_cols=254 Identities=24% Similarity=0.326 Sum_probs=204.4
Q ss_pred eeeeeeceeccEEEEEEC-------CeEEEEEEeccCCcc-chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWLC-------DQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~-------~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
+..+|+|+||.||+|... ++.||||++...... ..+++.+|+++++.++||||+++++++......+++||+
T Consensus 18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~ 97 (301)
T d1lufa_ 18 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEY 97 (301)
T ss_dssp EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEe
Confidence 578999999999999873 478999998754333 346799999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcccC--------------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEc
Q 021526 74 MPMGSLEDHLYDLE--------------------PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD 133 (311)
Q Consensus 74 ~~~~~L~~~l~~~~--------------------~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~ 133 (311)
+.+++|.+++.... .....+++..++.++.|++.||+|||+++ ++||||||+|||++
T Consensus 98 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~NILld 174 (301)
T d1lufa_ 98 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVG 174 (301)
T ss_dssp CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred cCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcccceEEC
Confidence 99999999996422 12345899999999999999999999999 99999999999999
Q ss_pred CCCceEEeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCC-CCccccCccccccc
Q 021526 134 NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR-KAMDLSKGQGEQNL 212 (311)
Q Consensus 134 ~~~~vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~-~p~~~~~~~~~~~~ 212 (311)
+++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++|. +||........
T Consensus 175 ~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~--- 251 (301)
T d1lufa_ 175 ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV--- 251 (301)
T ss_dssp GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---
T ss_pred CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHH---
Confidence 99999999999987543333333334566889999999999999999999999999999999986 56653321110
Q ss_pred hhcchhhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 021526 213 VSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 275 (311)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~ 275 (311)
. ..+.. ......+..++.++.+|+.+||+.+|++|||+.+|++.|++++
T Consensus 252 ---~----------~~v~~-~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 252 ---I----------YYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp ---H----------HHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ---H----------HHHHc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 0 00001 1111234566778999999999999999999999999999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=335.84 Aligned_cols=255 Identities=26% Similarity=0.336 Sum_probs=203.6
Q ss_pred eeeeeeceeccEEEEEE--CCe--EEEEEEeccC-CccchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEecCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQ--LVAIKQLNHE-GLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMP 75 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~--~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (311)
..++|+|+||.||++.. ++. .||||.+... .....+.+.+|+++++.+ +||||+++++++.+++..++||||++
T Consensus 15 ~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~ 94 (309)
T d1fvra_ 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 94 (309)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecC
Confidence 46899999999999998 444 5788887543 334567899999999998 79999999999999999999999999
Q ss_pred CCCHHHHhccc------------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeec
Q 021526 76 MGSLEDHLYDL------------EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 143 (311)
Q Consensus 76 ~~~L~~~l~~~------------~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df 143 (311)
+|+|.+++... ......+++..++.++.|++.|+.|||+++ ++||||||+|||++.++.+||+||
T Consensus 95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~kl~Df 171 (309)
T d1fvra_ 95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF 171 (309)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCT
T ss_pred CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCceEEccc
Confidence 99999999653 124578999999999999999999999999 999999999999999999999999
Q ss_pred CCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCC-CccccCccccccchhcchhhhhc
Q 021526 144 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK-AMDLSKGQGEQNLVSWSRPFLKD 222 (311)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~-p~~~~~~~~~~~~~~~~~~~~~~ 222 (311)
|+++... .........|+..|+|||.+.+..++.++||||||+++|+|++|.. ||.......
T Consensus 172 G~a~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~-------------- 234 (309)
T d1fvra_ 172 GLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------------- 234 (309)
T ss_dssp TCEESSC---EECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------------
T ss_pred ccccccc---ccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH--------------
Confidence 9987422 2222234458899999999999999999999999999999999764 564322110
Q ss_pred ccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 021526 223 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 279 (311)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~ 279 (311)
+...+....+-..+..++.++.+||.+||+.||++|||+++|++.|+++....+
T Consensus 235 ---~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 235 ---LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp ---HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred ---HHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 011111112223455677889999999999999999999999999999987654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=335.25 Aligned_cols=250 Identities=28% Similarity=0.324 Sum_probs=192.7
Q ss_pred eeeeeeceeccEEEEEE---C--CeEEEEEEeccCC---ccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL---C--DQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~---~--~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
+..+|+|+||.||+|.. + +..||||++.+.. ....+.+.+|+.+++.++||||+++++++.+ ...++||||
T Consensus 13 ~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~ 91 (273)
T d1u46a_ 13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTEL 91 (273)
T ss_dssp EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred EEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeee
Confidence 56799999999999987 2 2478999987542 2334678999999999999999999999965 467899999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 153 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~ 153 (311)
++++++.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++......
T Consensus 92 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 92 APLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp CTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred ecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 999999998865 4467999999999999999999999999 9999999999999999999999999998654333
Q ss_pred Ccce-eeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcchhhhhcccchhhhcC
Q 021526 154 NTHV-STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231 (311)
Q Consensus 154 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
.... .....++..|+|||.+.+..++.++||||||+++|||++ |..||........ ...+..
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~----------------~~~i~~ 229 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI----------------LHKIDK 229 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----------------HHHHHT
T ss_pred CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH----------------HHHHHh
Confidence 3222 223457789999999999999999999999999999998 8999863322110 011111
Q ss_pred ccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 021526 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 274 (311)
Q Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l 274 (311)
...+-..+..++..+.++|.+||..||++|||+.+|.+.|.+.
T Consensus 230 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 230 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1122233455677899999999999999999999999988875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-49 Score=338.08 Aligned_cols=244 Identities=15% Similarity=0.167 Sum_probs=199.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCCCH
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 79 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (311)
+..+|+|+||.||++.. +++.||+|.+.... .....+.+|+++|+.++||||++++++|.+++..|+||||+++++|
T Consensus 10 ~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L 88 (321)
T d1tkia_ 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI 88 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBH
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcH
Confidence 57899999999999998 78999999997553 3345688999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCC--CceEEeecCCCccCCCCCCcce
Q 021526 80 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND--FNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 80 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~--~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
.+++.. .+..+++..+..++.||+.||+|||+.| |+||||||+|||++.+ ..++|+|||++.... ....
T Consensus 89 ~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~---~~~~ 159 (321)
T d1tkia_ 89 FERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK---PGDN 159 (321)
T ss_dssp HHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECC---TTCE
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccc---cCCc
Confidence 999954 3457999999999999999999999999 9999999999999754 479999999997532 2233
Q ss_pred eeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCCC
Q 021526 158 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 237 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
.....+++.|+|||...+..++.++|||||||++|+|++|..||...... ............+.. .
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~------~~~~~i~~~~~~~~~--------~ 225 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNAEYTFDE--------E 225 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCCCCH--------H
T ss_pred ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCCCh--------h
Confidence 44566899999999999999999999999999999999999999643321 001111110000000 0
Q ss_pred CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 238 YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
....++.++.+||.+||..||++|||++|+++
T Consensus 226 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01134667899999999999999999999987
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.5e-48 Score=330.22 Aligned_cols=253 Identities=22% Similarity=0.236 Sum_probs=196.6
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc---chhHHHHHHHHHhcCCCCcccceeEEEEeCC----eeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD----QRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e 72 (311)
...+|+|+||.||++.. +++.||||++.+.... ....+.+|+++++.++||||+++++++..+. ..|+|||
T Consensus 12 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE 91 (277)
T d1o6ya_ 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 91 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEE
Confidence 57899999999999998 7999999999765433 3357889999999999999999999987654 3789999
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCC
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~ 152 (311)
|+++++|.+++.. .+.+++..++.++.|++.||+|||++| ++||||||+||+++.++.++++|||.+......
T Consensus 92 ~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 92 YVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp CCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred CCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhccc
Confidence 9999999998854 457999999999999999999999999 999999999999999999999999987643222
Q ss_pred CC-cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcC
Q 021526 153 DN-THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 231 (311)
Q Consensus 153 ~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|..||....... ...........
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~~~~~~~~------ 232 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPI------ 232 (277)
T ss_dssp --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCC------
T ss_pred cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH------HHHHHHhcCCC------
Confidence 22 122334568999999999999999999999999999999999999996432211 01111111100
Q ss_pred ccCCCCCcHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHhh
Q 021526 232 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-LINDIVVALDYLV 275 (311)
Q Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-s~~~l~~~L~~l~ 275 (311)
........++.++.++|.+||+.||++|| |++++++.|.++.
T Consensus 233 --~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 233 --PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp --CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 00011234567899999999999999999 8999999888764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.3e-49 Score=341.75 Aligned_cols=238 Identities=24% Similarity=0.237 Sum_probs=200.7
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccC---CccchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHE---GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
+..+|+|+||.||++.. +|+.||||++.+. .....+.+.+|+++++.++||||+++++++.+....++|||++.+
T Consensus 46 ~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~ 125 (350)
T d1rdqe_ 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccc
Confidence 57899999999999998 6999999998654 233456789999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
++|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 126 g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---- 194 (350)
T d1rdqe_ 126 GEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---- 194 (350)
T ss_dssp CBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred cchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc----
Confidence 999999954 457999999999999999999999999 999999999999999999999999999864322
Q ss_pred eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccCCC
Q 021526 157 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 236 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ........ .. .
T Consensus 195 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~i~~----------~~--~ 255 (350)
T d1rdqe_ 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIYEKIVS----------GK--V 255 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH----------CC--C
T ss_pred -cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH------HHHHHHhc----------CC--C
Confidence 23456899999999999999999999999999999999999999633211 11111111 00 1
Q ss_pred CCcHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 021526 237 RYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 269 (311)
Q Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~l~~ 269 (311)
..+..++.++.++|.+||+.||.+|+ |++++++
T Consensus 256 ~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 22445677899999999999999994 8999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-49 Score=338.06 Aligned_cols=256 Identities=25% Similarity=0.297 Sum_probs=194.4
Q ss_pred eeeeeeceeccEEEEEE-------CCeEEEEEEeccCCc-cchhHHHHHHHHHhcC-CCCcccceeEEEEeC-CeeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL-------CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSG-DQRLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~~~~lv~ 71 (311)
...+|+|+||.||++.. +++.||||.+..... ...+.+.+|...+.++ +|+||+.+++++..+ ...+++|
T Consensus 18 ~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~ 97 (299)
T d1ywna1 18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 97 (299)
T ss_dssp EEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred eeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEE
Confidence 56899999999999997 246899999865433 3345677888888776 688999999987654 4689999
Q ss_pred ecCCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceE
Q 021526 72 EYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 139 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vk 139 (311)
||+++|+|.+++..... ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+|
T Consensus 98 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~~~~~K 174 (299)
T d1ywna1 98 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVK 174 (299)
T ss_dssp ECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEE
T ss_pred EecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECCCCcEE
Confidence 99999999999965321 2346899999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCC-CCccccCccccccchhcchh
Q 021526 140 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR-KAMDLSKGQGEQNLVSWSRP 218 (311)
Q Consensus 140 l~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~-~p~~~~~~~~~~~~~~~~~~ 218 (311)
|+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++|. +||........
T Consensus 175 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~--------- 245 (299)
T d1ywna1 175 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--------- 245 (299)
T ss_dssp ECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH---------
T ss_pred EccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH---------
Confidence 99999997644333333334457899999999999999999999999999999999875 56753322110
Q ss_pred hhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhh
Q 021526 219 FLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 276 (311)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~ 276 (311)
+...+....+...+..++.++.++|.+||+.||++|||+++|++.|+.+.+
T Consensus 246 -------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 246 -------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp -------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------HHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 001111111223345567789999999999999999999999999998864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=339.63 Aligned_cols=259 Identities=21% Similarity=0.181 Sum_probs=192.8
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc-----chhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ-----GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
|.++|+|+||.||++.. +|+.||||++...... ..+.+.+|+++++.++||||+++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 57899999999999998 7899999998654322 1356889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
.++++.... .....+++..+..++.||+.||+|||++| ++||||||+|||++.++.+||+|||.+......
T Consensus 83 ~~~~~~~~~----~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~-- 153 (299)
T d1ua2a_ 83 ETDLEVIIK----DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-- 153 (299)
T ss_dssp SEEHHHHHT----TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC--
T ss_pred cchHHhhhh----hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCC--
Confidence 887766665 35677899999999999999999999999 999999999999999999999999999753322
Q ss_pred cceeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCcccccc-chhc----chhhhhcccchhh
Q 021526 155 THVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSW----SRPFLKDQKKFVH 228 (311)
Q Consensus 155 ~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~ 228 (311)
........||+.|+|||++... .++.++|||||||++|+|++|.+||.......... +... ....+........
T Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 154 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence 2223345689999999988654 67999999999999999999999996443211000 0000 0000000000000
Q ss_pred hcCccCCCCCc-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 229 LVDPLLHGRYP-----RRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 229 ~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..........+ ...+.++.+||.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00000000000 134567999999999999999999999975
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=332.12 Aligned_cols=257 Identities=25% Similarity=0.316 Sum_probs=205.0
Q ss_pred eeeeeceeccEEEEEE-C----CeEEEEEEeccC-CccchhHHHHHHHHHhcCCCCcccceeEEEEe-CCeeEEEEecCC
Q 021526 3 CCYLSCKFYNVGLVWL-C----DQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS-GDQRLLVYEYMP 75 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~-~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~ 75 (311)
.++|+|+||.||+|.+ . ...||||.+... .....+++.+|++++++++||||+++++++.. +...++||||++
T Consensus 33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~ 112 (311)
T d1r0pa_ 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 112 (311)
T ss_dssp EEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCT
T ss_pred eEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEee
Confidence 4789999999999998 2 236899998643 34455789999999999999999999999765 568899999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCc
Q 021526 76 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 76 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~ 155 (311)
+++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++........
T Consensus 113 ~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 113 HGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred cCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 9999999865 5567888899999999999999999999 999999999999999999999999999754332221
Q ss_pred c--eeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCcc
Q 021526 156 H--VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 233 (311)
Q Consensus 156 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
. ......|+..|+|||.+....++.++||||||+++|||++|..||....... +....... .
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-----~~~~~i~~-----------g 250 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DITVYLLQ-----------G 250 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHHHT-----------T
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-----HHHHHHHc-----------C
Confidence 1 1223457899999999999999999999999999999999888775322111 11111111 0
Q ss_pred CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccCCC
Q 021526 234 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSH 281 (311)
Q Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~~~ 281 (311)
.+...|..++.++.++|.+||..||++||++.||++.|+.+......+
T Consensus 251 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 251 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 111234456778999999999999999999999999999998764443
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=337.09 Aligned_cols=240 Identities=20% Similarity=0.190 Sum_probs=192.3
Q ss_pred eeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHh-cCCCCcccceeEEEEe----CCeeEEEEecCCC
Q 021526 4 CYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLS-LLHHDNLVTLIGYCTS----GDQRLLVYEYMPM 76 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~ 76 (311)
++|+|+||.||++.. +++.||||++.. ...+.+|++++. ..+||||++++++|.+ +..+|+|||||+|
T Consensus 19 ~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~g 93 (335)
T d2ozaa1 19 VLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 93 (335)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred EeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCC
Confidence 599999999999998 789999999853 256788998865 4589999999999875 4668999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcC---CCceEEeecCCCccCCCCC
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN---DFNPKLSDFGLAKLGPVGD 153 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~---~~~vkl~Df~~~~~~~~~~ 153 (311)
|+|.+++.. .....+++..+..++.||+.||+|||++| |+||||||+|||++. .+.+||+|||++......
T Consensus 94 g~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~- 167 (335)
T d2ozaa1 94 GELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH- 167 (335)
T ss_dssp EEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC-
T ss_pred CcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHHcC---CccccccccccccccccccccccccccceeeeccCC-
Confidence 999999965 23457999999999999999999999999 999999999999975 456999999999754322
Q ss_pred CcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCcccccc-chhcchhhhhcccchhhhcCc
Q 021526 154 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWSRPFLKDQKKFVHLVDP 232 (311)
Q Consensus 154 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (311)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||.......... +.. .....
T Consensus 168 --~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~-------------~i~~~ 232 (335)
T d2ozaa1 168 --NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT-------------RIRMG 232 (335)
T ss_dssp --CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------------CCCSC
T ss_pred --CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHH-------------HHhcC
Confidence 22344679999999999999999999999999999999999999996443221110 000 00000
Q ss_pred c--CCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 233 L--LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 233 ~--~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
. ........++.++.+||.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 001112356778999999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-49 Score=334.72 Aligned_cols=256 Identities=29% Similarity=0.367 Sum_probs=203.8
Q ss_pred eeeeeeceeccEEEEEEC---------CeEEEEEEeccCCc-cchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEE
Q 021526 2 LCCYLSCKFYNVGLVWLC---------DQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLV 70 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~---------~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 70 (311)
...+|+|+||.||++... +..||||.+..... .....+.+|...+..+ +||||+++++++.++...++|
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v 97 (299)
T d1fgka_ 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 97 (299)
T ss_dssp EEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEE
Confidence 467999999999999872 24799999876543 3346788898888877 799999999999999999999
Q ss_pred EecCCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCce
Q 021526 71 YEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 138 (311)
Q Consensus 71 ~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~v 138 (311)
|||+++|+|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+
T Consensus 98 ~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~~~~~~ 174 (299)
T d1fgka_ 98 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVM 174 (299)
T ss_dssp ECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCE
T ss_pred EEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeecCCCCe
Confidence 999999999999975432 2356899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHh-CCCCccccCccccccchhcch
Q 021526 139 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSR 217 (311)
Q Consensus 139 kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 217 (311)
||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |.+||.......
T Consensus 175 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~--------- 245 (299)
T d1fgka_ 175 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--------- 245 (299)
T ss_dssp EECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---------
T ss_pred EeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH---------
Confidence 9999999986544444344445668899999999999999999999999999999998 678875322110
Q ss_pred hhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 021526 218 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 277 (311)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~ 277 (311)
....+....+-..+..++..+.+||.+||+.||++|||+.||++.|+.|.+.
T Consensus 246 --------~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 246 --------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp --------HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------HHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 0011111122233455677899999999999999999999999999998754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=336.26 Aligned_cols=257 Identities=25% Similarity=0.334 Sum_probs=208.6
Q ss_pred eeeeeeceeccEEEEEE-------CCeEEEEEEeccCCc-cchhHHHHHHHHHhcC-CCCcccceeEEEEeCCeeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL-------CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 72 (311)
...+|+|+||.||+|.. .++.||||++..... .....+.+|+.+++.+ +||||+++++++.++...+++||
T Consensus 28 ~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE 107 (311)
T d1t46a_ 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE 107 (311)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEE
Confidence 46799999999999986 357999999975543 3445788999999998 69999999999999999999999
Q ss_pred cCCCCCHHHHhcccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCce
Q 021526 73 YMPMGSLEDHLYDLEP--------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 138 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~--------------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~v 138 (311)
|+++++|.+++..... ....+++..+..++.||+.|++|||+++ ++||||||+||+++.++.+
T Consensus 108 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~~~~~~ 184 (311)
T d1t46a_ 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRIT 184 (311)
T ss_dssp CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEE
T ss_pred cCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccccccCcc
Confidence 9999999999975331 2346899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhC-CCCccccCccccccchhcch
Q 021526 139 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG-RKAMDLSKGQGEQNLVSWSR 217 (311)
Q Consensus 139 kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~ 217 (311)
+++|||.++...............|++.|+|||.+.+..++.++||||||+++|+|+++ .+||........
T Consensus 185 ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~-------- 256 (311)
T d1t46a_ 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-------- 256 (311)
T ss_dssp EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--------
T ss_pred cccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH--------
Confidence 99999999865444444444456789999999999999999999999999999999995 555543322111
Q ss_pred hhhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 021526 218 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 277 (311)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~ 277 (311)
+..++....+...+..++..+.+||.+||+.||++|||+++|++.|+++.++
T Consensus 257 --------~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 257 --------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp --------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 1111111222233445678899999999999999999999999999887655
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.3e-48 Score=341.79 Aligned_cols=242 Identities=23% Similarity=0.242 Sum_probs=195.1
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc---cchhHHH---HHHHHHhcCCCCcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL---QGHQEFI---VEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~---~~~~~~~---~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
+.++|+|+||.||++.. +|+.||||++.+... .....+. +++.+++.++||||+++++++.+++..++||||
T Consensus 9 ~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~ 88 (364)
T d1omwa3 9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 88 (364)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEe
Confidence 57899999999999999 689999999865421 1222333 447778888999999999999999999999999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 153 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~ 153 (311)
+++++|.+++.. ...+++..++.++.||+.||+|||+++ ++||||||+|||++.++.+||+|||++......
T Consensus 89 ~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~- 160 (364)
T d1omwa3 89 MNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 160 (364)
T ss_dssp CCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred cCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCC-
Confidence 999999999954 467889999999999999999999999 999999999999999999999999999754322
Q ss_pred CcceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCc
Q 021526 154 NTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 232 (311)
Q Consensus 154 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
......||+.|+|||++.. ..++.++|||||||++|+|++|..||..........+.. ...
T Consensus 161 ---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~-------------~~~-- 222 (364)
T d1omwa3 161 ---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-------------MTL-- 222 (364)
T ss_dssp ---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH-------------HSS--
T ss_pred ---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------------hcc--
Confidence 2234569999999999864 568999999999999999999999997443221110000 000
Q ss_pred cCCCCCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 021526 233 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 269 (311)
Q Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs-----~~~l~~ 269 (311)
......+..++.++.+||.+||+.||++||| ++++++
T Consensus 223 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 223 TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1111234456778999999999999999999 688876
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.6e-48 Score=327.74 Aligned_cols=244 Identities=23% Similarity=0.212 Sum_probs=199.0
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccc---------hhHHHHHHHHHhcCC-CCcccceeEEEEeCCeeEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQG---------HQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLL 69 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~---------~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 69 (311)
...+|+|+||.||++.. +++.||||++.+..... .+.+.+|+.++++++ ||||+++++++.+++..++
T Consensus 8 ~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~i 87 (277)
T d1phka_ 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 87 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred ceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEE
Confidence 57899999999999998 78999999987653221 235789999999997 9999999999999999999
Q ss_pred EEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccC
Q 021526 70 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 149 (311)
Q Consensus 70 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~ 149 (311)
||||+++++|.+++.. ...+++..+..++.||+.||+|||++| ++||||||+||+++.++.+||+|||++...
T Consensus 88 vmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 88 VFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeEc
Confidence 9999999999999954 457999999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCCcceeeeccccccccCCccccC------CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcc
Q 021526 150 PVGDNTHVSTRVMGTYGYCAPEYAMS------GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 223 (311)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 223 (311)
.... ......|+..|.|||.+.+ ..++.++||||+||++|+|++|+.||........ ........
T Consensus 161 ~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~------~~~i~~~~ 231 (277)
T d1phka_ 161 DPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM------LRMIMSGN 231 (277)
T ss_dssp CTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHTC
T ss_pred cCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH------HHHHHhCC
Confidence 3321 2234568999999998763 3568899999999999999999999964321110 00111100
Q ss_pred cchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 224 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..........+++++.+++.+||+.||++|||++|+++
T Consensus 232 --------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 232 --------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp --------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred --------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 01112223467788999999999999999999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=331.42 Aligned_cols=267 Identities=22% Similarity=0.231 Sum_probs=197.9
Q ss_pred CeeeeeeceeccEEEEEECCeEEEEEEeccCCccchhHHHH--HHHHHhcCCCCcccceeEEEEeCC----eeEEEEecC
Q 021526 1 MLCCYLSCKFYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIV--EVLMLSLLHHDNLVTLIGYCTSGD----QRLLVYEYM 74 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~--e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~ 74 (311)
|...+|+|+||.||+|..+|+.||||++... ....+.+ |+..+..++||||+++++++.+++ ..++||||+
T Consensus 7 l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~ 83 (303)
T d1vjya_ 7 LQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEEEECCSSSEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEEEeeCCCeEEEEEEECCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecc
Confidence 3568999999999999999999999998643 2334444 444556789999999999987654 579999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh--------CCCCCeeecCCCCCcEEEcCCCceEEeecCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC--------KANPPVIYRDLKSANILLDNDFNPKLSDFGLA 146 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~--------~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~ 146 (311)
++|+|.+++.+ ..+++..++.++.+++.||+|||+ ++ |+||||||+|||++.++.+||+|||++
T Consensus 84 ~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~---IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 84 EHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp TTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---eeccccCccceEEcCCCCeEEEecCcc
Confidence 99999999954 468999999999999999999996 46 999999999999999999999999998
Q ss_pred ccCCCCCCcc--eeeeccccccccCCccccCCC------CCccccchhHHHHHHHHHhCCCCccccCccccccchhcchh
Q 021526 147 KLGPVGDNTH--VSTRVMGTYGYCAPEYAMSGK------LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP 218 (311)
Q Consensus 147 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~------~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 218 (311)
.......... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..|+.................
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 7543322211 223467899999999887643 56789999999999999999988864433221111000000
Q ss_pred hhhcccchhhhcCccCCCCC-----cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 021526 219 FLKDQKKFVHLVDPLLHGRY-----PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 279 (311)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~ 279 (311)
..............++... +......+.+++.+||+.||++|||+.||++.|+++..+.+
T Consensus 236 -~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 236 -PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp -CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred -chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence 0000000011111111111 23466779999999999999999999999999999986543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-49 Score=337.90 Aligned_cols=242 Identities=28% Similarity=0.348 Sum_probs=198.9
Q ss_pred CeeeeeeceeccEEEEEE--CCeEEEEEEeccCC---ccchhHHHHHHHHHh-cCCCCcccceeEEEEeCCeeEEEEecC
Q 021526 1 MLCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG---LQGHQEFIVEVLMLS-LLHHDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
+...+|+|+||.||++.. +++.||||++.+.. ....+.+.+|..++. .++||||+++++++.+++..|+||||+
T Consensus 6 i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~ 85 (320)
T d1xjda_ 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYL 85 (320)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeec
Confidence 357899999999999999 79999999986532 334456677777664 689999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCC
Q 021526 75 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 75 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~ 154 (311)
++|+|.+++.. ...+++..+..++.||+.||+|||+++ ++||||||+|||++.++.+||+|||++......
T Consensus 86 ~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~-- 156 (320)
T d1xjda_ 86 NGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-- 156 (320)
T ss_dssp TTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--
T ss_pred CCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcccc--
Confidence 99999999954 457899999999999999999999999 999999999999999999999999999753322
Q ss_pred cceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhhcCccC
Q 021526 155 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 234 (311)
Q Consensus 155 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
........||+.|+|||++.+..++.++|||||||++|+|++|..||....... ........
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i~~~------------ 218 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------LFHSIRMD------------ 218 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHC------------
T ss_pred cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHHcC------------
Confidence 223344679999999999999999999999999999999999999997433211 00011100
Q ss_pred CCCCcHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 021526 235 HGRYPRRCLNYAVAVTAMCLNEEANFRPLIN-DIVV 269 (311)
Q Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~-~l~~ 269 (311)
.-.+|..++.++.+||.+||+.||++||++. ++++
T Consensus 219 ~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1123445677899999999999999999995 6764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-48 Score=329.83 Aligned_cols=254 Identities=24% Similarity=0.326 Sum_probs=204.5
Q ss_pred eeeeeeceeccEEEEEEC-------CeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWLC-------DQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~~-------~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 73 (311)
...+|+|+||.||+|... ++.||||++..... .....+.+|++++++++||||+++++++..+...++|||+
T Consensus 25 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 104 (308)
T d1p4oa_ 25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 104 (308)
T ss_dssp EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEee
Confidence 467999999999999873 47899999875432 3335688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcccC------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 74 MPMGSLEDHLYDLE------PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 74 ~~~~~L~~~l~~~~------~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
+.+|+|.+++.... .....+++..+..++.|++.||+|||+++ ++||||||+|||+++++.+||+|||+++
T Consensus 105 ~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~DFGla~ 181 (308)
T d1p4oa_ 105 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR 181 (308)
T ss_dssp CTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCC
T ss_pred cCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEeecccce
Confidence 99999999886421 22346788999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCC-CCccccCccccccchhcchhhhhcccch
Q 021526 148 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR-KAMDLSKGQGEQNLVSWSRPFLKDQKKF 226 (311)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
...............+++.|+|||.+.+..++.++||||||+++|+|++|. +||....... . +
T Consensus 182 ~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~------~----------~ 245 (308)
T d1p4oa_ 182 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ------V----------L 245 (308)
T ss_dssp GGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH------H----------H
T ss_pred eccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH------H----------H
Confidence 543333323333346889999999999999999999999999999999985 6664322110 0 0
Q ss_pred hhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhh
Q 021526 227 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 275 (311)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~ 275 (311)
..+.+ ...-..+..++..+.++|.+||+.+|++|||+++|++.|++..
T Consensus 246 ~~i~~-~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 246 RFVME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp HHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHHh-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 11111 1112234566788999999999999999999999999987753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=327.65 Aligned_cols=261 Identities=20% Similarity=0.213 Sum_probs=194.4
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
+..+|+|+||.||++.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.++...++|||++.+
T Consensus 7 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~- 85 (298)
T d1gz8a_ 7 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ- 85 (298)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred ccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-
Confidence 67899999999999998 689999999865432 2357899999999999999999999999999999999999965
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
.+.+++.. .....+++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||.+..... ....
T Consensus 86 ~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~--~~~~ 158 (298)
T d1gz8a_ 86 DLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRT 158 (298)
T ss_dssp EHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCC--CSBC
T ss_pred chhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccC--Cccc
Confidence 45555433 34567999999999999999999999999 99999999999999999999999999875322 2222
Q ss_pred eeeccccccccCCccccCCC-CCccccchhHHHHHHHHHhCCCCccccCcccccc-chh----cchhhhhcccchhh---
Q 021526 158 STRVMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVS----WSRPFLKDQKKFVH--- 228 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~--- 228 (311)
.....|++.|+|||++.... ++.++|+||||+++|+|++|+.||.......... ... .....+........
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence 33456899999999877655 5789999999999999999999996443211000 000 00000000000000
Q ss_pred hcCccCCCCC---cHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 229 LVDPLLHGRY---PRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 229 ~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.......... ....+.++.+|+.+||+.||++|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000000000 11345678999999999999999999999873
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-47 Score=324.61 Aligned_cols=258 Identities=22% Similarity=0.241 Sum_probs=192.4
Q ss_pred eeeeeeceeccEEEEEE---CCeEEEEEEeccCCc--cchhHHHHHHHHHhcC---CCCcccceeEEEEe-----CCeeE
Q 021526 2 LCCYLSCKFYNVGLVWL---CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLL---HHDNLVTLIGYCTS-----GDQRL 68 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~---~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~~~~ 68 (311)
+..+|+|+||.||++.. +++.||||++..... .....+.+|+++++.+ +||||++++++|.. +...+
T Consensus 12 ~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~ 91 (305)
T d1blxa_ 12 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 91 (305)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred EEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEE
Confidence 57899999999999998 367899999865432 2334677788777655 79999999999853 34679
Q ss_pred EEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCcc
Q 021526 69 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 148 (311)
Q Consensus 69 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~ 148 (311)
++||+++++.+...... ....+++..+..++.|++.||+|||+++ |+||||||+|||++..+.+||+|||.+..
T Consensus 92 ~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 92 LVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp EEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred EEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 99999988766544432 5677999999999999999999999999 99999999999999999999999999874
Q ss_pred CCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCcccccc-c---------hhcchh
Q 021526 149 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-L---------VSWSRP 218 (311)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~---------~~~~~~ 218 (311)
. ..........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... + ..|...
T Consensus 166 ~---~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (305)
T d1blxa_ 166 Y---SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242 (305)
T ss_dssp C---CGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred h---cccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence 2 22233445679999999999999999999999999999999999999997543211100 0 000000
Q ss_pred hhhcccchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 219 FLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
... ...............+....+..+.+||.+||+.||++|||++|+++
T Consensus 243 ~~~-~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 243 VAL-PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CSS-CGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccc-hhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 00000000000001122345677899999999999999999999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-47 Score=320.12 Aligned_cols=233 Identities=21% Similarity=0.255 Sum_probs=191.2
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCcc------chhHHHHHHHHHhcCC--CCcccceeEEEEeCCeeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQ------GHQEFIVEVLMLSLLH--HDNLVTLIGYCTSGDQRLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~ 71 (311)
..++|+|+||.||++.. +|+.||||.+.+.... ....+.+|++++++++ ||||+++++++.+++..++||
T Consensus 9 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~ 88 (273)
T d1xwsa_ 9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 88 (273)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEE
Confidence 46899999999999999 6899999998754322 2245678999999886 899999999999999999999
Q ss_pred ecCCC-CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcC-CCceEEeecCCCccC
Q 021526 72 EYMPM-GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-DFNPKLSDFGLAKLG 149 (311)
Q Consensus 72 e~~~~-~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~-~~~vkl~Df~~~~~~ 149 (311)
|++.+ +++.+++.. ...+++..++.++.|++.||+|||+++ ++||||||+|||++. ++.+||+|||++...
T Consensus 89 e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 89 ERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp ECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccceec
Confidence 99976 578888743 467999999999999999999999999 999999999999985 478999999999753
Q ss_pred CCCCCcceeeeccccccccCCccccCCCC-CccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhh
Q 021526 150 PVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 228 (311)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... .....
T Consensus 162 ~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------------i~~~~----- 220 (273)
T d1xwsa_ 162 KDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQ----- 220 (273)
T ss_dssp CSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHHCC-----
T ss_pred ccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------------Hhhcc-----
Confidence 221 2234569999999999887655 5779999999999999999999963210 11100
Q ss_pred hcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 229 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 229 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..++..++.++.+||.+||..||++|||++|+++
T Consensus 221 -------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 -------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1123345678999999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.8e-46 Score=319.10 Aligned_cols=260 Identities=20% Similarity=0.201 Sum_probs=194.6
Q ss_pred CeeeeeeceeccEEEEEE-CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCCC
Q 021526 1 MLCCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
++..+|+|+||.||++.. +|+.||||.+..... ...+.+.+|+.+++.++||||+++++++.+++..+++++++.++
T Consensus 6 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~ 85 (286)
T d1ob3a_ 6 GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQD 85 (286)
T ss_dssp EEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEE
T ss_pred eccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhh
Confidence 367899999999999998 789999999866532 23468999999999999999999999999999999999999876
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcce
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 157 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~~ 157 (311)
.+..+. ...+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||.+...... ...
T Consensus 86 ~~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~--~~~ 156 (286)
T d1ob3a_ 86 LKKLLD----VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRK 156 (286)
T ss_dssp HHHHHH----TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred hHHHHH----hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC--ccc
Confidence 666665 34678999999999999999999999999 999999999999999999999999998653221 122
Q ss_pred eeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCcccccc-chh----cchhhhhcccchhhh--
Q 021526 158 STRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVS----WSRPFLKDQKKFVHL-- 229 (311)
Q Consensus 158 ~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~-- 229 (311)
.....+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||.......... +.. .....+.........
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 2334578899999988754 56899999999999999999999996433211000 000 000000000000000
Q ss_pred ----cCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 230 ----VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 230 ----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
..+..........+..+.+||.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000001112335677899999999999999999999975
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.9e-44 Score=304.07 Aligned_cols=259 Identities=17% Similarity=0.098 Sum_probs=204.0
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCC-CcccceeEEEEeCCeeEEEEecCCCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHH-DNLVTLIGYCTSGDQRLLVYEYMPMGS 78 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (311)
...+|+|+||.||+++. +|+.||||++.... ....+.+|++.++.++| +|++.+++++..+...++|||++ +++
T Consensus 10 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~ 86 (293)
T d1csna_ 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPS 86 (293)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCC
Confidence 56899999999999998 68999999875432 33567889999999875 89999999999999999999999 679
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcC-----CCceEEeecCCCccCCCCC
Q 021526 79 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-----DFNPKLSDFGLAKLGPVGD 153 (311)
Q Consensus 79 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~-----~~~vkl~Df~~~~~~~~~~ 153 (311)
|.+++.. .+..++...+..++.|++.+|+|||++| ++||||||+||+++. .+.++|+|||+++......
T Consensus 87 l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 87 LEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp HHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred HHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 9998865 4567999999999999999999999999 999999999999964 5779999999997643322
Q ss_pred Cc-----ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhh
Q 021526 154 NT-----HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 228 (311)
Q Consensus 154 ~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
.. .......||+.|+|||++.+..++.++|+||||+++|+|++|..||.................... .....+
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~-~~~~~~ 239 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ-STPLRE 239 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-HSCHHH
T ss_pred cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC-CCChHH
Confidence 21 122345699999999999999999999999999999999999999975443322211110000000 000111
Q ss_pred hcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhccC
Q 021526 229 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 279 (311)
Q Consensus 229 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~~~ 279 (311)
+ +..++.++.+++..|+..+|++||+++.+.+.|+.+.....
T Consensus 240 l---------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 240 L---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp H---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred h---------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 1 12345679999999999999999999999999988765443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=312.00 Aligned_cols=262 Identities=22% Similarity=0.222 Sum_probs=188.8
Q ss_pred CeeeeeeceeccEEEEEE--CCeEEEEEEeccCC--ccchhHHHHHHHHHhcCCCCcccceeEEEEe--------CCeeE
Q 021526 1 MLCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS--------GDQRL 68 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~~~~~ 68 (311)
++..+|+|+||.||+++. +|+.||||++.... .....++.+|+++++.++|||++++++++.. +...+
T Consensus 14 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~ 93 (318)
T d3blha1 14 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY 93 (318)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEE
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEE
Confidence 367899999999999998 78999999986553 2344678899999999999999999998754 34679
Q ss_pred EEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCcc
Q 021526 69 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 148 (311)
Q Consensus 69 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~ 148 (311)
++||++.++.+.... .....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 94 iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 94 LVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp EEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceeee
Confidence 999999876665554 35677999999999999999999999999 99999999999999999999999999965
Q ss_pred CCCCCCc--ceeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcch-----hhh
Q 021526 149 GPVGDNT--HVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR-----PFL 220 (311)
Q Consensus 149 ~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~ 220 (311)
....... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||................ ...
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 4322211 122334689999999998765 68899999999999999999999996433211110000000 000
Q ss_pred h--cccchhhhcCccCCCCCc-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 221 K--DQKKFVHLVDPLLHGRYP-------RRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 221 ~--~~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
. .................+ ......+.+||.+||+.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 0 000000000000000000 112456789999999999999999999985
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-44 Score=306.72 Aligned_cols=260 Identities=18% Similarity=0.150 Sum_probs=198.2
Q ss_pred CeeeeeeceeccEEEEEE--CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeCCeeEEEEecCCC
Q 021526 1 MLCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 76 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (311)
++..+|+|+||.||+++. +++.||||++..... .....+.+|+.+++.++||||+++++++.+....+++++++.+
T Consensus 6 ~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~ 85 (292)
T d1unla_ 6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSE
T ss_pred eeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccc
Confidence 367899999999999999 789999999865532 3346889999999999999999999999999999999999998
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCCCcc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 156 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~~~~ 156 (311)
+++..++. ..+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.+....... .
T Consensus 86 ~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~--~ 156 (292)
T d1unla_ 86 DLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--R 156 (292)
T ss_dssp EHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC--S
T ss_pred cccccccc----cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC--c
Confidence 88888774 4578899999999999999999999999 9999999999999999999999999997643322 2
Q ss_pred eeeeccccccccCCccccCCC-CCccccchhHHHHHHHHHhCCCCccccCccccc-cc-hhcc----hhhhhc------c
Q 021526 157 VSTRVMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NL-VSWS----RPFLKD------Q 223 (311)
Q Consensus 157 ~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~-~~~~----~~~~~~------~ 223 (311)
......++..|.|||++.... ++.++|||||||++|+|++|+.||......... .. .... ...+.. .
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence 223345678899999887654 689999999999999999999987432211100 00 0000 000000 0
Q ss_pred cchhhhcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 224 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
...................+..+.+|+.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000011111223345677999999999999999999999976
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-45 Score=317.50 Aligned_cols=264 Identities=24% Similarity=0.226 Sum_probs=192.0
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcccceeEEEEeC------CeeEEEEec
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG------DQRLLVYEY 73 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~ 73 (311)
+.++|+|+||.||++.. +|+.||||++.... ....+|+++++.++||||++++++|... ...++||||
T Consensus 25 ~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 25 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred eeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 46799999999999999 79999999986543 2334799999999999999999998532 347899999
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCC-ceEEeecCCCccCCCC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-NPKLSDFGLAKLGPVG 152 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~-~vkl~Df~~~~~~~~~ 152 (311)
+.++ +.+.+.........+++..+..++.||+.||+|||++| |+||||||+|||++.++ .+||+|||++......
T Consensus 101 ~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~ 176 (350)
T d1q5ka_ 101 VPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176 (350)
T ss_dssp CSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred cCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence 9765 44443322235678999999999999999999999999 99999999999998775 8999999998754322
Q ss_pred CCcceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCcccccc-chh----cchhhh-hcccc
Q 021526 153 DNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVS----WSRPFL-KDQKK 225 (311)
Q Consensus 153 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~----~~~~~~-~~~~~ 225 (311)
.......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.......... +.. .....+ .....
T Consensus 177 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 253 (350)
T d1q5ka_ 177 ---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253 (350)
T ss_dssp ---SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred ---cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence 22334568999999998765 578999999999999999999999996543211100 000 000000 00000
Q ss_pred hhhhcCc-----cCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHHhhh
Q 021526 226 FVHLVDP-----LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA--LDYLVS 276 (311)
Q Consensus 226 ~~~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~--L~~l~~ 276 (311)
......+ ..........+.++.+||.+||+.||++|||+.|+++. |+.+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 0000000 00011123456779999999999999999999999973 555543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-45 Score=316.79 Aligned_cols=259 Identities=24% Similarity=0.273 Sum_probs=189.1
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeCC------eeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD------QRLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~ 71 (311)
+..+|+|+||.||++.. +|+.||||++..... ...+.+.+|+++|+.++||||++++++|...+ ..++||
T Consensus 23 i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 102 (346)
T d1cm8a_ 23 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM 102 (346)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEE
Confidence 56899999999999998 699999999875432 23457889999999999999999999997654 469999
Q ss_pred ecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCC
Q 021526 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 151 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~ 151 (311)
||+ +.+|...+. ...+++..++.++.|++.||+|||++| |+||||||+|||++.++.+|++|||++.....
T Consensus 103 e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 103 PFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp ECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecc-cccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceeccCC
Confidence 999 567777773 357999999999999999999999999 99999999999999999999999999975432
Q ss_pred CCCcceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCccccccchhc-----chhhhhc---
Q 021526 152 GDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSW-----SRPFLKD--- 222 (311)
Q Consensus 152 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~--- 222 (311)
. .....+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.............. .......
T Consensus 174 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 174 E-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp S-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred c-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 2 233568999999998876 4568999999999999999999999965432111000000 0000000
Q ss_pred --ccchhhhcCccCCC---CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHHh
Q 021526 223 --QKKFVHLVDPLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA--LDYL 274 (311)
Q Consensus 223 --~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~--L~~l 274 (311)
.............. ......+..+.+||.+||..||++|||++|+++. |+.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 00000000000000 1112345678999999999999999999999984 5544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.1e-44 Score=304.14 Aligned_cols=257 Identities=20% Similarity=0.164 Sum_probs=195.8
Q ss_pred CeeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCccc-ceeEEEEeCCeeEEEEecCCCC
Q 021526 1 MLCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLV-TLIGYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~ 77 (311)
+...+|+|+||.||+|.. +|+.||||++.... ..+++.+|+++++.++|++++ .+..++.++...++|||++ ++
T Consensus 11 l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~ 87 (299)
T d1ckia_ 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP 87 (299)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CC
Confidence 357899999999999998 68999999876543 335688999999999877655 5556667888899999999 55
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcC---CCceEEeecCCCccCCCCCC
Q 021526 78 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN---DFNPKLSDFGLAKLGPVGDN 154 (311)
Q Consensus 78 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~---~~~vkl~Df~~~~~~~~~~~ 154 (311)
++.+.+.. ....+++..+..++.|++.||+|||++| |+||||||+|||++. +..++|+|||++........
T Consensus 88 ~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 88 SLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp BHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred chhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 77766644 4567999999999999999999999999 999999999999854 45699999999986433222
Q ss_pred c-----ceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccch-hcchhhhhcccchhh
Q 021526 155 T-----HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-SWSRPFLKDQKKFVH 228 (311)
Q Consensus 155 ~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 228 (311)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||............ ........
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~------- 234 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS------- 234 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-------
T ss_pred ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC-------
Confidence 1 1223457999999999999999999999999999999999999999754432222111 10000000
Q ss_pred hcCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhhhc
Q 021526 229 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 277 (311)
Q Consensus 229 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~L~~l~~~ 277 (311)
...+.. ...++.++.+++.+||..+|++||+++++.+.|+.+...
T Consensus 235 ~~~~~~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 235 TPIEVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp SCHHHH----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred CChhHh----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 000001 123567799999999999999999999999999887553
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3e-44 Score=311.08 Aligned_cols=252 Identities=17% Similarity=0.225 Sum_probs=191.3
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCC-CCcccceeEEEEe--CCeeEEEEecCCC
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTS--GDQRLLVYEYMPM 76 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~ 76 (311)
+.++|+|+||.||+++. +++.||||++... ..+++.+|+++|+.++ ||||++++++|.. ....++||||+.+
T Consensus 40 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~ 116 (328)
T d3bqca1 40 VRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 116 (328)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCS
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCC
Confidence 57899999999999998 7999999998643 3567899999999996 9999999999874 4568999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCC-ceEEeecCCCccCCCCCCc
Q 021526 77 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-NPKLSDFGLAKLGPVGDNT 155 (311)
Q Consensus 77 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~-~vkl~Df~~~~~~~~~~~~ 155 (311)
++|.... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++ .++|+|||++......
T Consensus 117 ~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~--- 183 (328)
T d3bqca1 117 TDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--- 183 (328)
T ss_dssp CBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT---
T ss_pred CcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCC---
Confidence 9987654 45899999999999999999999999 99999999999998655 5899999999754322
Q ss_pred ceeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCcccccc--chh---------cchhh-hhc
Q 021526 156 HVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN--LVS---------WSRPF-LKD 222 (311)
Q Consensus 156 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~--~~~---------~~~~~-~~~ 222 (311)
.......+|..|+|||.+.+. .++.++|+||+||++++|++|..||.......... +.. +.... ...
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence 223345689999999998765 57899999999999999999999986443211100 000 00000 000
Q ss_pred ccchhhhc--------CccCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 223 QKKFVHLV--------DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 223 ~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
........ ............+.++.+||.+||+.||++|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000 111111222345678999999999999999999999985
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=315.84 Aligned_cols=262 Identities=21% Similarity=0.213 Sum_probs=189.0
Q ss_pred CeeeeeeceeccEEEEEE--CCeEEEEEEeccCCc-cchhHHHHHHHHHhcCCCCcccceeEEEEeCC----eeEEEEec
Q 021526 1 MLCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD----QRLLVYEY 73 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~ 73 (311)
++.++|+|+||.||+++. +|+.||||.+.+... ...+.+.+|+++|+.++||||+++++++..+. ..++++++
T Consensus 12 ~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~ 91 (345)
T d1pmea_ 12 NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTH 91 (345)
T ss_dssp EEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred EEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEe
Confidence 367899999999999998 799999999875432 33467889999999999999999999986543 23444555
Q ss_pred CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCCC
Q 021526 74 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 153 (311)
Q Consensus 74 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~~ 153 (311)
+.+++|.+++.. ..+++..+..++.|++.||+|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 92 ~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 92 LMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp CCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred ecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 668999999954 46999999999999999999999999 9999999999999999999999999987543222
Q ss_pred Cc-ceeeeccccccccCCccccC-CCCCccccchhHHHHHHHHHhCCCCccccCccccccchh----cc-hhhhhc--cc
Q 021526 154 NT-HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS----WS-RPFLKD--QK 224 (311)
Q Consensus 154 ~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----~~-~~~~~~--~~ 224 (311)
.. .......|++.|+|||++.. ..++.++|+||+||++|+|++|..||............. .. ...... ..
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence 11 11234568999999998854 567899999999999999999999996443211100000 00 000000 00
Q ss_pred chhh--hcCccCCC-C---CcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 225 KFVH--LVDPLLHG-R---YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 225 ~~~~--~~~~~~~~-~---~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
.... ...+.... . ..+..+.++.+|+.+||+.||++|||++|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 00000000 0 011335678999999999999999999999874
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=311.43 Aligned_cols=246 Identities=27% Similarity=0.305 Sum_probs=196.6
Q ss_pred eeeeeeceeccEEEEEE-----CCeEEEEEEeccCC----ccchhHHHHHHHHHhcCCC-CcccceeEEEEeCCeeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL-----CDQLVAIKQLNHEG----LQGHQEFIVEVLMLSLLHH-DNLVTLIGYCTSGDQRLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~-----~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 71 (311)
+..+|+|+||.||++.. .|+.||||.+.+.. ....+.+.+|++++++++| |||+++++++++....+++|
T Consensus 29 ~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~ 108 (322)
T d1vzoa_ 29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL 108 (322)
T ss_dssp EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeee
Confidence 56899999999999987 47899999986542 2344678899999999976 89999999999999999999
Q ss_pred ecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCC
Q 021526 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 151 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~ 151 (311)
|++.+++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 109 e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 109 DYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp CCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred ecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 99999999999954 456788999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCcceeeeccccccccCCccccCC--CCCccccchhHHHHHHHHHhCCCCccccCccccccchhcchhhhhcccchhhh
Q 021526 152 GDNTHVSTRVMGTYGYCAPEYAMSG--KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 229 (311)
Q Consensus 152 ~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
. .........|++.|++||.+.+. .++.++|||||||++|+|++|..||.......... ........
T Consensus 182 ~-~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~--~i~~~~~~-------- 250 (322)
T d1vzoa_ 182 D-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRRILK-------- 250 (322)
T ss_dssp G-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHHHHHHH--------
T ss_pred c-ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhccc--------
Confidence 2 22223446789999999988754 46789999999999999999999997543322110 00000100
Q ss_pred cCccCCCCCcHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 021526 230 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 269 (311)
Q Consensus 230 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs-----~~~l~~ 269 (311)
....++..++.++.++|.+||+.||++||| ++|+++
T Consensus 251 ----~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 251 ----SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 011234466788999999999999999994 788875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-44 Score=311.74 Aligned_cols=256 Identities=22% Similarity=0.233 Sum_probs=185.1
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEe------CCeeEEEE
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS------GDQRLLVY 71 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~ 71 (311)
+.++|+|+||.||+++. +|+.||||++..... .....+.+|+.+++.++||||++++++|.. ....|+||
T Consensus 22 ~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~ 101 (355)
T d2b1pa1 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 101 (355)
T ss_dssp EEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred EEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEE
Confidence 57899999999999998 699999999975532 233568899999999999999999999853 46889999
Q ss_pred ecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCC
Q 021526 72 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 151 (311)
Q Consensus 72 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~ 151 (311)
||+.++ +.+.+. ..+++..++.++.|++.||+|||++| |+|+||||+|||++.++.++++|||++.....
T Consensus 102 Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 102 ELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp ECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred eccchH-HHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhcccc
Confidence 999765 444442 35889999999999999999999999 99999999999999999999999999874322
Q ss_pred CCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCcccccc-ch--------h-c------
Q 021526 152 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LV--------S-W------ 215 (311)
Q Consensus 152 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~--------~-~------ 215 (311)
........+|+.|+|||++.+..+++++||||+||++++|++|+.||...+...... +. . |
T Consensus 172 ---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (355)
T d2b1pa1 172 ---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred ---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence 223334568999999999999999999999999999999999999996433110000 00 0 0
Q ss_pred chhhhhc-----ccchhhhcCccCCC---CCcHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 021526 216 SRPFLKD-----QKKFVHLVDPLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 270 (311)
Q Consensus 216 ~~~~~~~-----~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~~ 270 (311)
....... .............. ......+.++.+||.+||..||++|||++|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000 00001111111111 1123467789999999999999999999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=309.89 Aligned_cols=255 Identities=22% Similarity=0.258 Sum_probs=187.7
Q ss_pred eeeeeeceeccEEEEEE--CCeEEEEEEeccCCc--cchhHHHHHHHHHhcCCCCcccceeEEEEeC-----CeeEEEEe
Q 021526 2 LCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG-----DQRLLVYE 72 (311)
Q Consensus 2 ~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e 72 (311)
+..+|+|+||.||+++. +|+.||||++.+... ...+.+.+|+++++.++|||++++++++... ...+++++
T Consensus 23 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~ 102 (348)
T d2gfsa1 23 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102 (348)
T ss_dssp EEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEE
Confidence 57899999999999998 799999999875532 3345788999999999999999999998533 33466677
Q ss_pred cCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeecCCCccCCCC
Q 021526 73 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 152 (311)
Q Consensus 73 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df~~~~~~~~~ 152 (311)
++.+++|.+++. ...+++..+..++.||+.||+|||++| |+||||||+|||++.++.++++|||.+....
T Consensus 103 ~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~-- 172 (348)
T d2gfsa1 103 HLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD-- 172 (348)
T ss_dssp ECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCT--
T ss_pred eecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccC--
Confidence 788999999993 356999999999999999999999999 9999999999999999999999999986422
Q ss_pred CCcceeeeccccccccCCccccCC-CCCccccchhHHHHHHHHHhCCCCccccCccccccch-hc----chhhhh--ccc
Q 021526 153 DNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-SW----SRPFLK--DQK 224 (311)
Q Consensus 153 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~----~~~~~~--~~~ 224 (311)
.......|+..|+|||+..+. .++.++|+|||||++|+|++|..||...+........ .. ...... ...
T Consensus 173 ---~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (348)
T d2gfsa1 173 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249 (348)
T ss_dssp ---GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred ---cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccch
Confidence 223345689999999987665 5688999999999999999999999644321110000 00 000000 000
Q ss_pred chhhhcC---ccCCCCC---cHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 021526 225 KFVHLVD---PLLHGRY---PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 269 (311)
Q Consensus 225 ~~~~~~~---~~~~~~~---~~~~~~~l~~li~~~l~~~p~~RPs~~~l~~ 269 (311)
....... ......+ ....+..+.+||.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0000000 0000000 0134567899999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-38 Score=279.40 Aligned_cols=258 Identities=17% Similarity=0.158 Sum_probs=183.9
Q ss_pred CeeeeeeceeccEEEEEE--CCeEEEEEEeccCCccchhHHHHHHHHHhcCC-----------CCcccceeEEEEe--CC
Q 021526 1 MLCCYLSCKFYNVGLVWL--CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-----------HDNLVTLIGYCTS--GD 65 (311)
Q Consensus 1 ~~~~~~~g~~~~v~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~--~~ 65 (311)
++.++|+|+||.||+++. +|+.||||++.+.. ...+.+.+|+.+++.++ |+||+++++++.. ..
T Consensus 17 i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~ 95 (362)
T d1q8ya_ 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPN 95 (362)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETT
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecccc
Confidence 367899999999999998 79999999997542 33457788888887775 4789999988754 34
Q ss_pred eeEEEEecCCCCCH-HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeecCCCCCcEEEcCCCc------
Q 021526 66 QRLLVYEYMPMGSL-EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFN------ 137 (311)
Q Consensus 66 ~~~lv~e~~~~~~L-~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~di~p~nil~~~~~~------ 137 (311)
..++++.++..... ...... .....+++..+..++.|++.|++|||+ .| |+||||||+|||++.++.
T Consensus 96 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 96 GVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp EEEEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEE
T ss_pred ceeeeeeeccccccccccccc--ccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccce
Confidence 55666666544432 222222 356788999999999999999999997 88 999999999999976653
Q ss_pred eEEeecCCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHHHHHHhCCCCccccCccccccchhcch
Q 021526 138 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR 217 (311)
Q Consensus 138 vkl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 217 (311)
++++|||.+..... ......|++.|+|||++....++.++|+||+||++++|++|..||................
T Consensus 171 ~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 171 IKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 89999999874321 2234568999999999999999999999999999999999999997543321111000000
Q ss_pred -----------hhhhcccchhhhc---------Cc----------cCCCCCcHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 021526 218 -----------PFLKDQKKFVHLV---------DP----------LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 267 (311)
Q Consensus 218 -----------~~~~~~~~~~~~~---------~~----------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~l 267 (311)
............. .. ......+...+.++.+||.+||+.||.+|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 0000000000000 00 00122345678889999999999999999999999
Q ss_pred HH
Q 021526 268 VV 269 (311)
Q Consensus 268 ~~ 269 (311)
++
T Consensus 326 L~ 327 (362)
T d1q8ya_ 326 VN 327 (362)
T ss_dssp HT
T ss_pred hc
Confidence 86
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=2e-22 Score=159.68 Aligned_cols=165 Identities=11% Similarity=-0.044 Sum_probs=113.6
Q ss_pred eeeeeceeccEEEEEE-CCeEEEEEEeccCCcc------------------chhHHHHHHHHHhcCCCCcccceeEEEEe
Q 021526 3 CCYLSCKFYNVGLVWL-CDQLVAIKQLNHEGLQ------------------GHQEFIVEVLMLSLLHHDNLVTLIGYCTS 63 (311)
Q Consensus 3 ~~~~~g~~~~v~~~~~-~~~~vaiK~~~~~~~~------------------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 63 (311)
+.+|.|+||.||++.. +|+.||||++...... ......+|+..+..+.|.+++..+++.
T Consensus 6 ~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~-- 83 (191)
T d1zara2 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE-- 83 (191)
T ss_dssp EEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE--
T ss_pred CEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec--
Confidence 5799999999999998 8999999987532110 012345688888999999998887652
Q ss_pred CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecCCCCCcEEEcCCCceEEeec
Q 021526 64 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 143 (311)
Q Consensus 64 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di~p~nil~~~~~~vkl~Df 143 (311)
..+++||++++..+.+ +....+..++.|++.++++||+.| ++|+||||+|||++++ .++|+||
T Consensus 84 --~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 84 --GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp --TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCC
T ss_pred --CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEEC
Confidence 2379999998754432 222335678999999999999999 9999999999999865 5899999
Q ss_pred CCCccCCCCCCcceeeeccccccccCCccccCCCCCccccchhHHHHH
Q 021526 144 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 191 (311)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~~l 191 (311)
|.+............. ..... -.+ +-...|+.++|+||+.--+
T Consensus 147 G~a~~~~~~~~~~~l~---rd~~~-~~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWREILE---RDVRN-IIT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHHHHHH---HHHHH-HHH-HHHHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCcHHHHH---HHHHH-HHH-HHcCCCCCcccHHHHHHHH
Confidence 9986432211110000 00000 001 1124567889999986544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.66 E-value=1.1e-07 Score=77.18 Aligned_cols=129 Identities=14% Similarity=0.013 Sum_probs=91.0
Q ss_pred eccEEEEEECCeEEEEEEeccCCccchhHHHHHHHHHhcCC-CCcccceeEEEEeCCeeEEEEecCCCCCHHHHhcccCC
Q 021526 10 FYNVGLVWLCDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP 88 (311)
Q Consensus 10 ~~~v~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 88 (311)
...||....+++.+++|............+.+|...+..+. +--+.+++.+..+++..++||+++.|.++.+....
T Consensus 27 ~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~--- 103 (263)
T d1j7la_ 27 PAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED--- 103 (263)
T ss_dssp SSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT---
T ss_pred CCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc---
Confidence 35789887788888999876554445567788888887664 33366778888888899999999998877655421
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhhCC----------------------------------------------------
Q 021526 89 DQEPLSWNTRMKIAVGAARGLEYLHCKA---------------------------------------------------- 116 (311)
Q Consensus 89 ~~~~l~~~~~~~~~~~i~~~l~~Lh~~~---------------------------------------------------- 116 (311)
. .. ...++.+++..++.||+..
T Consensus 104 -~--~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 177 (263)
T d1j7la_ 104 -E--QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTE 177 (263)
T ss_dssp -C--SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHS
T ss_pred -c--cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhc
Confidence 0 01 1223445555555555321
Q ss_pred ----CCCeeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 117 ----NPPVIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 117 ----~~~i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
...++|+|+.|.||++++++.+-|+||+.+.
T Consensus 178 ~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 178 KPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 0127899999999999887666799998875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.18 E-value=5e-06 Score=66.69 Aligned_cols=122 Identities=18% Similarity=0.072 Sum_probs=79.1
Q ss_pred ccEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCCC--CcccceeEEEEeCCeeEEEEecCCCCCHHHHhcccC
Q 021526 11 YNVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHH--DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLE 87 (311)
Q Consensus 11 ~~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 87 (311)
..||.... ++..+++|..... ....+..|...++.+.. -.+.+++.+..+++..+++|++++|.++.+..
T Consensus 25 ~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~~---- 97 (255)
T d1nd4a_ 25 AAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSH---- 97 (255)
T ss_dssp CEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTSC----
T ss_pred CeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccccc----
Confidence 56888888 5667888875433 33457778887776643 23567788878888889999999875543211
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhhCC---------------------------------------------------
Q 021526 88 PDQEPLSWNTRMKIAVGAARGLEYLHCKA--------------------------------------------------- 116 (311)
Q Consensus 88 ~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~--------------------------------------------------- 116 (311)
... ...+.++...++.||...
T Consensus 98 -----~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 169 (255)
T d1nd4a_ 98 -----LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM 169 (255)
T ss_dssp -----CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred -----ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhC
Confidence 111 111223333334444211
Q ss_pred ----CCCeeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 117 ----NPPVIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 117 ----~~~i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
...++|+|+.|.||+++++..+-|+||+.+.
T Consensus 170 ~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 170 PDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1227999999999999887667899998774
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.80 E-value=5.5e-05 Score=64.65 Aligned_cols=73 Identities=12% Similarity=-0.086 Sum_probs=46.3
Q ss_pred eeeeceeccEEEEEE--CCeEEEEEEeccC------C-ccchhHHHHHHHHHhcCC--CC-cccceeEEEEeCCeeEEEE
Q 021526 4 CYLSCKFYNVGLVWL--CDQLVAIKQLNHE------G-LQGHQEFIVEVLMLSLLH--HD-NLVTLIGYCTSGDQRLLVY 71 (311)
Q Consensus 4 ~~~~g~~~~v~~~~~--~~~~vaiK~~~~~------~-~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~lv~ 71 (311)
.+|-|..-.||++.. +++.|++|.-... . +-...+...|++.|+.+. .| .+.+++.+ ++...+++|
T Consensus 33 eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lvm 110 (392)
T d2pula1 33 EIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVM 110 (392)
T ss_dssp ECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEE
T ss_pred EeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEEE
Confidence 567788888999887 5678999964321 1 123345667888887663 23 35555544 455678999
Q ss_pred ecCCCCC
Q 021526 72 EYMPMGS 78 (311)
Q Consensus 72 e~~~~~~ 78 (311)
|++.+..
T Consensus 111 E~L~~~~ 117 (392)
T d2pula1 111 EDLSHLK 117 (392)
T ss_dssp CCCTTSE
T ss_pred eccCCcc
Confidence 9997643
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.05 E-value=0.001 Score=56.49 Aligned_cols=68 Identities=16% Similarity=0.149 Sum_probs=43.4
Q ss_pred eeeceeccEEEEEEC---------CeEEEEEEeccCCccchhHHHHHHHHHhcCC-CCcccceeEEEEeCCeeEEEEecC
Q 021526 5 YLSCKFYNVGLVWLC---------DQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYM 74 (311)
Q Consensus 5 ~~~g~~~~v~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~ 74 (311)
+..|-.=.+|.+... .+.|++++... ........+|..+++.+. +.-..++++++.+ ++|++|+
T Consensus 50 l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi 123 (395)
T d1nw1a_ 50 IKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYI 123 (395)
T ss_dssp ECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCC
T ss_pred cCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEe
Confidence 333445567777762 35688888652 334456678888888775 3334577776542 6889998
Q ss_pred CCCC
Q 021526 75 PMGS 78 (311)
Q Consensus 75 ~~~~ 78 (311)
+|.+
T Consensus 124 ~g~~ 127 (395)
T d1nw1a_ 124 PSRP 127 (395)
T ss_dssp CEEE
T ss_pred cccc
Confidence 7743
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.01 E-value=0.0025 Score=52.43 Aligned_cols=65 Identities=11% Similarity=-0.022 Sum_probs=42.7
Q ss_pred cEEEEEE-CCeEEEEEEeccCCccchhHHHHHHHHHhcCCCCcc--ccee-----EEEEeCCeeEEEEecCCCC
Q 021526 12 NVGLVWL-CDQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNL--VTLI-----GYCTSGDQRLLVYEYMPMG 77 (311)
Q Consensus 12 ~v~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i--~~~~-----~~~~~~~~~~lv~e~~~~~ 77 (311)
.||++.. +|..+++|+.... ....+++..|...+..|...++ ...+ ..+..+...+.+++++.|.
T Consensus 37 ~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 37 RVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp EEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred eeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 4888888 7889999997543 3345678888888876642211 1111 2345567788899998763
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.42 E-value=0.0052 Score=50.10 Aligned_cols=28 Identities=36% Similarity=0.309 Sum_probs=25.6
Q ss_pred eeecCCCCCcEEEcCCCceEEeecCCCc
Q 021526 120 VIYRDLKSANILLDNDFNPKLSDFGLAK 147 (311)
Q Consensus 120 i~H~di~p~nil~~~~~~vkl~Df~~~~ 147 (311)
++|+|+.++|++++++...-++||+.+.
T Consensus 185 iIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 185 VIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCcchhhhhcccccceeEecccccc
Confidence 9999999999999988777899999874
|